PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Nolde, SB; Vassilevski, AA; Rogozhin, EA; Barinov, NA; Balashova, TA; Samsonova, OV; Baranov, YV; Feofanov, AV; Egorov, TA; Arseniev, AS; Grishin, EV				Nolde, Svetlana B.; Vassilevski, Alexander A.; Rogozhin, Eugene A.; Barinov, Nikolay A.; Balashova, Tamara A.; Samsonova, Olga V.; Baranov, Yuri V.; Feofanov, Alexey V.; Egorov, Tsezi A.; Arseniev, Alexander S.; Grishin, Eugene V.			Disulfide-stabilized Helical Hairpin Structure and Activity of a Novel Antifungal Peptide EcAMP1 from Seeds of Barnyard Grass (Echinochloa crus-galli)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; NMR-SPECTROSCOPY; LIPOPOLYSACCHARIDE MICELLES; HOST-DEFENSE; PLANT; PROTEINS; MOTIF; PURIFICATION; INHIBITORS; ASSIGNMENT	This study presents purification, activity characterization, and H-1 NMR study of the novel antifungal peptide EcAMP1 from kernels of barnyard grass Echinochloa crus-galli. The peptide adopts a disulfide-stabilized alpha-helical hairpin structure in aqueous solution and thus represents a novel fold among naturally occurring antimicrobial peptides. Micromolar concentrations of EcAMP1 were shown to inhibit growth of several fungal phytopathogens. Confocal microscopy revealed intensive EcAMP1 binding to the surface of fungal conidia followed by internalization and accumulation in the cytoplasm without disturbance of membrane integrity. Close spatial structure similarity between EcAMP1, the trypsin inhibitor VhTI from seeds of Veronica hederifolia, and some scorpion and cone snail toxins suggests natural elaboration of different functions on a common fold.	[Nolde, Svetlana B.; Vassilevski, Alexander A.; Rogozhin, Eugene A.; Barinov, Nikolay A.; Balashova, Tamara A.; Samsonova, Olga V.; Baranov, Yuri V.; Feofanov, Alexey V.; Egorov, Tsezi A.; Arseniev, Alexander S.; Grishin, Eugene V.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Arseniev, AS (corresponding author), Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Miklukho Maklaya 16-10, Moscow 117997, Russia.	aars@nmr.ru; grev@mx.ibch.ru	Nolde, Svetlana B/AGQ-4485-2022; Rogozhin, Eugene/E-5333-2014; Rogozhin, Eugene A/Y-9273-2019; Vassilevski, Alexander/S-3824-2016; Barinov, Nikolay/L-9357-2016; Feofanov, Alexey V/K-3082-2012	Rogozhin, Eugene/0000-0003-0659-9547; Rogozhin, Eugene A/0000-0003-0659-9547; Vassilevski, Alexander/0000-0002-1359-0076; Barinov, Nikolay/0000-0002-0512-2547; Feofanov, Alexey V/0000-0002-1596-9506; Nolde, Svetlana/0000-0001-6866-4936	Russian Foundation for Basic Research [08-04-00783, 11-04-00190]; Ministry of Education and Science of Russian Federation [16.740.11.0424]; Russian scientific schools [4821.2008.4]; Russian Academy of Sciences	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); Russian scientific schools; Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by the Russian Foundation for Basic Research (Grants 08-04-00783 and 11-04-00190), the Ministry of Education and Science of Russian Federation (State Contract 16.740.11.0424), the Russian scientific schools Grant 4821.2008.4, and the Program of Cell and Molecular Biology of the Russian Academy of Sciences.	Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0; Barnham KJ, 1997, J MOL BIOL, V268, P886, DOI 10.1006/jmbi.1997.0980; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Barthe P, 2000, PROTEIN SCI, V9, P942, DOI 10.1110/ps.9.5.942; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Benko-Iseppon AM, 2010, CURR PROTEIN PEPT SC, V11, P181, DOI 10.2174/138920310791112075; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Bhunia A, 2009, CHEM-EUR J, V15, P2036, DOI 10.1002/chem.200802635; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI [10.1111/j.1574-6968.1990.tb04174.x, 10.1016/S0378-1097(98)00477-7]; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Castro MS, 2005, PROTEIN PEPTIDE LETT, V12, P13; Chagot B, 2005, BIOCHEM J, V388, P263, DOI 10.1042/BJ20041705; Conners R, 2007, J BIOL CHEM, V282, P27760, DOI 10.1074/jbc.M703871200; Delaglio F, 2001, J MAGN RESON, V149, P276, DOI 10.1006/jmre.2001.2297; Diamond G, 2009, CURR PHARM DESIGN, V15, P2377, DOI 10.2174/138161209788682325; DUVICK JP, 1992, J BIOL CHEM, V267, P18814; Egorov TA, 2005, PEPTIDES, V26, P2064, DOI 10.1016/j.peptides.2005.03.007; Egorov TA, 1997, SPRING LAB MAN, P259; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Keller R., 2004, COMPUTER AIDED RESON, V1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Li F, 2003, PEPTIDES, V24, P799, DOI 10.1016/S0196-9781(03)00173-6; Lobo DS, 2007, BIOCHEMISTRY-US, V46, P987, DOI 10.1021/bi061441j; Lorieau JL, 2010, P NATL ACAD SCI USA, V107, P11341, DOI 10.1073/pnas.1006142107; MARCHANT R, 1966, ANN BOT-LONDON, V30, P441, DOI 10.1093/oxfordjournals.aob.a084087; Marcus JP, 1999, PLANT J, V19, P699, DOI 10.1046/j.1365-313x.1999.00569.x; Moller C, 2005, BIOCHEMISTRY-US, V44, P15986, DOI 10.1021/bi0511181; Nicastro G, 2009, PROTEIN SCI, V18, P1786, DOI 10.1002/pro.168; Odintsova TI, 2009, FEBS J, V276, P4266, DOI 10.1111/j.1742-4658.2009.07135.x; Odintsova TI, 2008, BIOCHIMIE, V90, P1667, DOI 10.1016/j.biochi.2008.06.007; Park SS, 1997, FEBS LETT, V400, P103, DOI 10.1016/S0014-5793(96)01367-1; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Porcelli F, 2004, J BIOL CHEM, V279, P45815, DOI 10.1074/jbc.M405454200; Porcelli F, 2006, BIOCHEMISTRY-US, V45, P5793, DOI 10.1021/bi0601813; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Rogozhin E A, 2009, Prikl Biokhim Mikrobiol, V45, P403; Schoffelmeer EAM, 1999, FUNGAL GENET BIOL, V27, P275, DOI 10.1006/fgbi.1999.1153; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Spelbrink RG, 2004, PLANT PHYSIOL, V135, P2055, DOI 10.1104/pp.104.040873; Srinivasan KN, 2002, J BIOL CHEM, V277, P30040, DOI 10.1074/jbc.M111258200; SZYPERSKI T, 1992, J MAGN RESON, V99, P552, DOI 10.1016/0022-2364(92)90209-P; Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200; Thevissen K, 2003, FEMS MICROBIOL LETT, V226, P169, DOI 10.1016/S0378-1097(03)00590-1; Vila-Perello M, 2005, J BIOL CHEM, V280, P1661, DOI 10.1074/jbc.M410577200; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamada K, 1999, J BIOL CHEM, V274, P2563, DOI 10.1074/jbc.274.4.2563; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	57	66	73	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25145	25153		10.1074/jbc.M110.200378	http://dx.doi.org/10.1074/jbc.M110.200378			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21561864	Green Published, hybrid			2022-12-25	WOS:000292547900062
J	Kunchithapautham, K; Rohrer, B				Kunchithapautham, Kannan; Rohrer, Baerbel			Sublytic Membrane-Attack-Complex (MAC) Activation Alters Regulated Rather than Constitutive Vascular Endothelial Growth Factor (VEGF) Secretion in Retinal Pigment Epithelium Monolayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEGRADATION; AU-RICH ELEMENTS; MACULAR DEGENERATION; OXIDATIVE-STRESS; PROTEIN-KINASE; CELL-LINE; INDUCED EXPRESSION; SERPING1 GENE; PATHWAY; RAS	Uncontrolled activation of the alternative complement pathway and secretion of vascular endothelial growth factor (VEGF) are thought to be associated with age-related macular degeneration (AMD). Previously, we have shown that in RPE monolayers, oxidative-stress reduced complement inhibition on the cell surface. The resulting increased level of sublytic complement activation resulted in VEGF release, which disrupted the barrier facility of these cells as determined by transepithelial resistance (TER) measurements. Induced rather than basal VEGF release in RPE is thought to be controlled by different mechanisms, including voltage-dependent calcium channel (VDCC) activation and mitogen-activated protein kinases. Here we examined the potential intracellular links between sublytic complement activation and VEGF release in RPE cells challenged with H2O2 and complement-sufficient normal human serum (NHS). Disruption of barrier function by H2O2 + NHS rapidly increased Ras expression and Erk and Src phosphorylation, but had no effect on P38 phosphorylation. Either treatment alone had little effect. TER reduction could be attenuated by inhibiting Ras, Erk and Src activation, or blocking VDCC or VEGF-R2 activation, but not by inhibiting P38. Combinatorial analysis of inhibitor effects demonstrated that sublytic complement activation triggers VEGF secretion via two pathways, Src and Ras-Erk, with the latter being amplified by VEGF-R2 activation, but has no effect on constitutive VEGF secretion mediated via P38. Finally, effects on TER were directly correlated with release of VEGF; and sublytic MAC activation decreased levels of zfp36, a negative modulator of VEGF transcription, resulting in increased VEGF expression. Taken together, identifying how sublytic MAC induces VEGF expression and secretion might offer opportunities to selectively inhibit pathological VEGF release only.	[Rohrer, Baerbel] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Neurosci, Div Res, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Rohrer, B (corresponding author), Med Univ S Carolina, Dept Ophthalmol, 167 Ashley Ave,SEI 511, Charleston, SC 29425 USA.	rohrer@musc.edu			National Institutes of Health [R01 EY019320, C06 RR015455]; Dept. of Veterans Affairs, Foundation Fighting Blindness [I01 RX000444]; Research to Prevent Blindness, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019320] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Veterans Affairs, Foundation Fighting Blindness(US Department of Veterans Affairs); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by Grant R01 EY019320 from the National Institutes of Health, Grant I01 RX000444 from the Dept. of Veterans Affairs, Foundation Fighting Blindness, and an unrestricted grant to Medical University of South Carolina from Research to Prevent Blindness, Inc.; We thank Joshua Thurman (University of Colorado Denver School of Medicine, Denver, CO) for helpful discussions and Luanna Bartholomew for critical review (Medical University of South Carolina, Charleston, SC). Animal studies were conducted in a facility constructed with support from the National Institutes of Health (C06 RR015455).	Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Augustin AJ, 2009, CLIN OPHTHALMOL, V3, P175; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bhutto IA, 2006, EXP EYE RES, V82, P99, DOI 10.1016/j.exer.2005.05.007; Bohana-Kashtan O, 2004, MOL IMMUNOL, V41, P583, DOI 10.1016/j.molimm.2004.04.007; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Caparros E, 2006, BLOOD, V107, P3950, DOI 10.1182/blood-2005-03-1252; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen YW, 2007, EUR J IMMUNOL, V37, P167, DOI 10.1002/eji.200636285; CHOI NH, 1990, INT IMMUNOL, V2, P413, DOI 10.1093/intimm/2.5.413; Chong NHV, 2005, AM J PATHOL, V166, P241, DOI 10.1016/S0002-9440(10)62248-1; Choudhary S, 2005, TOXICOL APPL PHARM, V204, P122, DOI 10.1016/j.taap.2004.08.023; Dunn KC, 1998, INVEST OPHTH VIS SCI, V39, P2744; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Edwards MG, 2003, PHYSIOL GENOMICS, V13, P119, DOI 10.1152/physiolgenomics.00172.2002; Ennis S, 2008, LANCET, V372, P1828, DOI 10.1016/S0140-6736(08)61348-3; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Fearon DT, 1998, SEMIN IMMUNOL, V10, P355, DOI 10.1006/smim.1998.0137; Fehrenbach H, 1999, ANAT REC, V254, P61; Finnegan S, 2010, EUR J NEUROSCI, V32, P322, DOI 10.1111/j.1460-9568.2010.07301.x; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Holers VM, 2003, CLIN IMMUNOL, V107, P140, DOI 10.1016/S1521-6616(03)00034-2; Holers VM, 2000, IMMUNOPHARMACOLOGY, V49, P125, DOI 10.1016/S0162-3109(00)80298-2; Ito S, 2006, ONCOGENE, V25, P2420, DOI 10.1038/sj.onc.1209263; JACKSON MB, 1981, P NATL ACAD SCI-BIOL, V78, P6421, DOI 10.1073/pnas.78.10.6421; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kannan R, 2006, MOL VIS, V12, P1649; Kijlstra A, 2005, OCUL IMMUNOL INFLAMM, V13, P3, DOI 10.1080/09273940590909185; Klagsbrun Michael, 1996, Cytokine and Growth Factor Reviews, V7, P259, DOI 10.1016/S1359-6101(96)00027-5; Klettner A, 2009, GRAEF ARCH CLIN EXP, V247, P1487, DOI 10.1007/s00417-009-1139-x; Lai WS, 1998, J BIOL CHEM, V273, P506, DOI 10.1074/jbc.273.1.506; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; Lommatzsch A, 2008, GRAEF ARCH CLIN EXP, V246, P803, DOI 10.1007/s00417-007-0749-4; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P3248, DOI 10.1073/pnas.070049497; Moskovich O, 2007, J BIOL CHEM, V282, P29977, DOI 10.1074/jbc.M703742200; NICHOLSONWELLER A, 1993, IMMUNOL RES, V12, P244, DOI 10.1007/BF02918256; Ohno-Matsui K, 2001, J CELL PHYSIOL, V189, P323, DOI 10.1002/jcp.10026; Park KH, 2009, MOL VIS, V15, P200; Peng HW, 2002, J IMMUNOL, V169, P2594, DOI 10.4049/jimmunol.169.5.2594; PODACK ER, 1984, ACTA PATH MICRO IM C, V92, P89; PODACK ER, 1984, MOL IMMUNOL, V21, P589, DOI 10.1016/0161-5890(84)90044-0; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rohrer B, 2009, INVEST OPHTH VIS SCI, V50, P3056, DOI 10.1167/iovs.08-2222; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Rosenthal R, 2007, MOL VIS, V13, P443; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Sala-Newby GB, 1998, IMMUNOLOGY, V93, P601; Samuel W, 2008, J NEUROCHEM, V106, P591, DOI 10.1111/j.1471-4159.2008.05409.x; SARMA JV, 2010, CELL TISSUE RES; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Schneider-Merck T, 2009, EUR J CANCER, V45, P2050, DOI 10.1016/j.ejca.2009.04.014; SCOLDING NJ, 1989, NATURE, V339, P620, DOI 10.1038/339620a0; SNODDERLY DM, 1995, AM J CLIN NUTR, V62, P1448; STEPHENS CL, 1979, J IMMUNOL, V122, P455; Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; van Wijngaarden P, 2008, CLIN EXP OPTOM, V91, P427, DOI 10.1111/j.1444-0938.2008.00305.x; WOOD A, 1993, J NEUROSCI, V13, P3319; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Yun HY, 1999, DIABETES RES CLIN PR, V45, P113, DOI 10.1016/S0168-8227(99)00039-X; Zerbib J, 2010, MOL VIS, V16, P1324	73	56	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23717	23724		10.1074/jbc.M110.214593	http://dx.doi.org/10.1074/jbc.M110.214593			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566137	Green Published, hybrid			2022-12-25	WOS:000292294900013
J	Han, WN; Ming, M; He, YY				Han, Weinong; Ming, Mei; He, Yu-Ying			Caffeine Promotes Ultraviolet B-induced Apoptosis in Human Keratinocytes without Complete DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; UVB-INDUCED APOPTOSIS; HUMAN-SKIN FIBROBLASTS; ATAXIA-TELANGIECTASIA; PROTEIN-KINASE; CYCLOOXYGENASE-2 EXPRESSION; XERODERMA-PIGMENTOSUM; IONIZING-RADIATION; CELL-PROLIFERATION; GENOME MAINTENANCE	In response to ultraviolet B damage, keratinocytes undergo apoptosis to eliminate damaged cells, thereby preventing tumorigenic transformation. Caffeine, the most widely consumed psychoactive substance, produces complex pharmacological actions; it has been shown to be chemopreventive in non-melamona skin cancer in mice through increasing apoptosis. Here we have investigated the molecular and cellular mechanisms in the pro-apoptotic effect of caffeine on UVB-irradiated human HaCaT keratinocytes. Pretreatment with caffeine increased UVB-induced apoptosis in HaCaT cells. Caffeine blocked UVB-induced Chk1 phosphorylation. In addition, similar to the effect of the PI3K inhibitor LY294002, caffeine also inhibited phosphorylation of AKT and up-regulation of COX-2, two critical oncogenic pathways in skin tumorigenesis. However, phosphorylation of EGFR or ERK was unaffected. Inhibiting ATR pathways by siRNA targeting ATR had little effect on UVB-induced apoptosis or AKT activation, indicating that the inhibitory effect of caffeine on apoptosis and the AKT pathway does not require the ATR pathway. Inhibiting AKT by caffeine blocked UVB-induced COX-2 up-regulation. Expression of constitutively active AKT that was not inhibited by caffeine was found to protect cells from caffeine-promoted apoptosis post-UVB irradiation, indicating that AKT is an essential inhibitory target for caffeine to promote apoptosis. Caffeine specifically sensitized cells with unrepaired DNA damage to UVB-induced apoptosis. These findings indicate that in HaCaT keratinocytes, inhibiting the AKT/COX-2 pathways through an ATR-independent pathway is a critical molecular mechanism by which caffeine promotes UVB-induced apoptosis of unrepaired keratinocytes for elimination.	[Han, Weinong; Ming, Mei; He, Yu-Ying] Univ Chicago, Dept Med, Dermatol Sect, Chicago, IL 60637 USA	University of Chicago	He, YY (corresponding author), Univ Chicago, Dept Med, Dermatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yyhe@medicine.bsd.uchicago.edu			National Institutes of Health [ES016936]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES016936 (to Y.-Y. H.). Further support was provided by UC Friends of Dermatology Research Funds.	Ahn JY, 2000, CANCER RES, V60, P5934; An KP, 2002, PHOTOCHEM PHOTOBIOL, V76, P73, DOI 10.1562/0031-8655(2002)076<0073:CEIMAH>2.0.CO;2; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; BODE AM, 2003, SCI STKE, pRE2; Bowden GT, 2004, NAT REV CANCER, V4, P23, DOI 10.1038/nrc1253; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Buckman SY, 1998, CARCINOGENESIS, V19, P723, DOI 10.1093/carcin/19.5.723; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chun KS, 2007, CANCER RES, V67, P2015, DOI 10.1158/0008-5472.CAN-06-3617; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Cortez D, 2003, J BIOL CHEM, V278, P37139, DOI 10.1074/jbc.M307088200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; de Gruijl FR, 2002, EXP DERMATOL, V11, P37, DOI 10.1034/j.1600-0625.11.s.1.9.x; de Gruijl FR, 2008, PHOTOCHEM PHOTOBIOL, V84, P382, DOI 10.1111/j.1751-1097.2007.00275.x; Fiebich BL, 2000, NEUROPHARMACOLOGY, V39, P2205, DOI 10.1016/S0028-3908(00)00045-9; Fischer SM, 2007, MOL CARCINOGEN, V46, P363, DOI 10.1002/mc.20284; Foukas LC, 2002, J BIOL CHEM, V277, P37124, DOI 10.1074/jbc.M202101200; Han WN, 2010, J BIOL CHEM, V285, P11369, DOI 10.1074/jbc.M109.028142; Hannan MA, 2002, CARCINOGENESIS, V23, P1617, DOI 10.1093/carcin/23.10.1617; Hashimoto T, 2004, CANCER RES, V64, P3344, DOI 10.1158/0008-5472.CAN-03-3453; He YY, 2006, ONCOGENE, V25, P3680, DOI 10.1038/sj.onc.1209384; He ZW, 2003, CANCER RES, V63, P4396; Heffernan TP, 2009, J INVEST DERMATOL, V129, P1805, DOI 10.1038/jid.2008.435; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Johnson TM, 1998, J AM ACAD DERMATOL, V38, P681, DOI 10.1016/S0190-9622(98)70196-3; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Lawlor MA, 2001, J CELL SCI, V114, P2903; Ling G, 2001, AM J PATHOL, V159, P1247, DOI 10.1016/S0002-9440(10)62511-4; Liu QH, 2000, GENE DEV, V14, P1448; Lu YP, 2008, CANCER RES, V68, P2523, DOI 10.1158/0008-5472.CAN-07-5955; Lu YP, 2007, CARCINOGENESIS, V28, P199, DOI 10.1093/carcin/bgl112; Lu YP, 2004, CANCER RES, V64, P5020, DOI 10.1158/0008-5472.CAN-04-0760; Lu YP, 2002, P NATL ACAD SCI USA, V99, P12455, DOI 10.1073/pnas.182429899; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Menoyo A, 2001, CANCER RES, V61, P7727; Ming M, 2010, ONCOGENE, V29, P492, DOI 10.1038/onc.2009.357; Ming M, 2010, P NATL ACAD SCI USA, V107, P22623, DOI 10.1073/pnas.1010377108; Nakagawa A, 1998, J INVEST DERMATOL, V110, P143, DOI 10.1046/j.1523-1747.1998.00100.x; NAKAZAWA H, 1994, P NATL ACAD SCI USA, V91, P360, DOI 10.1073/pnas.91.1.360; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; NIGGLI HJ, 1988, J INVEST DERMATOL, V91, P579, DOI 10.1111/1523-1747.ep12477095; Nomura M, 2005, MOL CARCINOGEN, V44, P67, DOI 10.1002/mc.20120; Pentland AP, 1999, CARCINOGENESIS, V20, P1939, DOI 10.1093/carcin/20.10.1939; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; SELBY CP, 1990, P NATL ACAD SCI USA, V87, P3522, DOI 10.1073/pnas.87.9.3522; Sinn B, 2010, MOL CANCER THER, V9, P480, DOI 10.1158/1535-7163.MCT-09-0498; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; Tang QB, 2001, CANCER RES, V61, P4329; Tiano HF, 2002, CANCER RES, V62, P3395; VINK AA, 1991, CARCINOGENESIS, V12, P861, DOI 10.1093/carcin/12.5.861; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	59	45	45	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22825	22832		10.1074/jbc.M111.222349	http://dx.doi.org/10.1074/jbc.M111.222349			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561856	Green Published, hybrid			2022-12-25	WOS:000292025000017
J	Keshwani, MM; von Daake, S; Newton, AC; Harris, TK; Taylor, SS				Keshwani, Malik M.; von Daake, Sventja; Newton, Alexandra C.; Harris, Thomas K.; Taylor, Susan S.			Hydrophobic Motif Phosphorylation Is Not Required for Activation Loop Phosphorylation of p70 Ribosomal Protein S6 Kinase 1 (S6K1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGC KINASES; IN-VIVO; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; BINDING POCKET; PDK1; DOMAIN; P70(S6K); SITE; MECHANISM	p70 ribosomal protein S6 kinase 1 (S6K1) is regulated by multiple phosphorylation events. Three of these sites are highly conserved among AGC kinases (cAMP dependent Protein Kinase, cGMP dependent Protein Kinase, and Protein Kinase C subfamily): the activation loop in the kinase domain, and two C-terminal sites, the turn motif and the hydrophobic motif. The common dogma has been that phosphorylation of the hydrophobic motif primes S6K1 for the phosphorylation at the activation loop by phosphoinositide-dependent protein kinase 1 (PDK1). Here, we show that the turn motif is, in fact, phosphorylated first, the activation loop second, and the hydrophobic motif is third. Specifically, biochemical analyses of a construct of S6K1 lacking the C-terminal autoinhibitory domain as well as full-length S6K1, reveals that S6K1 is constitutively phosphorylated at the turn motif when expressed in insect cells and becomes phosphorylated in vitro by purified PDK1 at the activation loop. Only the species phosphorylated at the activation loop by PDK1 gets phosphorylated at the hydrophobic motif by mammalian target of rapamycin (mTOR) in vitro. These data are consistent with a previous model in which constitutive phosphorylation of the turn motif provides the key priming step in the phosphorylation of S6K1. The data provide evidence for regulation of S6K1, where hydrophobic motif phosphorylation is not required for PDK1 to phosphorylate S6K1 at the activation loop, but instead activation loop phosphorylation of S6K1 is required for mTOR to phosphorylate the hydrophobic motif of S6K1.	[von Daake, Sventja; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Keshwani, Malik M.; Newton, Alexandra C.; Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Keshwani, Malik M.; Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Harris, Thomas K.] Univ Miami, Dept Biochem & Mol Biol, Miami, FL 33136 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Miami	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	staylor@ucsd.edu			National Institutes of Health through the NIDDK [19301, DK054441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019301] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported, in whole or in part, by National Institutes of Health Grants 19301 (to S. S. T.) and DK054441 through the NIDDK (to S. S. T. and A. C. N.).	Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; FERRARI S, 1993, J BIOL CHEM, V268, P16091; FERRARI S, 1992, P NATL ACAD SCI USA, V89, P7282, DOI 10.1073/pnas.89.15.7282; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Keshwani MM, 2008, PROTEIN EXPRES PURIF, V58, P32, DOI 10.1016/j.pep.2007.11.003; Keshwani MM, 2009, J BIOL CHEM, V284, P22611, DOI 10.1074/jbc.M109.032177; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Moser BA, 1997, MOL CELL BIOL, V17, P5648, DOI 10.1128/MCB.17.9.5648; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Romanelli A, 2002, J BIOL CHEM, V277, P40281, DOI 10.1074/jbc.M205168200; Romano RA, 2009, PROTEIN SCI, V18, P1486, DOI 10.1002/pro.146; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3	37	34	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23552	23558		10.1074/jbc.M111.258004	http://dx.doi.org/10.1074/jbc.M111.258004			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561857	hybrid, Green Published			2022-12-25	WOS:000292025000085
J	Ujvari, A; Pal, M; Luse, DS				Ujvari, Andrea; Pal, Mahadeb; Luse, Donal S.			The Functions of TFIIF during Initiation and Transcript Elongation Are Differentially Affected by Phosphorylation by Casein Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TERMINAL DOMAIN PHOSPHATASE; START SITE UTILIZATION; SACCHAROMYCES-CEREVISIAE; RAP74 SUBUNIT; PREINITIATION COMPLEX; HUMAN-CELLS; CK2; BINDING; TRANSITION	The RNA polymerase II (pol II) initiation and elongation factor elongation factor TFIIF can be extensively phosphorylated in vivo, although the significance of this modification has not been clear. We now show that phosphorylation of recombinant TFIIF by casein kinase 2 (CK2) reduces or eliminates some of the functions of TFIIF while paradoxically leaving others intact. Phospho-IIF is fully functional in binding to free pol II and is able to support the initiation of transcription. However, the phosphorylated factor does not bind to stalled elongation complexes as measured in a gel mobility shift assay. Significantly, phosphorylation strongly reduces (or for some truncated versions of RAP74, eliminates) stimulation of transcript elongation by TFIIF. Thus, although TFIIF must participate at the initiation of transcription, its ability to continue its association with pol II and stimulate transcript elongation can be specifically regulated by CK2. This is particularly interesting because CK2 is required for initiation at a subset of pol II promoters. Modulation of TFIIF function could be important in controlling promoter-proximal pausing by pol II during the early stage of transcript elongation.	[Ujvari, Andrea; Pal, Mahadeb; Luse, Donal S.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Luse, DS (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Genet, 9500 Euclid Ave,NE20, Cleveland, OH 44195 USA.	lused@ccf.org			National Institute of General Medical Sciences [GM 29487]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029487] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service grant GM 29487 from the National Institute of General Medical Sciences (to D. S. L.).	Bierhoff H, 2008, MOL CELL BIOL, V28, P4988, DOI 10.1128/MCB.00492-08; BURTON ZF, 1988, MOL CELL BIOL, V8, P1602, DOI 10.1128/MCB.8.4.1602; Cabrejos ME, 2004, J CELL BIOCHEM, V93, P2, DOI 10.1002/jcb.20209; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Cheng B, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn630; Cojocaru M, 2008, BIOCHEM J, V409, P139, DOI 10.1042/BJ20070751; CONAWAY JW, 1990, SCIENCE, V248, P1550, DOI 10.1126/science.2193400; Egyhazi E, 1999, MOL CELL BIOCHEM, V191, P149; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; FLORES O, 1989, J BIOL CHEM, V264, P8913; Freire-Picos MA, 2005, NUCLEIC ACIDS RES, V33, P5045, DOI 10.1093/nar/gki825; Friedl EM, 2003, P NATL ACAD SCI USA, V100, P2328, DOI 10.1073/pnas.2628049100; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; Ghazy MA, 2004, MOL CELL BIOL, V24, P10975, DOI 10.1128/MCB.24.24.10975-10985.2004; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hu P, 2003, MOL CELL, V12, P699, DOI 10.1016/j.molcel.2003.08.011; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Johnston IM, 2002, MOL CELL BIOL, V22, P3757, DOI 10.1128/MCB.22.11.3757-3768.2002; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; Kamada K, 2001, P NATL ACAD SCI USA, V98, P3115, DOI 10.1073/pnas.051631098; KEPHART DD, 1994, J BIOL CHEM, V269, P13536; Khaperskyy DA, 2008, MOL CELL BIOL, V28, P3757, DOI 10.1128/MCB.02272-07; KITAJIMA S, 1994, J BIOL CHEM, V269, P29970; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Lei L, 1999, MOL CELL BIOL, V19, P8372; Lei L, 1998, MOL CELL BIOL, V18, P2130, DOI 10.1128/MCB.18.4.2130; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; Luse DS, 2011, J BIOL CHEM, V286, P6040, DOI 10.1074/jbc.M110.174722; Majovski RC, 2005, J BIOL CHEM, V280, P34917, DOI 10.1074/jbc.M502932200; Maldonado E, 1996, METHOD ENZYMOL, V274, P72; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Pal M, 2003, P NATL ACAD SCI USA, V100, P5700, DOI 10.1073/pnas.1037057100; Palancade B, 2002, J BIOL CHEM, V277, P36061, DOI 10.1074/jbc.M205192200; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; Rossignol M, 1999, J BIOL CHEM, V274, P22387, DOI 10.1074/jbc.274.32.22387; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; SOPTA M, 1985, J BIOL CHEM, V260, P353; SUN ZW, 1995, P NATL ACAD SCI USA, V92, P3127, DOI 10.1073/pnas.92.8.3127; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; WANG BQ, 1995, J BIOL CHEM, V270, P27035, DOI 10.1074/jbc.270.45.27035; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; YONAHA M, 1993, NUCLEIC ACIDS RES, V21, P273, DOI 10.1093/nar/21.2.273; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479; Zhang CF, 2005, MOL CELL BIOL, V25, P3583, DOI 10.1128/MCB.25.9.3583-3595.2005	52	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23160	23167		10.1074/jbc.M110.205658	http://dx.doi.org/10.1074/jbc.M110.205658			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21566144	Green Published, hybrid			2022-12-25	WOS:000292025000050
J	Liu, SF; Chu, J; Yucer, N; Leng, M; Wang, SY; Chen, BPC; Hittelman, WN; Wang, Y				Liu, Shangfeng; Chu, Jessica; Yucer, Nur; Leng, Mei; Wang, Shih-Ya; Chen, Benjamin P. C.; Hittelman, Walter N.; Wang, Yi			RING Finger and WD Repeat Domain 3 (RFWD3) Associates with Replication Protein A (RPA) and Facilitates RPA-mediated DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; IONIZING-RADIATION; BINDING PROTEIN; P34 SUBUNIT; HOMOLOGOUS RECOMBINATION; INDUCED PHOSPHORYLATION; GENOME INTEGRITY; NUCLEAR-BODIES; 32-KDA SUBUNIT; BREAK REPAIR	DNA damage response is crucial for maintaining genomic integrity and preventing cancer by coordinating the activation of checkpoints and the repair of damaged DNA. Central to DNA damage response are the two checkpoint kinases ATM and ATR that phosphorylate a wide range of substrates. RING finger and WD repeat domain 3 (RFWD3) was initially identified as a substrate of ATM/ATR from a proteomic screen. Subsequent studies showed that RFWD3 is an E3 ubiquitin ligase that ubiquitinates p53 in vitro and positively regulates p53 levels in response to DNA damage. We report here that RFWD3 associates with replication protein A (RPA), a single-stranded DNA-binding protein that plays essential roles in DNA replication, recombination, and repair. Binding of RPA to single-stranded DNA (ssDNA), which is generated by DNA damage and repair, is essential for the recruitment of DNA repair factors to damaged sites and the activation of checkpoint signaling. We show that RFWD3 is physically associated with RPA and rapidly localizes to sites of DNA damage in a RPA-dependent manner. In vitro experiments suggest that the C terminus of RFWD3, which encompass the coiled-coil domain and the WD40 domain, is necessary for binding to RPA. Furthermore, DNA damage-induced phosphorylation of RPA and RFWD3 is dependent upon each other. Consequently, loss of RFWD3 results in the persistent foci of DNA damage marker gamma H2AX and the repair protein Rad51 in damaged cells. These findings suggest that RFWD3 is recruited to sites of DNA damage and facilitates RPA-mediated DNA damage signaling and repair.	[Liu, Shangfeng; Chu, Jessica; Yucer, Nur; Wang, Yi] Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Leng, Mei; Wang, Yi] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Wang, Shih-Ya; Chen, Benjamin P. C.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Hittelman, Walter N.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Wang, Y (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.	yiw@bcm.edu			National Institutes of Health [GM080703]; McLean Foundation at Baylor College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McLean Foundation at Baylor College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080703 (to Y. W.). This work was also supported by McLean Foundation at Baylor College of Medicine (to Y. W.).	Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Barr SM, 2003, CURR BIOL, V13, P1047, DOI 10.1016/S0960-9822(03)00376-2; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Binz SK, 2003, J BIOL CHEM, V278, P35584, DOI 10.1074/jbc.M305388200; Block WD, 2004, NUCLEIC ACIDS RES, V32, P997, DOI 10.1093/nar/gkh265; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Bouquet F, 2006, CELL CYCLE, V5, P1116, DOI 10.4161/cc.5.10.2799; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Feng JJ, 2009, MOL CELL BIOL, V29, P5696, DOI 10.1128/MCB.00191-09; Fu XY, 2010, P NATL ACAD SCI USA, V107, P4579, DOI 10.1073/pnas.0912094107; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P24203; Jackson D, 2002, J MOL BIOL, V321, P133, DOI 10.1016/S0022-2836(02)00541-7; Lee DH, 2010, NAT STRUCT MOL BIOL, V17, P365, DOI 10.1038/nsmb.1769; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Niu HW, 1997, J BIOL CHEM, V272, P12634, DOI 10.1074/jbc.272.19.12634; Nuss JE, 2005, BIOCHEMISTRY-US, V44, P8428, DOI 10.1021/bi0480584; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; PAN ZQ, 1994, P NATL ACAD SCI USA, V91, P8343, DOI 10.1073/pnas.91.18.8343; Postow L, 2009, J BIOL CHEM, V284, P35951, DOI 10.1074/jbc.M109.048330; Richard DJ, 2009, CRIT REV BIOCHEM MOL, V44, P98, DOI 10.1080/10409230902849180; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Shi W, 2010, CARCINOGENESIS, V31, P994, DOI 10.1093/carcin/bgq035; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sleeth KM, 2007, J MOL BIOL, V373, P38, DOI 10.1016/j.jmb.2007.07.068; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Stephan H, 2009, NUCLEIC ACIDS RES, V37, P6028, DOI 10.1093/nar/gkp605; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wong JMS, 2003, ONCOGENE, V22, P28, DOI 10.1038/sj.onc.1206071; Wu X, 2005, BIOCHEM J, V391, P473, DOI 10.1042/BJ20050379; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yuan SSF, 1999, CANCER RES, V59, P3547; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509; ZernikKobak M, 1997, J BIOL CHEM, V272, P23896, DOI 10.1074/jbc.272.38.23896; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	54	47	50	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22314	22322		10.1074/jbc.M111.222802	http://dx.doi.org/10.1074/jbc.M111.222802			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21558276	Green Published, hybrid			2022-12-25	WOS:000291719900040
J	Prescott, J; Kraft, P; Chasman, DI; Savage, SA; Mirabello, L; Berndt, SI; Weissfeld, JL; Han, JL; Hayes, RB; Chanock, SJ; Hunter, DJ; De Vivo, I				Prescott, Jennifer; Kraft, Peter; Chasman, Daniel I.; Savage, Sharon A.; Mirabello, Lisa; Berndt, Sonja I.; Weissfeld, Joel L.; Han, Jiali; Hayes, Richard B.; Chanock, Stephen J.; Hunter, David J.; De Vivo, Immaculata			Genome-Wide Association Study of Relative Telomere Length	PLOS ONE			English	Article							LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; CIGARETTE-SMOKING; PATERNAL AGE; SEQUENCE VARIANTS; GENETIC-VARIATION; WOMENS HEALTH; RISK; CANCER	Telomere function is essential to maintaining the physical integrity of linear chromosomes and healthy human aging. The probability of forming proper telomere structures depends on the length of the telomeric DNA tract. We attempted to identify common genetic variants associated with log relative telomere length using genome-wide genotyping data on 3,554 individuals from the Nurses' Health Study and the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial that took part in the National Cancer Institute Cancer Genetic Markers of Susceptibility initiative for breast and prostate cancer. After genotyping 64 independent SNPs selected for replication in additional Nurses' Health Study and Women's Genome Health Study participants, we did not identify genome-wide significant loci; however, we replicated the inverse association of log relative telomere length with the minor allele variant [C] of rs16847897 at the TERC locus (per allele beta = -0.03, P = 0.003) identified by a previous genome-wide association study. We did not find evidence for an association with variants at the OBFC1 locus or other loci reported to be associated with telomere length. With this sample size we had > 80% power to detect beta estimates as small as +/- 0.10 for SNPs with minor allele frequencies of >= 0.15 at genome-wide significance. However, power is greatly reduced for beta estimates smaller than +/- 0.10, such as those for variants at the TERC locus. In general, common genetic variants associated with telomere length homeostasis have been difficult to detect. Potential biological and technical issues are discussed.	[Prescott, Jennifer; Han, Jiali; Hunter, David J.; De Vivo, Immaculata] Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp,Dept Med, Boston, MA 02115 USA; [Prescott, Jennifer; Kraft, Peter; Han, Jiali; Hunter, David J.; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Chasman, Daniel I.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02115 USA; [Savage, Sharon A.; Mirabello, Lisa; Berndt, Sonja I.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, NIH, Bethesda, MD 20892 USA; [Weissfeld, Joel L.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Han, Jiali] Harvard Univ, Sch Med, Dept Dermatol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Hayes, Richard B.] NYU Med Ctr, Div Epidemiol, New York, NY 10016 USA; [Hunter, David J.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School; New York University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Prescott, J (corresponding author), Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp,Dept Med, Boston, MA 02115 USA.	devivo@channing.harvard.edu	Savage, Sharon A/B-9747-2015; Savage, Sharon/AAB-5160-2019; Berndt, Sonja I/J-8423-2016; Mirabello, Lisa/H-5594-2018	Savage, Sharon A/0000-0001-6006-0740; Savage, Sharon/0000-0001-6006-0740; Hayes, Richard/0000-0002-0918-661X; De Vivo, Immaculata/0000-0002-7185-7402	National Institutes of Health (NIH) [CA49449, CA87969, CA065725, CA133914, U01-CA98233, T32 CA 09001]; National Cancer Institute [CA047988]; Amgen; National Heart, Lung, and Blood Institute [HL043851, HL69757]; Donald W. Reynolds Foundation; Leducq Foundation; NATIONAL CANCER INSTITUTE [T32CA009001, P01CA087969, U01CA049449, R01CA047988, R01CA065725, ZIACP010201, R01CA049449, R03CA133914, U01CA098233] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757, R01HL043851, U19HL069757] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Amgen(Amgen); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Donald W. Reynolds Foundation; Leducq Foundation(Leducq Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The NHS was supported by National Institutes of Health (NIH) grants CA49449, CA87969, CA065725, CA133914, and U01-CA98233. Dr. Prescott was supported by NIH training grant T32 CA 09001. The PLCO and work of Drs. Mirabello, Berndt, Hayes, Chanock, and Savage was supported by the Intramural Research Program of the National Institutes of Health and the National Cancer Institute. Primary financial support for the WGHS genome-wide scans was provided by Amgen, with additional financial support provided by the National Heart, Lung, and Blood Institute (HL043851 and HL69757), National Cancer Institute (CA047988), the Donald W. Reynolds Foundation, and the Leducq Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkad A, 2006, BJOG-INT J OBSTET GY, V113, P318, DOI 10.1111/j.1471-0528.2005.00839.x; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Britt-Compton B, 2006, HUM MOL GENET, V15, P725, DOI 10.1093/hmg/ddi486; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Butler MG, 1998, CANCER GENET CYTOGEN, V105, P138, DOI 10.1016/S0165-4608(98)00029-6; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Collerton J, 2007, EUR HEART J, V28, P172, DOI 10.1093/eurheartj/ehl437; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; De Meyer T, 2007, HUM MOL GENET, V16, P3097, DOI 10.1093/hmg/ddm271; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Epel ES, 2009, AGING-US, V1, P81; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; Garcia CK, 2007, NUCLEIC ACIDS RES, V35, P7406, DOI 10.1093/nar/gkm644; Gatbonton T, 2006, PLOS GENET, V2, P304, DOI 10.1371/journal.pgen.0020035; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Goldman F, 2005, P NATL ACAD SCI USA, V102, P17119, DOI 10.1073/pnas.0505318102; Graakjaer J, 2006, HUM GENET, V119, P344, DOI 10.1007/s00439-006-0137-x; Graakjaer J, 2003, MECH AGEING DEV, V124, P629, DOI 10.1016/S0047-6374(03)00081-2; Greider CW, 1999, CELL, V97, P419, DOI 10.1016/S0092-8674(00)80750-3; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Hosgood HD, 2009, LUNG CANCER, V66, P157, DOI 10.1016/j.lungcan.2009.02.005; Huda N, 2007, AGING CELL, V6, P709, DOI 10.1111/j.1474-9726.2007.00330.x; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Iwama H, 1998, HUM GENET, V102, P397, DOI 10.1007/s004390050711; Jang JS, 2008, CANCER SCI, V99, P1385, DOI 10.1111/j.1349-7006.2008.00831.x; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Kimura M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040037; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kyo S, 1997, CANCER RES, V57, P610; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Li MY, 2008, EUR J HUM GENET, V16, P635, DOI 10.1038/sj.ejhg.5202007; Lin KW, 2005, J CELL MOL MED, V9, P977, DOI 10.1111/j.1582-4934.2005.tb00395.x; Londono-Vallejo JA, 2001, NUCLEIC ACIDS RES, V29, P3164, DOI 10.1093/nar/29.15.3164; Mangino M, 2009, J MED GENET, V46, P451, DOI 10.1136/jmg.2008.064956; Mangino M, 2008, HUM MOL GENET, V17, P2518, DOI 10.1093/hmg/ddn152; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; MIRABELLO L, 2010, HUM MUTAT; Mirabello L, 2010, CANCER CAUSE CONTROL, V21, P77, DOI 10.1007/s10552-009-9436-6; Mirabello L, 2009, AGING CELL, V8, P405, DOI 10.1111/j.1474-9726.2009.00485.x; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Nettleton JA, 2008, AM J CLIN NUTR, V88, P1405, DOI 10.3945/ajcn.2008.26429; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Nordfjall K, 2005, P NATL ACAD SCI USA, V102, P16374, DOI 10.1073/pnas.0501724102; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; Nordfjall K, 2010, EUR J HUM GENET, V18, P385, DOI 10.1038/ejhg.2009.178; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; PRESCOTT J, 2010, CANCER; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Savage SA, 2005, HUM MUTAT, V26, P343, DOI 10.1002/humu.20226; Savage SA, 2009, HEMATOL ONCOL CLIN N, V23, P215, DOI 10.1016/j.hoc.2009.01.003; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Unryn BM, 2005, AGING CELL, V4, P97, DOI 10.1111/j.1474-9728.2005.00144.x; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Varadi V, 2009, EUR J CANCER, V45, P3008, DOI 10.1016/j.ejca.2009.08.012; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Wan M, 2009, J BIOL CHEM, V284, P26725, DOI 10.1074/jbc.M109.021105; Willeit P, 2010, ARTERIOSCL THROM VAS, V30, P1649, DOI 10.1161/ATVBAHA.110.205492; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Yasumoto S, 1996, ONCOGENE, V13, P433; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Youngren K, 1998, HUM GENET, V102, P640, DOI 10.1007/s004390050755; Zee RYL, 2009, CLIN CHIM ACTA, V403, P139, DOI 10.1016/j.cca.2009.02.004	108	81	83	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19635	10.1371/journal.pone.0019635	http://dx.doi.org/10.1371/journal.pone.0019635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573004	Green Published, Green Accepted, gold			2022-12-25	WOS:000290440200017
J	Stoddart, ES; Senadheera, S; MacDougall, IJA; Griffith, R; Finch, AM				Stoddart, Emily S.; Senadheera, Sevvandi; MacDougall, Iain J. A.; Griffith, Renate; Finch, Angela M.			A Novel Structural Framework for alpha(1A/D)-Adrenoceptor Selective Antagonists Identified Using Subtype Selective Pharmacophores	PLOS ONE			English	Article							ARYLPIPERAZINE DERIVATIVES; BIOLOGICAL EVALUATION; LIGAND DESIGN; ALPHA(1)-ADRENOCEPTOR; RECEPTOR; MODEL; AFFINITY; VALIDATION; DEFICIENT; RESPONSES	In this study four and five-feature pharmacophores for selective antagonists at each of the three alpha(1)-adrenoceptor (AR) subtypes were used to identify novel alpha(1)-AR subtype selective compounds in the National Cancer Institute and Tripos LeadQuest databases. 12 compounds were selected, based on diversity of structure, predicted high affinity and selectivity at the alpha(1D)-subtype compared to alpha(1A)- and alpha(1B)-ARs. 9 out of 12 of the tested compounds displayed affinity at the alpha(1A) and alpha(1D)-AR subtypes and 6 displayed affinity at all three a1-AR subtypes, no alpha(1B)-AR selective compounds were identified. 8 of the 9 compounds with alpha(1)-AR affinity were antagonists and one compound displayed partial agonist characteristics. This virtual screening has successfully identified an alpha(1A/D)-AR selective antagonist, with low mu M affinity with a novel structural scaffold of a an isoquinoline fused three-ring system and good lead-like qualities ideal for further drug development.	[Stoddart, Emily S.; Senadheera, Sevvandi; Griffith, Renate; Finch, Angela M.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Kensington, NSW 2033, Australia; [MacDougall, Iain J. A.; Griffith, Renate] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia	University of New South Wales Sydney; University of Newcastle	Stoddart, ES (corresponding author), Garvan Inst, Darlinghurst, NSW, Australia.	angela.finch@unsw.edu.au	Finch, Angela M/F-5962-2012; Griffith, Renate/A-3584-2015	Finch, Angela M/0000-0002-4598-6745; Griffith, Renate/0000-0001-7739-5686	UNSW	UNSW	This work was supported by a UNSW, Faculty Research Grant http://www.unsw.edu.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaro R, 2002, BIOORGAN MED CHEM, V10, P361, DOI 10.1016/S0968-0896(01)00286-3; Barbaro R, 2001, J MED CHEM, V44, P2118, DOI 10.1021/jm010821u; Becker OM, 2006, J MED CHEM, V49, P3116, DOI 10.1021/jm0508641; Betti L, 2002, BIOORG MED CHEM LETT, V12, P437, DOI 10.1016/S0960-894X(01)00772-7; Bremner JB, 2001, CURR MED CHEM, V8, P607, DOI 10.2174/0929867013373110; Bremner JB, 2000, BIOORGAN MED CHEM, V8, P201, DOI 10.1016/S0968-0896(99)00263-1; Calzada BC, 2001, PHARMACOL RES, V44, P195, DOI 10.1006/phrs.2001.0857; Chengalvala M, 1999, J BIOCHEM BIOPH METH, V38, P163, DOI 10.1016/S0165-022X(98)00046-3; Chu CP, 2004, NEUROSCI LETT, V356, P33, DOI 10.1016/j.neulet.2003.11.014; Eilers M, 2005, BIOCHEMISTRY-US, V44, P8959, DOI 10.1021/bi047316u; Flohr S, 2002, J MED CHEM, V45, P1799, DOI 10.1021/jm0111043; Ford APDW, 1997, BRIT J PHARMACOL, V121, P1127, DOI 10.1038/sj.bjp.0701207; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Handzlik J, 2008, BIOORGAN MED CHEM, V16, P5982, DOI 10.1016/j.bmc.2008.04.058; Harasawa I, 2003, NEUROREPORT, V14, P1857, DOI 10.1097/00001756-200310060-00020; HIEBLE JP, 1995, PHARMACOL REV, V47, P267; Ivorra MD, 2005, PLANTA MED, V71, P897, DOI 10.1055/s-2005-871281; Jain KS, 2008, BIOORGAN MED CHEM, V16, P4759, DOI 10.1016/j.bmc.2008.02.091; Klabunde T, 2005, CHEMBIOCHEM, V6, P876, DOI 10.1002/cbic.200400369; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Klebe G, 2006, DRUG DISCOV TODAY, V11, P580, DOI 10.1016/j.drudis.2006.05.012; Knauber J, 2000, EUR NEUROPSYCHOPHARM, V10, P423, DOI 10.1016/S0924-977X(00)00100-0; KO FN, 1994, BRIT J PHARMACOL, V112, P1174, DOI 10.1111/j.1476-5381.1994.tb13207.x; Li MY, 2005, BIOORG MED CHEM LETT, V15, P657, DOI 10.1016/j.bmcl.2004.11.032; Lopez-Rodriguez ML, 2001, J MED CHEM, V44, P186, DOI 10.1021/jm000929u; MacDougall IJA, 2006, J MOL GRAPH MODEL, V25, P146, DOI 10.1016/j.jmgm.2005.12.001; Malloy BJ, 1998, J UROLOGY, V160, P937, DOI 10.1016/S0022-5347(01)62836-2; Mishima K, 2004, BEHAV BRAIN RES, V152, P365, DOI 10.1016/j.bbr.2003.10.038; PEREZ DM, 1991, MOL PHARMACOL, V40, P876; Schwinn DA, 2008, INT J UROL, V15, P193, DOI 10.1111/j.1442-2042.2007.01956.x; Strappaghetti G, 2008, BIOORG MED CHEM LETT, V18, P5140, DOI 10.1016/j.bmcl.2008.07.084; Tanoue A, 2002, HYPERTENSION, V40, P101, DOI 10.1161/01.HYP.0000022062.70639.1C; Tanoue A, 2002, J CLIN INVEST, V109, P765, DOI 10.1172/JCI200214001; Tanoue A, 2002, LIFE SCI, V71, P2207, DOI 10.1016/S0024-3205(02)02012-X; Vaidehi N, 2010, DRUG DISCOV TODAY, V15, P951, DOI 10.1016/j.drudis.2010.08.018; Zuscik MJ, 2001, J BIOL CHEM, V276, P13738, DOI 10.1074/jbc.M008693200	36	3	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19695	10.1371/journal.pone.0019695	http://dx.doi.org/10.1371/journal.pone.0019695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572949	Green Published, gold			2022-12-25	WOS:000290440200022
J	Chambers, JR; Bender, KS				Chambers, Jacob R.; Bender, Kelly S.			The RNA Chaperone Hfq Is Important for Growth and Stress Tolerance in Francisella novicida	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; ESCHERICHIA-COLI K-12; PATHOGENICITY ISLAND; YERSINIA-PSEUDOTUBERCULOSIS; INTRAMACROPHAGE GROWTH; LISTERIA-MONOCYTOGENES; BIOFILM FORMATION; HEAT-SHOCK; TULARENSIS; PROTEIN	The RNA-binding protein Hfq is recognized as an important regulatory factor in a variety of cellular processes, including stress resistance and pathogenesis. Hfq has been shown in several bacteria to interact with small regulatory RNAs and act as a post-transcriptional regulator of mRNA stability and translation. Here we examined the impact of Hfq on growth, stress tolerance, and gene expression in the intracellular pathogen Francisella novicida. We present evidence of Hfq involvement in the ability of F. novicida to tolerate several cellular stresses, including heat-shock and oxidative stresses, and alterations in hfq gene expression under these conditions. Furthermore, expression of numerous genes, including several associated with virulence, is altered in a hfq mutant strain suggesting they are regulated directly or indirectly by Hfq. Strikingly, we observed a delayed entry into stationary phase and increased biofilm formation in the hfq mutant. Together, these data demonstrate a critical role for Hfq in F. novicida growth and survival.	[Chambers, Jacob R.; Bender, Kelly S.] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Chambers, JR (corresponding author), So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.	bender@micro.siu.edu		Bender, Kelly/0000-0002-0025-2166	National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) [RAI082502A]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI082502] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) through an Academic Research Enhancement Award #RAI082502A to K. S. Bender. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; Attia AS, 2008, INFECT IMMUN, V76, P2520, DOI 10.1128/IAI.01652-07; Bai G, 2010, J BACTERIOL, V192, P4239, DOI 10.1128/JB.00504-10; Bell BL, 2010, INFECT IMMUN, V78, P2189, DOI 10.1128/IAI.00021-10; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Broteke A, 2008, INFECT IMMUN, V76, P3473, DOI 10.1128/IAI.00430-08; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Dean RE, 2009, MICROBIOL-SGM, V155, P4104, DOI 10.1099/mic.0.031021-0; Dietrich M, 2009, FEBS J, V276, P5507, DOI 10.1111/j.1742-4658.2009.07234.x; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Durham-Colleran MW, 2009, ENVIRON MICROBIOL, V59, P457; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; FRANZE MT, 1968, NATURE, V219, P588, DOI 10.1038/219588a0; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Geng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006213; Gottesman S., 2010, COLD SPRING HARB PER, DOI [10.1101/cshperspect.a003798, DOI 10.1101/CSHPERSPECT.A003798]; Guina T, 2007, J BACTERIOL, V189, P6580, DOI 10.1128/JB.00809-07; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; Hamilton HL, 2001, J BACTERIOL, V183, P4718, DOI 10.1128/JB.183.16.4718-4726.2001; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Larson CL, 1955, PUBLIC HEALTH REP, V70, P253, DOI 10.2307/4589039; LoVullo ED, 2006, MICROBIOL-SGM, V152, P3425, DOI 10.1099/mic.0.29121-0; Margolis JJ, 2010, APPL ENVIRON MICROB, V76, P596, DOI 10.1128/AEM.02037-09; McCaffrey RL, 2006, J LEUKOCYTE BIOL, V80, P1224, DOI 10.1189/jlb.0406287; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Meibom KL, 2008, MOL MICROBIOL, V67, P1384, DOI 10.1111/j.1365-2958.2008.06139.x; Meibom KL, 2009, INFECT IMMUN, V77, P1866, DOI 10.1128/IAI.01496-08; Mellin JR, 2010, MICROBIOL-SGM, V156, P2316, DOI 10.1099/mic.0.039040-0; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Morner T., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P1123; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Nano FE, 2007, ANN NY ACAD SCI, V1105, P122, DOI 10.1196/annals.1409.000; Olsen AS, 2010, J MOL BIOL, V404, P173, DOI 10.1016/j.jmb.2010.09.038; Parker RR, 1951, B NATL I HLTH, V193, P7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reeser RJ, 2007, APPL ENVIRON MICROB, V73, P1908, DOI 10.1128/AEM.00740-06; Schiano CA, 2010, INFECT IMMUN, V78, P2034, DOI 10.1128/IAI.01046-09; Schilling D, 2009, J BACTERIOL, V191, P5553, DOI 10.1128/JB.00490-09; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1489, DOI 10.1099/mic.0.025379-0; Schulert GS, 2009, INFECT IMMUN, V77, P1324, DOI 10.1128/IAI.01318-08; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Sonnleitner E, 2006, MOL MICROBIOL, V59, P1542, DOI 10.1111/j.1365-2958.2006.05032.x; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; TSUI HCT, 1994, BIOCHIMIE, V76, P1168, DOI 10.1016/0300-9084(94)90046-9; Tsui HCT, 1996, J BACTERIOL, V178, P5719, DOI 10.1128/jb.178.19.5719-5731.1996; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3	56	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19797	10.1371/journal.pone.0019797	http://dx.doi.org/10.1371/journal.pone.0019797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573133	Green Published, gold, Green Submitted			2022-12-25	WOS:000290256400042
J	Chambers, JD; Bornstein, JC; Thomas, EA				Chambers, Jordan D.; Bornstein, Joel C.; Thomas, Evan A.			Multiple Neural Oscillators and Muscle Feedback Are Required for the Intestinal Fed State Motor Program	PLOS ONE			English	Article							INTRINSIC SENSORY NEURONS; PRIMARY AFFERENT NEURONS; POTASSIUM IK CHANNELS; GUINEA-PIG ILEUM; INTERMEDIATE-CONDUCTANCE; SYNAPTIC-TRANSMISSION; MYENTERIC NEURONS; RECURRENT NETWORKS; RECEPTOR BLOCKADE; MOTILITY REFLEXES	After a meal, the gastrointestinal tract exhibits a set of behaviours known as the fed state. A major feature of the fed state is a little understood motor pattern known as segmentation, which is essential for digestion and nutrient absorption. Segmentation manifests as rhythmic local constrictions that do not propagate along the intestine. In guinea-pig jejunum in vitro segmentation constrictions occur in short bursts together with other motor patterns in episodes of activity lasting 40-60 s and separated by quiescent episodes lasting 40-200 s. This activity is induced by luminal nutrients and abolished by blocking activity in the enteric nervous system (ENS). We investigated the enteric circuits that regulate segmentation focusing on a central feature of the ENS: a recurrent excitatory network of intrinsic sensory neurons (ISNs) which are characterized by prolonged after-hyperpolarizing potentials (AHPs) following their action potentials. We first examined the effects of depressing AHPs with blockers of the underlying channels (TRAM-34 and clotrimazole) on motor patterns induced in guinea-pig jejunum, in vitro, by luminal decanoic acid. Contractile episode durations increased markedly, but the frequency and number of constrictions within segmenting bursts and quiescent period durations were unaffected. We used these observations to develop a computational model of activity in ISNs, excitatory and inhibitory motor neurons and the muscle. The model predicted that: i) feedback to ISNs from contractions in the circular muscle is required to produce alternating activity and quiescence with the right durations; ii) transmission from ISNs to excitatory motor neurons is via fast excitatory synaptic potentials (EPSPs) and to inhibitory motor neurons via slow EPSPs. We conclude that two rhythm generators regulate segmentation: one drives contractions within segmentation bursts, the other the occurrence of bursts. The latter depends on AHPs in ISNs and feedback to these neurons from contraction of the circular muscle.	[Chambers, Jordan D.; Bornstein, Joel C.; Thomas, Evan A.] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia; [Thomas, Evan A.] Florey Neurosci Inst, Parkville, Vic, Australia; [Thomas, Evan A.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Chambers, JD (corresponding author), Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia.	j.bornstein@unimelb.edu.au	Chambers, Jordan D/H-6168-2016; Thomas, Evan/L-6390-2017; Thomas, Evan/AAD-8431-2021; Bornstein, Joel/I-3322-2019	Chambers, Jordan D/0000-0002-6760-2079; Thomas, Evan/0000-0001-7742-2031; Bornstein, Joel/0000-0002-7518-7717	Australia National Health and Medical Research Council (NHMRC) [566642]; Melbourne Research Scholarship	Australia National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Melbourne Research Scholarship	This study was supported by Australia National Health and Medical Research Council (NHMRC, www.nhmrc.gov.au) Grant 566642. JD Chambers was supported by a Melbourne Research Scholarship (www.unimelb.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex G, 2002, NEUROSCIENCE, V110, P361, DOI 10.1016/S0306-4522(01)00583-8; Alex G, 2001, NEUROSCIENCE, V104, P263, DOI 10.1016/S0306-4522(01)00064-1; Bertrand PP, 2006, J PHYSIOL-LONDON, V577, P689, DOI 10.1113/jphysiol.2006.117804; Bertrand PP, 2000, NEUROSCIENCE, V101, P459, DOI 10.1016/S0306-4522(00)00363-8; Bertrand PP, 2000, J COMPUT NEUROSCI, V8, P127, DOI 10.1023/A:1008969115017; Bertrand PP, 2004, NEUROSCIENCE, V128, P51, DOI 10.1016/j.neuroscience.2004.06.025; Bertrand PP, 2002, J NEUROSCI, V22, P4767, DOI 10.1523/JNEUROSCI.22-12-04767.2002; Bertrand PP, 1997, AM J PHYSIOL-GASTR L, V273, pG422; Bian XC, 2000, J PHYSIOL-LONDON, V528, P551, DOI 10.1111/j.1469-7793.2000.00551.x; Bornstein JC, 2002, INNERVATION GASTROIN, P1; Brookes SJH, 2001, ANAT RECORD, V262, P58; BULBRING E, 1958, J PHYSIOL-LONDON, V140, P381; Chambers JD, 2005, AM J PHYSIOL-GASTR L, V288, pG887, DOI 10.1152/ajpgi.00491.2004; Chambers JD, 2008, AM J PHYSL GASTROINT; Chambers JD, 2008, AM J PHYSIOL-GASTR L, V295, pG534, DOI 10.1152/ajpgi.90303.2008; Costa M, 2008, EUR REV MED PHARMACO, V12, P3; Ellis M., 2009, AUTON NEUROSCI-BASIC, V149, P42; Ellis M, 2009, AUTONOMIC NEUROSCIEN, V149, pS1115; Ferens D, 2007, NEUROGASTROENT MOTIL, V19, P383, DOI 10.1111/j.1365-2982.2007.00898.x; Foong JPP, 2010, AM J PHYSIOL-GASTR L, V298, pG384, DOI 10.1152/ajpgi.00438.2009; Foong JPP, 2009, NEUROREPORT, V20, P325, DOI 10.1097/WNR.0b013e3283232caa; Foong JP, 2010, AM J PHYSL IN PRESS; Fung C, 2010, FRONTIERS E IN PRESS; Furness J.B., 2006, ENTERIC NERVOUS SYST; Furness JB, 2004, AUTON NEUROSCI-BASIC, V112, P93, DOI 10.1016/j.autneu.2004.02.003; Furness JB, 2004, PROG NEUROBIOL, V72, P143, DOI 10.1016/j.pneurobio.2003.12.004; Furness JB, 2003, CELL TISSUE RES, V314, P179, DOI 10.1007/s00441-003-0808-z; GRAFE P, 1980, J PHYSIOL-LONDON, V305, P235, DOI 10.1113/jphysiol.1980.sp013360; Gwynne RM, 2007, CURR NEUROPHARMACOL, V5, P1, DOI 10.2174/157015907780077141; Gwynne RM, 2004, J PHYSIOL-LONDON, V556, P557, DOI 10.1113/jphysiol.2003.057182; Gwynne RM, 2007, AM J PHYSL GASTROINT; Hasler W, 2003, GASTROENTEROLOGY, P220; Hasler WL, 2008, TXB GASTROENTEROLOGY; Hennig GW, 1999, J PHYSIOL-LONDON, V517, P575, DOI 10.1111/j.1469-7793.1999.0575t.x; Heredia DJ, 2009, GASTROENTEROLOGY, V136, P1328, DOI 10.1053/j.gastro.2008.12.010; HUGE A, 1995, DIGEST DIS SCI, V40, P1024, DOI 10.1007/BF02064192; Huizinga JD, 2009, AM J PHYSIOL-GASTR L, V296, pG1, DOI 10.1152/ajpgi.90380.2008; Johnson PJ, 2004, NEUROSCIENCE, V126, P137, DOI 10.1016/j.neuroscience.2004.03.021; Johnson PJ, 1998, BRIT J PHARMACOL, V124, P1375, DOI 10.1038/sj.bjp.0701967; Johnson PJ, 1996, BRIT J PHARMACOL, V118, P973, DOI 10.1111/j.1476-5381.1996.tb15495.x; Joiner WJ, 2003, AM J PHYSIOL-GASTR L, V285, pG185, DOI 10.1152/ajpgi.00337.2002; Keating DJ, 2010, GASTROENTEROLOGY, V138, P659, DOI 10.1053/j.gastro.2009.09.020; Kunze WAA, 1998, J PHYSIOL-LONDON, V506, P827, DOI 10.1111/j.1469-7793.1998.827bv.x; Neylon CB, 2004, J NEUROCHEM, V90, P1414, DOI 10.1111/j.1471-4159.2004.02593.x; Nguyen TV, 2007, J NEUROPHYSIOL, V97, P2024, DOI 10.1152/jn.00935.2006; PAN H, 1995, EUR J PHARMACOL, V278, P67, DOI 10.1016/0014-2999(95)00101-P; PAN H, 1994, AM J PHYSIOL, V266, pG230, DOI 10.1152/ajpgi.1994.266.2.G230; Parsons SP, 2010, AM J PHYSIOL-GASTR L, V298, pG456, DOI 10.1152/ajpgi.00340.2009; SARR MG, 1980, AM J PHYSIOL, V239, pG167, DOI 10.1152/ajpgi.1980.239.3.G167; SCHEMANN M, 1986, GASTROENTEROLOGY, V90, P991, DOI 10.1016/0016-5085(86)90878-4; SCHMID HR, 1993, DIGEST DIS SCI, V38, P1062, DOI 10.1007/BF01295722; SIEGLE ML, 1988, AM J PHYSIOL, V254, pG552, DOI 10.1152/ajpgi.1988.254.4.G552; SONG ZM, 1994, NEUROSCI LETT, V180, P219, DOI 10.1016/0304-3940(94)90524-X; Spencer NJ, 2000, J PHYSIOL-LONDON, V522, P321, DOI 10.1111/j.1469-7793.2000.t01-1-00321.x; Tabak J, 2000, J NEUROSCI, V20, P3041; Thomas EA, 2000, NEUROSCI LETT, V287, P137, DOI 10.1016/S0304-3940(00)01182-4; Thomas EA, 2003, NEUROSCIENCE, V120, P333, DOI 10.1016/S0306-4522(03)00039-3; Thompson-Vest N, 2006, J ANAT, V208, P219, DOI 10.1111/j.1469-7580.2006.00515.x; Thornton PDJ, 2002, J PHYSIOL-LONDON, V539, P589, DOI 10.1113/jphysiol.2001.013399; TONINI M, 1990, NEUROSCIENCE, V38, P787, DOI 10.1016/0306-4522(90)90071-B; Wang B, 2010, NEUROGASTROENT MOTIL, V22, P98, DOI 10.1111/j.1365-2982.2009.01384.x; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Zhu YH, 2007, AM J PHYSIOL-GASTR L, V292, pG1715, DOI 10.1152/ajpgi.00524.2006	63	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19597	10.1371/journal.pone.0019597	http://dx.doi.org/10.1371/journal.pone.0019597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573176	Green Published, gold			2022-12-25	WOS:000290256400031
J	Hassani, K; Antoniak, E; Jardim, A; Olivier, M				Hassani, Kasra; Antoniak, Elisabeth; Jardim, Armando; Olivier, Martin			Temperature-Induced Protein Secretion by Leishmania mexicana Modulates Macrophage Signalling and Function	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE; TRYPANOSOMA-CRUZI; EXPRESSION; DONOVANI; SHP-1; MITOCHONDRIAL; LOCALIZATION; ACTIVATION; PREDICTION; RESPONSES	Protozoan parasites of genus Leishmania are h causative agents of leishmaniasis. These digenetic microorganisms undergo a marked environmental temperature shift (TS) during transmission from the sandfly vector (ambient temperature, 25-26 degrees C) to the mammalian host (37 degrees C). We have observed that this TS induces a rapid and dramatic increase in protein release from Leishmania mexicana (cutaneous leishmania) h within 4 proteomic identification of the TS-induced secreted proteins revealed 72 proteins he majority of which lack l signal peptide and are us thought to be secreted via nonconventional mechanisms. Interestingly, this protein release is accompanied by alterations in parasite morphology including an augmentation in the budding of exovesicles from its surface. Here we show that he exoproteome of L mexicana upon TS induces cleavage and activation of the host protein tyrosine phosphatases, specifically SHP-1 and PTP1-B, urine bone-marrow-derived macrophage cell line. Furthermore, translocation of prominent inflammatory transcription namely NF-kappa B and AP-1 is altered. The exoproteme also caused inhibition of nitric oxide production a crucial leishmanicidal function of the acrophage. Overall, our results provide strong evidence that within early momennteraction with the mammalian host, exkana rapidly releases proteins and exovesicles that modulate signalling unction of the macrophage. These modulations in attenuation of the inflammatory response and deactmacrophage aiding the parasite in the establishment of infection	[Hassani, Kasra; Antoniak, Elisabeth; Olivier, Martin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Hassani, Kasra; Olivier, Martin] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Jardim, Armando] McGill Univ, Inst Parasitol, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Hassani, K (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.	martin.olivier@mcgill.ca		Hassani, Kasra/0000-0003-0750-5629				Abu-Dayyeh I, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000305; Barak E, 2005, MOL BIOCHEM PARASIT, V141, P99, DOI 10.1016/j.molbiopara.2005.02.004; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blanchette J, 1999, EUR J IMMUNOL, V29, P3737, DOI 10.1002/(SICI)1521-4141(199911)29:11&lt;3737::AID-IMMU3737&gt;3.0.CO;2-S; Blanchette J, 2007, J LEUKOCYTE BIOL, V81, P835, DOI 10.1189/jlb.0505252; BONIFACINO JS, 2006, CURRENT PROTOCOLS CE; Brooks DR, 2000, J CELL SCI, V113, P4035; Castro H, 2002, FREE RADICAL BIO MED, V33, P1552, DOI 10.1016/S0891-5849(02)01089-4; Contreras I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001148; Corrales RM, 2010, FEMS IMMUNOL MED MIC, V58, P27, DOI 10.1111/j.1574-695X.2009.00608.x; Cuervo P, 2009, J PROTEOMICS, V73, P79, DOI 10.1016/j.jprot.2009.08.006; Forget G, 2006, INFECT IMMUN, V74, P6272, DOI 10.1128/IAI.00853-05; Geiger A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-20; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; Gonzalez-Aseguinolaza G, 1999, EUR J BIOCHEM, V259, P909, DOI 10.1046/j.1432-1327.1999.00122.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gregory DJ, 2008, EUR J IMMUNOL, V38, P1071, DOI 10.1002/eji.200737586; Heinonen KM, 2006, P NATL ACAD SCI USA, V103, P2776, DOI 10.1073/pnas.0508563103; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KLEIN KG, 1995, J EUKARYOT MICROBIOL, V42, P473, DOI 10.1111/j.1550-7408.1995.tb05893.x; Lapara NJ, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-8; Markova B, 2005, METHODS, V35, P22, DOI 10.1016/j.ymeth.2004.07.004; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Pabon MA, 2007, PARASITOL RES, V100, P803, DOI 10.1007/s00436-006-0351-4; RADZIOCH D, 1991, J LEUKOCYTE BIOL, V50, P263, DOI 10.1002/jlb.50.3.263; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Robinson JP, 1998, CURRENT PROTOCOLS CY; SHAPIRA M, 1989, EUR J BIOCHEM, V185, P231, DOI 10.1111/j.1432-1033.1989.tb15107.x; Shih S, 1998, J BIOL CHEM, V273, P1534, DOI 10.1074/jbc.273.3.1534; Silverman J. M., 2010, J IMMUNOL; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Torrecilhas ACT, 2009, MICROBES INFECT, V11, P29, DOI 10.1016/j.micinf.2008.10.003; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Xu HM, 2008, MOL IMMUNOL, V45, P3545, DOI 10.1016/j.molimm.2008.05.006; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1	40	71	73	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e18724	10.1371/journal.pone.0018724	http://dx.doi.org/10.1371/journal.pone.0018724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559274	Green Published, gold, Green Submitted			2022-12-25	WOS:000290223500002
J	Cesa, R; Premoselli, F; Renna, A; Ethell, IM; Pasquale, EB; Strata, P				Cesa, Roberta; Premoselli, Federica; Renna, Annamaria; Ethell, Iryna M.; Pasquale, Elena B.; Strata, Piergiorgio			Eph Receptors Are Involved in the Activity-Dependent Synaptic Wiring in the Mouse Cerebellar Cortex	PLOS ONE			English	Article							DENDRITIC SPINE MORPHOGENESIS; VESICULAR GLUTAMATE TRANSPORTERS; FOCAL ADHESION KINASE; ADULT-RAT; TYROSINE KINASE; PURKINJE-CELLS; SUBTOTAL LESION; INFERIOR OLIVE; EXPRESSION; EPHRINS	Eph receptor tyrosine kinases are involved in many cellular processes. In the developing brain, they act as migratory and cell adhesive cues while in the adult brain they regulate dendritic spine plasticity. Here we show a new role for Eph receptor signalling in the cerebellar cortex. Cerebellar Purkinje cells are innervated by two different excitatory inputs. The climbing fibres contact the proximal dendritic domain of Purkinje cells, where synapse and spine density is low; the parallel fibres contact the distal dendritic domain, where synapse and spine density is high. Interestingly, Purkinje cells have the intrinsic ability to generate a high number of spines over their entire dendritic arborisations, which can be innervated by the parallel fibres. However, the climbing fibre input continuously exerts an activity-dependent repression on parallel fibre synapses, thus confining them to the distal Purkinje cell dendritic domain. Such repression persists after Eph receptor activation, but is overridden by Eph receptor inhibition with EphA4/Fc in neonatal cultured cerebellar slices as well as mature acute cerebellar slices, following in vivo infusion of the EphA4/Fc inhibitor and in EphB receptor-deficient mice. When electrical activity is blocked in vivo by tetrodotoxin leading to a high spine density in Purkinje cell proximal dendrites, stimulation of Eph receptor activation recapitulates the spine repressive effects of climbing fibres. These results suggest that Eph receptor signalling mediates the repression of spine proliferation induced by climbing fibre activity in Purkinje cell proximal dendrites. Such repression is necessary to maintain the correct architecture of the cerebellar cortex.	[Cesa, Roberta; Premoselli, Federica; Renna, Annamaria] Univ Turin, Dept Neurosci, Turin, Italy; [Cesa, Roberta; Renna, Annamaria; Strata, Piergiorgio] Univ Turin, Natl Neurosci Inst Italy, Turin, Italy; [Ethell, Iryna M.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Pasquale, Elena B.] Sanford Burnham Med Res Inst, La Jolla, CA USA	University of Turin; University of Turin; University of California System; University of California Riverside; Sanford Burnham Prebys Medical Discovery Institute	Cesa, R (corresponding author), Univ Turin, Dept Neurosci, Turin, Italy.	piergiorgio.strata@unito.it		Ethell, Iryna/0000-0002-1324-6611	Italian Ministry of University and Research; European Community [214003-1]; Regione Piemonte, Italian Space Agency; Compagnia San Paolo Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067121] Funding Source: NIH RePORTER	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); European Community(European Commission); Regione Piemonte, Italian Space Agency(Agenzia Spaziale Italiana (ASI)Regione Piemonte); Compagnia San Paolo Foundation(Compagnia di San Paolo); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the Italian Ministry of University and Research, European Community contract number 214003-1, Regione Piemonte, Italian Space Agency, and Compagnia San Paolo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; AXELSSON J, 1959, J PHYSIOL-LONDON, V147, P178, DOI 10.1113/jphysiol.1959.sp006233; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Bourgin C, 2007, J CELL BIOL, V178, P1295, DOI 10.1083/jcb.200610139; Bouvier D, 2010, J NEUROCHEM, V113, P153, DOI 10.1111/j.1471-4159.2010.06582.x; Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Carulli D, 2004, PROG NEUROBIOL, V72, P373, DOI 10.1016/j.pneurobio.2004.03.007; Cesa R, 2005, PROG BRAIN RES, V148, P47, DOI 10.1016/S0079-6123(04)480005-4; Cesa R, 2005, EUR J NEUROSCI, V22, P579, DOI 10.1111/j.1460-9568.2005.04244.x; Cesa R, 2003, J NEUROSCI, V23, P2363; Cesa R, 2009, NEUROSCIENCE, V162, P624, DOI 10.1016/j.neuroscience.2009.02.061; Cesa R, 2007, J NEUROSCI, V27, P4603, DOI 10.1523/JNEUROSCI.5617-06.2007; Ciossek T, 1999, MOL BRAIN RES, V74, P231, DOI 10.1016/S0169-328X(99)00285-5; Cooper MA, 2009, J COMP NEUROL, V514, P310, DOI 10.1002/cne.22030; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gerlai R, 1999, J NEUROSCI, V19, P9538; Greferath U, 2002, MECH DEVELOP, V119, pS231, DOI 10.1016/S0925-4773(03)00122-9; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Ichikawa R, 2002, J NEUROSCI, V22, P8487; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Karam SD, 2000, J NEUROSCI, V20, P6488, DOI 10.1523/JNEUROSCI.20-17-06488.2000; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Liebl DJ, 2003, J NEUROSCI RES, V71, P7, DOI 10.1002/jnr.10457; Lippman J, 2005, J NEUROBIOL, V64, P47, DOI 10.1002/neu.20149; Mandolesi G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005243; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Martone ME, 1997, BRAIN RES, V771, P238, DOI 10.1016/S0006-8993(97)00792-0; McClelland AC, 2009, P NATL ACAD SCI USA, V106, P20487, DOI 10.1073/pnas.0811862106; Migani P, 2007, BRAIN RES, V1182, P60, DOI 10.1016/j.brainres.2007.08.065; Migani P, 2009, BRAIN RES, V1247, P50, DOI 10.1016/j.brainres.2008.09.100; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Morando L, 2001, P NATL ACAD SCI USA, V98, P9954, DOI 10.1073/pnas.171098398; Murai KK, 2004, NEUROSCIENTIST, V10, P304, DOI 10.1177/1073858403262221; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nishida K, 2002, DEVELOPMENT, V129, P5647, DOI 10.1242/dev.00162; Olivieri G, 1999, J HISTOCHEM CYTOCHEM, V47, P855, DOI 10.1177/002215549904700702; Palay S. L., 1974, CEREBELLAR CORTEX CY; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; PASQUALE EB, 1992, J NEUROSCI, V12, P3956; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; ROSSI F, 1991, J COMP NEUROL, V308, P513, DOI 10.1002/cne.903080403; ROSSI F, 1993, NEUROSCIENCE, V53, P759, DOI 10.1016/0306-4522(93)90622-M; ROSSI F, 1991, J COMP NEUROL, V308, P536, DOI 10.1002/cne.903080404; Scelfo B, 2003, J NEUROPHYSIOL, V89, P2555, DOI 10.1152/jn.00884.2002; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; Sotelo C, 1978, Prog Brain Res, V48, P149; Sotelo C, 2009, NEUROSCIENCE, V162, P589, DOI 10.1016/j.neuroscience.2008.12.035; SOTELO C, 1975, BRAIN RES, V98, P574, DOI 10.1016/0006-8993(75)90374-1; Strata P, 1998, TRENDS NEUROSCI, V21, P407, DOI 10.1016/S0166-2236(98)01305-8; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Willson CA, 2006, J MOL HISTOL, V37, P369, DOI 10.1007/s10735-006-9067-0; Xiao DQ, 2006, BRAIN RES, V1067, P67, DOI 10.1016/j.brainres.2005.10.073; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Yuzaki M, 2003, NEUROSCI RES, V46, P11, DOI 10.1016/S0168-0102(03)00036-1	68	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19160	10.1371/journal.pone.0019160	http://dx.doi.org/10.1371/journal.pone.0019160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559471	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700084
J	Lu, SS; Nie, JW; Luan, Q; Feng, QT; Xiao, Q; Chang, Z; Shan, CJ; Hess, D; Hemmings, BA; Yang, ZZ				Lu, Shuangshuang; Nie, Junwei; Luan, Qing; Feng, Qiuting; Xiao, Qi; Chang, Zai; Shan, Congjia; Hess, Daniel; Hemmings, Brian A.; Yang, Zhongzhou			Phosphorylation of the Twist1-Family Basic Helix-Loop-Helix Transcription Factors Is Involved in Pathological Cardiac Remodeling	PLOS ONE			English	Article							PROTEIN-KINASE B/AKT; DNA-BINDING; TRANSGENIC MICE; DEPENDENT PHOSPHORYLATION; SIGNALING PATHWAYS; HEART-FAILURE; HAND1; HYPERTROPHY; GROWTH; DHAND	Background: The Twist1-family basic helix-loop-helix (bHLH) transcription factors including Twist1, Hand1 and Hand2, play an essential role in heart development and are implicated in pathological heart remodeling. Previously, it was reported that these bHLH transcription factors can be regulated by phosphorylation within the basic-helix I domain, which is involved in developmental processes such as limb formation and trophoblast differentiation. However, how phosphorylation of Twist1 family functions in post-natal heart is elusive. Principal Findings: Here, we generated transgenic mice with over-expression of Hand1 and Twist1 mutants (to mimic or to abolish phosphorylation) in cardiomyocytes and found pathological cardiac remodeling leading to heart failure and sudden death. Gene expression profile analysis revealed up-regulation of growth-promoting genes and down-regulation of metabolic genes. It is well known that aberrant activation of Akt signaling causes pathological cardiac remodeling and results in heart failure. The basic-helix I domain of Twist1 family members contain Akt substrate consensus motif and may be downstream targets of Akt signaling. Using biochemical analysis, we demonstrated that Hand1 and Twist1 were phosphorylated by Akt in the basic-helix I domain. Phosphorylation of Hand1 regulated its transcriptional activation of luciferase reporter genes and DNA binding ability. Conclusions: This study provides novel insights into the regulation of Twist1 family in cardiac remodeling and suggests that the Twist1 family can be regulated by Akt signaling.	[Lu, Shuangshuang; Nie, Junwei; Luan, Qing; Feng, Qiuting; Xiao, Qi; Chang, Zai; Shan, Congjia; Yang, Zhongzhou] Nanjing Univ, Model Anim Res Ctr, Minist Educ, Key Lab Model Anim Dis Study, Nanjing 210008, Peoples R China; [Hess, Daniel; Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Nanjing University; Friedrich Miescher Institute for Biomedical Research	Lu, SS (corresponding author), Nanjing Univ, Model Anim Res Ctr, Minist Educ, Key Lab Model Anim Dis Study, Nanjing 210008, Peoples R China.	zhongzhouyang@nju.edu.cn			National Key Basic Research Program of China [2006CB943503]; National Science Foundation of China [30500264, 30671040]	National Key Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program of China (2006CB943503) and the National Science Foundation of China (30500264 and 30671040) with grants to Zhongzhou Yang. The Friedrich Miescher Institute for Biomedical Research is part of the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes RM, 2009, INT J DEV BIOL, V53, P909, DOI 10.1387/ijdb.082747rb; Borger DR, 1998, AM J PHYSIOL-HEART C, V274, pH965, DOI 10.1152/ajpheart.1998.274.3.H965; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Breckenridge RA, 2009, J MOL CELL CARDIOL, V47, P133, DOI 10.1016/j.yjmcc.2009.04.007; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Cook SA, 2002, J BIOL CHEM, V277, P22528, DOI 10.1074/jbc.M201462200; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Firulli AB, 2003, GENE, V312, P27, DOI 10.1016/S0378-1119(03)00669-3; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/ng0398-266; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; Firulli BA, 2003, MOL CELL, V12, P1225, DOI 10.1016/S1097-2765(03)00425-8; Firulli BA, 2007, J BIOL CHEM, V282, P27536, DOI 10.1074/jbc.M702613200; FOCUSES W, 2003, EMBO J, V22, P4666; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hill AA, 2004, MOL CELL BIOL, V24, P9835, DOI 10.1128/MCB.24.22.9835-9847.2004; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Ito K, 2009, P NATL ACAD SCI USA, V106, P8689, DOI 10.1073/pnas.0900064106; KIMBER S, 2002, BIOCHEM J, V361, P641; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Liu N, 2009, DEVELOPMENT, V136, P933, DOI 10.1242/dev.034025; Martindill DMJ, 2007, NAT CELL BIOL, V9, P1131, DOI 10.1038/ncb1633; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; McFadden DG, 2002, DEVELOPMENT, V129, P3077; Murakami M, 2004, EUR J BIOCHEM, V271, P3330, DOI 10.1111/j.1432-1033.2004.04267.x; Muslin Anthony J, 2006, Novartis Found Symp, V274, P118; Natarajan A, 2001, J MOL CELL CARDIOL, V33, P1607, DOI 10.1006/jmcc.2001.1434; O'Neill BT, 2005, J CLIN INVEST, V115, P2059, DOI 10.1172/JCI25900; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Reamon-Buettner SM, 2009, HUM MOL GENET, V18, P3567, DOI 10.1093/hmg/ddp305; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Shelton EL, 2008, DEV BIOL, V317, P282, DOI 10.1016/j.ydbio.2008.02.037; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Taniyama Yoshiaki, 2005, J Mol Cell Cardiol, V38, P375, DOI 10.1016/j.yjmcc.2004.12.002; Thattaliyath BD, 2002, BIOCHEM BIOPH RES CO, V297, P870, DOI 10.1016/S0006-291X(02)02297-0; Vincentz JW, 2008, DEV BIOL, V320, P131, DOI 10.1016/j.ydbio.2008.04.037; Walsh K, 2006, CIRCULATION, V113, P2032, DOI 10.1161/CIRCULATIONAHA.106.615138; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350	52	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19251	10.1371/journal.pone.0019251	http://dx.doi.org/10.1371/journal.pone.0019251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559426	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700112
J	Medina, MW; Gao, F; Naidoo, D; Rudel, LL; Temel, RE; McDaniel, AL; Marshall, SM; Krauss, RM				Medina, Marisa Wong; Gao, Feng; Naidoo, Devesh; Rudel, Lawrence L.; Temel, Ryan E.; McDaniel, Allison L.; Marshall, Stephanie M.; Krauss, Ronald M.			Coordinately Regulated Alternative Splicing of Genes Involved in Cholesterol Biosynthesis and Uptake	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; COENZYME-A REDUCTASE; HEPATOMA-CELL LINE; MEVALONATE KINASE; MESSENGER-RNA; SYNTHASE; TRACT; SIMVASTATIN; SEQUENCE; EXON	Genes involved in cholesterol biosynthesis and uptake are transcriptionally regulated in response to cellular sterol content in a coordinated manner. A number of these genes, including 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) and LDL receptor (LDLR), undergo alternative splicing, resulting in reductions of enzyme or protein activity. Here we demonstrate that cellular sterol depletion suppresses, and sterol loading induces, alternative splicing of multiple genes involved in the maintenance of cholesterol homeostasis including HMGCR and LDLR, the key regulators of cellular cholesterol biosynthesis and uptake, respectively. These changes were observed in both in vitro studies of the HepG2 human hepatoma derived cell line, as well as in vivo studies of St. Kitts vervets, also known as African green monkeys, a commonly used primate model for investigating cholesterol metabolism. These effects are mediated in part by sterol regulation of polypyrimidine tract binding protein 1 (PTBP1), since knock-down of PTBP1 eliminates sterol induced changes in alternative splicing of several of these genes. Single nucleotide polymorphisms (SNPs) that influence HMGCR and LDLR alternative splicing (rs3846662 and rs688, respectively), have been associated with variation in plasma LDL-cholesterol levels. Sterol-induced changes in alternative splicing are blunted in carriers of the minor alleles for each of these SNPs, indicating an interaction between genetic and non-genetic regulation of this process. Our results implicate alternative splicing as a novel mechanism of enhancing the robust transcriptional response to conditions of cellular cholesterol depletion or accumulation. Thus coordinated regulation of alternative splicing may contribute to cellular cholesterol homeostasis as well as plasma LDL levels.	[Medina, Marisa Wong; Gao, Feng; Naidoo, Devesh; Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Dept Atherosclerosis Res, Oakland, CA 94609 USA; [Rudel, Lawrence L.; Temel, Ryan E.; McDaniel, Allison L.; Marshall, Stephanie M.] Wake Forest Univ Hlth Sci, Dept Pathol Lipid Sci, Winston Salem, NC USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Wake Forest University; Wake Forest University School of Medicine	Medina, MW (corresponding author), Childrens Hosp, Oakland Res Inst, Dept Atherosclerosis Res, 747 52nd St, Oakland, CA 94609 USA.	mwmedina@chori.org; rkrauss@chori.org			National Institutes of Health [U01 HL69757, R01 HL 104133-01, R21 HL093507-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104133, R21HL093507, U01HL069757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by a grant from the National Institutes of Health, U01 HL69757. Additional support was provided by National Institutes of Health grants R01 HL 104133-01 and R21 HL093507-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALASUBRAMANIAM S, 1977, P NATL ACAD SCI USA, V74, P1421, DOI 10.1073/pnas.74.4.1421; Becker L, CELL METAB, V11, P125; Bourliere F., 1988, PRIMATE RAD EVOLUTIO; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; BROWN MS, 1980, J LIPID RES, V21, P505; Brunel F, 1996, NUCLEIC ACIDS RES, V24, P1608, DOI 10.1093/nar/24.9.1608; Burkhardt R, 2008, ARTERIOSCL THROM VAS, V28, P2078, DOI 10.1161/ATVBAHA.108.172288; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; CHANG TY, 1980, J BIOL CHEM, V255, P7787; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; George TN, 1998, AM J PHYSIOL-LUNG C, V274, pL560, DOI 10.1152/ajplung.1998.274.4.L560; GIL G, 1987, P NATL ACAD SCI USA, V84, P1863, DOI 10.1073/pnas.84.7.1863; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GRAEF E, 1994, ONCOGENE, V9, P81; GRAEF E, 1995, VIROLOGY, V208, P696, DOI 10.1006/viro.1995.1201; Hartmann B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r11; Holla OL, 2009, MOL GENET METAB, V96, P245, DOI 10.1016/j.ymgme.2008.12.014; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Houten SM, 2001, EUR J HUM GENET, V9, P253, DOI 10.1038/sj.ejhg.5200595; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Knouff CW, 2008, PHARMACOGENET GENOM, V18, P1051, DOI 10.1097/FPC.0b013e32831270eb; Krauss RM, 2008, CIRCULATION, V117, P1537, DOI 10.1161/CIRCULATIONAHA.107.708388; Li H, 2009, J LIPID RES, V50, P820, DOI 10.1194/jlr.M800375-JLR200; LIN CH, 1995, RNA, V1, P234; Medina MW, 2008, CIRCULATION, V118, P355, DOI 10.1161/CIRCULATIONAHA.108.773267; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; ROSSER DSE, 1989, J BIOL CHEM, V264, P12653; Rozen S, 2000, Methods Mol Biol, V132, P365; RUDEL LL, 1990, J LIPID RES, V31, P1873; Rustighi A, 2002, BIOCHEMISTRY-US, V41, P1229, DOI 10.1021/bi011666o; Schmidt RJ, 2008, DNA CELL BIOL, V27, P183, DOI 10.1089/dna.2007.0667; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; SHEN MMS, 1981, J LIPID RES, V22, P236; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Thompson JF, 2005, PHARMACOGENOMICS J, V5, P352, DOI 10.1038/sj.tpj.6500328; Thompson JF, 2009, CIRC-CARDIOVASC GENE, V2, P173, DOI 10.1161/CIRCGENETICS.108.818062; Tveten K, 2006, CLIN CHIM ACTA, V373, P151, DOI 10.1016/j.cca.2006.05.031; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; WILKIN DJ, 1990, J BIOL CHEM, V265, P4607; Zhu H, 2007, HUM MOL GENET, V16, P1765, DOI 10.1093/hmg/ddm124	45	49	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19420	10.1371/journal.pone.0019420	http://dx.doi.org/10.1371/journal.pone.0019420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559365	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700164
J	Ndenga, BA; Simbauni, JA; Mbugi, JP; Githeko, AK; Fillinger, U				Ndenga, Bryson A.; Simbauni, Jemimah A.; Mbugi, Jenard P.; Githeko, Andrew K.; Fillinger, Ulrike			Productivity of Malaria Vectors from Different Habitat Types in the Western Kenya Highlands	PLOS ONE			English	Article							ENTOMOLOGICAL INOCULATION RATES; MONOMOLECULAR SURFACE-FILM; ANOPHELES-GAMBIAE COMPLEX; MOSQUITO LARVAL HABITATS; SPATIAL-DISTRIBUTION; MICROBIAL LARVICIDES; AQUATIC STAGES; SENSU-STRICTO; LAND-COVER; ARABIENSIS	Background: Mosquito Larval Source Management (LSM) could be a valuable additional tool for integrated malaria vector control especially in areas with focal transmission like the highlands of western Kenya if it were not for the need to target all potential habitats at frequent intervals. The ability to determine the productivity of malaria vectors from identified habitats might be used to target LSM only at productive ones. Methods: Each aquatic habitat within three highland sites in western Kenya was classified as natural swamp, cultivated swamp, river fringe, puddle, open drain or burrow pit. Three habitats of each type were selected in each site in order to study the weekly productivity of adult malaria vectors from February to May 2009 using a sweep-net and their habitat characteristics recorded. Results: All surveyed habitat types produced adult malaria vectors. Mean adult productivity of Anopheles gambiae sensu lato in puddles (1.8/m(2)) was 11-900 times higher than in the other habitat types. However, puddles were the most unstable habitats having water at 43% of all sampling occasions and accounted for 5% of all habitats mapped in the study areas whereas open drains accounted for 72%. Densities of anopheline late instars larvae significantly increased with the presence of a biofilm but decreased with increasing surface area or when water was flowing. Taking stability and frequency of the habitat into account, puddles were still the most productive habitat types for malaria vectors but closely followed by open drains. Conclusion: Even though productivity of An. gambiae s.l. was greatest in small and unstable habitats, estimation of their overall productivity in an area needs to consider the more stable habitats over time and their surface extension. Therefore, targeting only the highly productive habitats is unlikely to provide sufficient reduction in malaria vector densities.	[Ndenga, Bryson A.; Githeko, Andrew K.] Kenyatta Univ, Dept Zool Sci, Nairobi, Kenya; [Ndenga, Bryson A.; Simbauni, Jemimah A.; Mbugi, Jenard P.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Fillinger, Ulrike] London Sch Hyg & Trop Med, Dis Control & Vector Biol Unit, London WC1, England	Kenyatta University; Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine	Ndenga, BA (corresponding author), Kenyatta Univ, Dept Zool Sci, Nairobi, Kenya.	bndenga@yahoo.com		Fillinger, Ulrike/0000-0002-4037-431X	World Health Organization (WHO); Valent BioSciences Corporation	World Health Organization (WHO)(World Health Organization); Valent BioSciences Corporation	This work was funded by the World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR)-Research Training Grant (RTG) and Valent BioSciences Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2007, AM J TROP MED HYG, V77, P660, DOI 10.4269/ajtmh.2007.77.660; [Anonymous], 1968, ANOPHELINAE AFR S SA; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; Briet OJT, 2003, TROP MED INT HEALTH, V8, P439, DOI 10.1046/j.1365-3156.2003.01054.x; Bukhari T, 2009, AM J TROP MED HYG, V80, P758, DOI 10.4269/ajtmh.2009.80.758; Carlson JC, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-33; Carlson JC, 2009, J MED ENTOMOL, V46, P460, DOI 10.1603/033.046.0307; Chen H, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-17; Chen H, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-48; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; COLUZZI M, 1984, B WORLD HEALTH ORGAN, V62, P107; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; Fillinger U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-20; Fillinger Ulrike, 2006, Trop Med Int Health, V11, P1629, DOI 10.1111/j.1365-3156.2006.01733.x; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Fillinger U, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-62; Gillett J. D., 1972, COMMON AFRICAN MOSQU; Gillies M, 1987, ANOPHELINAE AFRICA S; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282; Grieco JP, 2005, J VECTOR ECOL, V30, P235; Gu WD, 2005, AM J TROP MED HYG, V73, P546, DOI 10.4269/ajtmh.2005.73.546; Gu WD, 2008, AM J TROP MED HYG, V78, P2, DOI 10.4269/ajtmh.2008.78.2; Hay SI, 1998, T ROY SOC TROP MED H, V92, P12, DOI 10.1016/S0035-9203(98)90936-1; Himeidan YE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-234; Howard AFV, 2008, ACTA TROP, V105, P67, DOI 10.1016/j.actatropica.2007.09.010; KARANJA DMS, 1994, ACTA TROP, V56, P365, DOI 10.1016/0001-706X(94)90107-4; KHAEMBA BM, 1994, E AFR MED J, V71, P159; Killeen GF, 2004, AM J TROP MED HYG, V71, P87, DOI 10.4269/ajtmh.2004.71.2_suppl.0700087; Lindblade KA, 2000, J MED ENTOMOL, V37, P664, DOI 10.1603/0022-2585-37.5.664; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Majambere S, 2008, AM J TROP MED HYG, V79, P19, DOI 10.4269/ajtmh.2008.79.19; Majambere S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-76; MARTEN GG, 1989, J MED ENTOMOL, V26, P624, DOI 10.1093/jmedent/26.6.624; Mbogo CNM, 1996, MED VET ENTOMOL, V10, P251, DOI 10.1111/j.1365-2915.1996.tb00739.x; Minakawa N, 2002, J MED ENTOMOL, V39, P833, DOI 10.1603/0022-2585-39.6.833; Minakawa N, 2005, AM J TROP MED HYG, V73, P157, DOI 10.4269/ajtmh.2005.73.157; Minakawa N, 2004, MED VET ENTOMOL, V18, P301, DOI 10.1111/j.0269-283X.2004.00503.x; Minakawa N, 1999, AM J TROP MED HYG, V61, P1010, DOI 10.4269/ajtmh.1999.61.1010; Minakawa N, 2006, AM J TROP MED HYG, V75, P448, DOI 10.4269/ajtmh.2006.75.448; Munga S, 2006, AM J TROP MED HYG, V74, P69, DOI 10.4269/ajtmh.2006.74.69; Munyekenye OG, 2005, EMERG INFECT DIS, V11, P1571, DOI 10.3201/eid1110.050106; Mushinzimana E, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-13; Mutuku FM, 2006, AM J TROP MED HYG, V74, P54, DOI 10.4269/ajtmh.2006.74.54; Mwangangi Joseph M., 2007, Journal of Vector Borne Diseases, V44, P44; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; Okogun Godwin Ray Anugboba, 2005, Journal of Vector Borne Diseases, V42, P45; Paaijmans KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-196; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Protopopoff N, 2008, AM J TROP MED HYG, V79, P12, DOI 10.4269/ajtmh.2008.79.12; Robert Vincent, 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-4; Sattler MA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-4; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Shililu JI, 1998, TROP MED INT HEALTH, V3, P706; Shililu J, 2007, AM J TROP MED HYG, V76, P103, DOI 10.4269/ajtmh.2007.76.103; Sumba LA, 2008, J CHEM ECOL, V34, P1430, DOI 10.1007/s10886-008-9549-5; Sumba Leunita A, 2004, J Circadian Rhythms, V2, P6, DOI 10.1186/1740-3391-2-6; WHITE GB, 1985, SYST ENTOMOL, V10, P501, DOI 10.1111/j.1365-3113.1985.tb00155.x; Wotton RS, 2005, BIOSCIENCE, V55, P137, DOI 10.1641/0006-3568(2005)055[0137:SFAOWB]2.0.CO;2; Zhou GF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-67	61	55	55	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19473	10.1371/journal.pone.0019473	http://dx.doi.org/10.1371/journal.pone.0019473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559301	gold, Green Published, Green Accepted			2022-12-25	WOS:000290024700190
J	Pelle, R; Graham, SP; Njahira, MN; Osaso, J; Saya, RM; Odongo, DO; Toye, PG; Spooner, PR; Musoke, AJ; Mwangi, DM; Taracha, ELN; Morrison, WI; Weir, W; Silva, JC; Bishop, RP				Pelle, Roger; Graham, Simon P.; Njahira, Moses N.; Osaso, Julius; Saya, Rosemary M.; Odongo, David O.; Toye, Philip G.; Spooner, Paul R.; Musoke, Anthony J.; Mwangi, Duncan M.; Taracha, Evans L. N.; Morrison, W. Ivan; Weir, William; Silva, Joana C.; Bishop, Richard P.			Two Theileria parva CD8 T Cell Antigen Genes Are More Variable in Buffalo than Cattle Parasites, but Differ in Pattern of Sequence Diversity	PLOS ONE			English	Article							STRAIN SPECIFICITY; SYNCERUS-CAFFER; RESPONSES; SOFTWARE; IMMUNITY; PROTEIN; DNA; IMMUNIZATION; LYMPHOCYTES; POPULATION	Background: Theileria parva causes an acute fatal disease in cattle, but infections are asymptomatic in the African buffalo (Syncerus caffer). Cattle can be immunized against the parasite by infection and treatment, but immunity is partially strain specific. Available data indicate that CD8(+) T lymphocyte responses mediate protection and, recently, several parasite antigens recognised by CD8(+) T cells have been identified. This study set out to determine the nature and extent of polymorphism in two of these antigens, Tp1 and Tp2, which contain defined CD8(+) T-cell epitopes, and to analyse the sequences for evidence of selection. Methodology/Principal Findings: Partial sequencing of the Tp1 gene and the full-length Tp2 gene from 82 T. parva isolates revealed extensive polymorphism in both antigens, including the epitope-containing regions. Single nucleotide polymorphisms were detected at 51 positions (similar to 12%) in Tp1 and in 320 positions (similar to 61%) in Tp2. Together with two short indels in Tp1, these resulted in 30 and 42 protein variants of Tp1 and Tp2, respectively. Although evidence of positive selection was found for multiple amino acid residues, there was no preferential involvement of T cell epitope residues. Overall, the extent of diversity was much greater in T. parva isolates originating from buffalo than in isolates known to be transmissible among cattle. Conclusions/Significance: The results indicate that T. parva parasites maintained in cattle represent a subset of the overall T. parva population, which has become adapted for tick transmission between cattle. The absence of obvious enrichment for positively selected amino acid residues within defined epitopes indicates either that diversity is not predominantly driven by selection exerted by host T cells, or that such selection is not detectable by the methods employed due to unidentified epitopes elsewhere in the antigens. Further functional studies are required to address this latter point.	[Pelle, Roger; Graham, Simon P.; Njahira, Moses N.; Osaso, Julius; Saya, Rosemary M.; Odongo, David O.; Toye, Philip G.; Spooner, Paul R.; Musoke, Anthony J.; Mwangi, Duncan M.; Taracha, Evans L. N.; Bishop, Richard P.] ILRI, Nairobi, Kenya; [Morrison, W. Ivan] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Edinburgh EH9 1QH, Midlothian, Scotland; [Weir, William] Univ Glasgow, Sch Vet, Inst Comparat Med, Glasgow, Lanark, Scotland; [Silva, Joana C.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Silva, Joana C.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	CGIAR; International Livestock Research Institute (ILRI); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Glasgow; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Pelle, R (corresponding author), ILRI, Nairobi, Kenya.	r.pelle@cgiar.org	Silva, Joana/GVT-6441-2022; Graham, Simon P/C-8337-2011; Silva, Joana/GYQ-9526-2022	Graham, Simon P/0000-0003-4852-405X; Odongo, David/0000-0001-5745-4327; Weir, William/0000-0001-8648-666X	Department for International Development, United Kingdom [R8042]; International Livestock Research Institute; BBSRC [BBS/E/D/05201236] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05201236] Funding Source: researchfish	Department for International Development, United Kingdom; International Livestock Research Institute(CGIAR); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded with Grant No. R8042 from the Department for International Development, United Kingdom, and with International Livestock Research Institute core funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoolo L, 2008, VET IMMUNOL IMMUNOP, V121, P216, DOI 10.1016/j.vetimm.2007.09.012; BALDWIN CL, 1988, PARASITE IMMUNOL, V10, P393, DOI 10.1111/j.1365-3024.1988.tb00229.x; Brown C. G. D., 1979, Practical tissue culture applications. (Proc. Conf. Internat. Lab. Res. Anim. Dis., Nairobi, Kenya, August 24-29 1978)., P223; CONRAD PA, 1987, PARASITOLOGY, V94, P413, DOI 10.1017/S0031182000055761; Egan A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-524; Freeman AR, 2006, GENETICS, V173, P1503, DOI 10.1534/genetics.105.053280; GAUER M, 1995, PARASITOL RES, V81, P565, DOI 10.1007/BF00932023; Geysen D, 1999, TROP MED INT HEALTH, V4, pA21, DOI 10.1046/j.1365-3156.1999.00447.x; Goddeeris B.M., 1988, J TISSUE CULT METHOD, V11, P101, DOI [10.1007/BF01404140, DOI 10.1007/BF01404140]; GODDEERIS BM, 1990, IMMUNOLOGY, V69, P38; Graham Simon P, 2007, Immunome Res, V3, P2, DOI 10.1186/1745-7580-3-2; Graham SP, 2008, INFECT IMMUN, V76, P685, DOI 10.1128/IAI.01244-07; Graham SP, 2006, P NATL ACAD SCI USA, V103, P3286, DOI 10.1073/pnas.0511273103; GROOTENHUIS JG, 1987, PARASITOLOGY, V94, P425, DOI 10.1017/S0031182000055773; Katzer F, 2006, INFECT IMMUN, V74, P5456, DOI 10.1128/IAI.00472-06; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kumkhaek C, 2005, J IMMUNOL, V175, P3935, DOI 10.4049/jimmunol.175.6.3935; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MacHugh ND, 2009, EUR J IMMUNOL, V39, P2459, DOI 10.1002/eji.200939227; McKeever DJ, 2009, TRENDS PARASITOL, V25, P269, DOI 10.1016/j.pt.2009.03.005; MCKEEVER DJ, 1994, P NATL ACAD SCI USA, V91, P1959, DOI 10.1073/pnas.91.5.1959; MORRISON WI, 1989, VET IMMUNOL IMMUNOP, V20, P213, DOI 10.1016/0165-2427(89)90003-2; MORZARIA S, 1999, LIVE VACCINES THEILE, P56; Morzaria S. P., 1993, Genome analysis of protozoan parasites: Proceedings of a Workshop held at ILRAD, Nairobi, Kenya 11-13 November 1992., P67; MORZARIA SP, 1995, PARASITOLOGY, V111, P39, DOI 10.1017/S0031182000064581; Musoke A, 2005, VACCINE, V23, P3084, DOI 10.1016/j.vaccine.2004.09.039; Nene V, 1996, INFECT IMMUN, V64, P2056, DOI 10.1128/IAI.64.6.2056-2061.1996; Norval RAI., 1992, EPIDEMIOLOGY THEILER; Odongo DO, 2006, INT J PARASITOL, V36, P937, DOI 10.1016/j.ijpara.2006.01.008; Oura CAL, 2005, MOL BIOCHEM PARASIT, V140, P229, DOI 10.1016/j.molbiopara.2004.12.015; Oura CAL, 2003, INT J PARASITOL, V33, P1641, DOI 10.1016/S0020-7519(03)00280-7; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; RADLEY D E, 1975, Veterinary Parasitology, V1, P51, DOI 10.1016/0304-4017(75)90007-2; RADLEY DE, 1979, VET PARASITOL, V5, P117, DOI 10.1016/0304-4017(79)90003-7; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sambrook J, 1989, MOL CLONING LABORATO; TARACHA ELN, 1995, INFECT IMMUN, V63, P1258, DOI 10.1128/IAI.63.4.1258-1262.1995; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOYE PG, 1995, J IMMUNOL, V155, P1370; Uilenberg G, 1999, TROP MED INT HEALTH, V4, pA12, DOI 10.1046/j.1365-3156.1999.00446.x; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YOUNG AS, 1973, BRIT VET J, V129, P382, DOI 10.1016/S0007-1935(17)36442-4	45	57	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19015	10.1371/journal.pone.0019015	http://dx.doi.org/10.1371/journal.pone.0019015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559495	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000290024700052
J	Sandersius, SA; Chuai, M; Weijer, CJ; Newman, TJ				Sandersius, Sebastian A.; Chuai, Manli; Weijer, Cornelis J.; Newman, Timothy J.			Correlating Cell Behavior with Tissue Topology in Embryonic Epithelia	PLOS ONE			English	Article							PRIMITIVE STREAK FORMATION; DIVISION; CHICK; SHAPE	Measurements on embryonic epithelial tissues in a diverse range of organisms have shown that the statistics of cell neighbor numbers are universal in tissues where cell proliferation is the primary cell activity. Highly simplified non-spatial models of proliferation are claimed to accurately reproduce these statistics. Using a systematic critical analysis, we show that non-spatial models are not capable of robustly describing the universal statistics observed in proliferating epithelia, indicating strong spatial correlations between cells. Furthermore we show that spatial simulations using the Subcellular Element Model are able to robustly reproduce the universal histogram. In addition these simulations are able to unify ostensibly divergent experimental data in the literature. We also analyze cell neighbor statistics in early stages of chick embryo development in which cell behaviors other than proliferation are important. We find from experimental observation that cell neighbor statistics in the primitive streak region, where cell motility and ingression are also important, show a much broader distribution. A non-spatial Markov process model provides excellent agreement with this broader histogram indicating that cells in the primitive streak may have significantly weaker spatial correlations. These findings show that cell neighbor statistics provide a potentially useful signature of collective cell behavior.	[Sandersius, Sebastian A.; Newman, Timothy J.] Arizona State Univ, Dept Phys, Ctr Biol Phys, Tempe, AZ 85287 USA; [Chuai, Manli; Weijer, Cornelis J.; Newman, Timothy J.] Univ Dundee, Coll Life Sci, Wellcome Trust Bioctr, Div Cell & Dev Biol, Dundee, Scotland	Arizona State University; Arizona State University-Tempe; University of Dundee	Sandersius, SA (corresponding author), Arizona State Univ, Dept Phys, Ctr Biol Phys, Tempe, AZ 85287 USA.	t.newman@dundee.ac.uk	weijer, cornelis j/I-4538-2012	Weijer, Cornelis/0000-0003-2192-8150	Human Frontiers Science Program [RGP-0038]; National Institutes of Health Physical Sciences Oncology Centers [5U54CA143862]; Biotechnology and Biological Sciences Research Council [BB/G015082/1] Funding Source: researchfish; BBSRC [BB/G015082/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [U54CA143862] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); National Institutes of Health Physical Sciences Oncology Centers; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the Human Frontiers Science Program (RGP-0038, www.hfsp.org) and the National Institutes of Health Physical Sciences Oncology Centers (5U54CA143862, www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Blanchard GB, 2009, NAT METHODS, V6, P458, DOI [10.1038/nmeth.1327, 10.1038/NMETH.1327]; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Chickarmane V, 2010, ANNU REV PLANT BIOL, V61, P65, DOI 10.1146/annurev-arplant-042809-112213; Chuai M, 2008, CURR TOP DEV BIOL, V81, P135, DOI 10.1016/S0070-2153(07)81004-0; ERRERA L, 1988, BOT CENTRALBATT, V34; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hocevar A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011904; KADANOFF L, 2002, STAT PHYS; Lewis FT, 1926, ANAT REC, V33, P331, DOI 10.1002/ar.1090330502; Lewis FT, 1928, ANAT REC, V38, P341, DOI 10.1002/ar.1090380305; Naveed H, 2010, IEEE ENG MED BIO, P3808, DOI 10.1109/IEMBS.2010.5627601; NEWMAN T. J, 2007, SINGLE CELL BASED MO, P221; Newman TJ, 2005, MATH BIOSCI ENG, V2, P613, DOI 10.3934/mbe.2005.2.613; Patel AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000412; SAHLIN P, LECT NOTES I COMPUTE, V4, P971; Sahlin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011750; Sandersius SA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015002; Schaller G, 2004, COMPUT PHYS COMMUN, V162, P9, DOI 10.1016/j.cpc.2004.06.066; Stern C.D., 2004, GASTRULATION CELLS E; Wottawah F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098103	26	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18081	10.1371/journal.pone.0018081	http://dx.doi.org/10.1371/journal.pone.0018081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559520	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700006
J	Subramaniya, BR; Srinivasan, G; Sadullah, SSM; Davis, N; Subhadara, LBR; Halagowder, D; Sivasitambaram, ND				Subramaniya, Bharathi Raja; Srinivasan, Gayathri; Sadullah, Sakeena Mohammed Sadullah; Davis, Nimitha; Subhadara, Lakshmi Baddi Reddi; Halagowder, Devaraj; Sivasitambaram, Niranjali Devaraj			Apoptosis Inducing Effect of Plumbagin on Colonic Cancer Cells Depends on Expression of COX-2	PLOS ONE			English	Article							COLORECTAL-CANCER; BETA-CATENIN; KAPPA-B; ACTIVATION; INHIBITION; MUTATIONS; ZEYLANICA; TARGET; PLANT; DNA	Plumbagin, a quinonoid found in the plants of the Plumbaginaceae, possesses medicinal properties. In this study we investigated the anti-proliferative and apoptotic activity of plumbagin by using two human colonic cancer cell lines, HT29 and HCT15. IC50 of Plumbagin for HCT15 and HT29 cells (22.5 mu M and 62.5 mu M, respectively) were significantly different. To study the response of cancer cells during treatment strategies, cells were treated with two different concentrations, 15 mu M, 30 mu M for HCT15 and 50 mu M, 75 mu M for HT29 cells. Though activation of NF kappa B, Caspases-3, elevated levels of TNF-alpha, cytosolic Cytochrome C were seen in both HCT15 cells HT29 treated with plumbagin, aberrant apoptosis with decreased level of pEGFR, pAkt, pGsk-3 beta, PCNA and Cyclin D1was observed only in 15 mu M and 30 mu M plumbagin treated HCT15 and 75 mu M plumbagin treated HT29 cells. This suggests that plumbagin induces apoptosis in both HCT15 cells and HT29 treated, whereas, proliferation was inhibited only in 15 mu M and 30 mu M plumbagin treated HCT15 and 75 mu M plumbagin treated HT29 cells, but not in 50 mM plumbagin treated HT29 cells. Expression of COX-2 was decreased in 75 mu M plumbagin treated HT29 cells when compared to 50 mu M plumbagin treated HT29 cells, whereas HCT15 cells lack COX. Hence the observed resistance to induction of apoptosis in 50 mu M plumbagin treated HT29 cells are attributed to the expression of COX-2. In conclusion, plumbagin induces apoptosis in colonic cancer cells through TNF-alpha mediated pathway depending on expression of COX-2 expression.	[Subramaniya, Bharathi Raja; Srinivasan, Gayathri; Sadullah, Sakeena Mohammed Sadullah; Davis, Nimitha; Sivasitambaram, Niranjali Devaraj] Univ Madras, Dept Biochem, Sch Life Sci, Chennai, Tamil Nadu, India; [Halagowder, Devaraj] Univ Madras, Dept Zool, Sch Life Sci, Chennai 600025, Tamil Nadu, India; [Subhadara, Lakshmi Baddi Reddi] Anna Univ, Ctr Biotechnol, Madras 600025, Tamil Nadu, India	University of Madras; University of Madras; Anna University; Anna University Chennai	Subramaniya, BR (corresponding author), Univ Madras, Dept Biochem, Sch Life Sci, Guindy Campus, Chennai, Tamil Nadu, India.	niranjali@yahoo.com	Subramaniya, Bharathi raja/A-7024-2012	S, BHARATHIRAJA/0000-0002-5680-7036	National Medicinal Plants Board, Government of India	National Medicinal Plants Board, Government of India	This study was supported by a grant from the National Medicinal Plants Board, Government of India, to Dr. S. Niranjali Devaraj. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Arber N, 2005, RECENT RESULTS CANC, V166, P213; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Choudhury SR, 2010, INVEST NEW DRUG, V28, P812, DOI 10.1007/s10637-009-9324-7; Das Sarma M, 2007, BIOORGAN MED CHEM, V15, P3672, DOI 10.1016/j.bmc.2007.03.050; Ding YX, 2005, J PHARM PHARMACOL, V57, P111, DOI 10.1211/0022357055119; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Jaiswal AS, 2002, ONCOGENE, V21, P5912, DOI 10.1038/sj.onc.1205789; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; JODI R, 2000, GENE DEV, V14, P3102; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mossa JS, 2004, PHYTOTHER RES, V18, P934, DOI 10.1002/ptr.1420; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; OLENA B, 2008, CANCER CELL, V14, P68; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Rupnarain C, 2004, BIOL CHEM, V385, P449, DOI 10.1515/BC.2004.053; Samowitz WS, 2002, J CLIN ONCOL, V20, P3178, DOI 10.1200/JCO.2002.20.14.3178; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Srinivas P, 2004, MOL CARCINOGEN, V40, P201, DOI 10.1002/mc.20031; Sugie S, 1998, CANCER LETT, V127, P177, DOI 10.1016/S0304-3835(98)00035-4; Tilak JC, 2004, REDOX REP, V9, P219, DOI 10.1179/135100004225005976	32	63	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18695	10.1371/journal.pone.0018695	http://dx.doi.org/10.1371/journal.pone.0018695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559086	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700020
J	Teitz, T; Stanke, JJ; Federico, S; Bradley, CL; Brennan, R; Zhang, JK; Johnson, MD; Sedlacik, J; Inoue, M; Zhang, ZWM; Frase, S; Rehg, JE; Hillenbrand, CM; Finkelstein, D; Calabrese, C; Dyer, MA; Lahti, JM				Teitz, Tal; Stanke, Jennifer J.; Federico, Sara; Bradley, Cori L.; Brennan, Rachel; Zhang, Jiakun; Johnson, Melissa D.; Sedlacik, Jan; Inoue, Madoka; Zhang, Ziwei M.; Frase, Sharon; Rehg, Jerold E.; Hillenbrand, Claudia M.; Finkelstein, David; Calabrese, Christopher; Dyer, Michael A.; Lahti, Jill M.			Preclinical Models for Neuroblastoma: Establishing a Baseline for Treatment	PLOS ONE			English	Article							MYCN AMPLIFICATION; PROMINENT NUCLEOLI; TRANSGENIC MICE; STROMA-POOR; IN-VIVO; EXPRESSION; TUMORS; APOPTOSIS; TUMORIGENESIS; PROGRESS	Background: Preclinical models of pediatric cancers are essential for testing new chemotherapeutic combinations for clinical trials. The most widely used genetic model for preclinical testing of neuroblastoma is the TH-MYCN mouse. This neuroblastoma-prone mouse recapitulates many of the features of human neuroblastoma. Limitations of this model include the low frequency of bone marrow metastasis, the lack of information on whether the gene expression patterns in this system parallels human neuroblastomas, the relatively slow rate of tumor formation and variability in tumor penetrance on different genetic backgrounds. As an alternative, preclinical studies are frequently performed using human cell lines xenografted into immunocompromised mice, either as flank implant or orthtotopically. Drawbacks of this system include the use of cell lines that have been in culture for years, the inappropriate microenvironment of the flank or difficult, time consuming surgery for orthotopic transplants and the absence of an intact immune system. Principal Findings: Here we characterize and optimize both systems to increase their utility for preclinical studies. We show that TH-MYCN mice develop tumors in the paraspinal ganglia, but not in the adrenal, with cellular and gene expression patterns similar to human NB. In addition, we present a new ultrasound guided, minimally invasive orthotopic xenograft method. This injection technique is rapid, provides accurate targeting of the injected cells and leads to efficient engraftment. We also demonstrate that tumors can be detected, monitored and quantified prior to visualization using ultrasound, MRI and bioluminescence. Finally we develop and test a "standard of care'' chemotherapy regimen. This protocol, which is based on current treatments for neuroblastoma, provides a baseline for comparison of new therapeutic agents. Significance: The studies suggest that use of both the TH-NMYC model of neuroblastoma and the orthotopic xenograft model provide the optimal combination for testing new chemotherapies for this devastating childhood cancer.	[Teitz, Tal; Stanke, Jennifer J.; Inoue, Madoka; Lahti, Jill M.] St Jude Childrens Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; [Stanke, Jennifer J.; Federico, Sara; Bradley, Cori L.; Brennan, Rachel; Zhang, Jiakun; Dyer, Michael A.] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Federico, Sara] St Jude Childrens Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; [Johnson, Melissa D.; Zhang, Ziwei M.; Calabrese, Christopher] St Jude Childrens Hosp, Anim Imaging Ctr, Memphis, TN 38105 USA; [Sedlacik, Jan; Hillenbrand, Claudia M.] St Jude Childrens Hosp, Dept Radiol Sci, Memphis, TN 38105 USA; [Rehg, Jerold E.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Dyer, Michael A.] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN USA; [Dyer, Michael A.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Lahti, Jill M.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Howard Hughes Medical Institute; University of Tennessee System; University of Tennessee Health Science Center	Teitz, T (corresponding author), St Jude Childrens Hosp, Dept Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Michael.Dyer@stjude.org; Jill.Lahti@stjude.org	Dyer, Michael/N-8134-2018; Hillenbrand, Claudia/A-5152-2009; Rehg, Jerold E/N-8111-2018; Hillenbrand, Claudia/AAH-2591-2021	Hillenbrand, Claudia/0000-0001-8694-2178; Hillenbrand, Claudia/0000-0001-8694-2178; Johnson, Melissa/0000-0002-3794-3518	Comprehensive Cancer Center [CA021765]; Cancer Center; National Institutes of Health [CA067938-09, EY014867, EY018599, CA114102]; American Cancer Society; Research to Prevent Blindness Foundation; American Syrian Lebanese Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765, R01CA067938, R01CA114102, R56CA067938] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018599, R01EY014867] Funding Source: NIH RePORTER	Comprehensive Cancer Center; Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); American Syrian Lebanese Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by Comprehensive Cancer Center Support Grant CA021765, a Cancer Center Development grant (JML), National Institutes of Health grants CA067938-09 (JML), EY014867, EY018599 (MAD) and CA114102 (JS) [http://www.nih.gov], grants from the American Cancer Society [http://www.cancer.org], and Research to Prevent Blindness Foundation to (MAD) [http://www.rpbusa.org/rpb/], and American Syrian Lebanese Associated Charities (ALSAC)[http://www.StJude.org]. MAD is a Howard Hughes Medical Institute Early Career Scientist [http://www.hhmi.org]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam G, 2009, AM J PATHOL, V175, P856, DOI 10.2353/ajpath.2009.090019; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chen ZW, 2009, NEOPLASIA, V11, P753, DOI 10.1593/neo.09466; Cheng AJ, 2007, EUR J CANCER, V43, P1467, DOI 10.1016/j.ejca.2007.03.008; Chesler L, 2008, NEOPLASIA, V10, P1268, DOI 10.1593/neo.08778; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Dickson PV, 2007, J PEDIATR SURG, V42, P1172, DOI 10.1016/j.jpedsurg.2007.02.027; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Hackett CS, 2003, CANCER RES, V63, P5266; Hansford LM, 2004, P NATL ACAD SCI USA, V101, P12664, DOI 10.1073/pnas.0401083101; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hero B, 2008, J CLIN ONCOL, V26, P1504, DOI 10.1200/JCO.2007.12.3349; Hoehner JC, 1996, LAB INVEST, V75, P659; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janoueix-Lerosey I, 2010, ONCOGENE, V29, P1566, DOI 10.1038/onc.2009.518; Kobayashi C, 2005, CANCER-AM CANCER SOC, V103, P174, DOI 10.1002/cncr.20717; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mathew P, 2001, NEOPLASIA, V3, P105, DOI 10.1038/sj.neo.7900146; Matthay KK, 1998, J CLIN ONCOL, V16, P2003, DOI 10.1200/JCO.1998.16.6.2003; Monclair T, 2009, J CLIN ONCOL, V27, P298, DOI 10.1200/JCO.2008.16.6876; Moore HC, 2008, J CLIN PATHOL, V61, P1098, DOI 10.1136/jcp.2007.054627; Murphy DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008154; Rofsky NM, 1999, RADIOLOGY, V212, P876, DOI 10.1148/radiology.212.3.r99se34876; Rounbehler RJ, 2009, CANCER RES, V69, P547, DOI 10.1158/0008-5472.CAN-08-2968; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Schulte JH, 2010, INT J CANCER, V127, P2374, DOI 10.1002/ijc.25436; Sedlacik J., 2009, P INT SOC MAG RESON, V17, P3595; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Tang XX, 2006, CANCER RES, V66, P2826, DOI 10.1158/0008-5472.CAN-05-0854; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Tekautz TM, 2006, BBA-MOL CELL RES, V1763, P1000, DOI 10.1016/j.bbamcr.2006.06.014; Thiele C. J, 1998, NEUROBLASTOMA CELL L, V1, P21; Tornoczky T, 2004, CANCER-AM CANCER SOC, V100, P390, DOI 10.1002/cncr.20005; Tornoczky T, 2007, PATHOL ONCOL RES, V13, P269, DOI 10.1007/BF02940304; Wang XZ, 2007, MOL CELL BIOL, V27, P3098, DOI 10.1128/MCB.02357-06; Weidensteiner C, 2006, J MAGN RESON IMAGING, V24, P646, DOI 10.1002/jmri.20676; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985	41	63	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19133	10.1371/journal.pone.0019133	http://dx.doi.org/10.1371/journal.pone.0019133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559450	gold, Green Submitted, Green Published			2022-12-25	WOS:000290024700073
J	Wu, D; Lin, F				Wu, Dan; Lin, Francis			Modeling Cell Gradient Sensing and Migration in Competing Chemoattractant Fields	PLOS ONE			English	Article							FORMYL PEPTIDE-RECEPTOR; NEURONAL MIGRATION; HUMAN NEUTROPHILS; UP-REGULATION; CHEMOTAXIS; INTERNALIZATION; DYNAMICS; DESENSITIZATION; FLUCTUATIONS; DISSOCIATION	Directed cell migration mediates physiological and pathological processes. In particular, immune cell trafficking in tissues is crucial for inducing immune responses and is coordinated by multiple environmental cues such as chemoattractant gradients. Although the chemotaxis mechanism has been extensively studied, how cells integrate multiple chemotactic signals for effective trafficking and positioning in tissues is not clearly defined. Results from previous neutrophil chemotaxis experiments and modeling studies suggested that ligand-induced homologous receptor desensitization may provide an important mechanism for cell migration in competing chemoattractant gradients. However, the previous mathematical model is oversimplified to cell gradient sensing in one-dimensional (1-D) environment. To better understand the receptor desensitization mechanism for chemotactic navigation, we further developed the model to test the role of homologous receptor desensitization in regulating both cell gradient sensing and migration in different configurations of chemoattractant fields in two-dimension (2-D). Our results show that cells expressing normal desensitizable receptors preferentially orient and migrate toward the distant gradient in the presence of a second local competing gradient, which are consistent with the experimentally observed preferential migration of cells toward the distant attractant source and confirm the requirement of receptor desensitization for such migratory behaviors. Furthermore, our results are in qualitative agreement with the experimentally observed cell migration patterns in different configurations of competing chemoattractant fields.	[Wu, Dan; Lin, Francis] Univ Manitoba, Dept Phys & Astron, Winnipeg, MB, Canada; [Lin, Francis] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Lin, Francis] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Lin, Francis] Univ Manitoba, Dept Biosyst Engn, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Wu, D (corresponding author), Univ Manitoba, Dept Phys & Astron, Winnipeg, MB, Canada.	flin@physics.umanitoba.ca		Lin, Francis/0000-0003-1736-193X	Natural Sciences and Engineering Research Council of Canada (NSERC); Manitoba Health Research Council (MHRC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Health Research Council (MHRC)	Funding was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/index_eng.asp) and the Manitoba Health Research Council (MHRC) (http://www.mhrc.mb.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 1997, J BIOL CHEM, V272, P25037, DOI 10.1074/jbc.272.40.25037; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Britschgi MR, 2010, EUR J IMMUNOL, V40, P1266, DOI 10.1002/eji.200939921; Dekker LV, 2000, SCIENCE, V287, P982, DOI 10.1126/science.287.5455.982; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Heit B, 2005, J CELL SCI, V118, P5205, DOI 10.1242/jcs.02632; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Hoffman JF, 1996, J BIOL CHEM, V271, P18394, DOI 10.1074/jbc.271.31.18394; Iglesias Pablo A, 2002, Sci STKE, V2002, pre12, DOI 10.1126/stke.2002.148.re12; Kawai T, 2009, CURR OPIN HEMATOL, V16, P20, DOI 10.1097/MOH.0b013e32831ac557; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Kunkel EJ, 2003, MICROCIRCULATION, V10, P313, DOI 10.1038/sj.mn.7800196; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; LAUFFENBURGER DA, 1982, CELL BIOPHYS, V4, P177, DOI 10.1007/BF02918312; Lin F, 2005, ANN BIOMED ENG, V33, P475, DOI 10.1007/s10439-005-2503-6; Lin F, 2008, J IMMUNOL, V181, P8335, DOI 10.4049/jimmunol.181.12.8335; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Matsubayashi Y, 2004, CURR BIOL, V14, P731, DOI 10.1016/j.cub.2004.03.060; McDougall S, 2006, PHILOS T R SOC A, V364, P1385, DOI [10.1098/rsta.2006.1773, 10.1098/rsta.2000.1773]; MOGHE PV, 1995, J IMMUNOL METHODS, V180, P193, DOI 10.1016/0022-1759(94)00314-M; Mueller SG, 1997, J BIOL CHEM, V272, P8207, DOI 10.1074/jbc.272.13.8207; NORGAUER J, 1991, J IMMUNOL, V146, P975; Normark S, 2001, NAT MED, V7, P1182, DOI 10.1038/nm1101-1182; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; SKLAR LA, 1984, J BIOL CHEM, V259, P5661; SKLAR LA, 1986, ADV IMMUNOL, V39, P95; SKLAR LA, 1987, J BIOL CHEM, V262, P135; TRANQUILLO RT, 1988, J CELL BIOL, V106, P303, DOI 10.1083/jcb.106.2.303; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; ZIGMOND SH, 1981, J CELL BIOL, V88, P644, DOI 10.1083/jcb.88.3.644	36	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18805	10.1371/journal.pone.0018805	http://dx.doi.org/10.1371/journal.pone.0018805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559528	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700027
J	Dasgupta, S; Samantaray, S; Sahal, D; Roy, RP				Dasgupta, Sayani; Samantaray, Sharmishtha; Sahal, Dinkar; Roy, Rajendra P.			Isopeptide Ligation Catalyzed by Quintessential Sortase A MECHANISTIC CUES FROM CYCLIC AND BRANCHED OLIGOMERS OF INDOLICIDIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; STAPHYLOCOCCUS-AUREUS SORTASE; SURFACE-PROTEINS; CELL-WALL; CORYNEBACTERIUM-DIPHTHERIAE; STREPTOCOCCUS-PNEUMONIAE; STABILIZING ISOPEPTIDE; PILUS ADHESIN; PEPTIDE; BONDS	The housekeeping transpeptidase sortase A (SrtA) from Staphyloccocus aureus catalyzes the covalent anchoring of surface proteins to the cell wall by linking the threonyl carboxylate of the LPXTG recognition motif to the amino group of the pentaglycine cross-bridge of the peptidoglycan. SrtA-catalyzed ligation of an LPXTG containing polypeptide with an aminoglycine-terminated moiety occurs efficiently in vitro and has inspired the use of this enzyme as a synthetic tool in biological chemistry. Here we demonstrate the propensity of SrtA to catalyze "isopeptide" ligation. Using model peptide sequences, we show that SrtA can transfer LPXTG peptide substrates to the epsilon-amine of specific Lys residues and form cyclized and/or a gamut of branched oligomers. Our results provide insights about principles governing isopeptide ligation reactions catalyzed by SrtA and suggest that although cyclization is guided by distance relationship between Lys (epsilon-amine) and Thr (alpha-carboxyl) residues, facile branched oligomerization requires the presence of a stable and long-lived acyl-enzyme intermediate.	[Dasgupta, Sayani; Samantaray, Sharmishtha; Roy, Rajendra P.] Natl Inst Immunol, New Delhi 110067, India; [Sahal, Dinkar] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Roy, RP (corresponding author), Natl Inst Immunol, New Delhi 110067, India.	rproy@nii.res.in	SAHAL, DINKAR/GYD-7570-2022	Dasgupta, Sayani/0000-0003-4782-7956	Department of Biotechnology, Government of India [BT/PR-9934/BRB/10/579/2007]; Department of Biotechnology	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology	This work was supported by Grant BT/PR-9934/BRB/10/579/2007 from the Department of Biotechnology, Government of India (to R. P. R.), and core grants from the Department of Biotechnology to the National Institute of Immunology.	Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Antos JM, 2009, J BIOL CHEM, V284, P16028, DOI 10.1074/jbc.M901752200; Antos JM, 2008, J AM CHEM SOC, V130, P16338, DOI 10.1021/ja806779e; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Chan LY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001164; Clow F, 2008, BIOTECHNOL LETT, V30, P1603, DOI 10.1007/s10529-008-9718-1; El Mortaji L, 2010, J BIOL CHEM, V285, P12405, DOI 10.1074/jbc.M109.082776; Falker S, 2008, MOL MICROBIOL, V70, P595, DOI 10.1111/j.1365-2958.2008.06396.x; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Gaspar AH, 2006, J BACTERIOL, V188, P1526, DOI 10.1128/JB.188.4.1526-1533.2006; Guo XQ, 2009, J AM CHEM SOC, V131, P9878, DOI 10.1021/ja903231v; Guttilla IK, 2009, J BACTERIOL, V191, P5603, DOI 10.1128/JB.00627-09; HOMANDBERG GA, 1979, BIOCHEMISTRY-US, V18, P586, DOI 10.1021/bi00571a006; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Ito T, 2010, BIOCHEMISTRY-US, V49, P2604, DOI 10.1021/bi100094g; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2011, TRENDS BIOCHEM SCI, V36, P227, DOI 10.1016/j.tibs.2010.09.007; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manzano C, 2009, BIOCHEMISTRY-US, V48, P10549, DOI 10.1021/bi901261y; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Popp MW, 2011, P NATL ACAD SCI USA, V108, P3169, DOI 10.1073/pnas.1016863108; Samantaray S, 2008, J AM CHEM SOC, V130, P2132, DOI 10.1021/ja077358g; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Tanaka T, 2008, CHEMBIOCHEM, V9, P802, DOI 10.1002/cbic.200700614; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Ton-That H, 1999, J BIOL CHEM, V274, P24316, DOI 10.1074/jbc.274.34.24316; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; WALLACE CJA, 1995, CURR OPIN BIOTECH, V6, P403, DOI 10.1016/0958-1669(95)80069-7; Wu S, 2010, BIOTECHNOL LETT, V32, P1713, DOI 10.1007/s10529-010-0349-y; Wu ZM, 2010, J AM CHEM SOC, V132, P1567, DOI 10.1021/ja906611x; Yamamoto T, 2009, CHEM COMMUN, P1022, DOI 10.1039/b818792d	48	23	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23996	24006		10.1074/jbc.M111.247650	http://dx.doi.org/10.1074/jbc.M111.247650			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566128	hybrid, Green Published			2022-12-25	WOS:000292294900042
J	Ohnishi, A; Hull, JJ; Kaji, M; Hashimoto, K; Lee, JM; Tsuneizumi, K; Suzuki, T; Dohmae, N; Matsumoto, S				Ohnishi, Atsushi; Hull, J. Joe; Kaji, Misato; Hashimoto, Kana; Lee, Jae Min; Tsuneizumi, Kazuhide; Suzuki, Takehiro; Dohmae, Naoshi; Matsumoto, Shogo			Hormone Signaling Linked to Silkmoth Sex Pheromone Biosynthesis Involves Ca2+/Calmodulin-dependent Protein Kinase II-mediated Phosphorylation of the Insect PAT Family Protein Bombyx mori Lipid Storage Droplet Protein-1 (BmLsd1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING NEUROPEPTIDE PBAN; TRANSDUCTION CASCADE; MANDUCA-SEXTA; FAT-BODY; SILKWORM; IDENTIFICATION; INVOLVEMENT; EXPRESSION; LIPOLYSIS; RECEPTOR	Species-specific sex pheromones released by female moths to attract conspecific male moths are synthesized de novo in the pheromone gland (PG) via the fatty acid biosynthetic pathway. This pathway is regulated by a neurohormone termed pheromone biosynthesis activating neuropeptide (PBAN), a 33-amino acid peptide that originates in the subesophageal ganglion. In the silkmoth, Bombyx mori, cytoplasmic lipid droplets, which store the sex pheromone (bombykol) precursor fatty acid, accumulate in PG cells. PBAN stimulates lipolysis of the stored lipid droplet triacylglycerols (TAGs) and releases the precursor for final modification. PBAN exerts its physiological function via the PG cell-surface PBAN receptor, a G protein-coupled receptor that belongs to the neuromedin U receptor family. The PBAN receptor-mediated signal is transmitted via a canonical store-operated channel activation pathway utilizing Gq-mediated phospholipase C activation (Hull, J. J., Kajigaya, R., Imai, K., and Matsumoto, S. (2007) Biosci. Biotechnol. Biochem. 71, 1993-2001; Hull, J. J., Lee, J. M., Kajigaya, R., and Matsumoto, S. (2009) J. Biol. Chem. 284, 31200-31213; Hull, J. J., Lee, J. M., and Matsumoto, S. (2010) Insect Mol. Biol. 19, 553-566). Little, however, is known about the molecular components regulating TAG lipolysis in PG cells. In the current study we found that PBAN signaling involves phosphorylation of an insect PAT family protein named B. mori lipid storage droplet protein-1 (BmLsd1) and that BmLsd1 plays an essential role in the TAG lipolysis associated with bombykol production. Unlike mammalian PAT family perilipins, however, BmLsd1 activation is dependent on phosphorylation by B. mori Ca2+/calmodulin-dependent protein kinase II rather than protein kinase A.	[Ohnishi, Atsushi; Hull, J. Joe; Kaji, Misato; Hashimoto, Kana; Lee, Jae Min; Tsuneizumi, Kazuhide; Suzuki, Takehiro; Dohmae, Naoshi; Matsumoto, Shogo] RIKEN, Adv Sci Inst, Wako, Saitama 3510198, Japan	RIKEN	Ohnishi, A (corresponding author), RIKEN, Adv Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	aohnishi@riken.jp; smatsu@riken.jp	Dohmae, Naoshi/C-2040-2011; Suzuki, Takehiro/B-3210-2013	Dohmae, Naoshi/0000-0002-5242-9410; Ohnishi, Atsushi/0000-0003-1213-4439	RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan [20380040]	RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Lipid Dynamics Research Program from RIKEN and the Targeted Proteins Research Program and Grants-in-aid for Scientific Research (B) 20380040 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Arrese EL, 2008, INSECT BIOCHEM MOLEC, V38, P993, DOI 10.1016/j.ibmb.2008.08.004; Bjostad L.B., 1987, P77; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Choi MY, 2003, P NATL ACAD SCI USA, V100, P9721, DOI 10.1073/pnas.1632485100; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Fonagy A, 2005, ANN NY ACAD SCI, V1040, P310, DOI 10.1196/annals.1327.049; FONAGY A, 1992, J PESTIC SCI, V17, P47; Fonagy A, 2000, J INSECT PHYSIOL, V46, P735, DOI 10.1016/S0022-1910(99)00162-6; Fonagy A, 2001, ARTHROPOD STRUCT DEV, V30, P113, DOI 10.1016/S1467-8039(01)00027-5; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Gade G, 2003, GEN COMP ENDOCR, V132, P10, DOI 10.1016/S0016-6480(03)00159-X; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Hull JJ, 2010, INSECT MOL BIOL, V19, P553, DOI 10.1111/j.1365-2583.2010.01013.x; Hull JJ, 2007, BIOSCI BIOTECH BIOCH, V71, P1993, DOI 10.1271/bbb.70175; Hull JJ, 2007, J INSECT PHYSIOL, V53, P782, DOI 10.1016/j.jinsphys.2007.02.013; Hull JJ, 2009, J BIOL CHEM, V284, P31200, DOI 10.1074/jbc.M109.044198; Hull JJ, 2004, J BIOL CHEM, V279, P51500, DOI 10.1074/jbc.M408142200; Jurenka R.A., 2003, P53, DOI 10.1016/B978-012107151-6/50005-0; Kim YJ, 2008, PEPTIDES, V29, P268, DOI 10.1016/j.peptides.2007.12.001; KITAMURA A, 1989, BIOCHEM BIOPH RES CO, V163, P520, DOI 10.1016/0006-291X(89)92168-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; LAW JH, 1989, J BIOL CHEM, V264, P16335; MATSUMOTO S, 1995, BIOSCI BIOTECH BIOCH, V59, P560, DOI 10.1271/bbb.59.560; MATSUMOTO S, 1990, J INSECT PHYSIOL, V36, P427, DOI 10.1016/0022-1910(90)90060-S; Matsumoto S, 2002, INSECT BIOCHEM MOLEC, V32, P1447, DOI 10.1016/S0965-1748(02)00065-6; Matsumoto S, 2001, INSECT BIOCHEM MOLEC, V31, P603, DOI 10.1016/S0965-1748(00)00165-X; Matsumoto S, 2007, J INSECT PHYSIOL, V53, P752, DOI 10.1016/j.jinsphys.2007.02.014; Matsumoto S, 2010, VITAM HORM, V83, P425, DOI 10.1016/S0083-6729(10)83018-3; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Moto K, 2004, P NATL ACAD SCI USA, V101, P8631, DOI 10.1073/pnas.0402056101; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; Ohnishi A, 2009, J BIOL CHEM, V284, P5128, DOI 10.1074/jbc.M806072200; Ozawa R, 1996, INSECT BIOCHEM MOLEC, V26, P259, DOI 10.1016/0965-1748(95)00088-7; Patel RT, 2006, ARCH INSECT BIOCHEM, V63, P73, DOI 10.1002/arch.20143; Patel RT, 2005, J BIOL CHEM, V280, P22624, DOI 10.1074/jbc.M413128200; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Percy JE, 1974, PHEROMONES, P11; Rafaeli A, 2002, INT REV CYTOL, V213, P49; Rafaeli A, 2009, GEN COMP ENDOCR, V162, P69, DOI 10.1016/j.ygcen.2008.04.004; RAINA AK, 1989, SCIENCE, V244, P796, DOI 10.1126/science.244.4906.796; Uno T, 2006, ARCH INSECT BIOCHEM, V61, P65, DOI 10.1002/arch.20098; Van der Horst DJ, 2001, INT REV CYTOL, V211, P179, DOI 10.1016/S0074-7696(01)11019-3; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726	47	29	31	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24101	24112		10.1074/jbc.M111.250555	http://dx.doi.org/10.1074/jbc.M111.250555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572162	Green Published, hybrid			2022-12-25	WOS:000292294900052
J	McMaken, S; Exline, MC; Mehta, P; Piper, M; Wang, YJ; Fischer, SN; Newland, CA; Schrader, CA; Balser, SR; Sarkar, A; Baran, CP; Marsh, CB; Cook, CH; Phillips, GS; Ali, NA				McMaken, Sara; Exline, Matthew C.; Mehta, Payal; Piper, Melissa; Wang, Yijie; Fischer, Sara N.; Newland, Christie A.; Schrader, Carrie A.; Balser, Shannon R.; Sarkar, Anasuya; Baran, Christopher P.; Marsh, Clay B.; Cook, Charles H.; Phillips, Gary S.; Ali, Naeem A.			Thrombospondin-1 Contributes to Mortality in Murine Sepsis through Effects on Innate Immunity	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; POSTOPERATIVE ADHESIONS; UNITED-STATES; FIBROBLASTS; EXPRESSION; EPIDEMIOLOGY; PHAGOCYTOSIS; PERITONITIS; HOMEOSTASIS; PNEUMONIA	Background: Thrombospondin-1 (TSP-1) is involved in many biological processes, including immune and tissue injury response, but its role in sepsis is unknown. Cell surface expression of TSP-1 on platelets is increased in sepsis and could activate the anti-inflammatory cytokine transforming growth factor beta (TGF beta 1) affecting outcome. Because of these observations we sought to determine the importance of TSP-1 in sepsis. Methodology/Principal Findings: We performed studies on TSP-1 null and wild type (WT) C57BL/6J mice to determine the importance of TSP-1 in sepsis. We utilized the cecal ligation puncture (CLP) and intraperitoneal E. coli injection (IP E. coli) models of peritoneal sepsis. Additionally, bone-marrow-derived macrophages (BMMs) were used to determine phagocytic activity. TSP-1-/- animals experienced lower mortality than WT mice after CLP. Tissue and peritoneal lavage TGF beta 1 levels were unchanged between animals of each genotype. In addition, there is no difference between the levels of major innate cytokines between the two groups of animals. PLF from WT mice contained a greater bacterial load than TSP-1-/- mice after CLP. The survival advantage for TSP-1-/- animals persisted when IP E. coli injections were performed. TSP-1-/- BMMs had increased phagocytic capacity compared to WT. Conclusions: TSP-1 deficiency was protective in two murine models of peritoneal sepsis, independent of TGF beta 1 activation. Our studies suggest TSP-1 expression is associated with decreased phagocytosis and possibly bacterial clearance, leading to increased peritoneal inflammation and mortality in WT mice. These data support the contention that TSP-1 should be more fully explored in the human condition.	[McMaken, Sara; Exline, Matthew C.; Mehta, Payal; Piper, Melissa; Wang, Yijie; Fischer, Sara N.; Newland, Christie A.; Schrader, Carrie A.; Balser, Shannon R.; Sarkar, Anasuya; Baran, Christopher P.; Marsh, Clay B.; Ali, Naeem A.] Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Dept Internal Med, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Cook, Charles H.] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Phillips, Gary S.] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	McMaken, S (corresponding author), Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Dept Internal Med, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	Naeem.Ali@osumc.edu	Exline, Matthew/E-3047-2011; Cook, Charles/D-5574-2009; Piper, Melissa/E-3872-2011; Cook, Charles/AAE-3222-2020	Cook, Charles/0000-0003-4446-3616; ALI, NORA'AINI/0000-0003-1391-2757	National Institutes of Health [K23 RR019544]; American Lung Association [RG-52369-N]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755, K23RR019544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	National Institutes of Health K23 RR019544 to NAA; American Lung Association Award RG-52369-N to MCE. The funders had no role in the design of the study, data collection and analysis, decision to publish or preparation of the manuscript.	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Ali NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001914; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Aytekin FO, 2007, AM J SURG, V193, P723, DOI 10.1016/j.amjsurg.2006.06.035; BAENZIGE.NL, 1971, P NATL ACAD SCI USA, V68, P240, DOI 10.1073/pnas.68.1.240; Baran CP, 2003, J BIOL CHEM, V278, P38628, DOI 10.1074/jbc.M305021200; Barker TH, 2004, J BIOL CHEM, V279, P23510, DOI 10.1074/jbc.M402169200; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cook DJ, 1998, ANN INTERN MED, V129, P433, DOI 10.7326/0003-4819-129-6-199809150-00002; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Dellinger RP, 2003, CRIT CARE MED, V31, P946, DOI 10.1097/01.CCM.0000057403.73299.A6; Diamond MP, 2005, FERTIL STERIL, V83, P405, DOI 10.1016/j.fertnstert.2004.06.073; DiPietro LA, 1996, AM J PATHOL, V148, P1851; Esemuede N, 2004, J SURG RES, V122, P135, DOI 10.1016/j.jss.2004.05.015; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; IRUELAARISPE ML, 1991, P NATL ACAD SCI USA, V88, P5026, DOI 10.1073/pnas.88.11.5026; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Maloney JP, 2002, FASEB J, V16, pA879; MANSFIELD PJ, 1994, J IMMUNOL, V153, P4219; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martin-Manso G, 2008, CANCER RES, V68, P7090, DOI 10.1158/0008-5472.CAN-08-0643; Moodley Y, 2003, AM J PATHOL, V162, P771, DOI 10.1016/S0002-9440(10)63874-6; NARIZHNEVA NV, 2005, FASEB J; Piazuelo E, 2000, EUR SURG RES, V32, P191, DOI 10.1159/000008762; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; REN Y, 1995, J IMMUNOL, V154, P2366; Riche FC, 2009, CRIT CARE, V13, DOI 10.1186/cc7931; Saed GM, 2004, J AM ASSOC GYN LAP, V11, P307, DOI 10.1016/S1074-3804(05)60041-2; Saltzman AK, 1996, AM J OBSTET GYNECOL, V174, P1502, DOI 10.1016/S0002-9378(96)70596-3; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26783; SIMMS HH, 1994, BLOOD, V83, P1398; Steinhauser ML, 1999, J IMMUNOL, V162, P5437; Streit M, 2000, EMBO J, V19, P3272, DOI 10.1093/emboj/19.13.3272; Tridandapani S, 2000, J BIOL CHEM, V275, P20480, DOI 10.1074/jbc.M909462199; van der Wal JBC, 2007, COLORECTAL DIS, V9, P9, DOI 10.1111/j.1463-1318.2007.01345.x; van Zoelen MAD, 2008, J IMMUNOL, V180, P3357, DOI 10.4049/jimmunol.180.5.3357; Wirtz S, 2006, J EXP MED, V203, P1875, DOI 10.1084/jem.20060471; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044	42	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19654	10.1371/journal.pone.0019654	http://dx.doi.org/10.1371/journal.pone.0019654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573017	Green Published, Green Submitted, gold			2022-12-25	WOS:000290386800028
J	Lucifora, LO; Garcia, VB; Worm, B				Lucifora, Luis O.; Garcia, Veronica B.; Worm, Boris			Global Diversity Hotspots and Conservation Priorities for Sharks	PLOS ONE			English	Article							BIODIVERSITY HOTSPOTS; MARINE BIODIVERSITY; PREDATOR DIVERSITY; PATTERNS; COLLAPSE; RAYS	Sharks are one of the most threatened groups of marine animals, as high exploitation rates coupled with low resilience to fishing pressure have resulted in population declines worldwide. Designing conservation strategies for this group depends on basic knowledge of the geographic distribution and diversity of known species. So far, this information has been fragmented and incomplete. Here, we have synthesized the first global shark diversity pattern from a new database of published sources, including all 507 species described at present, and have identified hotspots of shark species richness, functional diversity and endemicity from these data. We have evaluated the congruence of these diversity measures and demonstrate their potential use in setting priority areas for shark conservation. Our results show that shark diversity across all species peaks on the continental shelves and at mid-latitudes (30-40 degrees N and S). Global hotspots of species richness, functional diversity and endemicity were found off Japan, Taiwan, the East and West coasts of Australia, Southeast Africa, Southeast Brazil and Southeast USA. Moreover, some areas with low to moderate species richness such as Southern Australia, Angola, North Chile and Western Continental Europe stood out as places of high functional diversity. Finally, species affected by shark finning showed different patterns of diversity, with peaks closer to the Equator and a more oceanic distribution overall. Our results show that the global pattern of shark diversity is uniquely different from land, and other well-studied marine taxa, and may provide guidance for spatial approaches to shark conservation. However, similar to terrestrial ecosystems, protected areas based on hotspots of diversity and endemism alone would provide insufficient means for safeguarding the diverse functional roles that sharks play in marine ecosystems.	[Lucifora, Luis O.] Consejo Nacl Invest Cient & Tecn, CIES, CeIBA, Puerto Iguazu, Misiones, Argentina; [Lucifora, Luis O.; Garcia, Veronica B.; Worm, Boris] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Dalhousie University	Lucifora, LO (corresponding author), Consejo Nacl Invest Cient & Tecn, CIES, CeIBA, Puerto Iguazu, Misiones, Argentina.	bworm@dal.ca	Lucifora, Luis/B-4602-2014	Worm, Boris/0000-0002-5742-8716; Lucifora, Luis/0000-0002-1443-303X	Lenfest Oceans Program; Sloan Foundation	Lenfest Oceans Program; Sloan Foundation(Alfred P. Sloan Foundation)	This study was supported financially by the Lenfest Oceans Program. Additional funding was provided by the Sloan Foundation (Census Of Marine Life FMAP Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bonfil R., 1994, FAO FISHERIES TECHNI, V341, P119; Boyce DG, 2008, MAR ECOL PROG SER, V355, P267, DOI 10.3354/meps07237; Camhi MD, 2009, CONSERVATION STATUS; Camhi Merry D., 2008, Fish and Aquatic Resources Series, V13, P418; Carpenter KE, 2005, ENVIRON BIOL FISH, V72, P467, DOI 10.1007/s10641-004-3154-4; Clarke S, 2004, SHARK PRODUCT TRADE; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Compagno L.J.V., 2001, SHARKS WORLD, V2; Compagno L.J.V., 2005, FIELD GUIDE SHARKS W; COMPAGNO LJV, 1990, ENVIRON BIOL FISH, V28, P33, DOI 10.1007/BF00751027; Compagno LJV., 1984, FAO FISH SYNOP, P20; COMPAGNO LJV, 1990, ELASMOBRANCHS LIVING, V90, P391; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fowler Sarah L., 2005, P58; Godin AC, 2010, MAR POLICY, V34, P995, DOI 10.1016/j.marpol.2010.02.006; Graham KJ, 2001, MAR FRESHWATER RES, V52, P549, DOI 10.1071/MF99174; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Last PR, 2009, SHARKS RAYS AUSTR; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Massa A., 2004, MAR ARGENTINO SUS RE, P193; Menni RC, 2010, BIODIVERS CONSERV, V19, P775, DOI 10.1007/s10531-009-9734-z; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; MUSICK JA, 1993, CONSERVATION BIOL EL, V115, P1; Pollard DA, 1996, AQUAT CONSERV, V6, P1, DOI 10.1002/(SICI)1099-0755(199603)6:1<1::AID-AQC177>3.0.CO;2-#; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; Schnute JT, 2008, CAN TECH REP FISH AQ, V2549, P1; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100; Yano K, 2005, SHARKS RAYS MALAYSIA	38	96	105	3	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19356	10.1371/journal.pone.0019356	http://dx.doi.org/10.1371/journal.pone.0019356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573162	Green Published, gold, Green Submitted			2022-12-25	WOS:000290256400006
J	Bhat, RK; Ellestad, KK; Wheatley, BM; Warren, R; Holt, RA; Power, C				Bhat, Rakesh K.; Ellestad, Kristofor K.; Wheatley, B. Matt; Warren, Rene; Holt, Robert A.; Power, Christopher			Age- and Disease-Dependent HERV-W Envelope Allelic Variation in Brain: Association with Neuroimmune Gene Expression	PLOS ONE			English	Article							HUMAN ENDOGENOUS RETROVIRUSES; MOLECULAR CHARACTERIZATION; MULTIPLE-SCLEROSIS; CODING CAPACITY; ENV; IDENTIFICATION; GLYCOPROTEIN; FAMILY; NEUROINFLAMMATION; SYNCYTIN-1	Background: The glycoprotein, Syncytin-1, is encoded by a human endogenous retrovirus (HERV)-W env gene and is capable of inducing neuroinflammation. The specific allele(s) responsible for Syncytin-1 expression in the brain is uncertain. Herein, HERV-W env diversity together with Syncytin-1 abundance and host immune gene profiles were examined in the nervous system using a multiplatform approach. Results: HERV-W env sequences were encoded by multiple chromosomal encoding loci in primary human neurons compared with less chromosomal diversity in astrocytes and microglia (p < 0.05). HERV-W env RNA sequences cloned from brains of patients with systemic or neurologic diseases were principally derived from chromosomal locus 7q21.2. Within the same specimens, HERV-W env transcript levels were correlated with the expression of multiple proinflammatory genes (p < 0.05). Deep sequencing of brain transcriptomes disclosed the env transcripts to be the most abundant HERV-W transcripts, showing greater expression in fetal compared with healthy adult brain specimens. Syncytin-1' s expression in healthy brain specimens was derived from multiple encoding loci and linked to distinct immune and developmental gene profiles. Conclusions: Syncytin-1 expression in the brain during disease was associated with neuroinflammation and was principally encoded by a full length provirus. The present studies also highlighted the diversity in HERV gene expression within the brain and reinforce the potential contributions of HERV expression to neuroinflammatory diseases.	[Bhat, Rakesh K.; Ellestad, Kristofor K.; Power, Christopher] Univ Alberta, Div Neurol, Edmonton, AB, Canada; [Wheatley, B. Matt] Univ Alberta, Div Neurosurg, Edmonton, AB, Canada; [Warren, Rene; Holt, Robert A.] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada	University of Alberta; University of Alberta; British Columbia Cancer Agency	Bhat, RK (corresponding author), Univ Alberta, Div Neurol, Edmonton, AB, Canada.	chris.power@ualberta.ca	Power, Christopher/C-7181-2013; Holt, Robert A/C-3303-2009; Bhat, Rakesh/B-4320-2009; Bhat, Rakesh Kumar/AID-0687-2022; Warren, Rene/R-7681-2016	Holt, Robert A/0000-0002-7259-1247; Bhat, Rakesh Kumar/0000-0001-7649-0470; Warren, Rene/0000-0002-9890-2293; Power, Christopher/0000-0002-5131-9711	Multiple Sclerosis Society of Canada; Canada Research Chair (CRC)	Multiple Sclerosis Society of Canada; Canada Research Chair (CRC)(Canada Research Chairs)	These studies were supported by the Multiple Sclerosis Society of Canada. CP holds a Canada Research Chair (CRC) (Tier 1) in Neurological Infection and Immunity and an AHFMR Senior Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliel PM, 1998, CR ACAD SCI III-VIE, V321, P857, DOI 10.1016/S0764-4469(99)80026-2; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Antony JM, 2007, AIDS RES HUM RETROV, V23, P1251, DOI 10.1089/aid.2006.0274; Antony JM, 2006, AIDS RES HUM RETROV, V22, P1253, DOI 10.1089/aid.2006.22.1253; Antony JM, 2007, J IMMUNOL, V179, P1210, DOI 10.4049/jimmunol.179.2.1210; Bannert N, 2006, ANNU REV GENOM HUM G, V7, P149, DOI 10.1146/annurev.genom.7.080505.115700; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Bonnaud B, 2004, MOL BIOL EVOL, V21, P1895, DOI 10.1093/molbev/msh206; Bonnaud B, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-57; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Clausen J, 2003, Int MS J, V10, P22; Costas J, 2002, MOL BIOL EVOL, V19, P526, DOI 10.1093/oxfordjournals.molbev.a004108; de Parseval N, 2003, J VIROL, V77, P10414, DOI 10.1128/JVI.77.19.10414-10422.2003; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Ellestad KK, 2009, J IMMUNOL, V183, P298, DOI 10.4049/jimmunol.0803576; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Khatkar MS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-171; Kim HS, 2008, MOL CELLS, V26, P53; Kim HS, 2001, AIDS RES HUM RETROV, V17, P643, DOI 10.1089/088922201300119752; LI WH, 1988, MOL BIOL EVOL, V5, P313; Maingat F, 2010, J IMMUNOL, V184, P1566, DOI 10.4049/jimmunol.0902575; Mangeney M, 2007, P NATL ACAD SCI USA, V104, P20534, DOI 10.1073/pnas.0707873105; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mayer J, 2002, GENOMICS, V80, P331, DOI 10.1006/geno.2002.6839; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Noorali S, 2009, APPL IMMUNOHISTO M M, V17, P319, DOI 10.1097/PAI.0b013e31819640f9; Noorbakhsh F, 2005, J IMMUNOL, V174, P7320, DOI 10.4049/jimmunol.174.11.7320; Noorbakhsh F, 2010, FASEB J, V24, P1799, DOI 10.1096/fj.09-147819; OGAWA T, 2005, INCREASED PRODUCTIVI; Pavlicek A, 2002, GENOME RES, V12, P391, DOI 10.1101/gr.216902; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Ryan FP, 2004, J ROY SOC MED, V97, P560, DOI 10.1258/jrsm.97.12.560; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VENABLES PJW, 1995, VIROLOGY, V211, P589, DOI 10.1006/viro.1995.1442; Voisset C, 2000, AIDS RES HUM RETROV, V16, P731, DOI 10.1089/088922200308738; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhu Y, 2009, FASEB J, V23, P2928, DOI 10.1096/fj.08-128819	41	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19176	10.1371/journal.pone.0019176	http://dx.doi.org/10.1371/journal.pone.0019176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559469	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700092
J	Li, YQ; Du, XL; Lu, ZJ; Wu, DQ; Zhao, YL; Ren, B; Huang, JF; Huang, XQ; Xu, YH; Xu, YQ				Li, Yaqian; Du, Xilin; Lu, Zhi John; Wu, Daqiang; Zhao, Yilei; Ren, Bin; Huang, Jiaofang; Huang, Xianqing; Xu, Yuhong; Xu, Yuquan			Regulatory Feedback Loop of Two phz Gene Clusters through 5 '-Untranslated Regions in Pseudomonas sp M18	PLOS ONE			English	Article							PHENAZINE-1-CARBOXYLIC ACID; BIOLOGICAL-CONTROL; VIRULENCE FACTORS; AERUGINOSA PAO1; FLUORESCENT PSEUDOMONADS; ANTIBIOTIC PRODUCTION; PHENAZINE COMPOUNDS; FUNCTIONAL-ANALYSIS; BIOSYNTHESIS; PYOCYANIN	Background: Phenazines are important compounds produced by pseudomonads and other bacteria. Two phz gene clusters called phzA1-G1 and phzA2-G2, respectively, were found in the genome of Pseudomonas sp. M18, an effective biocontrol agent, which is highly homologous to the opportunistic human pathogen P. aeruginosa PAO1, however little is known about the correlation between the expressions of two phz gene clusters. Methodology/Principal Findings: Two chromosomal insertion inactivated mutants for the two gene clusters were constructed respectively and the correlation between the expressions of two phz gene clusters was investigated in strain M18. Phenazine-1-carboxylic acid (PCA) molecules produced from phzA2-G2 gene cluster are able to auto-regulate expression itself and activate the expression of phzA1-G1 gene cluster in a circulated amplification pattern. However, the post-transcriptional expression of phzA1-G1 transcript was blocked principally through 5'-untranslated region (UTR). In contrast, the phzA2-G2 gene cluster was transcribed to a lesser extent and translated efficiently and was negatively regulated by the GacA signal transduction pathway, mainly at a post-transcriptional level. Conclusions/Significance: A single molecule, PCA, produced in different quantities by the two phz gene clusters acted as the functional mediator and the two phz gene clusters developed a specific regulatory mechanism which acts through 5'-UTR to transfer a single, but complex bacterial signaling event in Pseudomonas sp. strain M18.	[Li, Yaqian; Du, Xilin; Wu, Daqiang; Zhao, Yilei; Ren, Bin; Huang, Jiaofang; Huang, Xianqing; Xu, Yuquan] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Lu, Zhi John] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Li, Yaqian; Xu, Yuhong] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Yale University; Shanghai Jiao Tong University	Li, YQ (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	xuyq@sjtu.edu.cn	Xu, Yuhong/E-4247-2012	Huang, Xianqing/0000-0001-6649-518X; Wu, Daqiang/0000-0003-1581-1538	National Key Basic Research Program [2009CB118906]; National High Technology Research and Development Program of China [2006AA10A209, 2007AA02Z215]; Shanghai Leading Academic Discipline Project [B203]; Shanghai Science Technology Program [08391911900];  [201003273]	National Key Basic Research Program(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Science Technology Program; 	This work was supported in part by grants from the National Key Basic Research Program (973 Program, No. 2009CB118906), the National High Technology Research and Development Program of China (863 Program, No. 2006AA10A209 and 2007AA02Z215), the postdoctoral funding (No. 201003273) and the Shanghai Leading Academic Discipline Project (No. B203) and Shanghai Science Technology Program (No. 08391911900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; Brantl S, 2004, TRENDS MICROBIOL, V12, P473, DOI 10.1016/j.tim.2004.09.008; Burrowes E, 2006, MICROBIOL-SGM, V152, P405, DOI 10.1099/mic.0.28324-0; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chin-A-Woeng TFC, 2001, MOL PLANT MICROBE IN, V14, P1006, DOI 10.1094/MPMI.2001.14.8.1006; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; Delaney SM, 2001, J BACTERIOL, V183, P318, DOI 10.1128/JB.183.1.318-327.2001; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Dwivedi D, 2003, CURR SCI INDIA, V85, P1693; Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006; Fitzpatrick DA, 2009, J MOL EVOL, V68, P171, DOI 10.1007/s00239-009-9198-5; Ge YH, 2004, FEMS MICROBIOL LETT, V237, P41, DOI [10.1016/j.femsle.2004.06.028, 10.1111/j.1574-6968.2004.tb09676.x]; Ge YH, 2007, FEMS MICROBIOL LETT, V268, P81, DOI 10.1111/j.1574-6968.2006.00562.x; Gibson J, 2009, APPL ENVIRON MICROB, V75, P504, DOI 10.1128/AEM.01037-08; Greenhagen BT, 2008, BIOCHEMISTRY-US, V47, P5281, DOI 10.1021/bi702480t; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; HASSETT DJ, 1992, INFECT IMMUN, V60, P328, DOI 10.1128/IAI.60.2.328-336.1992; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hu HB, 2005, J MICROBIOL BIOTECHN, V15, P86; Huang JF, 2009, APPL ENVIRON MICROB, V75, P6568, DOI 10.1128/AEM.01148-09; Huang XQ, 2008, J MICROBIOL BIOTECHN, V18, P828; Klockgether J, 2010, J BACTERIOL, V192, P1113, DOI 10.1128/JB.01515-09; Lapouge K, 2007, MOL MICROBIOL, V66, P341, DOI 10.1111/j.1365-2958.2007.05909.x; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Ledgham F, 2003, MOL MICROBIOL, V48, P199, DOI 10.1046/j.1365-2958.2003.03423.x; Li YQ, 2008, APPL MICROBIOL BIOT, V77, P1207, DOI 10.1007/s00253-007-1213-4; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Mavrodi DV, 2010, APPL ENVIRON MICROB, V76, P866, DOI 10.1128/AEM.02009-09; Mavrodi DV, 1998, J BACTERIOL, V180, P2541, DOI 10.1128/JB.180.9.2541-2548.1998; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Miller JH., 1972, EXPT MOL GENETICS; Mlot C, 2009, SCIENCE, V324, P1637, DOI 10.1126/science.324_1637; Parsons JF, 2007, BIOCHEMISTRY-US, V46, P1821, DOI 10.1021/bi6024403; Perneel M, 2008, ENVIRON MICROBIOL, V10, P778, DOI 10.1111/j.1462-2920.2007.01501.x; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; Raaijmakers JM, 2002, ANTON LEEUW INT J G, V81, P537, DOI 10.1023/A:1020501420831; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; Sambrook J, 2001, MOL CLONING LAB MANU; Shi Mingqi, 2009, Weishengwu Xuebao, V49, P1306; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Yan A, 2007, MICROBIOL-SGM, V153, P16, DOI 10.1099/mic.0.29211-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	52	12	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19413	10.1371/journal.pone.0019413	http://dx.doi.org/10.1371/journal.pone.0019413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559370	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700162
J	Proudfoot, C; McPherson, AL; Kolb, AF; Stark, WM				Proudfoot, Chris; McPherson, Arlene L.; Kolb, Andreas F.; Stark, W. Marshall			Zinc Finger Recombinases with Adaptable DNA Sequence Specificity	PLOS ONE			English	Article							DIRECTED EVOLUTION; TN3 RESOLVASE; SITE; MUTANTS; ARCHITECTURE; NUCLEASES	Site-specific recombinases have become essential tools in genetics and molecular biology for the precise excision or integration of DNA sequences. However, their utility is currently limited to circumstances where the sites recognized by the recombinase enzyme have been introduced into the DNA being manipulated, or natural 'pseudosites' are already present. Many new applications would become feasible if recombinase activity could be targeted to chosen sequences in natural genomic DNA. Here we demonstrate efficient site-specific recombination at several sequences taken from a 1.9 kilobasepair locus of biotechnological interest (in the bovine beta-casein gene), mediated by zinc finger recombinases (ZFRs), chimaeric enzymes with linked zinc finger (DNA recognition) and recombinase (catalytic) domains. In the "Z-sites" tested here, 22 bp casein gene sequences are flanked by 9 bp motifs recognized by zinc finger domains. Asymmetric Z-sites were recombined by the concomitant action of two ZFRs with different zinc finger DNA-binding specificities, and could be recombined with a heterologous site in the presence of a third recombinase. Our results show that engineered ZFRs may be designed to promote site-specific recombination at many natural DNA sequences.	[Proudfoot, Chris; McPherson, Arlene L.; Stark, W. Marshall] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Kolb, Andreas F.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Life Long Hlth Div, Nutr & Epigenet Grp, Aberdeen, Scotland	University of Glasgow; University of Aberdeen	Proudfoot, C (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Marshall.Stark@glasgow.ac.uk		Stark, Marshall/0000-0001-8086-2572; Kolb, Andreas/0000-0001-9056-5504	Biotechnology and Biosciences Research Council [BB/C003543, BB/F021593]; BBSRC [BB/F021593/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C003543/1, BB/F021593/1] Funding Source: researchfish	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biosciences Research Council (grant numbers BB/C003543, BB/F021593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian A, 2003, P NATL ACAD SCI USA, V100, P8688, DOI 10.1073/pnas.1533177100; Akoplan A, 2005, ADV GENET, V55, P1, DOI 10.1016/S0065-2660(05)55001-6; Arnold PH, 1999, EMBO J, V18, P1407, DOI 10.1093/emboj/18.5.1407; Buchholz F, 2009, CURR OPIN BIOTECH, V20, P383, DOI 10.1016/j.copbio.2009.07.005; Burke ME, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03831.x; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Gaj T, 2011, P NATL ACAD IN PRESS; Gersbach CA, 2010, NUCLEIC ACIDS RES, V38, P4198, DOI 10.1093/nar/gkq125; Gordley RM, 2009, P NATL ACAD SCI USA, V106, P5053, DOI 10.1073/pnas.0812502106; Gordley RM, 2007, J MOL BIOL, V367, P802, DOI 10.1016/j.jmb.2007.01.017; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Hatfull GF, 1988, GENETIC RECOMBINATIO, P357; Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264; KLIPPEL A, 1988, EMBO J, V7, P3983, DOI 10.1002/j.1460-2075.1988.tb03286.x; Li WK, 2005, SCIENCE, V309, P1210, DOI 10.1126/science.1112064; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Olorunniji FJ, 2008, NUCLEIC ACIDS RES, V36, P7181, DOI 10.1093/nar/gkn885; Rowland SJ, 2009, MOL MICROBIOL, V74, P282, DOI 10.1111/j.1365-2958.2009.06756.x; Rowland SJ, 2002, MOL MICROBIOL, V44, P607, DOI 10.1046/j.1365-2958.2002.02897.x; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x; Sorrell DA, 2005, BIOTECHNOL ADV, V23, P431, DOI 10.1016/j.biotechadv.2005.03.003; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; YANG W, 1995, CELL, V82, P193, DOI 10.1016/0092-8674(95)90307-0; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049	27	23	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19537	10.1371/journal.pone.0019537	http://dx.doi.org/10.1371/journal.pone.0019537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559340	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000290024700203
J	Kapoula, Z; Matheron, E; Demule, E; Fauvel, C; Bucci, MP				Kapoula, Zoi; Matheron, Eric; Demule, Emilie; Fauvel, Caroline; Bucci, Maria-Pia			Postural Control during the Stroop Test in Dyslexic and Non Dyslexic Teenagers	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; DUAL-TASK; VERGENCE CONTROL; CHILDREN; INTERFERENCE; STABILITY; ATTENTION; DEMANDS; ABILITY; BALANCE	Postural control in quiet stance although simple still requires some cognitive resources; dual cognitive tasks influence further postural control. The present study examines whether or not dyslexic teenagers experience postural instability when performing a Stroop dual task for which their performances are known to be poor. Fifteen dyslexics and twelve non-dyslexics (14 to 17 years old) were recruited from the same school. They were asked to perform three tasks: (1) fixate a target, (2) perform an interference Stroop test (naming the colour or the word rather than reading the word), (3) performing flexibility Stroop task: the subject performed the interference task as in (2) except when the word was in a box, in which case he had to read the word. Postural performances were measured with a force platform. The results showed a main task effect on the variance of speed of body sway only: such variance was higher in the flexibility task than for the other two tasks. No group effect was found for any of the parameters of posture (surface, mediolateral and anteroposterior sway, variance of speed). Further wavelet analysis in the time-frequency domain revealed an increase in the spectral power of the medium frequency range believed to be related to cerebellum control; an accompanying increase in the cancellation time of the high frequency band related to reflexive loops occurred for non-dyslexics only. These effects occurred for the flexibility task and could be due to its high cognitive difficulty. Dyslexics displayed shorter cancellation time for the medium frequency band for all tasks, suggesting less efficient cerebellar control, perhaps of eye fixation and attention influencing body sway. We conclude that there is no evidence for a primary posture deficit in 15 year old teenagers who come from the general population and who were recruited in schools.	[Kapoula, Zoi; Matheron, Eric; Demule, Emilie; Fauvel, Caroline; Bucci, Maria-Pia] Univ Paris 07, Assistance Publ Hopitaux Paris, IRIS Lab, CNRS FRE 3375, Paris, France; [Matheron, Eric] Univ Paris 05, Paris, France; [Demule, Emilie; Fauvel, Caroline] Univ Catholique Paris, Ecole psychol praticiens, Paris, France	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Kapoula, Z (corresponding author), Univ Paris 07, Assistance Publ Hopitaux Paris, IRIS Lab, CNRS FRE 3375, Paris, France.	zoi.kapoula@egp.aphp.fr			Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This study is funded by the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Andersson G, 2002, BRAIN RES BULL, V58, P135, DOI 10.1016/S0361-9230(02)00770-0; Andersson G, 1998, AM J OTOL, V19, P632; Bernard-Demanze L, 2009, Curr Aging Sci, V2, P139; Brosnan M, 2002, NEUROPSYCHOLOGIA, V40, P2144, DOI 10.1016/S0028-3932(02)00046-5; Chevrie-Muller C, 1977, BATTERIE LANGAGE ORA; Everatt J., 1997, DYSLEXIA, V3, P222, DOI [DOI 10.1002/(SICI)1099-0909(199712)3:4<222::AID-DYS12>3.0.CO;2-P, 3.0.CO;2-P]; Faccioli C, 2008, CHILD NEUROPSYCHOL, V14, P277, DOI 10.1080/09297040701290040; GOLOMER E, 1994, ARCH INT PHYSIOL BIO, V102, P225, DOI 10.3109/13813459409007543; Helland T, 2000, CHILD NEUROPSYCHOL, V6, P37, DOI 10.1076/0929-7049(200003)6:1;1-B;FT037; Kapoula Z, 2007, J NEUROL, V254, P1174, DOI 10.1007/s00415-006-0460-0; Kapoula Z, 2006, EXP BRAIN RES, V173, P438, DOI 10.1007/s00221-006-0382-1; Kapoula Z, 2010, EXP BRAIN RES, V203, P419, DOI 10.1007/s00221-010-2247-x; KohenRaz R, 1996, PERCEPT MOTOR SKILL, V82, P547, DOI 10.2466/pms.1996.82.2.547; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Le TT, 2008, GAIT POSTURE, V27, P493, DOI 10.1016/j.gaitpost.2007.06.003; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; Maylor EA, 2001, BRIT J PSYCHOL, V92, P319, DOI 10.1348/000712601162211; Nashner L M, 1979, Prog Brain Res, V50, P177; Nicolson RI, 2005, J NEURAL TRANSM-SUPP, P19; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; NICOLSON RI, 1990, COGNITION, V35, P159, DOI 10.1016/0010-0277(90)90013-A; Olivier I, 2007, NEUROREPORT, V18, P817, DOI 10.1097/WNR.0b013e3280e129e1; Paillard T, 2002, BRIT J SPORT MED, V36, P304, DOI 10.1136/bjsm.36.4.304; Perennou D, 2006, EFFICIENCE DEFICIENC, P65; Peterka R J, 1990, J Vestib Res, V1, P87; Pozzo T, 2006, NEUROSCI LETT, V403, P211, DOI 10.1016/j.neulet.2006.03.049; Protopapas A, 2007, COGNITIVE PSYCHOL, V54, P251, DOI 10.1016/j.cogpsych.2006.07.003; Quercia P, 2005, J FR OPHTALMOL, V28, P713, DOI 10.1016/S0181-5512(05)80983-0; RIACH CL, 1987, DEV MED CHILD NEUROL, V29, P650; RIDDELL PM, 1990, PERCEPT MOTOR SKILL, V70, P707, DOI 10.2466/PMS.70.3.707-718; Rochelle KSH, 2009, EXP BRAIN RES, V192, P627, DOI 10.1007/s00221-008-1568-5; STEIN JF, 1987, EYE, V1, P433, DOI 10.1038/eye.1987.66; STEIN JF, 1988, BRIT J OPHTHALMOL, V72, P162, DOI 10.1136/bjo.72.3.162; Stoet G, 2007, COGN AFFECT BEHAV NE, V7, P192, DOI 10.3758/CABN.7.3.192; Stoodley CJ, 2005, EXP BRAIN RES, V167, P370, DOI 10.1007/s00221-005-0042-x; Takagi A., 1985, VESTIBULAR VISUAL CO, P74; Vieira S, 2009, NEUROSCI LETT, V462, P125, DOI 10.1016/j.neulet.2009.06.093; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yardley L, 1999, NEUROREPORT, V10, P215, DOI 10.1097/00001756-199902050-00003	42	10	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19272	10.1371/journal.pone.0019272	http://dx.doi.org/10.1371/journal.pone.0019272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556369	Green Published, gold, Green Submitted			2022-12-25	WOS:000290019400045
J	Jiang, YJ; Che, MX; Yuan, JQ; Xie, YY; Yan, XZ; Hu, HY				Jiang, Ya-Jun; Che, Mei-Xia; Yuan, Jin-Qiao; Xie, Yuan-Yuan; Yan, Xian-Zhong; Hu, Hong-Yu			Interaction with Polyglutamine-expanded Huntingtin Alters Cellular Distribution and RNA Processing of Huntingtin Yeast Two-hybrid Protein A (HYPA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM WW DOMAINS; PROLINE-RICH REGION; LIGAND RECOGNITION; GROUP-II/III; IN-VIVO; DISEASE; AGGREGATION; BINDING; PATHOGENESIS; SPECIFICITY	Huntington disease (HD) is an autosomal inherited disorder that causes the deterioration of brain cells. The polyglutamine (polyQ) expansion of huntingtin (Htt) is implicated in the pathogenesis of HD via interaction with an RNA splicing factor, Htt yeast two-hybrid protein A/forming-binding protein 11 (HYPA/FBP11). Besides the pathogenic polyQ expansion, Htt also contains a proline-rich region (PRR) located exactly in the C terminus to the polyQ tract. However, how the polyQ expansion influences the PRR-mediated protein interaction and how this abnormal interaction leads to the biological consequence remain elusive. Our NMR structural analysis indicates that the PRR motif of Htt cooperatively interacts with the tandem WW domains of HYPA through domain chaperoning effect of WW1 on WW2. The polyQ-expanded Htt sequesters HYPA to the cytosolic location and then significantly reduces the efficiency of pre-mRNA splicing. We propose that the toxic gain-of-function of the polyQ-expanded Htt that causes dysfunction of cellular RNA processing contributes to the pathogenesis of HD.	[Jiang, Ya-Jun; Che, Mei-Xia; Xie, Yuan-Yuan; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Yuan, Jin-Qiao; Yan, Xian-Zhong] Natl Ctr Biomed Anal, NMR Lab, Beijing 100850, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Hu, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	hyhu@sibs.ac.cn	Hu, Hong-Yu/AAQ-2633-2020; Xie, Yuanyuan/F-1974-2017; Che, Meixia/Q-2119-2019; Jiang, Yajun/AAE-7853-2020	Che, Meixia/0000-0002-4515-1414; Jiang, Yajun/0000-0002-0886-292X	National Basic Research Program of China [2006CB910305, 2006CB806508]; National Natural Science Foundation of China [30670431, 10979070]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2006CB910305 and 2006CB806508 and National Natural Science Foundation of China Grants 30670431 and 10979070.	Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Che M. X., 2011, FASEB J IN PRESS; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fedoroff OY, 2004, J BIOL CHEM, V279, P34991, DOI 10.1074/jbc.M404987200; Gao YG, 2006, STRUCTURE, V14, P1755, DOI 10.1016/j.str.2006.09.014; Goddard T. D., 2008, SPARKY 3; Huang XJ, 2009, J BIOL CHEM, V284, P25375, DOI 10.1074/jbc.M109.024828; Jennings MD, 2007, J BIOL CHEM, V282, P29032, DOI 10.1074/jbc.M703453200; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kato Y, 2006, PROTEINS, V63, P227, DOI 10.1002/prot.20880; Kato Y, 2004, J BIOL CHEM, V279, P31833, DOI 10.1074/jbc.M404719200; Kato Y, 2006, J BIOL CHEM, V281, P40321, DOI 10.1074/jbc.M609321200; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Li XJ, 2007, TRENDS GENET, V23, P531, DOI 10.1016/j.tig.2007.07.007; Lin KT, 2004, MOL CELL BIOL, V24, P9176, DOI 10.1128/MCB.24.20.9176-9185.2004; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mizutani K, 2004, BIOCHEM BIOPH RES CO, V313, P468, DOI 10.1016/j.bbrc.2003.11.139; Nasim MT, 2006, NAT PROTOC, V1, P1022, DOI 10.1038/nprot.2006.148; Neduva V., 2007, SCI STKE, V2007, ppe1; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Passani LA, 2000, HUM MOL GENET, V9, P2175, DOI 10.1093/hmg/9.14.2175; Pires JR, 2005, J MOL BIOL, V348, P399, DOI 10.1016/j.jmb.2005.02.056; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wiesner S, 2002, J MOL BIOL, V324, P807, DOI 10.1016/S0022-2836(02)01145-2; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	52	23	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25236	25245		10.1074/jbc.M110.216333	http://dx.doi.org/10.1074/jbc.M110.216333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21566141	Green Published, hybrid			2022-12-25	WOS:000292547900069
J	Barta, ML; Skaff, DA; McWhorter, WJ; Herdendorf, TJ; Miziorko, HM; Geisbrecht, BV				Barta, Michael L.; Skaff, D. Andrew; McWhorter, William J.; Herdendorf, Timothy J.; Miziorko, Henry M.; Geisbrecht, Brian V.			Crystal Structures of Staphylococcus epidermidis Mevalonate Diphosphate Decarboxylase Bound to Inhibitory Analogs Reveal New Insight into Substrate Binding and Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INHERITED DISEASE; CHOLESTEROL-BIOSYNTHESIS; ACTIVE-SITE; KINASE; LIVER; MECHANISM; GALACTOKINASE; PURIFICATION; AUREUS; IDENTIFICATION	The polyisoprenoid compound undecaprenyl phosphate is required for biosynthesis of cell wall peptidoglycans in Gram-positive bacteria, including pathogenic Enterococcus, Streptococcus, and Staphylococcus spp. In these organisms, the mevalonate pathway is used to produce the precursor isoprenoid, isopentenyl 5-diphosphate. Mevalonate diphosphate decarboxylase (MDD) catalyzes formation of isopentenyl 5-diphosphate in an ATP-dependent irreversible reaction and is therefore an attractive target for inhibitor development that could lead to new antimicrobial agents. To facilitate exploration of this possibility, we report the crystal structure of Staphylococcus epidermidis MDD (1.85 angstrom resolution) and, to the best of our knowledge, the first structures of liganded MDD. These structures include MDD bound to the mevalonate 5-diphosphate analogs diphosphoglycolyl proline (2.05 angstrom resolution) and 6-fluoromevalonate diphosphate (FMVAPP; 2.2 angstrom resolution). Comparison of these structures provides a physical basis for the significant differences in K-i values observed for these inhibitors. Inspection of enzyme/inhibitor structures identified the side chain of invariant Ser(192) as making potential contributions to catalysis. Significantly, Ser -> Ala substitution of this side chain decreases k(cat) by similar to 10(3)-fold, even though binding interactions between FMVAPP and this mutant are similar to those observed with wild type MDD, as judged by the 2.1 angstrom cocrystal structure of S192A with FMVAPP. Comparison of microbial MDD structures with those of mammalian counterparts reveals potential targets at the active site periphery that may be exploited to selectively target the microbial enzymes. These studies provide a structural basis for previous observations regarding the MDD mechanism and inform future work toward rational inhibitor design.	[Skaff, D. Andrew; Herdendorf, Timothy J.; Miziorko, Henry M.] Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA; [Barta, Michael L.; McWhorter, William J.; Geisbrecht, Brian V.] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Miziorko, HM (corresponding author), Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, 5100 Rockhill Rd, Kansas City, MO 64110 USA.	MiziorkoH@umkc.edu; GeisbrechtB@umkc.edu			National Institutes of Health [AI071028, AI090149]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071028, R21AI090149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants AI071028 and AI090149.; We acknowledge the generous technical assistance of Drs. Rod Salazar and Andy Howard during x-ray diffraction data collection and Dr. Samuel Bouyain for comments on the manuscript. Drs. Imogen Wilding and William Hunter generously provided plasmids used for production and characterization of S. aureus MDD and T. brucei MDD, respectively. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. Data were collected at Southeast Regional Collaborative Access Team (SER-CAT) beamlines at the Advanced Photon Source, Argonne National Laboratory. A list of supporting member institutions may be found on the SER-CAT website.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALVEAR M, 1982, BIOCHEMISTRY-US, V21, P4646, DOI 10.1021/bi00262a020; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BALLARD FJ, 1966, BIOCHEM J, V101, P70, DOI 10.1042/bj1010070; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; BEYTIA E, 1970, J BIOL CHEM, V245, P5450; BLOCH K, 1959, J BIOL CHEM, V234, P2595; Bonanno JB, 2001, P NATL ACAD SCI USA, V98, P12896, DOI 10.1073/pnas.181466998; Brons-Poulsen Jesper, 2002, Methods Mol Biol, V182, P71; Byres E, 2007, J MOL BIOL, V371, P540, DOI 10.1016/j.jmb.2007.05.094; CHIEW YE, 1987, BIOCHIM BIOPHYS ACTA, V916, P271, DOI 10.1016/0167-4838(87)90170-1; Cho YK, 2001, J BIOL CHEM, V276, P12573, DOI 10.1074/jbc.M011478200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan CG, 2009, J BIOL CHEM, V284, P20240, DOI 10.1074/jbc.M109.027425; Fromm H J, 1979, Methods Enzymol, V63, P467; Fu ZJ, 2002, J BIOL CHEM, V277, P18134, DOI 10.1074/jbc.M200912200; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GULBINSKY JS, 1968, BIOCHEMISTRY-US, V7, P566, DOI 10.1021/bi00842a009; Hartley A, 2004, J MOL BIOL, V337, P387, DOI 10.1016/j.jmb.2004.01.043; HELLINGA HW, 1987, NATURE, V327, P437, DOI 10.1038/327437a0; JABALQUINTO AM, 1989, BIOCHIM BIOPHYS ACTA, V996, P257, DOI 10.1016/0167-4838(89)90256-2; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Krepkiy D, 2004, PROTEIN SCI, V13, P1875, DOI 10.1110/ps.04725204; Krepkiy DV, 2005, BIOCHEMISTRY-US, V44, P2671, DOI 10.1021/bi0484217; Krishna SS, 2001, BIOCHEMISTRY-US, V40, P10810, DOI 10.1021/bi010851z; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Michihara A, 1997, J BIOCHEM, V122, P647; NAVE JF, 1985, BIOCHEM J, V227, P247, DOI 10.1042/bj2270247; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pilloff D, 2003, J BIOL CHEM, V278, P4510, DOI 10.1074/jbc.M210551200; REARDON JE, 1987, BIOCHEMISTRY-US, V26, P4717, DOI 10.1021/bi00389a018; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tenover FC, 2001, EMERG INFECT DIS, V7, P327, DOI 10.3201/eid0702.010237; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timson DJ, 2002, BIOCHIMIE, V84, P265, DOI 10.1016/S0300-9084(02)01399-8; Vlattas I, 1996, BIOORG MED CHEM LETT, V6, P2091, DOI 10.1016/0960-894X(96)00374-5; Voynova NE, 2008, ARCH BIOCHEM BIOPHYS, V480, P58, DOI 10.1016/j.abb.2008.08.024; Wilding EI, 2000, J BACTERIOL, V182, P4319, DOI 10.1128/JB.182.15.4319-4327.2000; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	50	28	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23900	23910		10.1074/jbc.M111.242016	http://dx.doi.org/10.1074/jbc.M111.242016			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21561869	Green Published, hybrid			2022-12-25	WOS:000292294900032
J	Chang, AHK; Jeong, J; Levine, RL				Chang, Allen H. K.; Jeong, Jinsook; Levine, Rodney L.			Iron Regulatory Protein 2 Turnover through a Nonproteasomal Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING-PROTEIN; DEPENDENT DEGRADATION; ACONITASE ACTIVITY; MOLECULAR CONTROL; RNA-BINDING; CELL-DEATH; HOMEOSTASIS; IRP2; TRANSFERRIN; INHIBITION	Iron regulatory protein 2 (IRP2) controls the synthesis of many proteins involved in iron metabolism, and the level of IRP2 itself is regulated by varying the rate of its degradation. The proteasome is known to mediate degradation, with specificity conferred by an iron-sensing E3 ligase. Most studies on the degradation of IRP2 have employed cells overexpressing IRP2 and also rendered iron deficient to further increase IRP2 levels. We utilized a sensitive, quantitative assay for IRP2, which allowed study of endogenous IRP2 degradation in HEK293A cells under more physiologic conditions. We found that under these conditions, the proteasome plays only a minor role in the degradation of IRP2, with almost all the IRP2 being degraded by a nonproteasomal pathway. This new pathway is calcium-dependent but is not mediated by calpain. Elevating the cellular level of IRP2 by inducing iron deficiency or by transfection causes the proteasomal pathway to account for the major fraction of IRP2 degradation. We conclude that under physiological, iron-sufficient conditions, the steady-state level of IRP2 in HEK293A cells is regulated by the nonproteasomal pathway.	[Chang, Allen H. K.; Jeong, Jinsook; Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Levine, RL (corresponding author), Bldg 50,Room 2351,MSC 8012, Bethesda, MD 20892 USA.	rlevine@nih.gov	Levine, Rodney L/D-9885-2011		NHLBI, National Institutes of Health [1Z01 HL000225]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006101, Z01HL000225] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the NHLBI, National Institutes of Health, (Project no. 1Z01 HL000225).	Bourdon E, 2003, BLOOD CELL MOL DIS, V31, P247, DOI 10.1016/S1079-9796(03)00161-X; Coulombe P, 2003, MOL CELL BIOL, V23, P4542, DOI 10.1128/MCB.23.13.4542-4558.2003; Dycke C, 2008, INT J BIOCHEM CELL B, V40, P2826, DOI 10.1016/j.biocel.2008.05.015; EVERS A, 1989, INORG CHEM, V28, P2189, DOI 10.1021/ic00310a035; GRAY NK, 1993, EUR J BIOCHEM, V218, P657, DOI 10.1111/j.1432-1033.1993.tb18420.x; GUO B, 1994, J BIOL CHEM, V269, P24252; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; KARIN M, 1981, J BIOL CHEM, V256, P3245; Kim G, 2010, J BIOL CHEM, V285, P18085, DOI 10.1074/jbc.M110.119701; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Landowski TH, 2005, CANCER RES, V65, P3828, DOI 10.1158/0008-5472.CAN-04-3684; Lee CS, 2005, BRAIN RES BULL, V67, P225, DOI 10.1016/j.brainresbull.2005.07.003; LLOYD JB, 1991, BIOCHEM PHARMACOL, V41, P1361, DOI 10.1016/0006-2952(91)90109-I; Luo S, 2006, ANAL BIOCHEM, V350, P233, DOI 10.1016/j.ab.2005.10.048; MORGAN EH, 1981, BIOCHIM BIOPHYS ACTA, V642, P119, DOI 10.1016/0005-2736(81)90143-7; OCTAVE JN, 1979, FEBS LETT, V108, P127, DOI 10.1016/0014-5793(79)81193-X; Persson HL, 2003, FREE RADICAL BIO MED, V34, P1295, DOI 10.1016/S0891-5849(03)00106-0; Rouault T, 1997, CURR TOP CELL REGUL, V35, P1, DOI 10.1016/S0070-2137(97)80001-5; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Van den Bosch L, 2002, NEUROPHARMACOLOGY, V42, P706, DOI 10.1016/S0028-3908(02)00010-2; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Wang J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-15; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Zimmermann D, 2006, BIOCHEM BIOPH RES CO, V348, P673, DOI 10.1016/j.bbrc.2006.07.112	33	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23698	23707		10.1074/jbc.M110.216788	http://dx.doi.org/10.1074/jbc.M110.216788			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21558272	Green Published, hybrid			2022-12-25	WOS:000292294900011
J	Wang, CJ; Wang, C; Hoch, EG; Pitt, GS				Wang, Chaojian; Wang, Chuan; Hoch, Ethan G.; Pitt, Geoffrey S.			Identification of Novel Interaction Sites that Determine Specificity between Fibroblast Growth Factor Homologous Factors and Voltage-gated Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EF-HAND DOMAIN; C-TERMINUS; FACTOR 1B; INACTIVATION; CALMODULIN; MODULATION; FIBROBLAST-GROWTH-FACTOR-14; EXCITABILITY; NA(V)1.5; MUTATION	Fibroblast growth factor homologous factors (FHFs, FGF11-14) bind to the C termini (CTs) of specific voltage-gated sodium channels (VGSC) and thereby regulate their function. The effect of an individual FHF on a specific VGSC varies greatly depending upon the individual FHF isoform. How individual FHFs impart distinctive effects on specific VGSCs is not known and the specificity of these pairwise interactions is not understood. Using several biochemical approaches combined with functional analysis, we mapped the interaction site for FGF12B on the Na(V)1.5 C terminus and discovered previously unknown determinants necessary for FGF12 interaction. Also, we demonstrated that FGF12B binds to some, but not all Na(V)1 CTs, suggesting specificity of interaction. Exploiting a human single nucleotide polymorphism in the core domain of FGF12 (P149Q), we identified a surface proline that contributes a part of this pairwise specificity. This proline is conserved among all FHFs, and mutation of the homologous residue in FGF13 also leads to loss of interaction with a specific VGSCCT(Na(V)1.1) and loss of modulation of the resultant Na+ channel function. We hypothesized that some of the specificity mediated by this proline may result from differences in the affinity of the binding partners. Consistent with this hypothesis, surface plasmon resonance data showed that the P149Q mutation decreased the binding affinity between FHFs and VGSC CTs. Moreover, immunocytochemistry revealed that the mutation prevented proper subcellular targeting of FGF12 to the axon initial segment in neurons. Together, these results give new insights into details of the interactions between FHFs and Na(V)1.x CTs, and the consequent regulation of Na+ channels.	[Wang, Chaojian; Wang, Chuan; Hoch, Ethan G.; Pitt, Geoffrey S.] Duke Univ, Med Ctr, Dept Med, Ion Channel Res Unit, Durham, NC 27710 USA	Duke University	Pitt, GS (corresponding author), Duke Univ, Med Ctr, Dept Med, Ion Channel Res Unit, Box 103030 Med Ctr, Durham, NC 27710 USA.	geoffrey.pitt@duke.edu	Pitt, Geoffrey/L-4927-2019	Pitt, Geoffrey/0000-0003-2246-0289	National Institutes of Health [HL71165, HL088089]; Duke University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088089, R01HL071165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by Grants HL71165 and HL088089 from the National Institutes of Health and a Duke University SOM SR Voucher Program Award.	Chagot B, 2009, J BIOL CHEM, V284, P6436, DOI 10.1074/jbc.M807747200; Cormier JW, 2002, J BIOL CHEM, V277, P9233, DOI 10.1074/jbc.M110204200; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; Laezza F, 2009, MOL CELL NEUROSCI, V42, P90, DOI 10.1016/j.mcn.2009.05.007; Liu CJ, 2003, J BIOL CHEM, V278, P1029, DOI 10.1074/jbc.M207074200; Liu CJ, 2001, J BIOL CHEM, V276, P18925, DOI 10.1074/jbc.M101606200; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Maltez JM, 2005, NAT STRUCT MOL BIOL, V12, P372, DOI 10.1038/nsmb909; Miloushev VZ, 2009, J BIOL CHEM, V284, P6446, DOI 10.1074/jbc.M807401200; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; Rusconi R, 2007, J NEUROSCI, V27, P11037, DOI 10.1523/JNEUROSCI.3515-07.2007; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; Wang C, 2008, J NEUROSCI, V28, P1865, DOI 10.1523/JNEUROSCI.5417-07.2008; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004	21	58	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24253	24263		10.1074/jbc.M111.245803	http://dx.doi.org/10.1074/jbc.M111.245803			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566136	hybrid, Green Published			2022-12-25	WOS:000292294900067
J	Mesaki, K; Tanabe, K; Obayashi, M; Oe, N; Takei, K				Mesaki, Kumi; Tanabe, Kenji; Obayashi, Masanori; Oe, Natsuko; Takei, Kohji			Fission of Tubular Endosomes Triggers Endosomal Acidification and Movement	PLOS ONE			English	Article							VESICLE FORMATION; MUTANT DYNAMIN; V-ATPASE; ENDOCYTOSIS; PROTEINS; TRANSPORT; RECEPTOR; LYSOSOMES; CELLS; MICRODOMAINS	The early endosome acts as a sorting station for internalized molecules destined for recycling or degradation. While recycled molecules are sorted and delivered to tubular endosomes, residual compartments containing molecules to be degraded undergo "maturation" before final degradation in the lysosome. This maturation involves acidification, microtubule-dependent motility, and perinuclear localization. It is currently unknown how sorting and the processes of maturation cooperate with each other. Here, we show that fission of a tubular endosome triggers the maturation of the residual endosome, leading to degradation. Use of the dynamin inhibitor dynasore to block tubular endosome fission inhibited acidification, endosomal motility along microtubules, perinuclear localization, and degradation. However, tubular endosome fission was not affected by inhibiting endosomal acidification or by depolymerizing the microtubules. These results demonstrate that the fission of recycling tubules is the first important step in endosomal maturation and degradation in the lysosome. We believe this to be the first evidence of a cascade from sorting to degradation.	[Mesaki, Kumi; Tanabe, Kenji; Obayashi, Masanori; Oe, Natsuko; Takei, Kohji] Okayama Univ, Dept Neurosci, Grad Sch Med, Okayama 700, Japan	Okayama University	Mesaki, K (corresponding author), Okayama Univ, Dept Neurosci, Grad Sch Med, Okayama 700, Japan.	ktanabe@md.okayama-u.ac.jp	TANABE, Kenji/B-2319-2011	Takei, Kohji/0000-0002-6555-9425; Tanabe, Kenji/0000-0003-2645-9429	Ministry of Education, Science, Sports, and Culture of Japan [23113721]; Grants-in-Aid for Scientific Research [23770148] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (23113721) http://kaken.nii.ac.jp/en/p/23113721. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Cao H, 2000, J CELL SCI, V113, P1993; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; DRISKELL OJ, 2006, NAT CELL BIOL; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; GEUZE HJ, 1987, J CELL BIOL, V104, P1715, DOI 10.1083/jcb.104.6.1715; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; HELENIUS A, 1983, TRENDS BIOCHEM SCI, V8, P245, DOI 10.1016/0968-0004(83)90350-X; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Murray JW, 2003, ADV DRUG DELIVER REV, V55, P1385, DOI 10.1016/j.addr.2003.07.008; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Recchi C, 2006, NAT CELL BIOL, V8, P107, DOI 10.1038/ncb0206-107; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; SCHMID SL, 1988, CELL, V52, P73, DOI 10.1016/0092-8674(88)90532-6; Schmid SL, 1998, NATURE, V392, P135, DOI 10.1038/32309; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; TRAER CJ, 2007, NAT CELL BIOL; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380	41	49	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19764	10.1371/journal.pone.0019764	http://dx.doi.org/10.1371/journal.pone.0019764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572956	Green Submitted, Green Published, gold			2022-12-25	WOS:000290440200027
J	Wallace, E; Benayoun, M; van Drongelen, W; Cowan, JD				Wallace, Edward; Benayoun, Marc; van Drongelen, Wim; Cowan, Jack D.			Emergent Oscillations in Networks of Stochastic Spiking Neurons	PLOS ONE			English	Article							FAST RIPPLES; GAMMA; NOISE	Networks of neurons produce diverse patterns of oscillations, arising from the network's global properties, the propensity of individual neurons to oscillate, or a mixture of the two. Here we describe noisy limit cycles and quasi-cycles, two related mechanisms underlying emergent oscillations in neuronal networks whose individual components, stochastic spiking neurons, do not themselves oscillate. Both mechanisms are shown to produce gamma band oscillations at the population level while individual neurons fire at a rate much lower than the population frequency. Spike trains in a network undergoing noisy limit cycles display a preferred period which is not found in the case of quasi-cycles, due to the even faster decay of phase information in quasi-cycles. These oscillations persist in sparsely connected networks, and variation of the network's connectivity results in variation of the oscillation frequency. A network of such neurons behaves as a stochastic perturbation of the deterministic Wilson-Cowan equations, and the network undergoes noisy limit cycles or quasi-cycles depending on whether these have limit cycles or a weakly stable focus. These mechanisms provide a new perspective on the emergence of rhythmic firing in neural networks, showing the coexistence of population-level oscillations with very irregular individual spike trains in a simple and general framework.	[Wallace, Edward; Cowan, Jack D.] Univ Chicago, Dept Math, Chicago, IL 60637 USA; [Benayoun, Marc; van Drongelen, Wim] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [van Drongelen, Wim] Univ Chicago, Computat Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Wallace, E (corresponding author), Univ Chicago, Dept Math, Chicago, IL 60637 USA.	ewallace@math.uchicago.edu		Wallace, Edward/0000-0001-8025-6361; van Drongelen, Wim/0000-0001-8950-5424	Dr. Ralph and Marian Falk Medical Research Trust; Frank Family Fund Fellowship; MSTP	Dr. Ralph and Marian Falk Medical Research Trust; Frank Family Fund Fellowship; MSTP	WvD and MB would like to thank the Dr. Ralph and Marian Falk Medical Research Trust, the Frank Family Fund Fellowship, and MSTP for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2007, J R SOC INTERFACE, V4, P575, DOI 10.1098/rsif.2006.0192; Anderson DF, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799998; Benayoun M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000846; Boland RP, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051131; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; Bragin A, 2002, J NEUROSCI, V22, P2012, DOI 10.1523/JNEUROSCI.22-05-02012.2002; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Bressloff PC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051903; Bressloff PC, 2009, SIAM J APPL MATH, V70, P1488, DOI 10.1137/090756971; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Brunel N, 2008, CHAOS, V18, DOI 10.1063/1.2779858; Buice MA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051919; Cowan JD, 1990, P 1990 C ADV NEUR IN, V3, P62; Doiron B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.030903; Ermentrout B, 1998, REP PROG PHYS, V61, P353, DOI 10.1088/0034-4885/61/4/002; Field R. J., 1985, OSCILLATIONS TRAVELI; Foffani G, 2007, NEURON, V55, P930, DOI 10.1016/j.neuron.2007.07.040; Freeman WJ, 2006, CLIN NEUROPHYSIOL, V117, P1228, DOI 10.1016/j.clinph.2006.03.012; Freeman WJ, 2000, J NEUROSCI METH, V95, P111, DOI 10.1016/S0165-0270(99)00160-0; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gardiner C. W, 2009, STOCHASTIC METHODS, V13; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; GOLOMB D, 1994, PHYSICA D, V72, P259, DOI 10.1016/0167-2789(94)90214-3; Hughes JR, 2008, EPILEPSY BEHAV, V13, P25, DOI 10.1016/j.yebeh.2008.01.011; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; Mattia M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.052903; McKane AJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041902; McKane AJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.218102; MEUNIER C, 1988, J STAT PHYS, V50, P345, DOI 10.1007/BF01022998; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; NIKOLIC D, 2009, NEUR NETW IEEE INNS, P2272; Nisbet R M, 1982, MODELING FLUCTUATING; NISBET RM, 1976, NATURE, V263, P319, DOI 10.1038/263319a0; Olufsen MS, 2003, J COMPUT NEUROSCI, V14, P33, DOI 10.1023/A:1021124317706; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Pineda-Krch M, 2007, OIKOS, V116, P53, DOI 10.1111/j.2006.0030-1299.14940.x; Roxin A, 2008, J NEUROSCI, V28, P10734, DOI 10.1523/JNEUROSCI.1016-08.2008; Staley KJ, 2007, NEURON, V55, P828, DOI 10.1016/j.neuron.2007.09.005; Traub RD, 2005, J NEUROPHYSIOL, V93, P2194, DOI 10.1152/jn.00983.2004; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; van Drongelen W, 2005, IEEE T NEUR SYS REH, V13, P236, DOI 10.1109/TNSRE.2005.847387; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; WALLACE E, 2010, ARXIV10044280CONDMAT; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; WINFREE A, 2001, GEOMETRY BIOL TIME, P808	48	84	85	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e14804	10.1371/journal.pone.0014804	http://dx.doi.org/10.1371/journal.pone.0014804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573105	gold, Green Published			2022-12-25	WOS:000290305600001
J	Eriksson, A; Anfora, G; Lucchi, A; Virant-Doberlet, M; Mazzoni, V				Eriksson, Anna; Anfora, Gianfranco; Lucchi, Andrea; Virant-Doberlet, Meta; Mazzoni, Valerio			Inter-Plant Vibrational Communication in a Leafhopper Insect	PLOS ONE			English	Article							VIRIDULA L HETEROPTERA; FUNCTIONAL-PROPERTIES; BEHAVIOR; HOMOPTERA; SIGNALS; ORGAN; MORPHOLOGY; SUBSTRATE; DETECTOR; SOUND	Vibrational communication is one of the least understood channels of communication. Most studies have focused on the role of substrate-borne signals in insect mating behavior, where a male and a female establish a stereotyped duet that enables partner recognition and localization. While the effective communication range of substrate-borne signals may be up to several meters, it is generally accepted that insect vibrational communication is limited to a continuous substrate. Until now, interplant communication in absence of physical contact between plants has never been demonstrated in a vibrational communicating insect. With a laser vibrometer we investigated transmission of natural and played back vibrational signals of a grapevine leafhopper, Scaphoideus titanus, when being transmitted between leaves of different cuttings without physical contact. Partners established a vibrational duet up to 6 cm gap width between leaves. Ablation of the antennae showed that antennal mechanoreceptors are not essential in detection of mating signals. Our results demonstrate for the first time that substrate discontinuity does not impose a limitation on communication range of vibrational signals. We also suggest that the behavioral response may depend on the signal intensity.	[Eriksson, Anna; Anfora, Gianfranco; Mazzoni, Valerio] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Italy; [Eriksson, Anna; Lucchi, Andrea] Univ Pisa, Dept Coltivaz & Difesa Specie Legnose, Pisa, Italy; [Virant-Doberlet, Meta] Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia	Fondazione Edmund Mach; University of Pisa; National Institute of Biology - Slovenia	Eriksson, A (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Italy.	gianfranco.anfora@iasma.it	LUCCHI, ANDREA/N-4088-2015; Virant-Doberlet, Meta/G-9251-2019; Mazzoni, Valerio/ABE-4661-2021	LUCCHI, ANDREA/0000-0002-9379-6495; Virant-Doberlet, Meta/0000-0001-7510-2392; Mazzoni, Valerio/0000-0003-4036-5322; ANFORA, Gianfranco/0000-0003-2545-1409	Slovenian Research Agency, Fondi Ateneo of Pisa University [P1-0255, V4-0525]	Slovenian Research Agency, Fondi Ateneo of Pisa University(Slovenian Research Agency - Slovenia)	This research was supported by the Autonomous Province of Trento (Accordo di Programma 2010, http://www.uniricerca.provincia.tn.it/ accordi_programma/), Funding Research Programme P1-0255 and Research Project V4-0525 by Slovenian Research Agency, Fondi Ateneo of Pisa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, PRINCIPLES ANIMAL CO; Barth FG, 2002, ZOOLOGY, V105, P271, DOI 10.1078/0944-2006-00082; Bennet-Clark HC, 1998, PHILOS T ROY SOC B, V353, P407, DOI 10.1098/rstb.1998.0219; Caldwell MS, 2010, CURR BIOL, V20, P1012, DOI 10.1016/j.cub.2010.03.069; Casas J, 1998, BIOL CONTROL, V11, P147, DOI 10.1006/bcon.1997.0593; Castellan NJ, 1988, NONPARAMETRIC STAT B; CLARIDGE MF, 1985, ANNU REV ENTOMOL, V30, P297, DOI 10.1146/annurev.en.30.010185.001501; CLARIDGE MF, 1986, BIOL J LINN SOC, V27, P381, DOI 10.1111/j.1095-8312.1986.tb01743.x; Cocroft RB, 2006, ETHOLOGY, V112, P779, DOI 10.1111/j.1439-0310.2006.01226.x; Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2; Cokl A, 2005, J EXP BIOL, V208, P1481, DOI 10.1242/jeb.01557; Cokl A, 1997, J EXP ZOOL, V278, P395, DOI 10.1002/(SICI)1097-010X(19970815)278:6&lt;395::AID-JEZ7&gt;3.0.CO;2-J; Cokl A, 2003, ANNU REV ENTOMOL, V48, P29, DOI 10.1146/annurev.ento.48.091801.112605; Cokl A, 1995, J EXP ZOOL, V273, P376, DOI 10.1002/jez.1402730503; COKL A, 1983, J COMP PHYSIOL, V150, P261; Cokl A, 2006, CONT T ENT, P71; Debaisieux P., 1938, CELLULE, V47, P77; Devetak D, 1978, BIOL VESTNIK LJUBLJA, V36, P131; DRASLAR K, 1973, J COMP PHYSIOL, V84, P175, DOI 10.1007/BF00697605; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GWYNNE DT, 1987, ANIM BEHAV, V35, P571, DOI 10.1016/S0003-3472(87)80283-X; Hill P.S., 2008, VIBRATIONAL COMMUNIC, DOI DOI 10.4159/9780674273825; Hill PSM, 2009, NATURWISSENSCHAFTEN, V96, P1355, DOI 10.1007/s00114-009-0588-8; HOWSE PE, 1970, J INSECT PHYSIOL, V16, P1665, DOI 10.1016/0022-1910(70)90266-0; HUNT RE, 1993, ANN ENTOMOL SOC AM, V86, P356, DOI 10.1093/aesa/86.3.356; HUNT RE, 1991, BEHAV ECOL SOCIOBIOL, V28, P315, DOI 10.1007/BF00164380; ICHIKAWA T, 1974, Applied Entomology and Zoology, V9, P196; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; KIRCHNER WH, 1994, J COMP PHYSIOL A, V175, P261, DOI 10.1007/BF00192985; Markl H., 1983, P332; Mazzoni V, 2009, ENTOMOL EXP APPL, V133, P174, DOI 10.1111/j.1570-7458.2009.00911.x; Mazzoni V, 2009, B ENTOMOL RES, V99, P401, DOI 10.1017/S0007485308006408; McVean A, 1996, J ZOOL, V239, P101, DOI 10.1111/j.1469-7998.1996.tb05440.x; MICHEL K, 1983, REV CAN BIOL EXPTL, V42, P139; MICHELSEN A, 1982, BEHAV ECOL SOCIOBIOL, V11, P269, DOI 10.1007/BF00299304; Miklas N, 2001, J INSECT BEHAV, V14, P313, DOI 10.1023/A:1011115111592; Ossiannilsson F, 1949, OPUSCULA ENTOMOLOGIC, V10, P1; Percy DM, 2006, INVERTEBR SYST, V20, P431, DOI 10.1071/IS05057; Romani R, 2009, ARTHROPOD STRUCT DEV, V38, P473, DOI 10.1016/j.asd.2009.08.002; SCHVESTER D., 1963, ANN EPIPHYT [PARIS], V14, P175; SHAW SR, 1994, J EXP BIOL, V193, P13; SHAW SR, 1994, J NEUROBIOL, V25, P1167, DOI 10.1002/neu.480250911; Stewart K.W., 1984, Annales de Limnologie, V20, P105; Virant-Doberlet M, 2004, NEOTROP ENTOMOL, V33, P121, DOI 10.1590/S1519-566X2004000200001; Virant-Doberlet M, 2006, CONT T ENT, P81; [No title captured]; [No title captured]	48	39	38	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19692	10.1371/journal.pone.0019692	http://dx.doi.org/10.1371/journal.pone.0019692			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573131	Green Published, Green Submitted, gold			2022-12-25	WOS:000290256400039
J	Hackett, NR; Shaykhiev, R; Walters, MS; Wang, R; Zwick, RK; Ferris, B; Witover, B; Salit, J; Crystal, RG				Hackett, Neil R.; Shaykhiev, Renat; Walters, Matthew S.; Wang, Rui; Zwick, Rachel K.; Ferris, Barbara; Witover, Bradley; Salit, Jacqueline; Crystal, Ronald G.			The Human Airway Epithelial Basal Cell Transcriptome	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; EMBRYONIC STEM-CELLS; CYSTIC-FIBROSIS; IN-VITRO; GENE-EXPRESSION; CIGARETTE SMOKERS; POOR-PROGNOSIS; BREAST-CANCER; UP-REGULATION; LUNG-CANCER	Background: The human airway epithelium consists of 4 major cell types: ciliated, secretory, columnar and basal cells. During natural turnover and in response to injury, the airway basal cells function as stem/progenitor cells for the other airway cell types. The objective of this study is to better understand human airway epithelial basal cell biology by defining the gene expression signature of this cell population. Methodology/Principal Findings: Bronchial brushing was used to obtain airway epithelium from healthy nonsmokers. Microarrays were used to assess the transcriptome of basal cells purified from the airway epithelium in comparison to the transcriptome of the differentiated airway epithelium. This analysis identified the "human airway basal cell signature" as 1,161 unique genes with > 5-fold higher expression level in basal cells compared to differentiated epithelium. The basal cell signature was suppressed when the basal cells differentiated into a ciliated airway epithelium in vitro. The basal cell signature displayed overlap with genes expressed in basal-like cells from other human tissues and with that of murine airway basal cells. Consistent with self-modulation as well as signaling to other airway cell types, the human airway basal cell signature was characterized by genes encoding extracellular matrix components, growth factors and growth factor receptors, including genes related to the EGF and VEGF pathways. Interestingly, while the basal cell signature overlaps that of basal-like cells of other organs, the human airway basal cell signature has features not previously associated with this cell type, including a unique pattern of genes encoding extracellular matrix components, G protein-coupled receptors, neuroactive ligands and receptors, and ion channels. Conclusion/Significance: The human airway epithelial basal cell signature identified in the present study provides novel insights into the molecular phenotype and biology of the stem/progenitor cells of the human airway epithelium.	[Hackett, Neil R.; Shaykhiev, Renat; Walters, Matthew S.; Wang, Rui; Zwick, Rachel K.; Ferris, Barbara; Witover, Bradley; Salit, Jacqueline; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med, Div Pulm & Crit Care Med, New York, NY USA	Cornell University; Cornell University	Hackett, NR (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY USA.	geneticmedicine@med.cornell.edu	Shaykhiev, Renat/D-2855-2011	Zwick, Rachel/0000-0003-2012-5890; Walters, Matthew/0000-0003-0010-8444	Starr Foundation/Starr Cancer Consortium;  [P50 HL084936];  [UL1-RR024996]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084936] Funding Source: NIH RePORTER	Starr Foundation/Starr Cancer Consortium; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by P50 HL084936; UL1-RR024996; and the Starr Foundation/Starr Cancer Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiseshaiah P, 2008, J CELL PHYSIOL, V216, P405, DOI 10.1002/jcp.21410; AN G, 1993, J CELL PHYSIOL, V157, P562, DOI 10.1002/jcp.1041570316; Araya J, 2007, J CLIN INVEST, V117, P3551, DOI 10.1172/JCI32526; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Boers JE, 1998, AM J RESP CRIT CARE, V157, P2000, DOI 10.1164/ajrccm.157.6.9707011; Booth BW, 2010, EXP CELL RES, V316, P422, DOI 10.1016/j.yexcr.2009.11.006; Boxall C, 2006, EUR RESPIR J, V27, P208, DOI 10.1183/09031936.06.00130004; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Carolan BJ, 2006, CANCER RES, V66, P10729, DOI 10.1158/0008-5472.CAN-06-2224; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; CHEVILLARD M, 1993, EPITHELIAL CELL BIOL, V2, P17; Choe MM, 2006, NAT PROTOC, V1, P357, DOI 10.1038/nprot.2006.54; Coussens M, 2010, P NATL ACAD SCI USA, V107, P13842, DOI 10.1073/pnas.0913834107; Crystal Ronald G, 2008, Proc Am Thorac Soc, V5, P772, DOI 10.1513/pats.200805-041HR; Danel C, 1996, AM J RESP CRIT CARE, V153, P362, DOI 10.1164/ajrccm.153.1.8542144; Davies Donna E, 2009, Proc Am Thorac Soc, V6, P678, DOI 10.1513/pats.200907-067DP; DI CF, 2008, MOL CANCER RES, V6, P743; DVORAK A, 2010, AM J RESP CELL MOL B; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; Erjefalt JS, 1997, THORAX, V52, P213, DOI 10.1136/thx.52.3.213; Evans MJ, 2001, EXP LUNG RES, V27, P401, DOI 10.1080/019021401300317125; Fukumoto J, 2010, AM J PHYSIOL-LUNG C, V298, pL131, DOI 10.1152/ajplung.90576.2008; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Hackett NR, 2003, AM J RESP CELL MOL, V29, P331, DOI 10.1165/rcmb.2002-0321OC; Hackett TL, 2008, STEM CELLS, V26, P2576, DOI 10.1634/stemcells.2008-0171; Hajj R, 2007, STEM CELLS, V25, P139, DOI 10.1634/stemcells.2006-0288; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Heguy A, 2007, PHYSIOL GENOMICS, V29, P139, DOI 10.1152/physiolgenomics.00167.2006; Hicks W, 1997, EXP CELL RES, V237, P357, DOI 10.1006/excr.1997.3796; Hogenesch JB, 2000, J NEUROSCI, V20, part. no.; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Ito S., 1968, J CELL BIOL, V39, p168a; JETTEN AM, 1989, ENVIRON HEALTH PERSP, V80, P149, DOI 10.2307/3430740; Jiang QS, 1998, EUR J HUM GENET, V6, P12, DOI 10.1038/sj.ejhg.5200158; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Keysar SB, 2010, MOL CANCER THER, V9, P2450, DOI 10.1158/1535-7163.MCT-10-0530; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Koo JS, 1999, AM J RESP CELL MOL, V20, P43, DOI 10.1165/ajrcmb.20.1.3310; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; Leir SH, 2000, AM J PHYSIOL-LUNG C, V278, pL1129, DOI 10.1152/ajplung.2000.278.6.L1129; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Li O, 2007, FEBS LETT, V581, P3533, DOI 10.1016/j.febslet.2007.06.072; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Matsuo M, 2006, CANCER SCI, V97, P155, DOI 10.1111/j.1349-7006.2006.00152.x; Matsuzaki Kyoichi, 2004, Int Wound J, V1, P135, DOI 10.1111/j.1742-4801.2004.00033.x; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; Nakanishi K, 2006, VIRCHOWS ARCH, V448, P142, DOI 10.1007/s00428-005-0063-7; Ooi AT, 2010, CANCER RES, V70, P6639, DOI 10.1158/0008-5472.CAN-10-0455; Pfannkuche K, 2009, STEM CELL REV REP, V5, P224, DOI 10.1007/s12015-009-9078-9; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; PUCHELLE E, 1992, AM J RESP CELL MOL, V7, P485, DOI 10.1165/ajrcmb/7.5.485; Raman T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-493; Rawlins EL, 2008, COLD SH Q B, V73, P291, DOI 10.1101/sqb.2008.73.037; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Rehfeld JF, 2004, BEST PRACT RES CL EN, V18, P569, DOI 10.1016/j.beem.2004.07.002; Reynolds SD, 2008, STEM CELLS, V26, P1337, DOI 10.1634/stemcells.2008-0053; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Ryu MH, 2010, BIOCHEM BIOPH RES CO, V393, P11, DOI 10.1016/j.bbrc.2010.01.060; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; SCHERMER A, 1989, DIFFERENTIATION, V42, P103, DOI 10.1111/j.1432-0436.1989.tb00611.x; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; SHAYKHIEV R, 2010, CELL MOL LIFE SCI; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; Shum WWC, 2008, CELL, V135, P1108, DOI 10.1016/j.cell.2008.10.020; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Tetreault MP, 2010, GASTROENTEROLOGY, V139, P171, DOI 10.1053/j.gastro.2010.03.048; THOMPSON AB, 1995, EUR RESPIR J, V8, P127, DOI 10.1183/09031936.95.08010127; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; Urbinati C, 2005, J CELL SCI, V118, P3949, DOI 10.1242/jcs.02518; Wadlow RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006888; WHITCUTT MJ, 1988, IN VITRO CELL DEV B, V24, P420; Wistuba II, 2006, ANNU REV PATHOL-MECH, V1, P331, DOI 10.1146/annurev.pathol.1.110304.100103; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; Wu R, 1997, EUR RESPIR J, V10, P2398, DOI 10.1183/09031936.97.10102398; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Yang YZ, 2007, FASEB J, V21, P543, DOI 10.1096/fj.06-6694com; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002; Zhong Sheng, 2004, Appl Bioinformatics, V3, P261, DOI 10.2165/00822942-200403040-00009; 2001, CELL TISSUE RES, V305, P285	95	138	140	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18378	10.1371/journal.pone.0018378	http://dx.doi.org/10.1371/journal.pone.0018378			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21572528	gold, Green Submitted, Green Published			2022-12-25	WOS:000290224800001
J	Huge, V; Lauchart, M; Magerl, W; Beyer, A; Moehnle, P; Kaufhold, W; Schelling, G; Azad, SC				Huge, Volker; Lauchart, Meike; Magerl, Walter; Beyer, Antje; Moehnle, Patrick; Kaufhold, Wibke; Schelling, Gustav; Azad, Shahnaz Christina			Complex Interaction of Sensory and Motor Signs and Symptoms in Chronic CRPS	PLOS ONE			English	Article							REGIONAL PAIN SYNDROME; POSTTRAUMATIC-STRESS-DISORDER; REFLEX SYMPATHETIC DYSTROPHY; SYNDROME TYPE-I; NEUROPATHIC PAIN; CORTICAL REORGANIZATION; NEUROGENIC INFLAMMATION; BRAIN; MECHANISMS; HYPERALGESIA	Spontaneous pain, hyperalgesia as well as sensory abnormalities, autonomic, trophic, and motor disturbances are key features of Complex Regional Pain Syndrome (CRPS). This study was conceived to comprehensively characterize the interaction of these symptoms in 118 patients with chronic upper limb CRPS (duration of disease: 43 +/- 23 months). Disease-related stress, depression, and the degree of accompanying motor disability were likewise assessed. Stress and depression were measured by Posttraumatic Stress Symptoms Score and Center for Epidemiological Studies Depression Test. Motor disability of the affected hand was determined by Sequential Occupational Dexterity Assessment and Michigan Hand Questionnaire. Sensory changes were assessed by Quantitative Sensory Testing according to the standards of the German Research Network on Neuropathic Pain. Almost two-thirds of all patients exhibited spontaneous pain at rest. Hand force as well as hand motor function were found to be substantially impaired. Results of Quantitative Sensory Testing revealed a distinct pattern of generalized bilateral sensory loss and hyperalgesia, most prominently to blunt pressure. Patients reported substantial motor complaints confirmed by the objective motor disability testings. Interestingly, patients displayed clinically relevant levels of stress and depression. We conclude that chronic CRPS is characterized by a combination of ongoing pain, pain-related disability, stress and depression, potentially triggered by peripheral nerve/tissue damage and ensuing sensory loss. In order to consolidate the different dimensions of disturbances in chronic CRPS, we developed a model based on interaction analysis suggesting a complex hierarchical interaction of peripheral (injury/sensory loss) and central factors (pain/disability/stress/depression) predicting motor dysfunction and hyperalgesia.	[Huge, Volker; Lauchart, Meike; Beyer, Antje; Moehnle, Patrick; Kaufhold, Wibke; Schelling, Gustav; Azad, Shahnaz Christina] Univ Munich, Dept Anaesthesiol, Munich, Germany; [Magerl, Walter] Heidelberg Univ, Ctr Biomed & Med Technol CBTM, Dept Neurobiol, Med Fac Mannheim, D-6800 Mannheim, Germany	University of Munich; Ruprecht Karls University Heidelberg	Huge, V (corresponding author), Univ Munich, Dept Anaesthesiol, Marchioninistr 15, Munich, Germany.	vhuge@med.uni-muenchen.de	Schelling, Gustav/U-2603-2018; Möhnle, Patrick/C-9243-2018	Schelling, Gustav/0000-0002-6538-0652; Möhnle, Patrick/0000-0003-4769-7100	German Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung; BMBF) [01EM 0118, 01EM 0506]; German Research Foundation [DFG FOR926/SP5, MA 1251/9-1]; nationwide German Research Network on Neuropathic Pain (DFNS)	German Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung; BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); nationwide German Research Network on Neuropathic Pain (DFNS)	This work was supported by the German Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung; BMBF) [grant number 01EM 0118 and 01EM 0506] and the German Research Foundation [grant number DFG FOR926/SP5 - grant MA 1251/9-1]. This research was supported by the nationwide German Research Network on Neuropathic Pain (DFNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht PJ, 2006, PAIN, V120, P244, DOI 10.1016/j.pain.2005.10.035; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baumgartner U, 2006, NEUROIMAGE, V30, P692, DOI 10.1016/j.neuroimage.2005.10.033; Berna C, 2010, BIOL PSYCHIAT, V67, P1083, DOI 10.1016/j.biopsych.2010.01.014; Bingel U, 2004, CEREB CORTEX, V14, P1340, DOI 10.1093/cercor/bhh094; Birklein F, 2000, ACTA NEUROL SCAND, V101, P262, DOI 10.1034/j.1600-0404.2000.101004262x./; Birklein F, 2001, PAIN, V93, P165, DOI 10.1016/S0304-3959(01)00309-8; Birklein F, 2008, NEUROSCI LETT, V437, P199, DOI 10.1016/j.neulet.2008.03.081; Bruehl S, 1999, PAIN, V81, P147, DOI 10.1016/S0304-3959(99)00011-1; Bruggeman AWA, 2009, NEUROLOGY, V73, P1711, DOI 10.1212/WNL.0b013e3181bd6b0d; CEYLER N, 2007, PAIN, V132, P195; Chen CC, 2009, NEUROIMAGE, V45, P453, DOI 10.1016/j.neuroimage.2008.12.041; CHUDLER EH, 1995, PAIN, V60, P3, DOI 10.1016/0304-3959(94)00172-B; Chung KC, 1998, J HAND SURG-AM, V23A, P575, DOI 10.1016/S0363-5023(98)80042-7; Cruccu G, 2004, EUR J NEUROL, V11, P153, DOI 10.1111/j.1468-1331.2004.00791.x; DAVIDOFF G, 1988, PAIN, V32, P27, DOI 10.1016/0304-3959(88)90020-6; de Mos M, 2008, PAIN, V139, P458, DOI 10.1016/j.pain.2008.07.002; de Mos M, 2009, CLIN J PAIN, V25, P590, DOI 10.1097/AJP.0b013e3181a11623; Defrin R, 2008, PAIN, V138, P450, DOI 10.1016/j.pain.2008.05.006; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Eberle T, 2009, NEUROLOGY, V72, P505, DOI 10.1212/01.wnl.0000341930.35494.66; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Geber C, 2008, PAIN, V139, P73, DOI 10.1016/j.pain.2008.03.006; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; Geertzen JHB, 1998, ACTA ORTHOP SCAND, V69, P12, DOI 10.1080/17453674.1998.11744781; Geertzen JHB, 1998, ACTA ORTHOP SCAND, V69, P4, DOI 10.1080/17453674.1998.11744780; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; Gieteling EW, 2008, PAIN, V134, P302, DOI 10.1016/j.pain.2007.04.029; Grachev ID, 2000, PAIN, V89, P7, DOI 10.1016/S0304-3959(00)00340-7; Grande LA, 2004, PAIN, V110, P495, DOI 10.1016/j.pain.2004.03.032; Hansson P, 2007, PAIN, V129, P256, DOI 10.1016/j.pain.2007.03.030; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; HORGER MM, 1990, AM J OCCUP THER, V44, P342, DOI 10.5014/ajot.44.4.342; Huge V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002742; Kapfhammer HP, 2004, AM J PSYCHIAT, V161, P45, DOI 10.1176/appi.ajp.161.1.45; Kaufmann I, 2007, CLIN IMMUNOL, V125, P103, DOI 10.1016/j.clim.2007.07.004; KILO S, 1994, BRAIN, V117, P385, DOI 10.1093/brain/117.2.385; Klauenberg S, 2008, PAIN, V140, P332, DOI 10.1016/j.pain.2008.09.003; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Kohr D, 2009, PAIN, V143, P246, DOI 10.1016/j.pain.2009.03.009; Lim SY, 2008, MOVEMENT DISORD, V23, P1689, DOI 10.1002/mds.22111; Maier C, 2010, PAIN; Maihofner C, 2007, BRAIN, V130, P2671, DOI 10.1093/brain/awm131; Maihofner C, 2004, NEUROLOGY, V63, P693, DOI 10.1212/01.WNL.0000134661.46658.B0; Maihofner C, 2003, NEUROLOGY, V61, P1707, DOI 10.1212/01.WNL.0000098939.02752.8E; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Metz AE, 2009, P NATL ACAD SCI USA, V106, P2423, DOI 10.1073/pnas.0809897106; Nederhand MJ, 2006, CLIN J PAIN, V22, P519, DOI 10.1097/01.ajp.0000202979.44163.da; Oaklander AL, 2009, ANN NEUROL, V65, P629, DOI 10.1002/ana.21692; Oerlemans HM, 1999, CLIN J PAIN, V15, P224, DOI 10.1097/00002508-199909000-00010; Pleger B, 2005, ANN NEUROL, V57, P425, DOI 10.1002/ana.20394; Pleger B, 2006, NEUROIMAGE, V32, P503, DOI 10.1016/j.neuroimage.2006.03.045; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Sandroni P, 2003, PAIN, V103, P199, DOI 10.1016/S0304-3959(03)00065-4; Schelling G, 2004, BIOL PSYCHIAT, V55, P627, DOI 10.1016/j.biopsych.2003.09.014; Schwenkreis P, 2003, NEUROLOGY, V61, P515, DOI 10.1212/WNL.61.4.515; Seifert F, 2009, BRAIN, V132, P788, DOI 10.1093/brain/awn346; STANTONHICKS M, 1995, PAIN, V63, P127, DOI 10.1016/0304-3959(95)00110-E; STERN EB, 1991, AM J OCCUP THER, V45, P801, DOI 10.5014/ajot.45.9.801; Stiasny-Kolster K, 2004, BRAIN, V127, P773, DOI 10.1093/brain/awh079; Stoll C, 1999, INTENS CARE MED, V25, P697, DOI 10.1007/s001340050932; TAIT RC, 1987, ARCH PHYS MED REHAB, V68, P438; Tan ECTH, 2009, INJURY, V40, P901, DOI 10.1016/j.injury.2009.01.134; Treede RD, 2002, PAIN, V98, P235, DOI 10.1016/S0304-3959(02)00203-8; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; van der Giesen FJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P1025, DOI 10.1002/art.24866; van Lankveld W, 1996, J Hand Ther, V9, P27; Vaneker M, 2006, EUR J PAIN, V10, P639, DOI 10.1016/j.ejpain.2005.10.003; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wasner G, 2001, BRAIN, V124, P587, DOI 10.1093/brain/124.3.587; Weber M, 2001, PAIN, V91, P251, DOI 10.1016/S0304-3959(00)00445-0; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455	76	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18775	10.1371/journal.pone.0018775	http://dx.doi.org/10.1371/journal.pone.0018775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559525	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700025
J	Ojaveer, H; Eero, M				Ojaveer, Henn; Eero, Margit			Methodological Challenges in Assessing the Environmental Status of a Marine Ecosystem: Case Study of the Baltic Sea	PLOS ONE			English	Article							REGIME SHIFTS; INDICATORS; FISHERIES; MANAGEMENT; FRAMEWORK; UTILITY	Assessments of the environmental status of marine ecosystems are increasingly needed to inform management decisions and regulate human pressures to meet the objectives of environmental policies. This paper addresses some generic methodological challenges and related uncertainties involved in marine ecosystem assessment, using the central Baltic Sea as a case study. The objectives of good environmental status of the Baltic Sea are largely focusing on biodiversity, eutrophication and hazardous substances. In this paper, we conduct comparative evaluations of the status of these three segments, by applying different methodological approaches. Our analyses indicate that the assessment results are sensitive to a selection of indicators for ecological quality objectives that are affected by a broad spectrum of human activities and natural processes (biodiversity), less so for objectives that are influenced by a relatively narrow array of drivers (eutrophications, hazardous substances). The choice of indicator aggregation rule appeared to be of essential importance for assessment results for all three segments, whereas the hierarchical structure of indicators had only a minor influence. Trend-based assessment was shown to be a useful supplement to reference-based evaluation, being independent of the problems related to defining reference values and indicator aggregation methodologies. Results of this study will help in setting priorities for future efforts to improve environmental assessments in the Baltic Sea and elsewhere, and to ensure the transparency of the assessment procedure.	[Ojaveer, Henn] Univ Tartu, Estonian Marine Inst, Parnu, Estonia; [Eero, Margit] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark	University of Tartu; Estonian Marine Institute; Technical University of Denmark	Ojaveer, H (corresponding author), Univ Tartu, Estonian Marine Inst, Parnu, Estonia.	henn.ojaveer@ut.ee	Eero, Margit/AAK-2845-2021; Ojaveer, Henn/K-2160-2016	Eero, Margit/0000-0002-1848-0597; Ojaveer, Henn/0000-0003-2742-6063	EU [044227, 212085, 266445]; Estonian Ministry of Education and Research [SF0180005s10]; Danish Network for Fisheries and Aquaculture Research (FISHNET)	EU(European Commission); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Danish Network for Fisheries and Aquaculture Research (FISHNET)	The study was supported by EU FP6 and FP7 research projects IMAGE (044227), MEECE (212085) and VECTORS (266445), Estonian Ministry of Education and Research (SF0180005s10), and Danish Network for Fisheries and Aquaculture Research (FISHNET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JH, 2010, MAR POLLUT BULL, V60, P919, DOI 10.1016/j.marpolbul.2010.03.020; [Anonymous], 2008, STATE EVOLUTION BALT, DOI DOI 10.1002/9780470283134.CH2; Bergstrom L, 2010, 302 ICES; Bowen RE, 2003, OCEAN COAST MANAGE, V46, P299, DOI 10.1016/S0964-5691(03)00008-5; CAIRNS J, 1993, HYDROBIOLOGIA, V263, P1, DOI 10.1007/BF00006084; Cardinale M, 2011, MAR ECOL PROG SER, V425, P297, DOI 10.3354/meps09098; Cisin-Sain B, 2007, RGS IBG C PEOPL SEA; Commission of the European Communities (CEC), 2006, GREEN PAP FUT MAR PO; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Fisher WS, 2001, HUM ECOL RISK ASSESS, V7, P961, DOI 10.1080/20018091094781; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; HELCOM, 2007, BALT SEA ACT PLAN HE, P101; HELCOM, 2009, BIOD BALT SEA INT TH, V116, P188; HELCOM, 2009, BALT SEA ENV P; HELCOM, 2010, BALT SEA ENV P, V122; Jennings S, 2005, ICES J MAR SCI, V62, P397, DOI 10.1016/j.icesjms.2004.07.030; Johnson D, 2008, ICES J MAR SCI, V65, P1387, DOI 10.1093/icesjms/fsn154; Kenny AJ, 2009, PROG OCEANOGR, V81, P132, DOI 10.1016/j.pocean.2009.04.007; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Link JS, 2005, ICES J MAR SCI, V62, P569, DOI 10.1016/j.icesjms.2004.12.015; Mee LD, 2008, MAR POLLUT BULL, V56, P187, DOI 10.1016/j.marpolbul.2007.09.038; MFSD, 2008, **NON-TRADITIONAL**, V164, P19; Miller B.J., 2002, The NetWeaver reference manual; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; Munoz-Erickson TA, 2007, ECOL SOC, V12; Nobre AM, 2009, ENVIRON MANAGE, V44, P185, DOI 10.1007/s00267-009-9291-y; Ojaveer E, 2008, J MARINE SYST, V74, P672, DOI 10.1016/j.jmarsys.2008.07.001; OSPAR, 2009, ECOQO HDB; Osterblom H, 2010, MAR POLICY, V34, P1290, DOI 10.1016/j.marpol.2010.05.007; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Paterson B, 2007, MAR FRESHWATER RES, V58, P1056, DOI 10.1071/MF07060; Piet GJ, 2010, ICES J MAR SCI, V67, P559, DOI 10.1093/icesjms/fsp293; Piet GJ, 2008, ICES J MAR SCI, V65, P1449, DOI 10.1093/icesjms/fsn124; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Queffelec B, 2009, MAR POLICY, V33, P871, DOI 10.1016/j.marpol.2009.04.016; Rees HL, 2008, ICES J MAR SCI, V65, P1381, DOI 10.1093/icesjms/fsn153; Rice JC, 2005, ICES J MAR SCI, V62, P516, DOI 10.1016/j.icesjms.2005.01.003; Rochet MJ, 2005, ICES J MAR SCI, V62, P1647, DOI 10.1016/j.icesjms.2005.06.009; Rogers SI, 2005, MAR POLLUT BULL, V50, P9, DOI 10.1016/j.marpolbul.2004.10.028; Shields D., 2002, ECOL INDIC, V2, P149, DOI [DOI 10.1016/S1470-160X(02)00042-0, 10.1016/S1470-160X(02)00042-0]; Shin YJ, 2010, ICES J MAR SCI, V67, P692, DOI 10.1093/icesjms/fsp294; U.S. Commission on Ocean Policy, 2004, OC BLUEPR 21 CENT; UNESCO, 2006, HDB MEAS PROG OUTC I, V46; *WSSD, 2002, WORLD SUMM SUST DEV	44	28	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19231	10.1371/journal.pone.0019231	http://dx.doi.org/10.1371/journal.pone.0019231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559423	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700106
J	Poleg-Polsky, A; Diamond, JS				Poleg-Polsky, Alon; Diamond, Jeffrey S.			Imperfect Space Clamp Permits Electrotonic Interactions between Inhibitory and Excitatory Synaptic Conductances, Distorting Voltage Clamp Recordings	PLOS ONE			English	Article							SELECTIVE GANGLION-CELLS; DIRECTION SELECTIVITY; NMDA-RECEPTOR; IN-VIVO; SIMULATIONS; ERRORS; INPUTS; MECHANISMS; CURRENTS; NEURONS	The voltage clamp technique is frequently used to examine the strength and composition of synaptic input to neurons. Even accounting for imperfect voltage control of the entire cell membrane ("space clamp"), it is often assumed that currents measured at the soma are a proportional indicator of the postsynaptic conductance. Here, using NEURON simulation software to model somatic recordings from morphologically realistic neurons, we show that excitatory conductances recorded in voltage clamp mode are distorted significantly by neighboring inhibitory conductances, even when the postsynaptic membrane potential starts at the reversal potential of the inhibitory conductance. Analogous effects are observed when inhibitory postsynaptic currents are recorded at the reversal potential of the excitatory conductance. Escape potentials in poorly clamped dendrites reduce the amplitude of excitatory or inhibitory postsynaptic currents recorded at the reversal potential of the other conductance. In addition, unclamped postsynaptic inhibitory conductances linearize the recorded current-voltage relationship of excitatory inputs comprising AMPAR and NMDAR-mediated components, leading to significant underestimation of the relative contribution by NMDARs, which are particularly sensitive to small perturbations in membrane potential. Voltage clamp accuracy varies substantially between neurons and dendritic arbors of different morphology; as expected, more reliable recordings are obtained from dendrites near the soma, but up to 80% of the synaptic signal on thin, distant dendrites may be lost when postsynaptic interactions are present. These limitations of the voltage clamp technique may explain how postsynaptic effects on synaptic transmission could, in some cases, be attributed incorrectly to presynaptic mechanisms.	[Poleg-Polsky, Alon; Diamond, Jeffrey S.] Natl Inst Neurol Disorders & Stroke, Synapt Physiol Sect, NIH, Bethesda, MD 20824 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Poleg-Polsky, A (corresponding author), Natl Inst Neurol Disorders & Stroke, Synapt Physiol Sect, NIH, Bethesda, MD 20824 USA.	polegpolskya@mail.nih.gov	Diamond, Jeffrey/C-1835-2015	Diamond, Jeffrey/0000-0002-1770-2629; Poleg-Polsky, Alon/0000-0003-1327-5129	NINDS; Rothschild Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003039] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Rothschild Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NINDS Intramural Program and by the Rothschild Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Yehuda D, 2008, J NEUROPHYSIOL, V99, P1127, DOI 10.1152/jn.01232.2007; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BorgGraham L, 1996, J PHYSIOLOGY-PARIS, V90, P185, DOI 10.1016/S0928-4257(97)81421-0; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hartline DK, 2003, J COMPUT NEUROSCI, V14, P253, DOI 10.1023/A:1023208926805; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hyngstrom AS, 2008, J NEUROPHYSIOL, V99, P1643, DOI 10.1152/jn.01253.2007; JAHR CE, 1990, J NEUROSCI, V10, P3178; JOHNSTON D, 1983, J NEUROPHYSIOL, V50, P464, DOI 10.1152/jn.1983.50.2.464; JONES KA, 1988, J NEUROSCI, V8, P3522; Kalbaugh TL, 2009, J NEUROSCI, V29, P1469, DOI 10.1523/JNEUROSCI.4240-08.2009; KOCH C, 1990, J NEUROSCI, V10, P1728; Kuo JJ, 2003, J NEUROPHYSIOL, V90, P3617, DOI 10.1152/jn.00521.2003; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; MAJOR G, 1993, BIOPHYS J, V65, P469, DOI 10.1016/S0006-3495(93)81039-7; Manookin MB, 2010, NEURON, V67, P280, DOI 10.1016/j.neuron.2010.06.020; MITTMAN S, 1990, J PHYSIOL-LONDON, V428, P175, DOI 10.1113/jphysiol.1990.sp018206; Monier C, 2008, J NEUROSCI METH, V169, P323, DOI 10.1016/j.jneumeth.2007.11.008; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Oesch NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012447; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Schachter MJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000899; Schaefer AT, 2003, BIOPHYS J, V84, P3508, DOI 10.1016/S0006-3495(03)75086-3; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; Sun WZ, 2006, J PHYSIOL-LONDON, V576, P197, DOI 10.1113/jphysiol.2006.115857; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Taylor WR, 2002, J NEUROSCI, V22, P7712; Velte TJ, 1997, VISUAL NEUROSCI, V14, P999, DOI 10.1017/S0952523800011731; Velte TJ, 1996, J NEUROPHYSIOL, V75, P2129, DOI 10.1152/jn.1996.75.5.2129; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; WHITE JA, 1995, J NEUROPHYSIOL, V73, P2369, DOI 10.1152/jn.1995.73.6.2369; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; YANG G, 1994, J NEUROSCI, V14, P5267; Zhang J, 2009, J NEUROSCI, V29, P4274, DOI 10.1523/JNEUROSCI.5602-08.2009	41	54	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19463	10.1371/journal.pone.0019463	http://dx.doi.org/10.1371/journal.pone.0019463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559357	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700185
J	Saponetti, MS; Bobba, F; Salerno, G; Scarfato, A; Corcelli, A; Cucolo, A				Saponetti, Matilde Sublimi; Bobba, Fabrizio; Salerno, Grazia; Scarfato, Alessandro; Corcelli, Angela; Cucolo, Annamaria			Morphological and Structural Aspects of the Extremely Halophilic Archaeon Haloquadratum walsbyi	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; S-LAYERS; SQUARE; CULTIVATION; SURFACES; IMAGES; LIPIDS; MUCIN; CELLS	Ultrathin square cell Haloquadratum walsbyi from the Archaea domain are the most abundant microorganisms in the hypersaline water of coastal salterns and continental salt lakes. In this work, we explore the cell surface of these microorganisms using amplitude-modulation atomic-force microscopy in nearly physiological conditions. We demonstrate the presence of a regular corrugation with a periodicity of 16-20 nm attributed to the surface layer ( S-layer) protein lattice, striped domains asymmetrically distributed on the cell faces and peculiar bulges correlated with the presence of intracellular granules. Besides, subsequent images of cell evolution during the drying process indicate the presence of an external capsule that might correspond to the giant protein halomucin, predicted by the genome but never before observed by other microscopy studies.	[Saponetti, Matilde Sublimi; Bobba, Fabrizio; Salerno, Grazia; Scarfato, Alessandro; Cucolo, Annamaria] Univ Salerno, Dept Phys, Fisciano, Italy; [Saponetti, Matilde Sublimi; Bobba, Fabrizio; Salerno, Grazia; Scarfato, Alessandro; Cucolo, Annamaria] Univ Salerno, Res Ctr NanoMateS, Fisciano, Italy; [Saponetti, Matilde Sublimi; Bobba, Fabrizio; Salerno, Grazia; Scarfato, Alessandro; Cucolo, Annamaria] SPIN CNR, Fisciano, Italy; [Corcelli, Angela] Univ Bari, Dept Med Biochem Biol & Phys, Bari, Italy; [Corcelli, Angela] IPCF CNR, Bari, Italy	University of Salerno; University of Salerno; Consiglio Nazionale delle Ricerche (CNR); Istituto Superconduttori, Materiali e Dispositivi Innovativi (SPIN-CNR); Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR)	Saponetti, MS (corresponding author), Univ Salerno, Dept Phys, Fisciano, Italy.	m.sublimi@sa.infn.it	Scarfato, Alessandro/A-2582-2013	Corcelli, Angela/0000-0001-9658-8520; BOBBA, Fabrizio/0000-0002-3472-642X				Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Bolhuis H, 2004, ENVIRON MICROBIOL, V6, P1287, DOI 10.1111/j.1462-2920.2004.00692.x; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Bolshakova AV, 2001, ULTRAMICROSCOPY, V86, P121, DOI 10.1016/S0304-3991(00)00075-9; Burns DG, 2007, INT J SYST EVOL MICR, V57, P387, DOI 10.1099/ijs.0.64690-0; Burns DG, 2004, APPL ENVIRON MICROB, V70, P5258, DOI 10.1128/AEM.70.9.5258-5265.2004; Burns DG, 2004, FEMS MICROBIOL LETT, V238, P469, DOI 10.1016/j.femsle.2004.08.016; Corcelli A, 2006, METHOD MICROBIOL, V35, P585, DOI 10.1016/S0580-9517(08)70028-X; de Kruijff B, 2006, BIOL CHEM, V387, P235, DOI 10.1515/BC.2006.031; Deacon MP, 2000, BIOCHEM J, V348, P557, DOI 10.1042/0264-6021:3480557; Dufrene YF, 2001, MICRON, V32, P153, DOI 10.1016/S0968-4328(99)00106-7; Engelhardt H, 2007, J STRUCT BIOL, V160, P190, DOI 10.1016/j.jsb.2007.08.004; Fang SJ, 1997, J APPL PHYS, V82, P5891, DOI 10.1063/1.366489; Gad M, 1995, BIOPHYS J, V69, P2226, DOI 10.1016/S0006-3495(95)80147-5; Hayhurst EJ, 2008, P NATL ACAD SCI USA, V105, P14603, DOI 10.1073/pnas.0804138105; JAVOR B, 1982, J BACTERIOL, V151, P1532, DOI 10.1128/JB.151.3.1532-1542.1982; KANOKPHORN S, 2008, ELECT J BIOTECHNOLOG, V11; KASAS S, 1995, BIOPHYS J, V68, P1678, DOI 10.1016/S0006-3495(95)80344-9; Lobasso Simona, 2008, Archaea, V2, P177, DOI 10.1155/2008/870191; McMaster TJ, 1996, BIOPHYS J, V70, P2432, DOI 10.1016/S0006-3495(96)79813-2; Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875; Stark M, 2001, BIOPHYS J, V80, P3009, DOI 10.1016/S0006-3495(01)76266-2; STOECKENIUS W, 1981, J BACTERIOL, V148, P352, DOI 10.1128/JB.148.1.352-360.1981; Toca-Herrera JL, 2005, SMALL, V1, P339, DOI 10.1002/smll.200400035; Walsby AE, 2005, TRENDS MICROBIOL, V13, P193, DOI 10.1016/j.tim.2005.03.002; WALSBY AE, 1980, NATURE, V283, P69, DOI 10.1038/283069a0; WALSBY AE, 1972, BACTERIOL REV, V36, P1	28	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18653	10.1371/journal.pone.0018653	http://dx.doi.org/10.1371/journal.pone.0018653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559517	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700018
J	Voronova, A; Fischer, A; Ryan, T; Al Madhoun, A; Skerjanc, IS				Voronova, Anastassia; Fischer, Anna; Ryan, Tammy; Al Madhoun, Ashraf; Skerjanc, Ilona Sylvia			Ascl1/Mash1 Is a Novel Target of Gli2 during Gli2-Induced Neurogenesis in P19 EC Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ACHAETE-SCUTE HOMOLOG-1; CENTRAL-NERVOUS-SYSTEM; ENHANCER FACTOR 2C; SONIC HEDGEHOG; CARCINOMA-CELLS; GENE-EXPRESSION; NEURONAL DIFFERENTIATION; FLOOR PLATE; NEURAL DIFFERENTIATION	The Sonic Hedgehog (Shh) signaling pathway is important for neurogenesis in vivo. Gli transcription factors, effector proteins of the Shh signaling pathway, have neurogenic properties in vivo, which are still poorly understood. To study the molecular basis of neurogenic properties of Gli2, we used a well-established embryonic stem cell model, the P19 embryonal carcinoma (EC) cell line, which can be induced to differentiate into neurons in the presence of retinoic acid (RA). We found that, in the absence of RA, overexpression of Gli2 induced P19 EC cells to differentiate into neurons, but not astrocytes during the first ten days of differentiation. To our knowledge, this is the first indication that the expression of Gli factors can convert EC cells into neurons. Furthermore, Gli2 upregulated expression of the neurogenic basic helix-loop-helix (bHLH) factors, such as NeuroD, Neurog1 and Ascl1/Mash1 in P19 EC cells. Using chromatin immunoprecipitation assays, we showed that Gli2 bound to multiple regulatory regions in the Ascl1 gene, including promoter and enhancer regions during Gli2-induced neurogenesis. In addition, Gli2 activated the Ascl1/Mash1 promoter in vitro. Using the expression of a dominant-negative form of Gli2, fused to the Engrailed repression domain, we observed a reduction in gliogenesis and a significant downregulation of the bHLH factors Ascl1/Mash1, Neurog1 and NeuroD, leading to delayed neurogenesis in P19 EC cells, further supporting the hypothesis that Ascl1/Mash1 is a direct target of Gli2. In summary, Gli2 is sufficient to induce neurogenesis in P19 stem cells at least in part by directly upregulating Ascl1/Mash1. Our results provide mechanistic insight into the neurogenic properties of Gli2 in vitro, and offer novel plausible explanations for its in vivo neurogenic properties.	[Voronova, Anastassia; Fischer, Anna; Ryan, Tammy; Al Madhoun, Ashraf; Skerjanc, Ilona Sylvia] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa	Voronova, A (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	iskerjan@uottawa.ca	Voronova, Anastassia/GLR-8891-2022; Skerjanc, Ilona/AAN-3318-2020	Voronova, Anastassia/0000-0001-7504-1905; Al Madhoun, Ashraf/0000-0001-8593-3878; Ryan, Tammy/0000-0002-0428-8932	Canadian Institutes of Health Research [MOP-84458, MOP-53277]; Heart and Stroke Foundation of Canada; Heart and Stroke Foundation of Ontario; OGSST	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); OGSST	This work was supported by grants MOP-84458 and MOP-53277 (to ISS) from the Canadian Institutes of Health Research. AV was supported by a Heart and Stroke Foundation of Canada Doctoral Research Award. TP was supported by Heart and Stroke Foundation of Ontario and OGSST studentships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Black BL, 1996, J BIOL CHEM, V271, P26659, DOI 10.1074/jbc.271.43.26659; Borycki AG, 2000, DEVELOPMENT, V127, P2075; Brewster R, 1998, NATURE, V393, P579, DOI 10.1038/31242; Cai C, 2008, STEM CELLS, V26, P1097, DOI 10.1634/stemcells.2007-0684; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Denham M, 2010, STEM CELLS, V28, P1805, DOI 10.1002/stem.510; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Ding Q, 1998, DEVELOPMENT, V125, P2533; Elmi M, 2007, MOL CELL NEUROSCI, V36, P248, DOI 10.1016/j.mcn.2007.07.001; Endo M, 2009, J BIOL CHEM, V284, P5107, DOI 10.1074/jbc.M807745200; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 2000, GENE DEV, V14, P67; Furimsky M, 2006, DEV DYNAM, V235, P594, DOI 10.1002/dvdy.20658; Gianakopoulos PJ, 2005, J BIOL CHEM, V280, P21022, DOI 10.1074/jbc.M502977200; Gianakopoulos PJ, 2011, J BIOL CHEM; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Ikram MS, 2004, J INVEST DERMATOL, V122, P1503, DOI 10.1111/j.0022-202X.2004.22612.x; Imbeault S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-13; Itoh F, 1997, TOHOKU J EXP MED, V182, P327, DOI 10.1620/tjem.182.327; Jin ZG, 2009, J BIOL CHEM, V284, P8160, DOI 10.1074/jbc.M805632200; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Karlstrom RO, 2003, DEVELOPMENT, V130, P1549, DOI 10.1242/dev.00364; Kennedy KAM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-67; Kunnimalaiyaan M, 2006, J BIOL CHEM, V281, P39819, DOI 10.1074/jbc.M603578200; Lang KJD, 2004, J NEUROSCI RES, V76, P184, DOI 10.1002/jnr.20036; Lee DS, 2006, LIFE SCI, V80, P154, DOI 10.1016/j.lfs.2006.08.039; Lee J, 1997, DEVELOPMENT, V124, P2537; Li Z, 2008, J NEUROSCI, V28, P6557, DOI 10.1523/JNEUROSCI.0134-08.2008; Lipinski RJ, 2006, EXP CELL RES, V312, P1925, DOI 10.1016/j.yexcr.2006.02.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe B, 2003, ANAL BIOCHEM, V315, P95, DOI 10.1016/S0003-2697(02)00695-4; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Marti E, 2002, TRENDS NEUROSCI, V25, P89, DOI 10.1016/S0166-2236(02)02062-3; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; Matise MP, 1998, DEVELOPMENT, V125, P2759; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; Miyagi S, 2009, CELL MOL LIFE SCI, V66, P3675, DOI 10.1007/s00018-009-0097-0; Mizugishi K, 2001, J BIOL CHEM, V276, P2180, DOI 10.1074/jbc.M004430200; Mo R, 1997, DEVELOPMENT, V124, P113; Nakada Y, 2004, DEVELOPMENT, V131, P1319, DOI 10.1242/dev.01008; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; Okamoto S, 2000, P NATL ACAD SCI USA, V97, P7561, DOI 10.1073/pnas.130502697; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Park HL, 2000, DEVELOPMENT, V127, P1593; Pattyn A, 2006, DEV BIOL, V295, P67, DOI 10.1016/j.ydbio.2006.03.008; Perron M, 2003, DEVELOPMENT, V130, P1565, DOI 10.1242/dev.00391; Petropoulos H, 2004, J BIOL CHEM, V279, P23874, DOI 10.1074/jbc.M312612200; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; Rho JY, 2006, HUM REPROD, V21, P405, DOI 10.1093/humrep/dei328; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Roessler E, 2003, P NATL ACAD SCI USA, V100, P13424, DOI 10.1073/pnas.2235734100; RUIZ IAA, 2002, NAT REV NEUROSCI, V3, P24, DOI DOI 10.1038/NRN704; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Sasagawa S, 2002, GENESIS, V33, P86, DOI 10.1002/gene.10095; Savage J, 2010, DIFFERENTIATION, V79, P31, DOI 10.1016/j.diff.2009.08.008; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Skerjanc IS, 2000, FEBS LETT, V472, P53, DOI 10.1016/S0014-5793(00)01438-1; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; SLACK RS, 1995, J CELL BIOL, V129, P779, DOI 10.1083/jcb.129.3.779; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Teramoto S, 2005, ONCOL REP, V14, P1231; Theil T, 1999, DEVELOPMENT, V126, P3561; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tole S, 2000, DEV BIOL, V217, P254, DOI 10.1006/dbio.1999.9509; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Ulrich H, 2006, CELL PROLIFERAT, V39, P281, DOI 10.1111/j.1365-2184.2006.00385.x; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wakabayashi N, 2000, J BIOCHEM, V128, P1087, DOI 10.1093/oxfordjournals.jbchem.a022837; Wall DS, 2009, J CELL BIOL, V184, P101, DOI 10.1083/jcb.200805155; Wang L, 2007, J BIOL CHEM, V282, P32462, DOI 10.1074/jbc.M706880200; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0	92	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19174	10.1371/journal.pone.0019174	http://dx.doi.org/10.1371/journal.pone.0019174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559470	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700090
J	Wang, W; Chen, DH; Chen, SC; Li, D; Li, M; Xia, SW; Zheng, HL				Wang, Wei; Chen, Donghui; Chen, Shicai; Li, Ding; Li, Meng; Xia, Siwen; Zheng, Hongliang			Laryngeal Reinnervation Using Ansa Cervicalis for Thyroid Surgery-Related Unilateral Vocal Fold Paralysis: A Long-Term Outcome Analysis of 237 Cases	PLOS ONE			English	Article							NERVE ANASTOMOSIS; PERCEPTUAL EVALUATION; MUSCLE; ELECTROMYOGRAPHY; RECONSTRUCTION; DENERVATION; EXPERIENCE; PHONATION; UPDATE	Objective: To evaluate the long-term efficacy of delayed laryngeal reinnervation using the main branch of the ansa cervicalis in treatment of unilateral vocal fold paralysis (UVFP) caused by thyroid surgery. Summary of Background Data: UVFP remains a serious complication of thyroid surgery. Up to now, a completely satisfactory surgical treatment of UVFP has been elusive. Methods: From Jan. 1996 to Jan. 2008, a total of 237 UVFP patients who underwent ansa cervicalis main branch-to-recurrent laryngeal nerve (RLN) anastomosis were enrolled as UVFP group; another 237 age-and gender-matched normal subjects served as control group. Videostroboscopy, vocal function assessment (acoustic analysis, perceptual evaluation and maximum phonation time), and electromyography were performed preoperatively and postoperatively. The mean follow-up period was 5.2+/-2.7 years, ranging from 2 to 12 years. Results: Analysis of videostroboscopic findings indicated that the glottic closure, vocal fold edge, vocal fold position, phase symmetry and regularity were significantly improved in the UVFP group (P<0.001, postoperative vs. preoperative). The postoperative parameters of vocal function were also significantly improved in the UVFP group (P<0.001) and showed no statistical differences compared to the control group (P>0.05, respectively). Postoperative laryngeal electromyography confirmed successful reinnervation of laryngeal muscle. Conclusions: Delayed laryngeal reinnervation with the main branch of ansa cervicalis is a feasible and effective approach for treatment of thyroid surgery-related UVFP; it can restore the physiological laryngeal phonatory function to the normal or a nearly normal voice quality.	[Wang, Wei; Chen, Donghui; Chen, Shicai; Li, Ding; Li, Meng; Xia, Siwen; Zheng, Hongliang] Second Mil Med Univ, Changhai Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai, Peoples R China	Naval Medical University	Wang, W (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai, Peoples R China.	zheng_hl2004@163.com		Li, Meng/0000-0001-8502-7621	National Natural Science Foundation of China [30772415, 81070774, 81070775]; Science and Technology Commission of Shanghai Municipality [09JC1400500, 10XD1405500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Grant No. 30772415, 81070774, 81070775 for science research from National Natural Science Foundation of China, and Grant No. 09JC1400500 and No. 10XD1405500 from the Science and Technology Commission of Shanghai Municipality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen DH, 2010, LARYNGOSCOPE, V120, P353, DOI 10.1002/lary.20796; Chhetri DK, 1997, LARYNGOSCOPE, V107, P1366, DOI 10.1097/00005537-199710000-00014; Chou FF, 2003, J AM COLL SURGEONS, V197, P52, DOI 10.1016/S1072-7515(03)00235-7; CRUMLEY RL, 1991, LARYNGOSCOPE, V101, P384; CRUMLEY RL, 1986, LARYNGOSCOPE, V96, P611; DEDO HH, 1971, ANN OTO RHINOL LARYN, V80, P664, DOI 10.1177/000348947108000507; FAABORGANDERSEN K, 1964, ANN OTO RHINOL LARYN, V73, P248, DOI 10.1177/000348946407300127; Fessler R, ATLAS NEUROSURGICAL; Heman-Ackah YD, 2007, OTOLARYNG CLIN N AM, V40, P1003, DOI 10.1016/j.otc.2007.05.007; Hermann M, 2002, ANN SURG, V235, P261, DOI 10.1097/00000658-200202000-00015; JATZKO GR, 1994, SURGERY, V115, P139; KANO S, 1991, ARCH OTOLARYNGOL, V117, P1019; Lee WT, 2007, OTOLARYNG HEAD NECK, V136, P450, DOI 10.1016/j.otohns.2006.11.040; Lo CY, 2000, ARCH SURG-CHICAGO, V135, P204, DOI 10.1001/archsurg.135.2.204; Lorenz RR, 2008, ANN OTO RHINOL LARYN, V117, P40, DOI 10.1177/000348940811700109; Miyamaru S, 2008, LARYNGOSCOPE, V118, P1318, DOI 10.1097/MLG.0b013e31816f693f; Miyauchi A, 2009, SURGERY, V146, P1056, DOI 10.1016/j.surg.2009.09.018; Olson DEL, 1998, LARYNGOSCOPE, V108, P1767, DOI 10.1097/00005537-199812000-00002; Paniello RC, 2004, OTOLARYNG CLIN N AM, V37, P161, DOI 10.1016/S0030-6665(03)00164-6; Paniello RC, 2000, LARYNGOSCOPE, V110, P739, DOI 10.1097/00005537-200005000-00004; Rosen CA, 2005, LARYNGOSCOPE, V115, P423, DOI 10.1097/01.mlg.0000157830.38627.85; Shaw GY, 2009, ANN OTO RHINOL LARYN, V118, P6, DOI 10.1177/000348940911800102; Smith ME, 2008, INT J PEDIATR OTORHI, V72, P1311, DOI 10.1016/j.ijporl.2008.05.004; Yumoto E, 2006, LARYNGOSCOPE, V116, P1657, DOI 10.1097/01.mlg.0000233245.27582.fc; Zheng H, 1995, Zhonghua Er Bi Yan Hou Ke Za Zhi, V30, P108; Zheng H, 1994, J CLIN OTORHINOLARYN, V8, P81; Zheng HL, 1996, LARYNGOSCOPE, V106, P1522, DOI 10.1097/00005537-199612000-00015; Zheng HL, 1996, LARYNGOSCOPE, V106, P1516, DOI 10.1097/00005537-199612000-00014; Zheng HL, 1998, OTOLARYNG HEAD NECK, V119, P540, DOI 10.1016/S0194-5998(98)70122-6	29	50	61	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19128	10.1371/journal.pone.0019128	http://dx.doi.org/10.1371/journal.pone.0019128			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559458	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700071
J	Suzuki, K; Mitsutake, N; Saenko, V; Suzuki, M; Matsuse, M; Ohtsuru, A; Kumagai, A; Uga, T; Yano, H; Nagayama, Y; Yamashita, S				Suzuki, Keiji; Mitsutake, Norisato; Saenko, Vladimir; Suzuki, Masatoshi; Matsuse, Michiko; Ohtsuru, Akira; Kumagai, Atsushi; Uga, Tatsuya; Yano, Hiroshi; Nagayama, Yuji; Yamashita, Shunichi			Dedifferentiation of Human Primary Thyrocytes into Multilineage Progenitor Cells without Gene Introduction	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; PLURIPOTENT STEM-CELLS; IN-VITRO; REGULATED EXPRESSION; THYROID-GLANDS; NESTS; FIBROBLASTS; DIFFERENTIATION; CYTOKERATIN; PROTEINS	While identification and isolation of adult stem cells have potentially important implications, recent reports regarding dedifferentiation/reprogramming from differentiated cells have provided another clue to gain insight into source of tissue stem/progenitor cells. In this study, we developed a novel culture system to obtain dedifferentiated progenitor cells from normal human thyroid tissues. After enzymatic digestion, primary thyrocytes, expressing thyroglobulin, vimentin and cytokeratin-18, were cultured in a serum-free medium called SAGM. Although the vast majority of cells died, a small proportion (similar to 0.5%) survived and proliferated. During initial cell expansion, thyroglobulin/cytokeratin-18 expression was gradually declined in the proliferating cells. Moreover, sorted cells expressing thyroid peroxidase gave rise to proliferating clones in SAGM. These data suggest that those cells are derived from thyroid follicular cells or at least thyroid-committed cells. The SAGM-grown cells did not express any thyroid-specific genes. However, after four-week incubation with FBS and TSH, cytokeratin-18, thyroglobulin, TSH receptor, PAX8 and TTF1 expressions re-emerged. Moreover, surprisingly, the cells were capable of differentiating into neuronal or adipogenic lineage depending on differentiating conditions. In summary, we have developed a novel system to generate multilineage progenitor cells from normal human thyroid tissues. This seems to be achieved by dedifferentiation of thyroid follicular cells. The presently described culture system may be useful for regenerative medicine, but the primary importance will be as a tool to elucidate the mechanisms of thyroid diseases.	[Suzuki, Keiji; Mitsutake, Norisato; Suzuki, Masatoshi; Matsuse, Michiko; Yamashita, Shunichi] Nagasaki Univ, Dept Mol Med, Atom Bomb Dis Inst, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Saenko, Vladimir; Yamashita, Shunichi] Nagasaki Univ, Dept Int Hlth & Radiat Res, Atom Bomb Dis Inst, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Nagayama, Yuji] Nagasaki Univ, Dept Med Gene Technol, Atom Bomb Dis Inst, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Ohtsuru, Akira; Kumagai, Atsushi; Yamashita, Shunichi] Nagasaki Univ Hosp, Takashi Nagai Mem Int Hibakusha Med Ctr, Nagasaki, Japan; [Uga, Tatsuya] Nagasaki Univ Hosp, Dept Transplantat & Digest Surg, Nagasaki, Japan; [Yano, Hiroshi] Nagasaki Univ Hosp, Div Surg Oncol, Dept Translat Med Sci, Nagasaki, Japan; [Mitsutake, Norisato] Nagasaki Univ Res Ctr Genom Instabil & Carcinogen, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University	Suzuki, K (corresponding author), Nagasaki Univ, Dept Mol Med, Atom Bomb Dis Inst, Grad Sch Biomed Sci, Nagasaki 852, Japan.	mitsu@nagasaki-u.ac.jp	Yamashita, Shunichi/GVS-9508-2022; Mitsutake, Norisato/U-9626-2018	Mitsutake, Norisato/0000-0002-2744-8046; matsuse, michiko/0000-0001-6178-3342; Yamashita, Shunichi/0000-0001-6399-6261	Ministry of Education, Culture, Sports, Science and Technology of Japan [19256003, 19390253, 20790662]; Uehara Memorial Foundation; Yamaguchi Endocrine Research Foundation; Grants-in-Aid for Scientific Research [22390189] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Yamaguchi Endocrine Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (#19256003, #19390253 and #20790662) and Global COE Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan. N.M. was also supported in part by The Uehara Memorial Foundation and Yamaguchi Endocrine Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BULEY ID, 1987, J CLIN PATHOL, V40, P136, DOI 10.1136/jcp.40.2.136; Burstein DE, 2004, HUM PATHOL, V35, P465, DOI 10.1016/j.humpath.2003.10.027; Cameselle-Teijeiro J, 2005, HUM PATHOL, V36, P590, DOI 10.1016/j.humpath.2005.02.010; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DOCKHORNDWORNICZAK B, 1987, DIFFERENTIATION, V35, P53, DOI 10.1111/j.1432-0436.1987.tb00151.x; Fierabracci A, 2008, J ENDOCRINOL, V198, P471, DOI 10.1677/JOE-07-0552; Grinnell KL, 2007, J INVEST DERMATOL, V127, P372, DOI 10.1038/sj.jid.5700531; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; KAWABE Y, 1989, J CLIN ENDOCR METAB, V68, P1174, DOI 10.1210/jcem-68-6-1174; Lan L, 2007, J CLIN ENDOCR METAB, V92, P3681, DOI 10.1210/jc.2007-0281; Lehmann I, 2000, J VASC RES, V37, P408, DOI 10.1159/000025757; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Ma WX, 2009, STEM CELLS, V27, P1376, DOI 10.1002/stem.48; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MATTEY DL, 1993, BRIT J RHEUMATOL, V32, P676; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Motoyama H, 2009, BIOCHEM BIOPH RES CO, V385, P123, DOI 10.1016/j.bbrc.2009.04.146; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nakazawa Y, 2008, INT J RADIAT ONCOL, V71, P567, DOI 10.1016/j.ijrobp.2007.10.036; PATTON WF, 1990, J CELL PHYSIOL, V143, P140, DOI 10.1002/jcp.1041430119; Preto A, 2004, MODERN PATHOL, V17, P819, DOI 10.1038/modpathol.3800124; RAMAEKERS F, 1984, ACTA CYTOL, V28, P385; Reis JS, 2003, MODERN PATHOL, V16, P43, DOI 10.1097/01.MP.0000047306.72278.39; Richter M, 2002, CELL TISSUE RES, V310, P103, DOI 10.1007/s00441-001-0501-z; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomas T, 2006, THYROID, V16, P537, DOI 10.1089/thy.2006.16.537; Tscheudschilsuren G, 2002, MICROVASC RES, V63, P243, DOI 10.1006/mvre.2001.2346; Wiese C, 2006, STEM CELLS, V24, P2085, DOI 10.1634/stemcells.2006-0008	31	12	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19354	10.1371/journal.pone.0019354	http://dx.doi.org/10.1371/journal.pone.0019354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556376	gold, Green Published, Green Submitted			2022-12-25	WOS:000290019400052
J	Mager, T; Rimon, A; Padan, E; Fendler, K				Mager, Thomas; Rimon, Abraham; Padan, Etana; Fendler, Klaus			Transport Mechanism and pH Regulation of the Na+/H+ Antiporter NhaA from Escherichia coli AN ELECTROPHYSIOLOGICAL STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CONFORMATIONAL-CHANGE; LOOP-VIII-IX; STRUCTURAL INTERACTIONS; CHARGE TRANSLOCATION; BINDING; H+; MEMBRANES; DYNAMICS; PERMEASE; MODEL	Using an electrophysiological assay the activity of NhaA was tested in a wide pH range from pH 5.0 to 9.5. Forward and reverse transport directions were investigated at zero membrane potential using preparations with inside-out and right side-out-oriented transporters with Na+ or H+ gradients as the driving force. Under symmetrical pH conditions with a Na+ gradient for activation, both the wt and the pH-shifted G338S variant exhibit highly symmetrical transport activity with bell-shaped pH dependences, but the optimal pH was shifted 1.8 pH units to the acidic range in the variant. In both strains the pH dependence was associated with a systematic increase of the K-m for Na+ at acidic pH. Under symmetrical Na+ concentration with a pH gradient for NhaA activation, an unexpected novel characteristic of the antiporter was revealed; rather than being down-regulated, it remained active even at pH as low as 5. These data allowed a transport mechanism to advance based on competing Na+ and H+ binding to a common transport site and a kinetic model to develop quantitatively explaining the experimental results. In support of these results, both alkaline pH and Na+ induced the conformational change of NhaA associated with NhaA cation translocation as demonstrated here by trypsin digestion. Furthermore, Na+ translocation was found to be associated with the displacement of a negative charge. In conclusion, the electrophysiological assay allows the revelation of the mechanism of NhaA antiport and sheds new light on the concept of NhaA pH regulation.	[Fendler, Klaus] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Rimon, Abraham; Padan, Etana] Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel	Max Planck Society; Hebrew University of Jerusalem	Fendler, K (corresponding author), Max Planck Inst Biophys, Max von Laue Str 3, D-60438 Frankfurt, Germany.	fendler@biophys.mpg.de		Fendler, Klaus/0000-0002-5699-7060; Mager, Thomas/0000-0002-9571-7033	Deutsche Forschungsgemeinschaft [SFB 807]; EDICT (European Drug Initiative on Channels and Transporters); USA-Israel Binational Science Foundation [20050130]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EDICT (European Drug Initiative on Channels and Transporters); USA-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by the Deutsche Forschungsgemeinschaft SFB 807.; Supported by EDICT (European Drug Initiative on Channels and Transporters) Grant EU EP7 and by USA-Israel Binational Science Foundation Grant BSF#20050130.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; ADLER LW, 1977, J SUPRAMOL STR CELL, V7, P15, DOI 10.1002/jss.400070103; Appel M, 2009, J MOL BIOL, V388, P659, DOI 10.1016/j.jmb.2009.03.010; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; ARONSON PS, 1985, ANNU REV PHYSIOL, V47, P545, DOI 10.1146/annurev.ph.47.030185.002553; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Dzafic E, 2009, SPECTROCHIM ACTA A, V72, P102, DOI 10.1016/j.saa.2008.08.015; Everberg H, 2006, J CHROMATOGR A, V1118, P244, DOI 10.1016/j.chroma.2006.03.123; Fuster D, 2008, J GEN PHYSIOL, V132, P465, DOI 10.1085/jgp.200810016; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; Ganea C, 2009, BBA-BIOENERGETICS, V1787, P706, DOI 10.1016/j.bbabio.2009.02.002; Garcia-Celma JJ, 2007, LANGMUIR, V23, P10074, DOI 10.1021/la701188f; Garcia-Celma JJ, 2010, BIOCHEMISTRY-US, V49, P6115, DOI 10.1021/bi100492p; Gerchman Y, 1999, J BIOL CHEM, V274, P24617, DOI 10.1074/jbc.274.35.24617; Herz K, 2010, J BIOL CHEM, V285, P2211, DOI 10.1074/jbc.M109.047134; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Karasawa A, 2005, J BIOL CHEM, V280, P41900, DOI 10.1074/jbc.M510795200; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Malo ME, 2006, CAN J PHYSIOL PHARM, V84, P1081, DOI 10.1139/Y06-065; Meyer-Lipp K, 2006, J BIOL CHEM, V281, P25882, DOI 10.1074/jbc.M601259200; Olkhova E, 2006, P NATL ACAD SCI USA, V103, P2629, DOI 10.1073/pnas.0510914103; Olkhova E, 2007, BIOPHYS J, V92, P3784, DOI 10.1529/biophysj.106.098269; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; Rimon A, 1998, J BIOL CHEM, V273, P26470, DOI 10.1074/jbc.273.41.26470; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; Rothman A, 1997, BIOCHEMISTRY-US, V36, P14572, DOI 10.1021/bi971800y; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Stein W. D., 1986, TRANSPORT DIFFUSION, P404; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; Tzubery T, 2004, J BIOL CHEM, V279, P3265, DOI 10.1074/jbc.M309021200; Tzubery T, 2008, J BIOL CHEM, V283, P15975, DOI 10.1074/jbc.M800482200; Venturi M, 2000, J BIOL CHEM, V275, P4734, DOI 10.1074/jbc.275.7.4734; Venturi M., 2002, PRACTICAL GUIDE MEMB, P179; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; Yerushalmi H, 2000, FEBS LETT, V476, P93, DOI 10.1016/S0014-5793(00)01677-X; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	40	73	76	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23570	23581		10.1074/jbc.M111.230235	http://dx.doi.org/10.1074/jbc.M111.230235			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21566125	hybrid, Green Published			2022-12-25	WOS:000292025000087
J	Munk, RB; Sugiyama, K; Ghosh, P; Sasaki, CY; Rezanka, L; Banerjee, K; Takahashi, H; Sen, R; Longo, DL				Munk, Rachel B.; Sugiyama, Katsuki; Ghosh, Paritosh; Sasaki, Carl Y.; Rezanka, Louis; Banerjee, Kasturi; Takahashi, Hidenori; Sen, Ranjan; Longo, Dan L.			Antigen-Independent IFN-gamma Production by Human Naive CD4(+) T Cells Activated by IL-12 Plus IL-18	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; PROMOTER ACTIVATION; CYTOKINE RECEPTORS; PERIPHERAL-BLOOD; LYMPHOCYTES; INTERLEUKIN-12; TRANSCRIPTION; SYNERGIZES; INDUCTION	The role of T cells in innate immunity is not well defined. In this report, we show that a subset of human peripheral blood CD4(+) T cells responds to IL-12 plus IL-18, but not to IL-12 or IL-18 alone, by producing IFN-gamma in the absence of any antigenic stimulation or cell proliferation. Intracellular staining reveals a small percentage of resting CD4(+) T cells (0.5 to 1.5%) capable of producing IFN-gamma in response to IL-12 plus IL-18. Interestingly, both naive (CD45RA(+)) and memory (CD45RO(+)) CD4(+) populations were responsive to IL-12 plus IL-18 stimulation in producing IFN-gamma. The expression of IFN-gamma induced by IL-12 and IL-18 is sensitive to rapamycin and SB203580, indicating the possible involvement of mTOR and p38 MAP kinase, respectively, in this synergistic pathway. While p38MAP kinase is involved in transcription, mTOR is involved in message stabilization. We have also shown that NF kappa B family member, cRel, but not GADD45 beta and GADD45 gamma, plays an important role in IL-12 plus IL-18-induced IFN-gamma transcription. Thus, the present study suggests that naive CD4(+) T cells may participate in innate immunity or amplify adaptive immune responses through cytokine-induced antigen-independent cytokine production.	[Munk, Rachel B.; Sugiyama, Katsuki; Ghosh, Paritosh; Sasaki, Carl Y.; Rezanka, Louis; Takahashi, Hidenori; Longo, Dan L.] NIA, Lymphocyte Cell Biol Unit, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA; [Banerjee, Kasturi; Sen, Ranjan] NIA, Gene Regulat Sect, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Munk, RB (corresponding author), NIA, Lymphocyte Cell Biol Unit, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA.	ghoshp@grc.nia.nih.gov	Longo, Dan L./F-6022-2011		National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIGAG000621, ZIAAG000115, ZIAAG000386, ZIAAG000384] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre-Schmutz I, 1999, EUR J IMMUNOL, V29, P245, DOI 10.1002/(SICI)1521-4141(199901)29:01<245::AID-IMMU245>3.3.CO;2-F; Barbulescu K, 1998, J IMMUNOL, V160, P3642; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Bofill M, 2004, CLIN EXP IMMUNOL, V138, P460, DOI 10.1111/j.1365-2249.2004.02651.x; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Chang JT, 2000, EUR J IMMUNOL, V30, P1113, DOI 10.1002/(SICI)1521-4141(200004)30:4<1113::AID-IMMU1113>3.0.CO;2-P; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McQuaid A, 2003, CLIN EXP IMMUNOL, V134, P321, DOI 10.1046/j.1365-2249.2003.02271.x; Nakahira M, 2002, J IMMUNOL, V168, P1146, DOI 10.4049/jimmunol.168.3.1146; Newton R, 1997, FEBS LETT, V418, P135, DOI 10.1016/S0014-5793(97)01362-8; Papadakis KA, 2005, J IMMUNOL, V174, P4985, DOI 10.4049/jimmunol.174.8.4985; Papadakis KA, 2004, J IMMUNOL, V172, P7002, DOI 10.4049/jimmunol.172.11.7002; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Sattler A, 2009, BLOOD, V113, P1948, DOI 10.1182/blood-2008-02-139147; Smeltz RB, 2007, J IMMUNOL, V178, P4786, DOI 10.4049/jimmunol.178.8.4786; Sugimoto N, 2003, EUR J IMMUNOL, V33, P243, DOI 10.1002/immu.200390027; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z	23	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e18553	10.1371/journal.pone.0018553	http://dx.doi.org/10.1371/journal.pone.0018553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572994	Green Published, gold, Green Submitted			2022-12-25	WOS:000290440200002
J	Pan, LL; Liu, XH; Gong, QH; Wu, D; Zhu, YZ				Pan, Li-Long; Liu, Xin-Hua; Gong, Qi-Hai; Wu, Dan; Zhu, Yi-Zhun			Hydrogen Sulfide Attenuated Tumor Necrosis Factor-alpha-Induced Inflammatory Signaling and Dysfunction in Vascular Endothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED OXIDATIVE STRESS; HEME OXYGENASE-1; ADHESION MOLECULES; NADPH OXIDASE; EXPRESSION; ACTIVATION; INHIBITION; DISEASE; H2S	Background: Hydrogen sulfide (H(2)S), the third physiologically relevant gaseous molecule, is recognized increasingly as an anti-inflammatory mediator in various inflammatory conditions. Herein, we explored the effects and mechanisms of sodium hydrosulfide (NaHS, a H(2)S donor) on tumor necrosis factor (TNF)-alpha-induced human umbilical vein endothelial cells (HUVEC) dysfunction. Methodology and Principal Findings: Application of NaHS concentration-dependently suppressed TNF-alpha-induced mRNA and proteins expressions of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), mRNA expression of P-selectin and E-selectin as well as U937 monocytes adhesion to HUVEC. Western blot analysis revealed that the expression of the cytoprotective enzyme, heme oxygenase-1 (HO-1), was induced and coincident with the anti-inflammatory action of NaHS. Furthermore, TNF-alpha-induced NF-kappa B activation assessed by I kappa B alpha degradation and p65 phosphorylation and nuclear translocation and ROS production were diminished in cells subjected to treatment with NaHS. Significance: H(2)S can exert an anti-inflammatory effect in endothelial cells through a mechanism that involves the up-regulation of HO-1.	[Pan, Li-Long; Liu, Xin-Hua; Gong, Qi-Hai; Wu, Dan; Zhu, Yi-Zhun] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China; [Zhu, Yi-Zhun] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Pan, LL (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China.	zhuyz@fudan.edu.cn	Qihai, Gong/AAM-9343-2021; Zhu, Yi Zhun/ABG-8449-2021	Qihai, Gong/0000-0002-8967-337X; Zhu, Yi Zhun/0000-0001-7700-8041; Wu, Dan/0000-0001-6117-5099	National Basic Research Program of China (973 Program) [2010CB912600]; National Science Fund for Distinguished Young Scholars [30888002]; Synthetic Department of Research and Development Technique of New Drugs [2009ZX09301-011]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Synthetic Department of Research and Development Technique of New Drugs	This work was supported by the National Basic Research Program of China (973 Program, Grant No. 2010CB912600), National Science Fund for Distinguished Young Scholars (Grant No. 30888002), and Synthetic Department of Research and Development Technique of New Drugs (2009ZX09301-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang SF, 2010, CRIT CARE MED, V38, P619, DOI 10.1097/CCM.0b013e3181c0df00; BARNES PJ, 1993, TRENDS PHARMACOL SCI, V14, P436, DOI 10.1016/0165-6147(93)90184-L; Borel JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006733; Chanani NK, 2002, CIRCULATION, V106, pI284, DOI 10.1161/01.cir.0000032904.33237.8e; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Frey RS, 2006, J BIOL CHEM, V281, P16128, DOI 10.1074/jbc.M508810200; Kida K, 2011, ANTIOXID REDOX SIGN, V15, P343, DOI 10.1089/ars.2010.3671; Kim EJ, 2010, ATHEROSCLEROSIS, V211, P77, DOI 10.1016/j.atherosclerosis.2010.01.040; Kumar S, 2007, BIOCHEM PHARMACOL, V73, P1602, DOI 10.1016/j.bcp.2007.01.015; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lefer DJ, 2007, P NATL ACAD SCI USA, V104, P17907, DOI 10.1073/pnas.0709010104; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Li L, 2008, TRENDS PHARMACOL SCI, V29, P84, DOI 10.1016/j.tips.2007.11.003; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin CC, 2008, ARTERIOSCL THROM VAS, V28, P739, DOI 10.1161/ATVBAHA.107.160085; Lin SJ, 2005, ARTERIOSCL THROM VAS, V25, P334, DOI 10.1161/01.ATV.0000152114.00114.d8; Liu XH, 2010, CURR PHARM BIOTECHNO, V11, P895; Mukherjee TK, 2007, J IMMUNOL, V178, P1835, DOI 10.4049/jimmunol.178.3.1835; Naidu S, 2009, J IMMUNOL, V182, P7048, DOI 10.4049/jimmunol.0900006; Oh GS, 2006, FREE RADICAL BIO MED, V41, P106, DOI 10.1016/j.freeradbiomed.2006.03.021; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; PAWLOWSKI NA, 1985, P NATL ACAD SCI USA, V82, P8208, DOI 10.1073/pnas.82.23.8208; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sasaki M, 2003, AM J PHYSIOL-CELL PH, V284, pC422, DOI 10.1152/ajpcell.00271.2002; Schubert SY, 2002, FASEB J, V16, P1931, DOI 10.1096/fj.02-0147fje; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Szmitko PE, 2003, CIRCULATION, V108, P2041, DOI 10.1161/01.CIR.0000089093.75585.98; Taniguchi S, 2011, BRIT J PHARMACOL, V162, P1171, DOI 10.1111/j.1476-5381.2010.01119.x; Tyagi N, 2009, ANTIOXID REDOX SIGN, V11, P25, DOI 10.1089/ars.2008.2073; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang R, 2003, ANTIOXID REDOX SIGN, V5, P493, DOI 10.1089/152308603768295249; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang TM, 2011, J NUTR BIOCHEM, V22, P187, DOI 10.1016/j.jnutbio.2010.01.007; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Yan SK, 2006, BIOCHEM BIOPH RES CO, V351, P485, DOI 10.1016/j.bbrc.2006.10.058; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang WS, 2010, ATHEROSCLEROSIS, V211, P48, DOI 10.1016/j.atherosclerosis.2010.01.018; Zhang HL, 2007, J LEUKOCYTE BIOL, V82, P894, DOI 10.1189/jlb.0407237; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	45	106	113	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19766	10.1371/journal.pone.0019766	http://dx.doi.org/10.1371/journal.pone.0019766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572963	Green Published, gold, Green Submitted			2022-12-25	WOS:000290440200028
J	Sasaki, S; Ishida, T; Toyota, M; Ota, A; Suzuki, H; Takaoka, A; Yasui, H; Yamamoto, H; Takagi, H; Maeda, M; Seito, T; Tsujisaki, M; Shinomura, Y; Imai, K				Sasaki, Shigeru; Ishida, Tadao; Toyota, Minoru; Ota, Akinobu; Suzuki, Hiromu; Takaoka, Akinori; Yasui, Hiroshi; Yamamoto, Hiroyuki; Takagi, Hideyasu; Maeda, Masahiro; Seito, Tsutomu; Tsujisaki, Masayuki; Shinomura, Yasuhisa; Imai, Kohzoh			Interferon-alpha/beta and Anti-Fibroblast Growth Factor Receptor 1 Monoclonal Antibody Suppress Hepatic Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; EXPRESSION; LINES; HEPATOCARCINOGENESIS; THERAPY; RESPOND; PLUS	Background: Hepatocellular carcinoma (HCC) is the most commonly occurring primary liver cancer and ranks as the fifth most frequently occurring cancer, overall, and the third leading cause of cancer deaths, worldwide. At present, effective therapeutic options available for HCC are limited; consequently, the prognosis for these patients is poor. Our aim in the present study was to identify a novel target for antibody therapy against HCC. Methodology/Principal Findings: We used Western blot and flow cytometric and immunocytochemical analyses to investigate the regulation of FGFR1 expression by interferon-alpha/beta in several human hepatic cancer cell lines. In addition, we tested the efficacy of combined treatment with anti-FGFR1 monoclonal antibody and interferon-alpha/beta in a murine xenograft model of human HCC. We found that interferon-alpha/beta induces expression of FGFR1 in human HCC cell lines, and that an anti-FGFR1 monoclonal antibody (mAb) targeting of the induced FGFR1 can effectively inhibit growth and survival of HCC cells in vitro and in vivo. Moreover, the combination of interferon-alpha, anti-FGFR1 mAb and peripheral blood mononuclear cells (PBMCs) exerted a significant antitumor effect in vitro. Conclusions: Our results suggest that the combined use of an anti-FGFR1 antibody and interferon-alpha/beta is a promising approach to the treatment of HCC.	[Sasaki, Shigeru; Ishida, Tadao; Suzuki, Hiromu; Yasui, Hiroshi; Yamamoto, Hiroyuki; Takagi, Hideyasu; Shinomura, Yasuhisa] Sapporo Med Univ, Dept Internal Med 1, Sapporo, Hokkaido, Japan; [Toyota, Minoru; Suzuki, Hiromu; Yasui, Hiroshi] Sapporo Med Univ, Dept Mol Biol, Sapporo, Hokkaido, Japan; [Ota, Akinobu; Maeda, Masahiro; Seito, Tsutomu] Immunobiol Labs Co Ltd, Fujioka, Japan; [Takaoka, Akinori] Hokkaido Univ, Div Signaling Canc & Immunol, Inst Med Genet, Sapporo, Hokkaido, Japan; [Tsujisaki, Masayuki] Tenshi Hosp, Dept Gastroenterol & Hematol, Sapporo, Hokkaido, Japan; [Imai, Kohzoh] Univ Tokyo, Inst Med Sci, Div Novel Therapy Canc, Adv Clin Res Ctr, Tokyo, Japan	Sapporo Medical University; Sapporo Medical University; Immuno-Biological Laboratories Co. Ltd.; Hokkaido University; University of Tokyo	Sasaki, S (corresponding author), Sapporo Med Univ, Dept Internal Med 1, Sapporo, Hokkaido, Japan.	ssasaki@sapmed.ac.jp; mtoyota@sapmed.ac.jp	Ota, Akinobu/AAI-9396-2020; Ota, Akinobu/CAC-5999-2022; Ota, Akinobu/H-4510-2019	Ota, Akinobu/0000-0002-6296-2921; Yasui, Hiroshi/0000-0003-0905-6855	Ministry of Education, Culture, Sports, Science, and Technology [17016060]; Japan Society for Promotion of Science [21590853, 17659218]; Grants-in-Aid for Scientific Research [21590853, 23591399] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology (17016060 to KI and TI); Grants-in-Aid for Scientific Research (C) from the Japan Society for Promotion of Science (21590853 to SS); Grant-in-Aid for Exploratory Research from the Japan Society for Promotion of Science (17659218 to SS and KI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo VD, 2009, CELL CYCLE, V8, P580, DOI 10.4161/cc.8.4.7657; Asada N, 2003, IN VITRO CELL DEV-AN, V39, P321; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dvorak P, 2005, FOLIA HISTOCHEM CYTO, V43, P203; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; GREINER JW, 1987, SCIENCE, V235, P895, DOI 10.1126/science.3580039; Harris M, 2004, LANCET ONCOL, V5, P292, DOI 10.1016/S1470-2045(04)01467-6; Hildebrandt MAT, 2010, ONCOGENE, V29, P5724, DOI 10.1038/onc.2010.305; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hu ZY, 1996, CARCINOGENESIS, V17, P931, DOI 10.1093/carcin/17.5.931; Huang XQ, 2006, CANCER RES, V66, P1481, DOI 10.1158/0008-5472.CAN-05-2412; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; KINEBUCHI M, 1991, J IMMUNOL, V146, P3721; Ku XM, 2007, SCAND J IMMUNOL, V65, P435, DOI 10.1111/j.1365-3083.2007.01930.x; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Mise M, 1996, HEPATOLOGY, V23, P455; MOTOO Y, 1991, LIVER, V11, P272; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Qu XJ, 2004, J UROLOGY, V172, P733, DOI 10.1097/01.ju.0000130751.83953.55; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; TAKAHASHI H, 1993, CANCER RES, V53, P1612; Tanaka S, 2009, CANCER SCI, V100, P1, DOI 10.1111/j.1349-7006.2008.01006.x; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Yang JL, 2004, GUT, V53, P123, DOI 10.1136/gut.53.1.123	28	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19618	10.1371/journal.pone.0019618	http://dx.doi.org/10.1371/journal.pone.0019618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573021	Green Published, gold, Green Submitted			2022-12-25	WOS:000290386800025
J	Steindler, L; Schwalbach, MS; Smith, DP; Chan, F; Giovannoni, SJ				Steindler, Laura; Schwalbach, Michael S.; Smith, Daniel P.; Chan, Francis; Giovannoni, Stephen J.			Energy Starved Candidatus Pelagibacter Ubique Substitutes Light-Mediated ATP Production for Endogenous Carbon Respiration	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; ESCHERICHIA-COLI; PROTEORHODOPSIN; FUR; BACTERIUM; SAR11; PHOTOTROPHY; EXPRESSION; BINDING; OPERON	Previous studies have demonstrated that Candidatus Pelagibacter ubique, a member of the SAR11 clade, constitutively expresses proteorhodopsin (PR) proteins that can function as light-dependent proton pumps. However, exposure to light did not significantly improve the growth rate or final cell densities of SAR11 isolates in a wide range of conditions. Thus, the ecophysiological role of PR in SAR11 remained unresolved. We investigated a range of cellular properties and here show that light causes dramatic changes in physiology and gene expression in Cand. P. ubique cells that are starved for carbon, but provides little or no advantage during active growth on organic carbon substrates. During logarithmic growth there was no difference in oxygen consumption by cells in light versus dark. Energy starved cells respired endogenous carbon in the dark, becoming spheres that approached the minimum predicted size for cells, and produced abundant pili. In the light, energy starved cells maintained size, ATP content, and higher substrate transport rates, and differentially expressed nearly 10% of their genome. These findings show that PR is a vital adaptation that supports Cand. P. ubique metabolism during carbon starvation, a condition that is likely to occur in the extreme conditions of ocean environments.	[Steindler, Laura; Schwalbach, Michael S.; Smith, Daniel P.; Giovannoni, Stephen J.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Chan, Francis] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Steindler, L (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	steve.giovannoni@oregonstate.edu	Smith, Daniel/L-6827-2019	Smith, Daniel/0000-0002-2479-2044	Marine Microbiology Initiative, Gordon and Betty Moore Foundation [607_01]	Marine Microbiology Initiative, Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work was supported by Marine Microbiology Initiative award number 607_01 from the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; de la Torre JR, 2003, P NATL ACAD SCI USA, V100, P12830, DOI 10.1073/pnas.2133554100; DELORENZO V, 1987, J BACTERIOL, V169, P2624, DOI 10.1128/jb.169.6.2624-2630.1987; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Escolar L, 1998, J MOL BIOL, V283, P537, DOI 10.1006/jmbi.1998.2119; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Fuhrman JA, 2008, NAT REV MICROBIOL, V6, P488, DOI 10.1038/nrmicro1893; Giovannoni SJ, 2005, NATURE, V438, P82, DOI 10.1038/nature04032; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Gomez-Consarnau L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000358; Gonzalez JM, 2008, P NATL ACAD SCI USA, V105, P8724, DOI 10.1073/pnas.0712027105; Johnson ET, 2010, APPL ENVIRON MICROB, V76, P4123, DOI 10.1128/AEM.02425-09; Knoll A, 1999, SIZE LIMITS VERY SMA; Lami R, 2009, ENVIRON MICROBIOL, V11, P3201, DOI 10.1111/j.1462-2920.2009.02028.x; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Man DL, 2003, EMBO J, V22, P1725, DOI 10.1093/emboj/cdg183; Man-Aharonovich D, 2004, PHOTOCH PHOTOBIO SCI, V3, P459, DOI 10.1039/b316071h; Martinez A, 2007, P NATL ACAD SCI USA, V104, P5590, DOI 10.1073/pnas.0611470104; McCarren J, 2007, ENVIRON MICROBIOL, V9, P846, DOI 10.1111/j.1462-2920.2006.01203.x; Moore LR, 2007, LIMNOL OCEANOGR-METH, V5, P353, DOI 10.4319/lom.2007.5.353; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Riedel T, 2010, APPL ENVIRON MICROB, V76, P3187, DOI 10.1128/AEM.02971-09; Sabehi G, 2005, PLOS BIOL, V3, P1409, DOI 10.1371/journal.pbio.0030273; Sabehi G, 2003, ENVIRON MICROBIOL, V5, P842, DOI 10.1046/j.1462-2920.2003.00493.x; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schwalbach MS, 2010, ENVIRON MICROBIOL, V12, P490, DOI 10.1111/j.1462-2920.2009.02092.x; Sowell SM, 2008, APPL ENVIRON MICROB, V74, P4091, DOI 10.1128/AEM.00599-08; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; SOWELL SM, 2010, ISME J; Stingl U, 2007, APPL ENVIRON MICROB, V73, P2290, DOI 10.1128/AEM.02559-06; Thompson DK, 2002, APPL ENVIRON MICROB, V68, P881, DOI 10.1128/AEM.68.2.881-892.2002; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vergin KL, 2007, ENVIRON MICROBIOL, V9, P2430, DOI 10.1111/j.1462-2920.2007.01361.x; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Walter JM, 2007, P NATL ACAD SCI USA, V104, P2408, DOI 10.1073/pnas.0611035104; Wan XF, 2004, J BACTERIOL, V186, P8385, DOI 10.1128/JB.186.24.8385-8400.2004	43	133	134	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19725	10.1371/journal.pone.0019725	http://dx.doi.org/10.1371/journal.pone.0019725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573025	Green Published, gold			2022-12-25	WOS:000290386800033
J	Saino, N; Caprioli, M; Romano, M; Boncoraglio, G; Rubolini, D; Ambrosini, R; Bonisoli-Alquati, A; Romano, A				Saino, Nicola; Caprioli, Manuela; Romano, Maria; Boncoraglio, Giuseppe; Rubolini, Diego; Ambrosini, Roberto; Bonisoli-Alquati, Andrea; Romano, Andrea			Antioxidant Defenses Predict Long-Term Survival in a Passerine Bird	PLOS ONE			English	Article							HISTORY TRADE-OFFS; OXIDATIVE STRESS; SEXUAL SELECTION; FREE-RADICALS; LIFE-SPAN; RESISTANCE; DAMAGE; IMMUNOCOMPETENCE; CAROTENOIDS; SENESCENCE	Background: Normal and pathological processes entail the production of oxidative substances that can damage biological molecules and harm physiological functions. Organisms have evolved complex mechanisms of antioxidant defense, and any imbalance between oxidative challenge and antioxidant protection can depress fitness components and accelerate senescence. While the role of oxidative stress in pathogenesis and aging has been studied intensively in humans and model animal species under laboratory conditions, there is a dearth of knowledge on its role in shaping life-histories of animals under natural selection regimes. Yet, given the pervasive nature and likely fitness consequences of oxidative damage, it can be expected that the need to secure efficient antioxidant protection is powerful in molding the evolutionary ecology of animals. Here, we test whether overall antioxidant defense varies with age and predicts long-term survival, using a wild population of a migratory passerine bird, the barn swallow (Hirundo rustica), as a model. Methodology/Principal Findings: Plasma antioxidant capacity (AOC) of breeding individuals was measured using standard protocols and annual survival was monitored over five years (2006-2010) on a large sample of selection episodes. AOC did not covary with age in longitudinal analyses after discounting the effect of selection. AOC positively predicted annual survival independently of sex. Individuals were highly consistent in their relative levels of AOC, implying the existence of additive genetic variance and/or environmental (including early maternal) components consistently acting through their lives. Conclusions: Using longitudinal data we showed that high levels of antioxidant protection positively predict long-term survival in a wild animal population. Present results are therefore novel in disclosing a role for antioxidant protection in determining survival under natural conditions, strongly demanding for more longitudinal eco-physiological studies of life-histories in relation to oxidative stress in wild populations.	[Saino, Nicola; Caprioli, Manuela; Romano, Maria; Boncoraglio, Giuseppe; Rubolini, Diego; Bonisoli-Alquati, Andrea; Romano, Andrea] Univ Milan, Dipartimento Biol, Milan, Italy; [Boncoraglio, Giuseppe] Univ Cambridge, Dept Zool, Cambridge, England; [Ambrosini, Roberto] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy	University of Milan; University of Cambridge; University of Milano-Bicocca	Saino, N (corresponding author), Univ Milan, Dipartimento Biol, Milan, Italy.	nicola.saino@unimi.it	Romano, Andrea/B-3930-2012; Romano, Andrea/A-2780-2017; Rubolini, Diego/F-2851-2011; Alquati, Andrea Bonisoli/S-2082-2017; Bonisoli Alquati, Andrea/A-6409-2008; Ambrosini, Roberto/F-3188-2012	Romano, Andrea/0000-0002-0945-6018; Rubolini, Diego/0000-0003-2703-5783; Alquati, Andrea Bonisoli/0000-0002-9255-7556; Ambrosini, Roberto/0000-0002-7148-1468; Saino, Nicola/0000-0002-0230-3967	Universita degli Studi di Milano [PUR-2009]; University of Milano; Marie Curie Intra-European fellowship [PIEF-GA-2009-252120]	Universita degli Studi di Milano; University of Milano; Marie Curie Intra-European fellowship(European Commission)	Funding was provided by the Universita degli Studi di Milano (PUR-2009). GB was funded by a grant from the University of Milano and by a Marie Curie Intra-European fellowship (PIEF-GA-2009-252120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2006, CURR OPIN OBSTET GYN, V18, P325, DOI 10.1097/01.gco.0000193003.58158.4e; Allison P. D., 2010, SURVIVAL ANAL USING, VSecond; Alonso-Alvarez C, 2006, EVOLUTION, V60, P1913, DOI 10.1111/j.0014-3820.2006.tb00534.x; Andersson Malte, 1994; Badyaev AV, 2008, ANN NY ACAD SCI, V1133, P151, DOI 10.1196/annals.1438.009; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Biard C, 2007, J EVOLUTION BIOL, V20, P326, DOI 10.1111/j.1420-9101.2006.01194.x; Bize P, 2008, ECOLOGY, V89, P2584, DOI 10.1890/07-1135.1; Blount JD, 2004, P ROY SOC B-BIOL SCI, V271, pS79, DOI 10.1098/rsbl.2003.0104; BOURDON RM, 1997, UNDERSTANDING ANIMAL; Brys K, 2007, EXP GERONTOL, V42, P845, DOI 10.1016/j.exger.2007.02.004; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2007, J COMP PHYSIOL B, V177, P723, DOI 10.1007/s00360-007-0169-0; Costantini D, 2006, COMP BIOCHEM PHYS A, V145, P137, DOI 10.1016/j.cbpa.2006.06.002; Costantini D, 2010, FUNCT ECOL, V24, P950, DOI 10.1111/j.1365-2435.2010.01746.x; Devevey G, 2010, J ORNITHOL, V151, P251, DOI 10.1007/s10336-009-0456-5; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fitze PS, 2003, OECOLOGIA, V137, P148, DOI 10.1007/s00442-003-1323-3; Halliwell B., 2007, FREE RADICALS BIOL M; HEYWOOD JS, 1989, EVOLUTION, V43, P1387, DOI [10.2307/2409455, 10.1111/j.1558-5646.1989.tb02590.x]; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Isaksson C, 2006, BEHAV ECOL SOCIOBIOL, V60, P556, DOI 10.1007/s00265-006-0200-6; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI 10.1111/j.1558-5646.1991.tb02646.x; Jablonka E., 1995, EPIGENETIC INHERITAN; Koutsos EA, 2006, J NUTR, V136, P1027, DOI 10.1093/jn/136.4.1027; Koutsos EA, 2003, J NUTR, V133, P1132, DOI 10.1093/jn/133.4.1132; Koutsos EA, 2007, COMP BIOCHEM PHYS B, V147, P87, DOI 10.1016/j.cbpb.2006.12.011; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Marko G, 2011, J COMP PHYSIOL B, V181, P73, DOI 10.1007/s00360-010-0502-x; Moller AP, 2007, BEHAV ECOL SOCIOBIOL, V61, P1311, DOI 10.1007/s00265-007-0362-x; Moller AP, 2002, ECOLOGY, V83, P2220, DOI 10.2307/3072053; Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137; Moller AP., 1994, SEXUAL SELECTION BAR; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nilsson JA, 2002, P ROY SOC B-BIOL SCI, V269, P1735, DOI 10.1098/rspb.2002.2071; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Nussey DH, 2009, FUNCT ECOL, V23, P809, DOI 10.1111/j.1365-2435.2009.01555.x; Rubolini D, 2006, J EVOLUTION BIOL, V19, P1571, DOI 10.1111/j.1420-9101.2006.01121.x; Rubolini D, 2004, BEHAV ECOL, V15, P592, DOI 10.1093/beheco/arh048; Safran RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009420; Saino N, 1999, J ANIM ECOL, V68, P999, DOI 10.1046/j.1365-2656.1999.00350.x; Saino N, 1997, P NATL ACAD SCI USA, V94, P549, DOI 10.1073/pnas.94.2.549; Saino N, 2004, P ROY SOC B-BIOL SCI, V271, P681, DOI 10.1098/rspb.2003.2656; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1729, DOI 10.1098/rspb.2002.2088; Saino N, 2011, BEHAV ECOL, V22, P411, DOI 10.1093/beheco/arq220; Salomons HM, 2009, P ROY SOC B-BIOL SCI, V276, P3157, DOI 10.1098/rspb.2009.0517; Surai P.F., 2002, NATURAL ANTIOXIDANTS; Turner A., 2006, BARN SWALLOW; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van de Pol M, 2006, AM NAT, V167, P766, DOI 10.1086/503331; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	62	80	81	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19593	10.1371/journal.pone.0019593	http://dx.doi.org/10.1371/journal.pone.0019593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573124	Green Published, gold, Green Submitted			2022-12-25	WOS:000290305600032
J	Duan, X; Ponomareva, L; Veeranki, S; Choubey, D				Duan, Xin; Ponomareva, Larissa; Veeranki, Sudhakar; Choubey, Divaker			IFI16 Induction by Glucose Restriction in Human Fibroblasts Contributes to Autophagy through Activation of the ATM/AMPK/p53 Pathway	PLOS ONE			English	Article							PROTEIN-KINASE; CELLULAR SENESCENCE; POTENTIAL MEDIATOR; TUMOR SUPPRESSION; OXIDATIVE STRESS; P53; AMP; CELLS; ATM; PHOSPHORYLATION	Background: Glucose restriction in cells increases the AMP/ATP ratio (energetic stress), which activates the AMPK/p53 pathway. Depending upon the energetic stress levels, cells undergo either autophagy or cell death. Given that the activated p53 induces the expression of IFI16 protein, we investigated the potential role of the IFI16 protein in glucose restriction-induced responses. Methodology/Principal Findings: We found that glucose restriction or treatment of human diploid fibroblasts (HDFs) with the activators of the AMPK/p53 pathway induced the expression of IFI16 protein. The induced levels of IFI16 protein were associated with the induction of autophagy and reduced cell survival. Moreover, the increase in the IFI16 protein levels was dependent upon the expression of the functional ATM protein kinase. Importantly, the knockdown of the IFI16 expression in HDFs inhibited the activation of the ATM/AMPK/p53 pathway in response to glucose restriction and also increased the survival of HDFs. Conclusions/Significance: Our observations demonstrate a role for the IFI16 protein in the energetic stress-induced regulation of autophagy and cell survival. Additionally, our findings also indicate that the loss of IFI16 expression, as found in certain cancers, may provide a survival advantage to cancer cells in microenvironments with low glucose levels.	[Duan, Xin; Ponomareva, Larissa; Veeranki, Sudhakar; Choubey, Divaker] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA; [Ponomareva, Larissa; Choubey, Divaker] Cincinnati VA Med Ctr, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Duan, X (corresponding author), Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA.	Divaker.choubey@uc.edu	Choubey, Divaker/A-4771-2008	Ponomareva, Larissa/0000-0003-2182-8774	Veterans Affairs (VA); National Institutes of Health [AG 025036]; NATIONAL INSTITUTE ON AGING [R01AG025036] Funding Source: NIH RePORTER	Veterans Affairs (VA)(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Merit Award from the Veterans Affairs (VA) and a grant (AG 025036) from the National Institutes of Health to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A, 2010, CELL CYCLE, V9, P3685, DOI 10.4161/cc.9.18.13253; Alexander A, 2010, AUTOPHAGY, V6, P672, DOI 10.4161/auto.6.5.12509; Birnbaum MJ, 2005, MOL CELL, V19, P289, DOI 10.1016/j.molcel.2005.07.012; Calabrese Vittorio, 2006, Ital J Biochem, V55, P263; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Caro-Maldonado A, 2010, CELL DEATH DIFFER, V17, P1335, DOI 10.1038/cdd.2010.21; CHOUBEY D, 1993, J INTERFERON RES, V13, P43, DOI 10.1089/jir.1993.13.43; Choubey D, 2008, FRONT BIOSCI-LANDMRK, V13, P598, DOI 10.2741/2705; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Fujiuchi N, 2004, J BIOL CHEM, V279, P20339, DOI 10.1074/jbc.M400344200; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; Gugliesi F, 2005, J LEUKOCYTE BIOL, V77, P820, DOI 10.1189/jlb.0904507; HARRIS J, 2011, J BIOL CHEM     0112; Johnstone RW, 2000, ONCOGENE, V19, P6033, DOI 10.1038/sj.onc.1204005; Johnstone RW, 1999, MOL CELL BIOL, V19, P5833; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Liao JCC, 2011, STRUCTURE, V19, P418, DOI 10.1016/j.str.2010.12.015; Maclaine NJ, 2009, AGING-US, V1, P490, DOI 10.18632/aging.100047; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pandita TK, 2002, ONCOGENE, V21, P611, DOI 10.1038/sj.onc.1205060; PETROVSKI G, 2011, AUTOPHAGY, V7; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Song LL, 2008, MOL CANCER RES, V6, P1732, DOI 10.1158/1541-7786.MCR-08-0208; Sun Y, 2007, MOL CELL BIOCHEM, V306, P239, DOI 10.1007/s11010-007-9575-6; Suzuki A, 2003, J BIOL CHEM, V278, P48, DOI 10.1074/jbc.M206025200; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; Um JH, 2007, J BIOL CHEM, V282, P20794, DOI 10.1074/jbc.C700070200; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Xin H, 2004, ONCOGENE, V23, P6209, DOI 10.1038/sj.onc.1207836; Xin H, 2003, ONCOGENE, V22, P4831, DOI 10.1038/sj.onc.1206754; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229	48	41	44	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19532	10.1371/journal.pone.0019532	http://dx.doi.org/10.1371/journal.pone.0019532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573174	gold, Green Published, Green Submitted			2022-12-25	WOS:000290256400019
J	Lee, YA; Goto, Y				Lee, Young-A; Goto, Yukiori			Neurodevelopmental Disruption of Cortico-Striatal Function Caused by Degeneration of Habenula Neurons	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; VENTRAL TEGMENTAL AREA; LATERAL HABENULA; FASCICULUS RETROFLEXUS; DOPAMINERGIC-NEURONS; INHIBITORY INFLUENCE; PREFRONTAL CORTEX; BRAIN-DEVELOPMENT; DECISION-MAKING; RAT	Background: The habenula plays an important role on cognitive and affective functions by regulating monoamines transmission such as the dopamine and serotonin, such that its dysfunction is thought to underlie a number of psychiatric conditions. Given that the monoamine systems are highly vulnerable to neurodevelopmental insults, damages in the habenula during early neurodevelopment may cause devastating effects on the wide-spread brain areas targeted by monoamine innervations. Methodology/Principal Findings: Using a battery of behavioral, anatomical, and biochemical assays, we examined the impacts of neonatal damage in the habenula on neurodevelopmental sequelae of the prefrontal cortex (PFC) and nucleus accumbens (NAcc) and associated behavioral deficits in rodents. Neonatal lesion of the medial and lateral habenula by ibotenic acid produced an assortment of behavioral manifestations consisting of hyper-locomotion, impulsivity, and attention deficit, with hyper-locomotion and impulsivity being observed only in the juvenile period, whereas attention deficit was sustained up until adulthood. Moreover, these behavioral alterations were also improved by amphetamine. Our study further revealed that impulsivity and attention deficit were associated with disruption of PFC volume and dopamine (DA) receptor expression, respectively. In contrast, hyper-locomotion was associated with decreased DA transporter expression in the NAcc. We also found that neonatal administration of nicotine into the habenula of neonatal brains produced selective lesion of the medial habenula. Behavioral deficits with neonatal nicotine administration were similar to those caused by ibotenic acid lesion of both medial and lateral habenula during the juvenile period, whereas they were different in adulthood. Conclusions/Significance: Because of similarity between behavioral and brain alterations caused by neonatal insults in the habenula and the symptoms and suggested neuropathology in attention deficit/hyperactivity disorder (ADHD), these results suggest that neurodevelopmental deficits in the habenula and the consequent cortico-striatal dysfunctions may be involved in the pathogenesis and pathophysiology of ADHD.	[Lee, Young-A; Goto, Yukiori] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	McGill University	Lee, YA (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	yukiori.goto@mcgill.ca			Canadian Institute of Health Research [MOP-82732]; McGill University Health Centre	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); McGill University Health Centre	This work was supported by Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) MOP-82732 and McGill University Health Centre (http://muhc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LG, 2010, J PSYCHIATR RES, V44, P1214, DOI 10.1016/j.jpsychires.2010.04.026; Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Araki KY, 2007, BRAIN RES, V1156, P31, DOI 10.1016/j.brainres.2007.04.043; Batty MJ, 2010, J AM ACAD CHILD PSY, V49, P229, DOI 10.1016/j.jaac.2009.11.008; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; Boire D, 2005, J CHEM NEUROANAT, V29, P193, DOI 10.1016/j.jchemneu.2005.01.003; Brinschwitz K, 2010, NEUROSCIENCE, V168, P463, DOI 10.1016/j.neuroscience.2010.03.050; Carlson J, 2001, BRAIN RES, V906, P127, DOI 10.1016/S0006-8993(01)02570-7; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; CREESE I, 1972, NATURE-NEW BIOL, V238, P247, DOI 10.1038/newbio238247a0; Daviss WB, 2008, J CHILD ADOL PSYCHOP, V18, P565, DOI 10.1089/cap.2008.032; DemotesMainard J, 1996, DEV BRAIN RES, V94, P166, DOI 10.1016/0165-3806(96)00041-7; Denk F, 2005, PSYCHOPHARMACOLOGY, V179, P587, DOI 10.1007/s00213-004-2059-4; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Ellison G, 2002, EUR NEUROPSYCHOPHARM, V12, P287, DOI 10.1016/S0924-977X(02)00020-2; Friedman A, 2011, NEUROPHARMACOLOGY, V60, P381, DOI 10.1016/j.neuropharm.2010.10.006; Friedman A, 2010, NEUROPHARMACOLOGY, V59, P452, DOI 10.1016/j.neuropharm.2010.06.008; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Glick SD, 2008, EUR J PHARMACOL, V599, P91, DOI 10.1016/j.ejphar.2008.09.038; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Gurevich EV, 2000, J COMP NEUROL, V420, P35, DOI 10.1002/(SICI)1096-9861(20000424)420:1<35::AID-CNE3>3.0.CO;2-K; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; JONES DNC, 1995, J NEUROSCI, V15, P7282; KALEN P, 1989, BRAIN RES, V492, P187, DOI 10.1016/0006-8993(89)90901-3; KAVOUSSI RJ, 1994, J CLIN PSYCHIAT, V55, P137; Kim U, 2005, J COMP NEUROL, V483, P236, DOI 10.1002/cne.20410; Kozak M, 2007, J CELL BIOCHEM, V102, P280, DOI 10.1002/jcb.21464; Langley K, 2005, Minerva Pediatr, V57, P359; Lecca S, 2011, NEUROPSYCHOPHARMACOL, V36, P589, DOI 10.1038/npp.2010.190; Lecourtier L, 2005, NEUROPSYCHOPHARMACOL, V30, P484, DOI 10.1038/sj.npp.1300595; Lecourtier L, 2004, EUR J NEUROSCI, V19, P2551, DOI 10.1111/j.0953-816X.2004.03356.x; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; Lee YA, 2010, BRIT J NUTR, V103, P479, DOI 10.1017/S0007114509992005; Lipska BK, 2000, NEUROPSYCHOPHARMACOL, V23, P223, DOI 10.1016/S0893-133X(00)00137-8; LISOPRAWSKI A, 1980, BRAIN RES, V183, P229, DOI 10.1016/0006-8993(80)90135-3; LUBOW RE, 1993, J CHILD PSYCHOL PSYC, V34, P959, DOI 10.1111/j.1469-7610.1993.tb01101.x; Lubow RE., 1989, LATENT INHIBITION CO; Lukaszewska Irena, 1993, Acta Neurobiologiae Experimentalis (Warsaw), V53, P243; Makris N, 2007, CEREB CORTEX, V17, P1364, DOI 10.1093/cercor/bhl047; Morissette MC, 2008, BEHAV BRAIN RES, V187, P17, DOI 10.1016/j.bbr.2007.08.021; Narr KL, 2009, J AM ACAD CHILD PSY, V48, P1014, DOI 10.1097/CHI.0b013e3181b395c0; NISHIKAWA T, 1985, BRAIN RES, V331, P81, DOI 10.1016/0006-8993(85)90717-6; NISHIKAWA T, 1986, BRAIN RES, V373, P324, DOI 10.1016/0006-8993(86)90347-1; Omelchenko N, 2009, EUR J NEUROSCI, V30, P1239, DOI 10.1111/j.1460-9568.2009.06924.x; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Petrof I, 2010, BEHAV BRAIN RES, V211, P248, DOI 10.1016/j.bbr.2010.03.045; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ranft K, 2010, PSYCHOL MED, V40, P557, DOI 10.1017/S0033291709990821; Salas R, 2009, J NEUROSCI, V29, P3014, DOI 10.1523/JNEUROSCI.4934-08.2009; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Savitz JB, 2011, BIOL PSYCHIAT, V69, P336, DOI 10.1016/j.biopsych.2010.09.027; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Shepard PD, 2006, SCHIZOPHRENIA BULL, V32, P417, DOI 10.1093/schbul/sbj083; Shumake J, 2003, Behav Cogn Neurosci Rev, V2, P198, DOI 10.1177/1534582303259057; Shumake J, 2010, J NEUROSCI, V30, P5876, DOI 10.1523/JNEUROSCI.3604-09.2010; Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005; THORNTON EW, 1991, PHYSIOL BEHAV, V49, P819, DOI 10.1016/0031-9384(91)90324-H; Ueno K, 2002, BEHAV PHARMACOL, V13, P1, DOI 10.1097/00008877-200202000-00001; ValeMartinez A, 1997, NEUROBIOL LEARN MEM, V68, P68, DOI 10.1006/nlme.1997.3777; VANEDEN CG, 1985, J COMP NEUROL, V241, P268, DOI 10.1002/cne.902410303; Wang YH, 2009, NEUROSCI LETT, V461, P167, DOI 10.1016/j.neulet.2009.06.029; WinzerSerhan UH, 1997, J COMP NEUROL, V386, P540, DOI 10.1002/(SICI)1096-9861(19971006)386:4<540::AID-CNE2>3.0.CO;2-2; [No title captured]	66	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19450	10.1371/journal.pone.0019450	http://dx.doi.org/10.1371/journal.pone.0019450			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559387	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700178
J	Li, DS; Lott, WB; Lowry, K; Jones, A; Thu, HM; Aaskov, J				Li, Dongsheng; Lott, William B.; Lowry, Kym; Jones, Anita; Thu, Hlaing Myat; Aaskov, John			Defective Interfering Viral Particles in Acute Dengue Infections	PLOS ONE			English	Article							FLAVIVIRUS RNA; AEDES-AEGYPTI; PERSISTENT INFECTION; VIRUS-PARTICLES; KUNJIN VIRUS; FEVER VIRUS; LENGTH CDNA; REPLICATION; GENOMES; CELLS	While much of the genetic variation in RNA viruses arises because of the error-prone nature of their RNA-dependent RNA polymerases, much larger changes may occur as a result of recombination. An extreme example of genetic change is found in defective interfering (DI) viral particles, where large sections of the genome of a parental virus have been deleted and the residual sub-genome fragment is replicated by complementation by co-infecting functional viruses. While most reports of DI particles have referred to studies in vitro, there is some evidence for the presence of DI particles in chronic viral infections in vivo. In this study, short fragments of dengue virus (DENV) RNA containing only key regulatory elements at the 3' and 5' ends of the genome were recovered from the sera of patients infected with any of the four DENV serotypes. Identical RNA fragments were detected in the supernatant from cultures of Aedes mosquito cells that were infected by the addition of sera from dengue patients, suggesting that the sub-genomic RNA might be transmitted between human and mosquito hosts in defective interfering (DI) viral particles. In vitro transcribed sub-genomic RNA corresponding to that detected in vivo could be packaged in virus like particles in the presence of wild type virus and transmitted for at least three passages in cell culture. DENV preparations enriched for these putative DI particles reduced the yield of wild type dengue virus following co-infections of C6-36 cells. This is the first report of DI particles in an acute arboviral infection in nature. The internal genomic deletions described here are the most extensive defects observed in DENV and may be part of a much broader disease attenuating process that is mediated by defective viruses.	[Li, Dongsheng; Lott, William B.; Lowry, Kym; Jones, Anita; Aaskov, John] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Thu, Hlaing Myat] Virol Res Div, Dept Med Res, Yangon, Myanmar	Queensland University of Technology (QUT)	Li, DS (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	j.aaskov@qut.edu.au	Lott, William B/J-1062-2012; Lowry, Kym/AAK-2711-2021	Lott, William B/0000-0001-7118-7560; Lowry, Kym/0000-0002-9666-149X	Australian National Health and Medical Research Council [497203]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grant 497203 from the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; BARRETT ADT, 1986, CURR TOP MICROBIOL, V128, P55; BRINTON MA, 1982, VIROLOGY, V116, P84, DOI 10.1016/0042-6822(82)90405-6; CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; CLEAVES GR, 1981, VIROLOGY, V111, P73, DOI 10.1016/0042-6822(81)90654-1; Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685; Ebner PD, 2008, VIROLOGY, V381, P98, DOI 10.1016/j.virol.2008.08.024; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018; Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Henle W, 1943, SCIENCE, V98, P87, DOI 10.1126/science.98.2534.87; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; JOHNSTON RE, 1975, J VIROL, V16, P951, DOI 10.1128/JVI.16.4.951-958.1975; Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034; Khromykh AA, 1998, J VIROL, V72, P5967, DOI 10.1128/JVI.72.7.5967-5977.1998; Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001; Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001; KIRKEGAARD K, 1986, CELL, V47, P433, DOI 10.1016/0092-8674(86)90600-8; Lancaster MU, 1998, J VIROL, V72, P2474, DOI 10.1128/JVI.72.3.2474-2482.1998; Li Z, 2005, J VIROL METHODS, V130, P154, DOI 10.1016/j.jviromet.2005.06.022; Marriott AC, 2010, REV MED VIROL, V20, P51, DOI 10.1002/rmv.641; MIMS CA, 1956, BRIT J EXP PATHOL, V37, P129; Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277; Noppornpanth S, 2007, J VIROL, V81, P12496, DOI 10.1128/JVI.01059-07; NUESCH JPF, 1989, J GEN VIROL, V70, P3475, DOI 10.1099/0022-1317-70-12-3475; Pacini L, 2009, J VIROL, V83, P9079, DOI 10.1128/JVI.00308-09; Paranjape SM, 2010, CURR TOP MICROBIOL, V338, P15, DOI 10.1007/978-3-642-02215-9_2; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; Polacek C, 2009, J VIROL, V83, P1161, DOI 10.1128/JVI.01362-08; PONS M, 1969, VIROLOGY, V38, P68, DOI 10.1016/0042-6822(69)90128-7; POPESCU M, 1977, VIROLOGY, V77, P78, DOI 10.1016/0042-6822(77)90407-X; REPIK PM, 1983, AM J TROP MED HYG, V32, P577, DOI 10.4269/ajtmh.1983.32.577; ROUX L, 1991, ADV VIRUS RES, V40, P181; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Thu HM, 2004, EMERG INFECT DIS, V10, P593, DOI 10.3201/eid1004.030216; Tuiskunen A, 2010, J GEN VIROL, V91, P1019, DOI 10.1099/vir.0.016667-0; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; VONMAGNUS P, 1954, ADV VIRUS RES, V2, P59, DOI 10.1016/S0065-3527(08)60529-1; Wang WK, 2002, J VIROL, V76, P4662, DOI 10.1128/JVI.76.9.4662-4665.2002; WHO, 1997, DENG HAEM FEV DIAGN; Wittke V, 2002, VIROLOGY, V301, P148, DOI 10.1006/viro.2002.1549; Yu L, 2008, VIROLOGY, V374, P170, DOI 10.1016/j.virol.2007.12.035; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	88	92	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19447	10.1371/journal.pone.0019447	http://dx.doi.org/10.1371/journal.pone.0019447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559384	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700176
J	Lubieniecka, JM; Streijger, F; Lee, JHT; Stoynov, N; Liu, J; Mottus, R; Pfeifer, T; Kwon, BK; Coorssen, JR; Foster, LJ; Grigliatti, TA; Tetzlaff, W				Lubieniecka, Joanna M.; Streijger, Femke; Lee, Jae H. T.; Stoynov, Nikolay; Liu, Jie; Mottus, Randy; Pfeifer, Tom; Kwon, Brian K.; Coorssen, Jens R.; Foster, Leonard J.; Grigliatti, Thomas A.; Tetzlaff, Wolfram			Biomarkers for Severity of Spinal Cord Injury in the Cerebrospinal Fluid of Rats	PLOS ONE			English	Article							PROTEINS; CONTUSION; FAMILY; EXCITOTOXICITY; REGENERATION; EXPRESSION; PROTEOMICS; ELEVATION; PROTECTS; CALCIUM	One of the major challenges in management of spinal cord injury (SCI) is that the assessment of injury severity is often imprecise. Identification of reliable, easily quantifiable biomarkers that delineate the severity of the initial injury and that have prognostic value for the degree of functional recovery would significantly aid the clinician in the choice of potential treatments. To find such biomarkers we performed quantitative liquid chromatography-mass spectrometry (LC-MS/MS) analyses of cerebrospinal fluid (CSF) collected from rats 24 h after either a moderate or severe SCI. We identified a panel of 42 putative biomarkers of SCI, 10 of which represent potential biomarkers of SCI severity. Three of the candidate biomarkers, Ywhaz, Itih4, and Gpx3 were also validated by Western blot in a biological replicate of the injury. The putative biomarkers identified in this study may potentially be a valuable tool in the assessment of the extent of spinal cord damage.	[Lubieniecka, Joanna M.; Mottus, Randy; Pfeifer, Tom; Grigliatti, Thomas A.; Tetzlaff, Wolfram] Univ British Columbia, Dept Zool, Inst Life Sci, Vancouver, BC, Canada; [Streijger, Femke; Lee, Jae H. T.; Liu, Jie; Kwon, Brian K.; Grigliatti, Thomas A.; Tetzlaff, Wolfram] Univ British Columbia, Blusson Spinal Cord Ctr, Int Collaborat Repair Discoveries ICORD, Vancouver, BC V5Z 1M9, Canada; [Stoynov, Nikolay; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada; [Stoynov, Nikolay; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Pfeifer, Tom] Univ British Columbia, Ctr Drug Res & Dev CDRD, Vancouver, BC V5Z 1M9, Canada; [Coorssen, Jens R.] Univ Western Sydney, Sch Med, Dept Mol Physiol, Penrith, NSW 1797, Australia; [Kwon, Brian K.] Univ British Columbia, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Western Sydney University; University of British Columbia	Lubieniecka, JM (corresponding author), Univ British Columbia, Dept Zool, Inst Life Sci, Vancouver, BC, Canada.	jlubieni@interchange.ubc.ca; grigliat@zoology.ubc.ca	Tetzlaff, Wolfram/AAY-4430-2020		Michael Smith Foundation for Health Research [MSFHR952]; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; British Columbia Proteomics Network	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; British Columbia Proteomics Network	This research was supported by the Michael Smith Foundation for Health Research (grant# MSFHR952). Mass spectrometry infrastructure was supported by the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, and the British Columbia Proteomics Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2007, FEBS LETT, V581, P3723, DOI 10.1016/j.febslet.2007.03.074; Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Boersema PJ, 2008, PROTEOMICS, V8, P4624, DOI 10.1002/pmic.200800297; Bost F, 1998, EUR J BIOCHEM, V252, P339, DOI 10.1046/j.1432-1327.1998.2520339.x; Boulos S, 2007, J NEUROSCI RES, V85, P3089, DOI 10.1002/jnr.21429; Burkhard PR, 2001, NEUROLOGY, V56, P1528, DOI 10.1212/WNL.56.11.1528; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Chan QWT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r156; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Choo AMT, 2009, J NEUROSCI METH, V181, P6, DOI 10.1016/j.jneumeth.2009.04.007; Coorssen JR, 2002, ANAL BIOCHEM, V307, P54, DOI 10.1016/S0003-2697(02)00015-5; Cuadrado-Corrales N, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-25; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Feng ZW, 2002, MOL CELL BIOL, V22, P5357, DOI 10.1128/MCB.22.15.5357-5366.2002; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Guez M, 2003, J NEUROTRAUM, V20, P853, DOI 10.1089/089771503322385782; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1007/BF03206569; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Inoue KI, 2005, MOL PHARMACOL, V67, P673, DOI 10.1124/mol.104.005967; Jakeman LB, 2000, J NEUROTRAUM, V17, P299, DOI 10.1089/neu.2000.17.299; Khaladj N, 2008, EUR J VASC ENDOVASC, V36, P11, DOI 10.1016/j.ejvs.2008.01.011; Khwaja FW, 2007, J PROTEOME RES, V6, P559, DOI 10.1021/pr060240z; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Liu Y, 1999, J NEUROSCI, V19, P4370; Loy DN, 2005, NEUROSURGERY, V56, P391, DOI 10.1227/01.NEU.0000148906.83616.D2; Ma JJ, 2001, SCAND J PLAST RECONS, V35, P355; MATTSON MP, 1992, EXP GERONTOL, V27, P29, DOI 10.1016/0531-5565(92)90027-W; Mizutani A, 2003, BLOOD, V101, P3029, DOI 10.1182/blood-2002-08-2406; MORTENSEN P, 2009, J PROTEOME RES; Namikawa K, 1998, MOL BRAIN RES, V55, P315, DOI 10.1016/S0169-328X(98)00012-6; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Ochi S, 2007, P NATL ACAD SCI USA, V104, P11394, DOI 10.1073/pnas.0701971104; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Ramer LM, 2005, SPINAL CORD, V43, P134, DOI 10.1038/sj.sc.3101715; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004; Sherman LS, 2008, TRENDS NEUROSCI, V31, P44, DOI 10.1016/j.tins.2007.11.001; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Struve J, 2005, GLIA, V52, P16, DOI 10.1002/glia.20215; Tsai MC, 2008, SURG NEUROL S1, V70, pS1; Tsai MC, 2008, SURG NEUROL, V70, P19, DOI 10.1016/j.surneu.2007.09.033; Van Linthout S, 2008, CIRCULATION, V117, P1563, DOI 10.1161/CIRCULATIONAHA.107.710830; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Zhang J, 2007, PROTEOM CLIN APPL, V1, P805, DOI 10.1002/prca.200700081	53	49	53	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19247	10.1371/journal.pone.0019247	http://dx.doi.org/10.1371/journal.pone.0019247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559420	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700111
J	Marinaro, C; Butti, E; Bergamaschi, A; Papale, A; Furlan, R; Comi, G; Martino, G; Muzio, L				Marinaro, Cinzia; Butti, Erica; Bergamaschi, Andrea; Papale, Alessandro; Furlan, Roberto; Comi, Giancarlo; Martino, Gianvito; Muzio, Luca			In Vivo Fate Analysis Reveals the Multipotent and Self-Renewal Features of Embryonic AspM Expressing Cells	PLOS ONE			English	Article							NEURAL STEM-CELLS; ADULT MAMMALIAN FOREBRAIN; RADIAL GLIAL-CELLS; SUBVENTRICULAR ZONE; PROGENITOR CELLS; RECOMBINASE ACTIVITY; CELLULAR COMPOSITION; NEURONAL MIGRATION; GENE-TRANSFER; BRAIN	Radial Glia (RG) cells constitute the major population of neural progenitors of the mouse developing brain. These cells are located in the ventricular zone (VZ) of the cerebral cortex and during neurogenesis they support the generation of cortical neurons. Later on, during brain maturation, RG cells give raise to glial cells and supply the adult mouse brain of Neural Stem Cells (NSC). Here we used a novel transgenic mouse line expressing the CreER(T2) under the control of AspM promoter to monitor the progeny of an early cohort of RG cells during neurogenesis and in the post natal brain. Long term fate mapping experiments demonstrated that AspM-expressing RG cells are multi-potent, as they can generate neurons, astrocytes and oligodendrocytes of the adult mouse brain. Furthermore, AspM descendants give also rise to proliferating progenitors in germinal niches of both developing and post natal brains. In the latter -i.e. the Sub Ventricular Zone-AspM descendants acquired several feature of neural stem cells, including the capability to generate neurospheres in vitro. We also performed the selective killing of these early progenitors by using a Nestin-GFP(flox)-TK allele. The forebrain specific loss of early AspM expressing cells caused the elimination of most of the proliferating cells of brain, a severe derangement of the ventricular zone architecture, and the impairment of the cortical lamination. We further demonstrated that AspM is expressed by proliferating cells of the adult mouse SVZ that can generate neuroblasts fated to become olfactory bulb neurons.	[Marinaro, Cinzia; Butti, Erica; Bergamaschi, Andrea; Papale, Alessandro; Furlan, Roberto; Martino, Gianvito; Muzio, Luca] San Raffaele Inst, Inst Expt Neurol INSPE, Dept Neurosci, Milan, Italy; [Comi, Giancarlo] San Raffaele Inst, Inst Expt Neurol INSPE, Dept Neurol, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Marinaro, C (corresponding author), San Raffaele Inst, Inst Expt Neurol INSPE, Dept Neurosci, Milan, Italy.	muzio.luca@hsr.it	Butti, Erica/AAN-1950-2020; Furlan, Roberto/J-9177-2016; Furlan, Roberto/N-5224-2019; Papale, Alessandro/K-9556-2016; martino, gianvito/AAL-2682-2020; Muzio, Luca/AAB-2308-2022; Bergamaschi, Andrea/AAN-3705-2020	Furlan, Roberto/0000-0001-7376-9425; Furlan, Roberto/0000-0001-7376-9425; Papale, Alessandro/0000-0002-8794-0171; martino, gianvito/0000-0003-1295-9131; Muzio, Luca/0000-0002-1068-865X; MARINARO, CINZIA/0000-0002-6283-4831; Butti, Erica/0000-0003-0362-273X	Fondazione Italiana Sclerosi Multipla; National Multiple Sclerosis Society [rg4016a2/1]; BMW Italy	Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); BMW Italy	This study was supported by the Fondazione Italiana Sclerosi Multipla. This investigation was supported in part by a grant from the National Multiple Sclerosis Society award no. rg4016a2/1. CM, AB, GM, and LM were supported by BMW Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; Bhat RV, 1996, GLIA, V17, P169; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Carlen M, 2006, EXP CELL RES, V312, P2851, DOI 10.1016/j.yexcr.2006.05.012; Centonze D, 2009, J NEUROSCI, V29, P3442, DOI 10.1523/JNEUROSCI.5804-08.2009; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; De Marchis S, 2007, J NEUROSCI, V27, P657, DOI 10.1523/JNEUROSCI.2870-06.2007; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Giachino C, 2009, EUR J NEUROSCI, V30, P9, DOI 10.1111/j.1460-9568.2009.06798.x; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gritti A, 1996, J NEUROSCI, V16, P1091; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kang WF, 2009, J NEUROSCI, V29, P14571, DOI 10.1523/JNEUROSCI.3844-09.2009; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kosaka T, 2005, CHEM SENSES, V30, pI107, DOI 10.1093/chemse/bjh137; Kosaka T, 2011, NEUROSCI RES, V69, P93, DOI 10.1016/j.neures.2010.10.002; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Malatesta P, 2000, DEVELOPMENT, V127, P5253; McCarthy M, 2001, J NEUROSCI, V21, P6772, DOI 10.1523/JNEUROSCI.21-17-06772.2001; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Muzio L, 2003, CEREB CORTEX, V13, P641, DOI 10.1093/cercor/13.6.641; Muzio L., 2009, MOL CELL NEUROSCI; Muzio L, 2010, MOL CELL NEUROSCI, V43, P268, DOI 10.1016/j.mcn.2009.11.008; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Parrish-Aungst S, 2007, J COMP NEUROL, V501, P825, DOI 10.1002/cne.21205; Peretto P, 2005, J COMP NEUROL, V487, P407, DOI 10.1002/cne.20576; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Pulvers JN, 2010, P NATL ACAD SCI US; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Wildner O, 1999, ANN MED, V31, P421, DOI 10.3109/07853899908998799; Willaime-Morawek S, 2006, J CELL BIOL, V175, P159, DOI 10.1083/jcb.200604123; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	77	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19419	10.1371/journal.pone.0019419	http://dx.doi.org/10.1371/journal.pone.0019419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559369	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700163
J	Rocha, JJE; Korolchuk, VI; Robinson, IM; O'Kane, CJ				Rocha, Joao J. E.; Korolchuk, Viktor I.; Robinson, Iain M.; O'Kane, Cahir J.			A Phagocytic Route for Uptake of Double-Stranded RNA in RNAi	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN SID-1; ESCHERICHIA-COLI; DROSOPHILA; CELLS; INTERFERENCE; ORGANIZATION; DSRNA; IDENTIFICATION; TRAFFICKING; ENDOCYTOSIS	RNA interference (RNAi) has a range of physiological functions including as a defence mechanism against viruses. To protect uninfected cells in a multicellular organism, not only a cell-autonomous RNAi response is required but also a systemic one. However, the route of RNA spread in systemic RNAi remains unclear. Here we show that phagocytosis can be a route for double-stranded RNA uptake. Double-stranded RNA expressed in Escherichia coli induces robust RNAi in Drosophila S2 cells, with effectiveness comparable to that of naked dsRNA. We could separate this phagocytic uptake route from that for RNAi induced by naked dsRNA. Therefore, phagocytic uptake of dsRNA offers a potential route for systemic spread of RNAi.	[Rocha, Joao J. E.; Korolchuk, Viktor I.; O'Kane, Cahir J.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Robinson, Iain M.] Univ Exeter, Peninsula Coll Med & Dent, Plymouth, Devon, England	University of Cambridge; University of Exeter; University of Plymouth	Rocha, JJE (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	j.rocha@gen.cam.ac.uk; c.okane@gen.cam.ac.uk	O'Kane, Cahir/Q-6681-2019	O'Kane, Cahir/0000-0002-3488-2078; Korolchuk, Viktor/0000-0002-4071-592X	Medical Research Council [G0802208]; UK Biotechnology and Biological Sciences Research Council [8/C19002, BB/D019699/1]; BBSRC [BB/D019699/1] Funding Source: UKRI; MRC [G0802208] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019699/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants G0802208 from the Medical Research Council to IMR and 8/C19002 and BB/D019699/1 from the UK Biotechnology and Biological Sciences Research Council to CJO'K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'Avino PP, 2004, J CELL BIOL, V166, P61, DOI 10.1083/jcb.200402157; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Korolchuk VI, 2007, J CELL SCI, V120, P4367, DOI 10.1242/jcs.012336; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; SAMBROOK J, 2000, MOL CLONING LAB MANU; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087	21	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19087	10.1371/journal.pone.0019087	http://dx.doi.org/10.1371/journal.pone.0019087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559499	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700064
J	Rossmanith, W				Rossmanith, Walter			Localization of Human RNase Z Isoforms: Dual Nuclear/Mitochondrial Targeting of the ELAC2 Gene Product by Alternative Translation Initiation	PLOS ONE			English	Article							TRNASE-Z; MITOCHONDRIAL; NUCLEAR; PROTEINS	RNase Z is an endonuclease responsible for the removal of 3' extensions from tRNA precursors, an essential step in tRNA biogenesis. Human cells contain a long form (RNase Z(L)) encoded by ELAC2, and a short form (RNase Z(S); ELAC1). We studied their subcellular localization by expression of proteins fused to green fluorescent protein. RNase Z(S) was found in the cytosol, whereas RNase Z(L) localized to the nucleus and mitochondria. We show that alternative translation initiation is responsible for the dual targeting of RNase Z(L). Due to the unfavorable context of the first AUG of ELAC2, translation apparently also starts from the second AUG, whereby the mitochondrial targeting sequence is lost and the protein is instead routed to the nucleus. Our data suggest that RNase Z(L) is the enzyme involved in both, nuclear and mitochondrial tRNA 3' end maturation.	Med Univ Vienna, Ctr Anat & Cell Biol, Vienna, Austria	Medical University of Vienna	Rossmanith, W (corresponding author), Med Univ Vienna, Ctr Anat & Cell Biol, Vienna, Austria.	walter.rossmanith@meduniwien.ac.at	Rossmanith, Walter/F-3662-2010	Rossmanith, Walter/0000-0003-2337-2248	Austrian Science Fund (FWF) [P17453]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The project was funded in part by the Austrian Science Fund (FWF): P17453. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canino G, 2009, PLANT PHYSIOL, V150, P1494, DOI 10.1104/pp.109.137950; Ceballos M, 2007, PROTEIN PEPTIDE LETT, V14, P137, DOI 10.2174/092986607779816050; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Deutscher Murray P., 1995, P51; Dubrovsky EB, 2004, NUCLEIC ACIDS RES, V32, P255, DOI 10.1093/nar/gkh182; Elbarbary RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005908; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Gan XH, 2011, BIOCHEM J, V435, P103, DOI 10.1042/BJ20101619; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Korver W, 2003, INT J CANCER, V104, P283, DOI 10.1002/ijc.10945; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Lai LB, 2010, FEBS LETT, V584, P287, DOI 10.1016/j.febslet.2009.11.048; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Mineri R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005713; Nair R, 2005, J MOL BIOL, V348, P85, DOI 10.1016/j.jmb.2005.02.025; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; ROBERTS BL, 1987, CELL, V50, P465, DOI 10.1016/0092-8674(87)90500-9; Rossmanith W, 2001, MOL CELL BIOL, V21, P8236, DOI 10.1128/MCB.21.23.8236-8237.2001; ROSSMANITH W, 1995, J BIOL CHEM, V270, P12885, DOI 10.1074/jbc.270.21.12885; Rossmanith W, 1998, BIOCHEM BIOPH RES CO, V247, P234, DOI 10.1006/bbrc.1998.8766; Rossmanith W, 2009, CELL CYCLE, V8, P1650, DOI 10.4161/cc.8.11.8502; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Spath B, 2007, CELL MOL LIFE SCI, V64, P2404, DOI 10.1007/s00018-007-7160-5; Takahashi M, 2008, FEBS LETT, V582, P2532, DOI 10.1016/j.febslet.2008.06.020; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Vogel A, 2005, BIOL CHEM, V386, P1253, DOI 10.1515/BC.2005.142; Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499; Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200; Yanaihara N, 2001, GENOMICS, V72, P169, DOI 10.1006/geno.2000.6454	35	55	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19152	10.1371/journal.pone.0019152	http://dx.doi.org/10.1371/journal.pone.0019152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559454	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700079
J	Sariol, CA; Martinez, MI; Rivera, F; Rodriguez, IV; Pantoja, P; Abel, K; Arana, T; Giavedoni, L; Hodara, V; White, LJ; Anglero, YI; Montaner, LJ; Kraiselburd, EN				Sariol, Carlos A.; Martinez, Melween I.; Rivera, Francheska; Rodriguez, Idia Vanessa; Pantoja, Petraleigh; Abel, Kristina; Arana, Teresa; Giavedoni, Luis; Hodara, Vida; White, Laura J.; Anglero, Yesseinia I.; Montaner, Luis J.; Kraiselburd, Edmundo N.			Decreased Dengue Replication and an Increased Anti-viral Humoral Response with the use of Combined Toll-Like Receptor 3 and 7/8 Agonists in Macaques	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; SIMIAN IMMUNODEFICIENCY VIRUS; POLYRIBOINOSINIC-POLYRIBOCYTIDYLIC ACID; T-CELLS; VIRAL REPLICATION; PRIMARY INFECTION; RHESUS MACAQUES; GENE-EXPRESSION; YELLOW-FEVER; B-CELLS	Background: Pathogenic versus protective outcomes to Dengue virus (DENV) infection are associated with innate immune function. This study aimed to determine the role of increased TLR3- and TLR7/8-mediated innate signaling after Dengue infection of rhesus macaques in vivo to evaluate its impact on disease and anti-DENV immune responses. Methodology/Principal Findings: TLR3 and TLR7/8 agonists (emulsified in Montanide) were administered subcutaneously to rhesus macaques at 48 hours and 7 days after DENV infection. The Frequency and activation of myeloid dendritic cells, plasmacytoid dendritic cells, and B cells were measured by flow cytometry while the serum levels of 14 different cytokines and chemokines were quantified. Adaptive immune responses were measured by DENV-specific antibody subtype measurements. Results showed that the combined TLR agonists reduced viral replication and induced the development of a proinflammatory reaction, otherwise absent in Dengue infection alone, without any clear signs of exacerbated disease. Specifically, the TLR-induced response was characterized by activation changes in mDC subsets concurrent with higher serum levels of CXCL-10 and IL-1Ra. TLR stimulation also induced higher titers of anti-DENV antibodies and acted to increase the IgG2/IgG1 ratio of anti-DENV to favor the subtype associated with DENV control. We also observed an effect of DENV-mediated suppression of mDC activation consistent with prior in vitro studies. Conclusions/Significance: These data show that concurrent TLR3/7/8 activation of the innate immune response after DENV infection in vivo acts to increase antiviral mechanisms via increased inflammatory and humoral responses in rhesus macaques, resulting in decreased viremia and melioration of the infection. These findings underscore an in vivo protective rather than a pathogenic role for combined TLR3/7/8-mediated activation in Dengue infection of rhesus macaques. Our study provides definitive proof-of-concept into the mechanism by which DENV evades immune recognition and activation in vivo.	[Sariol, Carlos A.; Martinez, Melween I.; Rivera, Francheska; Rodriguez, Idia Vanessa; Pantoja, Petraleigh; Kraiselburd, Edmundo N.] Univ Puerto Rico, Caribbean Primate Res Ctr, Unit Comparat Med, San Juan, PR 00936 USA; [Sariol, Carlos A.; Arana, Teresa; Anglero, Yesseinia I.; Kraiselburd, Edmundo N.] Univ Puerto Rico, Dept Microbiol & Med Zool, San Juan, PR 00936 USA; [Sariol, Carlos A.] Univ Puerto Rico, Dept Internal Med, San Juan, PR 00936 USA; [Abel, Kristina] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Giavedoni, Luis; Hodara, Vida] Texas Biomed Res Inst, Dept Virol, San Antonio, TX USA; [Giavedoni, Luis; Hodara, Vida] Texas Biomed Res Inst, Dept Immunol, San Antonio, TX USA; [White, Laura J.] Univ N Carolina, Carolina Vaccine Inst, Chapel Hill, NC USA; [Montaner, Luis J.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University of Puerto Rico; University of Puerto Rico Mayaguez; University of Puerto Rico; University of Puerto Rico; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Texas Biomedical Research Institute; Texas Biomedical Research Institute; University of North Carolina; University of North Carolina Chapel Hill; The Wistar Institute	Sariol, CA (corresponding author), Univ Puerto Rico, Caribbean Primate Res Ctr, Unit Comparat Med, Med Sci Campus, San Juan, PR 00936 USA.	carlos.sariol1@upr.edu	De Paris, Kristina/H-8174-2019; Sariol, Carlos A./W-6360-2019	De Paris, Kristina/0000-0001-5199-3004; Sariol, Carlos A./0000-0001-7535-4303	Northeast Biodefense Center [NBC-Lipkin AI57158]; NIH [U42 RR16021, U24 RR18108, UO1 1A1078060-01]; University of Puerto Rico Medical Sciences Campus [G12RR03051]; The Philadelphia Foundation; Commonwealth of Pennsylvania; Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health; Cancer Center [P30 CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR016021, G12RR003051, U24RR018108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	Northeast Biodefense Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico Medical Sciences Campus; The Philadelphia Foundation; Commonwealth of Pennsylvania; Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health; Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by a Northeast Biodefense Center Developmental grant (NBC-Lipkin AI57158) to C.A.S. (www.nbc.columbia.edu/) and partially by NIH grants U42 RR16021 and U24 RR18108 (http://cprc.rcm.upr.edu/) and the RCMI Program, University of Puerto Rico Medical Sciences Campus (G12RR03051)(http://rcmi.rcm.upr.edu/). L.J.W. was funded by NIH Grant (UO1 1A1078060-01), L.J.M. was funded by The Philadelphia Foundation (Robert I. Jacobs Fund), The Stengel-Miller family, AIDS funds from the Commonwealth of Pennsylvania and by the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health, as well as by a Cancer Center Grant (P30 CA10815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2006, J VIROL, V80, P6357, DOI 10.1128/JVI.02240-05; Abel K, 2002, J VIROL, V76, P8433, DOI 10.1128/JVI.76.16.8433-8445.2002; Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Becerra A, 2009, J MED VIROL, V81, P1403, DOI 10.1002/jmv.21538; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; de Kruif MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000215; Dejnirattisai W, 2008, J IMMUNOL, V181, P5865, DOI 10.4049/jimmunol.181.9.5865; Fink J, 2006, REV MED VIROL, V16, P263, DOI 10.1002/rmv.507; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811; HILL DA, 1971, P SOC EXP BIOL MED, V136, P853, DOI 10.3181/00379727-136-35379; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Ho LJ, 2004, IMMUNOL INVEST, V33, P423, DOI 10.1081/IMM-200038680; Ho LJ, 2001, J IMMUNOL, V166, P1499, DOI 10.4049/jimmunol.166.3.1499; Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005; Koraka P, 2001, J CLIN MICROBIOL, V39, P4332, DOI 10.1128/JCM.39.12.4332-4338.2001; KURANE I, 1994, ARCH VIROL, P59; Kurane I, 1990, Southeast Asian J Trop Med Public Health, V21, P658; Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005; Libraty DH, 2001, J VIROL, V75, P3501, DOI 10.1128/JVI.75.8.3501-3508.2001; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Mehlhop E, 2002, J IMMUNOL METHODS, V260, P219, DOI 10.1016/S0022-1759(01)00544-0; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Navarro-Sanchez E, 2005, ARCH MED RES, V36, P425, DOI 10.1016/j.arcmed.2005.04.007; Nightingale ZD, 2008, J LEUKOCYTE BIOL, V84, P1028, DOI 10.1189/jlb.0208105; Palmer DR, 2005, J VIROL, V79, P2432, DOI 10.1128/JVI.79.4.2432-2439.2005; Pasare C, 1998, J IMMUNOL, V160, P778; Pichyangkul S, 2003, J IMMUNOL, V171, P5571, DOI 10.4049/jimmunol.171.10.5571; Pinto LMO, 1999, MEM I OSWALDO CRUZ, V94, P387, DOI 10.1590/S0074-02761999000300019; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Rodriguez-Madoz JR, 2010, J VIROL, V84, P9760, DOI 10.1128/JVI.01051-10; Rodriguez-Madoz JR, 2010, J VIROL, V84, P4845, DOI 10.1128/JVI.02514-09; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; Rothwell SW, 1996, AM J TROP MED HYG, V54, P503, DOI 10.4269/ajtmh.1996.54.503; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Sariol CA, 2007, CLIN VACCINE IMMUNOL; Sariol CA, 2007, CLIN VACCINE IMMUNOL, V14, P756, DOI 10.1128/CVI.00052-07; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; STEPHEN EL, 1979, J INFECT DIS, V139, P267, DOI 10.1093/infdis/139.3.267; STEPHEN EL, 1977, J INFECT DIS, V136, P122, DOI 10.1093/infdis/136.1.122; Suharti C, 2003, EUR CYTOKINE NETW, V14, P172; Sun PF, 2006, J IMMUNOL, V177, P6497, DOI 10.4049/jimmunol.177.9.6497; Sun PF, 2009, VIROLOGY, V383, P207, DOI 10.1016/j.virol.2008.10.022; Taweechaisupapong Suwimol, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P664; Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; VANDEUREN M, 1995, J INFECT DIS, V172, P433, DOI 10.1093/infdis/172.2.433; Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114; Wang YC, 2005, J VIROL, V79, P14355, DOI 10.1128/JVI.79.22.14355-14370.2005; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Wille-Reece U, 2005, J IMMUNOL, V174, P7676, DOI 10.4049/jimmunol.174.12.7676; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Xu W, 2008, J IMMUNOL, V181, P276, DOI 10.4049/jimmunol.181.1.276	60	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19323	10.1371/journal.pone.0019323	http://dx.doi.org/10.1371/journal.pone.0019323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559444	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700134
J	Sordelli, MS; Beltrame, JS; Burdet, J; Zotta, E; Pardo, R; Cella, M; Franchi, AM; Ribeiro, ML				Sordelli, Micaela S.; Beltrame, Jimena S.; Burdet, Juliana; Zotta, Elsa; Pardo, Romina; Cella, Maximiliano; Franchi, Ana M.; Ribeiro, Maria Laura			The Effect of Anandamide on Uterine Nitric Oxide Synthase Activity Depends on the Presence of the Blastocyst	PLOS ONE			English	Article							CANNABINOID RECEPTOR; 1ST POTENT; SR 144528; EXPRESSION; IMPLANTATION; ANTAGONIST; PREGNANCY; SR141716A; UTERUS; EMBRYO	Nitric oxide production, catalyzed by nitric oxide synthase (NOS), should be strictly regulated to allow embryo implantation. Thus, our first aim was to study NOS activity during peri-implantation in the rat uterus. Day 6 inter-implantation sites showed lower NOS activity (0.19 +/- 0.01 pmoles L-citrulline mg prot(-1) h(-1)) compared to days 4 (0.34 +/- 0.03) and 5 (0.35 +/- 0.02) of pregnancy and to day 6 implantation sites (0.33 +/- 0.01). This regulation was not observed in pseudopregnancy. Both dormant and active blastocysts maintained NOS activity at similar levels. Anandamide (AEA), an endocannabinoid, binds to cannabinoid receptors type 1 (CB1) and type 2 (CB2), and high concentrations are toxic for implantation and embryo development. Previously, we observed that AEA synthesis presents an inverted pattern compared to NOS activity described here. We adopted a pharmacological approach using AEA, URB-597 (a selective inhibitor of fatty acid amide hydrolase, the enzyme that degrades AEA) and receptor selective antagonists to investigate the effect of AEA on uterine NOS activity in vitro in rat models of implantation. While AEA (0.70 +/- 0.02 vs 0.40 +/- 0.04) and URB-597 (1.08 +/- 0.09 vs 0.83 +/- 0.06) inhibited NOS activity in the absence of a blastocyst (pseudopregnancy) through CB2 receptors, AEA did not modulate NOS on day 5 pregnant uterus. Once implantation begins, URB-597 decreased NOS activity on day 6 implantation sites via CB1 receptors (0.25 +/- 0.04 vs 0.40 +/- 0.05). While a CB1 antagonist augmented NOS activity on day 6 inter-implantation sites (0.17 +/- 0.02 vs 0.27 +/- 0.02), a CB2 antagonist decreased it (0.17 +/- 0.02 vs 0.12 +/- 0.01). Finally, we described the expression and localization of cannabinoid receptors during implantation. In conclusion, AEA levels close to and at implantation sites seems to modulate NOS activity and thus nitric oxide production, fundamental for implantation, via cannabinoid receptors. This modulation depends on the presence of the blastocyst. These data establish cannabinoid receptors as an interesting target for the treatment of implantation deficiencies.	[Sordelli, Micaela S.; Beltrame, Jimena S.; Ribeiro, Maria Laura] CEFYBO CONICET UBA, Lab Fisiol & Farmacol Reprod, Buenos Aires, DF, Argentina; [Burdet, Juliana; Zotta, Elsa] UBA, Dept Fisiol, Lab Fisiopatogenia, Buenos Aires, DF, Argentina; [Pardo, Romina] UBA, Fac Farm & Bioquim, Dept Cs Biol, Lab Fisiopatol Mol,Catedra Fisiopatol, Buenos Aires, DF, Argentina; [Cella, Maximiliano; Franchi, Ana M.] CEFYBO CONICET UBA, Lab Fisiopatol Prenez & Parto, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Sordelli, MS (corresponding author), CEFYBO CONICET UBA, Lab Fisiol & Farmacol Reprod, Buenos Aires, DF, Argentina.	marialribeiro@yahoo.com.ar		zotta, elsa/0000-0002-8763-5046; Ribeiro, Maria Laura/0000-0002-3679-0193	Proyecto de Investigacion Plurianuales (PIP) [2204]; Proyectos de Investigacion Cientifica y Tecnologica (PICT) [34784]	Proyecto de Investigacion Plurianuales (PIP); Proyectos de Investigacion Cientifica y Tecnologica (PICT)(ANPCyT)	This work was supported by Proyecto de Investigacion Plurianuales (PIP) 2008 N<SUP>o</SUP>2204 to Dr. Ana Franchi and Proyectos de Investigacion Cientifica y Tecnologica (PICT) 2005 N<SUP>o</SUP>34784 to Dr. Maria Laura Ribeiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Buckley NE, 1998, NEUROSCIENCE, V82, P1131; Cella M, 2008, PLACENTA, V29, P699, DOI 10.1016/j.placenta.2008.05.003; Coutts AA, 2000, BRIT J PHARMACOL, V129, P645, DOI 10.1038/sj.bjp.0703094; DAS SK, 1995, P NATL ACAD SCI USA, V92, P4332, DOI 10.1073/pnas.92.10.4332; Demuth DG, 2006, LIFE SCI, V78, P549, DOI 10.1016/j.lfs.2005.05.055; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; EIM, 2006, HUM REPROD, V21, P1680, DOI 10.1093/humrep/del075; Farina M, 2001, REPRODUCTION, V121, P403, DOI 10.1530/rep.0.1210403; Fonseca BM, 2009, PLACENTA, V30, P686, DOI 10.1016/j.placenta.2009.05.012; Fonseca BM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-121; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Guo Y, 2005, J BIOL CHEM, V280, P23429, DOI 10.1074/jbc.C500168200; Hall W, 1998, LANCET, V352, P1611, DOI 10.1016/S0140-6736(98)05021-1; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Lahav M, 1989, J Reprod Fertil Suppl, V37, P233; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockwood CJ, 2000, LANCET, V355, P1292, DOI 10.1016/S0140-6736(00)02108-5; Maccarrone M, 2008, BRIT J PHARMACOL, V153, P189, DOI 10.1038/sj.bjp.0707444; Matias I, 2002, EUR J BIOCHEM, V269, P3771, DOI 10.1046/j.1432-1033.2002.03078.x; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Maul H, 2003, CURR PHARM DESIGN, V9, P359, DOI 10.2174/1381612033391784; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Novaro V, 2001, REPROD FERT DEVELOP, V13, P411, DOI 10.1071/RD01036; Novaro V, 1997, REPROD FERT DEVELOP, V9, P557, DOI 10.1071/R97005; Ota H, 1999, REPROD FERT DEVELOP, V11, P183, DOI 10.1071/RD99044; Paria BC, 1996, MOL REPROD DEV, V45, P183, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;183::AID-MRD11&gt;3.0.CO;2-2; Paria BC, 2001, J BIOL CHEM, V276, P20523, DOI 10.1074/jbc.M100679200; Piomelli D, 2004, NAT MED, V10, P19, DOI 10.1038/nm0104-19; Portier M, 1999, J PHARMACOL EXP THER, V288, P582; Purcell TL, 1999, MOL HUM REPROD, V5, P467, DOI 10.1093/molehr/5.5.467; Ribeiro ML, 2009, REPROD BIOMED ONLINE, V18, P209, DOI 10.1016/S1472-6483(10)60258-1; Rinaldi-Carmona M, 1998, J PHARMACOL EXP THER, V284, P644; RINALDICARMONA M, 1995, LIFE SCI, V56, P1941, DOI 10.1016/0024-3205(95)00174-5; Saxena D, 2000, NITRIC OXIDE-BIOL CH, V4, P384, DOI 10.1006/niox.2000.0286; Schuel H, 2002, CHEM PHYS LIPIDS, V121, P211, DOI 10.1016/S0009-3084(02)00158-5; Stefano George B, 2003, Med Sci Monit, V9, pRA63; Vercelli CA, 2009, REPROD BIOMED ONLINE, V18, P824, DOI 10.1016/S1472-6483(10)60033-8; Vercelli CA, 2009, PLACENTA, V30, P579, DOI 10.1016/j.placenta.2009.04.003; Wang HB, 2003, P NATL ACAD SCI USA, V100, P14914, DOI 10.1073/pnas.2436379100; Willoughby KA, 1997, J PHARMACOL EXP THER, V282, P243	43	15	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18368	10.1371/journal.pone.0018368	http://dx.doi.org/10.1371/journal.pone.0018368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559512	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700011
J	Sun, YC; Koumoutsi, A; Jarrett, C; Lawrence, K; Gherardini, FC; Darby, C; Hinnebusch, BJ				Sun, Yi-Cheng; Koumoutsi, Alexandra; Jarrett, Clayton; Lawrence, Kevin; Gherardini, Frank C.; Darby, Creg; Hinnebusch, B. Joseph			Differential Control of Yersinia pestis Biofilm Formation In Vitro and in the Flea Vector by Two c-di-GMP Diguanylate Cyclases	PLOS ONE			English	Article							EARLY-PHASE TRANSMISSION; STORAGE HMS(+) PHENOTYPE; ESCHERICHIA-COLI; PIGMENTATION PHENOTYPE; CAENORHABDITIS-ELEGANS; CYCLIC DIGUANYLATE; PROTEIN DOMAIN; PLAGUE; PSEUDOTUBERCULOSIS; MECHANISM	Yersinia pestis forms a biofilm in the foregut of its flea vector that promotes transmission by flea bite. As in many bacteria, biofilm formation in Y. pestis is controlled by intracellular levels of the bacterial second messenger c-di-GMP. Two Y. pestis diguanylate cyclase (DGC) enzymes, encoded by hmsT and y3730, and one phosphodiesterase (PDE), encoded by hmsP, have been shown to control biofilm production in vitro via their opposing c-di-GMP synthesis and degradation activities, respectively. In this study, we provide further evidence that hmsT, hmsP, and y3730 are the only three genes involved in c-di-GMP metabolism in Y. pestis and evaluated the two DGCs for their comparative roles in biofilm formation in vitro and in the flea vector. As with HmsT, the DGC activity of Y3730 depended on a catalytic GGDEF domain, but the relative contribution of the two enzymes to the biofilm phenotype was influenced strongly by the environmental niche. Deletion of y3730 had a very minor effect on in vitro biofilm formation, but resulted in greatly reduced biofilm formation in the flea. In contrast, the predominant effect of hmsT was on in vitro biofilm formation. DGC activity was also required for the Hms-independent autoaggregation phenotype of Y. pestis, but was not required for virulence in a mouse model of bubonic plague. Our results confirm that only one PDE (HmsP) and two DGCs (HmsT and Y3730) control c-di-GMP levels in Y. pestis, indicate that hmsT and y3730 are regulated post-transcriptionally to differentially control biofilm formation in vitro and in the flea vector, and identify a second c-di-GMP-regulated phenotype in Y. pestis.	[Sun, Yi-Cheng; Jarrett, Clayton; Lawrence, Kevin; Gherardini, Frank C.; Hinnebusch, B. Joseph] NIAID, Lab Zoonot Pathogens, Rocky Mt Labs, NIH, Hamilton, MT USA; [Koumoutsi, Alexandra; Darby, Creg] Univ Calif San Francisco, Dept Cell & Tissue Biol, Program Microbial Pathogenesis, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco	Sun, YC (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100037, Peoples R China.	sunyc@ipbcams.ac.cn		Koumoutsi, Alexandra/0000-0001-8368-4193	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NIH [AI057512]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000905, R56AI057512, ZIAAI000796, R01AI057512] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); and NIH Grant AI057512 (to C.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Appleman JA, 2003, J BACTERIOL, V185, P4872, DOI 10.1128/JB.185.16.4872-4882.2003; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; Bobrov AG, 2008, ENVIRON MICROBIOL, V10, P1419, DOI 10.1111/j.1462-2920.2007.01554.x; Bobrov AG, 2011, MOL MICROBIOL, V79, P533, DOI 10.1111/j.1365-2958.2010.07470.x; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; CHIANG SL, 1995, MOL MICROBIOL, V17, P1133, DOI 10.1111/j.1365-2958.1995.mmi_17061133.x; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Eisen RJ, 2007, J MED ENTOMOL, V44, P678, DOI 10.1603/0022-2585(2007)44[678:ETOYPB]2.0.CO;2; Eisen RJ, 2006, P NATL ACAD SCI USA, V103, P15380, DOI 10.1073/pnas.0606831103; Eisen RJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008039; Erickson DL, 2008, J BACTERIOL, V190, P8163, DOI 10.1128/JB.01181-08; Erickson DL, 2006, J BACTERIOL, V188, P1113, DOI 10.1128/JB.188.3.1113-1119.2006; Felek S, 2010, INFECT IMMUN, V78, P1163, DOI 10.1128/IAI.00997-09; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Hare JM, 1999, J BACTERIOL, V181, P4896, DOI 10.1128/JB.181.16.4896-4904.1999; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hinnebusch BJ, 2008, CURR TOP MICROBIOL, V322, P229; Hinnebusch BJ, 1996, SCIENCE, V273, P367, DOI 10.1126/science.273.5273.367; Jarrett CO, 2004, J INFECT DIS, V190, P783, DOI 10.1086/422695; Jonas K, 2009, FUTURE MICROBIOL, V4, P341, DOI [10.2217/fmb.09.7, 10.2217/FMB.09.7]; Jones HA, 1999, MICROBIOL-SGM, V145, P2117, DOI 10.1099/13500872-145-8-2117; Joshua GWP, 2003, MICROBIOL-SGM, V149, P3221, DOI 10.1099/mic.0.26475-0; Kirillina O, 2004, MOL MICROBIOL, V54, P75, DOI 10.1111/j.1365-2958.2004.04253.x; Kolodziejek AM, 2007, MICROBIOL-SGM, V153, P2941, DOI 10.1099/mic.0.2006/005694-0; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; LI QX, 1990, J BIOL CHEM, V265, P4111; Perry RD, 2004, J BACTERIOL, V186, P1638, DOI 10.1128/JB.186.6.1638-1647.2004; Perry RD, 1998, INFECT IMMUN, V66, P4611, DOI 10.1128/IAI.66.10.4611-4623.1998; PERRY RD, 1990, J BACTERIOL, V172, P5929, DOI 10.1128/jb.172.10.5929-5937.1990; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P11766, DOI 10.1073/pnas.0601182103; Simm R, 2005, J BACTERIOL, V187, P6816, DOI 10.1128/JB.187.19.6816-6823.2005; Sun YC, 2008, P NATL ACAD SCI USA, V105, P8097, DOI 10.1073/pnas.0803525105; Sun YC, 2009, FEMS MICROBIOL LETT, V290, P85, DOI 10.1111/j.1574-6968.2008.01409.x; SURGALLA MJ, 1969, APPL MICROBIOL, V18, P834, DOI 10.1128/AEM.18.5.834-837.1969; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Ulett GC, 2007, INFECT IMMUN, V75, P3233, DOI 10.1128/IAI.01952-06; Vetter SM, 2010, MICROBIOL-SGM, V156, P2216, DOI 10.1099/mic.0.037952-0	47	58	64	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19267	10.1371/journal.pone.0019267	http://dx.doi.org/10.1371/journal.pone.0019267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559445	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700118
J	Tam, JKV; Lau, KW; Lee, LTO; Chu, JYS; Ng, KM; Fournier, A; Vaudry, H; Chow, BKC				Tam, Janice K. V.; Lau, Kwan-Wa; Lee, Leo T. O.; Chu, Jessica Y. S.; Ng, Kwong-Man; Fournier, Alain; Vaudry, Hubert; Chow, Billy K. C.			Origin of Secretin Receptor Precedes the Advent of Tetrapoda: Evidence on the Separated Origins of Secretin and Orexin	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; PROTEIN-COUPLED RECEPTORS; MOLECULAR-CLONING; NEUROPEPTIDE-Y; EXPRESSION; CDNA; MECHANISMS; HORMONE; BINDING	At present, secretin and its receptor have only been identified in mammals, and the origin of this ligand-receptor pair in early vertebrates is unclear. In addition, the elusive similarities of secretin and orexin in terms of both structures and functions suggest a common ancestral origin early in the vertebrate lineage. In this article, with the cloning and functional characterization of secretin receptors from lungfish and X. laevis as well as frog (X. laevis and Rana rugulosa) secretins, we provide evidence that the secretin ligand-receptor pair has already diverged and become highly specific by the emergence of tetrapods. The secretin receptor-like sequence cloned from lungfish indicates that the secretin receptor was descended from a VPAC-like receptor prior the advent of sarcopterygians. To clarify the controversial relationship of secretin and orexin, orexin type-2 receptor was cloned from X. laevis. We demonstrated that, in frog, secretin and orexin could activate their mutual receptors, indicating their coordinated complementary role in mediating physiological processes in non-mammalian vertebrates. However, among the peptides in the secretin/glucagon superfamily, secretin was found to be the only peptide that could activate the orexin receptor. We therefore hypothesize that secretin and orexin are of different ancestral origins early in the vertebrate lineage.	[Tam, Janice K. V.; Lau, Kwan-Wa; Lee, Leo T. O.; Chu, Jessica Y. S.; Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, Res Ctr Heart Brain Hormone & Healthy Ageing, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Ng, Kwong-Man] Univ Hong Kong, Stem Cell & Regenerat Med Program, Res Ctr Heart Brain Hormone & Healthy Ageing, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Fournier, Alain] Univ Quebec, INRS Inst Armand Frappier, Laval, PQ, Canada; [Vaudry, Hubert] Univ Rouen, INSERM, U982, European Inst Peptide Res, Mont St Aignan, France	University of Hong Kong; University of Hong Kong; University of Quebec; Institut national de la recherche scientifique (INRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Tam, JKV (corresponding author), Univ Hong Kong, Sch Biol Sci, Res Ctr Heart Brain Hormone & Healthy Ageing, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.	bkcc@hkusua.hku.hk	Lee, Leo T.O./AAB-1581-2021; Chow, Billy/D-3064-2009	Chow, Billy/0000-0003-3390-0307	Hong Kong Government RGC [7639/07M, 7696/09M]; Committee on Research and Conference [10208128]	Hong Kong Government RGC; Committee on Research and Conference	The present study was supported by the Hong Kong Government RGC grants 7639/07M to Billy K. C. Chow, 7696/09M to Leo T. O. Lee and the Committee on Research and Conference Grants 10208128 to Leo T. O. Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alvarez CE, 2002, NEUROSCI LETT, V324, P169, DOI 10.1016/S0304-3940(02)00195-7; Bailes HJ, 2007, VISUAL NEUROSCI, V24, P377, DOI 10.1017/S0952523807070381; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P325; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bulbul M, 2010, PEPTIDES, V31, P1099, DOI 10.1016/j.peptides.2010.03.007; CAMPBELL RM, 1992, GROWTH REGULAT, V2, P175; Cardoso JCR, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-108; Cardoso JCR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-135; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Chan KYY, 2001, ENDOCRINOLOGY, V142, P3926, DOI 10.1210/en.142.9.3926; Cheng CYY, 2009, J MOL ENDOCRINOL, V43, P81, DOI 10.1677/JME-08-0123; CHOW BKC, 1995, BIOCHEM BIOPH RES CO, V212, P204, DOI 10.1006/bbrc.1995.1957; Chu JSC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-130; Chu JYS, 2009, P NATL ACAD SCI USA, V106, P15961, DOI 10.1073/pnas.0903695106; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Feillet CA, 2010, J NEUROENDOCRINOL, V22, P620, DOI 10.1111/j.1365-2826.2010.01998.x; Flemstrom G, 2010, ACTA PHYSIOL, V198, P373, DOI 10.1111/j.1748-1716.2009.02067.x; Fradinger EA, 2005, MOL CELL ENDOCRINOL, V231, P49, DOI 10.1016/j.mce.2004.12.002; Galas L, 2001, J COMP NEUROL, V429, P242, DOI 10.1002/1096-9861(20000108)429:2<242::AID-CNE5>3.0.CO;2-Z; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Graham JB, 2004, PHYSIOL BIOCHEM ZOOL, V77, P720, DOI 10.1086/425184; Harmar AJ, 2001, GENOME BIOL, V2; Heinonen MV, 2008, ACTA PHYSIOL, V192, P471, DOI 10.1111/j.1748-1716.2008.01836.x; Holmqvist T, 2001, NEUROSCI LETT, V305, P177, DOI 10.1016/S0304-3940(01)01839-0; Hoo RLC, 2001, J MOL ENDOCRINOL, V27, P229, DOI 10.1677/jme.0.0270229; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; JIANG SP, 1995, BIOCHEM BIOPH RES CO, V207, P883, DOI 10.1006/bbrc.1995.1268; Kane JK, 2000, BIOCHEM BIOPH RES CO, V272, P959, DOI 10.1006/bbrc.2000.2880; Laburthe M, 2002, RECEPTOR CHANNEL, V8, P137, DOI 10.1080/10606820290005191; Le Meuth-Metzinger V, 2005, PANCREAS, V31, P174, DOI 10.1097/01.mpa.0000174938.89815.e9; Massey SE, 2008, GENE, V418, P22, DOI 10.1016/j.gene.2008.03.017; Miller LJ, 2007, BIOCHEM SOC T, V35, P709, DOI 10.1042/BST0350709; Ng SSM, 2002, MOL NEUROBIOL, V26, P97, DOI 10.1385/MN:26:1:097; NILSSON A, 1980, EUR J BIOCHEM, V112, P383, DOI 10.1111/j.1432-1033.1980.tb07216.x; Ohkubo T, 2003, J MOL ENDOCRINOL, V31, P499, DOI 10.1677/jme.0.0310499; Ohkubo T, 2002, BBA-GENE STRUCT EXPR, V1577, P476, DOI 10.1016/S0167-4781(02)00483-9; Panula P, 2010, ACTA PHYSIOL, V198, P381, DOI 10.1111/j.1748-1716.2009.02038.x; PATEL DR, 1995, MOL PHARMACOL, V47, P467; Perret J, 2002, BIOCHEM J, V362, P389, DOI 10.1042/0264-6021:3620389; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; San Mauro D, 2010, MOL PHYLOGENET EVOL, V56, P554, DOI 10.1016/j.ympev.2010.04.019; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589; Siu FKY, 2006, REGUL PEPTIDES, V137, P95, DOI 10.1016/j.regpep.2006.02.011; Smart D, 2001, BRIT J PHARMACOL, V132, P1179, DOI 10.1038/sj.bjp.0703953; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Sutcliffe J G, 1999, Results Probl Cell Differ, V26, P239; Svoboda M, 1998, PEPTIDES, V19, P1055, DOI 10.1016/S0196-9781(98)00040-0; Szlachcic A, 2010, CURR PHARM DESIGN, V16, P1214, DOI 10.2174/138161210790945940; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tomasik PJ, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-92; Tse DLY, 2002, ENDOCRINOLOGY, V143, P1327, DOI 10.1210/en.143.4.1327; Tsujino N, 2009, PHARMACOL REV, V61, P162, DOI 10.1124/pr.109.001321; Ulrich CD, 1998, GASTROENTEROLOGY, V114, P382, DOI 10.1016/S0016-5085(98)70491-3; VanRampelbergh J, 1996, MOL PHARMACOL, V50, P1596; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Vaudry D, 2000, PHARMACOL REV, V52, P269; Zardoya R, 1996, P NATL ACAD SCI USA, V93, P13036, DOI 10.1073/pnas.93.23.13036	59	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19384	10.1371/journal.pone.0019384	http://dx.doi.org/10.1371/journal.pone.0019384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559418	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700153
J	Tseng, CH; Murray, KD; Jou, MF; Hsu, SM; Cheng, HJ; Huang, PH				Tseng, Chun-Hsien; Murray, Karl D.; Jou, Mu-Fan; Hsu, Su-Ming; Cheng, Hwai-Jong; Huang, Pei-Hsin			Sema3E/Plexin-D1 Mediated Epithelial-to-Mesenchymal Transition in Ovarian Endometrioid Cancer	PLOS ONE			English	Article							SEMAPHORIN 3E; SURFACE EPITHELIUM; GENE-EXPRESSION; E-CADHERIN; CELLS; SNAIL; GROWTH; IDENTIFICATION; METASTASIS; ACTIVATION	Cancer cells often employ developmental cues for advantageous growth and metastasis. Here, we report that an axon guidance molecule, Sema3E, is highly expressed in human high-grade ovarian endometrioid carcinoma, but not low-grade or other ovarian epithelial tumors, and facilitates tumor progression. Unlike its known angiogenic activity, Sema3E acted through Plexin-D1 receptors to augment cell migratory ability and concomitant epithelial-to-mesenchymal transition (EMT). Sema3E-induced EMT in ovarian endometrioid cancer cells was dependent on nuclear localization of Snail1 through activation of phosphatidylinositol-3-kinase and ERK/MAPK. RNAi-mediated knockdown of Sema3E, Plexin-D1 or Snail1 in Sema3E-expressing tumor cells resulted in compromised cell motility, concurrent reversion of EMT and diminished nuclear localization of Snail1. By contrast, forced retention of Snail1 within the nucleus of Sema3E-negative tumor cells induced EMT and enhanced cell motility. These results show that in addition to the angiogenic effects of Sema3E on tumor vascular endothelium, an EMT strategy could be exploited by Sema3E/Plexin-D1 signaling in tumor cells to promote cellular invasion/migration.	[Tseng, Chun-Hsien; Jou, Mu-Fan; Hsu, Su-Ming; Huang, Pei-Hsin] Natl Taiwan Univ, Grad Inst Pathol, Coll Med, Taipei 10764, Taiwan; [Murray, Karl D.; Cheng, Hwai-Jong] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Hsu, Su-Ming; Huang, Pei-Hsin] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan	National Taiwan University; University of California System; University of California Davis; National Taiwan University; National Taiwan University Hospital	Tseng, CH (corresponding author), Natl Taiwan Univ, Grad Inst Pathol, Coll Med, Taipei 10764, Taiwan.	hjcheng@ucdavis.edu; phhuang@ntu.edu.tw	Cheng, Hwai-Jong/AAY-5067-2021	Cheng, Hwai-Jong/0000-0003-0647-0567; HUANG, PEI-HSIN/0000-0002-2414-1487	National Taiwan University Hospital [NTUH98-P26-2, NTUH99-P21]	National Taiwan University Hospital(National Taiwan University)	This work was supported by a fund from National Taiwan University Hospital (NTUH98-P26-2 and NTUH99-P21) granted to P-H Huang. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bellon A, 2010, NEURON, V66, P205, DOI 10.1016/j.neuron.2010.04.006; Berndt JD, 2006, DEVELOPMENT, V133, P3983, DOI 10.1242/dev.02583; Blanc V, 2010, PROSTATE        1014; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Casazza A, 2010, J CLIN INVEST, V120, P2684, DOI 10.1172/JCI42118; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Chedotal A, 2007, PROG EXP TUMOR RES, V39, P78, DOI 10.1159/000100048; Choi YI, 2008, IMMUNITY, V29, P888, DOI 10.1016/j.immuni.2008.10.008; Christensen C, 2005, CANCER RES, V65, P6167, DOI 10.1158/0008-5472.CAN-04-4309; Chung L, 2007, DEVELOPMENT, V134, P2935, DOI 10.1242/dev.005066; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Derijck AAHA, 2010, TRENDS CELL BIOL, V20, P568, DOI 10.1016/j.tcb.2010.06.007; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Martin-Satue M, 1999, J SURG ONCOL, V72, P18; Murray MJ, 1999, SEMIN REPROD ENDOCR, V17, P275, DOI 10.1055/s-2007-1016235; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Roodink I, 2008, AM J PATHOL, V173, P1873, DOI 10.2353/ajpath.2008.080136; Rosano L, 2005, CANCER RES, V65, P11649, DOI 10.1158/0008-5472.CAN-05-2123; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; RUSSELL P, 1994, BLAUSTEINS PATHOLOGY, P705; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Swiercz JM, 2004, J CELL BIOL, V165, P869, DOI 10.1083/jcb.200312094; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Theriault BL, 2007, CARCINOGENESIS, V28, P1153, DOI 10.1093/carcin/bgm015; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Torng PL, 2008, ONCOGENE, V27, P2137, DOI 10.1038/sj.onc.1210864; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Waimey KE, 2006, NEUROSCIENTIST, V12, P398, DOI 10.1177/1073858406292631; Xiang RH, 2002, CANCER RES, V62, P2637; Yamada T, 1997, P NATL ACAD SCI USA, V94, P14713, DOI 10.1073/pnas.94.26.14713; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	51	47	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19396	10.1371/journal.pone.0019396	http://dx.doi.org/10.1371/journal.pone.0019396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559368	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700157
J	Vintermist, A; Bohm, S; Sadeghifar, F; Louvet, E; Mansen, A; Percipalle, P; Farrants, AKO				Vintermist, Anna; Bohm, Stefanie; Sadeghifar, Fatemeh; Louvet, Emilie; Mansen, Anethe; Percipalle, Pergiorgio; Farrants, Ann-Kristin Ostlund			The Chromatin Remodelling Complex B-WICH Changes the Chromatin Structure and Recruits Histone Acetyl-Transferases to Active rRNA Genes	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; REPLICATION FOCI; EPIGENETIC STATE; CELL-CYCLE; MYOSIN-I; NORC; DNA; BINDING; INTERACTS; RDNA	The chromatin remodelling complex B-WICH, which comprises the William syndrome transcription factor (WSTF), SNF2h, and nuclear myosin 1 (NM1), is involved in regulating rDNA transcription, and SiRNA silencing of WSTF leads to a reduced level of 45S pre-rRNA. The mechanism behind the action of B-WICH is unclear. Here, we show that the B-WICH complex affects the chromatin structure and that silencing of the WSTF protein results in a compaction of the chromatin structure over a 200 basepair region at the rRNA promoter. WSTF knock down does not show an effect on the binding of the rRNA-specific enhancer and chromatin protein UBF, which contributes to the chromatin structure at active genes. Instead, WSTF knock down results in a reduced level of acetylated H3-Ac, in particular H3K9-Ac, at the promoter and along the gene. The association of the histone acetyl-transferases PCAF, p300 and GCN5 with the promoter is reduced in WSTF knock down cells, whereas the association of the histone acetyl-transferase MOF is retained. A low level of H3-Ac was also found in growing cells, but here histone acetyl-transferases were present at the rDNA promoter. We propose that the B-WICH complex remodels the chromatin structure at actively transcribed rRNA genes, and this allows for the association of specific histone acetyl-transferases.	[Vintermist, Anna; Bohm, Stefanie; Sadeghifar, Fatemeh; Mansen, Anethe; Farrants, Ann-Kristin Ostlund] Stockholm Univ, Dept Cell Biol, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Louvet, Emilie; Percipalle, Pergiorgio] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Stockholm University; Karolinska Institutet	Vintermist, A (corresponding author), Stockholm Univ, Dept Cell Biol, Wenner Gren Inst, S-10691 Stockholm, Sweden.	anki.ostlund@cellbio.su.se			Cancer Foundation [090520]; Swedish Research Council; Magnus Bergvall Foundation; Fondation pour la Recherche Medicale (FRM); Wenner-Gren Foundation	Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Magnus Bergvall Foundation; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Wenner-Gren Foundation	Funding was provided by the Cancer Foundation (090520), Swedish Research Council, Magnus Bergvall Foundation, Fondation pour la Recherche Medicale (FRM) and Wenner-Gren Foundation. The funders had no role in study desogn, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOUZNI G, 1994, DEV BIOL, V165, P654, DOI 10.1006/dbio.1994.1283; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Birch JL, 2008, BIOCHEM SOC T, V36, P619, DOI 10.1042/BST0360619; Birch JL, 2009, EMBO J, V28, P854, DOI 10.1038/emboj.2009.33; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Bradsher J, 2002, MOL CELL, V10, P819, DOI 10.1016/S1097-2765(02)00678-0; Brown SE, 2008, CELL CYCLE, V7, P382, DOI 10.4161/cc.7.3.5283; Brown SE, 2007, MOL CELL BIOL, V27, P4938, DOI 10.1128/MCB.01880-06; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Chen DY, 2004, P NATL ACAD SCI USA, V101, P15106, DOI 10.1073/pnas.0404767101; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Fazzio TG, 2003, MOL CELL, V12, P1333, DOI 10.1016/S1097-2765(03)00436-2; Felle M, 2010, NUCLEIC ACIDS RES, V38, P5304, DOI 10.1093/nar/gkq263; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Fujiki R, 2005, EMBO J, V24, P3881, DOI 10.1038/sj.emboj.7600853; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; Gorski SA, 2008, MOL CELL, V30, P486, DOI 10.1016/j.molcel.2008.04.021; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grummt I, 2007, HUM MOL GENET, V16, pR21, DOI 10.1093/hmg/ddm020; Hannan KM, 1998, AM J PHYSIOL-CELL PH, V275, pC130, DOI 10.1152/ajpcell.1998.275.1.C130; Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619; Jones HS, 2007, NAT STRUCT MOL BIOL, V14, P123, DOI 10.1038/nsmb1199; Jones MH, 2000, GENOMICS, V63, P40, DOI 10.1006/geno.1999.6071; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Lebedev A, 2008, J MOL BIOL, V382, P266, DOI 10.1016/j.jmb.2008.07.018; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Mayer C, 2005, GENE DEV, V19, P933, DOI 10.1101/gad.333205; Mayer C, 2008, EMBO REP, V9, P774, DOI 10.1038/embor.2008.109; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nemeth A, 2004, NUCLEIC ACIDS RES, V32, P4091, DOI 10.1093/nar/gkh732; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Oya H, 2009, J BIOL CHEM, V284, P32472, DOI 10.1074/jbc.M109.009738; Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657; Percipalle P, 2006, CURR OPIN CELL BIOL, V18, P267, DOI 10.1016/j.ceb.2006.03.001; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Ryme J, 2009, J CELL BIOCHEM, V108, P565, DOI 10.1002/jcb.22288; Sanij E, 2009, EPIGENETICS-US, V4, P274, DOI 10.4161/epi.4.6.9449; Sanij E, 2008, J CELL BIOL, V183, P1259, DOI 10.1083/jcb.200805146; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Santoro R, 2005, MOL CELL BIOL, V25, P2539, DOI 10.1128/MCB.25.7.2539-2546.2005; Stefanovsky V, 2006, CELL CYCLE, V5, P735, DOI 10.4161/cc.5.7.2633; Takahashi Y, 2000, GENE DEV, V14, P804; van de Nobelen S, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-19; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460; Zhou YG, 2009, NAT CELL BIOL, V11, P1010, DOI 10.1038/ncb1914	63	40	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19184	10.1371/journal.pone.0019184	http://dx.doi.org/10.1371/journal.pone.0019184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559432	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700094
J	Wei, YZ; Hu, FC; Hu, GB; Li, XJ; Huang, XM; Wang, HC				Wei, Yong-Zan; Hu, Fu-Chu; Hu, Gui-Bing; Li, Xiao-Jing; Huang, Xu-Ming; Wang, Hui-Cong			Differential Expression of Anthocyanin Biosynthetic Genes in Relation to Anthocyanin Accumulation in the Pericarp of Litchi Chinensis Sonn	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTOR; TIME QUANTITATIVE PCR; RED COLORATION; WHITE GRAPES; APPLE SKIN; FRUIT; MATURATION; PATHWAY; L.	Litchi has diverse fruit color phenotypes, yet no research reflects the biochemical background of this diversity. In this study, we evaluated 12 litchi cultivars for chromatic parameters and pigments, and investigated the effects of abscisic acid, forchlorofenron (CPPU), bagging and debagging treatments on fruit coloration in cv. Feizixiao, an unevenly red cultivar. Six genes encoding chalcone synthase (CHS), chalcone isomerase (CHI), flavanone 3-hydroxylase (F3H), dihydroflavonol 4-reductase (DFR), anthocyanidin synthase (ANS) and UDP-glucose: flavonoid 3-O-glucosyltransferase (UFGT) were isolated from the pericarp of the fully red litchi cv. Nuomici, and their expression was analyzed in different cultivars and under the above mentioned treatments. Pericarp anthocyanin concentration varied from none to 734 mg m(-2) among the 12 litchi cultivars, which were divided into three coloration types, i.e. non-red ('Kuixingqingpitian', 'Xingqiumili', 'Yamulong' and 'Yongxing No. 2'), unevenly red ('Feizixiao' and 'Sanyuehong') and fully red ('Meiguili', 'Baila', Baitangying' 'Guiwei', 'Nuomici' and 'Guinuo'). The fully red type cultivars had different levels of anthocyanin but with the same composition. The expression of the six genes, especially LcF3H, LcDFR, LcANS and LcUFGT, in the pericarp of non-red cultivars was much weaker as compared to those red cultivars. Their expression, LcDFR and LcUFGT in particular, was positively correlated with anthocyanin concentrations in the pericarp. These results suggest the late genes in the anthocyanin biosynthetic pathway were coordinately expressed during red coloration of litchi fruits. Low expression of these genes resulted in absence or extremely low anthocyanin accumulation in non-red cultivars. Zero-red pericarp from either immature or CPPU treated fruits appeared to be lacking in anthocyanins due to the absence of UFGT expression. Among these six genes, only the expression of UFGT was found significantly correlated with the pericarp anthocyanin concentration (r = 0.84). These results suggest that UFGT played a predominant role in the anthocyanin accumulation in litchi as well as pericarp coloration of a given cultivar.	[Wei, Yong-Zan; Hu, Fu-Chu; Hu, Gui-Bing; Li, Xiao-Jing; Huang, Xu-Ming; Wang, Hui-Cong] S China Agr Univ, Coll Hort, Physiol Lab S China Fruits, Guangzhou, Guangdong, Peoples R China; [Wei, Yong-Zan] Chinese Acad Trop Agr Sci, S Subtrop Crops Res Inst, Zhanjiang, Guangdong, Peoples R China; [Hu, Fu-Chu] Hainan Acad Agr Sci, Inst Trop Fruit Trees, Haikou, Peoples R China	South China Agricultural University; Chinese Academy of Tropical Agricultural Sciences	Wei, YZ (corresponding author), S China Agr Univ, Coll Hort, Physiol Lab S China Fruits, Guangzhou, Guangdong, Peoples R China.	wanghc1972@263.net			National Natural Science Fund of China [30971985]; Special Fund for Agro-scientific Research in the Public Interest [nyhyzx07-31]; China Litchi Industry Technology Research System, Ministry of Agriculture, China [nycytx-32]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; China Litchi Industry Technology Research System, Ministry of Agriculture, China	The project was supported by National Natural Science Fund of China (Project No. 30971985), Special Fund for Agro-scientific Research in the Public Interest (Project No. nyhyzx07-31) and China Litchi Industry Technology Research System (Project No. nycytx-32), Ministry of Agriculture, China. The funders had no role in study design, data colletion and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Boss PK, 1996, PLANT MOL BIOL, V32, P565, DOI 10.1007/BF00019111; Chen DaCheng, 1999, Journal of South China Agricultural University, V20, P65; Deroles Simon, 2009, P107, DOI 10.1007/978-0-387-77335-3_5; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Feng SQ, 2010, PLANTA, V232, P245, DOI 10.1007/s00425-010-1170-5; FULEKI T, 1968, J FOOD SCI, V33, P78, DOI 10.1111/j.1365-2621.1968.tb00888.x; Goncalves B, 2007, FOOD CHEM, V103, P976, DOI 10.1016/j.foodchem.2006.08.039; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Honda C, 2002, PLANT PHYSIOL BIOCH, V40, P955, DOI 10.1016/S0981-9428(02)01454-7; Huang ZQ, 1996, BIOTECHNIQUES, V20, P1012; Jia HJ, 2005, POSTHARVEST BIOL TEC, V35, P61, DOI 10.1016/j.postharvbio.2004.06.004; JU ZG, 1995, SCI HORTIC-AMSTERDAM, V63, P175, DOI 10.1016/0304-4238(95)00807-6; Ju ZG, 1997, SCI HORTIC-AMSTERDAM, V70, P31, DOI 10.1016/S0304-4238(97)00040-X; Kim SH, 2003, PLANT SCI, V165, P403, DOI 10.1016/S0168-9452(03)00201-2; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Kobayashi S, 2001, PLANT SCI, V160, P543, DOI 10.1016/S0168-9452(00)00425-8; Koyama K, 2010, FUNCT INTEGR GENOMIC, V10, P367, DOI 10.1007/s10142-009-0145-8; Lee HS, 1991, J FOOD SCI, V56, P446; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; Lister CE, 1996, J SCI FOOD AGR, V71, P313, DOI [10.1002/(SICI)1097-0010(199607)71:3<313::AID-JSFA586>3.0.CO;2-N, 10.1002/(SICI)1097-0010(199607)71:3&lt;313::AID-JSFA586&gt;3.0.CO;2-N]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macheix JJ, 1990, FRUIT PHENOLICS; MCGUIRE RG, 1992, HORTSCIENCE, V27, P1254, DOI 10.21273/HORTSCI.27.12.1254; Niu SS, 2010, PLANTA, V231, P887, DOI 10.1007/s00425-009-1095-z; Palapol Y, 2009, PLANTA, V229, P1323, DOI 10.1007/s00425-009-0917-3; Rivera-Lopez J, 1999, FOOD CHEM, V65, P195, DOI 10.1016/S0308-8146(98)00195-2; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Takos AM, 2006, J HORTIC SCI BIOTECH, V81, P735; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; UNDERHILL S, 1994, AUST J EXP AGR, V34, P115, DOI 10.1071/EA9940115; VOSS DH, 1992, HORTSCIENCE, V27, P1256, DOI 10.21273/HORTSCI.27.12.1256; Wang HC, 2007, PLANT GROWTH REGUL, V52, P189, DOI 10.1007/s10725-007-9189-8; Wang HuiCong, 2004, Scientia Agricultura Sinica, V37, P2028; WHEELWRIGHT NT, 1985, AM NAT, V126, P777, DOI 10.1086/284453; Wu XL, 2005, J AGR FOOD CHEM, V53, P3101, DOI 10.1021/jf0478861; Zhang XD, 2011, PLANT MOL BIOL REP, V29, P305, DOI 10.1007/s11105-010-0231-z; Zhang ZQ, 2004, FOOD CHEM, V84, P601, DOI 10.1016/j.foodchem.2003.05.002; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8	40	153	190	8	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19455	10.1371/journal.pone.0019455	http://dx.doi.org/10.1371/journal.pone.0019455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559331	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700181
J	Yang, QL; Zhang, D; Leng, M; Yang, L; Zhong, LW; Cooke, HJ; Shi, QH				Yang, Qingling; Zhang, Ding; Leng, Mei; Yang, Ling; Zhong, Liangwen; Cooke, Howard J.; Shi, Qinghua			Synapsis and Meiotic Recombination in Male Chinese Muntjac (Muntiacus reevesi)	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEXES; INDIAN MUNTJAC; CROSSING-OVER; MOUSE; MLH1; EVOLUTION; CHROMOSOMES; PACHYTENE; FUSIONS; NUMBER	The muntjacs (Muntiacus, Cervidae) have been extensively studied in terms of chromosomal and karyotypic evolution. However, little is known about their meiotic chromosomes particularly the recombination patterns of homologous chromosomes. We used immunostained surface spreads to visualise synaptonemal complexes (SCs), recombination foci and kinetochores with antibodies against marker proteins. As in other mammals pachytene was the longest stage of meiotic prophase. 39.4% of XY bivalents lacked MLH1 foci compared to less than 0.5% of autosomes. The average number of MLH1 foci per pachytene cell in M. reevesi was 29.8. The distribution of MLH1 foci differed from other mammals. On SCs with one focus, the distribution was more even in M. reevesi than in other mammals; for SCs that have two or more MLH1 foci, usually there was a larger peak in the sub-centromere region than other regions on SC in M. reevesi. Additionally, there was a lower level of interference between foci in M. reevesi than in mouse or human. These observations may suggest that the regulation of homologous recombination in M. reevesi is slightly different from other mammals and will improve our understanding of the regulation of meiotic recombination, with respect to recombination frequency and position.	[Yang, Qingling; Zhang, Ding; Leng, Mei; Yang, Ling; Zhong, Liangwen; Shi, Qinghua] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Zhang, Ding] Bengbu Med Collage, Dept Biol Sci, Bengbu, Peoples R China; [Cooke, Howard J.] Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Cooke, Howard J.] Western Gen Hosp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Bengbu Medical College; University of Edinburgh; University of Edinburgh	Yang, QL (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.	qshi@ustc.edu.cn	Shi, Qinghua/N-2950-2013		National Basic Research Program China (973) [2006CB504003, 2007CB947401]; Chinese Academy of Sciences [KSCX1-YW-R-51]	National Basic Research Program China (973)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Basic Research Program (2006CB504003, 2007CB947401) of China (973) and the Program of Knowledge Innovation (KSCX1-YW-R-51) of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LK, 1999, GENETICS, V151, P1569; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Basheva EA, 2008, CHROMOSOME RES, V16, P709, DOI 10.1007/s10577-008-1221-y; Borodin PM, 2008, GENETICS, V178, P621, DOI 10.1534/genetics.107.079665; Brown PW, 2005, AM J HUM GENET, V77, P556, DOI 10.1086/468188; Chi JX, 2005, CHROMOSOMA, V114, P167, DOI 10.1007/s00412-005-0004-x; Choo KHA, 1998, GENOME RES, V8, P81, DOI 10.1101/gr.8.2.81; Codina-Pascual M, 2005, HUM REPROD, V20, P2133, DOI 10.1093/humrep/dei023; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; de Villena FPM, 2001, MAMM GENOME, V12, P318, DOI 10.1007/s003350020005; Falque M, 2007, GENETICS, V176, P1453, DOI 10.1534/genetics.106.070235; Froenicke L, 2002, AM J HUM GENET, V71, P1353, DOI 10.1086/344714; Fronicke L, 1997, CYTOGENET CELL GENET, V77, P223, DOI 10.1159/000134581; Gonsalves J, 2004, HUM MOL GENET, V13, P2875, DOI 10.1093/hmg/ddh302; Hassold T, 2000, HUM MOL GENET, V9, P2409, DOI 10.1093/hmg/9.16.2409; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2004, CYTOGENET GENOME RES, V107, P249, DOI 10.1159/000080602; Huang L, 2006, CHROMOSOME RES, V14, P637, DOI 10.1007/s10577-006-1073-2; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Li J, 2009, FERTIL STERIL, V4, p1293e17; LIMING S, 1980, CYTOGENET CELL GENET, V26, P22, DOI 10.1159/000131417; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Ma K, 1988, Yi Chuan Xue Bao, V15, P282; Murmann AE, 2008, GENETICA, V134, P345, DOI 10.1007/s10709-008-9242-1; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Pigozzi MI, 2001, CYTOGENET CELL GENET, V95, P129, DOI 10.1159/000059334; Rubtsov N. B., 2007, CELL TISSUE BIOL, V1, P503; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; Shi Q, 2000, CYTOGENET CELL GENET, V90, P219, DOI 10.1159/000056773; Sun F, 2004, HUM REPROD, V19, P1770, DOI 10.1093/humrep/deh335; Sun F, 2004, AM J HUM GENET, V74, P521, DOI 10.1086/382138; Sun F, 2006, HUM REPROD, V21, P2335, DOI 10.1093/humrep/del190; Yang F, 1997, CHROMOSOMA, V106, P37, DOI 10.1007/s004120050222; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	36	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19255	10.1371/journal.pone.0019255	http://dx.doi.org/10.1371/journal.pone.0019255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559438	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700113
J	Yuan, TC; Wang, YP; Pao, L; Anderson, SM; Gu, HH				Yuan, Taichang; Wang, Yongping; Pao, Lily; Anderson, Steve M.; Gu, Haihua			Lactation Defect in a Widely Used MMTV-Cre Transgenic Line of Mice	PLOS ONE			English	Article							MOUSE MAMMARY EPITHELIUM; SIGNALING PATHWAY; GLAND INVOLUTION; CELL-DEVELOPMENT; TUMOR-FORMATION; RECEPTOR-ALPHA; EXPRESSION; GENE; PREGNANCY; STAT3	Background: MMTV-Cre mouse lines have played important roles in our understanding about the functions of numerous genes in mouse mammary epithelial cells during mammary gland development and tumorigenesis. However, numerous studies have not included MMTV-Cre mice as controls, and many investigators have not indicated which of the different MMTV-Cre founder lines were used in their studies. Here, we describe a lactation defect that severely limits the use of one of the most commonly used MMTV-Cre founder lines. Methodology/Principal Findings: To explore the role of protein tyrosine phosphatase Shp1 in mammary gland development, mice bearing the floxed Shp1 gene were crossed with MMTV-Cre mice and mammary gland development was examined by histological and biochemical techniques, while lactation competency was assessed by monitoring pup growth. Surprisingly, both the Shp1fl/+; MMTV-Cre and MMTV-Cre female mice displayed a severe lactation defect when compared to the Shp1 fl/+ control mice. Histological and biochemical analyses reveal that female mice expressing the MMTV-Cre transgene, either alone or in combination with floxed genes, exhibit defects in lobuloalveolar expansion, presence of large cytoplasmic lipid droplets in luminal alveolar epithelial cells postpartum, and precocious induction of involution. Using a PCR-based genotyping method, the three different founder lines can be distinguished, and we determined that the MMTV-Cre line A, the most widely used MMTV-Cre founder line, exhibits a profound lactation defect that limits its use in studies on mammary gland development. Conclusions/Significance: The identification of a lactation defect in the MMTV-Cre line A mice indicates that investigators must use MMTV-Cre alone mice as control in studies that utilize Cre recombinase to excise genes of interest from mammary epithelial cells. Our results also suggest that previous results obtained in studies using the MMTV-Cre line A line should be re-evaluated if the controls did not include mice expressing only Cre recombinase.	[Yuan, Taichang; Wang, Yongping; Anderson, Steve M.; Gu, Haihua] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA; [Pao, Lily] Beth Israel & Deaconess Med Ctr, Div Hematol & Oncol, Canc Biol Program, Boston, MA USA; [Pao, Lily] Harvard Univ, Sch Med, Boston, MA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Yuan, TC (corresponding author), Roche R&D China Ctr, Zhangjiang High Tech Pk, Shanghai, Peoples R China.	Haihua.gu@ucdenver.edu	Gu, Haihua/G-6364-2011		Pathology Department at University of Colorado Denver; Public Health Service [PO1 HD38129]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD038129] Funding Source: NIH RePORTER	Pathology Department at University of Colorado Denver; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Pathology Department at University of Colorado Denver, and a grant from the Public Health Service PO1 HD38129 to SMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti V, 2004, J EXP MED, V199, P867, DOI 10.1084/jem.20031983; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Andrechek ER, 2000, P NATL ACAD SCI USA, V97, P3444, DOI 10.1073/pnas.050408497; ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Chan JHP, 2007, INT IMMUNOPHARMACOL, V7, P937, DOI 10.1016/j.intimp.2007.03.002; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Chapman RS, 2000, ADV EXP MED BIOL, V480, P129; Crawford BE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010691; Cui Y, 2002, J BIOL CHEM, V277, P17830, DOI 10.1074/jbc.M200186200; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Freeburn RW, 1997, EXP HEMATOL, V25, P306; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; Gu HH, 2003, J CELL BIOL, V161, P1151, DOI 10.1083/jcb.200212158; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Kucera GT, 1996, DEV BIOL, V173, P162, DOI 10.1006/dbio.1996.0014; Loladze AV, 2006, ENDOCRINOLOGY, V147, P5412, DOI 10.1210/en.2006-0427; Mak TW, 2001, NAT REV IMMUNOL, V1, P11, DOI 10.1038/35095551; Nemade RV, 2004, MECH DEVELOP, V121, P91, DOI 10.1016/j.mod.2003.09.007; OCHMAN H, 1988, GENETICS, V120, P621; Palmer CA, 2006, J MAMMARY GLAND BIOL, V11, P269, DOI 10.1007/s10911-006-9023-3; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Robinson GW, 2007, DEV DYNAM, V236, P654, DOI 10.1002/dvdy.21058; Robinson GW, 2011, ANAL BIOCH; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Schwertfeger KL, 2003, J LIPID RES, V44, P1100, DOI 10.1194/jlr.M300045-JLR200; Seagroves TN, 2003, DEVELOPMENT, V130, P1713, DOI 10.1242/dev.00403; Selbert S, 1998, TRANSGENIC RES, V7, P387, DOI 10.1023/A:1008848304391; Tuveson DA, 2002, CURR OPIN GENET DEV, V12, P105, DOI 10.1016/S0959-437X(01)00272-6; Ursini-Siegel J, 2007, MOL CELL BIOL, V27, P6361, DOI 10.1128/MCB.00686-07; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Xue B, 1998, FASEB J, V12, pA505; Yip SS, 2000, INT J CANCER, V88, P363, DOI 10.1002/1097-0215(20001101)88:3<363::AID-IJC7>3.0.CO;2-4	36	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19233	10.1371/journal.pone.0019233	http://dx.doi.org/10.1371/journal.pone.0019233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559430	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700107
J	Pirila, S; Taskinen, M; Viljakainen, H; Kajosaari, M; Turanlahti, M; Saarinen-Pihkala, UM; Makitie, O				Pirila, Satu; Taskinen, Mervi; Viljakainen, Heli; Kajosaari, Merja; Turanlahti, Maila; Saarinen-Pihkala, Ulla M.; Makitie, Outi			Infant Milk Feeding Influences Adult Bone Health: A Prospective Study from Birth to 32 Years	PLOS ONE			English	Article							DEVELOPMENTAL ORIGINS; IRON-ABSORPTION; OSTEOPOROTIC FRACTURE; INFECTIOUS-DISEASES; ATOPIC DISEASE; BREAST-MILK; EARLY-LIFE; MASS; PROPHYLAXIS; CHILDREN	Background: Peak bone mass, attained by early adulthood, is influenced by genetic and life-style factors. Early infant feeding and duration of breastfeeding in particular, associate with several health-related parameters in childhood. The aim of this study was to examine whether the effects of early infant feeding extend to peak bone mass and other bone health characteristics at adult age. Methods and Findings: A cohort of 158 adults (76 males) born in Helsinki, Finland, 1975, prospectively followed up from birth, underwent physical examination and bone densitometry to study bone area, bone mineral content (BMC), and bone mineral density (BMD) at 32 years of age. Life-style factors relevant for bone health were recorded. For data analysis the cohort was divided into three equal-size groups according to the total duration of breastfeeding (BF): Short (<= 3 months), Intermediate and Prolonged (>= 7 months) BF groups. In males short BF is associated with higher bone area, BMC, and BMD compared to longer BF. Males in the Short BF group had on average 4.7% higher whole body BMD than males in the Prolonged BF group. In multivariate analysis, after controlling for multiple confounding factors, the influence of BF duration on adult bone characteristics persisted in males. Differences between the three feeding groups were observed in lumbar spine bone area and BMC, and whole body BMD (MANCOVA; p = 0.025, p = 0.013, and p = 0.048, respectively), favoring the Short BF group. In women no differences were observed. Conclusions: In men, early infant milk feeding may have a significant impact on adult bone health. A potential explanation is that the calcium and phosphate contents were strikingly higher in formula milk and commercial cow milk/cow milk dilutions as opposed to human milk. Our novel finding merits further studies to determine means to ensure optimal bone mass development in infants with prolonged breastfeeding.	[Pirila, Satu] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; Univ Helsinki, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Pirila, S (corresponding author), Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland.	satu.pirila@hus.fi		Makitie, Outi/0000-0002-4547-001X	Foundation for Pediatric Research; Academy of Finland; Helsinki University Central Hospital; Sigrid Juselius Foundation; Yrjo Jahnsson Foundation	Foundation for Pediatric Research; Academy of Finland(Academy of Finland); Helsinki University Central Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Yrjo Jahnsson Foundation	This study was supported by grants from the following organizations in Helsinki, Finland: Foundation for Pediatric Research, Academy of Finland, Helsinki University Central Hospital Research Funds, the Sigrid Juselius Foundation, and the Yrjo Jahnsson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butte NF, 2000, PEDIATRICS, V106, P1355, DOI 10.1542/peds.106.6.1355; Chen JR, 2009, J NUTR, V139, P1839, DOI 10.3945/jn.109.109041; Cooper C, 2006, OSTEOPOROSIS INT, V17, P337, DOI 10.1007/s00198-005-2039-5; Cooper C, 2005, J NUTR, V135, p2728S, DOI 10.1093/jn/135.11.2728S; Cushing AH, 1998, AM J EPIDEMIOL, V147, P863, DOI 10.1093/oxfordjournals.aje.a009540; Duijts L, 2010, PEDIATRICS, V126, pE18, DOI 10.1542/peds.2008-3256; Duijts L, 2009, MATERN CHILD NUTR, V5, P199, DOI 10.1111/j.1740-8709.2008.00176.x; Fewtrell MS, 1999, J BONE MINER RES, V14, P810, DOI 10.1359/jbmr.1999.14.5.810; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; HANSEN MA, 1991, BMJ-BRIT MED J, V303, P961, DOI 10.1136/bmj.303.6808.961; Harvey NC, 2009, BRIT J NUTR, V102, P915, DOI 10.1017/S0007114509317420; HealthyPeople.gov, 2020, NUTR PHYS ACT; Hediger ML, 2000, AM J CLIN NUTR, V72, P159; Jones G, 2000, OSTEOPOROSIS INT, V11, P146, DOI 10.1007/PL00004176; Karlsson C, 2001, OSTEOPOROSIS INT, V12, P828, DOI 10.1007/s001980170033; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Mayranpaa MK, 2010, J BONE MINER RES, V25, P2476, DOI 10.1002/jbmr.155; Oddy WH, 2003, ARCH DIS CHILD, V88, P224, DOI 10.1136/adc.88.3.224; Owen CG, 2008, AM J CLIN NUTR, V88, P305, DOI 10.1093/ajcn/88.2.305; Pearce MS, 2005, J EPIDEMIOL COMMUN H, V59, P475, DOI 10.1136/jech.2004.025999; POCOCK NA, 1987, J CLIN INVEST, V80, P706, DOI 10.1172/JCI113125; Ravelli ACJ, 2000, ARCH DIS CHILD, V82, P248, DOI 10.1136/adc.82.3.248; RUIZ JC, 1995, J BONE MINER RES, V10, P675; SAARINEN UM, 1978, J PEDIATR-US, V93, P177, DOI 10.1016/S0022-3476(78)80490-9; SAARINEN UM, 1977, ACTA PAEDIATR SCAND, V66, P719, DOI 10.1111/j.1651-2227.1977.tb07978.x; SAARINEN UM, 1995, LANCET, V346, P1065, DOI 10.1016/S0140-6736(95)91742-X; SAARINEN UM, 1979, LANCET, V2, P163; SAARINEN UM, 1982, ACTA PAEDIATR SCAND, V71, P567, DOI 10.1111/j.1651-2227.1982.tb09476.x; SAARINEN UM, 1979, PEDIATR RES, V13, P143, DOI 10.1203/00006450-197903000-00001; SAARINEN UM, 1977, J PEDIATR-US, V91, P36, DOI 10.1016/S0022-3476(77)80439-3; SAARINEN UM, 1979, ACTA PAEDIATR SCAND, V68, P245, DOI 10.1111/j.1651-2227.1979.tb04996.x; Scholes D, 2010, CONTRACEPTION, V81, P35, DOI 10.1016/j.contraception.2009.07.001; Turpeinen U, 2003, CLIN CHEM, V49, P1521, DOI 10.1373/49.9.1521; Viljakainen HT, 2010, J CLIN ENDOCR METAB, V95, P1749, DOI 10.1210/jc.2009-1391	36	26	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19068	10.1371/journal.pone.0019068	http://dx.doi.org/10.1371/journal.pone.0019068			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556368	Green Submitted, Green Published, gold			2022-12-25	WOS:000290019400028
J	Shen, WJ; Liu, LF; Patel, S; Kraemer, FB				Shen, Wen-Jun; Liu, Li-Fen; Patel, Shailja; Kraemer, Fredric B.			Hormone-sensitive lipase-knockout mice maintain high bone density during aging	FASEB JOURNAL			English	Article						osteoblastogenesis; bone marrow adipocytes	PPAR-GAMMA; LEPTIN REGULATION; FATTY-ACIDS; BETA-CELL; MARROW; EXPRESSION; DIFFERENTIATION; OSTEOBLASTS; METABOLISM; ROLES	We tested the hypothesis that the actions of hormone-sensitive lipase (HSL) affect the microenvironment of the bone marrow and that removal of HSL function by gene deletion maintains high bone mass in aging mice. We compared littermate control wild-type (WT) and HSL-/- mice during aging for changes in serum biochemical values, trabecular bone density using micro-computed tomography, bone histomorphometry, and characteristics of primary bone marrow cells and preosteoblasts. There is a regulated expression of HSL and genes involved in lipid metabolism in the bone marrow during aging. HSL-/- mice have increased serum levels of insulin and osteocalcin with decreased leptin levels. Compared with the marked adipocyte infiltration in WT bone marrow (65% by area) at 14 mo, HSL-/- mice have fewer (16%, P < 0.05) and smaller adipocytes in bone marrow. While peak bone density is similar, HSL-/- mice maintain a higher bone density (bone volume/total volume 6.1%) with age than WT mice (2.6%, P < 0.05). Primary osteo-blasts from HSL-/- mice show increased growth rates and higher osteogenic potential, manifested by increased expression of Runx2 (3.5-fold, P < 0.05) and osteocalcin (4-fold, P < 0.05). The absence of HSL directs cells within the bone marrow toward osteoblast differentiation and favors the maintenance of bone density with aging.-Shen, W.-J., Liu, L.-F., Patel, S., Kraemer, F. B. Hormone-sensitive lipase-knockout mice maintain high bone density during aging. FASEB J. 25, 2722-2730 (2011). www.fasebj.org	[Shen, Wen-Jun; Liu, Li-Fen; Patel, Shailja; Kraemer, Fredric B.] Stanford Univ, Div Endocrinol, Stanford, CA 94305 USA; [Shen, Wen-Jun; Liu, Li-Fen; Patel, Shailja; Kraemer, Fredric B.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Kraemer, FB (corresponding author), Stanford Univ, Div Endocrinol, S-025,300 Pasteur Dr, Stanford, CA 94305 USA.	fbk@stanford.edu	Kraemer, Fredric/AAC-3633-2019	Kraemer, Fredric/0000-0003-2468-7807; Shen, Wen-Jun/0000-0001-5150-1698	U.S. Department of Veterans Affairs (Office of Research and Development, Medical Research Service); U.S. National Institutes of Health (NIH) [R01 AG028098]	U.S. Department of Veterans Affairs (Office of Research and Development, Medical Research Service)(US Department of Veterans Affairs); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by the U.S. Department of Veterans Affairs (Office of Research and Development, Medical Research Service) and by U.S. National Institutes of Health (NIH) grant R01 AG028098. W.J.S. designed and performed experiments and wrote the manuscript; L.F.L. and S.P. performed experiments; F.B.K. designed the experiments and wrote the manuscript.	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Araneta MRG, 2009, J BONE MINER RES, V24, P2016, DOI [10.1359/JBMR.090519, 10.1359/jbmr.090519]; Arikawa T, 2004, J CELL PHYSIOL, V200, P400, DOI 10.1002/jcp.20031; BENNETT JH, 1991, J CELL SCI, V99, P131; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Chen TL, 2007, STEM CELLS DEV, V16, P371, DOI 10.1089/scd.2006.0037; Diascro DD, 1998, J BONE MINER RES, V13, P96, DOI 10.1359/jbmr.1998.13.1.96; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Forman BM, 1996, ANN NY ACAD SCI, V804, P266, DOI 10.1111/j.1749-6632.1996.tb18621.x; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gimble JM, 1996, MOL PHARMACOL, V50, P1087; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; Hinoi E, 2009, ANN NY ACAD SCI, V1173, pE20, DOI 10.1111/j.1749-6632.2009.05061.x; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; Holm C, 2000, ANNU REV NUTR, V20, P365, DOI 10.1146/annurev.nutr.20.1.365; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Kawai M, 2009, NAT REV RHEUMATOL, V5, P365, DOI 10.1038/nrrheum.2009.102; Kolditz CI, 2010, CURR OPIN CLIN NUTR, V13, P377, DOI 10.1097/MCO.0b013e32833bed6a; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kraemer FB, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-12; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Liu LF, 2010, J CELL PHYSIOL, V225, P837, DOI 10.1002/jcp.22291; Magni P, 2010, CURR MOL MED, V10, P522; Maurin AC, 2000, BONE, V26, P485, DOI 10.1016/S8756-3282(00)00252-0; Mertelsmann R, 2000, J HEMATOTH STEM CELL, V9, P957, DOI 10.1089/152581600750062417; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; RAISZ LG, 1995, J NUTR, V125, pS2024, DOI 10.1093/jn/125.suppl_7.2024S; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; Reid IR, 2010, ARCH BIOCHEM BIOPHYS, V503, P20, DOI 10.1016/j.abb.2010.06.027; Rosen CJ, 2010, CELL, V142, P198, DOI 10.1016/j.cell.2010.07.001; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Shen WJ, 2011, BBA-MOL CELL BIOL L, V1811, P9, DOI 10.1016/j.bbalip.2010.10.001; Shen WJ, 1998, BIOCHEMISTRY-US, V37, P8973, DOI 10.1021/bi980545u; SUMIDA C, 1993, PROSTAG LEUKOTR ESS, V48, P117, DOI 10.1016/0952-3278(93)90019-S; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Tokuzawa Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001019; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; Wang SP, 2008, MOL GENET METAB, V95, P117, DOI 10.1016/j.ymgme.2008.06.012; Watkins BA, 2001, J AM COLL NUTR, V20, p410S, DOI 10.1080/07315724.2001.10719177; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811; Zimmermann R, 2009, BBA-MOL CELL BIOL L, V1791, P494, DOI 10.1016/j.bbalip.2008.10.005	52	6	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2011	25	8					2722	2730		10.1096/fj.11-181016	http://dx.doi.org/10.1096/fj.11-181016			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21566206	Green Published			2022-12-25	WOS:000293337800021
J	Zahn, KE; Tchesnokov, EP; Gotte, M; Doublie, S				Zahn, Karl E.; Tchesnokov, Egor P.; Goette, Matthias; Doublie, Sylvie			Phosphonoformic Acid Inhibits Viral Replication by Trapping the Closed Form of the DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; HUMAN CYTOMEGALOVIRUS RESISTANCE; ANTIVIRAL DRUGS; CRYSTAL-STRUCTURE; PHOSPHONOACETIC-ACID; FOSCARNET RESISTANCE; MULTIDRUG-RESISTANCE; BACTERIOPHAGE RB69; MUTATIONS; ALIGNMENT	Phosphonoformic acid (PFA, foscarnet) belongs to a class of antiviral drugs that inhibit the human cytomegalovirus DNA polymerase (UL54) by mimicking the pyrophosphate leaving group of the nucleotide transfer reaction. Difficulties expressing UL54 have hampered investigation of the precise structural requirements rendering inhibition by this drug. However, a previously engineered chimeric DNA polymerase, constructed by mutating the homologous polymerase from bacteriophage RB69 (gp43) to express several variable elements from UL54, can bypass this obstacle because of its favorable expression and acquired sensitivity to PFA (Tchesnokov, E. P., Obikhod, A., Schinazi, R. F., and Gotte, M. (2008) J. Biol. Chem. 283, 34218-34228). Here, we compare two crystal structures that depict the chimeric DNA polymerase with and without PFA bound. PFA is visualized for the first time in the active site of a DNA polymerase, where interactions are resolved between the PPi mimic and two basic residues absolutely conserved in the fingers domain of family B polymerases. PFA also chelates metal ion B, the cation that contacts the triphosphate tail of the incoming nucleotide. These DNA complexes utilize a primer-template pair enzymatically chain-terminated by incorporation of acyclo-GMP, the phosphorylated form of the anti-herpes drug acyclovir. We postulate that the V478W mutation present in the chimera is critical in that it pushes the fingers domain to more readily adopt the closed conformation whether or not the drug is bound. The closed state of the fingers domain traps the variant polymerase in the untranslocated state and increases affinity for PFA. This finding provides a model for the mechanism of UL54 stalling by PFA.	[Tchesnokov, Egor P.; Goette, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Zahn, Karl E.; Doublie, Sylvie] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	McGill University; University of Vermont	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg D-6,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca; sdoublie@uvm.edu		Doublie, Sylvie/0000-0002-6294-5304; Zahn, Karl/0000-0002-4865-2708	National Institutes of Health [CA52040]; Canadian Institutes of Health Research; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; U.S. Dept. of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA052040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Dept. of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA52040 (to S. D.). This work was also supported by a grant from the Canadian Institutes of Health Research (to M. G.). The beamline 23ID-B and the Advanced Photon Source were supported by National Cancer Institute Grant Y1-CO-1020, National Institute of General Medical Sciences Grant Y1-GM-1104, and U.S. Dept. of Energy, Basic Energy Sciences, Office of Science Contract DE-AC02-06CH11357.	Abou-Zeid KA, 2007, J FOOD PROTECT, V70, P2620, DOI 10.4315/0362-028X-70.11.2620; Baldanti F, 1996, J VIROL, V70, P1390, DOI 10.1128/JVI.70.3.1390-1395.1996; Baldanti F, 2003, J ANTIMICROB CHEMOTH, V52, P324, DOI 10.1093/jac/dkg354; Baldanti F, 2004, HUM IMMUNOL, V65, P403, DOI 10.1016/j.humimm.2004.02.007; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beilhartz GL, 2009, J MOL BIOL, V388, P462, DOI 10.1016/j.jmb.2009.03.025; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chou SW, 1998, J INFECT DIS, V178, P526, DOI 10.1086/515648; Chou SW, 1997, J INFECT DIS, V176, P786, DOI 10.1086/517302; Cihlar T, 1998, J VIROL, V72, P5927, DOI 10.1128/JVI.72.7.5927-5936.1998; De Clercq E, 2005, NAT REV DRUG DISCOV, V4, P928, DOI 10.1038/nrd1877; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garcia-Diaz M, 2007, DNA REPAIR, V6, P1333, DOI 10.1016/j.dnarep.2007.03.005; Gilbert C, 2002, DRUG RESIST UPDATE, V5, P88, DOI 10.1016/S1368-7646(02)00021-3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Hogg M, 2010, BIOCHEMISTRY-US, V49, P2317, DOI 10.1021/bi901488d; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LERNER CW, 1984, MEDICINE, V63, P155, DOI 10.1097/00005792-198405000-00002; Li L, 2005, GENETICS, V170, P569, DOI 10.1534/genetics.104.040295; Liu SP, 2006, J BIOL CHEM, V281, P18193, DOI 10.1074/jbc.M602414200; Magee WC, 2008, ANTIMICROB AGENTS CH, V52, P586, DOI 10.1128/AAC.01172-07; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Mercorelli B, 2008, REV MED VIROL, V18, P177, DOI 10.1002/rmv.558; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; REARDON JE, 1989, J BIOL CHEM, V264, P19039; REHAKRANTZ LJ, 1993, J VIROL, V67, P60, DOI 10.1128/JVI.67.1.60-66.1993; REHAKRANTZ LJ, 1994, J BIOL CHEM, V269, P5635; Rould MA, 1997, METHOD ENZYMOL, V276, P461, DOI 10.1016/S0076-6879(97)76072-5; Scott GM, 2007, ANTIMICROB AGENTS CH, V51, P89, DOI 10.1128/AAC.00633-06; Shi R, 2006, PROTEINS, V64, P301, DOI 10.1002/prot.21005; Smith IL, 1997, J INFECT DIS, V176, P69, DOI 10.1086/514041; SPECTOR SA, 1985, ANTIMICROB AGENTS CH, V27, P600, DOI 10.1128/AAC.27.4.600; STEIN M, 1994, TUMORI, V80, P216, DOI 10.1177/030089169408000310; Tchesnokov EP, 2009, J BIOL CHEM, V284, P26439, DOI 10.1074/jbc.M109.012500; Tchesnokov EP, 2008, J BIOL CHEM, V283, P34218, DOI 10.1074/jbc.M806797200; Tchesnokov EP, 2006, J VIROL, V80, P1440, DOI 10.1128/JVI.80.3.1440-1450.2006; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; WONG SW, 1988, EMBO J, V7, P37, DOI 10.1002/j.1460-2075.1988.tb02781.x; Xu CL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000225; Zahn KE, 2007, BIOCHEMISTRY-US, V46, P10551, DOI 10.1021/bi7008807; Zakharova E, 2004, BIOCHEMISTRY-US, V43, P6587, DOI 10.1021/bi049615p	50	41	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25246	25255		10.1074/jbc.M111.248864	http://dx.doi.org/10.1074/jbc.M111.248864			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21566148	Green Published, hybrid			2022-12-25	WOS:000292547900070
J	Machtens, JP; Kovermann, P; Fahlke, C				Machtens, Jan-Philipp; Kovermann, Peter; Fahlke, Christoph			Substrate-dependent Gating of Anion Channels Associated with Excitatory Amino Acid Transporter 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL GLUTAMATE TRANSPORTER; CHLORIDE CHANNEL; ION; EAAC1; SODIUM; FLUXES; GLT-1; TRANSLOCATION; DETERMINES; MECHANISM	EAAT glutamate transporters do not only function as secondary-active glutamate transporters but also as anion channels. EAAT anion channel activity depends on transport substrates. For most isoforms, it is negligible without external Na+ and increased by external glutamate. We here investigated gating of EAAT4 anion channels with various cations and amino acid substrates using patch clamp experiments on a mammalian cell line. We demonstrate that Li+ can substitute for Na+ in supporting substrate-activated anion currents, albeit with changed voltage dependence. Anion currents were recorded in glutamate, aspartate, and cysteine, and distinct time and voltage dependences were observed. For each substrate, gating was different in external Na+ or Li+. All features of voltage-dependent and substrate-specific anion channel gating can be described by a simplified nine-state model of the transport cycle in which only amino acid substrate-bound states assume high anion channel open probabilities. The kinetic scheme suggests that the substrate dependence of channel gating is exclusively caused by differences in substrate association and translocation. Moreover, the voltage dependence of anion channel gating arises predominantly from electrogenic cation binding and membrane translocation of the transporter. We conclude that all voltage-and substrate-dependent conformational changes of the EAAT4 anion channel are linked to transitions within the transport cycle.	[Fahlke, Christoph] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; Zentrum Syst Neurowissensch Hannover ZSN, D-30559 Hannover, Germany	Hannover Medical School	Fahlke, C (corresponding author), Hannover Med Sch, Inst Neurophysiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	fahlke.christoph@mh-hannover.de	Machtens, Jan-Philipp/M-8659-2013; Fahlke, Christoph/G-3635-2013; Kovermann, Peter/AAF-4411-2020	Machtens, Jan-Philipp/0000-0003-1673-8571; Fahlke, Christoph/0000-0001-8602-9952; Kovermann, Peter/0000-0001-5296-4918	Deutsche Forschungsgemeinschaft [FA301/9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (FA301/9 to Ch. F.).	Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Bergles DE, 2002, J NEUROSCI, V22, P10153; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fairman WA, 1999, AM J PHYSIOL-RENAL, V277, pF481, DOI 10.1152/ajprenal.1999.277.4.F481; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Huang SW, 2007, BIOCHEMISTRY-US, V46, P9685, DOI 10.1021/bi700647f; Huang S, 2009, J BIOL CHEM, V284, P4510, DOI 10.1074/jbc.M808495200; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Larsson HP, 1996, BIOPHYS J, V70, P733, DOI 10.1016/S0006-3495(96)79613-3; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Melzer N, 2005, P NATL ACAD SCI USA, V102, P19214, DOI 10.1073/pnas.0508837103; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Menaker D, 2006, J NEUROCHEM, V99, P20, DOI 10.1111/j.1471-4159.2006.04003.x; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Otis TS, 2000, J NEUROSCI, V20, P2749; PARSEGIAN A, 1969, NATURE, V221, P844, DOI 10.1038/221844a0; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104	32	20	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23780	23788		10.1074/jbc.M110.207514	http://dx.doi.org/10.1074/jbc.M110.207514			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572047	hybrid, Green Published			2022-12-25	WOS:000292294900020
J	Maudet, C; Bertrand, M; Le Rouzic, E; Lahouassa, H; Ayinde, D; Nisole, S; Goujon, C; Cimarelli, A; Margottin-Goguet, F; Transy, C				Maudet, Claire; Bertrand, Matthieu; Le Rouzic, Erwann; Lahouassa, Hichem; Ayinde, Diana; Nisole, Sebastien; Goujon, Caroline; Cimarelli, Andrea; Margottin-Goguet, Florence; Transy, Catherine			Molecular Insight into How HIV-1 Vpr Protein Impairs Cell Growth through Two Genetically Distinct Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CUL4A-DDB1(DCAF1) UBIQUITIN LIGASE; CYCLE ARREST; G(2) ARREST; MUTATIONAL ANALYSIS; IN-VIVO; PROTEASOMAL DEGRADATION; MACROPHAGE INFECTION; NUCLEAR-LOCALIZATION; REGULATORY PROTEIN	Vpr, a small HIV auxiliary protein, hijacks the CUL4 ubiquitin ligase through DCAF1 to inactivate an unknown cellular target, leading to cell cycle arrest at the G(2) phase and cell death. Here we first sought to delineate the Vpr determinants involved in the binding to DCAF1 and to the target. On the one hand, the three alpha-helices of Vpr are necessary and sufficient for binding to DCAF1; on the other hand, nonlinear determinants in Vpr are required for binding to the target, as shown by using protein chimeras. We also underscore that a SRIG motif conserved in the C-terminal tail of Vpr proteins from HIV-1/SIVcpz and HIV-2/SIVsmm lineages is critical for G(2) arrest. Our results suggest that this motif may be predictive of the ability of Vpr proteins from other SIV lineages to mediate G(2) arrest. We took advantage of the characterization of a subset of G(2) arrest-defective, but DCAF1 binding-proficient mutants, to investigate whether Vpr interferes with cell viability independently of its ability to induce G(2) arrest. These mutants inhibited cell colony formation in HeLa cells and are cytotoxic in lymphocytes, unmasking a G(2) arrest-independent cytopathic effect of Vpr. Furthermore these mutants do not block cell cycle progression at the G(1) or S phases but trigger apoptosis through caspase 3. Disruption of DCAF1 binding restored efficiency of colony formation. However, DCAF1 binding per se is not sufficient to confer cytopathicity. These data support a model in which Vpr recruits DCAF1 to induce the degradation of two host proteins independently required for proper cell growth.	[Maudet, Claire; Bertrand, Matthieu; Le Rouzic, Erwann; Lahouassa, Hichem; Ayinde, Diana; Nisole, Sebastien; Margottin-Goguet, Florence; Transy, Catherine] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Maudet, Claire; Bertrand, Matthieu; Le Rouzic, Erwann; Lahouassa, Hichem; Ayinde, Diana; Nisole, Sebastien; Margottin-Goguet, Florence; Transy, Catherine] CNRS, UMR8104, F-75014 Paris, France; [Maudet, Claire; Bertrand, Matthieu; Le Rouzic, Erwann; Lahouassa, Hichem; Ayinde, Diana; Nisole, Sebastien; Margottin-Goguet, Florence; Transy, Catherine] Univ Paris 05, F-75006 Paris, France; [Goujon, Caroline] Kings Coll London, Sch Med, Dept Infect Dis, London WC2R 2LS, England; [Cimarelli, Andrea] Ecole Normale Super Lyon, LaboRetro, Unite Virol Humaine, F-69007 Lyon, France; [Cimarelli, Andrea] INSERM, U758, F-69007 Lyon, France; [Cimarelli, Andrea] Univ Lyon, BioSci Lyon Gerland IFR128, F-69007 Lyon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of London; King's College London; Ecole Normale Superieure de Lyon (ENS de LYON); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm)	Margottin-Goguet, F (corresponding author), 27 Rue Faubourg St Jacques,Bat G Roussy, F-75014 Paris, France.	florence.margottin-goguet@inserm.fr; catherine.transy@inserm.fr	Margottin-Goguet, Florence/F-9272-2013; Maudet, Claire/AAH-1728-2019; Goujon, Caroline/B-3914-2014; Nisole, Sébastien/ABA-2367-2021	Margottin-Goguet, Florence/0000-0002-3124-6690; Maudet, Claire/0000-0001-8856-0819; Goujon, Caroline/0000-0001-8571-1108; Nisole, Sébastien/0000-0001-9793-419X; CIMARELLI, Andrea/0000-0003-0892-0488	Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales; Fondation de France; Sidaction; University Paris Diderot; INSERM; Ministere de l'Enseignement Superieur et de la Recherche	Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales(ANRSFrench National Research Agency (ANR)); Fondation de France(Fondation de France); Sidaction; University Paris Diderot; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported by grants from the Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales, Sidaction, and Fondation de France.; Received support from University Paris Diderot.; Received support from INSERM.; Received support from Ministere de l'Enseignement Superieur et de la Recherche.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Accola MA, 1999, J VIROL, V73, P9992, DOI 10.1128/JVI.73.12.9992-9999.1999; Agostini I, 2002, AIDS RES HUM RETROV, V18, P283, DOI 10.1089/088922202753472856; Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Amini S, 2004, J BIOL CHEM, V279, P46046, DOI 10.1074/jbc.M403792200; Andersen JL, 2005, CELL DEATH DIFFER, V12, P326, DOI 10.1038/sj.cdd.4401565; Andersen JL, 2008, EXP MOL PATHOL, V85, P2, DOI 10.1016/j.yexmp.2008.03.015; Andersen JL, 2006, PLOS PATHOG, V2, P1106, DOI 10.1371/journal.ppat.0020127; Arokium H, 2009, J VIROL, V83, P11283, DOI 10.1128/JVI.00756-09; Asaoka K, 2005, BIOCHEM BIOPH RES CO, V338, P1950, DOI 10.1016/j.bbrc.2005.10.173; Azuma A, 2006, MICROBES INFECT, V8, P670, DOI 10.1016/j.micinf.2005.09.002; Bachand F, 1999, J BIOL CHEM, V274, P9083, DOI 10.1074/jbc.274.13.9083; BALLIET JW, 1994, VIROLOGY, V200, P623, DOI 10.1006/viro.1994.1225; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001080; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Bolton DL, 2007, J VIROL, V81, P8878, DOI 10.1128/JVI.00122-07; CHAKRABARTI L, 1987, NATURE, V328, P543, DOI 10.1038/328543a0; Chen KY, 2006, J VIROL, V80, P7645, DOI 10.1128/JVI.00206-06; Cherrier T, 2009, ONCOGENE, V28, P3380, DOI 10.1038/onc.2009.193; Chowdhury IH, 2003, VIROLOGY, V305, P371, DOI 10.1006/viro.2002.1777; COHEN EA, 1990, J VIROL, V64, P3097, DOI 10.1128/JVI.64.6.3097-3099.1990; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Crews CM, 2003, CURR OPIN CHEM BIOL, V7, P534, DOI 10.1016/j.cbpa.2003.08.002; DeHart JL, 2008, J VIROL, V82, P9265, DOI 10.1128/JVI.00377-08; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Eckstein DA, 2001, J EXP MED, V194, P1407, DOI 10.1084/jem.194.10.1407; Elder RT, 2000, VIRUS RES, V68, P161, DOI 10.1016/S0168-1702(00)00167-2; Gao QS, 2002, CANCER RES, V62, P3315; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Jacquot G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-84; Kondo E, 1996, J VIROL, V70, P159, DOI 10.1128/JVI.70.1.159-164.1996; Lai MY, 2005, J VIROL, V79, P15443, DOI 10.1128/JVI.79.24.15443-15451.2005; LANG SM, 1993, J VIROL, V67, P902, DOI 10.1128/JVI.67.2.902-912.1993; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Li G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-59; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; McCall CM, 2008, MOL CELL BIOL, V28, P5621, DOI 10.1128/MCB.00232-08; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Morellet N, 2009, CURR HIV RES, V7, P184, DOI 10.2174/157016209787581490; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nishizawa M, 2000, VIROLOGY, V276, P16, DOI 10.1006/viro.2000.0534; Nishizawa M, 2000, J VIROL, V74, P6058, DOI 10.1128/JVI.74.13.6058-6067.2000; PAXTON W, 1993, J VIROL, V67, P7229, DOI 10.1128/JVI.67.12.7229-7237.1993; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Pestov DG, 1999, BIOTECHNIQUES, V26, P102, DOI 10.2144/99261st04; Planelles V, 1996, J VIROL, V70, P2516, DOI 10.1128/JVI.70.4.2516-2524.1996; Plesca D, 2007, CELL CYCLE, V6, P1147, DOI 10.4161/cc.6.10.4259; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Sakai K, 2006, P NATL ACAD SCI USA, V103, P3369, DOI 10.1073/pnas.0509417103; Sakuma R, 2007, J VIROL, V81, P10201, DOI 10.1128/JVI.00419-07; Sarkis PTN, 2006, J IMMUNOL, V177, P4530, DOI 10.4049/jimmunol.177.7.4530; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sitterlin D, 2000, ONCOGENE, V19, P4417, DOI 10.1038/sj.onc.1203771; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Stewart SA, 1999, P NATL ACAD SCI USA, V96, P12039, DOI 10.1073/pnas.96.21.12039; Stivahtis GL, 1997, J VIROL, V71, P4331, DOI 10.1128/JVI.71.6.4331-4338.1997; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Waldhuber MG, 2003, VIROLOGY, V313, P91, DOI 10.1016/S0042-6822(03)00258-7; Ward J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000613; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yuan HD, 2003, J VIROL, V77, P2063, DOI 10.1128/JVI.77.3.2063-2070.2003; Zhu YH, 2001, J VIROL, V75, P3791, DOI 10.1128/JVI.75.8.3791-3801.2001; Zimmerman ES, 2006, J VIROL, V80, P10407, DOI 10.1128/JVI.01212-06; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	79	9	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23742	23752		10.1074/jbc.M111.220780	http://dx.doi.org/10.1074/jbc.M111.220780			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566118	Green Published, hybrid			2022-12-25	WOS:000292294900016
J	Roy, S; Sun, Y; Pearlman, E				Roy, Sanhita; Sun, Yan; Pearlman, Eric			Interferon-gamma-induced MD-2 Protein Expression and Lipopolysaccharide (LPS) Responsiveness in Corneal Epithelial Cells Is Mediated by Janus Tyrosine Kinase-2 Activation and Direct Binding of STAT1 Protein to the MD-2 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; TLR4; ENDOTOXIN; COMPLEX; INFLAMMATION; RECOGNITION; INHIBITION; RESPONSES; SIGNALS	The inability of epithelial cells from the cornea and other tissues to respond to LPS is reportedly due to low expression of the TLR4 co-receptor MD-2. We generated MD-2(-/-) bone marrow chimeras, and showed that MD-2 expression on non-myeloid cells was sufficient to mediate LPS-induced corneal inflammation. As IFN-gamma is produced during Pseudomonas aeruginosa corneal infection, we examined the role of this cytokine on MD-2 expression by primary human corneal epithelial (HCE) cells and HCE cell lines. Exogenous IFN-gamma was found to induce MD-2 mRNA, MD-2 cell surface expression, and LPS responsiveness as determined by p65 translocation to the nucleus and production of IL-6, CXCL1, and CXCL8/IL-8. Incubation with either the AG490 JAK2 inhibitor or with STAT1 siRNA blocked STAT1 phosphorylation and MD-2 transcription. Furthermore, EMSA analysis demonstrated that STAT1 binds to the MD-2 promoter, indicating that STAT1 is an MD-2 transcription factor. Together, these findings demonstrate that IFN-gamma induces MD-2 expression and LPS responsiveness in HCE cells by JAK-2-dependent STAT1 activation and direct binding to the MD-2 promoter. Furthermore, given our findings on LPS-induced corneal inflammation, it is likely that IFN-gamma-induced MD-2 expression by corneal epithelial cells contributes to the host response in vivo, determining the extent of tissue damage and bacterial clearance.	[Roy, Sanhita; Sun, Yan; Pearlman, Eric] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44095 USA	Case Western Reserve University	Pearlman, E (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 10900 Euclid Ave, Cleveland, OH 44095 USA.	Eric.Pearlman@case.edu		ROY, SANHITA/0000-0002-0407-8177	National Institutes of Health [RO1EY14362, P30EY11373]; The Research to Prevent Blindness Foundation; Ohio Lions Eye Research Foundation; Alcon Research Institute; NATIONAL EYE INSTITUTE [P30EY011373, R01EY014362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; Alcon Research Institute(Novartis); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1EY14362 and P30EY11373 (both to E. P.). Additional support was provided by The Research to Prevent Blindness Foundation and the Ohio Lions Eye Research Foundation.; Recipient of an Alcon Research Institute award. To whom correspondence should be addressed: Dept. of Ophthalmology and Visual Sciences, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44095. E-mail: Eric.Pearlman@case.edu.	Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Adhikary G, 2008, J LEUKOCYTE BIOL, V83, P991, DOI 10.1189/jlb.1107783; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Chinnery HR, 2007, INVEST OPHTH VIS SCI, V48, P1568, DOI 10.1167/iovs.06-0746; Chinnery HR, 2009, J IMMUNOL, V182, P2738, DOI 10.4049/jimmunol.0803505; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Hazlett LD, 2007, J IMMUNOL, V179, P1138, DOI 10.4049/jimmunol.179.2.1138; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Johnson AC, 2005, INVEST OPHTH VIS SCI, V46, P589, DOI 10.1167/iovs.04-1077; Johnson AC, 2008, J BIOL CHEM, V283, P3988, DOI 10.1074/jbc.M707264200; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Knickelbein JE, 2009, OPHTHALMOL EYE DIS, V1, P45; Kumar A, 2006, MICROBES INFECT, V8, P380, DOI 10.1016/j.micinf.2005.07.006; Malemud CJ, 2009, CURR SIGNAL TRANSD T, V4, P201, DOI 10.2174/157436209789057467; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Rossignol DP, 2002, J ENDOTOXIN RES, V8, P483, DOI 10.1179/096805102125001127; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; Sun Y, 2009, INVEST OPHTH VIS SCI, V50, P1247, DOI 10.1167/iovs.08-2628; Talreja J, 2005, INFLAMMATION, V29, P170, DOI 10.1007/s10753-006-9014-y; Uehara A, 2002, J MED MICROBIOL, V51, P626, DOI 10.1099/0022-1317-51-8-626; Ueta M, 2005, BIOCHEM BIOPH RES CO, V331, P285, DOI 10.1016/j.bbrc.2005.02.196; Ueta M, 2004, J IMMUNOL, V173, P3337, DOI 10.4049/jimmunol.173.5.3337; Vamadevan AS, 2010, INNATE IMMUN-LONDON, V16, P93, DOI 10.1177/1753425909339231; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2005, J IMMUNOL, V175, P6465, DOI 10.4049/jimmunol.175.10.6465; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; Visintin A, 2006, J LEUKOCYTE BIOL, V80, P1584, DOI 10.1189/jlb.0606388; Zhang J, 2003, INVEST OPHTH VIS SCI, V44, P4247, DOI 10.1167/iovs.03-0219; Zhang J, 2009, IMMUNOL CELL BIOL, V87, P141, DOI 10.1038/icb.2008.75	41	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23753	23762		10.1074/jbc.M111.219345	http://dx.doi.org/10.1074/jbc.M111.219345			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572044	Green Published, hybrid			2022-12-25	WOS:000292294900017
J	Yanagi, K; Ashizaki, M; Yagi, H; Sakurai, K; Lee, YH; Goto, Y				Yanagi, Kotaro; Ashizaki, Mizue; Yagi, Hisashi; Sakurai, Kazumasa; Lee, Young-Ho; Goto, Yuji			Hexafluoroisopropanol Induces Amyloid Fibrils of Islet Amyloid Polypeptide by Enhancing Both Hydrophobic and Electrostatic Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORINE-SUBSTITUTED ALCOHOLS; ALPHA-SYNUCLEIN; PROTEIN; PEPTIDE; GROWTH; BETA(2)-MICROGLOBULIN; TRIFLUOROETHANOL; FLUORESCENCE; AGGREGATION; PROPAGATION	Although amyloid fibrils deposit with various proteins, the comprehensive mechanism by which they form remains unclear. We studied the formation of fibrils of human islet amyloid polypeptide associated with type II diabetes in the presence of various concentrations of 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) under acidic and neutral pH conditions using CD, amyloid-specific thioflavin T fluorescence, fluorescence imaging with thioflavin T, and atomic force microscopy. At low pH, the formation of fibrils was promoted by HFIP with an optimum at 5% (v/v). At neutral pH in the absence of HFIP, significant amounts of amorphous aggregates formed in addition to the fibrils. The addition of HFIP suppressed the formation of amorphous aggregates, leading to a predominance of fibrils with an optimum effect at 25% (v/v). Under both conditions, higher concentrations of HFIP dissolved the fibrils and stabilized the alpha-helical structure. The results indicate that fibrils and amorphous aggregates are different types of precipitates formed by exclusion from water-HFIP mixtures. The exclusion occurs through the combined effects of hydrophobic interactions and electrostatic interactions, both of which are strengthened by low concentrations of HFIP, and a subtle balance between the two types of interactions determines whether the fibrils or amorphous aggregates dominate. We suggest a general view of how the structure of precipitates varies dramatically from single crystals to amyloid fibrils and amorphous aggregates.	[Yanagi, Kotaro; Ashizaki, Mizue; Yagi, Hisashi; Sakurai, Kazumasa; Lee, Young-Ho; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology and by the Japan Society for the Promotion of Science Research Fellowships for Young Scientists (to H.Y.).	Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; Ahmad MF, 2006, J MOL BIOL, V364, P1061, DOI 10.1016/j.jmb.2006.09.085; Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Ban T, 2006, J BIOL CHEM, V281, P33677, DOI 10.1074/jbc.M606072200; Ban T, 2006, ACCOUNTS CHEM RES, V39, P663, DOI 10.1021/ar050074l; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CLARK A, 1987, LANCET, V2, P231; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Demeule B, 2007, INT J PHARMACEUT, V329, P37, DOI 10.1016/j.ijpharm.2006.08.024; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Giehm L, 2010, J MOL BIOL, V401, P115, DOI 10.1016/j.jmb.2010.05.060; Haggqvist B, 1999, P NATL ACAD SCI USA, V96, P8669, DOI 10.1073/pnas.96.15.8669; Hebda JA, 2009, ANNU REV BIOPHYS, V38, P125, DOI 10.1146/annurev.biophys.050708.133622; Hirota N, 1998, J MOL BIOL, V275, P365, DOI 10.1006/jmbi.1997.1468; Hong DP, 1999, J AM CHEM SOC, V121, P8427, DOI 10.1021/ja990833t; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Kozhukh GV, 2002, J BIOL CHEM, V277, P1310, DOI 10.1074/jbc.M108753200; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Marzban L, 2003, EXP GERONTOL, V38, P347, DOI 10.1016/S0531-5565(03)00004-4; Mishra R, 2007, J MOL BIOL, V366, P1029, DOI 10.1016/j.jmb.2006.11.084; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nelson R, 2006, ADV PROTEIN CHEM, V73, P235, DOI 10.1016/S0065-3233(06)73008-X; Parrini C, 2005, STRUCTURE, V13, P1143, DOI 10.1016/j.str.2005.04.022; Pechmann S, 2010, MOL BIOSYST, V6, P2490, DOI 10.1039/c005160h; Raimondi S, 2011, J MOL BIOL, V407, P465, DOI 10.1016/j.jmb.2011.01.044; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; SIPE JD, 1994, CRIT REV CL LAB SCI, V31, P325, DOI 10.3109/10408369409084679; Tartaglia GG, 2009, J MOL BIOL, V388, P381, DOI 10.1016/j.jmb.2009.03.002; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Yagi H, 2007, BIOCHEMISTRY-US, V46, P15009, DOI 10.1021/bi701842n; Yagi H, 2010, J BIOL CHEM, V285, P19660, DOI 10.1074/jbc.M109.076505; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030; Yamamoto S, 2005, BBA-PROTEINS PROTEOM, V1753, P4, DOI 10.1016/j.bbapap.2005.09.006	46	65	66	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23959	23966		10.1074/jbc.M111.226688	http://dx.doi.org/10.1074/jbc.M111.226688			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566116	hybrid, Green Published			2022-12-25	WOS:000292294900038
J	Taylor, MR; Conrad, JA; Wahl, D; O'Brien, PJ				Taylor, Mark R.; Conrad, John A.; Wahl, Daniel; O'Brien, Patrick J.			Kinetic Mechanism of Human DNA Ligase I Reveals Magnesium-dependent Changes in the Rate-limiting Step That Compromise Ligation Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE PROTEIN APRATAXIN; ESCHERICHIA-COLI; FUNCTIONAL EXPRESSION; CELLS; CDNA; STABILITY; COMPLEXES; REPAIR; RNA	DNA ligase I (LIG1) catalyzes the ligation of single-strand breaks to complete DNA replication and repair. The energy of ATP is used to form a new phosphodiester bond in DNA via a reaction mechanism that involves three distinct chemical steps: enzyme adenylylation, adenylyl transfer to DNA, and nick sealing. We used steady state and pre-steady state kinetics to characterize the minimal mechanism for DNA ligation catalyzed by human LIG1. The ATP dependence of the reaction indicates that LIG1 requires multiple Mg2+ ions for catalysis and that an essential Mg2+ ion binds more tightly to ATP than to the enzyme. Further dissection of the magnesium ion dependence of individual reaction steps revealed that the affinity for Mg2+ changes along the reaction coordinate. At saturating concentrations of ATP and Mg2+ ions, the three chemical steps occur at similar rates, and the efficiency of ligation is high. However, under conditions of limiting Mg2+, the nick-sealing step becomes rate-limiting, and the adenylylated DNA intermediate is prematurely released into solution. Subsequent adenylylation of enzyme prevents rebinding to the adenylylated DNA intermediate comprising an Achilles' heel of LIG1. These ligase-generated 5'-adenylylated nicks constitute persistent breaks that are a threat to genomic stability if they are not repaired. The kinetic and thermodynamic framework that we have determined for LIG1 provides a starting point for understanding the mechanism and specificity of mammalian DNA ligases.	[Taylor, Mark R.; Conrad, John A.; Wahl, Daniel; O'Brien, Patrick J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	O'Brien, PJ (corresponding author), 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	pjobrien@umich.edu			Rackham Graduate School at the University of Michigan; Dept. of Biological Chemistry	Rackham Graduate School at the University of Michigan(University of Michigan System); Dept. of Biological Chemistry	This work was supported in part by a research grant from the Rackham Graduate School at the University of Michigan (to P. J. O.) and a graduate fellowship from the Dept. of Biological Chemistry (to M. R. T.).	Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; BARNES DE, 1990, P NATL ACAD SCI USA, V87, P6679, DOI 10.1073/pnas.87.17.6679; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Cherepanov AV, 2002, J BIOL CHEM, V277, P1695, DOI 10.1074/jbc.M109616200; CRONIN CN, 1987, BIOCHEM J, V247, P41, DOI 10.1042/bj2470041; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Gunther T, 2006, MAGNESIUM RES, V19, P225; KODAMA K, 1991, NUCLEIC ACIDS RES, V19, P6093, DOI 10.1093/nar/19.22.6093; LEHMAN IR, 1974, SCIENCE, V186, P790; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; OSULLIVAN WJ, 1964, BIOCHEMISTRY-US, V3, P18, DOI 10.1021/bi00889a005; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; PETRINI JHJ, 1995, MOL CELL BIOL, V15, P4303; PHILLIPS RC, 1966, J AM CHEM SOC, V88, P2631, DOI 10.1021/ja00964a002; Rass U, 2008, J BIOL CHEM, V283, P33994, DOI 10.1074/jbc.M807124200; Sannai P, 2011, J BIOL CHEM, V286, P13314, DOI 10.1074/jbc.M111.226191; Sekiguchi J, 2001, P NATL ACAD SCI USA, V98, P3243, DOI 10.1073/pnas.051632098; Shuman S, 2009, J BIOL CHEM, V284, P17365, DOI 10.1074/jbc.R900017200; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Song W, 2009, DNA REPAIR, V8, P912, DOI 10.1016/j.dnarep.2009.05.002; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P3536, DOI 10.1093/nar/26.15.3536; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; TERAOKA H, 1993, J BIOL CHEM, V268, P24156; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Waas WF, 2003, BIOCHEMISTRY-US, V42, P2960, DOI 10.1021/bi027171w; YANG SW, 1992, J BIOL CHEM, V267, P8117	29	24	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23054	23062		10.1074/jbc.M111.248831	http://dx.doi.org/10.1074/jbc.M111.248831			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561855	hybrid, Green Published			2022-12-25	WOS:000292025000040
J	Bossan, B; Koehncke, A; Hammerstein, P				Bossan, Benjamin; Koehncke, Arnulf; Hammerstein, Peter			A New Model and Method for Understanding Wolbachia-Induced Cytoplasmic Incompatibility	PLOS ONE			English	Article							MOSQUITO CULEX-PIPIENS; DROSOPHILA-SIMULANS; COMPATIBILITY TYPES; MULTIPLE INFECTIONS; EVOLUTION; CROSSES; MELANOGASTER; POPULATIONS; EXPRESSION; SPECIATION	Wolbachia are intracellular bacteria transmitted almost exclusively vertically through eggs. In response to this mode of transmission, Wolbachia strategically manipulate their insect hosts' reproduction. In the most common manipulation type, cytoplasmic incompatibility, infected males can only mate with infected females, but infected females can mate with all males. The mechanism of cytoplasmic incompatibility is unknown; theoretical and empirical findings need to converge to broaden our understanding of this phenomenon. For this purpose, two prominent models have been proposed: the mistiming-model and the lock-key-model. The former states that Wolbachia manipulate sperm of infected males to induce a fatal delay of the male pronucleus during the first embryonic division, but that the bacteria can compensate the delay by slowing down mitosis in fertilized eggs. The latter states that Wolbachia deposit damaging "locks'' on sperm DNA of infected males, but can also provide matching "keys'' in infected eggs to undo the damage. The lock-key-model, however, needs to assume a large number of locks and keys to explain all existing incompatibility patterns. The mistiming-model requires fewer assumptions but has been contradicted by empirical results. We therefore expand the mistiming-model by one quantitative dimension to create the new, so-called goalkeeper-model. Using a method based on formal logic, we show that both lock-key-and goalkeeper-model are consistent with existing data. Compared to the lock-key-model, however, the goalkeeper-model assumes only two factors and provides an idea of the evolutionary emergence of cytoplasmic incompatibility. Available cytological evidence suggests that the hypothesized second factor of the goalkeeper-model may indeed exist. Finally, we suggest empirical tests that would allow to distinguish between the models. Generalizing our results might prove interesting for the study of the mechanism and evolution of other host-parasite interactions.	[Bossan, Benjamin; Koehncke, Arnulf; Hammerstein, Peter] Humboldt Univ, Inst Theoret Biol, Berlin, Germany	Humboldt University of Berlin	Bossan, B (corresponding author), Humboldt Univ, Inst Theoret Biol, Berlin, Germany.	benjamin.bossan@hu-berlin.de		Kohncke, Arnulf/0000-0002-4104-0477				ATYAME C, MOL ECOL, V286; Bordenstein Seth R., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020043; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; Bourtzis K, 1998, NATURE, V391, P852, DOI 10.1038/36017; Callaini G, 1997, J CELL SCI, V110, P271; Charlat S, 2005, GENETICS, V170, P495, DOI 10.1534/genetics.103.015198; Charlat S, 2004, EVOLUTION, V58, P1901, DOI 10.1111/j.0014-3820.2004.tb00478.x; Charlat S, 2001, GENETICS, V159, P1415; Clark ME, 2003, MECH DEVELOP, V120, P185, DOI 10.1016/S0925-4773(02)00424-0; Duron O, 2006, P ROY SOC B-BIOL SCI, V273, P495, DOI 10.1098/rspb.2005.3336; Duron O, 2006, HEREDITY, V96, P493, DOI 10.1038/sj.hdy.6800831; Duron O, 2006, MOL ECOL, V15, P3061, DOI 10.1111/j.1365-294X.2006.02996.x; Ferree PM, 2006, GENETICS, V173, P839, DOI 10.1534/genetics.105.053272; Flor M, 2007, J EVOLUTION BIOL, V20, P696, DOI 10.1111/j.1420-9101.2006.01252.x; Jaenike J, 2006, PLOS BIOL, V4, P1852, DOI 10.1371/journal.pbio.0040325; Kent BN, 2010, TRENDS MICROBIOL, V18, P173, DOI 10.1016/j.tim.2009.12.011; Landmann F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000343; Lassy CW, 1996, MECH DEVELOP, V57, P47, DOI 10.1016/0925-4773(96)00527-8; MERCOT H, 1995, GENETICS, V141, P1015; MONTCHAMPMOREAU C, 1991, GENETICS, V129, P399; Mouton L, 2005, HEREDITY, V94, P187, DOI 10.1038/sj.hdy.6800596; Mouton L, 2003, MOL ECOL, V12, P3459, DOI 10.1046/j.1365-294X.2003.02015.x; Mouton L, 2004, GENETICS, V168, P181, DOI 10.1534/genetics.104.026716; Nor I, 2010, LECT NOTES COMPUT SC, V6129, P202, DOI 10.1007/978-3-642-13509-5_19; ONEILL SL, 1990, NATURE, V348, P178, DOI 10.1038/348178a0; PerrotMinnot MJ, 1996, GENETICS, V143, P961; Poinsot D, 2003, BIOESSAYS, V25, P259, DOI 10.1002/bies.10234; Poinsot D, 1998, GENETICS, V150, P227; Rousset F, 1999, HEREDITY, V82, P620, DOI 10.1046/j.1365-2540.1999.00501.x; Sasaki T, 2005, HEREDITY, V95, P389, DOI 10.1038/sj.hdy.6800737; Shoemaker DD, 1999, EVOLUTION, V53, P1157, DOI [10.2307/2640819, 10.1111/j.1558-5646.1999.tb04529.x]; SINKINS SP, 1995, P ROY SOC B-BIOL SCI, V261, P325, DOI 10.1098/rspb.1995.0154; Telschow A, 2005, EVOLUTION, V59, P1607, DOI 10.1111/j.0014-3820.2005.tb01812.x; Telschow A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000701; Tram U, 2002, SCIENCE, V296, P1124, DOI 10.1126/science.1070536; Watanabe M., 2010, HDB FUEL CELLS FUNDA, P1; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Zabalou S, 2004, GENETICS, V167, P827, DOI 10.1534/genetics.103.015990; Zabalou S, 2008, GENETICS, V178, P2145, DOI 10.1534/genetics.107.086488	40	26	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19757	10.1371/journal.pone.0019757	http://dx.doi.org/10.1371/journal.pone.0019757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572955	gold, Green Published, Green Submitted			2022-12-25	WOS:000290440200025
J	Husson, J; Chemin, K; Bohineust, A; Hivroz, C; Henry, N				Husson, Julien; Chemin, Karine; Bohineust, Armelle; Hivroz, Claire; Henry, Nelly			Force Generation upon T Cell Receptor Engagement	PLOS ONE			English	Article							DEPENDENT ACTIVATION; TCR; RIGIDITY; MOTILITY; ADHESION; DETERMINES; MECHANICS; DYNAMICS; VELOCITY; SYNAPSE	T cells are major players of adaptive immune response in mammals. Recognition of an antigenic peptide in association with the major histocompatibility complex at the surface of an antigen presenting cell (APC) is a specific and sensitive process whose mechanism is not fully understood. The potential contribution of mechanical forces in the T cell activation process is increasingly debated, although these forces are scarcely defined and hold only limited experimental evidence. In this work, we have implemented a biomembrane force probe (BFP) setup and a model APC to explore the nature and the characteristics of the mechanical forces potentially generated upon engagement of the T cell receptor (TCR) and/or lymphocyte function-associated antigen-1 (LFA-1). We show that upon contact with a model APC coated with antibodies towards TCR-CD3, after a short latency, the T cell developed a timed sequence of pushing and pulling forces against its target. These processes were defined by their initial constant growth velocity and loading rate (force increase per unit of time). LFA-1 engagement together with TCR-CD3 reduced the growing speed during the pushing phase without triggering the same mechanical behavior when engaged alone. Intracellular Ca2+ concentration ([Ca2+](i)) was monitored simultaneously to verify the cell commitment in the activation process. [Ca2+](i) increased a few tens of seconds after the beginning of the pushing phase although no strong correlation appeared between the two events. The pushing phase was driven by actin polymerization. Tuning the BFP mechanical properties, we could show that the loading rate during the pulling phase increased with the target stiffness. This indicated that a mechanosensing mechanism is implemented in the early steps of the activation process. We provide here the first quantified description of force generation sequence upon local bidimensional engagement of TCR-CD3 and discuss its potential role in a T cell mechanically-regulated activation process.	[Husson, Julien; Chemin, Karine; Bohineust, Armelle; Hivroz, Claire; Henry, Nelly] Inst Curie, Ctr Rech, Paris, France; [Husson, Julien; Henry, Nelly] CNRS, UMR168, Paris, France; [Chemin, Karine; Bohineust, Armelle; Hivroz, Claire] INSERM, U932, Paris, France; [Husson, Julien; Henry, Nelly] Univ Paris 06, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Husson, J (corresponding author), Inst Curie, Ctr Rech, Paris, France.	claire.hivroz@curie.fr; nelly.henry@curie.fr	Husson, Julien/B-8466-2018; Hivroz, Claire/H-2711-2014	Husson, Julien/0000-0002-8230-1469; Hivroz, Claire/0000-0002-6794-2890; Chemin, Karine/0000-0002-2597-7809; Bohineust, Armelle/0000-0002-9734-0049	Agence Nationale pour la Recherche PCV [07-188055]; Association pour la Recherche contre le Cancer; Agence Nationale pour la Recherche; Fondation pour la Recherche Medicale (FRM); La Ligue contre le Cancer	Agence Nationale pour la Recherche PCV(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); La Ligue contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from Agence Nationale pour la Recherche PCV (07-188055) and Association pour la Recherche contre le Cancer. JH was supported by a fellowship from Agence Nationale pour la Recherche. KC is a recipient of a grant from Fondation pour la Recherche Medicale (FRM) and AB is a recipient of a grant from La Ligue contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AHMED KA, 2010, J CELL MOL MED; Allioux-Guerin M, 2009, BIOPHYS J, V96, P238, DOI 10.1529/biophysj.108.134627; Atilgan E, 2006, BIOPHYS J, V90, P65, DOI 10.1529/biophysj.105.071480; Aucher A, 2008, BLOOD, V111, P5621, DOI 10.1182/blood-2008-01-134155; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Carpentier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004784; Choudhuri K, 2007, SEMIN IMMUNOL, V19, P255, DOI 10.1016/j.smim.2007.04.005; CRAMER LP, 1994, CURR OPIN CELL BIOL, V6, P82, DOI 10.1016/0955-0674(94)90120-1; Dustin ML, 2006, P NATL ACAD SCI USA, V103, P4335, DOI 10.1073/pnas.0600899103; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; EVANS E, 1995, BIOPHYS J, V68, P2580, DOI 10.1016/S0006-3495(95)80441-8; EVANS E, 1993, J CELL BIOL, V122, P1295, DOI 10.1083/jcb.122.6.1295; FAURE S, 2004, NAT IMMUNOL, V1, P1; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Heinrich V, 2001, BIOPHYS J, V81, P1452, DOI 10.1016/S0006-3495(01)75800-6; Heinrich V, 2007, BIOPHYS J, V93, P363, DOI 10.1529/biophysj.107.104091; Heinrich V, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2909529; Herant M, 2006, J CELL SCI, V119, P1903, DOI 10.1242/jcs.02876; Hosseini BH, 2009, P NATL ACAD SCI USA, V106, P17852, DOI 10.1073/pnas.0905384106; Janmey PA, 2009, CELL MOTIL CYTOSKEL, V66, P597, DOI 10.1002/cm.20382; Kandula S, 2004, J IMMUNOL, V173, P4443, DOI 10.4049/jimmunol.173.7.4443; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Ma ZY, 2008, FASEB J, V22, P1002, DOI 10.1096/fj.07-9331hyp; Marcy Y, 2004, P NATL ACAD SCI USA, V101, P5992, DOI 10.1073/pnas.0307704101; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Miro F, 2006, J IMMUNOL, V177, P3625, DOI 10.4049/jimmunol.177.6.3625; Mitrossilis D, 2010, P NATL ACAD SCI USA, V107, P16518, DOI 10.1073/pnas.1007940107; Mitrossilis D, 2009, P NATL ACAD SCI USA, V106, P18243, DOI 10.1073/pnas.0903994106; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Parekh SH, 2005, NAT CELL BIOL, V7, P1219, DOI 10.1038/ncb1336; Picard C, 2009, EUR J IMMUNOL, V39, P1966, DOI 10.1002/eji.200939385; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Schreiber CH, 2010, P NATL ACAD SCI USA, V107, P9141, DOI 10.1073/pnas.1002538107; Sedwick CE, 1999, J IMMUNOL, V162, P1367; Simson DA, 1998, BIOPHYS J, V74, P2080, DOI 10.1016/S0006-3495(98)77915-9; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Stuurman N., 2007, MICROSC TODAY, V15, P42, DOI DOI 10.1017/S1551929500055541; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Trautmann A, 2003, CURR OPIN IMMUNOL, V15, P249, DOI 10.1016/S0952-7915(03)00040-2; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8	52	130	131	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19680	10.1371/journal.pone.0019680	http://dx.doi.org/10.1371/journal.pone.0019680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572959	gold, Green Submitted, Green Published			2022-12-25	WOS:000290440200021
J	Khadra, A; Pietropaolo, M; Nepom, GT; Sherman, A				Khadra, Anmar; Pietropaolo, Massimo; Nepom, Gerald T.; Sherman, Arthur			Investigating the Role of T-Cell Avidity and Killing Efficacy in Relation to Type 1 Diabetes Prediction	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; COMPUTATIONAL APPROACH; AUTOIMMUNE RESPONSES; MINIMAL MODEL; INSULIN; AUTOANTIBODIES; PROGRESSION; RISK; CHILDREN; IDDM	During the progression of the clinical onset of Type 1 Diabetes (T1D), high-risk individuals exhibit multiple islet autoantibodies and high-avidity T cells which progressively destroy beta cells causing overt T1D. In particular, novel autoantibodies, such as those against IA-2 epitopes (aa1-577), had a predictive rate of 100% in a 10-year follow up (rapid progressors), unlike conventional autoantibodies that required 15 years of follow up for a 74% predictive rate (slow progressors). The discrepancy between these two groups is thought to be associated with T-cell avidity, including CD8(+) and/or CD4(+) T cells. For this purpose, we build a series of mathematical models incorporating first one clone then multiple clones of islet-specific and pathogenic CD8(+) and/or CD4(+) T cells, together with B lymphocytes, to investigate the interaction of T-cell avidity with autoantibodies in predicting disease onset. These models are instrumental in examining several experimental observations associated with T-cell avidity, including the phenomenon of avidity maturation (increased average T-cell avidity over time), based on intra-and cross-clonal competition between T cells in high-risk human subjects. The model shows that the level and persistence of autoantibodies depends not only on the avidity of T cells, but also on the killing efficacy of these cells. Quantification and modeling of autoreactive T-cell avidities can thus determine the level of risk associated with each type of autoantibodies and the timing of T1D disease onset in individuals that have been tested positive for these autoantibodies. Such studies may lead to early diagnosis of the disease in high-risk individuals and thus potentially serve as a means of staging patients for clinical trials of preventive or interventional therapies far before disease onset.	[Khadra, Anmar; Sherman, Arthur] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD USA; [Pietropaolo, Massimo] Univ Michigan, Immunogenet Lab, Ann Arbor, MI 48109 USA; [Nepom, Gerald T.] Benaroya Res Inst Virginia Mason, Seattle, WA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Michigan System; University of Michigan; Benaroya Research Institute; Virginia Mason Medical Center	Khadra, A (corresponding author), NIDDK, Lab Biol Modeling, NIH, Bethesda, MD USA.	khadraa@niddk.nih.gov		Nepom, Gerald/0000-0002-8063-1464; Sherman, Arthur/0000-0002-8372-5941	National Institutes of Health [R01 DK53456, DK56200, NIDDK PA-04-081]; NIDDK; Brehm Coalition; University of Michigan Center for Computational Medicine and Biology (CCMB); Pilot Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053456, ZIADK013027, R01DK056200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Brehm Coalition; University of Michigan Center for Computational Medicine and Biology (CCMB)(University of Michigan System); Pilot Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health: grants R01 DK53456, DK56200, NIDDK PA-04-081 (M. Pietropaolo); Intramural Research Program of the NIDDK (A. Khadra and A. Sherman). Brehm Coalition (M. Pietropaolo). University of Michigan Center for Computational Medicine and Biology (CCMB). Pilot Research Program (M. Pietropaolo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman RN, 2003, DIABETES, V52, P2168, DOI 10.2337/diabetes.52.8.2168; Bingley PJ, 1996, DIABETES, V45, P1720, DOI 10.2337/diabetes.45.12.1720; BINGLEY PJ, 1994, DIABETES, V43, P1304, DOI 10.2337/diabetes.43.11.1304; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cretti A, 2001, EUR J CLIN INVEST, V31, P405, DOI 10.1046/j.1365-2362.2001.00827.x; DEBOER RJ, 1994, J THEOR BIOL, V169, P375, DOI 10.1006/jtbi.1994.1160; Durinovic-Bello I, 2010, GENES IMMUN, V11, P188, DOI 10.1038/gene.2009.108; Estella E, 2006, DIABETES, V55, P2212, DOI 10.2337/db06-0129; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Head M, 1996, J LAB CLIN MED, V128, P61, DOI 10.1016/S0022-2143(96)90114-6; Homann D, 1999, IMMUNITY, V11, P463, DOI 10.1016/S1074-7613(00)80121-1; Homann D, 2006, J CLIN INVEST, V116, P1212, DOI 10.1172/JCI28506; Khadra A, 2010, J IMMUNOL, V185, P5962, DOI 10.4049/jimmunol.1001306; Khadra A, 2010, INT IMMUNOL, V22, P571, DOI 10.1093/intimm/dxq041; Khadra A, 2009, J THEOR BIOL, V256, P126, DOI 10.1016/j.jtbi.2008.09.019; Kim PS, 2007, J THEOR BIOL, V246, P33, DOI 10.1016/j.jtbi.2006.12.012; Knip M, 2003, REV ENDOCR METAB DIS, V4, P213, DOI 10.1023/A:1025121510678; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; Kurrer MO, 1997, P NATL ACAD SCI USA, V94, P213, DOI 10.1073/pnas.94.1.213; Libman IM, 2003, DIABETES CARE, V26, P2876, DOI 10.2337/diacare.26.10.2876; Libman IM, 2003, DIABETES CARE, V26, P2871, DOI 10.2337/diacare.26.10.2871; Luppi P, 2000, DIABETOLOGIA, V43, P1484, DOI 10.1007/s001250051559; Maclaren N, 1999, J AUTOIMMUN, V12, P279, DOI 10.1006/jaut.1999.0281; Mahaffy JM, 2007, SIAM J APPL MATH, V67, P915, DOI 10.1137/060661144; Mallone R, 2005, BLOOD, V106, P2798, DOI 10.1182/blood-2004-12-4848; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Miao DM, 2007, FRONT BIOSCI-LANDMRK, V12, P1889, DOI 10.2741/2195; Morran MP, 2008, MT SINAI J MED, V75, P314, DOI 10.1002/msj.20052; Morran MP, 2010, ENDOCRINOLOGY, V151, P2528, DOI 10.1210/en.2009-1257; Nelson P, 2009, MATH BIOSCI ENG, V6, P753, DOI 10.3934/mbe.2009.6.753; Nepom GT, 2008, CLIN IMMUNOL, V129, P1, DOI 10.1016/j.clim.2008.06.013; Nepom GT, 2001, P NATL ACAD SCI USA, V98, P1763, DOI 10.1073/pnas.98.4.1763; Parham P, 2009, IMMUNE SYSTEM, V3rd; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Pietropaolo M, 2005, PEDIATR DIABETES, V6, P184, DOI 10.1111/j.1399-543X.2005.00127.x; Pietropaolo M, 1998, J AUTOIMMUN, V11, P1, DOI 10.1006/jaut.1997.0170; Pietropaolo M, 2001, CURR DIRECT AUTOIMMU, V4, P252; Pietropaolo M, 2002, DIABETOLOGIA, V45, P66, DOI 10.1007/s125-002-8246-5; Pietropaolo M, 2008, DIABETES, V57, P2872, DOI 10.2337/db07-1691; Pietropaolo M, 2007, DIABETES, V56, P1189, DOI 10.2337/db06-0880; Piganelli JD, 2007, PEDIATR DIABETES, V8, P249, DOI 10.1111/j.1399-5448.2007.00314.x; Redondo MJ, 2002, DIABETOLOGIA, V45, P605, DOI 10.1007/s00125-002-0781-1; Reijonen H, 2004, DIABETES, V53, P1987, DOI 10.2337/diabetes.53.8.1987; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; Rossini AA, 2004, DIABETES, V53, P267, DOI 10.2337/diabetes.53.2.267; Seyfert-Margolis V, 2006, DIABETES, V55, P2588, DOI 10.2337/db05-1378; Shahaf G, 2008, J THEOR BIOL, V255, P210, DOI 10.1016/j.jtbi.2008.08.005; Shannon M, 1999, J IMMUNOL, V162, P3950; Shochat E, 2007, B MATH BIOL, V69, P2299, DOI 10.1007/s11538-007-9221-1; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Standifer NE, 2009, CLIN IMMUNOL, V132, P312, DOI 10.1016/j.clim.2009.04.013; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; Vendrame F, 2010, DIABETES, V59, P947, DOI 10.2337/db09-0498; Verge CF, 1996, DIABETES, V45, P926, DOI 10.2337/diabetes.45.7.926; VERNINO L, 1992, J IMMUNOL, V148, P404; Winer S, 2003, NAT MED, V9, P198, DOI 10.1038/nm818; Yamamoto AM, 1998, J AUTOIMMUN, V11, P643, DOI 10.1006/jaut.1998.0244; YOON JW, 1995, DIABETES METAB REV, V11, P83, DOI 10.1002/dmr.5610110202	60	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e14796	10.1371/journal.pone.0014796	http://dx.doi.org/10.1371/journal.pone.0014796			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573001	gold, Green Published, Green Submitted			2022-12-25	WOS:000290440200001
J	Alherbish, A; Charrois, TL; Ackman, ML; Tsuyuki, RT; Ezekowitz, JA				Alherbish, Aws; Charrois, Theresa L.; Ackman, Margaret L.; Tsuyuki, Ross T.; Ezekowitz, Justin A.			The Prevalence of Natural Health Product Use in Patients with Acute Cardiovascular Disease	PLOS ONE			English	Article							ALTERNATIVE MEDICINE; CONTROLLED-TRIAL; HERBAL PRODUCTS; HEART-FAILURE; UNITED-STATES; COMPLEMENTARY; ANTIOXIDANT; INDIVIDUALS; THERAPIES	Background: Natural health products (NHP) use may have implications with respect to adverse effects, drug interactions and adherence yet the prevalence of NHP use by patients with acute cardiovascular disease and the best method to ascertain this information is unknown. Objective: To identify the best method to ascertain information on NHP, and the prevalence of use in a population with acute cardiovascular disease. Methods: Structured interviews were conducted with a convenience sample of consecutive patients admitted with acute cardiovascular disease to the University of Alberta Hospital during January 2009. NHP use was explored using structured and open-ended questions based on Health Canada's definition of NHP. The medical record was reviewed, and documentation of NHP use by physicians, nurses, and pharmacists, compared against the gold-standard structured interview. Results: 88 patients were interviewed (mean age 62 years, standard deviation [SD 14]; 80% male; 41% admitted for acute coronary syndromes). Common co-morbidities included hypertension (59%), diabetes (26%) and renal impairment (19%). NHP use was common (78% of patients) and 75% of NHP users reported daily use. The category of NHP most commonly used was vitamins and minerals (73%) followed by herbal products (20%), traditional medicines including Chinese medicines (9%), homeopathic preparations (1%) and other products including amino acids, essential fatty acids and probiotics (35%). In a multivariable model, only older age was associated with increased NHP use (OR 1.5 per age decile [95%CI 1.03 to 2.2]). When compared to the interview, the highest rate of NHP documentation was the pharmacist history (41%). NHP were documented in 22% of patients by the physician and 19% by the nurse. Conclusions: NHP use is common in patients admitted with acute cardiovascular disease. However, health professionals do not commonly identify NHP as part of the medication profile despite its potential importance. Structured interview appears to be the best method to accurately identify patient use of NHP.	[Alherbish, Aws; Charrois, Theresa L.; Tsuyuki, Ross T.; Ezekowitz, Justin A.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Tsuyuki, Ross T.; Ezekowitz, Justin A.] Univ Alberta, Div Cardiol, Edmonton, AB, Canada; [Ackman, Margaret L.] Alberta Hlth Serv, Serv Pharm, Edmonton, AB, Canada	University of Alberta; University of Alberta; Alberta Health Services (AHS)	Alherbish, A (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	Justin.ezekowitz@ualberta.ca	Charrois, Theresa/AAA-4695-2021; Tsuyuki, Ross T/E-2462-2016; Ezekowitz, Justin A/C-4579-2013	Tsuyuki, Ross T/0000-0002-3724-598X; Ezekowitz, Justin A/0000-0002-2724-4086	Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	Salary support is provided to Dr. Ezekowitz by the Canadian Institutes of Health Research New Investigator program and the Alberta Heritage Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman ML, 1999, ANN PHARMACOTHER, V33, P674, DOI 10.1345/aph.18283; Amira Oluwatoyin C, 2007, BMC Complement Altern Med, V7, P30, DOI 10.1186/1472-6882-7-30; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; *CAN NDMA, 2009, HLTH VIS 1999 2000 2; Cherniack E Paul, 2008, Complement Ther Clin Pract, V14, P116, DOI 10.1016/j.ctcp.2007.11.002; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; DE GG, 2001, LANCET, V357, P89; Decker C, 2007, AM J CARDIOL, V99, P930, DOI 10.1016/j.amjcard.2006.11.041; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Greenfield S, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-47; *HLTH CAN, 2004, NAT HLTH PROD REG 20; Krasuski RA, 2006, CLIN CARDIOL, V29, P161, DOI 10.1002/clc.4960290407; McGinn T, 2004, CAN MED ASSOC J, V171, P1369, DOI 10.1503/cmaj.1031981; Najm W, 2003, ALTERN THER HEALTH M, V9, P50; Pharand C, 2003, ANN PHARMACOTHER, V37, P899, DOI 10.1345/aph.1C163; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Tachjian A, 2010, J AM COLL CARDIOL, V55, P515, DOI 10.1016/j.jacc.2009.07.074; Wood MJ, 2003, AM HEART J, V145, P806, DOI 10.1016/S0002-8703(03)00084-X; Yeh GY, 2006, AM J CARDIOL, V98, P673, DOI 10.1016/j.amjcard.2006.03.051; Yuan CS, 2004, ANN INTERN MED, V141, P23, DOI 10.7326/0003-4819-141-1-200407060-00011; Zick SM, 2005, J CARD FAIL, V11, P586, DOI 10.1016/j.cardfail.2005.06.427; 1996, BMJ, V313, P131	23	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19623	10.1371/journal.pone.0019623	http://dx.doi.org/10.1371/journal.pone.0019623			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573067	Green Published, gold			2022-12-25	WOS:000290386800027
J	Chatelais, L; Jamin, A; Gras-Le Guen, C; Lalles, JP; Le Huerou-Luron, I; Boudry, G				Chatelais, Livie; Jamin, Agnes; Gras-Le Guen, Christele; Lalles, Jean-Paul; Le Huerou-Luron, Isabelle; Boudry, Gaelle			The Level of Protein in Milk Formula Modifies Ileal Sensitivity to LPS Later in Life in a Piglet Model	PLOS ONE			English	Article							INTESTINAL BARRIER FUNCTION; FACTOR-KAPPA-B; BACTERIAL TRANSLOCATION; PRETERM INFANTS; GLUTAMINE; RATS; INFLAMMATION; REQUIREMENTS; IMMUNITY; WEIGHT	Background: Milk formulas have higher protein contents than human milk. This high protein level could modify the development of intestinal microbiota, epithelial barrier and immune functions and have long-term consequences. Methodology/Principal findings: We investigated the effect of a high protein formula on ileal microbiota and physiology during the neonatal period and later in life. Piglets were fed from 2 to 28 days of age either a normoprotein (NP, equivalent to sow milk) or a high protein formula (HP, +40% protein). Then, they received the same solid diet until 160 days. During the formula feeding period ileal microbiota implantation was accelerated in HP piglets with greater concentrations of ileal bacteria at d7 in HP than NP piglets. Epithelial barrier function was altered with a higher permeability to small and large probes in Ussing chambers in HP compared to NP piglets without difference in bacterial translocation. Infiltration of T cells was increased in HP piglets at d28. IL-1b and NF-kappa B sub-units mRNA levels were reduced in HP piglets at d7 and d28 respectively; plasma haptoglobin also tended to be reduced at d7. Later in life, pro-inflammatory cytokines secretion in response to high doses of LPS in explants culture was reduced in HP compared to NP piglets. Levels of mRNA coding the NF-kappa B pathway sub-units were increased by the challenge with LPS in NP piglets, but not HP ones. Conclusions/Significance: A high protein level in formula affects the postnatal development of ileal microbiota, epithelial barrier and immune function in piglets and alters ileal response to inflammatory mediators later in life.	[Chatelais, Livie; Jamin, Agnes; Lalles, Jean-Paul; Le Huerou-Luron, Isabelle; Boudry, Gaelle] SENAH, INRA, UMR 1079, St Gilles, France; [Jamin, Agnes; Lalles, Jean-Paul; Le Huerou-Luron, Isabelle; Boudry, Gaelle] Agrocampus Ouest, Rennes, France; [Chatelais, Livie] CHU Rennes, Rennes, France; [Gras-Le Guen, Christele] CHU Nantes, Serv Reanimat Pediat, Hop Mere Enfan, F-44035 Nantes 01, France	INRAE; Institut Agro; Agrocampus Ouest; CHU Rennes; Nantes Universite; CHU de Nantes	Chatelais, L (corresponding author), SENAH, INRA, UMR 1079, St Gilles, France.	Gaelle.Boudry@rennes.inra.fr	Boudry, Gaelle/ABG-8836-2020	Boudry, Gaelle/0000-0002-5287-571X; Lalles, Jean-Paul/0000-0003-2732-5350; Luron, Isabelle/0000-0002-1769-5246; Jamin, Agnes/0000-0002-6210-4046; GRAS-LE GUEN, Christele/0000-0001-9060-2344	Agence Nationale de la Recherche [ANR-05-PNRA-09]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche (Grant ANR-05-PNRA-09 ProtNeonat). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amesz EM, 2010, J PEDIATR GASTR NUTR, V50, P200, DOI 10.1097/MPG.0b013e3181a8150d; Andriamihaja M, 2010, AM J PHYSIOL-GASTR L, V299, pG1030, DOI 10.1152/ajpgi.00149.2010; Bailey M, 2006, VET RES, V37, P443, DOI 10.1051/vetres:2006013; Bailey M, 2005, VET IMMUNOL IMMUNOP, V108, P189, DOI 10.1016/j.vetimm.2005.07.010; Barreau F, 2004, GUT, V53, P501, DOI 10.1136/gut.2003.024174; Boudry G, 2011, PEDIATR RES, V69, P4, DOI 10.1203/PDR.0b013e3181fc9d13; Calder PC, 2006, BRIT J NUTR, V96, P774, DOI [10.1079/BJN20061917, 10.1079/BJN20061881]; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Coeffier M, 2003, CLIN NUTR, V22, P407, DOI 10.1016/S0261-5614(03)00040-2; D'Inca R, 2010, J NUTR, V140, P925, DOI 10.3945/jn.109.116822; De Plaen IG, 2007, PEDIATR RES, V61, P716, DOI 10.1203/pdr.0b013e3180534219; des Robert C, 2009, EARLY HUM DEV, V85, P41, DOI 10.1016/j.earlhumdev.2008.06.009; Dourmad JY, 1998, J ANIM SCI, V76, P542; Dupont C, 2003, AM J CLIN NUTR, V77, p1544S, DOI 10.1093/ajcn/77.6.1544S; Embleton ND, 2005, PEDIATR RES, V58, P855, DOI 10.1203/01.PDR.0000182586.46532.7C; Faure M, 2006, J NUTR, V136, P1558, DOI 10.1093/jn/136.6.1558; FERNANDEZ F, 1985, MICROBIOL ALIMENTS N, V3, P47; Gareau MG, 2007, GUT, V56, P1522, DOI 10.1136/gut.2006.117176; Gebbers JO, 2004, ANN NY ACAD SCI, V1029, P337, DOI 10.1196/annals.1309.015; Gronlund MM, 2000, ARCH DIS CHILD-FETAL, V83, pF186, DOI 10.1136/fn.83.3.F186; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Haynes TE, 2009, AMINO ACIDS, V37, P131, DOI 10.1007/s00726-009-0243-x; Jost R, 1999, INT J FOOD SCI TECH, V34, P533, DOI 10.1046/j.1365-2621.1999.00324.x; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Koletzko B, 2009, ADV EXP MED BIOL, V646, P15, DOI 10.1007/978-1-4020-9173-5_2; Koletzko B, 2009, AM J CLIN NUTR, V89, P1836, DOI 10.3945/ajcn.2008.27091; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Laflamme N, 2001, FASEB J, V15, P155, DOI 10.1096/fj.00-0339com; Le Bacquer O, 2003, AM J PHYSIOL-GASTR L, V285, pG128, DOI 10.1152/ajpgi.00459.2002; Liboni KC, 2005, J NUTR, V135, P245, DOI 10.1093/jn/135.2.245; Mace K, 2006, NESTLE NUTR WORKS SE, V58, P189, DOI 10.1159/000095063; Menezes JD, 2003, INT IMMUNOL, V15, P447, DOI 10.1093/intimm/dxg043; Mitra AK, 2010, AM J PHYSIOL-CELL PH, V299, pC561, DOI 10.1152/ajpcell.00127.2010; Moro G, 2006, ARCH DIS CHILD, V91, P814, DOI 10.1136/adc.2006.098251; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; PREMJI SS, 2006, COCHRANE DB SYST REV, V1; Sarr O, 2011, AM J PHYSIOL-REG I, V300, pR387, DOI 10.1152/ajpregu.00459.2010; Shirkey TW, 2006, EXP BIOL MED, V231, P1333, DOI 10.1177/153537020623100807; Spehlmann ME, 2009, CURR OPIN GASTROEN, V25, P92, DOI 10.1097/MOG.0b013e328324f857; Spencer SJ, 2007, AM J PHYSIOL-REG I, V292, pR308, DOI 10.1152/ajpregu.00398.2006; Thureen P, 2005, PEDIATR RES, V57, p95R, DOI 10.1203/01.PDR.0000160434.69916.34; VEGALOPEZ MA, 1993, VET IMMUNOL IMMUNOP, V37, P49, DOI 10.1016/0165-2427(93)90015-V; Yajima M, 2001, J PEDIATR GASTR NUTR, V33, P592, DOI 10.1097/00005176-200111000-00015; Zareie M, 2006, GUT, V55, P1553, DOI 10.1136/gut.2005.080739	48	46	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19594	10.1371/journal.pone.0019594	http://dx.doi.org/10.1371/journal.pone.0019594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573022	gold, Green Published, Green Submitted			2022-12-25	WOS:000290386800022
J	An, FM; Hsiao, SR; Chan, MT				An, Feng-Ming; Hsiao, Shuan-Rung; Chan, Ming-Tsair			Sequencing-Based Approaches Reveal Low Ambient Temperature-Responsive and Tissue-Specific MicroRNAs in Phalaenopsis Orchid	PLOS ONE			English	Article							SIRNA BIOGENESIS; FLOWERING-TIME; MESSENGER-RNA; ARABIDOPSIS; EXPRESSION; IDENTIFICATION; ACCUMULATION; TARGETS; MIRNAS; GENOME	Plant small RNAs (smRNAs) are short, non-coding RNA molecules that mediate RNA silencing and regulate a group of genes involved in plant development and responses to environmental stimuli. Low temperature is necessary to initiate stalk development in the orchid Phalaenopsis aphrodite subsp. formosana. To identify smRNAs in Phalaenopsis responding to low temperatures, a smRNA profiling analysis using high-throughput sequencing technology was performed. Subsequent bioinformatic analysis was applied to categorize the miRNAs identified. A total of 37,533,509 smRNA reads yielded 11,129 independent orchid miRNA sequences, representing 329 known miRNA families identified in other plant species. Because the genomic resources available for Phalaenopsis are limited, a transcriptomic database was established using deep sequencing data sets to identify miRNAs precursors and their target transcripts. Comparing small RNAs and the transcriptomic database, 14 putative miRNA precursors of 10 miRNA families were identified, as were hundreds of putative targets. Comparing sequencing data and smRNA northern hybridization results identified miR156, miR162, miR528 and miR535 as low temperature-induced miRNAs. In addition, tissue-specific expression of these miRNAs was investigated. It was concluded that miR156 and miR172 may be components of a regulatory pathway mediating transition from the vegetative to the reproductive phase in Phalaenopsis. The smRNA and transcriptomic databases could be the foundations for further research aimed at elucidating the control of the flowering time in orchids.	[An, Feng-Ming; Chan, Ming-Tsair] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Biotechnol, Tainan 70101, Taiwan; [An, Feng-Ming; Hsiao, Shuan-Rung; Chan, Ming-Tsair] Acad Sinica, Biotechnol Ctr So Taiwan, Tainan, Taiwan; [Hsiao, Shuan-Rung; Chan, Ming-Tsair] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Trop Plant Sci, Tainan 70101, Taiwan; [Chan, Ming-Tsair] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan	National Cheng Kung University; Academia Sinica - Taiwan; National Cheng Kung University; Academia Sinica - Taiwan	An, FM (corresponding author), Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Biotechnol, Tainan 70101, Taiwan.	mbmtchan@gate.sinica.edu.tw	Chan, Ming-Tsair/L-2465-2015	Chan, Ming-Tsair/0000-0002-1942-9160	Academia Sinica; National Science Council, Republic of China [98-2324-B-001-003-CC1]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This research was supported by Academia Sinica and grant 98-2324-B-001-003-CC1 from the National Science Council, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; BARLOW JJ, 1963, BIOCHEM BIOPH RES CO, V13, P61, DOI 10.1016/0006-291X(63)90163-3; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Blanchard MG, 2006, J EXP BOT, V57, P4043, DOI 10.1093/jxb/erl176; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen WH, 2008, PLANT CELL REP, V27, P1667, DOI 10.1007/s00299-008-0591-0; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cheng YL, 2003, DEV CELL, V4, P53, DOI 10.1016/S1534-5807(02)00399-4; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; DAI X, 2010, BRIEF BIOINFORM; Deal RB, 2007, PLANT CELL, V19, P74, DOI 10.1105/tpc.106.048447; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Glazinska P, 2009, J PLANT PHYSIOL, V166, P1801, DOI 10.1016/j.jplph.2009.05.011; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hsu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-3; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jamalkandi SA, 2009, FUNCT INTEGR GENOMIC, V9, P419, DOI 10.1007/s10142-009-0141-z; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee H, 2010, NUCLEIC ACIDS RES, V38, P3081, DOI 10.1093/nar/gkp1240; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Liu B, 2005, PLANT PHYSIOL, V139, P296, DOI 10.1104/pp.105.063420; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Padmanabhan C, 2009, CURR OPIN PLANT BIOL, V12, P465, DOI 10.1016/j.pbi.2009.06.005; Risseeuw EP, 2003, PLANT J, V34, P753, DOI 10.1046/j.1365-313X.2003.01768.x; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sun W, 2010, ANNU REV BIOMED ENG, V12, P1, DOI 10.1146/annurev-bioeng-070909-105314; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie FL, 2010, PLANTA, V232, P417, DOI 10.1007/s00425-010-1182-1; Yang HP, 2009, PLANT BIOTECHNOL J, V7, P621, DOI 10.1111/j.1467-7652.2009.00429.x; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005	43	58	64	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e18937	10.1371/journal.pone.0018937	http://dx.doi.org/10.1371/journal.pone.0018937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573107	Green Published, Green Submitted, gold			2022-12-25	WOS:000290305600009
J	Banerjee, R; Vats, P; Dahale, S; Kasibhatla, SM; Joshi, R				Banerjee, Ruma; Vats, Pankaj; Dahale, Sonal; Kasibhatla, Sunitha Manjari; Joshi, Rajendra			Comparative Genomics of Cell Envelope Components in Mycobacteria	PLOS ONE			English	Article							MYCOLIC ACIDS; PHTHIOCEROL DIMYCOCEROSATE; METABOLIC PATHWAYS; CRYSTAL-STRUCTURE; GENE DECAY; TUBERCULOSIS; LIPOARABINOMANNAN; IDENTIFICATION; SEQUENCE; WALL	Mycobacterial cell envelope components have been a major focus of research due to their unique features that confer intrinsic resistance to antibiotics and chemicals apart from serving as a low-permeability barrier. The complex lipids secreted by Mycobacteria are known to evoke/repress host-immune response and thus contribute to its pathogenicity. This study focuses on the comparative genomics of the biosynthetic machinery of cell wall components across 21-mycobacterial genomes available in GenBank release 179.0. An insight into survival in varied environments could be attributed to its variation in the biosynthetic machinery. Gene-specific motifs like 'DLLAQPTPAW' of ufaA1 gene, novel functional linkages such as involvement of Rv0227c in mycolate biosynthesis; Rv2613c in LAM biosynthesis and Rv1209 in arabinogalactan peptidoglycan biosynthesis were detected in this study. These predictions correlate well with the available mutant and coexpression data from TBDB. It also helped to arrive at a minimal functional gene set for these biosynthetic pathways that complements findings using TraSH.	[Banerjee, Ruma; Vats, Pankaj; Dahale, Sonal; Kasibhatla, Sunitha Manjari; Joshi, Rajendra] Ctr Dev Adv Comp, Bioinformat Grp, Pune, Maharashtra, India	Centre for Development of Advanced Computing (C-DAC)	Banerjee, R (corresponding author), Ctr Dev Adv Comp, Bioinformat Grp, Pune Univ Campus, Pune, Maharashtra, India.	rajendra@cdac.in	Vats, Pankaj/AAL-1443-2020	Banerjee, Ruma/0000-0001-7890-8666; Vats, Pankaj/0000-0001-8441-7732	Bioinformatics Division, Depatment of Information Technology, Government of India	Bioinformatics Division, Depatment of Information Technology, Government of India(Ministry of Electronics and Information Technology (MEITY), Government of India)	Bioinformatics Division, Depatment of Information Technology, Government of India. url: http://www.mit.gov.in/content/bio-informatics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000817; Alahari A, 2009, MOL MICROBIOL, V71, P1263, DOI 10.1111/j.1365-2958.2009.06604.x; Arakaki AK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-107; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Azad AK, 1997, J BIOL CHEM, V272, P16741, DOI 10.1074/jbc.272.27.16741; Azad AK, 1996, P NATL ACAD SCI USA, V93, P4787, DOI 10.1073/pnas.93.10.4787; Barkan D, 2010, J BACTERIOL, V192, P3661, DOI 10.1128/JB.00312-10; Barkan D, 2009, CHEM BIOL, V16, P499, DOI 10.1016/j.chembiol.2009.04.001; Behr MA, 2000, J BACTERIOL, V182, P3394, DOI 10.1128/JB.182.12.3394-3399.2000; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Beste DJV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005349; Bhowruth V, 2008, BIOCHEM SOC T, V36, P555, DOI 10.1042/BST0360555; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Buglino J, 2004, J BIOL CHEM, V279, P30634, DOI 10.1074/jbc.M404011200; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; DAFFE M, 1991, RES MICROBIOL, V142, P397, DOI 10.1016/0923-2508(91)90109-N; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; DATE SV, 2008, METHOD MOL BIOL, P201; Daub CO, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-118; Delmas C, 1997, GLYCOBIOLOGY, V7, P811, DOI 10.1093/glycob/7.6.811; Dinadayala P, 2006, J BIOL CHEM, V281, P20027, DOI 10.1074/jbc.M603395200; Dos Vultos T, 2006, J BACTERIOL, V188, P3159, DOI 10.1128/JB.188.8.3159-3161.2006; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Flores AR, 2005, J BACTERIOL, V187, P1892, DOI 10.1128/JB.187.6.1892-1900.2005; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gebhardt H, 2007, MICROBIOL-SGM, V153, P1424, DOI 10.1099/mic.0.2006/003541-0; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2003, J BIOL CHEM, V278, P7844, DOI 10.1074/jbc.M212458200; Glickman MS, 2001, J BIOL CHEM, V276, P2228, DOI 10.1074/jbc.C000652200; Goldstone RM, 2008, PROTEIN EXPRES PURIF, V57, P81, DOI 10.1016/j.pep.2007.08.015; Guenin-Mace L, 2009, TRANSBOUND EMERG DIS, V56, P255, DOI 10.1111/j.1865-1682.2009.01072.x; Guerardel Y, 2003, J BIOL CHEM, V278, P36637, DOI 10.1074/jbc.M305427200; Guerardel Y, 2002, J BIOL CHEM, V277, P30635, DOI 10.1074/jbc.M204398200; Hasan S, 2006, PLOS COMPUT BIOL, V2, P539, DOI 10.1371/journal.pcbi.0020061; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Huet G, 2006, J BACTERIOL, V188, P3412, DOI 10.1128/JB.188.9.3412-3414.2006; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Jackson M, 2009, J BIOL CHEM, V284, P1949, DOI 10.1074/jbc.R800047200; Joe M, 2006, J AM CHEM SOC, V128, P5059, DOI 10.1021/ja057373q; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kaur D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005447; Kaur D, 2008, P NATL ACAD SCI USA, V105, P17973, DOI 10.1073/pnas.0807761105; Kinnings SL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000976; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Liu J, 1996, J BIOL CHEM, V271, P29545, DOI 10.1074/jbc.271.47.29545; Malen H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-18; Marri PR, 2006, FEMS MICROBIOL REV, V30, P906, DOI 10.1111/j.1574-6976.2006.00041.x; Meena LS, 2010, FEBS J, V277, P2416, DOI 10.1111/j.1742-4658.2010.07666.x; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; NIKAIDO H, 1993, MOL MICROBIOL, V8, P1025, DOI 10.1111/j.1365-2958.1993.tb01647.x; Onwueme KC, 2005, PROG LIPID RES, V44, P259, DOI 10.1016/j.plipres.2005.07.001; Parker SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004281; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Raman K, 2005, PLOS COMPUT BIOL, V1, P349, DOI 10.1371/journal.pcbi.0010046; Raman K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-109; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scherman H, 2009, J BACTERIOL, V191, P6769, DOI 10.1128/JB.00431-09; Seki M, 2009, VACCINE, V27, P1710, DOI 10.1016/j.vaccine.2009.01.034; Simeone R, 2007, J BACTERIOL, V189, P4597, DOI 10.1128/JB.00169-07; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Treumann A, 2002, J MOL BIOL, V316, P89, DOI 10.1006/jmbi.2001.5317; Trivedi OA, 2005, MOL CELL, V17, P631, DOI 10.1016/j.molcel.2005.02.009; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Turnbull WB, 2004, ANGEW CHEM INT EDIT, V43, P3918, DOI 10.1002/anie.200454119; *UNIPROT CONS, 2010, NUCL ACIDS RES, V0038; Vignal C, 2003, J IMMUNOL, V171, P2014, DOI 10.4049/jimmunol.171.4.2014; Vissa V. D., 2001, Genome Biology, V2, P1023, DOI 10.1186/gb-2001-2-8-reviews1023; Vissa V, 2009, INDIAN J MICROBIOL, V49, P11, DOI 10.1007/s12088-009-0006-0; Woodruff PJ, 2004, J BIOL CHEM, V279, P28835, DOI 10.1074/jbc.M313103200; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x; YUAN Y, 1995, P NATL ACAD SCI USA, V92, P6630, DOI 10.1073/pnas.92.14.6630; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375; Zuo YH, 2005, STRUCTURE, V13, P973, DOI 10.1016/j.str.2005.04.015	93	13	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19280	10.1371/journal.pone.0019280	http://dx.doi.org/10.1371/journal.pone.0019280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573108	gold, Green Published, Green Submitted			2022-12-25	WOS:000290305600019
J	Kou, I; Takahashi, A; Urano, T; Fukui, N; Ito, H; Ozaki, K; Tanaka, T; Hosoi, T; Shiraki, M; Inoue, S; Nakamura, Y; Kamatani, N; Kubo, M; Mori, S; Ikegawa, S				Kou, Ikuyo; Takahashi, Atsushi; Urano, Tomohiko; Fukui, Naoshi; Ito, Hideki; Ozaki, Kouichi; Tanaka, Toshihiro; Hosoi, Takayuki; Shiraki, Masataka; Inoue, Satoshi; Nakamura, Yusuke; Kamatani, Naoyuki; Kubo, Michiaki; Mori, Seijiro; Ikegawa, Shiro			Common Variants in a Novel Gene, FONG on Chromosome 2q33.1 Confer Risk of Osteoporosis in Japanese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BONE-MINERAL DENSITY; SUSCEPTIBILITY LOCI; IDENTIFICATION; SNP; SITE	Osteoporosis is a common disease characterized by low bone mass, decreased bone quality and increased predisposition to fracture. Genetic factors have been implicated in its etiology; however, the specific genes related to susceptibility to osteoporosis are not entirely known. To detect susceptibility genes for osteoporosis, we conducted a genome-wide association study in Japanese using similar to 270,000 SNPs in 1,747 subjects (190 cases and 1,557 controls) followed by multiple levels of replication of the association using a total of similar to 5,000 subjects (2,092 cases and 3,114 controls). Through these staged association studies followed by resequencing and linkage disequilibrium mapping, we identified a single nucleotide polymorphism (SNP), rs7605378 associated with osteoporosis. (combined P = 1.51 x 10(-8), odds ratio = 1.25). This SNP is in a previously unknown gene on chromosome 2q33.1, FONG. FONG is predicted to encode a 147 amino-acid protein with a formiminotransferase domain in its N-terminal (FTCD_N domain) and is ubiquitously expressed in various tissues including bone. Our findings would give a new insight into osteoporosis etiology and pathogenesis.	[Kou, Ikuyo; Ikegawa, Shiro] RIKEN, Lab Bone & Joint Dis, Ctr Genom Med, Tokyo, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Lab Stat Anal, Ctr Genom Med, Tokyo, Japan; [Urano, Tomohiko; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan; [Urano, Tomohiko; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Tokyo, Japan; [Urano, Tomohiko; Inoue, Satoshi] Saitama Med Univ, Div Gene Regulat & Signal Transduct, Res Ctr Genom Med, Hidaka, Japan; [Fukui, Naoshi] Sagamihara Natl Hosp, Natl Hosp Org, Dept Pathomechanisms, Clin Res Ctr Rheumatol & Allergy, Sagamihara, Kanagawa, Japan; [Ito, Hideki; Mori, Seijiro] Tokyo Metropolitan Geriatr Hosp, Dept Internal Med, Tokyo 173, Japan; [Ozaki, Kouichi; Tanaka, Toshihiro] RIKEN, Lab Cardiovasc Dis, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Hosoi, Takayuki] Natl Ctr Geriatr & Gerontol, Dept Adv Med, Obu, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; [Shiraki, Masataka] Res Inst & Practice Involut Dis, Azumino, Japan; [Nakamura, Yusuke] RIKEN, Ctr Genom Med, Lab Int Alliance, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] RIKEN, Lab Genotyping, Ctr Genom Med, Yokohama, Kanagawa, Japan	RIKEN; RIKEN; University of Tokyo; University of Tokyo; Saitama Medical University; Tokyo Metropolitan Institute of Gerontology; RIKEN; National Center for Geriatrics & Gerontology; University of Tokyo; RIKEN; RIKEN	Kou, I (corresponding author), RIKEN, Lab Bone & Joint Dis, Ctr Genom Med, Tokyo, Japan.	sikegawa@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015; Ikegawa, Shiro/N-6895-2015; Urano, Tomohiko/AFS-9574-2022; Tanaka, Toshihiro/J-9310-2014	Ikegawa, Shiro/0000-0003-0316-2147; Tanaka, Toshihiro/0000-0001-6201-9784; Ozaki, Kouichi/0000-0003-0028-1570	Japanese Government Ministry of Education, Culture, Sport, Science and Technology	Japanese Government Ministry of Education, Culture, Sport, Science and Technology	This work was conducted as a part of the BioBank Japan Project that was supported by the Japanese Government Ministry of Education, Culture, Sport, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Akhtar N, 2010, ARTHRITIS RHEUM-US, V62, P1361, DOI 10.1002/art.27329; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Guo Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000806; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Hata J, 2007, HUM MOL GENET, V16, P630, DOI 10.1093/hmg/ddm005; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Kubo M, 2007, NAT GENET, V39, P212, DOI 10.1038/ng1945; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Liu YZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003160; Liu YJ, 2006, J BONE MINER RES, V21, P1511, DOI 10.1359/JBMR.051002; Liu YZ, 2003, J ENDOCRINOL, V177, P147, DOI 10.1677/joe.0.1770147; Mann V, 2001, J CLIN INVEST, V107, P899, DOI 10.1172/JCI10347; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Miyamoto Y, 2008, NAT GENET, V40, P994, DOI 10.1038/ng.176; Morimoto R, 2006, EMBO J, V25, P4175, DOI 10.1038/sj.emboj.7601317; MURLEY LL, 1995, BIOCHEMISTRY-US, V34, P10358, DOI 10.1021/bi00033a006; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Nakashima M, 2010, NAT GENET, V42, P768, DOI 10.1038/ng.645; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ralston SH, 2006, GENE DEV, V20, P2492, DOI 10.1101/gad.1449506; Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025	37	20	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19641	10.1371/journal.pone.0019641	http://dx.doi.org/10.1371/journal.pone.0019641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573128	Green Published, gold, Green Submitted			2022-12-25	WOS:000290305600037
J	Comhair, SAA; Gaston, BM; Ricci, KS; Hammel, J; Dweik, RA; Teague, WG; Meyers, D; Ampleford, EJ; Bleecker, ER; Busse, WW; Calhoun, WJ; Castro, M; Chung, KF; Curran-Everett, D; Israel, E; Jarjour, WN; Moore, W; Peters, SP; Wenzel, S; Hazen, SL; Erzurum, SC				Comhair, Suzy A. A.; Gaston, Benjamin M.; Ricci, Kristin S.; Hammel, Jeffrey; Dweik, Raed A.; Teague, W. Gerald; Meyers, Deborah; Ampleford, Elizabeth J.; Bleecker, Eugene R.; Busse, William W.; Calhoun, William J.; Castro, Mario; Chung, Kian Fan; Curran-Everett, Douglas; Israel, Elliot; Jarjour, W. Nizar; Moore, Wendy; Peters, Stephen P.; Wenzel, Sally; Hazen, Stanley L.; Erzurum, Serpil C.		Natl Heart Lung Blood Inst Severe	Detrimental Effects of Environmental Tobacco Smoke in Relation to Asthma Severity	PLOS ONE			English	Article							PASSIVE CIGARETTE-SMOKE; ADULT-ONSET ASTHMA; SUPEROXIDE-DISMUTASE; RESPIRATORY SYMPTOMS; LUNG-FUNCTION; OXIDATIVE STRESS; ANTIOXIDANT CAPACITY; PULMONARY-FUNCTION; HEALTH OUTCOMES; AIRWAY DISEASE	Background: Environmental tobacco smoke (ETS) has adverse effects on the health of asthmatics, however the harmful consequences of ETS in relation to asthma severity are unknown. Methods: In a multicenter study of severe asthma, we assessed the impact of ETS exposure on morbidity, health care utilization and lung functions; and activity of systemic superoxide dismutase (SOD), a potential oxidative target of ETS that is negatively associated with asthma severity. Findings: From 2002-2006, 654 asthmatics (non-severe 366, severe 288) were enrolled, among whom 109 non-severe and 67 severe asthmatics were routinely exposed to ETS as ascertained by history and validated by urine cotinine levels. ETS-exposure was associated with lower quality of life scores; greater rescue inhaler use; lower lung function; greater bronchodilator responsiveness; and greater risk for emergency room visits, hospitalization and intensive care unit admission. ETS-exposure was associated with lower levels of serum SOD activity, particularly in asthmatic women of African heritage. Interpretation: ETS-exposure of asthmatic individuals is associated with worse lung function, higher acuity of exacerbations, more health care utilization, and greater bronchial hyperreactivity. The association of diminished systemic SOD activity to ETS exposure provides for the first time a specific oxidant mechanism by which ETS may adversely affect patients with asthma.	[Gaston, Benjamin M.; Teague, W. Gerald] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Dweik, Raed A.; Erzurum, Serpil C.] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA; [Meyers, Deborah; Ampleford, Elizabeth J.; Bleecker, Eugene R.; Moore, Wendy; Peters, Stephen P.] Wake Forest Univ, Winston Salem, NC 27109 USA; [Busse, William W.; Jarjour, W. Nizar] Univ Wisconsin, Dept Internal Med, Madison, WI USA; [Calhoun, William J.] Univ Texas Med Branch Galveston, Dept Internal Med, Galveston, TX USA; [Comhair, Suzy A. A.; Ricci, Kristin S.; Hammel, Jeffrey; Dweik, Raed A.; Erzurum, Serpil C.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44106 USA; [Castro, Mario] Washington Univ, St Louis, MO USA; [Chung, Kian Fan] Imperial Coll Sch Med, Natl Heart & Lung Inst, London, England; [Curran-Everett, Douglas] Natl Jewish Ctr, Div Biostat, Denver, CO USA; [Israel, Elliot] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Wenzel, Sally] Univ Pittsburgh, Asthma Inst, Pittsburgh, PA USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44106 USA; [Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44106 USA	University of Virginia; Cleveland Clinic Foundation; Wake Forest University; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Medical Branch Galveston; Cleveland Clinic Foundation; Washington University (WUSTL); Imperial College London; National Jewish Health; Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Comhair, SAA (corresponding author), Cleveland Clin, Dept Pathobiol, Cleveland, OH 44106 USA.	comhais@ccf.org; erzurus@ccf.org	Fain, Sean B./K-4260-2016; Chung, Kian Fan/I-8456-2019; Hazen, Stanley L/ABD-5845-2021; Chung, Kian Fan/B-1872-2012	Fain, Sean B./0000-0001-5461-0646; Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426; Calhoun, William/0000-0001-7075-712X; Curran-Everett, Douglas/0000-0001-5992-4839	NIH [HL081064, HL69170, HL69155, HL069174, HL069167, HL69116, HL69174, HL091762, 1UL1RR024989, 1UL1RR025011, RR03186, RR024992]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005, UL1TR000454, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011, UL1RR024992, UL1RR024989, M01RR003186] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069167, R01HL069170, P01HL081064, R01HL091762, R01HL069174, R01HL069155, R01HL069116, P01HL103453] Funding Source: NIH RePORTER; Medical Research Council [G0801056B] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by HL081064, HL69170, HL69155, HL069174, HL069167, HL69116, HL69170, HL69174, HL69116, HL091762 and research resources provided by 1UL1RR024989, 1UL1RR025011 and RR03186, RR024992. All the funds are from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2000, AM J CLIN NUTR, V72, P1576; [Anonymous], 2000, AM J RESP CRIT CARE, V162, P2341; Arcaroli JJ, 2009, AM J RESP CRIT CARE, V179, P105, DOI 10.1164/rccm.200710-1566OC; Aycicek A, 2005, PEDIATR INT, V47, P635, DOI 10.1111/j.1442-200x.2005.02137.x; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Bernert JT, 1997, CLIN CHEM, V43, P2281; Comhair SAA, 1999, AM J RESP CRIT CARE, V159, P1824, DOI 10.1164/ajrccm.159.6.9810044; Comhair SAA, 2005, AM J RESP CRIT CARE, V172, P306, DOI 10.1164/rccm.200502-180OC; Comhair SAA, 2005, AM J PATHOL, V166, P663, DOI 10.1016/S0002-9440(10)62288-2; Comhair SAA, 2000, LANCET, V355, P624, DOI 10.1016/S0140-6736(99)04736-4; Comhair SAA, 2002, AM J PHYSIOL-LUNG C, V283, pL246, DOI 10.1152/ajplung.00491.2001; Cook DG, 1999, THORAX, V54, P357, DOI 10.1136/thx.54.4.357; DAHMS TE, 1981, CHEST, V80, P530, DOI 10.1378/chest.80.5.530; DeRaeve HR, 1997, AM J PHYSIOL-LUNG C, V272, pL148, DOI 10.1152/ajplung.1997.272.1.L148; Dietrich M, 2003, AM J CLIN NUTR, V77, P160, DOI 10.1093/ajcn/77.1.160; Dweik RA, 2001, P NATL ACAD SCI USA, V98, P2622, DOI 10.1073/pnas.051629498; Eisner MD, 1998, JAMA-J AM MED ASSOC, V280, P1909, DOI 10.1001/jama.280.22.1909; Eisner MD, 2005, THORAX, V60, P814, DOI 10.1136/thx.2004.037283; Eisner MD, 1998, AM J RESP CRIT CARE, V158, P170, DOI 10.1164/ajrccm.158.1.9801028; Eisner MD, 2001, PUBLIC HEALTH REP, V116, P148, DOI 10.1016/S0033-3549(04)50006-7; GASTON B, 1994, AM J RESP CRIT CARE, V149, P538, DOI 10.1164/ajrccm.149.2.7508323; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; GREER JR, 1993, J OCCUP ENVIRON MED, V35, P909, DOI 10.1097/00043764-199309000-00014; Hu FB, 1997, J ASTHMA, V34, P67, DOI 10.3109/02770909709071205; Hung RJ, 2004, CARCINOGENESIS, V25, P973, DOI 10.1093/carcin/bgh080; Jaakkola MS, 2006, EUR RESPIR J, V28, P397, DOI 10.1183/09031936.06.00001306; Jaakkola MS, 2003, AM J PUBLIC HEALTH, V93, P2055, DOI 10.2105/AJPH.93.12.2055; Jaakkola MS, 2002, SCAND J WORK ENV HEA, V28, P52; Janson C, 2001, LANCET, V358, P2103, DOI 10.1016/S0140-6736(01)07214-2; JARJOUR NN, 1992, AM REV RESPIR DIS, V146, P905, DOI 10.1164/ajrccm/146.4.905; Jindal S K, 1999, Indian J Chest Dis Allied Sci, V41, P75; JINDAL SK, 1994, CHEST, V106, P746, DOI 10.1378/chest.106.3.746; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kunzli N, 2000, SOZ PRAVENTIV MED, V45, P208, DOI 10.1007/BF01306015; Larsson ML, 2003, EUR RESPIR J, V21, P672, DOI 10.1183/09031936.03.00033702; LEUENBERGER P, 1994, AM J RESP CRIT CARE, V150, P1222, DOI 10.1164/ajrccm.150.5.7952544; MacPherson JC, 2001, J IMMUNOL, V166, P5763, DOI 10.4049/jimmunol.166.9.5763; MENON P, 1992, J ALLERGY CLIN IMMUN, V89, P560, DOI 10.1016/0091-6749(92)90323-T; MENON PK, 1991, J ALLERGY CLIN IMMUN, V88, P861, DOI 10.1016/0091-6749(91)90242-G; Menzies D, 2006, JAMA-J AM MED ASSOC, V296, P1742, DOI 10.1001/jama.296.14.1742; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Nowak D, 1996, EUR RESPIR J, V9, P652, DOI 10.1183/09031936.96.09040652; Nowak D, 1997, INT ARCH OCC ENV HEA, V69, P125; Oryszczyn MP, 2000, AM J RESP CRIT CARE, V161, P1241, DOI 10.1164/ajrccm.161.4.9905027; OSTRO BD, 1994, AM J RESP CRIT CARE, V149, P1400, DOI 10.1164/ajrccm.149.6.8004290; PRYOR WA, 1983, ENVIRON HEALTH PERSP, V47, P345, DOI 10.1289/ehp.8347345; Rahman I, 1999, AM J PHYSIOL-LUNG C, V277, pL1067, DOI 10.1152/ajplung.1999.277.6.L1067; Rahman I, 2000, THORAX, V55, P189, DOI 10.1136/thorax.55.3.189; Rahman I, 1996, AM J RESP CRIT CARE, V154, P1055, DOI 10.1164/ajrccm.154.4.8887607; Redondo-Horcajo M, 2010, CARDIOVASC RES, V87, P356, DOI 10.1093/cvr/cvq028; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; SANDSTROM J, 1994, J BIOL CHEM, V269, P19163; SHEPHARD RJ, 1979, ENVIRON RES, V20, P392, DOI 10.1016/0013-9351(79)90015-X; Simoni M, 2007, RESP MED, V101, P531, DOI 10.1016/j.rmed.2006.06.021; Sippel JM, 1999, CHEST, V115, P691, DOI 10.1378/chest.115.3.691; Smith LJ, 1997, FREE RADICAL BIO MED, V22, P1301, DOI 10.1016/S0891-5849(96)00550-3; STANKUS RP, 1988, J ALLERGY CLIN IMMUN, V82, P331, DOI 10.1016/0091-6749(88)90003-6; Thorn J, 2001, ALLERGY, V56, P287, DOI 10.1034/j.1398-9995.2001.00805.x; TREDANIEL J, 1994, EUR RESPIR J, V7, P173, DOI 10.1183/09031936.94.07010173; Venarske DL, 2006, J INFECT DIS, V193, P1536, DOI 10.1086/503809; WIEDEMANN HP, 1986, CHEST, V89, P180, DOI 10.1378/chest.89.2.180; Wu WJ, 2000, J CLIN INVEST, V105, P1455, DOI 10.1172/JCI9702; XU XP, 1995, AM J RESP CRIT CARE, V151, P41, DOI 10.1164/ajrccm.151.1.7812570	64	71	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e18574	10.1371/journal.pone.0018574	http://dx.doi.org/10.1371/journal.pone.0018574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21572527	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000290224800003
J	Cleveland, SB; Davies, J; McClure, MA				Cleveland, Sean B.; Davies, John; McClure, Marcella A.			A Bioinformatics Approach to the Structure, Function, and Evolution of the Nucleoprotein of the Order Mononegavirales	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; RESPIRATORY SYNCYTIAL VIRUS; INTRINSICALLY UNSTRUCTURED PROTEINS; PHOSPHOPROTEIN BINDING-SITE; NUCLEOCAPSID PROTEIN; RNA COMPLEX; CORRELATED MUTATIONS; IMPORTANT RESIDUES; CRYSTAL-STRUCTURE; GENOME SEQUENCE	The goal of this Bioinformatic study is to investigate sequence conservation in relation to evolutionary function/structure of the nucleoprotein of the order Mononegavirales. In the combined analysis of 63 representative nucleoprotein (N) sequences from four viral families (Bomaviridae, Filoviridae, Rhabdoviridae, and Paramyxoviridae) we predict the regions of protein disorder, intra-residue contact and co-evolving residues. Correlations between location and conservation of predicted regions illustrate a strong division between families while high-lighting conservation within individual families. These results suggest the conserved regions among the nucleoproteins, specifically within Rhabdoviridae and Paramyxoviradae, but also generally among all members of the order, reflect an evolutionary advantage in maintaining these sites for the viral nucleoprotein as part of the transcription/replication machinery. Results indicate conservation for disorder in the C-terminus region of the representative proteins that is important for interacting with the phosphoprotein and the large subunit polymerase during transcription and replication. Additionally, the C-terminus region of the protein preceding the disordered region, is predicted to be important for interacting with the encapsidated genome. Portions of the N-terminus are responsible for N:N stability and interactions identified by the presence or lack of co-evolving intra-protein contact predictions. The validation of these prediction results by current structural information illustrates the benefits of the Disorder, Intra-residue contact and Compensatory mutation Correlator (DisICC) pipeline as a method for quickly characterizing proteins and providing the most likely residues and regions necessary to target for disruption in viruses that have little structural information available.	[Cleveland, Sean B.; McClure, Marcella A.] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; [Cleveland, Sean B.; McClure, Marcella A.] Montana State Univ, Ctr Computat Biol, Bozeman, MT 59717 USA; [Davies, John] NHLBI, Mol & Cellular Toxicol Sect, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Cleveland, SB (corresponding author), Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA.	sean.b.cleveland@gmail.com	Cleveland, Sean B/AAY-3957-2021	Cleveland, Sean/0000-0002-7130-3434; Davies, John/0000-0002-9482-1066	National Institutes of Health [1R21AI063510]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI063510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by a National Institutes of Health grant (1R21AI063510). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; ASSENBERG R, 2011, ANTIVIRAL R IN PRESS; Basta HA, 2009, J VIROL, V83, P10152, DOI 10.1128/JVI.02546-08; BECKER S, 1994, J GEN VIROL, V75, P809, DOI 10.1099/0022-1317-75-4-809; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bodjo SC, 2008, VIRUS RES, V131, P23, DOI 10.1016/j.virusres.2007.08.005; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Bowden TR, 2001, VIROLOGY, V283, P358, DOI 10.1006/viro.2001.0893; Cevik B, 2004, VIROLOGY, V325, P216, DOI 10.1016/j.virol.2004.05.012; Chuang JL, 1997, VIROLOGY, V229, P57, DOI 10.1006/viro.1996.8418; Chuang JL, 1997, J VIROL, V71, P1466, DOI 10.1128/JVI.71.2.1466-1475.1997; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fares MA, 2006, BIOINFORMATICS, V22, P2821, DOI 10.1093/bioinformatics/btl493; Fariselli P, 1999, PROTEIN ENG, V12, P15, DOI 10.1093/protein/12.1.15; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; HOWARD M, 1989, J GEN VIROL, V70, P2683, DOI 10.1099/0022-1317-70-10-2683; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Johnson JE, 2009, VACCINE, V27, P2930, DOI 10.1016/j.vaccine.2009.03.006; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kho CL, 2004, ARCH VIROL, V149, P997, DOI 10.1007/s00705-003-0273-8; Kingston RL, 2004, P NATL ACAD SCI USA, V101, P8301, DOI 10.1073/pnas.0402690101; Koser ML, 2004, P NATL ACAD SCI USA, V101, P9405, DOI 10.1073/pnas.0403060101; Kouznetzoff A, 1998, J GEN VIROL, V79, P1005, DOI 10.1099/0022-1317-79-5-1005; Kurath G, 2004, J VIROL, V78, P2045, DOI 10.1128/JVI.78.4.2045-2056.2004; LAFERLA FM, 1989, J VIROL, V63, P3582; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li Z, 2006, VIROLOGY, V346, P219, DOI 10.1016/j.virol.2005.10.039; Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; LUO M, 2007, VIROL J, V4, P1; McCarthy AJ, 2010, INFECT GENET EVOL, V10, P97, DOI 10.1016/j.meegid.2009.11.002; MERIC C, 1994, VIRUS RES, V31, P187, DOI 10.1016/0168-1702(94)90003-5; Mesa AD, 2003, J MOL BIOL, V326, P1289, DOI 10.1016/S0022-2836(02)01451-1; Miller PJ, 2003, VIROLOGY, V317, P330, DOI 10.1016/j.virol.2003.08.013; MOYER SA, 1991, J VIROL, V65, P2170, DOI 10.1128/JVI.65.5.2170-2178.1991; Murphy LB, 2003, VIROLOGY, V307, P143, DOI 10.1016/S0042-6822(02)00063-6; Myers TM, 1999, J GEN VIROL, V80, P1383, DOI 10.1099/0022-1317-80-6-1383; Olmea O, 1997, FOLD DES, V2, pS25, DOI 10.1016/S1359-0278(97)00060-6; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pazos F, 2006, BIOINFORMATICS, V22, P1440, DOI 10.1093/bioinformatics/btl104; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schoehn G, 2001, J VIROL, V75, P490, DOI 10.1128/JVI.75.1.490-498.2001; Stokes HL, 2003, J GEN VIROL, V84, P2679, DOI 10.1099/vir.0.19370-0; TAKACS AM, 1992, J VIROL, V66, P5842, DOI 10.1128/JVI.66.10.5842-5848.1992; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsai CJ, 2001, PROTEINS, V44, P418, DOI 10.1002/prot.1107; Watanabe S, 2006, J VIROL, V80, P3743, DOI 10.1128/JVI.80.8.3743-3751.2006; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; Whelan SPJ, 2004, CURR TOP MICROBIOL, V283, P61; Zhang X, 2008, J VIROL, V82, P674, DOI 10.1128/JVI.00935-07	61	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19275	10.1371/journal.pone.0019275	http://dx.doi.org/10.1371/journal.pone.0019275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559282	Green Published, gold			2022-12-25	WOS:000290223500015
J	Hu, R; Lam, W; Hsu, CH; Cheng, YC				Hu, Rong; Lam, Wing; Hsu, Chih-Hung; Cheng, Yung-Chi			UMP/CMPK Is Not the Critical Enzyme in the Metabolism of Pyrimidine Ribonucleotide and Activation of Deoxycytidine Analogs in Human RKO Cells	PLOS ONE			English	Article							UMP-CMP KINASE; NUCLEOSIDE MONOPHOSPHATE KINASE; PHOSPHORYLATION; CYTOTOXICITY; GEMCITABINE; RESISTANCE; LINES; P53	Background: Human UMP/CMP kinase was identified based on its enzymatic activity in vitro. The role of this protein is considered critical for the maintenance of pyrimidine nucleotide pool profile and for the metabolism of pyrimidine analogs in cells, based on the in vitro study of partially purified enzyme and recombinant protein. However, no detailed study has yet addressed the role of this protein in nucleotide metabolism in cells. Methodology/Principal Findings: Two stable cell lines in which UMP/CMP kinase (mRNA: AF087865, EC 2.7.4.14) can be either up-regulated or down-regulated were developed using Tet-On Gene Expression Systems. The amount and enzymatic activity of UMP/CMP kinase extracted from these two cell lines can be induced up by 500% or down by 95-98%. The ribonucleotides of endogenous pyrimidine as well as the metabolism of exogenous natural pyrimidine nucleosides and their analogs were not susceptible to the altered amount of UMP/CMP kinase in these two stable RKO cell lines. The level of incorporation of pyrimidine nucleoside analogs, such as gemcitabine (dFdC) and troxacitabine (L-OddC), into cellular DNA and their potency in inhibiting cell growth were not significantly altered by up-regulation or down-regulation of UMP/CMP kinase expression in cells. Conclusions/Significance:The UMP/CMP kinase (EC 2.7.4.14) expressed in RKO cells is not critical for the phosphorylation of (d)CMP and the maintenance of natural nucleotide pools. It also does not play an important role in the activation of dFdC and L-OddC. The increase by 500% or decrease by 95-98% in the levels of UMP/CMP kinase do not affect steady state levels of dFdC and L-OddC in RKO cells. Overall, the activity and possible mechanisms of recombinant UMP/CMP kinase expressed in the in vitro system can not be extended to that of UMP/CMP kinase expressed in a cell system or an in vivo system.	[Hu, Rong; Lam, Wing; Hsu, Chih-Hung] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Hsu, Chih-Hung] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan	Yale University; National Taiwan University; National Taiwan University Hospital	Hu, R (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	yccheng@yale.edu		HSU, CHIH-HUNG/0000-0003-0495-973X	National Institutes of Health [CA-63477, AI-38204]; NATIONAL CANCER INSTITUTE [U01CA063477, R01CA063477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the National Institutes of Health [grant CA-63477 and AI-38204]. Y-C.C. is a fellow of the National Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre JAC, 2007, NUCLEIC ACIDS RES, V35, P4895, DOI 10.1093/nar/gkm479; ARIMA T, 1977, CANCER RES, V37, P1598; Bono H, 1998, GENOME RES, V8, P203, DOI 10.1101/gr.8.3.203; Chabner BA., 2005, CANC CHEMOTHERAPY BI, V4; Chen M, 2000, CANCER CHEMOTH PHARM, V45, P369, DOI 10.1007/s002800051004; DARIO SP, 2004, J BIOL CHEM, V279, P33882; Dutschman GE, 2004, ANTIMICROB AGENTS CH, V48, P1640, DOI 10.1128/AAC.48.5.1640-1646.2004; HANDE KR, 1978, CANCER RES, V38, P579; Henriksen JR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm193; Hsu CH, 2005, MOL PHARMACOL, V67, P806, DOI 10.1124/mol.104.006098; Hsu CH, 2007, ANTIMICROB AGENTS CH, V51, P1687, DOI 10.1128/AAC.01432-06; Hu R, 2005, ANTIMICROB AGENTS CH, V49, P2044, DOI 10.1128/AAC.49.5.2044-2049.2005; Humeniuk R, 2009, MOL CANCER THER, V8, P1045, DOI 10.1158/1535-7163.MCT-08-0717; Humeniuk R, 2009, MOL CANCER THER, V8, P1037, DOI 10.1158/1535-7163.MCT-08-0716; Jenkins N, 2008, MOL BIOTECHNOL, V39, P113, DOI 10.1007/s12033-008-9049-4; Krishnan P, 2003, J BIOL CHEM, V278, P36726, DOI 10.1074/jbc.M307052200; Lam W, 2006, MOL PHARMACOL, V69, P1607, DOI 10.1124/mol.105.021527; Liou JY, 2010, BIOCHEM PHARMACOL, V79, P381, DOI 10.1016/j.bcp.2009.09.010; Liou JY, 2002, CANCER RES, V62, P1624; Pasti C, 2003, EUR J BIOCHEM, V270, P1784, DOI 10.1046/j.1432-1033.2003.03537.x; Pearman AT, 2001, LIFE SCI, V69, P2361, DOI 10.1016/S0024-3205(01)01322-4; Russo P, 2002, INT J CANCER, V100, P266, DOI 10.1002/ijc.10461; Segura-Pena D, 2004, J BIOL CHEM, V279, P33882, DOI 10.1074/jbc.M401989200; TENG YS, 1976, J BIOL CHEM, V251, P4179; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Van Rompay AR, 1999, MOL PHARMACOL, V56, P562, DOI 10.1124/mol.56.3.562	26	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19490	10.1371/journal.pone.0019490	http://dx.doi.org/10.1371/journal.pone.0019490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559290	Green Submitted, Green Published, gold			2022-12-25	WOS:000290223500025
J	Leong, MM; Chen, SCC; Hsieh, CS; Chin, YY; Tok, TS; Wu, SF; Peng, CT; Chen, AC				Leong, Mee-Mee; Chen, Solomon Chih-Cheng; Hsieh, Chih-Sung; Chin, Yow-Yue; Tok, Teck-Siang; Wu, Shu-Fen; Peng, Ching-Tien; Chen, An-Chyi			Epidemiological Features of Infantile Hypertrophic Pyloric Stenosis in Taiwanese Children: A Nation-Wide Analysis of Cases during 1997-2007	PLOS ONE			English	Article							POPULATION; ERYTHROMYCIN; EXPERIENCE; DIAGNOSIS; SMOKING; LINKAGE; BIRTH	Objective: To describe the epidemiological characteristics of infantile hypertrophic pyloric stenosis (IHPS) in ethnic Chinese children. Materials and Methods: We reviewed the National Health Insurance claims database and analyzed data from children less than one year of age who had been diagnosed with IHPS (ICD-9-CM 750.5) and had undergone pyloromyotomy (ICD-9-CM 43.3). We analyzed the incidence, gender, age at diagnosis, length of hospital stay, seasonal variation and cost of IHPS from data collected between January 1997 and December 2007. Results:A total of 1,077 infants met inclusion criteria, including 889 boys and 188 girls. The annual incidence of IHPS ranged from 0.30 to 0.47 per 1,000 live births with a mean incidence of 0.39 per 1,000 live births. Between 2002 and 2007, the incidence showed a declining trend (P=0.025) with coincidentally increasing trends for both exclusive breastfeeding (P=0.014) and breastfeeding plus bottle feeding (P=0.004). The male-to-female rate ratio was dynamic and increased from 3.03 during the first two weeks of life to 8.94 during the 8(th) through 10(th) weeks of life. The overall male-to-female rate ratio was 4.30. The mean age at diagnosis was 43.1 +/-.2.4 days. After analyzing the months of birth and hospital admission, no seasonal variation associated with IHPS was detected. The mean length of hospital stay was 8.28 +/- 7.10 days. Conclusions: The incidence of IHPS in Taiwan, a country with a majority ethnic Chinese population, was lower than observed incidences in Caucasian populations living in Western countries. Breastfeeding campaigns and low maternal smoking rates may contribute to the lower incidence of IHPS in Taiwan. However, additional studies with longer follow-up periods are needed.	[Leong, Mee-Mee; Chen, Solomon Chih-Cheng; Hsieh, Chih-Sung; Chin, Yow-Yue; Tok, Teck-Siang] Pingtung Christian Hosp, Dept Pediat, Pingtung, Taiwan; [Leong, Mee-Mee; Wu, Shu-Fen; Peng, Ching-Tien; Chen, An-Chyi] China Med Univ Hosp, Children Med Ctr, Taichung, Taiwan; [Chen, Solomon Chih-Cheng] Taipei Med Univ, Coll Med, Taipei, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Medical University	Leong, MM (corresponding author), Pingtung Christian Hosp, Dept Pediat, Pingtung, Taiwan.	d8427@mail.cmuh.org.tw						ADELSTEIN P, 1976, J MED GENET, V13, P439, DOI 10.1136/jmg.13.6.439; APPLEGATE MS, 1995, ARCH PEDIAT ADOL MED, V149, P1123, DOI 10.1001/archpedi.1995.02170230077011; *BUR PROM HLTH, BUR PROM HLTH BREAST; CAVELL B, 1979, ACTA PAEDIATR SCAND, V68, P725, DOI 10.1111/j.1651-2227.1979.tb18446.x; Chen SCC, 2010, PEDIATR NEONATOL, V51, P285, DOI 10.1016/S1875-9572(10)60055-1; Cooper WO, 2002, ARCH PEDIAT ADOL MED, V156, P647, DOI 10.1001/archpedi.156.7.647; CZEIZEL A, 1972, ARCH DIS CHILD, V47, P977, DOI 10.1136/adc.47.256.978; DAVIES RP, 1992, J ULTRAS MED, V11, P603, DOI 10.7863/jum.1992.11.11.603; *DEP STAT MIN INT, NAT STAT; DODGE JA, 1975, ARCH DIS CHILD, V50, P171, DOI 10.1136/adc.50.3.171; DODGE JA, 1971, J MED GENET, V8, P468, DOI 10.1136/jmg.8.4.468; Everett KV, 2008, AM J HUM GENET, V82, P756, DOI 10.1016/j.ajhg.2007.12.023; Fujimoto T, 1999, J PEDIATR SURG, V34, P370, DOI 10.1016/S0022-3468(99)90212-9; GIBBS MK, 1975, MAYO CLIN PROC, V50, P312; HABBICK BF, 1989, CAN MED ASSOC J, V140, P395; HABBICK BF, 1989, CAN MED ASSOC J, V140, P401; Hedback G, 2001, ARCH DIS CHILD, V85, P379, DOI 10.1136/adc.85.5.379; Hernanz-Schulman M, 2003, RADIOLOGY, V227, P319, DOI 10.1148/radiol.2272011329; HITCHCOCK NE, 1987, ARCH DIS CHILD, V62, P512, DOI 10.1136/adc.62.5.512; Hoey J, 2000, CAN MED ASSOC J, V162, P1198; KNOX EG, 1983, ARCH DIS CHILD, V58, P582, DOI 10.1136/adc.58.8.582; Krogh C, 2010, JAMA-J AM MED ASSOC, V303, P2393, DOI 10.1001/jama.2010.784; LAMMER EJ, 1987, J MED GENET, V24, P482, DOI 10.1136/jmg.24.8.482; LEMESSA D, 1990, ETHIOPIAN MED J, V28, P169; MacMahon B, 2006, EPIDEMIOLOGY, V17, P195, DOI 10.1097/01.ede.0000192032.83843.c9; MARCHINI G, 1994, ACTA PAEDIATR, V83, P374, DOI 10.1111/j.1651-2227.1994.tb18122.x; Osifo DO, 2009, J TROP PEDIATRICS, V55, P132, DOI 10.1093/tropej/fmn094; PASCALE JA, 1978, BIOL NEONATE, V34, P150, DOI 10.1159/000241118; Pisacane A, 1996, BRIT MED J, V312, P745, DOI 10.1136/bmj.312.7033.745; RASMUSSEN L, 1989, INT J EPIDEMIOL, V18, P413, DOI 10.1093/ije/18.2.413; Schechter R, 1997, PAEDIATR PERINAT EP, V11, P407, DOI 10.1046/j.1365-3016.1997.d01-32.x; Shaoul R, 2004, ISRAEL MED ASSOC J, V6, P134; Shih SF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-67; Sommerfield T, 2008, ARCH DIS CHILD, V93, P1007, DOI 10.1136/adc.2007.128090; Sorensen HT, 2002, BMJ-BRIT MED J, V325, P1011, DOI 10.1136/bmj.325.7371.1011; TEELE RL, 1977, NEW ENGL J MED, V296, P1149, DOI 10.1056/NEJM197705192962006; To T, 2005, ARCH PEDIAT ADOL MED, V159, P520, DOI 10.1001/archpedi.159.6.520; WALSWORTHBELL JP, 1983, J EPIDEMIOL COMMUN H, V37, P149, DOI 10.1136/jech.37.2.149; Wang J, 2008, BIRTH DEFECTS RES A, V82, P763, DOI 10.1002/bdra.20527; WEBB AR, 1983, ARCH DIS CHILD, V58, P586, DOI 10.1136/adc.58.8.586; *WHO, WHO FEM SMOK	41	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19404	10.1371/journal.pone.0019404	http://dx.doi.org/10.1371/journal.pone.0019404			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559291	gold, Green Submitted, Green Published			2022-12-25	WOS:000290223500022
J	Li, DF; Zhang, N; Hou, YJ; Huang, Y; Hu, YL; Zhang, Y; Liu, SJ; Wang, DC				Li, De-Feng; Zhang, Ning; Hou, Yan-Jie; Huang, Yan; Hu, Yonglin; Zhang, Ying; Liu, Shuang-Jiang; Wang, Da-Cheng			Crystal Structures of the Transcriptional Repressor RoIR Reveals a Novel Recognition Mechanism between Inducer and Regulator	PLOS ONE			English	Article							MULTIDRUG-BINDING-PROTEIN; TET REPRESSOR; TETRACYCLINE; RESISTANCE; INDUCTION; INSIGHTS; PROGRAM; COMPLEX; FAMILY	Many members of the TetR family control the transcription of genes involved in multidrug resistance and pathogenicity. RoIR (Resorcinol Regulator), the recently reported TetR-type regulator for aromatic catabolism from Corynebacterium glutamicum, distinguishes itself by low sequence similarities and different regulation from the previously known members of the TetR family. Here we report the crystal structures of RoIR in its effector-bound (with resorcinol) and aop- forms at 2.5 angstrom and 3.6 angstrom, respectively. The structure of resorcinol-RoIR complex reveal that the hydrogen-bonded network mediated the four-residue motif (Asp94- Arg145- Arg148- Asp149) with two water molecules and the hydrophobic interaction via five residues (Phe107, Leu111, Leu114, Leu142, and Phe172) are the key factors for the recognition and binding between the resorcinol and RoIR molecules. The center-to-center separation of the recognition helices h3-h3' is decreased upon effector-binding from 34.9 angstrom to 30.4 angstrom. This structural change results in that RoIR was unsuitable for DNA binding. Those observations are distinct from that in other TetR members. Structure-based mutagenesis on RoIR was carried out and the results confirmed the critical roles of the above mentioned residues for effector-binding specificity and affinity. Similar sequence searches and sequence alignments identified 29 RoIR homologues from GenBank, and all the above mentioned residues are highly conserved in the homologues. Based on these structural and other functional investigations, it is proposed that RoIR may represent a new subfamily of TetR proteins that are invovled in aromatic degradation and sharing common recognition mode as for RoIR	[Li, De-Feng; Zhang, Ning; Hou, Yan-Jie; Hu, Yonglin; Zhang, Ying; Wang, Da-Cheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Zhang, Ning; Hou, Yan-Jie] Chinese Acad Sci, Grad Sch, Beijing 100080, Peoples R China; [Huang, Yan; Liu, Shuang-Jiang] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Li, DF (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	liusj@sun.im.ac.cn; dcwang@ibp.ac.cn	Liu, Shuang-Jiang/E-5756-2013		National Natural Science Foundation of China [30800170]; "973" Research Programs of China [2011CB910304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973" Research Programs of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (30800170, http://www.nsfc.gov.cn/) and the "973" Research Programs of China (2011CB910304, http://www.973.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; BECK CF, 1982, J BACTERIOL, V150, P633, DOI 10.1128/JB.150.2.633-642.1982; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dover LG, 2004, J MOL BIOL, V340, P1095, DOI 10.1016/j.jmb.2004.06.003; Feng L, 2010, FASEB J, V24, P3861, DOI 10.1096/fj.10-159111; Gauto DF, 2009, J PHYS CHEM B, V113, P8717, DOI 10.1021/jp901196n; Hernandez A, 2009, J BIOL CHEM, V284, P14428, DOI 10.1074/jbc.M809221200; Huang Y, 2006, APPL ENVIRON MICROB, V72, P7238, DOI 10.1128/AEM.01494-06; Huang YH, 2007, THESIS CHINESE ACAD; Huffman JL, 2002, CURR OPIN STRUC BIOL, V12, P98, DOI 10.1016/S0959-440X(02)00295-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murray DS, 2004, J BIOL CHEM, V279, P14365, DOI 10.1074/jbc.M313870200; Natchiar SK, 2006, ACTA CRYSTALLOGR D, V62, P1413, DOI 10.1107/S0907444906035712; Natsume R, 2004, J MOL BIOL, V336, P409, DOI 10.1016/j.jmb.2003.12.040; Orth P, 1999, BIOCHEMISTRY-US, V38, P191, DOI 10.1021/bi9816610; Orth P, 1999, J MOL BIOL, V285, P455, DOI 10.1006/jmbi.1998.2290; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rossmann MG, 1999, ACTA CRYSTALLOGR D, V55, P1631, DOI 10.1107/S0907444999008379; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Schumacher MA, 2004, EMBO J, V23, P2923, DOI 10.1038/sj.emboj.7600288; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072	29	9	10	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19529	10.1371/journal.pone.0019529	http://dx.doi.org/10.1371/journal.pone.0019529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559286	Green Published, gold, Green Submitted			2022-12-25	WOS:000290223500027
J	Alvarado-Mora, MV; Fernandez, MFG; Gomes-Gouvea, MS; Neto, RSD; Carrilho, FJ; Pinho, JRR				Alvarado-Mora, Monica Viviana; Gutierrez Fernandez, Maria Fernanda; Gomes-Gouvea, Michele Soares; de Azevedo Neto, Raymundo Soares; Carrilho, Flair Jose; Rebello Pinho, Joao Renato			Hepatitis B (HBV), Hepatitis C (HCV) and Hepatitis Delta (HDV) Viruses in the Colombian Population-How Is the Epidemiological Situation?	PLOS ONE			English	Article							LATIN-AMERICA; SOUTH-AMERICA; MOLECULAR CHARACTERIZATION; SANTA-MARTA; GENOTYPE-I; INFECTION; DISEASE; VENEZUELA; SEQUENCE; INDIANS	Background: Viral hepatitis B, C and delta still remain a serious problem worldwide. In Colombia, data from 1980s described that HBV and HDV infection are important causes of hepatitis, but little is known about HCV infection. The aim of this study was to determine the currently frequency of HBV, HCV and HDV in four different Colombian regions. Methodology/Principal Findings: This study was conducted in 697 habitants from 4 Colombian departments: Amazonas, Choco, Magdalena and San Andres Islands. Epidemiological data were obtained from an interview applied to each individual aiming to evaluate risk factors related to HBV, HCV or HDV infections. All samples were tested for HBsAg, anti-HBc, anti-HBs and anti-HCV markers. Samples that were positive to HBsAg and/or anti-HBc were tested to anti-HDV. Concerning the geographical origin of the samples, the three HBV markers showed a statistically significant difference: HBsAg (p = 0.033) and anti-HBc (p < 0.001) were more frequent in Amazonas and Magdalena departments. Isolated anti-HBs (a marker of previous vaccination) frequencies were: Choco (53.26%), Amazonas (32.88%), Magdalena (17.0%) and San Andres (15.33%) p < 0.001. Prevalence of anti-HBc increased with age; HBsAg varied from 1.97 to 8.39% (p = 0.033). Amazonas department showed the highest frequency for anti-HCV marker (5.68%), while the lowest frequency was found in San Andres Island (0.66%). Anti-HDV was found in 9 (5.20%) out of 173 anti-HBc and/or HBsAg positive samples, 8 of them from the Amazonas region and 1 from them Magdalena department. Conclusions/Significance: In conclusion, HBV, HCV and HDV infections are detected throughout Colombia in frequency levels that would place some areas as hyperendemic for HBV, especially those found in Amazonas and Magdalena departments. Novel strategies to increase HBV immunization in the rural population and to strengthen HCV surveillance are reinforced by these results.	[Alvarado-Mora, Monica Viviana; Gomes-Gouvea, Michele Soares; Carrilho, Flair Jose; Rebello Pinho, Joao Renato] Univ Sao Paulo, Sao Paulo Inst Trop Med, Lab Gastroenterol & Hepatol, Sao Paulo, Brazil; [Gutierrez Fernandez, Maria Fernanda] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil; [Gutierrez Fernandez, Maria Fernanda] Pontificia Javeriana Univ, Dept Microbiol, Virol Lab, Bogota, Colombia; [de Azevedo Neto, Raymundo Soares] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Pontificia Universidad Javeriana; Universidade de Sao Paulo	Alvarado-Mora, MV (corresponding author), Univ Sao Paulo, Sao Paulo Inst Trop Med, Lab Gastroenterol & Hepatol, Sao Paulo, Brazil.	monica.viviana@usp.br	Alvarado-Mora, Monica/I-3180-2012; Pinho, Joao R. R./G-2850-2012; Carrilho, Flair J/I-3046-2012; Azevedo, Raymundo S/B-7593-2008; Gomes-Gouvea, Michele S/G-4216-2012	Pinho, Joao R. R./0000-0003-3999-0489; Azevedo, Raymundo S/0000-0003-0660-2371; Gomes-Gouvea, Michele S/0000-0001-5932-2360	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2007/53457-7, 2008/50461-6]; CNPq; Sao Paulo, SP, Brazil; Pontificia Universidad Javeriana, Bogota, Colombia	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo, SP, Brazil; Pontificia Universidad Javeriana, Bogota, Colombia	This work has been supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP 2007/53457-7 and 2008/50461-6 and CNPq, Sao Paulo, SP, Brazil and by Pontificia Universidad Javeriana, Bogota, Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mora MVA, 2011, INFECT GENET EVOL, V11, P103, DOI 10.1016/j.meegid.2010.10.003; Mora MVA, 2010, J MED VIROL, V82, P1889, DOI 10.1002/jmv.21908; Mora MVA, 2010, J GEN VIROL, V91, P501, DOI 10.1099/vir.0.015958-0; Beltran Mauricio, 2005, J Clin Virol, V34 Suppl 2, pS33, DOI 10.1016/S1386-6532(05)80032-0; Bensabath G, 1987, Bull Pan Am Health Organ, V21, P16; Bostan N, 2010, CRIT REV MICROBIOL, V36, P91, DOI 10.3109/10408410903357455; BUITRAGO B, 1986, HEPATOLOGY, V6, P1292, DOI 10.1002/hep.1840060611; Buitrago GB., 1991, BIOMEDICA, V11, P1; Carrilho FJ, 1998, THERAPIES FOR VIRAL HEPATITIS, P25; CASEY JL, 1993, P NATL ACAD SCI USA, V90, P9016, DOI 10.1073/pnas.90.19.9016; CHAO YC, 1990, VIROLOGY, V178, P384; De la Hoz F., 1992, BIOMEDICA, V12, P5; Echevarría José M., 2003, Cad. Saúde Pública, V19, P1583, DOI 10.1590/S0102-311X2003000600003; Espinal C. A., 1998, Biomedica, V18, P216; FAY OH, 1990, VACCINE, V8, pS100, DOI 10.1016/0264-410X(90)90228-E; Gaeta GB, 2000, HEPATOLOGY, V32, P824, DOI 10.1053/jhep.2000.17711; GAYOTTO LCD, 1991, PROG CLIN BIOL RES, V364, P123; Gish RG, 2006, J VIRAL HEPATITIS, V13, P787, DOI 10.1111/j.1365-2893.2006.00787.x; Gomes-Gouvea MS, 2009, J GEN VIROL, V90, P2638, DOI 10.1099/vir.0.013615-0; HADLER SC, 1984, ANN INTERN MED, V100, P339, DOI 10.7326/0003-4819-100-3-339; LAI MMC, 1995, ANNU REV BIOCHEM, V64, P259, DOI 10.1146/annurev.bi.64.070195.001355; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Le Gal F, 2006, EMERG INFECT DIS, V12, P1447, DOI 10.3201/eid1209.060112; LJUNGGREN KE, 1985, HEPATOLOGY, V5, P299, DOI 10.1002/hep.1840050225; MAKINO S, 1987, NATURE, V329, P343, DOI 10.1038/329343a0; Martinez M, 1991, BIOMEDICA, V11, P43; Ministerio de Salud, 1996, MAN NORM TECN ADM PR; Ministerio de Salud, 2002, B EP SEM SIT HEP B C; Pasquier C, 2005, J MED VIROL, V77, P390, DOI 10.1002/jmv.20468; PRIETO F, 2003, BIOMEDICA, V8, P2; Quintero A, 2001, J MED VIROL, V64, P356, DOI 10.1002/jmv.1058; Radjef N, 2004, J VIROL, V78, P2537, DOI 10.1128/JVI.78.5.2537-2544.2004; Ramsey GH, 1931, FEVER JAUNDICE PROVI; REEVES WC, 1975, AM J TROP MED HYG, V24, P873, DOI 10.4269/ajtmh.1975.24.873; Sakugawa H, 1999, J MED VIROL, V58, P366, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;366::AID-JMV8&gt;3.0.CO;2-X; Schmunis GA, 1998, EMERG INFECT DIS, V4, P5, DOI 10.3201/eid0401.980102; Schmunis GA, 2005, CLIN MICROBIOL REV, V18, P12, DOI 10.1128/CMR.18.1.12-29.2005; Shakil AO, 1997, VIROLOGY, V234, P160, DOI 10.1006/viro.1997.8644; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Slusarczyk J, 2000, VACCINE, V18, pS4, DOI 10.1016/S0264-410X(99)00451-X; Soza A, 2010, ANN HEPATOL, V9, pS30, DOI 10.1016/S1665-2681(19)31720-X; Tanaka J, 2000, VACCINE, V18, pS17, DOI 10.1016/S0264-410X(99)00455-7; Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009; Te HS, 2010, CLIN LIVER DIS, V14, pvii, DOI DOI 10.1016/J.CLD.2009.11.009]; Torres JR, 1996, GUT, V38, pS48, DOI 10.1136/gut.38.Suppl_2.S48; WANG KS, 1986, NATURE, V323, P508, DOI 10.1038/323508a0; Watanabe H, 2003, J GEN VIROL, V84, P3275, DOI 10.1099/vir.0.19499-0; World Health Organization, 2001, HEP DELT, P18; Wu JC, 1998, J GEN VIROL, V79, P1105, DOI 10.1099/0022-1317-79-5-1105; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009297	50	32	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18888	10.1371/journal.pone.0018888	http://dx.doi.org/10.1371/journal.pone.0018888			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559488	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700033
J	Brockmeier, U; Platzek, C; Schneider, K; Patak, P; Bernardini, A; Fandrey, J; Metzen, E				Brockmeier, Ulf; Platzek, Corinna; Schneider, Kirsten; Patak, Pauline; Bernardini, Andre; Fandrey, Joachim; Metzen, Eric			The Function of Hypoxia-Inducible Factor (HIF) Is Independent of the Endoplasmic Reticulum Protein OS-9	PLOS ONE			English	Article							NF-KAPPA-B; HYDROXYLASE DOMAIN PROTEIN-2; TUMOR-SUPPRESSOR PROTEIN; PROLYL HYDROXYLASE; TRANSCRIPTIONAL REGULATION; MISFOLDED GLYCOPROTEINS; INTRACELLULAR CALCIUM; OXIDATIVE STRESS; GENE-EXPRESSION; OXYGEN SENSOR	The protein "amplified in osteosarcoma-9'' (OS-9) has been shown previously to interact with the prolyl hydroxylases PHD2 and PHD3. These enzymes initiate oxygen-dependent degradation of the a-subunit of hypoxia-inducible factor (HIF), a transcription factor that adapts cells to insufficient oxygen supply (hypoxia). A new model has been proposed where OS-9 triggers PHD dependent degradation of HIF-alpha. It was the aim of our study to define the molecular mode of action of OS-9 in the regulation of PHD and HIF activity. Although initial co-immunoprecipitation experiments confirmed physical interaction between OS-9 and PHD2, neither overexpression nor lentiviral inhibition of OS-9 expression affected HIF regulation. Subcellular localization experiments revealed a distinct reticular staining pattern for OS-9 while PHD2 was mainly localized in the cytoplasm. Further cell fractionation experiments and glycosylation tests indicated that OS-9 is a luminal ER protein. In vivo protein interaction analysis by fluorescence resonance energy transfer (FRET) showed no significant physical interaction of overexpressed PHD2-CFP and OS-9-YFP. We conclude that OS-9 plays no direct functional role in HIF degradation since physical interaction of OS-9 with oxygen sensing HIF prolyl hydroxylases cannot occur in vivo due to their different subcellular localization.	[Brockmeier, Ulf; Schneider, Kirsten; Bernardini, Andre; Fandrey, Joachim; Metzen, Eric] Univ Duisburg Essen, Inst Physiol, Essen, Germany; [Platzek, Corinna] Univ Lubeck, Inst Physiol, Lubeck, Germany; [Patak, Pauline] Univ Duisburg Essen, Dept Neurol, Essen, Germany	University of Duisburg Essen; University of Lubeck; University of Duisburg Essen	Brockmeier, U (corresponding author), Univ Duisburg Essen, Inst Physiol, Essen, Germany.	eric.metzen@uni-due.de	Fandrey, Joachim/AAA-3524-2021	Fandrey, Joachim/0000-0001-9585-0531	Medical Faculty of the University of Lubeck; Deutsche Forschungsgemeinschaft [FA225/22-1, ME1712/6-1]	Medical Faculty of the University of Lubeck; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a personal grant from the Medical Faculty of the University of Lubeck to Corinna Platzek; Deutsche Forschungsgemeinschaft (FA225/22-1, ME1712/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock F, 2009, J MOL BIOL, V385, P1032, DOI 10.1016/j.jmb.2008.11.045; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Berchner-Pfannschmidt U, 2004, J BIOL CHEM, V279, P44976, DOI 10.1074/jbc.M313995200; Bernardini A, 2010, PROC SPIE, V7723, DOI 10.1117/12.854027; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Friedmann E, 2002, J BIOL CHEM, V277, P35274, DOI 10.1074/jbc.M201044200; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kim HL, 2006, INT J ONCOL, V29, P255; Kimura Y, 1997, J BIOCHEM-TOKYO, V122, P1190; Kimura Y, 1998, J BIOCHEM-TOKYO, V123, P876; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Litovchick L, 2002, J BIOL CHEM, V277, P34413, DOI 10.1074/jbc.M203986200; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; Liu Q, 2004, BLOOD, V104, P3993, DOI 10.1182/blood-2004-03-1017; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.e02-12-0791; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Ozer A, 2005, P NATL ACAD SCI USA, V102, P7481, DOI 10.1073/pnas.0502716102; Popov M, 2000, ANAL BIOCHEM, V279, P90, DOI 10.1006/abio.1999.4443; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Su YA, 1996, MOL CARCINOGEN, V15, P270, DOI 10.1002/(SICI)1098-2744(199604)15:4<270::AID-MC4>3.0.CO;2-K; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Thoms BL, 2010, J BIOL CHEM, V285, P20472, DOI 10.1074/jbc.M110.115238; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Werno C, 2008, J CELL PHYSIOL, V215, P708, DOI 10.1002/jcp.21351; Wotzlaw C, 2007, FASEB J, V21, P700, DOI 10.1096/fj.06-6280com; Wotzlaw Christoph, 2010, PMC Biophys, V3, P5, DOI 10.1186/1757-5036-3-5; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	56	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19151	10.1371/journal.pone.0019151	http://dx.doi.org/10.1371/journal.pone.0019151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559462	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700078
J	Cosnier, B; Kwapisz, M; Hatin, I; Namy, O; Denmat, SHL; Morillon, A; Rousset, JP; Fabret, C				Cosnier, Bruno; Kwapisz, Marta; Hatin, Isabelle; Namy, Olivier; Denmat, Sylvie Hermann-Le; Morillon, Antonin; Rousset, Jean-Pierre; Fabret, Celine			A Viable Hypomorphic Allele of the Essential IMP3 Gene Reveals Novel Protein Functions in Saccharomyces cerevisiae	PLOS ONE			English	Article							PRE-RIBOSOMAL-RNA; SMALL NUCLEOLAR RIBONUCLEOPROTEIN; U3; YEAST; COMPONENT; MAINTENANCE; BIOGENESIS; PROCESSOME; VERSATILE; METHYL	In Saccharomyces cerevisiae, the essential IMP3 gene encodes a component of the SSU processome, a large ribonucleoprotein complex required for processing of small ribosomal subunit RNA precursors. Mutation of the IMP3 termination codon to a sense codon resulted in a viable mutant allele producing a C-terminal elongated form of the Imp3 protein. A strain expressing the mutant allele displayed ribosome biogenesis defects equivalent to IMP3 depletion. This hypomorphic allele represented a unique opportunity to investigate and better understand the Imp3p functions. We demonstrated that the +1 frameshifting was increased in the mutant strain. Further characterizations revealed involvement of the Imp3 protein in DNA repair and telomere length control, pointing to a functional relationship between both pathways and ribosome biogenesis.	[Cosnier, Bruno; Hatin, Isabelle; Namy, Olivier; Denmat, Sylvie Hermann-Le; Rousset, Jean-Pierre; Fabret, Celine] IGM, CNRS, UMR 8621, Orsay, France; [Cosnier, Bruno; Hatin, Isabelle; Namy, Olivier; Rousset, Jean-Pierre] Univ Paris Sud, Orsay, France; [Fabret, Celine] Univ Paris 06, Paris, France; [Kwapisz, Marta; Morillon, Antonin] Inst Curie, UMR 3244, Paris, France; [Denmat, Sylvie Hermann-Le] Ecole Normale Super, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Cosnier, B (corresponding author), IGM, CNRS, UMR 8621, Orsay, France.	celine.fabret@igmors.u-psud.fr	Namy, olivier/B-8906-2008; Namy, Olivier/ABD-4379-2020; Morillon, Antonin/M-4751-2017	Morillon, Antonin/0000-0002-0575-5264; Hatin, Isabelle/0000-0002-4428-3079; Namy, Olivier/0000-0002-1143-5961	"Association Francaise contre les Myopathies" [9584, 10683]; "Association pour la Recherche sur le Cancer" [5097]; "Agence Nationale pour la Recherche"; French Ministry of Education and Research (MENESR); "Fondation pour la Recherche Medicale"	"Association Francaise contre les Myopathies"(Association Francaise contre les Myopathies); "Association pour la Recherche sur le Cancer"(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); "Agence Nationale pour la Recherche"(French National Research Agency (ANR)); French Ministry of Education and Research (MENESR); "Fondation pour la Recherche Medicale"(Fondation pour la Recherche Medicale)	This work was supported by the "Association Francaise contre les Myopathies" (grants N<SUP>o</SUP> 9584 and 10683 to JPR), by the "Association pour la Recherche sur le Cancer" (grant N<SUP>o</SUP> 5097 to JPR), by the "Agence Nationale pour la Recherche" (REGULncRNA to AM, and MK funding). BC was funded by fellowships from the French Ministry of Education and Research (MENESR) and from the "Fondation pour la Recherche Medicale". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudin-Baillieu A, 2009, NUCLEIC ACIDS RES, V37, P7665, DOI 10.1093/nar/gkp816; BELTRAME M, 1995, EMBO J, V14, P4350, DOI 10.1002/j.1460-2075.1995.tb00109.x; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; BIANCHI V, 1986, J BIOL CHEM, V261, P6037; Cadet J, 1999, MUTAT RES-FUND MOL M, V424, P9, DOI 10.1016/S0027-5107(99)00004-4; [Collart MASO Whiley NY], 2003, CURRENT PROTOCOLS MO; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; CULBERTSON MR, 1980, GENETICS, V95, P833; Dang VD, 1996, MOL MICROBIOL, V22, P681, DOI 10.1046/j.1365-2958.1996.d01-1715.x; Dunbar DA, 1997, MOL CELL BIOL, V17, P5803, DOI 10.1128/MCB.17.10.5803; Fabret C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-22; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Furtado C, 2007, EXP PARASITOL, V116, P25, DOI 10.1016/j.exppara.2006.11.001; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Gerczei T, 2004, P NATL ACAD SCI USA, V101, P15301, DOI 10.1073/pnas.0406819101; Gerczei T, 2009, J MOL BIOL, V390, P991, DOI 10.1016/j.jmb.2009.05.072; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Granneman S, 2003, NUCLEIC ACIDS RES, V31, P1877, DOI 10.1093/nar/gkg300; Hainrichson M, 2008, ORG BIOMOL CHEM, V6, P227, DOI 10.1039/b712690p; Hsieh YC, 2007, BIOCHEM J, V408, P387, DOI 10.1042/BJ20070968; Hsu CL, 2004, NUCLEIC ACIDS RES, V32, P511, DOI 10.1093/nar/gkh203; HUGHES JMX, 1991, EMBO J, V10, P4231, DOI 10.1002/j.1460-2075.1991.tb05001.x; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; James P, 1996, GENETICS, V144, P1425; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Lee J, 2010, NUCL ACIDS RES; Lee SJ, 1997, P NATL ACAD SCI USA, V94, P13536, DOI 10.1073/pnas.94.25.13536; Lee SJ, 1999, MOL CELL BIOL, V19, P5441; Lew JE, 1998, MOL CELL BIOL, V18, P6121, DOI 10.1128/MCB.18.10.6121; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luke B, 2009, EMBO J, V28, P2503, DOI 10.1038/emboj.2009.166; Luke B, 2008, MOL CELL, V32, P465, DOI 10.1016/j.molcel.2008.10.019; Meskauskas A, 2003, MOL CELL BIOL, V23, P1602, DOI 10.1128/MCB.23.5.1602-1613.2003; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Pike BL, 2007, MOL CELL BIOL, V27, P6532, DOI 10.1128/MCB.00471-07; Ramotar D, 2003, CURR GENET, V43, P213, DOI 10.1007/s00294-003-0396-1; Sharma K, 1999, MOL CELL BIOL, V19, P6012; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; Torchet C, 1998, RNA, V4, P1636, DOI 10.1017/S1355838298981511; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261	43	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19500	10.1371/journal.pone.0019500	http://dx.doi.org/10.1371/journal.pone.0019500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559332	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700197
J	Gomez, JAL; Hendrickx, APA; Willems, RJ; Top, J; Sava, I; Huebner, J; Witte, W; Werner, G				Gomez, Jenny A. Laverde; Hendrickx, Antoni P. A.; Willems, Rob J.; Top, Janetta; Sava, Irina; Huebner, Johannes; Witte, Wolfgang; Werner, Guido			Intra- and Interspecies Genomic Transfer of the Enterococcus faecalis Pathogenicity Island	PLOS ONE			English	Article							BIOFILM FORMATION; GENETIC-CHARACTERIZATION; SURFACE PROTEIN; VIBRIO-CHOLERAE; STAPHYLOCOCCUS-AUREUS; PROLONGED BACTEREMIA; NUCLEOTIDE-SEQUENCE; HORIZONTAL TRANSFER; PEDIOCIN FAMILY; VIRULENCE GENE	Enterococci are the third leading cause of hospital associated infections and have gained increased importance due to their fast adaptation to the clinical environment by acquisition of antibiotic resistance and pathogenicity traits. Enterococcus faecalis harbours a pathogenicity island (PAI) of 153 kb containing several virulence factors including the enterococcal surface protein (esp). Until now only internal fragments of the PAI or larger chromosomal regions containing it have been transfered. Here we demonstrate precise excision, circularization and horizontal transfer of the entire PAI element from the chromosome of E. faecalis strain UW3114. This PAI (ca. 200 kb) contained some deletions and insertions as compared to the PAI of the reference strain MMH594, transferred precisely and integrated site-specifically into the chromosome of E. faecalis (intergenic region) and Enterococcus faecium (tRNAlys). The internal PAI structure was maintained after transfer. We assessed phenotypic changes accompanying acquisition of the PAI and expression of some of its determinants. The esp gene is expressed on the surface of donor and both transconjugants. Biofilm formation and cytolytic activity were enhanced in E. faecalis transconjugants after acquisition of the PAI. No differences in pathogenicity of E. faecalis were detected using a mouse bacteraemia and a mouse peritonitis models (tail vein and intraperitoneal injection). A 66 kb conjugative pheromone-responsive plasmid encoding erm(B) (pLG2) that was transferred in parallel with the PAI was sequenced. pLG2 is a pheromone responsive plasmid that probably promotes the PAI horizontal transfer, encodes antibiotic resistance features and contains complete replication and conjugation modules of enterococcal origin in a mosaic-like composition. The E. faecalis PAI can undergo precise intra-and interspecies transfer probably with the help of conjugative elements like conjugative resistance plasmids, supporting the role of horizontal gene transfer and antibiotic selective pressure in the successful establishment of certain enterococci as nosocomial pathogens.	[Gomez, Jenny A. Laverde; Witte, Wolfgang; Werner, Guido] Robert Koch Inst, Wernigerode Branch, Wernigerode, Germany; [Hendrickx, Antoni P. A.; Willems, Rob J.; Top, Janetta] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Sava, Irina; Huebner, Johannes] Freiburg Univ Hosp, Div Infect Dis, Dept Med, Freiburg, Germany	Robert Koch Institute; Utrecht University; Utrecht University Medical Center; University of Freiburg	Gomez, JAL (corresponding author), Robert Koch Inst, Wernigerode Branch, Wernigerode, Germany.	wernerg@rki.de	Hendrickx, Antoni/AAN-1789-2021; Willems, Rob JL/E-3681-2010	Willems, Rob JL/0000-0002-7370-0812; Huebner, Johannes/0000-0003-1232-4646; Top, Janetta/0000-0002-4620-8128; Hendrickx, Antoni P.A./0000-0003-4431-9323	EU [LSHE-CT-2007-037410]	EU(European Commission)	This work was supported by the EU funded-project "Approaches to Control multi-resistant enterococci (ACE)" LSHE-CT-2007-037410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakra A, 2007, APPL ENVIRON MICROB, V73, P2207, DOI 10.1128/AEM.01599-06; Aymerich T, 1996, APPL ENVIRON MICROB, V62, P1676, DOI 10.1128/AEM.62.5.1676-1682.1996; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Casaus P, 1997, MICROBIOL-SGM, V143, P2287, DOI 10.1099/00221287-143-7-2287; Cintas LM, 1997, APPL ENVIRON MICROB, V63, P4321, DOI 10.1128/AEM.63.11.4321-4330.1997; Cintas LM, 1998, J BACTERIOL, V180, P1988, DOI 10.1128/JB.180.8.1988-1994.1998; Coburn PS, 2007, MOL MICROBIOL, V63, P530, DOI 10.1111/j.1365-2958.2006.05520.x; del Campo R, 2001, ANTIMICROB AGENTS CH, V45, P905, DOI 10.1128/AAC.45.3.905-912.2001; Di Rosa R, 2006, FEMS MICROBIOL LETT, V256, P145, DOI 10.1111/j.1574-6968.2006.00112.x; Doublet B, 2005, MOL MICROBIOL, V55, P1911, DOI 10.1111/j.1365-2958.2005.04520.x; Floriano B, 1998, APPL ENVIRON MICROB, V64, P4883; Francia MV, 2001, PLASMID, V46, P117, DOI 10.1006/plas.2001.1533; Freitas AR, 2009, ESCMID C ENT AN MAN, P34; Gilmore MS, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P301; GILMORE MS, 1994, J BACTERIOL, V176, P7335, DOI 10.1128/JB.176.23.7335-7344.1994; Hallgren A, 2009, INT J MED MICROBIOL, V299, P323, DOI 10.1016/j.ijmm.2008.10.001; Heikens E, 2007, J BACTERIOL, V189, P8233, DOI 10.1128/JB.01205-07; Hendrickx APA, 2007, J BACTERIOL, V189, P8321, DOI 10.1128/JB.00664-07; Hirt H, 2005, J BACTERIOL, V187, P1044, DOI 10.1128/JB.187.3.1044-1054.2005; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Hufnagel M, 2004, J INFECT DIS, V189, P420, DOI 10.1086/381150; Kristich CJ, 2004, J BACTERIOL, V186, P154, DOI 10.1128/JB.186.1.154-163.2004; Laverde-Gomez JA, 2010, INT J MED MICROBIOL; Leavis H, 2004, J BACTERIOL, V186, P672, DOI 10.1128/JB.186.3.672-682.2004; Lesic B, 2005, J BACTERIOL, V187, P3352, DOI 10.1128/JB.187.10.3352-3358.2005; Lesic B, 2004, MOL MICROBIOL, V52, P1337, DOI 10.1111/j.1365-2958.2004.04073.x; Lioy VS, 2010, PLASMID, V64, P1, DOI 10.1016/j.plasmid.2010.04.002; Manson JM, 2010, P NATL ACAD SCI US; McBride SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000582; McBride SM, 2009, J BACTERIOL, V191, P3392, DOI 10.1128/JB.00031-09; Middendorf B, 2004, J BACTERIOL, V186, P3086, DOI 10.1128/JB.186.10.3086-3096.2004; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; Muniesa M, 2006, INFECT IMMUN, V74, P4190, DOI 10.1128/IAI.00926-05; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Murphy RA, 2008, J BACTERIOL, V190, P636, DOI 10.1128/JB.00562-07; Novais C, 2004, ANTIMICROB AGENTS CH, V48, P3613, DOI 10.1128/AAC.48.9.3613-3617.2004; O'Shea YA, 2002, FEMS MICROBIOL LETT, V214, P153, DOI 10.1016/S0378-1097(02)00880-7; Oancea C, 2004, J ANTIMICROB CHEMOTH, V54, P232, DOI 10.1093/jac/dkh249; Rajanna C, 2003, J BACTERIOL, V185, P6893, DOI 10.1128/JB.185.23.6893-6901.2003; Ruiz-Barba JL, 2007, PLASMID, V57, P175, DOI 10.1016/j.plasmid.2006.06.003; Sakellaris H, 2004, MOL MICROBIOL, V52, P1329, DOI 10.1111/j.1365-2958.2004.04048.x; Sandoe JAT, 2003, J MED MICROBIOL, V52, P547, DOI 10.1099/jmm.0.05201-0; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Schubert S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000257; Schwarz S, 2001, INT J ANTIMICROB AG, V17, P431, DOI 10.1016/S0924-8579(01)00297-7; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Shankar N, 2006, J CLIN MICROBIOL, V44, P4200, DOI 10.1128/JCM.01218-06; SHAW JH, 1985, J BACTERIOL, V164, P782, DOI 10.1128/JB.164.2.782-796.1985; Solheim M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-194; Tendolkar PM, 2004, INFECT IMMUN, V72, P6032, DOI 10.1128/IAI.72.10.6032-6039.2004; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Toledo-Arana A, 2001, APPL ENVIRON MICROB, V67, P4538, DOI 10.1128/AEM.67.10.4538-4545.2001; Trevors JT, 1996, ANTON LEEUW INT J G, V69, P293, DOI 10.1007/BF00399618; Ubeda C, 2003, MOL MICROBIOL, V49, P193, DOI 10.1046/j.1365-2958.2003.03577.x; van Schaik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-239; Van Wamel WJB, 2007, INFECT IMMUN, V75, P924, DOI 10.1128/IAI.00941-06; Vancanneyt M, 2002, APPL ENVIRON MICROB, V68, P1381, DOI 10.1128/AEM.68.3.1381-1391.2002; Vankerckhoven V, 2004, J CLIN MICROBIOL, V42, P4473, DOI 10.1128/JCM.42.10.4473-4479.2004; Weaver KE, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P219; Weaver KE, 2009, PLASMID, V61, P94, DOI 10.1016/j.plasmid.2008.11.004; Werner G, 2003, J CLIN MICROBIOL, V41, P1499, DOI 10.1128/JCM.41.4.1499-1506.2003; Werner G, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-28; Werner G, 2010, INT J ANTIMICROB AG, V35, P119, DOI 10.1016/j.ijantimicag.2009.10.012; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	67	40	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e16720	10.1371/journal.pone.0016720	http://dx.doi.org/10.1371/journal.pone.0016720			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559082	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700003
J	Hoper, D; Hoffmann, B; Beer, M				Hoeper, Dirk; Hoffmann, Bernd; Beer, Martin			A Comprehensive Deep Sequencing Strategy for Full-Length Genomes of Influenza A	PLOS ONE			English	Article							VIRUS	Driven by the impact of influenza A viruses on human and animal health, much research is conducted on this pathogen. To support this research, we designed an all influenza A-embracing reverse transcription-PCR (RT-PCR) for the generation of DNA from influenza A virus negative strand RNA genome segments for full-length genome deep sequencing on a Genome Sequencer FLX instrument. For high reliability, the RT-PCRs are designed such that every genome segment is divided into two amplicons and for the most variable segments redundancy is included. Moreover, to minimize the risk of contamination of diagnostic real-time PCRs by sequencing amplicons, RT-PCR does not generate amplicons that are amenable to RT-qPCR detection. With the presented protocol we were able to generate virtually all amplicons (99.3% success rate) from isolates representing all so far known 16 hemagglutinin and 9 neuraminidase subtypes and from an additional 2009 pandemic influenza A H1N1 virus. Three isolates were sequenced to analyze the suitability of the DNA for sequencing. Moreover, we provide a short R script that disambiguates the sequences of the primers used. We show that using unambiguous primer sequences for read trimming prior to assembly with the genome sequencer assembler software results in higher quality of the final genome sequences. Using the disambiguated primer sequences, high quality full-length sequences for the three isolates used for sequencing trials could be established from the raw data in de novo assemblies.	[Hoeper, Dirk; Hoffmann, Bernd; Beer, Martin] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany	Friedrich Loeffler Institute	Hoper, D (corresponding author), Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany.	martin.beer@fli.bund.de		Hoper, Dirk/0000-0001-8408-2274	Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany [FSI 1-1.1.2.]; European Union [223498]	Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany; European Union(European Commission)	This project was supported by the Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany (project no. FSI 1-1.1.2.) and by the European Union FP7 project "European Management Platform for Emerging and Re-emerging Infectious Disease Entities (EMPERIE)'' (no. 223498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHARIF D, 2010, BIOL SEQUENCES RETRI; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Hoper D, 2009, J CLIN MICROBIOL, V47, P674, DOI 10.1128/JCM.01028-08; Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020; Huang YH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-224; Leifer I, 2010, J GEN VIROL, V91, P2687, DOI 10.1099/vir.0.023200-0; Monger WA, 2010, ARCH VIROL, V155, P1515, DOI 10.1007/s00705-010-0694-0; *NOM COMM INT UN B, 1986, P NATL ACAD SCI USA, V83, P4; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; R Development Core Team, 2009, R FDN STAT COMP; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SIMONS JF, 2007, RNA VIRUS SEQUENCING; WILEY G, 2009, CURR PROTOC HUM GENE, V61; [No title captured]	16	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19075	10.1371/journal.pone.0019075	http://dx.doi.org/10.1371/journal.pone.0019075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559493	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700061
J	Hughes, ATL; Guilding, C; Piggins, HD				Hughes, Alun T. L.; Guilding, Clare; Piggins, Hugh D.			Neuropeptide Signaling Differentially Affects Phase Maintenance and Rhythm Generation in SCN and Extra-SCN Circadian Oscillators	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; NUCLEI CELLULAR RHYTHMICITY; RECEPTOR MESSENGER-RNA; SUPRACHIASMATIC NUCLEUS; VPAC(2) RECEPTOR; GENE-EXPRESSION; MICE LACKING; PHOTIC REGULATION; PERIOD HOMOLOGS; CLOCK	Circadian rhythms in physiology and behavior are coordinated by the brain's dominant circadian pacemaker located in the suprachiasmatic nuclei (SCN) of the hypothalamus. Vasoactive intestinal polypeptide (VIP) and its receptor, VPAC(2), play important roles in the functioning of the SCN pacemaker. Mice lacking VPAC(2) receptors (Vipr2(-/-)) express disrupted behavioral and metabolic rhythms and show altered SCN neuronal activity and clock gene expression. Within the brain, the SCN is not the only site containing endogenous circadian oscillators, nor is it the only site of VPAC(2) receptor expression; both VPAC(2) receptors and rhythmic clock gene/protein expression have been noted in the arcuate (Arc) and dorsomedial (DMH) nuclei of the mediobasal hypothalamus, and in the pituitary gland. The functional role of VPAC(2) receptors in rhythm generation and maintenance in these tissues is, however, unknown. We used wild type (WT) and Vipr2(-/-) mice expressing a luciferase reporter (PER2::LUC) to investigate whether circadian rhythms in the clock gene protein PER2 in these extra-SCN tissues were compromised by the absence of the VPAC(2) receptor. Vipr2(-/-) SCN cultures expressed significantly lower amplitude PER2:: LUC oscillations than WT SCN. Surprisingly, in Vipr2(-/-) Arc/ME/PT complex (Arc, median eminence and pars tuberalis), DMH and pituitary, the period, amplitude and rate of damping of rhythms were not significantly different to WT. Intriguingly, while we found WT SCN and Arc/ME/PT tissues to maintain a consistent circadian phase when cultured, the phase of corresponding Vipr2(-/-) cultures was reset by cull/culture procedure. These data demonstrate that while the main rhythm parameters of extra-SCN circadian oscillations are maintained in Vipr2(-/-) mice, the ability of these oscillators to resist phase shifts is compromised. These deficiencies may contribute towards the aberrant behavior and metabolism associated with Vipr2(-/-) animals. Further, our data indicate a link between circadian rhythm strength and the ability of tissues to resist circadian phase resetting.	[Hughes, Alun T. L.; Guilding, Clare; Piggins, Hugh D.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Hughes, ATL (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	alun.t.hughes@manchester.ac.uk	Hughes, Alun/HCI-2220-2022	Guilding, Clare/0000-0003-2823-1575; Piggins, Hugh/0000-0003-2555-9858; Hughes, Alun/0000-0001-7460-3216	Biology and Biotechnology Research Council (BBSRC); Wellcome Trust [WT086352]; Biotechnology and Biological Sciences Research Council [BB/G004307/1] Funding Source: researchfish	Biology and Biotechnology Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by project grants to HDP from the Biology and Biotechnology Research Council (BBSRC) and Wellcome Trust (WT086352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Asnicar MA, 2002, ENDOCRINOLOGY, V143, P3994, DOI 10.1210/en.2002-220354; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bechtold DA, 2008, AM J PHYSIOL-REG I, V294, pR344, DOI 10.1152/ajpregu.00667.2007; Bernardis LL, 1998, P SOC EXP BIOL MED, V218, P284; Brown TM, 2007, J NEUROPHYSIOL, V97, P2553, DOI 10.1152/jn.01206.2006; Brown TM, 2005, J NEUROSCI, V25, P11155, DOI 10.1523/JNEUROSCI.3821-05.2005; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bur IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015316; Chauhan D, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S1; Ciarleglio CM, 2009, J NEUROSCI, V29, P1670, DOI 10.1523/JNEUROSCI.3801-08.2009; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Dolatshad H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009855; Dragich JM, 2010, EUR J NEUROSCI, V31, P864, DOI 10.1111/j.1460-9568.2010.07119.x; Gerhold LM, 2001, BRAIN RES, V919, P48, DOI 10.1016/S0006-8993(01)02993-6; Guilding C, 2010, NEUROSCIENCE, V169, P1630, DOI 10.1016/j.neuroscience.2010.06.015; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Guilding C, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-28; Hannibal J, 2011, AM J PHYSL IN PRESS; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hastings M H, 2003, Novartis Found Symp, V253, P203; Hastings M.H., 1999, J NEUROSCI, V11, P1; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Hezareh M, 1996, ANN NY ACAD SCI, V805, P315; HOUBEN H, 1993, MOL CELL ENDOCRINOL, V97, P159, DOI 10.1016/0303-7207(93)90223-7; Hu WP, 2011, SLEEP, V34, P49, DOI 10.1093/sleep/34.1.49; Hughes ATL, 2008, J BIOL RHYTHM, V23, P211, DOI 10.1177/0748730408316290; Hughes ATL, 2008, J NEUROCHEM, V106, P1646, DOI 10.1111/j.1471-4159.2008.05520.x; Hughes AT, 2004, J NEUROSCI, V24, P3522, DOI 10.1523/JNEUROSCI.5345-03.2004; IBATA Y, 1989, NEUROSCI LETT, V97, P1, DOI 10.1016/0304-3940(89)90129-8; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Kalamatianos T, 2004, J COMP NEUROL, V475, P19, DOI 10.1002/cne.20168; Kallo I, 2004, EUR J NEUROSCI, V19, P2201, DOI 10.1111/j.0953-816X.2004.03335.x; KALSBEEK A, 1993, J COMP NEUROL, V332, P293, DOI 10.1002/cne.903320304; Kamichi S, 2005, BRAIN RES, V1032, P162, DOI 10.1016/j.brainres.2004.10.068; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kriegsfeld LJ, 2003, EUR J NEUROSCI, V17, P212, DOI 10.1046/j.1460-9568.2003.02431.x; LAM KSL, 1991, NEUROENDOCRINOLOGY, V53, P45, DOI 10.1159/000125795; Loh DH, 2008, NEUROENDOCRINOLOGY, V88, P246, DOI 10.1159/000140676; Majumdar ID, 2011, CURR OPIN ENDOCRINOL, V18, P68, DOI 10.1097/MED.0b013e328340ff93; Marpegan L, 2009, J BIOL RHYTHM, V24, P135, DOI 10.1177/0748730409332042; Masumoto K, 2010, CURR BIOL, V20, P2199, DOI 10.1016/j.cub.2010.11.038; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Messager S, 2000, EUR J NEUROSCI, V12, P2865, DOI 10.1046/j.1460-9568.2000.00174.x; MOREL G, 1982, NEUROENDOCRINOLOGY, V34, P85, DOI 10.1159/000123282; Oster H, 2003, GENE DEV, V17, P1366, DOI 10.1101/gad.256103; Pantazopoulos H, 2010, AM J PHYSIOL-REG I, V299, pR379, DOI 10.1152/ajpregu.00176.2010; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PIGGINS HD, 1995, J NEUROSCI, V15, P5612; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Power A, 2010, J BIOL RHYTHM, V25, P235, DOI 10.1177/0748730410374446; Reed HE, 2001, EUR J NEUROSCI, V13, P839, DOI 10.1046/j.0953-816x.2000.01437.x; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sahu A, 2004, ENDOCRINOLOGY, V145, P2613, DOI 10.1210/en.2004-0032; Sakamoto K, 1998, J BIOL CHEM, V273, P27039, DOI 10.1074/jbc.273.42.27039; Schroeder A, 2011, AM J PHYSIOL-HEART C, V300, pH241, DOI 10.1152/ajpheart.00190.2010; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Sheward WJ, 2007, J NEUROSCI, V27, P4351, DOI 10.1523/JNEUROSCI.4843-06.2007; Sheward WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009783; SHEWARD WJ, 1995, NEUROSCIENCE, V67, P409, DOI 10.1016/0306-4522(95)00048-N; Shieh KR, 2005, J BIOMED SCI, V12, P209, DOI 10.1007/s11373-004-8176-6; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; VANDENPOL AN, 1980, J COMP NEUROL, V191, P661, DOI 10.1002/cne.901910410; Vosko AM, 2007, GEN COMP ENDOCR, V152, P165, DOI 10.1016/j.ygcen.2007.04.018; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	77	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18926	10.1371/journal.pone.0018926	http://dx.doi.org/10.1371/journal.pone.0018926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559484	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000290024700037
J	Ibarrola-Villava, M; Fernandez, LP; Alonso, S; Boyano, MD; Pena-Chilet, M; Pita, G; Aviles, JA; Mayor, M; Gomez-Fernandez, C; Casado, B; Martin-Gonzalez, M; Izagirre, N; De la Rua, C; Asumendi, A; Perez-Yarza, G; Arroyo-Berdugo, Y; Boldo, E; Lozoya, R; Torrijos-Aguilar, A; Pitarch, A; Pitarch, G; Sanchez-Motilla, JM; Valcuende-Cavero, F; Tomas-Cabedo, G; Perez-Pastor, G; Diaz-Perez, JL; Gardeazabal, J; de Lizarduy, IM; Sanchez-Diez, A; Valdes, C; Pizarro, A; Casado, M; Carretero, G; Botella-Estrada, R; Nagore, E; Lazaro, P; Lluch, A; Benitez, J; Martinez-Cadenas, C; Ribas, G				Ibarrola-Villava, Maider; Fernandez, Lara P.; Alonso, Santos; Dolores Boyano, M.; Pena-Chilet, Maria; Pita, Guillermo; Aviles, Jose A.; Mayor, Matias; Gomez-Fernandez, Cristina; Casado, Beatriz; Martin-Gonzalez, Manuel; Izagirre, Neskuts; De la Rua, Concepcion; Asumendi, Aintzane; Perez-Yarza, Gorka; Arroyo-Berdugo, Yoana; Boldo, Enrique; Lozoya, Rafael; Torrijos-Aguilar, Arantxa; Pitarch, Ana; Pitarch, Gerard; Sanchez-Motilla, Jose M.; Valcuende-Cavero, Francisca; Tomas-Cabedo, Gloria; Perez-Pastor, Gemma; Diaz-Perez, Jose L.; Gardeazabal, Jesus; Martinez de Lizarduy, Inigo; Sanchez-Diez, Ana; Valdes, Carlos; Pizarro, Angel; Casado, Mariano; Carretero, Gregorio; Botella-Estrada, Rafael; Nagore, Eduardo; Lazaro, Pablo; Lluch, Ana; Benitez, Javier; Martinez-Cadenas, Conrado; Ribas, Gloria			A Customized Pigmentation SNP Array Identifies a Novel SNP Associated with Melanoma Predisposition in the SLC45A2 Gene	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MALIGNANT-MELANOMA; OCULOCUTANEOUS ALBINISM; CUTANEOUS MELANOMA; TRANSCRIPTIONAL REGULATION; SKIN PIGMENTATION; COLOR VARIATION; RECEPTOR GENE; MATP GENE; VARIANTS	As the incidence of Malignant Melanoma (MM) reflects an interaction between skin colour and UV exposure, variations in genes implicated in pigmentation and tanning response to UV may be associated with susceptibility to MM. In this study, 363 SNPs in 65 gene regions belonging to the pigmentation pathway have been successfully genotyped using a SNP array. Five hundred and ninety MM cases and 507 controls were analyzed in a discovery phase I. Ten candidate SNPs based on a p-value threshold of 0.01 were identified. Two of them, rs35414 (SLC45A2) and rs2069398 (SILV/CKD2), were statistically significant after conservative Bonferroni correction. The best six SNPs were further tested in an independent Spanish series (624 MM cases and 789 controls). A novel SNP located on the SLC45A2 gene (rs35414) was found to be significantly associated with melanoma in both phase I and phase II (P < 0.0001). None of the other five SNPs were replicated in this second phase of the study. However, three SNPs in TYR, SILV/CDK2 and ADAMTS20 genes (rs17793678, rs2069398 and rs1510521 respectively) had an overall p-value < 0.05 when considering the whole DNA collection (1214 MM cases and 1296 controls). Both the SLC45A2 and the SILV/CDK2 variants behave as protective alleles, while the TYR and ADAMTS20 variants seem to function as risk alleles. Cumulative effects were detected when these four variants were considered together. Furthermore, individuals carrying two or more mutations in MC1R, a well-known low penetrance melanoma-predisposing gene, had a decreased MM risk if concurrently bearing the SLC45A2 protective variant. To our knowledge, this is the largest study on Spanish sporadic MM cases to date.	[Ibarrola-Villava, Maider; Pena-Chilet, Maria; Lluch, Ana; Ribas, Gloria] Fdn Hosp Clin Univ INCLIVA, Serv Oncol Med & Hematol, Valencia, Spain; [Ibarrola-Villava, Maider; Fernandez, Lara P.; Pita, Guillermo; Benitez, Javier; Ribas, Gloria] CNIO, Programa Genet Humana, Madrid, Spain; [Alonso, Santos; Izagirre, Neskuts; De la Rua, Concepcion] Univ Basque Country, Dept Genet Antropol Fis & Fisiol Anim, Leioa, Spain; [Dolores Boyano, M.; Asumendi, Aintzane; Perez-Yarza, Gorka; Arroyo-Berdugo, Yoana] Univ Basque Country, Dept Biol Celular & Histol, Leioa, Spain; [Aviles, Jose A.; Lazaro, Pablo] Hosp Gen Gregorio Maranon, Dept Dermatol, Madrid, Spain; [Mayor, Matias; Gomez-Fernandez, Cristina; Casado, Beatriz; Pizarro, Angel; Casado, Mariano] Hosp La Paz, Dept Dermatol, Madrid, Spain; [Martin-Gonzalez, Manuel] Hosp Ramon & Cajal, Dept Dermatol, E-28034 Madrid, Spain; [Boldo, Enrique; Lozoya, Rafael] Hosp Prov Castellon, Unidad Cirugia Oncol, Castellon de La Plana, Spain; [Torrijos-Aguilar, Arantxa] Hosp Prov Castellon, Serv Dermatol, Castellon de La Plana, Spain; [Pitarch, Ana; Pitarch, Gerard; Sanchez-Motilla, Jose M.] Hosp Gen Castellon, Serv Dermatol, Castellon de La Plana, Spain; [Valcuende-Cavero, Francisca; Tomas-Cabedo, Gloria; Perez-Pastor, Gemma] Hosp La Plana, Serv Dermatol, Vila Real, Castellon, Spain; [Diaz-Perez, Jose L.] Hosp Cruces, Serv Dermatol, Baracaldo, Spain; [Gardeazabal, Jesus; Martinez de Lizarduy, Inigo; Sanchez-Diez, Ana; Valdes, Carlos] Hosp Basurto, Serv Dermatol, Bilbao, Spain; [Carretero, Gregorio] Hosp Dr Negrin, Dept Dermatol, Las Palmas Gran Canaria, Spain; [Botella-Estrada, Rafael; Nagore, Eduardo] Inst Valenciano Oncol, Valencia, Spain; [Martinez-Cadenas, Conrado] Hosp Prov Castellon, Lab Biopatol Mol, Castellon de La Plana, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); University of Basque Country; University of Basque Country; General University Gregorio Maranon Hospital; Hospital Universitario La Paz; Hospital Universitario Ramon y Cajal; Hospital Universitario Cruces; Basurto Hospital; Instituto Valenciano De Oncologia	Ibarrola-Villava, M (corresponding author), Fdn Hosp Clin Univ INCLIVA, Serv Oncol Med & Hematol, Valencia, Spain.	martinezconrado@yahoo.es	Nagore, Eduardo/Z-2126-2019; Gardeazabal, Jesus/E-1751-2012; Álvarez, Lara Fernández/Z-4685-2019; Alonso, Santos/L-8316-2014; Peña-Chilet, Maria/A-8387-2015; Ribas-Despuig, Gloria/M-6190-2017; Perez-Yarza, Gorka/ABF-7159-2021; Boldo, Enrique/AAP-7388-2020; Lluch, Ana/R-5493-2019; Asumendi, Aintzane/ABF-7001-2021; BOYANO LOPEZ, MARIA DOLORES/ABF-6668-2021; Alvarez, Lara Paula Fernandez/ABF-3692-2020; Boyano, Maria Dolores/D-9114-2012; Ribas, Gloria/K-3379-2013	Nagore, Eduardo/0000-0003-3433-8707; Alonso, Santos/0000-0003-0221-4048; Peña-Chilet, Maria/0000-0002-6445-9617; Boldo, Enrique/0000-0001-6866-9796; Lluch, Ana/0000-0003-2766-407X; BOYANO LOPEZ, MARIA DOLORES/0000-0001-6051-1054; Bowcock, Anne/0000-0001-8691-9090; IZAGIRRE ARRIBALZAGA, NESKUTS/0000-0002-3345-9825; Ibarrola-Villava, Maider/0000-0003-0946-8075; Valcuende-Cavero, Francisca/0000-0002-4033-0771; Fernandez Alvarez, Lara Paula/0000-0001-8830-6300; DE LA RUA VACA, CONCEPCION/0000-0003-4599-0020; PEREZYARZA, GORKA/0000-0003-3236-491X; Ribas, Gloria/0000-0001-6883-4130; Asumendi, Aintzane/0000-0002-2156-2323	Ministerio de Educacion y Ciencia (MEC) [SAF2007-65542-C02-01, SAF2009_07072E, BES-2008-009234, CP08-0069]; Ministerio de Ciencia e Innovacion [CGL2008-04066/BOS]; Fundacion Mutua Madrilena and the Fundacion Hospital Provincial de Castellon, Spain;  [RD06-0020-1060]	Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Mutua Madrilena and the Fundacion Hospital Provincial de Castellon, Spain; 	This study was supported by grants from the Ministerio de Educacion y Ciencia (MEC) [SAF2007-65542-C02-01, SAF2009_07072E; BES-2008-009234 to M.I.V. and CP08-0069 "Miquel Servet SNS Contract'' to G.R.]; Ministerio de Ciencia e Innovacion [CGL2008-04066/BOS]; Network RD06-0020-1060; the Fundacion Mutua Madrilena and the Fundacion Hospital Provincial de Castellon, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-74; BAKKER ABH, 1994, J EXP MED, V179, P1005, DOI 10.1084/jem.179.3.1005; Bataille V, 2003, EUR J CANCER, V39, P1341, DOI 10.1016/S0959-8049(03)00313-7; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Bishop JAN, 2005, DRUG TODAY, V41, P193, DOI 10.1358/dot.2005.41.3.892524; Bishop JN, 2006, BRIT J HOSP MED, V67, P299; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Costin GE, 2003, J CELL SCI, V116, P3203, DOI 10.1242/jcs.00598; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Du JY, 2002, J BIOL CHEM, V277, P402, DOI 10.1074/jbc.M110229200; Duffy DL, 2010, AM J HUM GENET, V87, P6, DOI 10.1016/j.ajhg.2010.05.017; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Duffy DL, 2004, HUM MOL GENET, V13, P447, DOI 10.1093/hmg/ddh043; Fargnoli MC, 2006, MELANOMA RES, V16, P175, DOI 10.1097/01.cmr.0000198454.11580.b5; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; Fernandez LP, 2007, CARCINOGENESIS, V28, P1659, DOI 10.1093/carcin/bgm084; Fernandez LP, 2009, EXP DERMATOL, V18, P634, DOI 10.1111/j.1600-0625.2009.00846.x; Fukamachi S, 2001, NAT GENET, V28, P381, DOI 10.1038/ng584; Gerstenblith MR, 2007, HUM MUTAT, V28, P495, DOI 10.1002/humu.20476; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Graf J, 2007, HUM MUTAT, V28, P710, DOI 10.1002/humu.20504; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Guedj M, 2008, HUM MUTAT, V29, P1154, DOI 10.1002/humu.20823; Gunnarsson U, 2007, GENETICS, V175, P867, DOI 10.1534/genetics.106.063107; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014; Ibarrola-Villava M, EXP DERMATOL, V19, P836; Kushimoto T, 2003, PIGM CELL RES, V16, P237, DOI 10.1034/j.1600-0749.2003.00034.x; Laayouni H, 2010, HUM GENET, V127, P455, DOI 10.1007/s00439-010-0798-3; LERNER AB, 1949, J BIOL CHEM, V178, P185; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Mariat D, 2003, GENET SEL EVOL, V35, P119, DOI 10.1051/gse:2002039; Matichard E, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011536; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Mohrenweiser HW, 2003, MUTAT RES-FUND MOL M, V526, P93, DOI 10.1016/S0027-5107(03)00049-6; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ontology TG, 2000, NAT GENET, V25; Rao C, 2003, DEVELOPMENT, V130, P4665, DOI 10.1242/dev.00668; Ray K, 2007, PROG RETIN EYE RES, V26, P323, DOI 10.1016/j.preteyeres.2007.01.001; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Saenz S, 2005, ACTAS DERMO-SIFILOGR, V96, P411, DOI 10.1016/S0001-7310(05)73105-7; Scherer D, 2009, INT J CANCER, V125, P1868, DOI 10.1002/ijc.24548; Silver DL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000003; Soejima M, 2006, MOL BIOL EVOL, V23, P179, DOI 10.1093/molbev/msj018; Sturm RA, 2004, TRENDS GENET, V20, P327, DOI 10.1016/j.tig.2004.06.010; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328	51	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19271	10.1371/journal.pone.0019271	http://dx.doi.org/10.1371/journal.pone.0019271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559390	Green Submitted, gold, Green Published			2022-12-25	WOS:000290024700121
J	Jonsson, S; Lundberg, A; Kalvegren, H; Bergstrom, I; Szymanowski, A; Jonasson, L				Jonsson, Simon; Lundberg, Anna; Kalvegren, Hanna; Bergstrom, Ida; Szymanowski, Aleksander; Jonasson, Lena			Increased Levels of Leukocyte-Derived MMP-9 in Patients with Stable Angina Pectoris	PLOS ONE			English	Article							CIRCULATING MATRIX METALLOPROTEINASES; CORONARY-ARTERY-DISEASE; TISSUE INHIBITORS; PLASMA-CONCENTRATIONS; IN-VIVO; MATRIX-METALLOPROTEINASE-9; EXPRESSION; NEUTROPHILS; ACTIVATION; SERUM	Objective: There is a growing interest for matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in plasma as novel biomarkers in coronary artery disease (CAD). We aimed to identify the sources of MMP-8, MMP-9, TIMP-1 and TIMP-2 among peripheral blood cells and further explore whether gene expression or protein release was altered in patients with stable angina pectoris (SA). Methods: In total, plasma MMP-9 was measured in 44 SA patients and 47 healthy controls. From 10 patients and 10 controls, peripheral blood mononuclear cells (PBMC) and neutrophils were isolated and stimulated ex vivo. MMPs, TIMPs and myeloperoxidase were measured in plasma and supernatants by ELISA. The corresponding gene expression was measured by real-time PCR. Results: Neutrophils were the dominant source of MMP-8 and MMP-9. Upon moderate stimulation with IL-8, the neutrophil release of MMP-9 was higher in the SA patients compared with controls (p < 0.05). In PBMC, the TIMP-1 and MMP-9 mRNA expression was higher in SA patients compared with controls, p < 0.01 and 0.05, respectively. There were no differences in plasma levels between patients and controls except for TIMP-2, which was lower in patients, p < 0.01. Conclusion: Measurements of MMPs and TIMPs in plasma may be of limited use. Despite similar plasma levels in SA patients and controls, the leukocyte-derived MMP-9 and TIMP-1 are significantly altered in patients. The findings indicate that the leukocytes are more prone to release and produce MMP-9 in symptomatic and angiographically verified CAD-a phenomenon that may have clinical implications in the course of disease.	[Jonsson, Simon; Lundberg, Anna; Kalvegren, Hanna; Bergstrom, Ida; Szymanowski, Aleksander; Jonasson, Lena] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden	Linkoping University	Jonsson, S (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden.	lena.jonasson@liu.se			Swedish Research Council [2008-2282]; Swedish Heart-Lung Foundation [20060566, 20090489]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	The work was funded by the Swedish Research Council (2008-2282, www.vr.se) and the Swedish Heart-Lung Foundation (20060566, 20090489, www.hjart-lungfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardans JA, 2002, J LEUKOCYTE BIOL, V71, P1012; Aznaouridis K, 2007, ATHEROSCLEROSIS, V195, P212, DOI 10.1016/j.atherosclerosis.2006.12.015; Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Boekholdt SM, 2004, ARTERIOSCL THROM VAS, V24, P1503, DOI 10.1161/01.ATV.0000134294.54422.2e; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brunner S, 2010, AM J CARDIOL, V105, P429, DOI 10.1016/j.amjcard.2009.10.013; CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585; Claesson R, 2002, J PERIODONTAL RES, V37, P353, DOI 10.1034/j.1600-0765.2002.00365.x; Fang L, 2010, CLIN SCI, V119, P175, DOI 10.1042/CS20100011; Fiotti N, 2008, INT J CARDIOL, V127, P350, DOI 10.1016/j.ijcard.2007.05.011; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Gerlach RF, 2007, CLIN BIOCHEM, V40, P119, DOI 10.1016/j.clinbiochem.2006.10.007; HASTY KA, 1986, J BIOL CHEM, V261, P5645; Houard X, 2009, FASEB J, V23, P1376, DOI 10.1096/fj.08-116202; Inokubo Y, 2001, AM HEART J, V141, P211, DOI 10.1067/mhj.2001.112238; Jefferis BJ, 2010, ATHEROSCLEROSIS, V208, P557, DOI 10.1016/j.atherosclerosis.2009.08.018; Johnatty RN, 1997, J IMMUNOL, V158, P2327; Jones GT, 2006, ARTERIOSCL THROM VAS, V26, pE121, DOI 10.1161/01.ATV.0000226544.93089.7f; Kai HK, 1998, J AM COLL CARDIOL, V32, P368, DOI 10.1016/S0735-1097(98)00250-2; Mannello F, 2008, ARTERIOSCL THROM VAS, V28, P611, DOI 10.1161/ATVBAHA.107.159608; Molloy KJ, 2004, CIRCULATION, V110, P337, DOI 10.1161/01.CIR.0000135588.65188.14; Momiyama Y, 2010, ATHEROSCLEROSIS, V209, P206, DOI 10.1016/j.atherosclerosis.2009.07.037; Morris T, 2009, J IMMUNOL, V183, P2089, DOI 10.4049/jimmunol.0900477; Nanni S, 2007, TRANSL RES, V149, P137, DOI 10.1016/j.trsl.2006.09.001; Negrotto S, 2006, J PHARMACOL EXP THER, V319, P972, DOI 10.1124/jpet.106.109389; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Nijm J, 2005, AM J CARDIOL, V95, P452, DOI 10.1016/j.amjcard.2004.10.009; Noji Y, 2001, CLIN CHEM LAB MED, V39, P380, DOI 10.1515/CCLM.2001.060; Paulsson J, 2007, ATHEROSCLEROSIS, V192, P328, DOI 10.1016/j.atherosclerosis.2006.08.003; Pleiner J, 2004, CIRCULATION, V110, P3349, DOI 10.1161/01.CIR.0000147774.90396.ED; Pugin J, 1999, AM J RESP CELL MOL, V20, P458, DOI 10.1165/ajrcmb.20.3.3311; Rothenbacher D, 2006, ARTERIOSCL THROM VAS, V26, P194, DOI 10.1161/01.ATV.0000191633.52585.14; Sapienza P, 2005, SURGERY, V137, P355, DOI 10.1016/j.surg.2004.10.011; Sarndahl E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001056; Szymanowski A, 2011, PSYCHONEURO IN PRESS; Tayebjee MH, 2006, THROMB HAEMOSTASIS, V95, P202, DOI 10.1055/s-0037-1612586; Tayebjee MH, 2005, AM J CARDIOL, V96, P339, DOI 10.1016/j.amjcard.2005.03.072; Tuomainen AM, 2008, MICROB PATHOGENESIS, V44, P111, DOI 10.1016/j.micpath.2007.08.011; Tuomainen AM, 2007, ARTERIOSCL THROM VAS, V27, P2722, DOI 10.1161/ATVBAHA.107.154831; Zouridakis E, 2004, CIRCULATION, V110, P1747, DOI 10.1161/01.CIR.0000142664.18739.92	44	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19340	10.1371/journal.pone.0019340	http://dx.doi.org/10.1371/journal.pone.0019340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559401	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700142
J	Lau, C; Zhou, IY; Cheung, MM; Chan, KC; Wu, EX				Lau, Condon; Zhou, Iris Y.; Cheung, Matthew M.; Chan, Kevin C.; Wu, Ed X.			BOLD Temporal Dynamics of Rat Superior Colliculus and Lateral Geniculate Nucleus following Short Duration Visual Stimulation	PLOS ONE			English	Article							EVENT-RELATED FMRI; FUNCTIONAL MRI; MODEL; RESPONSES; REDUCTION; CONTRAST; GRADIENT; STIMULUS; CORTEX; ECHO	Background: The superior colliculus (SC) and lateral geniculate nucleus (LGN) are important subcortical structures for vision. Much of our understanding of vision was obtained using invasive and small field of view (FOV) techniques. In this study, we use non-invasive, large FOV blood oxygenation level-dependent (BOLD) fMRI to measure the SC and LGN's response temporal dynamics following short duration (1 s) visual stimulation. Methodology/Principal Findings: Experiments are performed at 7 tesla on Sprague Dawley rats stimulated in one eye with flashing light. Gradient-echo and spin-echo sequences are used to provide complementary information. An anatomical image is acquired from one rat after injection of monocrystalline iron oxide nanoparticles (MION), a blood vessel contrast agent. BOLD responses are concentrated in the contralateral SC and LGN. The SC BOLD signal measured with gradient-echo rises to 50% of maximum amplitude (PEAK) 0.2 +/- 0.2 s before the LGN signal (p < 0.05). The LGN signal returns to 50% of PEAK 1.4 +/- 1.2 s before the SC signal (p < 0.05). These results indicate the SC signal rises faster than the LGN signal but settles slower. Spin-echo results support these findings. The post-MION image shows the SC and LGN lie beneath large blood vessels. This subcortical vasculature is similar to that in the cortex, which also lies beneath large vessels. The LGN lies closer to the large vessels than much of the SC. Conclusions/Significance: The differences in response timing between SC and LGN are very similar to those between deep and shallow cortical layers following electrical stimulation, which are related to depth-dependent blood vessel dilation rates. This combined with the similarities in vasculature between subcortex and cortex suggest the SC and LGN timing differences are also related to depth-dependent dilation rates. This study shows for the first time that BOLD responses in the rat SC and LGN following short duration visual stimulation are temporally different.	[Lau, Condon; Zhou, Iris Y.; Cheung, Matthew M.; Chan, Kevin C.; Wu, Ed X.] Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Hong Kong, Hong Kong, Peoples R China; [Lau, Condon; Zhou, Iris Y.; Cheung, Matthew M.; Chan, Kevin C.; Wu, Ed X.] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Wu, Ed X.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Wu, Ed X.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Lau, C (corresponding author), Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Hong Kong, Hong Kong, Peoples R China.	ewu@eee.hku.hk	Cheung, Matthew Man Hin/ABD-6962-2021; Zhou, Iris Yuwen/A-2089-2017; Chan, Kevin C/AAK-7665-2020; Zhou, Yuwen/D-8009-2013; Wu, Ed Xuekui/C-1579-2009	Cheung, Matthew Man Hin/0000-0002-3477-6865; Zhou, Iris Yuwen/0000-0002-4351-7398; Chan, Kevin C/0000-0003-4012-7084; Wu, Ed Xuekui/0000-0001-5581-1546	Hong Kong Research Grants Council [GRF HKU 7793/08M, GRF HKU 7808/09 M]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by the Hong Kong Research Grants Council (GRF HKU 7793/08M and GRF HKU 7808/09 M; http://www.ugc.edu.hk/eng/rgc/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Calkins DJ, 2008, INVEST OPHTH VIS SCI, V49, P5083, DOI 10.1167/iovs.08-2205; Chan KC, 2008, NEUROIMAGE, V40, P1166, DOI 10.1016/j.neuroimage.2008.01.002; Chan KC, 2011, NEUROIMAGE, V54, P389, DOI 10.1016/j.neuroimage.2010.07.015; Chan KC, 2010, NEUROIMAGE, V49, P2013, DOI 10.1016/j.neuroimage.2009.10.069; Chan KC, 2009, EXP EYE RES, V88, P61, DOI 10.1016/j.exer.2008.10.002; Clare S, 1999, MAGNET RESON MED, V42, P1117, DOI 10.1002/(SICI)1522-2594(199912)42:6<1117::AID-MRM16>3.0.CO;2-J; Cooper BG, 1998, HIPPOCAMPUS, V8, P340, DOI 10.1002/(SICI)1098-1063(1998)8:4<340::AID-HIPO4>3.0.CO;2-L; Dennie J, 1998, MAGN RESON MED, V40, P793, DOI 10.1002/mrm.1910400602; DuBois RM, 2000, NEUROIMAGE, V12, P63, DOI 10.1006/nimg.2000.0590; Dubowitz DJ, 1998, NEUROREPORT, V9, P2213, DOI 10.1097/00001756-199807130-00012; Goodall N, 2009, EXP EYE RES, V89, P511, DOI 10.1016/j.exer.2009.05.014; Himmelbach M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-66; Huang W, 1996, P NATL ACAD SCI USA, V93, P6037, DOI 10.1073/pnas.93.12.6037; Jezzard P, 1997, MAGNET RESON MED, V38, P699, DOI 10.1002/mrm.1910380504; Liu TT, 2004, NEUROIMAGE, V21, P387, DOI 10.1016/j.neuroimage.2003.09.030; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; MARTIN PR, 1986, EXP BRAIN RES, V62, P77; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; MOLOTCHNIKOFF S, 1986, EXP BRAIN RES, V62, P321; MOLOTCHNIKOFF S, 1983, BRAIN RES BULL, V10, P719, DOI 10.1016/0361-9230(83)90041-2; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Naismith RT, 2009, NEUROLOGY, V72, P589, DOI 10.1212/01.wnl.0000335766.22758.cd; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Paulson OB, 2010, J CEREBR BLOOD F MET, V30, P2, DOI 10.1038/jcbfm.2009.188; Pawela CP, 2008, NEUROIMAGE, V41, P525, DOI 10.1016/j.neuroimage.2008.02.022; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Polyak S., 1957, VERTEBRATE VISUAL SY; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; SAHIBZADA N, 1986, J NEUROSCI, V6, P723; Scremin OU, 2004, RAT NERVOUS SYSTEM; Sefton AJ, 2004, RAT NERVOUS SYSTEM; Silva AC, 2002, P NATL ACAD SCI USA, V99, P15182, DOI 10.1073/pnas.222561899; Tian PF, 2010, P NATL ACAD SCI USA, V107, P15246, DOI 10.1073/pnas.1006735107; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; Van Camp N, 2006, J NEUROPHYSIOL, V95, P3164, DOI 10.1152/jn.00400.2005; Van Camp N, 2005, J MAGN RESON IMAGING, V22, P483, DOI 10.1002/jmri.20417; Wall MB, 2009, NEUROIMAGE, V47, P1620, DOI 10.1016/j.neuroimage.2009.05.094; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; Wu EX, 2004, NMR BIOMED, V17, P507, DOI 10.1002/nbm.921; Wu EX, 2004, NEUROSCI LETT, V365, P223, DOI 10.1016/j.neulet.2004.05.004; XUE JT, 1994, VISUAL NEUROSCI, V11, P1059, DOI 10.1017/S095252380000688X; Zhao FQ, 2004, MAGN RESON MED, V51, P518, DOI 10.1002/mrm.10720	45	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18914	10.1371/journal.pone.0018914	http://dx.doi.org/10.1371/journal.pone.0018914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559482	Green Published, gold			2022-12-25	WOS:000290024700035
J	Llop-Tous, I; Ortiz, M; Torrent, M; Ludevid, MD				Llop-Tous, Immaculada; Ortiz, Miriam; Torrent, Margarita; Dolors Ludevid, M.			The Expression of a Xylanase Targeted to ER-Protein Bodies Provides a Simple Strategy to Produce Active Insoluble Enzyme Polymers in Tobacco Plants	PLOS ONE			English	Article							ELASTIN-LIKE POLYPEPTIDE; MAIZE GAMMA-ZEIN; RECOMBINANT PROTEINS; GENE; PURIFICATION; FUSIONS; THERMOSTABILITY; IMMOBILIZATION; CHLOROPLASTS; ACCUMULATION	Background: Xylanases deserve particular attention due to their potential application in the feed, pulp bleaching and paper industries. We have developed here an efficient system for the production of an active xylanase in tobacco plants fused to a proline-rich domain (Zera) of the maize storage protein c-zein. Zera is a self-assembling domain able to form protein aggregates in vivo packed in newly formed endoplasmic reticulum-derived organelles known as protein bodies (PBs). Methodology/Principal Findings: Tobacco leaves were transiently transformed with a binary vector containing the Zera-xylanase coding region, which was optimized for plant expression, under the control of the 35S CaMV promoter. The fusion protein was efficiently expressed and stored in dense PBs, resulting in yields of up to 9% of total protein. Zera-xylanase was post-translationally modified with high-mannose-type glycans. Xylanase fused to Zera was biologically active not only when solubilized from PBs but also in its insoluble form. The resistance of insoluble Zera-xylanase to trypsin digestion demonstrated that the correct folding of xylanase in PBs was not impaired by Zera oligomerization. The activity of insoluble Zera-xylanase was enhanced when substrate accessibility was facilitated by physical treatments such as ultrasound. Moreover, we found that the thermostability of the enzyme was improved when Zera was fused to the C-terminus of xylanase. Conclusion/Significance: In the present work we have successfully produced an active insoluble aggregate of xylanase fused to Zera in plants. Zera-xylanase chimeric protein accumulates within ER-derived protein bodies as active aggregates that can easily be recovered by a simple density-based downstream process. The production of insoluble active Zera-xylanase protein in tobacco outlines the potential of Zera as a fusion partner for producing enzymes of biotechnological relevance. Zera-PBs could thus become efficient and low-cost bioreactors for industrial purposes.	[Llop-Tous, Immaculada; Ortiz, Miriam; Torrent, Margarita; Dolors Ludevid, M.] UAB, IRTA, Consortium CSIC, Dept Mol Genet,CRAG, Barcelona, Spain; [Llop-Tous, Immaculada] ERA Biotech, Barcelona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona	Llop-Tous, I (corresponding author), UAB, IRTA, Consortium CSIC, Dept Mol Genet,CRAG, Barcelona, Spain.	dlmgmd@cid.csic.es			ERA Biotech; Generalitat de Catalunya [SGR 2009/703]; Ministerio de Ciencia e Inovacion (MICINN) [CDS2007/00036, TRA 2009/0124]; ERA Biotech SA	ERA Biotech; Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Ciencia e Inovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ERA Biotech SA	This work was mainly supported by ERA Biotech (www.erabiotech.com). Additional support was supplied by grant SGR 2009/703 funded by the Generalitat de Catalunya (www10.gencat.net) and grants CDS2007/00036 of Consolider Ingenio program and TRA 2009/0124 of TRACE program funded by Ministerio de Ciencia e Inovacion (MICINN, www.micinn.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Part of this work has been supported by ERA Biotech SA, which performs research into recombinant protein production with a commercial purpose. Their funding does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alvarez ML, 2010, PLANT MOL BIOL, V72, P75, DOI 10.1007/s11103-009-9552-4; BECKER GW, 1986, FEBS LETT, V204, P145, DOI 10.1016/0014-5793(86)81403-X; Biesgen Christian, 2002, Phytochemistry Reviews, V1, P79, DOI 10.1023/A:1015836403629; Borisjuk NV, 1999, NAT BIOTECHNOL, V17, P466, DOI 10.1038/8643; Borkhardt B, 2010, PLANT BIOTECHNOL J, V8, P363, DOI 10.1111/j.1467-7652.2010.00506.x; Conley AJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-48; Conley AJ, 2009, BIOTECHNOL BIOENG, V103, P562, DOI 10.1002/bit.22278; Ge Y, 2007, ANAL BIOCHEM, V362, P63, DOI 10.1016/j.ab.2006.11.034; GELI MI, 1994, PLANT CELL, V6, P1911; Gomord V, 2004, CURR OPIN PLANT BIOL, V7, P171, DOI 10.1016/j.pbi.2004.01.015; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P1; Goytia E, 2006, J GEN VIROL, V87, P3413, DOI 10.1099/vir.0.82301-0; Harholt J, 2010, PLANT BIOTECHNOL J, V8, P351, DOI 10.1111/j.1467-7652.2009.00490.x; Hyunjong B, 2006, J EXP BOT, V57, P161, DOI 10.1093/jxb/erj019; Jaladi H, 2009, CHEM ENG SCI, V64, P1474, DOI 10.1016/j.ces.2008.10.042; Joensuu JJ, 2010, PLANT PHYSIOL, V152, P622, DOI 10.1104/pp.109.149021; Kanehara K, 2010, J CELL BIOL, V188, P707, DOI 10.1083/jcb.200907055; Kimura T, 2003, APPL MICROBIOL BIOT, V62, P374, DOI 10.1007/s00253-003-1301-z; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; Kogan MJ, 2001, J MOL BIOL, V312, P907, DOI 10.1006/jmbi.2001.4999; LARKINS BA, 1978, PLANT PHYSIOL, V62, P256, DOI 10.1104/pp.62.2.256; Leelavathi S, 2003, MOL BREEDING, V11, P59, DOI 10.1023/A:1022168321380; Liu JH, 1997, MOL BREEDING, V3, P463, DOI 10.1023/A:1009604119618; Llompart B, 2010, PROCESS BIOCHEM, V45, P1816, DOI 10.1016/j.procbio.2010.01.016; Llop-Tous I, 2010, J BIOL CHEM, V285, P35633, DOI 10.1074/jbc.M110.116285; Mainieri D, 2004, PLANT PHYSIOL, V136, P3447, DOI 10.1104/pp.104.046409; Makowski L, 2008, J MOL BIOL, V375, P529, DOI 10.1016/j.jmb.2007.07.075; Meyer DE, 2001, BIOTECHNOL PROGR, V17, P720, DOI 10.1021/bp010049o; Patel J, 2007, TRANSGENIC RES, V16, P239, DOI 10.1007/s11248-006-9026-2; Patel M, 2000, MOL BREEDING, V6, P113, DOI 10.1023/A:1009640427515; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Roessl U, 2010, BIOTECHNOL LETT, V32, P341, DOI 10.1007/s10529-009-0173-4; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Sharma AK, 2009, BIOTECHNOL ADV, V27, P811, DOI 10.1016/j.biotechadv.2009.06.004; Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082; Shibuya H, 2000, BIOCHEM J, V349, P651, DOI 10.1042/0264-6021:3490651; Subramaniyan S, 2002, CRIT REV BIOTECHNOL, V22, P33, DOI 10.1080/07388550290789450; Torrent Margarita, 2009, V483, P193, DOI 10.1007/978-1-59745-407-0_11; Torrent M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-5; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x; Verma D, 2010, PLANT BIOTECHNOL J, V8, P332, DOI 10.1111/j.1467-7652.2009.00486.x; Vezina LP, 2009, PLANT BIOTECHNOL J, V7, P442, DOI 10.1111/j.1467-7652.2009.00414.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang YR, 2007, AQUACULTURE, V267, P328, DOI 10.1016/j.aquaculture.2007.03.005; Yang HM, 2007, J IND MICROBIOL BIOT, V34, P213, DOI 10.1007/s10295-006-0188-y; Yang PL, 2007, BIOTECHNOL LETT, V29, P659, DOI 10.1007/s10529-006-9280-7; Zhang HL, 2003, CHINESE SCI BULL, V48, P761, DOI 10.1360/02wc0298; Zhang S, 2010, BIOCHEM BIOPH RES CO, V395, P200, DOI 10.1016/j.bbrc.2010.03.159	49	27	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19474	10.1371/journal.pone.0019474	http://dx.doi.org/10.1371/journal.pone.0019474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559333	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700191
J	Otsuka, Y; Osaka, N; Yaoi, K; Osaka, M				Otsuka, Yuki; Osaka, Naoyuki; Yaoi, Ken; Osaka, Mariko			First-Person Perspective Effects on Theory of Mind without Self-Reference	PLOS ONE			English	Article							SOCIAL COGNITION; PREFRONTAL CORTEX; RHESUS-MONKEYS; ROLE REVERSAL; COMPREHENSION; SYSTEM; BRAIN; METAANALYSIS; CHIMPANZEES; KNOWLEDGE	This study examined dissociations between brain networks involved in theory of mind, which is needed for guessing others' mental states, and the self, which might constitute the basis for theory of mind's development. We used event-related fMRI to compare a condition that required participants to guess the mental state of a subject featured in first-person perspective sentences (1stPP condition) with a third-person perspective sentence condition (3rdPP condition). The caudate nucleus was marginally more activated in the 1stPP than in the 3rdPP condition, while the left dorsolateral prefrontal cortex (DLPFC) was significantly more activated in the 3rdPP condition as compared to the 1stPP condition. Furthermore, we examined the correlation between activation (signal intensity) of the caudate nucleus and left DLPFC with that of the right DLPFC, which is thought to be closely connected with sense of self. We found a significant correlation between caudate nucleus and right DLPFC activation in the 1stPP condition, and between left and right DLPFC activation in the 3rdPP condition. Although theory of mind and the self both appear to recruit the right DLPFC, this region seems to be accessed through the left DLPFC during theory of mind tasks, but through the caudate nucleus when tasks require self reference.	[Otsuka, Yuki; Osaka, Naoyuki; Yaoi, Ken] Kyoto Univ, Dept Psychol, Grad Sch Letters, Kyoto, Japan; [Osaka, Mariko] Osaka Univ, Dept Psychol, Suita, Osaka, Japan	Kyoto University; Osaka University	Otsuka, Y (corresponding author), Kyoto Univ, Dept Psychol, Grad Sch Letters, Kyoto, Japan.	yotsuka@bun.kyoto-u.ac.jp		Lauwereyns, Jan/0000-0003-0551-2550	Japan Society for the Promotion of Science [20830041, 19203032, 16203037]; MEXT, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by research grants from the Japan Society for the Promotion of Science (20830041, 19203032, 16203037 to YO, NO, and MO, respectively) and in part by the Global COE Program "Revitalizing Education for Dynamic Hearts and Minds," MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew ZK, 2007, BRAIN RES REV, V54, P286, DOI 10.1016/j.brainresrev.2007.04.003; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Blackwood NJ, 2003, NEUROIMAGE, V20, P1076, DOI 10.1016/S1053-8119(03)00331-8; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Ferstl EC, 2002, NEUROIMAGE, V17, P1599, DOI 10.1006/nimg.2002.1247; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; GOEL V, 1995, NEUROREPORT, V6, P1741, DOI 10.1097/00001756-199509000-00009; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Johnson SC, 2005, J COGNITIVE NEUROSCI, V17, P1897, DOI 10.1162/089892905775008607; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Keenan JP, 2005, CORTEX, V41, P695, DOI 10.1016/S0010-9452(08)70286-7; Legrand D, 2009, PSYCHOL REV, V116, P252, DOI 10.1037/a0014172; Markowitsch HJ, 1999, CORTEX, V35, P243, DOI 10.1016/S0010-9452(08)70797-4; Markowitsch HJ, 1997, PSYCHIAT RES-NEUROIM, V74, P119, DOI 10.1016/S0925-4927(97)03041-2; Otsuka Y, 2009, NEUROSCI LETT, V463, P150, DOI 10.1016/j.neulet.2009.07.064; POVINELLI DJ, 1992, ANIM BEHAV, V43, P633, DOI 10.1016/0003-3472(92)90085-N; POVINELLI DJ, 1991, J COMP PSYCHOL, V105, P318, DOI 10.1037/0735-7036.105.4.318; POVINELLI DJ, 1992, ANIM BEHAV, V44, P269, DOI 10.1016/0003-3472(92)90033-6; POVINELLI DJ, 1990, J COMP PSYCHOL, V104, P203, DOI 10.1037/0735-7036.104.3.203; Ritblatt SN, 2000, J GENET PSYCHOL, V161, P53, DOI 10.1080/00221320009596694; Rochat P, 1998, EXP BRAIN RES, V123, P102, DOI 10.1007/s002210050550; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Talairach J., 1988, COPLANAR STEREOTAXIC; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Yaoi K, 2009, SOC NEUROSCI-UK, V4, P455, DOI 10.1080/17470910903027808	29	4	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19320	10.1371/journal.pone.0019320	http://dx.doi.org/10.1371/journal.pone.0019320			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756OZ	21559448	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700132
J	Ran, CZ; Zhao, W; Moir, RD; Moore, A				Ran, Chongzhao; Zhao, Wei; Moir, Robert D.; Moore, Anna			Non-Conjugated Small Molecule FRET for Differentiating Monomers from Higher Molecular Weight Amyloid Beta Species	PLOS ONE			English	Article							THIOFLAVIN-T BINDING; ALZHEIMERS-DISEASE; A-BETA; CEREBROSPINAL-FLUID; OLIGOMERS; PEPTIDE; FIBRILS; MEMORY; FIBRILLOGENESIS; MECHANISM	Background: Systematic differentiation of amyloid (A beta) species could be important for diagnosis of Alzheimer's disease (AD). In spite of significant progress, controversies remain regarding which species are the primary contributors to the AD pathology, and which species could be used as the best biomarkers for its diagnosis. These controversies are partially caused by the lack of reliable methods to differentiate the complicated subtypes of A beta species. Particularly, differentiation of A beta monomers from toxic higher molecular weight species (HrMW) would be beneficial for drug screening, diagnosis, and molecular mechanism studies. However, fast and cheap methods for these specific aims are still lacking. Principal Findings: We demonstrated the feasibility of a non-conjugated FRET (Forster resonance energy transfer) technique that utilized amyloid beta (A beta) species as intrinsic platforms for the FRET pair assembly. Mixing two structurally similar curcumin derivatives that served as the small molecule FRET pair with A beta 40 aggregates resulted in a FRET signal, while no signal was detected when using A beta 40 monomer solution. Lastly, this FRET technique enabled us to quantify the concentrations of A beta monomers and high molecular weight species in solution. Significance: We believe that this FRET technique could potentially be used as a tool for screening for inhibitors of A beta aggregation. We also suggest that this concept could be generalized to other misfolded proteins/peptides implicated in various pathologies including amyloid in diabetes, prion in bovine spongiform encephalopathy, tau protein in AD, and alpha-synuclein in Parkinson disease.	[Ran, Chongzhao; Zhao, Wei; Moore, Anna] Harvard Univ, MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Massachusetts Gen Hosp, Mol Imaging Lab,Dept Radiol,Sch Med, Charlestown, MA USA; [Moir, Robert D.] Massachusetts Gen Hosp, Dept Neurol, Alzheimers Dis Res Unit, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Ran, CZ (corresponding author), Harvard Univ, MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Massachusetts Gen Hosp, Mol Imaging Lab,Dept Radiol,Sch Med, Charlestown, MA USA.	amoore@helix.mgh.harvard.edu	Moir, Robert D./M-7612-2017	Moir, Robert D./0000-0001-5431-3553	NIA [K25AG036760]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG036760] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by K25AG036760 award from NIA to C.R. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Buerger K, 2009, EXP GERONTOL, V44, P579, DOI 10.1016/j.exger.2009.06.003; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Groenning M., 2009, J CHEM BIOL; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HAMLEY IW, 2007, ANGEW CHEM INT ED EN, V46; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lindgren M, 2010, FEBS J, V277, P1380, DOI 10.1111/j.1742-4658.2010.07571.x; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; Moir RD, 2005, J BIOL CHEM, V280, P17458, DOI 10.1074/jbc.M414176200; Morley JE, 2010, J ALZHEIMERS DIS, V19, P441, DOI [10.3233/JAD-2010-1230, 10.3233/JAD-2009-1230]; Ran CZ, 2009, J AM CHEM SOC, V131, P15257, DOI 10.1021/ja9047043; Schoonenboom NSM, 2005, CLIN CHEM, V51, P189, DOI 10.1373/clinchem.2004.039735; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Smith NW, 2009, BIOORGAN MED CHEM, V17, P2366, DOI 10.1016/j.bmc.2009.02.016; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Venkateswarlu S, 2005, BIOORGAN MED CHEM, V13, P6374, DOI 10.1016/j.bmc.2005.06.050; Verwey NA, 2009, ANN CLIN BIOCHEM, V46, P235, DOI 10.1258/acb.2009.008232; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	28	32	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19362	10.1371/journal.pone.0019362	http://dx.doi.org/10.1371/journal.pone.0019362			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559413	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700148
J	Sato, N; Yamakawa, N; Masuda, M; Sudo, K; Hatada, I; Muramatsu, M				Sato, Noriko; Yamakawa, Naomi; Masuda, Moe; Sudo, Katsuko; Hatada, Izuho; Muramatsu, Masaaki			Genome-Wide DNA Methylation Analysis Reveals Phytoestrogen Modification of Promoter Methylation Patterns during Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							MOUSE; EXPRESSION; SECRETION; REGIONS; TARGETS; GENES; MICE	Background: Environmental challenges during development affect the fetal epigenome, but the period(s) vulnerable to epigenetic dysregulation is(are) not clear. By employing a soy phytoestrogen, genistein, that is known to alter the epigenetic states of the A(vy) allele during embryogenesis, we have explored the sensitive period for epigenetic regulation. The post-implantation period, when de novo DNA methylation actively proceeds, is amenable to in vitro analysis using a mouse embryonic stem (ES) cell differentiation system. Methods and Findings: Mouse ES cells were differentiated in the presence or absence of genistein, and DNA methylation patterns on day 10 were compared by microarray-based promoter methylation analysis coupled with a methylation-sensitive endonuclease (HpaII/McrBC)-dependent enrichment procedure. Moderate changes in methylation levels were observed in a subset of promoters following genistein treatment. Detailed investigation of the Ucp1 and Sytl1 promoters further revealed that genistein does not affect de novo methylation occurring between day 0 and day 4, but interferes with subsequent regulatory processes and leads to a decrease in methylation level for both promoters. Conclusion: Genistein perturbed the methylation pattern of differentiated ES cells after de novo methylation. Our observations suggest that, for a subset of genes, regulation after de novo DNA methylation in the early embryo may be sensitive to genistein.	[Sato, Noriko; Masuda, Moe; Muramatsu, Masaaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Epidemiol, Tokyo, Japan; [Yamakawa, Naomi] Tokyo Metropolitan Geriatr Hosp, Tokyo 173, Japan; [Yamakawa, Naomi] Inst Gerontol, Res Team Geriatr Dis, Tokyo, Japan; [Sudo, Katsuko] Tokyo Med Univ, Anim Res Ctr, Tokyo, Japan; [Hatada, Izuho] Gunma Univ, Inst Mol & Cellular Regulat, Biosignal Genome Resource Ctr, Lab Genome Sci, Gunma, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Metropolitan Institute of Gerontology; Tokyo Medical University; Gunma University	Sato, N (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Epidemiol, Tokyo, Japan.	nsato.epi@mri.tmd.ac.jp	Sato, Noriko/Y-7693-2019; liu, li/HGC-0900-2022	Sato, Noriko/0000-0002-0384-5362	 [22659070]; Grants-in-Aid for Scientific Research [22659070] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Challenging Exploratory Research to NS (22659070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkowitz JKM, 2001, J BIOL CHEM, V276, P18855, DOI 10.1074/jbc.M011167200; Bernal AJ, 2010, BIRTH DEFECTS RES A, V88, P938, DOI 10.1002/bdra.20685; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Cooney CA, 2002, J NUTR, V132, p2393S; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Einstein F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008887; Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kiskinis E, 2007, EMBO J, V26, P4831, DOI 10.1038/sj.emboj.7601908; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Neumuller O, 2009, BLOOD, V114, P1396, DOI 10.1182/blood-2008-05-155234; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Rasbach KA, 2008, J PHARMACOL EXP THER, V325, P536, DOI 10.1124/jpet.107.134882; Saegusa C, 2008, ARCH BIOCHEM BIOPHYS, V475, P87, DOI 10.1016/j.abb.2008.04.031; Shore A, 2010, DIABETOLOGIA, V53, P1164, DOI 10.1007/s00125-010-1701-4; Suzuki Y, 2004, GENOME RES, V14, P1711, DOI 10.1101/gr.2435604; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003	24	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19278	10.1371/journal.pone.0019278	http://dx.doi.org/10.1371/journal.pone.0019278			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559447	Green Submitted, gold, Green Published			2022-12-25	WOS:000290024700123
J	Wang, J; Chen, Y; Yuan, QX; Tang, W; Zhang, XP; Osei, K				Wang, Jie; Chen, Ying; Yuan, Qingxin; Tang, Wei; Zhang, Xiaoping; Osei, Kwame			Control of Precursor Maturation and Disposal Is an Early Regulative Mechanism in the Normal Insulin Production of Pancreatic beta-Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; NECROSIS FACTOR-ALPHA; ENDOPLASMIC-RETICULUM; DIABETES-MELLITUS; GLUCOSE-METABOLISM; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; QUALITY-CONTROL; ISLETS; PROINSULIN	The essential folding and maturation process of proinsulin in beta-cells is largely uncharacterized. To analyze this process, we improved approaches to immunoblotting, metabolic labeling, and data analysis used to determine the proportion of monomers and non-monomers and changes in composition of proinsulin in cells. We found the natural occurrence of a large proportion of proinsulin in various non-monomer states, i.e., aggregates, in normal mouse and human beta-cells and a striking increase in the proportion of proinsulin non-monomers in Ins2(+/Akita) mice in response to a mutation (C96Y) in the insulin 2 (Ins2) gene. Proinsulin emerges in monomer and abundant dual-fate non-monomer states during nascent protein synthesis and shows heavy and preferential ATP/redox-sensitive disposal among secretory proteins during early post-translational processes. These findings support the preservation of proinsulin's aggregation-prone nature and low relative folding rate that permits the plentiful production of non-monomer forms with incomplete folding. Thus, in normal mouse/human beta-cells, proinsulin's integrated maturation and degradation processes maintain a balance of natively and nonnatively folded states, i.e., proinsulin homeostasis (PIHO). Further analysis discovered the high susceptibility of PIHO to cellular energy and calcium changes, endoplasmic reticulum (ER) and reductive/oxidative stress, and insults by thiol reagent and cytokine. These results expose a direct correlation between various extra-/intracellular influences and (a) typical integrations of proinsulin maturation and disposal processes. Overall, our findings demonstrated that the control of precursor maturation and disposal acts as an early regulative mechanism in normal insulin production, and its disorder is crucially linked to beta-cell failure and diabetes pathogenesis.	[Wang, Jie; Yuan, Qingxin; Tang, Wei; Zhang, Xiaoping; Osei, Kwame] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Chen, Ying] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Chen, Ying] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	University System of Ohio; Ohio State University; University of Chicago; University of Chicago	Wang, J (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	jie.wang2@osumc.edu			Ohio State University	Ohio State University(Ohio State University)	This work was supported by the start-up fund and the Manuel Tzagournis Medical Research Award from The Ohio State University (to J.W.). There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; CAMPBELL IL, 1988, J IMMUNOL, V141, P2325; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; DIXIT PK, 1962, NATURE, V195, P388, DOI 10.1038/195388a0; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Eisenbarth GS, 2010, DIABETES, V59, P759, DOI 10.2337/db09-1855; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; Furuta M, 1998, J BIOL CHEM, V273, P3431, DOI 10.1074/jbc.273.6.3431; Guidarelli A, 1997, BIOCHEM J, V328, P801, DOI 10.1042/bj3280801; Guo ZY, 2008, ANTIOXID REDOX SIGN, V10, P127, DOI 10.1089/ars.2007.1860; Gupta S, 2010, P NATL ACAD SCI USA, V107, P13246, DOI 10.1073/pnas.1005704107; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; HELLMAN B, 1969, DIABETOLOGIA, V5, P22, DOI 10.1007/BF01212214; Himsworth HP, 1936, LANCET, V1, P127; HOWELL SL, 1972, NATURE-NEW BIOL, V235, P85, DOI 10.1038/newbio235085a0; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Jahr H, 1995, TRANSPLANT P, V27, P3220; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim HE, 2008, J ENDOCRINOL, V198, P549, DOI 10.1677/JOE-08-0131; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Luheshi LM, 2008, CURR OPIN CHEM BIOL, V12, P25, DOI 10.1016/j.cbpa.2008.02.011; Mahler HC, 2009, J PHARM SCI-US, V98, P2909, DOI 10.1002/jps.21566; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Nozaki J, 2004, GENES CELLS, V9, P261, DOI 10.1111/j.1356-9597.2004.00721.x; ORCI L, 1985, CELL, V42, P671, DOI 10.1016/0092-8674(85)90124-2; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; PERMUTT MA, 1972, P NATL ACAD SCI USA, V69, P505, DOI 10.1073/pnas.69.2.505; Rapoport T A, 1980, Ann N Y Acad Sci, V343, P111, DOI 10.1111/j.1749-6632.1980.tb47246.x; Rebelato E, 2010, METABOLISM, V59, P409, DOI 10.1016/j.metabol.2009.08.010; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; ROE MW, 1994, J BIOL CHEM, V269, P18279; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; STEINER DF, 1967, SCIENCE, V157, P697, DOI 10.1126/science.157.3789.697; STEINER DF, 1968, P NATL ACAD SCI USA, V60, P622, DOI 10.1073/pnas.60.2.622; Steiner DF, 2001, CHEM BIOSYNTHESIS IS, P667; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Tsiotra PC, 2001, INT J OBESITY, V25, P1018, DOI 10.1038/sj.ijo.0801657; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; UNGER RH, 1985, DIABETOLOGIA, V28, P119; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Westerlund J, 2001, DIABETES, V50, P1785, DOI 10.2337/diabetes.50.8.1785; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; WOLLHEIM CB, 1978, J CLIN INVEST, V62, P451, DOI 10.1172/JCI109146; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Yorimitsu T, 2007, TRENDS CELL BIOL, V17, P279, DOI 10.1016/j.tcb.2007.04.005	56	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19446	10.1371/journal.pone.0019446	http://dx.doi.org/10.1371/journal.pone.0019446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559376	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700175
J	Zheng, Y; Ren, PP; Wang, JL; Wang, YF				Zheng, Ya; Ren, Pan-Pan; Wang, Jia-Lin; Wang, Yu-Feng			Wolbachia-Induced Cytoplasmic Incompatibility Is Associated with Decreased Hira Expression in Male Drosophila	PLOS ONE			English	Article							PATERNAL CHROMATIN; HISTONE H3.3; SPERM; SIMULANS; CHROMOSOME; FERTILITY; INFECTION; INSERTION; GENOME	Background: Wolbachia are obligate endosymbiotic bacteria that infect numerous species of arthropods and nematodes. Wolbachia can induce several reproductive phenotypes in their insect hosts including feminization, male-killing, parthenogenesis and cytoplasmic incompatibility (CI). CI is the most common phenotype and occurs when Wolbachia-infected males mate with uninfected females resulting in no or very low numbers of viable offspring. However, matings between males and females infected with the same strain of Wolbachia result in viable progeny. Despite substantial scientific effort, the molecular mechanisms underlying CI are currently unknown. Methodology/Principal Findings: Gene expression studies were undertaken in Drosophila melanogaster and D. simulans which display differential levels of CI using quantitative RT-PCR. We show that Hira expression is correlated with the induction of CI and occurs in a sex-specific manner. Hira expression is significantly lower in males which induce strong CI when compared to males inducing no CI or Wolbachia-uninfected males. A reduction in Hira expression is also observed in 1-day-old males that induce stronger CI compared to 5-day-old males that induce weak or no CI. In addition, Hira mutated D. melanogaster males mated to uninfected females result in significantly decreased hatch rates comparing with uninfected crosses. Interestingly, wMel-infected females may rescue the hatch rates. An obvious CI phenotype with chromatin bridges are observed in the early embryo resulting from Hira mutant fertilization, which strongly mimics the defects associated with CI. Conclusions/Significance: Our results suggest Wolbachia-induced CI in Drosophila occurs due to a reduction in Hira expression in Wolbachia-infected males leading to detrimental effects on sperm fertility resulting in embryo lethality. These results may help determine the underlying mechanism of CI and provide further insight in to the important role Hira plays in the interaction of Wolbachia and its insect host.	[Zheng, Ya; Ren, Pan-Pan; Wang, Jia-Lin; Wang, Yu-Feng] Huazhong Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China	Central China Normal University	Zheng, Y (corresponding author), Huazhong Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	yfengw@mail.ccnu.edu.cn	wang, yufeng/E-5122-2010		National Natural Science Foundation of China [30970405]; Chinese Ministry of Education [109118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/; no. 30970405) to Y.F. Wang and J.L. Wang and the Key Project of Chinese Ministry of Education (http://www.dost.moe.edu.cn/; no. 109118) to Y.F. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 1997, CHROMOSOMA, V106, P335, DOI 10.1007/s004120050255; Bonnefoy E, 2007, PLOS GENET, V3, P1991, DOI 10.1371/journal.pgen.0030182; Bourtzis K, 1998, NATURE, V391, P852, DOI 10.1038/36017; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; Callaini G, 1997, J CELL SCI, V110, P271; Caron C, 2005, PROG MOLEC, V38, P65; Clark ME, 2008, HEREDITY, V101, P420, DOI 10.1038/hdy.2008.71; Clark ME, 2003, MECH DEVELOP, V120, P185, DOI 10.1016/S0925-4773(02)00424-0; Couldrey C, 1999, HUM MOL GENET, V8, P2489, DOI 10.1093/hmg/8.13.2489; Ferree PM, 2006, GENETICS, V173, P839, DOI 10.1534/genetics.105.053272; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; HOFFMANN AA, 1988, GENETICS, V119, P435; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Landmann F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000343; Loppin B, 2005, NATURE, V437, P1386, DOI 10.1038/nature04059; Loppin B, 2001, CHROMOSOMA, V110, P430, DOI 10.1007/s004120100161; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Poinsot D, 2003, BIOESSAYS, V25, P259, DOI 10.1002/bies.10234; REED KM, 1995, MOL REPROD DEV, V40, P408, DOI 10.1002/mrd.1080400404; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Riparbelli MG, 2007, MECH DEVELOP, V124, P699, DOI 10.1016/j.mod.2007.07.001; Royou A, 2008, J CELL BIOL, V183, P63, DOI 10.1083/jcb.200801153; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; SHERWOOD PW, 1991, GENETICS, V128, P729; Snook RR, 2000, GENETICS, V155, P167; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tram U, 2002, SCIENCE, V296, P1124, DOI 10.1126/science.1070536; Tram U, 2003, MICROBES INFECT, V5, P999, DOI 10.1016/S1286-4579(03)00192-8; Tram U, 2006, J CELL SCI, V119, P3655, DOI 10.1242/jcs.03095; Wang Yu-Feng, 2005, Yichuan, V27, P989; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1; Yamada R, 2007, GENETICS, V177, P801, DOI 10.1534/genetics.106.068486	32	30	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19512	10.1371/journal.pone.0019512	http://dx.doi.org/10.1371/journal.pone.0019512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559343	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700199
J	Hagiwara, T; Ushimaru, T; Tainaka, K; Kurachi, H; Yoshimura, J				Hagiwara, Toshiyuki; Ushimaru, Takashi; Tainaka, Kei-ichi; Kurachi, Hironori; Yoshimura, Jin			Apoptosis at Inflection Point in Liquid Culture of Budding Yeasts	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-DIVISION; LIFE-SPAN; STAGE STRUCTURE; CYCLE; POPULATION; ASYMMETRY; STRAINS; GROWTH	Budding yeasts are highly suitable for aging studies, because the number of bud scars (stage) proportionally correlates with age. Its maximum stages are known to reach at 20-30 stages on an isolated agar medium. However, their stage dynamics in a liquid culture is virtually unknown. We investigate the population dynamics by counting scars in each cell. Here one cell division produces one new cell and one bud scar. This simple rule leads to a conservation law: "The total number of bud scars is equal to the total number of cells." We find a large discrepancy: extremely fewer cells with over 5 scars than expected. Almost all cells with 6 or more scars disappear within a short period of time in the late log phase (corresponds to the inflection point). This discrepancy is confirmed directly by the microscopic observations of broken cells. This finding implies apoptosis in older cells (6 scars or more).	[Hagiwara, Toshiyuki; Tainaka, Kei-ichi; Yoshimura, Jin] Shizuoka Univ, Grad Sch Sci & Technol, Hamamatsu, Shizuoka 4328011, Japan; [Hagiwara, Toshiyuki] Daiichi Sankyo Co Ltd, Fukuroi Res Ctr, Fukuroi, Japan; [Ushimaru, Takashi] Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka, Japan; [Tainaka, Kei-ichi; Kurachi, Hironori; Yoshimura, Jin] Shizuoka Univ, Dept Syst Engn, Hamamatsu, Shizuoka 4328011, Japan; [Yoshimura, Jin] Chiba Univ, Marine Biosyst Res Ctr, Chiba, Japan; [Yoshimura, Jin] SUNY Syracuse, Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA	Shizuoka University; Daiichi Sankyo Company Limited; Shizuoka University; Shizuoka University; Chiba University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Hagiwara, T (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Hamamatsu, Shizuoka 4328011, Japan.	tainaka@sys.eng.shizuoka.ac.jp; jin@sys.eng.shizuoka.ac.jp			Ministry of Education, Culture, Sports Science and Technology of Japan [22255004, 22370010, 20500204]; Ryozo Yamada Funds; Grants-in-Aid for Scientific Research [22370010, 21570100] Funding Source: KAKEN	Ministry of Education, Culture, Sports Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ryozo Yamada Funds; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports Science and Technology of Japan to J.Y. (nos. 22255004 and 22370010) and K. T. (20500204) and a research grant from Ryozo Yamada Funds to J.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barea F, 2009, MECH AGEING DEV, V130, P444, DOI 10.1016/j.mad.2009.04.005; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; Brachmann CB, 1998, YEAST, V14, P115; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Fabrizio P, 2008, BBA-MOL CELL RES, V1783, P1280, DOI 10.1016/j.bbamcr.2008.03.017; HAMADA T, 1985, J THEOR BIOL, V113, P737, DOI 10.1016/S0022-5193(85)80190-9; HAMADA T, 1982, J THEOR BIOL, V97, P393, DOI 10.1016/0022-5193(82)90373-3; HAMADA T, 1982, J THEOR BIOL, V99, P797, DOI 10.1016/0022-5193(82)90198-9; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; HARTWELL LH, 1974, BACTERIOL REV, V38, P164, DOI 10.1128/MMBR.38.2.164-198.1974; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; KRISTAN KS, 2009, J VISUALIZED EXPT, V28, P1209; MacLean M, 2001, YEAST, V18, P499, DOI 10.1002/yea.701; MATT K, 2005, MECH AGEING DEV, V126, P491; MICHAEL C, 2004, CELL, V117, P899; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; MORTIMER RK, 1986, GENETICS, V113, P35; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Tainaka K, 2006, J THEOR BIOL, V242, P736, DOI 10.1016/j.jtbi.2006.04.018; Thorpe PH, 2008, COLD SH Q B, V73, P81, DOI 10.1101/sqb.2008.73.010; Yang JY, 2011, CELL CYCLE, V10, P144, DOI 10.4161/cc.10.1.14455	23	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19224	10.1371/journal.pone.0019224	http://dx.doi.org/10.1371/journal.pone.0019224			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556367	Green Submitted, Green Published, gold			2022-12-25	WOS:000290019400038
J	Zou, SG; Liedo, P; Altamirano-Robles, L; Cruz-Enriquez, J; Morice, A; Ingram, DK; Kaub, K; Papadopoulos, N; Carey, JR				Zou, Sige; Liedo, Pablo; Altamirano-Robles, Leopoldo; Cruz-Enriquez, Janeth; Morice, Amy; Ingram, Donald K.; Kaub, Kevin; Papadopoulos, Nikos; Carey, James R.			Recording Lifetime Behavior and Movement in an Invertebrate Model	PLOS ONE			English	Article							DROSOPHILA; FLY	Characterization of lifetime behavioral changes is essential for understanding aging and aging-related diseases. However, such studies are scarce partly due to the lack of efficient tools. Here we describe and provide proof of concept for a stereo vision system that classifies and sequentially recordsat an extremely fine scalesix different behaviors (resting, micro-movement, walking, flying, feeding and drinking) and the within-cage (3D) location of individualtephritidfruit flies by time-of-day throughout their lives. Using flies fed on two different diets, full sugar-yeast and sugar-only diets, we report for the first time their behavioral changes throughout their lives at a high resolution. We have found that the daily activity peaks at the age of 15-20 days and then gradually declines with age for flies on both diets. However, the overall daily activity is higher for flies on sugar-only diet than those on the full diet. Flies on sugar-only diet show a stronger diurnal localization pattern with higher preference to staying on the top of the cage during the period of light-off when compared to flies on the full diet. Clustering analyses of age-specific behavior patterns reveal three distinct young, middle-aged and old clusters for flies on each of the two diets. The middle-aged groups for flies on sugar-only diet consist of much younger age groups when compared to flies on full diet. This technology providesresearch opportunitiesfor using a behavioral informatics approach for understanding different ways in which behavior, movement, and aging in model organisms are mutually affecting.	[Zou, Sige] NIA, Lab Expt Gerontol, Baltimore, MD 21224 USA; [Liedo, Pablo] El Colegio Frontera Sur, Dept Entomol, Tapachula, Chiapas, Mexico; [Altamirano-Robles, Leopoldo; Cruz-Enriquez, Janeth] Inst Nacl Astrofis Opt & Electr, Lab Vis Comp, Puebla, Mexico; [Morice, Amy; Kaub, Kevin; Carey, James R.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Ingram, Donald K.] Louisiana State Univ, Pennington Biomed Res Ctr, Nutrit Neurosci & Aging Lab, Baton Rouge, LA 70808 USA; [Papadopoulos, Nikos] Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Magnisias, Greece; [Carey, James R.] Univ Calif Berkeley, Ctr Econ & Demog Aging, Berkeley, CA 94720 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); El Colegio de la Frontera Sur (ECOSUR); Instituto Nacional de Astrofisica, Optica y Electronica; University of California System; University of California Davis; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of California System; University of California Berkeley	Zou, SG (corresponding author), NIA, Lab Expt Gerontol, Baltimore, MD 21224 USA.	jrcarey@ucdavis.edu	Altamirano, Leopoldo/V-5533-2019; Papadopoulos, Nikos T./B-9156-2011; Liedo, Pablo/E-9313-2010; Papadopoulos, Nikos/AAJ-1721-2020; Trejo, Yesenia YGTA/D-9257-2012	Papadopoulos, Nikos T./0000-0003-2480-8189; Liedo, Pablo/0000-0002-0004-1721; Papadopoulos, Nikos/0000-0003-2480-8189; Cruz-Enriquez, Janeth/0000-0002-6880-2478; Altamirano, Leopoldo/0000-0003-0965-6420	Ellison Medical Foundation; UC MEXUS; National Institute on Aging/National Institutes of Health (NIA/NIH) [P01 AG022500-01, P01 AG08761-10]; NATIONAL INSTITUTE ON AGING [ZIAAG000365, P01AG008761, P01AG022500, ZIAAG000366] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); UC MEXUS; National Institute on Aging/National Institutes of Health (NIA/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research funded by the Ellison Medical Foundation, UC MEXUS and National Institute on Aging/National Institutes of Health (NIA/NIH) grants P01 AG022500-01 and P01 AG08761-10 to JRC, and the Intramural Research Program of NIA, NIH to SZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Bross TG, 2005, AGING CELL, V4, P309, DOI 10.1111/j.1474-9726.2005.00181.x; Carey JR, 2008, AGING CELL, V7, P470, DOI 10.1111/j.1474-9726.2008.00389.x; Gabadinho A., 2010, MINING SEQUENCE DATA; GROVER D, 2009, BMC RES NOTES, V17, P2; Grover D, 2008, J R SOC INTERFACE, V5, P1181, DOI 10.1098/rsif.2007.1333; Grover D, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-93; Iliadi KG, 2010, ANN NY ACAD SCI, V1197, P9, DOI 10.1111/j.1749-6632.2009.05372.x; Inan OT, 2009, IEEE T BIO-MED ENG, V56, P522, DOI 10.1109/TBME.2008.2006018; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Nielsen CB, 2010, NAT METHODS, V7, pS5, DOI [10.1038/NMETH.1422, 10.1038/nmeth.1422]; Robie AA, 2010, J EXP BIOL, V213, P2494, DOI 10.1242/jeb.041749; Sharma P, 2009, J NEUROSCI METH, V182, P43, DOI 10.1016/j.jneumeth.2009.05.024; VALENTE D, 2007, PLOS ONE, P1; Wolf FW, 2002, J NEUROSCI, V22, P11035; Zimmerman JE, 2008, SLEEP, V31, P1587, DOI 10.1093/sleep/31.11.1587; ZOU S, 2006, MECH AGEING DEV, V128, P222	19	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18151	10.1371/journal.pone.0018151	http://dx.doi.org/10.1371/journal.pone.0018151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21559058	Green Published, gold, Green Submitted			2022-12-25	WOS:000289404700007
J	Yamanaka, Y; Karuppaiah, K; Abu-Amer, Y				Yamanaka, Yasuhiro; Karuppaiah, Kannan; Abu-Amer, Yousef			Polyubiquitination Events Mediate Polymethylmethacrylate (PMMA) Particle Activation of NF-kappa B Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; KINASE COMPLEX; INDUCED OSTEOCLASTOGENESIS; INFLAMMATORY OSTEOLYSIS; IKK ACTIVATION; PERIPROSTHETIC OSTEOLYSIS; NEMO; TAK1; GAMMA; ALPHA	The pathologic response to implant wear-debris constitutes a major component of inflammatory osteolysis and remains under intense investigation. Polymethylmethacrylate (PMMA) particles, which are released during implant wear and loosening, constitute a major culprit by virtue of inducing inflammatory and osteolytic responses by macrophages and osteoclasts, respectively. Recent work by several groups has identified important cellular entities and secreted factors that contribute to inflammatory osteolysis. In previous work, we have shown that PMMA particles contribute to inflammatory osteolysis through stimulation of major pathways in monocytes/macrophages, primarily NF-kappa B and MAP kinases. The former pathway requires assembly of large IKK complex encompassing IKK1, IKK2, and IKK gamma/NEMO. We have shown recently that interfering with the NF-gamma B and MAPK activation pathways, through introduction of inhibitors and decoy molecules, impedes PMMA-induced inflammation and osteolysis in mouse models of experimental calvarial osteolysis and inflammatory arthritis. In this study, we report that PMMA particles activate the upstream transforming growth factor beta-activated kinase-1 (TAK1), which is a key regulator of signal transduction cascades leading to activation of NF-kappa B and AP-1 factors. More importantly, we found that PMMA particles induce TAK1 binding to NEMO and UBC13. In addition, we show that PMMA particles induce TRAF6 and UBC13 binding to NEMO and that lack of TRAF6 significantly attenuates NEMO ubiquitination. Altogether, these observations suggest that PMMA particles induce ubiquitination of NEMO, an event likely mediated by TRAF6, TAK1, and UBC13. Our findings provide important information for better understanding of the mechanisms underlying PMMA particle-induced inflammatory responses.	[Yamanaka, Yasuhiro] Asahikawa Med Coll, Dept Orthoped Surg, Asahikawa, Hokkaido 0788510, Japan; [Karuppaiah, Kannan; Abu-Amer, Yousef] Washington Univ, Sch Med, Dept Orthoped, St Louis, MO 63110 USA; [Karuppaiah, Kannan; Abu-Amer, Yousef] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Asahikawa Medical College; Washington University (WUSTL); Washington University (WUSTL)	Abu-Amer, Y (corresponding author), 660 S Euclid Ave,Campus Box 8233, St Louis, MO 63110 USA.	abuamery@wustl.edu			National Institutes of Health [AR049192, AR054326]; Shriners Hospital for Children [8570, 8510]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049192, R01AR054326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospital for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR049192, and AR054326 and the Shriners Hospital for Children Grants 8570 and 8510.	Abbas S, 2003, J ORTHOPAED RES, V21, P1041, DOI 10.1016/S0736-0266(03)00081-0; Abu-Amer Y., 2006, FUTURE MED, V1, P133, DOI DOI 10.2217/17460816.1.1.133; Abu-Amer Y, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2170; ABUAMER Y, 2003, MOL BIOL ORTHOPEDICS, P229; Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Archibeck M J, 2001, Instr Course Lect, V50, P185; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Burns KA, 2004, CURR BIOL, V14, pR1040, DOI 10.1016/j.cub.2004.11.040; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; CLOHISY DR, 1989, J BIOL CHEM, V264, P5370; Clohisy JC, 2004, J ORTHOPAED RES, V22, P13, DOI 10.1016/S0736-0266(03)00156-6; Clohisy JC, 2003, J ORTHOPAED RES, V21, P202, DOI 10.1016/S0736-0266(02)00133-X; Clohisy JC, 2002, J ORTHOPAED RES, V20, P174, DOI 10.1016/S0736-0266(01)00088-2; Clohisy JC, 2006, J ORTHOP RES, V24, P1358, DOI 10.1002/jor.20184; Faccio R, 2003, J CLIN INVEST, V111, P749, DOI 10.1172/JCI200316924; Fukushima T, 2007, P NATL ACAD SCI USA, V104, P6371, DOI 10.1073/pnas.0700548104; Hay RT, 2004, NAT CELL BIOL, V6, P89, DOI 10.1038/ncb0204-89; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Kawadler H, 2006, CANCER BIOL THER, V5, P1273, DOI 10.4161/cbt.5.10.3289; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Li XH, 2001, J BIOL CHEM, V276, P4494, DOI 10.1074/jbc.M008353200; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; May MJ, 2002, J BIOL CHEM, V277, P45992, DOI 10.1074/jbc.M206494200; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Minematsu H, 2007, ANN NY ACAD SCI, V1117, P143, DOI 10.1196/annals.1402.026; Otero JE, 2010, J BONE MINER RES, V25, P1282, DOI 10.1002/jbmr.4; Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schwarz EM, 2000, J ORTHOPAED RES, V18, P472, DOI 10.1002/jor.1100180321; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Shifera AS, 2008, MOL CELL BIOCHEM, V310, P181, DOI 10.1007/s11010-007-9679-z; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Teitelbaum SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1857; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wei S, 2008, PATHOL RES PRACT, V204, P695, DOI 10.1016/j.prp.2008.07.002; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamamoto M, 2006, J IMMUNOL, V177, P7520, DOI 10.4049/jimmunol.177.11.7520; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yamamoto Y, 2001, J BIOL CHEM, V276, P36327, DOI 10.1074/jbc.M104090200; Yamanaka Y, 2006, J ORTHOP RES, V24, P1349, DOI 10.1002/jor.20199; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	51	19	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23735	23741		10.1074/jbc.M111.223669	http://dx.doi.org/10.1074/jbc.M111.223669			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566132	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000292294900015
J	Bello-Morales, R; Perez-Hernandez, M; Rejas, MT; Matesanz, F; Alcina, A; Lopez-Guerrero, JA				Bello-Morales, Raquel; Perez-Hernandez, Marta; Teresa Rejas, Maria; Matesanz, Fuencisla; Alcina, Antonio; Antonio Lopez-Guerrero, Jose			Interaction of PLP with GFP-MAL2 in the Human Oligodendroglial Cell Line HOG	PLOS ONE			English	Article							PELIZAEUS-MERZBACHER DISEASE; TO-APICAL TRANSCYTOSIS; HEPATOMA HEPG2 CELLS; MYELIN MEMBRANE; SUBAPICAL COMPARTMENT; POLARITY DEVELOPMENT; PROTEOLIPID PROTEIN; MAL2; TRAFFICKING; BIOGENESIS	The velocity of the nerve impulse conduction of vertebrates relies on the myelin sheath, an electrically insulating layer that surrounds axons in both the central and peripheral nervous systems, enabling saltatory conduction of the action potential. Oligodendrocytes are the myelin-producing glial cells in the central nervous system. A deeper understanding of the molecular basis of myelination and, specifically, of the transport of myelin proteins, will contribute to the search of the aetiology of many dysmyelinating and demyelinating diseases, including multiple sclerosis. Recent investigations suggest that proteolipid protein (PLP), the major myelin protein, could reach myelin sheath by an indirect transport pathway, that is, a transcytotic route via the plasma membrane of the cell body. If PLP transport relies on a transcytotic process, it is reasonable to consider that this myelin protein could be associated with MAL2, a raft protein essential for transcytosis. In this study, carried out with the human oligodendrocytic cell line HOG, we show that PLP colocalized with green fluorescent protein (GFP)-MAL2 after internalization from the plasma membrane. In addition, both immunoprecipitation and immunofluorescence assays, indicated the existence of an interaction between GFP-MAL2 and PLP. Finally, ultrastructural studies demonstrated colocalization of GFP-MAL2 and PLP in vesicles and tubulovesicular structures. Taken together, these results prove for the first time the interaction of PLP and MAL2 in oligodendrocytic cells, supporting the transcytotic model of PLP transport previously suggested.	[Bello-Morales, Raquel; Perez-Hernandez, Marta; Teresa Rejas, Maria; Antonio Lopez-Guerrero, Jose] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain; [Matesanz, Fuencisla; Alcina, Antonio] Inst Parasitol & Biomed Lopez Neyra, Consejo Super Invest Cient, Granada, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Bello-Morales, R (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain.	jal@cbm.uam.es	Bello-Morales, Raquel/AHD-5028-2022; LÓPEZ-GUERRERO, JOSÉ ANTONIO/L-5667-2017; Alcina, Antonio/T-1893-2017; Guerrero, Jose Antonio Lopez/Z-2413-2019; Matesanz, Fuencisla/F-3715-2016	LÓPEZ-GUERRERO, JOSÉ ANTONIO/0000-0003-2817-5956; Alcina, Antonio/0000-0001-7294-0948; Guerrero, Jose Antonio Lopez/0000-0002-7369-8388; Matesanz, Fuencisla/0000-0002-9429-1819; Bello-Morales, Raquel/0000-0002-4415-6483; Bello-Morales, Raquel/0000-0002-8526-6590; Perez-Hernandez, Marta/0000-0001-6119-103X	Severo Ochoa Foundation	Severo Ochoa Foundation	This work was supported by the Severo Ochoa Foundation project entitled "Differentiation and transcytosis in oligodendrocytes. Effect of HSV". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO MA, 1987, P NATL ACAD SCI USA, V84, P1997, DOI 10.1073/pnas.84.7.1997; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Bakhti M, 2011, J BIOL CHEM, V286, P787, DOI 10.1074/jbc.M110.190009; Baron W, 2010, FEBS LETT, V584, P1760, DOI 10.1016/j.febslet.2009.10.085; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bello-Morales R, 2005, J NEUROVIROL, V11, P190, DOI 10.1080/13550280590924179; Bello-Morales R, 2009, EXP CELL RES, V315, P3453, DOI 10.1016/j.yexcr.2009.08.003; BOISON D, 1995, J NEUROSCI, V15, P5502; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; de Marco MC, 2006, TRAFFIC, V7, P61, DOI 10.1111/j.1600-0854.2005.00361.x; de Marco MC, 2002, J CELL BIOL, V159, P37, DOI 10.1083/jcb.200206033; de Vries H, 1998, MOL BIOL CELL, V9, P599, DOI 10.1091/mbc.9.3.599; Dhaunchak AS, 2007, P NATL ACAD SCI USA, V104, P17813, DOI 10.1073/pnas.0704975104; Doeuvre L, 2009, J NEUROCHEM, V110, P457, DOI 10.1111/j.1471-4159.2009.06163.x; DUBOISDALCQ M, 1986, J CELL BIOL, V102, P384, DOI 10.1083/jcb.102.2.384; Gronborg M, 2010, J NEUROSCI, V30, P2, DOI 10.1523/JNEUROSCI.4074-09.2010; Hayashi T, 2004, P NATL ACAD SCI USA, V101, P14949, DOI 10.1073/pnas.0402890101; Hoekstra D, 2004, J CELL SCI, V117, P2183, DOI 10.1242/jcs.01217; Ihrke G, 1998, J CELL BIOL, V141, P115, DOI 10.1083/jcb.141.1.115; Jackman N, 2009, PHYSIOLOGY, V24, P290, DOI 10.1152/physiol.00016.2009; Klunder B, 2008, J NEUROSCI RES, V86, P1007, DOI 10.1002/jnr.21556; Koeppen AH, 2002, J NEUROPATH EXP NEUR, V61, P747, DOI 10.1093/jnen/61.9.747; Kramer-Albers EM, 2007, PROTEOM CLIN APPL, V1, P1446, DOI 10.1002/prca.200700522; Madrid R, 2010, DEV CELL, V18, P814, DOI [10.1016/j.devcel.2010.04.001, 10.1016/j.devce1.2010.04.001]; Maier O, 2003, J BIOL CHEM, V278, P164, DOI 10.1074/jbc.M208259200; Maier O, 2008, J MOL NEUROSCI, V35, P35, DOI 10.1007/s12031-007-9024-8; Marazuela M, 2004, J HISTOCHEM CYTOCHEM, V52, P243, DOI 10.1177/002215540405200212; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Schneider A, 2005, J CELL SCI, V118, P2415, DOI 10.1242/jcs.02365; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Simons M, 2000, J CELL BIOL, V151, P143, DOI 10.1083/jcb.151.1.143; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Trajkovic K, 2006, J CELL BIOL, V172, P937, DOI 10.1083/jcb.200509022; van IJzendoorn SCD, 1998, J CELL BIOL, V142, P683, DOI 10.1083/jcb.142.3.683; Wilson SHD, 2001, GENOMICS, V76, P81, DOI 10.1006/geno.2001.6610; Winterstein C, 2008, J CELL SCI, V121, P834, DOI 10.1242/jcs.022731; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722	39	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19388	10.1371/journal.pone.0019388	http://dx.doi.org/10.1371/journal.pone.0019388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573057	gold, Green Published, Green Submitted			2022-12-25	WOS:000290386800011
J	Shen, CI; Wang, CH; Shen, SC; Lee, HC; Liao, JW; Su, HL				Shen, Ching-I; Wang, Ching-Ho; Shen, Shih-Cheng; Lee, Hsiu-Chin; Liao, Jiunn-Wang; Su, Hong-Lin			The Infection of Chicken Tracheal Epithelial Cells with a H6N1 Avian Influenza Virus	PLOS ONE			English	Article							RECEPTOR SPECIFICITY; MAACKIA-AMURENSIS; ACID SUBSTITUTIONS; TARGET-CELLS; H5N1 CHICKEN; BASAL-CELLS; BINDING; HEMAGGLUTININ; PATHOGENICITY; GLYCOPROTEINS	Sialic acids (SAs) linked to galactose (Gal) in alpha 2,3- and alpha 2,6-configurations are the receptors for avian and human influenza viruses, respectively. We demonstrate that chicken tracheal ciliated cells express alpha 2,3-linked SA, while goblet cells mainly express alpha 2,6-linked SA. In addition, the plant lectin MAL-II, but not MAA/MAL-I, is bound to the surface of goblet cells, suggesting that SA2,3-linked oligosaccharides with Gal beta 1-3GalNAc subterminal residues are specifically present on the goblet cells. Moreover, both alpha 2,3- and alpha 2,6-linked SAs are detected on single tracheal basal cells. At a low multiplicity of infection (MOI) avian influenza virus H6N1 is exclusively detected in the ciliated cells, suggesting that the ciliated cell is the major target cell of the H6N1 virus. At a MOI of 1, ciliated, goblet and basal cells are all permissive to the AIV infection. This result clearly elucidates the receptor distribution for the avian influenza virus among chicken tracheal epithelial cells and illustrates a primary cell model for evaluating the cell tropisms of respiratory viruses in poultry.	[Shen, Ching-I] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; [Wang, Ching-Ho] Natl Taiwan Univ, Sch Vet Med, Taipei 10764, Taiwan; [Shen, Shih-Cheng; Lee, Hsiu-Chin; Su, Hong-Lin] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Liao, Jiunn-Wang] Natl Chung Hsing Univ, Grad Inst Vet Pathobiol, Taichung 40227, Taiwan; [Su, Hong-Lin] China Med Univ, Dept Phys Therapy, Taichung, Taiwan	National Chung Hsing University; National Taiwan University; National Chung Hsing University; National Chung Hsing University; China Medical University Taiwan	Shen, CI (corresponding author), Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan.	jwliao@dragon.nchu.edu.tw; suhonglin@nchu.edu.tw		Liao, Jiunn-Wang/0000-0001-7374-1203	National Science Council [NSC 99-2321-B-005-012-MY3]; Taiwan Department of Health Clinical Trial and Research Center of Excellence in Taiwan [DOH100-TD-B-111-004]	National Science Council(Ministry of Science and Technology, Taiwan); Taiwan Department of Health Clinical Trial and Research Center of Excellence in Taiwan	The funding for this project was provided by the National Science Council (NSC 99-2321-B-005-012-MY3) and supported in part by Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkman-Van der Linden ECM, 2002, ANAL BIOCHEM, V303, P98, DOI 10.1006/abio.2001.5539; Buschiazzo A, 2008, CURR OPIN CHEM BIOL, V12, P565, DOI 10.1016/j.cbpa.2008.06.017; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; Chen YT, 2010, VET MICROBIOL, V142, P205, DOI 10.1016/j.vetmic.2009.09.064; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Functional glycomics research website, 2005, FUNCTIONAL GLYCOMICS; Gambaryan A, 2002, ARCH VIROL, V147, P1197, DOI 10.1007/s00705-002-0796-4; Gambaryan AS, 2004, VIROLOGY, V326, P310, DOI 10.1016/j.virol.2004.06.002; Gambaryan AS, 2003, AVIAN DIS, V47, P1154, DOI 10.1637/0005-2086-47.s3.1154; Glaser L, 2007, VIRUS RES, V126, P9, DOI 10.1016/j.virusres.2007.01.011; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Hsu Chieh-Ning, 2006, Journal of Microbiology Immunology and Infection, V39, P292; Kesimer M, 2009, FASEB J, V23, P1858, DOI 10.1096/fj.08-119131; KNIBBS RN, 1991, J BIOL CHEM, V266, P83; KONAMI Y, 1994, FEBS LETT, V342, P334, DOI 10.1016/0014-5793(94)80527-X; LAMBLIN G, 1984, J BIOL CHEM, V259, P9051; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Mo IP, 1997, AVIAN DIS, V41, P125, DOI 10.2307/1592452; NAEVE CW, 1984, J VIROL, V51, P567, DOI 10.1128/JVI.51.2.567-569.1984; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Pillai SPS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-5; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Rowe RK, 2004, IN VITRO CELL DEV-AN, V40, P303; Schauer R, 2009, CARBOHYD RES, V344, P1494, DOI 10.1016/j.carres.2009.05.020; Shen CI, 2010, VET RES, V41, DOI 10.1051/vetres/2009054; SUZUKI Y, 1989, J VIROL, V63, P4298, DOI 10.1128/JVI.63.10.4298-4302.1989; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Viswanathan K, 2010, GLYCOCONJUGATE J, V27, P561, DOI 10.1007/s10719-010-9303-4; Wan HQ, 2006, VIROLOGY, V346, P278, DOI 10.1016/j.virol.2005.10.035; Wang CW, 2003, AVIAN DIS, V47, P1416, DOI 10.1637/6093	37	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e18894	10.1371/journal.pone.0018894	http://dx.doi.org/10.1371/journal.pone.0018894			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573102	gold, Green Submitted, Green Published			2022-12-25	WOS:000290305600007
J	Zhang, JP; Lu, HY; Wu, NQ; Yang, XY; Diao, XM				Zhang, Jianping; Lu, Houyuan; Wu, Naiqin; Yang, Xiaoyan; Diao, Xianmin			Phytolith Analysis for Differentiating between Foxtail Millet (Setaria italica) and Green Foxtail (Setaria viridis)	PLOS ONE			English	Article							WHEAT TRITICUM-MONOCOCCUM; ORYZA-SATIVA POACEAE; WHITNEY-U-TEST; INFLORESCENCE BRACTS; GENETIC-VARIABILITY; COMMON MILLET; LOWER YANGTZE; P-BEAUV; DOMESTICATION; RICE	Foxtail millet (Setaria italica) is one of the oldest domesticated cereal crops in Eurasia, but identifying foxtail millets, especially in charred grains, and differentiating it from its wild ancestor, green foxtail (Setaria viridis), in the archaeobotanical remains, is still problematic. Phytolithic analysis provides a meaningful method for identifying this important crop. In this paper, the silicon structure patterns in the glumes, lemmas, and paleas from inflorescence bracts in 16 modern plants of foxtail millet and green foxtail from China and Europe are examined using light microscopy with phase-contrast and a microscopic interferometer. Our research shows that the silicon structure of Omega III from upper lemmas and paleas in foxtail millet and green foxtail can be correspondingly divided into two groups. The size of Omega III type phytolith of foxtail millet is bigger than that from green foxtail. Discriminant function analysis reveals that 78.4% of data on foxtail millet and 76.9% of data on green foxtail are correctly classified. This means certain morphotypes of phytoliths are relatively reliable tools for distinguishing foxtail millet from green foxtail. Our results also revealed that the husk phytolith morphologies of foxtail millets from China and Eastern Europe are markedly different from those from Western Europe. Our research gives a meaningful method of separating foxtail millet and green foxtail. The implications of these findings for understanding the history of foxtail millet domestication and cultivation in ancient civilizations are significant.	[Zhang, Jianping; Lu, Houyuan; Wu, Naiqin] Chinese Acad Sci, Key Lab Cenozo Geol & Environm, Inst Geol & Geophys, Beijing, Peoples R China; [Yang, Xiaoyan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Diao, Xianmin] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhang, JP (corresponding author), Chinese Acad Sci, Key Lab Cenozo Geol & Environm, Inst Geol & Geophys, Beijing, Peoples R China.	jpzhang@mail.iggcas.ac.cn	Lu, houyuan/L-8661-2019; Liu, Kam-Biu/B-4966-2012; Lu, houyuan/AAD-3100-2019; Zhang, Jianping/A-8167-2014	Liu, Kam-Biu/0000-0002-0038-2198; Lu, houyuan/0000-0001-5721-6679; Zhang, Jianping/0000-0003-0815-009X; Yang, Xiaoyan/0000-0002-9088-1838	Chinese Academy of Sciences [XDA05130401]; National Basic Research Program of China [2010CB950201]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the "Strategic Priority Research Program'' of the Chinese Academy of Sciences, Grant No. XDA05130401, the National Basic Research Program of China (2010CB950201), the Chinese Academy of Sciences (100 Talents Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball T, 1996, J ARCHAEOL SCI, V23, P619, DOI 10.1006/jasc.1996.0058; Ball TB, 1999, AM J BOT, V86, P1615, DOI 10.2307/2656798; Ball TB, 2009, BREEDING SCI, V59, P505, DOI 10.1270/jsbbs.59.505; Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Bellwood P, 2004, 1 FARMERS ORIGIN AGR; Benabdelmouna A, 2001, THEOR APPL GENET, V103, P668, DOI 10.1007/s001220100596; Bettinger RL, 2010, EVOL ANTHROPOL, V19, P9, DOI 10.1002/evan.20236; Crawford GW, 1992, ORIGINS AGR INT PERS, P7; d'Ennequin ML, 2000, THEOR APPL GENET, V100, P1061, DOI 10.1007/s001220051387; Fukunaga K, 2006, THEOR APPL GENET, V113, P261, DOI 10.1007/s00122-006-0291-5; Fukunaga K, 2003, EUPHYTICA, V129, P7, DOI 10.1023/A:1021589019323; Fukunaga K, 2002, GENET RESOUR CROP EV, V49, P95, DOI 10.1023/A:1013852007770; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Fuller DQ, 2007, ANTIQUITY, V81, P316, DOI 10.1017/S0003598X0009520X; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; [葛威 Ge Wei], 2010, [第四纪研究, Quaternary Sciences], V30, P377; Hancock JF, 2003, PLANT EVOLUTION ORIG; HARLAN JR, 1973, EVOLUTION, V27, P311, DOI [10.2307/2406971, 10.1111/j.1558-5646.1973.tb00676.x]; Harlan JR, 1992, CROPS MAN; HARLAN JR, 1995, LIVING FIELDS AGR HE; Harvey EL, 2005, J ARCHAEOL SCI, V32, P739, DOI 10.1016/j.jas.2004.12.010; Hunt HV, 2008, VEG HIST ARCHAEOBOT, V17, pS5, DOI 10.1007/s00334-008-0187-1; Itzstein-Davey F, 2007, J ARCHAEOL SCI, V34, P2101, DOI 10.1016/j.jas.2007.02.018; Jones M. K., 2004, TRACES ANCESTRY STUD, P127; JUSUF M, 1985, THEOR APPL GENET, V71, P385, DOI 10.1007/BF00251177; Kachigan S.K., 1991, MULTIVARIATE STAT AN; Kasuya E, 2001, ANIM BEHAV, V61, P1247, DOI 10.1006/anbe.2001.1691; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Lee GA, 2007, P NATL ACAD SCI USA, V104, P1087, DOI 10.1073/pnas.0609763104; Liu C., 2004, ARCHAEOLOGY, V8, P76; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Lu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004448; Lu HY, 2005, NATURE, V437, P967, DOI 10.1038/437967a; Lu HY, 2003, DIVERS DISTRIB, V9, P73, DOI 10.1046/j.1472-4642.2003.00166.x; Lu HY, 2002, BOREAS, V31, P378, DOI 10.1080/030094802320942581; Lu Q.S., 1999, SORGHUM; Lu TLD, 2006, ASIAN PERSPECT, V45, P129; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Morris LR, 2009, REV PALAEOBOT PALYNO, V157, P339, DOI 10.1016/j.revpalbo.2009.06.007; Nasu H, 2007, VEG HIST ARCHAEOBOT, V16, P481, DOI 10.1007/s00334-006-0068-4; PARRY DW, 1982, ANN BOT-LONDON, V49, P531, DOI 10.1093/oxfordjournals.aob.a086278; PEARSALL DM, 1995, ECON BOT, V49, P183, DOI 10.1007/BF02862923; Pearsall DM., 2015, PALEOETHNOBOTANY HDB; Perry Carole C., 2009, V47, P295, DOI 10.1007/978-3-540-88552-8_13; Piperno D. R., 2006, PHYTOLITH COMPREHENS; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; PIPERNO DR, 1984, AM ANTIQUITY, V49, P361, DOI 10.2307/280024; Rosen A. M., 1987, SHIQMIM STUDIES CO 1, V356, P547; Rosen A.M., 1992, PHYTOLITH SYSTEMATIC, P129; ROSEN AM, 1994, J ARCHAEOL SCI, V21, P125, DOI 10.1006/jasc.1994.1013; Rosner B, 1999, STAT MED, V18, P1387, DOI 10.1002/(SICI)1097-0258(19990615)18:11<1387::AID-SIM126>3.0.CO;2-V; Rovner I., 1971, QUAT RES, V1, P343, DOI [10.1016/0033-5894(71)90070-6, DOI 10.1016/0033-5894(71)90070-6]; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; SAKAMOTO S, 1987, JARQ-JPN AGR RES Q, V21, P84; SANGSTER AG, 1983, NEW PHYTOL, V93, P105, DOI 10.1111/j.1469-8137.1983.tb02696.x; Schontz D, 1999, PLANT BREEDING, V118, P190, DOI 10.1046/j.1439-0523.1999.118002190.x; Shelach G, 2000, J WORLD PREHIST, V14, P363, DOI 10.1023/A:1011124209079; Smith BD, 1999, EMERGENCE AGR; TUBB HJ, 1993, ANN BOT-LONDON, V72, P537, DOI 10.1006/anbo.1993.1142; Underhill AP, 1997, J WORLD PREHIST, V11, P103, DOI 10.1007/BF02221203; WANG RL, 1995, AM J BOT, V82, P308, DOI 10.2307/2445576; Wet J. M. J. de, 1979, Journal d'Agriculture Traditionnelle et de Botanique Appliquee, V26, P53; Willcox G, 2004, J ARCHAEOL SCI, V31, P145, DOI 10.1016/j.jas.2003.07.003; [阎共波 Yan Hongbo], 2003, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V23, P926; [杨晓燕 Yang Xiaoyan], 2010, [第四纪研究, Quaternary Sciences], V30, P364; Yang XY, 2009, CHINESE SCI BULL, V54, P1738, DOI 10.1007/s11434-009-0048-z; [杨晓燕 Yang Xiaoyan], 2005, [第四纪研究, Quaternary Sciences], V25, P224; Zhao ZJ, 1998, ECON BOT, V52, P134, DOI 10.1007/BF02861201; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	69	63	77	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19726	10.1371/journal.pone.0019726	http://dx.doi.org/10.1371/journal.pone.0019726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573069	Green Published, gold			2022-12-25	WOS:000290305600043
J	Li, QH; Li, N; Hu, XX; Li, JX; Du, Z; Chen, L; Yin, GL; Duan, JJ; Zhang, HC; Zhao, YF; Wang, J; Li, N				Li, Qinghe; Li, Ning; Hu, Xiaoxiang; Li, Jinxiu; Du, Zhuo; Chen, Li; Yin, Guangliang; Duan, Jinjie; Zhang, Haichao; Zhao, Yaofeng; Wang, Jun; Li, Ning			Genome-Wide Mapping of DNA Methylation in Chicken	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; ARABIDOPSIS; TRANSCRIPTION; ELONGATION; M6P/IGF2R; CELLS; IGF2	Cytosine DNA methylation is an important epigenetic modification termed as the fifth base that functions in diverse processes. Till now, the genome-wide DNA methylation maps of many organisms has been reported, such as human, Arabidopsis, rice and silkworm, but the methylation pattern of bird remains rarely studied. Here we show the genome-wide DNA methylation map of bird, using the chicken as a model organism and an immunocapturing approach followed by high-throughput sequencing. In both of the red jungle fowl and the avian broiler, DNA methylation was described separately for the liver and muscle tissue. Generally, chicken displays analogous methylation pattern with that of animals and plants. DNA methylation is enriched in the gene body regions and the repetitive sequences, and depleted in the transcription start site (TSS) and the transcription termination site (TTS). Most of the CpG islands in the chicken genome are kept in unmethylated state. Promoter methylation is negatively correlated with the gene expression level, indicating its suppressive role in regulating gene transcription. This work contributes to our understanding of epigenetics in birds.	[Li, Qinghe; Hu, Xiaoxiang; Li, Jinxiu; Du, Zhuo; Chen, Li; Zhao, Yaofeng; Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Li, Ning; Yin, Guangliang; Duan, Jinjie; Zhang, Haichao; Wang, Jun] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Li, Ning] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	China Agricultural University; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, QH (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	ninglbau@public3.bta.net.cn	Du, Zhuo/AAD-2263-2019; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Du, Zhuo/0000-0002-6322-4656; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Duan, Jinjie/0000-0002-3402-302X	National Major Basic Research Program of China (973 program) [2007CB815704, 2009CB941600]; National High Technology and Development Program of China (863 Program) [2010AA10A102]; National Natural Science Foundation of China; China Agricultural University	National Major Basic Research Program of China (973 program)(National Basic Research Program of China); National High Technology and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agricultural University	This work was supported by the National Major Basic Research Program of China (973 program, No. 2007CB815704, No. 2009CB941600), the National High Technology and Development Program of China (863 Program, No. 2010AA10A102), the National Natural Science Foundation of China, and the Postgraduate Scientific Research Innovation Specific Program of China Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Burt D, 2003, SCIENCE, V300, P1669, DOI 10.1126/science.1086231; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; FUMIHITO A, 1994, P NATL ACAD SCI USA, V91, P12505, DOI 10.1073/pnas.91.26.12505; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li N, 2010, METHODS, V52, P203, DOI 10.1016/j.ymeth.2010.04.009; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Nolan CM, 2001, DEV GENES EVOL, V211, P179, DOI 10.1007/s004270000132; O'Neill MJ, 2000, DEV GENES EVOL, V210, P18, DOI 10.1007/PL00008182; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Rubin CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-208; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Xu Q, 2007, ANIM BIOTECHNOL, V18, P231, DOI 10.1080/10495390701574838; Yokomine T, 2005, GENOME RES, V15, P154, DOI 10.1101/gr.2609605; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	29	98	103	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19428	10.1371/journal.pone.0019428	http://dx.doi.org/10.1371/journal.pone.0019428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573164	gold, Green Submitted, Green Published			2022-12-25	WOS:000290256400010
J	Boyles, TH; Wilkinson, LS; Leisegang, R; Maartens, G				Boyles, Tom H.; Wilkinson, Lynne S.; Leisegang, Rory; Maartens, Gary			Factors Influencing Retention in Care after Starting Antiretroviral Therapy in a Rural South African Programme	PLOS ONE			English	Article							RESOURCE-POOR SETTINGS; FOLLOW-UP; DISEASE PROGRESSION; PREGNANT-WOMEN; CELL COUNT; OUTCOMES; MORTALITY; AIDS; KHAYELITSHA; DEPRESSION	Introduction: The prognosis of patients with HIV in Africa has improved with the widespread use of antiretroviral therapy (ART) but these successes are threatened by low rates of long-term retention in care. There are limited data on predictors of retention in care, particularly from rural sites. Methods: Prospective cohort analysis of outcome measures in adults from a rural HIV care programme in Madwaleni, Eastern Cape, South Africa. The ART programme operates from Madwaleni hospital and seven primary care feeder clinics with full integration between inpatient and outpatient services. Outreach workers conducted home visits for defaulters. Results: 1803 adults initiated ART from June 2005 to May 2009. At the end of the study period 82.4% were in active care or had transferred elsewhere, 11.1% had died and 6.5% were lost to follow-up (LTFU). Independent predictors associated with an increased risk of LTFU were CD4 nadir > 200, initiating ART as an inpatient or while pregnant, and younger age, while being in care for > 6 months before initiating ART was associated with a reduced risk. Independent factors associated with an increased risk of mortality were baseline CD4 count < 50 and initiating ART as an inpatient, while being in care for >6 months before initiating ART and initiating ART while pregnant were associated with a reduced risk. Conclusions: Serving a socioeconomically deprived rural population is not a barrier to successful ART delivery. Patients initiating ART while pregnant and inpatients may require additional counselling and support to reduce LTFU. Providing HIV care for patients not yet eligible for ART may be protective against being LTFU and dying after ART initiation.	[Boyles, Tom H.; Wilkinson, Lynne S.] Madwaleni Hosp, Eastern Cape, South Africa; [Boyles, Tom H.] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Leisegang, Rory; Maartens, Gary] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Boyles, TH (corresponding author), Madwaleni Hosp, Eastern Cape, South Africa.	tomboyles@yahoo.com	Maartens, Gary/F-3836-2014; Maartens, Gary/S-2788-2019	Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606; Boyles, Tom/0000-0002-5676-8081	Aurum Institute for Health Research; Donald Woods' Foundation	Aurum Institute for Health Research; Donald Woods' Foundation	We would like to thank all the staff who contributed to the Madwaleni HIV Wellness and ART programme as well as Aurum Institute for Health Research and Donald Woods' Foundation for donor support of the programme.	*AM DISTR MUN, DRAFT INT DEV PLAN R; [Anonymous], 1998, NEW ENGL J MED, V338, P853; Antelman G, 2007, JAIDS-J ACQ IMM DEF, V44, P470, DOI 10.1097/QAI.0b013e31802f1318; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Brodt HR, 1997, AIDS, V11, P1731, DOI 10.1097/00002030-199714000-00010; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Chibanda D, 2010, J WOMENS HEALTH, V19, P2071, DOI 10.1089/jwh.2010.2012; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Coetzee D, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406003-00006; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Ford N, 2010, AIDS, V24, P2645, DOI 10.1097/QAD.0b013e32833ec5b2; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Kranzer K, 2010, JAIDS-J ACQ IMM DEF, V55, pE17, DOI 10.1097/QAI.0b013e3181f275fd; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2005, CLIN INFECT DIS, V41, P1683, DOI 10.1086/498030; LEISEGANG R, 2010, BMC HLTH SERV RES S, V10, P3; Leisegang R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000189; MAJ M, 1994, ARCH GEN PSYCHIAT, V51, P51; MAQUTU D, 2010, AIDS BEHAV IN PRESS; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, pS127, DOI 10.1097/01.qai.0000248349.25630.3d; *NAT DEP HLTH, 2004, S AFR NAT ANT TREATM; Newell ML, 1997, AIDS, V11, P1859; Rochat TJ, 2006, JAMA-J AM MED ASSOC, V295, P1376, DOI 10.1001/jama.295.12.1376; SHISANA O, 2005, S AFRICAN NATL HIV P; Starace F, 2002, JAIDS, V31, pS136, DOI 10.1097/00126334-200212153-00010; *STAT S AFR, S AFR CENS 2001; Toro PL, 2010, AIDS, V24, P515, DOI 10.1097/QAD.0b013e3283350ecd; WHO, 2003, SCAL ANT THER RES LT; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010	36	63	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19201	10.1371/journal.pone.0019201	http://dx.doi.org/10.1371/journal.pone.0019201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559280	Green Submitted, gold, Green Published			2022-12-25	WOS:000290223500010
J	Chowdhury, S; Howell, GM; Rajput, A; Teggart, CA; Brattain, LE; Weber, HR; Chowdhury, A; Brattain, MG				Chowdhury, Sanjib; Howell, Gillian M.; Rajput, Ashwani; Teggart, Carol A.; Brattain, Lisa E.; Weber, Hannah R.; Chowdhury, Aparajita; Brattain, Michael G.			Identification of a Novel TGF beta/PKA Signaling Transduceome in Mediating Control of Cell Survival and Metastasis in Colon Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PROTEIN-KINASE-A; CARCINOMA CELLS; PHOSPHATASE 2A; PROTEASOME FUNCTION; FACTOR RECEPTOR; MCF-7 CELLS; EXPRESSION; PHOSPHORYLATION; APOPTOSIS	Background: Understanding drivers for metastasis in human cancer is important for potential development of therapies to treat metastases. The role of loss of TGF beta tumor suppressor activities in the metastatic process is essentially unknown. Methodology/Principal Findings: Utilizing in vitro and in vivo techniques, we have shown that loss of TGF beta tumor suppressor signaling is necessary to allow the last step of the metastatic process - colonization of the metastatic site. This work demonstrates for the first time that TGF beta receptor reconstitution leads to decreased metastatic colonization. Moreover, we have identified a novel TGF beta/PKA tumor suppressor pathway that acts directly on a known cell survival mechanism that responds to stress with the survivin/XIAP dependent inhibition of caspases that effect apoptosis. The linkage between the TGF beta/PKA transduceome signaling and control of metastasis through induction of cell death was shown by TGF beta receptor restoration with reactivation of the TGF beta/PKA pathway in receptor deficient metastatic colon cancer cells leading to control of aberrant cell survival. Conclusion/Significance:This work impacts our understanding of the possible mechanisms that are critical to the growth and maintenance of metastases as well as understanding of a novel TGF beta function as a metastatic suppressor. These results raise the possibility that regeneration of attenuated TGF beta signaling would be an effective target in the treatment of metastasis. Our work indicates the clinical potential for developing anti-metastasis therapy based on inhibition of this very important aberrant cell survival mechanism by the multifaceted TGF beta/PKA transduceome induced pathway. Development of effective treatments for metastatic disease is a pressing need since metastases are the major cause of death in solid tumors.	[Chowdhury, Sanjib; Howell, Gillian M.; Teggart, Carol A.; Brattain, Lisa E.; Weber, Hannah R.; Chowdhury, Aparajita; Brattain, Michael G.] Univ Nebraska Med Ctr, Eppley Canc Ctr, Omaha, NE 68131 USA; [Rajput, Ashwani] Univ New Mexico, Dept Surg, Albuquerque, NM 87131 USA	University of Nebraska System; University of Nebraska Medical Center; University of New Mexico	Chowdhury, S (corresponding author), Univ Nebraska Med Ctr, Eppley Canc Ctr, Omaha, NE 68131 USA.	mbrattain@unmc.edu			National Institutes of Health [CA72001, CA38173]; NATIONAL CANCER INSTITUTE [R01CA072001, R01CA038173, R37CA038173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA72001 and CA38173 to MGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammanamanchi S, 2004, J BIOL CHEM, V279, P32620, DOI 10.1074/jbc.M402691200; Ammanamanchi S, 2001, J BIOL CHEM, V276, P32854, DOI 10.1074/jbc.M103951200; Ammanamanchi S, 2001, J BIOL CHEM, V276, P3348, DOI 10.1074/jbc.M002462200; Borczuk AC, 2005, AM J RESP CRIT CARE, V172, P729, DOI 10.1164/rccm.200504-615OC; BOYD DD, 1988, CANCER RES, V48, P2469; Buck MB, 2004, CLIN CANCER RES, V10, P491, DOI 10.1158/1078-0432.CCR-0320-03; Carlucci A, 2008, TRENDS CELL BIOL, V18, P604, DOI 10.1016/j.tcb.2008.09.006; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Gobbi H, 2000, HISTOPATHOLOGY, V36, P168; Guo XN, 2007, CANCER RES, V67, P5851, DOI 10.1158/0008-5472.CAN-07-0049; Heider U, 2008, EUR J HAEMATOL, V80, P133, DOI 10.1111/j.1600-0609.2007.00995.x; Hong K, 2008, J BIOL CHEM, V283, P23129, DOI 10.1074/jbc.M800478200; Hu YP, 2008, CANCER RES, V68, P8004, DOI 10.1158/0008-5472.CAN-08-0280; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jarnaess E, 2008, J BIOL CHEM, V283, P33708, DOI 10.1074/jbc.M804807200; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu Y, 2000, J BIOL CHEM, V275, P12231, DOI 10.1074/jbc.275.16.12231; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Markowitz SD, 2009, ANN INTERN MED, V150, P816, DOI 10.7326/0003-4819-150-11-200906020-00013; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Newell AEH, 2008, CELL MOTIL CYTOSKEL, V65, P539, DOI 10.1002/cm.20279; Ongchin M, 2009, J SURG RES, V156, P250, DOI 10.1016/j.jss.2009.02.002; PEREIRA ME, 1990, ARCH BIOCHEM BIOPHYS, V283, P68, DOI 10.1016/0003-9861(90)90613-4; Periyasamy S, 2000, ONCOGENE, V19, P4660, DOI 10.1038/sj.onc.1203822; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Rajput A, 2007, CANCER RES, V67, P665, DOI 10.1158/0008-5472.CAN-06-2773; Rogne M, 2009, HUM MOL GENET, V18, P978, DOI 10.1093/hmg/ddn425; Schillace RV, 2001, J BIOL CHEM, V276, P12128, DOI 10.1074/jbc.M010398200; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; SUN LZ, 1994, J BIOL CHEM, V269, P26449; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Venkatasubbarao K, 2001, CANCER RES, V61, P6239; Wang J, 1996, J BIOL CHEM, V271, P17366, DOI 10.1074/jbc.271.29.17366; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Wang J, 2009, J BIOL CHEM, V284, P10912, DOI 10.1074/jbc.M809551200; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Ye SC, 1999, CANCER RES, V59, P4725; Zhang FX, 2007, PHYSIOLOGY, V22, P373, DOI 10.1152/physiol.00026.2007; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200; Zhang LZ, 2004, MOL CELL BIOL, V24, P2169, DOI 10.1128/MCB.24.5.2169-2180.2004; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	49	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19335	10.1371/journal.pone.0019335	http://dx.doi.org/10.1371/journal.pone.0019335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559296	gold, Green Published, Green Submitted			2022-12-25	WOS:000290223500017
J	Hawse, JR; Cicek, M; Grygo, SB; Bruinsma, ES; Rajamannan, NM; van Wijnen, AJ; Lian, JB; Stein, GS; Oursler, MJ; Subramaniam, M; Spelsberg, TC				Hawse, John R.; Cicek, Muzaffer; Grygo, Sarah B.; Bruinsma, Elizabeth S.; Rajamannan, Nalini M.; van Wijnen, Andre J.; Lian, Jane B.; Stein, Gary S.; Oursler, Merry Jo; Subramaniam, Malayannan; Spelsberg, Thomas C.			TIEG1/KLF10 Modulates Runx2 Expression and Activity in Osteoblasts	PLOS ONE			English	Article							INDUCIBLE EARLY GENE-1; OSTEOCLAST-DIFFERENTIATION; TRANSCRIPTIONAL CONTROL; CBFA1 CONTRIBUTES; DISPLAY DEFECTS; BONE-FORMATION; MICE DISPLAY; KAPPA-B; GROWTH; PROTEIN	Deletion of TIEG1/KLF10 in mice results in a gender specific osteopenic skeletal phenotype with significant defects in both cortical and trabecular bone, which are observed only in female animals. Calvarial osteoblasts isolated from TIEG1 knockout (KO) mice display reduced expression levels of multiple bone related genes, including Runx2, and exhibit significant delays in their mineralization rates relative to wildtype controls. These data suggest that TIEG1 plays an important role in regulating Runx2 expression in bone and that decreased Runx2 expression in TIEG1 KO mice is in part responsible for the observed osteopenic phenotype. In this manuscript, data is presented demonstrating that over-expression of TIEG1 results in increased expression of Runx2 while repression of TIEG1 results in suppression of Runx2. Transient transfection and chromatin immunoprecipitation assays reveal that TIEG1 directly binds to and activates the Runx2 promoter. The zinc finger containing domain of TIEG1 is necessary for this regulation supporting that activation occurs through direct DNA binding. A role for the ubiquitin/proteasome pathway in fine tuning the regulation of Runx2 expression by TIEG1 is also implicated in this study. Additionally, the regulation of Runx2 expression by cytokines such as TGF beta 1 and BMP2 is shown to be inhibited in the absence of TIEG1. Co-immunoprecipitation and co-localization assays indicate that TIEG1 protein associates with Runx2 protein resulting in co-activation of Runx2 transcriptional activity. Lastly, Runx2 adenoviral infection of TIEG1 KO calvarial osteoblasts leads to increased expression of Runx2 and enhancement of their ability to differentiate and mineralize in culture. Taken together, these data implicate an important role for TIEG1 in regulating the expression and activity of Runx2 in osteoblasts and suggest that decreased expression of Runx2 in TIEG1 KO mice contributes to the observed osteopenic bone phenotype.	[Hawse, John R.; Cicek, Muzaffer; Grygo, Sarah B.; Bruinsma, Elizabeth S.; Subramaniam, Malayannan; Spelsberg, Thomas C.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Rajamannan, Nalini M.] Northwestern Univ, Dept Med, Div Cardiol, Feinberg Sch Med, Chicago, IL 60611 USA; [van Wijnen, Andre J.; Lian, Jane B.; Stein, Gary S.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [van Wijnen, Andre J.; Lian, Jane B.; Stein, Gary S.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA; [Oursler, Merry Jo] Mayo Clin, Endocrine Res Unit, Rochester, MN USA	Mayo Clinic; Northwestern University; Feinberg School of Medicine; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Mayo Clinic	Hawse, JR (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	hawse.john@mayo.edu	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946	National Institutes of Health [DE14036, AR52004]; Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052004, R01AR049069, R01AR039588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014036, R37DE012528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE014036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grants DE14036 (to T. C. S.) and AR52004 (to M.J.O.) as well as the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Bensamoun SF, 2006, BONE, V39, P1244, DOI 10.1016/j.bone.2006.05.021; Bensamoun SF, 2006, J APPL PHYSIOL, V101, P1419, DOI 10.1152/japplphysiol.00800.2005; Cao ZX, 2009, J BIOL CHEM, V284, P24914, DOI 10.1074/jbc.M109.000059; Chalaux E, 1999, FEBS LETT, V457, P478, DOI 10.1016/S0014-5793(99)01051-0; Choi JY, 2000, J BONE MINER RES, V15, pS157; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Enomoto H, 2003, J BIOL CHEM, V278, P23971, DOI 10.1074/jbc.M302457200; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; Gao YH, 1998, BIOCHEM BIOPH RES CO, V252, P697, DOI 10.1006/bbrc.1998.9643; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Haddad Oualid, 2009, Journal of Musculoskeletal Research, V12, P127, DOI 10.1142/S0218957709002304; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; Hawse JR, 2008, BONE, V42, P1025, DOI 10.1016/j.bone.2008.02.004; Hawse JR, 2008, MOL ENDOCRINOL, V22, P1579, DOI 10.1210/me.2007-0253; Hefferan TE, 2000, J BIOL CHEM, V275, P20255, DOI 10.1074/jbc.C000135200; Hefferan TE, 2000, J CELL BIOCHEM, V78, P380, DOI 10.1002/1097-4644(20000901)78:3<380::AID-JCB4>3.0.CO;2-L; Hinoi E, 2006, J BIOL CHEM, V281, P18015, DOI 10.1074/jbc.M600603200; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Jheon AH, 2001, J BIOL CHEM, V276, P18282, DOI 10.1074/jbc.M010885200; Johnsen SA, 2002, ONCOGENE, V21, P5783, DOI 10.1038/sj.onc.1205681; Johnsen SA, 2002, J BIOL CHEM, V277, P30754, DOI 10.1074/jbc.M204812200; Johnsen SA, 2004, SIGNAL TRANSDUCT, V4, P29; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kanatani N, 2006, DEV BIOL, V296, P48, DOI 10.1016/j.ydbio.2006.03.039; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303; Kim Y, 2007, J CELL PHYSIOL, V211, P253, DOI 10.1002/jcp.20933; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Liu W, 2001, J CELL BIOCHEM, V83, P271, DOI 10.1002/jcb.1234; Luan Y, 2007, J BIOL CHEM, V282, P16860, DOI 10.1074/jbc.M610943200; Miller J, 2002, NAT GENET, V32, P645, DOI 10.1038/ng1049; Monroe DG, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-104; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; O'Brien CA, 2002, BONE, V30, P453, DOI 10.1016/S8756-3282(01)00692-5; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pratap J, 2003, CANCER RES, V63, P5357; Rajamannan NM, 2007, J CELL BIOCHEM, V100, P315, DOI 10.1002/jcb.21049; Reinholz MM, 2004, BREAST CANCER RES TR, V86, P75, DOI 10.1023/B:BREA.0000032926.74216.7d; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Schmidt K, 2005, J CELL BIOL, V168, P899, DOI 10.1083/jcb.200408013; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; SUBRAMANIAM M, 1995, J CELL BIOCHEM, V57, P52, DOI 10.1002/jcb.240570107; Subramaniam M, 2010, BIOCHEM BIOPH RES CO, V392, P72, DOI 10.1016/j.bbrc.2009.12.171; Subramaniam M, 2010, BIOFACTORS; Subramaniam M, 2007, J CELL BIOCHEM, V102, P539, DOI 10.1002/jcb.21492; Tachibana I, 1997, J CLIN INVEST, V99, P2365, DOI 10.1172/JCI119418; Thirunavukkarasu K, 2000, J BIOL CHEM, V275, P25163, DOI 10.1074/jbc.M000322200; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Tsubone T, 2006, J ORTHOP RES, V24, P569, DOI 10.1002/jor.20101; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Venuprasad K, 2008, NAT IMMUNOL, V9, P245, DOI 10.1038/ni1564; Westendorf JJ, 2006, J CELL BIOCHEM, V98, P54, DOI 10.1002/jcb.20805; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2007, P NATL ACAD SCI USA, V104, P19861, DOI 10.1073/pnas.0709650104; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang Y, 2009, J BIOL CHEM, V284, P3125, DOI 10.1074/jbc.M807466200; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	74	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19429	10.1371/journal.pone.0019429	http://dx.doi.org/10.1371/journal.pone.0019429			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559363	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700167
J	Prabha, S; Rao, DN; Nagaraja, V				Prabha, Swayam; Rao, Desirazu N.; Nagaraja, Valakunja			Distinct Properties of Hexameric but Functionally Conserved Mycobacterium tuberculosis Transcription-Repair Coupling Factor	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; STRUCTURAL BASIS; FACTOR MFD; DNA; PROTEIN; MOTIF; MODEL; UVRB	Transcription coupled nucleotide excision repair (TC-NER) is involved in correcting UV-induced damage and other roadblocks encountered in the transcribed strand. Mutation frequency decline (Mfd) is a transcription repair coupling factor, involved in repair of template strand during transcription. Mfd from M. tuberculosis (MtbMfd) is 1234 amino-acids long harboring characteristic modules for different activities. Mtbmfd complemented Escherichia coli mfd (Ecomfd) deficient strain, enhanced survival of UV irradiated cells and increased the road-block repression in vivo. The protein exhibited ATPase activity, which was stimulated similar to 1.5-fold in the presence of DNA. While the C-terminal domain (CTD) comprising amino acids 630 to 1234 showed similar to 2-fold elevated ATPase activity than MtbMfd, the N-terminal domain (NTD) containing the first 433 amino acid residues was able to bind ATP but deficient in hydrolysis. Overexpression of NTD of MtbMfd led to growth defect and hypersensitivity to UV light. Deletion of 184 amino acids from the C-terminal end of MtbMfd (Mfd Delta C) increased the ATPase activity by similar to 10-fold and correspondingly exhibited efficient translocation along DNA as compared to the MtbMfd and CTD. Surprisingly, MtbMfd was found to be distributed in monomer and hexamer forms both in vivo and in vitro and the monomer showed increased susceptibility to proteases compared to the hexamer. Mfd Delta C, on the other hand, was predominantly monomeric in solution implicating the extreme C-terminal region in oligomerization of the protein. Thus, although the MtbMfd resembles EcoMfd in many of its reaction characteristics, some of its hitherto unknown distinct properties hint at its species specific role in mycobacteria during transcription-coupled repair.	[Prabha, Swayam; Rao, Desirazu N.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Nagaraja, Valakunja] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Prabha, S (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	dnrao@biochem.iisc.ernet.in; vraj@mcbl.iisc.ernet.in			Department of Biotechnology, Government of India [DBTO/BBC/DNR/187]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This research was supported by a research grant from the Department of Biotechnology, Government of India (grant no. DBTO/BBC/DNR/187). The duration of this research grant was for three years (2006-2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambur OH, 2009, FEMS MICROBIOL REV, V33, P453, DOI 10.1111/j.1574-6976.2009.00173.x; Assenmacher N, 2006, J MOL BIOL, V355, P675, DOI 10.1016/j.jmb.2005.10.033; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chambers AL, 2003, NUCLEIC ACIDS RES, V31, P6409, DOI 10.1093/nar/gkg868; Chen BY, 2007, STRUCTURE, V15, P429, DOI 10.1016/j.str.2007.02.007; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Gorna AE, 2010, CLIN SCI, V119, P187, DOI 10.1042/CS20100041; Grossman L, 1998, CONT CANC RES, P11; Han J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000083; HARSHEY RM, 1977, J BACTERIOL, V129, P616, DOI 10.1128/JB.129.2.616-622.1977; Hasegawa K, 2008, GENES CELLS, V13, P459, DOI 10.1111/j.1365-2443.2008.01185.x; Garcia MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011575; Joseph N, 2004, DNA REPAIR, V3, P1561, DOI 10.1016/j.dnarep.2004.06.014; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Lloyd RS, 1992, DNA DAMAGE RECOGNITI, P25; Mahdi AA, 2003, EMBO J, V22, P724, DOI 10.1093/emboj/cdg043; Mellon I, 2005, MUTAT RES-FUND MOL M, V577, P155, DOI 10.1016/j.mrfmmm.2005.03.016; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Murphy MN, 2009, NUCLEIC ACIDS RES, V37, P6042, DOI 10.1093/nar/gkp680; Panne D, 2001, EMBO J, V20, P3210, DOI 10.1093/emboj/20.12.3210; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Pruteanu M, 2009, MOL MICROBIOL, V71, P912, DOI 10.1111/j.1365-2958.2008.06574.x; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Sambrook J, 2001, MOL CLONING LAB MANU; Saxowsky TT, 2006, CHEM REV, V106, P474, DOI 10.1021/cr040466q; Scicchitano DA, 2004, DNA REPAIR, V3, P1537, DOI 10.1016/j.dnarep.2004.06.004; SEELEY TW, 1989, P NATL ACAD SCI USA, V86, P6577, DOI 10.1073/pnas.86.17.6577; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1995, J BIOL CHEM, V270, P4890, DOI 10.1074/jbc.270.9.4890; SELBY CP, 1990, J BIOL CHEM, V265, P21330; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Smith AJ, 2007, NUCLEIC ACIDS RES, V35, P1802, DOI 10.1093/nar/gkm019; Smith I, 2005, CONTROL MYCOBACTERIA, P219; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; VANHOUTEN B, 1990, MICROBIOL REV, V54, P18, DOI 10.1128/MMBR.54.1.18-51.1990; Washburn RS, 2003, J MOL BIOL, V329, P655, DOI 10.1016/S0022-2836(03)00465-0; Zalieckas JM, 1998, MOL MICROBIOL, V27, P1031, DOI 10.1046/j.1365-2958.1998.00751.x	38	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19131	10.1371/journal.pone.0019131	http://dx.doi.org/10.1371/journal.pone.0019131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559463	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700072
J	Setohigashi, Y; Hamaji, T; Hayama, M; Matsuzaki, R; Nozaki, H				Setohigashi, Yuka; Hamaji, Takashi; Hayama, Mahoko; Matsuzaki, Ryo; Nozaki, Hisayoshi			Uniparental Inheritance of Chloroplast DNA Is Strict in the Isogamous Volvocalean Gonium	PLOS ONE			English	Article							MINUS-DOMINANCE GENE; SECONDARY STRUCTURE; MATING-TYPE; CHLAMYDOMONAS-REINHARDTII; SEXUAL REPRODUCTION; VOLVOX-CARTERI; CHLOROPHYTA; EVOLUTION; MITOCHONDRIAL; PREDICTION	Background: A problem has remained unresolved regarding the exceptions to the unilateral inheritance of chloroplast DNA (cpDNA) from MT+/female in Chlamydomonas and other volvocaleans demonstrated by the previous genetic analyses. For identification of the parental types of cpDNA, these studies used parents that have differences in restriction fragment length polymorphisms and exhibit partial sexual incompatibility. Methodology/Principal Findings: In the present study, we used sexually compatible parents of the isogamous colonial volvocalean Gonium maiaprilis that seemed an ideal species to identify the pattern of cpDNA inheritance based on the length difference in the putative group I intron interrupted in the Rubisco large subunit gene and objective identification of mating types by the presence or absence of the minus-dominance (MID) gene. We examined patterns of inheritance of cpDNA and presence/absence of a MID ortholog (GmMID) in 107 F(1) progeny of G. maiaprilis that were obtained by inducing germination of separated single zygotes. The results demonstrated no exception of the uniparental inheritance of cpDNA from the MT+ parent (lacking GmMID) in sexually compatible or genetically less divergent strains of G. maiaprilis. Conclusions/Significance: The present data suggest that the uniparental inheritance of cpDNA is likely more strict in crossings of less diverged strains or sexually compatible parental volvocaleans, and some genetic inconsistency between the parents may cause exceptional uniparental inheritance of cpDNA.	[Setohigashi, Yuka; Hamaji, Takashi; Hayama, Mahoko; Matsuzaki, Ryo; Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo	Setohigashi, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	nozaki@biol.s.u-tokyo.ac.jp	NOZAKI, HISAYOSHI/G-4926-2014	Hamaji, Takashi/0000-0002-2801-2148; Nozaki, Hisayoshi/0000-0002-9308-4498; Matsuzaki, Ryo/0000-0002-8989-5933	Ministry of Education, Culture, Sports, Science and Technology, Japan [22112505]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (no. 22112505 to HN) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/english/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CR, 1990, CURR GENET, V18, P141, DOI 10.1007/BF00312602; Anonymous, 2009, Japanese Journal of Phycology, V57, P1; BELL RA, 1983, PHYCOLOGIA, V22, P243, DOI 10.2216/i0031-8884-22-3-243.1; BOYNTON JE, 1987, P NATL ACAD SCI USA, V84, P2391, DOI 10.1073/pnas.84.8.2391; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Conover WJ, 1998, PRACTICAL NONPARAMET, P592; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferris P, 2010, SCIENCE, V328, P351, DOI 10.1126/science.1186222; Ferris PJ, 1997, GENETICS, V146, P859; Ferris PJ, 1997, P NATL ACAD SCI USA, V94, P8634, DOI 10.1073/pnas.94.16.8634; GILLHAM NW, 1962, GENETICS, V47, P1463; GOLDSTEIN M, 1964, J PROTOZOOL, V11, P317, DOI 10.1111/j.1550-7408.1964.tb01762.x; Hamada M, 2009, BIOINFORMATICS, V25, P465, DOI 10.1093/bioinformatics/btn601; Hamaji T, 2008, GENETICS, V178, P283, DOI 10.1534/genetics.107.078618; Hayama M, 2010, PHYCOLOGIA, V49, P221, DOI 10.2216/PH09-56.1; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; KATO S, 1982, Japanese Journal of Phycology, V30, P63; Mai JC, 1997, J MOL EVOL, V44, P258, DOI 10.1007/PL00006143; MISHRA NC, 1968, GENET RES, V11, P21, DOI 10.1017/S0016672300011162; Nakada T, 2010, J PLANT RES, V123, P67, DOI 10.1007/s10265-009-0266-0; Nishimura Y, 1999, P NATL ACAD SCI USA, V96, P12577, DOI 10.1073/pnas.96.22.12577; Nishimura Y, 2010, J PLANT RES, V123, P149, DOI 10.1007/s10265-009-0292-y; NOZAKI H, 1989, PHYCOLOGIA, V28, P252, DOI 10.2216/i0031-8884-28-2-252.1; NOZAKI H, 1988, PHYCOLOGIA, V27, P209, DOI 10.2216/i0031-8884-27-2-209.1; Nozaki H, 2006, CURR BIOL, V16, pR1018, DOI 10.1016/j.cub.2006.11.019; Proschold T, 2005, GENETICS, V170, P1601, DOI 10.1534/genetics.105.044503; SAGER R, 1954, P NATL ACAD SCI USA, V40, P356, DOI 10.1073/pnas.40.5.356; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Shitara H, 1998, GENETICS, V148, P851; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851	33	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19545	10.1371/journal.pone.0019545	http://dx.doi.org/10.1371/journal.pone.0019545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559302	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700205
J	Zheng, L; Foley, K; Huang, LQ; Leubner, A; Mo, GL; Olino, K; Edil, BH; Mizuma, M; Sharma, R; Le, DT; Anders, RA; Illei, PB; Van Eyk, JE; Maitra, A; Laheru, D; Jaffee, EM				Zheng, Lei; Foley, Kelly; Huang, Lanqing; Leubner, Ashley; Mo, Guanglan; Olino, Kelly; Edil, Barish H.; Mizuma, Masamichi; Sharma, Rajni; Le, Dung T.; Anders, Robert A.; Illei, Peter B.; Van Eyk, Jennifer E.; Maitra, Anirban; Laheru, Daniel; Jaffee, Elizabeth M.			Tyrosine 23 Phosphorylation-Dependent Cell-Surface Localization of Annexin A2 Is Required for Invasion and Metastases of Pancreatic Cancer	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; IMMUNE ACTIVATION; TUMOR VACCINE; EXPRESSION; GROWTH; THERAPY; PROTEIN; ADENOCARCINOMA; IMMUNOTHERAPY; PROGRESSION	The aggressiveness of pancreatic ductal adenocarcinoma (PDA) is characterized by its high metastatic potential and lack of effective therapies, which is the result of a lack of understanding of the mechanisms involved in promoting PDA metastases. We identified Annexin A2 (ANXA2), a member of the Annexin family of calcium-dependent phospholipid binding proteins, as a new molecule that promotes PDA invasion and metastases. We found ANXA2 to be a PDA-associated antigen recognized by post-treatment sera of patients who demonstrated prolonged survival following treatment with a PDA-specific vaccine. Cell surface ANXA2 increases with PDA development and progression. Knockdown of ANXA2 expression by RNA interference or blocking with anti-ANXA2 antibodies inhibits in vitro invasion of PDA cells. In addition, post-vaccination patient sera inhibits in vitro invasion of PDA cells, suggesting that therapeutic anti-ANXA2 antibodies are induced by the vaccine. Furthermore, cell-surface localization of ANXA2 is tyrosine 23 phosphorylation-dependent; and tyrosine 23 phosphorylation is required for PDA invasion. We demonstrated that tyrosine 23 phosphorylation resulting in surface expression of ANXA2 is required for TGF beta-induced, Rho-mediated epithelial-mesenchymal transition (EMT), linking the cellular function of ANXA2 which was previously shown to be associated with small GTPase-regulated cytoskeletal rearrangements, to the EMT process in PDA. Finally, using mouse PDA models, we showed that shRNA knock-down of ANXA2, a mutation at tyrosine 23, or anti-ANXA2 antibodies, inhibit PDA metastases and prolong mouse survival. Thus, ANXA2 is part of a novel molecular pathway underlying PDA metastases and a new target for development of PDA therapeutics.	[Zheng, Lei; Foley, Kelly; Huang, Lanqing; Leubner, Ashley; Mo, Guanglan; Olino, Kelly; Edil, Barish H.; Le, Dung T.; Anders, Robert A.; Illei, Peter B.; Maitra, Anirban; Laheru, Daniel; Jaffee, Elizabeth M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Zheng, Lei; Foley, Kelly; Huang, Lanqing; Leubner, Ashley; Mo, Guanglan; Edil, Barish H.; Le, Dung T.; Laheru, Daniel; Jaffee, Elizabeth M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Zheng, Lei; Foley, Kelly; Huang, Lanqing; Leubner, Ashley; Mo, Guanglan; Edil, Barish H.; Le, Dung T.; Laheru, Daniel; Jaffee, Elizabeth M.] Johns Hopkins Univ, Sch Med, Skip Viragh Ctr Pancreat Canc, Baltimore, MD USA; [Mizuma, Masamichi; Sharma, Rajni; Anders, Robert A.; Illei, Peter B.; Maitra, Anirban; Jaffee, Elizabeth M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Zheng, Lei; Edil, Barish H.; Le, Dung T.; Anders, Robert A.; Illei, Peter B.; Maitra, Anirban; Laheru, Daniel; Jaffee, Elizabeth M.] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Ctr, Baltimore, MD USA; [Zheng, Lei; Olino, Kelly; Edil, Barish H.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Foley, Kelly] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD USA; [Van Eyk, Jennifer E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Van Eyk, Jennifer E.] Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Prote Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Zheng, L (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	lzheng6@jhmi.edu; ejaffee@jhmi.edu	Olino, Kelly/X-2341-2019	Sharma, Rajni/0000-0003-0393-0943; Jaffee, Elizabeth/0000-0003-3841-6549; Olino, Kelly/0000-0001-6209-5218	NCI [P50 CA062924-14, R01 CA88058]; Lustgarten Foundation; Broad Foundation; Viragh Foundation; NIH [1K23 CA93566-01A1, 5T32 CA0090701-28]; ASCO; Sol Goldman Pancreatic Cancer Center; Leica Microsystems; NATIONAL CANCER INSTITUTE [T32CA009071, P30CA006973, R01CA088058, P50CA062924, K23CA148964, R01CA113669, K23CA093566, R01CA122081] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lustgarten Foundation; Broad Foundation; Viragh Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASCO; Sol Goldman Pancreatic Cancer Center; Leica Microsystems; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the NCI SPORE in Gastrointestinal Cancers P50 CA062924-14 (E.M.J.), Lustgarten Foundation (E.M.J.), Broad Foundation (E.M.J.), NCI R01 CA88058 (E.M.J.), Viragh Foundation, NIH 1K23 CA93566-01A1 (D. L.), ASCO Young Investigator Award (L.Z.), NIH 5T32 CA0090701-28 Training Grant (L.Z.), the Sol Goldman Pancreatic Cancer Center (L.Z.). Dr. Jaffee is the first recipient of the Dana and Albert "Cubby" Broccoli Endowed Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I have read the journal's policy and have the following conflicts: Under a licensing agreement between BioSante and the Johns Hopkins University, the University is entitled to milestone payments and royalty on sales of the vaccine product described in this manuscript. We do not have any other relevant conflicts of interest to be disclosed. P. Illei has given a lecture sponsored by Leica Microsystems. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.	ABRAMS HD, 1982, CELL, V29, P427, DOI 10.1016/0092-8674(82)90159-3; BIANCHI R, 1992, BIOCHIM BIOPHYS ACTA, V1160, P67, DOI 10.1016/0167-4838(92)90039-G; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Esposito I, 2006, J PATHOL, V208, P673, DOI 10.1002/path.1935; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Goggins M, 1999, ANN ONCOL, V10, P4, DOI 10.1023/A:1008307913019; Gordon KJ, 2008, CARCINOGENESIS, V29, P252, DOI 10.1093/carcin/bgm249; HART IR, 1980, CANCER RES, V40, P2281; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Hastie C, 2008, J BIOL CHEM, V283, P12595, DOI 10.1074/jbc.M800189200; IMAMURA H, 1994, CANCER RES, V54, P3620; Jaffee EM, 1998, CANCER J SCI AM, V4, P194; Jaffee EM, 2001, J CLIN ONCOL, V19, P145, DOI 10.1200/JCO.2001.19.1.145; Jain A, 2003, ANN SURG ONCOL, V10, P810, DOI 10.1245/ASO.2003.10.006; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim J, 2002, FRONT BIOSCI-LANDMRK, V7, pD341, DOI 10.2741/kim; Krishnan S, 2004, DEV BIOL, V265, P140, DOI 10.1016/j.ydbio.2003.08.026; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; Laheru D, 2008, CLIN CANCER RES, V14, P1455, DOI 10.1158/1078-0432.CCR-07-0371; LUTZ E, 2010, ANN SURG; Mackenzie RP, 2009, EXPERT REV ANTICANC, V9, P1473, DOI [10.1586/era.09.109, 10.1586/ERA.09.109]; Merrifield CJ, 2001, CURR BIOL, V11, P1136, DOI 10.1016/S0960-9822(01)00321-9; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Nedjadi T, 2009, BRIT J CANCER, V101, P1145, DOI 10.1038/sj.bjc.6605289; Pierantoni C, 2008, CRIT REV ONCOL HEMAT, V67, P27, DOI 10.1016/j.critrevonc.2008.01.009; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Salle V, 2008, J CLIN IMMUNOL, V28, P291, DOI 10.1007/s10875-008-9188-1; Sharma MC, 2007, CURR PHARM DESIGN, V13, P3568, DOI 10.2174/138161207782794167; Strimpakos A, 2008, CANCER METAST REV, V27, P495, DOI 10.1007/s10555-008-9134-y; Takano S, 2008, ANN SURG ONCOL, V15, P3157, DOI 10.1245/s10434-008-0061-5; Thomas AM, 2004, J EXP MED, V200, P297, DOI 10.1084/jem.20031435; Wang B, 2003, ONCOGENE, V22, P1771, DOI 10.1038/sj.onc.1206386; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yoshimura K, 2006, CANCER RES, V66, P1096, DOI 10.1158/0008-5472.CAN-05-2307; Zhao SJ, 2008, CANCER RES, V68, P4221, DOI 10.1158/0008-5472.CAN-07-5123; Zhao WQ, 2003, J BIOL CHEM, V278, P4205, DOI 10.1074/jbc.M210545200; Zhou XZ, 2003, HUM GENE THER, V14, P1089, DOI 10.1089/104303403322124800	40	128	139	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19390	10.1371/journal.pone.0019390	http://dx.doi.org/10.1371/journal.pone.0019390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21572519	Green Submitted, gold, Green Published			2022-12-25	WOS:000290024700155
J	Hibino, N; Villalona, G; Pietris, N; Duncan, DR; Schoffner, A; Roh, JD; Yi, T; Dobrucki, LW; Mejias, D; Sawh-Martinez, R; Harrington, JK; Sinusas, A; Krause, DS; Kyriakides, T; Saltzman, WM; Pober, JS; Shin'oka, T; Breuer, CK				Hibino, Narutoshi; Villalona, Gustavo; Pietris, Nicholas; Duncan, Daniel R.; Schoffner, Adam; Roh, Jason D.; Yi, Tai; Dobrucki, Lawrence W.; Mejias, Dane; Sawh-Martinez, Rajendra; Harrington, Jamie K.; Sinusas, Albert; Krause, Diane S.; Kyriakides, Themis; Saltzman, W. Mark; Pober, Jordan S.; Shin'oka, Toshiharu; Breuer, Christopher K.			Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel	FASEB JOURNAL			English	Article						bone marrow chimera; composite vascular implant; microcomputed tomography angiography	BONE-MARROW; AUTOGRAFTS; CELLS; INFLAMMATION	We developed a tissue-engineered vascular graft composed of biodegradable scaffold seeded with autologous bone marrow-derived mononuclear cells (BMMCs) that is currently in clinical trial and developed analogous mouse models to study mechanisms of neovessel formation. We previously reported that seeded human BMMCs were rapidly lost after implantation into immunodeficient mice as host macrophages invaded the graft. As a consequence, the resulting neovessel was entirely of host cell origin. Here, we investigate the source of neotissue cells in syngeneic BMMC-seeded grafts, implanted into immunocompetent mouse recipients. We again find that seeded BMMCs are lost, declining to 0.02% at 14 d, concomitant with host macrophage invasion. In addition, we demonstrate using sex-mismatched chimeric hosts that bone marrow is not a significant source of endothelial or smooth muscle cells that comprise the neovessel. Furthermore, using composite grafts formed from seeded scaffold anastomosed to sex-mismatched natural vessel segments, we demonstrate that the adjacent vessel wall is the principal source of these endothelial and smooth muscle cells, forming 93% of proximal neotissue. These findings have important implications regarding fundamental mechanisms underlying neotissue formation; in this setting, the tissue-engineered construct functions by mobilizing the body's innate healing capabilities to "regenerate" neotissue from preexisting committed tissue cells.-Hibino, N., Villalona, G., Pietris, N., Duncan, D. R., Schoffner, A., Roh, J. D., Yi, T., Dobrucki, L. W., Mejias, D., Sawh-Martinez, R., Harrington, J. K., Sinusas, A., Krause, D. S., Kyriakides, T., Saltzman, W. M., Pober, J. S., Shin'oka, T., Breuer, C. K. Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel. FASEB J. 25, 2731-2739 (2011). www.fasebj.org	[Hibino, Narutoshi; Villalona, Gustavo; Pietris, Nicholas; Duncan, Daniel R.; Schoffner, Adam; Roh, Jason D.; Yi, Tai; Dobrucki, Lawrence W.; Mejias, Dane; Sawh-Martinez, Rajendra; Harrington, Jamie K.; Sinusas, Albert; Krause, Diane S.; Kyriakides, Themis; Saltzman, W. Mark; Pober, Jordan S.; Shin'oka, Toshiharu; Breuer, Christopher K.] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, New Haven, CT USA	Yale University	Breuer, CK (corresponding author), 10 Amistad St,Amistad Bldg,Rm 301 C, New Haven, CT 06510 USA.	christopher.breuer@yale.edu	Sinusas, Albert J/A-7235-2009; Dobrucki, Wawrzyniec L/D-3987-2009; Sawh-Martinez, Rajendra/AAF-4842-2021	Dobrucki, Wawrzyniec L/0000-0002-6807-217X; Sawh-Martinez, Rajendra/0000-0002-8363-3529; Breuer, Christopher/0000-0003-0987-3898; Duncan, Daniel/0000-0003-4771-8901	U.S. National Institutes of Health (NIH) [AR46032]; Howard Hughes Medical Institute; Doris Duke Charitable Foundation;  [NIH K08HL083980];  [NIH R01HL098228];  [NIH UL1RR024139];  [NIH P30DK072442]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL083980, R01HL098228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072442] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Lin Wang for assisting with Y chromosome FISH analysis. Histological processing and embedding was done by the Yale Core Center for Musculoskeletal Disorders [U.S. National Institutes of Health (NIH) grant AR46032]. Research support was provided through the following grants: NIH K08HL083980, NIH R01HL098228, NIH UL1RR024139, and NIH P30DK072442; a Howard Hughes Medical Institute grant; and a Doris Duke Charitable Foundation Clinical Scientist Development Award. Gunze Ltd. has provided research support for the clinical trial evaluating the use of the use of tissue-engineered vascular grafts. None of the funding for the work done in this study was provided by Gunze Ltd.	Brennan MP, 2008, ANN SURG, V248, P370, DOI 10.1097/SLA.0b013e318184dcbd; Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106; Hibino N, 2005, J THORAC CARDIOV SUR, V129, P1064, DOI 10.1016/j.jtcvs.2004.10.030; Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057; Jones RJ, 1996, BLOOD, V88, P487, DOI 10.1182/blood.V88.2.487.bloodjournal882487; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Matsumura G, 2003, CIRCULATION, V108, P1729, DOI 10.1161/01.CIR.0000092165.32213.61; Roh JD, 2008, BIOMATERIALS, V29, P1454, DOI 10.1016/j.biomaterials.2007.11.041; Roh JD, 2007, TISSUE ENG, V13, P2743, DOI 10.1089/ten.2007.0171; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717; Shinoka T, 1998, J THORAC CARDIOV SUR, V115, P536, DOI 10.1016/S0022-5223(98)70315-0; Vacanti JP, 1999, LANCET, V354, pSI32; VILLALONA GA, TISSUE ENG B, V16, P341	16	112	118	0	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2011	25	8					2731	2739		10.1096/fj.11-182246	http://dx.doi.org/10.1096/fj.11-182246			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21566209	Green Published			2022-12-25	WOS:000293337800022
J	Boyle, KA; Stanitsa, ES; Greseth, MD; Lindgren, JK; Traktman, P				Boyle, Kathleen A.; Stanitsa, Eleni S.; Greseth, Matthew D.; Lindgren, Jill K.; Traktman, Paula			Evaluation of the Role of the Vaccinia Virus Uracil DNA Glycosylase and A20 Proteins as Intrinsic Components of the DNA Polymerase Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; TEMPERATURE-SENSITIVE MUTANTS; VIRAL-DNA; PROCESSIVITY FACTOR; GENETIC-CHARACTERIZATION; CRYSTAL-STRUCTURE; CATALYTIC-SITE; D5 PROTEIN; IN-VITRO; REPLICATION	The vaccinia virus DNA polymerase is inherently distributive but acquires processivity by associating with a heterodimeric processivity factor comprised of the viral A20 and D4 proteins. D4 is also an enzymatically active uracil DNA glycosylase (UDG). The presence of an active repair protein as an essential component of the polymerase holoenzyme is a unique feature of the replication machinery. We have shown previously that the A20-UDG complex has a stoichiometry of similar to 1:1, and our data suggest that A20 serves as a bridge between polymerase and UDG. Here we show that conserved hydrophobic residues in the N' terminus of A20 are important for its binding to UDG. Our data argue against the assembly of D4 into higher order multimers, suggesting that the processivity factor does not form a toroidal ring around the DNA. Instead, we hypothesize that the intrinsic, processive DNA scanning activity of UDG tethers the holoenzyme to the DNA template. The inclusion of UDG as an essential holoenzyme component suggests that replication and base excision repair may be coupled. Here we show that the DNA polymerase can utilize dUTP as a substrate in vitro. Moreover, uracil moieties incorporated into the nascent strand during holoenzyme-mediated DNA synthesis can be excised by the viral UDG present within this holoenzyme, leaving abasic sites. Finally, we show that the polymerase stalls upon encountering an abasic site in the template strand, indicating that, like many replicative polymerases, the poxviral holoenzyme cannot perform translesion synthesis across an abasic site.	[Boyle, Kathleen A.; Stanitsa, Eleni S.; Greseth, Matthew D.; Lindgren, Jill K.; Traktman, Paula] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Traktman, P (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, 8701 Watertown Plank Rd,BSB 273, Milwaukee, WI 53226 USA.	ptrakt@mcw.edu		Traktman, Paula/0000-0002-6517-0225	National Institutes of Health [2 R01 AI21758]; Great Lakes Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research [1-U54-AI057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI021758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Great Lakes Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 R01 AI21758. This work was also supported by developmental grants from the Great Lakes Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (1-U54-AI057153; to P. T.).	Andrei G, 2006, J VIROL, V80, P9391, DOI 10.1128/JVI.00605-06; Beaud G, 1995, BIOCHIMIE, V77, P774, DOI 10.1016/0300-9084(96)88195-8; Bogani F, 2008, P NATL ACAD SCI USA, V105, P11709, DOI 10.1073/pnas.0806375105; Bogani F, 2010, J BIOL CHEM, V285, P27664, DOI 10.1074/jbc.M110.131235; Bogani F, 2009, J BIOL CHEM, V284, P16784, DOI 10.1074/jbc.M109.010413; Boyle K, 2009, VIRAL GENOME REPLICATION, P225, DOI 10.1007/b135974_12; Boyle KA, 2007, J VIROL, V81, P844, DOI 10.1128/JVI.02217-06; BROYLES SS, 1993, VIROLOGY, V195, P863, DOI 10.1006/viro.1993.1446; Bruck I, 2001, GENOME BIOL, V2; CHALLBERG MD, 1979, J BIOL CHEM, V254, P7820; CHALLBERG MD, 1979, J BIOL CHEM, V254, P7812; D'Costa SM, 2010, VIROLOGY, V401, P49, DOI 10.1016/j.virol.2010.01.020; DALES S, 1978, VIROLOGY, V84, P403, DOI 10.1016/0042-6822(78)90258-1; De Silva FS, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-23; De Silva FS, 2007, P NATL ACAD SCI USA, V104, P18724, DOI 10.1073/pnas.0709276104; De Silva FS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-145; De Silva FS, 2003, J VIROL, V77, P159, DOI 10.1128/JVI.77.1.159-166.2003; DEFILIPPES FM, 1984, J VIROL, V52, P474, DOI 10.1128/JVI.52.2.474-482.1984; DEFILIPPES FM, 1989, J VIROL, V63, P4060, DOI 10.1128/JVI.63.9.4060-4063.1989; Ellison KS, 1996, J VIROL, V70, P7965, DOI 10.1128/JVI.70.11.7965-7973.1996; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; EVANS E, 1995, J VIROL, V69, P5353, DOI 10.1128/JVI.69.9.5353-5361.1995; EVANS E, 1992, CHROMOSOMA, V102, pS72, DOI 10.1007/BF02451789; Falkenberg M, 2000, P NATL ACAD SCI USA, V97, P3896, DOI 10.1073/pnas.97.8.3896; FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641; FOCHER F, 1990, MUTAT RES, V237, P65, DOI 10.1016/0921-8734(90)90012-G; FOCHER F, 1992, CHROMOSOMA, V102, pS67, DOI 10.1007/BF02451788; FREY MW, 1993, P NATL ACAD SCI USA, V90, P2579, DOI 10.1073/pnas.90.7.2579; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gammon DB, 2009, J VIROL, V83, P4236, DOI 10.1128/JVI.02255-08; Garcia AD, 2001, J VIROL, V75, P6460, DOI 10.1128/JVI.75.14.6460-6471.2001; Holzer GW, 1997, J VIROL, V71, P4997, DOI 10.1128/JVI.71.7.4997-5002.1997; Hwang YT, 1997, J VIROL, V71, P7791, DOI 10.1128/JVI.71.10.7791-7798.1997; Ishii K, 2002, VIROLOGY, V303, P232, DOI 10.1006/viro.2002.1721; Ishii K, 2001, J VIROL, V75, P1656, DOI 10.1128/JVI.75.4.1656-1663.2001; Kato SEM, 2008, VIROLOGY, V375, P213, DOI 10.1016/j.virol.2008.01.027; Klemperer N, 2001, J VIROL, V75, P12298, DOI 10.1128/JVI.75.24.12298-12307.2001; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lackner CA, 2003, VIROLOGY, V305, P240, DOI 10.1006/viro.2002.1745; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; McConnell M, 1996, BIOCHEMISTRY-US, V35, P8268, DOI 10.1021/bi9530649; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; McCulloch SD, 2006, DNA REPAIR, V5, P1373, DOI 10.1016/j.dnarep.2006.06.003; McDonald WF, 1997, VIROLOGY, V234, P168, DOI 10.1006/viro.1997.8639; MCDONALD WF, 1994, PROTEIN EXPRES PURIF, V5, P409, DOI 10.1006/prep.1994.1059; MCDONALD WF, 1994, J BIOL CHEM, V269, P31190; MILLNS AK, 1994, VIROLOGY, V198, P504, DOI 10.1006/viro.1994.1061; Moss Bernard, 2006, V47, P707; MULLANEY J, 1989, J GEN VIROL, V70, P449, DOI 10.1099/0022-1317-70-2-449; NEUMULLER M, 1990, BIOTECHNOL APPL BIOC, V12, P34; Paran N, 2009, CELL HOST MICROBE, V6, P563, DOI 10.1016/j.chom.2009.11.005; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Parikh SS, 2000, MUTAT RES-DNA REPAIR, V460, P183, DOI 10.1016/S0921-8777(00)00026-4; Parlanti E, 2007, NUCLEIC ACIDS RES, V35, P1569, DOI 10.1093/nar/gkl1159; Prichard MN, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-55; Punjabi A, 2001, J VIROL, V75, P12308, DOI 10.1128/JVI.75.24.12308-12318.2001; Randell JCW, 2004, J MOL BIOL, V335, P409, DOI 10.1016/j.jmb.2003.10.064; Ranneberg-Nilsen T, 2008, J MOL BIOL, V381, P276, DOI 10.1016/j.jmb.2008.05.028; Reddy SM, 1998, VIROLOGY, V251, P393, DOI 10.1006/viro.1998.9428; Reineks EZ, 2003, J MOL BIOL, V328, P1027, DOI 10.1016/S0022-2836(03)00370-X; REMPEL RE, 1990, J VIROL, V64, P574, DOI 10.1128/JVI.64.2.574-583.1990; REMPEL RE, 1992, J VIROL, V66, P4413, DOI 10.1128/JVI.66.7.4413-4426.1992; Rochester SC, 1998, J VIROL, V72, P2917, DOI 10.1128/JVI.72.4.2917-2926.1998; Salinas F, 2000, P NATL ACAD SCI USA, V97, P7196, DOI 10.1073/pnas.97.13.7196; Schormann N, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-45; Senkevich TG, 2009, P NATL ACAD SCI USA, V106, P17921, DOI 10.1073/pnas.0909529106; Shudofsky AMD, 2010, J VIROL, V84, P12325, DOI 10.1128/JVI.01435-10; SRIDHAR P, 1983, VIROLOGY, V128, P444, DOI 10.1016/0042-6822(83)90269-6; Stanitsa ES, 2006, J BIOL CHEM, V281, P3439, DOI 10.1074/jbc.M511239200; Strang BL, 2010, J GEN VIROL, V91, P2029, DOI 10.1099/vir.0.022160-0; STUART DT, 1993, J VIROL, V67, P2503, DOI 10.1128/JVI.67.5.2503-2512.1993; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; TADDIE JA, 1991, J VIROL, V65, P869, DOI 10.1128/JVI.65.2.869-879.1991; TADDIE JA, 1993, J VIROL, V67, P4323, DOI 10.1128/JVI.67.7.4323-4336.1993; Tanguy Le Gac Nicolas, 2004, J Mol Biol, V336, P1023; TRAKTMAN P, 1989, J BIOL CHEM, V264, P21458; TRAKTMAN P, 1989, J VIROL, V63, P841, DOI 10.1128/JVI.63.2.841-846.1989; TRAKTMAN P, 1996, DNA REPLICATION EUKA, P775; Traktman Paula, 2004, Methods Mol Biol, V269, P169; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; UPTON C, 1993, P NATL ACAD SCI USA, V90, P4518, DOI 10.1073/pnas.90.10.4518; Yang JS, 2003, J BIOL CHEM, V278, P49828, DOI 10.1074/jbc.M307406200; Zharkov DO, 2010, MUTAT RES-FUND MOL M, V685, P11, DOI 10.1016/j.mrfmmm.2009.10.017; Zhu Y, 2008, DNA REPAIR, V7, P95, DOI 10.1016/j.dnarep.2007.08.001; Zhu YL, 2003, J VIROL, V77, P10147, DOI 10.1128/JVI.77.18.10147-10153.2003	86	34	39	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24702	24713		10.1074/jbc.M111.222216	http://dx.doi.org/10.1074/jbc.M111.222216			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21572084	Green Published, hybrid			2022-12-25	WOS:000292547900021
J	Xu, T; Wang, XH; Zhong, B; Nurieva, RI; Ding, S; Dong, C				Xu, Tao; Wang, Xiaohu; Zhong, Bo; Nurieva, Roza I.; Ding, Sheng; Dong, Chen			Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of ROR lambda t Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; GAMMA-T; TH17 CELLS; DIFFERENTIATION; LINEAGE; ALPHA; EXPRESSION; DISTINCT	Th17 cells have recently emerged as a major player in inflammatory and autoimmune diseases via the production of pro-inflammatory cytokines IL-17, IL-17F, and IL-22. The differentiation of Th17 cells and the associated cytokine production is directly controlled by ROR gamma t. Here we show that ursolic acid (UA), a small molecule present in herbal medicine, selectively and effectively inhibits the function of ROR gamma t, resulting in greatly decreased IL-17 expression in both developing and differentiated Th17 cells. In addition, treatment with UA ameliorated experimental autoimmune encephalomyelitis. The results thus suggest UA as a valuable drug candidate or leading compound for developing treatments of Th17-mediated inflammatory diseases and cancer.	[Xu, Tao; Ding, Sheng] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wang, Xiaohu; Zhong, Bo; Nurieva, Roza I.; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Wang, Xiaohu; Zhong, Bo; Nurieva, Roza I.; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Ctr Inflammat & Canc, Houston, TX 77030 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ding, S (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.	sheng.ding@gladstone.ucsf.edu; CDong@mdanderson.org	Xu, Tao/I-1561-2014; dong, chen/B-3181-2009	Xu, Tao/0000-0002-3436-3024; dong, chen/0000-0002-0084-9130; Xu, Tao/0000-0002-4085-6191	National Multiple Sclerosis Society (NMSS); NIH through NIAID; National Institutes of Health through NICHD; NHLBI; National Institute of Mental Health; California Institute for Regenerative Medicine; Prostate Cancer Foundation; Fate Therapeutics; Esther B. O'Keeffe Foundation; Scripps Research Institute; National Institutes of Health through NIAMS; Leukemia and Lymphoma, Society; M.D. Anderson Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083761] Funding Source: NIH RePORTER	National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); NIH through NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health through NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Prostate Cancer Foundation; Fate Therapeutics; Esther B. O'Keeffe Foundation; Scripps Research Institute; National Institutes of Health through NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Leukemia and Lymphoma, Society(Leukemia and Lymphoma Society); M.D. Anderson Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Recipient of a National Multiple Sclerosis Society (NMSS) postdoctoral fellowship.; Supported by NIH through NIAID.; Supported by funding from the National Institutes of Health through NICHD, NHLBI, and the National Institute of Mental Health, the California Institute for Regenerative Medicine, the Prostate Cancer Foundation, Fate Therapeutics, the Esther B. O'Keeffe Foundation, and the Scripps Research Institute. To whom correspondence may be addressed. E-mail: sheng.ding@gladstone.ucsf.edu.; Supported by grants from the National Institutes of Health through NIAMS, the Leukemia and Lymphoma, Society, and the M.D. Anderson Cancer Center. To whom correspondence may be addressed. E-mail: CDong@mdanderson.org.	Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Huang HC, 2009, MOL CARCINOGEN, V48, P517, DOI 10.1002/mc.20490; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ikeda Y, 2008, MOL NUTR FOOD RES, V52, P26, DOI 10.1002/mnfr.200700389; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lauthier F, 2000, ANTI-CANCER DRUG, V11, P737; Lee AW, 2010, J AGR FOOD CHEM, V58, P12941, DOI 10.1021/jf103265x; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pathak AK, 2007, MOL CANCER RES, V5, P943, DOI 10.1158/1541-7786.MCR-06-0348; Shishodia S, 2003, CANCER RES, V63, P4375; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Xie HM, 2005, J IMMUNOL, V175, P3800, DOI 10.4049/jimmunol.175.6.3800; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001	23	160	173	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22707	22710		10.1074/jbc.C111.250407	http://dx.doi.org/10.1074/jbc.C111.250407			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21566134	Green Published, hybrid			2022-12-25	WOS:000292025000004
J	Volk, N; Shomron, N				Volk, Naama; Shomron, Noam			Versatility of MicroRNA Biogenesis	PLOS ONE			English	Article							RNA; PROTEINS; BINDING; COMPLEX	MicroRNAs (miRNAs) are short single-stranded RNA molecules that regulate gene expression. MiRNAs originate from large primary (pri) and precursor (pre) transcripts that undergo various processing steps along their biogenesis pathway till they reach their mature and functional form. It is not clear, however, whether all miRNAs are processed similarly. Here we show that the ratio between pre-miRNA and mature miRNA forms varies between different miRNAs. Moreover, over-expression of several factors involved in miRNA biogenesis, including Exportin-5, Drosha, NF90a, NF45 and KSRP, displayed bidirectional effects on pre/mature miRNA ratios, suggesting their intricate biogenesis sensitivity. In an attempt to identify additional factors that might explain the versatility in miRNA biogenesis we have analyzed the contribution of two hnRNP family members, hnRNPH1 and hnRNPR. Knock-down or over-expression of these genes suggested that hnRNPR inhibits, whereas hnRNPH1 facilitates, miRNA processing. Overall, our results emphasize that miRNA biogenesis is versatile.	[Volk, Naama; Shomron, Noam] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Volk, N (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel.	nshomron@post.tau.ac.il			Chief Scientist Office, Ministry of Health, Israel; Kurz-Lion Foundation; Tel Aviv University, Faculty of Medicine, Schreiber Foundation; Israel Cancer Association; Wolfson Family Charitable Fund	Chief Scientist Office, Ministry of Health, Israel; Kurz-Lion Foundation; Tel Aviv University, Faculty of Medicine, Schreiber Foundation; Israel Cancer Association; Wolfson Family Charitable Fund	This work was supported by the Chief Scientist Office, Ministry of Health, Israel; The Kurz-Lion Foundation; The Tel Aviv University, Faculty of Medicine, Schreiber Foundation; Israel Cancer Association; and The Wolfson Family Charitable Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chou MY, 1999, MOL CELL BIOL, V19, P69; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Fisette JF, 2010, RNA, V16, P228, DOI 10.1261/rna.1890310; Folini M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-12; Fukuda A, 2009, J BIOL CHEM, V284, P23472, DOI 10.1074/jbc.M109.013656; Kabat JL, 2009, J BIOL CHEM, V284, P28490, DOI 10.1074/jbc.M109.023101; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Shiohama A, 2007, EXP CELL RES, V313, P4196, DOI 10.1016/j.yexcr.2007.07.020; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	18	36	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19391	10.1371/journal.pone.0019391	http://dx.doi.org/10.1371/journal.pone.0019391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572999	Green Published, Green Submitted, gold			2022-12-25	WOS:000290440200006
J	Maulucci, G; Papi, M; Arcovito, G; De Spirito, M				Maulucci, Giuseppe; Papi, Massimiliano; Arcovito, Giuseppe; De Spirito, Marco			The Thermal Structural Transition of alpha-Crystallin Inhibits the Heat Induced Self-Aggregation	PLOS ONE			English	Article							DIFFUSION-LIMITED AGGREGATION; CHAPERONE-LIKE ACTIVITY; CLUSTER-CLUSTER AGGREGATION; QUATERNARY STRUCTURE; EYE LENS; PROTEINS; SCATTERING; MODEL; STABILITY; CATARACTS	alpha-crystallin, the major constituent of human lens, is a member of the heat-shock proteins family and it is known to have a quaternary structural transition at T-c = 45 degrees C. The presence of calcium ions and/or temperature changes induce supramolecular self-aggregation, a process of relevance in the cataractogenesis. Here we investigate the potential effect of the bovine alpha-crystallin's structural transition on the self-aggregation process. Along all the temperatures investigated, aggregation proceeds by forming intermediate molecular assemblies that successively aggregate in clusters. The final morphology of the aggregates, above and below T-c, is similar, but the aggregation kinetics are completely different. The size of the intermediate molecular assemblies, and their repulsive energy barrier show a marked increase while crossing T-c. Our results highlight the key role of heat modified form of alpha-crystallin in protecting from aggregation and preserving the transparency of the lens under hyperthermic conditions.	[Maulucci, Giuseppe; Papi, Massimiliano; Arcovito, Giuseppe; De Spirito, Marco] Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Maulucci, G (corresponding author), Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy.	m.despirito@rm.unicatt.it	De Spirito, Marco/C-5386-2008; Papi, Massimiliano/AAC-3657-2022; Papi, Massimiliano/B-3168-2012; De Spirito, Marco/U-3817-2019; Maulucci, Giuseppe/C-7400-2009	De Spirito, Marco/0000-0003-4260-5107; Papi, Massimiliano/0000-0002-0029-1309; De Spirito, Marco/0000-0003-4260-5107; Maulucci, Giuseppe/0000-0002-2154-319X				BALL RC, 1987, PHYS REV LETT, V58, P274, DOI 10.1103/PhysRevLett.58.274; Bassi FA, 1995, BIOPHYS J, V69, P2720, DOI 10.1016/S0006-3495(95)80143-8; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; BIOSCA JA, 1983, FEBS LETT, V153, P217, DOI 10.1016/0014-5793(83)80151-3; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; CLEARY SF, 1980, P IEEE, V68, P49, DOI 10.1109/PROC.1980.11580; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; DELAYE M, 1982, BIOPHYS J, V37, P647; Doss-Pepe EW, 1998, EXP EYE RES, V67, P657, DOI 10.1006/exer.1998.0561; Garland DL, 1996, EXP EYE RES, V62, P285, DOI 10.1006/exer.1996.0034; GUPTASARMA P, 1992, BIOCHEMISTRY-US, V31, P4296, DOI 10.1021/bi00132a021; GUY AW, 1975, IEEE T MICROW THEORY, VMT23, P492, DOI 10.1109/TMTT.1975.1128606; Harding JJ, 2002, AGEING RES REV, V1, P465, DOI 10.1016/S1568-1637(02)00012-0; HIRATA A, 1994, IEEE T ELECTROMAGNET, V269, P592; Horwitz J, 2004, EXP EYE RES, V79, P817, DOI 10.1016/j.exer.2004.05.007; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; JEDZINIAK JA, 1972, INVEST OPHTH VISUAL, V11, P905; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; KRAMAR P, 1987, BIOELECTROMAGNETICS, V8, P397, DOI 10.1002/bem.2250080408; KRAMPS HA, 1975, EUR J BIOCHEM, V50, P503, DOI 10.1111/j.1432-1033.1975.tb09889.x; Krivandin AV, 1999, BIOFIZIKA+, V44, P1088; Lin JC, 2003, IEEE ANTENN PROPAG M, V45, P171, DOI 10.1109/MAP.2003.1189664; LIN MY, 1990, PHYS REV A, V41, P2005, DOI 10.1103/PhysRevA.41.2005; LUTHRA M, 1993, J BIOL CHEM, V268, P18119; Maulucci G, 2005, BIOPHYS J, V88, P3545, DOI 10.1529/biophysj.104.048876; MEAKIN P, 1984, J PHYS A-MATH GEN, V17, pL975, DOI 10.1088/0305-4470/17/18/008; MIESBAUER LR, 1994, J BIOL CHEM, V269, P12494; Parasassi T, 2008, FASEB J, V22, P2350, DOI 10.1096/fj.07-097774; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; Putilina T, 2003, J BIOL CHEM, V278, P13747, DOI 10.1074/jbc.M208157200; Raman B, 1997, J BIOL CHEM, V272, P23559, DOI 10.1074/jbc.272.38.23559; RAMAN B, 1995, FEBS LETT, V365, P133, DOI 10.1016/0014-5793(95)00440-K; RAMAN B, 1994, J BIOL CHEM, V269, P27264; SANTINI SA, 1992, BIOCHEM J, V287, P107, DOI 10.1042/bj2870107; Schmelzer JWP, 2005, NUCLEATION THEORY AND APPLICATIONS, P1, DOI 10.1002/3527604790; SHIH WY, 1987, PHYS REV A, V36, P5015, DOI 10.1103/PhysRevA.36.5015; SIEZEN RJ, 1979, EXP EYE RES, V28, P551, DOI 10.1016/0014-4835(79)90043-5; TARDIEU A, 1986, J MOL BIOL, V192, P711, DOI 10.1016/0022-2836(86)90023-9; Verwey E.J., 1948, THEORY STABILITY LYO; Wainwright PR, 2007, PHYS MED BIOL, V52, P3335, DOI 10.1088/0031-9155/52/12/002; WALSH MT, 1991, J BIOL CHEM, V266, P20079; WEITZ DA, 1985, PHYS REV LETT, V54, P1416, DOI 10.1103/PhysRevLett.54.1416; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400; WITTEN TA, 1983, PHYS REV B, V27, P5686, DOI 10.1103/PhysRevB.27.5686; XIA JZ, 1994, BIOPHYS J, V66, P861, DOI 10.1016/S0006-3495(94)80862-8	45	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e18906	10.1371/journal.pone.0018906	http://dx.doi.org/10.1371/journal.pone.0018906			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573059	gold, Green Submitted, Green Published			2022-12-25	WOS:000290386800004
J	Nozawa, T; Furukawa, N; Aikawa, C; Watanabe, T; Haobam, B; Kurokawa, K; Maruyama, F; Nakagawa, I				Nozawa, Takashi; Furukawa, Nayuta; Aikawa, Chihiro; Watanabe, Takayasu; Haobam, Bijaya; Kurokawa, Ken; Maruyama, Fumito; Nakagawa, Ichiro			CRISPR Inhibition of Prophage Acquisition in Streptococcus pyogenes	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; GROUP-A STREPTOCOCCUS; PROVIDES ACQUIRED-RESISTANCE; GENOME SEQUENCE; IMMUNE-SYSTEM; M3 STRAIN; INTERFERENCE; EVOLUTION; ELEMENTS; BACTERIA	Streptococcus pyogenes, one of the major human pathogens, is a unique species since it has acquired diverse strain-specific virulence properties mainly through the acquisition of streptococcal prophages. In addition, S. pyogenes possesses clustered regularly interspaced short palindromic repeats (CRISPR)/Cas systems that can restrict horizontal gene transfer (HGT) including phage insertion. Therefore, it was of interest to examine the relationship between CRISPR and acquisition of prophages in S. pyogenes. Although two distinct CRISPR loci were found in S. pyogenes, some strains lacked CRISPR and these strains possess significantly more prophages than CRISPR harboring strains. We also found that the number of spacers of S. pyogenes CRISPR was less than for other streptococci. The demonstrated spacer contents, however, suggested that the CRISPR appear to limit phage insertions. In addition, we found a significant inverse correlation between the number of spacers and prophages in S. pyogenes. It was therefore suggested that S. pyogenes CRISPR have permitted phage insertion by lacking its own spacers. Interestingly, in two closely related S. pyogenes strains (SSI-1 and MGAS315), CRISPR activity appeared to be impaired following the insertion of phage genomes into the repeat sequences. Detailed analysis of this prophage insertion site suggested that MGAS315 is the ancestral strain of SSI-1. As a result of analysis of 35 additional streptococcal genomes, it was suggested that the influences of the CRISPR on the phage insertion vary among species even within the same genus. Our results suggested that limitations in CRISPR content could explain the characteristic acquisition of prophages and might contribute to strain-specific pathogenesis in S. pyogenes.	[Nozawa, Takashi; Furukawa, Nayuta; Watanabe, Takayasu; Haobam, Bijaya; Maruyama, Fumito; Nakagawa, Ichiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Bacterial Pathogenesis, Tokyo, Japan; [Aikawa, Chihiro] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Kurokawa, Ken] Technol Sch, Tokyo Inst, Div Informat Biotechnol, Dept Bioinformat Engn, Yokohama, Kanagawa, Japan; [Kurokawa, Ken] Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo	Nozawa, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Bacterial Pathogenesis, Tokyo, Japan.	fumito-m.bac@tmd.ac.jp	Maruyama, Fumito/AAK-5928-2020; Maruyama, Fumito/F-6875-2016	Maruyama, Fumito/0000-0003-2347-616X; Nozawa, Takashi/0000-0002-1822-5553; Watanabe, Takayasu/0000-0001-5487-8191	Japanese Ministry of Education;  [21390487];  [22592032]; Grants-in-Aid for Scientific Research [22380176] Funding Source: KAKEN	Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aids for Scientific Research (#21390487 and #22592032), and by the Japanese Ministry of Education, Global Center of Excellence (GCOE) Program, "International Research Center for Molecular Science in Tooth and Bone Diseases.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2005, NUCLEIC ACIDS RES, V33, pW728, DOI 10.1093/nar/gki415; Aklujkar M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-230; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aranaz A, 2004, J CLIN MICROBIOL, V42, P5388, DOI 10.1128/JCM.42.11.5388-5391.2004; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Davies MR, 2007, J BACTERIOL, V189, P2646, DOI 10.1128/JB.01590-06; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Deaconescu AM, 2007, CURR OPIN STRUC BIOL, V17, P96, DOI 10.1016/j.sbi.2007.01.005; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dobrindt U, 2010, MED MICROBIOL IMMUN, V199, P145, DOI 10.1007/s00430-010-0161-2; Fischetti VA, 2007, TRENDS MICROBIOL, V15, P297, DOI 10.1016/j.tim.2007.05.003; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; He JK, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.128102; Hiller NL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001108; Hoe N, 1999, EMERG INFECT DIS, V5, P254, DOI 10.3201/eid0502.990210; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ianeva O D, 2009, Mikrobiol Z, V71, P54; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jansen Rund, 2002, OMICS A Journal of Integrative Biology, V6, P23, DOI 10.1089/15362310252780816; KELLI L, 2010, MULIDRUG RESISTANT E, V1; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; Liu GR, 2002, J BACTERIOL, V184, P2626, DOI 10.1128/JB.184.10.2626-2633.2002; Liu MJ, 2009, APPL ENVIRON MICROB, V75, P4120, DOI 10.1128/AEM.02898-08; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Maruyama F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-358; McShan WM, 2008, J BACTERIOL, V190, P7773, DOI 10.1128/JB.00672-08; MEGRATH DVS, 2007, BACTERIOPHAGE GENETI; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rambaut A, 2009, FIGTREE V1 3 1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; SHEARER AC, 1993, PROTEIN SCI, V2, P1686, DOI 10.1002/pro.5560021014; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; STEWART CB, 1993, NATURE, V361, P603, DOI 10.1038/361603a0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Ploeg JR, 2009, MICROBIOL-SGM, V155, P1966, DOI 10.1099/mic.0.027508-0; van Embden JDA, 2000, J BACTERIOL, V182, P2393, DOI 10.1128/JB.182.9.2393-2401.2000; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; WESTRA ER, 2010, MOL MICROBIOL; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08	70	70	82	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19543	10.1371/journal.pone.0019543	http://dx.doi.org/10.1371/journal.pone.0019543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573110	Green Submitted, gold, Green Published			2022-12-25	WOS:000290305600029
J	Korcsmaros, T; Szalay, MS; Rovo, P; Palotai, R; Fazekas, D; Lenti, K; Farkas, IJ; Csermely, P; Vellai, T				Korcsmaros, Tamas; Szalay, Mate S.; Rovo, Petra; Palotai, Robin; Fazekas, David; Lenti, Katalin; Farkas, Illes J.; Csermely, Peter; Vellai, Tibor			Signalogs: Orthology-Based Identification of Novel Signaling Pathway Components in Three Metazoans	PLOS ONE			English	Article							COMPREHENSIVE RESOURCE; CAENORHABDITIS-ELEGANS; PROTEIN DATABASE; GENE ONTOLOGY; DISEASE; PREDICTION; TOOL; PHARMACOLOGY; INTEROLOGS; GENOMES	Background: Uncovering novel components of signal transduction pathways and their interactions within species is a central task in current biological research. Orthology alignment and functional genomics approaches allow the effective identification of signaling proteins by cross-species data integration. Recently, functional annotation of orthologs was transferred across organisms to predict novel roles for proteins. Despite the wide use of these methods, annotation of complete signaling pathways has not yet been transferred systematically between species. Principal Findings: Here we introduce the concept of 'signalog' to describe potential novel signaling function of a protein on the basis of the known signaling role(s) of its ortholog(s). To identify signalogs on genomic scale, we systematically transferred signaling pathway annotations among three animal species, the nematode Caenorhabditis elegans, the fruit fly Drosophila melanogaster, and humans. Using orthology data from InParanoid and signaling pathway information from the SignaLink database, we predict 88 worm, 92 fly, and 73 human novel signaling components. Furthermore, we developed an on-line tool and an interactive orthology network viewer to allow users to predict and visualize components of orthologous pathways. We verified the novelty of the predicted signalogs by literature search and comparison to known pathway annotations. In C. elegans, 6 out of the predicted novel Notch pathway members were validated experimentally. Our approach predicts signaling roles for 19 human orthodisease proteins and 5 known drug targets, and suggests 14 novel drug target candidates. Conclusions: Orthology-based pathway membership prediction between species enables the identification of novel signaling pathway components that we referred to as signalogs. Signalogs can be used to build a comprehensive signaling network in a given species. Such networks may increase the biomedical utilization of C. elegans and D. melanogaster. In humans, signalogs may identify novel drug targets and new signaling mechanisms for approved drugs.	[Korcsmaros, Tamas; Rovo, Petra; Fazekas, David; Vellai, Tibor] Eotvos Lorand Univ, Dept Genet, Budapest, Hungary; [Korcsmaros, Tamas; Szalay, Mate S.; Palotai, Robin; Csermely, Peter] Semmelweis Univ, Fac Med, Dept Med Chem, Budapest, Hungary; [Lenti, Katalin] Semmelweis Univ, Fac Hlth Sci, Dept Morphol & Physiol, Budapest, Hungary; [Farkas, Illes J.] Hungarian Acad Sci, Stat & Biol Phys Res Grp, Budapest, Hungary; [Farkas, Illes J.] Eotvos Lorand Univ, Budapest, Hungary	Eotvos Lorand University; Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; Eotvos Lorand University	Korcsmaros, T (corresponding author), Eotvos Lorand Univ, Dept Genet, Budapest, Hungary.	vellai@falco.elte.hu	Vellai, Tibor/AAG-2154-2020; Csermely, Peter/J-2067-2017; Korcsmaros, Tamas/C-3526-2015; Farkas, Illes/C-1504-2008	Csermely, Peter/0000-0001-9234-0659; Korcsmaros, Tamas/0000-0003-1717-996X; Rovo, Petra/0000-0001-8729-7326; Farkas, Illes/0000-0001-5341-5582; Fazekas, David/0000-0001-7605-592X	EU [FP6-518230]; EU-ESF [4.2.1./B-09/1/KMR-2010-0003]; OTKA [K69105, K75334]; Hungarian Research and Technology Office [5LET-08-2-2009-0041]	EU(European Commission); EU-ESF(European Commission); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Research and Technology Office	This work was supported by EU FP6-518230; EU-ESF TAMOP 4.2.1./B-09/1/KMR-2010-0003; Hungarian Scientific Research Fund, OTKA (K69105, K75334) (http://www.otka.hu/1; Hungarian Research and Technology Office (5LET-08-2-2009-0041) (http://www.nkth.gov.hu/1; EEA fellowship (LIF); Janos Bolyai scholarship (TV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bandyopadhyay S, 2006, GENOME RES, V16, P428, DOI 10.1101/gr.4526006; Bauer-Mehren A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.47; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Beltrao P, 2007, PLOS COMPUT BIOL, V3, P258, DOI 10.1371/journal.pcbi.0030025; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Boutet Emmanuel, 2007, V406, P89; BRENNER S, 1974, GENETICS, V77, P71; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Chaudhuri A, 2005, BIOESSAYS, V27, P958, DOI 10.1002/bies.20284; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Costello JC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r97; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; Fabbro D, 2002, PHARMACOL THERAPEUT, V93, P79, DOI 10.1016/S0163-7258(02)00179-1; Fay DS, 2007, DEV BIOL, V306, P1, DOI 10.1016/j.ydbio.2007.03.016; Fernandez JM, 2007, NUCLEIC ACIDS RES, V35, pW21, DOI 10.1093/nar/gkm298; Gabaldon T, 2004, CELL MOL LIFE SCI, V61, P930, DOI 10.1007/s00018-003-3387-y; Gao ZT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-104; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Green Iain, 2005, P1; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang TW, 2004, BIOINFORMATICS, V20, P3273, DOI 10.1093/bioinformatics/bth366; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelley BP, 2004, NUCLEIC ACIDS RES, V32, pW83, DOI 10.1093/nar/gkh411; Kemmer D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r106; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Korcsmaros T, 2010, BIOINFORMATICS, V26, P2042, DOI 10.1093/bioinformatics/btq310; Kuzniar A, 2008, TRENDS GENET, V24, P539, DOI 10.1016/j.tig.2008.08.009; Li D, 2008, MOL CELL PROTEOMICS, V7, P1043, DOI 10.1074/mcp.M700287-MCP200; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; O'Brien KP, 2004, HUM MUTAT, V24, P112, DOI 10.1002/humu.20068; Persico M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S21; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Sakharkar MK, 2007, INT J BIOCHEM CELL B, V39, P1156, DOI 10.1016/j.biocel.2007.02.018; Salgado D, 2008, BIOINFORMATICS, V24, P447, DOI 10.1093/bioinformatics/btm599; Schadt EE, 2009, NAT REV DRUG DISCOV, V8, P286, DOI 10.1038/nrd2826; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Storm CEV, 2003, GENOME RES, V13, P2353, DOI 10.1101/gr1305203; Szabo E, 2009, DEV BIOL, V330, P339, DOI 10.1016/j.ydbio.2009.04.005; Takacs-Vellai K, 2007, DEV BIOL, V302, P661, DOI 10.1016/j.ydbio.2006.09.049; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Wishart DS, 2008, PHARMACOGENOMICS, V9, P1155, DOI 10.2217/14622416.9.8.1155; Wist AD, 2009, GENOME MED, V1, DOI 10.1186/gm11; Yan H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012139; Yellaboina S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-465; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461	65	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19240	10.1371/journal.pone.0019240	http://dx.doi.org/10.1371/journal.pone.0019240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559328	gold, Green Published, Green Submitted			2022-12-25	WOS:000290223500012
J	Morimoto, YV; Kojima, S; Namba, K; Minamino, T				Morimoto, Yusuke V.; Kojima, Seiji; Namba, Keiichi; Minamino, Tohru			M153R Mutation in a pH-Sensitive Green Fluorescent Protein Stabilizes Its Fusion Proteins	PLOS ONE			English	Article							FLAGELLAR EXPORT APPARATUS; ESCHERICHIA-COLI; SALMONELLA; MOTOR; COMPONENTS; SINGLE	Background:. Green fluorescent protein (GFP) and its fusion proteins have been used extensively to monitor and analyze a wide range of biological processes. However, proteolytic cleavage often removes GFP from its fusion proteins not only causing a poor signal-to-noise ratio of the fluorescent images but also leading to wrong interpretations. Methodology/Principal Findings. Here, we we report that the M153R mutation in a ratiometric pH-sensitive GFP, pHluorin, significantly stabilizes its fusion products while the mutant protein still retaining a marked pH dependence of 410/470 nm excitation ratio of fluorescence intensity. The M153R mutation increases the brightness in vivo but does not affect the 410/470-nm excitation ratios at various pH values. Conclusions/Significance: Since the pHluorin(M153R) probe can be directly fused to the target proteins, we suggest that it will be potentially powerful tool for the measurement of local pH in living cells as well as for the analysis of subcellular localization of target proteins.	[Morimoto, Yusuke V.; Namba, Keiichi; Minamino, Tohru] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Kojima, Seiji] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Minamino, Tohru] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan	Osaka University; Nagoya University; Japan Science & Technology Agency (JST)	Morimoto, YV (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan.	tohru@fbs.osaka-u.ac.jp	Namba, Keiichi/A-9406-2016; Morimoto, Yusuke V./M-4022-2015	Morimoto, Yusuke V./0000-0003-1573-8967	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	YVM is a research fellow of the Japan Society for the Promotion of Science. TM is a PRESTO researcher of Japan Science and Technology Agency. This work has been supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to YVM, SK, and KN) and by the Takeda Science Foundation (to TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fukuoka H, 2010, BIOCHEM BIOPH RES CO, V394, P130, DOI 10.1016/j.bbrc.2010.02.129; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hess ST, 2004, J PHYS CHEM B, V108, P10138, DOI 10.1021/jp0362077; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; MALOY SR, 1981, J BACTERIOL, V145, P1110, DOI 10.1128/JB.145.2.1110-1111.1981; MEISTER M, 1987, CELL, V49, P643, DOI 10.1016/0092-8674(87)90540-X; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Minamino T, 2000, MOL MICROBIOL, V35, P1052, DOI 10.1046/j.1365-2958.2000.01771.x; Minamino T, 2003, J BACTERIOL, V185, P1190, DOI 10.1128/JB.185.4.1190-1194.2003; Morimoto YV, 2010, MOL MICROBIOL, V78, P1117, DOI 10.1111/j.1365-2958.2010.07391.x; Morimoto YV, 2010, FEBS LETT, V584, P1268, DOI 10.1016/j.febslet.2010.02.051; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakamura S, 2009, J MOL BIOL, V386, P332, DOI 10.1016/j.jmb.2008.12.034; Saijo-Hamano Y, 2004, J MOL BIOL, V343, P457, DOI 10.1016/j.jmb.2004.08.067; YAMAGUCHI S, 1984, J GEN MICROBIOL, V130, P255	19	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19598	10.1371/journal.pone.0019598	http://dx.doi.org/10.1371/journal.pone.0019598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559297	Green Published, Green Submitted, gold			2022-12-25	WOS:000290223500030
J	Christians, JK; Cheema, MS; Vergara, IA; Watt, CA; Pinto, LJ; Chen, NS; Moore, MM				Christians, Julian K.; Cheema, Manjinder S.; Vergara, Ismael A.; Watt, Cortney A.; Pinto, Linda J.; Chen, Nansheng; Moore, Margo M.			Quantitative Trait Locus (QTL) Mapping Reveals a Role for Unstudied Genes in Aspergillus Virulence	PLOS ONE			English	Article							CANDIDA-ALBICANS; INVASIVE ASPERGILLOSIS; GALLERIA-MELLONELLA; FUNGAL-INFECTIONS; LINKAGE MAP; FUMIGATUS; NIDULANS; STRAINS; PATHOGENICITY; SIDEROPHORES	Infections caused by the fungus Aspergillus are a major cause of morbidity and mortality in immunocompromised populations. To identify genes required for virulence that could be used as targets for novel treatments, we mapped quantitative trait loci (QTL) affecting virulence in the progeny of a cross between two strains of A. nidulans (FGSC strains A4 and A91). We genotyped 61 progeny at 739 single nucleotide polymorphisms (SNP) spread throughout the genome, and constructed a linkage map that was largely consistent with the genomic sequence, with the exception of one potential inversion of similar to 527 kb on Chromosome V. The estimated genome size was 3705 cM and the average intermarker spacing was 5.0 cM. The average ratio of physical distance to genetic distance was 8.1 kb/cM, which is similar to previous estimates, and variation in recombination rate was significantly positively correlated with GC content, a pattern seen in other taxa. To map QTL affecting virulence, we measured the ability of each progeny strain to kill model hosts, larvae of the wax moth Galleria mellonella. We detected three QTL affecting in vivo virulence that were distinct from QTL affecting in vitro growth, and mapped the virulence QTL to regions containing 7-24 genes, excluding genes with no sequence variation between the parental strains and genes with only synonymous SNPs. None of the genes in our QTL target regions have been previously associated with virulence in Aspergillus, and almost half of these genes are currently annotated as "hypothetical". This study is the first to map QTL affecting the virulence of a fungal pathogen in an animal host, and our results illustrate the power of this approach to identify a short list of unknown genes for further investigation.	[Christians, Julian K.; Cheema, Manjinder S.; Watt, Cortney A.; Pinto, Linda J.; Moore, Margo M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Vergara, Ismael A.; Chen, Nansheng] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Christians, JK (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	julian_christians@sfu.ca	Chen, Nansheng/E-6450-2012; Christians, J.K./AAL-2547-2020	Christians, J.K./0000-0003-1797-0591; Vergara, Ismael/0000-0002-2960-2967	BC Transplant Research Foundation; Natural Sciences and Engineering Research Council (NSERC); Simon Fraser University	BC Transplant Research Foundation; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Simon Fraser University	This study was funded by a BC Transplant Research Foundation Venture Grant to JKC and MMM, Natural Sciences and Engineering Research Council (NSERC) operating grants to JKC, MMM and NC and a Simon Fraser University President's Research Grant to JKC. NC is a Michael Smith Foundation for Health Research (MSFHR) Scholar and a Canadian Institutes of Health Research (CIHR) New Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpogheneta O, 2003, MYCOSES, V46, P77, DOI 10.1046/j.1439-0507.2003.00852.x; Aleksenko A, 2001, FUNGAL GENET BIOL, V32, P45, DOI 10.1006/fgbi.2001.1251; Araujo R, 2007, INT J ANTIMICROB AG, V29, P108, DOI 10.1016/j.ijantimicag.2006.09.019; Birdsell JA, 2002, MOL BIOL EVOL, V19, P1181, DOI 10.1093/oxfordjournals.molbev.a004176; Blanco JL, 2002, J CLIN MICROBIOL, V40, P1811, DOI 10.1128/JCM.40.5.1811-1813.2002; Brakhage AA, 2005, CURR DRUG TARGETS, V6, P875, DOI 10.2174/138945005774912717; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Bruggeman J, 2003, FUNGAL GENET BIOL, V39, P136, DOI 10.1016/S1087-1845(03)00016-1; BUTCHER AC, 1968, HEREDITY, V23, P443, DOI 10.1038/hdy.1968.55; CADRE, CENTR ASP DAT REP AS; Chamilos G, 2010, MED MYCOL, V48, P506, DOI 10.3109/13693780903225813; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; Cheema MS, 2010, MED MYCOL       0906, V6; CHURCHILL GA, 1994, GENETICS, V138, P963; Clutterbuck A. John, 2008, V26, P57; Clutterbuck AJ, 1997, FUNGAL GENET BIOL, V21, P267, DOI 10.1006/fgbi.1997.0984; Clutterbuck AJ, ASPERGILLUS NIDULANS; Coleman JJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000486; CROFT JH, 1977, GENETICS PHYSL ASPER, P339; Dutsky SR, 1962, P ENTOMOL SOC WASH, V64, P56; EGELMITANI M, 1982, HEREDITAS, V97, P179, DOI 10.1111/j.1601-5223.1982.tb00870.x; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gravelat FN, 2010, CELL MICROBIOL, V12, P473, DOI 10.1111/j.1462-5822.2009.01408.x; GRINDLE M, 1963, HEREDITY, V18, P191, DOI 10.1038/hdy.1963.21; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Jackson JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004224; Jin J, 2004, J CLIN MICROBIOL, V42, P4293, DOI 10.1128/JCM.42.9.4293-4296.2004; Keller N, 2006, MOLECULAR PRINCIPLES OF FUNGAL PATHOGENESIS, P235; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Kontoyiannis DP, 2002, MYCOSES, V45, P406, DOI 10.1046/j.1439-0507.2002.00797.x; KOTHARY MH, 1984, INFECT IMMUN, V43, P320, DOI 10.1128/IAI.43.1.320-325.1984; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Leger RJS, 2000, APPL ENVIRON MICROB, V66, P320, DOI 10.1128/AEM.66.1.320-324.2000; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lin XR, 2006, PLOS GENET, V2, P1801, DOI 10.1371/journal.pgen.0020187; Lorieux M, 2010, PLANT AN GEN 14 C SA; Lynch Michael, 1998; Marra RE, 2004, GENETICS, V167, P619, DOI 10.1534/genetics.103.023408; Marsolier-Kergoat MC, 2009, GENETICS, V183, P31, DOI 10.1534/genetics.109.105049; MAYORGA ME, 1990, GENETICS, V126, P73; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Mora-Montes HM, 2007, EUKARYOT CELL, V6, P2184, DOI 10.1128/EC.00350-07; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; Munoz P, 2006, CURR OPIN INFECT DIS, V19, P365, DOI 10.1097/01.qco.0000235164.70678.97; Mylonakis E, 2007, PLOS PATHOG, V3, P859, DOI 10.1371/journal.ppat.0030101; Neilands J.B., 1981, DEV IRON CHELATORS C, P13; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Pastor A, 2006, MYCOSES, V49, P73, DOI 10.1111/j.1439-0507.2006.01188.x; Perfect JR, 2001, CLIN INFECT DIS, V33, P1824, DOI 10.1086/323900; PERFECT JR, 2006, MOL PRINC FUNG PATH, P3; Reeves EP, 2004, MYCOPATHOLOGIA, V158, P73, DOI 10.1023/B:MYCO.0000038434.55764.16; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; Segal BH, 1998, MEDICINE, V77, P345, DOI 10.1097/00005792-199809000-00004; Singh N, 2008, MYCOSES, V51, P99, DOI 10.1111/j.1439-0507.2007.01479.x; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Steinbach WJ, 2006, EUKARYOT CELL, V5, P1091, DOI 10.1128/EC.00139-06; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Sun S, 2007, GENETICS, V177, P1475, DOI 10.1534/genetics.107.078923; Theiss S, 2002, MOL MICROBIOL, V43, P571, DOI 10.1046/j.1365-2958.2002.02769.x; TILBURN J, 1990, GENETICS, V126, P81; Tripathi N, 2009, P ROY SOC B-BIOL SCI, V276, P2195, DOI 10.1098/rspb.2008.1930; Wang S., WINDOWS QTL CARTOGRA; Wasylnka JA, 2001, MICROBIOL-UK, V147, P869, DOI 10.1099/00221287-147-4-869; Wasylnka JA, 2000, INFECT IMMUN, V68, P3377, DOI 10.1128/IAI.68.6.3377-3384.2000; Wortman JR, 2009, FUNGAL GENET BIOL, V46, pS2, DOI 10.1016/j.fgb.2008.12.003; Zhang L, 2008, FEMS MICROBIOL LETT, V289, P155, DOI 10.1111/j.1574-6968.2008.01376.x	72	15	62	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19325	10.1371/journal.pone.0019325	http://dx.doi.org/10.1371/journal.pone.0019325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559404	Green Submitted, gold, Green Published			2022-12-25	WOS:000290024700136
J	De Stefano, N; Stromillo, ML; Rossi, F; Battaglini, M; Giorgio, A; Portaccio, E; Hakiki, B; Malentacchi, G; Gasperini, C; Santangelo, M; Bartolozzi, ML; Sormani, MP; Federico, A; Amato, MP				De Stefano, Nicola; Stromillo, Maria Laura; Rossi, Francesca; Battaglini, Marco; Giorgio, Antonio; Portaccio, Emilio; Hakiki, Bahia; Malentacchi, Gianmichele; Gasperini, Claudio; Santangelo, Mario; Bartolozzi, Maria Letizia; Sormani, Maria Pia; Federico, Antonio; Amato, Maria Pia			Improving the Characterization of Radiologically Isolated Syndrome Suggestive of Multiple Sclerosis	PLOS ONE			English	Article							MAGNETIZATION-TRANSFER RATIO; VOXEL-BASED ANALYSIS; TRANSFER MR; ALZHEIMERS-DISEASE; IMAGING TECHNIQUES; BRAIN-DAMAGE; GRAY-MATTER; SPIN-ECHO; LESIONS; REMYELINATION	Objective: To improve the characterization of asymptomatic subjects with brain magnetic resonance imaging (MRI) abnormalities highly suggestive of multiple sclerosis (MS), a condition named as "radiologically isolated syndrome" (RIS). Methods: Quantitative MRI metrics such as brain volumes and magnetization transfer (MT) were assessed in 19 subjects previously classified as RIS, 20 demographically-matched relapsing-remitting MS (RRMS) patients and 20 healthy controls (HC). Specific measures were: white matter (WM) lesion volumes (LV), total and regional brain volumes, and MT ratio (MTr) in lesions, normal-appearing WM (NAWM) and cortex. Results: LV was similar in RIS and RRMS, without differences in distribution and frequency at lesion mapping. Brain volumes were similarly lower in RRMS and RIS than in HC (p<0.001). Lesional-MTr was lower in RRMS than in RIS (p = 0.048); NAWM-MTr and cortical-MTr were similar in RIS and HC and lower (p<0.01) in RRMS. These values were particularly lower in RRMS than in RIS in the sensorimotor and memory networks. A multivariate logistic regression analysis showed that 13/19 RIS had >= 70% probability of being classified as RRMS on the basis of their brain volume and lesional-MTr values. Conclusions: Macroscopic brain damage was similar in RIS and RRMS. However, the subtle tissue damage detected by MTr was milder in RIS than in RRMS in clinically relevant brain regions, suggesting an explanation for the lack of clinical manifestations of subjects with RIS. This new approach could be useful for narrowing down the RIS individuals with a high risk of progression to MS.	[De Stefano, Nicola; Stromillo, Maria Laura; Rossi, Francesca; Battaglini, Marco; Giorgio, Antonio; Federico, Antonio] Univ Siena, Dept Neurol & Behav Sci, I-53100 Siena, Italy; [Portaccio, Emilio; Hakiki, Bahia; Amato, Maria Pia] Univ Florence, Dept Neurol, Florence, Italy; [Malentacchi, Gianmichele] Arezzo Hosp, Neurol Unit, Arezzo, Italy; [Gasperini, Claudio] San Camillo Forlanini Hosp, Neurol Unit, Rome, Italy; [Santangelo, Mario] Carpi Hosp, Neurol Unit, Carpi, Italy; [Bartolozzi, Maria Letizia] Empoli Hosp, Neurol Unit, Empoli, Italy; [Sormani, Maria Pia] Univ Genoa, Biostat Unit, Dept Hlth Sci, Genoa, Italy	University of Siena; University of Florence; Azienda Ospedaliera San Camillo-Forlanini; University of Genoa	De Stefano, N (corresponding author), Univ Siena, Dept Neurol & Behav Sci, Via Laterina 8, I-53100 Siena, Italy.	destefano@unisi.it	Sormani, Maria Pia/ABH-8756-2020; Amato, Maria Pia/AAC-5940-2022; Hakiki, Bahia/AAB-8461-2022; amato, Maria Pia/AAL-5998-2020; De Stefano, Nicola/AHE-3052-2022; gasperini, claudio/K-5093-2016	Hakiki, Bahia/0000-0001-8540-7405; amato, Maria Pia/0000-0003-3325-3760; De Stefano, Nicola/0000-0003-4930-7639; Portaccio, Emilio/0000-0002-9662-1762; federico, antonio/0000-0002-5246-1621; SORMANI, MARIA PIA/0000-0001-6892-104X; gasperini, claudio/0000-0002-3959-4067	Italian MS Society; Merck Serono; Biogen-Idec; Bayer Schering; Sanofi Aventis; Bayer; Dompe; Novartis; Biogen Dompe	Italian MS Society; Merck Serono(Merck & Company); Biogen-Idec(Biogen); Bayer Schering(Bayer AG); Sanofi Aventis(Sanofi-Aventis); Bayer(Bayer AG); Dompe; Novartis(Novartis); Biogen Dompe(Biogen)	We have read the journal's policy and have the following conflicts: N. De Stefano has received honoraria from Schering, Biogen-Dompe, Teva and Merck-Serono for consulting services, speaking and travel support and research grant support from the Italian MS Society. E. Portaccio has received honoraria for participating in Advisory Board from Biogen-Idec and research support from Merck Serono, Biogen-Idec, Bayer Schering and Sanofi Aventis. C. Gasperini has received fees as invited speaker from Bayer, Dompe, Merck Serono and Novartis. M. P. Sormani has received honoraria from Actelion, Biogen Idec, Teva and Merck-Serono for consulting services, speaking and travel support. M. P. Amato has received personal compensation from Merck Serono, Biogen Dompe, Sanofi Aventis, Bayer Schering for serving on scientific advisory board and for speaking and financial support for research activites from Merck Serono, Sanofi Aventis, Biogen Dompe, Bayer Schering. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials as detailed online in the guide for authors. The other authors have no conflicts of interest.	Arnold DL, 2007, NEUROLOGY, V68, pS83, DOI 10.1212/01.wnl.0000275237.28259.9d; Audoin B, 2007, MULT SCLER J, V13, P483, DOI 10.1177/1352458506070450; Audoin B, 2004, J MAGN RESON IMAGING, V20, P765, DOI 10.1002/jmri.20178; Barkhof F, 2003, ARCH NEUROL-CHICAGO, V60, P1073, DOI 10.1001/archneur.60.8.1073; Battaglini M, 2009, INFLUENCE WHITE MATT; Battaglini M, 2008, NEUROIMAGE, V40, P583, DOI 10.1016/j.neuroimage.2007.10.067; Chen JT, 2007, NEUROIMAGE, V36, P1152, DOI 10.1016/j.neuroimage.2007.03.073; Chen JT, 2008, ANN NEUROL, V63, P254, DOI 10.1002/ana.21302; Comi G, 2009, CLIN THER, V31, P1142, DOI 10.1016/j.clinthera.2009.06.007; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; De Stefano N, 2006, ANN NEUROL, V59, P634, DOI 10.1002/ana.20767; De Stefano N, 2003, NEUROLOGY, V60, P1157, DOI 10.1212/01.WNL.0000055926.69643.03; De Stefano N, 2002, ARCH NEUROL-CHICAGO, V59, P1565, DOI 10.1001/archneur.59.10.1565; De Stefano N, 2006, BRAIN, V129, P2008, DOI 10.1093/brain/awl152; Di Perri C, 2008, ARCH NEUROL-CHICAGO, V65, P236, DOI 10.1001/archneurol.2007.51; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; ENGELL T, 1989, ACTA NEUROL SCAND, V79, P428, DOI 10.1111/j.1600-0404.1989.tb03811.x; Fazekas F, 2005, BRAIN, V128, P2926, DOI 10.1093/brain/awh567; Filippi M, 2010, J MAGN RESON IMAGING, V31, P770, DOI 10.1002/jmri.22102; Fox NC, 1999, LANCET, V353, P2125, DOI 10.1016/S0140-6736(99)00496-1; GILBERT JJ, 1983, ARCH NEUROL-CHICAGO, V40, P533, DOI 10.1001/archneur.1983.04050080033003; Ginestroni A, 2010, AM J NEURORADIOL, V31, P1807, DOI 10.3174/ajnr.A2225; Ginestroni A, 2009, J NEUROL, V256, P925, DOI 10.1007/s00415-009-5044-3; Goodin DS, 2009, MULT SCLER, V15, P1175, DOI 10.1177/1352458509107007; GROSSMAN RI, 1994, RADIOGRAPHICS, V14, P279, DOI 10.1148/radiographics.14.2.8190954; Horsfield MA, 2005, J NEUROIMAGING, V15, p58S, DOI 10.1177/1051228405282242; Lebrun C, 2010, MULT SCLER; Lebrun C, 2009, ARCH NEUROL-CHICAGO, V66, P841, DOI 10.1001/archneurol.2009.119; Lyoo IK, 1996, J NEUROPSYCH CLIN N, V8, P54; Mews I, 1998, MULT SCLER, V4, P55, DOI 10.1191/135245898678919582; Mitsumoto H, 2007, NEUROLOGY, V68, P1402, DOI 10.1212/01.wnl.0000260065.57832.87; Morris Z, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3016; Okuda DT, 2009, NEUROLOGY, V72, P800, DOI 10.1212/01.wnl.0000335764.14513.1a; Okuda DT, 2009, NAT REV NEUROL, V5, P591, DOI 10.1038/nrneurol.2009.157; Okuda DT, 2011, NEUROLOGY; PIKE GB, 1993, JMRI-J MAGN RESON IM, V3, P531; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Poser CM, 2004, ACTA NEUROL SCAND, V109, P239, DOI 10.1111/j.1600-0404.2004.00277.x; Rao S, 1990, MANUAL BRIEF REPEATA; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Sellner J, 2010, J NEUROL; Siva A, 2009, MULT SCLER J, V15, P918, DOI 10.1177/1352458509106214; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; van Buchem MA, 2000, NEUROIMAG CLIN N AM, V10, P771; van Waesberghe JHTM, 1998, AM J NEURORADIOL, V19, P675; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; Zivadinov R, 2007, NEUROLOGY, V68, pS72, DOI 10.1212/01.wnl.0000275236.51129.d2	48	58	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19452	10.1371/journal.pone.0019452	http://dx.doi.org/10.1371/journal.pone.0019452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559385	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700179
J	Frank, RAW; McRae, AF; Pocklington, AJ; van de Lagemaat, LN; Navarro, P; Croning, MDR; Komiyama, NH; Bradley, SJ; Challiss, RAJ; Armstrong, JD; Finn, RD; Malloy, MP; MacLean, AW; Harris, SE; Starr, JM; Bhaskar, SS; Howard, EK; Hunt, SE; Coffey, AJ; Ranganath, V; Deloukas, P; Rogers, J; Muir, WJ; Deary, IJ; Blackwood, DH; Visscher, PM; Grant, SGN				Frank, Rene A. W.; McRae, Allan F.; Pocklington, Andrew J.; van de lagemaat, Louie N.; Navarro, Pau; Croning, Mike D. R.; Komiyama, Noboru H.; Bradley, Sophie J.; Challiss, R. A. John; Armstrong, J. Douglas; Finn, Robert D.; Malloy, Mary P.; MacLean, Alan W.; Harris, Sarah E.; Starr, John M.; Bhaskar, Sanjeev S.; Howard, Eleanor K.; Hunt, Sarah E.; Coffey, Alison J.; Ranganath, Venkatesh; Deloukas, Pano; Rogers, Jane; Muir, Walter J.; Deary, Ian J.; Blackwood, Douglas H.; Visscher, Peter M.; Grant, Seth G. N.			Clustered Coding Variants in the Glutamate Receptor Complexes of Individuals with Schizophrenia and Bipolar Disorder	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; NMDA RECEPTOR; GROUP-I; PREFRONTAL CORTEX; FAMILIES; DOMAIN; RISK; PHENCYCLIDINE; ACTIVATION; INHIBITION	Current models of schizophrenia and bipolar disorder implicate multiple genes, however their biological relationships remain elusive. To test the genetic role of glutamate receptors and their interacting scaffold proteins, the exons of ten glutamatergic 'hub' genes in 1304 individuals were re-sequenced in case and control samples. No significant difference in the overall number of non-synonymous single nucleotide polymorphisms (nsSNPs) was observed between cases and controls. However, cluster analysis of nsSNPs identified two exons encoding the cysteine-rich domain and first transmembrane helix of GRM1 as a risk locus with five mutations highly enriched within these domains. A new splice variant lacking the transmembrane GPCR domain of GRM1 was discovered in the human brain and the GRM1 mutation cluster could perturb the regulation of this variant. The predicted effect on individuals harbouring multiple mutations distributed in their ten hub genes was also examined. Diseased individuals possessed an increased load of deleteriousness from multiple concurrent rare and common coding variants. Together, these data suggest a disease model in which the interplay of compound genetic coding variants, distributed among glutamate receptors and their interacting proteins, contribute to the pathogenesis of schizophrenia and bipolar disorders.	[Frank, Rene A. W.; van de lagemaat, Louie N.; Croning, Mike D. R.; Komiyama, Noboru H.; Finn, Robert D.; Bhaskar, Sanjeev S.; Howard, Eleanor K.; Hunt, Sarah E.; Coffey, Alison J.; Ranganath, Venkatesh; Deloukas, Pano; Rogers, Jane; Grant, Seth G. N.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [McRae, Allan F.; Visscher, Peter M.] Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Pocklington, Andrew J.; Armstrong, J. Douglas] Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland; [Navarro, Pau] Western Gen Hosp, MRC Human Genet, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Malloy, Mary P.; MacLean, Alan W.; Muir, Walter J.; Blackwood, Douglas H.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh, Midlothian, Scotland; [Harris, Sarah E.; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Bradley, Sophie J.; Challiss, R. A. John] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	Wellcome Trust Sanger Institute; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; University of Leicester	Frank, RAW (corresponding author), Wellcome Trust Sanger Inst, Genome Campus, Hinxton, Cambs, England.	sg3@sanger.ac.uk	Deloukas, Panos/B-2922-2013; Visscher, Peter/ABB-6151-2020; McRae, Allan F/J-2644-2014; Deary, Ian J/C-6297-2009; Navarro, Pau/AAJ-8091-2021; blackwood, douglas/AIB-8874-2022	Deloukas, Panos/0000-0001-9251-070X; Visscher, Peter/0000-0002-2143-8760; McRae, Allan F/0000-0001-5286-5485; Deary, Ian J/0000-0002-1733-263X; Navarro, Pau/0000-0001-5576-8584; Armstrong, Douglas/0000-0002-5397-3864; Hunt, Sarah/0000-0002-8350-1235; Challiss, John/0000-0001-5506-2848; Frank, Rene/0000-0001-9724-9547; Finn, Robert/0000-0001-8626-2148; Grant, Seth/0000-0001-8732-8735; Pocklington, Andrew/0000-0002-2137-0452	Genes to Cognition Program; Wellcome Trust Functional Genomics Initiative; MRC [G0700704, G0801418, MC_U127592696, MC_PC_U127592696] Funding Source: UKRI; Medical Research Council [G0700704, G0801418B, MC_U127592696, G0700704B, MC_PC_U127592696] Funding Source: researchfish; Chief Scientist Office [ETM/55, CZB/4/505] Funding Source: researchfish	Genes to Cognition Program; Wellcome Trust Functional Genomics Initiative(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	Research funded by Genes to Cognition Program and Wellcome Trust Functional Genomics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Bayes A, 2010, NAT NEUROSCI, P1; Bertolino A, 2009, GENETICS SCHIZOPHREN, P1; Brody SA, 2003, EUR J NEUROSCI, V18, P3361, DOI 10.1111/j.1460-9568.2003.03073.x; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Coba MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000102; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Consortium IS, 2009, NATURE, P1; Creighton TE, 1997, TRENDS BIOCHEM SCI, V22, P6, DOI 10.1016/S0968-0004(96)20030-1; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Endele S, 2010, NAT GENET, P1; Fagni Laurent, 2002, Sci STKE, V2002, pre8, DOI 10.1126/stke.2002.137.re8; Grant SGN, 2010, NEURON, V67, P8; Gunduz-Bruce H, 2009, BRAIN RES REV, V60, P279, DOI 10.1016/j.brainresrev.2008.07.006; Gupta DS, 2005, SYNAPSE, V57, P123, DOI 10.1002/syn.20164; Guruprasad K, 2000, J BIOSCIENCES, V25, P143, DOI 10.1007/BF03404909; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jingami H, 2003, CURR OPIN NEUROBIOL, V13, P271, DOI 10.1016/S0959-4388(03)00067-9; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; MacDonald AW, 2009, SCHIZOPHRENIA BULL, V35, P493, DOI 10.1093/schbul/sbp017; Maeda J, 2003, NEUROSCI LETT, V336, P171, DOI 10.1016/S0304-3940(02)01261-2; Meier S, 2007, CURR BIOL, V17, P173, DOI 10.1016/j.cub.2006.10.063; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pocklington AJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100041; Rea AM, 2008, BIOCHEMISTRY; Sartorius LJ, 2006, J NEUROCHEM, V96, P1139, DOI 10.1111/j.1471-4159.2005.03609.x; Shen MY, 2005, CHEM PHYS LETT, V405, P224, DOI 10.1016/j.cplett.2005.02.029; Shi J, 2009, NATURE, V1-5; SIBANDA BL, 1985, NATURE, V316, P170, DOI 10.1038/316170a0; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Snyder EM, 2008, NAT REV DRUG DISCOV, V7, P471, DOI 10.1038/nrd2571; Snyder SH, 2006, NEURON, V49, P484, DOI 10.1016/j.neuron.2006.02.002; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Yao WD, 2008, BIOCHEM PHARMACOL, V75, P2055, DOI 10.1016/j.bcp.2008.01.018; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zeggini E, 2005, NAT GENET, V37, P1320, DOI 10.1038/ng1670; Zeitz C, 2007, HUM MUTAT, V28, P771, DOI 10.1002/humu.20499; Zhang JP, 2007, J BIOL CHEM, V282, P15778, DOI 10.1074/jbc.M611485200	58	42	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19011	10.1371/journal.pone.0019011	http://dx.doi.org/10.1371/journal.pone.0019011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559497	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700051
J	Hsieh, YH; Gaydos, CA; Hogan, MT; Uy, OM; Jackman, J; Jett-Goheen, M; Albertie, A; Dangerfield, DT; Neustadt, CR; Wiener, ZS; Rompalo, AM				Hsieh, Yu-Hsiang; Gaydos, Charlotte A.; Hogan, M. Terry; Uy, O. Manuel; Jackman, Joany; Jett-Goheen, Mary; Albertie, Ariel; Dangerfield, Derek T., II; Neustadt, Celia R.; Wiener, Zachary S.; Rompalo, Anne M.			What Qualities Are Most Important to Making a Point of Care Test Desirable for Clinicians and Others Offering Sexually Transmitted Infection Testing?	PLOS ONE			English	Article								Background: To investigate the possible effects of different levels of attributes of a point-of-care test (POCT) on sexually transmitted infection (STI) professionals' decisions regarding an ideal POCT for STI(s). Methods: An online survey was designed based on a large-scale in-depth focus discussion study among STI experts and professionals. The last section of the survey "build your own POCT'' was designed by employing the discrete choice experiment approach. Practicing clinicians from two venues, STI-related international conference attendees and U. S. STD clinic clinicians were invited to participate in the survey. Conditional logistical regression modeling was used for data analysis. Results: Overall, 256 subjects took the online survey with 218 (85%) completing it. Most of the participants were STD clinic clinicians who already used some POCTs in their practice. "The time frame required'' was identified as a major barrier that currently made it difficult to use STI POCTs. Chlamydia trachomatis was the organism chosen as the top priority for a new POCT, followed by a test that would diagnose early seroconversion for HIV, and a syphilis POCT. Without regard to organism type selected, sensitivity of 90-99% was always the most important attribute to be considered, followed by a cost of $20. However, when the test platform was prioritized for early HIV seroconversion or syphilis, sensitivity was still ranked as most important, but specificity was rated second most important. Conclusions: STI professionals preferred C. trachomatis as the top priority for a new POCT with sensitivity over 90%, low cost, and a very short completion time.	[Hsieh, Yu-Hsiang] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA; [Gaydos, Charlotte A.; Hogan, M. Terry; Jett-Goheen, Mary; Albertie, Ariel; Dangerfield, Derek T., II; Neustadt, Celia R.; Wiener, Zachary S.; Rompalo, Anne M.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; [Uy, O. Manuel; Jackman, Joany] Johns Hopkins Univ, Appl Phys Lab, Milton Eisenhower Res Ctr, Laurel, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Hsieh, YH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA.	yhsieh1@jhmi.edu	Gaydos, Charlotte A./E-9937-2010	Dangerfield II, Derek T./0000-0002-2473-3183	NIH [U54-EB007958]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB007958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by NIH grant U54-EB007958. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryan Stirling, 2004, Eur J Health Econ, V5, P199, DOI 10.1007/s10198-004-0241-6; Centers for Disease Control and Prevention, 2009, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, 2009, SEX TRANSM DIS US 20; Chan YM, 2009, PRENATAL DIAG, V29, P1270, DOI 10.1002/pd.2394; Hsieh YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014144; Huppert J, 2010, POINT CARE, V9, P36, DOI 10.1097/POC.0b013e3181d2d8cc; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Porteous T, 2006, BRIT J GEN PRACT, V56, P911; Ryan M, 2004, BMJ-BRIT MED J, V328, P360, DOI 10.1136/bmj.328.7436.360; van Dommelen L, 2010, SEX TRANSM INFECT, V86, P355, DOI 10.1136/sti.2010.042598; Watson V, 2009, VALUE HEALTH, V12, P621, DOI 10.1111/j.1524-4733.2008.00451.x; WHO/OMS, 2001, WHO SEX TRANSM DIS D	12	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19263	10.1371/journal.pone.0019263	http://dx.doi.org/10.1371/journal.pone.0019263			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559435	gold, Green Submitted, Green Published			2022-12-25	WOS:000290024700116
J	Santini, D; Schiavon, G; Vincenzi, B; Gaeta, L; Pantano, F; Russo, A; Ortega, C; Porta, C; Galluzzo, S; Armento, G; La Verde, N; Caroti, C; Treilleux, I; Ruggiero, A; Perrone, G; Addeo, R; Clezardin, P; Muda, AO; Tonini, G				Santini, Daniele; Schiavon, Gaia; Vincenzi, Bruno; Gaeta, Laura; Pantano, Francesco; Russo, Antonio; Ortega, Cinzia; Porta, Camillo; Galluzzo, Sara; Armento, Grazia; La Verde, Nicla; Caroti, Cinzia; Treilleux, Isabelle; Ruggiero, Alessandro; Perrone, Giuseppe; Addeo, Raffaele; Clezardin, Philippe; Muda, Andrea Onetti; Tonini, Giuseppe			Receptor Activator of NF-kappa B (RANK) Expression in Primary Tumors Associates with Bone Metastasis Occurrence in Breast Cancer Patients	PLOS ONE			English	Article							GENE-EXPRESSION; LIGAND RANKL; IN-VITRO; OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN LIGAND; POSSIBLE INVOLVEMENT; MYELOMA CELLS; MIGRATION; RANKL/RANK/OPG; MECHANISMS	Background: Receptor activator of NFkB (RANK), its ligand (RANKL) and the decoy receptor of RANKL (osteoprotegerin, OPG) play a pivotal role in bone remodeling by regulating osteoclasts formation and activity. RANKL stimulates migration of RANK-expressing tumor cells in vitro, conversely inhibited by OPG. Materials and Methods: We examined mRNA expression levels of RANKL/RANK/OPG in a publicly available microarray dataset of 295 primary breast cancer patients. We next analyzed RANK expression by immunohistochemistry in an independent series of 93 primary breast cancer specimens and investigated a possible association with clinicopathological parameters, bone recurrence and survival. Results: Microarray analysis showed that lower RANK and high OPG mRNA levels correlate with longer overall survival (P = 0.0078 and 0.0335, respectively) and disease-free survival (P = 0.059 and 0.0402, respectively). Immunohistochemical analysis of RANK showed a positive correlation with the development of bone metastases (P = 0.023) and a shorter skeletal disease-free survival (SDFS, P = 0.037). Specifically, univariate analysis of survival showed that "RANK-negative'' and "RANK-positive'' patients had a SDFS of 105.7 months (95% CI: 73.9-124.4) and 58.9 months (95% CI: 34.7-68.5), respectively. RANK protein expression was also associated with accelerated bone metastasis formation in a multivariate analysis (P = 0.029). Conclusions: This is the first demonstration of the role of RANK expression in primary tumors as a predictive marker of bone metastasis occurrence and SDFS in a large population of breast cancer patients.	[Santini, Daniele; Schiavon, Gaia; Vincenzi, Bruno; Pantano, Francesco; Galluzzo, Sara; Armento, Grazia; Tonini, Giuseppe] Univ Campus Biomed Rome, Dept Med Oncol, Rome, Italy; [Schiavon, Gaia] Erasmus Univ, Med Ctr, Dept Med Oncol, Daniel den Hoed Canc Ctr, Rotterdam, Netherlands; [Gaeta, Laura; Perrone, Giuseppe; Muda, Andrea Onetti] Univ Campus Biomed Rome, Dept Pathol, Rome, Italy; [Russo, Antonio] Univ Palermo, Dept Surg & Oncol Sci, Sect Med Oncol, Palermo, Italy; [Ortega, Cinzia] Inst Canc Res & Treatment IRCC, Div Med Oncol & Haematol, Candiolo, Italy; [Porta, Camillo] IRCCS San Matteo Univ Hosp Fdn, Dept Med Oncol, Pavia, Italy; [La Verde, Nicla] Osped Fatebenefratelli & Oftalm, Azienda Osped, Dept Oncol, Milan, Italy; [Caroti, Cinzia] Ente Osped Osped Galliera, SC Med Oncol, Genoa, Italy; [Treilleux, Isabelle; Clezardin, Philippe] Univ Lyon 1, INSERM, Res Unit U664, F-69365 Lyon, France; [Addeo, Raffaele] San Giovanni di Dio Hosp, Dept Med Oncol, Naples, Italy; [Ruggiero, Alessandro] Erasmus MC, Dept Radiol, Rotterdam, Netherlands	University Campus Bio-Medico - Rome Italy; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University Campus Bio-Medico - Rome Italy; University of Palermo; IRCCS Fondazione del Piemonte per l'Oncologia; IRCCS Fondazione San Matteo; Ospedale di Vimercate; Ente Ospedaliero Ospedali Galliera; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Erasmus University Rotterdam; Erasmus MC	Santini, D (corresponding author), Univ Campus Biomed Rome, Dept Med Oncol, Rome, Italy.	d.santini@unicampus.it	Porta, Camillo/AAB-9482-2020; Clezardin, Philippe/M-8071-2014; Muda, Andrea Onetti/AAA-5105-2020; Perrone, Giuseppe/E-7062-2011; Pantano, Francesco/D-8459-2012; perrone, giuseppe/ABF-5105-2020; Perrone, Giuseppe/GLR-7098-2022; Onetti Muda, Andrea/G-5384-2012; la verde, nicla/AAW-9398-2020	Clezardin, Philippe/0000-0003-0149-4463; Perrone, Giuseppe/0000-0002-9538-5729; Pantano, Francesco/0000-0002-2894-9686; Onetti Muda, Andrea/0000-0002-0274-6178; la verde, nicla/0000-0002-2884-1632; Santini, Daniele/0000-0002-9118-3337; addeo, raffaele/0000-0001-9197-8060; Tonini, Giuseppe/0000-0003-4442-8677; Vincenzi, Bruno/0000-0001-8222-9025; Porta, Camillo/0000-0003-2412-1563				Armstrong AP, 2008, PROSTATE, V68, P92, DOI 10.1002/pros.20678; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Bhatia P, 2005, CLIN CANCER RES, V11, P162; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Brown Julie M, 2004, Cancer Treat Res, V118, P149; Chen G, 2006, CANCER-AM CANCER SOC, V107, P289, DOI 10.1002/cncr.21978; COX DR, 1972, J R STAT SOC B, V34, P187; Cross SS, 2006, J CLIN PATHOL, V59, P716, DOI 10.1136/jcp.2005.030031; Danovi SA, 2010, NAT REV CANCER, V10, P45; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Farrugia AN, 2003, CANCER RES, V63, P5438; Granchi D, 2004, INT J CANCER, V111, P829, DOI 10.1002/ijc.20308; Huang L, 2003, J CLIN PATHOL-MOL PA, V56, P116, DOI 10.1136/mp.56.2.116; Huang L, 2000, AM J PATHOL, V156, P761, DOI 10.1016/S0002-9440(10)64942-5; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 2000, AM J PATHOL, V157, P435, DOI 10.1016/S0002-9440(10)64556-7; Lai FPL, 2004, BRIT J HAEMATOL, V126, P192, DOI 10.1111/j.1365-2141.2004.05018.x; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Lipton A, 2007, J CLIN ONCOL, V25, P4431, DOI 10.1200/JCO.2007.11.8604; Matsuzaki K, 1998, BIOCHEM BIOPH RES CO, V246, P199, DOI 10.1006/bbrc.1998.8586; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Mikami S, 2009, J PATHOL, V218, P530, DOI 10.1002/path.2567; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Santini D, 2011, J CELL PHYSIOL, V226, P780, DOI 10.1002/jcp.22402; Sasaki A, 2007, ANN SURG ONCOL, V14, P1191, DOI 10.1245/s10434-006-9277-4; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tada T, 2005, INT J CANCER, V116, P253, DOI 10.1002/ijc.21008; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van Poznak C, 2006, J CLIN PATHOL, V59, P56, DOI 10.1136/jcp.2005.026534; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wittrant Y, 2006, INT J ONCOL, V28, P261	38	136	144	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19234	10.1371/journal.pone.0019234	http://dx.doi.org/10.1371/journal.pone.0019234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559440	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000290024700108
J	Saulnier, DM; Santos, F; Roos, S; Mistretta, TA; Spinler, JK; Molenaar, D; Teusink, B; Versalovic, J				Saulnier, Delphine M.; Santos, Filipe; Roos, Stefan; Mistretta, Toni-Ann; Spinler, Jennifer K.; Molenaar, Douwe; Teusink, Bas; Versalovic, James			Exploring Metabolic Pathway Reconstruction and Genome-Wide Expression Profiling in Lactobacillus reuteri to Define Functional Probiotic Features	PLOS ONE			English	Article							ADHESION-PROMOTING PROTEIN; NF-KAPPA-B; EXOPOLYSACCHARIDE BIOSYNTHESIS; SURFACE-PROTEINS; GENE-CLUSTER; RHAMNOSUS GG; ACID; MUCUS; GUT; ATCC-55730	The genomes of four Lactobacillus reuteri strains isolated from human breast milk and the gastrointestinal tract have been recently sequenced as part of the Human Microbiome Project. Preliminary genome comparisons suggested that these strains belong to two different clades, previously shown to differ with respect to antimicrobial production, biofilm formation, and immunomodulation. To explain possible mechanisms of survival in the host and probiosis, we completed a detailed genomic comparison of two breast milk-derived isolates representative of each group: an established probiotic strain (L. reuteri ATCC 55730) and a strain with promising probiotic features (L. reuteri ATCC PTA 6475). Transcriptomes of L. reuteri strains in different growth phases were monitored using strain-specific microarrays, and compared using a pan-metabolic model representing all known metabolic reactions present in these strains. Both strains contained candidate genes involved in the survival and persistence in the gut such as mucus-binding proteins and enzymes scavenging reactive oxygen species. A large operon predicted to encode the synthesis of an exopolysaccharide was identified in strain 55730. Both strains were predicted to produce health-promoting factors, including antimicrobial agents and vitamins (folate, vitamin B12). Additionally, a complete pathway for thiamine biosynthesis was predicted in strain 55730 for the first time in this species. Candidate genes responsible for immunomodulatory properties of each strain were identified by transcriptomic comparisons. The production of bioactive metabolites by human-derived probiotics may be predicted using metabolic modeling and transcriptomics. Such strategies may facilitate selection and optimization of probiotics for health promotion, disease prevention and amelioration.	[Saulnier, Delphine M.; Mistretta, Toni-Ann; Spinler, Jennifer K.; Versalovic, James] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Versalovic, James] Baylor Coll Med, Dept Translat Biol, Houston, TX 77030 USA; [Versalovic, James] Baylor Coll Med, Program Mol Med, Houston, TX 77030 USA; [Santos, Filipe; Molenaar, Douwe; Teusink, Bas] Vrije Univ, Ctr Integrat Bioinformat, Amsterdam, Netherlands; [Santos, Filipe; Molenaar, Douwe; Teusink, Bas] Netherlands Consortium Syst Biol, Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Saulnier, Delphine M.; Spinler, Jennifer K.; Versalovic, James] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA; [Roos, Stefan] Swedish Univ Agr Sci, Dept Microbiol, S-75007 Uppsala, Sweden	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Vrije Universiteit Amsterdam; Baylor College of Medicine; Swedish University of Agricultural Sciences	Saulnier, DM (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	Delphine.Saulnier@nizo.nl	Molenaar, Douwe/D-2017-2010; SAULNIER, Delphine DM/C-1307-2013; Santos, Filipe/M-7709-2013	Molenaar, Douwe/0000-0001-7108-4545; Teusink, Bas/0000-0003-3929-0423; Spinler, Jennifer/0000-0002-7830-7665; Santos, Filipe/0000-0001-7316-1479; Branco dos Santos, Filipe/0000-0002-4268-8080; Roos, Stefan/0000-0002-1606-1794	National Institutes of Health; National Institute of Diabetes, Digestive and Kidney Diseases [R01 DK065075, P30 DK56338]; National Center for Complementary and Alternative Medicine [R01 AT004326, R21 AT003482]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT003482, R01AT004326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R01DK065075] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been supported by National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases (R01 DK065075 and P30 DK56338), and National Center for Complementary and Alternative Medicine (R01 AT004326 and R21 AT003482). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JV receives financial research support (no salary) and holds a patent with Biogaia since 2004, Anti-Inflammatory Activity from Lactic Acid Bacteria (WO/2004/069178). JV and DMS have a patent pending with Biogaia but not related to the work and research presented in this manuscript. JV serves as a scientific advisor for Danone. However, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in PLoS ONE's guide for authors. All bacterial genome sequences presented in this manuscript are publicly available on National Center for Biotechnology Information (NCBI). All microarray data have also been deposited into a public database (GEO). All bacterial strains are deposited in public strain collections (ATCC, BEI), and available to everyone.	Abrahamsson TR, 2009, J PEDIATR GASTR NUTR, V49, P349, DOI 10.1097/MPG.0b013e31818f091b; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arskold E, 2008, J BACTERIOL, V190, P206, DOI 10.1128/JB.01227-07; Axelsson L.T., 1989, MICROB ECOL HEALTH D, V2, P131, DOI [DOI 10.3109/08910608909140210, 10.3109/08910608909140210]; Bartholome AL, 2004, JPEN-PARENTER ENTER, V28, P210, DOI 10.1177/0148607104028004210; Bath K, 2005, FEMS MICROBIOL LETT, V253, P75, DOI 10.1016/j.femsle.2005.09.042; Begley TP, 1999, ARCH MICROBIOL, V171, P293, DOI 10.1007/s002030050713; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; Bohle LA, 2010, APPL ENVIRON MICROB, V76, P7306, DOI 10.1128/AEM.01423-10; Chabot S, 2001, LAIT, V81, P683, DOI 10.1051/lait:2001157; Coccorullo P, 2010, J PEDIATR-US, V157, P598, DOI 10.1016/j.jpeds.2010.04.066; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; Coyne MJ, 2008, P NATL ACAD SCI USA, V105, P13099, DOI 10.1073/pnas.0804220105; CROW VL, 1982, J BACTERIOL, V150, P1024, DOI 10.1128/JB.150.3.1024-1032.1982; Eaton KA, 2010, INFECT IMMU IN PRESS; FAO/WHO, 2006, REPORT JOINT FAOWHO; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Hoppe B, 1998, J PEDIATR GASTR NUTR, V27, P383, DOI 10.1097/00005176-199810000-00002; Imura K, 1998, NUTRITION, V14, P143, DOI 10.1016/S0899-9007(97)00230-X; Indrio F, 2008, J PEDIATR-US, V152, P801, DOI 10.1016/j.jpeds.2007.11.005; Iwasaki W, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000402; Iyer C, 2008, CELL MICROBIOL, V10, P1442, DOI 10.1111/j.1462-5822.2008.01137.x; Jones SE, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-35; KANEUCHI C, 1988, APPL ENVIRON MICROB, V54, P3053, DOI 10.1128/AEM.54.12.3053-3056.1988; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Lamothe GT, 2002, ARCH MICROBIOL, V178, P218, DOI 10.1007/s00203-002-0447-x; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Markowitz VM, NUCL ACIDS RES, VD382-390; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Metges CC, 2000, J NUTR, V130, p1857S, DOI 10.1093/jn/130.7.1857S; Miniello VL, 2010, J PEDIATR GASTR NUTR, V50, P573, DOI 10.1097/MPG.0b013e3181bb343f; Miyoshi Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1622, DOI 10.1271/bbb.50688; Molenaar D, 2005, J BACTERIOL, V187, P6119, DOI 10.1128/JB.187.17.6119-6127.2005; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Notebaart RA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-296; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; OBRADORS N, 1988, J BACTERIOL, V170, P2159, DOI 10.1128/jb.170.5.2159-2162.1988; Oh PL, 2010, ISME J, V4, P377, DOI 10.1038/ismej.2009.123; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Peant B, 2005, MICROBIOL-SGM, V151, P1839, DOI 10.1099/mic.0.27852-0; Preidis GA, 2011, PROBIOTICS IN PRESS; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Rojas M, 2002, APPL ENVIRON MICROB, V68, P2330, DOI 10.1128/AEM.68.5.2330-2336.2002; Roos S, 1996, FEMS MICROBIOL LETT, V144, P33, DOI 10.1016/0378-1097(96)00334-5; Rosander A, 2008, APPL ENVIRON MICROB, V74, P6032, DOI 10.1128/AEM.00991-08; Santos F, 2008, VITAMIN B12 SYNTHESI; Santos F, 2008, MICROBIOL-SGM, V154, P81, DOI 10.1099/mic.0.2007/011569-0; Saulnier DMA, 2008, FEMS MICROBIOL ECOL, V66, P516, DOI 10.1111/j.1574-6941.2008.00561.x; SAVAGE DC, 1986, ANNU REV NUTR, V6, P155, DOI 10.1146/annurev.nu.06.070186.001103; Savino F, 2007, PEDIATRICS, V119, pE124, DOI 10.1542/peds.2006-1222; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Selengut JD, 2007, NUCLEIC ACIDS RES, V35, pD260, DOI 10.1093/nar/gkl1043; Sinkiewicz Gabriela, 2008, Microbial Ecology in Health and Disease, V20, P122, DOI 10.1080/08910600802341007; Spinler JK, 2008, ANAEROBE, V14, P166, DOI 10.1016/j.anaerobe.2008.02.001; Stalhammar-Carlemalm M, 1999, MOL MICROBIOL, V33, P208, DOI 10.1046/j.1365-2958.1999.01470.x; Szajewska H, 2010, DANONE HLTH AFFAIRS, V1, P2; TALARICO TL, 1988, ANTIMICROB AGENTS CH, V32, P1854, DOI 10.1128/AAC.32.12.1854; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Teusink B, 2006, J BIOL CHEM, V281, P40041, DOI 10.1074/jbc.M606263200; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; van Pijkeren JP, 2006, APPL ENVIRON MICROB, V72, P4143, DOI 10.1128/AEM.03023-05; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Wall T, 2007, APPL ENVIRON MICROB, V73, P3924, DOI 10.1128/AEM.01502-06; Walter J, 2010, P NATL ACAD IN PRESS; Whitehead K, 2008, APPL ENVIRON MICROB, V74, P1812, DOI 10.1128/AEM.02259-07; WHO, 2007, WHO TECH REP SER, V935, P1; Yasuda E, 2008, APPL ENVIRON MICROB, V74, P4746, DOI 10.1128/AEM.00412-08; YOUNG VR, 1994, J NUTR, V124, pS1517, DOI 10.1093/jn/124.suppl_8.1517S	80	115	119	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18783	10.1371/journal.pone.0018783	http://dx.doi.org/10.1371/journal.pone.0018783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559529	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700026
J	Tseng, ZJ; Mcnitt-Gray, JL; Flashner, H; Wang, XM; Enciso, R				Tseng, Zhijie Jack; Mcnitt-Gray, Jill L.; Flashner, Henryk; Wang, Xiaoming; Enciso, Reyes			Model Sensitivity and Use of the Comparative Finite Element Method in Mammalian Jaw Mechanics: Mandible Performance in the Gray Wolf	PLOS ONE			English	Article							CRANIAL FUNCTIONAL-MORPHOLOGY; ESTIMATED BITING FORCES; COMPUTER-SIMULATION; CROCUTA-CROCUTA; BONE-CRACKING; MUSCLE FORCE; TAIL CLUB; BIOMECHANICS; EVOLUTION; CARNIVORA	Finite Element Analysis (FEA) is a powerful tool gaining use in studies of biological form and function. This method is particularly conducive to studies of extinct and fossilized organisms, as models can be assigned properties that approximate living tissues. In disciplines where model validation is difficult or impossible, the choice of model parameters and their effects on the results become increasingly important, especially in comparing outputs to infer function. To evaluate the extent to which performance measures are affected by initial model input, we tested the sensitivity of bite force, strain energy, and stress to changes in seven parameters that are required in testing craniodental function with FEA. Simulations were performed on FE models of a Gray Wolf (Canis lupus) mandible. Results showed that unilateral bite force outputs are least affected by the relative ratios of the balancing and working muscles, but only ratios above 0.5 provided balancing-working side joint reaction force relationships that are consistent with experimental data. The constraints modeled at the bite point had the greatest effect on bite force output, but the most appropriate constraint may depend on the study question. Strain energy is least affected by variation in bite point constraint, but larger variations in strain energy values are observed in models with different number of tetrahedral elements, masticatory muscle ratios and muscle subgroups present, and number of material properties. These findings indicate that performance measures are differentially affected by variation in initial model parameters. In the absence of validated input values, FE models can nevertheless provide robust comparisons if these parameters are standardized within a given study to minimize variation that arise during the model-building process. Sensitivity tests incorporated into the study design not only aid in the interpretation of simulation results, but can also provide additional insights on form and function.	[Tseng, Zhijie Jack; Mcnitt-Gray, Jill L.; Flashner, Henryk; Wang, Xiaoming; Enciso, Reyes] Univ So Calif, Dept Biol Sci, Integrat & Evolutionary Biol Program, Los Angeles, CA 90089 USA; [Tseng, Zhijie Jack; Wang, Xiaoming] Nat Hist Museum Los Angeles Cty, Dept Vertebrate Paleontol, Los Angeles, CA USA; [Mcnitt-Gray, Jill L.] Univ So Calif, Dept Kinesiol, Los Angeles, CA USA; [Mcnitt-Gray, Jill L.] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Flashner, Henryk] Univ So Calif, Dept Aerosp & Mech Engn, Los Angeles, CA USA; [Enciso, Reyes] Univ So Calif, Ostrow Sch Dent, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Tseng, ZJ (corresponding author), Univ So Calif, Dept Biol Sci, Integrat & Evolutionary Biol Program, Los Angeles, CA 90089 USA.	jtseng@nhm.org	Wang, Xiaoming/I-9033-2019	Wang, Xiaoming/0000-0003-1610-3840	University of Southern California Zumberge; NSF [DEB-0909807]; American Society of Mammalogists	University of Southern California Zumberge; NSF(National Science Foundation (NSF)); American Society of Mammalogists	The work was supported by a University of Southern California Zumberge Grant (to JM, HF, XW, and RE), NSF Graduate Research Fellowship and Doctoral Dissertation Improvement Grant (DEB-0909807) and American Society of Mammalogists Grant-in-Aid of Research to ZJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour VM, 2009, ANAT REC, V292, P1412, DOI 10.1002/ar.20987; Bell PR, 2009, ANAT REC, V292, P1338, DOI 10.1002/ar.20978; BIKNEVICIUS AR, 1992, J ZOOL, V228, P479, DOI 10.1111/j.1469-7998.1992.tb04450.x; Bright JA, 2011, ANAT REC, V294, P610, DOI 10.1002/ar.21358; Davis JL, 2010, J EXP BIOL, V213, P1844, DOI 10.1242/jeb.041129; DESSEM D, 1989, J ANAT, V164, P101; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2011, J ANAT, V218, P151, DOI 10.1111/j.1469-7580.2010.01247.x; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Ellis JL, 2008, J ANAT, V212, P769, DOI 10.1111/j.1469-7580.2008.00911.x; Farke AA, 2008, J EXP BIOL, V211, P3085, DOI 10.1242/jeb.019042; Fastnacht Michael, 2002, Senckenbergiana Lethaea, V82, P195; Grosse IR, 2007, ANAT REC, V290, P1069, DOI 10.1002/ar.20568; Habelitz S, 2001, ARCH ORAL BIOL, V46, P173, DOI 10.1016/S0003-9969(00)00089-3; HAINES D J, 1968, Journal of Biomechanics, V1, P117, DOI 10.1016/0021-9290(68)90014-6; Herring SW, 2000, AM J PHYS ANTHROPOL, V112, P575, DOI 10.1002/1096-8644(200008)112:4&lt;575::AID-AJPA10&gt;3.0.CO;2-0; Hulsey CD, 2008, EVOLUTION, V62, P1587, DOI 10.1111/j.1558-5646.2008.00384.x; Hylander WL, 2000, AM J PHYS ANTHROPOL, V112, P469, DOI 10.1002/1096-8644(200008)112:4<469::AID-AJPA5>3.0.CO;2-V; HYLANDER WL, 1979, AM J PHYS ANTHROPOL, V51, P433, DOI 10.1002/ajpa.1330510317; Kupczik K, 2008, J ANTHROPOL SCI, V86, P193; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Mchenry CR, 2006, ANAT REC PART A, V288A, P827, DOI 10.1002/ar.a.20360; Moazen M, 2008, J ANAT, V213, P499, DOI 10.1111/j.1469-7580.2008.00980.x; Moreno K, 2008, J ANAT, V212, P736, DOI 10.1111/j.1469-7580.2008.00899.x; Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832; Panagiotopoulou O, 2011, J ANAT, V218, P75, DOI 10.1111/j.1469-7580.2010.01257.x; Qin QH, 2004, BIOMATERIALS, V25, P5081, DOI 10.1016/j.biomaterials.2003.12.042; Rayfield EJ, 2005, ZOOL J LINN SOC-LOND, V144, P309, DOI 10.1111/j.1096-3642.2005.00176.x; Rayfield EJ, 2004, P ROY SOC B-BIOL SCI, V271, P1451, DOI 10.1098/rspb.2004.2755; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; RENSBERGER JM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P151; RHO JY, 1995, MED ENG PHYS, V17, P347, DOI 10.1016/1350-4533(95)97314-F; Ross CF, 2005, ANAT REC PART A, V283A, P288, DOI 10.1002/ar.a.20170; Ross CF, 2005, ANAT REC PART A, V283A, P253, DOI 10.1002/ar.a.20177; SCAPINO RP, 1965, J MORPHOL, V116, P23, DOI 10.1002/jmor.1051160103; Schneider U, 1996, PHYS MED BIOL, V41, P111, DOI 10.1088/0031-9155/41/1/009; Schumacher GH., 1961, FUNKTIONELLE MORPHOL; Sellers WI, 2004, ANN ANAT, V186, P89, DOI 10.1016/S0940-9602(04)80132-8; Slater GJ, 2009, J EVOLUTION BIOL, V22, P2278, DOI 10.1111/j.1420-9101.2009.01845.x; Slater GJ, 2009, J ZOOL, V278, P181, DOI 10.1111/j.1469-7998.2009.00567.x; Slater GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013870; Soons J, 2010, PHILOS T R SOC B, V365, P1093, DOI 10.1098/rstb.2009.0280; Stefen C, 1997, TOOTH ENAMEL MICROSTRUCTURE, P123; Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Tanner JB, 2008, BIOL J LINN SOC, V95, P246, DOI 10.1111/j.1095-8312.2008.01052.x; THOMASON JJ, 1991, CAN J ZOOL, V69, P2326, DOI 10.1139/z91-327; Tseng ZJ, 2011, BIOL J LINN SOC, V102, P540, DOI 10.1111/j.1095-8312.2010.01602.x; Tseng ZJ, 2011, PALEOBIOLOGY, V37, P140, DOI 10.1666/09045.1; Tseng ZJ, 2010, J MORPHOL, V271, P1386, DOI 10.1002/jmor.10881; Tseng ZJ, 2010, ZOOL J LINN SOC-LOND, V158, P683, DOI 10.1111/j.1096-3642.2009.00555.x; Tseng ZJ, 2009, BIOL J LINN SOC, V96, P51, DOI 10.1111/j.1095-8312.2008.01095.x; TURNBULL WD, 1970, FIELDIANA GEOLOGY, V18, P149; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; Xing LD, 2009, ACTA GEOL SIN-ENGL, V83, P1031	57	33	33	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19171	10.1371/journal.pone.0019171	http://dx.doi.org/10.1371/journal.pone.0019171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559475	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700089
J	Jasion, VS; Polanco, JA; Meharenna, YT; Li, HY; Poulos, TL				Jasion, Victoria S.; Polanco, Julio A.; Meharenna, Yergalem T.; Li, Huiying; Poulos, Thomas L.			Crystal Structure of Leishmania major Peroxidase and Characterization of the Compound I Tryptophan Radical	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C PEROXIDASE; QUANTITATIVE EPR SPECTROMETRY; ENGINEERED CATION SITE; ASCORBATE-PEROXIDASE; SPINACH-CHLOROPLASTS; SUBSTRATE-BINDING; PRIMARY STANDARD; ACTIVE-SITE; WILD-TYPE; ENZYME	The parasitic protozoa Leishmania major produces a peroxidase (L. major peroxidase; LmP) that exhibits activities characteristic of both yeast cytochrome c peroxidase (CCP) and plant cytosolic ascorbate peroxidase (APX). One common feature is a key Trp residue, Trp(208) in LmP and Trp(191) in CCP, that is situated adjacent to the proximal His heme ligand in CCP, APX, and LmP. In CCP, Trp(191) forms a stable cationic radical after reaction with H2O2 to form Compound I; in APX, the radical is located on the porphyrin ring. In order to clarify the role of Trp(208) in LmP and to further probe peroxidase structure-function relationships, we have determined the crystal structure of LmP and have studied the role of Trp(208) using electron paramagnetic resonance spectroscopy (EPR), mutagenesis, and enzyme kinetics. Both CCP and LmP have an extended section of beta structure near Trp(191) and Trp(208), respectively, which is absent in APX. This region provides stability to the Trp(191) radical in CCP. EPR of LmP Compound I exhibits an intense and stable signal similar to CCP Compound I. In the LmP W208F mutant, this signal disappears, indicating that Trp(208) forms a stable cationic radical. In LmP conversion of the Cys(197) to Thr significantly weakens the Compound I EPR signal and dramatically lowers enzyme activity. These results further support the view that modulation of the local electrostatic environment controls the stability of the Trp radical in peroxidases. Our results also suggest that the biological role of LmP is to function as a cytochrome c peroxidase.	[Poulos, Thomas L.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Poulos, TL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	poulos@uci.edu			National Institutes of Health [GM42614]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM42614.	Adak S, 2005, BIOCHEM J, V390, P465, DOI 10.1042/BJ20050311; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Barrows TP, 2004, BIOCHEMISTRY-US, V43, P8826, DOI 10.1021/bi049531g; Barrows TP, 2005, BIOCHEMISTRY-US, V44, P14062, DOI 10.1021/bi0507128; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bonagura CA, 1996, BIOCHEMISTRY-US, V35, P6107, DOI 10.1021/bi960122x; Bonagura CA, 1999, BIOCHEMISTRY-US, V38, P5538, DOI 10.1021/bi982996k; BUETTNER GR, 1988, J BIOCHEM BIOPH METH, V16, P27, DOI 10.1016/0165-022X(88)90100-5; Bursey EH, 2000, BIOCHEMISTRY-US, V39, P7374, DOI 10.1021/bi000446s; Dolai S, 2009, EUKARYOT CELL, V8, P1721, DOI 10.1128/EC.00198-09; Dunford H. B., 2010, PEROXIDASES CATALASE; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FISHEL LA, 1991, BIOCHEMISTRY-US, V30, P1986, DOI 10.1021/bi00221a036; FITZGERALD MM, 1994, BIOCHEMISTRY-US, V33, P3807, DOI 10.1021/bi00179a004; Fowler RM, 1935, J RES NAT BUR STAND, V15, P493, DOI 10.6028/jres.015.032; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; GOODIN DB, 1993, BIOCHEMISTRY-US, V32, P3313, DOI 10.1021/bi00064a014; HOUSEMAN ALP, 1993, BIOCHEMISTRY-US, V32, P4430, DOI 10.1021/bi00067a036; Jensen GM, 1998, J PHYS CHEM B, V102, P8221, DOI 10.1021/jp9811326; Lad L, 2002, BIOCHEMISTRY-US, V41, P13774, DOI 10.1021/bi0261591; MARGOLIASH E, 1952, NATURE, V170, P1014, DOI 10.1038/1701014a0; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meharenna YT, 2008, BIOCHEMISTRY-US, V47, P10324, DOI 10.1021/bi8007565; MILLER MA, 1994, P NATL ACAD SCI USA, V91, P11118, DOI 10.1073/pnas.91.23.11118; Murphy EJ, 2008, BIOCHEMISTRY-US, V47, P13933, DOI 10.1021/bi801480r; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musah RA, 1997, BIOCHEMISTRY-US, V36, P11665, DOI 10.1021/bi9708038; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; NAKANO Y, 1987, PLANT CELL PHYSIOL, V28, P131; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4342, DOI 10.1021/bi00013a024; PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Yadav RK, 2008, BBA-PROTEINS PROTEOM, V1784, P863, DOI 10.1016/j.bbapap.2008.02.006; Yadav RK, 2010, ARCH BIOCHEM BIOPHYS, V495, P129, DOI 10.1016/j.abb.2010.01.002; YONETANI T, 1965, J BIOL CHEM, V240, P4509; YONETANI T, 1965, J BIOL CHEM, V240, P4503; YONETANI T, 1970, ADV ENZYMOL REL S BI, V33, P309; YORDANOV ND, 1994, APPL MAGN RESON, V6, P341, DOI 10.1007/BF03162498; Yordanov ND, 1996, APPL MAGN RESON, V10, P339, DOI 10.1007/BF03163117	42	29	29	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24608	24615		10.1074/jbc.M111.230524	http://dx.doi.org/10.1074/jbc.M111.230524			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21566139	Green Published, hybrid			2022-12-25	WOS:000292547900011
J	Allison, SE; D'Elia, MA; Arar, S; Monteiro, MA; Brown, ED				Allison, Sarah E.; D'Elia, Michael A.; Arar, Sharif; Monteiro, Mario A.; Brown, Eric D.			Studies of the Genetics, Function, and Kinetic Mechanism of TagE, the Wall Teichoic Acid Glycosyltransferase in Bacillus subtilis 168	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCEROL 3-PHOSPHATE CYTIDYLYLTRANSFERASE; STAPHYLOCOCCUS-AUREUS; POLY(GLYCEROL PHOSPHATE); D-ALANINE; ACCEPTOR; CATALYZES; GENES; BACTERIOPHAGE; RESISTANCE; PRODUCT	The biosynthetic enzymes involved in wall teichoic acid biogenesis in Gram-positive bacteria have been the subject of renewed investigation in recent years with the benefit of modern tools of biochemistry and genetics. Nevertheless, there have been only limited investigations into the enzymes that glycosylate wall teichoic acid. Decades-old experiments in the model Gram-positive bacterium, Bacillus subtilis 168, using phage-resistant mutants implicated tagE (also called gtaA and rodD) as the gene coding for the wall teichoic acid glycosyltransferase. This study and others have provided only indirect evidence to support a role for TagE in wall teichoic acid glycosylation. In this work, we showed that deletion of tagE resulted in the loss of alpha-glucose at the C-2 position of glycerol in the poly(glycerol phosphate) polymer backbone. We also reported the first kinetic characterization of pure, recombinant wall teichoic acid glycosyltransferase using clean synthetic substrates. We investigated the substrate specificity of TagE using a wide variety of acceptor substrates and found that the enzyme had a strong kinetic preference for the transfer of glucose from UDP-glucose to glycerol phosphate in polymeric form. Further, we showed that the enzyme recognized its polymeric (and repetitive) substrate with a sequential kinetic mechanism. This work provides direct evidence that TagE is the wall teichoic acid glycosyltransferase in B. subtilis 168 and provides a strong basis for further studies of the mechanism of wall teichoic acid glycosylation, a largely uncharted aspect of wall teichoic acid biogenesis.	[Allison, Sarah E.; D'Elia, Michael A.; Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Allison, Sarah E.; D'Elia, Michael A.; Brown, Eric D.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Arar, Sharif; Monteiro, Mario A.] Univ Guelph, Dept Chem, Guelph, ON N1G 2W1, Canada	McMaster University; McMaster University; University of Guelph	Brown, ED (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	ebrown@mcmaster.ca	Arar, Sharif Husni/F-9337-2017	Arar, Sharif Husni/0000-0001-9396-0518	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research [MOP-15496]; Canada Research Chair; Ontario Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by the Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research Grant MOP-15496, a Canada Research Chair (to E. D. B.), and an Ontario Graduate Scholarship (to S. E. A.).	Badurina DS, 2003, BBA-PROTEINS PROTEOM, V1646, P196, DOI 10.1016/S1570-9639(03)00019-0; BENSON AK, 1993, J BACTERIOL, V175, P2347, DOI 10.1128/JB.175.8.2347-2356.1993; Bhavsar AP, 2005, J BIOL CHEM, V280, P36691, DOI 10.1074/jbc.M507154200; Bhavsar AP, 2004, J BACTERIOL, V186, P7865, DOI 10.1128/JB.186.23.7865-7873.2004; Bhavsar AP, 2001, J BACTERIOL, V183, P6688, DOI 10.1128/JB.183.22.6688-6693.2001; Cleland W. W, 1970, ENZYMES, V2, P1; CUTTING SM, 1990, MOL BIOL METHODS BAC, P175; D'Elia MA, 2006, J BACTERIOL, V188, P8313, DOI 10.1128/JB.01336-06; D'Elia MA, 2009, J BACTERIOL, V191, P4030, DOI 10.1128/JB.00611-08; Ginsberg C, 2006, ACS CHEM BIOL, V1, P25, DOI 10.1021/cb0500041; GLASER L, 1964, J BIOL CHEM, V239, P3187; Ha S, 1999, J AM CHEM SOC, V121, P8415, DOI 10.1021/ja991556t; HONEYMAN AL, 1989, MOL MICROBIOL, V3, P1257, DOI 10.1111/j.1365-2958.1989.tb00276.x; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; MAUEL C, 1991, J GEN MICROBIOL, V137, P929, DOI 10.1099/00221287-137-4-929; MAUEL C, 1989, MOL GEN GENET, V215, P388, DOI 10.1007/BF00427034; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; PARK YS, 1993, J BIOL CHEM, V268, P16648; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Pereira MP, 2008, CHEMBIOCHEM, V9, P1385, DOI 10.1002/cbic.200800026; Pereira MP, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P337; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Sambrook J., 1989, MOL CLONING, pA1; Schertzer JW, 2008, J BACTERIOL, V190, P6940, DOI 10.1128/JB.00851-08; Schertzer JW, 2003, J BIOL CHEM, V278, P18002, DOI 10.1074/jbc.M300706200; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Xia GQ, 2010, J BIOL CHEM, V285, P13405, DOI 10.1074/jbc.M109.096172; YASBIN RE, 1976, J BACTERIOL, V125, P1120, DOI 10.1128/JB.125.3.1120-1126.1976; YOUNG FE, 1969, J BACTERIOL, V98, P1087, DOI 10.1128/JB.98.3.1087-1097.1969; YOUNG FE, 1967, P NATL ACAD SCI USA, V58, P2377, DOI 10.1073/pnas.58.6.2377; Zhang YH, 2006, BIOCHEMISTRY-US, V45, P10895, DOI 10.1021/bi060872z	34	35	36	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23708	23716		10.1074/jbc.M111.241265	http://dx.doi.org/10.1074/jbc.M111.241265			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21558268	Green Published, hybrid			2022-12-25	WOS:000292294900012
J	Montero, JC; Rodriguez-Barrueco, R; Pandiella, A				Carlos Montero, Juan; Rodriguez-Barrueco, Ruth; Pandiella, Atanasio			Transautocrine Signaling by Membrane Neuregulins Requires Cell Surface Targeting, Which Is Controlled by Multiple Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; BREAST-CANCER; CYTOPLASMIC TAIL; ANCHORING DOMAIN; HEREGULIN; ERBB2; RECEPTORS; CLEAVAGE; LIGAND; ALPHA	The neuregulins (NRGs) play important roles in animal development and homeostasis, and their deregulation has been linked to diseases such as cancer and schizophrenia. The NRGs belong to the epidermal growth factor (EGF) family of transmembrane growth factors. Although NRGs may be synthesized as transmembrane proteins (the pro-NRGs), some of them lack an N-terminal signal sequence, raising the question of how these pro-NRGs are directed to the plasma membrane. Here we have explored the domains of pro-NRGs that are required for their membrane anchoring, cell surface exposure, and biological activity. We show that an internal hydrophobic region acts as a membrane-anchoring domain, but other regions of pro-NRG are required for proper sorting to the plasma membrane. Using mutants that are located in different subcellular compartments, we show that only plasma membrane-exposed pro-NRG is biologically active. At this location, the pro-NRGs may act as transautocrine molecules (i.e. as membrane factors able to activate receptors present in cells that are in physical contact with the pro-NRG-producing cells (in trans) or capable of activating receptors present in the pro-NRG-producing cells (in cis)).	[Carlos Montero, Juan; Rodriguez-Barrueco, Ruth; Pandiella, Atanasio] Univ Salamanca, Consejo Super Invest Cient, Inst Biol Mol & Celular Canc, Ctr Invest Canc, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Pandiella, A (corresponding author), Univ Salamanca, Consejo Super Invest Cient, Inst Biol Mol & Celular Canc, Ctr Invest Canc, Campus Miguel de Unamuno, Salamanca 37007, Spain.	atanasio@usal.es	Rodriguez-Barrueco, Ruth/F-6810-2010; Montero, Juan Carlos/AAO-1780-2020; Pandiella, Atanasio/O-5180-2014	Rodriguez-Barrueco, Ruth/0000-0003-4925-8865; Montero, Juan Carlos/0000-0003-4773-053X; Pandiella, Atanasio/0000-0002-4704-8971	Ministry of Science and Technology of Spain [BMC2003-01192, BFU2006-01813/BMC, BFU2009-07728/BMC]; European Community; Fundacion Ramon Areces; Scientific Foundation of the Spanish Association for Cancer Research; Instituto de Salud Carlos III [RD06/0020/0041]; Spanish Ministry of Education	Ministry of Science and Technology of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission); Fundacion Ramon Areces; Scientific Foundation of the Spanish Association for Cancer Research; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Education(Spanish Government)	This work was supported in part by Ministry of Science and Technology of Spain Grants BMC2003-01192, BFU2006-01813/BMC, and BFU2009-07728/BMC. Our Cancer Research Institute receives support from the European Community through the regional development funding program (FEDER/ERDF) and the Fundacion Ramon Areces.; Supported by the Scientific Foundation of the Spanish Association for Cancer Research.; Supported by the Cancer Center Network Program from the Instituto de Salud Carlos III (RD06/0020/0041).; Recipient of a fellowship from the Spanish Ministry of Education.	Aguilar Z, 2001, J BIOL CHEM, V276, P44099, DOI 10.1074/jbc.M103442200; Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Atlas E, 2003, MOL CANCER RES, V1, P165; Borges J, 2007, CELL SIGNAL, V19, P1473, DOI 10.1016/j.cellsig.2007.01.023; BOSENBERG MW, 1992, CELL, V71, P1157, DOI 10.1016/S0092-8674(05)80064-9; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; BURGESS TL, 1995, J BIOL CHEM, V270, P19188, DOI 10.1074/jbc.270.32.19188; Cabrera N, 1996, J CELL BIOL, V132, P427, DOI 10.1083/jcb.132.3.427; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; de Alava E, 2007, J CLIN ONCOL, V25, P2656, DOI 10.1200/JCO.2006.08.6850; Dong JY, 2005, MOL BIOL CELL, V16, P2984, DOI 10.1091/mbc.E04-11-0994; Esparis-Ogando A, 2002, MOL CELL BIOL, V22, P270, DOI 10.1128/MCB.22.1.270-285.2002; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; Harari D, 1999, ONCOGENE, V18, P2681, DOI 10.1038/sj.onc.1202631; Hayes NVL, 2008, ONCOGENE, V27, P715, DOI 10.1038/sj.onc.1210689; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Krane IM, 1996, ONCOGENE, V12, P1781; Lemke G, 1996, MOL CELL NEUROSCI, V7, P247, DOI 10.1006/mcne.1996.0019; Liu XF, 1998, J BIOL CHEM, V273, P34335, DOI 10.1074/jbc.273.51.34335; Liu XF, 1998, P NATL ACAD SCI USA, V95, P13024, DOI 10.1073/pnas.95.22.13024; Maheshwari G, 2001, J CELL BIOL, V155, P1123, DOI 10.1083/jcb.200109060; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; MASSAGUE J, 1983, J BIOL CHEM, V258, P3614; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Montero JC, 2000, MOL CELL NEUROSCI, V16, P631, DOI 10.1006/mcne.2000.0896; Montero JC, 2007, MOL BIOL CELL, V18, P380, DOI 10.1091/mbc.E06-06-0511; Montero JC, 2008, CLIN CANCER RES, V14, P3237, DOI 10.1158/1078-0432.CCR-07-5133; Sambrook J, 1989, MOL CLONING LABORATO, V9, P16; THORNE BA, 1994, MOL CELL BIOL, V14, P1635, DOI 10.1128/MCB.14.3.1635; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909; Wiley HS, 1998, J CELL BIOL, V143, P1317, DOI 10.1083/jcb.143.5.1317; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Yuste L, 2005, CANCER RES, V65, P6801, DOI 10.1158/0008-5472.CAN-04-4023; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562	40	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24350	24363		10.1074/jbc.M110.190835	http://dx.doi.org/10.1074/jbc.M110.190835			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572038	hybrid, Green Published			2022-12-25	WOS:000292294900075
J	de Abreu, RT; Carvalho, MD; Carneiro, CM; Giunchetti, RC; Teixeira-Carvalho, A; Martins, OA; Coura-Vital, W; Correa-Oliveira, R; Reis, AB				de Abreu, Raquel Tropia; Carvalho, Maria das Gracas; Carneiro, Claudia Martins; Giunchetti, Rodolfo Cordeiro; Teixeira-Carvalho, Andrea; Martins-Filho, Olindo Assis; Coura-Vital, Wendel; Correa-Oliveira, Rodrigo; Reis, Alexandre Barbosa			Influence of Clinical Status and Parasite Load on Erythropoiesis and Leucopoiesis in Dogs Naturally Infected with Leishmania (Leishmania) chagasi	PLOS ONE			English	Article							CANINE VISCERAL LEISHMANIASIS; BONE-MARROW; CIRCULATING LEUKOCYTES; LYMPH-NODE; DENSITY; EOSINOPHILS; PARAMETERS; PATHOLOGY; FEATURES; DONOVANI	Background: The bone marrow is considered to be an important storage of parasites in Leishmania-infected dogs, although little is known about cellular genesis in this organ during canine visceral leishmaniasis (CVL). Methodology/Principal Findings: The aim of the present study was to evaluate changes in erythropoiesis and leucopoiesis in bone marrow aspirates from dogs naturally infected with Leishmania chagasi and presenting different clinical statuses and bone marrow parasite densities. The evolution of CVL from asymptomatic to symptomatic status was accompanied by increasing parasite density in the bone marrow. The impact of bone marrow parasite density on cellularity was similar in dogs at different clinical stages, with animals in the high parasite density group. Erythroid and eosinophilic hypoplasia, proliferation of neutrophilic precursor cells and significant increases in lymphocytes and plasma cell numbers were the major alterations observed. Differential bone marrow cell counts revealed increases in the myeloid: erythroid ratio associated to increased numbers of granulopoietic cells in the different clinical groups compared with non-infected dogs. Conclusions: Analysis of the data obtained indicated that the assessment of bone marrow constitutes an additional and useful tool by which to elaborate a prognosis for CVL.	[de Abreu, Raquel Tropia; Carneiro, Claudia Martins; Coura-Vital, Wendel; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol, Dept Anal Clin, Ouro Preto, MG, Brazil; [Carvalho, Maria das Gracas] Univ Fed Minas Gerais, Lab Hematol Clin, Fac Farm, Belo Horizonte, MG, Brazil; [Giunchetti, Rodolfo Cordeiro] Univ Fed Ouro Preto, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol, Dept Ciencias Biol, Ouro Preto, MG, Brazil; [Teixeira-Carvalho, Andrea; Martins-Filho, Olindo Assis] Fundacao Oswaldo Cruz, Lab Biomarcadores Diagnost & Monitoracao, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Giunchetti, Rodolfo Cordeiro; Correa-Oliveira, Rodrigo; Reis, Alexandre Barbosa] Fundacao Oswaldo Cruz, Lab Imunol Celular & Mol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil	Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	de Abreu, RT (corresponding author), Univ Fed Ouro Preto, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol, Dept Anal Clin, Ouro Preto, MG, Brazil.	alexreis@nupeb.ufop.br	Coura-Vital, Wendel/AAP-9624-2021; Reis, Alexandre Barbosa/I-9945-2014; carneiro, Claudia Martins/AAP-4455-2020; Carvalho, Maria das Graças/AAY-1619-2021; carneiro, claudia m/B-6205-2013; Martins-Filho, Olindo Assis/ABE-6278-2021; Giunchetti, Rodolfo/O-9878-2014	Reis, Alexandre Barbosa/0000-0001-8123-4164; carneiro, Claudia Martins/0000-0002-6002-857X; Martins-Filho, Olindo Assis/0000-0002-5494-4889; /0000-0002-1434-7676; Cordeiro Giunchetti, Rodolfo/0000-0003-4181-7546; Correa-Oliveira, Rodrigo/0000-0001-6419-9459	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG/CNPq/PRONEX)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG/CNPq/PRONEX)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The study was supported by the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG/CNPq/PRONEX 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRANCHES P, 1991, PARASITE IMMUNOL, V13, P537, DOI 10.1111/j.1365-3024.1991.tb00550.x; Amusategui I, 2003, EUR J EPIDEMIOL, V18, P147, DOI 10.1023/A:1023090929302; ANOSA VO, 1983, ZBL VET MED B, V30, P600; Barrouin-Melo SM, 2004, MEM I OSWALDO CRUZ, V99, P195, DOI 10.1590/S0074-02762004000200014; Bourdoiseau G, 1997, VET IMMUNOL IMMUNOP, V56, P345, DOI 10.1016/S0165-2427(96)05768-6; CARDOSO L, 1998, REV PORT C, V93, P122; CERVIA JS, 1993, INFECT IMMUN, V61, P1330, DOI 10.1128/IAI.61.4.1330-1333.1993; Coterell SEJ, 2000, INFECT IMMUN, V68, P1840, DOI 10.1128/IAI.68.4.1840-1848.2000; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Giunchetti RC, 2006, J COMP PATHOL, V135, P100, DOI 10.1016/j.jcpa.2006.06.005; Giunchetti RC, 2008, VET IMMUNOL IMMUNOP, V121, P23, DOI 10.1016/j.vetimm.2007.07.009; Giunchetti RC, 2008, RES VET SCI, V84, P269, DOI 10.1016/j.rvsc.2007.04.020; Guerra LL, 2009, PARASITOL RES, V104, P611, DOI 10.1007/s00436-008-1237-4; HOFF B, 1985, CAN J COMP MED, V49, P34; Jain NC, 1986, SCHALMS VET HEMATOLO, P8; KEENAN CM, 1984, VET PATHOL, V21, P74, DOI 10.1177/030098588402100113; MANCIANTI F, 1988, T ROY SOC TROP MED H, V82, P566, DOI 10.1016/0035-9203(88)90510-X; Manzillo VF, 2006, VET REC, V158, P690, DOI 10.1136/vr.158.20.690; MARTINEZMORENO A, 1993, VET PARASITOL, V51, P49, DOI 10.1016/0304-4017(93)90195-S; MIRKOVICH AM, 1986, CLIN EXP IMMUNOL, V64, P1; Mischke R, 2002, J VET MED A, V49, P499, DOI 10.1046/j.1439-0442.2002.00491.x; MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4; MURRAY HW, 1995, J CLIN INVEST, V95, P1183, DOI 10.1172/JCI117767; Oliveira SHP, 1997, MEM I OSWALDO CRUZ, V92, P233, DOI 10.1590/S0074-02761997000800034; PEARSON RD, 1987, ANN TROP MED PARASIT, V81, P735, DOI 10.1080/00034983.1987.11812179; PENNY RHC, 1974, J SMALL ANIM PRACT, V15, P553, DOI 10.1111/j.1748-5827.1974.tb06535.x; Reis AB, 2006, CLIN EXP IMMUNOL, V146, P303, DOI 10.1111/j.1365-2249.2006.03206.x; Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001; Reis AB, 2006, RES VET SCI, V81, P68, DOI 10.1016/j.rvsc.2005.09.011; Reis AB, 2009, VET IMMUNOL IMMUNOP, V128, P87, DOI 10.1016/j.vetimm.2008.10.307; Sanchez MA, 2004, AM J TROP MED HYG, V70, P618, DOI 10.4269/ajtmh.2004.70.618; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; TRYPHONAS L, 1977, CAN J COMP MED, V41, P1; Vieira J B, 1998, Rev Soc Bras Med Trop, V31 Suppl 2, P85; YAMAGUCHI RA, 1983, J AM ANIM HOSP ASSOC, V19, P723	35	23	23	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e18873	10.1371/journal.pone.0018873	http://dx.doi.org/10.1371/journal.pone.0018873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572995	Green Published, gold			2022-12-25	WOS:000290440200004
J	Dittmar, K; Morse, S; Gruwell, M; Mayberry, J; DiBlasi, E				Dittmar, Katharina; Morse, Solon; Gruwell, Matthew; Mayberry, Jason; DiBlasi, Emily			Spatial and Temporal Complexities of Reproductive Behavior and Sex Ratios: A Case from Parasitic Insects	PLOS ONE			English	Article							BAT FLIES DIPTERA; PHYLOGENETIC ANALYSIS; LICE INSECTA; ECOLOGY; STREBLIDAE; SELECTION; COMPETITION; CHIROPTERA; MORTALITY; EVOLUTION	Background: Sex ratios are important empirical data in predicting sex allocation strategy and selection in populations. Therefore, they should be sampled at crucial developmental steps before and after parental investment. In parasites with free-living (off-host) developmental stages the timing and method of sampling is not trivial, because ecological niches are frequently poorly known. Consequently, information is scarce for sex ratios of these parasites between conception and sexual maturity. Often, only data from adult parasites are available, which usually were collected from the parasite's hosts. Generally, these ratios are assumed to represent operational sex ratios. Methodology/Principal Findings: We here report three years of empirical data on population sex differentials from a bat ectoparasite (Trichobius frequens) with off-host developmental stages. At emergence these parasites exhibit a significant and seasonally stable female biased sex ratio. This bias is lost in the adult population on the roosting host, which shows sex ratios at equality. This is best explained by a behaviorally driven, sex-dependent mortality differential. Because consistently only subsets of females are available to mate, the operational sex ratio in the population is likely male biased. Host capture experiments throughout the day show a statistically significant, but temporary male excess in bat flies on foraging bats. This phenomenon is partly driven by the diurnal rhythms of female larviposition, and partly due to parasites remaining in the bat roost during foraging. Because most previous research in bat flies is based only on foraging bats, female contributions to physical sex ratios have been underestimated. Conclusion/Significance: Our results highlight the importance of detailed natural history observations, and emphasize that ignoring the spatial and temporal heterogeneity of reproduction in any organism will lead to significant empirical sampling errors of sex ratios, and may obscure operational sex ratios.	[Dittmar, Katharina; Morse, Solon; Gruwell, Matthew; Mayberry, Jason; DiBlasi, Emily] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Dittmar, Katharina; Morse, Solon; Gruwell, Matthew; Mayberry, Jason; DiBlasi, Emily] SUNY Buffalo, Grad Program Ecol Evolut & Behav, Buffalo, NY 14260 USA; [Gruwell, Matthew] Penn State Univ, Behrend Coll, Erie, PA 16563 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Dittmar, K (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	katharinad@gmail.com			SUNY Buffalo; National Science Foundation [NSF DEB 0744628]; Direct For Biological Sciences [0743491] Funding Source: National Science Foundation	SUNY Buffalo; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Research related to this publication was funded by SUNY Buffalo, and the National Science Foundation through a grant awarded to KD, NSF DEB 0744628, nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL JF, 1962, EXP PARASITOL, V12, P176, DOI 10.1016/0014-4894(62)90055-3; CHARNOV E L, 1982; Ching L., 1968, MALAY NAT J, V21, P171; CLAYTON DH, 1992, J ANIM ECOL, V61, P781, DOI 10.2307/5631; Clayton DH, 1999, AM NAT, V154, P261, DOI 10.1086/303237; Codd JR, 2003, AUST J ZOOL, V51, P307, DOI 10.1071/ZO01079; COTGREAVE P, 1994, BEHAVIOUR, V131, P171, DOI 10.1163/156853994X00424; Dick CW, 2008, EVOL ECOL, V22, P757, DOI 10.1007/s10682-007-9201-9; Dick CW, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P179, DOI 10.1007/978-4-431-36025-4_11; DICK CW, 2005, THESIS TEXAS TU; Dittmar K, 2006, MOL PHYLOGENET EVOL, V38, P155, DOI 10.1016/j.ympev.2005.06.008; Dittmar Katharina, 2010, Speleobiology Notes, V2, P12; Dittmar K, 2009, J PARASITOL, V95, P308, DOI 10.1645/GE-1664.1; Dusing C, 1883, JENA Z NATURWISS, V16, P428; Fisher R.A., 1930, GENETICAL THEORY NAT; FRITZ GN, 1983, J MED ENTOMOL, V20, P1, DOI 10.1093/jmedent/20.1.1; GHERNA RL, 1991, INT J SYST BACTERIOL, V41, P563, DOI 10.1099/00207713-41-4-563; Graciolli G, 2006, ZOOTAXA, P35, DOI 10.11646/zootaxa.1220.1.3; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; HURST LD, 1991, P ROY SOC B-BIOL SCI, V244, P91, DOI 10.1098/rspb.1991.0056; Kapranas A, 2011, J ANIM ECOL, V80, P192, DOI 10.1111/j.1365-2656.2010.01767.x; Kim K. C., 1985, Coevolution of parasitic arthropods and mammals, P3; Koga R, 2009, APPL ENTOMOL ZOOL, V44, P281, DOI 10.1303/aez.2009.281; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; LEIGH EG, 1970, AM NAT, V104, P205, DOI 10.1086/282650; MAA TC, 1987, MANUAL NEARCTIC DIPT, V2, P1271; MADSEN T, 1993, AM NAT, V141, P167, DOI 10.1086/285467; MARSHALL AG, 1981, ECOL ENTOMOL, V6, P155, DOI 10.1111/j.1365-2311.1981.tb00602.x; MARSHALL AG, 1981, ECOLOGY ECTOPARASITI; Murray KL, 2008, J MAMMAL, V89, P1391, DOI 10.1644/08-MAMM-S-068.1; MURRAY M. D., 1961, AUSTRALIAN JOUR ZOOL, V9, P1, DOI 10.1071/ZO9610001; Oliveira RF, 1999, J FISH BIOL, V54, P499, DOI 10.1006/jfbi.1998.0886; OVERAL W L, 1980, University of Kansas Science Bulletin, V52, P1; OVERAL WL, 1980, THESIS U KANSAS; Petersen FT, 2007, MOL PHYLOGENET EVOL, V45, P111, DOI 10.1016/j.ympev.2007.04.023; PETERSON BV, 1974, CAN ENTOMOL, V106, P1049, DOI 10.4039/Ent1061049-10; REYNOLDS JD, 1986, BEHAV ECOL SOCIOBIOL, V18, P303, DOI 10.1007/BF00300008; Rozsa L, 1996, J ANIM ECOL, V65, P242, DOI 10.2307/5727; Rozsa L, 1997, J PARASITOL, V83, P543, DOI 10.2307/3284430; Trowbridge RE, 2006, J INVERTEBR PATHOL, V91, P64, DOI 10.1016/j.jip.2005.08.009; Walter DE, 2003, BIOL CONTROL, V26, P253, DOI 10.1016/S1049-9644(02)00171-8; WENZEL RL, 1976, BRIGH YOUNG U SCI, V20, P1; West SA, 2005, EVOLUTION, V59, P1211; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; West SA, 2009, MONOGR POPUL BIOL, V44, P162; Winchell JM, 1996, CAN J ZOOL, V74, P431, DOI 10.1139/z96-050	46	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19438	10.1371/journal.pone.0019438	http://dx.doi.org/10.1371/journal.pone.0019438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572996	Green Published, Green Submitted, gold			2022-12-25	WOS:000290440200008
J	Lo, ATS; Salam, NK; Hibbs, DE; Rutledge, PJ; Todd, MH				Lo, Anthony T. S.; Salam, Noeris K.; Hibbs, David E.; Rutledge, Peter J.; Todd, Matthew H.			Polyamide-Scorpion Cyclam Lexitropsins Selectively Bind AT-Rich DNA Independently of the Nature of the Coordinated Metal	PLOS ONE			English	Article							MINOR-GROOVE-BINDING; PYRROLE-IMIDAZOLE POLYAMIDES; COPPER-CHELATING PEPTIDE; CROSS-LINKED POLYAMIDES; DOUBLE-STRANDED DNA; DISTAMYCIN ANALOGS; HAIRPIN POLYAMIDE; MOLECULAR RECOGNITION; CENTER-DOT; TRANSCRIPTION FACTORS	Cyclam was attached to 1-, 2- and 3-pyrrole lexitropsins for the first time through a synthetically facile copper-catalyzed "click" reaction. The corresponding copper and zinc complexes were synthesized and characterized. The ligand and its complexes bound AT-rich DNA selectively over GC-rich DNA, and the thermodynamic profile of the binding was evaluated by isothermal titration calorimetry. The metal, encapsulated in a scorpion azamacrocyclic complex, did not affect the binding, which was dominated by the organic tail.	[Salam, Noeris K.] Schrodinger Inc, New York, NY USA; [Lo, Anthony T. S.; Rutledge, Peter J.; Todd, Matthew H.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Hibbs, David E.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Lo, ATS (corresponding author), Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.	matthew.todd@sydney.edu.au	Rutledge, Peter J/D-6253-2012; Todd, Matthew/S-2678-2018	Lo, Anthony/0000-0002-5921-9854; Rutledge, Peter/0000-0002-0767-5196; Todd, Matthew/0000-0001-7096-4751	University of Sydney	University of Sydney(University of Sydney)	This work was supported by the University of Sydney, via a Major Equipment Grant for the purchase of the isothermal titration calorimeter. Schrodinger, Inc. provided software and hardware used for the generation of Figure 5. The funders had no other role in study design, data collection, decision to publish, or preparation of the manuscript.	Aoki S, 2004, CHEM REV, V104, P769, DOI 10.1021/cr020617u; BAILLY C, 1992, BIOCONJUGATE CHEM, V3, P100, DOI 10.1021/bc00014a002; Bailly C, 1998, BIOCONJUGATE CHEM, V9, P513, DOI 10.1021/bc980008m; Baraldi PG, 2000, BIOORG MED CHEM LETT, V10, P1397, DOI 10.1016/S0960-894X(00)00250-X; Baraldi PG, 2004, MED RES REV, V24, P475, DOI 10.1002/med.20000; Baraldi PG, 2007, BIOORGAN MED CHEM, V15, P17, DOI 10.1016/j.bmc.2006.07.004; BERMAN HM, 1994, CURR OPIN STRUC BIOL, V4, P345, DOI 10.1016/S0959-440X(94)90102-3; Bhattacharya S, 2000, TETRAHEDRON LETT, V41, P5571, DOI 10.1016/S0040-4039(00)00802-9; Boerner LJK, 2005, CURR OPIN CHEM BIOL, V9, P135, DOI 10.1016/j.cbpa.2005.02.010; Boger DL, 2000, J AM CHEM SOC, V122, P6382, DOI 10.1021/ja994192d; BRESLAUER KJ, 1987, P NATL ACAD SCI USA, V84, P8922, DOI 10.1073/pnas.84.24.8922; Brown T, 2007, BIOORGAN MED CHEM, V15, P474, DOI 10.1016/j.bmc.2006.09.037; BRUICE TC, 1992, P NATL ACAD SCI USA, V89, P1700, DOI 10.1073/pnas.89.5.1700; Buchmueller KL, 2006, BIOCHEMISTRY-US, V45, P13551, DOI 10.1021/bi061245c; Buchmueller KL, 2005, CHEMBIOCHEM, V6, P2305, DOI 10.1002/cbic.200500179; Buchmueller KL, 2005, J AM CHEM SOC, V127, P742, DOI 10.1021/ja044359p; BUCKIN VA, 1989, NATURE, V340, P321, DOI 10.1038/340321a0; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chaires JB, 2008, ANNU REV BIOPHYS, V37, P135, DOI 10.1146/annurev.biophys.36.040306.132812; Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027; CHALIKIAN TV, 1994, BIOCHEMISTRY-US, V33, P8629, DOI 10.1021/bi00195a003; CHEN X, 1994, NAT STRUCT BIOL, V1, P169, DOI 10.1038/nsb0394-169; DERVAN PB, 1986, SCIENCE, V232, P464, DOI 10.1126/science.2421408; Dervan PB, 2003, CURR OPIN STRUC BIOL, V13, P284, DOI 10.1016/S0959-440X(03)00081-2; Dervan PB, 1999, CURR OPIN CHEM BIOL, V3, P688, DOI 10.1016/S1367-5931(99)00027-7; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0; Dolenc J, 2006, BIOPHYS J, V91, P1460, DOI 10.1529/biophysj.105.074617; Dudouet B, 2003, CHEM BIOL, V10, P859, DOI 10.1016/j.chembiol.2003.09.001; FAGAN P, 1992, J AM CHEM SOC, V114, P1080, DOI 10.1021/ja00029a042; Fishleigh RV, 2000, J MED CHEM, V43, P3257, DOI 10.1021/jm990620e; Gallicchio E, 1998, J AM CHEM SOC, V120, P4526, DOI 10.1021/ja974061h; Gallmeier HC, 2003, EUR J ORG CHEM, V2003, P3473, DOI 10.1002/ejoc.200300096; GILLI P, 1994, J PHYS CHEM-US, V98, P1515, DOI 10.1021/j100056a024; GRIFFIN JH, 1987, J AM CHEM SOC, V109, P6840, DOI 10.1021/ja00256a043; Hashimoto S, 2000, CHEM PHARM BULL, V48, P603; Hawkins CA, 2000, J AM CHEM SOC, V122, P5235, DOI 10.1021/ja0001198; Hegg EL, 1998, COORDIN CHEM REV, V173, P133, DOI 10.1016/S0010-8545(98)00157-X; HUANG L, 1993, BIOORG MED CHEM LETT, V3, P1751, DOI 10.1016/S0960-894X(00)80056-6; HUANG LR, 1995, BIOCONJUGATE CHEM, V6, P21, DOI 10.1021/bc00031a003; Hurley AL, 2001, ORG LETT, V3, P2761, DOI 10.1021/ol0163676; Iida H, 1999, CURR OPIN BIOTECH, V10, P29, DOI 10.1016/S0958-1669(99)80006-8; Izatt R.M., 1989, CHEM MACROCYCLIC LIG, Vviii, DOI 10.1126/science.246.4932.942.a; Jaramillo D, 2004, J ORG CHEM, V69, P8151, DOI 10.1021/jo048686r; Jaramillo D, 2006, INORG CHEM, V45, P6004, DOI 10.1021/ic060383n; Khalaf AI, 2004, J MED CHEM, V47, P2133, DOI 10.1021/jm031089x; Koh JT, 2007, ACS CHEM BIOL, V2, P599, DOI 10.1021/cb700183s; KOIKE T, 1991, J AM CHEM SOC, V113, P8935, DOI 10.1021/ja00023a048; KOPKA ML, 1985, P NATL ACAD SCI USA, V82, P1376, DOI 10.1073/pnas.82.5.1376; Lacy ER, 2002, J AM CHEM SOC, V124, P2153, DOI 10.1021/ja016154b; Lah J, 2004, J MOL BIOL, V342, P73, DOI 10.1016/j.jmb.2004.07.005; Lah J, 2000, BIOCHEMISTRY-US, V39, P9317, DOI 10.1021/bi000748u; Lansiaux A, 2002, J MED CHEM, V45, P1994, DOI 10.1021/jm010539n; Lee LW, 2010, J BIOL CHEM, V285, P11033, DOI 10.1074/jbc.R109.075044; LEE M, 1988, J AM CHEM SOC, V110, P3641, DOI 10.1021/ja00219a045; Li C, 2008, BIOORG MED CHEM LETT, V18, P5766, DOI 10.1016/j.bmcl.2008.09.074; Liang XY, 2004, CHEM SOC REV, V33, P246, DOI 10.1039/b313659k; Liu B, 2009, J MED CHEM, V52, P4604, DOI 10.1021/jm9002999; Liu D, 2006, BIOORG MED CHEM LETT, V16, P5032, DOI 10.1016/j.bmcl.2006.07.049; Lown J. William, 1994, Journal of Molecular Recognition, V7, P79, DOI 10.1002/jmr.300070205; MACCARTHY P, 1978, ANAL CHEM, V50, P2165, DOI 10.1021/ac50036a059; Mapp AK, 2000, P NATL ACAD SCI USA, V97, P3930, DOI 10.1073/pnas.97.8.3930; MARKY LA, 1987, P NATL ACAD SCI USA, V84, P4359, DOI 10.1073/pnas.84.13.4359; Marques MA, 2002, HELV CHIM ACTA, V85, P4485, DOI 10.1002/hlca.200290024; Melander C, 2004, J BIOTECHNOL, V112, P195, DOI 10.1016/j.jbiotec.2004.03.018; MICHELONI M, 1978, J CHEM SOC PERK T 2, P828, DOI 10.1039/p29780000828; MISRA VK, 1994, J MOL BIOL, V238, P245, DOI 10.1006/jmbi.1994.1285; Murty MSRC, 2004, BIOL PHARM BULL, V27, P468, DOI 10.1248/bpb.27.468; Neamati N, 1998, MOL PHARMACOL, V54, P280, DOI 10.1124/mol.54.2.280; Neidle S, 2001, NAT PROD REP, V18, P291, DOI 10.1039/a705982e; Nguyen B, 2009, ACCOUNTS CHEM RES, V42, P11, DOI 10.1021/ar800016q; NIKOLAEV VA, 1993, MOL BIOL+, V27, P117; O'Hare CC, 2002, P NATL ACAD SCI USA, V99, P72, DOI 10.1073/pnas.012588799; OTSUKA M, 1990, J AM CHEM SOC, V112, P838, DOI 10.1021/ja00158a052; OWA T, 1992, TETRAHEDRON, V48, P1193, DOI 10.1016/S0040-4020(01)90783-5; Parkinson JA, 2009, HELV CHIM ACTA, V92, P795, DOI 10.1002/hlca.200800390; PASSADORE M, 1995, BIOCHEM J, V308, P513, DOI 10.1042/bj3080513; PATEL DJ, 1982, P NATL ACAD SCI-BIOL, V79, P6424, DOI 10.1073/pnas.79.21.6424; PELTON JG, 1989, P NATL ACAD SCI USA, V86, P5723, DOI 10.1073/pnas.86.15.5723; Pilch DS, 1999, BIOCHEMISTRY-US, V38, P2143, DOI 10.1021/bi982628g; Pitie M, 2000, BIOCONJUGATE CHEM, V11, P892, DOI 10.1021/bc000050t; PJURA PE, 1987, J MOL BIOL, V197, P257, DOI 10.1016/0022-2836(87)90123-9; Ramana AV, 2008, BIOORG MED CHEM LETT, V18, P3007, DOI 10.1016/j.bmcl.2008.03.045; Reddy BSP, 1999, PHARMACOL THERAPEUT, V84, P1, DOI 10.1016/S0163-7258(99)00021-2; RENTZEPERIS D, 1995, BIOCHEMISTRY-US, V34, P2937, DOI 10.1021/bi00009a025; RODRIGUEZ M, 1992, INORG CHEM, V31, P1129, DOI 10.1021/ic00033a004; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Routier S, 1997, BIOORG MED CHEM LETT, V7, P1729, DOI 10.1016/S0960-894X(97)00299-0; Satz AL, 2002, ACCOUNTS CHEM RES, V35, P86, DOI 10.1021/ar0101032; Satz AL, 2001, J AM CHEM SOC, V123, P2469, DOI 10.1021/ja003095d; SCHULTZ PG, 1982, J AM CHEM SOC, V104, P6861; Seio K, 2005, J ORG CHEM, V70, P10311, DOI 10.1021/jo051247n; Sharma SK, 2000, J ORG CHEM, V65, P1102, DOI 10.1021/jo991571g; Simon P, 2008, NUCLEIC ACIDS RES, V36, P3531, DOI 10.1093/nar/gkn231; Spitzer GM, 2008, CHEMPHYSCHEM, V9, P2766, DOI 10.1002/cphc.200800647; Suckling CJ, 2008, J PHYS ORG CHEM, V21, P575, DOI 10.1002/poc.1323; Supekova L, 2002, CHEM BIOL, V9, P821, DOI 10.1016/S1074-5521(02)00174-6; Surovaya AN, 1999, MOL BIOL+, V33, P539; Taleb RI, 2007, CHEM-EUR J, V13, P3177, DOI 10.1002/chem.200601486; Tamanini E, 2010, INORG CHEM, V49, P3789, DOI 10.1021/ic901939x; Tamanini E, 2009, CHEM-EUR J, V15, P3720, DOI 10.1002/chem.200802425; Tamanini E, 2009, INORG CHEM, V48, P319, DOI 10.1021/ic8017634; Tanious FA, 2004, J AM CHEM SOC, V126, P143, DOI 10.1021/ja030403+; Thomas M, 2002, EUR J ORG CHEM, V2002, P3604; Tietze LF, 2003, ANGEW CHEM INT EDIT, V42, P3996, DOI 10.1002/anie.200200553; Trauger JW, 1996, NATURE, V382, P559, DOI 10.1038/382559a0; Treesuwan W, 2009, PHYS CHEM CHEM PHYS, V11, P10682, DOI 10.1039/b910574c; Tse WC, 2004, CHEM BIOL, V11, P1607, DOI 10.1016/j.chembiol.2003.08.012; Urbach AR, 2001, P NATL ACAD SCI USA, V98, P4343, DOI 10.1073/pnas.081070798; Vazquez ME, 2003, CHEM SOC REV, V32, P338, DOI 10.1039/b206274g; Vazquez O, 2007, ANGEW CHEM INT EDIT, V46, P6886, DOI 10.1002/anie.200702345; Vazquez O, 2008, CHEMBIOCHEM, V9, P2822, DOI 10.1002/cbic.200800345; WADE WS, 1992, J AM CHEM SOC, V114, P8783, DOI 10.1021/ja00049a006; Walker WL, 1997, BIOPOLYMERS, V44, P323, DOI 10.1002/(SICI)1097-0282(1997)44:4<323::AID-BIP2>3.0.CO;2-0; Weber PC, 2003, CURR OPIN STRUC BIOL, V13, P115, DOI 10.1016/S0959-440X(03)00003-4; Wemmer DE, 2000, ANNU REV BIOPH BIOM, V29, P439, DOI 10.1146/annurev.biophys.29.1.439; Wender PA, 2003, BIOORG MED CHEM LETT, V13, P1763, DOI 10.1016/S0960-894X(03)00212-9; Westrate L, 2009, BIOCHEMISTRY-US, V48, P5679, DOI 10.1021/bi900242t; White S, 1998, NATURE, V391, P468, DOI 10.1038/35106; White S, 1996, BIOCHEMISTRY-US, V35, P12532, DOI 10.1021/bi960744i; Xiao XS, 2007, ANGEW CHEM INT EDIT, V46, P2865, DOI 10.1002/anie.200604485; Yang YW, 1996, BIOCONJUGATE CHEM, V7, P670, DOI 10.1021/bc960065k; YOUNGQUIST RS, 1985, P NATL ACAD SCI USA, V82, P2565, DOI 10.1073/pnas.82.9.2565; Zhu YY, 2009, J PHYS CHEM B, V113, P839, DOI 10.1021/jp8091545; ZIMMER C, 1979, NUCLEIC ACIDS RES, V6, P2831, DOI 10.1093/nar/6.8.2831; ZIMMER C, 1986, PROG BIOPHYS MOL BIO, V47, P31, DOI 10.1016/0079-6107(86)90005-2	125	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e17446	10.1371/journal.pone.0017446	http://dx.doi.org/10.1371/journal.pone.0017446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573061	Green Published, Green Submitted, gold			2022-12-25	WOS:000290386800001
J	Fassan, M; D'Arca, D; Letko, J; Vecchione, A; Gardiman, MP; McCue, P; Wildemore, B; Rugge, M; Shupp-Byrne, D; Gomella, LG; Morrione, A; Iozzo, RV; Baffa, R				Fassan, Matteo; D'Arca, Domenico; Letko, Juraj; Vecchione, Andrea; Gardiman, Marina P.; McCue, Peter; Wildemore, Bernadette; Rugge, Massimo; Shupp-Byrne, Dolores; Gomella, Leonard G.; Morrione, Andrea; Iozzo, Renato V.; Baffa, Raffaele			Mitostatin Is Down-Regulated in Human Prostate Cancer and Suppresses the Invasive Phenotype of Prostate Cancer Cells	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; GROWTH-FACTOR RECEPTOR; TUMOR-SUPPRESSOR; DECORIN GENE; CHROMOSOMAL IMBALANCES; ENDOTHELIAL-CELLS; BLADDER-CANCER; MIGRATION; CARCINOMA; EXPRESSION	MITOSTATIN, a novel putative tumor suppressor gene induced by decorin overexpression, is expressed in most normal human tissues but is markedly down-regulated in advanced stages of mammary and bladder carcinomas. Mitostatin negatively affects cell growth, induces cell death and regulates the expression and activation levels of Hsp27. In this study, we demonstrated that ectopic expression of Mitostatin in PC3, DU145, and LNCaP prostate cancer cells not only induced a significant reduction in cell growth, but also inhibited migration and invasion. Moreover, Mitostatin inhibited colony formation in soft-agar of PC3 and LNCaP cells as well as tumorigenicity of LNCaP cells in nude mice. Conversely, targeting endogenous Mitostatin by siRNA and anti-sense strategies in PC3 and DU145 prostate cancer cells enhanced the malignant phenotype in both cell lines. In agreement of these anti-oncogenic roles, we discovered that Mitostatin was absent in similar to 35% (n = 124) of prostate tumor samples and its overall reduction was associated with advanced cancer stages. Collectively, our findings indicate that MITOSTATIN may acts as a tumor suppressor gene in prostate cancer and provide a novel cellular and molecular mechanism to be further exploited and deciphered in our understanding of prostate cancer progression.	[Fassan, Matteo; D'Arca, Domenico; Letko, Juraj; Vecchione, Andrea; Shupp-Byrne, Dolores; Gomella, Leonard G.; Morrione, Andrea; Baffa, Raffaele] Thomas Jefferson Univ, Dept Urol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [McCue, Peter; Wildemore, Bernadette; Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Fassan, Matteo; Gardiman, Marina P.; Rugge, Massimo] Univ Padua, Dept Diagnost Med & Special Therapies, Padua, Italy; [Vecchione, Andrea] Univ Roma La Sapienza, Fac Med 2, Div Pathol, Osped St Andrea, Rome, Italy	Jefferson University; Jefferson University; University of Padua; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Fassan, M (corresponding author), Thomas Jefferson Univ, Dept Urol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	R_Baffa@mail.jci.tju.edu	Iozzo, Renato/AAS-1980-2020; Rugge, Massimo/K-7525-2016; D'Arca, Domenico/B-9212-2016; Fassan, Matteo/F-5152-2012; Letko, Juraj/AAN-5710-2020	D'Arca, Domenico/0000-0002-7240-6005; Fassan, Matteo/0000-0001-6515-5482; Letko, Juraj/0000-0001-6285-5846; Vecchione, Andrea/0000-0002-5497-6856; Iozzo, Renato/0000-0002-5908-5112	Sidney Kimmel Foundation for Cancer Research; Benjamin Perkins Bladder Cancer Fund; Martin Greitzer Fund; National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA120975, RO1 DK068419]; NATIONAL CANCER INSTITUTE [R01CA120975, R01CA047282, R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068419] Funding Source: NIH RePORTER	Sidney Kimmel Foundation for Cancer Research; Benjamin Perkins Bladder Cancer Fund; Martin Greitzer Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was in part supported by the Sidney Kimmel Foundation for Cancer Research, the Benjamin Perkins Bladder Cancer Fund and the Martin Greitzer Fund (to R. B.), the National Institutes of Health grants RO1 CA39481, RO1 CA47282 and RO1 CA120975 (to R. V. I.), RO1 DK068419 (to A. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubele MM, 2000, DIAGN MOL PATHOL, V9, P14, DOI 10.1097/00019606-200003000-00003; Cerqua C, 2010, EMBO REP, V11, P854, DOI 10.1038/embor.2010.151; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; DANIELSON KG, 1993, GENOMICS, V15, P146, DOI 10.1006/geno.1993.1022; Edlund M, 2001, CELL GROWTH DIFFER, V12, P99; Ferdous Z, 2010, J BIOMED MATER RES A, V93A, P419, DOI 10.1002/jbm.a.32545; FIELD JK, 1995, BRIT J CANCER, V72, P1180, DOI 10.1038/bjc.1995.483; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goldoni S, 2008, AM J PATHOL, V173, P844, DOI 10.2353/ajpath.2008.080275; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang F, 1998, AM J PATHOL, V153, P1467, DOI 10.1016/S0002-9440(10)65734-3; Kim YR, 2010, GUT LIVER, V4, P149, DOI 10.5009/gnl.2010.4.1.149; Kimura M, 1998, CANCER RES, V58, P2456; Kinsella MG, 2000, J BIOL CHEM, V275, P13924, DOI 10.1074/jbc.275.18.13924; Koo SH, 1999, CANCER GENET CYTOGEN, V110, P87, DOI 10.1016/S0165-4608(98)00193-9; Lovat F, 2009, CARCINOGENESIS, V30, P861, DOI 10.1093/carcin/bgp050; Merle B, 1999, J CELL BIOCHEM, V75, P538; Monami G, 2006, CANCER RES, V66, P7103, DOI 10.1158/0008-5472.CAN-06-0633; Monami G, 2009, AM J PATHOL, V174, P1037, DOI 10.2353/ajpath.2009.080735; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; RABINOVITZ I, 1994, PROSTATE, V25, P97, DOI 10.1002/pros.2990250207; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Rijken AM, 1999, GENE CHROMOSOME CANC, V26, P185, DOI 10.1002/(SICI)1098-2264(199911)26:3<185::AID-GCC1>3.0.CO;2-9; Romano G, 2001, GENE THER, V8, P600, DOI 10.1038/sj.gt.3301441; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; SANTRA M, 1995, P NATL ACAD SCI USA, V92, P7016, DOI 10.1073/pnas.92.15.7016; Sattler HP, 1999, PROSTATE, V39, P79; Schmutte C, 1997, CANCER RES, V57, P3010; Schonherr E, 2001, J BIOL CHEM, V276, P40687, DOI 10.1074/jbc.M105426200; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Shi HY, 2001, CANCER RES, V61, P6945; Shiseki M, 1996, GENE CHROMOSOME CANC, V17, P71, DOI 10.1002/(SICI)1098-2264(199610)17:2<71::AID-GCC1>3.0.CO;2-Y; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tamura M, 1999, CANCER RES, V59, P442; Tirkkonen M, 1997, CANCER RES, V57, P1222; Tralhao JG, 2003, FASEB J, V17, P464, DOI 10.1096/fj.02-0534fje; Vecchione A, 2007, J EXP CLIN CANC RES, V26, P25; Vecchione A, 2002, AM J PATHOL, V160, P1345, DOI 10.1016/S0002-9440(10)62561-8; Vecchione A, 2009, ONCOGENE, V28, P257, DOI 10.1038/onc.2008.381; Xaus J, 2001, BLOOD, V98, P2124, DOI 10.1182/blood.V98.7.2124; Xu GX, 2002, BIOL REPROD, V67, P681, DOI 10.1095/biolreprod67.2.681	44	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19771	10.1371/journal.pone.0019771	http://dx.doi.org/10.1371/journal.pone.0019771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573075	Green Published, gold, Green Submitted			2022-12-25	WOS:000290305600047
J	Holme, P; Huss, M; Lee, SH				Holme, Petter; Huss, Mikael; Lee, Sang Hoon			Atmospheric Reaction Systems as Null-Models to Identify Structural Traces of Evolution in Metabolism	PLOS ONE			English	Article							LARGE-SCALE ORGANIZATION	The metabolism is the motor behind the biological complexity of an organism. One problem of characterizing its large-scale structure is that it is hard to know what to compare it to. All chemical reaction systems are shaped by the same physics that gives molecules their stability and affinity to react. These fundamental factors cannot be captured by standard null-models based on randomization. The unique property of organismal metabolism is that it is controlled, to some extent, by an enzymatic machinery that is subject to evolution. In this paper, we explore the possibility that reaction systems of planetary atmospheres can serve as a null-model against which we can define metabolic structure and trace the influence of evolution. We find that the two types of data can be distinguished by their respective degree distributions. This is especially clear when looking at the degree distribution of the reaction network (of reaction connected to each other if they involve the same molecular species). For the Earth's atmospheric network and the human metabolic network, we look into more detail for an underlying explanation of this deviation. However, we cannot pinpoint a single cause of the difference, rather there are several concurrent factors. By examining quantities relating to the modular-functional organization of the metabolism, we confirm that metabolic networks have a more complex modular organization than the atmospheric networks, but not much more. We interpret the more variegated modular arrangement of metabolism as a trace of evolved functionality. On the other hand, it is quite remarkable how similar the structures of these two types of networks are, which emphasizes that the constraints from the chemical properties of the molecules has a larger influence in shaping the reaction system than does natural selection.	[Holme, Petter; Lee, Sang Hoon] Umea Univ, Dept Phys, IceLab, Umea, Sweden; [Holme, Petter] Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea; [Huss, Mikael] Sci Life Lab Stockholm, Solna, Sweden; [Huss, Mikael] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Umea University; Sungkyunkwan University (SKKU); Stockholm University	Holme, P (corresponding author), Umea Univ, Dept Phys, IceLab, Umea, Sweden.	petter.holme@physics.umu.se	Holme, Petter/A-7646-2008	Holme, Petter/0000-0003-2156-1096; Huss, Mikael/0000-0003-0839-2451	Swedish Research Council; Ministry of Education, Science and Technology [R31-2008-000-10029-0]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	PH was supported by the Swedish Research Council and the World Class University program through National Research Foundation Korea funded by Ministry of Education, Science and Technology R31-2008-000-10029-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, NETWORKS INTRO NETWO, DOI DOI 10.1093/ACPROF:OSO/9780199206650.001.0001; Bethe HA, 1939, PHYS REV, V55, P0434, DOI 10.1103/PhysRev.55.434; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Holme P, 2003, BIOINFORMATICS, V19, P532, DOI 10.1093/bioinformatics/btg033; Holme P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016605; Holme P, 2010, CHINESE SCI BULL, V55, P3161, DOI 10.1007/s11434-010-4086-3; Holme P, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.034801; Huss M, 2007, IET SYST BIOL, V1, P280, DOI 10.1049/iet-syb:20060077; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Klamt S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000385; KREBS H. A., 1937, Enzymologia, V4, P148; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Miyake S, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P634; Serrano MA, 2010, ARXIV10083166; Sole RV, 2004, EUROPHYS LETT, V68, P170, DOI 10.1209/epl/i2004-10241-3; Veeramani B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-95; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Woodall J, 2007, ASTRON ASTROPHYS, V466, P1197, DOI 10.1051/0004-6361:20064981; Yung Y.L., 1999, PHOTOCHEMISTRY PLANE	24	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19759	10.1371/journal.pone.0019759	http://dx.doi.org/10.1371/journal.pone.0019759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573072	Green Published, gold, Green Submitted			2022-12-25	WOS:000290305600046
J	Rieder, F; Lopez, R; Franke, A; Wolf, A; Schleder, S; Dirmeier, A; Schirbel, A; Rosenstiel, P; Dotan, N; Schreiber, S; Rogler, G; Klebl, F				Rieder, Florian; Lopez, Rocio; Franke, Andre; Wolf, Alexandra; Schleder, Stephan; Dirmeier, Andrea; Schirbel, Anja; Rosenstiel, Philip; Dotan, Nir; Schreiber, Stefan; Rogler, Gerhard; Klebl, Frank			Characterization of Changes in Serum Anti-Glycan Antibodies in Crohn's Disease - a Longitudinal Analysis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; SACCHAROMYCES-CEREVISIAE ANTIBODIES; EVIDENCE-BASED CONSENSUS; TERM-FOLLOW-UP; SEROLOGICAL MARKERS; NOD2/CARD15 GENOTYPE; MICROBIAL ANTIGENS; DIAGNOSIS; BEHAVIOR	Introduction: Anti-glycan antibodies are a promising tool for differential diagnosis and disease stratification of patients with Crohn's disease (CD). We longitudinally assessed level and status changes of anti-glycan antibodies over time in individual CD patients as well as determinants of this phenomenon. Methods: 859 serum samples derived from a cohort of 253 inflammatory bowel disease (IBD) patients (207 CD, 46 ulcerative colitis (UC)) were tested for the presence of anti-laminarin (Anti-L), anti-chitin (Anti-C), anti-chitobioside (ACCA), anti-laminaribioside (ALCA), anti-mannobioside (AMCA) and anti-Saccharomyces cerevisiae (gASCA) antibodies by ELISA. All patients had at least two and up to eleven serum samples taken during the disease course. Results: Median follow-up time for CD was 17.4 months (Interquartile range (IQR) 8.0, 31.6 months) and for UC 10.9 months (IQR 4.9, 21.0 months). In a subgroup of CD subjects marked changes in the overall immune response (quartile sum score) and levels of individual markers were observed over time. The marker status (positive versus negative) remained widely stable. Neither clinical phenotype nor NOD2 genotype was associated with the observed fluctuations. In a longitudinal analysis neither changes in disease activity nor CD behavior led to alterations in the levels of the glycan markers. The ability of the panel to discriminate CD from UC or its association with CD phenotypes remained stable during follow-up. In the serum of UC patients neither significant level nor status changes were observed. Conclusions: While the levels of anti-glycan antibodies fluctuate in a subgroup of CD patients the antibody status is widely stable over time.	[Rieder, Florian; Wolf, Alexandra; Schleder, Stephan; Dirmeier, Andrea; Klebl, Frank] Univ Regensburg, Dept Internal Med 1, Regensburg, Germany; [Rieder, Florian; Schirbel, Anja] Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Rieder, Florian] Cleveland Clin Fdn, Dept Gastroenterol, Cleveland, OH 44195 USA; [Lopez, Rocio] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Franke, Andre; Rosenstiel, Philip; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Franke, Andre; Rosenstiel, Philip; Schreiber, Stefan] Univ Kiel, Dept Gen Internal Med, Kiel, Germany; [Dotan, Nir] Glycominds Ltd, Lod, Israel; [Rogler, Gerhard] Univ Zurich Hosp, Dept Internal Med, Clin Gastroenterol & Hepatol, Zurich, Switzerland	University of Regensburg; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Kiel; University of Kiel; University of Zurich; University Zurich Hospital	Rieder, F (corresponding author), Univ Regensburg, Dept Internal Med 1, Regensburg, Germany.	florian.rieder@t-online.de	Rosenstiel, Philip/A-5137-2009; Rogler, Gerhard/O-5308-2015; Franke, Andre/B-2151-2010	Rosenstiel, Philip/0000-0002-9692-8828; Rogler, Gerhard/0000-0002-1733-9188; Franke, Andre/0000-0003-1530-5811; Lopez, Ana Rocio/0000-0002-4319-420X; Schleder, Stephan/0000-0002-7785-3015	German Ministry of Education and Research (BMBF) via the Kompetenznetz "Chronisch entzundliche Darmerkrankungen''; DFG Excellence Cluster Inflammation at Interfaces; Deutsche Forschungsgemeinschaft (DFG)	German Ministry of Education and Research (BMBF) via the Kompetenznetz "Chronisch entzundliche Darmerkrankungen''(Federal Ministry of Education & Research (BMBF)); DFG Excellence Cluster Inflammation at Interfaces(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the German Ministry of Education and Research (BMBF) via the Kompetenznetz "Chronisch entzundliche Darmerkrankungen'', the DFG Excellence Cluster Inflammation at Interfaces and by the Deutsche Forschungsgemeinschaft (DFG) to F.R. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nir Dotan is employed by Glycominds Ltd. and was involved in study design and preparation of the manuscript.	Andres PG, 1999, GASTROENTEROL CLIN N, V28, P255, DOI 10.1016/S0889-8553(05)70056-X; Arnott IDR, 2004, AM J GASTROENTEROL, V99, P2376, DOI 10.1111/j.1572-0241.2004.40417.x; Bartunkova J, 2002, CLIN IMMUNOL, V102, P162, DOI 10.1006/clim.2001.5145; Desir B, 2004, CLIN GASTROENTEROL H, V2, P139, DOI 10.1016/S1542-3565(03)00321-5; Devlin SM, 2008, INFLAMM BOWEL DIS, V14, P125, DOI 10.1002/ibd.20292; Dotan I, 2006, GASTROENTEROLOGY, V131, P366, DOI 10.1053/j.gastro.2006.04.030; Dotan N, 2006, LUPUS, V15, P442, DOI 10.1191/0961203306lu2331oa; Dubinsky MC, 2008, CLIN GASTROENTEROL H, V6, P1105, DOI 10.1016/j.cgh.2008.04.032; Eser A, 2009, GASTROENTEROLOGY, V136, pA188; FARMER RG, 1985, GASTROENTEROLOGY, V88, P1818, DOI 10.1016/0016-5085(85)90006-X; Ferrante M, 2007, GUT, V56, P1394, DOI 10.1136/gut.2006.108043; Israeli E, 2005, GUT, V54, P1232, DOI 10.1136/gut.2004.060228; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; Oshitani N, 2000, J GASTROEN HEPATOL, V15, P1400, DOI 10.1046/j.1440-1746.2000.02357.x; Papp M, 2008, AM J GASTROENTEROL, V103, P665, DOI 10.1111/j.1572-0241.2007.01652.x; Rieder F, 2010, INFLAMM BOWEL DIS, V16, P1367, DOI 10.1002/ibd.21179; Rieder F, 2010, INFLAMM BOWEL DIS, V16, P263, DOI 10.1002/ibd.21046; Ruemmele FM, 1998, GASTROENTEROLOGY, V115, P822, DOI 10.1016/S0016-5085(98)70252-5; Seow CH, 2009, AM J GASTROENTEROL, V104, P1426, DOI 10.1038/ajg.2009.79; Simondi D, 2008, INFLAMM BOWEL DIS, V14, P645, DOI 10.1002/ibd.20368; Spivak J, 2006, INFLAMM BOWEL DIS, V12, P1122, DOI 10.1097/01.mib.0000235833.47423.d7; Stange EF, 2008, J CROHNS COLITIS, V2, P1, DOI 10.1016/j.crohns.2007.11.001; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Targan SR, 1999, INFLAMM BOWEL DIS, V5, P61, DOI 10.1097/00054725-199902000-00008; Teml A, 2003, AM J GASTROENTEROL, V98, P2226, DOI 10.1016/S0002-9270(03)00658-0; TEUBER M, 2005, JALA-J ASSOC LAB AUT, V10, P43	29	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e18172	10.1371/journal.pone.0018172	http://dx.doi.org/10.1371/journal.pone.0018172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573154	Green Published, Green Submitted, gold			2022-12-25	WOS:000290305600003
J	Soberon, J; Ceballos, G				Soberon, Jorge; Ceballos, Gerardo			Species Richness and Range Size of the Terrestrial Mammals of the World: Biological Signal within Mathematical Constraints	PLOS ONE			English	Article							NESTEDNESS TEMPERATURE; BIODIVERSITY HOTSPOTS; DIVERSITY; NULL; CONSERVATION; PATTERNS; MODELS	We explore global spatial diversity patterns for terrestrial mammals using as a tool range-diversity plots. These plots display simultaneously information about the number of species in localities and their spatial covariance in composition. These are highly informative, as we show by linking range-diversity plots with maps and by highlighting the correspondences between well defined regions of the plots with geographical regions or with taxonomic groups. Range-diversity plots are mathematically constrained by the lines of maximum and minimum mean covariance in species composition. We show how regions in the range-diversity plot corresponding to the line of maximum covariance correspond to large continental masses, and regions near the lower limit of the range-diversity plot correspond to archipelagos and mountain ranges. We show how curves of constant covariance correspond to nested faunas. Finally, we show that the observed distribution of the covariance range has significantly longer tails than random, with clear geographic correspondences. At the scale of our data we found that range-diversity plots reveal biodiversity patterns that cannot be replicated by null models, and correspond to conspicuous terrain features and taxonomic groupings.	[Soberon, Jorge] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Soberon, Jorge] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico	University of Kansas; University of Kansas; Universidad Nacional Autonoma de Mexico	Soberon, J (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.	jsoberon@ku.edu	Soberon, Jorge/ABF-1306-2021; Soberon, Jorge/N-7444-2015	Soberon, Jorge/0000-0003-2160-4148; Soberon, Jorge/0000-0003-2160-4148; Ceballos, Gerardo/0000-0001-8374-2656	National University of Mexico (UNAM)	National University of Mexico (UNAM)(Universidad Nacional Autonoma de Mexico)	The National Commission on Biodiversity supported J. Soberon by allowing him to allocate time for the organization of data and analyses of preliminary versions of this research. The National University of Mexico (UNAM) supported G. Ceballos with funds for traveling and paying technical personnel to assemble the database. These funders had no role in designing the study, the data collection or the analysis; nor on the decision to publish or the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2007, OIKOS, V116, P716, DOI 10.1111/j.2007.0030-1299.15803.x; Arita HT, 2008, AM NAT, V172, P519, DOI 10.1086/590954; Arita HT, 2005, J BIOGEOGR, V32, P961, DOI 10.1111/j.1365-2699.2005.01276.x; Austin MP, 1999, OIKOS, V86, P170, DOI 10.2307/3546582; Bell G, 2005, ECOLOGY, V86, P1757, DOI 10.1890/04-1028; Borregaard MK, 2010, ECOGRAPHY, V33, P402, DOI 10.1111/j.1600-0587.2010.06323.x; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Christen A., 2009, MISCELANEA MATEMATIC, V49, P51; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; EISENBERG JF, 1981, MAMMALIAN RAD ANLYSI; Fischer J, 2002, OIKOS, V99, P193, DOI 10.1034/j.1600-0706.2002.990121.x; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Godsoe W, 2010, SYST BIOL, V59, P298, DOI 10.1093/sysbio/syq005; Gotelli N., 2001, ECOSIM NULL MODELS S, V78, DOI 10.5281/zenodo.16504; Gotelli NJ, 2006, ECOGRAPHY, V29, P793, DOI 10.1111/j.2006.0906-7590.04714.x; Gotelli NJ, 2009, ECOL LETT, V12, P873, DOI 10.1111/j.1461-0248.2009.01353.x; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Graves GR, 2005, P NATL ACAD SCI USA, V102, P7871, DOI 10.1073/pnas.0500424102; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Jetz W, 2009, P ROY SOC B-BIOL SCI, V276, P269, DOI 10.1098/rspb.2008.1005; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Koleff P., 2008, CAPITAL NATURAL ME X; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lennon JJ, 2000, ECOGRAPHY, V23, P101, DOI 10.1034/j.1600-0587.2000.230111.x; Lomolino M., 1998, BIOGEOGRAPHY; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Rosenzwieg M.L., 1975, P121; SMITH C H, 1983, Evolutionary Theory, V6, P225; Udvardy MDF, 1969, DYNAMIC ZOOGEOGRAPHY; Villalobos F, 2010, GLOBAL ECOL BIOGEOGR, V19, P200, DOI 10.1111/j.1466-8238.2009.00503.x; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563	39	26	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19359	10.1371/journal.pone.0019359	http://dx.doi.org/10.1371/journal.pone.0019359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573112	gold, Green Published, Green Submitted			2022-12-25	WOS:000290305600021
J	Kong, GY; Zhang, JP; Zhang, S; Shan, CL; Ye, LH; Zhang, XD				Kong, Guangyao; Zhang, Junping; Zhang, Shuai; Shan, Changliang; Ye, Lihong; Zhang, Xiaodong			Upregulated MicroRNA-29a by Hepatitis B Virus X Protein Enhances Hepatoma Cell Migration by Targeting PTEN in Cell Culture Model	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; HEPATOCELLULAR-CARCINOMA; HBX PROTEIN; EXPRESSION; GENE; OVEREXPRESSION; MIR-29; GROWTH; CANCER; LOCUS	Hepatitis B virus X protein (HBx) plays important roles in the development of hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) contribute to cancer development by acting as oncogenes or tumor suppressors. Previously, we reported that HBx was able to promote the migration of hepatoma HepG2 cells. However, the regulation of miRNAs in the development of HBV-related HCC is poorly understood. In the present study, we reported that miR-29a was a novel regulator of migration of hepatoma cells mediated by HBx. Our data showed that the expression of miR-29a was dramatically increased in p21-HBx transgenic mice, HBx-transfected hepatoma HepG2-X (or H7402-X) cells and HepG2.2.15 cells that constitutively replicate HBV. However, our data showed that miR-29a was upregulated in 4 of the 11 clinical HCC samples. We found that the overexpression of miR-29a promoted the migration of HepG2 cells, while a specific miR-29a inhibitor could partially abolish the enhanced migration of HepG2-X cells. Moreover, we identified PTEN was one of the target genes of miR-29a in HepG2 cells. The deletion of the miR-29a-binding site was able to abolish the role of miR-29a in suppression of luciferase activity of the PTEN 3'UTR reporter. Meanwhile, the overexpression of PTEN was able to reverse the promoted migration of HepG2 cells mediated by miR-29a. Moreover, our data showed that the modulation of Akt phosphorylation, a downstream factor of PTEN, was involved in the cell migration enhanced by miR-29a, suggesting that miR-29a is responsible for the cell migration through its target gene PTEN. Thus, we conclude that miR-29a is involved in the regulation of migration of hepatoma cells mediated by HBx through PTEN in cell culture model.	[Kong, Guangyao; Zhang, Junping; Zhang, Shuai; Shan, Changliang; Zhang, Xiaodong] Nankai Univ, Key Lab Mol Microbiol & Technol, Minist Educ, Dept Canc Res,Inst Mol Biol,Coll Life Sci, Tianjin 300071, Peoples R China; [Ye, Lihong] Nankai Univ, Dept Biochem, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Kong, GY (corresponding author), Nankai Univ, Key Lab Mol Microbiol & Technol, Minist Educ, Dept Canc Res,Inst Mol Biol,Coll Life Sci, Tianjin 300071, Peoples R China.	yelihong@nankai.edu.cn; zhangxd@nankai.edu.cn	Kong, Guangyao/L-2162-2013; Shan, changliang/L-9029-2016	Zhang, Shuai/0000-0003-0272-0856	National Basic Research Program of China (973 Program) [2007CB914804, 2007CB914802, 2009CB521702]; National Natural Science Foundation of China [30670959, 81000870]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China (973 Program; nos. 2007CB914804, 2007CB914802, and 2009CB521702) and the National Natural Science Foundation of China (nos. 30670959 and 81000870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chung TW, 2003, CANCER RES, V63, P3453; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010350; Dey N, 2008, CANCER RES, V68, P1862, DOI 10.1158/0008-5472.CAN-07-1182; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Goswami S, 2010, J BIOL CHEM, V285, P20532, DOI 10.1074/jbc.M110.109298; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Katome T, 2003, J BIOL CHEM, V278, P28312, DOI 10.1074/jbc.M302094200; Lara-Pezzi E, 2001, J HEPATOL, V34, P409, DOI 10.1016/S0168-8278(00)00090-8; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Liu Y, 2010, HYPERTENSION, V55, P974, DOI 10.1161/HYPERTENSIONAHA.109.144428; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; McGlynn KA, 2005, BEST PRACT RES CL GA, V19, P3, DOI 10.1016/j.bpg.2004.10.004; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Qin XR, 2007, TRANSL RES, V150, P281, DOI 10.1016/j.trsl.2007.06.005; Santanam U, 2010, P NATL ACAD SCI USA, V107, P12210, DOI 10.1073/pnas.1007186107; Steele Robert, 2010, Genes Cancer, V1, P381; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Wan XW, 2003, J CANCER RES CLIN, V129, P100, DOI 10.1007/s00432-002-0410-x; Wang Q, 2010, NEOPLASIA, V12, P103, DOI 10.1593/neo.91298; Wang YL, 2004, HEPATOLOGY, V39, P318, DOI 10.1002/hep.20076; Xia LM, 2009, VIROLOGY, V385, P335, DOI 10.1016/j.virol.2008.11.042; You JC, 2009, ENDOCRINOLOGY, V150, P1607, DOI 10.1210/en.2008-0616; Zhang F, 2010, J MED VIROL, V82, P920, DOI 10.1002/jmv.21753; Zhang WY, 2009, ACTA PHARMACOL SIN, V30, P1153, DOI 10.1038/aps.2009.99; Zhang XD, 2006, J LAB CLIN MED, V147, P58, DOI 10.1016/j.lab.2005.10.003; Zhang XD, 2005, J MED VIROL, V77, P374, DOI 10.1002/jmv.20466; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008	42	148	162	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19518	10.1371/journal.pone.0019518	http://dx.doi.org/10.1371/journal.pone.0019518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573166	gold, Green Submitted, Green Published			2022-12-25	WOS:000290256400017
J	Phillips, M; Boman, E; Osterman, H; Willhite, D; Laska, M				Phillips, Matthew; Boman, Erik; Osterman, Hanna; Willhite, David; Laska, Matthias			Olfactory and Visuospatial Learning and Memory Performance in Two Strains of Alzheimer's Disease Model Mice-A Longitudinal Study	PLOS ONE			English	Article							APPSWE/PS1DE9 MOUSE MODEL; AGE-RELATED-CHANGES; CD-1 MICE; TRANSGENIC MICE; DISCRIMINATION ABILITY; ALIPHATIC-ALDEHYDES; ODOR DISCRIMINATION; SPIDER MONKEYS; SENSITIVITY; DEFICITS	Using a longitudinal study design, two strains of Alzheimer's disease ( AD) model mice, one expressing beta-amyloid plaques and one expressing Tau protein-associated neurofibrillary tangles were assessed for olfactory and visuospatial learning and memory and their performance compared to that of age-matched controls. No significant difference between AD and control mice was found in the initial set of olfactory tasks performed at 6 months of age whereas both strains of AD mice performed significantly poorer than the controls in visuospatial learning at this age. Subsequent tests performed on the same individual animals at 7, 8, 9, 11, 13, 15, and 18 months of age also failed to find systematic differences in olfactory performance between AD and control mice. In contrast, the AD mice performed consistently poorer than the controls in visuospatial re-learning tests performed at these ages. With most olfactory tasks, both AD and control mice displayed a marked decrease in performance between testing at 15 and 18 months of age. These results show that the two strains of AD model mice do not display an olfactory impairment in a time course consistent with human AD, but are impaired in visuospatial capabilities. The marked age-related changes observed with the olfactory tasks in both AD and control mice suggest that the observed lack of an AD-related olfactory impairment is not due to an insensitivity of the tests employed. Rather, they suggest that the olfactory system of the two AD mouse model strains may be surprisingly robust against AD-typical neuropathologies.	[Phillips, Matthew; Willhite, David] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06511 USA; [Phillips, Matthew] Yale Univ, Dept Phys, New Haven, CT USA; [Boman, Erik; Osterman, Hanna; Laska, Matthias] Linkoping Univ, Dept Phys Chem & Biol, Sect Zool, Linkoping, Sweden	Yale University; Yale University; Linkoping University	Phillips, M (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06511 USA.	malas@ifm.liu.se		Boman, Erik Maitz/0000-0003-1935-2682; Laska, Matthias/0000-0001-5583-2697	National Institute on Deafness and other Communication Disorders (NIDCD) [R01 DC000086, R03 DC008874]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000086, R03DC008874] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and other Communication Disorders (NIDCD) R01 DC000086 (Gordon M. Shepherd) and R03 DC008874 (David Willhite). URL of the funder's website: www.nidcd.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Boon WC, 2010, BEHAV BRAIN RES, V209, P27, DOI 10.1016/j.bbr.2010.01.013; Costanzo RM, 2010, CHEM SENSES, V35, P417, DOI 10.1093/chemse/bjq029; deIpolyi AR, 2008, NEUROBIOL AGING, V29, P253, DOI 10.1016/j.neurobiolaging.2006.10.021; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Forster S, 2010, J ALZHEIMERS DIS, V22, P581, DOI 10.3233/JAD-2010-091549; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Hedner M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00024; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Joshi D, 2006, CHEM SENSES, V31, P655, DOI 10.1093/chemse/bjl006; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Laska M, 2007, NEUROSCIENCE, V144, P295, DOI 10.1016/j.neuroscience.2006.08.063; Laska M, 2006, BEHAV BRAIN RES, V167, P349, DOI 10.1016/j.bbr.2005.09.022; Laska M, 2008, J COMP PHYSIOL A, V194, P971, DOI 10.1007/s00359-008-0370-y; Laska M, 2007, J COMP PHYSIOL A, V193, P955, DOI 10.1007/s00359-007-0248-4; Laska M, 2009, J EXP ZOOL PART A, V311A, P278, DOI 10.1002/jez.527; Macknin JB, 2004, BRAIN RES, V1000, P174, DOI 10.1016/j.brainres.2004.01.047; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Mirich JM, 2002, J COMP NEUROL, V454, P361, DOI 10.1002/cne.10426; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Murphy C, 2001, ALZHEIMER'S DISEASE, P237, DOI 10.1002/0470846453.ch22; O'Leary TP, 2009, BEHAV BRAIN RES, V201, P120, DOI 10.1016/j.bbr.2009.01.039; Patel RC, 2009, NEUROBIOL AGING, V30, P829, DOI 10.1016/j.neurobiolaging.2007.08.007; Rosli Y, 1999, J ELECTRON MICROSC, V48, P77, DOI 10.1093/oxfordjournals.jmicro.a023653; Shimshek DR, 2005, PLOS BIOL, V3, P2017, DOI 10.1371/journal.pbio.0030354; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Vloeberghs E, 2008, BEHAV NEUROSCI, V122, P491, DOI 10.1037/0735-7044.122.3.491; Volianskis A, 2010, NEUROBIOL AGING, V31, P1173, DOI 10.1016/j.neurobiolaging.2008.08.005; Weast RC., 1987, HDB CHEM PHYS, V68; Wersinger SR, 2007, GENES BRAIN BEHAV, V6, P540, DOI 10.1111/j.1601-183X.2006.00281.x; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Wilcock DM, 2010, CNS NEUROL DISORD-DR, V9, P386; Zhuo JM, 2008, CURR ALZHEIMER RES, V5, P385, DOI 10.2174/156720508785132280	39	29	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19567	10.1371/journal.pone.0019567	http://dx.doi.org/10.1371/journal.pone.0019567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573167	gold, Green Published, Green Submitted			2022-12-25	WOS:000290256400025
J	Rantamaki, AH; Seppanen-Laakso, T; Oresic, M; Jauhiainen, M; Holopainen, JM				Rantamaki, Antti H.; Seppanen-Laakso, Tuulikki; Oresic, Matej; Jauhiainen, Matti; Holopainen, Juha M.			Human Tear Fluid Lipidome: From Composition to Function	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; INDUCED OXIDATION; NONPOLAR LIPIDS; HUMAN MEIBUM; QUANTIFICATION; CHROMATOGRAPHY; TISSUES	We have explored human aqueous tear fluid lipidome with an emphasis to identify the major lipids. We also address the physiological significance of the lipidome. The tears were analysed using thin layer chromatographic, enzymatic and mass spectrometric techniques. To emphasize the physiological aspect of the lipidome, we modelled the spreading of the non-polar tear fluid lipids at air-water interface in macroscopic scale with olive oil and egg yolk phosphatidylcholine. Based on enzymatic analysis the respective concentrations of choline-containing lipids, triglycerides, and cholesteryl esters were 48 +/- 14, 10 +/- 0, and 21 +/- 18 mu M. Ultra performance liquid chromatography quadrupole time of flight mass spectrometry analysis showed that phosphatidylcholine and phosphatidylethanolamine were the two most common polar lipids comprising 88 +/- 6% of all identified lipids. Triglycerides were the only non-polar lipids detected in mass spectrometric analysis i.e. no cholesteryl or wax esters were identified. The spreading experiments show that the presence of polar lipids is an absolute necessity for a proper spreading of non-polar tear fluid lipids. We provide evidence that polar lipids are the most common lipid species. Furthermore, we provide a physiological rationale for the observed lipid composition. The results open insights into the functional role of lipids in the tear fluid and also aids in providing new means to understand and treat diseases of the ocular surface.	[Rantamaki, Antti H.; Holopainen, Juha M.] Univ Helsinki, Dept Ophthalmol, Helsinki Eye Lab, Helsinki, Finland; [Seppanen-Laakso, Tuulikki; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland; [Jauhiainen, Matti] Natl Inst Hlth & Welf, Helsinki, Finland; [Jauhiainen, Matti] FIMM Inst Mol Med Finland, Helsinki, Finland	University of Helsinki; VTT Technical Research Center Finland; Finland National Institute for Health & Welfare	Rantamaki, AH (corresponding author), Univ Helsinki, Dept Ophthalmol, Helsinki Eye Lab, Helsinki, Finland.	juha.holopainen@hus.fi	Oresic, Matej/K-7673-2016; Oresic, Matej/AAV-3978-2020; Rantamäki, Antti H/L-6565-2018	Oresic, Matej/0000-0002-2856-9165; Rantamäki, Antti H/0000-0001-8490-6069	Finnish Eye Foundation; Academy of Finland; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation	Finnish Eye Foundation; Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	The Finnish Eye Foundation (JMH), the Academy of Finland (JMH), the Finnish Foundation for Cardiovascular Research (MJ), and Sigrid Juselius Foundation (MJ, JMH) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butovich IA, 2008, INVEST OPHTH VIS SCI, V49, P3779, DOI 10.1167/iovs.08-1889; Butovich IA, 2008, CURR EYE RES, V33, P405, DOI 10.1080/02713680802018419; Butovich IA, 2009, J LIPID RES, V50, P501, DOI 10.1194/jlr.M800426-JLR200; Chen JZ, 2010, INVEST OPHTH VIS SCI, V51, P6220, DOI 10.1167/iovs.10-5687; de Souza GA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r72; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ham BM, 2005, ANAL CHEM, V77, P4439, DOI 10.1021/ac058000a; Ham BM, 2004, J MASS SPECTROM, V39, P1321, DOI 10.1002/jms.725; Jiang XT, 2007, RAPID COMMUN MASS SP, V21, P141, DOI 10.1002/rcm.2820; Khanal S, 2010, NANOMED-NANOTECHNOL, V6, P707, DOI 10.1016/j.nano.2010.06.002; Kulovesi P, 2010, BIOPHYS J, V99, P2559, DOI 10.1016/j.bpj.2010.08.001; Laaksonen R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000097; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; McCulley J P, 1997, Trans Am Ophthalmol Soc, V95, P79; Medina-Gomez G, 2005, DIABETES, V54, P1706, DOI 10.2337/diabetes.54.6.1706; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Morandat S, 2003, BBA-BIOMEMBRANES, V1616, P137, DOI 10.1016/j.bbamem.2003.08.001; Murphy RC, 2001, CHEM RES TOXICOL, V14, P463, DOI 10.1021/tx000250t; Nygren H, 2011, METHODS MOL BIOL, V708, P247, DOI 10.1007/978-1-61737-985-7_15; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; RANTAMAKI AH, 2011, PROG RETIN IN PRESS; Saari KM, 2001, INVEST OPHTH VIS SCI, V42, P318; SAVILLE JT, 2010, EXP EYE RES IN PRESS; Tiffany JM., 1997, BIOCH EYE, P45; WHIKEHART DR, 2004, BIOCH EYE, P11; WOLLENSAK G, 1990, GRAEF ARCH CLIN EXP, V228, P78, DOI 10.1007/BF02764296; Yetukuri L, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-12	29	99	99	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19553	10.1371/journal.pone.0019553	http://dx.doi.org/10.1371/journal.pone.0019553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573170	Green Submitted, gold, Green Published			2022-12-25	WOS:000290256400022
J	Chen, Y; Sanchez, A; Rubio, ME; Kohl, T; Pardo, LA; Stuhmer, W				Chen, Ye; Sanchez, Araceli; Rubio, Maria E.; Kohl, Tobias; Pardo, Luis A.; Stuehmer, Walter			Functional K(v)10.1 Channels Localize to the Inner Nuclear Membrane	PLOS ONE			English	Article							GO POTASSIUM CHANNEL; INTRACELLULAR TRAFFICKING; ION CHANNELS; ABERRANT EXPRESSION; MAMMALIAN-CELLS; CANCER PATIENTS; PROTEIN; ENVELOPE; EAG1; ETHER	Ectopically expressed human K(v)10.1 channels are relevant players tumor biology. However, their function as ion channel at the plasma membrane does not totally explain their crucial role in tumors. Both in native and heterologous systems, it has been observed that a majority of K(v)10.1 channels remain at intracellular locations. In this study we investigated localization and possible roles of perinuclear K(v)10.1. We show that K(v)10.1 is expressed at the inner nuclear membrane in both human and rat models; it co-purifies with established inner nuclear membrane markers, shows resistance to detergent extraction and restricted mobility, all of them typical features of proteins at the inner nuclear membrane. K(v)10.1 channels at he inner nuclear membrane are not all transported directly from the ER but rather have been exposed to the extracellular millieu. Patch clamp experiments on nuclei devoid of external nuclear membrane reveal the existence of channel activity h K(v)10.1. We hypothesize that K(v)10.1 channels at the nuclear envelope might participate in the homeostasis indirectly interact with heterochromatin, both factors known to affect gene expression.	[Chen, Ye; Sanchez, Araceli; Rubio, Maria E.; Kohl, Tobias; Pardo, Luis A.; Stuehmer, Walter] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany; [Rubio, Maria E.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	Max Planck Society; University of Connecticut	Chen, Y (corresponding author), Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, Hermann Rein Str 3, D-37075 Gottingen, Germany.	pardo@em.mpg.de; ws@em.mpg.de	Stuehmer, Walter/A-2176-2009; Pardo, Luis/C-5066-2013	Stuehmer, Walter/0000-0002-0642-7764; Pardo, Luis/0000-0003-1375-4349	Max-Planck Gesselschaft; NEUREST [MEST-CT-2004-504193, R01 DC-006881]	Max-Planck Gesselschaft; NEUREST	This work was supported by Max-Planck Gesselschaft, NEUREST (MEST-CT-2004-504193), R01 DC-006881. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Agarwal JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-18; Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; BAILER SM, 1991, J CELL BIOL, V114, P389, DOI 10.1083/jcb.114.3.389; Bengtsson L, 2008, J CELL SCI, V121, P536, DOI 10.1242/jcs.019281; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bootman MD, 2009, J CELL SCI, V122, P2337, DOI 10.1242/jcs.028100; Brachner A, 2005, J CELL SCI, V118, P5797, DOI 10.1242/jcs.02701; BUSTAMANTE JO, 1993, BIOPHYS J, V64, P1735, DOI 10.1016/S0006-3495(93)81545-5; BUSTAMANTE JO, 1995, J MEMBRANE BIOL, V146, P239; Bustamante JO, 2006, CAN J PHYSIOL PHARM, V84, P347, DOI 10.1139/Y05-096; de Queiroz FM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-42; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Diaz L, 2009, CANCER RES, V69, P3300, DOI 10.1158/0008-5472.CAN-08-2036; Ding XW, 2008, DIGEST DIS SCI, V53, P2039, DOI 10.1007/s10620-007-0116-7; Ding XW, 2007, MED ONCOL, V24, P345, DOI 10.1007/s12032-007-0015-y; Ding XW, 2007, WORLD J GASTROENTERO, V13, P1257, DOI 10.3748/wjg.v13.i8.1257; Douyard J, 2007, J COMP NEUROL, V502, P141, DOI 10.1002/cne.21294; Downie BR, 2008, J BIOL CHEM, V283, P36234, DOI 10.1074/jbc.M801830200; Dyer JA, 1997, CHROMOSOME RES, V5, P383, DOI 10.1023/A:1018496309156; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Fedorenko O, 2010, PFLUG ARCH EUR J PHY, V460, P1045, DOI 10.1007/s00424-010-0882-5; FURUKAWA K, 1995, EMBO J, V14, P1626, DOI 10.1002/j.1460-2075.1995.tb07151.x; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0306s07, 10.1002/0471143030.cb0309s10]; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; Hegle AP, 2006, P NATL ACAD SCI USA, V103, P2886, DOI 10.1073/pnas.0505909103; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Hieda M, 2008, J CELL BIOL, V180, P763, DOI 10.1083/jcb.200710022; Hofemeister H, 2005, J BIOL CHEM, V280, P2512, DOI 10.1074/jbc.M410504200; Hoffman JF, 2005, P NATL ACAD SCI USA, V102, P921, DOI 10.1073/pnas.0408597102; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; HOZAK P, 1995, J CELL SCI, V108, P635; KOCSIS E, 1991, J STRUCT BIOL, V107, P6, DOI 10.1016/1047-8477(91)90025-R; KOWARSKI D, 1985, J PHYSIOL-LONDON, V366, P153, DOI 10.1113/jphysiol.1985.sp015790; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Lizak B, 2008, MOL MEMBR BIOL, V25, P95, DOI 10.1080/09687680701670481; Longin AS, 1997, BIOCHEM BIOPH RES CO, V235, P236, DOI 10.1006/bbrc.1997.6752; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; Maeshima K, 2006, J CELL SCI, V119, P4442, DOI 10.1242/jcs.03207; Makatsori D, 2004, J BIOL CHEM, V279, P25567, DOI 10.1074/jbc.M313606200; Marchenko SM, 2005, J PHYSIOL-LONDON, V565, P897, DOI 10.1113/jphysiol.2004.081299; Martin S, 2008, NEUROSCIENCE, V155, P833, DOI 10.1016/j.neuroscience.2008.05.019; MAZZANTI M, 1990, NATURE, V343, P764, DOI 10.1038/343764a0; Mazzanti M, 2001, PHYSIOL REV, V81, P1, DOI 10.1152/physrev.2001.81.1.1; Napp J, 2005, J BIOL CHEM, V280, P29506, DOI 10.1074/jbc.M504228200; Ostlund C, 1999, J CELL SCI, V112, P1709; Ousingsawat J, 2007, CLIN CANCER RES, V13, P824, DOI 10.1158/1078-0432.CCR-06-1940; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pezer Z, 2008, SEMIN CANCER BIOL, V18, P123, DOI 10.1016/j.semcancer.2008.01.003; Rolls MM, 1999, J CELL BIOL, V146, P29, DOI 10.1083/jcb.146.1.29; ROSENBERGER U, 1995, J CELL BIOCHEM, V59, P177, DOI 10.1002/jcb.240590207; Rousseau E, 1996, BIOPHYS J, V70, P703, DOI 10.1016/S0006-3495(96)79610-8; Roy J, 2008, ONCOL REP, V19, P1511; SCHINDLER M, 1984, EXP CELL RES, V150, P84, DOI 10.1016/0014-4827(84)90704-3; SCHINDLER M, 1985, J CELL BIOL, V100, P1408, DOI 10.1083/jcb.100.5.1408; Schirmer EC, 2005, TRENDS BIOCHEM SCI, V30, P551, DOI 10.1016/j.tibs.2005.08.003; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Schirmer EC, 2007, EXP CELL RES, V313, P2167, DOI 10.1016/j.yexcr.2007.03.012; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Turgay Y, 2010, EMBO J, V29, P2262, DOI 10.1038/emboj.2010.119; WADHWA S, 2008, INT UROL NEPHROL; Wu W, 2002, J CELL SCI, V115, P1361	75	35	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19257	10.1371/journal.pone.0019257	http://dx.doi.org/10.1371/journal.pone.0019257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559285	Green Published, Green Submitted, gold			2022-12-25	WOS:000290223500014
J	Schuetz, J				Schuetz, Justin			Reproductive Declines in an Endangered Seabird: Cause for Concern or Signs of Conservation Success?	PLOS ONE			English	Article							CALIFORNIA LEAST TERN; COMMON TERNS; FOOD; IMPROVEMENT; ECOLOGY	Collection and analysis of demographic data play a critical role in monitoring and management of endangered taxa. I analyzed long-term clutch size and fledgling productivity data for California least tern (Stemula antillarum browni), a federally endangered subspecies that has recently become a candidate for down-listing. While the breeding population grew from approximately 1,253 to 7,241 pairs (578%) during the study period (1988-2009) both clutch size and fledgling productivity declined. Clutch size decreased by approximately 0.27 eggs (14%) from 1990-2004 then showed a moderate increase of 0.11 eggs from 2004-2009. Estimates of fledgling productivity showed a similar pattern of decline and moderate increase even after controlling for clutch size. Sea surface temperature anomalies, an index of El Nino-Southern Oscillation activity, did not influence clutch size but were associated with fledgling productivity through a non-linear relationship. Both clutch size and fledgling productivity increased with latitude, potentially indicating a gradient of life-history trade-offs. Random site effects explained little of the overall variation in dutch size (3%) or fledgling productivity (< 1%) suggesting that site characteristics beyond those associated with latitude had little bearing on either measure of reproduction. Despite intensive monitoring and management, causes of variation in key demographic parameters remain poorly understood. Long-term declines in clutch size and fledgling productivity may reflect: 1) reduced food availability, 2) increased density-dependent competition, and/or 3) age-dependent reproduction coupled with a shifting population age-structure. Until the mechanisms shaping demographic parameters and population change are better understood, the success of past management and the probability of ongoing recovery will remain difficult to characterize.	Audubon Calif, Emeryville, CA 94608 USA		Schuetz, J (corresponding author), Audubon Calif, Emeryville, CA 94608 USA.	justinschuetz@gmail.com						Anderson SK, 2007, ESTUAR COAST SHELF S, V73, P447, DOI 10.1016/j.ecss.2007.02.006; [Anonymous], 2010, R LANG ENV STAT COMP; Ardia DR, 2005, ECOLOGY, V86, P2040, DOI 10.1890/04-1619; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Atwood J., 1983, Western Birds, V14, P57; ATWOOD JL, 1984, WILSON BULL, V96, P34; Ballance LT, 2009, J AVIAN BIOL, V40, P279, DOI 10.1111/j.1600-048X.2008.04538.x; Bates D., 2010, IME4 LINEAR MIXED EF; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; BIRT VL, 1987, MAR ECOL PROG SER, V40, P205, DOI 10.3354/meps040205; Both C, 2000, ECOLOGY, V81, P3391, DOI 10.2307/177502; Cane MA, 2005, EARTH PLANET SC LETT, V230, P227, DOI 10.1016/j.epsl.2004.12.003; Caswell H, 2000, MATRIX POPULATION MO, V2nd; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Elliotr ML, 2007, WATERBIRDS, V30, P317, DOI 10.1675/1524-4695(2007)030[0317:BBASOT]2.0.CO;2; Galbraith H, 1999, J AVIAN BIOL, V30, P85, DOI 10.2307/3677247; Haussmann MF, 2008, MOL ECOL RESOUR, V8, P264, DOI 10.1111/j.1471-8286.2007.01973.x; Haussmann MF, 2003, EXP GERONTOL, V38, P787, DOI 10.1016/S0531-5565(03)00109-8; Horn T, 2010, HEREDITY, V105, P497, DOI 10.1038/hdy.2010.113; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Lewis S, 2006, OECOLOGIA, V147, P606, DOI 10.1007/s00442-005-0321-z; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; Limmer B, 2009, ANIM BEHAV, V77, P1095, DOI 10.1016/j.anbehav.2009.01.015; MASSEY BW, 1981, AUK, V98, P596; MASSEY BW, 1992, CONDOR, V94, P976, DOI 10.2307/1369293; MONAGHAN P, 1989, J ANIM ECOL, V58, P261, DOI 10.2307/4999; Moore DJ, 2000, J AVIAN BIOL, V31, P183, DOI 10.1034/j.1600-048X.2000.310210.x; MOREAU R. E., 1944, IBIS, V86, P286, DOI 10.1111/j.1474-919X.1944.tb04093.x; Nisbet ICT, 2002, J FIELD ORNITHOL, V73, P117, DOI 10.1648/0273-8570-73.2.117; Rebke M, 2010, P NATL ACAD SCI USA, V107, P7841, DOI 10.1073/pnas.1002645107; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Wendeln H, 2000, BEHAV ECOL SOCIOBIOL, V47, P382, DOI 10.1007/s002650050681; Winkler D.W., 1983, Current Ornithology, V1, P33; Wood SN, 2008, J R STAT SOC B, V70, P495, DOI 10.1111/j.1467-9868.2007.00646.x; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Xue Y, 2003, J CLIMATE, V16, P1601, DOI 10.1175/1520-0442-16.10.1601; Zuur Alain F., 2009, P1; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	47	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19489	10.1371/journal.pone.0019489	http://dx.doi.org/10.1371/journal.pone.0019489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559287	Green Published, Green Submitted, gold			2022-12-25	WOS:000290223500024
J	Warr, N; Bogani, D; Siggers, P; Brixey, R; Tateossian, H; Dopplapudi, A; Wells, S; Cheeseman, M; Xia, Y; Ostrer, H; Greenfield, A				Warr, Nick; Bogani, Debora; Siggers, Pam; Brixey, Rachel; Tateossian, Hilda; Dopplapudi, Asha; Wells, Sara; Cheeseman, Michael; Xia, Ying; Ostrer, Harry; Greenfield, Andy			Minor Abnormalities of Testis Development in Mice Lacking the Gene Encoding the MAPK Signalling Component, MAP3K1	PLOS ONE			English	Article							SEXUALLY DIMORPHIC EXPRESSION; SRY-RELATED GENE; MEK KINASE 1; 46,XY GONADAL-DYSGENESIS; AUTOSOMAL SEX REVERSAL; MOUSE GONAD; CAMPOMELIC DYSPLASIA; CELL-MIGRATION; SERTOLI-CELLS; DIFFERENTIATION	In mammals, the Y chromosome is a dominant male determinant, causing the bipotential gonad to develop as a testis. Recently, cases of familial and spontaneous 46,XY disorders of sex development (DSD) have been attributed to mutations in the human gene encoding mitogen-activated protein kinase kinase kinase 1, MAP3K1, a component of the mitogen-activated protein kinase (MAPK) signal transduction pathway. In individuals harbouring heterozygous mutations in MAP3K1, dysregulation of MAPK signalling was observed in lymphoblastoid cell lines, suggesting a causal role for these mutations in disrupting XY sexual development. Mice lacking the cognate gene, Map3k1, are viable and exhibit the eyes open at birth (EOB) phenotype on a mixed genetic background, but on the C57BL/6J genetic background most mice die at around 14.5 dpc due to a failure of erythropoiesis in the fetal liver. However, no systematic examination of sexual development in Map3k1-deficient mice has been described, an omission that is especially relevant in the case of C57BL/6J, a genetic background that is sensitized to disruptions to testis determination. Here, we report that on a mixed genetic background mice lacking Map3k1 are fertile and exhibit no overt abnormalities of testis development. On C57BL/6J, significant non-viability is observed with very few animals surviving to adulthood. However, an examination of development in Map3k1-deficient XY embryos on this genetic background revealed no significant defects in testis determination, although minor abnormalities were observed, including an increase in gonadal length. Based on these observations, we conclude that MAP3K1 is not required for mouse testis determination. We discuss the significance of these data for the functional interpretation of sex-reversing MAP3K1 mutations in humans.	[Warr, Nick; Bogani, Debora; Siggers, Pam; Brixey, Rachel; Tateossian, Hilda; Dopplapudi, Asha; Cheeseman, Michael; Greenfield, Andy] MRC, Mammalian Genet Unit, Harwell, Berks, England; [Wells, Sara; Cheeseman, Michael] MRC, Mary Lyon Ctr, Harwell, Berks, England; [Xia, Ying] Univ Cincinnati, Sch Med, Dept Environm Hlth, Cincinnati, OH USA; [Xia, Ying] Univ Cincinnati, Sch Med, Ctr Environm Genet, Cincinnati, OH USA; [Ostrer, Harry] NYU, Sch Med, Human Genet Program, New York, NY USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; New York University	Warr, N (corresponding author), MRC, Mammalian Genet Unit, Harwell, Berks, England.	a.greenfield@har.mrc.ac.uk	Greenfield, Andy/F-5099-2017	Greenfield, Andy/0000-0002-1477-1776; Warr, Nick/0000-0003-0767-1360; Xia, Ying/0000-0001-9532-9527	Medical Research Council [U.1426.00.004.00001.01]; MRC [MC_U142670371, MC_UP_1502/1, MC_U142684167] Funding Source: UKRI; Medical Research Council [MC_U142670371, MC_UP_1502/1, MC_U142684167] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by core funding from the Medical Research Council to AG at the Mammalian Genetics Unit (U.1426.00.004.00001.01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Bagheri-Fam S, 2008, DEV BIOL, V314, P71, DOI 10.1016/j.ydbio.2007.11.010; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Bogani D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000196; Bonnesen B, 2005, BLOOD, V106, P3396, DOI 10.1182/blood-2005-04-1739; Bouma GJ, 2007, P NATL ACAD SCI USA, V104, P14994, DOI 10.1073/pnas.0701677104; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; Chi HB, 2005, P NATL ACAD SCI USA, V102, P3846, DOI 10.1073/pnas.0500026102; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Cox S, 2006, MOL REPROD DEV, V73, P1008, DOI 10.1002/mrd.20507; Craig EA, 2008, DEV DYNAM, V237, P3102, DOI 10.1002/dvdy.21750; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; ESPINER EA, 1970, NEW ENGL J MED, V283, P6, DOI 10.1056/NEJM197007022830102; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Grimmond S, 2000, HUM MOL GENET, V9, P1553, DOI 10.1093/hmg/9.10.1553; Hiramatsu R, 2010, DEVELOPMENT, V137, P303, DOI 10.1242/dev.040519; Hubner A, 2010, MOL CELL BIOL, V30, P98, DOI 10.1128/MCB.01155-09; Jawaheer D, 2003, CLIN GENET, V63, P530, DOI 10.1034/j.1399-0004.2003.00082.x; Johnson NL, 1996, J BIOL CHEM, V271, P3229, DOI 10.1074/jbc.271.6.3229; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Karl J, 1998, DEV BIOL, V203, P323, DOI 10.1006/dbio.1998.9068; Kim Y, 2007, P NATL ACAD SCI USA, V104, P16558, DOI 10.1073/pnas.0702581104; Le Caignec C, 2003, AM J MED GENET A, V116A, P37, DOI 10.1002/ajmg.a.10820; Lee PA, 2006, PEDIATRICS, V118, pE488, DOI 10.1542/peds.2006-0738; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Moniot B, 2009, DEVELOPMENT, V136, P1813, DOI 10.1242/dev.032631; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; OSTER H, 2008, GENEREVIEWS GENETEST; Ostrer H, 2001, CLIN GENET, V59, P207, DOI 10.1034/j.1399-0004.2001.590401.x; Pearlman A, 2010, AM J HUM GENET, V87, P898, DOI 10.1016/j.ajhg.2010.11.003; Sarafoglou K, 2000, J CLIN ENDOCR METAB, V85, P483, DOI 10.1210/jc.85.2.483; Schlesinger Thomas K., 1998, Frontiers in Bioscience, V3, pD1181; Schmahl J, 2000, DEVELOPMENT, V127, P65; Siggers P, 2002, MECH DEVELOP, V111, P159, DOI 10.1016/S0925-4773(01)00602-5; Smith L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004091; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Warr N, 2009, DEV BIOL, V326, P273, DOI 10.1016/j.ydbio.2008.11.023; WHITING J, 1991, GENE DEV, V5, P2048, DOI 10.1101/gad.5.11.2048; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Wilhelm D, 2009, MECH DEVELOP, V126, P324, DOI 10.1016/j.mod.2009.02.006; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440	50	43	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19572	10.1371/journal.pone.0019572	http://dx.doi.org/10.1371/journal.pone.0019572			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559298	gold, Green Submitted, Green Published			2022-12-25	WOS:000290223500029
J	Donate, A; Coppola, D; Cruz, Y; Heller, R				Donate, Amy; Coppola, Domenico; Cruz, Yolmari; Heller, Richard			Evaluation of a Novel Non-Penetrating Electrode for Use in DNA Vaccination	PLOS ONE			English	Article							IN-VIVO ELECTROPORATION; INFLUENZA-VIRUS INFECTION; CELLULAR IMMUNE-RESPONSES; GENE-TRANSFER; RHESUS MACAQUES; PLASMID DNA; CUTANEOUS TRANSFECTION; SKELETAL-MUSCLES; DELIVERY; VACCINES	Current progress in the development of vaccines has decreased the incidence of fatal and non-fatal infections and increased longevity. However, new technologies need to be developed to combat an emerging generation of infectious diseases. DNA vaccination has been demonstrated to have great potential for use with a wide variety of diseases. Alone, this technology does not generate a significant immune response for vaccination, but combined with delivery by electroporation (EP), can enhance plasmid expression and immunity. Most EP systems, while effective, can be invasive and painful making them less desirable for use in vaccination. Our lab recently developed a non-invasive electrode known as the multi-electrode array (MEA), which lies flat on the surface of the skin without penetrating the tissue. In this study we evaluated the MEA for its use in DNA vaccination using Hepatitis B virus as the infectious model. We utilized the guinea pig model because their skin is similar in thickness and morphology to humans. The plasmid encoding Hepatitis B surface antigen (HBsAg) was delivered intradermally with the MEA to guinea pig skin. The results show increased protein expression resulting from plasmid delivery using the MEA as compared to injection alone. Within 48 hours of treatment, there was an influx of cellular infiltrate in experimental groups. Humoral responses were also increased significantly in both duration and intensity as compared to injection only groups. While this electrode requires further study, our results suggest that the MEA has potential for use in electrically mediated intradermal DNA vaccination.	[Donate, Amy; Coppola, Domenico] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Donate, Amy; Heller, Richard] Old Dominion Univ, Ctr Bioelect, Norfolk, VA USA; [Heller, Richard] Old Dominion Univ, Coll Hlth Sci, Norfolk, VA USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Old Dominion University; Old Dominion University	Donate, A (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	rheller@odu.edu	Heller, Richard/I-6605-2012; Heller, Richard/ABF-1445-2020	Heller, Richard/0000-0003-1899-3859; Donate, Amy/0000-0002-0481-5675	National Institutes of Health [R01 EB005441]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported in part by a research grant from the National Institutes of Health R01 EB005441. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abdulhaqq SA, 2008, IMMUNOL RES, V42, P219, DOI 10.1007/s12026-008-8076-3; Babiuk S, 2002, VACCINE, V20, P3399, DOI 10.1016/S0264-410X(02)00269-4; Babiuk S, 2007, BIOELECTROCHEMISTRY, V70, P269, DOI 10.1016/j.bioelechem.2006.10.003; Bachy M, 2001, VACCINE, V19, P1688, DOI 10.1016/S0264-410X(00)00406-0; Best SR, 2009, VACCINE, V27, P5450, DOI 10.1016/j.vaccine.2009.07.005; Broderick KE, 2011, GENE THER, V18, P258, DOI 10.1038/gt.2010.137; Chen JJ, 2005, VACCINE, V23, P4322, DOI 10.1016/j.vaccine.2005.03.035; Chen Z, 2000, VACCINE, V18, P3214, DOI 10.1016/S0264-410X(00)00149-3; Daud AI, 2008, J CLIN ONCOL, V26, P5896, DOI 10.1200/JCO.2007.15.6794; Dobano C, 2007, VACCINE, V25, P6635, DOI 10.1016/j.vaccine.2007.06.036; Drabick JJ, 2001, MOL THER, V3, P249, DOI 10.1006/mthe.2000.0257; Dujardin N, 2001, PHARM RES-DORDR, V18, P61, DOI 10.1023/A:1011026726938; Encke J, 1999, INTERVIROLOGY, V42, P117, DOI 10.1159/000024971; Fattori Elena, 2002, Somatic Cell and Molecular Genetics, V27, P75, DOI 10.1023/A:1022927822244; Giese M, 1998, VIRUS GENES, V17, P219, DOI 10.1023/A:1008013720032; Gilbert RA, 1997, BBA-GEN SUBJECTS, V1334, P9, DOI 10.1016/S0304-4165(96)00119-5; Glasspool-Malone J, 2000, MOL THER, V2, P140, DOI 10.1006/mthe.2000.0107; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Heller LC, 2006, HUM GENE THER, V17, P890, DOI 10.1089/hum.2006.17.890; Heller R, 1996, FEBS LETT, V389, P225, DOI 10.1016/0014-5793(96)00590-X; Heller R, 2001, DNA CELL BIOL, V20, P21, DOI 10.1089/10445490150504666; Heller R, 2010, HUM GENE THER, V21, P357, DOI 10.1089/hum.2009.065; Hirao LA, 2008, VACCINE, V26, P440, DOI 10.1016/j.vaccine.2007.10.041; Hu H, 2009, VACCINE, V27, P1758, DOI 10.1016/j.vaccine.2009.01.021; Kadowaki S, 2000, VACCINE, V18, P2779, DOI 10.1016/S0264-410X(00)00087-6; Kim CY, 2008, EXP MOL MED, V40, P669, DOI 10.3858/emm.2008.40.6.669; Laddy DJ, 2009, J VIROL, V83, P4624, DOI 10.1128/JVI.02335-08; Littel-van den Hurk SV, 2008, VACCINE, V26, P5503, DOI 10.1016/j.vaccine.2008.07.093; Lu BJ, 2009, CLIN VACCINE IMMUNOL, V16, P73, DOI 10.1128/CVI.00261-08; Luxembourg A, 2008, VACCINE, V26, P5216, DOI 10.1016/j.vaccine.2008.03.064; Luxembourg A, 2006, VACCINE, V24, P4490, DOI 10.1016/j.vaccine.2005.08.014; Makidon PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002954; Martinon F, 2009, HUM GENE THER, V20, P1291, DOI 10.1089/hum.2009.044; Maruyama H, 2001, GENE THER, V8, P1808, DOI 10.1038/sj.gt.3301604; McMahon JM, 2004, BIODRUGS, V18, P155, DOI 10.2165/00063030-200418030-00002; Medi Babu M., 2008, V423, P225, DOI 10.1007/978-1-59745-194-9_16; Medi BM, 2005, INT J PHARMACEUT, V294, P53, DOI 10.1016/j.ijpharm.2004.12.014; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Muthumani K, 2009, CURR HIV RES, V7, P144, DOI 10.2174/157016209787581481; Muttil P, 2010, AAPS J, V12, P699, DOI 10.1208/s12248-010-9229-6; Nishi T, 1996, CANCER RES, V56, P1050; Otten G, 2004, VACCINE, V22, P2489, DOI 10.1016/j.vaccine.2003.11.073; Otten GR, 2006, VACCINE, V24, P4503, DOI 10.1016/j.vaccine.2005.08.017; Peachman KK, 2003, METHODS, V31, P232, DOI 10.1016/S1046-2023(03)00137-3; Ramanathan MP, 2009, VACCINE, V27, P4370, DOI 10.1016/j.vaccine.2009.01.137; Rosati M, 2009, P NATL ACAD SCI USA, V106, P15831, DOI 10.1073/pnas.0902628106; Scheerlinck JPY, 2004, VACCINE, V22, P1820, DOI 10.1016/j.vaccine.2003.09.053; Seo SH, 2009, VACCINE, V27, P5906, DOI 10.1016/j.vaccine.2009.07.033; Sueki H, 2000, EUR J DERMATOL, V10, P357; Tollefsen S, 2002, VACCINE, V20, P3370, DOI 10.1016/S0264-410X(02)00289-X; Trollet C, 2009, INFECT IMMUN, V77, P2221, DOI 10.1128/IAI.01269-08; Tuting T, 1998, J INVEST DERMATOL, V111, P183, DOI 10.1046/j.1523-1747.1998.00261.x; Vandermeulen G, 2007, J CONTROL RELEASE, V124, P81, DOI 10.1016/j.jconrel.2007.08.010; Wallace M, 2009, MOL THER, V17, P922, DOI 10.1038/mt.2009.27; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Wu CJ, 2004, VACCINE, V22, P1457, DOI 10.1016/j.vaccine.2003.10.011; Zhang L, 2004, BIOELECTROCHEMISTRY, V63, P369, DOI 10.1016/j.bioelechem.2003.11.011; Zhang L, 2002, BBA-GEN SUBJECTS, V1572, P1, DOI 10.1016/S0304-4165(02)00270-2; Zhao YG, 2006, VACCINE, V24, P897, DOI 10.1016/j.vaccine.2005.08.093; Zheng LY, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-17; Zucchelli S, 2000, J VIROL, V74, P11598, DOI 10.1128/JVI.74.24.11598-11607.2000; 2004, DRUGS R D, V5, P293	62	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19181	10.1371/journal.pone.0019181	http://dx.doi.org/10.1371/journal.pone.0019181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559474	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700093
J	Konshina, AG; Boldyrev, IA; Utkin, YN; Omel'kov, AV; Efremov, RG				Konshina, Anastasia G.; Boldyrev, Ivan A.; Utkin, Yuri N.; Omel'kov, Anton V.; Efremov, Roman G.			Snake Cytotoxins Bind to Membranes via Interactions with Phosphatidylserine Head Groups of Lipids	PLOS ONE			English	Article							P-TYPE CARDIOTOXIN; DEPENDENT CONFORMATIONAL-CHANGE; PROTEIN-KINASE-C; NAJA-NAJA-ATRA; COBRA CARDIOTOXIN; VENOM CARDIOTOXIN; PHOSPHOLIPID ASYMMETRY; ANTIMICROBIAL PEPTIDES; GENETIC ALGORITHM; CRYSTAL-STRUCTURE	The major representatives of Elapidae snake venom, cytotoxins (CTs), share similar three-fingered fold and exert diverse range of biological activities against various cell types. CT-induced cell death starts from the membrane recognition process, whose molecular details remain unclear. It is known, however, that the presence of anionic lipids in cell membranes is one of the important factors determining CT-membrane binding. In this work, we therefore investigated specific interactions between one of the most abundant of such lipids, phosphatidylserine (PS), and CT 4 of Naja kaouthia using a combined, experimental and modeling, approach. It was shown that incorporation of PS into zwitterionic liposomes greatly increased the membrane-damaging activity of CT 4 measured by the release of the liposome-entrapped calcein fluorescent dye. The CT-induced leakage rate depends on the PS concentration with a maximum at approximately 20% PS. Interestingly, the effects observed for PS were much more pronounced than those measured for another anionic lipid, sulfatide. To delineate the potential PS binding sites on CT 4 and estimate their relative affinities, a series of computer simulations was performed for the systems containing the head group of PS and different spatial models of CT 4 in aqueous solution and in an implicit membrane. This was done using an original hybrid computational protocol implementing docking, Monte Carlo and molecular dynamics simulations. As a result, at least three putative PS-binding sites with different affinities to PS molecule were delineated. Being located in different parts of the CT molecule, these anion-binding sites can potentially facilitate and modulate the multi-step process of the toxin insertion into lipid bilayers. This feature together with the diverse binding affinities of the sites to a wide variety of anionic targets on the membrane surface appears to be functionally meaningful and may adjust CT action against different types of cells.	[Konshina, Anastasia G.; Boldyrev, Ivan A.; Utkin, Yuri N.; Omel'kov, Anton V.; Efremov, Roman G.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Konshina, AG (corresponding author), Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow, Russia.	efremov@nmr.ru	Utkin, Yuri/L-2952-2019; Roman, Efremov/A-7460-2014; Konshina, Anastasia/T-8430-2017; Utkin, Yuri N./F-1958-2014; Boldyrev, Ivan/L-7879-2017	Utkin, Yuri/0000-0002-4609-970X; Roman, Efremov/0000-0002-5474-4721; Konshina, Anastasia/0000-0003-1270-9933; Utkin, Yuri N./0000-0002-4609-970X; 	Russian Foundation for Basic Research; RAS	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); RAS(Russian Academy of SciencesRegione Sardegna)	This work was supported by the Russian Foundation for Basic Research and by the RAS Programmes (MCB and "Basic Fundamental Research for Nanotechnologies and Nanomaterials"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN TM, 1984, LIPOSOME TECHNOLOGY, V3, P177; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Boas FE, 1998, P NATL ACAD SCI USA, V95, P3077, DOI 10.1073/pnas.95.6.3077; Buckland AG, 2000, BBA-MOL CELL BIOL L, V1483, P199, DOI 10.1016/S1388-1981(99)00188-2; BUTIKOFER P, 1990, J BIOL CHEM, V265, P16035; Chen KC, 2007, TOXICON, V50, P816, DOI 10.1016/j.toxicon.2007.06.011; CHIEN KY, 1994, J BIOL CHEM, V269, P14473; CHIOU SH, 1993, BIOCHEMISTRY-US, V32, P2062, DOI 10.1021/bi00059a025; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAUPLAIS M, 1995, EUR J BIOCHEM, V230, P213, DOI 10.1111/j.1432-1033.1995.0213i.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dementieva DV, 1999, EUR J BIOCHEM, V263, P152, DOI 10.1046/j.1432-1327.1999.00478.x; Dubovskii PV, 2001, J MOL BIOL, V305, P137, DOI 10.1006/jmbi.2000.4283; DUFOURCQ J, 1982, TOXICON, V20, P165, DOI 10.1016/0041-0101(82)90187-8; DUFTON MJ, 1988, PHARMACOL THERAPEUT, V36, P1, DOI 10.1016/0163-7258(88)90111-8; Efremov R, 2001, THEOR CHEM ACC, V106, P48, DOI 10.1007/s002140000220; Efremov RG, 1999, BIOPHYS J, V76, P2448, DOI 10.1016/S0006-3495(99)77400-X; Efremov RG, 2002, BIOPHYS J, V83, P144, DOI 10.1016/S0006-3495(02)75156-4; EFREMOV RG, 1992, J PROTEIN CHEM, V11, P665, DOI 10.1007/BF01024968; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Feofanov AV, 2005, BIOCHEM J, V390, P11, DOI 10.1042/BJ20041892; Feofanov AV, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1148, DOI 10.1023/B:BIRY.0000046890.46901.7e; Forouhar F, 2003, J BIOL CHEM, V278, P21980, DOI 10.1074/jbc.M208650200; GATINEAU E, 1987, BIOCHEMISTRY-US, V26, P8046, DOI 10.1021/bi00399a004; GATINEAU E, 1990, BIOCHEMISTRY-US, V29, P6480, DOI 10.1021/bi00479a021; GILQUIN B, 1993, BIOPOLYMERS, V33, P1659, DOI 10.1002/bip.360331104; Harris F, 2009, CURR PROTEIN PEPT SC, V10, P585, DOI 10.2174/138920309789630589; HODGES SJ, 1987, EUR J BIOCHEM, V165, P373, DOI 10.1111/j.1432-1033.1987.tb11450.x; Ishizuka I, 1997, PROG LIPID RES, V36, P245, DOI 10.1016/S0163-7827(97)00011-8; Jayaraman G, 1999, J BIOL CHEM, V274, P17869, DOI 10.1074/jbc.274.25.17869; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1989, J AM CHEM SOC, V111, P3770, DOI 10.1021/ja00192a057; Konshina A. G., 2003, Bioorganicheskaya Khimiya, V29, P577; Kukhtina VV, 2000, BIOORG KHIM+, V26, P803; Kumar TKS, 1997, J BIOMOL STRUCT DYN, V15, P431, DOI 10.1080/07391102.1997.10508957; Lee SC, 2005, J BIOL CHEM, V280, P9567, DOI 10.1074/jbc.M412398200; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Polyansky AA, 2010, J PHYS CHEM LETT, V1, P3108, DOI 10.1021/jz101163e; Polyansky AA, 2009, J PHYS CHEM B, V113, P1120, DOI 10.1021/jp803641x; Pyrkov TV, 2009, BIOINFORMATICS, V25, P1201, DOI 10.1093/bioinformatics/btp111; RAYNOR RL, 1991, J BIOL CHEM, V266, P2753; Scheuplein F, 2009, J IMMUNOL, V182, P2898, DOI 10.4049/jimmunol.0801711; Schlegel RA, 2001, CELL DEATH DIFFER, V8, P551, DOI 10.1038/sj.cdd.4400817; SESSIONS A, 1983, BIOCHIM BIOPHYS ACTA, V728, P103, DOI 10.1016/0005-2736(83)90442-X; Sevcsik E, 2008, BIOPHYS J, V94, P4688, DOI 10.1529/biophysj.107.123620; Shao C, 2008, J BIOL CHEM, V283, P7230, DOI 10.1074/jbc.M705195200; SHARONOV GV, 2008, INNOVATIVE MICROSCOP, P49; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; StevensTruss R, 1996, TOXICOL APPL PHARM, V139, P234, DOI 10.1006/taap.1996.0162; Sue SC, 2002, J BIOL CHEM, V277, P2666, DOI 10.1074/jbc.M104887200; Sue SC, 2001, BIOCHEMISTRY-US, V40, P10436, DOI 10.1021/bi010847n; Sue SC, 2001, BIOCHEMISTRY-US, V40, P12782, DOI 10.1021/bi010848f; Sun YJ, 1997, BIOCHEMISTRY-US, V36, P2403, DOI 10.1021/bi962594h; TAKECHI M, 1986, FEBS LETT, V205, P143, DOI 10.1016/0014-5793(86)80882-1; Tjong SC, 2007, BIOCHEMISTRY-US, V46, P12111, DOI 10.1021/bi700871x; Tjong SC, 2007, BIOCHEMISTRY-US, V46, P9941, DOI 10.1021/bi700995v; TZENG WF, 1988, BIOCHEM J, V256, P89, DOI 10.1042/bj2560089; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V323, P178, DOI 10.1016/0005-2736(73)90143-0; Wang CH, 2006, J BIOL CHEM, V281, P656, DOI 10.1074/jbc.M507880200; Wang CH, 2005, FEBS LETT, V579, P3169, DOI 10.1016/j.febslet.2005.05.006; Wang PC, 2009, BIOCHEM BIOPH RES CO, V387, P617, DOI 10.1016/j.bbrc.2009.07.097; Wu PL, 2006, J BIOL CHEM, V281, P7937, DOI 10.1074/jbc.M513035200; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3	69	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19064	10.1371/journal.pone.0019064	http://dx.doi.org/10.1371/journal.pone.0019064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559494	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700058
J	Morlighem, JE; Aoki, S; Kishima, M; Hanami, M; Ogawa, C; Jalloh, A; Takahashi, Y; Kawai, Y; Saga, S; Hayashi, E; Ban, T; Izumi, S; Wada, A; Mano, M; Fukunaga, M; Kijima, Y; Shiomi, S; Inoue, K; Hata, T; Koretsune, Y; Kudo, K; Himeno, Y; Hirai, A; Takahashi, K; Sakai-Tagawa, Y; Iwatsuki-Horimoto, K; Kawaoka, Y; Hayashizaki, Y; Ishikawa, T				Morlighem, Jean-Etienne; Aoki, Shintaro; Kishima, Mami; Hanami, Mitsue; Ogawa, Chihiro; Jalloh, Amadu; Takahashi, Yukari; Kawai, Yuki; Saga, Satomi; Hayashi, Eiji; Ban, Toshiaki; Izumi, Shinyu; Wada, Akira; Mano, Masayuki; Fukunaga, Megumu; Kijima, Yoshiyuki; Shiomi, Shoji; Inoue, Kaoru; Hata, Takeshi; Koretsune, Yukihiro; Kudo, Koichiro; Himeno, Yuji; Hirai, Aizan; Takahashi, Kazuo; Sakai-Tagawa, Yuko; Iwatsuki-Horimoto, Kiyoko; Kawaoka, Yoshihiro; Hayashizaki, Yoshihide; Ishikawa, Toshihisa			Mutation Analysis of 2009 Pandemic Influenza A(H1N1) Viruses Collected in Japan during the Peak Phase of the Pandemic	PLOS ONE			English	Article							ORIGIN; HEMAGGLUTININ; EMERGENCE; CLEAVAGE; MODEL	Background: Pandemic influenza A(H1N1) virus infection quickly circulated worldwide in 2009. In Japan, the first case was reported in May 2009, one month after its outbreak in Mexico. Thereafter, A(H1N1) infection spread widely throughout the country. It is of great importance to profile and understand the situation regarding viral mutations and their circulation in Japan to accumulate a knowledge base and to prepare clinical response platforms before a second pandemic (pdm) wave emerges. Methodology: A total of 253 swab samples were collected from patients with influenza-like illness in the Osaka, Tokyo, and Chiba areas both in May 2009 and between October 2009 and January 2010. We analyzed partial sequences of the hemagglutinin (HA) and neuraminidase (NA) genes of the 2009 pdm influenza virus in the collected clinical samples. By phylogenetic analysis, we identified major variants of the 2009 pdm influenza virus and critical mutations associated with severe cases, including drug-resistance mutations. Results and Conclusions: Our sequence analysis has revealed that both HA-S220T and NA-N248D are major non-synonymous mutations that clearly discriminate the 2009 pdm influenza viruses identified in the very early phase (May 2009) from those found in the peak phase (October 2009 to January 2010) in Japan. By phylogenetic analysis, we found 14 micro-clades within the viruses collected during the peak phase. Among them, 12 were new micro-clades, while two were previously reported. Oseltamivir resistance-related mutations, i.e., NA-H275Y and NA-N295S, were also detected in sporadic cases in Osaka and Tokyo.	[Morlighem, Jean-Etienne; Aoki, Shintaro; Kishima, Mami; Hanami, Mitsue; Ogawa, Chihiro; Jalloh, Amadu; Takahashi, Yukari; Kawai, Yuki; Saga, Satomi; Hayashizaki, Yoshihide; Ishikawa, Toshihisa] RIKEN Yokohama Inst, Omics Sci Ctr, Yokohama, Kanagawa, Japan; [Hayashi, Eiji; Hirai, Aizan] Chiba Prefectural Togane Hosp, Togane, Japan; [Ban, Toshiaki; Himeno, Yuji] Isumi Med Ctr, Isumi, Japan; [Izumi, Shinyu; Kudo, Koichiro] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Wada, Akira; Mano, Masayuki; Koretsune, Yukihiro] Osaka Natl Hosp, Natl Hosp Org, Osaka, Japan; [Fukunaga, Megumu] Toyonaka City Hosp, Toyonaka, Osaka, Japan; [Kijima, Yoshiyuki; Hata, Takeshi] Higashi Osaka City Gen Hosp, Higashi Osaka, Japan; [Shiomi, Shoji; Inoue, Kaoru] Osaka City Gen Hosp, Osaka, Japan; [Takahashi, Kazuo] Osaka Prefectural Inst Publ Hlth, Osaka 537, Japan; [Sakai-Tagawa, Yuko; Iwatsuki-Horimoto, Kiyoko; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Tokyo, Japan	RIKEN; National Center for Global Health & Medicine - Japan; Osaka National Hospital; Osaka City General Hospital; Osaka Prefectural Institute of Public Health; University of Tokyo	Morlighem, JE (corresponding author), RIKEN Yokohama Inst, Omics Sci Ctr, Yokohama, Kanagawa, Japan.	toshi-i@gsc.riken.jp	Morlighem, Jean-Etienne/D-1814-2010; Hayashizaki, Yoshihide/N-6590-2015	Morlighem, Jean-Etienne/0000-0003-2754-8677	Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [23590145] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Special Coordination Funds for Promoting Science and Technology as well as a Research Grant for RIKEN Omics Science Center (to Y. Hayashizaki) from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; [Anonymous], 2009, NOV INFL; Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Fereidouni SR, 2009, EUROSURVEILLANCE, V14; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUNTHER I, 1993, VIRUS RES, V27, P147, DOI 10.1016/0168-1702(93)90078-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jhung M., 2010, Morbidity and Mortality Weekly Report, V59, P423; Kilander A, 2010, EUROSURVEILLANCE, V15, P6; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Kiso M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001079; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Leung TWC, 2009, J CLIN VIROL, V46, P298, DOI 10.1016/j.jcv.2009.08.004; LUOH SM, 1992, J VIROL, V66, P1066, DOI 10.1128/JVI.66.2.1066-1073.1992; Mai LQ, 2010, NEW ENGL J MED, V362, P86, DOI 10.1056/NEJMc0910448; Matsuzaki Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-53; Munier S, 2010, J VIROL, V84, P940, DOI 10.1128/JVI.01581-09; Nelson Martha, 2009, PLoS Curr, V1, pRRN1126; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, TRACER V1 4; Reid AH, 2003, EMERG INFECT DIS, V9, P1249; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schnitzler SU, 2009, VIRUS GENES, V39, P279, DOI 10.1007/s11262-009-0404-8; SHEERAR MG, 1989, J GEN VIROL, V70, P3297, DOI 10.1099/0022-1317-70-12-3297; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taubenberger JK, 1997, SCIENCE, V275, P1793, DOI 10.1126/science.275.5307.1793; WHO, 2010, H1N1 POSTP PER; *WHO, 2008, INFL A H1N1 VIR RES; WHO (World Health Organization), 2010, PAND H1N1 2009 UPD 9; World Health Organization (WHO), 2010, INFL UPD 115; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905; Zambon M, 2001, ANTIVIR RES, V49, P147, DOI 10.1016/S0166-3542(01)00124-3; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09; Zhou HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006277	53	37	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18956	10.1371/journal.pone.0018956	http://dx.doi.org/10.1371/journal.pone.0018956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21572517	Green Submitted, gold, Green Published			2022-12-25	WOS:000290024700042
J	Raveh, B; London, N; Zimmerman, L; Schueler-Furman, O				Raveh, Barak; London, Nir; Zimmerman, Lior; Schueler-Furman, Ora			Rosetta FlexPepDockab-initio: Simultaneous Folding, Docking and Refinement of Peptides onto Their Receptors	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; STRUCTURAL BASIS; PHAGE DISPLAY; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; BINDING; RECOGNITION; IDENTIFICATION; DOMAIN; INTERFACES	Flexible peptides that fold upon binding to another protein molecule mediate a large number of regulatory interactions in the living cell and may provide highly specific recognition modules. We present Rosetta FlexPepDockab-initio, a protocol for simultaneous docking and de-novo folding of peptides, starting from an approximate specification of the peptide binding site. Using the Rosetta fragments library and a coarse-grained structural representation of the peptide and the receptor, FlexPepDockab-initio samples efficiently and simultaneously sampled the space of possible peptide backbone conformations and rigid-body orientations over the receptor surface of a given binding site. The subsequent all-atom refinement of the coarse-grained models includes full side-chain modeling of both the receptor and the peptide, resulting in high-resolution models in which key side-chain interactions are recapitulated. The protocol was applied to a benchmark in which peptides were modeled over receptors in either their bound backbone conformations or in their free, unbound form. Near-native peptide conformations were identified in 18/26 of the bound cases and 7/14 of the unbound cases. The protocol performswell on peptides from various classes of secondary structures, including coiled peptides with unusual turns and kinks. The results presented here significantly extend the scope of state-of-the-art methods for high-resolution peptide modeling, which can now be applied to a wide variety of peptide-protein interactions where no prior information about the peptide backbone conformation is available, enabling detailed structure-based studies and manipulation of those interactions.	[Raveh, Barak; London, Nir; Zimmerman, Lior; Schueler-Furman, Ora] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel; [Raveh, Barak] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Tel Aviv University	Raveh, B (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel.	oraf@ekmd.huji.ac.il	Schueler-Furman, Ora/AAC-5932-2020	Schueler-Furman, Ora/0000-0002-1624-0362; Zimmerman, Lior/0000-0003-2775-0330; London, Nir/0000-0003-2687-0699	Israel Academy of Science and Humanities ISF [306/6]; USA-Israel Bi-national Science Foundation [2009418]; European Commission [255827]	Israel Academy of Science and Humanities ISF; USA-Israel Bi-national Science Foundation(US-Israel Binational Science Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work has been supported by the Israel Science Foundation, funded by the Israel Academy of Science and Humanities ISF Grant 306/6, the USA-Israel Bi-national Science Foundation Grant 2009418 (to OSF), and in part by the 7th Framework Programme for Research of the European Commission, under FET-Open grant number 255827, CGL, Computational Geometry Learning (to BR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-451; Antes I, 2010, PROTEINS, V78, P1084, DOI 10.1002/prot.22629; Audie J, 2010, CURR PHARM DESIGN, V16, P567, DOI 10.2174/138161210790361425; BELITSKY M, 2011, MOL CELL IN PRESS; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brenke R, 2009, BIOINFORMATICS, V25, P621, DOI 10.1093/bioinformatics/btp036; Buch I, 2010, BIOCHEMISTRY-US, V49, P10890, DOI 10.1021/bi100822q; Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; CRAWLEY SW, 2010, J BIOL CHEM IN PRESS; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Gehmlich K, 2007, J MOL BIOL, V369, P665, DOI 10.1016/j.jmb.2007.03.050; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Guhaniyogi J, 2006, J MOL BIOL, V359, P624, DOI 10.1016/j.jmb.2006.03.050; Hashemzadeh Mehrnoosh, 2008, Exp Clin Cardiol, V13, P192; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KATZ C, 2011, CHEMSOC REV IN PRESS; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Ladner RC, 2004, DRUG DISCOV TODAY, V9, P525, DOI 10.1016/S1359-6446(04)03104-6; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; London N, 2010, PROTEINS, V78, P3140, DOI 10.1002/prot.22785; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Mandell JG, 1998, P NATL ACAD SCI USA, V95, P14705, DOI 10.1073/pnas.95.25.14705; Molek P, 2011, MOLECULES, V16, P857, DOI 10.3390/molecules16010857; Moncalian G, 2006, J BIOL CHEM, V281, P38845, DOI 10.1074/jbc.M606411200; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Niv MY, 2005, J AM CHEM SOC, V127, P14072, DOI 10.1021/ja054195s; Parthasarathi L, 2008, J CHEM INF MODEL, V48, P1943, DOI 10.1021/ci800174c; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Petsalaki E, 2008, CURR OPIN BIOTECH, V19, P344, DOI 10.1016/j.copbio.2008.06.004; Petsalaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000335; Prasad PA, 2008, J COMPUT AID MOL DES, V22, P815, DOI 10.1007/s10822-008-9216-5; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rubinstein M, 2009, BIOPOLYMERS, V91, P505, DOI 10.1002/bip.21164; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Stein A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002524; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; VANHEE P, 2011, TRENDS BIOT IN PRESS; Vanhee P, 2010, NUCLEIC ACIDS RES, V38, pD545, DOI 10.1093/nar/gkp893; Vanhee P, 2009, STRUCTURE, V17, P1128, DOI 10.1016/j.str.2009.06.013; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Zachariae U, 2006, J BIOL CHEM, V281, P7413, DOI 10.1074/jbc.M510939200	55	187	190	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18934	10.1371/journal.pone.0018934	http://dx.doi.org/10.1371/journal.pone.0018934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21572516	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700038
J	Shapiro, AG; Knight, EJ; Lu, ZL				Shapiro, Arthur G.; Knight, Emily J.; Lu, Zhong-Lin			A First- and Second-Order Motion Energy Analysis of Peripheral Motion Illusions Leads to Further Evidence of "Feature Blur" in Peripheral Vision	PLOS ONE			English	Article							VISUAL-MOTION; PERCEPTION; CONTRAST; SENSITIVITY; INTEGRATION; DISCRIMINATION; MECHANISMS; FREQUENCY; FOVEAL; PHASE	Background: Anatomical and physiological differences between the central and peripheral visual systems are well documented. Recent findings have suggested that vision in the periphery is not just a scaled version of foveal vision, but rather is relatively poor at representing spatial and temporal phase and other visual features. Shapiro, Lu, Huang, Knight, and Ennis (2010) have recently examined a motion stimulus (the "curveball illusion") in which the shift from foveal to peripheral viewing results in a dramatic spatial/temporal discontinuity. Here, we apply a similar analysis to a range of other spatial/temporal configurations that create perceptual conflict between foveal and peripheral vision. Methodology/Principal Findings: To elucidate how the differences between foveal and peripheral vision affect super-threshold vision, we created a series of complex visual displays that contain opposing sources of motion information. The displays (referred to as the peripheral escalator illusion, peripheral acceleration and deceleration illusions, rotating reversals illusion, and disappearing squares illusion) create dramatically different perceptions when viewed foveally versus peripherally. We compute the first-order and second-order directional motion energy available in the displays using a three-dimensional Fourier analysis in the (x, y, t) space. The peripheral escalator, acceleration and deceleration illusions and rotating reversals illusion all show a similar trend: in the fovea, the first-order motion energy and second-order motion energy can be perceptually separated from each other; in the periphery, the perception seems to correspond to a combination of the multiple sources of motion information. The disappearing squares illusion shows that the ability to assemble the features of Kanisza squares becomes slower in the periphery. Conclusions/Significance: The results lead us to hypothesize "feature blur" in the periphery (i.e., the peripheral visual system combines features that the foveal visual system can separate). Feature blur is of general importance because humans are frequently bringing the information in the periphery to the fovea and vice versa.	[Shapiro, Arthur G.] American Univ, Dept Psychol, Washington, DC 20016 USA; [Knight, Emily J.] Guggenheim 2 Mayo Grad Mayo Med Sch, Rochester, MN USA; [Lu, Zhong-Lin] Univ So Calif, Dept Psychol, Grad Program Neurosci, Los Angeles, CA 90089 USA; [Lu, Zhong-Lin] Univ So Calif, Dept Biomed Engn, Grad Program Neurosci, Los Angeles, CA 90089 USA	American University; University of Southern California; University of Southern California	Shapiro, AG (corresponding author), American Univ, Dept Psychol, Washington, DC 20016 USA.	Arthur.Shapiro@american.edu		Lu, Zhong-Lin/0000-0002-7295-727X; Knight, Emily/0000-0002-6971-1148	National Eye Institute [EY017491, R15EY021008]; National Institute of Mental Health [MH081018]; NATIONAL EYE INSTITUTE [R15EY021008, R01EY017491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081018] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work is supported by the National Eye Institute (EY017491 and R15EY021008 [Z-LL], and R15EY021008 [AGS]) and the National Institute of Mental Health (MH081018 [Z-LL]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; BENNETT PJ, 1987, NATURE, V326, P873, DOI 10.1038/326873a0; BRADY T, 2005, SOC NEUR ANN M; Bressler DW, 2006, VISION RES, V46, P1120, DOI 10.1016/j.visres.2005.10.012; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P2985, DOI 10.1073/pnas.86.8.2985; Chung STL, 2001, VISION RES, V41, P1833, DOI 10.1016/S0042-6989(01)00071-2; COHEN MA, 1984, PERCEPT PSYCHOPHYS, V36, P428, DOI 10.3758/BF03207497; CORMACK R, 1992, VISION RES, V32, P73, DOI 10.1016/0042-6989(92)90114-X; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Falchier A, 2002, J NEUROSCI, V22, P5749; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; HILZ R, 1981, EXP BRAIN RES, V43, P111; Hsieh PJ, 2006, VISION RES, V46, P2251, DOI 10.1016/j.visres.2005.11.030; Juttner M, 1996, VISION RES, V36, P1007, DOI 10.1016/0042-6989(95)00250-2; KNIGHT EJ, 2007, ILLUSION CONTEST ENT; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Levi DM, 2002, J VISION, V2, P140, DOI 10.1167/2.2.2; LEVI DM, 1983, VISION RES, V23, P1005, DOI 10.1016/0042-6989(83)90011-1; LEVI DM, 1984, VISION RES, V24, P789, DOI 10.1016/0042-6989(84)90150-0; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; Lu ZL, 1996, J OPT SOC AM A, V13, P2305, DOI 10.1364/JOSAA.13.002305; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; MARKOV NT, 2008, SOC NEUR ANN M; MARTIN PR, 2004, VISUAL NEUROSCIENCES; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MATEEFF S, 1983, BIOL CYBERN, V49, P111, DOI 10.1007/BF00320391; May KA, 2007, J VISION, V7, DOI 10.1167/7.12.13; MEILSTRUP PB, 2008, SOC NEUR ANN M; MORRONE MC, 1989, VISION RES, V29, P433, DOI 10.1016/0042-6989(89)90007-2; Nandy AS, 2007, J VISION, V7, DOI 10.1167/7.2.5; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; ROVAMO J, 1984, PERCEPTION, V13, P665, DOI 10.1068/p130665; Shapiro AG, 2005, J VISION, V5, P764, DOI 10.1167/5.10.2; Shapiro AG, 2004, J VISION, V4, P459, DOI 10.1167/4.6.5; SHAPIRO AG, 2008, SOC NEUR ANN M; Shapiro A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013296; Shapiro AG, 2008, J VISION, V8, DOI 10.1167/8.1.8; SHAPLEY R, 1985, PERCEPT PSYCHOPHYS, V37, P84, DOI 10.3758/BF03207143; Smith AT, 1998, VISION RES, V38, P403, DOI 10.1016/S0042-6989(97)00134-X; SOLOMON JA, 1994, VISION RES, V34, P2239, DOI 10.1016/0042-6989(94)90105-8; STRASBURGER H, 1994, EUR J NEUROSCI, V6, P1583, DOI 10.1111/j.1460-9568.1994.tb00548.x; STRASBURGER H, 1991, PERCEPT PSYCHOPHYS, V49, P495, DOI 10.3758/BF03212183; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; Tse PU, 2006, VISION RES, V46, P3881, DOI 10.1016/j.visres.2006.06.010; WASSLE H, 1989, NATURE, V341, P643, DOI 10.1038/341643a0; Whitney D, 2002, VIS COGN, V9, P139, DOI 10.1080/13506280143000368; Whitney D, 2000, NAT NEUROSCI, V3, P954, DOI 10.1038/78878; Xing J, 2000, VISION RES, V40, P3065, DOI 10.1016/S0042-6989(00)00152-8; Zanker JM, 1997, J OPT SOC AM A, V14, P1385, DOI 10.1364/JOSAA.14.001385; ZHANG J, 1993, VISION RES, V33, P2721, DOI 10.1016/0042-6989(93)90231-K	53	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18719	10.1371/journal.pone.0018719	http://dx.doi.org/10.1371/journal.pone.0018719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559513	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700021
J	Singh, A; Prasad, R				Singh, Ashutosh; Prasad, Rajendra			Comparative Lipidomics of Azole Sensitive and Resistant Clinical Isolates of Candida albicans Reveals Unexpected Diversity in Molecular Lipid Imprints	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; FLUCONAZOLE RESISTANCE; MULTIDRUG-RESISTANCE; PHOSPHATIDYLSERINE DECARBOXYLASE; DRUG SUSCEPTIBILITIES; MEMBRANE-PROTEIN; GENETIC-BASIS; DIACYLGLYCEROL; EPIDEMIOLOGY; ACTIVATION	Although transcriptome and proteome approaches have been applied to determine the regulatory circuitry behind multidrug resistance (MDR) in Candida, its lipidome remains poorly characterized. Lipids do acclimatize to the development of MDR in Candida, but exactly how the acclimatization is achieved is poorly understood. In the present study, we have used a high-throughput mass spectrometry-based shotgun approach and analyzed the lipidome of genetically matched clinical azole-sensitive (AS) and -resistant (AR) isolates of C. albicans. By comparing the lipid profiling of matched isolates, we have identified major classes of lipids and determined more than 200 individual molecular lipid species among these major classes. The lipidome analysis has been statistically validated by principal component analysis. Although each AR isolate was similar with regard to displaying a high MIC to drugs, they had a distinct lipid imprint. There were some significant commonalities in the lipid profiles of these pairs, including molecular lipid species ranging from monounsaturated to polyunsaturated fatty acid-containing phosphoglycerides. Consistent fluctuation in phosphatidyl serine, mannosylinositol-phosphorylceramides, and sterol esters levels indicated their compensatory role in maintaining lipid homeostasis among most AR isolates. Notably, overexpression of either CaCdr1p or CaMdr1p efflux pump proteins led to a different lipidomic response among AR isolates. This study clearly establishes the versatility of lipid metabolism in handling azole stress among various matched AR isolates. This comprehensive lipidomic approach will serve as a resource for assessing strategies aimed at disrupting the functions of Candida lipids, particularly the functional interactions between lipids and MDR determinants.	[Singh, Ashutosh; Prasad, Rajendra] Jawaharlal Nehru Univ, Sch Life Sci, Membrane Biol Lab, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Singh, A (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Membrane Biol Lab, New Delhi 110067, India.	rp47@mail.jnu.ac.in	SINGH, ASHUTOSH/AAR-1283-2021	SINGH, ASHUTOSH/0000-0002-0995-6696	Department of Biotechnology [BT/PR9100/Med/29/03/2007, BT/PR9563/BRB/10/567/2007, BT/PR11158/BRB/10/640/2008, BT/PR13641/MED/29/175/2010]; National Science Foundation [EPS 0236913, MCB 0455318, DBI 0521587]; Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institutes of Health [P20RR16475]; Johnson Cancer Center; Kansas State University; University Grants Commission; Council of Scientific and Industrial Research, Government of India; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	Department of Biotechnology; National Science Foundation(National Science Foundation (NSF)); Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson Cancer Center; Kansas State University; University Grants Commission(University Grants Commission, India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work presented in this paper has been supported in part by grants to R.P. from Department of Biotechnology (BT/PR9100/Med/29/03/2007, BT/PR9563/BRB/10/567/2007, BT/PR11158/BRB/10/640/2008, BT/PR13641/MED/29/175/2010). The lipid analyses described in this work were partly performed at the Kansas Lipidomics Research Center Analytical Laboratory, where equipment acquisition and method development were funded by National Science Foundation (EPS 0236913, MCB 0455318, DBI 0521587), Kansas Technology Enterprise Corporation, K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institutes of Health (P20RR16475), the Johnson Cancer Center, and Kansas State University. A.S. is thankful to the University Grants Commission, and Council of Scientific and Industrial Research, Government of India, for junior research fellowships award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Batova M, 2008, CURR GENET, V53, P313, DOI 10.1007/s00294-008-0187-9; Bleijerveld OB, 2006, ANAL BIOCHEM, V352, P1, DOI 10.1016/j.ab.2006.02.016; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bogdanov M, 1999, J BIOL CHEM, V274, P12339, DOI 10.1074/jbc.274.18.12339; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; Chen YL, 2010, MOL MICROBIOL, V75, P1112, DOI 10.1111/j.1365-2958.2009.07018.x; Clark TA, 2002, CURR OPIN INFECT DIS, V15, P569, DOI 10.1097/00001432-200212000-00003; Cowen LE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000471; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ferreira CR, 2010, J LIPID RES, V51, P1218, DOI 10.1194/jlr.D001768; Franz R, 1999, MYCOSES, V42, P453, DOI 10.1046/j.1439-0507.1999.00498.x; Franz R, 1998, ANTIMICROB AGENTS CH, V42, P3065, DOI 10.1128/AAC.42.12.3065; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gulshan K, 2008, MOL CELL BIOL, V28, P5851, DOI 10.1128/MCB.00405-08; HAN XL, 1994, P NATL ACAD SCI USA, V91, P10635, DOI 10.1073/pnas.91.22.10635; HITCHCOCK CA, 1986, J GEN MICROBIOL, V132, P2421; Hunte C, 2005, BIOCHEM SOC T, V33, P938, DOI 10.1042/BST0330938; Karababa M, 2004, ANTIMICROB AGENTS CH, V48, P3064, DOI 10.1128/AAC.48.8.3064-3079.2004; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; Kohli A, 2002, ANTIMICROB AGENTS CH, V46, P1046, DOI 10.1128/AAC.46.4.1046-1052.2002; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Loffler J, 2000, FEMS MICROBIOL LETT, V185, P59, DOI 10.1016/S0378-1097(00)00071-9; Madani S, 2001, FASEB J, V15, P2595, DOI 10.1096/fj.01-0753int; Marie C, 2009, CURR FUNGAL INFECT R, V3, P163, DOI 10.1007/s12281-009-0021-y; Morschhauser J, 2002, BBA-MOL BASIS DIS, V1587, P240, DOI 10.1016/S0925-4439(02)00087-X; Mukhopadhyay K, 2004, ANTIMICROB AGENTS CH, V48, P1778, DOI 10.1128/AAC.48.5.1778-1787.2004; Mukhopadhyay K, 2002, ANTIMICROB AGENTS CH, V46, P3695, DOI 10.1128/AAC.46.12.3695-3705.2002; NEWTON AC, 1994, BIOCHEMISTRY-US, V33, P6651, DOI 10.1021/bi00187a035; NEWTON AC, 1993, ANNU REV BIOPH BIOM, V22, P1, DOI 10.1146/annurev.bb.22.060193.000245; Pasrija R, 2005, BIOCHEM SOC T, V33, P1219, DOI 10.1042/BST20051219; Pasrija R, 2008, ANTIMICROB AGENTS CH, V52, P694, DOI 10.1128/AAC.00861-07; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Prasad R, 2005, INT REV CYTOL, V242, P215; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Roberts LD, 2008, J CHROMATOGR B, V871, P174, DOI 10.1016/j.jchromb.2008.04.002; Sanglard D, 2005, MOL PRINCIPLES FUNGA, P197; Sanglard D, 2009, FEMS YEAST RES, V9, P1029, DOI 10.1111/j.1567-1364.2009.00578.x; Shahi P, 2009, BBA-PROTEINS PROTEOM, V1794, P852, DOI 10.1016/j.bbapap.2008.12.012; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Singh A, 2010, OMICS, V14, P665, DOI 10.1089/omi.2010.0041; TAKAI Y, 1979, BIOCHEM BIOPH RES CO, V91, P1218, DOI 10.1016/0006-291X(79)91197-5; Tate CG, 2001, FEBS LETT, V504, P94, DOI 10.1016/S0014-5793(01)02711-9; Tortorano AM, 2006, INT J ANTIMICROB AG, V27, P359, DOI 10.1016/j.ijantimicag.2006.01.002; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Wisching S, 2000, MOL MICROBIOL, V36, P856	52	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19266	10.1371/journal.pone.0019266	http://dx.doi.org/10.1371/journal.pone.0019266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559392	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700117
J	Steel, C; Nutman, TB				Steel, Cathy; Nutman, Thomas B.			Altered T Cell Memory and Effector Cell Development in Chronic Lymphatic Filarial Infection That Is Independent of Persistent Parasite Antigen	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; CHRONIC CHAGAS-DISEASE; C HIV-1 INFECTION; LEISHMANIA-MAJOR; BANCROFTIAN FILARIASIS; HUMAN IMMUNOSENESCENCE; RECEPTOR EXPRESSION; ENDEMIC FILARIASIS; CYTOKINE CONTROL; PACIFIC ISLAND	Chronic lymphatic filarial (LF) infection is associated with suppression of parasite-specific T cell responses that persist even following elimination of infection. While several mechanisms have been implicated in mediating this T cell specific downregulation, a role for alterations in the homeostasis of T effector and memory cell populations has not been explored. Using multiparameter flow cytometry, we investigated the role of persistent filarial infection on the maintenance of T cell memory in patients from the filarial-endemic Cook Islands. Compared to filarial-uninfected endemic normals (EN), microfilaria (mf) positive infected patients (Inf) had a reduced CD4 central memory (T(CM)) compartment. In addition, Inf patients tended to have more effector memory cells (T(EM)) and fewer effector cells (T(EFF)) than did ENs giving significantly smaller T(EFF) : T(EM) ratios. These contracted T(CM) and T(EFF) populations were still evident in patients previously mf+ who had cleared their infection (CLInf). Moreover, the density of IL-7R alpha, necessary for T memory cell maintenance (but decreased in T effector cells), was significantly higher on memory cells of Inf and CLInf patients, although there was no evidence for decreased IL-7 or increased soluble IL7-R alpha, both possible mechanisms for signaling defects in memory cells. However, effector cells that were present in Inf and CLInf patients had lower percentages of HLA-DR suggesting impaired function. These changes in T cell populations appear to reflect chronicity of infection, as filarial-infected children, despite the presence of active infection, did not show alterations in the frequencies of these T cell phenotypes. These data indicate that filarial-infected patients have contracted T(CM) compartments and a defect in effector cell development, defects that persist even following clearance of infection. The fact that these global changes in memory and effector cell compartments do not yet occur in infected children makes early treatment of LF even more crucial.	[Steel, Cathy; Nutman, Thomas B.] NIH, Parasit Dis Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Steel, C (corresponding author), NIH, Parasit Dis Lab, Bethesda, MD 20892 USA.	csteel@niaid.nih.gov			NIH/NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000197] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIH/NIAID. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albareda MC, 2006, INT IMMUNOL, V18, P465, DOI 10.1093/intimm/dxh387; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Arens R, 2001, IMMUNITY, V15, P801, DOI 10.1016/S1074-7613(01)00236-9; Babu S, 2006, J IMMUNOL, V176, P3248, DOI 10.4049/jimmunol.176.5.3248; Babu S, 2006, J IMMUNOL, V176, P3885, DOI 10.4049/jimmunol.176.7.3885; Babu S, 2009, J INFECT DIS, V200, P288, DOI 10.1086/599797; Bhadra R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010842; Bouneauld C, 2005, J EXP MED, V201, P579, DOI 10.1084/jem.20040876; Boutboul F, 2005, AIDS, V19, P1981, DOI 10.1097/01.aids.0000191919.24185.46; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Burgers WA, 2009, J IMMUNOL, V182, P4751, DOI 10.4049/jimmunol.0803801; Bustamante JM, 2008, NAT MED, V14, P542, DOI 10.1038/nm1744; Albareda MC, 2009, J IMMUNOL, V183, P4103, DOI 10.4049/jimmunol.0900852; Chandele A, 2008, J IMMUNOL, V180, P5309, DOI 10.4049/jimmunol.180.8.5309; Colpitts SL, 2010, J IMMUNOL, V185, P2416, DOI 10.4049/jimmunol.1000483; Cooper PJ, 1998, J INFECT DIS, V178, P1133, DOI 10.1086/515661; Cooper PJ, 2003, AM J RESP CRIT CARE, V168, P313, DOI 10.1164/rccm.200211-1320OC; Cooper PJ, 2001, INFECT IMMUN, V69, P1574, DOI 10.1128/IAI.69.3.1574-1580.2001; Crawley AM, 2010, J IMMUNOL, V184, P4679, DOI 10.4049/jimmunol.0903758; Faucher S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006690; Fuller MJ, 2005, J IMMUNOL, V174, P5926, DOI 10.4049/jimmunol.174.10.5926; Gollob KJ, 2008, INT IMMUNOPHARMACOL, V8, P1338, DOI 10.1016/j.intimp.2008.03.016; Hammerbeck CD, 2008, J IMMUNOL, V180, P2107, DOI 10.4049/jimmunol.180.4.2107; Harnett W, 2009, ADV EXP MED BIOL, V666, P88; Jenson JS, 2002, EUR J IMMUNOL, V32, P858, DOI 10.1002/1521-4141(200203)32:3<858::AID-IMMU858>3.0.CO;2-E; KING CL, 1993, J CLIN INVEST, V92, P1667, DOI 10.1172/JCI116752; Lang A, 2008, J IMMUNOL, V180, P4848, DOI 10.4049/jimmunol.180.7.4848; Lang KS, 2005, EUR J IMMUNOL, V35, P738, DOI 10.1002/eji.200425828; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; Leng QB, 2006, INT IMMUNOL, V18, P637, DOI 10.1093/intimm/dxh375; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Liu D, 2009, J IMMUNOL, V183, P1921, DOI 10.4049/jimmunol.0901099; Maenetje P, 2010, J IMMUNOL, V184, P4926, DOI 10.4049/jimmunol.0903771; Mahanty S, 1996, J INFECT DIS, V173, P769, DOI 10.1093/infdis/173.3.769; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Malhotra I, 2006, J INFECT DIS, V193, P1005, DOI 10.1086/500472; Mercier F, 2008, CLIN EXP IMMUNOL, V152, P72, DOI 10.1111/j.1365-2249.2008.03610.x; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Messaoudi I, 2006, J IMMUNOL, V177, P2784, DOI 10.4049/jimmunol.177.5.2784; Metenou S, 2010, J IMMUNOL, V184, P5375, DOI 10.4049/jimmunol.0904067; Metenou S, 2009, J IMMUNOL, V183, P916, DOI 10.4049/jimmunol.0900257; Nielsen NO, 2007, AM J TROP MED HYG, V77, P507, DOI 10.4269/ajtmh.2007.77.507; NUTMAN TB, 1987, J CLIN INVEST, V79, P1516, DOI 10.1172/JCI112982; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; OTTESEN EA, 1982, AM J TROP MED HYG, V31, P953, DOI 10.4269/ajtmh.1982.31.953; Ouyang Qin, 2003, Experimental Gerontology, V38, P911, DOI 10.1016/S0531-5565(03)00134-7; Pawelec G, 2006, ANN NY ACAD SCI, V1067, P56, DOI 10.1196/annals.1354.009; Pawelec G, 2009, REV MED VIROL, V19, P47, DOI 10.1002/rmv.598; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Sabin EA, 1996, J INFECT DIS, V173, P269, DOI 10.1093/infdis/173.1.269; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schierack P, 2003, INFECT IMMUN, V71, P2422, DOI 10.1128/IAI.71.5.2422-2429.2003; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Semnani RT, 2003, J IMMUNOL, V171, P1950, DOI 10.4049/jimmunol.171.4.1950; Shen T, 2010, ARCH VIROL, V155, P627, DOI 10.1007/s00705-010-0626-z; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Specht S, 2004, INFECT IMMUN, V72, P6287, DOI 10.1128/IAI.72.11.6287-6293.2004; Steel C, 2003, J IMMUNOL, V170, P1930, DOI 10.4049/jimmunol.170.4.1930; STEEL C, 1994, LANCET, V343, P890, DOI 10.1016/S0140-6736(94)90009-4; Steel C, 1996, J INFECT DIS, V174, P598, DOI 10.1093/infdis/174.3.598; Steel C, 2001, J INFECT DIS, V184, P73, DOI 10.1086/321004; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; Waller ECP, 2008, MED MICROBIOL IMMUN, V197, P83, DOI 10.1007/s00430-008-0082-5; WELLER PF, 1982, AM J TROP MED HYG, V31, P942, DOI 10.4269/ajtmh.1982.31.942; Wherry EJ, 2006, VIROLOGY, V353, P366, DOI 10.1016/j.virol.2006.06.017; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108; Zaph C, 2006, J IMMUNOL, V177, P511, DOI 10.4049/jimmunol.177.1.511; Zhang XH, 2002, J EXP MED, V195, P283, DOI 10.1084/jem.20011267	75	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19197	10.1371/journal.pone.0019197	http://dx.doi.org/10.1371/journal.pone.0019197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559422	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700098
J	Wang, XH; Duan, XM; Yang, GL; Zhang, XY; Deng, LY; Zheng, H; Deng, CY; Wen, JL; Wang, N; Peng, C; Zhao, X; Wei, YQ; Chen, LJ				Wang, Xianhuo; Duan, Xingmei; Yang, Guangli; Zhang, Xiaoyan; Deng, Linyu; Zheng, Hao; Deng, Chongyang; Wen, Jiaolin; Wang, Ning; Peng, Cheng; Zhao, Xia; Wei, Yuquan; Chen, Lijuan			Honokiol Crosses BBB and BCSFB, and Inhibits Brain Tumor Growth in Rat 9L Intracerebral Gliosarcoma Model and Human U251 Xenograft Glioma Model	PLOS ONE			English	Article							P-GLYCOPROTEIN; IN-VIVO; MAGNOLIA BARK; BARRIER; THERAPY; AGENT; CELLS; MICE; ANGIOGENESIS; IDENTIFICATION	Background: Gliosarcoma is one of the most common malignant brain tumors, and anti-angiogenesis is a promising approach for the treatment of gliosarcoma. However, chemotherapy is obstructed by the physical obstacle formed by the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB). Honokiol has been known to possess potent activities in the central nervous system diseases, and anti-angiogenic and anti-tumor properties. Here, we hypothesized that honokiol could cross the BBB and BCSFB for the treatment of gliosarcoma. Methodologies: We first evaluated the abilities of honokiol to cross the BBB and BCSFB by measuring the penetration of honokiol into brain and blood-cerebrospinal fluid, and compared the honokiol amount taken up by brain with that by other tissues. Then we investigated the effect of honokiol on the growth inhibition of rat 9L gliosarcoma cells and human U251 glioma cells in vitro. Finally we established rat 9L intracerebral gliosarcoma model in Fisher 344 rats and human U251 xenograft glioma model in nude mice to investigate the anti-tumor activity. Principal Findings: We showed for the first time that honokiol could effectively cross BBB and BCSFB. The ratios of brain/plasma concentration were respectively 1.29, 2.54, 2.56 and 2.72 at 5, 30, 60 and 120 min. And about 10% of honokiol in plasma crossed BCSFB into cerebrospinal fluid (CSF). In vitro, honokiol produced dose-dependent inhibition of the growth of rat 9L gliosarcoma cells and human U251 glioma cells with IC(50) of 15.61 mu g/mL and 16.38 mu g/mL, respectively. In vivo, treatment with 20 mg/kg body weight of honokiol (honokiol was given twice per week for 3 weeks by intravenous injection) resulted in significant reduction of tumor volume (112.70 +/- 10.16 mm(3)) compared with vehicle group (238.63 +/- 19.69 mm(3), P = 0.000), with 52.77% inhibiting rate in rat 9L intracerebral gliosarcoma model, and (1450.83 +/- 348.36 mm(3)) compared with vehicle group (2914.17 +/- 780.52 mm(3), P = 0.002), with 50.21% inhibiting rate in human U251 xenograft glioma model. Honokiol also significantly improved the survival over vehicle group in the two models (P < 0.05). Conclusions/Significance: This study provided the first evidence that honokiol could effectively cross BBB and BCSFB and inhibit brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model. It suggested a significant strategy for offering a potential new therapy for the treatment of gliosarcoma.	[Wang, Xianhuo; Duan, Xingmei; Yang, Guangli; Zhang, Xiaoyan; Deng, Linyu; Zheng, Hao; Deng, Chongyang; Wen, Jiaolin; Wang, Ning; Zhao, Xia; Wei, Yuquan; Chen, Lijuan] Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Wang, Xianhuo; Duan, Xingmei; Yang, Guangli; Zhang, Xiaoyan; Deng, Linyu; Zheng, Hao; Deng, Chongyang; Wen, Jiaolin; Wang, Ning; Zhao, Xia; Wei, Yuquan; Chen, Lijuan] Sichuan Univ, W China Med Sch, W China Hosp, Ctr Canc, Chengdu 610064, Peoples R China; [Peng, Cheng; Chen, Lijuan] Chengdu Univ Tradit Chinese Med, State Key Lab Breeding Base Systemat Res Dev & Ut, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Chengdu University of Traditional Chinese Medicine	Wang, XH (corresponding author), Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China.	lijuan17@hotmail.com	Wen, Jiaolin/GZL-0162-2022	Peng, Cheng/0000-0003-3303-906X; Wang, Xianhuo/0000-0002-7663-2923	National Key Programs of China [2009ZX09501-015]; National Natural Science Foundation of China [81071251]; State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine, Chengdu University of Traditional Chinese Medicine	National Key Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine, Chengdu University of Traditional Chinese Medicine	The work was supported by National Key Programs of China during the 11th Five-Year Plan Period (2009ZX09501-015), the National Natural Science Foundation of China (81071251) and the Open-Study Funds of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine, Chengdu University of Traditional Chinese Medicine. The URLs of three funder's websites are respectively http://www.most.gov.cn/, http://www.nsfc.gov.cn/Portal0/default124.htm and http://vtual.cdutcm.edu.cn/zyzyxt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott N Joan, 2004, Drug Discov Today Technol, V1, P407, DOI 10.1016/j.ddtec.2004.11.014; Badruddoja MA, 2003, NEURO-ONCOLOGY, V5, P235, DOI 10.1215/S1152851703000073; Bai XH, 2003, J BIOL CHEM, V278, P35501, DOI 10.1074/jbc.M302967200; Barth RF, 1998, J NEURO-ONCOL, V36, P91, DOI 10.1023/A:1005805203044; Beaumont TL, 2007, J NEURO-ONCOL, V83, P39, DOI 10.1007/s11060-006-9295-x; BREM SS, 1990, AM J PATHOL, V137, P1121; BURGER PC, 1994, TUMORS CENTRAL NERVO, P265; Camphausen K, 2005, P NATL ACAD SCI USA, V102, P8287, DOI 10.1073/pnas.0502887102; Chen LJ, 2007, J CHROMATOGR A, V1142, P115, DOI 10.1016/j.chroma.2006.09.098; Crane C, 2009, J IMMUNOTHER, V32, P585, DOI 10.1097/CJI.0b013e3181a8efe6; Feng MR, 2002, CURR DRUG METAB, V3, P647, DOI 10.2174/1389200023337063; Gallo JM, 2003, CANCER RES, V63, P5114; Grossman SA, 2003, SEMIN ONCOL, V30, P19, DOI 10.1053/j.seminoncol.2003.11.035; Guo M, 2006, J PHARMACOL EXP THER, V317, P97, DOI 10.1124/jpet.105.097782; Hagihara N, 2000, CANCER RES, V60, P230; Haraguchi H, 1997, J PHARM PHARMACOL, V49, P209, DOI 10.1111/j.2042-7158.1997.tb06781.x; Hibasami H, 1998, INT J MOL MED, V2, P671; HIRANO T, 1994, LIFE SCI, V55, P1061, DOI 10.1016/0024-3205(94)00641-5; Hu J, 2008, EXP MOL MED, V40, P617, DOI 10.3858/emm.2008.40.6.617; Kim JH, 2003, RADIAT RES, V160, P662, DOI 10.1667/RR3069; Kim JH, 1999, INT J RADIAT ONCOL, V45, P1035, DOI 10.1016/S0360-3016(99)00273-4; Kuribara H, 1999, J PHARM PHARMACOL, V51, P97; Kuribara H, 1998, J PHARM PHARMACOL, V50, P819, DOI 10.1111/j.2042-7158.1998.tb07146.x; Kuribara H, 2000, PHARMACOL BIOCHEM BE, V67, P597, DOI 10.1016/S0091-3057(00)00401-9; LAMPSON LA, 1992, CANCER RES, V52, P1018; Liou KT, 2003, BRAIN RES, V992, P159, DOI 10.1016/j.brainres.2003.08.026; Maruyama Y, 1998, J NAT PROD, V61, P135, DOI 10.1021/np9702446; MEIS JM, 1991, CANCER, V67, P2342, DOI 10.1002/1097-0142(19910501)67:9<2342::AID-CNCR2820670922>3.0.CO;2-B; Murphy S, 2007, J NEURO-ONCOL, V85, P181, DOI 10.1007/s11060-007-9406-3; Quarles CC, 2007, MAGN RESON MED, V57, P680, DOI 10.1002/mrm.21193; Sade B, 2006, J NEUROSURG, V105, P904, DOI 10.3171/jns.2006.105.6.904; SAKATA A, 1994, BIOCHEM PHARMACOL, V48, P1989, DOI 10.1016/0006-2952(94)90601-7; Sasaki M, 1998, ANN ONCOL, V9, P1155, DOI 10.1023/A:1008488709359; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; SCHMIDEK HH, 1971, J NEUROSURG, V34, P335, DOI 10.3171/jns.1971.34.3.0335; Sung JH, 2009, TOXICOL SCI, V108, P452, DOI 10.1093/toxsci/kfn246; TEICHER BA, 1995, INT J CANCER, V61, P732, DOI 10.1002/ijc.2910610523; van Rooy I, 2010, PHARM RES-DORDR, V27, P673, DOI 10.1007/s11095-010-0053-6; Wang T, 2004, WORLD J GASTROENTERO, V10, P2205; WATANABE K, 1983, PLANTA MED, V49, P103, DOI 10.1055/s-2007-969825; WEN P, 1990, J NEUROIMMUNOL, V27, P239, DOI 10.1016/0165-5728(90)90074-W; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu XN, 2003, TALANTA, V59, P115, DOI 10.1016/S0039-9140(02)00470-8; Yang SE, 2002, BIOCHEM PHARMACOL, V63, P1641, DOI 10.1016/S0006-2952(02)00894-8	45	103	112	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18490	10.1371/journal.pone.0018490	http://dx.doi.org/10.1371/journal.pone.0018490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559510	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700013
J	Piedfer, M; Dauzonne, D; Tang, RP; N'Guyen, J; Billard, C; Bauvois, B				Piedfer, Marion; Dauzonne, Daniel; Tang, Ruoping; N'Guyen, Juliette; Billard, Christian; Bauvois, Brigitte			Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells	FASEB JOURNAL			English	Article						AML; APN; antibody; inhibitor; Bcl-2 family	P38 MAP KINASE; N CD13; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; LEUKEMIC-CELLS; KAPPA-B; APOPTOSIS; INHIBITION; PATHWAYS; SURVIVAL	The transmembrane metalloprotease aminopeptidase-N (APN)/CD13 is overexpressed in various solid and hematological malignancies in humans, including acute myeloid leukemia (AML) and is thought to influence tumor progression. Here, we investigated the contribution of APN/CD13 to the regulation of growth and survival processes in AML cells in vitro. Anti-CD13 monoclonal antibodies MY7 and SJ1D1 (which do not inhibit APN activity) and WM15 (an APN-blocking antibody) inhibited the growth of the AML cell line U937 and induced apoptosis, as evidenced by cell accumulation in the sub-G(1) phase, DNA fragmentation, and phosphatidylserine externalization. Isotype-matched IgG1 and the APN/CD13 enzymatic inhibitors bestatin and 2',3-dinitroflavone-8-acetic acid, were ineffective. Internalization of CD13-MY7 complex into cells was followed by mitochondrial membrane depolarization, Bcl-2 and Mcl-1 down-regulation, Bax up-regulation, caspase-9, caspase-8, and caspase-3 activation, and cleavage of the caspase substrate PARP-1. The broad-spectrum caspase inhibitor Z-VAD-fmk and the caspase-9- and caspase-8-specific inhibitors significantly attenuated apoptosis. CD13 ligation also induced apoptosis and PARP-1 cleavage in primary AML blasts, whereas normal blood cells were not affected. Overall, these data provide new evidence that CD13 can serve as a target for inducing caspase-dependent apoptosis in AML (independently of its APN activity). These findings may have implications for tumor biology and treatment.-Piedfer, M., Dauzonne, D., Tang, R., N'Guyen, J., Billard, C., Bauvois, B. Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells. FASEB J. 25, 2831-2842 (2011). www.fasebj.org	[Piedfer, Marion; Billard, Christian; Bauvois, Brigitte] INSERM, Ctr Rech Cordeliers, U872, F-75270 Paris 06, France; [Piedfer, Marion; Billard, Christian; Bauvois, Brigitte] Univ Paris 06, UMRS 872, Paris, France; [Piedfer, Marion; Billard, Christian; Bauvois, Brigitte] Univ Paris 05, UMRS 872, Paris, France; [Dauzonne, Daniel] Inst Curie, CNRS 176, Paris, France; [Tang, Ruoping] Hop St Antoine, Dept Hematol, F-75571 Paris, France; [N'Guyen, Juliette] Hop Cochin, Dept Malad Infect, F-75674 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Bauvois, B (corresponding author), INSERM, Ctr Rech Cordeliers, U872, 15 Rue Ecole Med, F-75270 Paris 06, France.	brigitte.bauvois@crc.jussieu.fr	Bauvois, Brigitte/F-6776-2013	Bauvois, Brigitte/0000-0002-1751-6922	Institut National de la Sante et de la Recherche Medicale; Association pour la Recherche sur le Cancer; Ligue contre le Cancer (Comite de Paris)	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue contre le Cancer (Comite de Paris)(Ligue nationale contre le cancer)	This work was funded by grants from the Institut National de la Sante et de la Recherche Medicale, the Association pour la Recherche sur le Cancer, and the Ligue contre le Cancer (Comite de Paris). The authors thank Fanny Fava for technical assistance. The authors declare no conflicting financial interests.	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; ASHMUN RA, 1990, BLOOD, V75, P462; Bauvois B, 2006, MED RES REV, V26, P88, DOI 10.1002/med.20044; Bauvois B, 2003, J MED CHEM, V46, P3900, DOI 10.1021/jm021109f; Bauvois B, 1996, EXP CELL RES, V222, P209, DOI 10.1006/excr.1996.0026; Bauvois B, 2000, ONCOGENE, V19, P265, DOI 10.1038/sj.onc.1203292; Bernardi P., 2007, V45, P481; Bhagwat SV, 2001, BLOOD, V97, P652, DOI 10.1182/blood.V97.3.652; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; BRELJAK D, 2003, HAEMA, V6, P453; Bremer E, 2006, TRENDS MOL MED, V12, P382, DOI 10.1016/j.molmed.2006.06.002; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Bulat N, 2009, BRAIN RES BULL, V80, P251, DOI 10.1016/j.brainresbull.2009.07.007; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Cowburn AS, 2006, J BIOL CHEM, V281, P12458, DOI 10.1074/jbc.M511277200; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; FAVALORO EJ, 1988, BRIT J HAEMATOL, V69, P163, DOI 10.1111/j.1365-2141.1988.tb07618.x; FAVALORO EJ, 1991, IMMUNOL CELL BIOL, V69, P253, DOI 10.1038/icb.1991.36; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Fujita N, 1998, BIOCHEM BIOPH RES CO, V246, P484, DOI 10.1006/bbrc.1998.8587; Grandage VL, 2005, LEUKEMIA, V19, P586, DOI 10.1038/sj.leu.2403653; Gredmark S, 2004, J IMMUNOL, V173, P4897, DOI 10.4049/jimmunol.173.8.4897; GRIFFIN JD, 1981, J CLIN INVEST, V68, P932, DOI 10.1172/JCI110348; Grujic M, 2002, CANCER LETT, V182, P113, DOI 10.1016/S0304-3835(02)00086-1; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Hashida H, 2002, GASTROENTEROLOGY, V122, P376, DOI 10.1053/gast.2002.31095; INO K, 1994, JPN J CANCER RES, V85, P927, DOI 10.1111/j.1349-7006.1994.tb02970.x; King ME, 2007, ONCOLOGIST, V12, P14, DOI 10.1634/theoncologist.12-S2-14; Lai A, 2010, MOL CELL BIOCHEM, V343, P191, DOI 10.1007/s11010-010-0513-7; Lendeckel U, 2000, ADV EXP MED BIOL, V477, P1; Lohn M, 1997, ADV EXP MED BIOL, V421, P85; Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Martelli AM, 2007, EUR J HISTOCHEM, V51, P125; Mason KD, 2006, BLOOD REV, V20, P71, DOI 10.1016/j.blre.2005.08.002; Mina-Osorio P, 2005, J LEUKOCYTE BIOL, V77, P1008, DOI 10.1189/jlb.1204714; Mina-Osorio P, 2008, TRENDS MOL MED, V14, P361, DOI 10.1016/j.molmed.2008.06.003; Mina-Osorio P, 2008, J LEUKOCYTE BIOL, V84, P448, DOI 10.1189/jlb.1107802; Mina-Osorio P, 2006, J LEUKOCYTE BIOL, V79, P719, DOI 10.1189/jlb.0705425; Nguyen J, 2006, IMMUNOL LETT, V106, P34, DOI 10.1016/j.imlet.2006.04.003; Park C, 2008, TOXICOL APPL PHARM, V227, P219, DOI 10.1016/j.taap.2007.10.003; Pasqualini R, 2000, CANCER RES, V60, P722; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Plesa C, 2008, CANCER-AM CANCER SOC, V112, P572, DOI 10.1002/cncr.23219; Quiney C, 2006, LEUKEMIA, V20, P491, DOI 10.1038/sj.leu.2404098; Rahmani M, 2003, ONCOGENE, V22, P6231, DOI 10.1038/sj.onc.1206646; Riemann D, 2005, BIOCHEM BIOPH RES CO, V331, P1408, DOI 10.1016/j.bbrc.2005.04.061; SAIKI I, 1993, INT J CANCER, V54, P137, DOI 10.1002/ijc.2910540122; Sanceau J, 2002, J BIOL CHEM, V277, P35766, DOI 10.1074/jbc.M202959200; Santos AN, 2000, CELL IMMUNOL, V201, P22, DOI 10.1006/cimm.2000.1629; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Song G, 2010, CURR CANCER DRUG TAR, V10, P584, DOI 10.2174/156800910791859515; Sordet O, 1999, CELL DEATH DIFFER, V6, P351, DOI 10.1038/sj.cdd.4400499; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Wang ZB, 2005, CELL BIOL INT, V29, P489, DOI 10.1016/j.cellbi.2005.04.001; Wickstrom M, 2011, CANCER SCI, V102, P501, DOI 10.1111/j.1349-7006.2010.01826.x; Xie J, 2005, EXP HEMATOL, V33, P564, DOI 10.1016/j.exphem.2005.03.001; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhao S, 2004, LEUKEMIA, V18, P267, DOI 10.1038/sj.leu.2403220	59	40	45	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2011	25	8					2831	2842		10.1096/fj.11-181396	http://dx.doi.org/10.1096/fj.11-181396			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21566207	Green Published			2022-12-25	WOS:000293337800031
J	Gu, DM; Tonthat, NK; Lee, M; Ji, H; Bhat, KP; Hollingsworth, F; Aldape, KD; Schumacher, MA; Zwaka, TP; McCrea, PD				Gu, Dongmin; Tonthat, Nam Ky; Lee, Moonsup; Ji, Hong; Bhat, Krishna P.; Hollingsworth, Faith; Aldape, Kenneth D.; Schumacher, Maria A.; Zwaka, Thomas P.; McCrea, Pierre D.			Caspase-3 Cleavage Links delta-Catenin to the Novel Nuclear Protein ZIFCAT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; E-CADHERIN; CELL-ADHESION; DESMOSOMAL CADHERIN; SIGNALING PATHWAY; APOPTOSIS; CANCER; P120-CATENIN; PROTEOLYSIS; MECHANISMS	delta-Catenin is an Armadillo protein of the p120-catenin subfamily capable of modulating cadherin stability, small GTPase activity, and nuclear transcription. From yeast two-hybrid screening of a human embryonic stem cell cDNA library, we identified delta-catenin as a potential interacting partner of the caspase-3 protease, which plays essential roles in apoptotic as well as non-apoptotic processes. Interaction of delta-catenin with caspase-3 was confirmed using cleavage assays conducted in vitro, in Xenopus apoptotic extracts, and in cell line chemically induced contexts. The cleavage site, a highly conserved caspase consensus motif (DELD) within Armadillo repeat 6 of delta-catenin, was identified through peptide sequencing. Cleavage thus generates an amino-terminal (residues 1-816) and carboxyl-terminal (residues 817-1314) fragment, each containing about half of the central Armadillo domain. We found that cleavage of delta-catenin both abolishes its association with cadherins and impairs its ability to modulate small GTPases. Interestingly, 817-1314 possesses a conserved putative nuclear localization signal that may facilitate the nuclear targeting of delta-cateninin defined contexts. To probe for novel nuclear roles of delta-catenin, we performed yeast two-hybrid screening of a mouse brain cDNA library, resolving and then validating interaction with an uncharacterized KRAB family zinc finger protein, ZIFCAT. Our results indicate that ZIFCAT is nuclear and suggest that it may associate with DNA as a transcriptional repressor. We further determined that other p120 subfamily catenins are similarly cleaved by caspase-3 and likewise bind ZIFCAT. Our findings potentially reveal a simple yet novel signaling pathway based upon caspase-3 cleavage of p120-catenin subfamily members, facilitating the coordinate modulation of cadherins, small GTPases, and nuclear functions.	[Gu, Dongmin; Tonthat, Nam Ky; Lee, Moonsup; Schumacher, Maria A.; McCrea, Pierre D.] Univ Texas Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA; [Gu, Dongmin; Tonthat, Nam Ky; Lee, Moonsup; Ji, Hong; Schumacher, Maria A.; McCrea, Pierre D.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Bhat, Krishna P.; Hollingsworth, Faith; Aldape, Kenneth D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Zwaka, Thomas P.] Dept Mol & Cellular Biol, Baylor Coll Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	McCrea, PD (corresponding author), Univ Texas Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA.	pdmccrea@mdanderson.org	Gu, Dongmin/C-9048-2013		National Institutes of Health [RO1 GM52112]; National Institutes of Health, NCI [CA-16672]; Texas ARP Grant; March of Dimes [1-FY-07-461-01]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052112, R01GM077442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Texas ARP Grant; March of Dimes(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM52112 (to P. D. M.), and assistance with DNA sequencing and other core facilities was provided by National Institutes of Health, NCI, Core Grant CA-16672 (to M. D. Anderson Cancer Center). This work was also supported by a Texas ARP Grant and March of Dimes Grant 1-FY-07-461-01 (to P. D. M.).	Abdul-Ghani M, 2011, MOL CELL BIOL, V31, P163, DOI 10.1128/MCB.01539-09; Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Arikkath J, 2009, J NEUROSCI, V29, P5435, DOI 10.1523/JNEUROSCI.0835-09.2009; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bareiss S, 2010, J NEUROSCI RES, V88, P2350, DOI 10.1002/jnr.22414; Brancolini C, 1997, J CELL BIOL, V139, P759, DOI 10.1083/jcb.139.3.759; Cirillo N, 2008, J CELL BIOCHEM, V103, P598, DOI 10.1002/jcb.21431; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; DAVIDOFF AN, 1992, LEUKEMIA RES, V16, P1077, DOI 10.1016/0145-2126(92)90046-A; DeBusk LM, 2010, J EXP MED, V207, P77, DOI 10.1084/jem.20091097; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Dusek RL, 2006, J BIOL CHEM, V281, P3614, DOI 10.1074/jbc.M508258200; Fang X, 2004, J CELL BIOL, V165, P87, DOI 10.1083/jcb.200307109; Feinstein-Rotkopf Y, 2009, APOPTOSIS, V14, P980, DOI 10.1007/s10495-009-0346-6; Ferber EC, 2008, J BIOL CHEM, V283, P12691, DOI 10.1074/jbc.M708887200; FISHMAN JA, 1985, AM J PATHOL, V118, P398; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gu DM, 2009, J CELL SCI, V122, P4049, DOI 10.1242/jcs.031948; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Hong JY, 2010, J CELL SCI, V123, P4351, DOI 10.1242/jcs.067199; Hosking CR, 2007, MOL BIOL CELL, V18, P1918, DOI 10.1091/mbc.E06-10-0941; Hunter I, 2001, J BONE MINER RES, V16, P466, DOI 10.1359/jbmr.2001.16.3.466; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kessler T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-15; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; Kim K, 2002, EXP CELL RES, V275, P171, DOI 10.1006/excr.2002.5503; Kornbluth S., 2001, CURRENT PROTOCOLS CE; Kosik KS, 2005, TRENDS CELL BIOL, V15, P172, DOI 10.1016/j.tcb.2005.01.004; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Ling YH, 2001, MOL PHARMACOL, V59, P593, DOI 10.1124/mol.59.3.593; Lockshin RA, 2007, J CELL MOL MED, V11, P1214, DOI 10.1111/j.1582-4934.2007.00150.x; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Lu JP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-304; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Lu Q, 2009, PROSTATE, V69, P411, DOI 10.1002/pros.20902; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; McCrea PD, 2010, J CELL SCI, V123, P637, DOI 10.1242/jcs.039842; McCusker Catherine D, 2009, Commun Integr Biol, V2, P155; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Oh M, 2009, J BIOL CHEM, V284, P28579, DOI 10.1074/jbc.M109.002659; Parisiadou L, 2004, NEURODEGENER DIS, V1, P184, DOI 10.1159/000080984; Park JI, 2006, DEV CELL, V11, P683, DOI 10.1016/j.devcel.2006.09.022; Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Senthivinayagam S, 2009, J BIOL CHEM, V284, P13577, DOI 10.1074/jbc.M900248200; Solary E, 1998, CELL BIOL TOXICOL, V14, P121, DOI 10.1023/A:1007481921502; Steinhusen U, 2000, J BIOL CHEM, V275, P16345, DOI 10.1074/jbc.M001458200; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Suzanne Magali, 2009, Journal of Biology (London), V8, P49, DOI 10.1186/jbiol152; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Weiske J, 2004, METH MOL B, V289, P175; Xiao K, 2007, BBA-MOL CELL RES, V1773, P8, DOI 10.1016/j.bbamcr.2006.07.005; Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156; Zeng Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-19; Zhang JY, 2010, J PATHOL, V222, P76, DOI 10.1002/path.2742; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983	68	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23178	23188		10.1074/jbc.M110.167544	http://dx.doi.org/10.1074/jbc.M110.167544			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561870	hybrid, Green Published			2022-12-25	WOS:000292025000052
J	Gutsch, R; Kandemir, JD; Pietsch, D; Cappello, C; Meyer, J; Simanowski, K; Huber, R; Brand, K				Gutsch, Romina; Kandemir, Judith D.; Pietsch, Daniel; Cappello, Christian; Meyer, Johann; Simanowski, Kathrin; Huber, Rene; Brand, Korbinian			CCAAT/Enhancer-binding Protein beta Inhibits Proliferation in Monocytic Cells by Affecting the Retinoblastoma Protein/E2F/Cyclin E Pathway but Is Not Directly Required for Macrophage Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; C/EBP-BETA; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; TRANSLATIONAL CONTROL; FAMILY-MEMBERS; TOLERANT CELLS; DEFICIENT MICE; GROWTH ARREST; C-MYC	Monocytic differentiation is orchestrated by complex networks that are not fully understood. This study further elucidates the involvement of transcription factor CCAAT/enhancer-binding protein beta (C/EBP beta). Initially, we demonstrated a marked increase in nuclear C/EBP beta-liver-enriched activating protein* (LAP*)/liver-enriched activating protein (LAP) levels and LAP/liver- enriched inhibiting protein (LIP) ratios in phorbol 12-myristate 13-acetate (PMA)-treated differentiating THP-1 premonocytic cells accompanied by reduced proliferation. To directly study C/EBP beta effects on monocytic cells, we generated novel THP-1-derived (low endogenous C/EBP beta) cell lines stably overexpressing C/EBP beta isoforms. Most importantly, cells predominantly overexpressing LAP* (C/EBP beta-long), but not those overexpressing LIP (C/EBP beta-short), exhibited a reduced proliferation, with no effect on morphology. PMA-induced inhibition of proliferation was attenuated in C/EBP beta-short cells. In C/EBP beta(WT) macrophage-like cells (high endogenous C/EBP beta), we measured a reduced proliferation/cycling index compared with C/EBP beta(KO). The typical macrophage morphology was only observed in C/EBP beta(WT), whereas C/EBP beta(KO) stayed round. C/EBP beta alpha did not compensate for C/EBP beta effects on proliferation/morphology. Serum reduction, an independent approach known to inhibit proliferation, induced macrophage morphology in C/EBP beta(KO) macrophage-like cells but not THP-1. In PMA-treated THP-1 and C/EBP beta-long cells, a reduced phosphorylation of cell cycle repressor retinoblastoma was found. In addition, C/EBP beta-long cells showed reduced c-Myc expression accompanied by increased CDK inhibitor p27 and reduced cyclin D1 levels. Finally, C/EBP beta-long and C/EBP beta(WT) cells exhibited low E2F1 and cyclin E levels, and C/EBP beta overexpression was found to inhibit cyclin E1 promoter-dependent transcription. Our results suggest that C/EBP beta reduces monocytic proliferation by affecting the retinoblastoma/E2F/cyclin E pathway and that it may contribute to, but is not directly required for, macrophage morphology. Inhibition of proliferation by C/EBP beta may be important for coordinated monocytic differentiation.	[Gutsch, Romina; Kandemir, Judith D.; Pietsch, Daniel; Cappello, Christian; Simanowski, Kathrin; Huber, Rene; Brand, Korbinian] Hannover Med Sch, Inst Clin Chem, D-30625 Hannover, Germany; [Meyer, Johann] Hannover Med Sch, Dept Expt Hematol, D-30625 Hannover, Germany	Hannover Medical School; Hannover Medical School	Huber, R (corresponding author), Hannover Med Sch, Inst Clin Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	huber.rene@mh-hannover.de; brand.korbinian@mh-hannover.de		Huber, Rene/0000-0002-1041-9935	Stiftung fur Pathobiochemie und Molekulare Diagnostik der Deutschen Gesellschaft fur Klinische Chemie und Laboratoriumsmedizin	Stiftung fur Pathobiochemie und Molekulare Diagnostik der Deutschen Gesellschaft fur Klinische Chemie und Laboratoriumsmedizin	This work was supported by the Stiftung fur Pathobiochemie und Molekulare Diagnostik der Deutschen Gesellschaft fur Klinische Chemie und Laboratoriumsmedizin.	Adams PD, 2001, BBA-REV CANCER, V1471, pM123, DOI 10.1016/S0304-419X(01)00019-1; Akagi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015419; Araki K, 2003, ONCOGENE, V22, P7632, DOI 10.1038/sj.onc.1206840; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; BASHEERUDDIN K, 1992, J BIOL CHEM, V267, P1219; Berberich-Siebelt F, 2006, J IMMUNOL, V176, P4843, DOI 10.4049/jimmunol.176.8.4843; Bergh G, 1999, BLOOD, V94, P1971; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; Calkhoven CF, 2000, GENE DEV, V14, P1920; Cappello C, 2009, CELL SIGNAL, V21, P1918, DOI 10.1016/j.cellsig.2009.08.009; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chen PL, 1996, P NATL ACAD SCI USA, V93, P465, DOI 10.1073/pnas.93.1.465; Chen S, 2009, LEUKEMIA RES, V33, P1108, DOI 10.1016/j.leukres.2008.10.016; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488; Gagliardi M, 2003, J BIOL CHEM, V278, P43846, DOI 10.1074/jbc.M304085200; Gheorghiu I, 2001, J BIOL CHEM, V276, P44331, DOI 10.1074/jbc.M107591200; Gorgoni B, 2002, J IMMUNOL, V168, P4055, DOI 10.4049/jimmunol.168.8.4055; Haas SC, 2010, BRIT J HAEMATOL, V148, P777, DOI 10.1111/j.1365-2141.2009.08012.x; Hayashida M, 2009, ARTHRITIS RHEUM-US, V60, P708, DOI 10.1002/art.24332; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Huber R, 2003, Z RHEUMATOL, V62, P378, DOI 10.1007/S00393-003-0472-4; Ji Y, 2004, CANCER RES, V64, P370, DOI 10.1158/0008-5472.CAN-03-3029; Kraunus J, 2004, GENE THER, V11, P1568, DOI 10.1038/sj.gt.3302309; Lee S, 2010, MOL CELL BIOL, V30, P2621, DOI 10.1128/MCB.00782-09; Li ZX, 2003, EXP HEMATOL, V31, P1206, DOI 10.1016/j.exphem.2003.08.008; Li-Weber M, 2001, EUR J IMMUNOL, V31, P3694, DOI 10.1002/1521-4141(200112)31:12<3694::AID-IMMU3694>3.0.CO;2-S; Macleod KF, 2008, NAT REV CANCER, V8, P769, DOI 10.1038/nrc2504; Matsushita H, 2008, ONCOGENE, V27, P6749, DOI 10.1038/onc.2008.285; Muller C, 2010, EMBO J, V29, P897, DOI 10.1038/emboj.2009.404; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Orellana D, 2010, J BIOL CHEM, V285, P23442, DOI 10.1074/jbc.M110.129825; Park MH, 2008, FEBS LETT, V582, P415, DOI 10.1016/j.febslet.2008.01.001; Pham TH, 2007, J BIOL CHEM, V282, P21924, DOI 10.1074/jbc.M611618200; Prosch S, 2001, J BIOL CHEM, V276, P40712, DOI 10.1074/jbc.M009815200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; RAMP U, 1990, VIRCHOWS ARCH B, V59, P271, DOI 10.1007/BF02899414; Schambach A, 2006, MOL THER, V13, P391, DOI 10.1016/j.ymthe.2005.08.012; Screpanti I, 1996, J EXP MED, V184, P1561, DOI 10.1084/jem.184.4.1561; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; Studzinski GP, 1997, EXP CELL RES, V232, P376, DOI 10.1006/excr.1997.3484; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tissieres P, 2009, J BIOL CHEM, V284, P26261, DOI 10.1074/jbc.M109.042580; Traore K, 2005, LEUKEMIA RES, V29, P863, DOI 10.1016/j.leukres.2004.12.011; Wang QF, 2002, BLOOD, V99, P2776, DOI 10.1182/blood.V99.8.2776; Weber M, 2003, J BIOL CHEM, V278, P23586, DOI 10.1074/jbc.M211646200; Wethmar K, 2010, GENE DEV, V24, P15, DOI 10.1101/gad.557910; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xiong W, 2001, NUCLEIC ACIDS RES, V29, P3087, DOI 10.1093/nar/29.14.3087; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yang ZY, 2000, J BIOL CHEM, V275, P21272, DOI 10.1074/jbc.M000145200; Yu QY, 2005, ONCOGENE, V24, P7114, DOI 10.1038/sj.onc.1208853; Zahnow CA, 2001, CANCER RES, V61, P261; Zhu SY, 1999, MOL CELL BIOL, V19, P7181; Zwergal A, 2006, J IMMUNOL, V177, P665, DOI 10.4049/jimmunol.177.1.665	60	29	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22716	22729		10.1074/jbc.M110.152538	http://dx.doi.org/10.1074/jbc.M110.152538			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21558273	Green Published, hybrid			2022-12-25	WOS:000292025000006
J	Lin, ZH; Jin, S; Duan, XH; Wang, T; Martini, S; Hulamm, P; Cha, BY; Hubbard, A; Donowitz, M; Guggino, SE				Lin, Zhihong; Jin, Shi; Duan, Xiaohong; Wang, Tong; Martini, Sabrina; Hulamm, Phuson; Cha, Boyoung; Hubbard, Ann; Donowitz, Mark; Guggino, Sandra E.			Chloride Channel (Clc)-5 Is Necessary for Exocytic Trafficking of Na+/H+ Exchanger 3 (NHE3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOSOMAL CLC PROTEINS; KNOCKOUT MOUSE MODEL; DENTS-DISEASE; PROXIMAL TUBULE; BRUSH-BORDER; IMPAIRS ENDOCYTOSIS; REGULATORY PROTEIN; NULL MICE; KIDNEY; INHIBITION	ClC-5, a chloride/proton exchanger, is predominantly expressed and localized in subapical endosomes of the renal proximal tubule. Mutations of the CLCN5 gene cause Dent disease. The symptoms of Dent disease are replicated in Clcn5 knockout mice. Absence of ClC-5 in mice is associated with reduced surface expression of NHE3 in proximal tubules. The molecular basis for this change is not fully understood. In this study, we investigated the mechanisms by which ClC-5 regulates trafficking of NHE3. Whether ClC-5-dependent endocytosis, exocytosis, or both contributed to the altered distribution of NHE3 was examined. First, NHE3 activity in proximal tubules of wild type (WT) and Clcn5 KO mice was determined by two-photon microscopy. Basal and dexamethasone-stimulated NHE3 activity of Clcn5 KO mice was decreased compared with that seen in WT mice, whereas the degree of inhibition of NHE3 activity by increasing cellular concentration of cAMP (forskolin) or Ca2+ (A23187) was not different in WT and Clcn5 KO mice. Second, NHE3-dependent absorption of HCO3-, measured by single tubule perfusion, was reduced in proximal tubules of Clcn5 KO mice. Third, by cell surface biotinylation, trafficking of NHE3 was examined in short hairpin RNA (shRNA) plasmid-transfected opossum kidney cells. Surface NHE3 was reduced in opossum kidney cells with reduced expression of ClC-5, whereas the total protein level of NHE3 did not change. Parathyroid hormone decreased NHE3 surface expression, but the extent of decrease and the rate of endocytosis observed in both scrambled and ClC-5 knockdown cells were not significantly different. However, the rates of basal and dexamethasone-stimulated exocytosis of NHE3 were attenuated in ClC-5 knockdown cells. These results show that ClC-5 plays an essential role in exocytosis of NHE3.	[Lin, Zhihong; Jin, Shi; Duan, Xiaohong; Martini, Sabrina; Hulamm, Phuson; Cha, Boyoung; Donowitz, Mark; Guggino, Sandra E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Donowitz, Mark; Guggino, Sandra E.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Hubbard, Ann] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Wang, Tong] Yale Univ, Sch Med, Dept Physiol, New Haven, CT 06520 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Yale University	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 925 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu		Jin, Shi/0000-0003-0177-5716	National Institutes of Health [PO1 DK72084, RO1 DK26523, RO1 DK61765, R24 DK64388, P30 DK079310]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Technologico; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061765, R01DK026523, R24DK064388, P30DK079310, P01DK072084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Technologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 DK72084, RO1 DK26523, RO1 DK61765, R24 DK64388, and P30 DK079310.; Supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro and Conselho Nacional de Desenvolvimento Cientifico e Technologico. Present address: Inst. de Biophysica Carlos Chagas, University Federal do Rio De Janeiro, Rio De Janeiro, Brazil 21941.	Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Bachmann S, 2004, J AM SOC NEPHROL, V15, P892, DOI 10.1097/01.ASN.0000120389.09938.21; Bacic D, 2003, PFLUG ARCH EUR J PHY, V446, P475, DOI 10.1007/s00424-003-1057-4; Bobulescu IA, 2005, AM J PHYSIOL-RENAL, V289, pF685, DOI 10.1152/ajprenal.00447.2004; Cavet ME, 2001, AM J PHYSIOL-CELL PH, V281, pC2039, DOI 10.1152/ajpcell.2001.281.6.C2039; Cebotaru V, 2005, KIDNEY INT, V68, P642, DOI 10.1111/j.1523-1755.2005.00442.x; Chow CW, 1999, J BIOL CHEM, V274, P37551, DOI 10.1074/jbc.274.53.37551; Christensen EI, 2003, P NATL ACAD SCI USA, V100, P8472, DOI 10.1073/pnas.1432873100; Cinar A, 2007, J PHYSIOL-LONDON, V581, P1235, DOI 10.1113/jphysiol.2007.131722; Collazo R, 2000, J BIOL CHEM, V275, P31601, DOI 10.1074/jbc.M000600200; DENT CE, 1964, ARCH DIS CHILD, V39, P240, DOI 10.1136/adc.39.205.240; Devuyst O, 1999, HUM MOL GENET, V8, P247, DOI 10.1093/hmg/8.2.247; Devuyst Olivier, 2005, Nephron Physiology, V99, P69; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; FISHER SE, 1994, HUM MOL GENET, V3, P2053; Guggino SE, 2007, NAT CLIN PRACT NEPHR, V3, P449, DOI 10.1038/ncpneph0541; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Hryciw DH, 2006, J BIOL CHEM, V281, P16068, DOI 10.1074/jbc.M512559200; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; JENTSCH TJ, 1993, ANN NY ACAD SCI, V707, P285, DOI 10.1111/j.1749-6632.1993.tb38059.x; Jentsch TJ, 1999, PFLUG ARCH EUR J PHY, V437, P783, DOI 10.1007/s004240050847; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lloyd SE, 1997, J CLIN INVEST, V99, P967, DOI 10.1172/JCI119262; Ludwig M, 2006, NEPHROL DIAL TRANSPL, V21, P2708, DOI 10.1093/ndt/gfl346; Luyckx VA, 1998, AM J PHYSIOL-RENAL, V275, pF761, DOI 10.1152/ajprenal.1998.275.5.F761; McDonough AA, 2003, CURR OPIN NEPHROL HY, V12, P533, DOI 10.1097/00041552-200309000-00009; Moulin P, 2003, KIDNEY INT, V63, P1285, DOI 10.1046/j.1523-1755.2003.00851.x; MURER H, 1992, J AM SOC NEPHROL, V2, P1649; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Novarino G, 2010, SCIENCE, V328, P1398, DOI 10.1126/science.1188070; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; POOK MA, 1993, HUM MOL GENET, V2, P2129, DOI 10.1093/hmg/2.12.2129; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Silva IV, 2003, J BONE MINER RES, V18, P615, DOI 10.1359/jbmr.2003.18.4.615; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; Wang SS, 2000, HUM MOL GENET, V9, P2937, DOI 10.1093/hmg/9.20.2937; Wang T, 1999, AM J PHYSIOL-RENAL, V277, pF298, DOI 10.1152/ajprenal.1999.277.2.F298; Wang YH, 2005, AM J PHYSIOL-RENAL, V289, pF850, DOI 10.1152/ajprenal.00011.2005; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200	49	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22833	22845		10.1074/jbc.M111.224998	http://dx.doi.org/10.1074/jbc.M111.224998			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561868	Green Published, hybrid			2022-12-25	WOS:000292025000018
J	Rodriguez, M; Cabal-Hierro, L; Carcedo, MT; Iglesias, JM; Artime, N; Darnay, BG; Lazo, PS				Rodriguez, Montserrat; Cabal-Hierro, Lucia; Teresa Carcedo, Maria; Manuel Iglesias, Juan; Artime, Noelia; Darnay, Bryant G.; Lazo, Pedro S.			NF-kappa B Signal Triggering and Termination by Tumor Necrosis Factor Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; STRUCTURAL BASIS; TNF RECEPTOR-2; TRAF2; ACTIVATION; KINASE; DEGRADATION; COMPLEX; P80; UBIQUITINATION	Tumor necrosis factor receptor 2 (TNFR2) activates transcription factor kappa B (NF-kappa B) and c-Jun N-terminal kinase (JNK). The mechanisms mediating these activations are dependent on the recruitment of TNF receptor-associated factor 2 (TRAF2) to the intracellular region of the receptor. TNFR2 also induces TRAF2 degradation. We show that in addition to the well characterized TRAF2 binding motif 402-SKEE-405, the human receptor contains another sequence located at the C-terminal end (amino acids 425-439), which also recruits TRAF2 and activates NF-kappa B. In addition to that, human TNFR2 contains a conserved region (amino acids 338-379) which is responsible for TRAF2 degradation and therefore of terminating NF-kappa B signaling. TRAF2 degradation and the lack of NF-kappa B activation when both TNFR1 and TNFR2 are co-expressed results in an enhanced ability of TNFR1 to induce cell death, showing that the cross-talk between both receptors is of a great biological relevance. Induction of TRAF2 degradation appears to be independent of TRAF2 binding to the receptor. Amino acids 343-TGSSDSS-349 are essential for inducing TRAF2 degradation because deletion mutants of this region or point mutations at serine residues 345 and 346 or 348 and 349 obliterate the ability of TNFR2 to induce TRAF2 degradation.	[Rodriguez, Montserrat; Cabal-Hierro, Lucia; Teresa Carcedo, Maria; Manuel Iglesias, Juan; Artime, Noelia; Lazo, Pedro S.] Univ Oviedo, Dept Bioquim & Biol Mol, E-33071 Oviedo, Spain; [Rodriguez, Montserrat; Cabal-Hierro, Lucia; Teresa Carcedo, Maria; Manuel Iglesias, Juan; Artime, Noelia; Lazo, Pedro S.] Univ Oviedo, IUOPA, E-33071 Oviedo, Spain; [Darnay, Bryant G.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Texas System; UTMD Anderson Cancer Center	Lazo, PS (corresponding author), Univ Oviedo, Dept Bioquim & Biol Mol, Campus El Cristo, E-33071 Oviedo, Spain.	pslazo@uniovi.es	Lazo, Pranvera/I-5299-2019; Cabal-Hierro, Lucía/AAB-4119-2019; Lazo, Pedro/C-4087-2008	Lazo, Pranvera/0000-0002-7202-4058; Cabal-Hierro, Lucía/0000-0003-3552-2215; Lazo, Pedro/0000-0002-1278-6878	Spanish Ministry of Science and Technology (MICINN) [SAF2009-07227]; Plan Regional de Ciencia y Tecnologia del Principado de Asturias (PCTI) [IB09-066]; Obra Social Cajastur; Spanish Ministry of Education; PCTI	Spanish Ministry of Science and Technology (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Plan Regional de Ciencia y Tecnologia del Principado de Asturias (PCTI); Obra Social Cajastur; Spanish Ministry of Education(Spanish Government); PCTI	This work was supported by Grant SAF2009-07227 from the Spanish Ministry of Science and Technology (MICINN) and by Grant IB09-066 from the Plan Regional de Ciencia y Tecnologia del Principado de Asturias (PCTI). The IUOPA is supported by Obra Social Cajastur.; Recipient of a fellowship from the Spanish Ministry of Education.; Recipients of fellowships from the PCTI.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Arch RH, 2000, BIOCHEM BIOPH RES CO, V272, P936, DOI 10.1006/bbrc.2000.2873; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boucher LM, 1997, BIOCHEM BIOPH RES CO, V233, P592, DOI 10.1006/bbrc.1997.6509; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Choi JW, 2009, J CELL SCI, V122, P2710, DOI 10.1242/jcs.049767; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Darnay BG, 1997, FEBS LETT, V406, P101, DOI 10.1016/S0014-5793(97)00251-2; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; ESPEVIK T, 1990, SCAND J CLIN LAB INV, V50, P160; Feng X, 2001, J BIOL CHEM, V276, P8341, DOI 10.1074/jbc.M007116200; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Grech AP, 2005, J BIOL CHEM, V280, P31572, DOI 10.1074/jbc.M504849200; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Li LY, 2009, BBA-MOL CELL RES, V1793, P346, DOI 10.1016/j.bbamcr.2008.09.013; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Pan S, 2002, MOL CELL BIOL, V22, P7512, DOI 10.1128/MCB.22.21.7512-7523.2002; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; PENNICA D, 1993, BIOCHEMISTRY-US, V32, P3131, DOI 10.1021/bi00063a027; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tzimas C, 2006, CELL SIGNAL, V18, P83, DOI 10.1016/j.cellsig.2005.03.017; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Weiss T, 1997, J IMMUNOL, V158, P2398; Wicovsky A, 2009, ONCOGENE, V28, P1769, DOI 10.1038/onc.2009.29; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Yin Q, 2009, BIOCHEMISTRY-US, V48, P10558, DOI 10.1021/bi901462e	39	42	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22814	22824		10.1074/jbc.M111.225631	http://dx.doi.org/10.1074/jbc.M111.225631			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21558270	hybrid, Green Published			2022-12-25	WOS:000292025000016
J	Procaccini, A; Lunt, B; Szurmant, H; Hwa, T; Weigt, M				Procaccini, Andrea; Lunt, Bryan; Szurmant, Hendrik; Hwa, Terence; Weigt, Martin			Dissecting the Specificity of Protein-Protein Interaction in Bacterial Two-Component Signaling: Orphans and Crosstalks	PLOS ONE			English	Article							DIRECT RESIDUE CONTACTS; CELL-CYCLE; BACILLUS-SUBTILIS; SYSTEMS; RECOGNITION; REGULATOR	Predictive understanding of the myriads of signal transduction pathways in a cell is an outstanding challenge of systems biology. Such pathways are primarily mediated by specific but transient protein-protein interactions, which are difficult to study experimentally. In this study, we dissect the specificity of protein-protein interactions governing two-component signaling (TCS) systems ubiquitously used in bacteria. Exploiting the large number of sequenced bacterial genomes and an operon structure which packages many pairs of interacting TCS proteins together, we developed a computational approach to extract a molecular interaction code capturing the preferences of a small but critical number of directly interacting residue pairs. This code is found to reflect physical interaction mechanisms, with the strongest signal coming from charged amino acids. It is used to predict the specificity of TCS interaction: Our results compare favorably to most available experimental results, including the prediction of 7 (out of 8 known) interaction partners of orphan signaling proteins in Caulobacter crescentus. Surveying among the available bacterial genomes, our results suggest 15 similar to 25% of the TCS proteins could participate in out-of-operon "crosstalks''. Additionally, we predict clusters of crosstalking candidates, expanding from the anecdotally known examples in model organisms. The tools and results presented here can be used to guide experimental studies towards a system-level understanding of two-component signaling.	[Procaccini, Andrea; Weigt, Martin] Human Genet Fdn, Turin, Italy; [Procaccini, Andrea; Weigt, Martin] Politecn Torino, Ctr Computat Studies, Turin, Italy; [Procaccini, Andrea; Weigt, Martin] Politecn Torino, Dipartimento Fis, Turin, Italy; [Lunt, Bryan; Hwa, Terence] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Lunt, Bryan; Hwa, Terence] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Szurmant, Hendrik] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Polytechnic University of Turin; Polytechnic University of Turin; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Procaccini, A (corresponding author), Human Genet Fdn, Turin, Italy.	szurmant@scripps.edu; hwa@ucsd.edu; martin.weigt@hugef-torino.org	Hwa, Terence/J-4012-2013; Weigt, Martin/L-8851-2016; Hwa, Terry/GOJ-9904-2022	Hwa, Terence/0000-0003-1837-6842; Weigt, Martin/0000-0002-0492-3684; Lunt, Bryan/0000-0001-8328-8633	Center for Theoretical Biological Physics (CTBP) sponsored by the NSF [PHY-0822283]; NIH [R01GM077298, R01GM019416]; EC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019416, R01GM077298] Funding Source: NIH RePORTER	Center for Theoretical Biological Physics (CTBP) sponsored by the NSF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EC(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T.H. acknowledges funding by the Center for Theoretical Biological Physics (CTBP) sponsored by the NSF (Grant PHY-0822283) and by NIH grant R01GM077298. H.S. was supported by NIH grant R01GM019416 awarded to James Hoch. B.L. and A.P. acknowledge funding from the EC via the STREP GENNETEC ("Genetic networks: emergence and complexity''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Doan T, 2003, MICROBIOL-SGM, V149, P2331, DOI 10.1099/mic.0.26256-0; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hoch JA, 2001, J BACTERIOL, V183, P4941, DOI 10.1128/JB.183.17.4941-4949.2001; Howell A, 2006, MOL MICROBIOL, V59, P1199, DOI 10.1111/j.1365-2958.2005.05017.x; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lunt B, 2010, METHOD ENZYMOL, V471, P17, DOI 10.1016/S0076-6879(10)71002-8; Mezard M, 2009, J PHYSIOL-PARIS, V103, P107, DOI 10.1016/j.jphysparis.2009.05.013; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Ohta N, 2003, J BACTERIOL, V185, P4424, DOI 10.1128/JB.185.15.4424-4431.2003; Reisinger SJ, 2007, J BACTERIOL, V189, P8308, DOI 10.1128/JB.00868-07; Rietkotter E, 2008, MOL MICROBIOL, V68, P768, DOI 10.1111/j.1365-2958.2008.06194.x; Shi XQ, 2008, J BACTERIOL, V190, P613, DOI 10.1128/JB.01502-07; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; SOKAL RR, 1958, U KANSAS SCI B, V38, P1409; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Szurmant H, 2010, CURR OPIN MICROBIOL, V13, P190, DOI 10.1016/j.mib.2010.01.007; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; White RA, 2007, METHOD ENZYMOL, V422, P75, DOI 10.1016/S0076-6879(06)22004-4; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wu JG, 1999, P NATL ACAD SCI USA, V96, P13068, DOI 10.1073/pnas.96.23.13068; Yamamoto H, 2000, MOL MICROBIOL, V37, P898, DOI 10.1046/j.1365-2958.2000.02055.x; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zapf J, 2000, STRUCTURE, V8, P851, DOI 10.1016/S0969-2126(00)00174-X	36	65	66	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19729	10.1371/journal.pone.0019729	http://dx.doi.org/10.1371/journal.pone.0019729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573011	Green Published, gold, Green Submitted			2022-12-25	WOS:000290386800034
J	Deiner, K; Lemmon, AR; Mack, AL; Fleischer, RC; Dumbacher, JP				Deiner, Kristy; Lemmon, Alan R.; Mack, Andrew L.; Fleischer, Robert C.; Dumbacher, John P.			A Passerine Bird's Evolution Corroborates the Geologic History of the Island of New Guinea	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; RAIN-FOREST; IRIAN-JAYA; SUBSTITUTIONS; BIOGEOGRAPHY; VEGETATION; PHYLOGENY; AUSTRALIA; COMMUNITY	New Guinea is a biologically diverse island, with a unique geologic history and topography that has likely played a role in the evolution of species. Few island-wide studies, however, have examined the phylogeographic history of lowland species. The objective of this study was to examine patterns of phylogeographic variation of a common and widespread New Guinean bird species (Colluricincla megarhyncha). Specifically, we test the mechanisms hypothesized to cause geographic and genetic variation (e.g., vicariance, isolation by distance and founder-effect with dispersal). To accomplish this, we surveyed three regions of the mitochondrial genome and a nuclear intron and assessed differences among 23 of the 30 described subspecies from throughout their range. We found support for eight highly divergent lineages within C. megarhyncha. Genetic lineages were found within continuous lowland habitat or on smaller islands, but all individuals within clades were not necessarily structured by predicted biogeographic barriers. There was some evidence of isolation by distance and potential founder-effects. Mitochondrial DNA sequence divergence among lineages was at a level often observed among different species or even genera of birds (5-11%), suggesting lineages within regions have been isolated for long periods of time. When topographical barriers were associated with divergence patterns, the estimated divergence date for the clade coincided with the estimated time of barrier formation. We also found that dispersal distance and range size are positively correlated across lineages. Evidence from this research suggests that different phylogeographic mechanisms concurrently structure lineages of C. megarhyncha and are not mutually exclusive. These lineages are a result of evolutionary forces acting at different temporal and spatial scales concordant with New Guinea's geological history.	[Deiner, Kristy; Dumbacher, John P.] Calif Acad Sci, Dept Vertebrate Zool & Anthropol, San Francisco, CA 94118 USA; [Deiner, Kristy; Dumbacher, John P.] Calif Acad Sci, Ctr Comparat Genom, San Francisco, CA 94118 USA; [Deiner, Kristy] Univ Calif Davis, Genom Variat Lab, Davis, CA 95616 USA; [Lemmon, Alan R.] Florida State Univ, Dept Comp Sci, Tallahassee, FL 32306 USA; [Mack, Andrew L.] Carnegie Museum Nat Hist, Pittsburgh, PA USA; [Fleischer, Robert C.; Dumbacher, John P.] Smithsonian Inst, Ctr Conservat & Evolutionary Genet, Washington, DC 20560 USA	California Academy of Sciences; California Academy of Sciences; University of California System; University of California Davis; State University System of Florida; Florida State University; Smithsonian Institution	Deiner, K (corresponding author), Calif Acad Sci, Dept Vertebrate Zool & Anthropol, San Francisco, CA 94118 USA.	kldeiner@ucdavis.edu	Dumbacher, John/B-5280-2009	Dumbacher, John/0000-0001-8942-1554; Mack, Andrew L./0000-0001-8823-9101; Deiner, Kristy/0000-0001-9755-3223	Smithsonian Scholarly Studies Program; National Zoo; Abbott and Sisley Funds; Christensen Fund; NSF [DEB 0108247]	Smithsonian Scholarly Studies Program(Smithsonian Institution); National Zoo(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); Abbott and Sisley Funds; Christensen Fund; NSF(National Science Foundation (NSF))	Funding was provided by the Smithsonian Scholarly Studies Program, Friends of the National Zoo, the Abbott and Sisley Funds, the Christensen Fund, and NSF Grant DEB 0108247 (PIs Dumbacher, Fleischer and Mack). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LD, 1997, NATURE, V385, P501, DOI 10.1038/385501a0; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Baldwin Bruce G., 1995, P259; Bandelt HJ, 2009, J HUM GENET, V54, P174, DOI 10.1038/jhg.2009.9; Beehler B.M., 1986, BIRDS NEW GUINEA; BELL HL, 1982, EMU, V82, P65, DOI 10.1071/MU9820065; BELL HL, 1982, EMU, V82, P24, DOI 10.1071/MU9820024; CRACRAFT J, 1986, PALEOBIOLOGY, V12, P383, DOI 10.1017/S0094837300003122; Cracraft J., 1983, Current Ornithology, V1, P159; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Davies JM, 1997, MAR FRESHWATER RES, V48, P513, DOI 10.1071/MF96128; de Guia APO, 2007, ECOL RES, V22, P604, DOI 10.1007/s11284-006-0059-z; DOW DB, 1984, TECTONOPHYSICS, V106, P109, DOI 10.1016/0040-1951(84)90224-5; Dow DB, 1977, GEOLOGY GEOPHYSICS B, V201, P41; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dumbacher JP, 2008, MOL PHYLOGENET EVOL, V49, P774, DOI 10.1016/j.ympev.2008.09.018; Dumbacher JP, 2003, MOL PHYLOGENET EVOL, V29, P540, DOI 10.1016/S1055-7903(03)00135-0; Edwards Scott V., 1997, P251, DOI 10.1016/B978-012498315-1/50015-7; Excoffier L, 2007, ARLEQUIN VER 3 11 IN; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; FORD J, 1979, EMU, V79, P195, DOI 10.1071/MU9790195; Fu YX, 1997, GENETICS, V147, P915; Garrick RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-118; Greenberg R, 1998, AUK, V115, P706, DOI 10.2307/4089418; Greenway JC, 1967, CHECK LIST BIRDS WOR; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heads M, 2002, J BIOGEOGR, V29, P261, DOI 10.1046/j.1365-2699.2002.00667.x; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Higgins P. J., 2002, HDB AUSTR NZ ANTARCT, V6; Hillis David M., 1996, P515; HOPE G, 1994, PALAEOGEOGR PALAEOCL, V109, P385, DOI 10.1016/0031-0182(94)90187-2; Hope Geoff, 1996, P165; Jennings J.N., 1971, ABORIGINAL MAN ENV A, P1; JIN L, 1990, MOL BIOL EVOL, V7, P82; Kerr KCR, 2007, MOL ECOL NOTES, V7, P535, DOI 10.1111/j.1471-8286.2006.01670.x; KERSHAW AP, 1994, PALAEOGEOGR PALAEOCL, V109, P399, DOI 10.1016/0031-0182(94)90188-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Lemmon AR, 2008, SYST BIOL, V57, P544, DOI 10.1080/10635150802304761; Lovette IJ, 2004, AUK, V121, P1, DOI 10.1642/0004-8038(2004)121[0001:MDAMSF]2.0.CO;2; Mack AL, 1996, EMU, V96, P89, DOI 10.1071/MU9960089; Mack Andrew, 2007, P654; Mayr E., 1942, P1; Mayr E., 2001, BIRDS NO MELANESIA S; Mayr E., 1941, LIST NEW GUINEA BIRD; Mayr E., 1963, ANIMAL SPECIES EVOLU, pxiv; McGuigan K, 2000, MAR FRESHWATER RES, V51, P713, DOI 10.1071/MF99159; Moritz C, 2001, P ROY SOC B-BIOL SCI, V268, P1875, DOI 10.1098/rspb.2001.1713; Murphy SA, 2007, J BIOGEOGR, V34, P1534, DOI 10.1111/j.1365-2699.2007.01706.x; NEI M, 1989, MOL BIOL EVOL, V6, P290; Nielsen R, 2005, STAT METHODS MOL EVO, P183; Peterson AT, 2006, J AVIAN BIOL, V37, P541, DOI 10.1111/j.0908-8857.2006.04029.x; Pigram C. J., 1987, BMR Journal of Australian Geology & Geophysics, V10, P193; Pigram C.J., 1991, J SE ASIAN EARTH SCI, V6, P307, DOI DOI 10.1016/0743-9547(91)90076-A; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ray N, 2005, MOL ECOL NOTES, V5, P177, DOI 10.1111/j.1471-8286.2004.00843.x; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Shaw Kerry L., 1995, P39; Slater Peter, 1986, SLATER FIELD GUIDE A; Sorenson MD, 1999, P ROY SOC B-BIOL SCI, V266, P2187, DOI 10.1098/rspb.1999.0907; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stevens C, 1998, GEOLOGY, V26, P847, DOI 10.1130/0091-7613(1998)026<0847:MCDARF>2.3.CO;2; TAJIMA F, 1989, GENETICS, V123, P597; Tarr Cheryl L., 1995, P147; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wagner WL, 1995, HAWAIIAN BIOGEOGRAPH; Wallace A, 1869, MALAY ARCHIPELAGO MA; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Zink R.M., 1986, Current Ornithology, V4, P1; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.1111/j.1558-5646.1996.tb04494.x; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI; Zwiers PB, 2008, MOL PHYLOGENET EVOL, V46, P923, DOI 10.1016/j.ympev.2007.11.019	76	27	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19479	10.1371/journal.pone.0019479	http://dx.doi.org/10.1371/journal.pone.0019479			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573115	Green Published, Green Submitted, gold			2022-12-25	WOS:000290305600027
J	Herbst, S; Schaible, UE; Schneider, BE				Herbst, Susanne; Schaible, Ulrich E.; Schneider, Bianca E.			Interferon Gamma Activated Macrophages Kill Mycobacteria by Nitric Oxide Induced Apoptosis	PLOS ONE			English	Article							MEDIATED APOPTOSIS; HOST MACROPHAGES; CELL APOPTOSIS; TUBERCULOSIS; MURINE; INFECTION; NECROSIS; SURVIVAL; STRAINS; DEFENSE	Mycobacterium tuberculosis is an intracellular pathogen of macrophages and escapes the macrophages' bactericidal effectors by interfering with phagosome-lysosome fusion. IFN-gamma activation renders the macrophages capable of killing intracellular mycobacteria by overcoming the phagosome maturation block, nutrient deprivation and exposure to microbicidal effectors including nitric oxide (NO). While the importance about NO for the control of mycobacterial infection in murine macrophages is well documented, the underlying mechanism has not been revealed yet. In this study we show that IFN-gamma induced apoptosis in mycobacteria-infected macrophages, which was strictly dependent on NO. Subsequently, NO-mediated apoptosis resulted in the killing of intracellular mycobacteria independent of autophagy. In fact, killing of mycobacteria was susceptible to the autophagy inhibitor 3-methyladenine (3-MA). However, 3-MA also suppressed NO production, which is an important off-target effect to be considered in autophagy studies using 3-MA. Inhibition of caspase 3/7 activation, as well as NO production, abolished apoptosis and elimination of mycobacteria by IFN-gamma activated macrophages. In line with the finding that drug-induced apoptosis kills intracellular mycobacteria in the absence of NO, we identified NO-mediated apoptosis as a new defense mechanism of activated macrophages against M. tuberculosis.	[Herbst, Susanne; Schaible, Ulrich E.; Schneider, Bianca E.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1, England; [Schaible, Ulrich E.; Schneider, Bianca E.] Res Ctr Borstel, Dept Mol Infect Biol, Borstel, Germany	University of London; London School of Hygiene & Tropical Medicine; Forschungszentrum Borstel	Herbst, S (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1, England.	uschaible@fz-borstel.de	Schaible, Ulrich/C-7837-2011	Schaible, Ulrich/0000-0002-6638-7282	Medical Research Council UK [G0700163]; Wellcome Trust UK [WT082825]; MRC [G0700163] Funding Source: UKRI; Medical Research Council [G0700163] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust UK(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded through grants by the Medical Research Council UK (Grant no. G0700163), and the Wellcome Trust UK (Grant no. WT082825) to U. E. Schaible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINA JE, 1993, J IMMUNOL, V150, P5080; Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; Axelrod S, 2008, CELL MICROBIOL, V10, P1530, DOI 10.1111/j.1462-5822.2008.01147.x; Bal-Price A, 2000, J NEUROCHEM, V75, P1455, DOI 10.1046/j.1471-4159.2000.0751455.x; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; BANCROFT GJ, 1994, METHOD CELL BIOL, V45, P129; Brune B, 1997, J BIOL CHEM, V272, P7253, DOI 10.1074/jbc.272.11.7253; Brune B, 1999, CELL DEATH DIFFER, V6, P969, DOI 10.1038/sj.cdd.4400582; Chan ED, 2001, AM J RESP CELL MOL, V25, P606, DOI 10.1165/ajrcmb.25.5.4487; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; de Chastellier C, 2009, IMMUNOBIOLOGY, V214, P526, DOI 10.1016/j.imbio.2008.12.005; Dellacasagrande J, 1999, J IMMUNOL, V162, P2259; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fullard JF, 2009, APOPTOSIS, V14, P1029, DOI 10.1007/s10495-009-0335-9; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Gotoh T, 1999, J CELL BIOL, V144, P427, DOI 10.1083/jcb.144.3.427; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Holscher C, 2008, EUR J IMMUNOL, V38, P680, DOI 10.1002/eji.200736458; Hortelano S, 1999, FASEB J, V13, P2311, DOI 10.1096/fasebj.13.15.2311; Ismail N, 2002, FEMS MICROBIOL LETT, V207, P111, DOI 10.1111/j.1574-6968.2002.tb11038.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kim SO, 2001, AM J PHYSIOL-LUNG C, V281, pL1095, DOI 10.1152/ajplung.2001.281.5.L1095; Long R, 1999, ANTIMICROB AGENTS CH, V43, P403, DOI 10.1128/AAC.43.2.403; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Messmer UK, 1996, FEBS LETT, V384, P162; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Moriya R, 2000, FEBS LETT, V484, P253, DOI 10.1016/S0014-5793(00)02167-0; Munder M, 1999, J IMMUNOL, V163, P3771; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; OBRIEN L, 1994, INFECT IMMUN, V62, P5187, DOI 10.1128/IAI.62.11.5187-5190.1994; Oddo M, 1998, J IMMUNOL, V160, P5448; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Penaloza C, 2006, HISTOCHEM CELL BIOL, V126, P149, DOI 10.1007/s00418-006-0214-1; Perfetto B, 2004, RES MICROBIOL, V155, P259, DOI 10.1016/j.resmic.2004.01.007; Purdy GE, 2007, CELL MICROBIOL, V9, P2768, DOI 10.1111/j.1462-5822.2007.01039.x; Rhoades ER, 1997, INFECT IMMUN, V65, P1189, DOI 10.1128/IAI.65.4.1189-1195.1997; Rodrigues MF, 2009, IMMUNOLOGY, V128, pe691, DOI 10.1111/j.1365-2567.2009.03062.x; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Sakai K, 2006, J BIOL CHEM, V281, P17736, DOI 10.1074/jbc.M601896200; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Shiloh MU, 2000, CURR OPIN MICROBIOL, V3, P35, DOI 10.1016/S1369-5274(99)00048-X; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Sly LM, 2003, J IMMUNOL, V170, P430, DOI 10.4049/jimmunol.170.1.430; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Yabuki M, 2000, FREE RADICAL RES, V32, P507, DOI 10.1080/10715760000300511; Yang Chul-Su, 2009, Immune Netw, V9, P46, DOI 10.4110/in.2009.9.2.46	53	157	166	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2011	6	5							e19105	10.1371/journal.pone.0019105	http://dx.doi.org/10.1371/journal.pone.0019105			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759ED	21559306	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000290222600003
J	Bakanda, C; Birungi, J; Mwesigwa, R; Nachega, JB; Chan, K; Palmer, A; Ford, N; Mills, EJ				Bakanda, Celestin; Birungi, Josephine; Mwesigwa, Robert; Nachega, Jean B.; Chan, Keith; Palmer, Alexis; Ford, Nathan; Mills, Edward J.			Survival of HIV-Infected Adolescents on Antiretroviral Therapy in Uganda: Findings from a Nationally Representative Cohort in Uganda	PLOS ONE			English	Article							IMMUNOLOGICAL OUTCOMES; SOUTHERN AFRICA; ADHERENCE; CHILDREN	Background: Adolescents have been identified as a high-risk group for poor adherence to and defaulting from combination antiretroviral therapy (cART) care. However, data on outcomes for adolescents on cART in resource-limited settings remain scarce. Methods: We developed an observational study of patients who started cART at The AIDS Service Organization (TASO) in Uganda between 2004 and 2009. Age was stratified into three groups: children (<= 10 years), adolescents (11-19 years), and adults (>= 20 years). Kaplan-Meier survival curves were generated to describe time to mortality and loss to follow-up, and Cox regression used to model associations between age and mortality and loss to follow-up. To address loss to follow up, we applied a weighted analysis that assumes 50% of lost patients had died. Findings: A total of 23,367 patients were included in this analysis, including 810 (3.5%) children, 575 (2.5%) adolescents, and 21 982 (94.0%) adults. A lower percentage of children (5.4%) died during their cART treatment compared to adolescents (8.5%) and adults (10%). After adjusting for confounding, other features predicted mortality than age alone. Mortality was higher among males (p < 0.001), patients with a low initial CD4 cell count (p < 0.001), patients with advanced WHO clinical disease stage (p < 0.001), and shorter duration of time receiving cART (p < 0.001). The crude mortality rate was lower for children (22.8 per 1000 person-years; 95% CI: 16.1, 29.5), than adolescents (36.5 per 1000 person-years; 95% CI: 26.3, 46.8) and adults (37.5 per 1000 person-years; 95% CI: 35.9, 39.1). Interpretation: This study is the largest assessment of adolescents receiving cART in Africa. Adolescents did not have cART mortality outcomes different from adults or children.	[Bakanda, Celestin; Birungi, Josephine; Mwesigwa, Robert] AIDS Support Org TASO, Kampala, Uganda; [Nachega, Jean B.] Univ Stellenbosch, Fac Hlth Sci, Dept Med, Cape Town, South Africa; [Nachega, Jean B.] Univ Stellenbosch, Fac Hlth Sci, Ctr Infect Dis, Cape Town, South Africa; [Chan, Keith; Palmer, Alexis; Mills, Edward J.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada	Stellenbosch University; Stellenbosch University; B.C. Centre for Excellence in HIV/AIDS; University of Cape Town; University of Ottawa	Bakanda, C (corresponding author), AIDS Support Org TASO, Kampala, Uganda.	emills@cfenet.ubc.ca		Nachega, Jean/0000-0002-2862-4443	European and Developing Countries Clinical Trials Partnership Fellowship	European and Developing Countries Clinical Trials Partnership Fellowship	EM has received a Canada Research Chair. JBN has received a European and Developing Countries Clinical Trials Partnership Fellowship.	Allison P. D., 1995, SURVIVAL ANAL USING; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; CHARLES M, 2008, B WORLD HEALTH ORGAN, V86, P909; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Ferrand RA, 2009, AIDS, V23, P2039, DOI 10.1097/QAD.0b013e32833016ce; Flynn PM, 2007, AIDS RES HUM RETROV, V23, P1208, DOI 10.1089/aid.2006.0290; Kiboneka A, 2008, AIDS, V22, P2493, DOI 10.1097/QAD.0b013e328318f148; Kiboneka A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b201; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Murphy DA, 2003, ARCH PEDIAT ADOL MED, V157, P249, DOI 10.1001/archpedi.157.3.249; Murphy DA, 2001, AIDS CARE, V13, P27, DOI 10.1080/09540120020018161; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; RONGKAVILIT C, 2007, J ADOLESCENT HEALTH, V40, P1; Sauvageot D, 2010, PEDIATRICS, V125, pE1039, DOI 10.1542/peds.2009-1062; Uganda Ministry of Health, 2003, NAT ANT TREATM CAR G; *UNAIDS, 2008, AIDS EP UPD; WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; Wilson CM, 2010, JAIDS-J ACQ IMM DEF, V54, pS5, DOI 10.1097/QAI.0b013e3181e243a1	19	53	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19261	10.1371/journal.pone.0019261	http://dx.doi.org/10.1371/journal.pone.0019261			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559441	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700115
J	Jeong, HJ; Choi, Y; Kim, KY; Kim, MH; Kim, HM				Jeong, Hyun-Ja; Choi, Youngjin; Kim, Kyu-Yeob; Kim, Min-Ho; Kim, Hyung-Min			C-Kit Binding Properties of Hesperidin (a Major Component of KMP6) as a Potential Anti-Allergic Agent	PLOS ONE			English	Article							STEM-CELL FACTOR; FACTOR-INDUCED MIGRATION; MAST-CELLS; TNF-ALPHA; ACTIVATION; EXPRESSION; DIFFERENTIATION; INFLAMMATION; PATHWAYS; RECEPTOR	Accumulation of mast cells can be causally related to several allergic inflammations. Stem cell factor (SCF) as a mast cell chemotaxin induces mast cell migration. To clarify a new effect of Pyeongwee-San extract (KMP6, a drug for indigestion) for the treatment of allergy, we investigated the effects of KMP6 on SCF-induced migration of rat peritoneal mast cells (RPMCs). A molecular docking simulation showed that hesperidin, a major component of KMP6, controls the SCF and c-kit binding by interaction with the active site of the c-kit. KMP6 and hesperidin significantly inhibited SCF-induced migration of RPMCs (P<0.05). The ability of the SCF to enhance morphological alteration and F-actin formation was also abolished by treatment with KMP6 or hesperidin. KMP6 and hesperidin inhibited SCF-induced p38 MAPK activation. In addition, SCF-induced inflammatory cytokine production was significantly inhibited by treatment with KMP6 or hesperidin (P<0.05). Our results show for the first time that KMP6 potently regulates SCF-induced migration, p38 MAPK activation and inflammatory cytokines production through hindrance of SCF and c-kit binding in RPMCs. Such modulation may have functional consequences during KMP6 treatment, especially mast cell-mediated allergic inflammation disorders.	[Jeong, Hyun-Ja; Choi, Youngjin] Hoseo Univ, Biochip Res Ctr, Asan, South Korea; [Kim, Kyu-Yeob; Kim, Hyung-Min] Kyung Hee Univ, Dept Pharmacol, Seoul, South Korea; [Kim, Min-Ho] Chonbuk Natl Univ, High Enthalpy Plasma Res Ctr, Jeonju, South Korea	Hoseo University; Kyung Hee University; Jeonbuk National University	Jeong, HJ (corresponding author), Hoseo Univ, Biochip Res Ctr, Asan, South Korea.	hmkim@khu.ac.kr			Ministry for Health and Welfare and Family Affairs, Republic of Korea [B100037]	Ministry for Health and Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Traditional Korean Medicine R&D Project, Ministry for Health and Welfare and Family Affairs, Republic of Korea (No. B100037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafa HMM, 2009, TOXICOL IND HEALTH, V25, P417, DOI 10.1177/0748233709106624; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Brunet A, 1996, SCIENCE, V272, P1652, DOI 10.1126/science.272.5268.1652; Chai OH, 2011, EXP MOL MED, V43, P35, DOI 10.3858/emm.2011.43.1.004; Chang YL, 2010, ACTA PHARMACOL SIN, V31, P546, DOI 10.1038/aps.2010.34; Choi IY, 2007, MOL CELL BIOCHEM, V305, P153, DOI 10.1007/s11010-007-9539-x; COATES TD, 1992, J CELL BIOL, V117, P765, DOI 10.1083/jcb.117.4.765; Costa JJ, 1996, J EXP MED, V183, P2681, DOI 10.1084/jem.183.6.2681; ENERBACK L, 1986, INT ARCH ALLER A IMM, V80, P44, DOI 10.1159/000234024; Farooqi IS, 1998, THORAX, V53, P927, DOI 10.1136/thx.53.11.927; Grzelewska-Rzymowska Iwona, 2004, Pol Merkur Lekarski, V16, P179; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Imhof BA, 1997, HORM METAB RES, V29, P614, DOI 10.1055/s-2007-979112; IRANI AMA, 1992, BLOOD, V80, P3009; Ishizuka T, 1999, J IMMUNOL, V162, P2087; Jeong HJ, 2003, ENDOCRINOLOGY, V144, P4080, DOI 10.1210/en.2003-0115; Jeong HJ, 2002, CELL SIGNAL, V14, P633, DOI 10.1016/S0898-6568(02)00005-0; Kuo DH, 2010, J AGR FOOD CHEM, V58, P5777, DOI 10.1021/jf100601r; LAITINEN LA, 1993, AM REV RESPIR DIS, V147, P697, DOI 10.1164/ajrccm/147.3.697; Lorentz A, 2001, IMMUNOL REV, V179, P57, DOI 10.1034/j.1600-065X.2001.790106.x; MEININGER CJ, 1992, BLOOD, V79, P958; NILSSON G, 1994, J IMMUNOL, V153, P3717; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; PTEIFFER JR, 1994, J IMMUNOL, V152, P270; Seo MJ, 2011, IMMUNOPHARM IMMUNOT, V33, P178, DOI 10.3109/08923973.2010.491082; Sundstrom M, 2001, EXP CELL RES, V267, P144, DOI 10.1006/excr.2001.5239; Thong BYH, 2010, ALLERGY ASTHMA IMMUN, V2, P77, DOI 10.4168/aair.2010.2.2.77; WASSERMAN SI, 1984, ARTHRITIS RHEUM, V27, P841, DOI 10.1002/art.1780270801; Yeh MH, 2009, TOXICOL LETT, V184, P204, DOI 10.1016/j.toxlet.2008.11.018	30	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19528	10.1371/journal.pone.0019528	http://dx.doi.org/10.1371/journal.pone.0019528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559359	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700202
J	Kuhlein, HN; Tegeder, I; Moser, C; Lim, HY; Haussler, A; Spieth, K; Jennes, I; Marschalek, R; Beckhaus, T; Karas, M; Fauth, M; Ehnert, C; Geisslinger, G; Niederberger, E				Kuehlein, Hilmar Nils; Tegeder, Irmgard; Moeser, Christine; Lim, Hee-Young; Haeussler, Annett; Spieth, Katharina; Jennes, Ingo; Marschalek, Rolf; Beckhaus, Tobias; Karas, Michael; Fauth, Markus; Ehnert, Corina; Geisslinger, Gerd; Niederberger, Ellen			Nerve Injury Evoked Loss of Latexin Expression in Spinal Cord Neurons Contributes to the Development of Neuropathic Pain	PLOS ONE			English	Article							CARBOXYPEPTIDASE-A; RAT; INHIBITOR; CELL; PROTEINS; NEUROTENSIN; SENSITIVITY; ENDOTHELIN; MECHANISM; SUBSTRATE	Nerve injury leads to sensitization mechanisms in the peripheral and central nervous system which involve transcriptional and post-transcriptional modifications in sensory nerves. To assess protein regulations in the spinal cord after injury of the sciatic nerve in the Spared Nerve Injury model (SNI) we performed a proteomic analysis using 2D-difference gel electrophoresis (DIGE) technology. Among approximately 2300 protein spots separated on each gel we detected 55 significantly regulated proteins after SNI whereof 41 were successfully identified by MALDI-TOF MS. Out of the proteins which were regulated in the DIGE analyses after SNI we focused on the carboxypeptidase A inhibitor latexin because protease dysfunctions contribute to the development of neuropathic pain. Latexin protein expression was reduced after SNI which could be confirmed by Western Blot analysis, quantitative RT-PCR and in-situ hybridisation. The decrease of latexin was associated with an increase of the activity of carboxypeptidase A indicating that the balance between latexin and carboxypeptidase A was impaired in the spinal cord after peripheral nerve injury due to a loss of latexin expression in spinal cord neurons. This may contribute to the development of cold allodynia because normalization of neuronal latexin expression in the spinal cord by AAV-mediated latexin transduction or administration of a small molecule carboxypeptidase A inhibitor significantly reduced acetone-evoked nociceptive behavior after SNI. Our results show the usefulness of proteomics as a screening tool to identify novel mechanisms of nerve injury evoked hypernociception and suggest that carboxypeptidase A inhibition might be useful to reduce cold allodynia.	[Kuehlein, Hilmar Nils; Tegeder, Irmgard; Moeser, Christine; Lim, Hee-Young; Haeussler, Annett; Spieth, Katharina; Ehnert, Corina; Geisslinger, Gerd; Niederberger, Ellen] Univ Frankfurt Klinikum, Inst Klin Pharmakol, Pharmazentrum Frankfurt ZAFES, D-6000 Frankfurt, Germany; [Jennes, Ingo; Marschalek, Rolf] Goethe Univ Frankfurt, Inst Pharmazeut Biol ZAFES, Frankfurt, Germany; [Beckhaus, Tobias; Karas, Michael] Goethe Univ Frankfurt, Inst Pharmazeut Chem ZAFES, Frankfurt, Germany; [Fauth, Markus] Goethe Univ Frankfurt, Inst Mol Biowissensch, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Kuhlein, HN (corresponding author), Univ Frankfurt Klinikum, Inst Klin Pharmakol, Pharmazentrum Frankfurt ZAFES, D-6000 Frankfurt, Germany.	e.niederberger@em.uni-frankfurt.de	Tegeder, Irmgard/AAM-2266-2020; Marschalek, Rolf/D-3404-2011; Tegeder, Irmgard/AAM-2246-2020	Tegeder, Irmgard/0000-0001-7524-8025; Marschalek, Rolf/0000-0003-4870-3445; Tegeder, Irmgard/0000-0001-7524-8025	Deutsche Forschungsgemeinschaft [SFB-815 A12, TE322_5.1, NI705-3-1]; German Network of Neuropathic Pain [BMBF 01EM0103]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Network of Neuropathic Pain	This study was supported by the Deutsche Forschungsgemeinschaft (SFB-815 A12 and TE322_5.1 to IT), (NI705-3-1 to EN) and the German Network of Neuropathic Pain (BMBF 01EM0103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimatsu Y, 1999, NEUROSCIENCE, V88, P93, DOI 10.1016/S0306-4522(98)00185-7; Bai WZ, 2004, NEUROSCIENCE, V123, P257, DOI 10.1016/j.neuroscience.2003.08.056; Bradbury A F, 1976, Ciba Found Symp, V41, P61; BROWN KS, 1987, ANAL BIOCHEM, V161, P219, DOI 10.1016/0003-2697(87)90674-9; BYERS LD, 1972, J BIOL CHEM, V247, P606; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Corvey C, 2005, J BIOL CHEM, V280, P25323, DOI 10.1074/jbc.M503719200; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Dray A, 2008, BRIT J ANAESTH, V101, P48, DOI 10.1093/bja/aen107; GOLDSTEIN SM, 1991, PEPTIDES, V12, P995, DOI 10.1016/0196-9781(91)90049-U; Griffin RS, 2007, J NEUROSCI, V27, P8699, DOI 10.1523/JNEUROSCI.2018-07.2007; HATANAKA Y, 1994, EUR J NEUROSCI, V6, P973, DOI 10.1111/j.1460-9568.1994.tb00592.x; Jin M, 2006, BRAIN RES, V1075, P117, DOI 10.1016/j.brainres.2005.12.099; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Khodorova A, 2009, J PAIN, V10, P4, DOI 10.1016/j.jpain.2008.09.009; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Krondahl E, 2000, J PHARM PHARMACOL, V52, P785, DOI 10.1211/0022357001774642; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929; Lundequist A, 2004, J BIOL CHEM, V279, P32339, DOI 10.1074/jbc.M405576200; Lyons PJ, 2010, J BIOL CHEM, V285, P38234, DOI 10.1074/jbc.M110.158626; Matsugi S, 2007, CLIN CHIM ACTA, V378, P147, DOI 10.1016/j.cca.2006.11.010; Miller LA, 1998, INT ARCH ALLERGY IMM, V116, P147, DOI 10.1159/000023938; Niederberger E, 2008, ANESTHESIOLOGY, V108, P314, DOI 10.1097/01.anes.0000299838.13368.6e; Normant E, 1995, P NATL ACAD SCI USA, V92, P12225, DOI 10.1073/pnas.92.26.12225; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Pallares I, 2005, P NATL ACAD SCI USA, V102, P3978, DOI 10.1073/pnas.0500678102; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Sindrup SH, 1999, PAIN, V83, P389, DOI 10.1016/S0304-3959(99)00154-2; Stewart JD, 2000, CLIN CHIM ACTA, V292, P107, DOI 10.1016/S0009-8981(99)00209-0; Takiguchi-Hayashi K, 2001, DEV BRAIN RES, V132, P87, DOI 10.1016/S0165-3806(01)00262-0; Takiguchi-Hayashi K, 1998, BRAIN RES, V801, P9, DOI 10.1016/S0006-8993(98)00496-X; TAKIGUCHIHAYASHI K, 1995, NEUROREPORT, V6, P281, DOI 10.1097/00001756-199501000-00014; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Wang JY, 2008, NEUROCHEM RES, V33, P2134, DOI 10.1007/s11064-008-9733-6; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0	38	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19270	10.1371/journal.pone.0019270	http://dx.doi.org/10.1371/journal.pone.0019270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21572518	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700120
J	Marchini, C; Gabrielli, F; Iezzi, M; Zenobi, S; Montani, M; Pietrella, L; Kalogris, C; Rossini, A; Ciravolo, V; Castagnoli, L; Tagliabue, E; Pupa, SM; Musiani, P; Monaci, P; Menard, S; Amici, A				Marchini, Cristina; Gabrielli, Federico; Iezzi, Manuela; Zenobi, Santa; Montani, Maura; Pietrella, Lucia; Kalogris, Cristina; Rossini, Anna; Ciravolo, Valentina; Castagnoli, Lorenzo; Tagliabue, Elda; Pupa, Serenella M.; Musiani, Piero; Monaci, Paolo; Menard, Sylvie; Amici, Augusto			The Human Splice Variant Delta 16HER2 Induces Rapid Tumor Onset in a Reporter Transgenic Mouse	PLOS ONE			English	Article							MAMMARY-TUMORS; NEU PROTOONCOGENE; BREAST-CANCER; MICE; HER2; EXPRESSION; INDUCTION; ONCOGENE; ADENOCARCINOMA; PROGRESSION	Several transgenic mice models solidly support the hypothesis that HER2 (ERBB2) overexpression or mutation promotes tumorigenesis. Recently, a HER2 splice variant lacking exon-16 (Delta 16HER2) has been detected in human breast carcinomas. This alternative protein, a normal byproduct of HER2, has an increased transforming potency compared to wild-type (wt) HER2 receptors. To examine the ability of Delta 16HER2 to transform mammary epithelium in vivo and to monitor Delta 16HER2-driven tumorigenesis in live mice, we generated and characterized a mouse line that transgenically expresses both human Delta 16HER2 and firefly luciferase under the transcriptional control of the MMTV promoter. All the transgenic females developed multifocal mammary tumors with a rapid onset and an average latency of 15.11 weeks. Immunohistochemical analysis revealed the concurrent expression of luciferase and the human Delta 16HER2 oncogene only in the mammary gland and in strict correlation with tumor development. Transgenic Delta 16HER2 expressed on the tumor cell plasma membrane from spontaneous mammary adenocarcinomas formed constitutively active homodimers able to activate the oncogenic signal transduction pathway mediated through Src kinase. These new transgenic animals demonstrate the ability of the human Delta 16HER2 isoform to transform "perse" mammary epithelium in vivo. The high tumor incidence as well as the short latency strongly suggests that the Delta 16HER2 splice variant represents the transforming form of the HER2 oncoprotein.	[Marchini, Cristina; Gabrielli, Federico; Zenobi, Santa; Montani, Maura; Pietrella, Lucia; Kalogris, Cristina; Monaci, Paolo; Amici, Augusto] Univ Camerino, Dept Biosci & Biotechnol, I-62032 Camerino, Italy; [Iezzi, Manuela; Musiani, Piero] Univ G DAnnunzio, Aging Res Ctr, Chieti, Italy; [Rossini, Anna; Ciravolo, Valentina; Castagnoli, Lorenzo; Tagliabue, Elda; Pupa, Serenella M.; Menard, Sylvie] Ist Nazl Tumori, Fdn IRCCS, Dept Expt Oncol & Mol Med, Mol Targeting Unit, I-20133 Milan, Italy	University of Camerino; G d'Annunzio University of Chieti-Pescara; Fondazione IRCCS Istituto Nazionale Tumori Milan	Marchini, C (corresponding author), Univ Camerino, Dept Biosci & Biotechnol, I-62032 Camerino, Italy.	augusto.amici@unicam.it	menard, sylvie mm/C-7940-2011; Iezzi, Manuela/AAB-7939-2019; Tagliabue, Elda/B-9377-2017; Castagnoli, Lorenzo/J-1893-2014; Pupa, Serenella/K-6388-2016	Iezzi, Manuela/0000-0002-6296-6498; Tagliabue, Elda/0000-0001-9877-2903; Castagnoli, Lorenzo/0000-0002-0220-6497; Pupa, Serenella/0000-0002-4592-6830; Marchini, Cristina/0000-0001-7692-8428; Amici, Augusto/0000-0002-4634-1500	Ministero dell'Universita e della Ricerca, FIRB [RBLA03KWBS_005]	Ministero dell'Universita e della Ricerca, FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by grants from the Ministero dell'Universita e della Ricerca, FIRB 2003 (RBLA03KWBS_005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRYDA EC, METHODS MOL BIOL, V597, P287; Bryda EC, 2006, BIOTECHNIQUES, V41, P715, DOI 10.2144/000112289; Castiglioni F, 2006, ENDOCR-RELAT CANCER, V13, P221, DOI 10.1677/erc.1.01047; Finkle D, 2004, CLIN CANCER RES, V10, P2499, DOI 10.1158/1078-0432.CCR-03-0448; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Guy CT, 1996, J BIOL CHEM, V271, P7673, DOI 10.1074/jbc.271.13.7673; HOGAN B, 1986, MANIPULATING MOUSE E; Kwong KY, 1998, MOL CARCINOGEN, V23, P62, DOI 10.1002/(SICI)1098-2744(199810)23:2<62::AID-MC2>3.0.CO;2-O; Mitra D, 2009, MOL CANCER THER, V8, P2152, DOI 10.1158/1535-7163.MCT-09-0295; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Pedersen K, 2009, MOL CELL BIOL, V29, P3319, DOI 10.1128/MCB.01803-08; Piechocki MP, 2003, J IMMUNOL, V171, P5787, DOI 10.4049/jimmunol.171.11.5787; Rocuts F, 2010, J IMMUNOL, V185, P2134, DOI 10.4049/jimmunol.0902782; Shepherd CT, 2009, METHODS MOL BIOL, V526, P129, DOI 10.1007/978-1-59745-494-0_11; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Street SEA, 2007, CANCER RES, V67, P5454, DOI 10.1158/0008-5472.CAN-06-4084; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; Zatyka M, 2008, HUM MOL GENET, V17, P190, DOI 10.1093/hmg/ddm296	21	56	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18727	10.1371/journal.pone.0018727	http://dx.doi.org/10.1371/journal.pone.0018727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559085	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700022
J	Romi, B; Soldaini, E; Pancotto, L; Castellino, F; Del Giudice, G; Schiavetti, F				Romi, Benedetta; Soldaini, Elisabetta; Pancotto, Laura; Castellino, Flora; Del Giudice, Giuseppe; Schiavetti, Francesca			Helicobacter pylori Induces Activation of Human Peripheral gamma delta plus T Lymphocytes	PLOS ONE			English	Article							PEPTIC-ULCER DISEASE; TYROSINE PHOSPHORYLATION; VIRULENCE FACTORS; CELL RESPONSES; GASTRIC-CANCER; CAGA; INFECTION; ANTIGEN; STRAINS; ADENOCARCINOMA	Helicobacter pylori is a Gram-negative bacterium that causes gastric and duodenal diseases in humans. Despite a robust antibody and cellular immune response, H. pylori infection persists chronically. To understand if and how H. pylori could modulate T cell activation, in the present study we investigated in vitro the interaction between H. pylori and human T lymphocytes freshly isolated from peripheral blood of H. pylori-negative donors. A direct interaction of live, but not killed bacteria with purified CD3+ T lymphocytes was observed by microscopy and confirmed by flow cytometry. Live H. pylori activated CD3+ T lymphocytes and predominantly gamma delta+ T cells bearing the TCR chain V delta 2. Upon interaction with H. pylori, these cells up-regulated the activation molecule CD69 and produced cytokines (such as TNF alpha, IFN gamma) and chemokines (such as MIP-1 beta, RANTES) in a non-antigen-specific manner. This activation required viable H. pylori and was not exhibited by other Gram-negative bacteria. The cytotoxin-associated antigen-A (CagA), was at least partially responsible of this activation. Our results suggest that H. pylori can directly interact with T cells and modulate the response of gamma delta+ T cells, thereby favouring an inflammatory environment which can contribute to the chronic persistence of the bacteria and eventually to the gastric pathology.	[Romi, Benedetta; Soldaini, Elisabetta; Pancotto, Laura; Castellino, Flora; Del Giudice, Giuseppe; Schiavetti, Francesca] Novartis Vaccines & Diagnost Res Ctr, Siena, Italy	Novartis	Romi, B (corresponding author), Novartis Vaccines & Diagnost Res Ctr, Siena, Italy.	francesca.schiavetti@novartis.com						Aihara M, 1997, INFECT IMMUN, V65, P3218, DOI 10.1128/IAI.65.8.3218-3224.1997; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Bagchi D, 1996, FREE RADICAL RES, V24, P439, DOI 10.3109/10715769609088043; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Beetz S, 2007, IMMUNOL RES, V37, P97, DOI 10.1007/BF02685893; BLASER MJ, 1995, CANCER RES, V55, P2111; Bonneville M, 2006, CURR OPIN IMMUNOL, V18, P539, DOI 10.1016/j.coi.2006.07.002; Bukowski JF, 1999, ARTHRITIS RHEUM, V42, pS259; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; Ching CK, 1996, AM J GASTROENTEROL, V91, P949; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; DElios MM, 1997, J IMMUNOL, V158, P962; Dundon WG, 2001, INT J MED MICROBIOL, V290, P647, DOI 10.1016/S1438-4221(01)80002-3; Feurle J, 2002, J BIOL CHEM, V277, P148, DOI 10.1074/jbc.M106443200; Futagami S, 2006, J GASTROEN HEPATOL, V21, P32, DOI 10.1111/j.1440-1746.2005.04148.x; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Morita CT, 2000, SPRINGER SEMIN IMMUN, V22, P191, DOI 10.1007/s002810000042; Newton DJ, 2006, INFECT IMMUN, V74, P1097, DOI 10.1128/IAI.74.2.1097-1105.2006; Papini E, 1998, J CLIN INVEST, V102, P813, DOI 10.1172/JCI2764; Peek RM, 1995, LAB INVEST, V73, P760; Petersen AM, 2001, FEMS IMMUNOL MED MIC, V30, P103, DOI 10.1016/S0928-8244(00)00246-7; Pietschmann K, 2009, SCAND J IMMUNOL, V70, P245, DOI 10.1111/j.1365-3083.2009.02290.x; Pinto-Santini D, 2005, CANCER EPIDEM BIOMAR, V14, P1853, DOI 10.1158/1055-9965.EPI-04-0784; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Rohde M, 2003, MOL MICROBIOL, V49, P219, DOI 10.1046/j.1365-2958.2003.03549.x; Rosenplanter C, 2007, EUR J IMMUNOL, V37, P1905, DOI 10.1002/eji.200636676; Shrestha N, 2005, ANN NY ACAD SCI, V1062, P79, DOI 10.1196/annals.1358.011; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; WANG Y, 1993, J GEN MICROBIOL, V139, P2485, DOI 10.1099/00221287-139-10-2485; Wesch D, 2006, J IMMUNOL, V176, P1348, DOI 10.4049/jimmunol.176.3.1348; Yurchenko E, 2006, J EXP MED, V203, P2451, DOI 10.1084/jem.20060956	38	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19324	10.1371/journal.pone.0019324	http://dx.doi.org/10.1371/journal.pone.0019324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559446	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700135
J	Tian, G; Qiu, YF; Qi, ZZ; Wu, XH; Zhang, QW; Bi, YJ; Yang, YH; Li, YC; Yang, XY; Xin, YQ; Li, CX; Cui, BZ; Wang, ZY; Wang, H; Yang, RF; Wang, XY				Tian, Guang; Qiu, Yefeng; Qi, Zhizhen; Wu, Xiaohong; Zhang, Qingwen; Bi, Yujing; Yang, Yonghai; Li, Yuchuan; Yang, Xiaoyan; Xin, Youquan; Li, Cunxiang; Cui, Baizhong; Wang, Zuyun; Wang, Hu; Yang, Ruifu; Wang, Xiaoyi			Histopathological Observation of Immunized Rhesus Macaques with Plague Vaccines after Subcutaneous Infection of Yersinia pestis	PLOS ONE			English	Article							PNEUMONIC PLAGUE; MOUSE MODEL; PATHOLOGY; PROGRESSION; PROTECTION	In our previous study, complete protection was observed in Chinese-origin rhesus macaques immunized with SV1 (20 mu g F1 and 10 mu g rV270) and SV2 (200 mu g F1 and 100 mu g rV270) subunit vaccines and with EV76 live attenuated vaccine against subcutaneous challenge with 6 x 10(6) CFU of Y. pestis. In the present study, we investigated whether the vaccines can effectively protect immunized animals from any pathologic changes using histological and immunohistochemical techniques. In addition, the glomerular basement membranes (GBMs) of the immunized animals and control animals were checked by electron microscopy. The results show no signs of histopathological lesions in the lungs, livers, kidneys, lymph nodes, spleens and hearts of the immunized animals at Day 14 after the challenge, whereas pathological alterations were seen in the corresponding tissues of the control animals. Giemsa staining, ultrastructural examination, and immunohistochemical staining revealed bacteria in some of the organs of the control animals, whereas no bacterium was observed among the immunized animals. Ultrastructural observation revealed that no glomerular immune deposits on the GBM. These observations suggest that the vaccines can effectively protect animals from any pathologic changes and eliminate Y. pestis from the immunized animals. The control animals died from multi-organ lesions specifically caused by the Y. pestis infection. We also found that subcutaneous infection of animals with Y. pestis results in bubonic plague, followed by pneumonic and septicemic plagues. The histopathologic features of plague in rhesus macaques closely resemble those of rodent and human plagues. Thus, Chinese-origin rhesus macaques serve as useful models in studying Y. pestis pathogenesis, host response and the efficacy of new medical countermeasures against plague.	[Tian, Guang; Wu, Xiaohong; Bi, Yujing; Li, Yuchuan; Yang, Ruifu; Wang, Xiaoyi] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Qiu, Yefeng] Acad Mil Med Sci, Lab Anim Ctr, Beijing, Peoples R China; [Qi, Zhizhen; Zhang, Qingwen; Yang, Yonghai; Yang, Xiaoyan; Xin, Youquan; Li, Cunxiang; Cui, Baizhong; Wang, Zuyun; Wang, Hu] Qinghai Inst Endem Dis Prevent & Control Qinghai, Xining, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Academy of Military Medical Sciences - China	Tian, G (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	ruifuyang@gmail.com; wgenome@yahoo.com.cn	Yang, Ruifu/A-2273-2011; li, JACK/HHC-6755-2022	Yang, Ruifu/0000-0003-3219-7269; 	National Key Program for Infectious Diseases of China [2009ZX10004-4001]; National Natural Science Foundation of China [30930001]	National Key Program for Infectious Diseases of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Program for Infectious Diseases of China (2009ZX10004-4001) and the National Natural Science Foundation of China (contract no. 30930001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar SL, 2008, MICROBIOL-SGM, V154, P1939, DOI 10.1099/mic.0.2008/017335-0; AGODOA LYC, 1987, KIDNEY INT, V32, P13, DOI 10.1038/ki.1987.165; Al-Haddawi MH, 2001, RES VET SCI, V70, P191, DOI 10.1053/rvsc.2001.0459; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P338; Bashaw J, 2007, CLIN VACCINE IMMUNOL, V14, P605, DOI 10.1128/CVI.00398-06; Chen S, 2009, VET IMMUNOL IMMUNOP, V130, P226, DOI 10.1016/j.vetimm.2009.02.011; Chen Z, 2009, PHOTODERMATOL PHOTO, V25, P310, DOI 10.1111/j.1600-0781.2009.00465.x; Cornelius CA, 2008, INFECT IMMUN, V76, P5588, DOI 10.1128/IAI.00699-08; COUSER WG, 1985, KIDNEY INT, V28, P569, DOI 10.1038/ki.1985.167; Davis KJ, 1996, ARCH PATHOL LAB MED, V120, P156; Do Y, 2008, EUR J IMMUNOL, V38, P20, DOI 10.1002/eji.200737799; FMedSci SDWF, 2006, US NONH PRIM RES, P1; Guinet F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001688; Jennings GT, 2009, ANNU REV PHARMACOL, V49, P303, DOI 10.1146/annurev-pharmtox-061008-103129; Kurul S, 2004, PEDIATR NEPHROL, V19, P621, DOI 10.1007/s00467-004-1423-2; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Parent MA, 2005, INFECT IMMUN, V73, P7304, DOI 10.1128/IAI.73.11.7304-7310.2005; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Qi ZZ, 2010, VACCINE, V28, P1655, DOI 10.1016/j.vaccine.2009.02.078; Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x; Riedel Stefan, 2005, Proc (Bayl Univ Med Cent), V18, P116; Rohr LR, 2001, AM J CLIN PATHOL, V115, P703; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; Smiley ST, 2008, IMMUNOL REV, V225, P256, DOI 10.1111/j.1600-065X.2008.00674.x; Van Andel R, 2008, COMPARATIVE MED, V58, P68; Watson RP, 2001, VET PATHOL, V38, P165, DOI 10.1354/vp.38-2-165; Williamson ED, 2007, MICROB PATHOGENESIS, V42, P11, DOI 10.1016/j.micpath.2006.09.003; Williamson ED, 1999, CLIN EXP IMMUNOL, V116, P107; Williamson ED, 1997, VACCINE, V15, P1079, DOI 10.1016/S0264-410X(96)00303-9	29	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19260	10.1371/journal.pone.0019260	http://dx.doi.org/10.1371/journal.pone.0019260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559437	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700114
J	Song, AY; Xu, M; Bi, YF; Xu, Y; Huang, Y; Li, M; Wang, TG; Wu, YH; Liu, Y; Li, XY; Chen, YH; Wang, WQ; Ning, G				Song, Aiyun; Xu, Min; Bi, Yufang; Xu, Yu; Huang, Yun; Li, Mian; Wang, Tiange; Wu, Yaohua; Liu, Yu; Li, Xiaoying; Chen, Yuhong; Wang, Weiqing; Ning, Guang			Serum Fetuin-A Associates with Type 2 Diabetes and Insulin Resistance in Chinese Adults	PLOS ONE			English	Article							ALPHA(2)-HEREMANS-SCHMID GLYCOPROTEIN/FETUIN-A; METABOLIC SYNDROME; TYROSINE KINASE; INHIBITOR; CALCIFICATION; RECEPTOR; DISEASE; GLUCOSE; PROTEIN; ATHEROSCLEROSIS	Background: Previous studies have demonstrated that fetuin-A is related to insulin resistance among subjects with normal glucose tolerance but not patients with type 2 diabetes. There are limited data available concerning fetuin-A and insulin resistance in Chinese. We aimed to study the association of feuin-A with insulin resistance among participants with or without type 2 diabetes in a large sample size of adults aged 40 and older. Methodology and Principal Findings: A community-based cross-sectional study was performed among 5,227 Chinese adults. The average age of our study was 61.5 +/- 9.9 years. Serum fetuin-A concentrations were not significantly different between male and female (296.9 vs. 292.9 mg/l, p = 0.11). Compared with the lowest quartile, the highest quartile of serum fetuin-A revealed a significant higher proportion of type 2 diabetic patients (34.8% vs. 27.3%, p<0.0001). In the multinomial logit models, the risk of type 2 diabetes was associated with each one quartile increase of serum fetuin-A concentrations when referenced not only to normal glucose tolerance (OR 1.24, 95% CI 1.07-1.43, p = 0.004) but also to impaired glucose regulation (OR 1.25, 95% CI 1.08-1.44, p = 0.003, respectively), after adjustment for age, sex, community, current smoking, and current drinking. The logistic regression analysis showed that fetuin-A were associated with elevated HOMA-IR and fasting serum insulin both among the participants with or without type 2 diabetes in the full adjusted analysis. There was no significant association between elevated serum fetuin-A concentrations and impaired glucose regulation (all p >= 0.12). Conclusions and Significance: Higher fetuin-A concentrations were associated with type 2 diabetes and insulin resistance in middle aged and elderly Chinese.	[Song, Aiyun; Xu, Min; Bi, Yufang; Xu, Yu; Huang, Yun; Li, Mian; Wang, Tiange; Wu, Yaohua; Liu, Yu; Li, Xiaoying; Chen, Yuhong; Wang, Weiqing; Ning, Guang] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Endocrinol & Metab, Shanghai Inst Endocrine & Metab Dis,Shanghai Clin, Shanghai 200030, Peoples R China; [Li, Xiaoying; Ning, Guang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Song, AY (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Endocrinol & Metab, Shanghai Inst Endocrine & Metab Dis,Shanghai Clin, Shanghai 200030, Peoples R China.	gning@sibs.ac.cn	Li, Mian/HGE-6038-2022	Li, Xiaoying/0000-0002-9383-5757	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Chinese Public Health [1994DP131044]; National Key New Drug Creation and Manufacturing Program [2008ZX09312/019]; Nature Science Foundation of China [30911120493, 30800536]; Shanghai Committee of Science and Technology [08dj1400602]	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Chinese Public Health; National Key New Drug Creation and Manufacturing Program; Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This study is supported by grants from Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Chinese Public Health (No. 1994DP131044), National Key New Drug Creation and Manufacturing Program (2008ZX09312/019), Nature Science Foundation of China (No. 30911120493, 30800536), and Shanghai Committee of Science and Technology (No. 08dj1400602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; AUBERGER P, 1989, CELL, V58, P631, DOI 10.1016/0092-8674(89)90098-6; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Cintron V J, 2001, Int J Exp Diabetes Res, V1, P249; Denecke B, 2003, BIOCHEM J, V376, P135, DOI 10.1042/BJ20030676; Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765; Ishibashi A, 2010, J ATHEROSCLER THROMB, V17, P925, DOI 10.5551/jat.3830; Ix JH, 2006, CIRCULATION, V113, P1760, DOI 10.1161/CIRCULATIONAHA.105.588723; Ix JH, 2008, JAMA-J AM MED ASSOC, V300, P182, DOI 10.1001/jama.300.2.182; Ix JH, 2007, CIRCULATION, V115, P2533, DOI 10.1161/CIRCULATIONAHA.106.682450; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Levitzky YS, 2008, J AM COLL CARDIOL, V51, P264, DOI 10.1016/j.jacc.2007.09.038; Li XY, 2009, CLIN ENDOCRINOL, V70, P691, DOI 10.1111/j.1365-2265.2008.03371.x; Lorenzo C, 2010, DIABETES CARE, V33, P67, DOI 10.2337/dc09-1115; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mathews ST, 1997, LIFE SCI, V61, P1583, DOI 10.1016/S0024-3205(97)00737-6; Mathews ST, 2000, MOL CELL ENDOCRINOL, V164, P87, DOI 10.1016/S0303-7207(00)00237-9; Mathews ST, 2002, DIABETES, V51, P2450, DOI 10.2337/diabetes.51.8.2450; Mathews ST, 2006, BIOCHEM BIOPH RES CO, V350, P437, DOI 10.1016/j.bbrc.2006.09.071; Moe SM, 2005, KIDNEY INT, V67, P2295, DOI 10.1111/j.1523-1755.2005.00333.x; Mori K, 2006, DIABETES CARE, V29, P468, DOI 10.2337/diacare.29.02.06.dc05-1484; Ombrellino M, 2001, SHOCK, V15, P181, DOI 10.1097/00024382-200115030-00004; RAUTH G, 1992, EUR J BIOCHEM, V204, P523, DOI 10.1111/j.1432-1033.1992.tb16663.x; Reinehr T, 2008, J CLIN ENDOCR METAB, V93, P4479, DOI 10.1210/jc.2008-1505; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; SRINIVAS PR, 1993, MOL ENDOCRINOL, V7, P1445, DOI 10.1210/me.7.11.1445; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Wang AYM, 2005, NEPHROL DIAL TRANSPL, V20, P1676, DOI 10.1093/ndt/gfh891; Xiang J, 2008, J CLIN ENDOCR METAB, V93, P4107, DOI 10.1210/jc.2008-0161; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	32	52	57	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19228	10.1371/journal.pone.0019228	http://dx.doi.org/10.1371/journal.pone.0019228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556362	Green Published, Green Submitted, gold			2022-12-25	WOS:000290019400039
J	Graham, SA; Antonopoulos, A; Hitchen, PG; Haslam, SM; Dell, A; Drickamer, K; Taylor, ME				Graham, Sarah A.; Antonopoulos, Aristotelis; Hitchen, Paul G.; Haslam, Stuart M.; Dell, Anne; Drickamer, Kurt; Taylor, Maureen E.			Identification of Neutrophil Granule Glycoproteins as Lewis(x)-containing Ligands Cleared by the Scavenger Receptor C-type Lectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCAN-BINDING RECEPTORS; CYSTEINE-RICH DOMAIN; LEWIS-X RESIDUES; CELL-ADHESION; DC-SIGN; HUMAN-GRANULOCYTES; MANNOSE RECEPTOR; MONOCLONAL-ANTIBODIES; MASS-SPECTROMETRY; HUMAN LACTOFERRIN	The scavenger receptor C-type lectin (SRCL) is a glycanbinding receptor that has the capacity to mediate endocytosis of glycoproteins carrying terminal Lewis(x) groups (Gal beta 1-4(Fuc alpha 1-3) GlcNAc). A screen for glycoprotein ligands for SRCL using affinity chromatography on immobilized SRCL followed by mass spectrometry-based proteomic analysis revealed that soluble glycoproteins from secondary granules of neutrophils, including lactoferrin and matrix metalloproteinases 8 and 9, are major ligands. Binding competition and surface plasmon resonance analysis showed affinities in the low micromolar range. Comparison of SRCL binding to neutrophil and milk lactoferrin indicates that the binding is dependent on cell-specific glycosylation in the neutrophils, as the milk form of the glycoprotein is a much poorer ligand. Binding to neutrophil glycoproteins is fucose-dependent, and mass spectrometry-based glycomic analysis of neutrophil and milk lactoferrin was used to establish a correlation between high affinity binding to SRCL and the presence of multiple clustered terminal Lewis(x) groups on a heterogeneous mixture of branched glycans, some with poly N-acetyllactosamine extensions. The ability of SRCL to mediate uptake of neutrophil lactoferrin was confirmed using fibroblasts transfected with SRCL. The common presence of Lewisx groups in granule protein glycans can thus target granule proteins for clearance by SRCL. PCR and immunohistochemical analysis confirm that SRCL is widely expressed on endothelial cells and thus represents a distributed system that could scavenge released neutrophil glycoproteins both locally at sites of inflammation or systemically when they are released in the circulation.	[Graham, Sarah A.; Antonopoulos, Aristotelis; Hitchen, Paul G.; Haslam, Stuart M.; Dell, Anne; Drickamer, Kurt; Taylor, Maureen E.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Dept Life Sci, London SW7 2AZ, England	Imperial College London	Taylor, ME (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Dept Life Sci, Biochem Bldg, London SW7 2AZ, England.	maureen.taylor@imperial.ac.uk	Graham, Sarah/G-7765-2014	Graham, Sarah/0000-0003-2521-2416; Taylor, Maureen/0000-0001-8300-4987; Drickamer, Kurt/0000-0001-5026-5996	Wellcome Trust [075565]; Biotechnology and Biological Sciences Research Council [B19088, SF19107, BBF0083091, BBC5196701]	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant 075565 from the Wellcome Trust (to M. E. T. and K. D.) and Grants B19088, SF19107, BBF0083091, and BBC5196701 from the Biotechnology and Biological Sciences Research Council (to A. D.).	ALBRECHTSEN M, 1989, BRIT J HAEMATOL, V72, P312, DOI 10.1111/j.1365-2141.1989.tb07710.x; Babu P, 2009, GLYCOCONJUGATE J, V26, P975, DOI 10.1007/s10719-008-9146-4; Bogoevska V, 2006, GLYCOBIOLOGY, V16, P197, DOI 10.1093/glycob/cwj057; Bogoevska V, 2007, GLYCOBIOLOGY, V17, P324, DOI 10.1093/glycob/cwl073; BUESCHER ES, 1990, ANAT REC, V228, P306, DOI 10.1002/ar.1092280310; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; Coombs PJ, 2010, J MOL BIOL, V396, P685, DOI 10.1016/j.jmb.2009.11.073; Coombs PJ, 2005, J BIOL CHEM, V280, P22993, DOI 10.1074/jbc.M504197200; DELL A, 1993, GLYCOBIOLOGY PRACTIC, P187; DERISBOURG P, 1990, BIOCHEM J, V269, P821, DOI 10.1042/bj2690821; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Elola MT, 2007, BREAST CANCER RES TR, V101, P161, DOI 10.1007/s10549-006-9286-9; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; FUKUDA M, 1984, J BIOL CHEM, V259, P925; Houston DR, 2003, J BIOL CHEM, V278, P30206, DOI 10.1074/jbc.M303371200; Imberty A, 1997, CURR OPIN STRUC BIOL, V7, P617, DOI 10.1016/S0959-440X(97)80069-3; Jang S, 2009, J BIOL CHEM, V284, P3956, DOI 10.1074/jbc.M807477200; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; KERR MA, 1992, HISTOCHEM J, V24, P811, DOI 10.1007/BF01046353; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Legrand D, 2008, ADV EXP MED BIOL, V606, P163, DOI 10.1007/978-0-387-74087-4_6; Lucka L, 2005, GLYCOBIOLOGY, V15, P87, DOI 10.1093/glycob/cwh139; MATSUMOTO A, 1982, J BIOCHEM-TOKYO, V91, P143, DOI 10.1093/oxfordjournals.jbchem.a133671; MCCARTHY NC, 1985, BIOSCIENCE REP, V5, P933, DOI 10.1007/BF01119906; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; MIROLI AA, 1986, J IMMUNOL METHODS, V88, P91, DOI 10.1016/0022-1759(86)90055-4; MOLLICONE R, 1995, TRANSFUS CLIN BIOL, V2, P235, DOI 10.1016/S1246-7820(05)80089-8; Nakamura K, 2001, BIOCHEM BIOPH RES CO, V280, P1028, DOI 10.1006/bbrc.2000.4210; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Nauseef WM, 1999, J LEUKOCYTE BIOL, V66, P867, DOI 10.1002/jlb.66.6.867; Nishihara S, 1999, FEBS LETT, V462, P289, DOI 10.1016/S0014-5793(99)01549-5; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pipirou Z, 2011, GLYCOBIOLOGY, V21, P806, DOI 10.1093/glycob/cwr008; Powlesland AS, 2009, GLYCOBIOLOGY, V19, P899, DOI 10.1093/glycob/cwp065; Resnick D, 1996, J BIOL CHEM, V271, P26924, DOI 10.1074/jbc.271.43.26924; Revelle BM, 1996, J BIOL CHEM, V271, P4289; Samsen A, 2010, EUR J CELL BIOL, V89, P87, DOI 10.1016/j.ejcb.2009.11.018; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; SHEPHERD VL, 1990, AM J RESP CELL MOL, V2, P335, DOI 10.1165/ajrcmb/2.4.335; SKUBITZ KM, 1987, J IMMUNOL, V139, P1631; Smith PA, 1998, NUCLEIC ACIDS RES, V26, P1414, DOI 10.1093/nar/26.6.1414; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; SPIK G, 1982, EUR J BIOCHEM, V121, P413, DOI 10.1111/j.1432-1033.1982.tb05803.x; Steirer LM, 2009, J BIOL CHEM, V284, P3777, DOI 10.1074/jbc.M808689200; Taylor ME, 2007, CURR OPIN CELL BIOL, V19, P572, DOI 10.1016/j.ceb.2007.09.004; TERSTAPPEN LWMM, 1990, J LEUKOCYTE BIOL, V48, P138, DOI 10.1002/jlb.48.2.138; van Gisbergen KPJM, 2005, TRENDS IMMUNOL, V26, P626, DOI 10.1016/j.it.2005.09.007; van Gisbergen KPJM, 2005, FEBS LETT, V579, P6159, DOI 10.1016/j.febslet.2005.09.089; vanBerkel PHC, 1996, BIOCHEM J, V319, P117, DOI 10.1042/bj3190117; Volck B, 1998, P ASSOC AM PHYSICIAN, V110, P351; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301	57	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24336	24349		10.1074/jbc.M111.244772	http://dx.doi.org/10.1074/jbc.M111.244772			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21561871	Green Published, hybrid			2022-12-25	WOS:000292294900074
J	Zhang, P; Liu, JZ; Xu, QA; Harber, G; Feng, X; Michalek, SM; Katz, J				Zhang, Ping; Liu, Jianzhong; Xu, Qingan; Harber, Gregory; Feng, Xu; Michalek, Suzanne M.; Katz, Jenny			TLR2-dependent Modulation of Osteoclastogenesis by Porphyromonas gingivalis through Differential Induction of NFATc1 and NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; PERIODONTAL-DISEASE; BONE LOSS; CYTOKINE PRODUCTION; SIGNALING PATHWAY; LIPOPOLYSACCHARIDE; EXPRESSION; RANKL; OSTEOIMMUNOLOGY; INHIBITION	Osteolytic diseases, including rheumatoid arthritis, osteomyelitis, and periodontitis, are usually associated with bacterial infections. However, the precise mechanisms by which bacteria induce bone loss still remain unclear. Evidence exists that Toll-like receptor (TLR) signaling regulates both inflammation and bone metabolism and that the receptor activator of NF-kappa B ligand (RANKL) and its receptor RANK are the key regulators for bone remodeling and for the activation of osteoclasts. Here, we investigate the direct effects of the periodontal pathogen Porphyromonas gingivalis on osteoclast differentiation and show that P. gingivalis differentially modulates RANKL-induced osteoclast formation contingent on the state of differentiation of osteoclast precursors. In addition, although an optimal induction of cytokines by P. gingivalis is dependent on TLR2 and TLR4, as well as myeloid differentiation factor 88 and Toll/IL-1R domain-containing adaptor-inducing IFN-beta, P. gingivalis utilizes TLR2/ myeloid differentiation factor 88 in modulating osteoclast differentiation. P. gingivalis modulates RANKL-induced osteoclast formation by differential induction of NFATc1 and c-Fos. More importantly, RANKL-mediated lineage commitment also has an impact on P. gingivalis-induced cytokine production. RANKL inhibits P. gingivalis-induced cytokine production by down-regulation of TLR/NF-kappa B and up-regulation of NFATc1. Our findings reveal novel aspects of the interactions between TLR and RANK signaling and provide a new model for understanding the mechanism underlying the pathogenesis of bacteria-mediated bone loss.	[Zhang, Ping; Katz, Jenny] Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35294 USA; [Xu, Qingan] Wuhan Univ, Key Lab Oral Biomed Engn, Sch Stomatol, Minist Educ, Wuhan 430079, Hubei, Peoples R China; [Xu, Qingan] Wuhan Univ, Key Lab Oral Biomed Engn, Hosp Stomatol, Minist Educ, Wuhan 430079, Hubei, Peoples R China	University of Alabama System; University of Alabama Birmingham; Wuhan University; Wuhan University	Zhang, P (corresponding author), 845 19th St S,BBRB 258-5, Birmingham, AL 35294 USA.	pingz@uab.edu; meow@uab.edu		Zhang, Ping/0000-0002-4585-9893	University of Alabama at Birmingham Center for Metabolic Bone Disease through National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30 AR0406031]; UAB School of Dentistry; National Institute of Dental and Craniofacial Research [DE14215]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014215, R56DE014215] Funding Source: NIH RePORTER	University of Alabama at Birmingham Center for Metabolic Bone Disease through National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); UAB School of Dentistry; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a pilot project award from the University of Alabama at Birmingham Center for Metabolic Bone Disease (to P. Z.) through Grant P30 AR0406031 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (to Dr. Jay M. McDonald), by a faculty development award from the UAB School of Dentistry (to P. Z.), and by Grant DE14215 from the National Institute of Dental and Craniofacial Research (to J. K.).	Abu-Amer Y, 2008, AUTOIMMUNITY, V41, P204, DOI 10.1080/08916930701694543; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Bobetsis YA, 2006, J AM DENT ASSOC, V137, p7S, DOI 10.14219/jada.archive.2006.0403; Bochniak Mariusz, 2004, Przegl Lek, V61, P518; Boggess KA, 2006, AM J OBSTET GYNECOL, V194, P1316, DOI 10.1016/j.ajog.2005.11.059; Bradley EW, 2010, MOL ENDOCRINOL, V24, P1581, DOI 10.1210/me.2010-0037; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; David JP, 2007, ADV IMMUNOL, V95, P149, DOI 10.1016/S0065-2776(07)95005-1; de Lumley M, 2004, J MOL BIOL, V339, P1059, DOI 10.1016/j.jmb.2004.03.083; Feng X, 2005, IUBMB LIFE, V57, P389, DOI 10.1080/15216540500137669; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Grossi S G, 2001, Ann Periodontol, V6, P138, DOI 10.1902/annals.2001.6.1.138; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Gyurko R, 2005, BONE, V36, P472, DOI 10.1016/j.bone.2004.12.002; Hiramine H, 2003, FEMS MICROBIOL LETT, V229, P49, DOI 10.1016/S0378-1097(03)00788-2; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; HOLT S C, 1991, Critical Reviews in Oral Biology and Medicine, V2, P177; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Ji JD, 2009, J IMMUNOL, V183, P7223, DOI 10.4049/jimmunol.0900072; Jiang YL, 2002, INFECT IMMUN, V70, P3143, DOI 10.1128/IAI.70.6.3143-3148.2002; Kadono H, 1999, INFECT IMMUN, V67, P2841, DOI 10.1128/IAI.67.6.2841-2846.1999; Kaneko H, 2007, PROSTAG LEUKOTR ESS, V77, P181, DOI 10.1016/j.plefa.2007.09.002; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Kubota T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2298; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lessem Jan, 2005, J Int Acad Periodontol, V7, P49; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Martin M, 2001, J IMMUNOL, V167, P5278, DOI 10.4049/jimmunol.167.9.5278; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Michalek SM, 2002, IMMUNOL RES, V26, P223, DOI 10.1385/IR:26:1-3:223; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oliver RC, 1998, J PERIODONTOL, V69, P269, DOI 10.1902/jop.1998.69.2.269; Paquette David W, 2004, Compend Contin Educ Dent, V25, P681; Pussinen PJ, 2004, STROKE, V35, P2020, DOI 10.1161/01.STR.0000136148.29490.fe; Rho J, 2004, MOL CELLS, V17, P1; Sato N, 2004, J EXP MED, V200, P601, DOI 10.1084/jem.20040689; Seinost G, 2005, AM HEART J, V149, P1050, DOI 10.1016/j.ahj.2004.09.059; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Suda K, 2004, J IMMUNOL, V172, P2504, DOI 10.4049/jimmunol.172.4.2504; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takatsuna H, 2005, J BONE MINER RES, V20, P653, DOI 10.1359/JBMR.041213; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Teng YTA, 2006, J DENT RES, V85, P198, DOI 10.1177/154405910608500301; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yeo H, 2007, BONE, V40, P1502, DOI 10.1016/j.bone.2007.02.017; Yoshimura A, 2002, INFECT IMMUN, V70, P218, DOI 10.1128/IAI.70.1.218-225.2002; Zhang P, 2005, INFECT IMMUN, V73, P3990, DOI 10.1128/IAI.73.7.3990-3998.2005; Zhang P, 2009, MOL IMMUNOL, V46, P677, DOI 10.1016/j.molimm.2008.08.281; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	66	74	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24159	24169		10.1074/jbc.M110.198085	http://dx.doi.org/10.1074/jbc.M110.198085			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566133	Green Published, hybrid			2022-12-25	WOS:000292294900058
J	Malle, E; Zhou, HW; Neuhold, J; Spitzenberger, B; Klepsch, F; Pollak, T; Bergner, O; Ecker, GF; Stolt-Bergner, PC				Malle, Elisabeth; Zhou, Hongwen; Neuhold, Jana; Spitzenberger, Bettina; Klepsch, Freya; Pollak, Thomas; Bergner, Oliver; Ecker, Gerhard F.; Stolt-Bergner, Peggy C.			Random Mutagenesis of the Prokaryotic Peptide Transporter YdgR Identifies Potential Periplasmic Gating Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LACTOSE PERMEASE; MEMBRANE; PROTEINS; MUTATIONS; MECHANISM; PATHWAY; HPEPT1; FAMILY; DOMAIN	The peptide transporter (PTR) family represents a group of proton-coupled secondary transporters responsible for bulk uptake of amino acids in the form of di- and tripeptides, an essential process employed across species ranging from bacteria to humans. To identify amino acids critical for peptide transport in a prokaryotic PTR member, we have screened a library of mutants of the Escherichia coli peptide transporter YdgR using a high-throughput substrate uptake assay. We have identified 35 single point mutations that result in a full or partial loss of transport activity. Additional analysis, including homology modeling based on the crystal structure of the Shewanella oneidensis peptide transporter PepT(so), identifies Glu(56) and Arg(305) as potential periplasmic gating residues. In addition to providing new insights into transport by members of the PTR family, these mutants provide valuable tools for further study of the mechanism of peptide transport.	[Malle, Elisabeth; Zhou, Hongwen; Neuhold, Jana; Spitzenberger, Bettina; Pollak, Thomas; Bergner, Oliver; Stolt-Bergner, Peggy C.] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Zhou, Hongwen; Neuhold, Jana] Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, A-1030 Vienna, Austria; [Klepsch, Freya; Ecker, Gerhard F.] Univ Vienna, Dept Med Chem, A-1090 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Vienna	Stolt-Bergner, PC (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	stolt@imp.ac.at		Trasischker, Freya/0000-0003-1410-695X; Ecker, Gerhard/0000-0003-4209-6883; Stolt-Bergner, Peggy/0000-0002-5887-2915	Austrian Science Fund [SFB35, F3507, F3502]; Federal Ministry of Economy, Family and Youth through "Laura Bassi Centre of Expertise" initiative [253275]; Boehringer Ingelheim; Austrian Science Fund (FWF) [F 3507] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Federal Ministry of Economy, Family and Youth through "Laura Bassi Centre of Expertise" initiative; Boehringer Ingelheim(Boehringer Ingelheim); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund, SFB35 projects F3507 and F3502, the Federal Ministry of Economy, Family and Youth through "Laura Bassi Centre of Expertise" initiative project Number 253275, and Boehringer Ingelheim.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Bolger MB, 1998, J PHARM SCI-US, V87, P1286, DOI 10.1021/js980090u; Brandsch M, 2008, J PHARM PHARMACOL, V60, P543, DOI 10.1211/jpp.60.5.0002; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Daniel H, 2006, PHYSIOLOGY, V21, P93, DOI 10.1152/physiol.00054.2005; DANIEL H, 1992, J BIOL CHEM, V267, P9565; Fei YJ, 1998, BIOCHEM BIOPH RES CO, V246, P39, DOI 10.1006/bbrc.1998.8566; GIBSON MM, 1984, J BACTERIOL, V160, P122, DOI 10.1128/JB.160.1.122-130.1984; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Harder D, 2008, FEBS J, V275, P3290, DOI 10.1111/j.1742-4658.2008.06477.x; Hauser M, 2005, MOL MEMBR BIOL, V22, P215, DOI 10.1080/09687860500093248; HENDERSON PJF, 1990, PHILOS T ROY SOC B, V326, P391, DOI 10.1098/rstb.1990.0020; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JESSENMARSHALL AE, 1995, J BIOL CHEM, V270, P16251, DOI 10.1074/jbc.270.27.16251; JessenMarshall AE, 1997, J BACTERIOL, V179, P2616, DOI 10.1128/jb.179.8.2616-2622.1997; Kulkarni AA, 2003, J BIOL CHEM, V278, P51833, DOI 10.1074/jbc.M308356200; Kulkarni AA, 2003, BIOCHEM BIOPH RES CO, V306, P177, DOI 10.1016/S0006-291X(03)00926-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law CJ, 2008, J MOL BIOL, V378, P828, DOI 10.1016/j.jmb.2008.03.029; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; PAULSEN IT, 1994, TRENDS BIOCHEM SCI, V19, P404, DOI 10.1016/0968-0004(94)90087-6; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; STEINER HY, 1995, MOL MICROBIOL, V16, P825, DOI 10.1111/j.1365-2958.1995.tb02310.x; Surade S, 2006, PROTEIN SCI, V15, P2178, DOI 10.1110/ps.062312706; Weitz D, 2007, J BIOL CHEM, V282, P2832, DOI 10.1074/jbc.M604866200; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhou YG, 2009, J MOL BIOL, V394, P219, DOI 10.1016/j.jmb.2009.09.043	31	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23121	23131		10.1074/jbc.M111.239657	http://dx.doi.org/10.1074/jbc.M111.239657			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21558271	Green Published, hybrid			2022-12-25	WOS:000292025000046
J	dos Santos, PR; Rancez, M; Pretet, JL; Michel-Salzat, A; Messent, V; Bogdanova, A; Couedel-Courteille, A; Souil, E; Cheynier, R; Butor, C				dos Santos, Patricia Ribeiro; Rancez, Magali; Pretet, Jean-Luc; Michel-Salzat, Alice; Messent, Valerie; Bogdanova, Anna; Couedel-Courteille, Anne; Souil, Evelyne; Cheynier, Remi; Butor, Cecile			Rapid Dissemination of SIV Follows Multisite Entry after Rectal Inoculation	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTING DRUG-USERS; INTESTINAL EPITHELIAL-CELLS; HIV-1 RNA LEVELS; HOMOSEXUAL-MEN; DENDRITIC CELLS; TRANSEPITHELIAL TRANSPORT; HETEROSEXUAL TRANSMISSION; INTRAVAGINAL INOCULATION; ANTIRETROVIRAL THERAPY	Receptive ano-rectal intercourse is a major cause of HIV infection in men having sex with men and in heterosexuals. Current knowledge of the mechanisms of entry and dissemination during HIV rectal transmission is scarce and does not allow the development of preventive strategies. We investigated the early steps of rectal infection in rhesus macaques inoculated with the pathogenic isolate SIVmac251 and necropsied four hours to nine days later. All macaques were positive for SIV. Control macaques inoculated with heat-inactivated virus were consistently negative for SIV. SIV DNA was detected in the rectum as early as four hours post infection by nested PCR for gag in many laser-microdissected samples of lymphoid aggregates and lamina propria but never in follicle-associated epithelium. Scarce SIV antigen positive cells were observed by immunohistofluorescence in the rectum, among intraepithelial and lamina propria cells as well as in clusters in lymphoid aggregates, four hours post infection and onwards. These cells were T cells and non-T cells that were not epithelial cells, CD68(+) macrophages, DC-SIGN(+) cells or fascin(+) dendritic cells. DC-SIGN(+) cells carried infectious virus. Detection of Env singly spliced mRNA in the mucosa by nested RT-PCR indicated ongoing viral replication. Strikingly, four hours post infection colic lymph nodes were also infected in all macaques as either SIV DNA or infectious virus was recovered. Rapid SIV entry and dissemination is consistent with trans-epithelial transport. Virions appear to cross the follicle-associated epithelium, and also the digestive epithelium. Viral replication could however be more efficient in lymphoid aggregates. The initial sequence of events differs from both vaginal and oral infections, which implies that prevention strategies for rectal transmission will have to be specific. Microbicides will need to protect both digestive and follicle-associated epithelia. Vaccines will need to induce immunity in lymph nodes as well as in the rectum.	[dos Santos, Patricia Ribeiro; Rancez, Magali; Pretet, Jean-Luc; Michel-Salzat, Alice; Messent, Valerie; Bogdanova, Anna; Couedel-Courteille, Anne; Butor, Cecile] Univ Paris Diderot, Lab Transmiss & Disseminat Virales, Paris, France; [Cheynier, Remi] Univ Paris 05, Inst Cochin, INSERM, Dept Immunol Hematol,CNRS,URA8104,UMR S1016,U1016, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	dos Santos, PR (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1200 Lisbon, Portugal.	butor@univ-paris-diderot.fr	Cheynier, Remi/E-9921-2010; Couedel-Courteille, Anne/O-7485-2017; Prétet, Jean-Luc/B-2911-2012	Cheynier, Remi/0000-0003-1146-660X; Couedel-Courteille, Anne/0000-0002-0060-2509; Prétet, Jean-Luc/0000-0002-8430-214X; RANCEZ, Magali/0000-0001-5184-1334; Messent, Valerie/0000-0001-7038-1302	Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS); Institut National de Recherche Medicale; association "Ensemble contre le Sida"; Universite Paris Diderot; NIH [1 R21 AI42628-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI042628] Funding Source: NIH RePORTER	Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS)(ANRSFrench National Research Agency (ANR)); Institut National de Recherche Medicale; association "Ensemble contre le Sida"; Universite Paris Diderot; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by several grants from the Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS, http://www.anrs.fr), by the Institut National de Recherche Medicale (http://www.inserm.fr) and by grants from the association "Ensemble contre le Sida" (http://www.sidaction.org), the Universite Paris Diderot (http://www.univ-paris-diderot.fr) and the NIH (http://www.nih.gov, grant 1 R21 AI42628-01). PRS was a predoctoral fellow of the Fundacao para a Ciencia e a Tecnologia (http://alfa.fct.mctes.pt), then was Attache Temporaire d'Enseignement et de Recherche for the Universite Paris Diderot, MR is a predoctoral fellow of the Ministere de l'Enseignement Superieur et de la Recherche (http://www.enseignementsup-recherche.gouv.fr), JLP was a predoctoral fellow of the Fondation Merieux (http://www.fondation-merieux.org), then of the ANRS, VGM and AB were postdoctoral fellows of the association "Ensemble contre le Sida". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1987, J VIROL, V61, P209, DOI 10.1128/JVI.61.1.209-213.1987; Alioum A, 1998, EPIDEMIOLOGY, V9, P605, DOI 10.1097/00001648-199811000-00007; AMERONGEN HM, 1991, J ACQ IMMUN DEF SYND, V4, P760; [Anonymous], 1992, BMJ, V304, P809; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; BIGGAR RJ, 1990, AIDS, V4, P1059, DOI 10.1097/00002030-199011000-00002; BIRD G, 1994, AIDS, V8, P911; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; BORZY MS, 1988, J ACQ IMMUN DEF SYND, V1, P419; BRETTLE RP, 1995, QJM-INT J MED, V88, P479; Butler DM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000447; Centers for Disease Control and Prevention, 2011, HIV SURV REP 2009, V21; Chenine AL, 1998, AIDS RES HUM RETROV, V14, P1235, DOI 10.1089/aid.1998.14.1235; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Chrystie IL, 1998, J REPROD IMMUNOL, V41, P301, DOI 10.1016/S0165-0378(98)00066-7; CLAYTON F, 1992, GASTROENTEROLOGY, V103, P919, DOI 10.1016/0016-5085(92)90026-U; COATES RA, 1988, AM J EPIDEMIOL, V128, P729, DOI 10.1093/oxfordjournals.aje.a115026; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; Coplan PM, 1996, AM J EPIDEMIOL, V144, P817, DOI 10.1093/oxfordjournals.aje.a009016; Couedel-Courteille A, 2003, VIROLOGY, V316, P290, DOI 10.1016/j.virol.2003.08.021; Couedel-Courteille A, 1999, VIROLOGY, V260, P277, DOI 10.1006/viro.1999.9809; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; de Witte L, 2008, TRENDS MOL MED, V14, P12, DOI 10.1016/j.molmed.2007.11.001; DEBOURNE MNG, 1975, ANATOMY PHYSL, V1, P170; DORMONT D, 1993, 8 C CENT GARD FOND M, P157; ESKILD A, 1994, SCAND J SOC MED, V22, P309, DOI 10.1177/140349489402200411; Eskild A, 1997, SCAND J INFECT DIS, V29, P103, DOI 10.3109/00365549709035868; Exner TM, 2008, AIDS EDUC PREV, V20, P148, DOI 10.1521/aeap.2008.20.2.148; FANTINI J, 1993, P NATL ACAD SCI USA, V90, P2700, DOI 10.1073/pnas.90.7.2700; Fotopoulos G, 2002, P NATL ACAD SCI USA, V99, P9410, DOI 10.1073/pnas.142586899; GALAI N, 1995, J ACQ IMMUN DEF SYND, V8, P66; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; Gurney KB, 2005, J VIROL, V79, P5762, DOI 10.1128/JVI.79.9.5762-5773.2005; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Hu Shiu-Lok, 2005, Current Drug Targets - Infectious Disorders, V5, P193, DOI 10.2174/1568005054201508; Jameson B, 2002, J VIROL, V76, P1866, DOI 10.1128/JVI.76.4.1866-1875.2002; Kittikraisak W, 2009, JAIDS-J ACQ IMM DEF, V51, P601, DOI 10.1097/QAI.0b013e3181a44700; Kuller L, 1998, AIDS RES HUM RETROV, V14, P1345, DOI 10.1089/aid.1998.14.1345; LEGRAND R, 1992, VACCINE, V10, P873, DOI 10.1016/0264-410X(92)90052-L; Leichliter JS, 2008, SEX TRANSM DIS, V35, P910, DOI 10.1097/OLQ.0b013e31818af12f; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Lyles CM, 1999, EUR J EPIDEMIOL, V15, P99, DOI 10.1023/A:1007556327269; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Marthas ML, 2001, AIDS RES HUM RETROV, V17, P1455, DOI 10.1089/088922201753197123; MATHIJS JM, 1988, LANCET, V1, P1111; Maynard E, 2009, PERSPECT SEX REPRO H, V41, P142, DOI 10.1363/4114209; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Milush JA, 2004, AIDS, V18, P2371; Miyake A, 2006, J GEN VIROL, V87, P1311, DOI 10.1099/vir.0.81307-0; MOYER MP, 1991, J LEUKOCYTE BIOL, V49, P499, DOI 10.1002/jlb.49.5.499; NELSON JA, 1988, LANCET, V1, P259; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; OPERSKALSKI EA, 1995, J INFECT DIS, V172, P648, DOI 10.1093/infdis/172.3.648; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Pehrson P, 1997, AIDS, V11, P1007, DOI 10.1097/00002030-199708000-00009; PELLETIER E, 1995, VIROLOGY, V208, P644, DOI 10.1006/viro.1995.1195; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pezzotti P, 1999, J ACQ IMMUN DEF SYND, V20, P275, DOI 10.1097/00042560-199903010-00010; Prins M, 1997, AIDS, V11, P621, DOI 10.1097/00002030-199705000-00010; Prins M, 2000, AIDS, V14, P1829, DOI 10.1097/00002030-200008180-00019; Prost S, 2008, J CLIN INVEST, V118, P1765, DOI 10.1172/JCI33037; Public Health Agency of Canada, 2010, HIV AIDS CAN SURV RE; REED L. J., 1938, AMER JOUR HYG, V27, P493; Renoux C, 2005, J VIROL, V79, P11231, DOI 10.1128/JVI.79.17.11231-11238.2005; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rezza G, 1998, J ACQ IMMUN DEF SYND, V17, pS13, DOI 10.1097/00042560-199801001-00005; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; SEIDLIN M, 1993, AIDS, V7, P1247, DOI 10.1097/00002030-199309000-00015; Shacklett Barbara L, 2010, Curr Infect Dis Rep, V12, P19, DOI 10.1007/s11908-009-0072-9; Shen RZ, 2010, J LEUKOCYTE BIOL, V87, P663, DOI 10.1189/jlb.0909605; Shepard RN, 2000, J CLIN MICROBIOL, V38, P1414, DOI 10.1128/JCM.38.4.1414-1418.2000; Sodora DL, 1998, AIDS RES HUM RETROV, V14, pS119; Spijkerman IJB, 1996, EPIDEMIOLOGY, V7, P571, DOI 10.1097/00001648-199611000-00002; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; Touloumi G, 2004, AIDS, V18, P1697, DOI 10.1097/01.aids.0000131395.14339.f5; UNAIDS, 2010, UNAIDS REP GLOB AIDS; van Wijk F, 2009, SEMIN IMMUNOL, V21, P130, DOI 10.1016/j.smim.2009.03.003; Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007; Veazey RS, 2008, CURR OPIN HIV AIDS, V3, P567, DOI 10.1097/COH.0b013e32830891bb; VELLA S, 1995, AIDS, V9, P51, DOI 10.1097/00002030-199501000-00007; Vernazza PL, 1997, AIDS, V11, P987, DOI 10.1097/00002030-199708000-00006; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; WOLFS TFW, 1989, VOX SANG, V57, P127, DOI 10.1111/j.1423-0410.1989.tb01149.x; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zuckerman RA, 2004, J INFECT DIS, V190, P156, DOI 10.1086/421246	93	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19493	10.1371/journal.pone.0019493	http://dx.doi.org/10.1371/journal.pone.0019493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573012	Green Submitted, gold, Green Published			2022-12-25	WOS:000290386800016
J	Kumar, V; Butcher, SJ; Oorni, K; Engelhardt, P; Heikkonen, J; Kaski, K; Ala-Korpela, M; Kovanen, PT				Kumar, Vibhor; Butcher, Sarah J.; Oorni, Katariina; Engelhardt, Peter; Heikkonen, Jukka; Kaski, Kimmo; Ala-Korpela, Mika; Kovanen, Petri T.			Three-Dimensional cryoEM Reconstruction of Native LDL Particles to 16 angstrom Resolution at Physiological Body Temperature	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; CRYOELECTRON MICROSCOPY; APOLIPOPROTEIN-B; STATISTICAL-ANALYSIS; SERUM-LIPOPROTEINS; TRANSFER PROTEIN; MODEL; LIPOVITELLIN; IMAGES; B-100	Background: Low-density lipoprotein (LDL) particles, the major carriers of cholesterol in the human circulation, have a key role in cholesterol physiology and in the development of atherosclerosis. The most prominent structural components in LDL are the core-forming cholesteryl esters (CE) and the particle-encircling single copy of a huge, non-exchangeable protein, the apolipoprotein B-100 (apoB-100). The shape of native LDL particles and the conformation of native apoB-100 on the particles remain incompletely characterized at the physiological human body temperature (37 degrees C). Methodology/Principal Findings: To study native LDL particles, we applied cryo-electron microscopy to calculate 3D reconstructions of LDL particles in their hydrated state. Images of the particles vitrified at 6 degrees C and 37 degrees C resulted in reconstructions at,16 A resolution at both temperatures. 3D variance map analysis revealed rigid and flexible domains of lipids and apoB-100 at both temperatures. The reconstructions showed less variability at 6 degrees C than at 37 degrees C, which reflected increased order of the core CE molecules, rather than decreased mobility of the apoB-100. Compact molecular packing of the core and order in a lipid-binding domain of apoB-100 were observed at 6 degrees C, but not at 37 degrees C. At 37 degrees C we were able to highlight features in the LDL particles that are not clearly separable in 3D maps at 6 degrees C. Segmentation of apoB-100 density, fitting of lipovitellin X-ray structure, and antibody mapping, jointly revealed the approximate locations of the individual domains of apoB-100 on the surface of native LDL particles. Conclusions/Significance: Our study provides molecular background for further understanding of the link between structure and function of native LDL particles at physiological body temperature.	[Kumar, Vibhor; Engelhardt, Peter; Heikkonen, Jukka; Kaski, Kimmo] Aalto Univ Aalto, Sch Sci & Technol, Dept Biomed Engn & Computat Sci, Ctr Excellence Computat Complex Syst Res, Helsinki, Finland; [Kumar, Vibhor] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Butcher, Sarah J.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Oorni, Katariina; Kovanen, Petri T.] Wihuri Res Inst, SF-00140 Helsinki, Finland; [Engelhardt, Peter] Univ Helsinki, Dept Pathol, Haartman Inst, Helsinki, Finland; [Engelhardt, Peter] Aalto Univ, Sch Sci & Technol, Dept Appl Phys, Nanomicroscopy Ctr, Espoo, Finland; [Heikkonen, Jukka] Univ Turku, Dept Informat Technol, Turku, Finland; [Ala-Korpela, Mika] Univ Oulu, Inst Clin Med, Computat Med Res Grp, Fac Med,Bioctr Oulu, Oulu, Finland; [Ala-Korpela, Mika] Univ Oulu, Dept Internal Med, SF-90220 Oulu, Finland; [Ala-Korpela, Mika] Univ Oulu, Bioctr Oulu, Clin Res Ctr, SF-90220 Oulu, Finland	Aalto University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Helsinki; Wihuri Research Institute; University of Helsinki; Aalto University; University of Turku; University of Oulu; University of Oulu; University of Oulu	Kumar, V (corresponding author), Aalto Univ Aalto, Sch Sci & Technol, Dept Biomed Engn & Computat Sci, Ctr Excellence Computat Complex Syst Res, Helsinki, Finland.	petri.kovanen@wri.fi	Oorni, Katariina/G-2484-2011; Kaski, Kimmo/AAO-4320-2021; Butcher, Sarah J/H-5579-2012; Kaski, Kimmo K K/G-8067-2012; Heikkonen, Jukka/R-4912-2017	Oorni, Katariina/0000-0002-9525-0250; Kaski, Kimmo/0000-0002-3805-9687; Kumar, Vibhor/0000-0002-9523-9422; Butcher, Sarah/0000-0001-7060-5871; Ala-Korpela, Mika/0000-0001-5905-1206	Academy of Finland [1129684]; Finnish Cardiovascular Research Foundation; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Finnish Cardiovascular Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work has been supported by the Academy of Finland Centre of Excellence Programme in Computational Complex Systems Research (KK), the Academy of Finland Centre of Excellence Programme in Virus Research (2006-2011; 1129684 to SJB), the Academy of Finland's Responding to Public Health Challenges Research Programme (MAK), the Finnish Cardiovascular Research Foundation (MAK), and the Sigrid Juselius Foundation (SJB). Wihuri Research Institute is maintained by the Jenny and Antti Wihuri Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; Anderson TA, 1998, STRUCT FOLD DES, V6, P895, DOI 10.1016/S0969-2126(98)00091-4; BAUMSTARK MW, 1990, BIOCHIM BIOPHYS ACTA, V1037, P48, DOI 10.1016/0167-4838(90)90100-T; BROWN MS, 1981, SCIENCE, V212, P628, DOI 10.1126/science.6261329; CHATTERTON JE, 1995, J LIPID RES, V36, P2027; Coronado-Gray A, 2005, LIPIDS, V40, P495, DOI 10.1007/s11745-005-1409-x; Coronado-Gray A, 2003, FEBS LETT, V533, P21, DOI 10.1016/S0014-5793(02)03731-6; Elad N, 2008, J STRUCT BIOL, V162, P108, DOI 10.1016/j.jsb.2007.11.007; Elmlund D, 2010, STRUCTURE, V18, P777, DOI 10.1016/j.str.2010.06.001; Frank J, 2006, 3 DIMENSIONAL ELECT; Garzon JI, 2007, BIOINFORMATICS, V23, P427, DOI 10.1093/bioinformatics/btl625; GINSBURG GS, 1984, PROG LIPID RES, V23, P135, DOI 10.1016/0163-7827(84)90002-X; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; Huiskonen JT, 2004, NAT STRUCT MOL BIOL, V11, P850, DOI 10.1038/nsmb807; Jiang ZG, 2005, BIOCHEMISTRY-US, V44, P1163, DOI 10.1021/bi048286y; Johs A, 2006, J BIOL CHEM, V281, P19732, DOI 10.1074/jbc.M601688200; Koivuniemi A, 2008, BBA-PROTEINS PROTEOM, V1784, P1668, DOI 10.1016/j.bbapap.2008.06.007; Krisko A, 2007, PROTEINS, V66, P342, DOI 10.1002/prot.21229; Kumar V, 2004, J STRUCT BIOL, V145, P41, DOI 10.1016/j.jsb.2003.09.036; Kumpula LS, 2008, CHEM PHYS LIPIDS, V155, P57, DOI 10.1016/j.chemphyslip.2008.06.003; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Oorni K, 2000, J LIPID RES, V41, P1703; Orlova EV, 1999, P NATL ACAD SCI USA, V96, P8420, DOI 10.1073/pnas.96.15.8420; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Penczek PA, 2006, J STRUCT BIOL, V154, P168, DOI 10.1016/j.jsb.2006.01.003; Pentikainen MO, 2000, J INTERN MED, V247, P359, DOI 10.1046/j.1365-2796.2000.00655.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POULOS GW, 2001, 3 DIMENSIONAL STRUCT; Prassl R, 2009, EUR BIOPHYS J BIOPHY, V38, P145, DOI 10.1007/s00249-008-0368-y; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Ren G, 2010, P NATL ACAD SCI USA, V107, P1059, DOI 10.1073/pnas.0908004107; Richardson PE, 2005, BIOPHYS J, V88, P2789, DOI 10.1529/biophysj.104.046235; Ritter S, 1997, PROTEINS, V28, P293; Roseman AM, 2000, ACTA CRYSTALLOGR D, V56, P1332, DOI 10.1107/S0907444900010908; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; SCHUMAKER VN, 1994, ADV PROTEIN CHEM, V45, P205; Segrest JP, 1999, J LIPID RES, V40, P1401; Segrest JP, 2001, J LIPID RES, V42, P1346; SEGREST JP, 1994, ARTERIOSCLER THROMB, V14, P1674, DOI 10.1161/01.ATV.14.10.1674; Sherman MB, 2003, BIOCHEMISTRY-US, V42, P14988, DOI 10.1021/bi0354738; STEIM JM, 1968, SCIENCE, V162, P909, DOI 10.1126/science.162.3856.909; Thompson JR, 2002, BIOCHEMISTRY-US, V41, P9398, DOI 10.1021/bi025674w; van Antwerpen R, 1999, J LIPID RES, V40, P1827; VANANTWERPEN R, 1994, J LIPID RES, V35, P2223; vanAntwerpen R, 1997, J LIPID RES, V38, P659; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; Wang LCH, 2006, J ETHNOPHARMACOL, V103, P103, DOI 10.1016/j.jep.2005.07.010; White HE, 2004, J MOL BIOL, V336, P453, DOI 10.1016/j.jmb.2003.12.015; Williams KJ, 1998, CURR OPIN LIPIDOL, V9, P471, DOI 10.1097/00041433-199810000-00012	51	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e18841	10.1371/journal.pone.0018841	http://dx.doi.org/10.1371/journal.pone.0018841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573056	Green Published, gold, Green Submitted			2022-12-25	WOS:000290386800003
J	Llopis-Hernandez, V; Rico, P; Ballester-Beltran, J; Moratal, D; Salmeron-Sanchez, M				Llopis-Hernandez, Virginia; Rico, Patricia; Ballester-Beltran, Jose; Moratal, David; Salmeron-Sanchez, Manuel			Role of Surface Chemistry in Protein Remodeling at the Cell-Material Interface	PLOS ONE			English	Article							FOCAL ADHESION KINASE; MATRIX METALLOPROTEINASES; FIBRONECTIN; ADSORPTION; DIFFERENTIATION; EXPRESSION; BINDING; FIBRINOGEN; INTEGRINS; ACTIVATOR	Background: The cell-material interaction is a complex bi-directional and dynamic process that mimics to a certain extent the natural interactions of cells with the extracellular matrix. Cells tend to adhere and rearrange adsorbed extracellular matrix (ECM) proteins on the material surface in a fibril-like pattern. Afterwards, the ECM undergoes proteolytic degradation, which is a mechanism for the removal of the excess ECM usually approximated with remodeling. ECM remodeling is a dynamic process that consists of two opposite events: assembly and degradation. Methodology/Principal Findings: This work investigates matrix protein dynamics on mixed self-assembled monolayers (SAMs) of -OH and -CH3 terminated alkanethiols. SAMs assembled on gold are highly ordered organic surfaces able to provide different chemical functionalities and well-controlled surface properties. Fibronectin (FN) was adsorbed on the different surfaces and quantified in terms of the adsorbed surface density, distribution and conformation. Initial cell adhesion and signaling on FN-coated SAMs were characterized via the formation of focal adhesions, integrin expression and phosphorylation of FAKs. Afterwards, the reorganization and secretion of FN was assessed. Finally, matrix degradation was followed via the expression of matrix metalloproteinases MMP2 and MMP9 and correlated with Runx2 levels. We show that matrix degradation at the cell material interface depends on surface chemistry in MMP-dependent way. Conclusions/Significance: This work provides a broad overview of matrix remodeling at the cell-material interface, establishing correlations between surface chemistry, FN adsorption, cell adhesion and signaling, matrix reorganization and degradation. The reported findings improve our understanding of the role of surface chemistry as a key parameter in the design of new biomaterials. It demonstrates the ability of surface chemistry to direct proteolytic routes at the cell-material interface, which gains a distinct bioengineering interest as a new tool to trigger matrix degradation in different biomedical applications.	[Llopis-Hernandez, Virginia; Rico, Patricia; Ballester-Beltran, Jose; Moratal, David; Salmeron-Sanchez, Manuel] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46071 Valencia, Spain; [Rico, Patricia; Salmeron-Sanchez, Manuel] CIBER Bioingn Biomat & Nanomed CIBER BBN, Valencia, Spain; [Salmeron-Sanchez, Manuel] Ctr Invest Principe Felipe, Regenerat Med Unit, Valencia, Spain	Universitat Politecnica de Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Prince Felipe Research Center	Llopis-Hernandez, V (corresponding author), Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46071 Valencia, Spain.	masalsan@fis.upv.es	Rico, Patricia/N-2540-2014; Salmeron-Sanchez, Manuel/E-4680-2010; Moratal, David/D-1853-2010	Rico, Patricia/0000-0002-4918-9313; Salmeron-Sanchez, Manuel/0000-0002-8112-2100; Moratal, David/0000-0002-2825-3646; BALLESTER-BELTRAN, JOSE/0000-0002-3287-2925; Llopis-Hernandez, Virginia/0000-0002-7616-7347	Spanish Ministry of Science and Innovation [MAT2009-14440-C02-01]; Instituto de Salud Carlos III; Conselleria de Sanidad (Generalitat Valenciana)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Conselleria de Sanidad (Generalitat Valenciana)(Center for Forestry Research & Experimentation (CIEF))	The support of the Spanish Ministry of Science and Innovation through project MAT2009-14440-C02-01 is acknowledged. CIBER-BBN is an initiative funded by the VI National R&D&i Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. This work was supported by funds for research in the field of Regenerative Medicine through the collaboration agreement from the Conselleria de Sanidad (Generalitat Valenciana), and the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366; Altankov G, 1997, J BIOMAT SCI-POLYM E, V8, P721, DOI 10.1163/156856297X00524; Altankov G, 1996, J MATER SCI-MATER M, V7, P425, DOI 10.1007/BF00122012; ALTANKOV G, 2006, J MATER SCI-MATER M, V7, P425; AOTA S, 1994, J BIOL CHEM, V269, P24756; Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013; AVNUR Z, 1981, CELL, V25, P121, DOI 10.1016/0092-8674(81)90236-1; Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048; Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046; BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273; Cary LA, 1996, J CELL SCI, V109, P1787; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Chung AS, 2009, J BIOMED MATER RES A, V91A, P742, DOI 10.1002/jbm.a.32259; Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Dumbauld DW, 2010, J CELL PHYSIOL, V223, P746, DOI 10.1002/jcp.22084; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029; Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021; Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210; GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697; Gugutkov D, 2009, LANGMUIR, V25, P10893, DOI 10.1021/la9012203; Hayami T, 2008, MATRIX BIOL, V27, P682, DOI 10.1016/j.matbio.2008.07.005; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Heymans S, 2006, CIRCULATION, V114, P565, DOI 10.1161/CIRCULATIONAHA.105.591032; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; ILLC D, 1995, NATURE, V377, P539; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537; Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096; McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H; Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Monchaux Emmanuelle, 2010, Front Biosci (Schol Ed), V2, P239; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Palacio MLB, 2011, J R SOC INTERFACE, V8, P630, DOI 10.1098/rsif.2010.0557; Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107; Pompe T, 2005, EUR BIOPHYS J BIOPHY, V34, P1049, DOI 10.1007/s00249-005-0490-z; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Raynor JE, 2009, BIOINTERPHASES, V4, pFA3, DOI 10.1116/1.3089252; Reisenauer A, 2007, BIOL CHEM, V388, P639, DOI 10.1515/BC.2007.072; Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361; Rico P, 2009, TISSUE ENG PT A, V15, P3271, DOI [10.1089/ten.tea.2009.0141, 10.1089/ten.TEA.2009.0141]; Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rouahi M, 2006, BIOMATERIALS, V27, P2829, DOI 10.1016/j.biomaterials.2006.01.001; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059; SCHOEN RC, 1982, HYBRIDOMA, V1, P99, DOI 10.1089/hyb.1.1982.1.99; Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Tzoneva R, 2002, J MATER SCI-MATER M, V13, P1235, DOI 10.1023/A:1021131113711; Uchida M, 2000, J CELL PHYSIOL, V185, P207, DOI 10.1002/1097-4652(200011)185:2<207::AID-JCP5>3.0.CO;2-J; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; Wan R, 2008, TOXICOL APPL PHARM, V233, P276, DOI 10.1016/j.taap.2008.08.022; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Yang CM, 2004, J BIOL CHEM, V279, P22158, DOI 10.1074/jbc.M401343200; Zambuzzi WF, 2009, J MOL HISTOL, V40, P301, DOI 10.1007/s10735-009-9241-2; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997	72	65	66	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19610	10.1371/journal.pone.0019610	http://dx.doi.org/10.1371/journal.pone.0019610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573010	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000290386800023
J	Sun, M; Yang, Y; Yang, PZ; Lei, B; Du, LP; Kijlstra, A				Sun, Min; Yang, Yan; Yang, Peizeng; Lei, Bo; Du, Liping; Kijlstra, Aize			Regulatory Effects of IFN-beta on the Development of Experimental Autoimmune Uveoretinitis in B10RIII Mice	PLOS ONE			English	Article							T-HELPER TYPE-1; INTERFERON-BETA; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; I INTERFERON; TH17; INFLAMMATION; DISTINCT; DISEASE; ALPHA	Background: Experimental autoimmune uveoretinitis (EAU) serves as a model for human intraocular inflammation. IFN-beta has been used in the treatment of certain autoimmune diseases. Earlier studies showed that it ameliorated EAU; however, the mechanisms involved in this inhibition are still largely unknown. Methodology/Principal Findings: B10RIII mice were immunized with interphotoreceptor retinoid-binding protein (IRBP) peptide 161-180 in Complete Freund's adjuvant. Splenocytes from different time points after immunization were used to evaluate the expression of IFN-beta. An increased expression of IFN-beta was observed during EAU and its highest expression was observed on day 16, 3 days after the peak of intraocular inflammation. Splenocytes and draining lymph node cells from mice immunized with IRBP161-180 on day 13 and control mice were activated with anti-CD3/anti-CD28 antibodies or IRBP161-180 to evaluate the production of IFN-gamma and IL-17. The results showed that IFN-gamma and IL-17 were significantly higher in immunized mice as compared to the control mice when exposed to anti-CD3/anti-CD28 antibodies. However, the production of IFN-gamma and IL-17 was detected only in immunized mice, but not in the control mice when stimulated with IRBP161-180. Multiple subcutaneous injections of IFN-beta significantly inhibited EAU activity in association with a down-regulated expression of IFN-gamma, IL-17 and an enhanced IL-10 production. In an in vitro system using cells from mice, IFN-beta suppressed IFN-gamma production by CD4(+)CD62L(-) T cells, IL-17 production by CD4(+)CD62L(+/-) T cells and proliferation of CD4(+)CD62L(+/-) T cells. IFN-beta inhibited the secretion of IL-6, but promoted the secretion of IL-10 by monocytes. IFN-beta-treated monocytes inhibited IL-17 secretion by CD4(+)CD62L(+/-) T cells, but did not influence IFN-gamma expression and T cell proliferation. Conclusions/Significance: IFN-beta may exert its inhibitory effect on EAU by inhibiting Th1, Th17 cells and modulating relevant cytokines. IFN-beta may provide a potential treatment for diseases mediated by Th1 and Th17 cells.	[Sun, Min; Yang, Yan; Yang, Peizeng; Lei, Bo; Du, Liping] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Sun, Min; Yang, Yan; Yang, Peizeng; Lei, Bo; Du, Liping] Chongqing Eye Inst, Chongqing, Peoples R China; [Yang, Yan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Kijlstra, Aize] Univ Hosp Maastricht, Eye Res Inst Maastricht, Dept Ophthalmol, Maastricht, Netherlands	Chongqing Medical University; Sun Yat Sen University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com	Yang, Peizeng/C-6336-2013; Du, Liping/M-9495-2019	Lei, Bo/0000-0002-5497-0905	National Natural Science Foundation [30973242]; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Natural Science Foundation of Chongqing [2009BA5037]; Chongqing Key Laboratory of Ophthalmology [2008CA5003]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing); Chongqing Key Laboratory of Ophthalmology	This work was supported by National Natural Science Foundation Project (30973242), http://159.226.244.15/portal/Proj_List.asp; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality, http://cqkjdj.cstc.gov.cn/View.aspx?id = 1000; Key Project of Natural Science Foundation of Chongqing (CSTC, 2009BA5037), http://www.ctin.ac.cn/Class.aspx?clsId = 226; Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003) http://www.ctin.ac.cn/View.aspx?id = 14380; and PAR-EU Scholars Program, http://www.cqhrss.gov.cn/u/cqhrss/news_37398.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Berenson LS, 2004, IMMUNOL REV, V202, P157, DOI 10.1111/j.0105-2896.2004.00208.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Caspi Rachel R, 2002, Int Rev Immunol, V21, P197, DOI 10.1080/08830180212063; Caspi Rachel R, 2003, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1506s53; CASPI RR, 1988, J IMMUNOL, V140, P1490; Chang EY, 2007, J IMMUNOL, V178, P6705, DOI 10.4049/jimmunol.178.11.6705; Chen MY, 2009, EUR J IMMUNOL, V39, P2525, DOI 10.1002/eji.200838879; Crow MK, 2010, RHEUM DIS CLIN N AM, V36, P173, DOI 10.1016/j.rdc.2009.12.008; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; Deuter CME, 2009, BRIT J OPHTHALMOL, V93, P906, DOI 10.1136/bjo.2008.153874; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; Ersoy E, 2005, EUR J NEUROL, V12, P208, DOI 10.1111/j.1468-1331.2004.00986.x; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hedegaard CJ, 2008, CLIN IMMUNOL, V129, P80, DOI 10.1016/j.clim.2008.06.007; Hegelich BM, 2006, NATURE, V439, P441, DOI 10.1038/nature04400; Kozovska ME, 1999, NEUROLOGY, V53, P1692, DOI 10.1212/WNL.53.8.1692; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Martin-Saavedra FM, 2008, MOL IMMUNOL, V45, P4008, DOI 10.1016/j.molimm.2008.06.006; McRae BL, 1998, J IMMUNOL, V160, P4298; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; NUSSENBLATT RB, 1991, INVEST OPHTH VIS SCI, V32, P3131; Okada AA, 1998, OCUL IMMUNOL INFLAMM, V6, P215, DOI 10.1076/ocii.6.4.215.4024; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Plskova J, 2007, AM J OPHTHALMOL, V144, P55, DOI 10.1016/j.ajo.2007.03.050; Pogue SL, 2004, J INTERF CYTOK RES, V24, P131, DOI 10.1089/107999004322813372; Ramgolam VS, 2009, J IMMUNOL, V183, P5418, DOI 10.4049/jimmunol.0803227; Rizzo LV, 1998, INT IMMUNOL, V10, P807, DOI 10.1093/intimm/10.6.807; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; Somani AK, 2008, ARCH DERMATOL, V144, P1341, DOI 10.1001/archderm.144.10.1341; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Steinman L, 2009, EUR J IMMUNOL, V39, P2358, DOI 10.1002/eji.200939814; Stubiger N, 2003, ADV EXP MED BIOL, V528, P537; Sun M, 2010, INVEST OPHTH VIS SCI, V51, P383, DOI 10.1167/iovs.09-3514; Suzuki J, 2002, GRAEF ARCH CLIN EXP, V240, P314, DOI 10.1007/s00417-001-0425-z; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Warde Nick, 2010, Nat Rev Rheumatol, V6, P437, DOI 10.1038/nrrheum.2010.115; Yong VW, 1998, NEUROLOGY, V51, P682; Yoshimura T, 2008, INT IMMUNOL, V20, P209, DOI 10.1093/intimm/dxm135; Zang Y, 2003, J NEUROIMMUNOL, V137, P144, DOI 10.1016/S0165-5728(03)00049-3; Zhang X, 2010, CLIN NEUROL NEUROSUR, V112, P641, DOI 10.1016/j.clineuro.2010.04.020; Zhang X, 2009, J IMMUNOL, V182, P3928, DOI 10.4049/jimmunol.0802226	45	9	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19870	10.1371/journal.pone.0019870	http://dx.doi.org/10.1371/journal.pone.0019870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573074	Green Published, Green Submitted, gold			2022-12-25	WOS:000290305600048
J	Hudson, DM; Weis, MA; Eyre, DR				Hudson, David M.; Weis, Mary Ann; Eyre, David R.			Insights on the Evolution of Prolyl 3-Hydroxylation Sites from Comparative Analysis of Chicken and Xenopus Fibrillar Collagens	PLOS ONE			English	Article							RECESSIVE OSTEOGENESIS IMPERFECTA; CYANOGEN-BROMIDE PEPTIDES; SKIN COLLAGEN; CROSS-LINKING; MUTATIONS; DEFICIENCY; CARTILAGE; PROTEINS; CLEAVAGE; ENZYMES	Recessive multations that prevent formation collagen have been shown osteagenesis imperfecta. in mammals, all A-clad collagen chains with a GRP sequence at the Al site (P986), except have 3Hyp at residue P986. Available avian, amphibian and reptilian type I collagen sequences from the genomic database Ensenlbl) all differ in sequence motif from mammals at the Al This suggests a potential evolutionary distinction in hydroxylation between mammals and earlier vertebrates. Using peptide mass spectrometry, we confirmed that hi fully occupied in alpha 1(III) from an amphibian, Xenopus laevis, it is in chicken. A thorough a h characterization of all Hyp sites in collagen types I II, III and V from chicken and xenopus revealed further differences in the pattern of occupancy of the A3 site (P707). In mammals only alpha z2(I) and ca(V) chains had any 3Hyp at he A3 site, whereas in chicken all alpha-chains except alpha 1(III) had A3 at least partially hydroxylated. The A3 site was also partially hydroxylated in xenopus I Minor differences in covalent cross-linking between chicken, xenopus and mammal type I and Ill collagens were also found as a potential index of evolving functional differences. The function of 3Hyp is still unknown but observed differences in occupancy during vertebrate evolution are likely to give important clues.	[Hudson, David M.; Weis, Mary Ann; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hudson, DM (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	deyre@u.washington.edu			NIAMS, National Institutes of Health [AR37694, AR37318]; University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037318, R01AR036794, R37AR037318] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Washington(University of Washington); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR37694 and AR37318 from the NIAMS (to D.R.E.). This work was also supported by funds from the Ernest M. Burgess Endowed Chair research program of the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Boot-Handford RP, 2003, BIOESSAYS, V25, P142, DOI 10.1002/bies.10230; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Capellini TD, 2008, GENESIS, V46, P683, DOI 10.1002/dvg.20406; CHUNG E, 1974, BIOCHEMISTRY-US, V13, P3459, DOI 10.1021/bi00714a006; EPSTEIN EH, 1975, J BIOL CHEM, V250, P9304; EPSTEIN EH, 1971, J BIOL CHEM, V246, P1718; EYRE D, 1987, METHOD ENZYMOL, V144, P115; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; FIETZEK PP, 1972, EUR J BIOCHEM, V30, P163, DOI 10.1111/j.1432-1033.1972.tb02083.x; Garrone R., 1985, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V93, P157; Hanna SL, 2000, MICROBIOL-UK, V146, P2495, DOI 10.1099/00221287-146-10-2495; HERRMANN H, 1975, H-S Z PHYSIOL CHEM, V356, P1605, DOI 10.1515/bchm2.1975.356.2.1605; HILKEN G, 1995, LAB ANIM, V29, P152, DOI 10.1258/002367795780740276; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; KANG AH, 1969, BIOCHEMISTRY-US, V8, P1506, DOI 10.1021/bi00832a029; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mizuno K, 2008, FEBS J, V275, P5830, DOI 10.1111/j.1742-4658.2008.06704.x; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Randall WC, 1939, AM J PHYSIOL, V127, P761, DOI 10.1152/ajplegacy.1939.127.4.761; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; WELGUS HG, 1985, J BIOL CHEM, V260, P1052; Willaert A, 2009, J MED GENET, V46, P233, DOI 10.1136/jmg.2008.062729; Wu JJ, 2010, J BIOL CHEM, V285, P18537, DOI 10.1074/jbc.M110.112904; WU JJ, 1985, ANN NY ACAD SCI, V460, P520, DOI 10.1111/j.1749-6632.1985.tb51228.x; Zhang XM, 2007, J BIOL CHEM, V282, P6792, DOI 10.1074/jbc.M607528200	33	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19336	10.1371/journal.pone.0019336	http://dx.doi.org/10.1371/journal.pone.0019336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559283	Green Published, Green Submitted, gold			2022-12-25	WOS:000290223500018
J	He, L; Li, H; Chen, L; Miao, JY; Jiang, YL; Zhang, Y; Xiao, ZX; Hanley, G; Li, Y; Zhang, XM; LeSage, G; Peng, Y; Yin, DL				He, Lei; Li, Hui; Chen, Lin; Miao, Junying; Jiang, Yulin; Zhang, Yi; Xiao, Zuoxiang; Hanley, Gregory; Li, Yi; Zhang, Xiumei; LeSage, Gene; Peng, Ying; Yin, Deling			Toll-Like Receptor 9 Is Required for Opioid-Induced Microglia Apoptosis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MORPHINE PROMOTES APOPTOSIS; BETA-ARRESTIN 2; INNATE IMMUNITY; MAP KINASES; CELL-DEATH; P38 MAPK; B-CELLS; RESPONSES; PATHWAY	Opioids have been widely applied in clinics as one of the most potent pain relievers for centuries, but their abuse has deleterious physiological effects beyond addiction. However, the underlying mechanism by which microglia in response to opioids remains largely unknown. Here we show that morphine induces the expression of Toll-like receptor 9 (TLR9), a key mediator of innate immunity and inflammation. Interestingly, TLR9 deficiency significantly inhibited morphine-induced apoptosis in microglia. Similar results were obtained when endogenous TLR9 expression was suppressed by the TLR9 inhibitor CpGODN. Inhibition of p38 MAPK by its specific inhibitor SB203580 attenuated morphine-induced microglia apoptosis in wild type microglia. Morphine caused a dramatic decrease in Bcl-2 level but increase in Bax level in wild type microglia, but not in TLR9 deficient microglia. In addition, morphine treatment failed to induce an increased levels of phosphorylated p38 MAPK and MAP kinase kinase 3/6 (MKK3/6), the upstream MAPK kinase of p38 MAPK, in either TLR9 deficient or mu-opioid receptor (mu OR) deficient primary microglia, suggesting an involvement of MAPK and mu OR in morphine-mediated TLR9 signaling. Moreover, morphine-induced TLR9 expression and microglia apoptosis appears to require mu OR. Collectively, these results reveal that opioids prime microglia to undergo apoptosis through TLR9 and mu OR as well. Taken together, our data suggest that inhibition of TLR9 and/or blockage of mu OR is capable of preventing opioid-induced brain damage.	[He, Lei; Li, Yi; Peng, Ying] Sun Yat Sen Univ, Dept Neurol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [He, Lei; Li, Hui; Chen, Lin; Zhang, Yi; LeSage, Gene; Yin, Deling] E Tennessee State Univ, Coll Med, Dept Internal Med, Johnson City, TN 37614 USA; [Chen, Lin; Zhang, Xiumei] Shandong Univ, Sch Med, Dept Pharmacol, Jinan 250100, Peoples R China; [Miao, Junying] Shandong Univ, Sch Life Sci, Inst Dev Biol, Jinan 250100, Peoples R China; [Jiang, Yulin] E Tennessee State Univ, Dept Chem, Johnson City, TN 37614 USA; [Xiao, Zuoxiang] NCI, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA; [Hanley, Gregory] E Tennessee State Univ, Coll Med, Div Lab Anim Resources, Johnson City, TN 37614 USA	Sun Yat Sen University; East Tennessee State University; Shandong University; Shandong University; East Tennessee State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); East Tennessee State University	He, L (corresponding author), Sun Yat Sen Univ, Dept Neurol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	lesage@etsu.edu; docpengy@yahoo.com.cn; yin@etsu.edu			National Institutes of Health [DA020120-03A1]; East Tennessee State University Research Development Committee; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA020120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); East Tennessee State University Research Development Committee; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grant DA020120-03A1 and East Tennessee State University Research Development Committee grant to D. Yin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Boronat MA, 2001, BRIT J PHARMACOL, V134, P1263, DOI 10.1038/sj.bjp.0704364; Chang CW, 2009, J BIOL CHEM, V284, P33195, DOI 10.1074/jbc.M109.020586; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009205; Cui Y, 2006, BRAIN RES, V1069, P235, DOI 10.1016/j.brainres.2005.11.066; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Esen N, 2006, J IMMUNOL, V176, P6802, DOI 10.4049/jimmunol.176.11.6802; Gomez-Lazaro M, 2007, MOL PHARMACOL, V71, P736, DOI 10.1124/mol.106.030718; Horvath RJ, 2009, J NEUROSCI, V29, P998, DOI 10.1523/JNEUROSCI.4595-08.2009; Hu SX, 2002, NEUROPHARMACOLOGY, V42, P829, DOI 10.1016/S0028-3908(02)00030-8; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Lehnardt S, 2006, J IMMUNOL, V177, P583, DOI 10.4049/jimmunol.177.1.583; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Li H, 2010, IMMUNOLOGY, V130, P556, DOI 10.1111/j.1365-2567.2010.03256.x; Li Y, 2010, BIOCHEM BIOPH RES CO, V391, P426, DOI 10.1016/j.bbrc.2009.11.074; Li Y, 2009, BIOCHEM BIOPH RES CO, V378, P857, DOI 10.1016/j.bbrc.2008.12.001; Liang XQ, 2010, BLOOD, V115, P5041, DOI 10.1182/blood-2009-03-213363; Ma WY, 2001, EUR J NEUROSCI, V14, P1091, DOI 10.1046/j.0953-816x.2001.01731.x; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Moorman J, 2009, BBA-MOL CELL RES, V1793, P1366, DOI 10.1016/j.bbamcr.2009.05.007; Nelyudova A, 2007, CELL CYCLE, V6, P2171, DOI 10.4161/cc.6.17.4610; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Papadimitraki ED, 2006, ARTHRITIS RHEUM-US, V54, P3601, DOI 10.1002/art.22197; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Roy S, 1996, NEUROCHEM RES, V21, P1375, DOI 10.1007/BF02532379; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Singhal PC, 2002, J IMMUNOL, V168, P4025, DOI 10.4049/jimmunol.168.8.4025; Singhal PG, 1999, J LEUKOCYTE BIOL, V66, P650, DOI 10.1002/jlb.66.4.650; Svensson AL, 2008, P NATL ACAD SCI USA, V105, P7304, DOI 10.1073/pnas.0802531105; Tegeder I, 2004, PHARMACOL REV, V56, P351, DOI 10.1124/pr.56.3.2; Toh ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013416; Wang JH, 2008, J IMMUNOL, V180, P3594, DOI 10.4049/jimmunol.180.5.3594; Watkins LR, 2009, TRENDS PHARMACOL SCI, V30, P581, DOI 10.1016/j.tips.2009.08.002; Xie NC, 2010, NEUROPHARMACOLOGY, V59, P444, DOI 10.1016/j.neuropharm.2010.06.006; Xie NC, 2010, NEUROSCI LETT, V482, P51, DOI 10.1016/j.neulet.2010.07.004; Yin DL, 2006, J NEUROIMMUNOL, V174, P101, DOI 10.1016/j.jneuroim.2006.02.001; Yin DL, 1999, NATURE, V397, P218, DOI 10.1038/16612; Yin DL, 1997, NEUROSCI RES, V29, P121, DOI 10.1016/S0168-0102(97)00080-1; Yin DL, 2000, J EXP MED, V191, P1423, DOI 10.1084/jem.191.8.1423; Zhang Y, 2011, NEUROSCI LETT, V489, P43, DOI 10.1016/j.neulet.2010.11.063; Zheng LQ, 2008, BLOOD, V111, P2704, DOI 10.1182/blood-2007-07-104141; Zhou S, 2008, J NEUROIMMUNOL, V194, P70, DOI 10.1016/j.jneuroim.2007.11.018; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607	48	24	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18190	10.1371/journal.pone.0018190	http://dx.doi.org/10.1371/journal.pone.0018190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559519	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700008
J	Luo, Y; Zhang, ML; Zhang, J; Zhang, JF; Chen, CL; Chen, YE; Xiong, JW; Zhu, XJ				Luo, Yan; Zhang, Meiling; Zhang, Ji; Zhang, Jifeng; Chen, Chunlei; Chen, Y. Eugene; Xiong, Jing-Wei; Zhu, Xiaojun			Platelet-Derived Growth Factor Induces Rad Expression through Egr-1 in Vascular Smooth Muscle Cells	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTION; ACTIVATION; GTPASE; FAMILY; ATHEROSCLEROSIS; COREPRESSOR; MODULATION; HEART; LEADS	Background: Ras associated with diabetes (Rad) inhibits vascular lesion formation by reducing the attachment and migration of vascular smooth muscle cells (VSMCs). However, the transcriptional regulation of Rad in VSMCs is unclear. Methodology and Principal Findings: We found that Platelet-Derived Growth Factor (PDGF) induced Rad expression in a time-and dose-dependent manner in rat aortic smooth muscle cells (RASMCs) using quantitative real-time PCR. By serial deletion analysis of the Rad promoter, we identified that two GC-rich early growth response-1 (Egr-1) binding sites are essential for PDGF-induced Rad promoter activation. Overexpression of Egr-1 in RASMCs strongly stimulated Rad expression while the Egr-1 corepressor, NGFI-A binding protein 2 (NAB2), repressed PDGF-induced Rad up-regulation in a dose-dependent manner. Direct binding of Egr-1 to the Rad promoter region was further confirmed by chromatin immunoprecipitation assays. Conclusions: Our results demonstrate that Rad is regulated by PDGF through the transcriptional factor Egr-1 in RASMCs.	[Luo, Yan; Zhang, Meiling; Zhang, Ji; Chen, Chunlei; Xiong, Jing-Wei; Zhu, Xiaojun] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Ctr Cardiovasc, Ann Arbor, MI 48109 USA	Peking University; University of Michigan System; University of Michigan	Luo, Y (corresponding author), Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.	zhuxiaojun@pku.edu.cn	Xiong, Jing-Wei/A-7113-2011; Zhang, Ji/J-4009-2014		Natural Science Foundation of China [30400223, 30671027]; Peking University; National Basic Research Program of China [2007CB512100, 2010CB529503]; American Heart Association [0835237N]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University(Peking University); National Basic Research Program of China(National Basic Research Program of China); American Heart Association(American Heart Association)	This work was supported by Natural Science Foundation of China [30400223 and 30671027 to X.Z.]; Peking University 985 Project; National Basic Research Program of China [2007CB512100 and 2010CB529503]; and American Heart Association National Career Development Grant [0835237N to J.Z.] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bilan PJ, 1998, EXP CELL RES, V242, P391, DOI 10.1006/excr.1998.4092; Caldwell JS, 1996, BBA-MOL BASIS DIS, V1316, P145, DOI 10.1016/0925-4439(96)00034-8; Chang L, 2007, CIRCULATION, V116, P2976, DOI 10.1161/CIRCULATIONAHA.107.707257; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Fu MG, 2005, CIRCULATION, V111, P1071, DOI 10.1161/01.CIR.0000156439.55349.AD; Fu MG, 2002, J BIOL CHEM, V277, P26808, DOI 10.1074/jbc.M203748200; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; GASHLER AL, 1993, MOL CELL BIOL, V13, P4556, DOI 10.1128/MCB.13.8.4556; Harja E, 2004, CIRC RES, V94, P333, DOI 10.1161/01.RES.0000112405.61577.95; Hart CE, 1999, CIRCULATION, V99, P564, DOI 10.1161/01.CIR.99.4.564; Hawke TJ, 2006, AM J PHYSIOL-CELL PH, V290, pC379, DOI 10.1152/ajpcell.00270.2005; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Kamimura M, 2004, HYPERTENSION, V44, P944, DOI 10.1161/01.HYP.0000146908.75091.99; Kelly K, 2005, TRENDS CELL BIOL, V15, P640, DOI 10.1016/j.tcb.2005.10.002; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; Lewis CD, 2001, PLATELETS, V12, P352; LIU QF, 2009, MOL CELL BIOCH; McCaffrey TA, 2000, J CLIN INVEST, V105, P653, DOI 10.1172/JCI8592; Paillard G, 2004, NUCLEIC ACIDS RES, V32, P6673, DOI 10.1093/nar/gkh1003; REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Wang G, 2010, CIRC RES, V106, P317, DOI 10.1161/CIRCRESAHA.109.208272; Yada H, 2007, CIRC RES, V101, P69, DOI 10.1161/CIRCRESAHA.106.146399; Yamasaki Y, 2001, CIRC RES, V88, P630, DOI 10.1161/01.RES.88.6.630; Zhu JH, 1996, J BIOL CHEM, V271, P768, DOI 10.1074/jbc.271.2.768; Zhu XJ, 2007, CARDIOVASC RES, V76, P141, DOI 10.1016/j.cardiores.2007.06.015	29	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19408	10.1371/journal.pone.0019408	http://dx.doi.org/10.1371/journal.pone.0019408			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559360	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700159
J	Mayor, A; Hafiz, A; Bassat, Q; Rovira-Vallbona, E; Sanz, S; Machevo, S; Aguilar, R; Cistero, P; Sigauque, B; Menendez, C; Alonso, PL; Chitnis, CE				Mayor, Alfredo; Hafiz, Abdul; Bassat, Quique; Rovira-Vallbona, Eduard; Sanz, Sergi; Machevo, Sonia; Aguilar, Ruth; Cistero, Pau; Sigauque, Betuel; Menendez, Clara; Alonso, Pedro L.; Chitnis, Chetan E.			Association of Severe Malaria Outcomes with Platelet-Mediated Clumping and Adhesion to a Novel Host Receptor	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; HUMAN CEREBRAL MALARIA; RED-BLOOD-CELLS; PLASMODIUM-FALCIPARUM; CLINICAL-FEATURES; CYTOADHERENCE CHARACTERISTICS; UNCOMPLICATED MALARIA; MALAWIAN CHILDREN; AFRICAN CHILDREN; RANDOMIZED-TRIAL	Introduction: Severe malaria has been attributed partly to the sequestration of Plasmodium falciparum-infected erythrocytes (IEs) in the microvasculature of vital host organs. Identification of P. falciparum cytoadherence phenotypes that are associated with severe malaria may lead to the development of novel strategies against life-threatening malaria. Methods and Findings: Forty-six P. falciparum isolates from Mozambican children under 5 years of age with severe malaria (cases) were examined and compared to 46 isolates from sex and age matched Mozambican children with uncomplicated malaria (controls). Cytoadherence properties such as platelet-mediated clumping, rosetting and adhesion to purified receptors (CD36, ICAM1 and gC1qR), were compared between these matched pairs by non-parametric tests. The most common clinical presentation associated with severe malaria was prostration. Compared to matched controls, prevalence of platelet-mediated clumping was higher in cases (P = .019), in children presenting with prostration (P = .049) and in children with severe anaemia (P = .025). Prevalence of rosetting and gC1qR adhesion were also higher in isolates from cases with severe anemia and multiple seizures, respectively (P = .045 in both cases), than in controls. Conclusions: These data indicate a role for platelet-mediated clumping, rosetting and adhesion to gC1qR in the pathogenesis of severe malaria. Inhibition of these cytoadherence phenotypes may reduce the occurrence or improve the prognosis of severe malaria outcomes.	[Mayor, Alfredo; Bassat, Quique; Rovira-Vallbona, Eduard; Sanz, Sergi; Aguilar, Ruth; Cistero, Pau; Menendez, Clara; Alonso, Pedro L.] Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, IDIBAPS, Barcelona, Spain; [Mayor, Alfredo; Bassat, Quique; Machevo, Sonia; Aguilar, Ruth; Sigauque, Betuel; Menendez, Clara; Alonso, Pedro L.] CISM, Maputo, Mozambique; [Mayor, Alfredo; Bassat, Quique; Rovira-Vallbona, Eduard; Menendez, Clara; Alonso, Pedro L.] Consorcio Invest Biomed Epidemiol & Salud Publ CI, Madrid, Spain; [Chitnis, Chetan E.] ICGEB, New Delhi, India	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centro de Investigacao em Saude de Manhica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Mayor, A (corresponding author), Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, IDIBAPS, Barcelona, Spain.	cchitnis@icgeb.res.in	Alonso, Pedro L/AAZ-3645-2020; Cisteró, Pau/H-2468-2017; Rovira-Vallbona, Eduard/D-3053-2015; Sanz, Sergi/AAY-7211-2020; Bassat, Quique/P-2341-2016; Menéndez, Clara/Q-3446-2016; Mayor, Alfredo/H-7488-2017; Aguilar, Ruth/D-2147-2018	Alonso, Pedro L/0000-0003-3292-3443; Cisteró, Pau/0000-0001-7225-4331; Bassat, Quique/0000-0003-0875-7596; Menéndez, Clara/0000-0002-2641-6907; Mayor, Alfredo/0000-0003-3890-2897; Aguilar, Ruth/0000-0003-3277-3107; Rovira-Vallbona, Eduard/0000-0002-4765-1076; Chitnis, Chetan/0000-0002-8773-9865; Sanz Bravo, Sergi/0000-0001-5010-4527; Hafiz, Abdul/0000-0001-6402-5408	Instituto de Salud Carlos III [PS0901113, CP-04/00220, CM05/00134, FI06/00019]; European Commission; Spanish Agency for International Cooperation; Council of Scientific and Industrial Research [09/512 (70)/2004]; Department of Biotechnology, Government of India	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Agency for International Cooperation(Spanish Government); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study received partial support from Instituto de Salud Carlos III (PS0901113) and Biomalpar grant of the European Commission (CEC). The Manhica Health Research Centre receives core support from the Spanish Agency for International Cooperation. AH was supported by a Fellowship from the Council of Scientific and Industrial Research (09/512 (70)/2004), AM, QB and ERV by the Instituto de Salud Carlos III (CP-04/00220, CM05/00134 and FI06/00019, respectively). CEC is a recipient of a TATA Innovation Fellowship from Department of Biotechnology, Government of India. Work in the laboratory of CEC is partially supported by EVIMalaR, PregVax, PreMalStruct and MalSig grants from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; Alonso PL, 2002, POPULATION HLTH DEV, P189; ALYAMAN F, 1995, T ROY SOC TROP MED H, V89, P55, DOI 10.1016/0035-9203(95)90658-4; Arman M, 2007, AM J TROP MED HYG, V77, P943, DOI 10.4269/ajtmh.2007.77.943; Arman M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-243; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Bassat Q, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-37; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Biswas AK, 2007, PLOS PATHOG, V3, P1271, DOI 10.1371/journal.ppat.0030130; Boggild AK, 2009, CLIN INFECT DIS, V49, P841, DOI 10.1086/605431; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Choe H, 2005, MOL MICROBIOL, V55, P1413, DOI 10.1111/j.1365-2958.2004.04478.x; Chotivanich K, 2004, J INFECT DIS, V189, P1052, DOI 10.1086/381900; Clark IA, 2000, PARASITOL TODAY, V16, P451, DOI 10.1016/S0169-4758(00)01757-9; Crawley J, 1996, QJM-INT J MED, V89, P591; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Dondorp AM, 2007, J INFECT DIS, V196, P460, DOI 10.1086/519287; Faiz MA, 2005, LANCET, V366, P717; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; GOODYER ID, 1994, ANN TROP MED PARASIT, V88, P209, DOI 10.1080/00034983.1994.11812859; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; HO M, 1991, INFECT IMMUN, V59, P873, DOI 10.1128/IAI.59.3.873-878.1991; Howie SRC, 2011, B WORLD HEALTH ORGAN, V89, P46, DOI 10.2471/BLT.10.080010; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MOLYNEUX ME, 1989, Q J MED, V71, P441; Montgomery J, 2007, MOL MICROBIOL, V65, P959, DOI 10.1111/j.1365-2958.2007.05837.x; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; OCKENHOUSE CF, 1991, J INFECT DIS, V164, P163, DOI 10.1093/infdis/164.1.163; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; Patel SN, 2004, J INFECT DIS, V189, P204, DOI 10.1086/380764; REEDER JC, 1994, AM J TROP MED HYG, V51, P45, DOI 10.4269/ajtmh.1994.51.45; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rogerson SJ, 1999, AM J TROP MED HYG, V61, P467, DOI 10.4269/ajtmh.1999.61.467; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Saute F, 2003, T ROY SOC TROP MED H, V97, P661, DOI 10.1016/S0035-9203(03)80098-6; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Traore B, 2000, AM J TROP MED HYG, V62, P38, DOI 10.4269/ajtmh.2000.62.38; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503; UDOMSANGPETCH R, 1989, J EXP MED, V169, P1835, DOI 10.1084/jem.169.5.1835; Vogt AM, 2006, PLOS PATHOG, V2, P853, DOI 10.1371/journal.ppat.0020100; WALLER D, 1995, CLIN INFECT DIS, V21, P577, DOI 10.1093/clinids/21.3.577; Wassmer SC, 2008, J INFECT DIS, V197, P72, DOI 10.1086/523761; Xiong ZQ, 2003, J NEUROSCI, V23, P955	54	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19422	10.1371/journal.pone.0019422	http://dx.doi.org/10.1371/journal.pone.0019422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559373	Green Submitted, gold, Green Published			2022-12-25	WOS:000290024700165
J	Sousa, FL; Alves, RJ; Pereira-Leal, JB; Teixeira, M; Pereira, MM				Sousa, Filipa L.; Alves, Renato J.; Pereira-Leal, Jose B.; Teixeira, Miguel; Pereira, Manuela M.			A Bioinformatics Classifier and Database for Heme-Copper Oxygen Reductases	PLOS ONE			English	Article							NITRIC-OXIDE REDUCTASE; CYTOCHROME-C-OXIDASE; BAYESIAN PHYLOGENETIC INFERENCE; ACTIVE-SITE; PROTON TRANSLOCATION; TERMINAL OXIDASES; EVOLUTION; SEQUENCES; PROTEINS; MODELS	Background: Heme-copper oxygen reductases (HCOs) are the last enzymatic complexes of most aerobic respiratory chains, reducing dioxygen to water and translocating up to four protons across the inner mitochondrial membrane (eukaryotes) or cytoplasmatic membrane (prokaryotes). The number of completely sequenced genomes is expanding exponentially, and concomitantly, the number and taxonomic distribution of HCO sequences. These enzymes were initially classified into three different types being this classification recently challenged. Methodology: We reanalyzed the classification scheme and developed a new bioinformatics classifier for the HCO and Nitric oxide reductases (NOR), which we benchmark against a manually derived gold standard sequence set. It is able to classify any given sequence of subunit I from HCO and NOR with a global recall and precision both of 99.8%. We use this tool to classify this protein family in 552 completely sequenced genomes. Conclusions: We concluded that the new and broader data set supports three functional and evolutionary groups of HCOs. Homology between NORs and HCOs is shown and NORs closest relationship with C Type HCOs demonstrated. We established and made available a classification web tool and an integrated Heme-Copper Oxygen reductase and NOR protein database (www.evocell.org/hco).	[Sousa, Filipa L.; Teixeira, Miguel; Pereira, Manuela M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Alves, Renato J.; Pereira-Leal, Jose B.] Inst Gulbenkian Ciencias, Oeiras, Portugal	Universidade Nova de Lisboa; Instituto Gulbenkian de Ciencia	Sousa, FL (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	mpereira@itqb.unl.pt	Pereira-Leal, Jose/C-5616-2012; Sousa, Filipa/ACC-2848-2022; Teixeira, Miguel/A-9098-2011; Pereira, Manuela M./B-9029-2011; Sousa, Filipa/F-3812-2011; Teixeira, Miguel/M-1509-2019; Sousa, Filipa L./H-6192-2012	Sousa, Filipa/0000-0002-4084-1942; Teixeira, Miguel/0000-0003-4124-6237; Pereira, Manuela M./0000-0003-2033-4553; Teixeira, Miguel/0000-0003-4124-6237; Sousa, Filipa L./0000-0002-4075-1701; Alves, Renato/0000-0002-7212-0234; Pereira Leal, Jose/0000-0002-3111-7119	FCT-Fundacao para a Ciencia e a Tecnologia, Portuguese Funding agency [PTPC/Qui/66559/2006, PTPC/BIA-PRO/103310/2008, SFRH/BD/27972/2006]	FCT-Fundacao para a Ciencia e a Tecnologia, Portuguese Funding agency(Portuguese Foundation for Science and Technology)	This work was supported by FCT-Fundacao para a Ciencia e a Tecnologia, Portuguese Funding agency, projects PTPC/Qui/66559/2006 to MMP, PTPC/BIA-PRO/103310/2008 to MT and fellowships SFRH/BD/27972/2006 to FLS and FCG to RJA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BELL LC, 1992, J GEN MICROBIOL, V138, P437, DOI 10.1099/00221287-138-3-437; Branden G, 2006, BBA-BIOENERGETICS, V1757, P1052, DOI 10.1016/j.bbabio.2006.05.020; Brochier-Armanet C, 2009, MOL BIOL EVOL, V26, P285, DOI 10.1093/molbev/msn246; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Buse G, 1999, PROTEIN SCI, V8, P985, DOI 10.1110/ps.8.5.985; de Vries S, 2002, BIOCHEM SOC T, V30, P662, DOI 10.1042/bst0300662; Ducluzeau AL, 2009, TRENDS BIOCHEM SCI, V34, P9, DOI 10.1016/j.tibs.2008.10.005; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gennis RB, 1998, BBA-BIOENERGETICS, V1365, P241, DOI 10.1016/S0005-2728(98)00075-9; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Gribaldo S, 2009, TRENDS BIOCHEM SCI, V34, P375, DOI 10.1016/j.tibs.2009.04.002; Hao WL, 2006, J MOL EVOL, V62, P132, DOI 10.1007/s00239-005-0005-7; Hemp J, 2005, BIOCHEMISTRY-US, V44, P10766, DOI 10.1021/bi050464f; Hemp James, 2008, V45, P1, DOI 10.1007/400_2007_046; Hendriks J, 1998, J BIOENERG BIOMEMBR, V30, P15, DOI 10.1023/A:1020547225398; Hendriks JHM, 2002, BIOCHEMISTRY-US, V41, P2331, DOI 10.1021/bi0121050; Hino T, 2010, SCIENCE, V330, P1666, DOI 10.1126/science.1195591; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keeling PJ, 2008, CURR BIOL, V18, pR345, DOI 10.1016/j.cub.2008.02.065; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nicholas KB., 1997, GENEDOC TOOL EDITING; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SARASTE M, 1994, FEBS LETT, V341, P1, DOI 10.1016/0014-5793(94)80228-9; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHAPLEIGH JP, 1985, J BACTERIOL, V163, P837, DOI 10.1128/JB.163.3.837-840.1985; Sigrist C.J., NUCL ACIDS RES, V38, pD161; Sousa FL, 2011, SEARCHING COMMON DEN; SVENSSON M, 1995, BIOCHEMISTRY-US, V34, P5252, DOI 10.1021/bi00015a040; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VANDEROOST J, 1994, FEMS MICROBIOL LETT, V121, P1, DOI 10.1016/0378-1097(94)90137-6; Vanlerberghe GC, 1997, ANNU REV PLANT PHYS, V48, P703, DOI 10.1146/annurev.arplant.48.1.703; Verkhovskaya ML, 1997, P NATL ACAD SCI USA, V94, P10128, DOI 10.1073/pnas.94.19.10128; Zumft WG, 2005, J INORG BIOCHEM, V99, P194, DOI 10.1016/j.jinorgbio.2004.09.024	45	44	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19117	10.1371/journal.pone.0019117	http://dx.doi.org/10.1371/journal.pone.0019117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559461	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700067
J	Wang, Z; Yang, DH; Zhang, XJ; Li, T; Li, J; Tang, Y; Le, WD				Wang, Zheng; Yang, Dehua; Zhang, Xiaojie; Li, Ting; Li, Jia; Tang, Yu; Le, Weidong			Hypoxia-Induced Down-Regulation of Neprilysin by Histone Modification in Mouse Primary Cortical and Hippocampal Neurons	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDE; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; GENE-EXPRESSION; CANCER-CELLS; A-BETA; DNA; METHYLATION; PROMOTER; 5-AZA-2'-DEOXYCYTIDINE	Amyloid beta-peptide (A beta) accumulation leads to neurodegeneration and Alzheimer's disease (AD). A beta metabolism is a dynamic process in the A beta production and clearance that requires neprilysin (NEP) and other enzymes to degrade A beta. It has been reported that NEP expression is significantly decreased in the brain of AD patients. Previously we have documented hypoxia is a risk factor for A beta generation in vivo and in vitro through increasing A beta generation by altering beta-cleavage and gamma-cleavage of APP and down-regulating NEP, and causing tau hyperphosphorylation. Here, we investigated the molecular mechanisms of hypoxia-induced down-regulation of NEP. We found a significant decrease in NEP expression at the mRNA and protein levels after hypoxic treatment in mouse primary cortical and hippocampal neurons. Chromatin immunoprecipitation (ChIP) assays and relative quantitative PCR (q-PCR) revealed an increase of histone H3-lysine9 demethylation (H3K9me2) and a decrease of H3 acetylation (H3-Ace) in the NEP promoter regions following hypoxia. In addition, we found that hypoxia caused up-regulation of histone methyl transferase (HMT) G9a and histone deacetylases (HDACs) HDAC-1. Decreased expression of NEP during hypoxia can be prevented by application with the epigenetic regulators 5-Aza-2'-deoxycytidine (5-Aza), HDACs inhibitor sodium valproate (VA), and siRNA-mediated knockdown of G9a or HDAC1. DNA methylation PCR data do not support that hypoxia affects the methylation of NEP promoters. This study suggests that hypoxia may down-regulate NEP by increasing H3K9me2 and decreasing H3-Ace modulation.	[Wang, Zheng; Yang, Dehua; Le, Weidong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Inst Neurol, Shanghai 200030, Peoples R China; [Zhang, Xiaojie; Li, Ting; Li, Jia; Tang, Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Zhang, Xiaojie; Li, Ting; Li, Jia; Tang, Yu] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Le, Weidong] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Baylor College of Medicine	Wang, Z (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Inst Neurol, Shanghai 200030, Peoples R China.	weidongl@bcm.edu	Yang, Dehua/S-6156-2017; Yang, Dehua/M-5789-2019		Shanghai International Science and Technology Cooperation Project [10410712900]; National Basic Research Program of China [2007CB947904, 2010CB945200]; Chinese National Nature Science Foundation [30970925/30730096]; Shanghai Jiao Tong University School of Medicine [BXJ201013]	Shanghai International Science and Technology Cooperation Project; National Basic Research Program of China(National Basic Research Program of China); Chinese National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University School of Medicine	This work was supported by the Shanghai International Science and Technology Cooperation Project (No. 10410712900; http://www.stcsm.gov.cn/structure/index.htm); the National Basic Research Program of China (2007CB947904 and 2010CB945200; http://www.973.gov.cn/English/Index.aspx); Chinese National Nature Science Foundation (No. 30970925/30730096; http://www.nsfc.gov.cn/Portal0) and by the the PhD Innovation Fund of Shanghai Jiao Tong University School of Medicine (BXJ201013; http://yjsy.shsmu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; Anderson CJ, 2006, ONCOGENE, V25, P61, DOI 10.1038/sj.onc.1209011; Baiden-Amissah K, 1998, NEUROPATH APPL NEURO, V24, P346; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; Byrne JA, 2007, LAB INVEST, V87, P1138, DOI 10.1038/labinvest.3700677; Cacabelos Ramon, 2008, V448, P213, DOI 10.1007/978-1-59745-205-2_10; Campos ACE, 2007, NEOPLASIA, V9, P1111, DOI 10.1593/neo.07712; Carson JA, 2002, J NEUROCHEM, V81, P1, DOI 10.1046/j.1471-4159.2002.00855.x; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Chen HB, 2010, CARCINOGENESIS, V31, P2136, DOI 10.1093/carcin/bgq197; Chen UL, 2009, BIOCHEM BIOPH RES CO, V378, P57, DOI 10.1016/j.bbrc.2008.10.173; Cho IH, 2008, BRAIN, V131, P3019, DOI 10.1093/brain/awn230; Du F, 2005, EUR J NEUROSCI, V22, P2422, DOI 10.1111/j.1460-9568.2005.04438.x; Fahrner JA, 2002, CANCER RES, V62, P7213; Fisk L, 2007, NEUROCHEM RES, V32, P1741, DOI 10.1007/s11064-007-9349-2; Fowler BA, 2004, BIOMETALS, V17, P567, DOI 10.1023/B:BIOM.0000045740.52182.9d; Hama E, 2005, MED HYPOTHESES, V65, P498, DOI 10.1016/j.mehy.2005.02.045; Hersh LB, 2008, CURR ALZHEIMER RES, V5, P225, DOI 10.2174/156720508783954703; Honig LS, 2005, NEUROLOGY, V64, P494, DOI 10.1212/01.WNL.0000150886.50187.30; ISHIMARU F, 1995, BLOOD, V85, P3199, DOI 10.1182/blood.V85.11.3199.bloodjournal85113199; Jacobsen JS, 2008, P NATL ACAD SCI USA, V105, P8754, DOI 10.1073/pnas.0710823105; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Lee SH, 2009, ONCOGENE, V28, P184, DOI 10.1038/onc.2008.377; LI CW, 1995, J BIOL CHEM, V270, P5723, DOI 10.1074/jbc.270.11.5723; Li L, 2009, NEUROBIOL AGING, V30, P1091, DOI 10.1016/j.neurobiolaging.2007.10.011; Marr RA, 2003, J NEUROSCI, V23, P1992; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; Maruyama M, 2005, ANN NEUROL, V57, P832, DOI 10.1002/ana.20494; Miners JS, 2006, J NEUROPATH EXP NEUR, V65, P1012, DOI 10.1097/01.jnen.0000240463.87886.9a; Morrison BE, 2007, CELL MOL LIFE SCI, V64, P2258, DOI 10.1007/s00018-007-7035-9; Nalivaeva NN, 2008, CURR ALZHEIMER RES, V5, P212, DOI 10.2174/156720508783954785; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nguyen CT, 2002, CANCER RES, V62, P6456; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Scarpa S, 2003, FEBS LETT, V541, P145, DOI 10.1016/S0014-5793(03)00277-1; Schneider JA, 2003, NEUROLOGY, V60, P1082, DOI 10.1212/01.WNL.0000055863.87435.B2; Takebayashi S, 2001, BIOCHEM BIOPH RES CO, V288, P921, DOI 10.1006/bbrc.2001.5863; Wang SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002698; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhang X, 2010, EXP NEUROL, V223, P299, DOI 10.1016/j.expneurol.2009.07.033	45	77	86	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19229	10.1371/journal.pone.0019229	http://dx.doi.org/10.1371/journal.pone.0019229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559427	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700105
J	Jurkowska, RZ; Rajavelu, A; Anspach, N; Urbanke, C; Jankevicius, G; Ragozin, S; Nellen, W; Jeltsch, A				Jurkowska, Renata Z.; Rajavelu, Arumugam; Anspach, Nils; Urbanke, Claus; Jankevicius, Gytis; Ragozin, Sergey; Nellen, Wolfgang; Jeltsch, Albert			Oligomerization and Binding of the Dnmt3a DNA Methyltransferase to Parallel DNA Molecules HETEROCHROMATIC LOCALIZATION AND ROLE OF Dnmt3L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-CHROMOSOME INACTIVATION; DE-NOVO METHYLATION; HUMAN-DISEASE; PWWP DOMAIN; CHROMATIN; PROTEIN; EPIGENETICS; MECHANISM; CANCER; ULTRACENTRIFUGATION	Structural studies showed that Dnmt3a has two interfaces for protein-protein interaction in the heterotetrameric Dnmt3a/3L C-terminal domain complex: the RD interface (mediating the Dnmt3a-3a contact) and the FF interface (mediating the Dnmt3a-3L contact). Here, we demonstrate that Dnmt3a-C forms dimers via the FF interface as well, which further oligomerize via their RD interfaces. Each RD interface of the Dnmt3a-C oligomer creates an independent DNA binding site, which allows for binding of separate DNA molecules oriented in parallel. Because Dnmt3L does not have an RD interface, it prevents Dnmt3a oligomerization and binding of more than one DNA molecule. Both interfaces of Dnmt3a are necessary for the heterochromatic localization of the enzyme in cells. Overexpression of Dnmt3L in cells leads to the release of Dnmt3a from heterochromatic regions, which may increase its activity for methylation of euchromatic targets like the differentially methylated regions involved in imprinting.	[Jeltsch, Albert] Jacobs Univ Bremen, Sch Sci & Engn, Biochem Lab, D-28759 Bremen, Germany; [Anspach, Nils; Nellen, Wolfgang; Jeltsch, Albert] Univ Kassel, CINSaT, Abt Genet, D-34132 Kassel, Germany; [Urbanke, Claus] Hannover Med Sch, Abt Strukturanal OE 8830, D-30625 Hannover, Germany; [Jankevicius, Gytis] Jacobs Univ Bremen, MoLife Grad Program, Sch Engn & Sci, D-28759 Bremen, Germany	Jacobs University; Universitat Kassel; Hannover Medical School; Jacobs University	Jeltsch, A (corresponding author), Jacobs Univ Bremen, Albert Jeltsch Sch Engn & Sci, Campus Ring 1, D-28759 Bremen, Germany.	a.jeltsch@jacobs-university.de	Jurkowska, Renata/AAE-2504-2020; Rajavelu, Arumugam/B-7832-2013; Jeltsch, Albert/O-7404-2014; Jankevicius, Gytis/C-7126-2015	Jurkowska, Renata/0000-0002-4507-2222; Jeltsch, Albert/0000-0001-6113-9290; Jankevicius, Gytis/0000-0002-0212-3923; Rajavelu, Arumugam/0000-0001-6666-8925	DFG [JE 252/6]	DFG(German Research Foundation (DFG))	This work was supported by the DFG (JE 252/6).	ALLIS C.D., 2007, EPIGENETICS; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; Bell CE, 2005, MOL MICROBIOL, V58, P358, DOI 10.1111/j.1365-2958.2005.04876.x; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Chang SC, 2006, FRONT BIOSCI-LANDMRK, V11, P852, DOI 10.2741/1842; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Delaval K, 2004, CURR OPIN GENET DEV, V14, P188, DOI 10.1016/j.gde.2004.01.005; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Gowher H, 2006, J MOL BIOL, V357, P928, DOI 10.1016/j.jmb.2006.01.035; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Gowher H, 2002, J BIOL CHEM, V277, P20409, DOI 10.1074/jbc.M202148200; Hata K, 2002, DEVELOPMENT, V129, P1983; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Hore TA, 2007, TRENDS GENET, V23, P440, DOI 10.1016/j.tig.2007.07.003; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Jeltsch Albert, 2002, Methods Mol Biol, V182, P85; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jurkowska RZ, 2008, NUCLEIC ACIDS RES, V36, P6656, DOI 10.1093/nar/gkn747; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lande-Diner L, 2007, J BIOL CHEM, V282, P12194, DOI 10.1074/jbc.M607838200; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Nimura K, 2006, GENES CELLS, V11, P1225, DOI 10.1111/j.1365-2443.2006.01012.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rodenhiser D, 2006, CAN MED ASSOC J, V174, P341, DOI 10.1503/cmaj.050774; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sha K, 2008, ANNU REV GENOM HUM G, V9, P197, DOI 10.1146/annurev.genom.122007.110031; Straub T, 2007, NAT REV GENET, V8, P47, DOI 10.1038/nrg2013; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Yen ZC, 2007, GENOMICS, V90, P453, DOI 10.1016/j.ygeno.2007.07.002; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	51	68	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24200	24207		10.1074/jbc.M111.254987	http://dx.doi.org/10.1074/jbc.M111.254987			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566127	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000292294900062
J	Cadotte, MW; Strauss, SY				Cadotte, Marc W.; Strauss, Sharon Y.			Phylogenetic Patterns of Colonization and Extinction in Experimentally Assembled Plant Communities	PLOS ONE			English	Article							ECOLOGICAL COMMUNITIES; RAIN-FOREST; DIVERSITY; NICHE; PRODUCTIVITY; NEUTRALITY; HISTORY; MODEL; SUBSTITUTION; COMPETITION	Background: Evolutionary history has provided insights into the assembly and functioning of plant communities, yet patterns of phylogenetic community structure have largely been based on non-dynamic observations of natural communities. We examined phylogenetic patterns of natural colonization, extinction and biomass production in experimentally assembled communities. Methodology/Principal Findings: We used plant community phylogenetic patterns two years after experimental diversity treatments (1, 2, 4, 8 or 32 species) were discontinued. We constructed a 5-gene molecular phylogeny and statistically compared relatedness of species that colonized or went extinct to remaining community members and patterns of aboveground productivity. Phylogenetic relatedness converged as species-poor plots were colonized and speciose plots experienced extinctions, but plots maintained more differences in composition than in phylogenetic diversity. Successful colonists tended to either be closely or distantly related to community residents. Extinctions did not exhibit any strong relatedness patterns. Finally, plots that increased in phylogenetic diversity also increased in community productivity, though this effect was inseparable from legume colonization, since these colonists tended to be phylogenetically distantly related. Conclusions: We found that successful non-legume colonists were typically found where close relatives already existed in the sown community; in contrast, successful legume colonists (on their own long branch in the phylogeny) resulted in plots that were colonized by distant relatives. While extinctions exhibited no pattern with respect to relatedness to sown plotmates, extinction plus colonization resulted in communities that converged to similar phylogenetic diversity values, while maintaining differences in species composition.	[Cadotte, Marc W.] Univ Toronto, Dept Biol Sci, Scarborough, ON M1C 1A4, Canada; [Strauss, Sharon Y.] Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA	University of Toronto; University Toronto Scarborough; University of California System; University of California Davis	Cadotte, MW (corresponding author), Univ Toronto, Dept Biol Sci, Scarborough, ON M1C 1A4, Canada.	mcadotte@utsc.utoronto.ca; systrauss@ucdavis.edu	Cadotte, Marc/AAG-8147-2020; Strauss, Sharon/J-1827-2012	Cadotte, Marc/0000-0002-5816-7693; Strauss, Sharon/0000-0002-6117-4085	NSF [DEB-0553768]; NSERC [386151]	NSF(National Science Foundation (NSF)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was indirectly funded by an NSF grant to the National Center for Ecological Analysis and Synthesis (DEB-0553768) and by an NSERC grant to MC (#386151). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bartelt-Ryser J, 2005, PERSPECT PLANT ECOL, V7, P27, DOI 10.1016/j.ppees.2004.11.002; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2010, DIVERS DISTRIB, V16, P892, DOI 10.1111/j.1472-4642.2010.00700.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cadotte MW, 2007, P ROY SOC B-BIOL SCI, V274, P2739, DOI 10.1098/rspb.2007.0925; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cavender-Bares J, 2003, ECOLOGY, V84, P592, DOI 10.1890/0012-9658(2003)084[0592:IMAMPI]2.0.CO;2; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diemer Matthias, 1997, Bulletin of the Geobotanical Institute ETH, V63, P95; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; Futuyma DJ, 2010, EVOLUTION, V64, P1865, DOI 10.1111/j.1558-5646.2010.00960.x; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Holt RD, 2006, TRENDS ECOL EVOL, V21, P531, DOI 10.1016/j.tree.2006.08.003; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kembel SW, 2009, ECOL LETT, V12, P949, DOI 10.1111/j.1461-0248.2009.01354.x; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Letcher SG, 2010, P ROY SOC B-BIOL SCI, V277, P97, DOI 10.1098/rspb.2009.0865; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; MacDougall AS, 2009, J ECOL, V97, P609, DOI 10.1111/j.1365-2745.2009.01514.x; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Petermann JS, 2010, ECOLOGY, V91, P408, DOI 10.1890/08-2304.1; Pfisterer AB, 2004, BASIC APPL ECOL, V5, P5, DOI 10.1078/1439-1791-00215; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Silvertown J, 2001, J ECOL, V89, P428, DOI 10.1046/j.1365-2745.2001.00553.x; Silvertown J, 2006, ECOLOGY, V87, pS39, DOI 10.1890/0012-9658(2006)87[39:PATHOO]2.0.CO;2; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Webb CO, 2006, ECOLOGY, V87, pS123, DOI 10.1890/0012-9658(2006)87[123:PSMSSA]2.0.CO;2; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; WEDIN D, 1993, ECOL MONOGR, V63, P199, DOI 10.2307/2937180	47	28	28	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19363	10.1371/journal.pone.0019363	http://dx.doi.org/10.1371/journal.pone.0019363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573117	Green Submitted, Green Published, gold			2022-12-25	WOS:000290305600022
J	Sun, L; Han, X; He, SG				Sun, Le; Han, Xu; He, Shigang			Direction-Selective Circuitry in Rat Retina Develops Independently of GABAergic, Cholinergic and Action Potential Activity	PLOS ONE			English	Article							STARBURST AMACRINE CELLS; NICOTINIC ACETYLCHOLINE-RECEPTOR; DEVELOPING MAMMALIAN RETINA; OLFACTORY SENSORY MAP; GANGLION-CELLS; RABBIT RETINA; MOUSE RETINA; VISUAL EXPERIENCE; HIPPOCAMPAL-NEURONS; NEURAL ACTIVITY	The ON-OFF direction selective ganglion cells (DSGCs) in the mammalian retina code image motion by responding much more strongly to movement in one direction. They do so by receiving inhibitory inputs selectively from a particular sector of processes of the overlapping starburst amacrine cells, a type of retinal interneuron. The mechanisms of establishment and regulation of this selective connection are unknown. Here, we report that in the rat retina, the morphology, physiology of the ON-OFF DSGCs and the circuitry for coding motion directions develop normally with pharmacological blockade of GABAergic, cholinergic activity and/or action potentials for over two weeks from birth. With recent results demonstrating light independent formation of the retinal DS circuitry, our results strongly suggest the formation of the circuitry, i.e., the connections between the second and third order neurons in the visual system, can be genetically programmed, although emergence of direction selectivity in the visual cortex appears to require visual experience.	[Sun, Le; Han, Xu; He, Shigang] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Sun, L (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	shiganghe@moon.ibp.ac.cn			NSFC [30530280]; NSFC-NRF [30811140333]; National Basic Research Program of China [2007CB512208, 2006CB911003]	NSFC(National Natural Science Foundation of China (NSFC)); NSFC-NRF; National Basic Research Program of China(National Basic Research Program of China)	This project was supported by a NSFC key project grant (30530280), a NSFC-NRF grant (30811140333) and two grants of National Basic Research Program of China (2007CB512208 and 2006CB911003) to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMTHOR FR, 1995, P NATL ACAD SCI USA, V92, P4002, DOI 10.1073/pnas.92.9.4002; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BRECHA N, 1988, P NATL ACAD SCI USA, V85, P6187, DOI 10.1073/pnas.85.16.6187; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025; Chan YC, 2008, VISION RES, V48, P2466, DOI 10.1016/j.visres.2008.08.010; Chen MG, 2009, J PHYSIOL-LONDON, V587, P819, DOI 10.1113/jphysiol.2008.161240; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Diao L, 2004, J NEUROBIOL, V61, P236, DOI 10.1002/neu.20041; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Famiglietti EV, 2010, VISUAL NEUROSCI, V27, P19, DOI 10.1017/S0952523810000052; FAWCETT JW, 1984, P NATL ACAD SCI-BIOL, V81, P5589, DOI 10.1073/pnas.81.17.5589; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; GRASSE KL, 1990, VISUAL NEUROSCI, V4, P605, DOI 10.1017/S0952523800005800; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jones BW, 2003, J COMP NEUROL, V464, P1, DOI 10.1002/cne.10703; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kim IJ, 2010, J NEUROSCI, V30, P1452, DOI 10.1523/JNEUROSCI.4779-09.2010; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Ren L, 2010, DEV NEUROBIOL, V70, P397, DOI 10.1002/dneu.20777; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Sun C, 2008, P NATL ACAD SCI USA, V105, P13638, DOI 10.1073/pnas.0807178105; Sun C, 2008, J NEUROPHYSIOL, V100, P3253, DOI 10.1152/jn.90303.2008; Sun WZ, 2006, J PHYSIOL-LONDON, V576, P197, DOI 10.1113/jphysiol.2006.115857; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; [谭洁 TAN Jie], 2010, [生物物理学报, Acta Biophysica Sinica], V26, P194; Vu TQ, 2000, J NEUROSCI, V20, P1414; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; WYATT HJ, 1976, SCIENCE, V191, P204, DOI 10.1126/science.1857; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; [张海涛 Zhang Haitao], 2010, [生物物理学报, Acta Biophysica Sinica], V26, P389; Zhang LL, 2006, J NEUROPHYSIOL, V95, P2404, DOI 10.1152/jn.00578.2005; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015; Zhou ZJ, 2001, J NEUROSCI, V21, P5158, DOI 10.1523/JNEUROSCI.21-14-05158.2001; Zhou ZJ, 1998, J NEUROSCI, V18, P4155; Zhou ZJ, 1996, P NATL ACAD SCI USA, V93, P8057, DOI 10.1073/pnas.93.15.8057	62	170	172	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19477	10.1371/journal.pone.0019477	http://dx.doi.org/10.1371/journal.pone.0019477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573161	Green Published, gold, Green Submitted			2022-12-25	WOS:000290256400014
J	Rankin, TL; Sponaugle, S				Rankin, Tauna L.; Sponaugle, Su			Temperature Influences Selective Mortality during the Early Life Stages of a Coral Reef Fish	PLOS ONE			English	Article							POLYCHAETE HYDROIDS ELEGANS; COD GADUS-MORHUA; MARINE FISH; LARVAL GROWTH; POSTSETTLEMENT SURVIVORSHIP; COMPENSATORY GROWTH; THALASSOMA-BIFASCIATUM; RECRUITMENT SUCCESS; STEGASTES-PARTITUS; JUVENILE SURVIVAL	For organisms with complex life cycles, processes occurring at the interface between life stages can disproportionately impact survival and population dynamics. Temperature is an important factor influencing growth in poikilotherms, and growth-related processes are frequently correlated with survival. We examined the influence of water temperature on growth-related early life history traits (ELHTs) and differential mortality during the transition from larval to early juvenile stage in sixteen monthly cohorts of bicolor damselfish Stegastes partitus, sampled on reefs of the upper Florida Keys, USA over 6 years. Otolith analysis of settlers and juveniles coupled with environmental data revealed that mean near-reef water temperature explained a significant proportion of variation in pelagic larval duration (PLD), early larval growth, size-at-settlement, and growth during early juvenile life. Among all cohorts, surviving juveniles were consistently larger at settlement, but grew more slowly during the first 6 d post-settlement. For the other ELHTs, selective mortality varied seasonally: during winter and spring months, survivors exhibited faster larval growth and shorter PLDs, whereas during warmer summer months, selection on PLD reversed and selection on larval growth became non-linear. Our results demonstrate that temperature not only shapes growth-related traits, but can also influence the direction and intensity of selective mortality.	[Rankin, Tauna L.; Sponaugle, Su] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	University of Miami	Rankin, TL (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	trankin@rsmas.miami.edu			Maytag Chair Endowment; EPA; NSF [OCE-9986359]	Maytag Chair Endowment; EPA(United States Environmental Protection Agency); NSF(National Science Foundation (NSF))	We thank S. Cappell, E. D'Alessandro, K. Denit, J. Fortuna, K. Grorud-Colvert, C. Guigand, K. Huebert, J. Llopiz, M. Paddack, D. Pinkard, D. Richardson, and M. Sullivan for field assistance. Fish were collected under permits #00S-524 and 02R-524 from the Florida FWC, and permits #2001-004 and 2002-025A from the FKNMS. All collections and fish handling procedures were approved under the UM-ACUC Permit #01-056. Collections were made from a vessel purchased with funds from the Maytag Chair Endowment and the EPA-funded UM-NCORE. D. Pinkard assisted with otolith aging. Water temperature and current velocity data were provided by S. Miller and O. Rutten from the NURC. SST and ocean color images were provided by F. Muller-Karger at University of South Florida. The manuscript benefited from comments of R. Cowen, G. Kellison, M. Schmale, D. Williams, and two anonymous reviewers. This study was funded by NSF Grant No. OCE-9986359 to S. Sponaugle. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2007, FUNCT ECOL, V21, P873, DOI 10.1111/j.1365-2435.2007.01300.x; ANDERSON J T, 1988, Journal of Northwest Atlantic Fishery Science, V8, P55; Arendt JD, 2003, FUNCT ECOL, V17, P328, DOI 10.1046/j.1365-2435.2003.00737.x; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Atkinson D., 1994, V25, P1; Bergenius MAJ, 2002, OECOLOGIA, V131, P521, DOI 10.1007/s00442-002-0918-4; Biro PA, 2004, P ROY SOC B-BIOL SCI, V271, P2233, DOI 10.1098/rspb.2004.2861; BLAXTER JHS, 1992, NETH J ZOOL, V42, P336, DOI 10.1163/156854291X00379; BOOTH DJ, 1995, ECOLOGY, V76, P91, DOI 10.2307/1940634; BRETT JR, 1969, J FISH RES BOARD CAN, V26, P2363, DOI 10.1139/f69-230; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Buckley LJ, 2006, DEEP-SEA RES PT II, V53, P2758, DOI 10.1016/j.dsr2.2006.08.009; CARR MH, 1995, MAR ECOL PROG SER, V124, P31, DOI 10.3354/meps124031; Caselle JE, 1999, ECOL MONOGR, V69, P177, DOI 10.1890/0012-9615(1999)069[0177:EPSMIA]2.0.CO;2; D'Alessandro E, 2007, MAR ECOL PROG SER, V331, P85, DOI 10.3354/meps331085; De Block M, 2005, ECOLOGY, V86, P185, DOI 10.1890/04-0116; De Block M, 2008, P ROY SOC B-BIOL SCI, V275, P781, DOI 10.1098/rspb.2007.1515; Durieux EDH, 2009, J FISH BIOL, V74, P921, DOI 10.1111/j.1095-8649.2009.02179.x; Gagliano M, 2007, P R SOC B, V274, P1575, DOI 10.1098/rspb.2007.0242; Gagliano M, 2007, OECOLOGIA, V152, P219, DOI 10.1007/s00442-006-0647-1; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Gimenez L, 2010, ECOLOGY, V91, P1401, DOI 10.1890/09-1028.1; GOATER CP, 1994, ECOLOGY, V75, P2264, DOI 10.2307/1940882; Grorud-Colvert K, 2011, OECOLOGIA, V165, P675, DOI 10.1007/s00442-010-1748-4; HOUDE ED, 1989, FISH B-NOAA, V87, P471; Hurst TP, 2005, MAR ECOL PROG SER, V293, P233, DOI 10.3354/meps293233; Jarrett JN, 2003, ECOLOGY, V84, P384, DOI 10.1890/0012-9658(2003)084[0384:SVILCA]2.0.CO;2; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; Johnson DW, 2010, J EVOLUTION BIOL, V23, P724, DOI 10.1111/j.1420-9101.2010.01938.x; Johnsson JI, 2006, P ROY SOC B-BIOL SCI, V273, P1281, DOI 10.1098/rspb.2005.3437; Leis Jeffrey L., 2002, P171, DOI 10.1016/B978-012615185-5/50011-6; LIMA SL, 1990, CANADIAN J ZOOLOGY, V68; LITVAK MK, 1992, MAR ECOL PROG SER, V81, P13, DOI 10.3354/meps081013; Maldonado M, 1999, J EXP MAR BIOL ECOL, V232, P9, DOI 10.1016/S0022-0981(98)00076-8; McCormick MI, 2004, OIKOS, V106, P225, DOI 10.1111/j.0030-1299.2004.13131.x; Meekan MG, 1996, MAR ECOL PROG SER, V137, P25, DOI 10.3354/meps137025; Monro K, 2010, FUNCT ECOL, V24, P676, DOI 10.1111/j.1365-2435.2009.01665.x; Moran AL, 2001, ECOLOGY, V82, P1597, DOI 10.2307/2679803; Pepin P, 2003, FISH OCEANOGR, V12, P19, DOI 10.1046/j.1365-2419.2003.00221.x; PEPIN P, 1991, CAN J FISH AQUAT SCI, V48, P503, DOI 10.1139/f91-065; Qian PY, 1998, J EXP MAR BIOL ECOL, V227, P169, DOI 10.1016/S0022-0981(97)00267-0; Qiu JW, 1998, MAR ECOL PROG SER, V168, P127, DOI 10.3354/meps168127; Raventos N, 2005, MAR ECOL PROG SER, V285, P205, DOI 10.3354/meps285205; ROBERTSON DR, 1988, ECOLOGY, V69, P370, DOI 10.2307/1940435; RUTHERFORD ES, 1995, FISH B-NOAA, V93, P315; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; Searcy SP, 2001, ECOLOGY, V82, P2452; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; Sinclair AF, 2002, CAN J FISH AQUAT SCI, V59, P361, DOI 10.1139/F02-015; Sogard SM, 1997, B MAR SCI, V60, P1129; Sogard SM, 2002, MAR ECOL PROG SER, V243, P165, DOI 10.3354/meps243165; Sponaugle S, 2006, MAR ECOL PROG SER, V308, P1, DOI 10.3354/meps308001; Sponaugle S, 2005, LIMNOL OCEANOGR, V50, P1033, DOI 10.4319/lo.2005.50.4.1033; Sponaugle S, 2004, J FISH BIOL, V64, P34, DOI 10.1111/j.1095-8649.2004.00279.x; Sponaugle S, 1996, MAR FRESHWATER RES, V47, P433, DOI 10.1071/MF9960433; Sponaugle S, 2006, INTEGR COMP BIOL, V46, P623, DOI 10.1093/icb/icl014; Thorrold Simon R., 2002, P243, DOI 10.1016/B978-012615185-5/50015-3; Vigliola L, 2002, OECOLOGIA, V131, P89, DOI 10.1007/s00442-001-0866-4; Vigliola L, 2007, ECOLOGY, V88, P1263, DOI 10.1890/06-0066; WILBUR HM, 1980, ANNU REV ECOL SYST, V11, P67, DOI 10.1146/annurev.es.11.110180.000435; Wilson DT, 2002, MAR ECOL PROG SER, V231, P247, DOI 10.3354/meps231247	61	39	40	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2011	6	5							e16814	10.1371/journal.pone.0016814	http://dx.doi.org/10.1371/journal.pone.0016814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759ED	21559305	Green Published, Green Submitted, gold			2022-12-25	WOS:000290222600001
J	Hunziker, L; Benitah, SA; Braun, KM; Jensen, K; McNulty, K; Butler, C; Potton, E; Nye, E; Boyd, R; Laurent, G; Glogauer, M; Wright, NA; Watt, FM; Janes, SM				Hunziker, Lukas; Aznar Benitah, Salvador; Braun, Kristin M.; Jensen, Kim; McNulty, Katrina; Butler, Colin; Potton, Elspeth; Nye, Emma; Boyd, Richard; Laurent, Geoff; Glogauer, Michael; Wright, Nick A.; Watt, Fiona M.; Janes, Sam M.			Rac1 Deletion Causes Thymic Atrophy	PLOS ONE			English	Article							EPITHELIAL PROGENITOR CELLS; STEM-CELLS; MEDULLARY EPITHELIUM; POSITIVE SELECTION; EPIDERMAL DELETION; MYC ACTIVATION; DIFFERENTIATION; MOUSE; EXPRESSION; PROLIFERATION	The thymic stroma supports T lymphocyte development and consists of an epithelium maintained by thymic epithelial progenitors. The molecular pathways that govern epithelial homeostasis are poorly understood. Here we demonstrate that deletion of Rac1 in Keratin 5/Keratin 14 expressing embryonic and adult thymic epithelial cells leads to loss of the thymic epithelial compartment. Rac1 deletion led to an increase in c-Myc expression and a generalized increase in apoptosis associated with a decrease in thymic epithelial proliferation. Our results suggest Rac1 maintains the epithelial population, and equilibrium between Rac1 and c-Myc may control proliferation, apoptosis and maturation of the thymic epithelial compartment. Understanding thymic epithelial maintenance is a step toward the dual goals of in vitro thymic epithelial cell culture and T cell differentiation, and the clinical repair of thymic damage from graft-versus-host-disease, chemotherapy or irradiation.	[Hunziker, Lukas; McNulty, Katrina; Butler, Colin; Potton, Elspeth; Laurent, Geoff; Janes, Sam M.] UCL, Ctr Resp Res, London, England; [Hunziker, Lukas] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Aznar Benitah, Salvador] CRG, Barcelona, Spain; [Aznar Benitah, Salvador] UPF, Barcelona, Spain; [Braun, Kristin M.] Barts & London Queen Marys Sch Med & Dent, Ctr Cutaneous Res, London, England; [Jensen, Kim; Watt, Fiona M.] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England; [Nye, Emma] Canc Res UK, London Res Inst, Dept Expt Pathol, London, England; [Boyd, Richard] Monash Univ, Sch Med, Dept Pathol & Immunol, Melbourne, Vic 3004, Australia; [Glogauer, Michael] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Wright, Nick A.] Canc Res UK, London Res Inst, Histopathol Unit, London, England; [Watt, Fiona M.] CR UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England	University of London; University College London; University of Basel; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of London; Queen Mary University London; University of Cambridge; Cancer Research UK; Monash University; University of Toronto; Cancer Research UK; CRUK Cambridge Institute	Hunziker, L (corresponding author), UCL, Ctr Resp Res, London, England.	s.janes@ucl.ac.uk	Jensen, Kim/F-5333-2014; Watt, Fiona/AHB-0226-2022; Glogauer, Michael/D-2504-2011; Wright, Nicholas/HHY-7227-2022; Aznar-Benitah, Salvador/F-4761-2016	Watt, Fiona/0000-0001-9151-5154; Aznar-Benitah, Salvador/0000-0002-9059-5049; Butler, Colin/0000-0003-4192-0519; Jensen, Kim/0000-0001-6569-1664; Glogauer, Michael/0000-0002-6248-5977; Wright, Nicholas/0000-0002-5525-3457; Hunziker, Lukas/0000-0003-0081-8518	Cancer Research UK; Swiss national foundation [PBBSB-108681]; Freiwillige Akademische Gesellschaft; Margarete und Walter Lichtenstein Stiftung; EuroStemCel; Department of Health's NIHR Biomedical Research Centre; Medical Research Council [G0800784B, G108/596, G0500502, G0800784] Funding Source: researchfish; MRC [G0500502, G108/596, G0800784] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Swiss national foundation(Swiss National Science Foundation (SNSF)); Freiwillige Akademische Gesellschaft; Margarete und Walter Lichtenstein Stiftung; EuroStemCel; Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SAB, KMB, NW, and FMW were supported by Cancer Research UK (http://www.cancerresearchuk.org). LH was supported by the following grants: Swiss national foundation PBBSB-108681, the Freiwillige Akademische Gesellschaft and the Margarete und Walter Lichtenstein Stiftung. KMB was supported by EuroStemCell (http://www.eurostemcell.org/). KM is an MRC Clinical Training Fellow (http://www.mrc.ac.uk/index.htm). SMJ is a Wellcome Senior Fellow in Clinical Science (WT091730MA)(http://www.wellcome.ac.uk/). This work was partially undertaken at UCLH/UCL who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 1997, EUR J IMMUNOL, V27, P1838, DOI 10.1002/eji.1830270803; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Benitah SA, 2007, J INVEST DERMATOL, V127, P1555, DOI 10.1038/sj.jid.5700738; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Cantrell DA, 2003, IMMUNOL REV, V192, P122, DOI 10.1034/j.1600-065X.2003.00028.x; Conway SJ, 1997, DEVELOPMENT, V124, P505; Depreter MGL, 2008, P NATL ACAD SCI USA, V105, P961, DOI 10.1073/pnas.0711170105; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Ge Q, 2000, INT IMMUNOL, V12, P1127, DOI 10.1093/intimm/12.8.1127; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Gomez M, 2000, NAT IMMUNOL, V1, P348, DOI 10.1038/79808; Gomez M, 2001, IMMUNITY, V15, P703, DOI 10.1016/S1074-7613(01)00235-7; Hare KJ, 1999, J IMMUNOL, V162, P3978; HOFFMANN MW, 1992, P NATL ACAD SCI USA, V89, P2526, DOI 10.1073/pnas.89.7.2526; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; JANES SM, 2008, CELL RES; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Lopez-Rovira T, 2005, J INVEST DERMATOL, V125, P1215, DOI 10.1111/j.0022-202X.2005.23956.x; Mainiero F, 2003, EUR J IMMUNOL, V33, P3038, DOI 10.1002/eji.200323931; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; NEUBUSER A, 1995, DEV BIOL, V170, P701, DOI 10.1006/dbio.1995.1248; Oukka M, 1996, IMMUNITY, V4, P545, DOI 10.1016/S1074-7613(00)80481-1; Oukka M, 1997, EUR J IMMUNOL, V27, P855, DOI 10.1002/eji.1830270408; Rossi SW, 2007, EUR J IMMUNOL, V37, P2411, DOI 10.1002/eji.200737275; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Stappenbeck TS, 2000, DEVELOPMENT, V127, P2629; Su DM, 2000, J IMMUNOL, V164, P5753, DOI 10.4049/jimmunol.164.11.5753; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889	43	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19292	10.1371/journal.pone.0019292	http://dx.doi.org/10.1371/journal.pone.0019292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559396	Green Published, gold			2022-12-25	WOS:000290024700126
J	Im, SH; Li, WH; Taghert, PH				Im, Seol Hee; Li, Weihua; Taghert, Paul H.			PDFR and CRY Signaling Converge in a Subset of Clock Neurons to Modulate the Amplitude and Phase of Circadian Behavior in Drosophila	PLOS ONE			English	Article							CRYPTOCHROME; PROTEIN; MUTATION; RECEPTOR; PERIOD; PHOTORECEPTOR; OSCILLATORS; EXPRESSION	Background: To synchronize their molecular rhythms, circadian pacemaker neurons must input both external and internal timing cues and, therefore, signal integration between sensory information and internal clock status is fundamental to normal circadian physiology. Methodology/Principal Findings: We demonstrate the specific convergence of clock-derived neuropeptide signaling with that of a deep brain photoreceptor. We report that the neuropeptide PDF receptor and the circadian photoreceptor CRYPTOCROME (CRY) are precisely co-expressed in a subset of pacemakers, and that these pathways together provide a requisite drive for circadian control of daily locomotor rhythms. These convergent signaling pathways influence the phase of rhythm generation, but also its amplitude. In the absence of both pathways, PER rhythms were greatly reduced in only those specific pacemakers that receive convergent inputs and PER levels remained high in the nucleus throughout the day. This suggested a large-scale dis-regulation of the pacemaking machinery. Behavioral rhythms were likewise disrupted: in light: dark conditions they were aberrant, and under constant dark conditions, they were lost. Conclusions/Significance: We speculate that the convergence of environmental and clock-derived signals may produce a coincident detection of light, synergistic responses to it, and thus more accurate and more efficient re-setting properties.	[Im, Seol Hee; Li, Weihua; Taghert, Paul H.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Im, SH (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	taghertp@pcg.wustl.edu		Im, Seol Hee/0000-0002-0777-3466	National Institutes of Health (NIH) [R01MH067122]; Korea Science and Engineering Foundation [M06-2004-000-10108]; NIH [NS057105]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Institutes of Health (NIH) (R01MH067122) to P.H.T., a scholarship to S.H.I. from Korea Science and Engineering Foundation (M06-2004-000-10108), and a P30 NIH Neuroscience Blueprint Core Grant (#NS057105) to Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera NP, 2005, TRENDS PHARMACOL SCI, V26, P526, DOI 10.1016/j.tips.2005.08.003; Benito J, 2008, J BIOL RHYTHM, V23, P296, DOI 10.1177/0748730408318588; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; Cusumano P, 2009, NAT NEUROSCI, V12, P1431, DOI 10.1038/nn.2429; Cyran SA, 2005, J NEUROSCI, V25, P5430, DOI 10.1523/JNEUROSCI.0263-05.2005; DIRCKSEN H, 1987, CELL TISSUE RES, V250, P377; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Helfrich-Forster C, 2009, J BIOL RHYTHM, V24, P259, DOI 10.1177/0748730409339614; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Im SH, 2010, J COMP NEUROL, V518, P1925, DOI 10.1002/cne.22311; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Knaden M, 2006, J EXP BIOL, V209, P26, DOI 10.1242/jeb.01976; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; LEVINE JD, 2002, BMC NEUROSCI, V3; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; LIU X, 1992, J NEUROSCI, V12, P2735; Muller M, 2010, CURR BIOL, V20, P1368, DOI 10.1016/j.cub.2010.06.035; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Sheeba V, 2008, CRIT REV BIOCHEM MOL, V43, P37, DOI [10.1080/10409230701829128, 10.1080/10409230701829128 ]; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009; Zhang LY, 2009, CURR BIOL, V19, P2050, DOI 10.1016/j.cub.2009.10.058	36	45	46	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18974	10.1371/journal.pone.0018974	http://dx.doi.org/10.1371/journal.pone.0018974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559487	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700046
J	Pol, J; Vidova, V; Hyotylainen, T; Volny, M; Novak, P; Strohalm, M; Kostiainen, R; Havlicek, V; Wiedmer, SK; Holopainen, JM				Pol, Jaroslav; Vidova, Veronika; Hyotylainen, Tuulia; Volny, Michael; Novak, Petr; Strohalm, Martin; Kostiainen, Risto; Havlicek, Vladimir; Wiedmer, Susanne K.; Holopainen, Juha M.			Spatial Distribution of Glycerophospholipids in the Ocular Lens	PLOS ONE			English	Article							IMAGING MASS-SPECTROMETRY; MEMBRANE-PROTEINS; PORCINE LENS; IN-SITU; PHOSPHOLIPIDS; LIPIDS; AGE	Knowledge of the spatial distribution of lipids in the intraocular lens is important for understanding the physiology and biochemistry of this unique tissue and for gaining a better insight into the mechanisms underlying diseases of the lens. Following our previous study showing the spatial distribution of sphingolipids in the porcine lens, the current study used ultra performance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS) to provide the whole lipidome of porcine lens and these studies were supplemented by matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI MSI) of the lens using ultra-high resolution Fourier transform ion cyclotron resonance mass spectrometry (FTICR MS) to determine the spatial distribution of glycerophospholipids. Altogether 172 lipid species were identified with high confidence and their concentration was determined. Sphingomyelins, phosphatidylcholines, and phosphatidylethanolamines were the most abundant lipid classes. We then determined the spatial and concentration-dependent distributions of 20 phosphatidylcholines, 6 phosphatidylethanolamines, and 4 phosphatidic acids. Based on the planar molecular images of the lipids, we report the organization of fiber cell membranes within the ocular lens and suggest roles for these lipids in normal and diseased lenses.	[Pol, Jaroslav; Vidova, Veronika; Volny, Michael; Novak, Petr; Strohalm, Martin; Havlicek, Vladimir] Acad Sci Czech Republ, Inst Microbiol, Lab Mol Struct Characterizat, Prague, Czech Republic; [Pol, Jaroslav; Kostiainen, Risto] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem, Helsinki, Finland; [Vidova, Veronika] Palacky Univ, Fac Sci, Dept Analyt Chem, CR-77147 Olomouc, Czech Republic; [Hyotylainen, Tuulia] VTT Tech Res Ctr Finland, Espoo, Finland; [Wiedmer, Susanne K.] Univ Helsinki, Dept Chem, Analyt Chem Lab, SF-00100 Helsinki, Finland; [Holopainen, Juha M.] Univ Helsinki, Dept Ophthalmol, Helsinki Eye Lab, Helsinki, Finland	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Helsinki; Palacky University Olomouc; VTT Technical Research Center Finland; University of Helsinki; University of Helsinki	Pol, J (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Lab Mol Struct Characterizat, Prague, Czech Republic.	jaroslav.pol@gmail.com; juha.holopainen@hus.fi	Volny, Michael/B-5778-2008; Kostiainen, Risto K/B-5491-2008; Hyötyläinen, Tuulia/AAP-6266-2020; Novak, Petr/F-9655-2014; Havlicek, Vladimir/H-2626-2014	Volny, Michael/0000-0001-7456-5408; Novak, Petr/0000-0001-8688-529X; Havlicek, Vladimir/0000-0002-8614-7059; Kostiainen, Risto/0000-0003-2454-4574; Wiedmer, Susanne/0000-0002-3097-6165; Hyotylainen, Tuulia/0000-0002-1389-8302	Sigrid Juselius Foundation; Finnish Eye Foundation; Academy of Finland [122354]; University of Helsinki [2105060]; Ministry of Education, Youth, and Sports of the Czech Republic [LC07017]; Institutional Research Concept of the Institute of Microbiology; Academy of Sciences of the Czech Republic [AV0Z50200510]; EC; Czech Science Foundation [P206/10/P018]	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Eye Foundation; Academy of Finland(Academy of Finland); University of Helsinki; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Institutional Research Concept of the Institute of Microbiology; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); EC(European CommissionEuropean Commission Joint Research Centre); Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by funding from the Sigrid Juselius Foundation (JMH), The Finnish Eye Foundation (JMH), the Academy of Finland (JP project No. 122354), research funds from the University of Helsinki (SKW: University of Helsinki project No. 2105060), the Ministry of Education, Youth, and Sports of the Czech Republic (LC07017), the Institutional Research Concept of the Institute of Microbiology, and the Academy of Sciences of the Czech Republic (AV0Z50200510). MV is supported by a Marie Curie IR Grant within the EC FP7 and by the Czech Science Foundation (Project P206/10/P018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altelaar AFM, 2007, NAT PROTOC, V2, P1185, DOI 10.1038/nprot.2007.117; Borchman D, 1989, Lens Eye Toxic Res, V6, P703; Borchman D, 2010, J LIPID RES, V51, P2473, DOI 10.1194/jlr.R004119; BYRDWELL WC, 1994, INVEST OPHTH VIS SCI, V35, P4333; Cantor RS, 1999, BIOPHYS J, V77, P2643, DOI 10.1016/S0006-3495(99)77098-0; Chughtai K, 2010, CHEM REV, V110, P3237, DOI 10.1021/cr100012c; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Deeley JM, 2008, BBA-MOL CELL BIOL L, V1781, P288, DOI 10.1016/j.bbalip.2008.04.002; Deeley JM, 2010, J LIPID RES, V51, P2753, DOI 10.1194/jlr.M007716; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Ellis SR, 2010, J AM SOC MASS SPECTR, V21, P2095, DOI 10.1016/j.jasms.2010.09.003; Estrada R, 2004, J MASS SPECTROM, V39, P1531, DOI 10.1002/jms.759; Fletcher JS, 2009, ANALYST, V134, P2204, DOI 10.1039/b913575h; Grey AC, 2009, INVEST OPHTH VIS SCI, V50, P4319, DOI 10.1167/iovs.09-3522; Grey AC, 2009, J PROTEOME RES, V8, P3278, DOI 10.1021/pr800956y; Han J, 2006, INVEST OPHTH VIS SCI, V47, P2990, DOI 10.1167/iovs.05-1529; Heeren RMA, 2009, J AM SOC MASS SPECTR, V20, P1006, DOI 10.1016/j.jasms.2009.01.011; HUANG L, 2005, INVEST OPHTH VIS S S, V46, pNI427; LI LK, 1985, J LIPID RES, V26, P600; McDonnell LA, 2007, MASS SPECTROM REV, V26, P606, DOI 10.1002/mas.20124; MULDERS SM, 1995, J BIOL CHEM, V270, P9010, DOI 10.1074/jbc.270.15.9010; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; Rujoi M, 2004, ANAL CHEM, V76, P1657, DOI 10.1021/ac0349680; Sane P, 2010, BBA-BIOMEMBRANES, V1798, P958, DOI 10.1016/j.bbamem.2010.01.011; Seeley EH, 2008, P NATL ACAD SCI USA, V105, P18126, DOI 10.1073/pnas.0801374105; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; Vidova V, 2010, J LIPID RES, V51, P2295, DOI 10.1194/jlr.M005488; Wiseman JM, 2006, ANGEW CHEM INT EDIT, V45, P7188, DOI 10.1002/anie.200602449; Wiseman JM, 2008, P NATL ACAD SCI USA, V105, P18120, DOI 10.1073/pnas.0801066105; Yappert MC, 2003, EXP EYE RES, V76, P725, DOI 10.1016/S0014-4835(03)00051-4	31	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19441	10.1371/journal.pone.0019441	http://dx.doi.org/10.1371/journal.pone.0019441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559377	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700172
J	Rahim, S; Beauchamp, EM; Kong, YL; Brown, ML; Toretsky, JA; Uren, A				Rahim, Said; Beauchamp, Elspeth M.; Kong, Yali; Brown, Milton L.; Toretsky, Jeffrey A.; Ueren, Aykut			YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion	PLOS ONE			English	Article							ETS TRANSCRIPTION FACTORS; TMPRSS2-ERG GENE FUSION; ANDROGEN RECEPTOR; RNA HELICASE; IN-VITRO; FREQUENCY; DIFFERENTIATION; ONCOPROTEIN; PROGRESSION; METASTASIS	Background: Genomic rearrangements involving the ETS family of transcription factors occur in 40-70% of prostate cancer cases. ERG and ETV1 are the most common ETS members observed in these genetic alterations. The high prevalence of these rearrangements and their biological significance represents a novel therapeutic target for the treatment of prostate cancer. Methods and Findings: We recently reported the development of YK-4-279, a small molecule inhibitor of EWS-FLI1 oncoprotein in Ewing's Sarcoma. Since ERG and ETV1 belong to the same class of ETS factors as FLI1, we tested the ability of YK-4-279 to inhibit biological functions of ERG and ETV1 proteins in prostate cancer. YK-4-279 inhibited ERG and ETV1 mediated transcriptional activity in a luciferase assay. YK-4-279 also decreased ERG and ETV1 downstream target mRNA and protein expression in ETV1-fusion positive LNCaP and ERG fusion positive VCaP cells. YK-4-279 reduced the motility of LNCaP cells in a scratch assay and the invasive phenotype of both LNCaP and VCaP cells in a HUVEC invasion assay. Fusion-negative PC3 cells were unresponsive to YK-4-279. SiRNA mediated ERG knockdown in VCaP cells resulted in a loss of drug responsiveness. Concurrently, transient ERG expression in PC-3 cells resulted in increased invasive potential, which was reduced by YK-4-279. Conclusion: These data demonstrate that YK-4-279 inhibits ERG and ETV1 biological activity in fusion-positive prostate cancer cells leading to decreased motility and invasion. Therefore, YK-4-279 may have an impact on metastasis in prostate cancer and it may be further evaluated for its clinical applications in prostate cancer in addition to Ewing's sarcoma.	[Rahim, Said; Beauchamp, Elspeth M.; Kong, Yali; Brown, Milton L.; Toretsky, Jeffrey A.; Ueren, Aykut] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA	Georgetown University	Rahim, S (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	au26@georgetown.edu			Cancer Center [P30-CA051008]; Children's Cancer Foundation (Baltimore MD); Go4theGoal; Dani's Foundation; Alex's Lemonade Stand Foundation; Liddy Shriver Sarcoma Initiative; Burroughs Wellcome Clinical Scientist Award in Translational Research; NIH [R01CA133662, R01CA138212, R01CA108641]; NATIONAL CANCER INSTITUTE [T32CA009686, R01CA138212, P30CA051008, R01CA133662, R01CA108641] Funding Source: NIH RePORTER	Cancer Center; Children's Cancer Foundation (Baltimore MD); Go4theGoal; Dani's Foundation; Alex's Lemonade Stand Foundation; Liddy Shriver Sarcoma Initiative; Burroughs Wellcome Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was generously supported by the Cancer Center Support grant P30-CA051008 for use of Biacore Molecular Interaction Shared Resource. Support for the work also came from the Children's Cancer Foundation (Baltimore MD), Go4theGoal, Dani's Foundation, Alex's Lemonade Stand Foundation, Liddy Shriver Sarcoma Initiative, Burroughs Wellcome Clinical Scientist Award in Translational Research (JT), and the NIH R01CA133662 (JT), R01CA138212 (JT), R01CA108641 (AU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Cai CM, 2009, CANCER RES, V69, P6027, DOI 10.1158/0008-5472.CAN-09-0395; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Dewor M, 2007, FEBS LETT, V581, P4734, DOI 10.1016/j.febslet.2007.08.071; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Esquenet M, 1997, J STEROID BIOCHEM, V62, P391, DOI 10.1016/S0960-0760(97)00054-X; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Hermans KG, 2008, CANCER RES, V68, P7541, DOI 10.1158/0008-5472.CAN-07-5930; Jiang WG, 2009, MICROVASC RES, V77, P150, DOI 10.1016/j.mvr.2008.09.010; Keese CR, 2002, BIOTECHNIQUES, V33, P842, DOI 10.2144/02334rr01; Nam RK, 2007, CANCER BIOL THER, V6, P40, DOI 10.4161/cbt.6.1.3489; Nasca MR, 1999, J INVEST DERMATOL, V113, P720, DOI 10.1046/j.1523-1747.1999.00744.x; Rajput AB, 2007, J CLIN PATHOL, V60, P1238, DOI 10.1136/jcp.2006.043810; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Simbulan-Rosenthal CM, 2005, ONCOGENE, V24, P5443, DOI 10.1038/sj.onc.1208709; Soller MJ, 2006, GENE CHROMOSOME CANC, V45, P717, DOI 10.1002/gcc.20329; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Toretsky JA, 2006, CANCER RES, V66, P5574, DOI 10.1158/0008-5472.CAN-05-3293; Tu JJ, 2007, MODERN PATHOL, V20, P921, DOI 10.1038/modpathol.3800903; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018	25	70	82	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19343	10.1371/journal.pone.0019343	http://dx.doi.org/10.1371/journal.pone.0019343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559405	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700143
J	Shaik, MM; Cendron, L; Percudani, R; Zanotti, G				Shaik, Md Munan; Cendron, Laura; Percudani, Riccardo; Zanotti, Giuseppe			The Structure of Helicobacter pylori HP0310 Reveals an Atypical Peptidoglycan Deacetylase	PLOS ONE			English	Article							CHITIN DEACETYLASE; DEUTEROMYCETE; RECOGNITION; ALIGNMENT; SYSTEM	Peptidoglycan deacetlyase (HP0310, HpPgdA) from the gram-negative pathogen Helicobacter pylori, has been indicated as the enzyme responsible for a peptidoglycan modification that counteracts the host immune response. HpPgdA has been cloned, purified and expressed in good yield in E. coli. It has been crystallized, its structure determined and activity tests in vitro performed. The enzyme, which belongs to the polysaccharide deacetylases protein family, is a homo-tetramer. The four polypeptide chains, each folded into a single domain characterized by a non-canonical TIM-barrel fold, are arranged around a four-fold symmetry axis. The active site, one per monomer, contains a heavy ion coordinated in a way similar to other deacetylases. However, the enzyme showed no in vitro activity on the typical polysaccharide substrates of peptidoglycan deacetylases. In striking contrast with the known peptidoglycan deacetylases, HpPgdA does not exhibit a solvent-accessible polysaccharide binding groove, suggesting that the enzyme binds a small molecule at the active site.	[Shaik, Md Munan; Cendron, Laura; Zanotti, Giuseppe] Univ Padua, Dept Biol Chem, Padua, Italy; [Cendron, Laura; Zanotti, Giuseppe] VIMM, Padua, Italy; [Percudani, Riccardo] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy	University of Padua; Veneto Institute Molecular Medicine; University of Parma	Shaik, MM (corresponding author), Univ Padua, Dept Biol Chem, Padua, Italy.	giuseppe.zanotti@unipd.it	cendron, Laura/A-5202-2014; percudani, riccardo/B-4872-2011	percudani, riccardo/0000-0001-8452-1062; Zanotti, Giuseppe/0000-0002-0945-6501; Cendron, Laura/0000-0002-0125-0461	University of Padua; CARIPARO	University of Padua; CARIPARO(Fondazione Cariparo)	This work was supported by the University of Padua. Md Shaik's position was supported by CARIPARO grants for foreign Students at the University of Padua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANNER DW, 1976, BIOCHEM BIOPH RES CO, V72, P146, DOI 10.1016/0006-291X(76)90972-4; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dickmanns A, 2006, ACTA CRYSTALLOGR D, V62, P262, DOI [10.1107/S0907444905041363, 10.1107/S0904777905041363]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Franco AT, 2009, MOL CELL PROTEOMICS, V8, P1947, DOI 10.1074/mcp.M900139-MCP200; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hekmat O, 2003, BIOCHEM J, V374, P369, DOI 10.1042/BJ20030204; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KAMIO Y, 1987, J BACTERIOL, V169, P2881, DOI 10.1128/jb.169.6.2881-2884.1987; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Luthy L, 2002, J BIOL CHEM, V277, P10187, DOI 10.1074/jbc.M108993200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Patti GJ, 2008, J AM SOC MASS SPECTR, V19, P1467, DOI 10.1016/j.jasms.2008.06.020; Ramazzina I, 2008, J BIOL CHEM, V283, P23295, DOI 10.1074/jbc.M801195200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith TG, 2007, PROTEOMICS, V7, P2240, DOI 10.1002/pmic.200600875; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tokuyasu K, 2000, BIOCHEMISTRY-US, V39, P8837, DOI 10.1021/bi0005355; Wang G, 2010, INFECT IMMUN, V78, P4660, DOI 10.1128/IAI.00307-10; Wang G, 2009, J BIOL CHEM, V284, P6790, DOI 10.1074/jbc.M808071200	31	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19207	10.1371/journal.pone.0019207	http://dx.doi.org/10.1371/journal.pone.0019207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559431	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700102
J	Hazen, EL; Nowacek, DP; Laurent, LS; Halpin, PN; Moretti, DJ				Hazen, Elliott L.; Nowacek, Douglas P.; Laurent, Louis St.; Halpin, Patrick N.; Moretti, David J.			The Relationship among Oceanography, Prey Fields, and Beaked Whale Foraging Habitat in the Tongue of the Ocean	PLOS ONE			English	Article							EASTERN TROPICAL PACIFIC; CUVIERS ZIPHIUS-CAVIROSTRIS; DEEP SCATTERING LAYERS; VERTICAL MIGRATION; FISH; DIEL; PREDATOR; SCALE; PERFORMANCE; ECHOLOCATE	Beaked whales, specifically Blainville's (Mesoplodon densirostris) and Cuvier's (Ziphius cavirostris), are known to feed in the Tongue of the Ocean, Bahamas. These whales can be reliably detected and often localized within the Atlantic Undersea Test and Evaluation Center (AUTEC) acoustic sensor system. The AUTEC range is a regularly spaced bottom mounted hydrophone array covering >350 nm(2) providing a valuable network to record anthropogenic noise and marine mammal vocalizations. Assessments of the potential risks of noise exposure to beaked whales have historically occurred in the absence of information about the physical and biological environments in which these animals are distributed. In the fall of 2008, we used a downward looking 38 kHz SIMRAD EK60 echosounder to measure prey scattering layers concurrent with fine scale turbulence measurements from an autonomous turbulence profiler. Using an 8 km, 4-leaf clover sampling pattern, we completed a total of 7.5 repeat surveys with concurrently measured physical and biological oceanographic parameters, so as to examine the spatiotemporal scales and relationships among turbulence levels, biological scattering layers, and beaked whale foraging activity. We found a strong correlation among increased prey density and ocean vertical structure relative to increased click densities. Understanding the habitats of these whales and their utilization patterns will improve future models of beaked whale habitat as well as allowing more comprehensive assessments of exposure risk to anthropogenic sound.	[Hazen, Elliott L.; Nowacek, Douglas P.; Halpin, Patrick N.] Duke Univ, Marine Lab, Beaufort, NC 28516 USA; [Hazen, Elliott L.] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Hazen, Elliott L.] Natl Ocean & Atmospher Assoc, Pacific Fisheries Environm Lab, Pacific Grove, CA USA; [Nowacek, Douglas P.] Duke Univ, Pratt Sch Engn, Durham, NC USA; [Laurent, Louis St.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Moretti, David J.] Naval Undersea Warfare Ctr, Newport, RI USA	Duke University; University of Hawaii System; National Oceanic Atmospheric Admin (NOAA) - USA; Duke University; Woods Hole Oceanographic Institution; United States Department of Defense; United States Navy; US Navy Naval Sea Systems Command	Hazen, EL (corresponding author), Duke Univ, Marine Lab, Beaufort, NC 28516 USA.	Elliott.hazen@noaa.gov	Hazen, Elliott/G-4149-2014	Hazen, Elliott/0000-0002-0412-7178	Office of Naval Research [N00014-08-1-1162]	Office of Naval Research(Office of Naval Research)	The data collection and analysis was funded by the Office of Naval Research as N00014-08-1-1162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2010, R LANG ENV STAT COMP; Bailey H, 2009, MAR ECOL PROG SER, V378, P279, DOI 10.3354/meps07887; Baird RW, 2008, MAR MAMMAL SCI, V24, P630, DOI 10.1111/j.1748-7692.2008.00211.x; Baird RW, 2006, CAN J ZOOL, V84, P1120, DOI 10.1139/Z06-095; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Barham E. G., 1957, ECOLOGY SONIC SCATTE; Barlow J, 2006, MAR MAMMAL SCI, V22, P446, DOI 10.1111/j.1748-7692.2006.00032.x; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Benoit-Bird KJ, 2001, MAR ECOL PROG SER, V217, P1, DOI 10.3354/meps217001; C?lix M., 2018, EUROPEAN RED LIST SA; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1053, DOI 10.1098/rstb.1996.0093; Cox T. M., 2005, Journal of Cetacean Research and Management, V7, P177; Dewar WK, 2006, J MAR RES, V64, P541, DOI 10.1357/002224006778715720; Domokos R, 2007, FISH OCEANOGR, V16, P555, DOI 10.1111/j.1365-2419.2007.00451.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Embling CB, 2010, BIOL CONSERV, V143, P267, DOI 10.1016/j.biocon.2009.09.005; Ferguson Megan C., 2005, Journal of Cetacean Research and Management, V7, P287; Fock HO, 2002, MAR ECOL PROG SER, V244, P219, DOI 10.3354/meps244219; FOOTE KG, 1982, J ACOUST SOC AM, V71, P742, DOI 10.1121/1.387497; Gauthier S, 2004, ICES J MAR SCI, V61, P836, DOI 10.1016/j.icesjms.2004.03.033; Hareide NR, 2001, FISH RES, V51, P297, DOI 10.1016/S0165-7836(01)00253-3; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Hazen EL, 2010, FISH OCEANOGR, V19, P427, DOI 10.1111/j.1365-2419.2010.00561.x; Horne JK, 2000, FISH OCEANOGR, V9, P356, DOI 10.1046/j.1365-2419.2000.00143.x; HUNTLEY M, 1982, MAR BIOL, V71, P23, DOI 10.1007/BF00396989; ISAACS JD, 1974, DEEP-SEA RES, V21, P651, DOI 10.1016/0011-7471(74)90049-7; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Johnston DW, 2008, BIOL LETTERS, V4, P208, DOI 10.1098/rsbl.2007.0614; Jones BA, 2008, J ACOUST SOC AM, V123, P1753, DOI 10.1121/1.2828210; KALISH JM, 1986, DEEP-SEA RES, V33, P631, DOI 10.1016/0198-0149(86)90058-0; Kloser RJ, 2009, ICES J MAR SCI, V66, P998, DOI 10.1093/icesjms/fsp077; Krige D.G, 1951, J S AFR I MIN METALL, V52, P201, DOI DOI 10.2307/3006914; Laidre KL, 2010, MAR ECOL PROG SER, V402, P269, DOI 10.3354/meps08423; MacLeod CD, 2003, J MAR BIOL ASSOC UK, V83, P651, DOI 10.1017/S0025315403007616h; MacLeod CD, 2005, MAR BIOL, V147, P1, DOI 10.1007/s00227-004-1546-9; Madsen PT, 2007, AQUAT BIOL, V1, P141, DOI 10.3354/ab00014; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; O'Driscoll RL, 2009, ICES J MAR SCI, V66, P1310, DOI 10.1093/icesjms/fsp015; Oleson EM, 2007, ANIM BEHAV, V74, P881, DOI 10.1016/j.anbehav.2007.01.022; Perry JN, 2002, ECOGRAPHY, V25, P578, DOI 10.1034/j.1600-0587.2002.250507.x; PETITGAS P, 1993, ICES J MAR SCI, V50, P285, DOI 10.1006/jmsc.1993.1031; Redfern JV, 2008, MAR ECOL PROG SER, V363, P1, DOI 10.3354/meps07495; Schorr Gregory S., 2010, Endangered Species Research, V10, P203, DOI 10.3354/esr00229; Simmonds J., 2005, FISHERIES ACOUSTICS; Soldevilla MS, 2008, J ACOUST SOC AM, V124, P609, DOI 10.1121/1.2932059; Soule M, 1997, ICES J MAR SCI, V54, P934, DOI 10.1006/jmsc.1997.0270; Stafford KM, 2009, MAR ECOL PROG SER, V395, P37, DOI 10.3354/meps08362; Sutton TT, 2008, DEEP-SEA RES PT II, V55, P161, DOI 10.1016/j.dsr2.2007.09.013; Tont S. A., 1976, CALIFORNIA COOPERATI, V18, P112, DOI DOI 10.1046/J.1365-2419.1999.00103.X.; Torres LG, 2008, ECOL APPL, V18, P1702, DOI 10.1890/07-1455.1; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Van Parijs SM, 2009, MAR ECOL PROG SER, V395, P21, DOI 10.3354/meps08123; Ward J., 2008, CAN ACOUST, V36, P60; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	60	39	39	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19269	10.1371/journal.pone.0019269	http://dx.doi.org/10.1371/journal.pone.0019269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556355	Green Submitted, gold, Green Published			2022-12-25	WOS:000290019400044
J	Akai, M; Onai, K; Kusano, M; Sato, M; Redestig, H; Toyooka, K; Morishita, M; Miyake, H; Hazama, A; Checchetto, V; Szabo, I; Matsuoka, K; Saito, K; Yasui, M; Ishiura, M; Uozumi, N				Akai, Masaro; Onai, Kiyoshi; Kusano, Miyako; Sato, Mayuko; Redestig, Henning; Toyooka, Kiminori; Morishita, Megumi; Miyake, Hiroshi; Hazama, Akihiro; Checchetto, Vanessa; Szabo, Ildiko; Matsuoka, Ken; Saito, Kazuki; Yasui, Masato; Ishiura, Masahiro; Uozumi, Nobuyuki			Plasma Membrane Aquaporin AqpZ Protein Is Essential for Glucose Metabolism during Photomixotrophic Growth of Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN PCC-6803; LACTIC-ACID BACTERIA; DEPENDENT K+ UPTAKE; ESCHERICHIA-COLI; GENE-EXPRESSION; WATER CHANNELS; FUNCTIONAL-CHARACTERIZATION; PHOTOSYSTEM STOICHIOMETRY; HETEROTROPHIC GROWTH; POTASSIUM CHANNEL	The genome of Synechocystis PCC 6803 contains a single gene encoding an aquaporin, aqpZ. The AqpZ protein functioned as a water-permeable channel in the plasma membrane. However, the physiological importance of AqpZ in Synechocystis remains unclear. We found that growth in glucose-containing medium inhibited proper division of Delta aqpZ cells and led to cell death. Deletion of a gene encoding a glucose transporter in the Delta aqpZ background alleviated the glucose-mediated growth inhibition of the Delta aqpZ cells. The Delta aqpZ cells swelled more than the wild type after the addition of glucose, suggesting an increase in cytosolic osmolarity. This was accompanied by a down-regulation of the pentose phosphate pathway and concurrent glycogen accumulation. Metabolite profiling by GC/TOF-MS of wild-type and Delta aqpZ cells revealed a relative decrease of intermediates of the tricarboxylic acid cycle and certain amino acids in the mutant. The changed levels of metabolites may have been the cause for the observed decrease in growth rate of the Delta aqpZ cells along with decreased PSII activity at pH values ranging from 7.5 to 8.5. A mutant in sll1961, encoding a putative transcription factor, and a Delta hik31 mutant, lacking a putative glucose-sensing kinase, both exhibited higher glucose sensitivity than the Delta aqpZ cells. Examination of protein expression indicated that sll1961 functioned as a positive regulator of aqpZ gene expression but not as the only regulator. Overall, the Delta aqpZ cells showed defects in macronutrient metabolism, pH homeostasis, and cell division under photomixotrophic conditions, consistent with an essential role of AqpZ in glucose metabolism.	[Akai, Masaro; Uozumi, Nobuyuki] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; [Onai, Kiyoshi; Morishita, Megumi; Ishiura, Masahiro] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 4648602, Japan; [Kusano, Miyako; Sato, Mayuko; Redestig, Henning; Toyooka, Kiminori; Matsuoka, Ken; Saito, Kazuki] RIKEN, Plant Sci Ctr, Kanagawa 2300045, Japan; [Miyake, Hiroshi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648603, Japan; [Hazama, Akihiro] Fukushima Med Univ, Sch Med, Dept Physiol, Fukushima 9601295, Japan; [Checchetto, Vanessa; Szabo, Ildiko] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Matsuoka, Ken] Kyushu Univ, Fac Agr, Lab Plant Nutr, Higashi Ku, Fukuoka 8128581, Japan; [Saito, Kazuki] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba 2638522, Japan; [Yasui, Masato] Keio Univ, Sch Med, Dept Pharmacol, Shinjyuku Ku, Tokyo 1608582, Japan	Tohoku University; Nagoya University; RIKEN; Nagoya University; Fukushima Medical University; University of Padua; Kyushu University; Chiba University; Keio University	Uozumi, N (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aobayama 6-6-07, Sendai, Miyagi 9808579, Japan.	uozumi@biophy.che.tohoku.ac.jp	Uozumi, Nobuyuki/AAG-3252-2019; Toyooka, Kiminori/B-5027-2011; Matsuoka, Ken/E-3215-2010; Saito, Kazuki/D-2670-2009; Yasui, Masato/L-3312-2013; Szabo, Ildiko/AAW-5972-2021; Kusano, Miyako/A-3879-2012; Padova, Ildiko/K-5344-2016	Saito, Kazuki/0000-0001-6310-5342; Szabo, Ildiko/0000-0002-3637-3947; Kusano, Miyako/0000-0002-0052-6155; Uozumi, Nobuyuki/0000-0003-4268-1126; Redestig, Henning/0000-0003-2130-9288; Matsuoka, Ken/0000-0001-7229-7294; checchetto, vanessa/0000-0001-8911-6146; Onai, Kiyoshi/0000-0001-9062-2548	MEXT; Japan Society for the Promotion of Science [22020002, 22380056]; Salt Science Research Foundation	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Salt Science Research Foundation	This work was supported by MEXT and Japan Society for the Promotion of Science Grants-in-aid for Scientific Research 22020002 and 22380056 (to N. U.) and the Salt Science Research Foundation.	Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; ANDERSON SL, 1991, J BACTERIOL, V173, P2761, DOI 10.1128/JB.173.9.2761-2767.1991; Azad AK, 2011, PLANT SCI, V180, P375, DOI 10.1016/j.plantsci.2010.10.010; Bandell M, 1997, J BIOL CHEM, V272, P18140, DOI 10.1074/jbc.272.29.18140; Berry S, 2003, FEBS LETT, V548, P53, DOI 10.1016/S0014-5793(03)00729-4; Calamita G, 1998, P NATL ACAD SCI USA, V95, P3627, DOI 10.1073/pnas.95.7.3627; Chakrabarti N, 2004, J MOL BIOL, V343, P493, DOI 10.1016/j.jmb.2004.08.036; Czempinski K, 2002, PLANT J, V29, P809, DOI 10.1046/j.1365-313X.2002.01260.x; DAESCHEL MA, 1988, APPL ENVIRON MICROB, V54, P1627, DOI 10.1128/AEM.54.6.1627-1629.1988; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delamarche C, 1999, J BACTERIOL, V181, P4193, DOI 10.1128/JB.181.14.4193-4197.1999; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Elanskaya IV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P432, DOI 10.1023/A:1015281906254; FORCHHAMMER K, 1995, J BACTERIOL, V177, P2033, DOI 10.1128/jb.177.8.2033-2040.1995; Froger A, 2001, MICROBIOL-SGM, V147, P1129, DOI 10.1099/00221287-147-5-1129; Fujimori T, 2005, PLANT PHYSIOL, V139, P408, DOI 10.1104/pp.105.064782; Hagen KD, 2001, J BIOL CHEM, V276, P11477, DOI 10.1074/jbc.M010472200; Hibuse T, 2006, BBA-BIOMEMBRANES, V1758, P1004, DOI 10.1016/j.bbamem.2006.01.008; Hill AE, 2004, J MEMBRANE BIOL, V197, P1, DOI 10.1007/s00232-003-0639-6; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; Inaba M, 2001, J BACTERIOL, V183, P1376, DOI 10.1128/JB.183.4.1376-1384.2001; Jonsson P, 2004, ANAL CHEM, V76, P1738, DOI 10.1021/ac0352427; Jonsson P, 2006, J PROTEOME RES, V5, P1407, DOI 10.1021/pr0600071; Kahlon S, 2006, MICROBIOL-SGM, V152, P647, DOI 10.1099/mic.0.28510-0; Knowles VL, 2003, PLANT CELL PHYSIOL, V44, P758, DOI 10.1093/pcp/pcg086; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Korithoski B, 2005, J BACTERIOL, V187, P4451, DOI 10.1128/JB.187.13.4451-4456.2005; Kusano M, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-53; Kusano M, 2007, J CHROMATOGR B, V855, P71, DOI 10.1016/j.jchromb.2007.05.002; Lee S, 2007, PLANT PHYSIOL, V145, P1018, DOI 10.1104/pp.107.105023; Liu K, 2005, P NATL ACAD SCI USA, V102, P2192, DOI 10.1073/pnas.0409232102; MA TH, 1993, BIOCHEM BIOPH RES CO, V197, P654, DOI 10.1006/bbrc.1993.2529; Matsuda N, 2006, BIOSCI BIOTECH BIOCH, V70, P273, DOI 10.1271/bbb.70.273; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; MAUREL C, 1993, EMBO J, V12, P2241, DOI 10.1002/j.1460-2075.1993.tb05877.x; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; Meetam M, 1999, PLANT PHYSIOL, V121, P1267, DOI 10.1104/pp.121.4.1267; Mikkat S, 2000, PLANT CELL ENVIRON, V23, P549, DOI 10.1046/j.1365-3040.2000.00565.x; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Ohkawa H, 2000, J BACTERIOL, V182, P2591, DOI 10.1128/JB.182.9.2591-2596.2000; OMATA T, 1995, PLANT CELL PHYSIOL, V36, P207, DOI 10.1093/oxfordjournals.pcp.a078751; Osanai T, 2005, J BIOL CHEM, V280, P30653, DOI 10.1074/jbc.M505043200; Osanai T, 2006, DNA RES, V13, P185, DOI 10.1093/dnares/dsl010; Ozaki H, 2007, PLANT CELL PHYSIOL, V48, P451, DOI 10.1093/pcp/pcm015; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Redestig H, 2009, ANAL CHEM, V81, P7974, DOI 10.1021/ac901143w; Ryu JY, 2004, J BIOL CHEM, V279, P25320, DOI 10.1074/jbc.M402541200; Sakuragi Y, 2006, PLANT PHYSIOL, V141, P508, DOI 10.1104/pp.105.074765; Schauer N, 2005, FEBS LETT, V579, P1332, DOI 10.1016/j.febslet.2005.01.029; SCHMETTERER GR, 1990, PLANT MOL BIOL, V14, P697, DOI 10.1007/BF00016502; Shapiguzov A, 2005, MICROBIOL-SGM, V151, P447, DOI 10.1099/mic.0.27530-0; Singh AK, 2005, J BACTERIOL, V187, P2368, DOI 10.1128/JB.187.7.2368-2376.2005; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Soupene E, 2002, J BACTERIOL, V184, P4304, DOI 10.1128/JB.184.15.4304-4307.2002; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Sundaram S, 1998, MICROBIOL-SGM, V144, P1549, DOI 10.1099/00221287-144-6-1549; Takahashi H, 2008, J EXP BOT, V59, P3009, DOI 10.1093/jxb/ern157; Tanghe A, 2006, TRENDS MICROBIOL, V14, P78, DOI 10.1016/j.tim.2005.12.001; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Toyooka K, 2006, AUTOPHAGY, V2, P96, DOI 10.4161/auto.2.2.2366; Tsunekawa K, 2009, J BIOL CHEM, V284, P16513, DOI 10.1074/jbc.M109.001875; UOZUMI N, 1995, J BIOL CHEM, V270, P24276, DOI 10.1074/jbc.270.41.24276; Williams J. G. K., 1988, METHOD ENZYMOL, V167, P776; Wintour EM, 2006, TRENDS ENDOCRIN MET, V17, P77, DOI 10.1016/j.tem.2006.01.009; Yang C, 2002, METAB ENG, V4, P202, DOI 10.1006/mben.2002.0226; Yang C, 2002, APPL MICROBIOL BIOT, V58, P813, DOI 10.1007/s00253-002-0949-0; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; Zanetti M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010118; Zhang CC, 1998, FEMS MICROBIOL LETT, V161, P285, DOI 10.1016/S0378-1097(98)00084-6; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526; Zulkifli L, 2006, J BACTERIOL, V188, P7985, DOI 10.1128/JB.00886-06; Zulkifli L, 2010, J BACTERIOL, V192, P5063, DOI 10.1128/JB.00569-10	72	22	22	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25224	25235		10.1074/jbc.M111.236380	http://dx.doi.org/10.1074/jbc.M111.236380			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21558269	Green Published, hybrid			2022-12-25	WOS:000292547900068
J	Contreras-Jurado, C; Garcia-Serrano, L; Gomez-Ferreria, M; Costa, C; Paramio, JM; Aranda, A				Contreras-Jurado, Constanza; Garcia-Serrano, Laura; Gomez-Ferreria, Mariana; Costa, Clotilde; Paramio, Jesus M.; Aranda, Ana			The Thyroid Hormone Receptors as Modulators of Skin Proliferation and Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; NEGATIVE RESPONSE ELEMENTS; SPECIFICITY PHOSPHATASE 1; NITRIC-OXIDE SYNTHASE; HUMAN HAIR FOLLICLE; CELL-PROLIFERATION; MEDIATED TRANSCRIPTION; GENE-TRANSCRIPTION; TUMOR INVASIVENESS	We have analyzed the role of the thyroid hormone receptors (TRs) in epidermal homeostasis. Reduced keratinocyte proliferation is found in interfollicular epidermis of mice lacking the thyroid hormone binding isoforms TR alpha 1 and TR beta (KO mice). Similar results were obtained in hypothyroid animals, showing the important role of the liganded TRs in epidermal proliferation. In addition, KO and hypothyroid animals display decreased hyperplasia in response to 12-O-tetradecanolyphorbol-13-acetate. Both receptor isoforms play overlapping functional roles in the skin because mice lacking individually TR alpha 1 or TR beta also present a proliferative defect but not as marked as that found in double KO mice. Defective proliferation in KO mice is associated with reduction of cyclin D1 expression and up-regulation of the cyclin-dependent kinase inhibitors p19 and p27. Paradoxically, ERK and AKT activity and expression of downstream targets, such as AP-1 components, are increased in KO mice. Increased p65/NF-kappa B and STAT3 phosphorylation and, as a consequence, augmented expression of chemokines and proinflammatory cytokines is also found in these animals. These results show that thyroid hormones and their receptors are important mediators of skin proliferation and demonstrate that TRs act as endogenous inhibitors of skin inflammation, most likely due to interference with AP-1, NF-kappa B, and STAT3 activation.	[Contreras-Jurado, Constanza; Garcia-Serrano, Laura; Gomez-Ferreria, Mariana; Aranda, Ana] CSIC, Inst Invest Biomed Madrid, Madrid 28029, Spain; [Contreras-Jurado, Constanza; Garcia-Serrano, Laura; Gomez-Ferreria, Mariana; Aranda, Ana] Univ Autonoma Madrid, Madrid 28029, Spain; [Costa, Clotilde; Paramio, Jesus M.] Ctr Invest Energet Medioambientales & Tecnol, Div Biomed, Mol Oncol Unit, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas	Paramio, JM (corresponding author), Ave Complutense 22, Madrid 28040, Spain.	jesusm.paramio@ciemat.es; aaranda@iib.uam.es	Contreras-Jurado, Constanza/K-9028-2014; Paramio, Jesus M/M-8482-2014; Aranda, Ana/ABG-8820-2020	Contreras-Jurado, Constanza/0000-0002-4578-801X; Paramio, Jesus M/0000-0001-7520-3177; Aranda, Ana/0000-0002-8338-9589; Costa, Clotilde/0000-0001-7327-2259	Ministerio de Ciencia e Innovacion [BFU2007-62402, SAF2008-00121]; Fondo de Investigaciones Sanitarias [RD06/0020/0036, RD06/0020/0029]; European CRESCENDO [FP-018652]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); European CRESCENDO	This work was supported by Ministerio de Ciencia e Innovacion Grants BFU2007-62402 and SAF2008-00121, Fondo de Investigaciones Sanitarias Grants RD06/0020/0036 and RD06/0020/0029, and European CRESCENDO Grant FP-018652.	Ahsan Mohammad Kamrul, 1998, Journal of Medical Investigation, V44, P179; Aranda A, 2009, TRENDS ENDOCRIN MET, V20, P318, DOI 10.1016/j.tem.2009.03.011; ARGYRIS TS, 1985, CRC CR REV TOXICOL, V14, P211, DOI 10.3109/10408448509037459; Aziz MH, 2007, MOL CARCINOGEN, V46, P646, DOI 10.1002/mc.20356; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; Bell S, 2003, CELL SIGNAL, V15, P1, DOI 10.1016/S0898-6568(02)00080-3; Billoni N, 2000, BRIT J DERMATOL, V142, P645, DOI 10.1046/j.1365-2133.2000.03408.x; Bodo E, 2009, J INVEST DERMATOL, V129, P1126, DOI 10.1038/jid.2008.361; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Chiloeches A, 2008, MOL ENDOCRINOL, V22, P2466, DOI 10.1210/me.2008-0107; Chung WY, 2007, CARCINOGENESIS, V28, P1224, DOI 10.1093/carcin/bgm005; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Flamant F, 2006, PHARMACOL REV, V58, P705, DOI 10.1124/pr.58.4.3; Forrest D, 1996, NAT GENET, V13, P354, DOI 10.1038/ng0796-354; Fraichard A, 1997, EMBO J, V16, P4412, DOI 10.1093/emboj/16.14.4412; FREINKEL RK, 1972, ARCH DERMATOL, V106, P349, DOI 10.1001/archderm.106.3.349; Garcia-Silva S, 2004, MOL CELL BIOL, V24, P7514, DOI 10.1128/MCB.24.17.7514-7523.2004; Garcia-Silva S, 2011, ONCOGENE, V30, P854, DOI 10.1038/onc.2010.464; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Jho SH, 2001, J BIOL CHEM, V276, P45914, DOI 10.1074/jbc.M103144200; Kaufman CK, 2000, J CELL BIOL, V149, P999, DOI 10.1083/jcb.149.5.999; Khavari TA, 2007, CELL CYCLE, V6, P2928, DOI 10.4161/cc.6.23.4998; Lasa M, 2010, MOL ENDOCRINOL, V24, P412, DOI 10.1210/me.2009-0298; Li JJ, 2010, BIOORG MED CHEM LETT, V20, P306, DOI 10.1016/j.bmcl.2009.10.109; Martinez-Iglesias O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006428; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; Medeiros R, 2009, BIOCHEM PHARMACOL, V78, P390, DOI 10.1016/j.bcp.2009.04.021; Mendez-Pertuz M, 2003, EMBO J, V22, P3102, DOI 10.1093/emboj/cdg295; Messenger AG, 2000, BRIT J DERMATOL, V142, P633, DOI 10.1046/j.1365-2133.2000.03521.x; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Mueller MM, 2006, EUR J CANCER, V42, P735, DOI 10.1016/j.ejca.2006.01.014; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Paus R, 2010, J INVEST DERMATOL, V130, P7, DOI 10.1038/jid.2009.359; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; PEREZ P, 1994, BIOCHEM BIOPH RES CO, V205, P135, DOI 10.1006/bbrc.1994.2640; Porlan E, 2008, ONCOGENE, V27, P2795, DOI 10.1038/sj.onc.1210936; Radoja N, 2004, MOL CELL BIOL, V24, P3168, DOI 10.1128/MCB.24.8.3168-3179.2004; Radoja N, 1997, J INVEST DERMATOL, V109, P566, DOI 10.1111/1523-1747.ep12337483; RAICK AN, 1973, CANCER RES, V33, P269; Ramot Y, 2009, BIOESSAYS, V31, P389, DOI 10.1002/bies.200800121; Robles AI, 1998, GENE DEV, V12, P2469, DOI 10.1101/gad.12.16.2469; Rodriguez-Puebla ML, 1998, CELL GROWTH DIFFER, V9, P31; Safer JD, 2005, ENDOCRINOLOGY, V146, P4425, DOI 10.1210/en.2005-0192; Safer JD, 2004, ENDOCRINOLOGY, V145, P2357, DOI 10.1210/en.2003-1696; Safer JD, 2001, THYROID, V11, P717, DOI 10.1089/10507250152484547; Santos M, 2002, J BIOL CHEM, V277, P19122, DOI 10.1074/jbc.M201001200; Segrelles C, 2006, ONCOGENE, V25, P1174, DOI 10.1038/sj.onc.1209155; Segrelles C, 2008, MOL BIOL CELL, V19, P137, DOI 10.1091/mbc.E07-08-0764; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2002, J INVEST DERMATOL, V119, P1449, DOI 10.1046/j.1523-1747.2002.19617.x; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; THIBOUTOT DM, 1995, J CLIN ENDOCR METAB, V80, P3082, DOI 10.1210/jc.80.10.3082; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Beek N, 2008, J CLIN ENDOCR METAB, V93, P4381, DOI 10.1210/jc.2008-0283; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Viglietto G, 2002, CELL CYCLE, V1, P394, DOI 10.4161/cc.1.6.263; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455; Wondisford FE, 2003, J INVEST MED, V51, P215, DOI 10.1136/jim-51-04-22; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8	69	41	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24079	24088		10.1074/jbc.M111.218487	http://dx.doi.org/10.1074/jbc.M111.218487			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566120	Green Published, hybrid			2022-12-25	WOS:000292294900050
J	Mi, Q; Constantine, G; Ziraldo, C; Solovyev, A; Torres, A; Namas, R; Bentley, T; Billiar, TR; Zamora, R; Puyana, JC; Vodovotz, Y				Mi, Qi; Constantine, Gregory; Ziraldo, Cordelia; Solovyev, Alexey; Torres, Andres; Namas, Rajaie; Bentley, Timothy; Billiar, Timothy R.; Zamora, Ruben; Puyana, Juan Carlos; Vodovotz, Yoram			A Dynamic View of Trauma/Hemorrhage-Induced Inflammation in Mice: Principal Drivers and Networks	PLOS ONE			English	Article							KERATINOCYTE-DERIVED CHEMOKINE; NECROSIS-FACTOR RECEPTORS; ENDOTHELIAL GROWTH-FACTOR; PLASMA CYTOKINE LEVELS; HEMORRHAGIC-SHOCK; SEVERE TRAUMA; SYSTEMIC INFLAMMATION; IMMUNE-RESPONSE; IN-SILICO; INJURY	Background: Complex biological processes such as acute inflammation induced by trauma/hemorrhagic shock/(T/HS) are dynamic and multi-dimensional. We utilized multiplexing cytokine analysis coupled with data-driven modeling to gain a systems perspective into T/HS. Methodology/Principal Findings: Mice were subjected to surgical cannulation trauma (ST) +/- hemorrhagic shock (HS; 25 mmHg), and followed for 1, 2, 3, or 4 h in each case. Serum was assayed for 20 cytokines and NO2-/NO3-. These data were analyzed using four data-driven methods (Hierarchical Clustering Analysis [HCA], multivariate analysis [MA], Principal Component Analysis [PCA], and Dynamic Network Analysis [DyNA]). Using HCA, animals subjected to ST vs. ST + HS could be partially segregated based on inflammatory mediator profiles, despite a large overlap. Based on MA, interleukin [IL]-12p40/p70 (IL-12.total), monokine induced by interferon-gamma (CXCL-9) [MIG], and IP-10 were the best discriminators between ST and ST/HS. PCA suggested that the inflammatory mediators found in the three main principal components in animals subjected to ST were IL-6, IL-10, and IL-13, while the three principal components in ST + HS included a large number of cytokines including IL-6, IL-10, keratinocyte-derived cytokine (CXCL-1) [KC], and tumor necrosis factor-alpha [TNF-alpha]. DyNA suggested that the circulating mediators produced in response to ST were characterized by a high degree of interconnection/complexity at all time points; the response to ST + HS consisted of different central nodes, and exhibited zero network density over the first 2 h with lesser connectivity vs. ST at all time points. DyNA also helped link the conclusions from MA and PCA, in that central nodes consisting of IP-10 and IL-12 were seen in ST, while MIG and IL-6 were central nodes in ST + HS. Conclusions/Significance: These studies help elucidate the dynamics of T/HS-induced inflammation, complementing other forms of dynamic mechanistic modeling. These methods should be applicable to the analysis of other complex biological processes.	[Mi, Qi] Univ Pittsburgh, Dept Sports Med & Nutr, Pittsburgh, PA 15260 USA; [Constantine, Gregory; Solovyev, Alexey] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA; [Ziraldo, Cordelia; Torres, Andres; Namas, Rajaie; Billiar, Timothy R.; Zamora, Ruben; Puyana, Juan Carlos; Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Bentley, Timothy] Off Naval Res, Arlington, VA 22217 USA; [Mi, Qi; Constantine, Gregory; Puyana, Juan Carlos; Vodovotz, Yoram] Univ Pittsburgh, Ctr Inflammat & Regenerat Modeling, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Defense; United States Navy; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mi, Q (corresponding author), Univ Pittsburgh, Dept Sports Med & Nutr, Pittsburgh, PA 15260 USA.	vodovotzy@upmc.edu	Namas, Rajaie/U-2206-2019	Namas, Rajaie/0000-0003-0353-895X	National Institutes of Health [P50-GM-53789, R33-HL-089082, RO1-HL-076157]; IBM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076157, R33HL089082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IBM(International Business Machines (IBM)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants P50-GM-53789, R33-HL-089082, and RO1-HL-076157 and IBM Shared University Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Brand JM, 2003, SHOCK, V20, P213, DOI 10.1097/00024382-200309000-00003; Buchman TG, 2001, SHOCK, V16, P248, DOI 10.1097/00024382-200116040-00002; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; CHAUDRY IH, 1990, AM J PHYSIOL, V259, pR663, DOI 10.1152/ajpregu.1990.259.4.R663; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; CINAT ME, 1994, J AM COLL SURGEONS, V179, P529; Cobb JP, 2004, LANCET, V363, P2076, DOI 10.1016/S0140-6736(04)16460-X; COBB JP, 2009, ANNSURG; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Delogu G., 1998, Annali Italiani di Chirurgia, V69, P15; DeLong WG, 2004, CLIN ORTHOP RELAT R, P57, DOI 10.1097/01.blo.0000130840.64528.1e; Dewar D, 2009, INJURY, V40, P912, DOI 10.1016/j.injury.2009.05.024; Diefenbach A, 1999, SCIENCE, V284, P951, DOI 10.1126/science.284.5416.951; DIPIRO JT, 1992, ADV NEUROIMMUNOL, V2, P55; Eckels P, 2008, SHOCK, V29, P17; Faist E, 1996, WORLD J SURG, V20, P454, DOI 10.1007/s002689900071; Fan Jie, 2010, Open Crit Care Med J, V2, P1; Frangen TM, 2008, SHOCK, V29, P462, DOI 10.1097/SHK.0b013e3181598a9d; Frink M, 2007, SHOCK, V28, P576, DOI 10.1097/shk.0b013e31814b8e0d; Hamaya Y, 2000, ANESTH ANALG, V90, P1177, DOI 10.1097/00000539-200005000-00034; Hardaway RM, 2006, MIL MED, V171, P278, DOI 10.7205/MILMED.171.4.278; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; Hierholzer C, 1998, J EXP MED, V187, P917, DOI 10.1084/jem.187.6.917; Hofstetter C, 2005, INT IMMUNOPHARMACOL, V5, P1519, DOI 10.1016/j.intimp.2005.04.008; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Jarrar D, 1999, INT J MOL MED, V4, P575; Jin T, 2008, CYTOKINE, V44, P1, DOI 10.1016/j.cyto.2008.06.017; Jolliffe, 2002, PRINCIPAL COMPONENT; Karakozis S, 2000, J SURG RES, V90, P109, DOI 10.1006/jsre.2000.5860; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Lagoa CE, 2006, SHOCK, V26, P592, DOI 10.1097/01.shk.0000232272.03602.0a; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Li NYK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002789; LI NYK, 2010, OTOLRHINOLLARYNGOL; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; Lomas JL, 2003, SHOCK, V19, P358, DOI 10.1097/00024382-200304000-00011; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Marcu AC, 2007, J TRAUMA, V63, P662, DOI 10.1097/TA.0b013e31802e70d9; Martin C, 1997, CRIT CARE MED, V25, P1813, DOI 10.1097/00003246-199711000-00018; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mcbee ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013277; McCloskey CA, 2004, SHOCK, V22, P380, DOI 10.1097/01.shk.0000140660.78744.bf; MCCLOSKEY CA, 2001, SHOCK S1, V15, P14; Mesarovic M. D., 2004, Systems Biology, V1, P19, DOI 10.1049/sb:20045010; Mi Q, 2010, PERS MED, V7, P549, DOI 10.2217/PME.10.45; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Namas R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008406; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981; Neugebauer EAM, 2001, SHOCK, V16, P252, DOI 10.1097/00024382-200116040-00003; Ombrellino M, 1999, LANCET, V354, P1446, DOI 10.1016/S0140-6736(99)02658-6; Peitzman A B, 1995, Curr Probl Surg, V32, P925, DOI 10.1016/S0011-3840(05)80008-5; Prince JM, 2006, MOL MED, V12, P88, DOI 10.2119/2006-00012.Prince; Procopio MA, 2001, ANESTH ANALG, V93, P460, DOI 10.1097/00000539-200108000-00044; Romagnani S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2392; Rose S, 1998, LANGENBECK ARCH SURG, V383, P199, DOI 10.1007/s004230050119; Schinkel C, 1996, EUR J SURG, V162, P763; Schlag G, 1996, WORLD J SURG, V20, P406, DOI 10.1007/s002689900064; Shapiro NI, 2008, SHOCK, V29, P452, DOI 10.1097/SHK.0b013e31815072c1; SHIMADA M, 1993, J CRIT CARE, V8, P109, DOI 10.1016/0883-9441(93)90015-D; Smith RM, 1998, J ROY SOC MED, V91, P417, DOI 10.1177/014107689809100805; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; Stoiser B, 1998, EUR J CLIN INVEST, V28, P672; Tabata H, 1998, LAB ANIM-UK, V32, P143, DOI 10.1258/002367798780599983; Tjardes T, 2002, SHOCK, V17, P1, DOI 10.1097/00024382-200201000-00001; Torres A, 2009, SHOCK, V32, P172, DOI 10.1097/SHK.0b013e318193cc2b; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; VODOVOTZ Y, 2009, SYSTEMS BIOL DRUG DI; Vodovotz Y, 2006, IMMUNOL RES, V36, P237, DOI 10.1385/IR:36:1:237; Vodovotz Y, 2010, IMMUNOPHARM IMMUNOT, V32, P181, DOI 10.3109/08923970903369867; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Warren HS, 2009, MOL MED, V15, P220, DOI 10.2119/molmed.2009.00027; YANG R, 2006, MOLMED; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Zenati MS, 2002, J TRAUMA, V53, P232, DOI 10.1097/00005373-200208000-00007; Zuckerbraun BS, 2005, SHOCK, V23, P527, DOI 10.1097/01.shk.0000163206.22032.a1	78	75	77	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19424	10.1371/journal.pone.0019424	http://dx.doi.org/10.1371/journal.pone.0019424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573002	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000290440200007
J	Wagstaff, BJ; Barnerssoi, M; Roy-Engel, AM				Wagstaff, Bradley J.; Barnerssoi, Miriam; Roy-Engel, Astrid M.			Evolutionary Conservation of the Functional Modularity of Primate and Murine LINE-1 Elements	PLOS ONE			English	Article							OPEN READING FRAME; L1 RETROTRANSPOSITION; ORF1 PROTEIN; REVERSE-TRANSCRIPTASE; RIBONUCLEOPROTEIN-PARTICLES; ALU RETROTRANSPOSITION; CHAPERONE ACTIVITY; GENE-EXPRESSION; HUMAN GENOMES; ENDONUCLEASE	LINE-1 (L1) retroelements emerged in mammalian genomes over 80 million years ago with a few dominant subfamilies amplifying over discrete time periods that led to distinct human and mouse L1 lineages. We evaluated the functional conservation of L1 sequences by comparing retrotransposition rates of chimeric human-rodent L1 constructs to their parental L1 counterparts. Although amino acid conservation varies from similar to 35% to 63% for the L1 ORF1p and ORF2p, most human and mouse L1 sequences can be functionally exchanged. Replacing either ORF1 or ORF2 to create chimeric human-mouse L1 elements did not adversely affect retrotransposition. The mouse ORF2p retains retrotransposition-competency to support both Alu and L1 mobilization when any of the domain sequences we evaluated were substituted with human counterparts. However, the substitution of portions of the mouse cys-domain into the human ORF2p reduces both L1 retrotransposition and Alu trans-mobilization by 200-1000 fold. The observed loss of ORF2p function is independent of the endonuclease or reverse transcriptase activities of ORF2p and RNA interaction required for reverse transcription. In addition, the loss of function is physically separate from the cysteine-rich motif sequence previously shown to be required for RNP formation. Our data suggest an additional role of the less characterized carboxy-terminus of the L1 ORF2 protein by demonstrating that this domain, in addition to mediating RNP interaction(s), provides an independent and required function for the retroelement amplification process. Our experiments show a functional modularity of most of the LINE sequences. However, divergent evolution of interactions within L1 has led to non-reciprocal incompatibilities between human and mouse ORF2 cys-domain sequences.	[Wagstaff, Bradley J.; Barnerssoi, Miriam; Roy-Engel, Astrid M.] Tulane Univ, Hlth Sci Ctr, Tulane Canc Ctr, Dept Epidemiol, New Orleans, LA 70118 USA	Tulane University	Wagstaff, BJ (corresponding author), Tulane Univ, Hlth Sci Ctr, Tulane Canc Ctr, Dept Epidemiol, New Orleans, LA 70118 USA.	aengel@tulane.edu		Engel, Astrid/0000-0002-8884-4544	National Institutes of Health [R01GM079709A, NIH/NCRR P20 RR020152]; National Center for Research Resources [NCRR P20 RR020152]; Louisiana Cancer Research Consortium (LCRC); Tulane Cancer Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Louisiana Cancer Research Consortium (LCRC); Tulane Cancer Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health [R01GM079709A] and the National Center for Research Resources [NCRR P20 RR020152] awarded to AMR-E. Competitive Advantage Funds from the Louisiana Cancer Research Consortium (LCRC) were also awarded to AMR-E. BJW was supported by a Louisiana Cancer Research Consortium (LCRC) Fellowship and a Matching Funds Fellowship Award, 2006-2008 provide from the developmental funds of the Tulane Cancer Center. The Tulane Cancer COBRE CORE facility was supported by National Institutes NIH/NCRR P20 RR020152. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of General Medical Sciences, National Center for Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WF, 2006, P NATL ACAD SCI USA, V103, P18662, DOI 10.1073/pnas.0605300103; An WF, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-2; Basame S, 2006, J MOL BIOL, V357, P351, DOI 10.1016/j.jmb.2005.12.063; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13; Boissinot SP, 2001, MOL BIOL EVOL, V18, P2186, DOI 10.1093/oxfordjournals.molbev.a003765; BURTON FH, 1986, J MOL BIOL, V187, P291, DOI 10.1016/0022-2836(86)90235-4; Cabot EL, 1997, J MOL EVOL, V45, P412, DOI 10.1007/PL00006246; Cantrell MA, 2008, GENETICS, V178, P393, DOI 10.1534/genetics.107.080275; Casavant NC, 2000, GENETICS, V154, P1809; Clements AP, 1998, NUCLEIC ACIDS RES, V26, P3528, DOI 10.1093/nar/26.15.3528; Comeaux MS, 2009, GENOME RES, V19, P545, DOI 10.1101/gr.089789.108; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; DeBerardinis RJ, 1999, GENOMICS, V56, P317, DOI 10.1006/geno.1998.5729; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; DOMBROSKI BA, 1993, P NATL ACAD SCI USA, V90, P6513, DOI 10.1073/pnas.90.14.6513; Doucet AJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001150; El-Sawy M, 2005, J MOL BIOL, V354, P246, DOI 10.1016/j.jmb.2005.09.050; Ergun S, 2004, J BIOL CHEM, V279, P27753, DOI 10.1074/jbc.M312985200; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Furano AV, 2000, PROG NUCLEIC ACID RE, V64, P255, DOI 10.1016/S0079-6603(00)64007-2; Furano AV, 2004, TRENDS GENET, V20, P9, DOI 10.1016/j.tig.2003.11.006; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Goodier JL, 2004, HUM MOL GENET, V13, P1041, DOI 10.1093/hmg/ddh118; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; Hayward BE, 1997, GENETICS, V146, P641; Howell R, 1997, MOL BIOL EVOL, V14, P144, DOI 10.1093/oxfordjournals.molbev.a025747; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Hulme AE, 2007, GENE, V390, P199, DOI 10.1016/j.gene.2006.08.032; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jones RB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001547; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Khazina E, 2009, P NATL ACAD SCI USA, V106, P731, DOI 10.1073/pnas.0809964106; KOLOSHA VO, 1995, J BIOL CHEM, V270, P2868, DOI 10.1074/jbc.270.6.2868; Kroutter EN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000458; Kubo S, 2006, P NATL ACAD SCI USA, V103, P8036, DOI 10.1073/pnas.0601954103; Kulpa DA, 2005, HUM MOL GENET, V14, P3237, DOI 10.1093/hmg/ddi354; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Ling MM, 1997, ANAL BIOCHEM, V254, P157, DOI 10.1006/abio.1997.2428; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Martin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/45621; Martin SL, 1991, CURR OPIN GENET DEV, V1, P505, DOI 10.1016/S0959-437X(05)80199-6; Martin SL, 2005, J MOL BIOL, V348, P549, DOI 10.1016/j.jmb.2005.03.003; Martin SL, 2003, P NATL ACAD SCI USA, V100, P13815, DOI 10.1073/pnas.2336221100; Martin SL, 2001, MOL CELL BIOL, V21, P467, DOI 10.1128/MCB.21.2.467-475.2001; Mayorov VI, 1999, MAMM GENOME, V10, P724, DOI 10.1007/s003359901079; Mears ML, 2001, J MOL EVOL, V52, P51, DOI 10.1007/s002390010133; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; PASCALE E, 1990, P NATL ACAD SCI USA, V87, P9481, DOI 10.1073/pnas.87.23.9481; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Repanas K, 2007, NUCLEIC ACIDS RES, V35, P4914, DOI 10.1093/nar/gkm516; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; SCOTT A F, 1987, Genomics, V1, P113, DOI 10.1016/0888-7543(87)90003-6; Takahashi H, 2002, EMBO J, V21, P408, DOI 10.1093/emboj/21.3.408; Tamura M, 2007, GENE, V390, P221, DOI 10.1016/j.gene.2006.09.003; Wallace N, 2008, GENE, V419, P1, DOI 10.1016/j.gene.2008.04.007; Weichenrieder O, 2004, STRUCTURE, V12, P975, DOI 10.1016/j.str.2004.04.011; XING J, 2009, GENOME RES	62	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19672	10.1371/journal.pone.0019672	http://dx.doi.org/10.1371/journal.pone.0019672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572950	Green Submitted, Green Published, gold			2022-12-25	WOS:000290440200020
J	Canchihuaman, FA; Garcia, PJ; Gloyd, SS; Holmes, KK				Canchihuaman, Fredy A.; Garcia, Patricia J.; Gloyd, Stephen S.; Holmes, King K.			An Interactive Internet-Based Continuing Education Course on Sexually Transmitted Diseases for Physicians and Midwives in Peru	PLOS ONE			English	Article							HEALTH INFORMATION; MEDICAL-STUDENTS; CME; KNOWLEDGE; COUNTRIES; EFFICACY	Background: Clinicians in developing countries have had limited access to continuing education (CE) outside major cities, and CE strategies have had limited impact on sustainable change in performance. New educational tools could improve CE accessibility and effectiveness. Methodology/Principal Findings: The objective of this study was to evaluate an interactive Internet-based CE course on Sexually Transmitted Diseases (STDs) management for clinicians in Peru. Participants included physicians and midwives in private practice drawn from a census of 10 Peruvian cities. The CE included a three-hour workshop for improving Internet skills, followed by a 22-hour online course on STD-syndrome-management, with subsequent educational support. The course used case-based clinical vignettes tailored to local STD problems. Knowledge and reported practices on STD management were assessed before, immediately after and at four months after completion of the course. Statistical analysis included parametric tests-linear regression multivariate analysis, paired t-test and repeated measures ANOVA using SPSS 14.0. Of 1,071 eligible clinicians, 510 agreed to participate, as did an additional 132 public sector clinicians. Of these 642 participants, 619 (96.4%) completed the course, and 596 (96.3%) took the four-month follow-up evaluation. Physician and midwife scores improved from 64.2% correct answers on the pre-test to 77.9% correct on the four-month follow-up test (p < 0.001). Most participants (95%) found the online course useful for their work needs. Self reported STD management practices did not change. Conclusions/Significance: Among physicians and midwives in Peru, an Internet-based CE course was feasible, acceptable with high participation rates, and led to sustained improvement in knowledge at four months. Further studies are needed to test it as a model for improving the training of physicians, midwives, and other health care providers.	[Canchihuaman, Fredy A.; Garcia, Patricia J.] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru; [Canchihuaman, Fredy A.; Gloyd, Stephen S.; Holmes, King K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Canchihuaman, Fredy A.; Gloyd, Stephen S.; Holmes, King K.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Garcia, Patricia J.; Gloyd, Stephen S.; Holmes, King K.] Univ Washington, Ctr AIDS & STD, Seattle, WA 98195 USA; [Holmes, King K.] Univ Washington, Dept Med, Seattle, WA 98195 USA	Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Canchihuaman, FA (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru.	freancri@u.washington.edu	, Holmes/K-6215-2019		Wellcome Trust [059131/Z/99/Z, 078835/Z/05/Z, 078835/Z/05/B]; National Institutes of Health/NIAID STD Cooperative Research Center [AI31448]; University of Washington Center for AIDS Research [P30-AI27757]; NIH [D43-TW00007]; Peru ICOHRTA Network for AIDS/TB Research Training [U2-RTW007368, U2-RTW007374]; FOGARTY INTERNATIONAL CENTER [D43TW000007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031448, U01AI031448, P30AI027757] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health/NIAID STD Cooperative Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Center for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peru ICOHRTA Network for AIDS/TB Research Training; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative (059131/Z/99/Z, 078835/Z/05/Z, 078835/Z/05/B), the National Institutes of Health/NIAID STD Cooperative Research Center (AI31448), the University of Washington Center for AIDS Research (P30-AI27757), the NIH Fogarty International Center AIDS International Training and Research Program (grant D43-TW00007) and by the Peru ICOHRTA Network for AIDS/TB Research Training (grant U2-RTW007368, U2-RTW007374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JJ, 2005, AM J PREV MED, V28, P285, DOI 10.1016/j.amepre.2004.12.013; Alur P, 2002, MED TEACH, V24, P422, DOI 10.1080/01421590220145815; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Casebeer Linda, 2004, J Contin Educ Health Prof, V24, P68, DOI 10.1002/chp.1340240203; Casebeer L, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-42; Casebeer LL, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.3.e20; Chandrasekhar CP, 2001, B WORLD HEALTH ORGAN, V79, P850; Chung S, 2004, ACAD EMERG MED, V11, P143, DOI 10.1197/j.aem.2003.09.012; Cook DA, 2008, JAMA-J AM MED ASSOC, V300, P1181, DOI 10.1001/jama.300.10.1181; Cook DA, 2007, TEACH LEARN MED, V19, P230, DOI 10.1080/10401330701366325; Cook DA, 2007, CLIN MED, V7, P37, DOI 10.7861/clinmedicine.7-1-37; Cook DA, 2010, MED EDUC, V44, P765, DOI 10.1111/j.1365-2923.2010.03723.x; Curran VR, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-10; Curran VR, 2005, MED EDUC, V39, P561, DOI 10.1111/j.1365-2929.2005.02173.x; DAVIS DA, 1992, JAMA-J AM MED ASSOC, V268, P1111, DOI 10.1001/jama.268.9.1111; Fordis M, 2005, JAMA-J AM MED ASSOC, V294, P1043, DOI 10.1001/jama.294.9.1043; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Garcia PJ, 2003, SEX TRANSM INFECT, V79, P403, DOI 10.1136/sti.79.5.403; Godlee F, 2004, LANCET, V364, P295, DOI 10.1016/S0140-6736(04)16681-6; Green LA, 2005, J AM BOARD FAM PRACT, V18, P541, DOI 10.3122/jabfm.18.6.541; Harden RM, 2005, J CONTIN EDUC HEALTH, V25, P43, DOI 10.1002/chp.8; Harris AD, 2006, J AM MED INFORM ASSN, V13, P16, DOI 10.1197/jamia.M1749; Hsieh Evelyn J., 2006, Rev Panam Salud Publica, V20, P223, DOI 10.1590/S1020-49892006000900002; Hsieh EJ, 2008, REV PANAM SALUD PUBL, V24, P271, DOI 10.1590/S1020-49892008001000007; Kerfoot BP, 2009, ANN SURG, V249, P744, DOI 10.1097/SLA.0b013e31819f6db8; McKimm J, 2003, BRIT MED J, V326, P870, DOI 10.1136/bmj.326.7394.870; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; *PROY PREVEN, 2010, PREV COM ENF TRANSM; Raupach T, 2009, MED TEACH, V31, pE431, DOI 10.1080/01421590903095502; Rodrigues RJ, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.1.e4; Stewart M, 2005, FAM MED, V37, P131; STIGMA, 2019, GUID MAN SEX TRANSM; Tian LC, 2007, AIDS, V21, pS137, DOI 10.1097/01.aids.0000304709.02412.3c; Tomasi E, 2004, B WORLD HEALTH ORGAN, V82, P867; US Department of Education Office of Planning Evaluation and Policy Development, 2009, EV EV BAS PRACT ONL; Voelker R, 2003, JAMA-J AM MED ASSOC, V290, P1700, DOI 10.1001/jama.290.13.1700; Wall TC, 2005, J MED INTERNET RES, V7, P25, DOI 10.2196/jmir.7.4.e48; Zary Nabil, 2006, BMC Med Educ, V6, P10, DOI 10.1186/1472-6920-6-10; Zbar RIS, 2001, PLAST RECONSTR SURG, V108, P460, DOI 10.1097/00006534-200108000-00029; Zimitat C, 2001, MED TEACH, V23, P117, DOI 10.1080/01421590120036538	40	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19318	10.1371/journal.pone.0019318	http://dx.doi.org/10.1371/journal.pone.0019318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573054	Green Published, Green Submitted, gold			2022-12-25	WOS:000290386800009
J	Saridaki, A; Sapountzis, P; Harris, HL; Batista, PD; Biliske, JA; Pavlikaki, H; Oehler, S; Savakis, C; Braig, HR; Bourtzis, K				Saridaki, Aggeliki; Sapountzis, Panagiotis; Harris, Harriet L.; Batista, Philip D.; Biliske, Jennifer A.; Pavlikaki, Harris; Oehler, Stefan; Savakis, Charalambos; Braig, Henk R.; Bourtzis, Kostas			Wolbachia Prophage DNA Adenine Methyltransferase Genes in Different Drosophila-Wolbachia Associations	PLOS ONE			English	Article							CYTOPLASMIC INCOMPATIBILITY; BACTERIOPHAGE-WO; PARB PROTEIN; METHYLATION; EXPRESSION; INFECTION; SIMULANS; ENDOSYMBIONT; SEQUENCES; EVOLUTION	Wolbachia is an obligatory intracellular bacterium which often manipulates the reproduction of its insect and isopod hosts. In contrast, Wolbachia is an essential symbiont in filarial nematodes. Lately, Wolbachia has been implicated in genomic imprinting of host DNA through cytosine methylation. The importance of DNA methylation in cell fate and biology calls for in depth studing of putative methylation-related genes. We present a molecular and phylogenetic analysis of a putative DNA adenine methyltransferase encoded by a prophage in the Wolbachia genome. Two slightly different copies of the gene, met1 and met2, exhibit a different distribution over various Wolbachia strains. The met2 gene is present in the majority of strains, in wAu, however, it contains a frameshift caused by a 2 bp deletion. Phylogenetic analysis of the met2 DNA sequences suggests a long association of the gene with the Wolbachia host strains. In addition, our analysis provides evidence for previously unnoticed multiple infections, the detection of which is critical for the molecular elucidation of modification and/or rescue mechanism of cytoplasmic incompatibility.	[Saridaki, Aggeliki; Sapountzis, Panagiotis; Bourtzis, Kostas] Univ Ioannina, Dept Environm & Nat Resources Management, Agrinion, Greece; [Harris, Harriet L.; Batista, Philip D.; Biliske, Jennifer A.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Pavlikaki, Harris; Oehler, Stefan; Savakis, Charalambos; Bourtzis, Kostas] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece; [Pavlikaki, Harris] Technol Educ Inst Kalamata, Kalamata, Greece; [Oehler, Stefan; Savakis, Charalambos; Bourtzis, Kostas] Biomed Sci Res Ctr Alexander Fleming, Vari, Greece; [Savakis, Charalambos] Univ Crete, Sch Med, Iraklion, Crete, Greece; [Braig, Henk R.] Univ Bangor, Sch Biol Sci, Bangor, Gwynedd, Wales	University of Ioannina; University of Alberta; Foundation for Research & Technology - Hellas (FORTH); Technical Educational Institute Kalamata; Alexander Fleming Biomedical Sciences Research Center; University of Crete; Bangor University	Saridaki, A (corresponding author), Univ Ioannina, Dept Environm & Nat Resources Management, Agrinion, Greece.	kbourtz@uoi.gr	Braig, Henk/I-5477-2013	Braig, Henk/0000-0001-9592-1141; Sapountzis, Panagiotis/0000-0001-6286-3918	European Union [QLK3-2000-01079]; European Community [CSA-SA_REGPROT-2007-1]; BBSRC, United Kingdom; NSERC, Canada	European Union(European Commission); European Community(European Commission); BBSRC, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NSERC, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported in part by the European Union grant QLK3-2000-01079 (to KB, HRB, CS, and Richard Stouthamer), by the European Community's Seventh Framework Programme CSA-SA_REGPROT-2007-1 (to KB), by BBSRC, United Kingdom (to HRB), and by the NSERC, Canada grant (to HLH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Blaisdell BE, 1996, P NATL ACAD SCI USA, V93, P5854, DOI 10.1073/pnas.93.12.5854; Bordenstein Seth R., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020043; Bordenstein SR, 2004, MOL BIOL EVOL, V21, P1981, DOI 10.1093/molbev/msh211; Bourtzis K, 1998, NATURE, V391, P852, DOI 10.1038/36017; Bourtzis K., 1994, Insect Molecular Biology, V3, P131, DOI 10.1111/j.1365-2583.1994.tb00160.x; Bourtzis K, 1996, GENETICS, V144, P1063; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Clark ME, 2003, MECH DEVELOP, V120, P185, DOI 10.1016/S0925-4773(02)00424-0; Collier J, 2007, P NATL ACAD SCI USA, V104, P17111, DOI 10.1073/pnas.0708112104; Cordaux R, 2008, GENE, V409, P20, DOI 10.1016/j.gene.2007.10.035; Drummond AJ., 2010, GENEIOUS V5 3 3; Duron O, 2006, MOL ECOL, V15, P3061, DOI 10.1111/j.1365-294X.2006.02996.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Fujii Y, 2004, BIOCHEM BIOPH RES CO, V317, P1183, DOI 10.1016/j.bbrc.2004.03.164; Gavotte L, 2004, INSECT MOL BIOL, V13, P147, DOI 10.1111/j.0962-1075.2004.00471.x; Gavotte L, 2007, MOL BIOL EVOL, V24, P427, DOI 10.1093/molbev/msl171; GIORDANO R, 1995, GENETICS, V140, P1307; Grohmann E, 1997, MICROBIOL-UK, V143, P3889, DOI 10.1099/00221287-143-12-3889; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hattman S, 1997, NUCLEIC ACIDS RES, V25, P4385, DOI 10.1093/nar/25.21.4385; Heusipp G, 2007, INT J MED MICROBIOL, V297, P1, DOI 10.1016/j.ijmm.2006.10.002; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 1996, HEREDITY, V76, P1, DOI 10.1038/hdy.1996.1; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; Hung MS, 1999, P NATL ACAD SCI USA, V96, P11940, DOI 10.1073/pnas.96.21.11940; Ishmael N, 2009, MICROBIOL-SGM, V155, P2211, DOI 10.1099/mic.0.027581-0; James AC, 2000, EVOLUTION, V54, P1661, DOI 10.1111/j.0014-3820.2000.tb00710.x; Johnson EP, 1999, J BACTERIOL, V181, P6010, DOI 10.1128/JB.181.19.6010-6018.1999; Kahng LS, 2001, J BACTERIOL, V183, P3065, DOI 10.1128/JB.183.10.3065-3075.2001; Kent BN, 2010, TRENDS MICROBIOL, V18, P173, DOI 10.1016/j.tim.2009.12.011; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Klasson L, 2009, P NATL ACAD SCI USA, V106, P5725, DOI 10.1073/pnas.0810753106; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Landmann F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000343; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; Low DA, 2008, CURR OPIN MICROBIOL, V11, P106, DOI 10.1016/j.mib.2008.02.012; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 2000, MECH DEVELOP, V95, P215, DOI 10.1016/S0925-4773(00)00325-7; Lynch KH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-599; Masui S, 2000, J MOL EVOL, V51, P491, DOI 10.1007/s002390010112; Masui S, 2001, BIOCHEM BIOPH RES CO, V283, P1099, DOI 10.1006/bbrc.2001.4906; Mercot H, 1998, NATURE, V391, P853, DOI 10.1038/36021; MERCOT H, 1995, GENETICS, V141, P1015; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Murphy KC, 2008, J BACTERIOL, V190, P438, DOI 10.1128/JB.01373-07; Murray NE, 2002, MICROBIOL-SGM, V148, P3, DOI 10.1099/00221287-148-1-3; Navajas M, 1998, HEREDITY, V80, P742, DOI 10.1046/j.1365-2540.1998.00349.x; Negri H, 2009, P ROY SOC B-BIOL SCI, V276, P2485, DOI 10.1098/rspb.2009.0324; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Poinsot D, 1998, GENETICS, V150, P227; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pouillot F, 2007, MICROBIOL-SGM, V153, P2426, DOI 10.1099/mic.0.2007/005736-0; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Robertson GT, 2000, J BACTERIOL, V182, P3482, DOI 10.1128/JB.182.12.3482-3489.2000; ROUSSET F, 1995, P NATL ACAD SCI USA, V92, P6389, DOI 10.1073/pnas.92.14.6389; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanogo YO, 2005, J MED ENTOMOL, V42, P789, DOI 10.1603/0022-2585(2005)042[0789:NEFBWO]2.0.CO;2; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Sinkins SP, 2005, NATURE, V436, P257, DOI 10.1038/nature03629; STERNBERG N, 1990, P NATL ACAD SCI USA, V87, P8070, DOI 10.1073/pnas.87.20.8070; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Tanaka K, 2009, APPL ENVIRON MICROB, V75, P5676, DOI 10.1128/AEM.01172-09; Unger E, 2001, TRANSGENIC RES, V10, P409, DOI 10.1023/A:1012032000383; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; WRIGHT JD, 1978, J ULTRA MOL STRUCT R, V63, P79, DOI 10.1016/S0022-5320(78)80046-X; Wright R, 1997, J BACTERIOL, V179, P5869, DOI 10.1128/jb.179.18.5869-5877.1997; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yamada R, 2011, INSECT MOL BIOL, V20, P75, DOI 10.1111/j.1365-2583.2010.01042.x; Zabalou S, 2004, GENETICS, V167, P827, DOI 10.1534/genetics.103.015990; Zabalou S, 2008, GENETICS, V178, P2145, DOI 10.1534/genetics.107.086488; Zhang JZ, 2006, VACCINE, V24, P2317, DOI 10.1016/j.vaccine.2005.11.044	75	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19708	10.1371/journal.pone.0019708	http://dx.doi.org/10.1371/journal.pone.0019708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573076	Green Published, gold, Green Submitted			2022-12-25	WOS:000290305600041
J	van Gremberghe, I; Leliaert, F; Mergeay, J; Vanormelingen, P; Van der Gucht, K; Debeer, AE; Lacerot, G; De Meester, L; Vyverman, W				van Gremberghe, Ineke; Leliaert, Frederik; Mergeay, Joachim; Vanormelingen, Pieter; Van der Gucht, Katleen; Debeer, Ann-Eline; Lacerot, Gissell; De Meester, Luc; Vyverman, Wim			Lack of Phylogeographic Structure in the Freshwater Cyanobacterium Microcystis aeruginosa Suggests Global Dispersal	PLOS ONE			English	Article							16S RDNA SEQUENCES; GENETIC DIVERSITY; TOXIC CYANOBACTERIUM; MICROBIAL BIOGEOGRAPHY; SPATIOTEMPORAL CHANGES; NATURAL-POPULATIONS; SOFTWARE PACKAGE; SPACER SEQUENCES; LOCAL FACTORS; STRAINS	Background: Free-living microorganisms have long been assumed to have ubiquitous distributions with little biogeographic signature because they typically exhibit high dispersal potential and large population sizes. However, molecular data provide contrasting results and it is far from clear to what extent dispersal limitation determines geographic structuring of microbial populations. We aimed to determine biogeographical patterns of the bloom-forming freshwater cyanobacterium Microcystis aeruginosa. Being widely distributed on a global scale but patchily on a regional scale, this prokaryote is an ideal model organism to study microbial dispersal and biogeography. Methodology/Principal Findings: The phylogeography of M. aeruginosa was studied based on a dataset of 311 rDNA internal transcribed spacer (ITS) sequences sampled from six continents. Richness of ITS sequences was high (239 ITS types were detected). Genetic divergence among ITS types averaged 4% (maximum pairwise divergence was 13%). Preliminary analyses revealed nearly completely unresolved phylogenetic relationships and a lack of genetic structure among all sequences due to extensive homoplasy at multiple hypervariable sites. After correcting for this, still no clear phylogeographic structure was detected, and no pattern of isolation by distance was found on a global scale. Concomitantly, genetic differentiation among continents was marginal, whereas variation within continents was high and was mostly shared with all other continents. Similarly, no genetic structure across climate zones was detected. Conclusions/Significance: The high overall diversity and wide global distribution of common ITS types in combination with the lack of phylogeographic structure suggest that intercontinental dispersal of M. aeruginosa ITS types is not rare, and that this species might have a truly cosmopolitan distribution.	[van Gremberghe, Ineke; Vanormelingen, Pieter; Van der Gucht, Katleen; Debeer, Ann-Eline; Vyverman, Wim] Univ Ghent, Lab Protistol & Aquat Ecol, B-9000 Ghent, Belgium; [Leliaert, Frederik] Univ Ghent, Phycol Res Grp, B-9000 Ghent, Belgium; [Mergeay, Joachim; De Meester, Luc] Katholieke Univ Leuven, Lab Aquat Ecol & Evolutionary Biol, Leuven, Belgium; [Mergeay, Joachim] Res Inst Nat & Forest, Geraardsbergen, Belgium; [Lacerot, Gissell] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, Wageningen, Netherlands; [Lacerot, Gissell] Univ Republica, Fac Ciencias, Secc Limnol, Montevideo, Uruguay	Ghent University; Ghent University; KU Leuven; Research Institute for Nature & Forest; Wageningen University & Research; Universidad de la Republica, Uruguay	van Gremberghe, I (corresponding author), Univ Ghent, Lab Protistol & Aquat Ecol, B-9000 Ghent, Belgium.	Wim.Vyverman@ugent.be	De Meester, Luc/F-3832-2015; Mergeay, Joachim/E-7670-2011; Leliaert, Frederik/A-9162-2009	De Meester, Luc/0000-0001-5433-6843; Mergeay, Joachim/0000-0002-6504-0551; Leliaert, Frederik/0000-0002-4627-7318; Lacerot, Gissell/0000-0002-9705-5715	BELSPO (Belgian Science Policy); European Commission - Research Directorate-General [EVK2-CT-1999-00046]; VLIR (Vlaamse Interuniversitaire Raad); NWO/WOTRO (The Netherlands Organisation for Scientific Research/Science for Global Development); FWO (Research Foundation Flanders) [G.0419.08]	BELSPO (Belgian Science Policy)(Belgian Federal Science Policy Office); European Commission - Research Directorate-General(European CommissionEuropean Commission Joint Research Centre); VLIR (Vlaamse Interuniversitaire Raad); NWO/WOTRO (The Netherlands Organisation for Scientific Research/Science for Global Development)(Netherlands Organization for Scientific Research (NWO)); FWO (Research Foundation Flanders)(FWO)	Sampling of lakes containing Microcystis was done in the framework of different projects: B-Blooms (EV/34) and B-Blooms2 (SD/TE/01A) nationally supported by BELSPO (Belgian Science Policy, www.belspo.be), BIOMAN "Biodiversity and human impact in shallow lakes'' (EVK2-CT-1999-00046) supported by the European Commission - Research Directorate-General, Aquatic Ecology project in Institutional Cooperation with Mekelle University supported by VLIR (Vlaamse Interuniversitaire Raad, www.vlir.be), SALGA "South American Lake Gradient Analysis'' supported by NWO/WOTRO (The Netherlands Organisation for Scientific Research/Science for Global Development) and other financiers see www.projectenaew.wur.nl/salga, and "Thermal adaptation and its interplay with biotic interactions across a latitude gradient'' (G.0419.08) supported by FWO (Research Foundation Flanders, www.fwo.be). FL, JM, and PV are indebted to the FWO for a postdoctoral fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Baurain D, 2002, J PHYCOL, V38, P384, DOI 10.1046/j.1529-8817.2002.01010.x; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Bittencourt-Oliveira MD, 2001, J PHYCOL, V37, P810; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; BOILEAU MG, 1992, J EVOLUTION BIOL, V5, P25, DOI 10.1046/j.1420-9101.1992.5010025.x; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Briand E, 2009, ISME J, V3, P419, DOI 10.1038/ismej.2008.121; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Brunberg AK, 2002, J PLANKTON RES, V24, P1247, DOI 10.1093/plankt/24.11.1247; Cadel-Six S, 2008, MOL BIOL EVOL, V25, P2031, DOI 10.1093/molbev/msn150; Casteleyn G, 2010, P NATL ACAD SCI USA, V107, P12952, DOI 10.1073/pnas.1001380107; Chen F, 2006, APPL ENVIRON MICROB, V72, P2239, DOI 10.1128/AEM.72.3.2239-2243.2006; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dadheech PK, 2010, PHYCOLOGIA, V49, P361, DOI 10.2216/09-71.1; de Figueiredo DR, 2006, HYDROBIOLOGIA, V568, P145, DOI 10.1007/s10750-006-0196-y; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Figueredo CC, 2009, LIMNOLOGICA, V39, P264, DOI 10.1016/j.limno.2009.06.009; Figuerola J, 2003, GLOBAL ECOL BIOGEOGR, V12, P427, DOI 10.1046/j.1466-822X.2003.00043.x; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Fu YX, 1997, GENETICS, V147, P915; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Haande S, 2008, HARMFUL ALGAE, V7, P692, DOI 10.1016/j.hal.2008.02.010; Haande S, 2007, ARCH MICROBIOL, V188, P15, DOI 10.1007/s00203-007-0219-8; Havel JE, 2006, BIOL INVASIONS, V8, P459, DOI 10.1007/s10530-005-6410-4; Hillebrand H, 2001, ECOGRAPHY, V24, P251, DOI 10.1034/j.1600-0587.2001.240302.x; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; Hoffmann L, 1996, HYDROBIOLOGIA, V336, P33, DOI 10.1007/BF00010817; Hugenholtz P, 2003, INT J SYST EVOL MICR, V53, P289, DOI 10.1099/ijs.0.02441-0; HUISMAN J, HARMFUL CYANOBACTERI; Humbert JF, 2005, MICROB ECOL, V49, P308, DOI 10.1007/s00248-004-0004-z; Ionescu D, 2010, FEMS MICROBIOL ECOL, V72, P103, DOI 10.1111/j.1574-6941.2010.00835.x; Iteman I, 2000, MICROBIOL-SGM, V146, P1275, DOI 10.1099/00221287-146-6-1275; Janse I, 2004, APPL ENVIRON MICROB, V70, P3979, DOI 10.1128/AEM.70.7.3979-3987.2004; Janse I, 2003, APPL ENVIRON MICROB, V69, P6634, DOI 10.1128/AEM.69.11.6634-6643.2003; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Jungblut AD, 2010, ISME J, V4, P191, DOI 10.1038/ismej.2009.113; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kardinaal WEA, 2007, AQUAT MICROB ECOL, V48, P1, DOI 10.3354/ame048001; Kellogg CA, 2006, TRENDS ECOL EVOL, V21, P638, DOI 10.1016/j.tree.2006.07.004; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kristiansen J, 1996, HYDROBIOLOGIA, V336, P151, DOI 10.1007/BF00010829; KRISTIANSEN J, 1996, BIOGEOGRAPHY FRESHWA; Lepere Claire, 2000, Systematics and Geography of Plants, V70, P275, DOI 10.2307/3668646; Litvaitis MK, 2002, HYDROBIOLOGIA, V468, P135, DOI 10.1023/A:1015262621848; Lodders N, 2005, ENVIRON MICROBIOL, V7, P434, DOI 10.1111/j.1462-2920.2005.00730.x; Marshall WA, 1997, ECOGRAPHY, V20, P585, DOI 10.1111/j.1600-0587.1997.tb00427.x; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McGregor Glenn B., 2000, Lakes and Reservoirs Research and Management, V5, P195, DOI 10.1046/j.1440-1770.2000.00115.x; Miller SR, 2007, APPL ENVIRON MICROB, V73, P4751, DOI 10.1128/AEM.02945-06; MULLINS TD, 1995, LIMNOL OCEANOGR, V40, P148, DOI 10.4319/lo.1995.40.1.0148; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Oberholster PJ, 2005, AFR J BIOTECHNOL, V4, P389; Otsuka S, 2001, INT J SYST EVOL MICR, V51, P873, DOI 10.1099/00207713-51-3-873; Otsuka S, 1999, FEMS MICROBIOL LETT, V172, P15, DOI 10.1111/j.1574-6968.1999.tb13443.x; Otsuka S, 1998, FEMS MICROBIOL LETT, V164, P119, DOI 10.1016/S0378-1097(98)00202-X; Padisak J., 1997, ARCH HYDROBIOL, V4, P563; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Parnell JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012919; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Pena A, 2010, ISME J, V4, P882, DOI 10.1038/ismej.2010.6; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Ramette A, 2007, MICROB ECOL, V53, P197, DOI 10.1007/s00248-005-5010-2; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; ROUND F, ECOLOGY ALGAE; Rounge TB, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-141; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rudi K, 1997, APPL ENVIRON MICROB, V63, P2593, DOI 10.1128/AEM.63.7.2593-2599.1997; Rudi K, 1998, J BACTERIOL, V180, P3453, DOI 10.1128/JB.180.13.3453-3461.1998; Rudi K, 2002, J BACTERIOL, V184, P666, DOI 10.1128/JB.184.3.666-671.2002; Sabart M, 2009, ENV MICROBIOL REP, V1, P263, DOI 10.1111/j.1758-2229.2009.00042.x; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tanabe Y, 2007, MICROBIOL-SGM, V153, P3695, DOI 10.1099/mic.0.2007/010645-0; Tanabe Y, 2009, ENV MICROBIOL REP, V1, P575, DOI 10.1111/j.1758-2229.2009.00088.x; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; TEMPLETON AR, 1992, GENETICS, V132, P619; TEMPLETON AR, POPULATION GENETICS; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; van Gremberghe I, 2009, HYDROBIOLOGIA, V635, P147, DOI 10.1007/s10750-009-9907-5; VANGREMBERGHE I, 2011, GENETIC DIV IN PRESS; Vareli K, 2009, J ENVIRON MONITOR, V11, P1506, DOI 10.1039/b903093j; Verleyen E, 2009, OIKOS, V118, P1239, DOI 10.1111/j.1600-0706.2009.17575.x; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Vyverman W, 2007, ECOLOGY, V88, P1924, DOI 10.1890/06-1564.1; Wang GCY, 1996, MICROBIOL-SGM, V142, P1107, DOI 10.1099/13500872-142-5-1107; Wells RDS, 1999, J AQUAT PLANT MANAGE, V37, P49; Whitaker RJ, 2006, PHILOS T R SOC B, V361, P1975, DOI 10.1098/rstb.2006.1927; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wilson AE, 2006, APPL ENVIRON MICROB, V72, P7386, DOI 10.1128/AEM.00834-06; Wu ZX, 2007, J INTEGR PLANT BIOL, V49, P262, DOI 10.1111/j.1744-7909.2007.00368.x; Wu ZX, 2008, HYDROBIOLOGIA, V596, P47, DOI 10.1007/s10750-007-9056-7; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yoshida M, 2008, J APPL MICROBIOL, V105, P407, DOI 10.1111/j.1365-2672.2008.03754.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zwart G, 1998, FEMS MICROBIOL ECOL, V25, P159, DOI 10.1016/S0168-6496(97)00092-5; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	115	89	90	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19561	10.1371/journal.pone.0019561	http://dx.doi.org/10.1371/journal.pone.0019561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573169	Green Published, Green Submitted, gold			2022-12-25	WOS:000290256400023
J	Kar, UK; Srivastava, MK; Andersson, A; Baratelli, F; Huang, M; Kickhoefer, VA; Dubinett, SM; Rome, LH; Sharma, S				Kar, Upendra K.; Srivastava, Minu K.; Andersson, Asa; Baratelli, Felicita; Huang, Min; Kickhoefer, Valerie A.; Dubinett, Steven M.; Rome, Leonard H.; Sharma, Sherven			Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth	PLOS ONE			English	Article							VAULT RIBONUCLEOPROTEIN-PARTICLES; BRONCHOALVEOLAR CELL-CARCINOMA; MODIFIED DENDRITIC CELLS; REGULATORY T-CELLS; TUMOR-BEARING MICE; BONE-MARROW CELLS; SUPPRESSOR-CELLS; ANTITUMOR RESPONSES; MYELOID CELLS; IMMUNITY	Background: Based on our preclinical findings, we are assessing the efficacy of intratumoral injection of dendritic cells (DC) transduced with an adenoviral vector expressing the secondary lymphoid chemokine (CCL21) gene (Ad-CCL21-DC) in a phase I trial in advanced non-small cell lung cancer (NSCLC). While this approach shows immune enhancement, the preparation of autologous DC for CCL21 genetic modification is cumbersome, expensive and time consuming. We are evaluating a non-DC based approach which utilizes vault nanoparticles for intratumoral CCL21 delivery to mediate antitumor activity in lung cancer. Principal Findings: Here we describe that vault nanocapsule platform for CCL21 delivery elicits antitumor activity with inhibition of lung cancer growth. Vault nanocapsule packaged CCL21 (CCL21-vaults) demonstrated functional activity in chemotactic and antigen presenting activity assays. Recombinant vaults impacted chemotactic migration of T cells and this effect was predominantly CCL21 dependent as CCL21 neutralization abrogated the CCL21 mediated enhancement in chemotaxis. Intratumoral administration of CCL21-vaults in mice bearing lung cancer enhanced leukocytic infiltrates (CXCR3(+)T, CCR7(+)T, IFN gamma T+ lymphocytes, DEC205(+) DC), inhibited lung cancer tumor growth and reduced the frequencies of immune suppressive cells [myeloid derived suppressor cells (MDSC), T regulatory cells (Treg), IL-10 T cells]. CCL21-vaults induced systemic antitumor responses by augmenting splenic T cell lytic activity against parental tumor cells. Significance: This study demonstrates that the vault nanocapsule can efficiently deliver CCL21 to sustain antitumor activity and inhibit lung cancer growth. The vault nanocapsule can serve as an "off the shelf" approach to deliver antitumor cytokines to treat a broad range of malignancies.	[Kar, Upendra K.; Kickhoefer, Valerie A.; Rome, Leonard H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Dubinett, Steven M.; Sharma, Sherven] Univ Calif Los Angeles, David Geffen Sch Med, Lung Canc Res Program, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Srivastava, Minu K.; Andersson, Asa; Baratelli, Felicita; Huang, Min; Dubinett, Steven M.; Sharma, Sherven] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA; [Srivastava, Minu K.; Andersson, Asa; Huang, Min; Dubinett, Steven M.; Sharma, Sherven] Vet Affairs Greater Los Angeles Healthcare Syst, Mol Med Lab, Los Angeles, CA USA; [Kickhoefer, Valerie A.; Dubinett, Steven M.; Rome, Leonard H.; Sharma, Sherven] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles	Kar, UK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	sdubinett@mednet.ucla.edu; lrome@mednet.ucla.edu; ssharma@mednet.ucla.edu	Rome, Leonard H/E-8786-2016; Kar, Upendra K/H-5250-2012	Rome, Leonard H/0000-0002-1236-2063; Kar, Upendra K/0000-0003-4065-0860; Kickhoefer, Valerie/0000-0002-0048-0580	University of California [15RT-0207]; Jonnson Comprehensive Cancer Center; National Institutes of Health [RO1 CA95686, RO1 CAl26944]; NATIONAL CANCER INSTITUTE [R01CA126944] Funding Source: NIH RePORTER	University of California(University of California System); Jonnson Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a University of California Discovery Grant (to LHR and VAK) a Jonnson Comprehensive Cancer Center Fellowship to UKK) and by National Institutes of Health Grants (RO1 CA95686 and RO1 CAl26944), University of California Los Angeles Lung Cancer Program, Department of Veterans Affairs Medical Research Funds and Tobacco Related Disease Program Award Program of University of California (15RT-0207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Andersson A, 2009, J IMMUNOL, V182, P6951, DOI 10.4049/jimmunol.0803340; Baratelli F, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-38; Berger W, 2009, CELL MOL LIFE SCI, V66, P43, DOI 10.1007/s00018-008-8364-z; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Champion CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005409; Chen H, 2009, P NATL ACAD SCI USA, V106, P2729, DOI 10.1073/pnas.0813175106; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Hiraoka K, 2006, BRIT J CANCER, V94, P275, DOI 10.1038/sj.bjc.6602934; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johnson SK, 2000, LUNG CANCER-J IASLC, V27, P27, DOI 10.1016/S0169-5002(99)00095-1; KEDERSHA NL, 1991, J CELL BIOL, V112, P225, DOI 10.1083/jcb.112.2.225; KEDERSHA NL, 1986, J CELL BIOL, V103, P699, DOI 10.1083/jcb.103.3.699; Kickhoefer VA, 2005, P NATL ACAD SCI USA, V102, P4348, DOI 10.1073/pnas.0500929102; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Kickhoefer VA, 2009, ACS NANO, V3, P27, DOI 10.1021/nn800638x; Kirk CJ, 2001, CANCER RES, V61, P8794; Kong LB, 1999, STRUCT FOLD DES, V7, P371, DOI 10.1016/S0969-2126(99)80050-1; Kusmartsev SA, 1998, ADV EXP MED BIOL, V451, P189; KUSMARTSEV SA, 1989, EKSP ONKOL, V11, P23; Kusmartsev SA, 2000, J IMMUNOL, V165, P779, DOI 10.4049/jimmunol.165.2.779; Lai CY, 2009, ACS NANO, V3, P691, DOI 10.1021/nn8008504; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liang CM, 2007, J VIROL, V81, P9502, DOI 10.1128/JVI.00208-07; Liu CR, 2007, BLOOD, V109, P4336, DOI 10.1182/blood-2006-09-046201; LIU CY, 2009, J CANC RES CLIN ONCO; Liu L, 2009, CANCER BIOTHER RADIO, V24, P357, DOI 10.1089/cbr.2008.0612; Mikyas Y, 2004, J MOL BIOL, V344, P91, DOI 10.1016/j.jmb.2004.09.021; Novak L, 2007, MOL CANCER THER, V6, P1755, DOI 10.1158/1535-7163.MCT-06-0709; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sharma S, 2000, J IMMUNOL, V164, P4558, DOI 10.4049/jimmunol.164.9.4558; Sharma S, 2001, CANCER RES, V61, P6406; Sharma Sherven, 2003, Mol Cancer, V2, P22; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Siva AC, 2001, INT J CANCER, V92, P195, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1168>3.0.CO;2-7; Smyth MJ, 2006, J IMMUNOL, V176, P1582, DOI 10.4049/jimmunol.176.3.1582; Srivastava MK, 2008, CANCER IMMUNOL IMMUN, V57, P1493, DOI 10.1007/s00262-008-0490-9; Stephen AG, 2001, J BIOL CHEM, V276, P23217, DOI 10.1074/jbc.C100226200; SUBIZA JL, 1989, INT J CANCER, V44, P307, DOI 10.1002/ijc.2910440220; Suprenant KA, 2002, BIOCHEMISTRY-US, V41, P14447, DOI 10.1021/bi026747e; Warnock RA, 2000, J EXP MED, V191, P77, DOI 10.1084/jem.191.1.77; Willimann K, 1998, EUR J IMMUNOL, V28, P2025, DOI 10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C; Woo EY, 2002, J IMMUNOL, V168, P4272, DOI 10.4049/jimmunol.168.9.4272; Wu S, 2008, IMMUNOBIOLOGY, V213, P417, DOI 10.1016/j.imbio.2007.10.003; Yang SC, 2004, CLIN CANCER RES, V10, P2891, DOI 10.1158/1078-0432.CCR-03-0380; Yang SC, 2006, CANCER RES, V66, P3205, DOI 10.1158/0008-5472.CAN-05-3619; YOUNG MR, 1987, CANCER RES, V47, P100; YOUSEFIEH N, 2009, CANC MICROENVIRON, V6, P6	50	83	88	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e18758	10.1371/journal.pone.0018758	http://dx.doi.org/10.1371/journal.pone.0018758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559281	Green Published, Green Submitted, gold			2022-12-25	WOS:000290223500003
J	Bos, N; Grinsted, L; Holman, L				Bos, Nick; Grinsted, Lena; Holman, Luke			Wax On, Wax Off: Nest Soil Facilitates Indirect Transfer of Recognition Cues between Ant Nestmates	PLOS ONE			English	Article							APIS-MELLIFERA; CUTICULAR HYDROCARBONS; HYMENOPTERA; EVOLUTION; QUEEN; WASP	Social animals use recognition cues to discriminate between group members and non-members. These recognition cues may be conceptualized as a label, which is compared to a neural representation of acceptable cue combinations termed the template. In ants and other social insects, the label consists of a waxy layer of colony-specific hydrocarbons on the body surface. Genetic and environmental differences between colony members may confound recognition and social cohesion, so many species perform behaviors that homogenize the odor label, such as mouth-to-mouth feeding and allogrooming. Here, we test for another mechanism of cue exchange: indirect transfer of cuticular hydrocarbons via the nest material. Using a combination of chemical analysis and behavioral experiments with Camponotus aethiops ants, we show that nest soil indirectly transfers hydrocarbons between ants and affects recognition behavior. We also found evidence that olfactory cues on the nest soil influence nestmate recognition, but this effect was not observed in all colonies. These results demonstrate that cuticular hydrocarbons deposited on the nest soil are important in creating uniformity in the odor label and may also contribute to the template.	[Bos, Nick; Grinsted, Lena; Holman, Luke] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Grinsted, Lena] Aarhus Univ, Dept Biol Sci, Aarhus, Denmark	University of Copenhagen; Aarhus University	Bos, N (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	nbos@bio.ku.dk	Holman, Luke/L-4392-2014; Bos, Nick/H-4903-2012; Grinsted, Aslak/J-9273-2012	Grinsted, Aslak/0000-0003-1634-6009; Grinsted, Lena/0000-0003-3904-3721; Bos, Nick/0000-0002-1982-1525	Marie Curie Intra-European Fellowship [235403]	Marie Curie Intra-European Fellowship(European Commission)	LH was supported by a Marie Curie Intra-European Fellowship (#235403; CHEMDOC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino Toshiharu, 2008, Myrmecological News, V11, P173; Benabentos R, 2009, CURR BIOL, V19, P567, DOI 10.1016/j.cub.2009.02.037; BONAVITACOUGOURDAN A, 1987, J ENTOMOL SCI, V22, P1; Boomsma JJ, 2003, P NATL ACAD SCI USA, V100, P8799, DOI 10.1073/pnas.1430283100; Boulay R, 2001, BEHAV PROCESS, V55, P67, DOI 10.1016/S0376-6357(01)00163-2; Boulay R, 2000, ANIM BEHAV, V59, P1127, DOI 10.1006/anbe.2000.1408; Couvillon MJ, 2007, BIOL LETTERS, V3, P228, DOI 10.1098/rsbl.2006.0612; Couvillon MJ, 2009, J APICULT RES, V48, P225, DOI 10.3896/IBRA.1.48.4.01; CROZIER RH, 1979, BEHAV ECOL SOCIOBIOL, V4, P217, DOI 10.1007/BF00297645; D'Ettorre P, 2006, ANIM BEHAV, V71, P773, DOI 10.1016/j.anbehav.2005.05.014; d'Ettorre P, 2010, ANT ECOLOGY, P194; Darmaillacq AS, 2008, ANIM BEHAV, V76, P131, DOI 10.1016/j.anbehav.2008.02.006; Dietemann V, 2005, ANIM BEHAV, V69, P777, DOI 10.1016/j.anbehav.2004.07.006; Downs SG, 2000, BEHAV ECOL, V11, P326, DOI 10.1093/beheco/11.3.326; GAMBOA GJ, 1991, ETHOLOGY, V88, P109; Gardner A, 2010, EVOLUTION, V64, P25, DOI 10.1111/j.1558-5646.2009.00842.x; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hefetz Abraham, 2007, Myrmecological News, V10, P59; Holman L, 2010, P ROY SOC B-BIOL SCI, V277, P3793, DOI 10.1098/rspb.2010.0984; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Lenoir A, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P219; Lenoir A, 2009, J CHEM ECOL, V35, P913, DOI 10.1007/s10886-009-9669-6; Liebert AE, 2004, ANN ZOOL FENN, V41, P747; Martin SJ, 2009, INSECT SOC, V56, P375, DOI 10.1007/s00040-009-0035-z; McGlothlin JW, 2010, EVOLUTION, V64, P2558, DOI 10.1111/j.1558-5646.2010.01012.x; MESKALI M, 1995, INSECT SOC, V42, P347, DOI 10.1007/BF01242163; Nehring V, 2010, P ROYAL SOC B, P1; Oppelt A, 2009, J INSECT PHYSIOL, V55, P624, DOI 10.1016/j.jinsphys.2009.03.010; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; REEVE HK, 1989, AM NAT, V133, P407, DOI 10.1086/284926; Sharp SP, 2005, NATURE, V434, P1127, DOI 10.1038/nature03522; Singer TL, 1996, J INSECT BEHAV, V9, P857, DOI 10.1007/BF02208974; SOROKER V, 1995, J CHEM ECOL, V21, P365, DOI 10.1007/BF02036724; Stroeymeyt N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012377; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Torres CW, 2007, INSECT SOC, V54, P363, DOI 10.1007/s00040-007-0954-5; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; TURILLAZZI S, 1990, ETHOLOGY, V84, P47, DOI 10.1111/j.1439-0310.1990.tb00784.x; van Zweden JS, 2010, J EVOLUTION BIOL, V23, P1498, DOI 10.1111/j.1420-9101.2010.02020.x; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001	45	35	35	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19435	10.1371/journal.pone.0019435	http://dx.doi.org/10.1371/journal.pone.0019435			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559364	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000290024700170
J	Bush, TJV; Bishop, GA				Bush, Tony J. Vanden; Bishop, Gail A.			CDK-Mediated Regulation of Cell Functions via c-Jun Phosphorylation and AP-1 Activation	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITORS; DNA-DAMAGING AGENTS; B-LYMPHOCYTES; RHEUMATOID-ARTHRITIS; TRANSCRIPTION FACTOR; APOPTOSIS; MICE; EXPRESSION; ROLES; DIFFERENTIATION	Cyclin-dependent kinases (CDKs) and their targets have been primarily associated with regulation of cell-cycle progression. Here we identify c-Jun, a transcription factor involved in the regulation of a broad spectrum of cellular functions, as a newly recognized CDK substrate. Using immune cells from mouse and human, and several complementary in vitro and in vivo approaches including dominant negative protein expression, pharmacologic inhibitors, kinase assays and CDK4 deficient cells, we demonstrate the ability of CDK4 to phosphorylate c-Jun. Additionally, the activity of AP-1, a ubiquitous transcription factor containing phosphorylated c-Jun as a subunit, was inhibited by abrogating CDK4. Surprisingly, the regulation of c-Jun phosphorylation by CDK4 occurred in non-dividing cells, indicating that this pathway is utilized for cell functions that are independent of proliferation. Our studies identify a new substrate for CDK4 and suggest a mechanism by which CDKs can regulate multiple cellular activation functions, not all of which are directly associated with cell cycle progression. These findings point to additional roles of CDKs in cell signaling and reveal potential implications for therapeutic manipulations of this kinase pathway.	[Bush, Tony J. Vanden; Bishop, Gail A.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Bishop, Gail A.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Bishop, Gail A.] Iowa City Vet Affairs Med Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Bush, TJV (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	gail-bishop@uiowa.edu		Bishop, Gail/0000-0002-1291-5078	VA Merit Review award [383]; Carver Trust, University of Iowa	VA Merit Review award(US Department of Veterans Affairs); Carver Trust, University of Iowa	Funding was provided by VA Merit Review award 383 to GAB and the Carver Trust, University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccam M, 2003, J IMMUNOL, V170, P3099, DOI 10.4049/jimmunol.170.6.3099; Benson RJ, 2006, EUR J IMMUNOL, V36, P2535, DOI 10.1002/eji.200535483; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Besirli CG, 2003, J BIOL CHEM, V278, P22357, DOI 10.1074/jbc.M300742200; Besson A, 2004, NAT REV CANCER, V4, P948, DOI 10.1038/nrc1501; BISHOP GA, 1994, INT IMMUNOL, V6, P1049, DOI 10.1093/intimm/6.7.1049; Bush TJV, 2008, EUR J IMMUNOL, V38, P400, DOI 10.1002/eji.200737602; Cho YY, 2009, CANCER RES, V69, P272, DOI 10.1158/0008-5472.CAN-08-3125; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fulciniti M, 2009, CLIN CANCER RES, V15, P7144, DOI 10.1158/1078-0432.CCR-09-1483; Galons H, 2010, EXPERT OPIN THER PAT, V20, P377, DOI 10.1517/13543770903524284; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hostager BS, 2003, J BIOL CHEM, V278, P45382, DOI 10.1074/jbc.M306708200; Hostager BS, 1999, J IMMUNOL, V162, P6307; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jirawatnotai S, 2004, J BIOL CHEM, V279, P51100, DOI 10.1074/jbc.M409080200; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kraus ZJ, 2008, J IMMUNOL, V181, P7800, DOI 10.4049/jimmunol.181.11.7800; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Kyriakis JM, 1999, GENE EXPRESSION, V7, P217; Lane ME, 2001, CANCER RES, V61, P6170; Lehtonen A, 2002, J LEUKOCYTE BIOL, V71, P511; LEOPOLD P, 1991, CELL, V66, P1207, DOI 10.1016/0092-8674(91)90043-X; Liu L, 2008, J IMMUNOL, V180, P1808, DOI 10.4049/jimmunol.180.3.1808; Mahale S, 2006, BIOORG CHEM, V34, P287, DOI 10.1016/j.bioorg.2006.06.004; Mohamedali A, 2003, J LEUKOCYTE BIOL, V74, P1139, DOI 10.1189/jlb.0803363; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Moses AM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r23; Nonomura Y, 2006, ARTHRITIS RHEUM, V54, P2074, DOI 10.1002/art.21927; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Paul-Pletzer K, 2006, DRUG TODAY, V42, P559, DOI 10.1358/dot.2006.42.9.1025692; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Sekine C, 2008, J IMMUNOL, V180, P1954, DOI 10.4049/jimmunol.180.3.1954; SHERR CJ, 1992, CIBA F SYMP, V170, P209; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Smolen JS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1969; Solvason N, 2000, INT IMMUNOL, V12, P631, DOI 10.1093/intimm/12.5.631; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; Su Tin Tin, 2004, Sci STKE, V2004, ppe11; Taylor PC, 2001, MOL BIOTECHNOL, V19, P153, DOI 10.1385/MB:19:2:153; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; van den Berg WB, 2001, ARTHRITIS RES, V3, P18, DOI 10.1186/ar136; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Zoja C, 2007, ARTHRITIS RHEUM, V56, P1629, DOI 10.1002/art.22593	48	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19468	10.1371/journal.pone.0019468	http://dx.doi.org/10.1371/journal.pone.0019468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559334	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700189
J	Kim, KK; Singh, RK; Strongin, RM; Moore, RG; Brard, L; Lange, TS				Kim, Kyu Kwang; Singh, Rakesh K.; Strongin, Robert M.; Moore, Richard G.; Brard, Laurent; Lange, Thilo S.			Organometallic Iron(III)-Salophene Exerts Cytotoxic Properties in Neuroblastoma Cells via MAPK Activation and ROS Generation	PLOS ONE			English	Article							CANCER-CELLS; OXIDATIVE STRESS; DNA-BINDING; CLEAVING PROPERTIES; APOPTOSIS; COMPLEXES; TARGET; COPPER	The objective of the present study was to investigate the specific effects of Iron(III)-salophene (Fe-SP) on viability, morphology, proliferation, cell cycle progression, ROS generation and pro-apoptotic MAPK activation in neuroblastoma (NB) cells. A NCI-DTP cancer screen revealed that Fe-SP displayed high toxicity against cell lines of different tumor origin but not tumor type-specificity. In a viability screen Fe-SP exhibited high cytotoxicity against all three NB cell lines tested. The compound caused cell cycle arrest in G1 phase, suppression of cells progressing through S phase, morphological changes, disruption of the mitochondrial membrane depolarization potential, induction of apoptotic markers as well as p38 and JNK MAPK activation, DNA degradation, and elevated generation of reactive oxygen species (ROS) in SMS-KCNR NB cells. In contrast to Fe-SP, non-complexed salophene or Cu(II)-SP did not raise ROS levels in NB or SKOV-3 ovarian cancer control cells. Cytotoxicity of Fe-SP and activation of caspase-3, -7, PARP, pro-apoptotic p38 and JNK MAPK could be prevented by co-treatment with antioxidants suggesting ROS generation is the primary mechanism of cytotoxic action. We report here that Fe-SP is a potent growth-suppressing and cytotoxic agent for in vitro NB cell lines and, due to its high tolerance in previous animal toxicity studies, a potential therapeutic drug to treat NB tumors in vivo.	[Kim, Kyu Kwang; Singh, Rakesh K.; Moore, Richard G.; Lange, Thilo S.] Brown Univ, Women & Infants Hosp, Dept Obstet & Gynecol, Mol Therapeut Lab,Program Womens Oncol,Alpert Med, Providence, RI 02912 USA; [Strongin, Robert M.] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [Brard, Laurent] So Illinois Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Springfield, IL 62794 USA; [Lange, Thilo S.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Brown University; Women & Infants Hospital Rhode Island; Portland State University; Southern Illinois University System; Southern Illinois University; Brown University	Kim, KK (corresponding author), Brown Univ, Women & Infants Hosp, Dept Obstet & Gynecol, Mol Therapeut Lab,Program Womens Oncol,Alpert Med, Providence, RI 02912 USA.	kkim@wihri.org; thilo_Lange@brown.edu	Strongin, Robert M./F-1026-2010	Brard, Laurent/0000-0003-0065-1826	NCI [1 RO1 CA136491-01]; Swim Across America; NATIONAL CANCER INSTITUTE [R01CA136491] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swim Across America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	RGM is partially supported by NCI Grant #1 RO1 CA136491-01 and Grants from Swim Across America. RKS is partially supported by Grants from Swim Across America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CP, 2000, MED PEDIATR ONCOL, V35, P659, DOI 10.1002/1096-911X(20001201)35:6<659::AID-MPO38>3.0.CO;2-4; ATER JL, 2007, NELSON TXB PEDIAT, pCH498; BURROWS CJ, 1994, ACCOUNTS CHEM RES, V27, P295, DOI 10.1021/ar00046a002; Cerchiaro G, 2005, J INORG BIOCHEM, V99, P1433, DOI 10.1016/j.jinorgbio.2005.03.013; Goldsby Robert E, 2004, Paediatr Drugs, V6, P107, DOI 10.2165/00148581-200406020-00004; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Gupte A, 2009, CANCER TREAT REV, V35, P32, DOI 10.1016/j.ctrv.2008.07.004; Hettmer S, 2004, BRIT J CANCER, V91, P389, DOI 10.1038/sj.bjc.6601914; Hileman EO, 2004, CANCER CHEMOTH PHARM, V53, P209, DOI 10.1007/s00280-003-0726-5; Huang RL, 2005, BIOCHEM PHARMACOL, V69, P1009, DOI 10.1016/j.bcp.2005.01.001; Kang YH, 2008, J CELL PHYSIOL, V217, P23, DOI 10.1002/jcp.21470; Kim JS, 2008, INT J CANCER, V122, P672, DOI 10.1002/ijc.23158; Kim KK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-72; Lange TS, 2008, DRUG DES DEV THER, V3, P1; Lange TS, 2010, CHEM BIOL DRUG DES, V76, P164, DOI 10.1111/j.1747-0285.2010.00988.x; Lange TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002303; Mandal SS, 1997, BIOCONJUGATE CHEM, V8, P798, DOI 10.1021/bc970121x; Mansat-De Mas V, 1999, MOL PHARMACOL, V56, P867, DOI 10.1124/mol.56.5.867; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Mazumder S, 2004, CURR CANCER DRUG TAR, V4, P65, DOI 10.2174/1568009043481669; Osone S, 2004, INT J CANCER, V112, P219, DOI 10.1002/ijc.20412; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Perez CA, 2000, J CLIN ONCOL, V18, P18, DOI 10.1200/JCO.2000.18.1.18; PETIT PX, 1995, J CELL BIOL, V130, P157, DOI 10.1083/jcb.130.1.157; Pochedly C, 1990, NEUROBLASTOMA TUMOR; ROSS RA, 1983, J NATL CANCER I, V71, P741; Routier S, 1999, NUCLEIC ACIDS RES, V27, P4160, DOI 10.1093/nar/27.21.4160; Routier S, 1997, BIOCONJUGATE CHEM, V8, P789, DOI 10.1021/bc970131y; Routier S, 1996, BIOORGAN MED CHEM, V4, P1185, DOI 10.1016/0968-0896(96)00082-X; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Shrivastava HY, 2005, FREE RADICAL BIO MED, V38, P58, DOI 10.1016/j.freeradbiomed.2004.09.029; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsai-Turton M, 2007, TOXICOL SCI, V98, P216, DOI 10.1093/toxsci/kfm087; Waris Gulam, 2006, J Carcinog, V5, P14; Woldemariam GA, 2008, J INORG BIOCHEM, V102, P740, DOI 10.1016/j.jinorgbio.2007.11.008	37	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19049	10.1371/journal.pone.0019049	http://dx.doi.org/10.1371/journal.pone.0019049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559503	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700056
J	Mizuki, F; Tanaka, A; Hirose, Y; Ohkuma, Y				Mizuki, Fumitaka; Tanaka, Aki; Hirose, Yutaka; Ohkuma, Yoshiaki			The HIRA Complex Subunit Hip3 Plays Important Roles in the Silencing of Meiosis-Specific Genes in Schizosaccharomyces pombe	PLOS ONE			English	Article							HISTONE CHAPERONE ASF1; RNA-POLYMERASE-II; FISSION YEAST; MESSENGER-RNA; BUDDING YEAST; TRANSCRIPTION; CHROMATIN; PROTEIN; METHYLATION; SUPPRESSION	Background: The control of gene expression is essential for growth and responses to environmental changes in various organisms. It is known that some meiosis-specific genes are silenced during mitosis and expressed upon nitrogen starvation in Schizosaccharomyces pombe. When the factors responsible for this regulation were studied, a hip3 mutant was isolated via discovery of a defect in the transcriptional repression of meiosis-specific genes. Hip3 is a subunit of the HIRA (histone regulatory complex A) complex, which consists of four subunits (Hip1, Hip3, Hip4 and Slm9) and acts as a histone chaperone that is independent of DNA replication. Methodology/Principal Findings: In a search for mutants, the meiosis-specific gene SPCC663.14c(+) was identified by screening for genes that are silenced during mitosis and induced upon nitrogen starvation. A reporter plasmid that expresses the ura4(+) gene driven by the SPCC663.14c(+) promoter was constructed. Screening for suppressor mutants was then carried out in nitrogen-rich medium without uracil. A mutant with a mutation in the hip3(+) gene was isolated and named hip3-1. This mutation alleviated the transcriptional repression of the ura4(+) gene on the reporter plasmid and of the endogenous SPCC663.14c(+) gene in the presence of nitrogen. A ChIP assay revealed that RNA polymerase II (Pol II) and TFIIE were enriched at the SPCC663.14c(+) locus, whereas the levels of histone H3 were decreased in hip3-1 cells. Intriguingly, histone H3 was heavily modified at the SPCC663.14c(+) locus in hip3-1 cells; these modifications included tri-methylation and acetylation of H3 lysine 9 (H3K9), mono-methylation of H3 arginine 2 (H3R2), and tri-methylation of H3 lysine 4 (H3K4). In addition, the tri-methylation of H3K9 and H3K4 were strongly elevated in hip3-1 mutants. Conclusions: Taken together, these results indicate that Hip3 plays important roles in the control of histone modifications at meiosis-specific gene loci and induces their transcriptional repression.	[Mizuki, Fumitaka; Tanaka, Aki; Hirose, Yutaka; Ohkuma, Yoshiaki] Toyama Univ, Lab Gene Regulat, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan	University of Toyama	Mizuki, F (corresponding author), Toyama Univ, Lab Gene Regulat, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan.	ohkumay@pha.u-toyama.ac.jp			Ministry of Educations, Culture, Sports, Science and Technology of Japan	Ministry of Educations, Culture, Sports, Science and Technology of Japan	This work was supported in part by grants from the Targeted Proteins Research Program and the Grants-in-Aid for Scientific Research from the Ministry of Educations, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013488; Anderson HE, 2009, MOL CELL BIOL, V29, P5158, DOI 10.1128/MCB.00698-09; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Blackwell C, 2004, MOL CELL BIOL, V24, P4309, DOI 10.1128/MCB.24.10.4309-4320.2004; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Fischer T, 2009, P NATL ACAD SCI USA, V106, P8998, DOI 10.1073/pnas.0813063106; Gasch AP, 2007, YEAST, V24, P961, DOI 10.1002/yea.1512; Greenall A, 2006, J BIOL CHEM, V281, P8732, DOI 10.1074/jbc.M512170200; Haraguchi N, 2007, J BIOL CHEM, V282, P2221, DOI 10.1074/jbc.M609430200; Hayashi K, 2005, GENES CELLS, V10, P207, DOI 10.1111/j.1365-2443.2005.00833.x; HUGHES DA, 1990, NATURE, V344, P355, DOI 10.1038/344355a0; Ito T, 2007, J BIOCHEM, V141, P609, DOI 10.1093/jb/mvm091; Kirmizis A, 2009, NAT STRUCT MOL BIOL, V16, P449, DOI 10.1038/nsmb.1569; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Malay AD, 2008, J BIOL CHEM, V283, P14022, DOI 10.1074/jbc.M800594200; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Mizuki F, 2007, GENES CELLS, V12, P35, DOI 10.1111/j.1365-2443.2006.01032.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Ohkuma Y, 1997, J BIOCHEM-TOKYO, V122, P481; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tsukahara K, 1998, MOL CELL BIOL, V18, P4488, DOI 10.1128/MCB.18.8.4488; Tyler JK, 1999, CELL, V99, P443, DOI 10.1016/S0092-8674(00)81530-5; Urushiyama S, 1997, GENETICS, V147, P101; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Watanabe Y, 1997, NATURE, V386, P187, DOI 10.1038/386187a0; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Xue-Franzen YT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-303; Yamamoto M, 1996, CELL STRUCT FUNCT, V21, P431, DOI 10.1247/csf.21.431; Yamane K, 2011, MOL CELL, V41, P56, DOI 10.1016/j.molcel.2010.12.009; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	39	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19442	10.1371/journal.pone.0019442	http://dx.doi.org/10.1371/journal.pone.0019442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559379	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700173
J	Morohashi, K; Sahara, H; Watashi, K; Iwabata, K; Sunoki, T; Kuramochi, K; Takakusagi, K; Miyashita, H; Sato, N; Tanabe, A; Shimotohno, K; Kobayashi, S; Sakaguchi, K; Sugawara, F				Morohashi, Kengo; Sahara, Hiroeki; Watashi, Koichi; Iwabata, Kazuki; Sunoki, Takashi; Kuramochi, Kouji; Takakusagi, Kaori; Miyashita, Hiroki; Sato, Noriyuki; Tanabe, Atsushi; Shimotohno, Kunitada; Kobayashi, Susumu; Sakaguchi, Kengo; Sugawara, Fumio			Cyclosporin A Associated Helicase-Like Protein Facilitates the Association of Hepatitis C Virus RNA Polymerase with Its Cellular Cyclophilin B	PLOS ONE			English	Article							ISOMERASE ACTIVITY; PHAGE DISPLAY; DRUG TARGET; IN-VITRO; REPLICATION; CALCINEURIN; IDENTIFICATION; ACTIVATION; RESISTANCE; INHIBITION	Background: Cyclosporin A (CsA) is well known as an immunosuppressive drug useful for allogeneic transplantation. It has been reported that CsA inhibits hepatitis C virus (HCV) genome replication, which indicates that cellular targets of CsA regulate the viral replication. However, the regulation mechanisms of HCV replication governed by CsA target proteins have not been fully understood. Principal Findings: Here we show a chemical biology approach that elucidates a novel mechanism of HCV replication. We developed a phage display screening to investigate compound-peptide interaction and identified a novel cellular target molecule of CsA. This protein, named CsA associated helicase-like protein (CAHL), possessed RNA-dependent ATPase activity that was negated by treatment with CsA. The downregulation of CAHL in the cells resulted in a decrease of HCV genome replication. CAHL formed a complex with HCV-derived RNA polymerase NS5B and host-derived cyclophilin B (CyPB), known as a cellular cofactor for HCV replication, to regulate NS5B-CyPB interaction. Conclusions: We found a cellular factor, CAHL, as CsA associated helicase-like protein, which would form trimer complex with CyPB and NS5B of HCV. The strategy using a chemical compound and identifying its target molecule by our phage display analysis is useful to reveal a novel mechanism underlying cellular and viral physiology.	[Morohashi, Kengo; Iwabata, Kazuki; Sunoki, Takashi; Kuramochi, Kouji; Takakusagi, Kaori; Kobayashi, Susumu; Sakaguchi, Kengo; Sugawara, Fumio] Tokyo Univ Sci, Genome & Drug Res Ctr, Chiba, Japan; [Sahara, Hiroeki; Tanabe, Atsushi] Azabu Univ, Sch Vet Med, Biol Lab, Kanagawa, Japan; [Watashi, Koichi] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo 1628640, Japan; [Miyashita, Hiroki; Sato, Noriyuki] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Shimotohno, Kunitada] Chiba Inst Technol, Res Inst, Chiba, Japan	Tokyo University of Science; Azabu University; National Institute of Infectious Diseases (NIID); Sapporo Medical University; Chiba Institute of Technology	Morohashi, K (corresponding author), Tokyo Univ Sci, Genome & Drug Res Ctr, Chiba, Japan.	sahara@azabu-u.ac.jp	Morohashi, Kengo/C-5511-2014; Morohashi, Kengo/AAV-2545-2021	Tanabe, Atsushi/0000-0001-7651-3943; Kuramochi, Kouji/0000-0003-0571-9703	Promotion and Mutual Aid Corporation for Private Schools of Japan; Matching Fund; Grants-in-Aid for Scientific Research [22710219, 22390004] Funding Source: KAKEN	Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Matching Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by The Promotion and Mutual Aid Corporation for Private Schools of Japan, Grant-in-Aid for Matching Fund Subsidy for Private Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki S, 2005, FEBS J, V272, P2132, DOI 10.1111/j.1742-4658.2005.04600.x; Aoki S, 2007, BIOCONJUGATE CHEM, V18, P1981, DOI 10.1021/bc700287V; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; CALNE RY, 1978, LANCET, V2, P1323; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Fischer G, 1998, FEBS LETT, V426, P17, DOI 10.1016/S0014-5793(98)00242-7; Flisiak R, 2009, HEPATOLOGY, V49, P1460, DOI 10.1002/hep.22835; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; Goh PY, 2004, J VIROL, V78, P5288, DOI 10.1128/JVI.78.10.5288-5298.2004; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Imai A, 2007, EUR J IMMUNOL, V37, P1730, DOI 10.1002/eji.200636392; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370; Kuramochi K, 2005, BIOCONJUGATE CHEM, V16, P97, DOI 10.1021/bc0497970; Larrea E, 1996, HEPATOLOGY, V23, P210, DOI 10.1002/hep.510230203; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Loor F, 2002, J MED CHEM, V45, P4613, DOI 10.1021/jm010987v; Makowski Lee, 2003, Human Genomics, V1, P41; Mandava S, 2004, PROTEOMICS, V4, P1439, DOI 10.1002/pmic.200300680; Morohashi K, 2005, BIOCHEM PHARMACOL, V70, P37, DOI 10.1016/j.bcp.2005.03.035; Okanami M, 1998, NUCLEIC ACIDS RES, V26, P2638, DOI 10.1093/nar/26.11.2638; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; Rodi DJ, 2004, BIOINFORMATICS, V20, P3481, DOI 10.1093/bioinformatics/bth432; Rodi DJ, 2002, J MOL BIOL, V322, P1039, DOI 10.1016/S0022-2836(02)00844-6; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Watashi K, 2003, MOL CELL BIOL, V23, P7498, DOI 10.1128/MCB.23.21.7498-7509.2003; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07	36	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18285	10.1371/journal.pone.0018285	http://dx.doi.org/10.1371/journal.pone.0018285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559518	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700009
J	Okada, Y; Imendra, KG; Miyazaki, T; Hotokezaka, H; Fujiyama, R; Toda, K				Okada, Yukio; Imendra, Kotapola G.; Miyazaki, Toshihiro; Hotokezaka, Hitoshi; Fujiyama, Rie; Toda, Kazuo			High Extracellular Ca2+ Stimulates Ca2+-Activated Cl- Currents in Frog Parathyroid Cells through the Mediation of Arachidonic Acid Cascade	PLOS ONE			English	Article							ION-CHANNEL REGULATION; PROTEIN-KINASE-C; CA2+-SENSING RECEPTOR; K+ CHANNELS; INSULIN-SECRETION; MAP KINASE; CALCIUM; MODULATION; ACTIVATION; PRODUCTS	Elevation of extracellular Ca2+ concentration induces intracellular Ca2+ signaling in parathyroid cells. The response is due to stimulation of the phospholipase C/Ca2+ pathways, but the direct mechanism responsible for the rise of intracellular Ca2+ concentration has remained elusive. Here, we describe the electrophysiological property associated with intracellular Ca2+ signaling in frog parathyroid cells and show that Ca2+-activated Cl- channels are activated by intracellular Ca2+ increase through an inositol 1,4,5-trisphophate (IP3)-independent pathway. High extracellular Ca2+ induced an outwardly-rectifying conductance in a dose-dependent manner (EC50 similar to 6 mM). The conductance was composed of an instantaneous time-independent component and a slowly activating time-dependent component and displayed a deactivating inward tail current. Extracellular Ca2+-induced and Ca2+ dialysis-induced currents reversed at the equilibrium potential of Cl- and were inhibited by niflumic acid (a specific blocker of Ca2+-activated Cl- channel). Gramicidin-perforated whole-cell recording displayed the shift of the reversal potential in extracellular Ca2+-induced current, suggesting the change of intracellular Cl- concentration in a few minutes. Extracellular Ca2+-induced currents displayed a moderate dependency on guanosine triphosphate (GTP). All blockers for phospholipase C, diacylglycerol (DAG) lipase, monoacylglycerol (MAG) lipase and lipoxygenase inhibited extracellular Ca2+-induced current. IP3 dialysis failed to induce conductance increase, but 2-arachidonoylglycerol (2-AG), arachidonic acid and 12S-hydroperoxy-5Z, 8Z, 10E, 14Z-eicosatetraenoic acid (12(S)-HPETE) dialysis increased the conductance identical to extracellular Ca2+-induced conductance. These results indicate that high extracellular Ca2+ raises intracellular Ca2+ concentration through the DAG lipase/lipoxygenase pathway, resulting in the activation of Cl- conductance.	[Okada, Yukio; Imendra, Kotapola G.; Miyazaki, Toshihiro; Hotokezaka, Hitoshi; Fujiyama, Rie; Toda, Kazuo] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Imendra, Kotapola G.] Univ Ruhuna, Fac Med, Dept Physiol, Galle, Sri Lanka	Nagasaki University; University Ruhuna	Okada, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan.	okada@nagasaki-u.ac.jp	Toda, Kazuo/A-7385-2013	Toda, Kazuo/0000-0002-8848-8017; Fujiyama, Rie/0000-0002-7305-0864	Japan Society for the Promotion of Science [14540630, 17570064, 20570073]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid (Nos. 14540630, 17570064 and 20570073) from Japan Society for the Promotion of Science to YO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai M, 1998, J BIOL CHEM, V273, P21267, DOI 10.1074/jbc.273.33.21267; Barg S, 2001, J CELL SCI, V114, P2145; BOUDREAU A, 1994, ENDOCRINOLOGY, V135, P1109; BOURDEAU A, 1992, ENDOCRINOLOGY, V130, P1339, DOI 10.1210/en.130.3.1339; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 1999, VITAM HORM, V55, P1; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; BRUCE BR, 1979, AM J PHYSIOL, V236, pC15, DOI 10.1152/ajpcell.1979.236.1.C15; BUTTNER N, 1989, NATURE, V342, P553, DOI 10.1038/342553a0; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CASTELLANO A, 1987, CELL CALCIUM, V8, P377, DOI 10.1016/0143-4160(87)90012-1; Chakrabarti SK, 2009, OBESITY, V17, P1657, DOI 10.1038/oby.2009.192; Chang WH, 2001, AM J PHYSIOL-ENDOC M, V281, pE180, DOI 10.1152/ajpendo.2001.281.1.E180; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; DeCostanzo AJ, 2010, J NEUROSCI, V30, P1822, DOI 10.1523/JNEUROSCI.2168-09.2010; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; Gerasimenko O, 2005, CELL CALCIUM, V38, P201, DOI 10.1016/j.ceca.2005.06.025; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hammerland LG, 1998, MOL PHARMACOL, V53, P1083; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; JIA M, 1988, P NATL ACAD SCI USA, V85, P7236, DOI 10.1073/pnas.85.19.7236; Jia ZF, 2008, PFLUG ARCH EUR J PHY, V456, P857, DOI 10.1007/s00424-008-0444-2; KANAZIRSKA MPV, 1995, ENDOCRINOLOGY, V136, P2238, DOI 10.1210/en.136.5.2238; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; KIFOR O, 1992, J BONE MINER RES, V7, P1327; Kifor O, 1997, J BONE MINER RES, V12, P715, DOI 10.1359/jbmr.1997.12.5.715; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; KOMWATANA P, 1994, PFLUG ARCH EUR J PHY, V426, P320, DOI 10.1007/BF00374788; Li DQ, 2009, CELL METAB, V10, P309, DOI 10.1016/j.cmet.2009.08.011; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; LOPEZBARNEO J, 1983, J GEN PHYSIOL, V82, P269, DOI 10.1085/jgp.82.2.269; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Lu M, 2010, J MOL ENDOCRINOL, V44, P285, DOI 10.1677/JME-09-0138; Ma K, 2010, J CLIN ENDOCR METAB, V95, P887, DOI 10.1210/jc.2009-1102; McHenry CR, 1998, J SURG RES, V76, P37, DOI 10.1006/jsre.1998.5263; Mignen O, 2005, J PHYSIOL-LONDON, V564, P791, DOI 10.1113/jphysiol.2005.085704; Mignen O, 2009, J PHYSIOL-LONDON, V587, P4181, DOI 10.1113/jphysiol.2009.174193; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; Okada Y, 2005, J EXP BIOL, V208, P4747, DOI 10.1242/jeb.01967; Qu ZQ, 2003, AM J PHYSIOL-RENAL, V285, pF326, DOI 10.1152/ajprenal.00034.2003; RACKE FK, 1993, J PHYSIOL-LONDON, V468, P141, DOI 10.1113/jphysiol.1993.sp019764; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Rey O, 2005, J BIOL CHEM, V280, P22875, DOI 10.1074/jbc.M503455200; SAND O, 1981, ACTA PHYSIOL SCAND, V113, P45, DOI 10.1111/j.1748-1716.1981.tb06859.x; SASAYAMA Y, 1974, Annotationes Zoologicae Japonenses, V47, P232; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Valimaki S, 2003, J BIOL CHEM, V278, P49685, DOI 10.1074/jbc.M310595200; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yokoyama K, 2009, EXP PHYSIOL, V94, P847, DOI 10.1113/expphysiol.2009.046813	53	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19158	10.1371/journal.pone.0019158	http://dx.doi.org/10.1371/journal.pone.0019158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559478	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700083
J	Ryu, M; Chen, Y; Qi, JX; Liu, J; Fan, Z; Nam, G; Shi, Y; Cheng, H; Gao, GF				Ryu, Myongchol; Chen, Yong; Qi, Jianxun; Liu, Jun; Fan, Zheng; Nam, Gol; Shi, Yi; Cheng, Hao; Gao, George F.			LILRA3 Binds Both Classical and Non-Classical HLA Class I Molecules but with Reduced Affinities Compared to LILRB1/LILRB2: Structural Evidence	PLOS ONE			English	Article							INHIBITORY RECEPTOR; CRYSTAL-STRUCTURE; ACTIVATING RECEPTOR; CUTTING EDGE; LIR-1; PROTEIN; FAMILY; SPECIFICITY; EXPRESSION; SYSTEM	Structurally, Group 1 LILR (Leukocyte Immunogloblin (Ig)-Like Receptor, also known as Ig-like transcripts, ILT; Leukocyte Ig-like receptor, LIR; and CD85) members are very similar in terms of the HLAIs (human leukocyte antigen class I molecules) binding region and were hypothesized that they all bind to HLAIs. As one of the Group 1 LILRs, LILRA3 is the only secretory LILR and may greatly control the inhibitory immune response induced by LILRB1, LILRB2, and other HLA-binding LILR molecules like LILRA1. Nevertheless, little was known about the binding of LILRA3 to HLAIs. In this report, we present the crystal structure of the LILRA3 domain 1 (D1) and evaluate the D1 and D1D2 (domain 1 and domain 2) binding to classical and non-classical HLAIs using BIAcore (R) surface plasmon resonance analysis (SPR). We found that LILRA3 binds both classical HLA-A*0201 and non-classical HLA-G1 but with reduced affinities compared to either LILRB1 or LILRB2. The polymorphic amino acids and the LILRA3 D1 structure support this notion.	[Ryu, Myongchol; Chen, Yong; Qi, Jianxun; Liu, Jun; Fan, Zheng; Nam, Gol; Shi, Yi; Cheng, Hao; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Ryu, Myongchol; Chen, Yong; Liu, Jun; Nam, Gol; Shi, Yi; Cheng, Hao; Gao, George F.] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Ryu, Myongchol; Nam, Gol] State Acad Sci, Inst Microbiol, Pyongyang, North Korea; [Fan, Zheng] Chinese Acad Sci, Inst Microbiol, Core Facil, Beijing, Peoples R China; [Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences	Ryu, M (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	gaof@im.ac.cn	Gao, George Fu/ABD-5229-2021; Qi, Jianxun/ABF-1646-2021		National 973 Project [2010CB911902]; National Natural Science Foundation of China (NSFC) Innovative Research Group [81021003]	National 973 Project(National Basic Research Program of China); National Natural Science Foundation of China (NSFC) Innovative Research Group(National Natural Science Foundation of China (NSFC))	This work is supported by a Special Grant for Protein Science of the National 973 Project (grant No. 2010CB911902). www.973.gov.cn/Default_3.aspx. GFG is a leading principal investigator of the National Natural Science Foundation of China (NSFC) Innovative Research Group (grant No. 81021003). www.nsfc.gov.cn/Portal0/default124.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen RL, 2001, J IMMUNOL, V167, P5543, DOI 10.4049/jimmunol.167.10.5543; An HY, 2010, J RHEUMATOL, V37, P1596, DOI 10.3899/jrheum.091119; Andre P, 2001, NAT IMMUNOL, V2, P661, DOI 10.1038/90589; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bonetti A, 2009, J NEUROIMMUNOL, V208, P119, DOI 10.1016/j.jneuroim.2009.01.003; Borges L, 2003, BLOOD, V101, P1484, DOI 10.1182/blood-2002-05-1432; Borges L, 1997, J IMMUNOL, V159, P5192; Cao W, 2010, IMMUNOL REV, V234, P163, DOI 10.1111/j.0105-2896.2009.00867.x; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Chapman TL, 2000, IMMUNITY, V13, P727, DOI 10.1016/S1074-7613(00)00071-6; Chen Y, 2007, PROTEIN EXPRES PURIF, V56, P253, DOI 10.1016/j.pep.2007.08.010; Chen Y, 2010, PROTEIN CELL, V1, P153, DOI 10.1007/s13238-010-0022-1; Chen Y, 2009, IUBMB LIFE, V61, P579, DOI 10.1002/iub.208; Chen Y, 2009, J MOL BIOL, V386, P841, DOI 10.1016/j.jmb.2009.01.006; Cheng H, 2011, J BIOL CHEM IN PRESS; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P375, DOI 10.1002/jlb.66.3.375; Colonna M, 1998, J IMMUNOL, V160, P3096; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanger NA, 1998, EUR J IMMUNOL, V28, P3423, DOI 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2; Gao GF, 2000, J BIOL CHEM, V275, P15232, DOI 10.1074/jbc.275.20.15232; Garner LI, 2006, PROTEIN EXPRES PURIF, V47, P490, DOI 10.1016/j.pep.2005.11.020; Gonen-Gross T, 2005, J IMMUNOL, V175, P4866, DOI 10.4049/jimmunol.175.8.4866; Jones DC, 2011, J IMMUNOL, V186, P2990, DOI 10.4049/jimmunol.1003078; Kabalak G, 2009, ARTHRITIS RHEUM-US, V60, P2923, DOI 10.1002/art.24804; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lepin EJM, 2000, EUR J IMMUNOL, V30, P3552, DOI 10.1002/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L; Liu J, 2010, J INFECT DIS, V202, P1171, DOI 10.1086/656315; McIntire RH, 2008, PLACENTA, V29, P631, DOI 10.1016/j.placenta.2008.04.007; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navarro F, 1999, EUR J IMMUNOL, V29, P277, DOI 10.1002/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Shiroishi M, 2006, J BIOL CHEM, V281, P10439, DOI 10.1074/jbc.M512305200; Shiroishi M, 2003, P NATL ACAD SCI USA, V100, P8856, DOI 10.1073/pnas.1431057100; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Shiroishi M, 2006, J BIOL CHEM, V281, P19536, DOI 10.1074/jbc.M603076200; Thomas R, 2010, CLIN REV ALLERG IMMU, V38, P159, DOI 10.1007/s12016-009-8148-8; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Vitale M, 1999, INT IMMUNOL, V11, P29, DOI 10.1093/intimm/11.1.29; Wagtmann N, 1997, CURR BIOL, V7, P615, DOI 10.1016/S0960-9822(06)00263-6; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Willcox Benjamin E, 2002, BMC Struct Biol, V2, P6, DOI 10.1186/1472-6807-2-6; Young NT, 2001, IMMUNOGENETICS, V53, P270, DOI 10.1007/s002510100332	46	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19245	10.1371/journal.pone.0019245	http://dx.doi.org/10.1371/journal.pone.0019245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559424	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700109
J	Tong, WC; Choi, CY; Karche, S; Holden, AV; Zhang, HG; Taggart, MJ				Tong, Wing-Chiu; Choi, Cecilia Y.; Karche, Sanjay; Holden, Arun V.; Zhang, Henggui; Taggart, Michael J.			A Computational Model of the Ionic Currents, Ca2+ Dynamics and Action Potentials Underlying Contraction of Isolated Uterine Smooth Muscle	PLOS ONE			English	Article							NA+/CA2+ EXCHANGER ISOFORMS; ACTIVATED CHLORIDE CHANNEL; SODIUM-CALCIUM EXCHANGER; SINGLE MYOMETRIAL CELLS; RAT MYOMETRIUM; K+-CHANNELS; T-TYPE; ELECTRICAL-ACTIVITY; POTASSIUM CHANNELS; ELECTROPHYSIOLOGICAL CHARACTERIZATION	Uterine contractions during labor are discretely regulated by rhythmic action potentials (AP) of varying duration and form that serve to determine calcium-dependent force production. We have employed a computational biology approach to develop a fuller understanding of the complexity of excitation-contraction (E-C) coupling of uterine smooth muscle cells (USMC). Our overall aim is to establish a mathematical platform of sufficient biophysical detail to quantitatively describe known uterine E-C coupling parameters and thereby inform future empirical investigations of physiological and pathophysiological mechanisms governing normal and dysfunctional labors. From published and unpublished data we construct mathematical models for fourteen ionic currents of USMCs: Ca2+ currents (L-and T-type), Na+ current, an hyperpolarization-activated current, three voltage-gated K+ currents, two Ca2+-activated K+ current, Ca2+-activated Cl current, non-specific cation current, Na+-Ca2+ exchanger, Na+-K+ pump and background current. The magnitudes and kinetics of each current system in a spindle shaped single cell with a specified surface area: volume ratio is described by differential equations, in terms of maximal conductances, electrochemical gradient, voltage-dependent activation/inactivation gating variables and temporal changes in intracellular Ca2+ computed from known Ca2+ fluxes. These quantifications are validated by the reconstruction of the individual experimental ionic currents obtained under voltage-clamp. Phasic contraction is modeled in relation to the time constant of changing [Ca2+](i). This integrated model is validated by its reconstruction of the different USMC AP configurations (spikes, plateau and bursts of spikes), the change from bursting to plateau type AP produced by estradiol and of simultaneous experimental recordings of spontaneous AP, [Ca2+](i) and phasic force. In summary, our advanced mathematical model provides a powerful tool to investigate the physiological ionic mechanisms underlying the genesis of uterine electrical E-C coupling of labor and parturition. This will furnish the evolution of descriptive and predictive quantitative models of myometrial electrogenesis at the whole cell and tissue levels.	[Tong, Wing-Chiu; Taggart, Michael J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Tong, Wing-Chiu; Taggart, Michael J.] Univ Manchester, St Marys Hosp, Maternal & Fetal Hlth Res Ctr, Manchester M13 0JH, Lancs, England; [Choi, Cecilia Y.; Karche, Sanjay; Zhang, Henggui] Univ Manchester, Sch Phys & Astron, Manchester, Lancs, England; [Holden, Arun V.] Univ Leeds, Inst Membrane & Syst Biol, Leeds, W Yorkshire, England	Newcastle University - UK; University of Manchester; University of Manchester; University of Leeds	Tong, WC (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	henggui.zhang@manchester.ac.uk; michael.taggart@ncl.ac.uk	Zhang, Henggui/AAM-1043-2020; Kharche, Sanjay Ram/I-2130-2014; Zhang, Henggui/D-6712-2011	Kharche, Sanjay Ram/0000-0002-2634-4894; Taggart, Michael/0000-0002-9981-2783	MRC [G0900525, G0902091]; BBSRC [BBSRC/B/1678X]; EU Network of Excellence BioSim [LSHB-CT-2004-005137]; Medical Research Council [G0900525, G0902091] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU Network of Excellence BioSim; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work described here was supported by grants from MRC (G0900525 and G0902091, www.mrc.ac.uk), BBSRC (BBSRC/B/1678X, www.bbsrc.ac.uk), Tommy's (www.tommys.org) and EU Network of Excellence BioSim (LSHB-CT-2004-005137, http://biosim.fysik.dtu.dk:8080/biosim/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE Y, 1971, J PHYSIOL-LONDON, V214, P173, DOI 10.1113/jphysiol.1971.sp009426; AMEDEE T, 1987, J PHYSIOL-LONDON, V392, P253, DOI 10.1113/jphysiol.1987.sp016779; Angermann JE, 2006, J GEN PHYSIOL, V128, P73, DOI 10.1085/jgp.200609507; ANWER K, 1992, AM J PHYSIOL, V263, pC1049; ANWER K, 1993, AM J PHYSIOL, V265, pC976, DOI 10.1152/ajpcell.1993.265.4.C976; Arreola J, 1996, J GEN PHYSIOL, V108, P35, DOI 10.1085/jgp.108.1.35; Asokan KT, 2002, EUR J PHARMACOL, V455, P65, DOI 10.1016/S0014-2999(02)02487-1; Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; BENGTSSON B, 1984, AM J PHYSIOL, V246, pC216, DOI 10.1152/ajpcell.1984.246.3.C216; Benkusky NA, 2000, J BIOL CHEM, V275, P27712; Blanks AM, 2007, J PHYSIOL-LONDON, V581, P915, DOI 10.1113/jphysiol.2007.132126; Brown A, 2007, AM J PHYSIOL-CELL PH, V292, pC832, DOI 10.1152/ajpcell.00268.2006; Bugg GJ, 2006, EUR J OBSTET GYN R B, V124, P37, DOI 10.1016/j.ejogrb.2005.04.015; Burdyga T, 2007, ANN NY ACAD SCI, V1101, P85, DOI 10.1196/annals.1389.002; Burdyga T, 2009, EUR J OBSTET GYN R B, V144, pS25, DOI 10.1016/j.ejogrb.2009.02.017; Bursztyn L, 2007, AM J PHYSIOL-CELL PH, V292, pC1816, DOI 10.1152/ajpcell.00478.2006; CAMPBELL DL, 1988, J PHYSIOL-LONDON, V403, P317, DOI 10.1113/jphysiol.1988.sp017251; CHANG DC, 1983, BIOPHYS J, V43, P149, DOI 10.1016/S0006-3495(83)84335-5; COLEMAN HA, 1987, PFLUG ARCH EUR J PHY, V410, P560, DOI 10.1007/BF00586540; CRICHTON CA, 1993, J PHYSIOL-LONDON, V465, P629, DOI 10.1113/jphysiol.1993.sp019697; CSAPO IA, 1963, J PHYSIOL-LONDON, V165, P575, DOI 10.1113/jphysiol.1963.sp007081; Curley Michael, 2004, Reprod Biol Endocrinol, V2, P67, DOI 10.1186/1477-7827-2-67; Ermentrout G. B., 2002, SIMULATING ANAL ANIM; ERULKAR SD, 1994, P ROY SOC B-BIOL SCI, V256, P59, DOI 10.1098/rspb.1994.0049; Esplin MS, 2003, AM J OBSTET GYNECOL, V188, P759, DOI 10.1067/mob.2003.166; Floyd RV, 2010, REPROD SCI, V17, P366, DOI 10.1177/1933719109355196; Garfield RE, 2007, SEMIN CELL DEV BIOL, V18, P289, DOI 10.1016/j.semcdb.2007.05.004; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Greenwood IA, 1996, PFLUG ARCH EUR J PHY, V432, P970, DOI 10.1007/s004240050224; GROVER AK, 1981, AM J PHYSIOL, V240, pC175, DOI 10.1152/ajpcell.1981.240.5.C175; Helguera G, 2002, BBA-GEN SUBJECTS, V1569, P59, DOI 10.1016/S0304-4165(01)00234-3; Hering J, 2004, J PHYSIOL-LONDON, V555, P331, DOI 10.1113/jphysiol.2003.054361; INOUE Y, 1991, AM J PHYSIOL, V260, pC658, DOI 10.1152/ajpcell.1991.260.3.C658; Inoue Y, 1999, CAN J PHYSIOL PHARM, V77, P447, DOI 10.1139/cjpp-77-6-447; INOUE Y, 1990, AM J OBSTET GYNECOL, V162, P1090, DOI 10.1016/0002-9378(90)91322-4; Iwamoto T, 1998, AM J PHYSIOL-CELL PH, V275, pC423, DOI 10.1152/ajpcell.1998.275.2.C423; Jeong JW, 2006, J ENDOCRINOL, V189, P473, DOI 10.1677/joe.1.06747; JMARI K, 1986, J PHYSIOL-LONDON, V380, P111, DOI 10.1113/jphysiol.1986.sp016275; Jones K, 2004, PFLUG ARCH EUR J PHY, V448, P36, DOI 10.1007/s00424-003-1224-7; Kamishima T, 1996, J PHYSIOL-LONDON, V492, P61, DOI 10.1113/jphysiol.1996.sp021289; KAWARABAYASHI T, 1994, CAMBRIDGE REV HUMAN, P148; Khan RN, 1998, HUM REPROD, V13, P208, DOI 10.1093/humrep/13.1.208; KHAN RN, 1993, P ROY SOC B-BIOL SCI, V251, P9, DOI 10.1098/rspb.1993.0002; Khan RN, 2001, EXP PHYSIOL, V86, P255, DOI 10.1113/eph8602181; Knock GA, 1999, J PHYSIOL-LONDON, V518, P769, DOI 10.1111/j.1469-7793.1999.0769p.x; Knock GA, 2001, BIOL REPROD, V64, P1526, DOI 10.1095/biolreprod64.5.1526; Knock GA, 1999, BRIT J PHARMACOL, V127, P1470, DOI 10.1038/sj.bjp.0702685; Kusaka M, 1995, BBA-BIOMEMBRANES, V1240, P196, DOI 10.1016/0005-2736(95)00191-3; Lammers WJEP, 2008, AM J PHYSIOL-REG I, V294, pR919, DOI 10.1152/ajpregu.00704.2007; LANDA JF, 1959, AM J PHYSIOL, V196, P905, DOI 10.1152/ajplegacy.1959.196.4.905; Lee SE, 2009, KOREAN J PHYSIOL PHA, V13, P241, DOI 10.4196/kjpp.2009.13.3.241; Levitsky DO, 2007, ANN NY ACAD SCI, V1099, P221, DOI 10.1196/annals.1387.063; LI ZP, 1994, J BIOL CHEM, V269, P17434; Linck B, 1998, AM J PHYSIOL-CELL PH, V274, pC415, DOI 10.1152/ajpcell.1998.274.2.C415; MANABE K, 1995, J PHYSIOL-LONDON, V487, P407, DOI 10.1113/jphysiol.1995.sp020889; Mankouri HW, 1998, J PHYSIOL-LONDON, V509P, p2P; Matharoo-Ball B, 2003, BIOL REPROD, V68, P2135, DOI 10.1095/biolreprod.102.010454; McCallum LA, 2011, J CELL MOL MED, V15, P577, DOI 10.1111/j.1582-4934.2010.01021.x; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; MEISHERI KD, 1979, EUR J PHARMACOL, V60, P1, DOI 10.1016/0014-2999(79)90045-1; MERSHON JL, 1994, BIOL REPROD, V51, P993, DOI 10.1095/biolreprod51.5.993; Mironneau J, 1996, CELL CALCIUM, V20, P153, DOI 10.1016/S0143-4160(96)90104-9; Mitchell BF, 2009, AM J PHYSIOL-REG I, V297, pR525, DOI 10.1152/ajpregu.00153.2009; Miyoshi H, 2004, PFLUG ARCH EUR J PHY, V447, P457, DOI 10.1007/s00424-003-1175-z; MIYOSHI H, 1991, PFLUG ARCH EUR J PHY, V419, P386, DOI 10.1007/BF00371121; MOLLARD P, 1986, AM J PHYSIOL, V250, pC47, DOI 10.1152/ajpcell.1986.250.1.C47; Nakamura Y, 1999, J PHYSIOL-LONDON, V519, P203, DOI 10.1111/j.1469-7793.1999.0203o.x; NAKAO M, 1989, J GEN PHYSIOL, V94, P539, DOI 10.1085/jgp.94.3.539; Noble K, 2010, CELL CALCIUM, V47, P47, DOI 10.1016/j.ceca.2009.11.004; Ohkubo T, 2005, GYNECOL OBSTET INVES, V59, P80, DOI 10.1159/000082333; OHYA Y, 1989, AM J PHYSIOL, V257, pC408, DOI 10.1152/ajpcell.1989.257.2.C408; Okabe K, 1999, PFLUG ARCH EUR J PHY, V439, P76, DOI 10.1007/s004240051130; Okabe K, 1999, EUR J PHARMACOL, V376, P101, DOI 10.1016/S0014-2999(99)00353-2; Orio P, 2006, J GEN PHYSIOL, V127, P191, DOI 10.1085/jgp.200509370; Parkington HC, 1999, J PHYSIOL-LONDON, V514, P229, DOI 10.1111/j.1469-7793.1999.229af.x; Parkington HC, 2001, FRONT HORM RES, V27, P179; PEREZ GJ, 1993, AM J OBSTET GYNECOL, V168, P652, DOI 10.1016/0002-9378(93)90513-I; PIEDRASRENTERIA E, 1991, AM J PHYSIOL, V261, pC278, DOI 10.1152/ajpcell.1991.261.2.C278; Pierce SL, 2008, BIOL REPROD, V78, P1058, DOI 10.1095/biolreprod.107.066423; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Rihana S, 2009, MED BIOL ENG COMPUT, V47, P665, DOI 10.1007/s11517-009-0433-4; SATOH H, 1995, GEN PHARMACOL-VASC S, V26, P1335, DOI 10.1016/0306-3623(95)00006-M; Serrano JR, 1999, J GEN PHYSIOL, V114, P185, DOI 10.1085/jgp.114.2.185; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Shmigol A, 1998, PFLUG ARCH EUR J PHY, V437, P158, DOI 10.1007/s004240050761; Shmigol AV, 1998, J PHYSIOL-LONDON, V511, P803, DOI 10.1111/j.1469-7793.1998.803bg.x; Shmigol AV, 1999, J PHYSIOL-LONDON, V520, P153, DOI 10.1111/j.1469-7793.1999.00153.x; Smith RC, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-41; Song JF, 2009, BIOL REPROD, V80, P788, DOI 10.1095/biolreprod.108.071258; Song M, 1999, FEBS LETT, V460, P427, DOI 10.1016/S0014-5793(99)01394-0; SPERELAKIS N, 1992, MOL CELL BIOCHEM, V114, P79; STANDEN NB, 1982, PROC R SOC SER B-BIO, V217, P101, DOI 10.1098/rspb.1982.0097; Taggart M.J., 2007, NEW FRONTIERS SMOOTH, P523; Taggart MJ, 2007, SEMIN CELL DEV BIOL, V18, P296, DOI 10.1016/j.semcdb.2007.05.006; Taggart Michael John, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS3, DOI 10.1186/1471-2393-7-S1-S3; Taggart MJ, 1997, CELL CALCIUM, V22, P333, DOI 10.1016/S0143-4160(97)90018-X; TAYLOR GS, 1969, LIFE SCI PT 1 PHYSI, V8, P769, DOI 10.1016/0024-3205(69)90268-9; TAYLOR GS, 1970, J GEN PHYSIOL, V56, P360, DOI 10.1085/jgp.56.3.360; TEZUKA N, 1995, AM J PHYSIOL-CELL PH, V269, pC1008, DOI 10.1152/ajpcell.1995.269.4.C1008; TURI A, 1992, BIOCHEM BIOPH RES CO, V188, P1191, DOI 10.1016/0006-291X(92)91357-V; Vance CJ, 2006, AM J OBSTET GYNECOL, V195, P1407, DOI 10.1016/j.ajog.2006.05.009; VIGNE P, 1988, J BIOL CHEM, V263, P8087; Wang SY, 1998, J GEN PHYSIOL, V112, P737, DOI 10.1085/jgp.112.6.737; Weber CR, 2001, J GEN PHYSIOL, V117, P119, DOI 10.1085/jgp.117.2.119; WEST TC, 1956, AM J PHYSIOL, V187, P333, DOI 10.1152/ajplegacy.1956.187.2.333; WILDE DW, 1988, BIOL REPROD, V38, P836, DOI 10.1095/biolreprod38.4.836; YAMAMOTO T, 1995, AM J PHYSIOL-CELL PH, V268, pC64, DOI 10.1152/ajpcell.1995.268.1.C64; Yoshino M, 1997, J GEN PHYSIOL, V110, P565, DOI 10.1085/jgp.110.5.565; YOUNG RC, 1993, AM J OBSTET GYNECOL, V169, P785, DOI 10.1016/0002-9378(93)90006-5; Young RC, 2009, REPROD SCI, V16, P734, DOI 10.1177/1933719109334965; Zhang J, 2010, REPROD SCI, V17, p78A; Zhou XB, 2000, J PHYSIOL-LONDON, V524, P339, DOI 10.1111/j.1469-7793.2000.t01-1-00339.x; Zhou XB, 2000, AM J PHYSIOL-CELL PH, V279, pC1751, DOI 10.1152/ajpcell.2000.279.6.C1751	113	54	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18685	10.1371/journal.pone.0018685	http://dx.doi.org/10.1371/journal.pone.0018685			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559514	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700019
J	Tucker, BA; Park, IH; Qi, SD; Klassen, HJ; Jiang, CH; Yao, J; Redenti, S; Daley, GQ; Young, MJ				Tucker, Budd A.; Park, In-Hyun; Qi, Sara D.; Klassen, Henry J.; Jiang, Caihui; Yao, Jing; Redenti, Stephen; Daley, George Q.; Young, Michael J.			Transplantation of Adult Mouse iPS Cell-Derived Photoreceptor Precursors Restores Retinal Structure and Function in Degenerative Mice	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MACULAR DEGENERATION; PROGENITOR CELLS; HEAD INDUCTION; GENERATION; DIFFERENTIATION; EXPRESSION; PROMOTE; ROD	This study was designed to determine whether adult mouse induced pluripotent stem cells (iPSCs), could be used to produce retinal precursors and subsequently photoreceptor cells for retinal transplantation to restore retinal function in degenerative hosts. iPSCs were generated using adult dsRed mouse dermal fibroblasts via retroviral induction of the transcription factors Oct4, Sox2, KLF4 and c-Myc. As with normal mouse ES cells, adult dsRed iPSCs expressed the pluripotency genes SSEA1, Oct4, Sox2, KLF4, c-Myc and Nanog. Following transplantation into the eye of immunecompromised retinal degenerative mice these cells proceeded to form teratomas containing tissue comprising all three germ layers. At 33 days post-differentiation a large proportion of the cells expressed the retinal progenitor cell marker Pax6 and went on to express the photoreceptor markers, CRX, recoverin, and rhodopsin. When tested using calcium imaging these cells were shown to exhibit characteristics of normal retinal physiology, responding to delivery of neurotransmitters. Following subretinal transplantation into degenerative hosts differentiated iPSCs took up residence in the retinal outer nuclear layer and gave rise to increased electro retinal function as determined by ERG and functional anatomy. As such, adult fibroblast-derived iPSCs provide a viable source for the production of retinal precursors to be used for transplantation and treatment of retinal degenerative disease.	[Tucker, Budd A.; Jiang, Caihui; Redenti, Stephen] Univ Iowa, Dept Ophthalmol, Carver Coll Med, Inst Vis Res, Iowa City, IA 52242 USA; [Qi, Sara D.; Yao, Jing; Young, Michael J.] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA USA; [Park, In-Hyun] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Park, In-Hyun] Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Harvard Stem Cell Inst, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Klassen, Henry J.] Univ Calif Irvine, Gavin Herbert Eye Inst, Sch Med, Dept Ophthalmol, Orange, CA 92668 USA; [Yao, Jing] Fudan Univ, Shanghai Med Sch, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China	University of Iowa; Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; University of California System; University of California Irvine; Fudan University	Tucker, BA (corresponding author), Univ Iowa, Dept Ophthalmol, Carver Coll Med, Inst Vis Res, Iowa City, IA 52242 USA.	budd-tucker@uiowa.edu		Tucker, Budd/0000-0003-2178-1742	National Institutes of Health (NIH); Foundation Fighting Blindness; Lincy and Discovery Eye Foundations; Research to Prevent Blindness	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Lincy and Discovery Eye Foundations; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	BAT is supported by grants from the National Institutes of Health (NIH) (DP2 new innovators award) and the Foundation Fighting Blindness; MJY is supported by grants from the Lincy and Discovery Eye Foundations and Research to Prevent Blindness; GQD is supported by grants from the NIH, and is an investigator of the Manton Center for Orphan Disease Research and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2002, DEVELOPMENT, V129, P4975; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Choi M, 2009, NATURE, V461, DOI 10.1038/nature08493; Chopdar A, 2003, BRIT MED J, V326, P485, DOI 10.1136/bmj.326.7387.485; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Earnshaw SR, 2007, CLIN THER, V29, P2096, DOI 10.1016/j.clinthera.2007.09.001; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Huerta JJ, 1997, NEUROSCI LETT, V232, P143, DOI 10.1016/S0304-3940(97)00595-8; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; Jiang CH, 2010, MOL VIS, V16, P983; Klassen HJ, 2004, INVEST OPHTH VIS SCI, V45, P4167, DOI 10.1167/iovs.04-0511; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Meyer JS, 2009, P NATL ACAD SCI US; Mitchell J, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-97; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Pera EM, 2001, DEV CELL, V1, P655, DOI 10.1016/S1534-5807(01)00069-7; Reh TA, 2010, METHODS MOL BIOL, V636, P139, DOI 10.1007/978-1-60761-691-7_9; Schraermeyer U, 2001, CELL TRANSPLANT, V10, P673, DOI 10.3727/000000001783986215; Shao LJ, 2009, CELL RES, V19, P296, DOI 10.1038/cr.2009.20; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Sun W, 2002, NEUROREPORT, V13, P2421, DOI 10.1097/00001756-200212200-00009; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tomita M, 2005, STEM CELLS, V23, P1579, DOI 10.1634/stemcells.2005-0111; Tucker BA, 2009, ASS RES VISION OPHTH; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007; Welstead GG, 2008, J VIS EXP	39	225	240	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18992	10.1371/journal.pone.0018992	http://dx.doi.org/10.1371/journal.pone.0018992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559507	Green Published, gold			2022-12-25	WOS:000290024700047
J	Barnett-Cowan, M; Fleming, RW; Singh, M; Bulthoff, HH				Barnett-Cowan, Michael; Fleming, Roland W.; Singh, Manish; Buelthoff, Heinrich H.			Perceived Object Stability Depends on Multisensory Estimates of Gravity	PLOS ONE			English	Article							REFERENCE FRAMES; ORIENTATION; MOTION; MODEL; TILT; PERCEPTION; JUDGMENT; BALANCE; SEX	Background: How does the brain estimate object stability? Objects fall over when the gravity-projected centre-of-mass lies outside the point or area of support. To estimate an object's stability visually, the brain must integrate information across the shape and compare its orientation to gravity. When observers lie on their sides, gravity is perceived as tilted toward body orientation, consistent with a representation of gravity derived from multisensory information. We exploited this to test whether vestibular and kinesthetic information affect this visual task or whether the brain estimates object stability solely from visual information. Methodology/Principal Findings: In three body orientations, participants viewed images of objects close to a table edge. We measured the critical angle at which each object appeared equally likely to fall over or right itself. Perceived gravity was measured using the subjective visual vertical. The results show that the perceived critical angle was significantly biased in the same direction as the subjective visual vertical (i.e., towards the multisensory estimate of gravity). Conclusions/Significance: Our results rule out a general explanation that the brain depends solely on visual heuristics and assumptions about object stability. Instead, they suggest that multisensory estimates of gravity govern the perceived stability of objects, resulting in objects appearing more stable than they are when the head is tilted in the same direction in which they fall.	[Barnett-Cowan, Michael; Fleming, Roland W.; Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany; [Singh, Manish] Rutgers State Univ, Dept Psychol, Ctr Cognit Sci, Piscataway, NJ USA; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; Rutgers State University New Brunswick; Korea University	Barnett-Cowan, M (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany.	mbarnettcowan@gmail.com; hhb@tuebingen.mpg.de	Bülthoff, Heinrich/AAC-8818-2019; Fleming, Roland William/GLV-1534-2022; Bülthoff, Heinrich H/J-6579-2012	Fleming, Roland William/0000-0001-5033-5069; Bülthoff, Heinrich H/0000-0003-2568-0607	Max Planck Society; Deutsche Forschungsgemeinschaft (DFG) [FL 624/1-1]; National Science Foundation; Ministry of Education, Science and Technology [R31-10008]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by a postdoc stipend to MB-C from the Max Planck Society, a Deutsche Forschungsgemeinschaft to RWF (DFG FL 624/1-1); a National Science Foundation grant to MS (CCF); and by the WCU (World Class University) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-10008) to HHB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azulay JP, 2002, PERCEPT MOTOR SKILL, V95, P1106, DOI 10.2466/PMS.95.7.1106-1114; Barnett-Cowan M, 2005, ANN NY ACAD SCI, V1039, P314, DOI 10.1196/annals.1325.030; Barnett-Cowan M, 2010, EUR J NEUROSCI, V31, P1899, DOI 10.1111/j.1460-9568.2010.07199.x; Barnett-Cowan M, 2010, NEUROSCIENCE, V167, P1138, DOI 10.1016/j.neuroscience.2010.02.065; Barnett-Cowan M, 2008, BRAIN RES, V1242, P231, DOI 10.1016/j.brainres.2008.07.075; BINGHAM GP, 1993, PERCEPT PSYCHOPHYS, V54, P617, DOI 10.3758/BF03211785; Cadieux ML, 2010, EXP BRAIN RES, V204, P431, DOI 10.1007/s00221-010-2268-5; DANTA G, 1975, NEUROLOGY, V25, P43, DOI 10.1212/WNL.25.1.43; DAVI M, 1993, ACTA NEUROBIOL EXP, V53, P367; De Vrijer M, 2008, J NEUROPHYSIOL, V99, P915, DOI 10.1152/jn.00921.2007; Dyde RT, 2006, EXP BRAIN RES, V173, P612, DOI 10.1007/s00221-006-0405-y; Gori M, 2008, CURR BIOL, V18, P694, DOI 10.1016/j.cub.2008.04.036; HERBERT AM, 1994, CAN J EXP PSYCHOL, V48, P140, DOI 10.1037/1196-1961.48.1.140; HUMPHREYS GW, 1983, COGNITIVE PSYCHOL, V15, P151, DOI 10.1016/0010-0285(83)90008-7; Inhelder B., 1955, LOGIQUE ENFANT LOGIQ; Kennedy RS, 1996, J VESTIBUL RES-EQUIL, V6, P331, DOI 10.1016/0957-4271(96)00002-X; KOPFERMAN H, 1930, PSYCHOLOGISCHE FORSC, V67, P358; Laurens J, 2007, BIOL CYBERN, V96, P389, DOI 10.1007/s00422-006-0133-1; LAWTHER A, 1998, J VESTIBUL RES-EQUIL, V8, P151; Le Seac'h AB, 2007, NEUROSCI LETT, V423, P211, DOI 10.1016/j.neulet.2007.07.034; Le Seac'h AB, 2010, EXP BRAIN RES, V201, P653, DOI 10.1007/s00221-009-2081-1; MacNeilage PR, 2007, EXP BRAIN RES, V179, P263, DOI 10.1007/s00221-006-0792-0; MCCLOSKEY M, 1980, SCIENCE, V210, P1139, DOI 10.1126/science.210.4474.1139; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Merfeld DM, 1999, NATURE, V398, P615, DOI 10.1038/19303; MITTELSTAEDT H, 1986, ACTA PSYCHOL, V63, P63, DOI 10.1016/0001-6918(86)90043-0; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; Mittelstaedt H., 1988, PROCESSING STRUCTURE, P217; NEWTON I, PHILOS NATURAL PRINC; Palmer S. E., 1989, OBJECT PERCEPTION ST, P121; PALMER SE, 1980, COGNITIVE PSYCHOL, V12, P285, DOI 10.1016/0010-0285(80)90012-2; PROCTOR F, 1964, NEUROLOGY, V14, P287, DOI 10.1212/WNL.14.4.287; PROFFITT DR, 1989, J EXP PSYCHOL HUMAN, V15, P384, DOI 10.1037/0096-1523.15.2.384; ROCK I, 1973, ORIENTATION FORM; Samuel F, 2011, J EXP PSYCHOL HUMAN, V37, P529, DOI 10.1037/a0018732; Tanner T, 2008, PERCEPTION, V37, P93; Thomas L, 1996, CAH PSYCHOL COGN, V15, P137; van Beuzekom AD, 2000, J NEUROPHYSIOL, V84, P11, DOI 10.1152/jn.2000.84.1.11; Viaud-Delmon I, 1998, NAT NEUROSCI, V1, P15, DOI 10.1038/215; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Witkin H. A., 1954, PERSONALITY PERCEPTI; YAKIMOFF N, 1990, Spatial Vision, V5, P51, DOI 10.1163/156856890X00084; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	44	19	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19289	10.1371/journal.pone.0019289	http://dx.doi.org/10.1371/journal.pone.0019289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756NO	21556363	Green Published, Green Submitted, gold			2022-12-25	WOS:000290019400046
J	Weitzman, ER; Adida, B; Kelemen, S; Mandl, KD				Weitzman, Elissa R.; Adida, Ben; Kelemen, Skyler; Mandl, Kenneth D.			Sharing Data for Public Health Research by Members of an International Online Diabetes Social Network	PLOS ONE			English	Article							GLOBAL BURDEN; MEDICINE; OBESITY; POWER	Background: Surveillance and response to diabetes may be accelerated through engaging online diabetes social networks (SNs) in consented research. We tested the willingness of an online diabetes community to share data for public health research by providing members with a privacy-preserving social networking software application for rapid temporal-geographic surveillance of glycemic control. Methods and Findings: SN-mediated collection of cross-sectional, member-reported data from an international online diabetes SN entered into a software applicaction we made available in a "Facebook-like" environment to enable reporting, charting and optional sharing of recent hemoglobin A1c values through a geographic display. Self-enrollment by 17% (n = 1,136) of n = 6,500 active members representing 32 countries and 50 US states. Data were current with 83.1% of most recent A1c values reported obtained within the past 90 days. Sharing was high with 81.4% of users permitting data donation to the community display. 34.1% of users also displayed their A1cs on their SN profile page. Users selecting the most permissive sharing options had a lower average A1c (6.8%) than users not sharing with the community (7.1%, p = .038). 95% of users permitted re-contact. Unadjusted aggregate A1c reported by US users closely resembled aggregate 2007-2008 NHANES estimates (respectively, 6.9% and 6.9%, p = 0.85). Conclusions: Success within an early adopter community demonstrates that online SNs may comprise efficient platforms for bidirectional communication with and data acquisition from disease populations. Advancing this model for cohort and translational science and for use as a complementary surveillance approach will require understanding of inherent selection and publication (sharing) biases in the data and a technology model that supports autonomy, anonymity and privacy.	[Weitzman, Elissa R.; Adida, Ben; Kelemen, Skyler; Mandl, Kenneth D.] Childrens Hosp, Harvard Mit Div Hlth Sci & Technol, Childrens Hosp Informat Program, Boston, MA 02115 USA; [Weitzman, Elissa R.] Childrens Hosp, Div Adolescent Med, Boston, MA 02115 USA; [Adida, Ben; Mandl, Kenneth D.] Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Weitzman, Elissa R.; Mandl, Kenneth D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Mandl, Kenneth D.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Weitzman, ER (corresponding author), Childrens Hosp, Harvard Mit Div Hlth Sci & Technol, Childrens Hosp Informat Program, 300 Longwood Ave, Boston, MA 02115 USA.	elissa.weitzman@childrens.harvard.edu			Centers for Disease Control and Prevention (CDC) [P01HK000016, P01HK000088-01]; National Institute of Alcohol Abuse and Alcoholism (NIAAA) [R21 AA016638-01A1]; National Center for Research Resources/NIH [1U54RR025224-01]; Children's Hospital; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA016638] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Center for Research Resources/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Children's Hospital; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by P01HK000016 and P01HK000088-01 from the Centers for Disease Control and Prevention (CDC)(http://www.cdc.gov), by R21 AA016638-01A1 from the National Institute of Alcohol Abuse and Alcoholism (NIAAA) (http://www.niaaa.nih.gov), by 1U54RR025224-01 from National Center for Research Resources/NIH (http://www.ncrr.nih.gov), and by intramural funding from the Children's Hospital Program for Patient Safety and Quality (PPSQ) (http://web2.tch.harvard.edu/ppsq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Brownstein CA, 2009, NAT BIOTECHNOL, V27, P888, DOI 10.1038/nbt1009-888; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cobb NK, 2010, AM J PUBLIC HEALTH, V100, P1282, DOI 10.2105/AJPH.2009.165449; Frost JH, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1053; Gomez-Perez FJ, 2010, ARCH MED RES, V41, P302, DOI 10.1016/j.arcmed.2010.05.007; Hammond RA, 2010, CURR OPIN ENDOCRINOL, V17, P467, DOI 10.1097/MED.0b013e32833d4687; Hand E, 2010, NATURE, V466, P685, DOI 10.1038/466685a; Heaney C. A., 2002, HLTH BEHAV HLTH ED T, V3, P185; Hernandez M, 2010, COMMUNICATION   1012; Kohane IS, 2005, NEW ENGL J MED, V353, P2074, DOI 10.1056/NEJMsb051220; Kohane IS, 2007, SCIENCE, V316, P836, DOI 10.1126/science.1135489; Mandl KD, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-25; Mandl KD, 2008, NEW ENGL J MED, V358, P1732, DOI 10.1056/NEJMsb0800220; Mercken L, 2009, SOC SCI MED, V69, P1506, DOI 10.1016/j.socscimed.2009.08.003; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Saudek CD, 2006, JAMA-J AM MED ASSOC, V295, P1688, DOI 10.1001/jama.295.14.1688; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; van Noort S P, 2007, Euro Surveill, V12, pE5; Vilhauer RP, 2009, WOMEN HEALTH, V49, P381, DOI 10.1080/03630240903238719; Weitzman ER, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1356; Weitzman ER, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1187; Weitzman ER, 2011, J AM MED INFORM ASS; Wicks P, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1549; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616	28	39	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19256	10.1371/journal.pone.0019256	http://dx.doi.org/10.1371/journal.pone.0019256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756NO	21556358	Green Submitted, Green Published, gold			2022-12-25	WOS:000290019400042
J	Velasco, J; Li, J; DiPietro, L; Stepp, MA; Sandy, JD; Plaas, A				Velasco, Jennifer; Li, Jun; DiPietro, Luisa; Stepp, Mary Ann; Sandy, John D.; Plaas, Anna			Adamts5 Deletion Blocks Murine Dermal Repair through CD44-mediated Aggrecan Accumulation and Modulation of Transforming Growth Factor beta 1 (TGF beta 1) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; WOUND REPAIR; HUMAN-SKIN; EXTRACELLULAR-MATRIX; HAIR FOLLICLE; FIBROBLASTS; HYALURONAN; EXPRESSION; CELLS; COLLAGEN	ADAMTS5 has been implicated in the degradation of cartilage aggrecan in human osteoarthritis. Here, we describe a novel role for the enzyme in the regulation of TGF beta 1 signaling in dermal fibroblasts both in vivo and in vitro. Adamts5(-/-) mice, generated by deletion of exon 2, exhibit impaired contraction and dermal collagen deposition in an excisional wound healing model. This was accompanied by accumulation in the dermal layer of cell aggregates and fibroblastic cells surrounded by a pericellular matrix enriched in full-length aggrecan. Adamts5(-/-) wounds exhibit low expression ( relative to wild type) of collagen type I and type III but show a persistently elevated expression of tgfbRII and alk1. Aggrecan deposition and impaired dermal repair in Adamts5(-/-) mice are both dependent on CD44, and Cd44(-/-)/Adamts5(-/-) mice display robust activation of TGF beta receptor II and collagen type III expression and the dermal regeneration seen in WT mice. TGF beta 1 treatment of newborn fibroblasts from wild type mice results in Smad2/3 phosphorylation, whereas cells from Adamts5(-/-) mice phosphorylate Smad1/5/8. The altered TGF beta 1 response in the Adamts5(-/-) cells is dependent on the presence of aggrecan and expression of CD44, because Cd44(-/-)/Adamts5(-/-) cells respond like WT cells. We propose that ADAMTS5 deficiency in fibrous tissues results in a poor repair response due to the accumulation of aggrecan in the pericellular matrix of fibroblast progenitor cells, which prevents their transition to mature fibroblasts. Thus, the capacity of ADAMTS5 to modulate critical tissue repair signaling events suggests a unique role for this enzyme, which sets it apart from other members of the ADAMTS family of proteases.	[Velasco, Jennifer; Sandy, John D.; Plaas, Anna] Rush Univ Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Li, Jun; Plaas, Anna] Rush Univ Med Ctr, Dept Internal Med Rheumatol, Chicago, IL 60612 USA; [DiPietro, Luisa] Univ Illinois, Coll Dent, Ctr Wound Repair & Regenerat, Chicago, IL 60612 USA; [Stepp, Mary Ann] George Washington Univ Med Sch, Dept Anat & Regenerat Biol, Washington, DC 20037 USA	Rush University; Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Plaas, A (corresponding author), Rush Univ Med Ctr, Dept Biochem, Chicago, IL 60612 USA.	anna_plaas@rush.edu	Stepp, Mary Ann/ABF-2702-2020	Stepp, Mary Ann/0000-0001-5623-2538	National Institutes of Health [AR007590]; Katz/Rubschlager Endowment for OA Research; Rush Arthritis Institute, Rush University Medical Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Katz/Rubschlager Endowment for OA Research; Rush Arthritis Institute, Rush University Medical Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Training Grant AR007590 (to J. V.). This work was also supported by the Katz/Rubschlager Endowment for OA Research and the Rush Arthritis Institute, Rush University Medical Center (to A. P. and J. D. S.).	Arufe MC, 2010, J CELL BIOCHEM, V111, P834, DOI 10.1002/jcb.22768; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bell R. M., 2010, T ORTHOP RES SOC, V35, P1098; Bell R. M., 2010, T ORTHOP RES SOC, V35, P276; Bell R. M., 2009, T ORTHOP RES SOC, V34, P1399; Bourguignon LYW, 2006, J INVEST DERMATOL, V126, P1356, DOI 10.1038/sj.jid.5700260; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Carrino DA, 2003, J BIOL CHEM, V278, P17566, DOI 10.1074/jbc.M300124200; Chen YL, 2006, ARTHRITIS RHEUM-US, V54, P1309, DOI 10.1002/art.21725; David-Raoudi M, 2008, WOUND REPAIR REGEN, V16, P274, DOI 10.1111/j.1524-475X.2007.00342.x; Derwin KA, 2001, J ORTHOP RES, V19, P269, DOI 10.1016/S0736-0266(00)00032-2; EPSTEIN EH, 1978, J BIOL CHEM, V253, P1336; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Huebener P, 2008, J IMMUNOL, V180, P2625, DOI 10.4049/jimmunol.180.4.2625; Kenagy RD, 2005, J HISTOCHEM CYTOCHEM, V53, P131, DOI 10.1369/jhc.4A6493.2005; Kenagy RD, 2006, TRENDS CARDIOVAS MED, V16, P209, DOI 10.1016/j.tcm.2006.03.011; Klass BR, 2009, POSTGRAD MED J, V85, P9, DOI 10.1136/pgmj.2008.069831; KNUDSON CB, 1987, DEV BIOL, V124, P82, DOI 10.1016/0012-1606(87)90462-3; Lemire JM, 2006, MECH AGEING DEV, V127, P660, DOI 10.1016/j.mad.2006.03.004; Lemke AK, 2010, CELL TISSUE RES, V340, P179, DOI 10.1007/s00441-010-0941-4; Lemons ML, 2001, J NEUROSCI, V21, P4772, DOI 10.1523/JNEUROSCI.21-13-04772.2001; Li J, 2011, J ORTHOP RES, V29, P516, DOI 10.1002/jor.21215; Li LL, 2006, J BIOL CHEM, V281, P26512, DOI 10.1074/jbc.M605607200; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Malfait AM, 2010, OSTEOARTHR CARTILAGE, V18, P572, DOI 10.1016/j.joca.2009.11.013; Malgouries S, 2008, BRIT J DERMATOL, V158, P234, DOI 10.1111/j.1365-2133.2007.08339.x; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Moses MA, 1996, J CELL BIOCHEM, V60, P379, DOI 10.1002/(SICI)1097-4644(19960301)60:3<379::AID-JCB9>3.0.CO;2-T; Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947; Patel KP, 2007, SPINE, V32, P2596, DOI 10.1097/BRS.0b013e318158cb85; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plaas A, 2007, OSTEOARTHR CARTILAGE, V15, P719, DOI 10.1016/j.joca.2006.12.008; Plaas AHK, 1997, J BIOL CHEM, V272, P20603, DOI 10.1074/jbc.272.33.20603; PLAAS AHK, 1993, MATRIX, V13, P135, DOI 10.1016/S0934-8832(11)80072-7; Plaas A, 2011, J ORTHOP RES, V29, P900, DOI 10.1002/jor.21332; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Saed GM, 2004, WOUND REPAIR REGEN, V12, P557, DOI 10.1111/j.1067-1927.2004.012508.x; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Schrementi ME, 2008, WOUND REPAIR REGEN, V16, P80, DOI 10.1111/j.1524-475X.2007.00320.x; Sumiyoshi K, 2003, BRIT J DERMATOL, V149, P464, DOI 10.1046/j.1365-2133.2003.05490.x; TAMMI R, 1991, J INVEST DERMATOL, V97, P126, DOI 10.1111/1523-1747.ep12478553; TAMMI R, 1988, J INVEST DERMATOL, V90, P412, DOI 10.1111/1523-1747.ep12456530; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; Toriseva M, 2009, CELL MOL LIFE SCI, V66, P203, DOI 10.1007/s00018-008-8388-4; Voros G, 2006, BBA-GEN SUBJECTS, V1760, P1837, DOI 10.1016/j.bbagen.2006.08.016; Wang XJ, 2006, J INVEST DERM SYMP P, V11, P112, DOI 10.1038/sj.jidsymp.5650004; Wang Z, 2007, J PLAST RECONSTR AES, V60, P1193, DOI 10.1016/j.bjps.2006.05.007; Wilson CG, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2862; Yu Q, 2000, GENE DEV, V14, P163	54	57	57	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26016	26027		10.1074/jbc.M110.208694	http://dx.doi.org/10.1074/jbc.M110.208694			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21566131	Green Published, hybrid			2022-12-25	WOS:000293073000060
J	Dissing, BS; Nielsen, ME; Ersboll, BK; Frosch, S				Dissing, Bjorn S.; Nielsen, Michael E.; Ersboll, Bjarne K.; Frosch, Stina			Multispectral Imaging for Determination of Astaxanthin Concentration in Salmonids	PLOS ONE			English	Article							ATLANTIC SALMON; QUALITY; VISION; LIVE	Multispectral imaging has been evaluated for characterization of the concentration of a specific cartenoid pigment; astaxanthin. 59 fillets of rainbow trout, Oncorhynchus mykiss, were filleted and imaged using a rapid multispectral imaging device for quantitative analysis. The multispectral imaging device captures reflection properties in 19 distinct wavelength bands, prior to determination of the true concentration of astaxanthin. The samples ranged from 0.20 to 4.34 mu g per g fish. A PLSR model was calibrated to predict astaxanthin concentration from novel images, and showed good results with a RMSEP of 0.27. For comparison a similar model were built for normal color images, which yielded a RMSEP of 0.45. The acquisition speed of the multispectral imaging system and the accuracy of the PLSR model obtained suggest this method as a promising technique for rapid in-line estimation of astaxanthin concentration in rainbow trout fillets.	[Dissing, Bjorn S.; Ersboll, Bjarne K.] Tech Univ Denmark, Dept Informat & Math Modeling, Lyngby, Denmark; [Nielsen, Michael E.; Frosch, Stina] Tech Univ Denmark, Div Ind Food Technol, Natl Food Inst, Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Dissing, BS (corresponding author), Tech Univ Denmark, Dept Informat & Math Modeling, Lyngby, Denmark.	bdi@imm.dtu.dk; sfr@aqua.dtu.dk	Nielsen, Michael Canova Engelbrecht/L-4911-2019	Nielsen, Michael Canova Engelbrecht/0000-0001-5044-4441; Ersboll, Bjarne Kjaer/0000-0003-1262-7890	Danish Food Industry Agency under The Ministry of Food, Agriculture and Fisheries [3304-FVFP-07-770-01]	Danish Food Industry Agency under The Ministry of Food, Agriculture and Fisheries	This study was supported by grant No 3304-FVFP-07-770-01 from The Danish Food Industry Agency under The Ministry of Food, Agriculture and Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 2000, P 10 BIENN C INT I F; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brosnan T, 2004, J FOOD ENG, V61, P3, DOI 10.1016/S0260-8774(03)00183-3; Brown SD, 1995, APPL SPECTROSC, V49, pA14, DOI 10.1366/0003702953965876; BUCHWALD M, 1968, BIOCHEMISTRY-US, V7, P834, DOI 10.1021/bi00842a042; Carstensen J.M., 2006, 9 MED IM COMP COMP A; CLEMMENSEN LH, 2009, MACHINE VISION APPL; CLEMMESEN LH, 2006, MICCAI 06 WORKSH BIO, P15; Gomez DD, 2007, COMPUT VIS IMAGE UND, V106, P183, DOI 10.1016/j.cviu.2006.06.011; DISSING BS, 2009, P I EL EL ENG IEEE C; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Folkestad A, 2008, AQUACULTURE, V280, P129, DOI 10.1016/j.aquaculture.2008.04.037; FOLMHANSEN J, 1999, THESIS DTU R PETERSE; GOMEZ DD, 2005, THESIS DTU R PETERSE; GORMLEY TR, 1992, IRISH J AGR FOOD RES, V31, P199; GREEN AA, 1988, IEEE T GEOSCI REMOTE, V26, P65, DOI 10.1109/36.3001; Hansen ME, 2005, LECT NOTES COMPUT SC, V3540, P1228; Hansen ME, 2003, J MICROBIOL METH, V52, P221, DOI 10.1016/S0167-7012(02)00160-4; HANSEN ME, 2005, THESIS DTU R PETERSE; Hastie T., 2009, UNSUPERVISED LEARNIN; HEIA K, 2008, 38 W EUR FISH TECHN; Heia K, 2007, J FOOD SCI, V72, pE11, DOI 10.1111/j.1750-3841.2006.00212.x; MALETTI GM, 2003, THESIS DTU R PETERSE; Misimi E, 2007, J FOOD SCI, V72, pS30, DOI 10.1111/j.1750-3841.2006.00241.x; NIELSEN ME, 2005, 7 JOINT M 50 ANN ATL; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; QUEVEDO RA, 2008, FOOD BIOPROCESS TECH; Sivertsen AH, 2009, J FOOD ENG, V90, P317, DOI 10.1016/j.jfoodeng.2008.06.035; SIVERTSEN AH, 2008, INFOFISH INT, V3; Skjervold PO, 2001, AQUACULTURE, V194, P315, DOI 10.1016/S0044-8486(00)00531-7; SKREDE G, 1986, AQUACULTURE, V53, P279, DOI 10.1016/0044-8486(86)90358-3; SKREDE G, 1990, J FOOD SCI, V55, P361, DOI 10.1111/j.1365-2621.1990.tb06763.x; STONE M, 1977, BIOMETRIKA, V64, P29; Wyszecki G., 2000, COLOR SCI CONCEPTS M; ZHAO Y, 2005, 10 C INT COL ASS	35	52	55	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19032	10.1371/journal.pone.0019032	http://dx.doi.org/10.1371/journal.pone.0019032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573000	Green Published, gold, Green Submitted			2022-12-25	WOS:000290440200005
J	Lu, JB; Jiang, L; Yu, L; Sun, Q				Lu, Jianbo; Jiang, Lin; Yu, Lin; Sun, Que			Local Factors Determine Plant Community Structure on Closely Neighbored Islands	PLOS ONE			English	Article							COMPREHENSIVE FRAMEWORK; METACOMMUNITY STRUCTURE; INTERCONNECTED PONDS; SPATIAL PROCESSES; SPECIES RICHNESS; BETA-DIVERSITY; MODEL SYSTEMS; ECOLOGY; DISPERSAL; MATRICES	Despite the recent popularity of the metacommunity concept, ecologists have not evaluated the applicability of different metacommunity frameworks to insular organisms. We surveyed 50 closely spaced islands in the Thousand-Island Lake of China to examine the role of local (environmental) and regional (dispersal) factors in structuring woody plant assemblages (tree and shrub species) on these islands. By partitioning the variation in plant community structure into local and regional causes, we showed that local environmental conditions, specifically island morphometric characteristics, accounted for the majority of the variation in plant community structure among the studied islands. Spatial variables, representing the potential importance of species dispersal, explained little variation. We conclude that one metacommunity framework-species sorting-best characterizes these plant communities. This result reinforces the idea that the traditional approach of emphasizing the local perspective when studying ecological communities continues to hold its value.	[Lu, Jianbo] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Jiang, Lin] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Yu, Lin; Sun, Que] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Hangzhou Normal University; University System of Georgia; Georgia Institute of Technology; Zhejiang University	Lu, JB (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Xiasha Campus, Hangzhou, Zhejiang, Peoples R China.	jianbo.lu63@gmail.com; lin.jiang@biology.gatech.edu	Jiang, Lin/K-5572-2019		Natural Science Foundation of China [30570320]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the Natural Science Foundation of China (grant no. 30570320). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P335; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cottenie K, 2003, ECOLOGY, V84, P991, DOI 10.1890/0012-9658(2003)084[0991:ZMSRVL]2.0.CO;2; Cottenie K, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P189; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Davies KF, 2009, J ANIM ECOL, V78, P937, DOI 10.1111/j.1365-2656.2009.01559.x; Ding LiZhong, 2004, Biodiversity Science, V12, P473; [丁立仲 DING Lizhong], 2006, [浙江大学学报. 农业与生命科学版, Journal of Zhejiang University. Agriculture and Life Sciences], V32, P563; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Driscoll DA, 2009, ECOL MONOGR, V79, P485, DOI 10.1890/08-1114.1; Duivenvoorden JF, 2002, SCIENCE, V295, P636, DOI 10.1126/science.295.5555.636; Ellis AM, 2006, ECOLOGY, V87, P2582, DOI 10.1890/0012-9658(2006)87[2582:ETLMDO]2.0.CO;2; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gonzalez A, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P146; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Guelat J, 2008, ECOLOGY, V89, P2033, DOI 10.1890/07-0905.1; Harrison S, 2008, ECOL LETT, V11, P969, DOI 10.1111/j.1461-0248.2008.01210.x; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jiang PeiKun, 1999, Journal of Zhejiang Forestry College, V16, P260; Kolasa J, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P212; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Li X. H., 2001, BIODIVERSITY SCI, V9, P68; LU J. B., 2005, CHINESE J APPL ECOLO, V16, P1672; MAC ARTHUR ROBERT H., 1967; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Michels E, 2001, HYDROBIOLOGIA, V442, P117, DOI 10.1023/A:1017549416362; Moser D, 2002, LANDSCAPE ECOL, V17, P657, DOI 10.1023/A:1021513729205; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Myers JA, 2009, ECOL LETT, V12, P1250, DOI 10.1111/j.1461-0248.2009.01373.x; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pringle RM, 2007, P NATL ACAD SCI USA, V104, P193, DOI 10.1073/pnas.0609840104; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Seifert, 2000, AUSTR GEOGRAPHICAL S, V38, P263, DOI [https://doi.org/10.1111/1467-8470.00115, DOI 10.1111/1467-8470.00115]; [孙雀 SUN Que], 2009, [生态学报, Acta Ecologica Sinica], V29, P2195; Sun Que, 2008, Shengwu Duoyangxing, V16, P1, DOI 10.3724/SP.J.1003.2008.07168; Svoray T, 2007, LANDSCAPE ECOL, V22, P105, DOI 10.1007/s10980-006-9004-3; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Urban MC, 2004, ECOLOGY, V85, P2971, DOI 10.1890/03-0631; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Vitousek PM, 2002, J BIOGEOGR, V29, P573, DOI 10.1046/j.1365-2699.2002.00707.x; Wardle DA, 2002, J BIOGEOGR, V29, P583, DOI 10.1046/j.1365-2699.2002.00708.x; Wu J.G., 2007, LANDSCAPE ECOLOGY PA, V2nd; [张欣 ZHANG Xin], 2007, [生态学报, Acta Ecologica Sinica], V27, P424, DOI 10.1016/S1872-2032(07)60014-6; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3	58	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19762	10.1371/journal.pone.0019762	http://dx.doi.org/10.1371/journal.pone.0019762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572960	Green Published, Green Submitted, gold			2022-12-25	WOS:000290440200026
J	Du, XN; Fleiss, B; Li, HF; D'angelo, B; Sun, YY; Zhu, CL; Hagberg, H; Levy, O; Mallard, C; Wang, XY				Du, Xiaonan; Fleiss, Bobbi; Li, Hongfu; D'angelo, Barbara; Sun, Yanyan; Zhu, Changlian; Hagberg, Henrik; Levy, Ofer; Mallard, Carina; Wang, Xiaoyang			Systemic Stimulation of TLR2 Impairs Neonatal Mouse Brain Development	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ADULT HIPPOCAMPAL NEUROGENESIS; PROGENITOR-CELL PROLIFERATION; FOCAL CEREBRAL-ISCHEMIA; WHITE-MATTER INJURY; INNATE IMMUNITY; ISCHEMIA/REPERFUSION INJURY; LIPOTEICHOIC ACID; HYPOXIA-ISCHEMIA; PREMATURE-INFANT	Background: Inflammation is associated with perinatal brain injury but the underlying mechanisms are not completely characterized. Stimulation of Toll-like receptors (TLRs) through specific agonists induces inflammatory responses that trigger both innate and adaptive immune responses. The impact of engagement of TLR2 signaling pathways on the neonatal brain is still unclear. The aim of this study was to investigate the potential effect of a TLR2 agonist on neonatal brain development. Methodology/Principal Findings: Mice were injected intraperitoneally (i.p.) once a day from postnatal day (PND) 3 to PND11 with endotoxin-free saline, a TLR2 agonist Pam(3)CSK(4) (5 mg/kg) or Lipopolysaccharide (LPS, 0.3 mg/kg). Pups were sacrificed at PND12 or PND53 and brain, spleen and liver were collected and weighed. Brain sections were stained for brain injury markers. Long-term effects on memory function were assessed using the Trace Fear Conditioning test at PND50. After 9 days of Pam(3)CSK(4) administration, we found a decreased volume of cerebral gray matter, white matter in the forebrain and cerebellar molecular layer that was accompanied by an increase in spleen and liver weight at PND12. Such effects were not observed in Pam3CSK4-treated TLR 2-deficient mice. Pam3CSK4-treated mice also displayed decreased hippocampus neuronal density, and increased cerebral microglia density, while there was no effect on caspase-3 or general cell proliferation at PND12. Significantly elevated levels of IL-1 beta, IL-6, KC, and MCP-1 were detected after the first Pam3CSK4 injection in brain homogenates of PND3 mice. Pam(3)CSK(4) administration did not affect long-term memory function nor the volume of gray or white matter. Conclusions/Significance: Repeated systemic exposure to the TLR2 agonist Pam(3)CSK(4) can have a short-term negative impact on the neonatal mouse brain.	[Du, Xiaonan; Fleiss, Bobbi; D'angelo, Barbara; Hagberg, Henrik; Mallard, Carina; Wang, Xiaoyang] Univ Gothenburg, Dept Neurosci & Physiol, Perinatal Ctr, Gothenburg, Sweden; [Du, Xiaonan; Li, Hongfu; Sun, Yanyan; Zhu, Changlian; Wang, Xiaoyang] Zhengzhou Univ, Dept Pediat, Affiliated Hosp 3, Zhengzhou, Peoples R China; [Li, Hongfu; Sun, Yanyan; Zhu, Changlian] Univ Gothenburg, Ctr Brain Repair & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden; [Hagberg, Henrik] Univ Gothenburg, Perinatal Ctr, Dept Obstet & Gynecol, Gothenburg, Sweden; [Hagberg, Henrik] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Levy, Ofer] Harvard Univ, Sch Med, Boston, MA USA; [Levy, Ofer] Childrens Hosp Boston, Dept Med, Div Infect Dis, Boston, MA USA	University of Gothenburg; Zhengzhou University; University of Gothenburg; University of Gothenburg; Imperial College London; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Du, XN (corresponding author), Univ Gothenburg, Dept Neurosci & Physiol, Perinatal Ctr, Gothenburg, Sweden.	xiaoyang.wang@fysiologi.gu.se	Fleiss, Bobbi/F-9899-2011; Zhu, Changlian/AAN-6205-2020	Fleiss, Bobbi/0000-0001-7828-673X; Levy, Ofer/0000-0002-5859-1945; Zhu, Changlian/0000-0002-5029-6730; Mallard, Carina/0000-0001-8953-919X; Wang, Xiaoyang/0000-0001-9717-8160; Hagberg, Henrik/0000-0003-3962-1448	Swedish Medical Research Council [VR K2009-54X-21119-01-4, VR K2007-54x-14185-06-3, VR 2006-3396]; Wilhelm and Martina Lundgren [vet2-41/2010]; Signhild Engkvists Stiftelse; Linnea och Josef Carlssons stiftelse; National Natural Science Foundation of China [30973240]; Swedish governmental grants [ALFGBG2863]; Medical Research Council in United Kingdom [P19381]; Ahlen stiftelse; National Institutes of Health, USA [RO1 NIAID-AI067353-01A1]; EU [036534, HEALTH-F2-2009-241778]; 3M Drug Delivery Systems; VentiRx; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067353] Funding Source: NIH RePORTER; Medical Research Council [G0802853] Funding Source: researchfish; Action Medical Research [1764] Funding Source: researchfish; MRC [G0802853] Funding Source: UKRI	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Wilhelm and Martina Lundgren; Signhild Engkvists Stiftelse; Linnea och Josef Carlssons stiftelse; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swedish governmental grants; Medical Research Council in United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ahlen stiftelse; National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); 3M Drug Delivery Systems(3M); VentiRx; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Swedish Medical Research Council (VR K2009-54X-21119-01-4 to XW, VR K2007-54x-14185-06-3 to CM, VR 2006-3396 to HH), Wilhelm and Martina Lundgren (vet2-41/2010 to XW), Signhild Engkvists Stiftelse (to XW), Linnea och Josef Carlssons stiftelse (HH), National Natural Science Foundation of China (30973240 to XW), Swedish governmental grants to researchers in the public health service (ALFGBG2863 to HH) and Medical Research Council in United Kingdom (P19381 to HH). Ahlen stiftelse (CM), National Institutes of Health, USA (RO1 NIAID-AI067353-01A1 to OL). EU FP6, Neobrain (036534 to HH and CM) and the European Union (HEALTH-F2-2009-241778 to CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; OL served as a consultant to MedImmune and Biosynexus. OL's laboratory receives material and/or sponsored research support from 3M Drug Delivery Systems and VentiRx. None of the other authors declare any conflicts.	Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; Atkins AL, 2008, PHARMACOL BIOCHEM BE, V90, P481, DOI 10.1016/j.pbb.2008.04.007; Bizzarro MJ, 2005, PEDIATRICS, V116, P595, DOI 10.1542/peds.2005-0552; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Chau TA, 2009, NAT MED, V15, P641, DOI 10.1038/nm.1965; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; Dean JM, 2009, NEUROSCIENCE, V160, P606, DOI 10.1016/j.neuroscience.2009.02.071; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Eklind S, 2004, DEV NEUROSCI-BASEL, V26, P61, DOI 10.1159/000080713; Favrais G, 2007, NEUROBIOL DIS, V25, P496, DOI 10.1016/j.nbd.2006.10.012; Gerlai R, 1998, BEHAV BRAIN RES, V95, P191, DOI 10.1016/S0166-4328(97)00144-7; Ha TZ, 2010, CARDIOVASC RES, V87, P694, DOI 10.1093/cvr/cvq116; Hagberg H, 1996, PEDIATR RES, V40, P603, DOI 10.1203/00006450-199610000-00015; Heldwein KA, 2003, J LEUKOCYTE BIOL, V74, P277, DOI 10.1189/jlb.0103026; Hoffmann O, 2007, J IMMUNOL, V178, P6476, DOI 10.4049/jimmunol.178.10.6476; Hua F, 2008, J NEUROIMMUNOL, V199, P75, DOI 10.1016/j.jneuroim.2008.05.009; Hua F, 2009, BRAIN RES, V1262, P100, DOI 10.1016/j.brainres.2009.01.018; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Khashu M, 2006, PEDIATRICS, V117, P340, DOI 10.1542/peds.2005-0333; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; Laflamme N, 2001, J NEUROCHEM, V79, P648, DOI 10.1046/j.1471-4159.2001.00603.x; Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008; Latz E, 2004, J IMMUNOL, V172, P2431, DOI 10.4049/jimmunol.172.4.2431; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2006, J IMMUNOL, V177, P583, DOI 10.4049/jimmunol.177.1.583; Lehnardt S, 2007, J NEUROIMMUNOL, V190, P28, DOI 10.1016/j.jneuroim.2007.07.023; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Long EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005601; Mallard C, 2000, NEUROSCIENCE, V100, P327, DOI 10.1016/S0306-4522(00)00271-2; Mallard C, 2009, CLIN PERINATOL, V36, P763, DOI 10.1016/j.clp.2009.07.009; Mersmann J, 2010, CRIT CARE MED, V38, P903, DOI 10.1097/CCM.0b013e3181ce50e6; Messerschmidt A, 2005, AM J NEURORADIOL, V26, P1659; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nadeau S, 2003, J NEUROSCI, V23, P5536, DOI 10.1523/jneurosci.23-13-05536.2003; Okun E, 2010, J NEUROCHEM, V114, P462, DOI 10.1111/j.1471-4159.2010.06778.x; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Reddy K, 1998, PEDIATR RES, V43, P674, DOI 10.1203/00006450-199805000-00017; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Rousset CI, 2006, PEDIATR RES, V59, P428, DOI 10.1203/01.pdr.0000199905.08848.55; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Sellner J, 2009, J NEUROIMMUNOL, V206, P28, DOI 10.1016/j.jneuroim.2008.10.004; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; Strunk T, 2010, J MATERN FETAL NEONA; Strunk T, 2007, CURR OPIN INFECT DIS, V20, P370, DOI 10.1097/QCO.0b013e3281a7ec98; Strunk T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010111; Svedin P, 2009, DEV NEUROSCI-BASEL, V31, P427, DOI 10.1159/000232561; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Volpe JJ, 2011, INT J DEV NEUROS MAR; Volpe JJ, 2009, J CHILD NEUROL, V24, P1085, DOI 10.1177/0883073809338067; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wang XY, 2007, BRAIN RES, V1144, P180, DOI 10.1016/j.brainres.2007.01.083; Wang XY, 2010, STROKE, V41, P2050, DOI 10.1161/STROKEAHA.110.589051; Wang XY, 2009, J CHILD NEUROL, V24, P1171, DOI 10.1177/0883073809338068; Wolfberg AJ, 2007, SEMIN FETAL NEONAT M, V12, P296, DOI 10.1016/j.siny.2007.01.021; Zhang JP, 2010, PEDIAT RES AUG, V2010; Ziegler G, 2007, BIOCHEM BIOPH RES CO, V359, P574, DOI 10.1016/j.bbrc.2007.05.157	59	63	67	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19583	10.1371/journal.pone.0019583	http://dx.doi.org/10.1371/journal.pone.0019583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573120	Green Submitted, Green Published, gold			2022-12-25	WOS:000290305600031
J	Hofmann, N; Wurm, R; Wagner, R				Hofmann, Nina; Wurm, Reinhild; Wagner, Rolf			The E. coli Anti-Sigma Factor Rsd: Studies on the Specificity and Regulation of Its Expression	PLOS ONE			English	Article							RNA-POLYMERASE HOLOENZYME; PHASE GENE-REGULATION; ESCHERICHIA-COLI; 6S RNA; H-NS; TRANSCRIPTION REGULATION; CORE ENZYME; FACTOR ASIA; T4 ASIA; PROMOTER	Background: Among the seven different sigma factors in E. coli sigma(70) has the highest concentration and affinity for the core RNA polymerase. The E. coli protein Rsd is regarded as an anti-sigma factor, inhibiting sigma(70)-dependent transcription at the onset of stationary growth. Although binding of Rsd to sigma(70) has been shown and numerous structural studies on Rsd have been performed the detailed mechanism of action is still unknown. Methodology/Principal Findings: We have performed studies to unravel the function and regulation of Rsd expression in vitro and in vivo. Cross-linking and affinity binding revealed that Rsd is able to interact with sigma(70), with the core enzyme of RNA polymerase and is able to form dimers in solution. Unexpectedly, we find that Rsd does also interact with sigma(38), the stationary phase-specific sigma factor. This interaction was further corroborated by gel retardation and footprinting studies with different promoter fragments and sigma(38)- or sigma(70)-containing RNA polymerase in presence of Rsd. Under competitive in vitro transcription conditions, in presence of both sigma factors, a selective inhibition of sigma(70)-dependent transcription was prevailing, however. Analysis of rsd expression revealed that the nucleoid-associated proteins H-NS and FIS, StpA and LRP bind to the regulatory region of the rsd promoters. Furthermore, the major promoter P2 was shown to be down-regulated in vivo by RpoS, the stationary phase-specific sigma factor and the transcription factor DksA, while induction of the stringent control enhanced rsd promoter activity. Most notably, the dam-dependent methylation of a cluster of GATC sites turned out to be important for efficient rsd transcription. Conclusions/Significance: The results contribute to a better understanding of the intricate mechanism of Rsd-mediated sigma factor specificity changes during stationary phase.	[Hofmann, Nina; Wurm, Reinhild; Wagner, Rolf] Univ Dusseldorf, Inst Phys Biol, D-4000 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Wagner, R (corresponding author), Univ Dusseldorf, Inst Phys Biol, D-4000 Dusseldorf, Germany.	r.wagner@rz.uni-duesseldorf.de			Grunderstiftung; Deutsche Forschungsgemeinschaft [WA 455/12]	Grunderstiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	N.H. was supported by a grant from the Grunderstiftung (http://www.unifreunde-duesseldorf.de/stiftungen/gruenderstiftung.php). The authors are grateful to the Deutsche Forschungsgemeinschaft for financial support (WA 455/12; http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg A, 2008, MOL MICROBIOL, V67, P1223, DOI 10.1111/j.1365-2958.2008.06115.x; Aberg A, 2009, J BACTERIOL, V191, P3226, DOI 10.1128/JB.01410-08; Adelman K, 1997, J BIOL CHEM, V272, P27435, DOI 10.1074/jbc.272.43.27435; Bernardo LMD, 2006, MOL MICROBIOL, V60, P749, DOI 10.1111/j.1365-2958.2006.05129.x; Bordes P, 2000, MOL MICROBIOL, V35, P845, DOI 10.1046/j.1365-2958.2000.01758.x; BORUKHOV S, 1993, PROTEIN EXPRES PURIF, V4, P503, DOI 10.1006/prep.1993.1066; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; Campbell EA, 2008, CURR OPIN MICROBIOL, V11, P121, DOI 10.1016/j.mib.2008.02.016; Checroun C, 2004, NUCLEIC ACIDS RES, V32, P45, DOI 10.1093/nar/gkh155; Chen S, 2002, J MOL BIOL, V318, P1031, DOI 10.1016/S0022-2836(02)00187-0; Colland F, 1999, EMBO J, V18, P4049, DOI 10.1093/emboj/18.14.4049; Colland F, 2002, GENES CELLS, V7, P233, DOI 10.1046/j.1365-2443.2002.00517.x; Dorman CJ, 2009, ADV APPL MICROBIOL, V67, P47, DOI 10.1016/S0065-2164(08)01002-2; Geissen R, 2010, RNA BIOL, V7, P564, DOI 10.4161/rna.7.5.12969; GONZALEZ N, 1977, ARCH BIOCHEM BIOPHYS, V182, P404, DOI 10.1016/0003-9861(77)90521-5; Grigorova IL, 2006, P NATL ACAD SCI USA, V103, P5332, DOI 10.1073/pnas.0600828103; HAYATSU H, 1967, BIOCHEM BIOPH RES CO, V29, P556, DOI 10.1016/0006-291X(67)90521-9; Helmann JD, 1999, CURR OPIN MICROBIOL, V2, P135, DOI 10.1016/S1369-5274(99)80024-1; Hengge-Aronis R, 2002, CURR OPIN MICROBIOL, V5, P591, DOI 10.1016/S1369-5274(02)00372-7; HENGGEARONIS R, 1993, CELL, V72, P165, DOI 10.1016/0092-8674(93)90655-A; Hillebrand A, 2005, BIOL CHEM, V386, P523, DOI 10.1515/BC.2005.062; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; IGARASHI K, 1991, J MOL BIOL, V218, P1, DOI 10.1016/0022-2836(91)90865-4; Ilag LL, 2004, STRUCTURE, V12, P269, DOI 10.1016/j.str.2004.01.007; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Jishage M, 1999, J BACTERIOL, V181, P3768, DOI 10.1128/JB.181.12.3768-3776.1999; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995; Kim EY, 2004, J MICROBIOL, V42, P103; KOLB A, 1995, NUCLEIC ACIDS RES, V23, P819, DOI 10.1093/nar/23.5.819; Kvaratskhelia M, 2002, J BIOL CHEM, V277, P16689, DOI 10.1074/jbc.M109914200; Lambert LJ, 2004, EMBO J, V23, P2952, DOI 10.1038/sj.emboj.7600312; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Maxam A M, 1980, Methods Enzymol, V65, P499; Minakhin L, 2003, J MOL BIOL, V326, P679, DOI 10.1016/S0022-2836(02)01442-0; Mitchell JE, 2007, J BACTERIOL, V189, P3489, DOI 10.1128/JB.00019-07; Munch R, 2003, NUCLEIC ACIDS RES, V31, P266, DOI 10.1093/nar/gkg037; Neusser T, 2008, BIOL CHEM, V389, P285, DOI 10.1515/BC.2008.023; Neusser T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-165; Nguyen LH, 1997, BIOCHEMISTRY-US, V36, P1748, DOI 10.1021/bi961175h; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Orsini G, 2001, J BIOL CHEM, V276, P19812, DOI 10.1074/jbc.M010105200; Oshima T, 2002, MOL MICROBIOL, V45, P673, DOI 10.1046/j.1365-2958.2002.03037.x; Patikoglou GA, 2007, J MOL BIOL, V372, P649, DOI 10.1016/j.jmb.2007.06.081; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Pineda M, 2004, J MOL BIOL, V344, P1183, DOI 10.1016/j.jmb.2004.10.003; Piper SE, 2009, MOL BIOSYST, V5, P1943, DOI [10.1039/b904955j, 10.1039/B904955j]; Pul U, 2005, MOL MICROBIOL, V58, P864, DOI 10.1111/j.1365-2958.2005.04873.x; Pul U, 2007, J MOL BIOL, V366, P900, DOI 10.1016/j.jmb.2006.11.067; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Rutherford ST, 2009, GENE DEV, V23, P236, DOI 10.1101/gad.1745409; Sharma UK, 2008, J BACTERIOL, V190, P3434, DOI 10.1128/JB.01792-07; Sharma UK, 2010, FEMS MICROBIOL REV, V34, P646, DOI 10.1111/j.1574-6976.2010.00223.x; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P3511, DOI 10.1073/pnas.90.8.3511; Trotochaud AE, 2004, J BACTERIOL, V186, P4978, DOI 10.1128/JB.186.15.4978-4985.2004; Typas A, 2007, MOL MICROBIOL, V63, P1296, DOI 10.1111/j.1365-2958.2007.05601.x; Typas A, 2007, EMBO J, V26, P1569, DOI 10.1038/sj.emboj.7601629; Urbauer JL, 2002, P NATL ACAD SCI USA, V99, P1831, DOI 10.1073/pnas.032464699; Urbauer JL, 2001, J BIOL CHEM, V276, P41128, DOI 10.1074/jbc.M106400200; VANDERWOUDE MW, 1994, MOL MICROBIOL, V11, P605; VICENTE M, 1991, MOL MICROBIOL, V5, P2085, DOI 10.1111/j.1365-2958.1991.tb02137.x; Wassarman KM, 2007, MOL MICROBIOL, V65, P1425, DOI 10.1111/j.1365-2958.2007.05894.x; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Yuan AH, 2008, MOL MICROBIOL, V70, P1136, DOI 10.1111/j.1365-2958.2008.06462.x; ZACHARIAS M, 1990, NUCLEIC ACIDS RES, V18, P6271, DOI 10.1093/nar/18.21.6271	67	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19235	10.1371/journal.pone.0019235	http://dx.doi.org/10.1371/journal.pone.0019235			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573101	Green Published, gold, Green Submitted			2022-12-25	WOS:000290305600016
J	Gu, B; Zhang, JR; Wu, Y; Zhang, XZ; Tan, Z; Lin, YJ; Huang, X; Chen, LB; Yao, KS; Zhang, M				Gu, Bin; Zhang, Jiarong; Wu, Ying; Zhang, Xinzong; Tan, Zhou; Lin, Yuanji; Huang, Xiao; Chen, Liangbiao; Yao, Kangshou; Zhang, Ming			Proteomic Analyses Reveal Common Promiscuous Patterns of Cell Surface Proteins on Human Embryonic Stem Cells and Sperms	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; GROWTH-FACTOR; SELF-RENEWAL; MEMBRANE-PROTEINS; PLURIPOTENCY; DIFFERENTIATION; CHROMATIN; MOUSE; EXPRESSION; LINES	Background: It has long been proposed that early embryos and reproductive organs exhibit similar gene expression profiles. However, whether this similarity is propagated to the protein level remains largely unknown. We have previously characterised the promiscuous expression pattern of cell surface proteins on mouse embryonic stem (mES) cells. As cell surface proteins also play critical functions in human embryonic stem (hES) cells and germ cells, it is important to reveal whether a promiscuous pattern of cell surface proteins also exists for these cells. Methods and Principal Findings:Surface proteins of hES cells and human mature sperms (hSperms) were purified by biotin labelling and subjected to proteomic analyses. More than 1000 transmembrane or secreted cell surface proteins were identified on the two cell types, respectively. Proteins from both cell types covered a large variety of functional categories including signal transduction, adhesion and transporting. Moreover, both cell types promiscuously expressed a wide variety of tissue specific surface proteins, and some surface proteins were heterogeneously expressed. Conclusions/Significance: Our findings indicate that the promiscuous expression of functional and tissue specific cell surface proteins may be a common pattern in embryonic stem cells and germ cells. The conservation of gene expression patterns between early embryonic cells and reproductive cells is propagated to the protein level. These results have deep implications for the cell surface signature characterisation of pluripotent stem cells and germ cells and may lead the way to a new area of study, i.e., the functional significance of promiscuous gene expression in pluripotent and germ cells.	[Gu, Bin; Zhang, Jiarong; Tan, Zhou; Lin, Yuanji; Zhang, Ming] Zhejiang Univ, Coll Life Sci, Inst Genet, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Ying; Zhang, Xinzong; Yao, Kangshou] Zhejiang Inst Planned Parenthood Res, Hangzhou, Zhejiang, Peoples R China; [Wu, Ying; Zhang, Xinzong; Yao, Kangshou] Zhejiang Human Sperm Bank, Hangzhou, Zhejiang, Peoples R China; [Huang, Xiao] Zhejiang Univ, Coll Life Sci, Inst Cell & Dev Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Liangbiao] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Gu, B (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Genet, Hangzhou 310003, Zhejiang, Peoples R China.	ksyao@163.net; zhangming_ls@zju.edu.cn	Huang, Xiao/Q-2410-2019; HUANG, xiao/F-9527-2013	Huang, Xiao/0000-0002-7536-1762; , liangbiao/0000-0002-0717-8536; Gu, Bin/0000-0002-5594-2463	Ministry of Science and Technology of the People's Republic of China; National Key Scientific Research Program of China [2007947804]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Key Scientific Research Program of China	This work was supported by grants from the Ministry of Science and Technology of the People's Republic of China and the National Key Scientific Research Program of China (2007947804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelalim EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005341; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Bialas M, 2009, AM J REPROD IMMUNOL, V62, P51, DOI 10.1111/j.1600-0897.2009.00711.x; Boerke A, 2007, THERIOGENOLOGY, V68, pS147, DOI 10.1016/j.theriogenology.2007.05.058; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brimble SN, 2007, STEM CELLS, V25, P54, DOI 10.1634/stemcells.2006-0232; Choi Y, 2006, CELL MOL LIFE SCI, V63, P579, DOI 10.1007/s00018-005-5394-7; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dihazi H, 2009, J PROTEOME RES, V8, P5497, DOI 10.1021/pr900565b; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Gu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015795; Gu B, 2010, BIOCHEM BIOPH RES CO, V394, P418, DOI 10.1016/j.bbrc.2010.03.042; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kurosaki H, 2007, BIOCHEM BIOPH RES CO, V353, P259, DOI 10.1016/j.bbrc.2006.12.025; Lanctot PM, 2007, CURR OPIN CHEM BIOL, V11, P373, DOI 10.1016/j.cbpa.2007.05.032; Li CY, 2010, HUM REPROD, V25, P317, DOI 10.1093/humrep/dep406; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Nagano K, 2008, PROTEOMICS, V8, P4025, DOI 10.1002/pmic.200800073; Nishikawa Y, 2010, J EXP MED, V207, P963, DOI 10.1084/jem.20092144; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Oliva-Hernandez J, 2008, THERIOGENOLOGY, V70, P1159, DOI 10.1016/j.theriogenology.2008.06.090; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pangas SA, 2006, HUM REPROD UPDATE, V12, P65, DOI 10.1093/humupd/dmi033; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Schaller CE, 2008, J IMMUNOL, V180, P1338, DOI 10.4049/jimmunol.180.3.1338; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; von Kopylow K, 2010, HUM REPROD, V25, P1104, DOI 10.1093/humrep/deq053; Walker A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1074; *WHO, 1992, WHO LAB MAN EX HUM S, P4; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu XB, 2008, CELL STEM CELL, V2, P461, DOI 10.1016/j.stem.2008.03.001; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037; Zuccotti M, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-97; Zulli A, 2008, HISTOL HISTOPATHOL, V23, P741, DOI 10.14670/HH-23.741	54	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19386	10.1371/journal.pone.0019386	http://dx.doi.org/10.1371/journal.pone.0019386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559292	Green Published, gold, Green Submitted			2022-12-25	WOS:000290223500020
J	Kinoshita, K; Inada, S; Seki, K; Sasaki, A; Hama, N; Kusunoki, H				Kinoshita, Kodzue; Inada, Sayaka; Seki, Kazuya; Sasaki, Aiko; Hama, Natsuki; Kusunoki, Hiroshi			Long-Term Monitoring of Fecal Steroid Hormones in Female Snow Leopards (Panthera uncia) during Pregnancy or Pseudopregnancy	PLOS ONE			English	Article							CHEETAH ACINONYX-JUBATUS; ADRENOCORTICAL FUNCTION; DOMESTIC CAT; FELIDS; METABOLITES; ESTRADIOL; BEHAVIOR; FECES; SERUM	Knowledge of the basic reproductive physiology of snow leopards is required urgently in order to develop a suitable management conditions under captivity. In this study, the long-term monitoring of concentrations of three steroid hormones in fecal matter of three female snow leopards was performed using enzyme immunoassays: (1) estradiol-17 beta, (2) progesterone and (3) cortisol metabolite. Two of the female animals were housed with a male during the winter breeding season, and copulated around the day the estradiol-17 beta metabolite peaked subsequently becoming pregnant. The other female was treated in two different ways: (1) first housed with a male in all year round and then (2) in the winter season only. She did not mate with him on the first occasion, but did so latter around when estradiol-17 beta metabolite peaked, and became pseudopregnant. During pregnancy, progesterone metabolite concentrations increased for 92 or 94 days, with this period being approximately twice as long as in the pseudopregnant case (31, 42, 49 and 53 days). The levels of cortisol metabolite in the pseudopregnant female (1.35 mu g/g) were significantly higher than in the pregnant females (0.33 and 0.24 mu g/g) (P<0.05). Similarly, during the breeding season, the levels of estradiol-17 beta metabolite in the pseudopregnant female (2.18 mu g/g) were significantly higher than those in the pregnant females (0.81 and 0.85 mu g/g) (P<0.05). Unlike cortisol the average levels of estradiol-17 beta during the breeding season were independent of reproductive success. The hormone levels may also be related to housing conditions and the resulting reproductive success in female leopards. The female housed with a male during the non-breeding season had high levels of cortisol metabolites and low levels of estradiol-17 beta in the breeding season, and failed to become pregnant. This indicates that housing conditions in snow leopards may be an important factor for normal endocrine secretion and resulting breeding success.	[Kinoshita, Kodzue; Inada, Sayaka; Kusunoki, Hiroshi] Kobe Univ, Grad Sch Agr, Nada Ku, Kobe, Hyogo 657, Japan; [Seki, Kazuya; Hama, Natsuki] Kobe Municipal Oji Zoo, Nada Ku, Kobe, Hyogo, Japan; [Sasaki, Aiko] Tama Zool Pk, Hino, Tokyo, Japan	Kobe University	Kinoshita, K (corresponding author), Kobe Univ, Grad Sch Agr, Nada Ku, Kobe, Hyogo 657, Japan.	kusunoki@kobe-u.ac.jp		Kinoshita, Kodzue/0000-0002-5804-5485				Aziz T, 1996, CBI B, VIV; Brown JL, 2006, THERIOGENOLOGY, V66, P25, DOI 10.1016/j.theriogenology.2006.03.011; Brown JL, 2001, J REP FER S, P71; BROWN JL, 1994, BIOL REPROD, V51, P776, DOI 10.1095/biolreprod51.4.776; C?lix M., 2018, EUROPEAN RED LIST SA; FOOSE TJ, 1983, RELEVANCE CAPTIVE PO, P374; Freeman H., 1983, Zoo Biology, V2, P1, DOI 10.1002/zoo.1430020102; GRAHAM LH, 1995, ZOO BIOL, V14, P223, DOI 10.1002/zoo.1430140304; Graham LH, 2000, THERIOGENOLOGY, V54, P1117, DOI 10.1016/S0093-691X(00)00420-9; Graham LH, 1996, ZOO BIOL, V15, P71, DOI 10.1002/(SICI)1098-2361(1996)15:1<71::AID-ZOO7>3.0.CO;2-9; Jurke MH, 1997, ZOO BIOL, V16, P133, DOI 10.1002/(SICI)1098-2361(1997)16:2<133::AID-ZOO4>3.0.CO;2-B; KINOSHITA K, 2011, ANIMAL REPR IN PRESS; Kinoshita Kozue, 2009, Japanese Journal of Zoo and Wildlife Medicine, V14, P59; McCarthy T, 2003, SNOW LEOPARD SURVIVA; MELTZER DGA, 1999, MED MANAGEMENT CHEET, P415; Moreira N, 2007, ZOO BIOL, V26, P441, DOI 10.1002/zoo.20139; Pelican KM, 2005, GEN COMP ENDOCR, V144, P110, DOI 10.1016/j.ygcen.2005.04.014; Roth TL, 1997, REPROD FERT DEVELOP, V9, P285, DOI 10.1071/R96048; Schaller GB, 1980, STONES SILENCE JOURN; SCHALLER GB, 1977, MOUNTAIN MONACHS WIL; Schatz S, 2001, VET RES COMMUN, V25, P271, DOI 10.1023/A:1010626608498; SCHMIDT AM, 1993, J REPROD FERTIL, V98, P91; SHILLE VM, 1990, THERIOGENOLOGY, V34, P779, DOI 10.1016/0093-691X(90)90032-O; Terio KA, 1999, J ZOO WILDLIFE MED, V30, P484; TOMITA Y, 2010, REGIONAL STUDBOOK SN; VANJAARSVELD AD, 2003, COMP BIOCH PHYSL A, V103, P73; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; Wielebnowski N, 1998, ZOO BIOL, V17, P193, DOI 10.1002/(SICI)1098-2361(1998)17:3<193::AID-ZOO4>3.0.CO;2-4; Wielebnowski NC, 2002, ZOO BIOL, V21, P77, DOI 10.1002/zoo.10005; Wielebnowski NC, 1999, ZOO BIOL, V18, P335, DOI 10.1002/(SICI)1098-2361(1999)18:4<335::AID-ZOO8>3.0.CO;2-X; Young KM, 2004, GEN COMP ENDOCR, V137, P148, DOI 10.1016/j.ygcen.2004.02.016	31	26	27	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2011	6	5							e19314	10.1371/journal.pone.0019314	http://dx.doi.org/10.1371/journal.pone.0019314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759ED	21559303	Green Published, Green Submitted, gold			2022-12-25	WOS:000290222600004
J	Rosemberg, DB; Rico, EP; Mussulini, BM; Piato, AL; Calcagnotto, ME; Bonan, CD; Dias, RD; Blaser, RE; Souza, DO; de Oliveira, DL				Rosemberg, Denis B.; Rico, Eduardo P.; Mussulini, Ben Hur M.; Piato, Angelo L.; Calcagnotto, Maria E.; Bonan, Carla D.; Dias, Renato D.; Blaser, Rachel E.; Souza, Diogo O.; de Oliveira, Diogo L.			Differences in Spatio-Temporal Behavior of Zebrafish in the Open Tank Paradigm after a Short-Period Confinement into Dark and Bright Environments	PLOS ONE			English	Article							RATS RATTUS-NORVEGICUS; MEDAKA ORYZIAS-LATIPES; OPEN-FIELD BEHAVIOR; DANIO-RERIO; EXPLORATORY-BEHAVIOR; ADULT ZEBRAFISH; GENETIC MODEL; HOME BASE; ANXIETY; HABITUATION	The open tank paradigm, also known as novel tank diving test, is a protocol used to evaluate the zebrafish behavior. Several characteristics have been described for this species, including scototaxis, which is the natural preference for dark environments in detriment of bright ones. However, there is no evidence regarding the influence of "natural stimuli" in zebrafish subjected to novelty-based paradigms. In this report, we evaluated the spatio-temporal exploratory activity of the short-fin zebrafish phenotype in the open tank after a short-period confinement into dark/bright environments. A total of 44 animals were individually confined during a 10-min single session into one of three environments: black-painted, white-painted, and transparent cylinders (dark, bright, and transparent groups). Fish were further subjected to the novel tank test and their exploratory profile was recorded during a 15-min trial. The results demonstrated that zebrafish increased their vertical exploratory activity during the first 6-min, where the bright group spent more time and travelled a higher distance in the top area. Interestingly, all behavioral parameters measured for the dark group were similar to the transparent one. These data were confirmed by automated analysis of track and occupancy plots and also demonstrated that zebrafish display a classical homebase formation in the bottom area of the tank. A detailed spatio-temporal study of zebrafish exploratory behavior and the construction of representative ethograms showed that the experimental groups presented significant differences in the first 3-min vs. last 3-min of test. Although the main factors involved in these behavioral responses still remain ambiguous and require further investigation, the current report describes an alternative methodological approach for assessing the zebrafish behavior after a forced exposure to different environments. Additionally, the analysis of ethologically-relevant patterns across time could be a potential phenotyping tool to evaluate the zebrafish exploratory profile in the open tank task.	[Rosemberg, Denis B.; Rico, Eduardo P.; Mussulini, Ben Hur M.; Calcagnotto, Maria E.; Souza, Diogo O.; de Oliveira, Diogo L.] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil; [Rosemberg, Denis B.; Rico, Eduardo P.; Mussulini, Ben Hur M.; Calcagnotto, Maria E.; Dias, Renato D.; Souza, Diogo O.; de Oliveira, Diogo L.] INCT EN, Porto Alegre, RS, Brazil; [Piato, Angelo L.; Bonan, Carla D.] Pontificia Univ Catolica Rio Grande do Sul, Dept Biol Celular & Mol, Porto Alegre, RS, Brazil; [Bonan, Carla D.] Inst Nacl Translac Med INCT TM, Porto Alegre, RS, Brazil; [Blaser, Rachel E.] Univ San Diego, Dept Psychol, San Diego, CA 92110 USA	Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; University of San Diego	Rosemberg, DB (corresponding author), Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil.	dbrosemberg@gmail.com; losch@ufrgs.br	Bonan, Carla Denise/J-7899-2015; calcagnotto, maria elisa/B-1645-2013; PIATO, ANGELO/K-3444-2012; Rosemberg, Denis B/E-5971-2016; Souza, Diogo O/J-8894-2014; CALCAGNOTTO, MARIA ELISA/AAU-7718-2020; Blaser, Rachel E/A-3341-2012	Bonan, Carla Denise/0000-0001-9715-6244; calcagnotto, maria elisa/0000-0001-8196-0596; PIATO, ANGELO/0000-0001-5109-7306; Souza, Diogo O/0000-0002-4322-0404; CALCAGNOTTO, MARIA ELISA/0000-0001-8196-0596; Blaser, Rachel E/0000-0002-4342-532X; Marins Mussulini, Ben Hur/0000-0003-4321-5709; Rosemberg, Denis/0000-0003-2538-8761; Losch de Oliveira, Diogo/0000-0002-9028-6959	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); INCT para Excitotoxicidade e Neuroprotecao; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); FINEP [01.06.0842-00]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT para Excitotoxicidade e Neuroprotecao; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); FINEP(Financiadora de Inovacao e Pesquisa (Finep))	This study was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), INCT para Excitotoxicidade e Neuroprotecao, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), and by the FINEP research grant "Rede Instituto Brasileiro de Neurociencia (IBN-Net)" #01.06.0842-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; BIRKE LIA, 1975, ANIM BEHAV, V23, P509, DOI 10.1016/0003-3472(75)90127-X; Blaser RE, 2010, BEHAV BRAIN RES, V208, P56, DOI 10.1016/j.bbr.2009.11.009; Blaser R, 2006, BEHAV RES METHODS, V38, P456, DOI 10.3758/BF03192800; Burt MA, 2008, PHYSIOL BEHAV, V93, P327, DOI 10.1016/j.physbeh.2007.09.003; CACHAT J, 2011, PLOS ONE, V6; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Chon TS, 2005, ENVIRON MONIT ASSESS, V101, P1; Clifford JJ, 2000, NEUROPHARMACOLOGY, V39, P382, DOI 10.1016/S0028-3908(99)00150-1; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Drai D, 2001, BEHAV BRAIN RES, V125, P133, DOI 10.1016/S0166-4328(01)00290-X; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Eilam D, 2003, BEHAV BRAIN RES, V142, P53, DOI 10.1016/S0166-4328(02)00382-0; EILAM D, 1989, BEHAV BRAIN RES, V34, P199, DOI 10.1016/S0166-4328(89)80102-0; Eisenstein EM, 2006, REV NEUROSCIENCE, V17, P533; ESPEJO EF, 1993, BEHAV BRAIN RES, V56, P171, DOI 10.1016/0166-4328(93)90035-O; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2003, BEHAV GENET, V33, P461, DOI 10.1023/A:1025762314250; Gerlai R, 2006, PHARMACOL BIOCHEM BE, V85, P752, DOI 10.1016/j.pbb.2006.11.010; Gerlai R, 2010, MOLECULES, V15, P2609, DOI 10.3390/molecules15042609; Gerlai R, 2010, BEHAV BRAIN RES, V207, P223, DOI 10.1016/j.bbr.2009.10.008; Grossman L, 2010, BEHAV BRAIN RES, V214, P277, DOI 10.1016/j.bbr.2010.05.039; Kalueff AV, 2008, BEHAV BRAIN RES, V188, P243, DOI 10.1016/j.bbr.2007.11.011; Kalueff AV, 2007, BRAIN RES REV, V53, P328, DOI 10.1016/j.brainresrev.2006.09.003; Kim D, 2005, GENES BRAIN BEHAV, V4, P302, DOI 10.1111/j.1601-183X.2005.00133.x; Lamprea MR, 2008, BRAZ J MED BIOL RES, V41, P135, DOI 10.1590/S0100-879X2008000200010; Lau BYB, 2011, P NATL ACAD SCI USA, V108, P2581, DOI 10.1073/pnas.1018275108; Leussis MP, 2006, NEUROSCI BIOBEHAV R, V30, P1045, DOI 10.1016/j.neubiorev.2006.03.006; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; Lopez-Patino MA, 2008, PHYSIOL BEHAV, V93, P160, DOI 10.1016/j.physbeh.2007.08.013; Lynn DA, 2009, DEV PSYCHOBIOL, V51, P513, DOI 10.1002/dev.20386; MAXIMINO C, 2008, INT J COMP PSYCHOL, V20, P351; Maximino C, 2011, PROG NEURO-PSYCHOPH, V35, P624, DOI 10.1016/j.pnpbp.2011.01.006; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Maximino C, 2010, BEHAV BRAIN RES, V210, P1, DOI 10.1016/j.bbr.2010.01.031; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; Mintz M, 2005, BEHAV PHARMACOL, V16, P227, DOI 10.1097/01.fbp.0000169182.44998.8e; OKEEFE J, 1990, PROG BRAIN RES, V83, P301; Park YS, 2005, AQUAT TOXICOL, V71, P215, DOI 10.1016/j.aquatox.2004.11.002; Sackerman James, 2010, Int J Comp Psychol, V23, P43; Seibt KJ, 2010, BEHAV BRAIN RES, V214, P417, DOI 10.1016/j.bbr.2010.06.014; Serra EL, 1999, BRAZ J MED BIOL RES, V32, P1551, DOI 10.1590/S0100-879X1999001200016; Stewart A, 2010, BEHAV PROCESS, V85, P198, DOI 10.1016/j.beproc.2010.07.009; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023; Yu LL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000014	47	118	118	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2011	6	5							e19397	10.1371/journal.pone.0019397	http://dx.doi.org/10.1371/journal.pone.0019397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759ED	21559304	Green Published, gold, Green Submitted			2022-12-25	WOS:000290222600005
J	Jacobson, EM; Concepcion, E; Ho, K; Kopp, P; Toniolo, JV; Tomer, Y				Jacobson, Eric M.; Concepcion, Erlinda; Ho, Kenneth; Kopp, Peter; Toniolo, Jussara Vono; Tomer, Yaron			cDNA Immunization of Mice with Human Thyroglobulin Generates Both Humoral and T Cell Responses: A Novel Model of Thyroid Autoimmunity	PLOS ONE			English	Article							RECEPTOR A-SUBUNIT; HASHIMOTOS-THYROIDITIS; GENE-TRANSFER; IN-VIVO; ANTITHYROGLOBULIN AUTOANTIBODIES; THYROTROPIN RECEPTOR; SKELETAL-MUSCLE; INTRAMUSCULAR INJECTION; GRAVES HYPERTHYROIDISM; DNA ELECTROTRANSFER	Thyroglobulin (Tg) represents one of the largest known self-antigens involved in autoimmunity. Numerous studies have implicated it in triggering and perpetuating the autoimmune response in autoimmune thyroid diseases (AITD). Indeed, traditional models of autoimmune thyroid disease, experimental autoimmune thyroiditis (EAT), are generated by immunizing mice with thyroglobulin protein in conjunction with an adjuvant, or by high repeated doses of Tg alone, without adjuvant. These extant models are limited in their experimental flexibility, i.e. the ability to make modifications to the Tg used in immunizations. In this study, we have immunized mice with a plasmid cDNA encoding the full-length human Tg (hTG) protein, in order to generate a model of Hashimoto's thyroiditis which is closer to the human disease and does not require adjuvants to breakdown tolerance. Human thyroglobulin cDNA was injected and subsequently electroporated into skeletal muscle using a square wave generator. Following hTg cDNA immunizations, the mice developed both B and T cell responses to Tg, albeit with no evidence of lymphocytic infiltration of the thyroid. This novel model will afford investigators the means to test various hypotheses which were unavailable with the previous EAT models, specifically the effects of hTg sequence variations on the induction of thyroiditis.	[Jacobson, Eric M.] Univ Cincinnati, Coll Med, Div Endocrinol, Cincinnati, OH 45221 USA; [Concepcion, Erlinda; Ho, Kenneth; Tomer, Yaron] Mt Sinai Sch Med, Dept Med, Div Endocrinol, New York, NY USA; [Kopp, Peter; Toniolo, Jussara Vono] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Tomer, Yaron] James J Peters VA Med Ctr, Bronx, NY USA	University System of Ohio; University of Cincinnati; Icahn School of Medicine at Mount Sinai; Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Jacobson, EM (corresponding author), Univ Cincinnati, Coll Med, Div Endocrinol, Cincinnati, OH 45221 USA.	Eric.Jacobson@uc.edu	Tomer, Yaron/GWU-8933-2022	Kopp, Peter A/0000-0001-5980-0529	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK061659, DK067555, DK073681, DK063024]; American Thyroid Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073681, R01DK063024, R01DK061659, R01DK067555] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Thyroid Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants DK061659, DK067555, DK073681 (to YT) and DK063024 (to PK) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). EMJ was supported by a grant from the American Thyroid Association (http://www.thyroid.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alimi E, 1998, EUR J IMMUNOL, V28, P201, DOI 10.1002/(SICI)1521-4141(199801)28:01<201::AID-IMMU201>3.0.CO;2-N; Ban Y, 2003, P NATL ACAD SCI USA, V100, P15119, DOI 10.1073/pnas.2434175100; BEISEL KW, 1982, IMMUNOGENETICS, V15, P427, DOI 10.1007/BF00364266; Berglund J, 1996, J INTERN MED, V239, P57, DOI 10.1046/j.1365-2796.1996.415757000.x; BERNARD NF, 1992, DIABETES, V41, P40, DOI 10.2337/diabetes.41.1.40; Bloquel C, 2004, J GENE MED, V6, pS11, DOI 10.1002/jgm.508; Cappelletti M, 2003, J GENE MED, V5, P324, DOI 10.1002/jgm.352; CHARREIRE J, 1989, ADV IMMUNOL, V46, P263, DOI 10.1016/S0065-2776(08)60656-2; Chen CR, 2007, ENDOCRINOLOGY, V148, P2375, DOI 10.1210/en.2006-1754; Chen CR, 2010, ENDOCRINOLOGY, V151, P4583, DOI 10.1210/en.2010-0321; Chen CR, 2004, ENDOCRINOLOGY, V145, P228, DOI 10.1210/en.2003-1134; CHRONOPOULOU E, 1994, CLIN EXP IMMUNOL, V98, P89; CREEMERS P, 1983, J EXP MED, V157, P559, DOI 10.1084/jem.157.2.559; DEVEY ME, 1989, CLIN EXP IMMUNOL, V77, P191; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; ELREHEWY M, 1981, EUR J IMMUNOL, V11, P146, DOI 10.1002/eji.1830110216; Flynn JC, 2004, CLIN EXP IMMUNOL, V137, P503, DOI 10.1111/j.1365-2249.2004.02553.x; FUKUMA N, 1991, AUTOIMMUNITY, V10, P291, DOI 10.3109/08916939109001903; FULLER BE, 1994, AUTOIMMUNITY, V19, P161, DOI 10.3109/08916939408995691; Guo J, 2003, CLIN EXP IMMUNOL, V132, P408, DOI 10.1046/j.1365-2249.2003.02170.x; Herweijer H, 2003, GENE THER, V10, P453, DOI 10.1038/sj.gt.3301983; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; HUREZ V, 1993, SCAND J IMMUNOL, V38, P190, DOI 10.1111/j.1365-3083.1993.tb01712.x; Jacobson EM, 2007, J AUTOIMMUN, V28, P85, DOI 10.1016/j.jaut.2007.02.006; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Kong YCM, 1996, J EXP MED, V184, P1167, DOI 10.1084/jem.184.3.1167; KONG YCM, 1980, TRANSPLANT P, V12, P129; KONG YM, 1989, CLIN EXP IMMUNOL, V77, P428; Lu QL, 2003, GENE THER, V10, P131, DOI 10.1038/sj.gt.3301874; Mathiesen I, 1999, GENE THER, V6, P508, DOI 10.1038/sj.gt.3300847; MCINTOSH RS, 1994, BBA-MOL BASIS DIS, V1227, P171, DOI 10.1016/0925-4439(94)90091-4; McIntosh RS, 1996, J IMMUNOL, V157, P927; Menconi F, 2008, P NATL ACAD SCI USA, V105, P14034, DOI 10.1073/pnas.0806584105; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Mizutori Y, 2008, CLIN EXP IMMUNOL, V154, P305, DOI 10.1111/j.1365-2249.2008.03769.x; Mizutori Y, 2006, J AUTOIMMUN, V26, P32, DOI 10.1016/j.jaut.2005.08.008; Morris GP, 2003, CELL IMMUNOL, V226, P20, DOI 10.1016/j.cellimm.2003.11.002; Nagayama Y, 2002, J IMMUNOL, V168, P2789, DOI 10.4049/jimmunol.168.6.2789; Nakahara M, 2010, ENDOCRINOLOGY, V151, P4047, DOI 10.1210/en.2010-0315; ROITT IM, 1956, LANCET, V271, P820; ROITT IM, 1958, BIOCHEM J, V69, P248, DOI 10.1042/bj0690248; Sakai K, 2001, HUM MOL GENET, V10, P1379, DOI 10.1093/hmg/10.13.1379; Shulman S, 1971, Adv Immunol, V14, P85, DOI 10.1016/S0065-2776(08)60284-9; SILVERMAN DA, 1971, P SOC EXP BIOL MED, V138, P579; SIMON LL, 1985, CELL IMMUNOL, V94, P243, DOI 10.1016/0008-8749(85)90101-7; SOLLEVELD HA, 1985, AM J PATHOL, V119, P345; Stafford E A, 2000, Int Rev Immunol, V19, P501, DOI 10.3109/08830180009088510; STERNTHAL E, 1981, DIABETES, V30, P1058, DOI 10.2337/diabetes.30.12.1058; STULL SJ, 1988, CELL IMMUNOL, V117, P188, DOI 10.1016/0008-8749(88)90087-1; Sundick RS, 1996, EXP CLIN ENDOCR DIAB, V104, P4, DOI 10.1055/s-0029-1211668; Taguchi O, 1996, IMMUNOLOGY, V89, P13, DOI 10.1046/j.1365-2567.1996.d01-712.x; TOMAZIC V, 1976, IMMUNOLOGY, V30, P63; Tomer Y, 2003, AM J HUM GENET, V73, P736, DOI 10.1086/378588; Tomer Y, 2002, J CLIN ENDOCR METAB, V87, P404, DOI 10.1210/jc.87.1.404; Tomer Y, 1997, CLIN IMMUNOL IMMUNOP, V82, P3, DOI 10.1006/clin.1996.4243; Tomer Y, 2009, J AUTOIMMUN, V32, P231, DOI 10.1016/j.jaut.2009.02.007; Trezise AEO, 2002, DNA CELL BIOL, V21, P869, DOI 10.1089/104454902762053837; TUCKER WE, 1962, AM J CLIN PATHOL, V38, P70; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; van de Graaf SAR, 2001, J ENDOCRINOL, V170, P307, DOI 10.1677/joe.0.1700307; VITADELLO M, 1994, HUM GENE THER, V5, P11, DOI 10.1089/hum.1994.5.1-11; VLADUTIU AO, 1971, SCIENCE, V174, P1137, DOI 10.1126/science.174.4014.1137; Waisman A, 1996, NAT MED, V2, P899, DOI 10.1038/nm0896-899; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; YANKAUCKAS MA, 1993, DNA CELL BIOL, V12, P771, DOI 10.1089/dna.1993.12.771	67	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19200	10.1371/journal.pone.0019200	http://dx.doi.org/10.1371/journal.pone.0019200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559421	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700100
J	Li, DC; Ji, BH; Hwang, KC; Huang, YG				Li, Dechang; Ji, Baohua; Hwang, Keh-Chih; Huang, Yonggang			Strength of Hydrogen Bond Network Takes Crucial Roles in the Dissociation Process of Inhibitors from the HIV-1 Protease Binding Pocket	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DYNAMIC FORCE SPECTROSCOPY; SUBSTRATE-BINDING; FLAP TIPS; MECHANISM; ADHESION; MODEL; SIMULATIONS; EQUALITY; PATHWAYS	To understand the underlying mechanisms of significant differences in dissociation rate constant among different inhibitors for HIV-1 protease, we performed steered molecular dynamics (SMD) simulations to analyze the entire dissociation processes of inhibitors from the binding pocket of protease at atomistic details. We found that the strength of hydrogen bond network between inhibitor and the protease takes crucial roles in the dissociation process. We showed that the hydrogen bond network in the cyclic urea inhibitors AHA001/XK263 is less stable than that of the approved inhibitor ABT538 because of their large differences in the structures of the networks. In the cyclic urea inhibitor bound complex, the hydrogen bonds often distribute at the flap tips and the active site. In contrast, there are additional accessorial hydrogen bonds formed at the lateral sides of the flaps and the active site in the ABT538 bound complex, which take crucial roles in stabilizing the hydrogen bond network. In addition, the water molecule W301 also plays important roles in stabilizing the hydrogen bond network through its flexible movement by acting as a collision buffer and helping the rebinding of hydrogen bonds at the flap tips. Because of its high stability, the hydrogen bond network of ABT538 complex can work together with the hydrophobic clusters to resist the dissociation, resulting in much lower dissociation rate constant than those of cyclic urea inhibitor complexes. This study may provide useful guidelines for design of novel potent inhibitors with optimized interactions.	[Li, Dechang; Ji, Baohua; Hwang, Keh-Chih] Tsinghua Univ, Dept Engn Mech, Sch Aerosp, Beijing 100084, Peoples R China; [Ji, Baohua] Beijing Inst Technol, Dept Appl Mech, Biomech & Biomat Lab, Beijing 100081, Peoples R China; [Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL USA	Tsinghua University; Beijing Institute of Technology; Northwestern University	Li, DC (corresponding author), Tsinghua Univ, Dept Engn Mech, Sch Aerosp, Beijing 100084, Peoples R China.	bhji@bit.edu.cn	HWANG, Keh-Chih/A-9989-2014; Li, Dechang/D-2766-2009; Li, Dechang/ABH-7349-2020; huang, yonggang/O-6236-2019; Huang, Yonggang/B-6998-2009; Ji, Baohua/B-6713-2008	Li, Dechang/0000-0002-9528-6851; Li, Dechang/0000-0002-9528-6851; Ji, Baohua/0000-0002-0092-6562	National Natural Science Foundation of China [10732050, 10872115, 11025208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China through Grant Nos. 10732050, 10872115, and 11025208. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackbarow T, 2007, P NATL ACAD SCI USA, V104, P16410, DOI 10.1073/pnas.0705759104; Ala PJ, 1998, J BIOL CHEM, V273, P12325, DOI 10.1074/jbc.273.20.12325; Backbro K, 1997, J MED CHEM, V40, P898, DOI 10.1021/jm960588d; Bastug T, 2007, CHEM PHYS LETT, V436, P383, DOI 10.1016/j.cplett.2007.01.078; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang CEA, 2007, CHEM BIOL DRUG DES, V69, P5, DOI 10.1111/j.1747-0285.2007.00464.x; Cheng YA, 2010, J MOL GRAPH MODEL, V29, P171, DOI 10.1016/j.jmgm.2010.05.009; Colizzi F, 2010, J AM CHEM SOC, V132, P7361, DOI 10.1021/ja100259r; Collin D, 2005, NATURE, V437, P231, DOI 10.1038/nature04061; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Dudko OK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.108101; Dudko OK, 2003, P NATL ACAD SCI USA, V100, P11378, DOI 10.1073/pnas.1534554100; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; FURFINE ES, 1992, BIOCHEMISTRY-US, V31, P7886, DOI 10.1021/bi00149a020; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Hamelberg D, 2005, J AM CHEM SOC, V127, P13778, DOI 10.1021/ja054338a; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hornak V, 2006, J AM CHEM SOC, V128, P2812, DOI 10.1021/ja058211x; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Hulten J, 1997, J MED CHEM, V40, P885, DOI 10.1021/jm960728j; Hummer G, 2005, ACCOUNTS CHEM RES, V38, P504, DOI 10.1021/ar040148d; Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098; Hummer G, 2003, BIOPHYS J, V85, P5, DOI 10.1016/S0006-3495(03)74449-X; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.bi.63.070194.001025; KEMPF DJ, 1995, P NATL ACAD SCI USA, V92, P2484, DOI 10.1073/pnas.92.7.2484; Keten S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198301; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LAM PYS, 1994, SCIENCE, V263, P380, DOI 10.1126/science.8278812; Lemkul JA, 2010, J PHYS CHEM B, V114, P1652, DOI 10.1021/jp9110794; Li DC, 2009, INT J APPL MECH, V1, P113, DOI 10.1142/S1758825109000034; Li DC, 2010, J PHYS CHEM B, V114, P3060, DOI 10.1021/jp1005549; Li DC, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3148022; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liphardt J, 2002, SCIENCE, V296, P1832, DOI 10.1126/science.1071152; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Markgren PO, 2002, J MED CHEM, V45, P5430, DOI 10.1021/jm0208370; Maschera B, 1996, J BIOL CHEM, V271, P33231, DOI 10.1074/jbc.271.52.33231; Morfill J, 2008, J MOL BIOL, V381, P1253, DOI 10.1016/j.jmb.2008.06.065; Neumann J, 2009, BIOPHYS J, V97, P1687, DOI 10.1016/j.bpj.2009.01.052; Pecht I, 1977, CHEM RELAXATION MOL; Pietrucci F, 2009, J AM CHEM SOC, V131, P11811, DOI 10.1021/ja903045y; Qin Z, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425101; Root DD, 2006, BIOPHYS J, V90, P2852, DOI 10.1529/biophysj.105.071597; Sadiq SK, 2007, BIOCHEMISTRY-US, V46, P14865, DOI 10.1021/bi700864p; Scott WRP, 2000, STRUCTURE, V8, P1259, DOI 10.1016/S0969-2126(00)00537-2; Sheu SY, 2003, P NATL ACAD SCI USA, V100, P12683, DOI 10.1073/pnas.2133366100; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Toth G, 2006, BIOCHEMISTRY-US, V45, P6606, DOI 10.1021/bi060188k; Tozzini V, 2005, CHEM PHYS LETT, V413, P123, DOI 10.1016/j.cplett.2005.07.075; Trylska J, 2007, BIOPHYS J, V92, P4179, DOI 10.1529/biophysj.106.100560; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; West DK, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2393232; Wiley AP, 2009, J CHEM THEORY COMPUT, V5, P1117, DOI 10.1021/ct800152d; Wittayanarakul K, 2008, J COMPUT CHEM, V29, P673, DOI 10.1002/jcc.20821; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P10791, DOI 10.1021/ja00102a057; Zhao Q, 2010, PHYS REV E, V86	64	31	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19268	10.1371/journal.pone.0019268	http://dx.doi.org/10.1371/journal.pone.0019268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559397	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700119
J	Su, YW; Xie, TX; Sano, D; Myers, JN				Su, Ying-Wen; Xie, Tong-Xin; Sano, Daisuke; Myers, Jeffrey N.			IL-6 Stabilizes Twist and Enhances Tumor Cell Motility in Head and Neck Cancer Cells through Activation of Casein Kinase 2	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NF-KAPPA-B; UP-REGULATION; MEDIATED DEGRADATION; TRANSCRIPTION FACTOR; CATALYTIC-SUBUNIT; BETA-CATENIN; IN-VITRO; CK2; PROTEIN	Background: Squamous cell carcinoma of the head and neck (SCCHN) is the seventh most common cancer worldwide. Unfortunately, the survival of patients with SCCHN has not improved in the last 40 years, and thus new targets for therapy are needed. Recently, elevations in serum level of interleukin 6 (IL-6) and expression of Twist in tumor samples were found to be associated with poor clinical outcomes in multiple types of cancer, including SCCHN. Although Twist has been proposed as a master regulator of epithelial-mesenchymal transition and metastasis in cancers, the mechanisms by which Twist levels are regulated post-translationally are not completely understood. Tumor progression is characterized by the involvement of cytokines and growth factors and Twist induction has been connected with a number of these signaling pathways including IL-6. Since many of the effects of IL-6 are mediated through activation of protein phosphorylation cascades, this implies that Twist expression must be under a tight control at the post-translational level in order to respond in a timely manner to external stimuli. Methodology/Principal Findings: Our data show that IL-6 increases Twist expression via a transcription-independent mechanism in many SCCHN cell lines. Further investigation revealed that IL-6 stabilizes Twist in SCCHN cell lines through casein kinase 2 (CK2) phosphorylation of Twist residues S18 and S20, and that this phosphorylation inhibits degradation of Twist. Twist phosphorylation not only increases its stability but also enhances cell motility. Thus, post-translational modulation of Twist contributes to its tumor-promoting properties. Conclusions/Significance: Our study shows Twist expression can be regulated at the post-translational level through phosphorylation by CK2, which increases Twist stability in response to IL-6 stimulation. Our findings not only provide novel mechanistic insights into post-translational regulation of Twist but also suggest that CK2 may be a viable therapeutic target in SCCHN.	[Su, Ying-Wen; Myers, Jeffrey N.] Univ Texas Houston, Grad Sch Biomed Sci, Program Canc Biol, Houston, TX 77030 USA; [Su, Ying-Wen; Xie, Tong-Xin; Sano, Daisuke; Myers, Jeffrey N.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Su, YW (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci, Program Canc Biol, Houston, TX 77030 USA.	jmyers@mdanderson.org	Sano, Daisuke/R-6591-2018	Sano, Daisuke/0000-0002-7686-4724	University of Texas MD Anderson Cancer Center [P50 CA097007]; National Institutes of Health Cancer Center [CA016672]; PANTHEON foundation; The Broudy "Commit to the Cure" foundation; NATIONAL CANCER INSTITUTE [P50CA097007, P30CA016672] Funding Source: NIH RePORTER	University of Texas MD Anderson Cancer Center; National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PANTHEON foundation; The Broudy "Commit to the Cure" foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The University of Texas MD Anderson Cancer Center SPORE in Head and Neck Cancer grant P50 CA097007, the National Institutes of Health Cancer Center Support grant CA016672, and the PANTHEON and The Broudy "Commit to the Cure" foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Allen C, 2007, CLIN CANCER RES, V13, P3182, DOI 10.1158/1078-0432.CCR-06-3047; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003; Chen Z, 1999, CLIN CANCER RES, V5, P1369; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Demontis S, 2006, CELL DEATH DIFFER, V13, P335, DOI 10.1038/sj.cdd.4401744; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; GAPANY M, 1995, MOL MED, V1, P659, DOI 10.1007/BF03401606; Gitelman I, 1997, DEV BIOL, V189, P205, DOI 10.1006/dbio.1997.8614; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Hosono S, 2007, BRIT J CANCER, V96, P314, DOI 10.1038/sj.bjc.6603533; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lou DY, 2008, MOL CELL BIOL, V28, P131, DOI 10.1128/MCB.01119-07; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Ou DL, 2008, ANTICANCER RES, V28, P1355; Pagano MA, 2004, BIOCHEM BIOPH RES CO, V321, P1040, DOI 10.1016/j.bbrc.2004.07.067; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Scaglioni PP, 2008, MOL CELL BIOCHEM, V316, P149, DOI 10.1007/s11010-008-9812-7; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Schultz JD, 2010, ONCOL REP, V24, P1213, DOI 10.3892/or_00000974; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; Shinriki S, 2009, CLIN CANCER RES, V15, P5426, DOI 10.1158/1078-0432.CCR-09-0287; Singh S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-47; Solares AM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-146; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; Vichalkovski A, 2010, ONCOGENE, V29, P3554, DOI 10.1038/onc.2010.115; Wallerand H, 2010, UROL ONCOL-SEMIN ORI, V28, P473, DOI 10.1016/j.urolonc.2008.12.018; Wang GX, 2005, MOL CELL BIOCHEM, V274, P77, DOI 10.1007/s11010-005-3077-1; Xu X, 1999, NAT GENET, V23, P118, DOI 10.1038/12729; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zhou G, 2008, ONCOGENE, V27, P3527, DOI 10.1038/sj.onc.1211015	50	52	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19412	10.1371/journal.pone.0019412	http://dx.doi.org/10.1371/journal.pone.0019412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559372	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700161
J	Wang, LI; Lin, YS; Liu, KH; Jong, AY; Shen, WC				Wang, Lin-Ing; Lin, Yu-Sheng; Liu, Kung-Hung; Jong, Ambrose Y.; Shen, Wei-Chiang			Cryptococcus neoformans Mediator Protein Ssn8 Negatively Regulates Diverse Physiological Processes and Is Required for Virulence	PLOS ONE			English	Article							RNA-POLYMERASE-II; STRESS-INDUCED DESTRUCTION; CELL-WALL INTEGRITY; ALPHA-MATING TYPE; SACCHAROMYCES-CEREVISIAE; FILAMENTOUS GROWTH; INVASIVE GROWTH; YEAST MEDIATOR; TRANSCRIPTIONAL REGULATION; FUSARIUM-VERTICILLIOIDES	Cryptococcus neoformans is a ubiquitously distributed human pathogen. It is also a model system for studying fungal virulence, physiology and differentiation. Light is known to inhibit sexual development via the evolutionarily conserved white collar proteins in C. neoformans. To dissect molecular mechanisms regulating this process, we have identified the SSN8 gene whose mutation suppresses the light-dependent CWC1 overexpression phenotype. Characterization of sex-related phenotypes revealed that Ssn8 functions as a negative regulator in both heterothallic a-alpha mating and same-sex mating processes. In addition, Ssn8 is involved in the suppression of other physiological processes including invasive growth, and production of capsule and melanin. Interestingly, Ssn8 is also required for the maintenance of cell wall integrity and virulence. Our gene expression studies confirmed that deletion of SSN8 results in de-repression of genes involved in sexual development and melanization. Epistatic and yeast two hybrid studies suggest that C. neoformans Ssn8 plays critical roles downstream of the Cpk1 MAPK cascade and Ste12 and possibly resides at one of the major branches downstream of the Cwc complex in the light-mediated sexual development pathway. Taken together, our studies demonstrate that the conserved Mediator protein Ssn8 functions as a global regulator which negatively regulates diverse physiological and developmental processes and is required for virulence in C. neoformans.	[Wang, Lin-Ing; Lin, Yu-Sheng; Liu, Kung-Hung; Shen, Wei-Chiang] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Jong, Ambrose Y.] Childrens Hosp Los Angeles, Div Hematol Oncol, Los Angeles, CA 90027 USA	National Taiwan University; Children's Hospital Los Angeles	Wang, LI (corresponding author), Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan.	wcshen@ntu.edu.tw		SHEN, WEI-CHIANG/0000-0002-8921-1132; Wang, Lin-Ing/0000-0001-7916-9885	National Science Council [NSC96-2311-B-002-022-MY3, NSC99-2311-B-002-008-MY3]; Diseases Research and Education Center, Department of Health and National Taiwan University	National Science Council(Ministry of Science and Technology, Taiwan); Diseases Research and Education Center, Department of Health and National Taiwan University	This work has been funded by National Science Council Grants NSC96-2311-B-002-022-MY3 and NSC99-2311-B-002-008-MY3 (to WCS ). The authors also acknowledge the financial support provided by Infectious Diseases Research and Education Center, Department of Health and National Taiwan University (to LIW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 2000, MOL MICROBIOL, V36, P352, DOI 10.1046/j.1365-2958.2000.01852.x; Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; BALCIUNAS D, 1995, NUCLEIC ACIDS RES, V23, P4421, DOI 10.1093/nar/23.21.4421; Biddick R, 2005, CR BIOL, V328, P773, DOI 10.1016/j.crvi.2005.03.004; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Blankenship JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000752; Bluhm BH, 2006, FUNGAL GENET BIOL, V43, P146, DOI 10.1016/j.fgb.2005.09.006; Borggrefe T, 2002, J BIOL CHEM, V277, P44202, DOI 10.1074/jbc.M207195200; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; CARLSON M, 1984, GENETICS, V107, P19; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Chang YC, 2001, P NATL ACAD SCI USA, V98, P3258, DOI 10.1073/pnas.061031998; Chang YW, 2004, MOL CELL, V15, P107, DOI 10.1016/j.molcel.2004.05.021; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Cohen TJ, 2003, EUKARYOT CELL, V2, P962, DOI 10.1128/EC.2.5.962-970.2003; Cooper KF, 1999, MOL CELL BIOL, V19, P3338; Cooper KF, 2002, EUKARYOT CELL, V1, P66, DOI 10.1128/EC.01.1.66-74.2002; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Davidson RC, 2003, MOL MICROBIOL, V49, P469, DOI 10.1046/j.1365-2958.2003.03563.x; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Fuchs BB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000368; Fuchs BB, 2007, ANTIMICROB AGENTS CH, V51, P2929, DOI 10.1128/AAC.00121-07; Gagiano M, 2002, FEMS YEAST RES, V2, P433, DOI 10.1016/S1567-1356(02)00133-2; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Hartmann HA, 1996, EMBO J, V15, P1632, DOI 10.1002/j.1460-2075.1996.tb00508.x; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Hirst M, 1999, MOL CELL, V3, P673, DOI 10.1016/S1097-2765(00)80360-3; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hsueh YP, 2007, MOL BIOL CELL, V18, P3237, DOI 10.1091/mbc.E07-02-0133; Hsueh YP, 2009, EMBO J, V28, P1220, DOI 10.1038/emboj.2009.68; Hsueh YP, 2005, EUKARYOT CELL, V4, P147, DOI 10.1128/EC.4.1.147-155.2005; Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095; James P, 1996, GENETICS, V144, P1425; JAMES PG, 1990, CARBOHYD RES, V198, P23, DOI 10.1016/0008-6215(90)84273-W; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Krasley E, 2006, GENETICS, V172, P1477, DOI 10.1534/genetics.105.052266; KWONCHUNG KJ, 1982, A VAN LEEUW J MICROB, V48, P25, DOI 10.1007/BF00399484; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Lin XR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000953; Lin XR, 2009, INFECT GENET EVOL, V9, P401, DOI 10.1016/j.meegid.2009.01.013; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Linder T, 2004, J BIOL CHEM, V279, P49455, DOI 10.1074/jbc.M409046200; Liu L, 1999, INFECT IMMUN, V67, P6034, DOI 10.1128/IAI.67.11.6034-6039.1999; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Lu YK, 2005, MOL MICROBIOL, V56, P480, DOI 10.1111/j.1365-2958.2005.04549.x; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; MOORE TDE, 1993, MOL CELL BIOL, V13, P1962, DOI 10.1128/MCB.13.3.1962; NEILSON JB, 1978, INFECT IMMUN, V20, P262, DOI 10.1128/IAI.20.1.262-266.1978; Nelson C, 2003, NATURE, V421, P187, DOI 10.1038/nature01243; Palecek SP, 2000, GENETICS, V156, P1005; Papamichos-Chronakis M, 2004, EMBO REP, V5, P368, DOI 10.1038/sj.embor.7400120; Rohde JR, 2000, MOL CELL BIOL, V20, P3880, DOI 10.1128/MCB.20.11.3880-3886.2000; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Shen WC, 2002, EUKARYOT CELL, V1, P366, DOI 10.1128/EC.1.3.366-377.2002; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shim WB, 2001, APPL ENVIRON MICROB, V67, P1607, DOI 10.1128/AEM.67.4.1607-1612.2001; Stanhill A, 1999, MOL CELL BIOL, V19, P7529; STRICH R, 1989, P NATL ACAD SCI USA, V86, P10018, DOI 10.1073/pnas.86.24.10018; Tang RJ, 2005, INFECT IMMUN, V73, P8219, DOI 10.1128/IAI.73.12.8219-8225.2005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Urban M, 1996, MOL GEN GENET, V251, P31; Wang P, 2002, EUKARYOT CELL, V1, P257, DOI 10.1128/EC.1.2.257-272.2002; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Wickes BL, 1997, MOL MICROBIOL, V26, P951, DOI 10.1046/j.1365-2958.1997.6322001.x; Yan J, 2000, IMMUNOPHARMACOLOGY, V46, P39, DOI 10.1016/S0162-3109(99)00157-5; Yeh YL, 2009, FUNGAL GENET BIOL, V46, P42, DOI 10.1016/j.fgb.2008.10.007; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003; Zarnack K, 2008, MOL MICROBIOL, V69, P1041, DOI 10.1111/j.1365-2958.2008.06345.x; Zhou XD, 2009, INT J ORAL SCI, V1, P1	82	9	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19162	10.1371/journal.pone.0019162	http://dx.doi.org/10.1371/journal.pone.0019162			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559476	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700085
J	Dong, M; Lam, PCH; Pinon, DI; Hosohata, K; Orry, A; Sexton, PM; Abagyan, R; Miller, LJ				Dong, Maoqing; Lam, Polo C. -H.; Pinon, Delia I.; Hosohata, Keiko; Orry, Andrew; Sexton, Patrick M.; Abagyan, Ruben; Miller, Laurence J.			Molecular Basis of Secretin Docking to Its Intact Receptor Using Multiple Photolabile Probes Distributed throughout the Pharmacophore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; GLUCAGON-LIKE PEPTIDE-1; VASOACTIVE-INTESTINAL-PEPTIDE; CORTICOTROPIN-RELEASING-FACTOR; AMINO-TERMINAL REGION; CRYSTAL-STRUCTURE; SPATIAL APPROXIMATION; PARATHYROID-HORMONE; EXTRACELLULAR DOMAIN; AGONIST-BINDING	The molecular basis of ligand binding and activation of family B G protein-coupled receptors is not yet clear due to the lack of insight into the structure of intact receptors. Although NMR and crystal structures of amino-terminal domains of several family members support consistency in general structural motifs that include a peptide-binding cleft, there are variations in the details of docking of the carboxyl terminus of peptide ligands within this cleft, and there is no information about siting of the amino terminus of these peptides. There are also no empirical data to orient the receptor amino terminus relative to the core helical bundle domain. Here, we prepared a series of five new probes, incorporating photolabile moieties into positions 2, 15, 20, 24, and 25 of full agonist secretin analogues. Each bound specifically to the receptor and covalently labeled single distinct receptor residues. Peptide mapping of labeled wild-type and mutant receptors identified that the position 15, 20, and 25 probes labeled residues within the distal amino terminus of the receptor, whereas the position 24 probe labeled the amino terminus adjacent to TM1. Of note, the position 2 probe labeled a residue within the first extracellular loop of the receptor, a region not previously labeled, providing an important new constraint for docking the amino-terminal region of secretin to its receptor core. These additional experimentally derived constraints help to refine our understanding of the structure of the secretin-intact receptor complex and provide new insights into understanding the molecular mechanism for activation of family B G protein-coupled receptors.	[Dong, Maoqing; Pinon, Delia I.; Hosohata, Keiko; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Lam, Polo C. -H.; Orry, Andrew; Abagyan, Ruben] Molsoft LLC, La Jolla, CA 92037 USA; [Sexton, Patrick M.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92037 USA	Mayo Clinic; Mayo Clinic Phoenix; Monash University; Monash University; University of California System; University of California San Diego	Miller, LJ (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu	Sexton, Patrick M/B-1319-2008	Sexton, Patrick M/0000-0001-8902-2473	National Institutes of Health [DK46577]; Australian Research Council [DP0985210]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046577, R01DK046577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46577 (to L.J.M.). This work was also supported by Australian Research Council Grant DP0985210 (to P. M. S.).	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Bisello A, 1998, J BIOL CHEM, V273, P22498, DOI 10.1074/jbc.273.35.22498; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Di Paolo E, 1998, FEBS LETT, V424, P207, DOI 10.1016/S0014-5793(98)00175-6; Dong MQ, 2008, MOL PHARMACOL, V74, P413, DOI 10.1124/mol.108.047209; Dong MQ, 2007, MOL PHARMACOL, V72, P280, DOI 10.1124/mol.107.035402; Dong MQ, 2010, J BIOL CHEM, V285, P9919, DOI 10.1074/jbc.M109.089730; Dong MQ, 2000, J BIOL CHEM, V275, P26032, DOI 10.1074/jbc.M000612200; Dong MQ, 2004, J BIOL CHEM, V279, P31177, DOI 10.1074/jbc.M404113200; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Dong MQ, 2003, J BIOL CHEM, V278, P48300, DOI 10.1074/jbc.M309166200; Dong MQ, 1999, J BIOL CHEM, V274, P19161, DOI 10.1074/jbc.274.27.19161; Dong MQ, 2002, MOL ENDOCRINOL, V16, P2490, DOI 10.1210/me.2002-0111; Dong MQ, 1999, J BIOL CHEM, V274, P903, DOI 10.1074/jbc.274.2.903; GARDNER JD, 1977, GASTROENTEROLOGY, V73, P52; Gensure RC, 2003, MOL ENDOCRINOL, V17, P2647, DOI 10.1210/me.2003-0275; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Greenberg Z, 2000, BIOCHEMISTRY-US, V39, P8142, DOI 10.1021/bi000195n; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Harikumar KG, 2007, J BIOL CHEM, V282, P32834, DOI 10.1074/jbc.M704563200; Harikumar KG, 2006, J BIOL CHEM, V281, P2543, DOI 10.1074/jbc.M509197200; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Igarashi H, 2002, J PHARMACOL EXP THER, V303, P445, DOI 10.1124/jpet.102.038075; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Ji ZS, 1997, J BIOL CHEM, V272, P24393, DOI 10.1074/jbc.272.39.24393; KOFOD H, 1991, INT J PEPT PROT RES, V37, P185; Koth CM, 2010, BIOCHEMISTRY-US, V49, P1862, DOI 10.1021/bi901848m; Kraetke O, 2005, BIOCHEMISTRY-US, V44, P15569, DOI 10.1021/bi0507027; KUROSE T, 1994, J BIOL CHEM, V269, P29190; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Nicole P, 2000, J BIOL CHEM, V275, P24003, DOI 10.1074/jbc.M002325200; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; ULRICH CD, 1993, GASTROENTEROLOGY, V105, P1534, DOI 10.1016/0016-5085(93)90162-6; Ulrich CD, 1998, GASTROENTEROLOGY, V114, P382, DOI 10.1016/S0016-5085(98)70491-3; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zang MW, 2003, MOL PHARMACOL, V63, P993, DOI 10.1124/mol.63.5.993	56	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23888	23899		10.1074/jbc.M111.245969	http://dx.doi.org/10.1074/jbc.M111.245969			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566140	Green Published, hybrid			2022-12-25	WOS:000292294900031
J	Muruganandan, S; Parlee, SD; Rourke, JL; Ernst, MC; Goralski, KB; Sinal, CJ				Muruganandan, Shanmugam; Parlee, Sebastian D.; Rourke, Jillian L.; Ernst, Matthew C.; Goralski, Kerry B.; Sinal, Christopher J.			Chemerin, a Novel Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Target Gene That Promotes Mesenchymal Stem Cell Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; CCAAT/ENHANCER-BINDING PROTEINS; TYPE-2 DIABETES-MELLITUS; ADIPOCYTE DIFFERENTIATION; METABOLIC SYNDROME; ROSIGLITAZONE TREATMENT; SKELETAL-MUSCLE; REGULATES ADIPOGENESIS; INSULIN-RESISTANCE; C3H10T1/2 CELLS	Chemerin is an adipocyte-secreted protein that regulates adipogenesis and the metabolic function of mature adipocytes via activation of chemokine-like receptor 1 (CMKLR1). Herein we report the interaction of peroxisome proliferator-activated receptor gamma (PPAR gamma) and chemerin in the context of adipogenesis. Knockdown of chemerin or CMKLR1 expression or antibody neutralization of secreted chemerin protein arrested adipogenic clonal expansion of bone marrow mesenchymal stem cells (BMSCs) by inducing a loss of G(2)/M cyclins (cyclin A2/B2) but not the G(1)/S cyclin D2. Forced expression of PPAR gamma in BMSCs did not completely rescue this loss of clonal expansion and adipogenesis following chemerin or CMKLR1 knockdown. However, forced expression and/or activation of PPAR gamma in BMSCs as well as non-adipogenic cell types such as NIH-3T3 embryonic fibroblasts and MCA38 colon carcinoma cells significantly induced chemerin expression and secretion. Sequence analysis revealed a putative PPAR gamma response element (PPRE) sequence within the chemerin promoter. This PPRE was able to confer PPAR gamma responsiveness on a heterologous promoter, and mutation of this sequence abolished activation of the chemerin promoter by PPAR gamma. Chromatin immunoprecipitation confirmed the direct association of PPAR gamma with this PPRE. Treatment of mice with rosiglitazone elevated chemerin mRNA levels in adipose tissue and bone marrow coincident with an increase in circulating chemerin levels. Together, these findings support a fundamental role for chemerin/CMKLR1 signaling in clonal expansion during adipocyte differentiation as well as a role for PPAR gamma in regulating chemerin expression.	[Muruganandan, Shanmugam; Parlee, Sebastian D.; Rourke, Jillian L.; Ernst, Matthew C.; Goralski, Kerry B.; Sinal, Christopher J.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4R2, Canada; [Goralski, Kerry B.] Dalhousie Univ, Coll Pharm, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University	Sinal, CJ (corresponding author), Dalhousie Univ, Dept Pharmacol, 1459 Oxford St, Halifax, NS B3H 4R2, Canada.	csinal@dal.ca	Muruganandan, Shanmugam/H-5673-2019	Sinal, Christopher/0000-0001-8301-3349; Goralski, Kerry/0000-0003-0040-5879; Shanmugam, Muruganandan/0000-0001-9552-2175	Canadian Institutes of Health Research; Canadian Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported in part by grants from the Canadian Institutes of Health Research and the Canadian Foundation for Innovation.	Abella A, 2005, CELL METAB, V2, P239, DOI 10.1016/j.cmet.2005.09.003; Aguilar V, 2010, ENDOCRINOLOGY, V151, P5247, DOI 10.1210/en.2010-0461; Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Bahia L, 2007, ATHEROSCLEROSIS, V195, P138, DOI 10.1016/j.atherosclerosis.2006.09.003; Banga A, 2009, AM J PHYSIOL-ENDOC M, V296, pE480, DOI 10.1152/ajpendo.90892.2008; Becker M, 2010, DIABETES, V59, P2898, DOI 10.2337/db10-0362; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Bozaoglu K, 2009, J CLIN ENDOCR METAB, V94, P3085, DOI 10.1210/jc.2008-1833; Bullen JW, 2007, AM J PHYSIOL-ENDOC M, V292, pE1079, DOI 10.1152/ajpendo.00245.2006; Cho YC, 2004, J CELL BIOCHEM, V91, P336, DOI 10.1002/jcb.10743; DeVos P, 1996, J CLIN INVEST, V98, P1004, DOI 10.1172/JCI118860; Duncan BB, 2004, DIABETES, V53, P2473, DOI 10.2337/diabetes.53.9.2473; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Ernst MC, 2010, ENDOCRINOLOGY, V151, P1998, DOI 10.1210/en.2009-1098; Fajas L, 2001, J MOL ENDOCRINOL, V27, P1, DOI 10.1677/jme.0.0270001; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Ghanim H, 2006, J CLIN ENDOCR METAB, V91, P3553, DOI 10.1210/jc.2005-2609; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Goralski KB, 2007, CAN J PHYSIOL PHARM, V85, P113, DOI 10.1139/Y06-092; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gurnell M, 2005, BEST PRACT RES CL EN, V19, P501, DOI 10.1016/j.beem.2005.10.001; Haluzik Martin, 2005, Curr Opin Investig Drugs, V6, P988; Hishida T, 2008, BIOCHEM BIOPH RES CO, V370, P289, DOI 10.1016/j.bbrc.2008.03.091; Jefcoate Colin R., 2008, V456, P173, DOI 10.1007/978-1-59745-245-8_13; Kantartzis K, 2005, OBES RES, V13, P1683, DOI 10.1038/oby.2005.206; Kaul S, 2010, NAT REV CARDIOL, V7, P670, DOI 10.1038/nrcardio.2010.160; Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380; Liu Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE657, DOI 10.1152/ajpendo.00186.2009; Long QQ, 2010, ENDOCRINOLOGY, V151, P3195, DOI 10.1210/en.2009-1501; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Mensink M, 2007, INT J OBESITY, V31, P1302, DOI 10.1038/sj.ijo.0803567; Miard S, 2005, INT J OBESITY, V29, pS10, DOI 10.1038/sj.ijo.0802906; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Mundle SD, 2003, FASEB J, V17, P569, DOI 10.1096/fj.02-0431rev; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Muruganandan S, 2010, J BONE MINER RES, V25, P222, DOI 10.1359/jbmr.091106; Nishimura Satoshi, 2009, Discov Med, V8, P55; O'Rourke RW, 2009, SURGERY, V145, P255, DOI 10.1016/j.surg.2008.08.038; Park KW, 2008, CELL METAB, V8, P454, DOI 10.1016/j.cmet.2008.11.001; Parlee SD, 2010, ENDOCRINOLOGY, V151, P2590, DOI 10.1210/en.2009-0794; Qatanani M, 2009, J CLIN INVEST, V119, P531, DOI 10.1172/JCI37273; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sell H, 2009, DIABETES, V58, P2731, DOI 10.2337/db09-0277; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Spiroglou SG, 2010, J ATHEROSCLER THROMB, V17, P115; Stejskal D, 2008, BIOMED PAP, V152, P217, DOI 10.5507/bp.2008.033; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Tomaru T, 2009, J BIOL CHEM, V284, P6116, DOI 10.1074/jbc.M808407200; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Weigert J, 2010, CLIN ENDOCRINOL, V72, P342, DOI 10.1111/j.1365-2265.2009.03664.x; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Yang ML, 2010, J INVEST MED, V58, P883, DOI 10.231/JIM.0b013e3181ec5db2; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zhu Hui-Li, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1050	61	97	106	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23982	23995		10.1074/jbc.M111.220491	http://dx.doi.org/10.1074/jbc.M111.220491			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572083	Green Published, hybrid			2022-12-25	WOS:000292294900041
J	Schurmann, K; Anton, M; Ivanov, I; Richter, C; Kuhn, H; Walther, M				Schurmann, Kathrin; Anton, Monika; Ivanov, Igor; Richter, Constanze; Kuhn, Hartmut; Walther, Matthias			Molecular Basis for the Reduced Catalytic Activity of the Naturally Occurring T560M Mutant of Human 12/15-Lipoxygenase That Has Been Implicated in Coronary Artery Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN 15-LIPOXYGENASE; CARDIOVASCULAR-DISEASE; LIPOXYGENASE PATHWAYS; HUMAN ATHEROGENESIS; SULFOXIDE FORMATION; SELF-INACTIVATION; ATHEROSCLEROSIS; DETERMINANTS; RETICULOCYTE; INFLAMMATION	Lipoxygenases have been implicated in cardiovascular disease. A rare single-nucleotide polymorphism causing T560M exchange has recently been described, and this mutation leads to a near null variant of the enzyme encoded for by the ALOX15 gene. When we inspected the three-dimensional structure of the rabbit ortholog, we localized Thr-560 outside the active site and identified a hydrogen bridge between its side chain and Gln-294. This interaction is part of a complex hydrogen bond network that appears to be conserved in other mammalian lipoxygenases. Gln-294 and Asn-287 are key amino acids in this network, and we hypothesized that disturbance of this hydrogen bond system causes the low activity of the T560M mutant. To test this hypothesis, we first mutated Thr-560 to amino acids not capable of forming side chain hydrogen bridges (T560M and T560A) and obtained enzyme variants with strongly reduced catalytic activity. In contrast, enzymatic activity was retained after T560S exchange. Enzyme variants with strongly reduced activity were also obtained when we mutated Gln-294 (binding partner of Thr-560) and Asn-287 (binding partner of Gln-294 and Met-418) to Leu. Basic kinetic characterization of the T560M mutant indicated that the enzyme lacks a kinetic lag phase but is rapidly inactivated. These data suggest that the low catalytic efficiency of the naturally occurring T560M mutant is caused by alterations of a hydrogen bond network interconnecting this residue with active site constituents. Disturbance of this bonding network increases the susceptibility of the enzyme for suicidal inactivation.	[Schurmann, Kathrin; Anton, Monika; Ivanov, Igor; Kuhn, Hartmut; Walther, Matthias] Charite, Inst Biochem, D-10117 Berlin, Germany; [Richter, Constanze] Tech Univ Berlin, Inst Food Chem & Toxicol, D-13355 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Berlin	Kuhn, H (corresponding author), Charite, Inst Biochem, Oudenarder Str 16, D-13347 Berlin, Germany.	hartmut.kuehn@charite.de	Ivanov, Igor V./I-5606-2016	Ivanov, Igor V./0000-0003-0543-2067	Deutsche Forschungsgemeinschaft [GRK1673]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant GRK1673.	Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Assimes TL, 2008, ATHEROSCLEROSIS, V198, P136, DOI 10.1016/j.atherosclerosis.2007.09.003; Bishnoi M, 2005, METHOD FIND EXP CLIN, V27, P465, DOI 10.1358/mf.2005.27.7.920929; Borngraber S, 1999, J BIOL CHEM, V274, P37345, DOI 10.1074/jbc.274.52.37345; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Funk CD, 2006, ARTERIOSCL THROM VAS, V26, P1204, DOI 10.1161/01.ATV.0000222960.43792.ff; GAN QF, 1995, BIOCHEMISTRY-US, V34, P7069, DOI 10.1021/bi00021a019; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Hersberger M, 2010, CLIN CHEM LAB MED, V48, P1063, DOI 10.1515/CCLM.2010.212; Hersberger M, 2009, ATHEROSCLEROSIS, V205, P192, DOI 10.1016/j.atherosclerosis.2008.11.017; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivanov I, 2005, FEBS J, V272, P2523, DOI 10.1111/j.1742-4658.2005.04673.x; Klingenberg R, 2009, EUR HEART J, V30, P2838, DOI 10.1093/eurheartj/ehp477; Krishnaswamy Guha, 2010, Cardiovascular & Hematological Disorders - Drug Targets, V10, P234; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kuhn H, 1997, J CLIN INVEST, V99, P888, DOI 10.1172/JCI119253; Liu SH, 2010, BRIT J PHARMACOL, V160, P1963, DOI 10.1111/j.1476-5381.2010.00804.x; Moreno JJ, 2009, BIOCHEM PHARMACOL, V77, P1, DOI 10.1016/j.bcp.2008.07.033; Palacios-Pelaez R, 2010, MOL NEUROBIOL, V41, P367, DOI 10.1007/s12035-010-8139-z; Poeckel D, 2010, CARDIOVASC RES, V86, P243, DOI 10.1093/cvr/cvq016; RAPOPORT S, 1984, EUR J BIOCHEM, V139, P573, DOI 10.1111/j.1432-1033.1984.tb08043.x; RAPOPORT SM, 1979, EUR J BIOCHEM, V96, P545, DOI 10.1111/j.1432-1033.1979.tb13068.x; SCHILSTRA MJ, 1993, BIOCHEMISTRY-US, V32, P7686, DOI 10.1021/bi00081a012; SCHILSTRA MJ, 1992, BIOCHEMISTRY-US, V31, P7692, DOI 10.1021/bi00148a033; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Vogel R, 2010, J BIOL CHEM, V285, P5369, DOI 10.1074/jbc.M109.057802; Walther M, 2002, J BIOL CHEM, V277, P27360, DOI 10.1074/jbc.M203234200; Wittwer J, 2007, PROSTAG LEUKOTR ESS, V77, P67, DOI 10.1016/j.plefa.2007.08.001; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959; Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003; Zheng YX, 2010, J BIOL CHEM, V285, P39876, DOI 10.1074/jbc.M110.180794; Zheng YX, 2010, J BIOL CHEM, V285, P39866, DOI 10.1074/jbc.M110.155374	36	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23920	23927		10.1074/jbc.M110.211821	http://dx.doi.org/10.1074/jbc.M110.211821			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21558275	Green Published, hybrid			2022-12-25	WOS:000292294900034
J	Wang, XJ; Wang, JR; Jiang, XJ				Wang, Xinjiang; Wang, Junru; Jiang, Xuejun			MdmX Protein Is Essential for Mdm2 Protein-mediated p53 Polyubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE; DNA-DAMAGE; EMBRYONIC LETHALITY; DEGRADATION; ACTIVATION; PHOSPHORYLATION; DIMERIZATION; INHIBITION; EXPRESSION; E3	Genetic evidence has implicated both Mdm2 and MdmX as essential in negative regulation of p53. However, the exact role of MdmX in this Mdm2-dependent protein degradation is not well understood. Most, if not all, previous Mdm2 studies used GST-Mdm2 fusion proteins in the in vitro assays. Here, we show that the p53 polyubiquitination activity of GST-Mdm2 is conferred by the GST tag and non-GST-tagged Mdm2 only catalyzes monoubiquitination of p53 even at extremely high concentrations. We further demonstrate that MdmX is a potent activator of Mdm2, facilitating dose-dependent p53 polyubiquitination. This activation process requires the RING domains of both MdmX and Mdm2 proteins. The polyubiquitination activity of Mdm2/MdmX is Mdm2-dependent. Unlike Mdm2 or MdmX overexpression alone, co-overexpression of MdmX and Mdm2 consistently triggered p53 degradation in cells. Moreover, cellular polyubiquitination of p53 was only observable in the cytoplasm where both Mdm2 and MdmX are readily detectable. Importantly, RNAi knockdown of MdmX increased levels of endogenous p53 accompanied by reduced p53 polyubiquitination. In conclusion, our work has resolved a major confusion in the field derived from using GST-Mdm2 and demonstrated that MdmX is the cellular activator that converts Mdm2 from a monoubiquitination E3 ligase to a polyubiquitination E3 ligase toward p53. Together, our findings provide a biochemical basis for the requirement of both Mdm2 and MdmX in the dynamic regulation of p53 stability.	[Wang, Xinjiang] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Wang, Junru; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA	Roswell Park Cancer Institute; Memorial Sloan Kettering Cancer Center	Wang, XJ (corresponding author), Elm & Carlton St, Buffalo, NY 14263 USA.	xinjiang.wang@roswellpark.org; jiangx@mskcc.org			American Cancer Society; Geoffrey Beene Cancer Research Fund award; Roswell Park Cancer Institute; Elsa U. Pardee Foundation	American Cancer Society(American Cancer Society); Geoffrey Beene Cancer Research Fund award; Roswell Park Cancer Institute; Elsa U. Pardee Foundation	This work was supported by the American Cancer Society and a Geoffrey Beene Cancer Research Fund award (to X. J.) and by start-up funds from the Roswell Park Cancer Institute (to X. W.) and Elsa U. Pardee Foundation (to X. W.).	Badciong JC, 2002, J BIOL CHEM, V277, P49668, DOI 10.1074/jbc.M208593200; Barboza JA, 2008, MOL CANCER RES, V6, P947, DOI 10.1158/1541-7786.MCR-07-2079; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Gilkes DM, 2008, MOL CELL BIOL, V28, P1999, DOI 10.1128/MCB.01633-07; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; Jackson MW, 1999, DNA CELL BIOL, V18, P693, DOI 10.1089/104454999314971; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1998, MOL CELL BIOL, V18, P5690, DOI 10.1128/MCB.18.10.5690; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li CG, 2002, MOL CELL BIOL, V22, P7562, DOI 10.1128/MCB.22.21.7562-7571.2002; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Maru Y, 1996, J BIOL CHEM, V271, P15353, DOI 10.1074/jbc.271.26.15353; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Ohtsubo C, 2009, CANCER SCI, V100, P1291, DOI 10.1111/j.1349-7006.2009.01180.x; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Okamoto K, 2009, FEBS LETT, V583, P2710, DOI 10.1016/j.febslet.2009.07.021; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wang XJ, 2004, FEBS LETT, V561, P195, DOI 10.1016/S0014-5793(04)00168-1; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Xiong SB, 2006, P NATL ACAD SCI USA, V103, P3226, DOI 10.1073/pnas.0508500103; Xiong SB, 2007, CIRCULATION, V115, P2925, DOI 10.1161/CIRCULATIONAHA.107.689901; YAN H, 1995, ANAL BIOCHEM, V231, P455, DOI 10.1006/abio.1995.0080	47	78	84	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23725	23734		10.1074/jbc.M110.213868	http://dx.doi.org/10.1074/jbc.M110.213868			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572037	hybrid, Green Published			2022-12-25	WOS:000292294900014
J	Flannery, AR; Huynh, C; Mittra, B; Mortara, RA; Andrews, NW				Flannery, Andrew R.; Huynh, Chau; Mittra, Bidyottam; Mortara, Renato A.; Andrews, Norma W.			LFR1 Ferric Iron Reductase of Leishmania amazonensis Is Essential for the Generation of Infective Parasite Forms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CHELATE REDUCTASE; NADPH OXIDASE; ARABIDOPSIS-THALIANA; ACQUISITION; PROTEIN; PROMASTIGOTES; TRANSFERRIN; ANTIGEN; FAMILY	The protozoan parasite Leishmania is the causative agent of serious human infections worldwide. The parasites alternate between insect and vertebrate hosts and cause disease by invading macrophages, where they replicate. Parasites lacking the ferrous iron transporter LIT1 cannot grow intracellularly, indicating that a plasma membrane-associated mechanism for iron uptake is essential for the establishment of infections. Here, we identify and functionally characterize a second member of the Leishmania iron acquisition pathway, the ferric iron reductase LFR1. The LFR1 gene is up-regulated under iron deprivation and accounts for all the detectable ferric reductase activity exposed on the surface of Leishmania amazonensis. LFR1 null mutants grow normally as promastigote insect stages but are defective in differentiation into the vertebrate infective forms, metacyclic promastigotes and amastigotes. LFR1 overexpression partially restores the abnormal morphology of infective stages but markedly reduces parasite viability, precluding its ability to rescue LFR1 null replication in macrophages. However, LFR1 overexpression is not toxic for amastigotes lacking the ferrous iron transporter LIT1 and rescues their growth defect. In addition, the intracellular growth of both LFR1 and LIT1 null parasites is rescued in macrophages loaded with exogenous iron. This indicates that the Fe3+ reductase LFR1 functions upstream of LIT1 and suggests that LFR1 overexpression results in excessive Fe2+ production, which impairs parasite viability after intracellular transport by LIT1.	[Flannery, Andrew R.; Huynh, Chau; Mittra, Bidyottam; Andrews, Norma W.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Mortara, Renato A.] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, BR-04023062 Sao Paulo, Brazil	University System of Maryland; University of Maryland College Park; Universidade Federal de Sao Paulo (UNIFESP)	Andrews, NW (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, 2134 Biosci Res Bldg, College Pk, MD 20742 USA.	andrewsn@umd.edu	Mortara, Renato A./C-1864-2012	Mortara, Renato A./0000-0002-2311-8349; Andrews, Norma/0000-0002-0611-2412	National Institutes of Health [R01 AI067979]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067979] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI067979 (to N. W. A.).	ANDERSON E, 1983, TISSUE CELL, V15, P853, DOI 10.1016/0040-8166(83)90054-X; ANDERSON GJ, 1992, J INORG BIOCHEM, V47, P249, DOI 10.1016/0162-0134(92)84070-4; Askwith CC, 1996, MOL MICROBIOL, V20, P27, DOI 10.1111/j.1365-2958.1996.tb02485.x; Becker SM, 2009, IMMUNOBIOLOGY, V214, P495, DOI 10.1016/j.imbio.2008.11.006; CHANG CS, 1985, MOL BIOCHEM PARASIT, V16, P267, DOI 10.1016/0166-6851(85)90069-6; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Courret N, 1999, EUR J IMMUNOL, V29, P762, DOI 10.1002/(SICI)1521-4141(199903)29:03&lt;762::AID-IMMU762&gt;3.0.CO;2-4; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; Depledge DP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000476; Finegold AA, 1996, J BIOL CHEM, V271, P31021, DOI 10.1074/jbc.271.49.31021; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GOLDBERG MW, 1992, J CELL BIOL, V119, P1429, DOI 10.1083/jcb.119.6.1429; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hodgkinson VH, 1996, EXP PARASITOL, V83, P94, DOI 10.1006/expr.1996.0053; Huynh C, 2008, CELL MICROBIOL, V10, P293, DOI 10.1111/j.1462-5822.2007.01095.x; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Jacques I, 2010, MOL BIOCHEM PARASIT, V170, P28, DOI 10.1016/j.molbiopara.2009.12.003; Kar S, 2000, J BIOL CHEM, V275, P37789, DOI 10.1074/jbc.M002149200; LEBOWITZ JH, 1990, P NATL ACAD SCI USA, V87, P9736, DOI 10.1073/pnas.87.24.9736; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; MORRIS CJ, 1995, INT J BIOCHEM CELL B, V27, P109, DOI 10.1016/1357-2725(94)00084-O; Olakanmi O, 1997, J BIOL CHEM, V272, P2599, DOI 10.1074/jbc.272.5.2599; Pinto-da-Silva LH, 2005, INT J PARASITOL, V35, P757, DOI 10.1016/j.ijpara.2005.03.004; Radisky DC, 1998, BIOCHEM J, V336, P201, DOI 10.1042/bj3360201; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Schagerlof U, 2006, PLANT MOL BIOL, V62, P215, DOI 10.1007/s11103-006-9015-0; SEGOVIA M, 1989, ANN TROP MED PARASIT, V83, P357, DOI 10.1080/00034983.1989.11812357; Sengupta S, 1999, J BIOL CHEM, V274, P2758, DOI 10.1074/jbc.274.5.2758; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; SOTERIADOU K, 1995, J ANTIMICROB CHEMOTH, V35, P23, DOI 10.1093/jac/35.1.23; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Tabbara KS, 2005, INFECT IMMUN, V73, P4714, DOI 10.1128/IAI.73.8.4714-4722.2005; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Vasconcelos M, 2006, PLANTA, V224, P1116, DOI 10.1007/s00425-006-0293-1; Waters BM, 2002, PLANT PHYSIOL, V129, P85, DOI 10.1104/pp.010829; Wilson ME, 2002, EXP PARASITOL, V100, P196, DOI 10.1016/S0014-4894(02)00018-8; WILSON ME, 1994, INFECT IMMUN, V62, P3262, DOI 10.1128/IAI.62.8.3262-3269.1994; Wu HL, 2005, PLANT CELL PHYSIOL, V46, P1505, DOI 10.1093/pcp/pci163; Zhang DL, 2006, BBA-GEN SUBJECTS, V1760, P1903, DOI 10.1016/j.bbagen.2006.07.019	46	57	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23266	23279		10.1074/jbc.M111.229674	http://dx.doi.org/10.1074/jbc.M111.229674			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21558274	hybrid, Green Published			2022-12-25	WOS:000292025000060
J	Noinaj, N; Bosserman, MA; Schickli, MA; Piszczek, G; Kharel, MK; Pahari, P; Buchanan, SK; Rohr, J				Noinaj, Nicholas; Bosserman, Mary A.; Schickli, M. Alexandra; Piszczek, Grzegorz; Kharel, Madan K.; Pahari, Pallab; Buchanan, Susan K.; Rohr, Juergen			The Crystal Structure and Mechanism of an Unusual Oxidoreductase, GilR, Involved in Gilvocarcin V Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BERBERINE BRIDGE ENZYME; COVALENTLY ATTACHED FAD; COMBINATORIAL BIOSYNTHESIS; ACLACINOMYCIN OXIDOREDUCTASE; DNA; DRUG; OXIDASE; BINDING; RAVIDOMYCIN; FLAVOENZYME	GilR is a recently identified oxidoreductase that catalyzes the terminal step of gilvocarcin V biosynthesis and is a unique enzyme that establishes the lactone core of the polyketide-derived gilvocarcin chromophore. Gilvocarcin-type compounds form a small distinct family of anticancer agents that are involved in both photo-activated DNA-alkylation and histone H3 cross-linking. High resolution crystal structures of apoGilR and GilR in complex with its substrate pregilvocarcin V reveals that GilR belongs to the small group of a relatively new type of the vanillyl-alcohol oxidase flavoprotein family characterized by bicovalently tethered cofactors. GilR was found as a dimer, with the bicovalently attached FAD cofactor mediated through His-65 and Cys-125. Subsequent mutagenesis and functional assays indicate that Tyr-445 may be involved in reaction catalysis and in mediating the covalent attachment of FAD, whereas Tyr-448 serves as an essential residue initiating the catalysis by swinging away from the active site to accommodate binding of the 6R-configured substrate and consequently abstracting the proton of the hydroxyl residue of the substrate hemiacetal 6-OH group. These studies lay the groundwork for future enzyme engineering to broaden the substrate specificity of this bottleneck enzyme of the gilvocarcin biosynthetic pathway for the development of novel anti-cancer therapeutics.	[Bosserman, Mary A.; Schickli, M. Alexandra; Kharel, Madan K.; Pahari, Pallab; Rohr, Juergen] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Noinaj, Nicholas; Buchanan, Susan K.] NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA; [Piszczek, Grzegorz] NHLBI, NIH, Bethesda, MD 20892 USA	University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rohr, J (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, 789 S Limestone St, Lexington, KY 40536 USA.	jrohr2@email.uky.edu	Pahari, Pallab/AAF-5664-2019; Piszczek, Grzegorz/GYU-2029-2022; Rohr, Jurgen/G-5375-2014	Rohr, Jurgen/0000-0001-6447-5951; Pahari, Pallab/0000-0003-3662-2015	National Institutes of Health [CA102102, CA091901]; NATIONAL CANCER INSTITUTE [R01CA102102, R01CA091901] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL000338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA102102 and CA091901 (to J. R.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALEGRIA AE, 1995, PHOTOCHEM PHOTOBIOL, V62, P409, DOI 10.1111/j.1751-1097.1995.tb02361.x; Alexeev I, 2007, P NATL ACAD SCI USA, V104, P6170, DOI 10.1073/pnas.0700579104; Baig I, 2008, J NAT PROD, V71, P199, DOI 10.1021/np0705763; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bashiri G, 2008, J BIOL CHEM, V283, P17531, DOI 10.1074/jbc.M801854200; Beam MP, 2009, BIOCHEMISTRY-US, V48, P4476, DOI 10.1021/bi8023509; Borchardt JK, 1999, MODERN DRUG DISCOV, V2, P22; CARTER GT, 1984, TETRAHEDRON LETT, V25, P255, DOI 10.1016/S0040-4039(00)99854-X; CARTER GT, 1985, J ANTIBIOT, V38, P242, DOI 10.7164/antibiotics.38.242; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cropp TA, 2002, BIOTECHNOL GENET ENG, V19, P159, DOI 10.1080/02648725.2002.10648028; ELESPURU RK, 1984, SCIENCE, V223, P69, DOI 10.1126/science.6229029; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer C, 2003, J AM CHEM SOC, V125, P7818, DOI 10.1021/ja034781q; Fitzpatrick PF, 2004, BIOORG CHEM, V32, P125, DOI 10.1016/j.bioorg.2003.02.001; Floss HG, 2006, J BIOTECHNOL, V124, P242, DOI 10.1016/j.jbiotec.2005.12.001; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; GLOCK GE, 1952, NATURE, V170, P119, DOI 10.1038/170119a0; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; Hutchinson CR, 2000, SPR DESKT EDIT CHEM, P233; Hutchinson CR, 1998, CURR OPIN MICROBIOL, V1, P319, DOI 10.1016/S1369-5274(98)80036-2; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Kharel MK, 2007, J AM CHEM SOC, V129, P3780, DOI 10.1021/ja0680515; Kharel MK, 2010, CHEMBIOCHEM, V11, P523, DOI 10.1002/cbic.200900673; Kharel MK, 2009, CHEMBIOCHEM, V10, P1305, DOI 10.1002/cbic.200900130; Khosla C, 1996, TRENDS BIOTECHNOL, V14, P335, DOI 10.1016/0167-7799(96)10046-9; KNOBLER RM, 1992, NUCLEIC ACIDS RES, V20, P4553, DOI 10.1093/nar/20.17.4553; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; KUTCHAN TM, 1995, J BIOL CHEM, V270, P24475, DOI 10.1074/jbc.270.41.24475; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leadlay PF, 1997, CURR OPIN CHEM BIOL, V1, P162, DOI 10.1016/S1367-5931(97)80005-1; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Leferink NGH, 2008, ARCH BIOCHEM BIOPHYS, V474, P292, DOI 10.1016/j.abb.2008.01.027; Lerner MG, 2006, APBS PLUGIN PYMOL; Liu T, 2004, J AM CHEM SOC, V126, P12262, DOI 10.1021/ja0467521; Luzhetskyy A, 2005, MOL MICROBIOL, V58, P3, DOI 10.1111/j.1365-2958.2005.04815.x; MATSUMOTO A, 1994, PHOTOCHEM PHOTOBIOL, V60, P225, DOI 10.1111/j.1751-1097.1994.tb05095.x; Matsumoto A, 2000, CANCER RES, V60, P3921; Mattevi A, 1997, STRUCTURE, V5, P907, DOI 10.1016/S0969-2126(97)00245-1; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MCGEE LR, 1990, J AM CHEM SOC, V112, P2386, DOI 10.1021/ja00162a046; Menzella HG, 2007, CURR OPIN MICROBIOL, V10, P238, DOI 10.1016/j.mib.2007.05.005; MISRA R, 1985, J ANTIBIOT, V38, P1280, DOI 10.7164/antibiotics.38.1280; Olano C, 2010, NAT PROD REP, V27, P571, DOI 10.1039/b911956f; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyola R, 1997, PHOTOCHEM PHOTOBIOL, V65, P802, DOI 10.1111/j.1751-1097.1997.tb01927.x; Remsing LL, 2003, J AM CHEM SOC, V125, P5745, DOI 10.1021/ja034162h; Rohr J, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P227; Sanchez C, 2005, P NATL ACAD SCI USA, V102, P461, DOI 10.1073/pnas.0407809102; Shepherd MD, 2010, ORG BIOMOL CHEM, V8, P3851, DOI 10.1039/c0ob00036a; Staunton J, 2001, CURR OPIN CHEM BIOL, V5, P159, DOI 10.1016/S1367-5931(00)00185-X; Sultana A, 2007, ACTA CRYSTALLOGR D, V63, P149, DOI 10.1107/S0907444906044271; TAKAHASHI K, 1983, J ANTIBIOT, V36, P1531, DOI 10.7164/antibiotics.36.1531; TSEDINH YC, 1987, BIOCHEM BIOPH RES CO, V143, P808, DOI 10.1016/0006-291X(87)90320-2; Van Lanen Steven G, 2006, Drug Discov Today Technol, V3, P285, DOI 10.1016/j.ddtec.2006.09.014; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walsh CT, 2002, CHEMBIOCHEM, V3, P125; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Winkler A, 2007, J BIOL CHEM, V282, P24437, DOI 10.1074/jbc.M703642200; Winkler A, 2006, J BIOL CHEM, V281, P21276, DOI 10.1074/jbc.M603267200; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Yamashita Y., 1988, NUCLEIC ACIDS S SER, V20, P65; Zhang WJ, 2008, J MED CHEM, V51, P2629, DOI 10.1021/jm701269v; Zhou H, 2008, CURR OPIN BIOTECH, V19, P590, DOI 10.1016/j.copbio.2008.10.012	71	19	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23533	23543		10.1074/jbc.M111.247833	http://dx.doi.org/10.1074/jbc.M111.247833			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561854	Green Published, hybrid			2022-12-25	WOS:000292025000083
J	Pelat, C; Falchi, A; Carrat, F; Mosnier, A; Bonmarin, I; Turbelin, C; Vaux, S; van der Werf, S; Cohen, JM; Lina, B; Blanchon, T; Hanslik, T				Pelat, Camille; Falchi, Alessandra; Carrat, Fabrice; Mosnier, Anne; Bonmarin, Isabelle; Turbelin, Clement; Vaux, Sophie; van der Werf, Sylvie; Cohen, Jean Marie; Lina, Bruno; Blanchon, Thierry; Hanslik, Thomas			Field Effectiveness of Pandemic and 2009-2010 Seasonal Vaccines against 2009-2010 A(H1N1) Influenza: Estimations from Surveillance Data in France	PLOS ONE			English	Article							VACCINATION; ILLNESS; HOSPITALIZATIONS; EFFICACY; PEOPLE; SYSTEM	Background: In this study, we assess how effective pandemic and trivalent 2009-2010 seasonal vaccines were in preventing influenza-like illness (ILI) during the 2009 A(H1N1) pandemic in France. We also compare vaccine effectiveness against ILI versus laboratory-confirmed pandemic A(H1N1) influenza, and assess the possible bias caused by using non-specific endpoints and observational data. Methodology and Principal Findings: We estimated vaccine effectiveness by using the following formula: VE = (PPV-PCV)/(PPV(1-PCV)) X 100%, where PPV is the proportion vaccinated in the population and PCV the proportion of vaccinated influenza cases. People were considered vaccinated three weeks after receiving a dose of vaccine. ILI and pandemic A(H1N1) laboratory-confirmed cases were obtained from two surveillance networks of general practitioners. During the epidemic, 99.7% of influenza isolates were pandemic A(H1N1). Pandemic and seasonal vaccine uptakes in the population were obtained from the National Health Insurance database and by telephonic surveys, respectively. Effectiveness estimates were adjusted by age and week. The presence of residual biases was explored by calculating vaccine effectiveness after the influenza period. The effectiveness of pandemic vaccines in preventing ILI was 52% (95% confidence interval: 30-69) during the pandemic and 33% (4-55) after. It was 86% (56-98) against confirmed influenza. The effectiveness of seasonal vaccines against ILI was 61% (56-66) during the pandemic and 19% (-10-41) after. It was 60% (41-74) against confirmed influenza. Conclusions: The effectiveness of pandemic vaccines in preventing confirmed pandemic A(H1N1) influenza on the field was high, consistently with published findings. It was significantly lower against ILI. This is unsurprising since not all ILI cases are caused by influenza. Trivalent 2009-2010 seasonal vaccines had a statistically significant effectiveness in preventing ILI and confirmed pandemic influenza, but were not better in preventing confirmed pandemic influenza than in preventing ILI. This lack of difference might be indicative of selection bias.	[Pelat, Camille; Falchi, Alessandra; Carrat, Fabrice; Turbelin, Clement; Blanchon, Thierry] UPMC Univ Paris 06, UMRS 707, Paris, France; [Pelat, Camille; Falchi, Alessandra; Carrat, Fabrice; Turbelin, Clement; Blanchon, Thierry; Hanslik, Thomas] INSERM, U707, Paris, France; [Carrat, Fabrice] Hop St Antoine, Unite Sante Publ, Assistance Publ Hop Paris, F-75571 Paris, France; [Mosnier, Anne; Cohen, Jean Marie] Grp Regionaux Observat Grippe, Reseau GROG, Paris, France; [Bonmarin, Isabelle; Vaux, Sophie] Inst Veille Sanit, St Maurice, France; [van der Werf, Sylvie] Inst Pasteur, Unit Mol Genet RNA Viruses, Natl Influenza Ctr No France, Dept Virol, Paris, France; [van der Werf, Sylvie] CNRS, URA3015, Paris, France; [van der Werf, Sylvie] Univ Paris Diderot, Paris, France; [Lina, Bruno] Hosp Civils Lyon, Virol Lab, Ctr Biol & Pathol Est, CNR Virus Influenzae Reg Sud, Bron, France; [Hanslik, Thomas] Hop Ambroise Pare, Serv Med Interne, Assistance Publ Hop Paris, Boulogne Billancourt, France; [Hanslik, Thomas] Univ Versailles St Quentin en Yvelines, Versailles, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Institute of Public Health Surveillance; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Universite Paris Saclay	Pelat, C (corresponding author), UPMC Univ Paris 06, UMRS 707, Paris, France.	pelat@u707.jussieu.fr	FALCHI, Alessandra/AAQ-8039-2020; BLANCHON, Thierry/AAK-6254-2020; lina, bruno/N-3663-2019; Carrat, Fabrice/AAU-8480-2020; LINA, bruno/M-4572-2014	lina, bruno/0000-0002-8959-2123; Carrat, Fabrice/0000-0002-8672-7918; van der WERF, Sylvie/0000-0002-1148-4456; Vaux, Sophie/0000-0001-6648-6320; Alessandra, FALCHI/0000-0003-0799-1460	Epiconcept society; GSK; Roche; Sanofi-Pasteur	Epiconcept society; GSK(GlaxoSmithKline); Roche(Roche Holding); Sanofi-Pasteur	This study was funded by a European Vaccine Manufacturers grant through the Epiconcept society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Several authors have competing interests, unrelated to the submitted study: SVDW has had a conference invitation from GSK; a research grant from GSK on an unrelated subject; joined patent from institution with GSK on an unrelated subject: vaccines against severe acute respiratory syndrome coronavirus (SARS-CoV) infection and their use in the prevention of SARS (patent US 2010/0233250 A1, published September 16 2010); travel grants for meetings from GSK; contributed to a clinical trial financed by Roche; is a member of the advisory committee on influenza of the French ministry of health; is a member of ESWI; is a member of the scientific committee of the GEIG; and is vice-president of the GROG network. BL has had paid consultancy and board membership (Roche, GSK, Novartis, BioCryst, MedImmune); has had research grants from Roche and Sanofi-Pasteur; and has received travel grants and honoraria for speaking or participation at meetings (Roche, Sanofi-Pasteur). TB has had a conference invitation from Roche in 2010 and is a member of the scientific committee of the GEIG. JMC has involvement in some epidemiological studies partially or fully granted by Roche and GSK, and travel grants from Roche for participation in scientific meetings. AM has a membership in the ministry of health advisory board on influenza; involvement in some epidemiological studies partially or fully granted by Roche and GSK; and travel grants from Roche for participation in scientific meetings. FC was a consultant for Novartis and GSK. The other authors have declared that no competing interests exist.	Laguna-Torres VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011719; BAXTER R, 2010, VACCINE; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; CARCIONE D, 2010, EUROSURVEILL, V15; Carlson SJ, 2010, VACCINE, V28, P6809, DOI 10.1016/j.vaccine.2010.08.051; Chowell G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008164; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Eurich DT, 2008, AM J RESP CRIT CARE, V178, P527, DOI 10.1164/rccm.200802-282OC; Falchi A, 2009, J CLIN VIROL, V45, P265, DOI 10.1016/j.jcv.2009.05.004; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; Fireman B, 2009, AM J EPIDEMIOL, V170, P650, DOI 10.1093/aje/kwp173; Furuse Y, 2010, J MED VIROL, V82, P1071, DOI 10.1002/jmv.21763; Halloran ME, 2001, AM J EPIDEMIOL, V154, P391, DOI 10.1093/aje/154.5.391; HANNOUN C, 1989, EUR J EPIDEMIOL, V5, P285, DOI 10.1007/BF00144828; HARDELID P, 2011, EUROSURVEILL, V16; *HAUT CONS SANT PU, 2009, REC SAN PRIOR INFL A; *HAUT CONS SANT PU, 2009, LIST PRIOR TARG GROU; Janjua NZ, 2010, CLIN INFECT DIS, V51, P1017, DOI 10.1086/656586; JEFFERIES S, 2011, EUROSURVEILL, V16; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; Kawai N, 2003, VACCINE, V21, P4507, DOI 10.1016/S0264-410X(03)00508-5; Mangtani P, 2004, J INFECT DIS, V190, P1, DOI 10.1086/421274; Millot JL, 2002, OCCUP MED-OXFORD, V52, P281, DOI 10.1093/occmed/52.5.281; Nichol KL, 2008, ARCH PEDIAT ADOL MED, V162, P1113, DOI 10.1001/archpedi.162.12.1113; Ochiai H, 2009, VACCINE, V27, P7031, DOI 10.1016/j.vaccine.2009.09.067; Orellano PW, 2010, VACCINE, V28, P5288, DOI 10.1016/j.vaccine.2010.05.051; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Oshitani H, 2000, INFECT CONT HOSP EP, V21, P728, DOI 10.1086/501725; Plennevaux E, 2011, VACCINE, V29, P1569, DOI 10.1016/j.vaccine.2010.12.116; Puig-Barbera J, 2010, VACCINE, V28, P7460, DOI 10.1016/j.vaccine.2010.09.042; Rivetti D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub2; ROUSSET D, 2011, INFL OTH RE IN PRESS; Scharfstein DO, 2006, BIOSTATISTICS, V7, P615, DOI 10.1093/biostatistics/kxj031; Simpson CR, 2010, HEALTH TECHNOL ASSES, V14, P323, DOI 10.3310/hta14340-05; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; Song JY, 2011, VACCINE, V29, P1395, DOI 10.1016/j.vaccine.2010.12.050; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; VALLERON AJ, 1986, AM J PUBLIC HEALTH, V76, P1289, DOI 10.2105/AJPH.76.11.1289; Vaux S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-30; Vu T, 2002, VACCINE, V20, P1831, DOI 10.1016/S0264-410X(02)00041-5; WICHMANN O, 2010, EUROSURVEILL, V15	43	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19621	10.1371/journal.pone.0019621	http://dx.doi.org/10.1371/journal.pone.0019621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573005	Green Published, gold, Green Submitted			2022-12-25	WOS:000290440200015
J	Soderberg, JAE; Birse, RT; Nassel, DR				Soderberg, Jeannette A. E.; Birse, Ryan T.; Nassel, Dick R.			Insulin Production and Signaling in Renal Tubules of Drosophila Is under Control of Tachykinin-Related Peptide and Regulates Stress Resistance	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; CAENORHABDITIS-ELEGANS; LOCOMOTOR-ACTIVITY; OXIDATIVE STRESS; S6 KINASE; MALPIGHIAN TUBULE; SEXUAL-DIMORPHISM; INNATE IMMUNITY; BODY-SIZE; FRUIT-FLY	The insulin-signaling pathway is evolutionarily conserved in animals and regulates growth, reproduction, metabolic homeostasis, stress resistance and life span. In Drosophila seven insulin-like peptides (DILP1-7) are known, some of which are produced in the brain, others in fat body or intestine. Here we show that DILP5 is expressed in principal cells of the renal tubules of Drosophila and affects survival at stress. Renal (Malpighian) tubules regulate water and ion homeostasis, but also play roles in immune responses and oxidative stress. We investigated the control of DILP5 signaling in the renal tubules by Drosophila tachykinin peptide (DTK) and its receptor DTKR during desiccative, nutritional and oxidative stress. The DILP5 levels in principal cells of the tubules are affected by stress and manipulations of DTKR expression in the same cells. Targeted knockdown of DTKR, DILP5 and the insulin receptor dInR in principal cells or mutation of Dilp5 resulted in increased survival at either stress, whereas over-expression of these components produced the opposite phenotype. Thus, stress seems to induce hormonal release of DTK that acts on the renal tubules to regulate DILP5 signaling. Manipulations of S6 kinase and superoxide dismutase (SOD2) in principal cells also affect survival at stress, suggesting that DILP5 acts locally on tubules, possibly in oxidative stress regulation. Our findings are the first to demonstrate DILP signaling originating in the renal tubules and that this signaling is under control of stress-induced release of peptide hormone.	[Soderberg, Jeannette A. E.; Birse, Ryan T.; Nassel, Dick R.] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Stockholm University	Soderberg, JAE (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	dnassel@zoologi.su.se			Swedish Research Council (VR) [621-2007-6500]	Swedish Research Council (VR)(Swedish Research Council)	This work was funded by the Swedish Research Council (VR, Grant 621-2007-6500; http://www.vr.se/) to D. R. Nassel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E, 2001, PEPTIDES, V22, P99, DOI 10.1016/S0196-9781(00)00361-2; Albiston AL, 2011, REGUL PEPTIDES, V166, P83, DOI 10.1016/j.regpep.2010.09.003; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Barcelo H, 2002, GENESIS, V34, P83, DOI 10.1002/gene.10132; Belgacem YH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000187; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Beyenbach KW, 2010, ANNU REV ENTOMOL, V55, P351, DOI 10.1146/annurev-ento-112408-085512; Birse RT, 2006, J NEUROBIOL, V66, P33, DOI 10.1002/neu.20189; Blumenthal EM, 2003, AM J PHYSIOL-CELL PH, V284, pC718, DOI 10.1152/ajpcell.00359.2002; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Davies SA, 2009, GEN COMP ENDOCR, V162, P113, DOI 10.1016/j.ygcen.2008.09.012; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Enell LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015780; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Geminard C, 2006, DIABETES, V55, pS5, DOI 10.2337/db06-S001; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Helfand SL, 2003, ANNU REV GENET, V37, P329, DOI 10.1146/annurev.genet.37.040103.095211; Helfand SL, 2003, BIOESSAYS, V25, P134, DOI 10.1002/bies.10225; Huang YQ, 2011, PEPTIDES, V32, P483, DOI 10.1016/j.peptides.2010.09.014; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Kabil H, 2007, BIOGERONTOLOGY, V8, P201, DOI 10.1007/s10522-006-9065-3; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kaplan DD, 2008, GENE DEV, V22, P1877, DOI 10.1101/gad.1670508; Kawli T, 2008, NAT IMMUNOL, V9, P1415, DOI 10.1038/ni.1672; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; Kreneisz O, 2010, NEUROREPORT, V21, P1116, DOI 10.1097/WNR.0b013e3283409200; Lange AB, 2001, PEPTIDES, V22, P229, DOI 10.1016/S0196-9781(00)00386-7; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Martin I, 2009, FEBS LETT, V583, P2308, DOI 10.1016/j.febslet.2009.06.023; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; MONNIER D, 1992, J BIOL CHEM, V267, P1298; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Poels J, 2009, PEPTIDES, V30, P545, DOI 10.1016/j.peptides.2008.10.012; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; REIHER W, 2011, J PROTEOME RES; Rosay P, 1997, J CELL SCI, V110, P1683; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sarafidis PA, 2008, CURR OPIN NEPHROL HY, V17, P450, DOI 10.1097/MNH.0b013e328305b994; Schmidt PT, 2000, PANCREAS, V20, P241, DOI 10.1097/00006676-200004000-00004; Siviter RJ, 2000, J BIOL CHEM, V275, P23273, DOI 10.1074/jbc.M002875200; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Sozen MA, 1997, P NATL ACAD SCI USA, V94, P5207, DOI 10.1073/pnas.94.10.5207; Stergiopoulos K, 2009, PHYSIOL GENOMICS, V37, P1, DOI 10.1152/physiolgenomics.90360.2008; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Terhzaz S, 2010, PHYSIOL GENOMICS, V41, P33, DOI 10.1152/physiolgenomics.00147.2009; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Tiwari S, 2008, P NATL ACAD SCI USA, V105, P6469, DOI 10.1073/pnas.0711283105; Vanfleteren JR, 1996, J EXP ZOOL, V274, P93, DOI 10.1002/(SICI)1097-010X(19960201)274:2&lt;93::AID-JEZ2&gt;3.0.CO;2-8; Veenstra JA, 2008, CELL TISSUE RES, V334, P499, DOI 10.1007/s00441-008-0708-3; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Winther AME, 2006, MOL CELL NEUROSCI, V31, P399, DOI 10.1016/j.mcn.2005.10.010; Winther AME, 2001, J EXP BIOL, V204, P1269; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	72	52	53	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19866	10.1371/journal.pone.0019866	http://dx.doi.org/10.1371/journal.pone.0019866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572965	Green Submitted, Green Published, gold			2022-12-25	WOS:000290440200031
J	de Witte, L; Bobardt, MD; Chatterji, U; van Loenen, FB; Verjans, GMGM; Geijtenbeek, TBH; Gallay, PA				de Witte, Lot; Bobardt, Michael D.; Chatterji, Udayan; van Loenen, Freek B.; Verjans, Georges M. G. M.; Geijtenbeek, Teunis B. H.; Gallay, Philippe A.			HSV Neutralization by the Microbicidal Candidate C5A	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; DENDRITIC CELLS; SEXUAL TRANSMISSION; HIV-1 TRANSMISSION; DC-SIGN; INFECTION; TYPE-1; NONOXYNOL-9; METAANALYSIS	Genital herpes is a major risk factor in acquiring human immunodeficiency virus type-1 (HIV-1) infection and is caused by both Herpes Simplex virus type 1 (HSV-1) and HSV-2. The amphipathic peptide C5A, derived from the non-structural hepatitis C virus (HCV) protein 5A, was shown to prevent HIV-1 infection but neither influenza nor vesicular stomatitis virus infections. Here we investigated the antiviral function of C5A on HSV infections. C5A efficiently inhibited both HSV-1 and HSV-2 infection in epithelial cells in vitro as well as in an ex vivo epidermal infection model. C5A destabilized the integrity of the viral HSV membrane. Furthermore, drug resistant HSV strains were inhibited by this peptide. Notably, C5A-mediated neutralization of HSV-1 prevented HIV-1 transmission. An in vitro HIV-1 transmigration assay was developed using primary genital epithelial cells and HSV infection increased HIV-1 transmigration. Treatment with C5A abolished HIV-1 transmigration by preventing HSV infection and by preserving the integrity of the genital epithelium that was severely compromised by HSV infection. In conclusion, this study demonstrates that C5A represents a multipurpose microbicide candidate, which neutralizes both HIV-1 and HSV, and which may interfere with HIV-1 transmission through the genital epithelium.	[de Witte, Lot; Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Bobardt, Michael D.; Chatterji, Udayan; Gallay, Philippe A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [van Loenen, Freek B.; Verjans, Georges M. G. M.] Erasmus MC, Dept Virol, Rotterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Scripps Research Institute; Erasmus University Rotterdam; Erasmus MC	de Witte, L (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	gallay@scripps.edu	de Witte, Lot/H-1499-2011; de Witte, Lot/GZG-9717-2022	de Witte, Lot/0000-0002-7235-9958; Verjans, Georges/0000-0002-2465-2674	United States Public Health Service [AI079782, AI078791]; Dutch Scientific Organization (NWO) [91204025, 91746367]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI079782, R21AI078791, R01AI087470, R21AI079782] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Dutch Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge financial support from the United States Public Health Service grants no. AI079782 and AI078791 (P.A.G.) and the Dutch Scientific Organization (NWO) grants no. 91204025 and 91746367 (T.B.H.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreca C, 2004, J VIROL, V78, P8641, DOI 10.1128/JVI.78.16.8641-8653.2004; Bobardt MD, 2008, P NATL ACAD SCI USA, V105, P5525, DOI 10.1073/pnas.0801388105; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105; Coffin RS, 1998, GENE THER, V5, P718, DOI 10.1038/sj.gt.3300634; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; de Jong MAWP, 2008, J GEN VIROL, V89, P2398, DOI 10.1099/vir.0.2008/003129-0; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Duan R, 2008, J INFECT DIS, V198, P659, DOI 10.1086/590668; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Lin Q, 2011, J IMMUNOL, V186, P2087, DOI 10.4049/jimmunol.1002340; McFarland W, 1999, J INFECT DIS, V180, P1459, DOI 10.1086/315076; Mesquita PMM, 2008, J VIROL, V82, P6576, DOI 10.1128/JVI.00335-08; Mikloska Z, 2001, J VIROL, V75, P5958, DOI 10.1128/JVI.75.13.5958-5964.2001; Nicola AV, 2005, J VIROL, V79, P7609, DOI 10.1128/JVI.79.12.7609-7616.2005; NIRUTHISARD S, 1992, LANCET, V339, P1371, DOI 10.1016/0140-6736(92)91195-E; Patton DL, 2002, SEX TRANSM DIS, V29, P581, DOI 10.1097/00007435-200210000-00004; Phillips DM, 2000, CONTRACEPTION, V62, P149, DOI 10.1016/S0010-7824(00)00156-6; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Stafford MK, 1998, J ACQ IMMUN DEF SYND, V17, P327, DOI 10.1097/00042560-199804010-00006; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Vanpouille C, 2010, J INFECT DIS, V201, P635, DOI 10.1086/650343; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002	29	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e18917	10.1371/journal.pone.0018917	http://dx.doi.org/10.1371/journal.pone.0018917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573158	Green Published, gold, Green Submitted			2022-12-25	WOS:000290305600008
J	Loughlin, DT; Artlett, CM				Loughlin, Danielle T.; Artlett, Carol M.			Modification of Collagen by 3-Deoxyglucosone Alters Wound Healing through Differential Regulation of p38 MAP Kinase	PLOS ONE			English	Article							FIBROBLAST-MATRIX INTERACTIONS; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR; IN-VIVO; H-RAS; CELL-MIGRATION; VENOUS ULCERS; APOPTOSIS; PATHWAY; ASK1	Background: Wound healing is a highly dynamic process that requires signaling from the extracellular matrix to the fibroblasts for migration and proliferation, and closure of the wound. This rate of wound closure is impaired in diabetes, which may be due to the increased levels of the precursor for advanced glycation end products, 3-deoxyglucosone (3DG). Previous studies suggest a differential role for p38 mitogen-activated kinase (MAPK) during wound healing; whereby, p38 MAPK acts as a growth kinase during normal wound healing, but acts as a stress kinase during diabetic wound repair. Therefore, we investigated the signaling cross-talk by which p38 MAPK mediates wound healing in fibroblasts cultured on native collagen and 3DG-collagen. Methodology/Principal Findings: Using human dermal fibroblasts cultured on 3DG-collagen as a model of diabetic wounds, we demonstrated that p38 MAPK can promote either cell growth or cell death, and this was dependent on the activation of AKT and ERK1/2. Wound closure on native collagen was dependent on p38 MAPK phosphorylation of AKT and ERK1/2. Furthermore, proliferation and collagen production in fibroblasts cultured on native collagen was dependent on p38 MAPK regulation of AKT and ERK1/2. In contrast, 3DG-collagen decreased fibroblast migration, proliferation, and collagen expression through ERK1/2 and AKT downregulation via p38 MAPK. Conclusions/Significance: Taken together, the present study shows that p38 MAPK is a key signaling molecule that plays a significantly opposite role during times of cellular growth and cellular stress, which may account for the differing rates of wound closure seen in diabetic populations.	[Loughlin, Danielle T.; Artlett, Carol M.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA	Drexel University	Loughlin, DT (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.	carol.artlett@drexelmed.edu			Department of Defense [WX81XWh-07-1-0450]; Dynamis Therapeutics, Inc.	Department of Defense(United States Department of Defense); Dynamis Therapeutics, Inc.	This work was funded by grants to C.M. Artlett from the Department of Defense WX81XWh-07-1-0450 and from Dynamis Therapeutics, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen SM, 2006, MECH AGEING DEV, V127, P726, DOI 10.1016/j.mad.2006.05.003; Asano Y, 2004, J IMMUNOL, V172, P7123, DOI 10.4049/jimmunol.172.11.7123; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Brunet A, 1996, SCIENCE, V272, P1652, DOI 10.1126/science.272.5268.1652; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen J, 2002, CIRC RES, V90, P1290, DOI 10.1161/01.RES.0000022161.42655.98; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Chen ZH, 1999, ONCOGENE, V18, P173, DOI 10.1038/sj.onc.1202276; Chiacchiera F, 2009, CELL DEATH DIFFER, V16, P1203, DOI 10.1038/cdd.2009.36; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Du J, 2004, CELL RES, V14, P148, DOI 10.1038/sj.cr.7290214; Du J, 2001, FREE RADICAL BIO MED, V31, P469, DOI 10.1016/S0891-5849(01)00611-6; Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Estrada Y, 2009, PIGM CELL MELANOMA R, V22, P66, DOI 10.1111/j.1755-148X.2008.00520.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harper EG, 2005, J CELL SCI, V118, P3471, DOI 10.1242/jcs.02475; Hasan A, 1997, J DERMATOL SCI, V16, P59, DOI 10.1016/S0923-1811(97)00622-1; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; Hehenberger Karin, 1998, Wound Repair and Regeneration, V6, P135, DOI 10.1046/j.1524-475X.1998.60207.x; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Huang Q, 2008, AM J PHYSIOL-CELL PH, V295, pC1647, DOI 10.1152/ajpcell.00322.2008; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kim BC, 2003, J CELL PHYSIOL, V195, P331, DOI 10.1002/jcp.10301; Kim MS, 2003, CANCER RES, V63, P5454; Li, 2000, Arterioscler Thromb Vasc Biol, V20, pE1; Liu QH, 2004, AM J PHYSIOL-HEART C, V286, pH2204, DOI 10.1152/ajpheart.01050.2003; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Loots MAM, 1999, ARCH DERMATOL RES, V291, P93, DOI 10.1007/s004030050389; Loughlin DT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011093; Loughlin DT, 2009, WOUND REPAIR REGEN, V17, P739, DOI 10.1111/j.1524-475X.2009.00532.x; Matsumoto T, 1999, J BIOL CHEM, V274, P13954, DOI 10.1074/jbc.274.20.13954; MAUCH C, 1990, RHEUM DIS CLIN N AM, V16, P93; MEDICHERLA S, 2009, MAPK INHIBITION REDU, P91; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513; Pozzi A, 2009, J AM SOC NEPHROL, V20, P2119, DOI 10.1681/ASN.2008080900; Raffetto JD, 2008, VASC ENDOVASC SURG, V42, P367, DOI 10.1177/1538574408316140; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Sassi-Gaha S, 2010, MATRIX BIOL, V29, P127, DOI 10.1016/j.matbio.2009.09.007; Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200; Stein W., 1989, CELL SHAPE DETERMINA; Grande MT, 2010, KIDNEY INT, V77, P509, DOI 10.1038/ki.2009.498; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Ye M, 2008, INVEST OPHTH VIS SCI, V49, P497, DOI 10.1167/iovs.07-0975; Zhang GY, 2009, EXP DERMATOL, V18, P947, DOI 10.1111/j.1600-0625.2009.00880.x; ZUMKELLER W, 1995, ANTICANCER RES, V15, P343	48	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e18676	10.1371/journal.pone.0018676	http://dx.doi.org/10.1371/journal.pone.0018676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573155	Green Published, Green Submitted, gold			2022-12-25	WOS:000290305600005
J	Tinsley, JM; Fairclough, RJ; Storer, R; Wilkes, FJ; Potter, AC; Squire, SE; Powell, DS; Cozzoli, A; Capogrosso, RF; Lambert, A; Wilson, FX; Wren, SP; De Luca, A; Davies, KE				Tinsley, Jonathon M.; Fairclough, Rebecca J.; Storer, Richard; Wilkes, Fraser J.; Potter, Allyson C.; Squire, Sarah E.; Powell, Dave S.; Cozzoli, Anna; Capogrosso, Roberta F.; Lambert, Adam; Wilson, Francis X.; Wren, Stephen P.; De Luca, Annamaria; Davies, Kay E.			Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; UP-REGULATION; MICE; EXPRESSION; PATHOLOGY	Background: Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the muscle fibers leading to the gradual depletion of skeletal muscle. There is significant evidence demonstrating that increasing levels of the dystrophin-related protein, utrophin, in mouse models results in sarcolemmal bound utrophin and prevents the muscular dystrophy pathology. The aim of this work was to develop a small molecule which increases the levels of utrophin in muscle and thus has therapeutic potential. Methodology and Principal Findings: We describe the in vivo activity of SMT C1100; the first orally bioavailable small molecule utrophin upregulator. Once-a-day daily-dosing with SMT C1100 reduces a number of the pathological effects of dystrophin deficiency. Treatment results in reduced pathology, better muscle physiology leading to an increase in overall strength, and an ability to resist fatigue after forced exercise; a surrogate for the six minute walk test currently recommended as the pivotal outcome measure in human trials for DMD. Conclusions and Significance: This study demonstrates proof-of-principle for the use of in vitro screening methods in allowing identification of pharmacological agents for utrophin transcriptional upregulation. The best compound identified, SMT C1100, demonstrated significant disease modifying effects in DMD models. Our data warrant the full evaluation of this compound in clinical trials in DMD patients.	[Tinsley, Jonathon M.; Storer, Richard; Wilkes, Fraser J.; Lambert, Adam; Wilson, Francis X.; Wren, Stephen P.] Summit plc, Abingdon, Oxon, England; [Fairclough, Rebecca J.; Potter, Allyson C.; Squire, Sarah E.; Powell, Dave S.; Davies, Kay E.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford, England; [Cozzoli, Anna; Capogrosso, Roberta F.; De Luca, Annamaria] Univ Bari A Moro, Dept Pharmacobiol, Pharmacol Unit, Bari, Italy	University of Oxford; Universita degli Studi di Bari Aldo Moro	Tinsley, JM (corresponding author), Summit plc, Abingdon, Oxon, England.	Jon.Tinsley@summitplc.com; kay.davies@dpag.ox.ac.uk		Davies, Kelvin/0000-0001-7790-3003; De Luca, Annamaria/0000-0002-5652-7341	Medical Research Council; Muscular Dystrophy Campaign; Muscular Dystrophy Association USA; Association Francaise contre les Myopathies in Oxford; Telethon-Italy [GGP05130]; MRC [MC_U137761449] Funding Source: UKRI; Medical Research Council [MC_U137761449] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Muscular Dystrophy Association USA(Muscular Dystrophy Association); Association Francaise contre les Myopathies in Oxford; Telethon-Italy(Fondazione Telethon); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Covance for designing and conducting the safety evaluation programme for SMT C1100. For the study on exercised mdx mice we thank Dr. Karina Litvinova and Dr. Valeriana Sblendorio for assistance with the physiology and in vivo experiments, respectively, Dr. Antonella Liantonio for fura-2 microspectofluometry and Prof. Beatrice Nico for supervision on immunofluorescence and morphological studies. We acknowledge Charles J. Sherr, M.D., Ph.D., a Howard Hughes Medical Institute Investigator at St. Jude Children's Research Hospital, Memphis, USA, who developed the retroviral vector pSRalphaMSV-CDK4-tkneo used to generate the human DMD cell line provided by Vincent Mouly and Gillian Butler-Browne (Institute of Myology, Paris). We further acknowledge Prof. Steve Davies and Dr. Angela Russell (Chemistry Research Laboratories, Oxford University) who performed the initial pilot compound screens. We are grateful to the Medical Research Council, Muscular Dystrophy Campaign, Muscular Dystrophy Association USA and the Association Francaise contre les Myopathies for support of the work in Oxford. The support of Telethon-Italy (project GGP05130) for part of the work conducted in Bari is also gratefully acknowledged.	Amenta AR, 2011, P NATL ACAD SCI USA, V108, P762, DOI 10.1073/pnas.1013067108; Beroud C, 2007, HUM MUTAT, V28, P196, DOI 10.1002/humu.20428; Bogdanovich S, 2004, J MOL MED, V82, P102, DOI 10.1007/s00109-003-0484-1; Burdi R, 2009, J APPL PHYSIOL, V106, P1311, DOI 10.1152/japplphysiol.90985.2008; Cooper ST, 2003, NEUROLOGY, V61, P93, DOI 10.1212/01.WNL.0000069460.53438.38; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; De Luca A, 2008, NEUROBIOL DIS, V32, P243, DOI 10.1016/j.nbd.2008.07.009; Goemans N, 2010, NEUROMUSCULAR DISORD, V20, P639, DOI 10.1016/j.nmd.2010.07.139; Goyenvalle A, 2010, MOL THER, V18, P198, DOI 10.1038/mt.2009.248; Hirst R C, 2005, Acta Myol, V24, P209; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mattei E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000774; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Miura P, 2006, TRENDS MOL MED, V12, P122, DOI 10.1016/j.molmed.2006.01.002; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; Peter AK, 2008, J CELL BIOL, V183, P419, DOI 10.1083/jcb.200808027; Shrewsbury SB, 2010, NEUROMUSCULAR DISORD, V20, P639, DOI 10.1016/j.nmd.2010.07.140; Squire S, 2002, HUM MOL GENET, V11, P3333, DOI 10.1093/hmg/11.26.3333; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033	21	128	134	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19189	10.1371/journal.pone.0019189	http://dx.doi.org/10.1371/journal.pone.0019189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573153	Green Published, Green Submitted, gold			2022-12-25	WOS:000290305600014
J	Dobel, C; Junghofer, M; Gruber, T				Dobel, Christian; Junghoefer, Markus; Gruber, Thomas			The Role of Gamma-Band Activity in the Representation of Faces: Reduced Activity in the Fusiform Face Area in Congenital Prosopagnosia	PLOS ONE			English	Article							NEURAL MECHANISMS; PARIETAL CORTEX; REPETITION; BRAIN; RECOGNITION; RESPONSES; EEG; ACTIVATION; SYNCHRONY; ATTENTION	Background: Congenital prosopagnosia (CP) describes an impairment in face processing that is presumably present from birth. The neuronal correlates of this dysfunction are still under debate. In the current paper, we investigate high-frequent oscillatory activity in response to faces in persons with CP. Such neuronal activity is thought to reflect higher-level representations for faces. Methodology: Source localization of induced Gamma-Band Responses (iGBR) measured by magnetoencephalography (MEG) was used to establish the origin of oscillatory activity in response to famous and unknown faces which were presented in upright and inverted orientation. Persons suffering from congenital prosopagnosia (CP) were compared to matched controls. Principal Findings: Corroborating earlier research, both groups revealed amplified iGBR in response to upright compared to inverted faces predominately in a time interval between 170 and 330 ms and in a frequency range from 50-100 Hz. Oscillatory activity upon known faces was smaller in comparison to unknown faces, suggesting a "sharpening'' effect reflecting more efficient processing for familiar stimuli. These effects were seen in a wide cortical network encompassing temporal and parietal areas involved in the disambiguation of homogenous stimuli such as faces, and in the retrieval of semantic information. Importantly, participants suffering from CP displayed a strongly reduced iGBR in the left fusiform area compared to control participants. Conclusions: In sum, these data stress the crucial role of oscillatory activity for face representation and demonstrate the involvement of a distributed occipito-temporo-parietal network in generating iGBR. This study also provides the first evidence that persons suffering from an agnosia actually display reduced gamma band activity. Finally, the results argue strongly against the view that oscillatory activity is a mere epiphenomenon brought fourth by rapid eye-movements (micro saccades).	[Dobel, Christian; Junghoefer, Markus] Univ Munster, Otto Creutzfeldt Ctr, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Gruber, Thomas] Univ Osnabruck, Inst Psychol, Osnabruck, Germany	University of Munster; University Osnabruck	Dobel, C (corresponding author), Univ Munster, Otto Creutzfeldt Ctr, Inst Biomagnetism & Biosignalanal, Munster, Germany.	cdobel@uni-muenster.de	Junghoefer, Markus/AAA-2892-2021	Junghoefer, Markus/0000-0002-8532-2986				Anaki D, 2007, NEUROIMAGE, V37, P1407, DOI 10.1016/j.neuroimage.2007.05.054; Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Behrmann M, 2007, CEREB CORTEX, V17, P2354, DOI 10.1093/cercor/bhl144; Bentin S, 1999, NEUROREPORT, V10, P823, DOI 10.1097/00001756-199903170-00029; Bentin S, 2007, J COGNITIVE NEUROSCI, V19, P132, DOI 10.1162/jocn.2007.19.1.132; Bindemann M, 2008, VISION RES, V48, P2555, DOI 10.1016/j.visres.2008.09.001; Bosch-Bayard J, 2001, CLIN ELECTROENCEPHAL, V32, P47, DOI 10.1177/155005940103200203; Busch NA, 2006, NEUROIMAGE, V33, P1169, DOI 10.1016/j.neuroimage.2006.07.034; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; DeGutis JM, 2007, J COGNITIVE NEUROSCI, V19, P1790, DOI 10.1162/jocn.2007.19.11.1790; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Dobel C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002326; Dobel C, 2007, CORTEX, V43, P718, DOI 10.1016/S0010-9452(08)70501-X; EVANS AC, 1993, STAT NEUROANATOMICAL; FAST K, 2004, VERFAHREN ERFASSUNG; Fiebach CJ, 2005, J NEUROSCI, V25, P3414, DOI 10.1523/JNEUROSCI.4107-04.2005; Fries P, 2008, NEURON, V58, P303, DOI 10.1016/j.neuron.2008.04.020; Garrido L, 2009, BRAIN, V132, P3443, DOI 10.1093/brain/awp271; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; GRUBER R, 2002, EUR J NEUROSCI, V19, P1073; Gruber T, 2008, BRAIN RES, V1196, P74, DOI 10.1016/j.brainres.2007.12.037; Gruber T, 2006, NEUROIMAGE, V29, P888, DOI 10.1016/j.neuroimage.2005.09.004; Gruber T, 2005, CEREB CORTEX, V15, P109, DOI 10.1093/cercor/bhh113; Gruber T, 2002, COGNITIVE BRAIN RES, V13, P377, DOI 10.1016/S0926-6410(01)00130-6; Harris AM, 2005, NEUROPSYCHOLOGIA, V43, P2125, DOI 10.1016/j.neuropsychologia.2005.03.017; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RNA, 2002, CEREB CORTEX, V12, P178, DOI 10.1093/cercor/12.2.178; Itier RJ, 2007, J COGNITIVE NEUROSCI, V19, P1815, DOI 10.1162/jocn.2007.19.11.1815; Jacques C, 2006, PSYCHOL SCI, V17, P485, DOI 10.1111/j.1467-9280.2006.01733.x; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Keil A, 1999, J NEUROSCI, V19, P7152, DOI 10.1523/JNEUROSCI.19-16-07152.1999; Kloth N, 2006, EUR J NEUROSCI, V24, P3317, DOI 10.1111/j.1460-9568.2006.05211.x; Kress T, 2003, BEHAV NEUROL, V14, P109, DOI 10.1155/2003/520476; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; LOBMAIER J, 2010, ADV COGN PS IN PRESS; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Penny WD, 2005, NEUROIMAGE, V24, P350, DOI 10.1016/j.neuroimage.2004.08.034; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Schweinberger SR, 2004, NEUROREPORT, V15, P1501, DOI 10.1097/01.wnr.0000131675.00319.42; Schweinberger SR, 2007, BRAIN RES, V1184, P226, DOI 10.1016/j.brainres.2007.09.079; Shafritz KM, 2002, P NATL ACAD SCI USA, V99, P10917, DOI 10.1073/pnas.152694799; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Supp GG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000684; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; van Turennout M, 2003, CEREB CORTEX, V13, P381, DOI 10.1093/cercor/13.4.381; WARRINGTON EK, 1992, VISUAL OBJECT SPACE; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P74, DOI 10.1002/(SICI)1097-0193(1996)4:1<74::AID-HBM5>3.0.CO;2-M; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; Zion-Golumbic E, 2008, NEUROIMAGE, V39, P1980, DOI 10.1016/j.neuroimage.2007.10.025; Zion-Golumbic E, 2007, CEREB CORTEX, V17, P1741, DOI 10.1093/cercor/bhl100	56	19	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19550	10.1371/journal.pone.0019550	http://dx.doi.org/10.1371/journal.pone.0019550			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573175	Green Submitted, Green Published, gold			2022-12-25	WOS:000290256400021
J	Mech, F; Thywissen, A; Guthke, R; Brakhage, AA; Figge, MT				Mech, Franziska; Thywissen, Andreas; Guthke, Reinhard; Brakhage, Axel A.; Figge, Marc Thilo			Automated Image Analysis of the Host-Pathogen Interaction between Phagocytes and Aspergillus fumigatus	PLOS ONE			English	Article							CONIDIA; SEGMENTATION; RECOGNITION; ALGORITHMS; INTENSITY	Aspergillus fumigatus is a ubiquitous airborne fungus and opportunistic human pathogen. In immunocompromised hosts, the fungus can cause life-threatening diseases like invasive pulmonary aspergillosis. Since the incidence of fungal systemic infections drastically increased over the last years, it is a major goal to investigate the pathobiology of A. fumigatus and in particular the interactions of A. fumigatus conidia with immune cells. Many of these studies include the activity of immune effector cells, in particular of macrophages, when they are confronted with conidia of A. fumigus wild-type and mutant strains. Here, we report the development of an automated analysis of confocal laser scanning microscopy images from macrophages coincubated with different A. fumigatus strains. At present, microscopy images are often analysed manually, including cell counting and determination of interrelations between cells, which is very time consuming and error-prone. Automation of this process overcomes these disadvantages and standardises the analysis, which is a prerequisite for further systems biological studies including mathematical modeling of the infection process. For this purpose, the cells in our experimental setup were differentially stained and monitored by confocal laser scanning microscopy. To perform the image analysis in an automatic fashion, we developed a ruleset that is generally applicable to phagocytosis assays and in the present case was processed by the software Definiens Developer XD. As a result of a complete image analysis we obtained features such as size, shape, number of cells and cell-cell contacts. The analysis reported here, reveals that different mutants of A. fumigatus have a major influence on the ability of macrophages to adhere and to phagocytose the respective conidia. In particular, we observe that the phagocytosis ratio and the aggregation behaviour of pksP mutant compared to wild-type conidia are both significantly increased.	[Mech, Franziska; Figge, Marc Thilo] HKI, Leibniz Inst Nat Prod Res & Infect Biol, Res Grp Appl Syst Biol, Jena, Germany; [Thywissen, Andreas; Brakhage, Axel A.] HKI, Leibniz Inst Nat Prod Res & Infect Biol, Dept Mol & Appl Microbiol, Jena, Germany; [Thywissen, Andreas; Brakhage, Axel A.; Figge, Marc Thilo] Univ Jena, Jena, Germany; [Guthke, Reinhard] HKI, Leibniz Inst Nat Prod Res & Infect Biol, Res Grp Syst Biol Bioinformat, Jena, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Hans Knoll Institute (HKI)	Mech, F (corresponding author), HKI, Leibniz Inst Nat Prod Res & Infect Biol, Res Grp Appl Syst Biol, Jena, Germany.	Thilo.Figge@hki-jena.de	Figge, Marc Thilo/J-7547-2017	Figge, Marc Thilo/0000-0002-4044-9166; Braun, Franziska/0000-0003-1027-8084	International Leibniz Research School (ILRS); BMBF; TMBWK	International Leibniz Research School (ILRS); BMBF(Federal Ministry of Education & Research (BMBF)); TMBWK	This work was supported by the International Leibniz Research School (ILRS: http://www.ilrs.hki-jena.de/) for Microbial and Biomolecular Interactions as part of the excellence graduate school Jena School for Microbial Communication (JSMC: http://www.jsmc.uni-jena.de/) and the "Pakt fur Forschung und Innovation'' of the BMBF (http://www.bmbf.de/) and TMBWK (http://www.thueringen.de/de/tmbwk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Baatz M, 2009, COMB CHEM HIGH T SCR, V12, P908, DOI 10.2174/138620709789383196; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Behnsen J, 2010, INFECT IMMUN, V78, P3585, DOI 10.1128/IAI.01353-09; Binnig G, 2002, EUROPHYSICS NEWS, V33; BRAKHAGE AA, 1995, J BACTERIOL, V177, P2781, DOI 10.1128/jb.177.10.2781-2788.1995; Brakhage AA, 2010, CURR OPIN MICROBIOL, V13, P409, DOI 10.1016/j.mib.2010.04.009; Bruns S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000873; Codina R, 2008, J INVEST ALLERG CLIN, V18, P156; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; Dagenais TRT, 2010, INFECT IMMUN, V78, P823, DOI 10.1128/IAI.00980-09; Dzyubachyk O, 2010, BIOINFORMATICS, V26, P2424, DOI 10.1093/bioinformatics/btq434; Fontaine T, 2010, FUNGAL GENET BIOL, V47, P707, DOI 10.1016/j.fgb.2010.04.006; Garrido A, 2000, PATTERN RECOGN, V33, P821, DOI 10.1016/S0031-3203(99)00091-6; de Ana SG, 2006, J INVEST ALLERG CLIN, V16, P357; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; HILDRETH EC, 1983, COMPUT VISION GRAPH, V22, P1, DOI 10.1016/0734-189X(83)90093-2; Ibrahim-Granet O, 2003, INFECT IMMUN, V71, P891, DOI 10.1128/IAI.71.2.891-903.2003; Jahn B, 2002, CELL MICROBIOL, V4, P793, DOI 10.1046/j.1462-5822.2002.00228.x; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Malpica N, 1997, CYTOMETRY, V28, P289, DOI 10.1002/(SICI)1097-0320(19970801)28:4<289::AID-CYTO3>3.0.CO;2-7; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Patel K, 2010, INT DRUG DISCOVERY, V5, P64; Schonmeyer R, 2011, INT J COMPUT ASS RAD, V6, P127, DOI 10.1007/s11548-010-0486-8; Shamir L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000974; Soille P., 2013, MORPHOLOGICAL IMAGE; Sysko LR, 2010, CURR PROTOC CYTOM; Vogt A, 2009, DEV DYNAM, V238, P656, DOI 10.1002/dvdy.21892; Wahlby C, 2004, J MICROSC-OXFORD, V215, P67, DOI 10.1111/j.0022-2720.2004.01338.x; Yang YM, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P42, DOI 10.1145/312624.312647; Zhou XB, 2006, IEEE SIGNAL PROC MAG, V23, P63, DOI 10.1109/MSP.2006.1628879	34	45	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19591	10.1371/journal.pone.0019591	http://dx.doi.org/10.1371/journal.pone.0019591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573171	Green Published, Green Submitted, gold			2022-12-25	WOS:000290256400029
J	Ullrich, RT; Jikeli, JF; Diedenhofen, M; Bohm-Sturm, P; Unruh, M; Vollmar, S; Hoehn, M				Ullrich, Roland T.; Jikeli, Jan F.; Diedenhofen, Michael; Boehm-Sturm, Philipp; Unruh, Maike; Vollmar, Stefan; Hoehn, Mathias			In-Vivo Visualization of Tumor Microvessel Density and Response to Anti-Angiogenic Treatment by High Resolution MRI in Mice	PLOS ONE			English	Article							EXPERIMENTAL BRAIN-TUMORS; CONTRAST AGENTS; DIFFUSION; SIZE; RELAXATION; INHIBITOR	Purpose: Inhibition of angiogenesis has shown clinical success in patients with cancer. Thus, imaging approaches that allow for the identification of angiogenic tumors and the detection of response to anti-angiogenic treatment are of high clinical relevance. Experimental Design: We established an in vivo magnetic resonance imaging (MRI) approach that allows us to simultaneously image tumor microvessel density and tumor vessel size in a NSCLC model in mice. Results: Using microvessel density imaging we demonstrated an increase in microvessel density within 8 days after tumor implantation, while tumor vessel size decreased indicating a switch from macro-to microvessels during tumor growth. Moreover, we could monitor in vivo inhibition of angiogenesis induced by the angiogenesis inhibitor PTK787, resulting in a decrease of microvessel density and a slight increase in tumor vessel size. Conclusions: We present an in vivo imaging approach that allows us to monitor both tumor microvessel density and tumor vessel size in the tumor. Moreover, this approach enables us to assess, early-on, treatment effects on tumor microvessel density as well as on tumor vessel size. Thus, this imaging-based strategy of validating anti-angiogenic treatment effects has high potential in applications to preclinical and clinical trials.	[Ullrich, Roland T.; Jikeli, Jan F.; Diedenhofen, Michael; Boehm-Sturm, Philipp; Unruh, Maike; Vollmar, Stefan; Hoehn, Mathias] Max Planck Inst Neurol Res, Cologne, Germany; [Ullrich, Roland T.] Ctr Mol Med, Cologne, Germany; [Ullrich, Roland T.] Univ Hosp, Dept Internal Med 1, Cologne, Germany	Max Planck Society; University of Cologne; University of Cologne	Ullrich, RT (corresponding author), Max Planck Inst Neurol Res, Cologne, Germany.	ullrich@nf.mpg.de		Boehm-Sturm, Philipp/0000-0001-8777-4823	Deutsche Forschungsgemeinschaft [SFB 832]; European funds (project ENCITE) [HEALTH-F5-2008-201842]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European funds (project ENCITE)	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft through SFB 832 (to R.T.U.), and by European funds (project ENCITE) under the 7th Framework HEALTH-F5-2008-201842 (to M. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; Cizek J, 2004, NEUROIMAGE, V22, P434, DOI 10.1016/j.neuroimage.2004.01.016; Dennie J, 1998, MAGN RESON MED, V40, P793, DOI 10.1002/mrm.1910400602; Drevs J, 2002, CANCER RES, V62, P4015; Drevs J, 2007, J CLIN ONCOL, V25, P3045, DOI 10.1200/JCO.2006.07.2066; EIS M, 1995, MAGN RESON MED, V34, P835, DOI 10.1002/mrm.1910340608; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Hamstra DA, 2005, P NATL ACAD SCI USA, V102, P16759, DOI 10.1073/pnas.0508347102; Huang MQ, 2008, NMR BIOMED, V21, P1021, DOI 10.1002/nbm.1261; Ivy SP, 2009, NAT REV CLIN ONCOL, V6, P569, DOI 10.1038/nrclinonc.2009.130; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jensen JH, 2006, MAGN RESON MED, V56, P1145, DOI 10.1002/mrm.21052; Jensen JH, 2000, MAGNET RESON MED, V44, P224, DOI 10.1002/1522-2594(200008)44:2<224::AID-MRM9>3.0.CO;2-M; Kiselev VG, 1999, MAGN RESON MED, V41, P499, DOI 10.1002/(SICI)1522-2594(199903)41:3<499::AID-MRM12>3.0.CO;2-O; Kiselev VG, 2010, JOINT ANN M ISMRM ES; Lin CY, 2008, J CEREBR BLOOD F MET, V28, P1491, DOI 10.1038/jcbfm.2008.42; Schwarz AJ, 2003, MAGN RESON IMAGING, V21, P1191, DOI 10.1016/j.mri.2003.08.020; Tropres I, 2001, MAGN RESON MED, V45, P397, DOI 10.1002/1522-2594(200103)45:3<397::AID-MRM1052>3.0.CO;2-3; Ullrich RT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003908; Valonen PK, 2004, J MAGN RESON IMAGING, V19, P389, DOI 10.1002/jmri.20026; Wertman R, 2008, RADIOLOGY, V248, P799, DOI 10.1148/radiol.2483072093; Wong CI, 2009, J CLIN ONCOL, V27, P4718, DOI 10.1200/JCO.2008.21.7125; Wu EX, 2004, NMR BIOMED, V17, P507, DOI 10.1002/nbm.921; Zwick S, 2009, J MAGN RESON IMAGING, V29, P1125, DOI 10.1002/jmri.21710	25	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19592	10.1371/journal.pone.0019592	http://dx.doi.org/10.1371/journal.pone.0019592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573168	gold, Green Published, Green Submitted			2022-12-25	WOS:000290256400030
J	Matthes, D; Gapsys, V; Daebel, V; de Groot, BL				Matthes, Dirk; Gapsys, Vytautas; Daebel, Venita; de Groot, Bert L.			Mapping the Conformational Dynamics and Pathways of Spontaneous Steric Zipper Peptide Oligomerization	PLOS ONE			English	Article							AMYLOID FIBRIL FORMATION; SOLID-STATE NMR; PAIRED HELICAL FILAMENTS; PARTICLE MESH EWALD; YEAST PRION SUP35; MOLECULAR-DYNAMICS; BETA-SHEET; AGGREGATION KINETICS; SECONDARY STRUCTURE; PROTEIN AGGREGATION	The process of protein misfolding and self-assembly into various, polymorphic aggregates is associated with a number of important neurodegenerative diseases. Only recently, crystal structures of several short peptides have provided detailed structural insights into beta-sheet rich aggregates, known as amyloid fibrils. Knowledge about early events of the formation and interconversion of small oligomeric states, an inevitable step in the cascade of peptide self-assembly, however, remains still limited. We employ molecular dynamics simulations in explicit solvent to study the spontaneous aggregation process of steric zipper peptide segments from the tau protein and insulin in atomistic detail. Starting from separated chains with random conformations, we find a rapid formation of structurally heterogeneous, beta-sheet rich oligomers, emerging from multiple bimolecular association steps and diverse assembly pathways. Furthermore, our study provides evidence that aggregate intermediates as small as dimers can be kinetically trapped and thus affect the structural evolution of larger oligomers. Alternative aggregate structures are found for both peptide sequences in the different independent simulations, some of which feature characteristics of the known steric zipper conformation (e.g., beta-sheet bilayers with a dry interface). The final aggregates interconvert with topologically distinct oligomeric states exclusively via internal rearrangements. The peptide oligomerization was analyzed through the perspective of a minimal oligomer, i.e., the dimer. Thereby all observed multimeric aggregates can be consistently mapped onto a space of reduced dimensionality. This novel method of conformational mapping reveals heterogeneous association and reorganization dynamics that are governed by the characteristics of peptide sequence and oligomer size.	[Matthes, Dirk; Gapsys, Vytautas; de Groot, Bert L.] Max Planck Inst Biophys Chem, Computat Biomol Dynam Grp, Gottingen, Germany; [Daebel, Venita] Max Planck Inst Biophys Chem, Solid State NMR, Gottingen, Germany	Max Planck Society; Max Planck Society	Matthes, D (corresponding author), Max Planck Inst Biophys Chem, Computat Biomol Dynam Grp, Gottingen, Germany.	bgroot@gwdg.de	Gapsys, Vytautas/AAF-7922-2020	Gapsys, Vytautas/0000-0002-6761-7780; Matthes, Dirk/0000-0003-3969-6335	Graduate School Spectroscopy and Dynamics of Molecular Coils and Aggregates [GRK 782]	Graduate School Spectroscopy and Dynamics of Molecular Coils and Aggregates	This work was funded by the Graduate School Spectroscopy and Dynamics of Molecular Coils and Aggregates (grant no. GRK 782). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; [Anonymous], 2010, R LANG ENV STAT COMP; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; Balbirnie M, 2001, P NATL ACAD SCI USA, V98, P2375, DOI 10.1073/pnas.041617698; Bellesia G, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216103; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buchete NV, 2005, J MOL BIOL, V353, P804, DOI 10.1016/j.jmb.2005.08.066; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cecchini M, 2004, J CHEM PHYS, V121, P10748, DOI 10.1063/1.1809588; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199; de la Paz ML, 2005, J MOL BIOL, V349, P583, DOI 10.1016/j.jmb.2005.03.081; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Espinosa E, 1998, CHEM PHYS LETT, V285, P170, DOI 10.1016/S0009-2614(98)00036-0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Esteras-Chopo A, 2005, P NATL ACAD SCI USA, V102, P16672, DOI 10.1073/pnas.0505905102; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Gibson TJ, 2006, PROTEIN SCI, V15, P1133, DOI 10.1110/ps.051879606; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; Gsponer J, 2003, P NATL ACAD SCI USA, V100, P5154, DOI 10.1073/pnas.0835307100; Haas J, 2009, CHEMBIOCHEM, V10, P1816, DOI 10.1002/cbic.200900266; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang W, 2004, P NATL ACAD SCI USA, V101, P12916, DOI 10.1073/pnas.0402634101; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; Jiang P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000357; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kelley NW, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3010881; Kelly JW, 2000, NAT STRUCT BIOL, V7, P824, DOI 10.1038/82815; Klimov DK, 2003, STRUCTURE, V11, P295, DOI 10.1016/S0969-2126(03)00031-5; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Koo BW, 2008, PROTEIN ENG DES SEL, V21, P147, DOI 10.1093/protein/gzm076; KRZANOWSKI WJ, 1988, BIOMETRICS, V44, P23, DOI 10.2307/2531893; Kutzner C, 2007, J COMPUT CHEM, V28, P2075, DOI 10.1002/jcc.20703; Li DW, 2007, J PHYS CHEM B, V111, P5425, DOI 10.1021/jp0703051; Li DW, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000238; Likas A, 2003, PATTERN RECOGN, V36, P451, DOI 10.1016/S0031-3203(02)00060-2; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Lu Y, 2009, PROTEINS, V75, P954, DOI 10.1002/prot.22305; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2006, CURR OPIN CHEM BIOL, V10, P445, DOI 10.1016/j.cbpa.2006.08.018; Marshall KE, 2010, SOFT MATTER, V6, P2110, DOI 10.1039/b926623b; Matthes D, 2009, BIOPHYS J, V97, P599, DOI 10.1016/j.bpj.2009.04.061; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Modler AJ, 2004, AMYLOID, V11, P215, DOI 10.1080/13506120400014831; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nguyen HD, 2004, P NATL ACAD SCI USA, V101, P16180, DOI 10.1073/pnas.0407273101; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; O'Brien EP, 2009, J PHYS CHEM B, V113, P14421, DOI 10.1021/jp9050098; Park J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000492; Pellarin R, 2006, J MOL BIOL, V360, P882, DOI 10.1016/j.jmb.2006.05.033; Pellarin R, 2010, J AM CHEM SOC, V132, P14960, DOI 10.1021/ja106044u; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petty SA, 2005, P NATL ACAD SCI USA, V102, P14272, DOI 10.1073/pnas.0502804102; Reddy G, 2009, P NATL ACAD SCI USA, V106, P11948, DOI 10.1073/pnas.0902473106; Roberts CJ, 2007, BIOTECHNOL BIOENG, V98, P927, DOI 10.1002/bit.21627; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Santini S, 2004, STRUCTURE, V12, P1245, DOI 10.1016/j.str.2004.04.018; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Seeber M, 2007, BIOINFORMATICS, V23, P2625, DOI 10.1093/bioinformatics/btm378; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SIPE JD, 1992, ANNU REV BIOCHEM, V61, P947, DOI 10.1146/annurev.bi.61.070192.004503; Stone, 1998, EFFICIENT LIB PARALL; Straub JE, 2010, CURR OPIN STRUC BIOL, V20, P187, DOI 10.1016/j.sbi.2009.12.017; Strodel B, 2007, J AM CHEM SOC, V129, P16005, DOI 10.1021/ja075346p; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; Tenidis K, 2000, J MOL BIOL, V295, P1055, DOI 10.1006/jmbi.1999.3422; Tito P, 2000, J MOL BIOL, V303, P267, DOI 10.1006/jmbi.2000.4142; Urbanc B, 2010, J AM CHEM SOC, V132, P4266, DOI 10.1021/ja9096303; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van der Wel PCA, 2007, J AM CHEM SOC, V129, P5117, DOI 10.1021/ja068633m; van Gunsteren WF., 1996, BIOMOLECULAR SIMULAT, P1044; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wei GH, 2010, PHYS CHEM CHEM PHYS, V12, P3622, DOI 10.1039/c000755m; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Wu C, 2004, BIOPHYS J, V87, P3000, DOI 10.1529/biophysj.104.047076; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Yan SD, 2007, J MOL BIOL, V368, P230, DOI 10.1016/j.jmb.2007.02.003; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zhang ZQ, 2007, BIOPHYS J, V93, P1484, DOI 10.1529/biophysj.106.100537; [No title captured]; [No title captured]	114	36	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19129	10.1371/journal.pone.0019129	http://dx.doi.org/10.1371/journal.pone.0019129			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559277	Green Published, gold, Green Submitted			2022-12-25	WOS:000290223500007
J	Cornil, CA; Ball, GF; Balthazart, J; Charlier, TD				Cornil, Charlotte A.; Ball, Gregory F.; Balthazart, Jacques; Charlier, Thierry D.			Organizing Effects of Sex Steroids on Brain Aromatase Activity in Quail	PLOS ONE			English	Article							MALE JAPANESE-QUAIL; SEXUALLY DIMORPHIC AROMATASE; IMMUNOREACTIVE CELLS; MESSENGER-RNA; PREOPTIC AREA; IMMUNOCYTOCHEMICAL LOCALIZATION; PERIAQUEDUCTAL GRAY; COTURNIX-JAPONICA; FEMALE QUAIL; RAT	Preoptic/hypothalamic aromatase activity (AA) is sexually differentiated in birds and mammals but the mechanisms controlling this sex difference remain unclear. We determined here (1) brain sites where AA is sexually differentiated and (2) whether this sex difference results from organizing effects of estrogens during ontogeny or activating effects of testosterone in adulthood. In the first experiment we measured AA in brain regions micropunched in adult male and female Japanese quail utilizing the novel strategy of basing the microdissections on the distribution of aromatase-immunoreactive cells. The largest sex difference was found in the medial bed nucleus of the stria terminalis (mBST) followed by the medial preoptic nucleus (POM) and the tuberal hypothalamic region. A second experiment tested the effect of embryonic treatments known to sex-reverse male copulatory behavior (i.e., estradiol benzoate [EB] or the aromatase inhibitor, Vorozole) on brain AA in gonadectomized adult males and females chronically treated as adults with testosterone. Embryonic EB demasculinized male copulatory behavior, while vorozole blocked demasculinization of behavior in females as previously demonstrated in birds. Interestingly, these treatments did not affect a measure of appetitive sexual behavior. In parallel, embryonic vorozole increased, while EB decreased AA in pooled POM and mBST, but the same effect was observed in both sexes. Together, these data indicate that the early action of estrogens demasculinizes AA. However, this organizational action of estrogens on AA does not explain the behavioral sex difference in copulatory behavior since AA is similar in testosterone-treated males and females that were or were not exposed to embryonic treatments with estrogens.	[Cornil, Charlotte A.; Balthazart, Jacques; Charlier, Thierry D.] Univ Liege, GIGA Neurosci, Liege, Belgium; [Ball, Gregory F.] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD USA	University of Liege; Johns Hopkins University	Cornil, CA (corresponding author), Univ Liege, GIGA Neurosci, Liege, Belgium.	Charlotte.Cornil@ulg.ac.be	Cornil, Charlotte Anne/J-2462-2019; Charlier, Thierry/J-4668-2015	Cornil, Charlotte Anne/0000-0002-5536-7753; Ball, Gregory/0000-0002-4784-0520	National Institutes of Health (NIH/NIMH) [R01 MH50388]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050388] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Grant from the National Institutes of Health (NIH/NIMH R01 MH50388) to JB and GFB. CAC is a F.R.S.-FNRS Research Associate. TDC was a F.R.S.-FNRS Post-doctoral researcher and is a ULg Research Associate. F.R.S.-FNRS is the Belgian National Science Foundation: http://www1.frs-fnrs.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absil P, 2001, HORM BEHAV, V40, P369, DOI 10.1006/hbeh.2001.1702; ADKINS E K, 1975, Journal of Comparative and Physiological Psychology, V89, P61, DOI 10.1037/h0076406; ADKINS EK, 1972, J COMP PHYSIOL PSYCH, V81, P27, DOI 10.1037/h0033315; Adkins-Regan E, 2006, PHYSIOL BEHAV, V87, P82, DOI 10.1016/j.physbeh.2005.08.047; [Anonymous], 2008, SEX DIFFERENCES BRAI; [Anonymous], PHYSL REPRODUCTION, DOI DOI 10.1016/B978-012532104-4/50003-2; [Anonymous], 2011, J SEX MED, DOI DOI 10.1111/j.1743-6109.2011.02449.x; Aste N, 1998, J CHEM NEUROANAT, V14, P103, DOI 10.1016/S0891-0618(97)10023-0; Baillien M, 1997, J STEROID BIOCHEM, V63, P99, DOI 10.1016/S0960-0760(97)00080-0; Ball GF, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P855; BALTHAZART J, 1990, J NEUROENDOCRINOL, V2, P675, DOI 10.1111/j.1365-2826.1990.tb00464.x; BALTHAZART J, 1990, PHYSIOL BEHAV, V47, P83, DOI 10.1016/0031-9384(90)90045-6; Balthazart J, 2006, ENDOCRINOLOGY, V147, P359, DOI 10.1210/en.2005-0845; Balthazart J, 2004, PHYSIOL BEHAV, V83, P247, DOI 10.1016/j.physbeh.2004.08.025; Balthazart J, 1996, J CHEM NEUROANAT, V11, P147, DOI 10.1016/0891-0618(96)00149-4; BALTHAZART J, 1990, BRAIN RES, V514, P327, DOI 10.1016/0006-8993(90)91428-J; Balthazart J, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1745; Balthazart J, 2003, EUR J NEUROSCI, V17, P1591, DOI 10.1046/j.1460-9568.2003.02598.x; BALTHAZART J, 1989, ARCH INT PHYSIOL BIO, V97, P465, DOI 10.3109/13813458909075078; BALTHAZART J, 1992, HORM BEHAV, V26, P179, DOI 10.1016/0018-506X(92)90041-S; Balthazart J, 2001, J NEUROENDOCRINOL, V13, P63, DOI 10.1046/j.1365-2826.2001.00598.x; Balthazart J, 2008, J EXP ZOOL PART A, V309A, P1; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005; BAYLE JD, 1974, J PHYSIOL-PARIS, V68, P219; Carere C, 2007, J COMP NEUROL, V500, P894, DOI 10.1002/cne.21210; Cornil CA, 2006, HORM BEHAV, V49, P45, DOI 10.1016/j.yhbeh.2005.05.003; Cornil CA, 2005, ENDOCRINOLOGY, V146, P3809, DOI 10.1210/en.2005-0441; Cornil CA, 2008, SOC NEUR ABSTR, V34, P994; Cornil CA, 2009, 13 ANN M SOC BEH NEU; Dickens M. J., 2010, Society for Neuroscience Abstract Viewer and Itinerary Planner, V40; Evrard HC, 2004, J COMP NEUROL, V473, P194, DOI 10.1002/cne.20068; FOIDART A, 1995, J CHEM NEUROANAT, V8, P267, DOI 10.1016/0891-0618(95)00054-B; FOIDART A, 1994, PHYSIOL BEHAV, V55, P453, DOI 10.1016/0031-9384(94)90100-7; Gu G, 2003, J COMP NEUROL, V460, P542, DOI 10.1002/cne.10677; Halem HA, 2001, J NEUROSCI, V21, P2474, DOI 10.1523/JNEUROSCI.21-07-02474.2001; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; Hull EM, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P5; HUTCHISON RE, 1978, HORM BEHAV, V11, P363, DOI 10.1016/0018-506X(78)90038-7; Konkle ATM, 2011, J NEUROENDOCRINOL, V23, P424, DOI 10.1111/j.1365-2826.2011.02121.x; Loyd DR, 2006, J COMP NEUROL, V496, P723, DOI 10.1002/cne.20962; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Martel KL, 2007, EUR J NEUROSCI, V26, P463, DOI 10.1111/j.1460-9568.2007.05651.x; Naftolin F, 1996, NEUROENDOCRINOLOGY, V63, P149, DOI 10.1159/000126951; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; PAXINOS G, 1986, RAT BRAIN STEREOTAXI, pR8; Peterson RS, 2005, P ROY SOC B-BIOL SCI, V272, P2089, DOI 10.1098/rspb.2005.3181; Remage-Healey L, 2009, J NEUROENDOCRINOL, V21, P191, DOI 10.1111/j.1365-2826.2009.01820.x; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Rohmann KN, 2007, DEV NEUROBIOL, V67, P1, DOI 10.1002/dneu.20303; ROSELLI CE, 1991, ENDOCRINOLOGY, V128, P1310, DOI 10.1210/endo-128-3-1310; Roselli CE, 1998, ENDOCRINOLOGY, V139, P3193, DOI 10.1210/en.139.7.3193; ROSELLI CE, 1995, J STEROID BIOCHEM, V52, P469, DOI 10.1016/0960-0760(94)00192-O; ROSELLI CE, 1984, ENDOCRINOLOGY, V114, P2183, DOI 10.1210/endo-114-6-2183; ROSELLI CE, 1985, ENDOCRINOLOGY, V117, P2471, DOI 10.1210/endo-117-6-2471; Roselli CE, 1997, BRAIN RES BULL, V44, P351, DOI 10.1016/S0361-9230(97)00214-1; Roselli CE, 2009, SEMIN REPROD MED, V27, P207, DOI 10.1055/s-0029-1216274; SACHS BD, 1967, SCIENCE, V157, P201, DOI 10.1126/science.157.3785.201; SCHLINGER BA, 1989, NEUROENDOCRINOLOGY, V49, P434, DOI 10.1159/000125149; SCHUMACHER M, 1987, BRAIN RES, V422, P137, DOI 10.1016/0006-8993(87)90548-8; SCHUMACHER M, 1986, BRAIN RES, V370, P285, DOI 10.1016/0006-8993(86)90483-X; SCHUMACHER M, 1983, PHYSIOL BEHAV, V30, P335, DOI 10.1016/0031-9384(83)90135-X; SCHUMACHER M, 1988, J ENDOCRINOL, V118, P127, DOI 10.1677/joe.0.1180127; SCHUMACHER M, 1989, HORM BEHAV, V23, P130, DOI 10.1016/0018-506X(89)90080-9; Seiwert CM, 1998, BRAIN BEHAV EVOLUT, V52, P61, DOI 10.1159/000006553; SIMERLY RB, 1984, J COMP NEUROL, V225, P151, DOI 10.1002/cne.902250202; STEIMER T, 1990, J NEUROBIOL, V21, P787, DOI 10.1002/neu.480210512; Thompson RR, 1998, BRAIN BEHAV EVOLUT, V51, P215; Voigt C, 2007, J CHEM NEUROANAT, V33, P75, DOI 10.1016/j.jchemneu.2006.12.004; Voigt C, 2011, GEN COMP ENDOCR, V170, P180, DOI 10.1016/j.ygcen.2010.10.003	70	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19196	10.1371/journal.pone.0019196	http://dx.doi.org/10.1371/journal.pone.0019196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559434	Green Submitted, gold, Green Published			2022-12-25	WOS:000290024700097
J	Glas, J; Seiderer, J; Fries, C; Tillack, C; Pfennig, S; Weidinger, M; Beigel, F; Olszak, T; Lass, U; Goke, B; Ochsenkuhn, T; Wolf, C; Lohse, P; Muller-Myhsok, B; Diegelmann, J; Czamara, D; Brand, S				Glas, Juergen; Seiderer, Julia; Fries, Christoph; Tillack, Cornelia; Pfennig, Simone; Weidinger, Maria; Beigel, Florian; Olszak, Torsten; Lass, Ulrich; Goeke, Burkhard; Ochsenkuehn, Thomas; Wolf, Christiane; Lohse, Peter; Mueller-Myhsok, Bertram; Diegelmann, Julia; Czamara, Darina; Brand, Stephan			CEACAM6 Gene Variants in Inflammatory Bowel Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALPHA-DEFENSIN EXPRESSION; INVASIVE ESCHERICHIA-COLI; ILEAL CROHNS-DISEASE; INTESTINAL INFLAMMATION; FRAMESHIFT MUTATION; SUSCEPTIBILITY LOCI; DENDRITIC CELLS; T-CELLS; ADHESION	Background: The carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) acts as a receptor for adherent-invasive E. coli (AIEC) and its ileal expression is increased in patients with Crohn's disease (CD). Given its contribution to the pathogenesis of CD, we aimed to investigate the role of genetic variants in the CEACAM6 region in patients with inflammatory bowel diseases (IBD). Methodology: In this study, a total of 2,683 genomic DNA samples (including DNA from 858 CD patients, 475 patients with ulcerative colitis (UC), and 1,350 healthy, unrelated controls) was analyzed for eight CEACAM6 SNPs (rs10415946, rs1805223 = p.Pro42Pro, rs4803507, rs4803508, rs11548735 = p.Gly239Val, rs7246116 = pHis260His, rs2701, rs10416839). In addition, a detailed haplotype analysis and genotype-phenotype analysis were performed. Overall, our genotype analysis did not reveal any significant association of the investigated CEACAM6 SNPs and haplotypes with CD or UC susceptibility, although certain CEACAM6 SNPs modulated CEACAM6 expression in intestinal epithelial cell lines. Despite its function as receptor of AIEC in ileal CD, we found no association of the CEACAM6 SNPs with ileal or ileocolonic CD. Moreover, there was no evidence of epistasis between the analyzed CEACAM6 variants and the main CD-associated NOD2, IL23R and ATG16L1 variants. Conclusions: This study represents the first detailed analysis of CEACAM6 variants in IBD patients. Despite its important role in bacterial attachment in ileal CD, we could not demonstrate a role for CEACAM6 variants in IBD susceptibility or regarding an ileal CD phenotype. Further functional studies are required to analyze if these gene variants modulate ileal bacterial attachment.	[Glas, Juergen; Seiderer, Julia; Fries, Christoph; Tillack, Cornelia; Pfennig, Simone; Weidinger, Maria; Beigel, Florian; Olszak, Torsten; Goeke, Burkhard; Ochsenkuehn, Thomas; Diegelmann, Julia; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Glas, Juergen; Fries, Christoph; Diegelmann, Julia] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, Aachen, Germany; [Olszak, Torsten] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA; [Lass, Ulrich] TIB MOLBIOL Syntheselabor GmbH, Berlin, Germany; [Wolf, Christiane; Mueller-Myhsok, Bertram; Czamara, Darina] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Lohse, Peter] Univ Munich, Dept Clin Chem, Munich, Germany	University of Munich; University of Munich; RWTH Aachen University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Max Planck Society; University of Munich	Glas, J (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Müller-Myhsok, Bertram/A-3289-2013		Broad Medical Foundation [IBD-0126R2]; Ludwig-Maximilians-University Munich [422]; Robert-Bosch-Foundation; Else Kroener-Fresenius-Stiftung [81/08//EKMS08/01, P50/05/EKMS05/62]; DFG [BR 1912/5-1]; DCCV e.V.	Broad Medical Foundation; Ludwig-Maximilians-University Munich; Robert-Bosch-Foundation; Else Kroener-Fresenius-Stiftung; DFG(German Research Foundation (DFG)); DCCV e.V.	J. Glas was supported by a grant from the Broad Medical Foundation (IBD-0126R2). J. Seiderer and J. Diegelmann were supported by grants from the Ludwig-Maximilians-University Munich (FoeFoLe Nr. 422; Habilitationsstipendium, LMUExcellent to J.S. and Promotionsstipendium to J.D.); J. Seiderer was also supported by the Robert-Bosch-Foundation and the Else Kroener-Fresenius-Stiftung (81/08//EKMS08/01). S. Brand was supported by grants from the DFG (BR 1912/5-1), the Else Kroener-Fresenius-Stiftung (Else Kroener Fresenius Memorial Stipendium 2005; P50/05/EKMS05/62), by the Ludwig-Demling Grant 2007 from DCCV e.V., and by grants of Ludwig-Maximilians-University Munich (Excellence Initiative, Investment Funds 2008 and FFoLe program). U. Lass is a employee of TIB MOLBIOL Syntheselabor GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TIB MOLBIOL Syntheselabor GmbH provided help with designing the FRET probes but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2007, NEW ENGL J MED, V357, P708, DOI 10.1056/NEJMcibr073420; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Bresso F, 2007, INFLAMM BOWEL DIS, V13, P531, DOI 10.1002/ibd.20067; Callaghan M, 2008, GENES IMMUN, V9, P30, DOI 10.1038/sj.gene.6364442; Cario E, 2006, ANN NY ACAD SCI, V1072, P332, DOI 10.1196/annals.1326.006; Carvalho FA, 2009, J EXP MED, V206, P2179, DOI 10.1084/jem.20090741; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Dango S, 2008, LUNG CANCER, V60, P426, DOI 10.1016/j.lungcan.2007.11.015; de Chambrun GP, 2008, CURR OPIN GASTROEN, V24, P440, DOI 10.1097/MOG.0b013e3283023be5; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2009, AM J GASTROENTEROL, V104, P665, DOI 10.1038/ajg.2008.65; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Greicius G, 2003, J LEUKOCYTE BIOL, V74, P126, DOI 10.1189/jlb.1202594; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Han SU, 2008, ONCOGENE, V27, P675, DOI 10.1038/sj.onc.1210686; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; KHAN WN, 1992, GENOMICS, V14, P384, DOI 10.1016/S0888-7543(05)80230-7; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Mudter J, 2007, GUT, V56, P293, DOI 10.1136/gut.2005.090464; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Nagaishi T, 2006, ANN NY ACAD SCI, V1072, P155, DOI 10.1196/annals.1326.004; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rhodes JM, 2007, GUT, V56, P610, DOI 10.1136/gut.2006.111872; Roda G, 2009, INFLAMM BOWEL DIS, V15, P1775, DOI 10.1002/ibd.21023; Rolhion N, 2007, INFLAMM BOWEL DIS, V13, P1277, DOI 10.1002/ibd.20176; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Silva MA, 2009, INFLAMM BOWEL DIS, V15, P436, DOI 10.1002/ibd.20660; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Simms LA, 2008, GUT, V57, P903, DOI 10.1136/gut.2007.142588; Sokol H, 2008, INFLAMM BOWEL DIS, V14, P858, DOI 10.1002/ibd.20392; Stanke F, 2010, HUM GENET, V127, P383, DOI 10.1007/s00439-009-0779-6; Sydora BC, 2007, INFLAMM BOWEL DIS, V13, P947, DOI 10.1002/ibd.20155; Thom I, 2009, ANTICANCER RES, V29, P249; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	56	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19319	10.1371/journal.pone.0019319	http://dx.doi.org/10.1371/journal.pone.0019319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559399	Green Published, gold			2022-12-25	WOS:000290024700131
J	Reich, NG; Perl, TM; Cummings, DAT; Lessler, J				Reich, Nicholas G.; Perl, Trish M.; Cummings, Derek A. T.; Lessler, Justin			Visualizing Clinical Evidence: Citation Networks for the Incubation Periods of Respiratory Viral Infections	PLOS ONE			English	Article							INFLUENZA	Simply by repetition, medical facts can become enshrined as truth even when there is little empirical evidence supporting them. We present an intuitive and clear visual design for tracking the citation history of a particular scientific fact over time. We apply this method to data from a previously published literature review on the incubation period of nine respiratory viral infections. The resulting citation networks reveal that the conventional wisdom about the incubation period for these diseases was based on a small fraction of available data and in one case, on no retrievable empirical evidence. Overall, 50% of all incubation period statements did not provide a source for their estimate and 65% of original sources for incubation period data were not incorporated into subsequent publications. More standardized and widely available methods for visualizing these histories of medical evidence are needed to ensure that conventional wisdom cannot stray too far from empirically supported knowledge.	[Reich, Nicholas G.; Cummings, Derek A. T.; Lessler, Justin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Perl, Trish M.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Reich, NG (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	nreich@jhsph.edu	Reich, Nicholas/L-1168-2019	Reich, Nicholas/0000-0003-3503-9899; Lessler, Justin/0000-0002-9741-8109	National Institute of General Medical Sciences of the US National Institutes of Health [1U54GM088491-0109]; Burroughs Wellcome Fund; US Department of Homeland Security [N00014-06-1-0991]; U.S. Centers for Disease Control; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); US Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Centers for Disease Control; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.A.T. Cummings' work on this project was funded by a grant from the National Institute of General Medical Sciences of the US National Institutes of Health (1U54GM088491-0109), and he holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. J. Lessler and N.G. Reich were funded by a grant from the US Department of Homeland Security (N00014-06-1-0991). T. Perl was funded by a grant from the U.S. Centers for Disease Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COCHRANE HDB SYSTEMA; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Lessler J, 2007, AM J EPIDEMIOL, V166, P1220, DOI 10.1093/aje/kwm188; Lessler J, 2010, INFECT CONT HOSP EP, V31, P809, DOI 10.1086/655023; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Nishiura H, 2009, INT J HYG ENVIR HEAL, V212, P97, DOI 10.1016/j.ijheh.2007.10.003; Valtin H, 2002, AM J PHYSIOL-REG I, V283, pR993, DOI 10.1152/ajpregu.00365.2002	10	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19496	10.1371/journal.pone.0019496	http://dx.doi.org/10.1371/journal.pone.0019496			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559339	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700195
J	Tebben, J; Tapiolas, DM; Motti, CA; Abrego, D; Negri, AP; Blackall, LL; Steinberg, PD; Harder, T				Tebben, Jan; Tapiolas, Dianne M.; Motti, Cherie A.; Abrego, David; Negri, Andrew P.; Blackall, Linda L.; Steinberg, Peter D.; Harder, Tilmann			Induction of Larval Metamorphosis of the Coral Acropora millepora by Tetrabromopyrrole Isolated from a Pseudoalteromonas Bacterium	PLOS ONE			English	Article							BUILDING TUBE WORM; GREGARIOUS SETTLEMENT; MICROBIAL BIOFILMS; COLONIZATION; RECRUITMENT; ALGA; NEUROPEPTIDE; INHIBITION; SURFACES; ELEGANS	The induction of larval attachment and metamorphosis of benthic marine invertebrates is widely considered to rely on habitat specific cues. While microbial biofilms on marine hard substrates have received considerable attention as specific signals for a wide and phylogenetically diverse array of marine invertebrates, the presumed chemical settlement signals produced by the bacteria have to date not been characterized. Here we isolated and fully characterized the first chemical signal from bacteria that induced larval metamorphosis of acroporid coral larvae (Acropora millepora). The metamorphic cue was identified as tetrabromopyrrole (TBP) in four bacterial Pseudoalteromonas strains among a culture library of 225 isolates obtained from the crustose coralline algae Neogoniolithon fosliei and Hydrolithon onkodes. Coral planulae transformed into fully developed polyps within 6 h, but only a small proportion of these polyps attached to the substratum. The biofilm cell density of the four bacterial strains had no influence on the ratio of attached vs. non-attached polyps. Larval bioassays with ethanolic extracts of the bacterial isolates, as well as synthetic TBP resulted in consistent responses of coral planulae to various doses of TBP. The lowest bacterial density of one of the Pseudoalteromonas strains which induced metamorphosis was 7,000 cells mm(-2) in laboratory assays, which is on the order of 0.1-1% of the total numbers of bacteria typically found on such surfaces. These results, in which an actual cue from bacteria has been characterized for the first time, contribute significantly towards understanding the complex process of acroporid coral larval settlement mediated through epibiotic microbial biofilms on crustose coralline algae.	[Tebben, Jan; Steinberg, Peter D.; Harder, Tilmann] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Tapiolas, Dianne M.; Motti, Cherie A.; Abrego, David; Negri, Andrew P.; Blackall, Linda L.; Harder, Tilmann] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Steinberg, Peter D.] Sydney Inst Marine Sci, Mosman, Australia	University of New South Wales Sydney; Australian Institute of Marine Science; Sydney Institute of Marine Science	Tebben, J (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	t.harder@unsw.edu.au	Blackall, Linda Louise/AAC-4312-2020; Abrego, David/AAT-8120-2020; Blackall, Linda L/H-1947-2013; Motti, Cherie/A-2588-2012; Negri, Andrew P/G-9909-2017; Harder, Tilmann/B-6861-2008; Tebben, Jan/ABD-2247-2020	Blackall, Linda Louise/0000-0002-8848-7698; Abrego, David/0000-0003-3311-2730; Blackall, Linda L/0000-0002-8848-7698; Negri, Andrew P/0000-0003-1388-7395; Harder, Tilmann/0000-0003-3173-6806; Tebben, Jan/0000-0002-2780-2236; Steinberg, Peter/0000-0002-1781-0726; Motti, Cherie/0000-0002-3292-2785	German Research Foundation [HA 3496/5-1]; Australian Institute of Marine Science [2233]	German Research Foundation(German Research Foundation (DFG)); Australian Institute of Marine Science	T. Harder was partially supported by a Research Fellowship awarded by the German Research Foundation (HA 3496/5-1). Funding was also provided by the Australian Institute of Marine Science, Futures Project, Appropriation Fund 2233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RJ, 1974, MAR BIOL, V27, P281, DOI 10.1007/BF00394363; Bengtsson MM, 2010, AQUAT MICROB ECOL, V60, P71, DOI 10.3354/ame01409; CLARKE KR, 2006, PRIMERE V6 USER MANU; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Dreanno C, 2006, P NATL ACAD SCI USA, V103, P14396, DOI 10.1073/pnas.0602763103; Erwin P., 2008, P 11 INT COR REEF S, P1219; Erwin PM, 2010, CORAL REEFS, V29, P929, DOI 10.1007/s00338-010-0634-1; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Hertiani T, 2010, BIOORGAN MED CHEM, V18, P1297, DOI 10.1016/j.bmc.2009.12.028; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Huang SY, 2003, MAR ECOL PROG SER, V260, P161, DOI 10.3354/meps260161; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hung OS, 2009, AQUAT BIOL, V4, P253, DOI 10.3354/ab00110; Iwao K, 2002, CORAL REEFS, V21, P127, DOI 10.1007/s00338-002-0219-8; JOHNSON CR, 1991, MAR ECOL PROG SER, V71, P143, DOI 10.3354/meps071143; LAATSCH H, 1989, MARINE BACTERIA, V1, P863; Leitz T, 1997, INVERTEBR REPROD DEV, V31, P109, DOI 10.1080/07924259.1997.9672569; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Muller WA, 2002, CAN J ZOOL, V80, P1755, DOI 10.1139/Z02-130; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Nylund GM, 2008, MAR ECOL PROG SER, V369, P39, DOI 10.3354/meps07577; Palmer M. H., 1967, STRUCTURE REACTIONS; PAWLIK JR, 1992, OCEANOGR MAR BIOL, V30, P273; PAWLIK JR, 1986, MAR BIOL, V91, P59, DOI 10.1007/BF00397571; PAWLIK JR, 1991, SCIENCE, V251, P421, DOI 10.1126/science.251.4992.421; Qian PY, 2007, MAR BIOTECHNOL, V9, P399, DOI 10.1007/s10126-007-9001-9; RASBAND WS, 2010, IMAGEJ V 1 43; Ritson-Williams R, 2010, CORAL REEFS, V29, P71, DOI 10.1007/s00338-009-0555-z; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Steinberg PD, 2002, J PHYCOL, V38, P621, DOI 10.1046/j.1529-8817.2002.02042.x; Swanson RL, 2004, BIOL BULL-US, V206, P161, DOI 10.2307/1543640; Thiyagarajan V, 2006, MICROB ECOL, V51, P431, DOI 10.1007/s00248-006-9041-0; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Tsukamoto S, 1999, EUR J BIOCHEM, V264, P785, DOI 10.1046/j.1432-1327.1999.00642.x; Vermeij MJA, 2009, CORAL REEFS, V28, P987, DOI 10.1007/s00338-009-0535-3; Wang S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r126; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; WOODIN SA, 1993, J CHEM ECOL, V19, P517, DOI 10.1007/BF00994322; YVIN JC, 1985, J NAT PROD, V48, P814, DOI 10.1021/np50041a018	40	149	157	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19082	10.1371/journal.pone.0019082	http://dx.doi.org/10.1371/journal.pone.0019082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559509	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700062
J	Yang, RT; Lenaghan, SC; Wikswo, JP; Zhang, MJ				Yang, Ruoting; Lenaghan, Scott C.; Wikswo, John P.; Zhang, Mingjun			External Control of the GAL Network in S. cerevisiae: A View from Control Theory	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; SENSITIVITY-ANALYSIS; GLUCOSE REPRESSION; MODELS; SWITCH	While there is a vast literature on the control systems that cells utilize to regulate their own state, there is little published work on the formal application of control theory to the external regulation of cellular functions. This paper chooses the GAL network in S. cerevisiae as a well understood benchmark example to demonstrate how control theory can be employed to regulate intracellular mRNA levels via extracellular galactose. Based on a mathematical model reduced from the GAL network, we have demonstrated that a galactose dose necessary to drive and maintain the desired GAL genes' mRNA levels can be calculated in an analytic form. And thus, a proportional feedback control can be designed to precisely regulate the level of mRNA. The benefits of the proposed feedback control are extensively investigated in terms of stability and parameter sensitivity. This paper demonstrates that feedback control can both significantly accelerate the process to precisely regulate mRNA levels and enhance the robustness of the overall cellular control system.	[Yang, Ruoting; Lenaghan, Scott C.; Zhang, Mingjun] Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA; [Wikswo, John P.] Vanderbilt Univ, Vanderbilt Inst Integrat Biosyst Res & Educ, Dept Biomed Engn, Dept Mol Physiol & Biophys, Nashville, TN USA; [Wikswo, John P.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN USA	University of Tennessee System; University of Tennessee Knoxville; Vanderbilt University; Vanderbilt University	Yang, RT (corresponding author), Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA.	mjzhang@utk.edu		Lenaghan, Scott/0000-0002-7539-1726	National Academies Keck Futures Initiative; US Defense Threat Reduction Agency [HDTRA-09-1-0013]; NIH National Institute on Drug Abuse [RC2DA028981]; Vanderbilt Institute for Integrative Biosystems Research and Education; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA028981] Funding Source: NIH RePORTER	National Academies Keck Futures Initiative; US Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NIH National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Vanderbilt Institute for Integrative Biosystems Research and Education; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to thank the National Academies Keck Futures Initiative for its support of this research, as well as the US Defense Threat Reduction Agency (HDTRA-09-1-0013), the NIH National Institute on Drug Abuse (RC2DA028981), and the Vanderbilt Institute for Integrative Biosystems Research and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett MR, 2008, NATURE; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; de Atauri P., 2004, Systems Biology, V1, P28, DOI 10.1049/sb:20045013; Diep CQ, 2008, GENETICS, V178, P725, DOI 10.1534/genetics.107.074799; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Horak J, 1997, J BACTERIOL, V179, P1541, DOI 10.1128/jb.179.5.1541-1549.1997; JOHNSTON M, 1994, MOL CELL BIOL, V14, P3834, DOI 10.1128/MCB.14.6.3834; McLean JA, 2010, ELECTROSPRAY MALDI M, P411; Menolascina F, 2010, ATL GA US P 49 IEEE; Menolascina F, AUTOMATICA IN PRESS; Ramsey SA, 2006, NAT GENET, V38, P1082, DOI 10.1038/ng1869; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Saltelli A, 2000, STAT SCI, V15, P377, DOI 10.1214/ss/1009213004; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; TRUMBLY RJ, 1992, MOL MICROBIOL, V6, P15, DOI 10.1111/j.1365-2958.1992.tb00832.x; Varma A, 1999, PARAMETERIC SENSITIV; Wikswo JP, 2006, IEE P-NANOBIOTECHNOL, V153, P81, DOI 10.1049/ip-nbt:20050045; Yano KI, 1997, P NATL ACAD SCI USA, V94, P1721, DOI 10.1073/pnas.94.5.1721	24	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19353	10.1371/journal.pone.0019353	http://dx.doi.org/10.1371/journal.pone.0019353			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559408	Green Published, gold			2022-12-25	WOS:000290024700145
J	Chen, CC; Liou, SW; Chen, CC; Chen, WC; Hu, FR; Wang, IJ; Lin, SJ				Chen, Chun-Chen; Liou, Shiow-Wen; Chen, Chi-Chih; Chen, Wen-Chung; Hu, Fung-Rong; Wang, I-Jong; Lin, Shing-Jong			Coenzyme Q(10) Reduces Ethanol-Induced Apoptosis in Corneal Fibroblasts	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; CEREBELLAR GRANULE NEURONS; GROWTH-FACTOR; PHOTOREFRACTIVE KERATECTOMY; KERATOCYTE APOPTOSIS; OXIDATIVE STRESS; CYTOCHROME-C; CELL-DEATH; IN-VITRO; ALCOHOL	Dilute ethanol (EtOH) is a widely used agent to remove the corneal epithelium during the modern refractive surgery. The application of EtOH may cause the underlying corneal fibroblasts to undergo apoptosis. This study was designed to investigate the protective effect and potential mechanism of the respiratory chain coenzyme Q(10) (CoQ(10)), an electron transporter of the mitochondrial respiratory chain and a ubiquitous free radical scavenger, against EtOH-induced apoptosis of corneal fibroblasts. Corneal fibroblasts were pretreated with CoQ(10) (10 mu M) for 2 h, followed by exposure to different concentrations of EtOH (0.4, 2, 4, and 20%) for 20 s. After indicated incubation period (2-12 h), MTT assay was used to examine cell viability. Treated cells were further assessed by flow cytometry to identify apoptosis. Reactive oxygen species (ROS) and the change in mitochondrial membrane potential were assessed using dichlorodihydrofluorescein diacetate /2',7'-dichlorofluorescein (DCFH-DA/DCF) assays and flow-cytometric analysis of JC-1 staining, respectively. The activity and expression of caspases 2, 3, 8, and 9 were evaluated with a colorimetric assay and western blot analysis. We found that EtOH treatment significantly decreased the viability of corneal fibroblasts characterized by a higher percentage of apoptotic cells. CoQ(10) could antagonize the apoptosis inducing effect of EtOH. The inhibition of cell apoptosis by CoQ(10) was significant at 8 and 12 h after EtOH exposure. In EtOH-exposed corneal fibroblasts, CoQ(10) pretreatment significantly reduced mitochondrial depolarization and ROS production at 30, 60, 90, and 120 min and inhibited the activation and expression of caspases 2 and 3 at 2 h after EtOH exposure. In summary, pretreatment with CoQ(10) can inhibit mitochondrial depolarization, caspase activation, and cell apoptosis. These findings support the proposition that CoQ(10) plays an antiapoptotic role in corneal fibroblasts after ethanol exposure.	[Chen, Chun-Chen; Liou, Shiow-Wen] Taipei City Hosp, Renai Branch, Dept Ophthalmol, Taipei, Taiwan; [Chen, Chun-Chen; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lin, Shing-Jong] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Chen, Chi-Chih; Chen, Wen-Chung] Taipei Vet Gen Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Liou, Shiow-Wen; Hu, Fung-Rong; Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Liou, Shiow-Wen] Taipei Med Univ, Taipei, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University	Chen, CC (corresponding author), Taipei City Hosp, Renai Branch, Dept Ophthalmol, Taipei, Taiwan.	ijong@ms8.hinet.net; sjlin@vghtpe.gov.tw		HU, FUNG-RONG/0000-0002-2102-5317; Wang, I-Jong/0000-0002-3045-0614	Department of Health, Taipei City Government, Taipei, Taiwan [96002-62-105]	Department of Health, Taipei City Government, Taipei, Taiwan	This work was supported by the Department of Health, Taipei City Government, Taipei, Taiwan, 96002-62-105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad JC, 1997, OPHTHALMOLOGY, V104, P1566, DOI 10.1016/S0161-6420(97)30095-5; Alleva R, 2001, FEBS LETT, V503, P46, DOI 10.1016/S0014-5793(01)02694-1; Bailey SM, 1998, HEPATOLOGY, V28, P1318, DOI 10.1002/hep.510280521; Behndig A, 1998, INVEST OPHTH VIS SCI, V39, P471; Bilgihan K, 2000, EYE, V14, P231, DOI 10.1038/eye.2000.60; Brancato R, 2000, EUR J OPHTHALMOL, V10, P32, DOI 10.1177/112067210001000106; Browning AC, 2003, INVEST OPHTH VIS SCI, V44, P510, DOI 10.1167/iovs.02-0488; CAMPOS M, 1994, OPHTHALMOLOGY, V101, P890; Castaneda F, 2004, CANCER BIOL THER, V3, P430, DOI 10.4161/cbt.3.5.806; Chen CC, 2002, INVEST OPHTH VIS SCI, V43, P2593; Chen YL, 2006, J CELL BIOCHEM, V98, P618, DOI 10.1002/jcb.20793; Cherian PP, 2008, ALCOHOL CLIN EXP RES, V32, P1884, DOI 10.1111/j.1530-0277.2008.00769.x; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; CUNNINGHAM CC, 1990, ALCOHOL ALCOHOLISM, V25, P127, DOI 10.1093/oxfordjournals.alcalc.a044987; EPSTEIN D, 1994, OPHTHALMOLOGY, V101, P1558; Fontaine E, 1999, J BIOENERG BIOMEMBR, V31, P335, DOI 10.1023/A:1005475802350; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Funderburgh JL, 2001, J BIOL CHEM, V276, P44173, DOI 10.1074/jbc.M107596200; Gabison E, 2004, EXP EYE RES, V78, P579, DOI 10.1016/j.exer.2003.09.005; Helena MC, 1998, INVEST OPHTH VIS SCI, V39, P276; Hersh PS, 1998, OPHTHALMOLOGY, V105, P1512, DOI 10.1016/S0161-6420(98)98038-1; Higuchi H, 2001, HEPATOLOGY, V34, P320, DOI 10.1053/jhep.2001.26380; Hoek JB, 2002, GASTROENTEROLOGY, V122, P2049, DOI 10.1053/gast.2002.33613; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; Kanno S, 2006, TOXICOL LETT, V166, P131, DOI 10.1016/j.toxlet.2006.06.005; Kasetsuwan N, 1999, ARCH OPHTHALMOL-CHIC, V117, P649; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kim SY, 2002, CORNEA, V21, P388, DOI 10.1097/00003226-200205000-00011; Kim TI, 2004, INVEST OPHTH VIS SCI, V45, P2978, DOI 10.1167/iovs.04-0070; Kim TI, 2004, INVEST OPHTH VIS SCI, V45, P86, DOI 10.1167/iovs.03-0520; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lambert JC, 2003, EXP BIOL MED, V228, P406, DOI 10.1177/153537020322800411; Lee JB, 2002, ARCH OPHTHALMOL-CHIC, V120, P1700; LENAZ G, 1993, CLIN INVESTIGATOR, V71, pS66; Li DQ, 1996, INVEST OPHTH VIS SCI, V37, P2068; Lieber C S, 1997, Adv Pharmacol, V38, P601; Lopez-Lluch G, 1999, BIOFACTORS, V9, P171, DOI 10.1002/biof.5520090212; Maffi SK, 2008, J NEUROSCI RES, V86, P1064, DOI 10.1002/jnr.21562; Minana JB, 2002, HEPATOLOGY, V35, P1205, DOI 10.1053/jhep.2002.32969; Nanji AA, 1998, SEMIN LIVER DIS, V18, P187, DOI 10.1055/s-2007-1007154; NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K; Papucci L, 2003, J BIOL CHEM, V278, P28220, DOI 10.1074/jbc.M302297200; Pastorino JG, 2003, AM J PHYSIOL-GASTR L, V285, pG503, DOI 10.1152/ajpgi.00442.2002; Pepper C, 1998, LEUKEMIA RES, V22, P439, DOI 10.1016/S0145-2126(98)00013-7; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; PHILLIPS AF, 1993, ARCH OPHTHALMOL-CHIC, V111, P1273, DOI 10.1001/archopht.1993.01090090125030; Rouach H, 1997, HEPATOLOGY, V25, P351; Rutjes SK, 1999, J BIOL CHEM, V274, P24799, DOI 10.1074/jbc.274.35.24799; Shim HY, 2007, MOL CELLS, V24, P95; Shimmura S, 1999, INVEST OPHTH VIS SCI, V40, P1245; Song IK, 2004, INVEST OPHTH VIS SCI, V45, P423, DOI 10.1167/iovs.03-0947; Sosne G, 2004, INVEST OPHTH VIS SCI, V45, P1095, DOI 10.1167/iovs.03-1002; Stein HA, 1997, J CATARACT REFR SURG, V23, P1160, DOI 10.1016/S0886-3350(97)80309-4; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tomasetti M, 2001, FASEB J, V15, P1425, DOI 10.1096/fj.00-0694fje; VALLS V, 1994, BIOCHEM MOL BIOL INT, V33, P633; Vaudry D, 2002, P NATL ACAD SCI USA, V99, P6398, DOI 10.1073/pnas.082112699; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; Wilson SE, 2007, EXP EYE RES, V85, P305, DOI 10.1016/j.exer.2007.06.009; Zhang FX, 1998, J NEUROCHEM, V71, P196, DOI 10.1046/j.1471-4159.1998.71010196.x; Zhou ZX, 2001, AM J PATHOL, V159, P329, DOI 10.1016/S0002-9440(10)61699-9	61	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19111	10.1371/journal.pone.0019111	http://dx.doi.org/10.1371/journal.pone.0019111			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556371	Green Submitted, Green Published, gold			2022-12-25	WOS:000290019400030
J	Hettinga, K; van Valenberg, H; de Vries, S; Boeren, S; van Hooijdonk, T; van Arendonk, J; Vervoort, J				Hettinga, Kasper; van Valenberg, Hein; de Vries, Sacco; Boeren, Sjef; van Hooijdonk, Toon; van Arendonk, Johan; Vervoort, Jacques			The Host Defense Proteome of Human and Bovine Milk	PLOS ONE			English	Article							BIOACTIVE COMPONENTS; MAMMARY-GLANDS; FAT; IMMUNOGLOBULINS; IDENTIFICATION; LACTOPEROXIDASE; QUANTIFICATION; EXPRESSION; SECRETION; RESPONSES	Milk is the single source of nutrients for the newborn mammal. The composition of milk of different mammals has been adapted during evolution of the species to fulfill the needs of the offspring. Milk not only provides nutrients, but it also serves as a medium for transfer of host defense components to the offspring. The host defense proteins in the milk of different mammalian species are expected to reveal signatures of evolution. The aim of this study is therefore to study the difference in the host defense proteome of human and bovine milk. We analyzed human and bovine milk using a shot-gun proteomics approach focusing on host defense-related proteins. In total, 268 proteins in human milk and 269 proteins in bovine milk were identified. Of these, 44 from human milk and 51 from bovine milk are related to the host defense system. Of these proteins, 33 were found in both species but with significantly different quantities. High concentrations of proteins involved in the mucosal immune system, immunoglobulin A, CD14, lactoferrin, and lysozyme, were present in human milk. The human newborn is known to be deficient for at least two of these proteins (immunoglobulin A and CD14). On the other hand, antimicrobial proteins (5 cathelicidins and lactoperoxidase) were abundant in bovine milk. The high concentration of lactoperoxidase is probably linked to the high amount of thiocyanate in the plant-based diet of cows. This first detailed analysis of host defense proteins in human and bovine milk is an important step in understanding the function of milk in the development of the immune system of these two mammals.	[Hettinga, Kasper; van Valenberg, Hein; van Hooijdonk, Toon] Wageningen Univ, Dairy Sci & Technol Grp, Wageningen, Netherlands; [de Vries, Sacco; Boeren, Sjef; Vervoort, Jacques] Wageningen Univ, Biochem Lab, Wageningen, Netherlands; [van Hooijdonk, Toon] FrieslandCampina, Amersfoort, Netherlands; [van Arendonk, Johan] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Hettinga, K (corresponding author), Wageningen Univ, Dairy Sci & Technol Grp, Wageningen, Netherlands.	kasper.hettinga@wur.nl	van Arendonk, Johan/E-2536-2011	van Arendonk, Johan/0000-0003-2592-3947; van Valenberg, Hein/0000-0002-7228-2073	Dutch Dairy Association	Dutch Dairy Association	Funding support was provided by the Dutch Dairy Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2010, J PROTEOMICS, V73, P1079, DOI 10.1016/j.jprot.2009.11.008; ALLEN WD, 1975, CLIN EXP IMMUNOL, V21, P407; Armogida SA, 2004, ALLERGY ASTHMA PROC, V25, P297; Bu HF, 2007, J CLIN INVEST, V117, P3673, DOI 10.1172/JCI31841; Charlwood J, 2002, ANAL BIOCHEM, V301, P314, DOI 10.1006/abio.2001.5498; Cho JK, 2000, BIOSCI BIOTECH BIOCH, V64, P633, DOI 10.1271/bbb.64.633; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; D'Alessandro A, 2010, J PROTEOME RES, V9, P3339, DOI 10.1021/pr100123f; D'Amato A, 2009, J PROTEOME RES, V8, P3925, DOI 10.1021/pr900221x; DOWBENKO D, 1993, J CLIN INVEST, V92, P952, DOI 10.1172/JCI116671; Fonteh FA, 2002, J DAIRY RES, V69, P401, DOI 10.1017/S0022029902005538; Fortunato D, 2003, PROTEOMICS, V3, P897, DOI 10.1002/pmic.200300367; Fox PF, 2003, ADV DAIRY CHEM 1 PRO, P9; German JB, 2002, CURR OPIN CLIN NUTR, V5, P653, DOI 10.1097/00075197-200211000-00007; Gillenwaters EN, 2009, J HERED, V100, P241, DOI 10.1093/jhered/esn112; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Heid HW, 2005, EUR J CELL BIOL, V84, P245, DOI 10.1016/j.ejcb.2004.12.002; Hou ZY, 2000, ENDOCRINOLOGY, V141, P4278, DOI 10.1210/en.141.11.4278; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Korhonen H, 2000, BRIT J NUTR, V84, pS75; KOVAR MG, 1984, PEDIATRICS, V74, P615; Kussendrager KD, 2000, BRIT J NUTR, V84, pS19, DOI 10.1155/2014/517164; Labeta MO, 2000, J EXP MED, V191, P1807, DOI 10.1084/jem.191.10.1807; Lemay DG, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r43; Mookherjee N, 2006, J LEUKOCYTE BIOL, V80, P1563, DOI 10.1189/jlb.0106048; Murakami M, 2005, PEDIATR RES, V57, P10, DOI 10.1203/01.PDR.0000148068.32201.50; Nakatani H, 2006, BIOCHEM J, V395, P21, DOI 10.1042/BJ20051459; Newburg DS, 2001, ADV EXP MED BIOL, V501, P3; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; PORTER P, 1972, IMMUNOLOGY, V23, P225; Reinhardt TA, 2008, J DAIRY SCI, V91, P2307, DOI 10.3168/jds.2007-0952; Reinhardt TA, 2006, J DAIRY RES, V73, P406, DOI 10.1017/S0022029906001889; Russell MW, 2005, MUCOSAL IMMUNOLOGY; Sanderson IR, 1999, DEV GASTROINTESTINAL; Severin S, 2005, CRIT REV FOOD SCI, V45, P645, DOI 10.1080/10408690490911756; Shah NP, 2000, BRIT J NUTR, V84, pS3; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Smolenski G, 2007, J PROTEOME RES, V6, P207, DOI 10.1021/pr0603405; Walker A, 2010, J PEDIATR-US, V156, pS3, DOI 10.1016/j.jpeds.2009.11.021; Walstra P., 2005, DAIRY SCI TECHNOL; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O	43	160	165	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19433	10.1371/journal.pone.0019433	http://dx.doi.org/10.1371/journal.pone.0019433			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556375	Green Published, Green Submitted, gold			2022-12-25	WOS:000290019400059
J	Guimaraes, AMS; Santos, AP; SanMiguel, P; Walter, T; Timenetsky, J; Messick, JB				Guimaraes, Ana M. S.; Santos, Andrea P.; SanMiguel, Phillip; Walter, Thomas; Timenetsky, Jorge; Messick, Joanne B.			Complete Genome Sequence of Mycoplasma suis and Insights into Its Biology and Adaption to an Erythrocyte Niche	PLOS ONE			English	Article							DEPENDENT GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; INTRAERYTHROCYTIC MALARIA PARASITE; GRAM-POSITIVE BACTERIA; RIBOSOMAL-RNA GENE; EPERYTHROZOON-SUIS; FUNCTIONAL-CHARACTERIZATION; HOMOLOGOUS RECOMBINATION; UREAPLASMA-UREALYTICUM; HAEMOBARTONELLA-FELIS; IMMUNOGENIC PROTEIN	Mycoplasma suis, the causative agent of porcine infectious anemia, has never been cultured in vitro and mechanisms by which it causes disease are poorly understood. Thus, the objective herein was to use whole genome sequencing and analysis of M. suis to define pathogenicity mechanisms and biochemical pathways. M. suis was harvested from the blood of an experimentally infected pig. Following DNA extraction and construction of a paired end library, whole-genome sequencing was performed using GS-FLX (454) and Titanium chemistry. Reads on paired-end constructs were assembled using GS De Novo Assembler and gaps closed by primer walking; assembly was validated by PFGE. Glimmer and Manatee Annotation Engine were used to predict and annotate protein-coding sequences (CDS). The M. suis genome consists of a single, 742,431 bp chromosome with low G+C content of 31.1%. A total of 844 CDS, 3 single copies, unlinked rRNA genes and 32 tRNAs were identified. Gene homologies and GC skew graph show that M. suis has a typical Mollicutes oriC. The predicted metabolic pathway is concise, showing evidence of adaptation to blood environment. M. suis is a glycolytic species, obtaining energy through sugars fermentation and ATP-synthase. The pentose-phosphate pathway, metabolism of cofactors and vitamins, pyruvate dehydrogenase and NAD(+) kinase are missing. Thus, ribose, NADH, NADPH and coenzyme A are possibly essential for its growth. M. suis can generate purines from hypoxanthine, which is secreted by RBCs, and cytidine nucleotides from uracil. Toxins orthologs were not identified. We suggest that M. suis may cause disease by scavenging and competing for host nutrients, leading to decreased life-span of RBCs. In summary, genome analysis shows that M. suis is dependent on host cell metabolism and this characteristic is likely to be linked to its pathogenicity. The prediction of essential nutrients will aid the development of in vitro cultivation systems.	[Guimaraes, Ana M. S.; Santos, Andrea P.; Messick, Joanne B.] Purdue Univ, Sch Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Guimaraes, Ana M. S.] Minist Educ, CAPES Fulbright Program, Brasilia, DF, Brazil; [SanMiguel, Phillip] Purdue Univ, Purdue Genom Core Facil, W Lafayette, IN 47907 USA; [Walter, Thomas] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Timenetsky, Jorge] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, BR-05508 Sao Paulo, Brazil	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universidade de Sao Paulo	Guimaraes, AMS (corresponding author), Purdue Univ, Sch Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	anamsg@purdue.edu; jmessic@purdue.edu	Guimaraes, Ana M. S./N-5603-2016; SanMiguel, Phillip J/I-2196-2015; dos Santos, Andrea Pires/O-5371-2019	SanMiguel, Phillip J/0000-0002-3742-9527; dos Santos, Andrea Pires/0000-0002-1037-970X; Guimaraes, Ana/0000-0002-8261-5863	Hatch Act Formula Grant [IND020395]; Brazilian Ministerio da Educacao through Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fulbright Commission - Fulbright-Capes	Hatch Act Formula Grant; Brazilian Ministerio da Educacao through Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fulbright Commission - Fulbright-Capes	Funding support was provided from Hatch Act Formula Grant, project number - IND020395. Funding support for PhD studies was provided by the Brazilian Ministerio da Educacao through Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fulbright Commission - Fulbright-Capes Scholarship Program. CAPES-Fulbright Program, ID 167307/6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLAH KM, 1991, J BACTERIOL, V173, P5597, DOI 10.1128/jb.173.18.5597-5603.1991; Arutyunov DY, 2003, BIOCHEM BIOPH RES CO, V300, P149, DOI 10.1016/S0006-291X(02)02802-4; BAKER TA, 1992, ANNU REV GENET, V26, P447; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BenMenachem G, 1997, MICROBIOL-SGM, V143, P1933, DOI 10.1099/00221287-143-6-1933; Berent LM, 2003, INFECT IMMUN, V71, P3657, DOI 10.1128/IAI.71.6.3657-3662.2003; Bizarro CV, 2007, GENET MOL BIOL, V30, P190, DOI 10.1590/S1415-47572007000200005; BOYD DA, 1995, J BACTERIOL, V177, P2622, DOI 10.1128/jb.177.10.2622-2627.1995; BROWN DR, 2011, BERGEYS MANUAL SYSTE, P639; BROWNBACK A, 1981, VET MED SM ANIM CLIN, V76, P375; Caspersen K, 2002, INFECT IMMUN, V70, P1230, DOI 10.1128/IAI.70.3.1230-1234.2002; Chambaud I, 2001, NUCLEIC ACIDS RES, V29, P2145, DOI 10.1093/nar/29.10.2145; CHANG CJ, 1984, J BACTERIOL, V160, P488, DOI 10.1128/JB.160.1.488-490.1984; Chopra-Dewasthaly R, 2005, FEMS MICROBIOL LETT, V253, P89, DOI 10.1016/j.femsle.2005.09.021; Citti C, 2010, FUTURE MICROBIOL, V5, P1073, DOI 10.2217/FMB.10.71; Clark GW, 2010, BIOCHEM CELL BIOL, V88, P185, DOI [10.1139/o09-157, 10.1139/O09-157]; Commans S, 1999, FEMS MICROBIOL REV, V23, P335, DOI 10.1111/j.1574-6976.1999.tb00403.x; Cordova CMM, 2002, J BACTERIOL, V184, P5426, DOI 10.1128/JB.184.19.5426-5435.2002; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Downie MJ, 2008, INT J PARASITOL, V38, P203, DOI 10.1016/j.ijpara.2007.07.005; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Dybvig K, 2008, INFECT IMMUN, V76, P4000, DOI 10.1128/IAI.00516-08; EDWARD DGF, 1953, J GEN MICROBIOL, V8, P256, DOI 10.1099/00221287-8-2-256; Felder KM, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-18; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; FURNESS G, 1977, J INFECT DIS, V135, P507, DOI 10.1093/infdis/135.4.507; Groebel K, 2009, INFECT IMMUN, V77, P576, DOI 10.1128/IAI.00773-08; Guimaraes AMS, 2007, VET REC, V160, P50, DOI 10.1136/vr.160.2.50; HALDIMANN A, 1993, J GEN MICROBIOL, V139, P317, DOI 10.1099/00221287-139-2-317; HEINRITZI K, 1992, BERL MUNCH TIERARZTL, V105, P380; Henderson JP, 1997, VET REC, V140, P144, DOI 10.1136/vr.140.6.144; HENRY SC, 1979, J AM VET MED ASSOC, V174, P601; Hoelzle LE, 2007, FEMS IMMUNOL MED MIC, V49, P215, DOI 10.1111/j.1574-695X.2006.00184.x; Hsu T, 1998, INFECT IMMUN, V66, P4762, DOI 10.1128/IAI.66.10.4762-4766.1998; HU PC, 1987, INFECT IMMUN, V55, P1126, DOI 10.1128/IAI.55.5.1126-1131.1987; Iddar A, 2005, INT MICROBIOL, V8, P251; Iddar A, 2002, PROTEIN EXPRES PURIF, V25, P519, DOI 10.1016/S1046-5928(02)00032-3; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Lee SW, 2008, MICROBIOL-SGM, V154, P2571, DOI 10.1099/mic.0.2008/019208-0; Lewthwaite J, 1998, TRENDS MICROBIOL, V6, P426, DOI 10.1016/S0966-842X(98)01362-6; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MAEDE Y, 1978, JPN J VET SCI, V40, P203; MAEDE Y, 1978, JPN J VET SCI, V40, P141; MAYER M, 1921, ARCH SCHIFFS TROP HY, P115; McElhaney Ronald N., 1992, P231; Messick JB, 2000, CAN J MICROBIOL, V46, P1082, DOI 10.1139/cjm-46-11-1082; Messick JB, 2004, VET CLIN PATH, V33, P2, DOI 10.1111/j.1939-165X.2004.tb00342.x; MOULDER JW, 1974, BERGEYS MANUAL DETER, P882; Murray A W, 1970, Prog Nucleic Acid Res Mol Biol, V10, P87; Neimark H, 1997, FEMS MICROBIOL LETT, V156, P287, DOI 10.1111/j.1574-6968.1997.tb12742.x; Neimark H, 2001, INT J SYST EVOL MICR, V51, P891, DOI 10.1099/00207713-51-3-891; Nicolas MF, 2007, GENET MOL BIOL, V30, P202, DOI 10.1590/S1415-47572007000200006; OBERST RD, 1993, J VET DIAGN INVEST, V5, P351, DOI 10.1177/104063879300500308; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Papazisi L, 2003, MICROBIOL-SGM, V149, P2307, DOI 10.1099/mic.0.26427-0; Pei JM, 2001, TRENDS BIOCHEM SCI, V26, P275, DOI 10.1016/S0968-0004(01)01813-8; Pollack J. Dennis, 1992, P181; Pollack J. Dennis, 2002, OMICS A Journal of Integrative Biology, V6, P247, DOI 10.1089/15362310260256909; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; Pollack JD, 2001, TRENDS MICROBIOL, V9, P169, DOI 10.1016/S0966-842X(01)01950-3; RAHMAN O, 2003, PROTEIN SCI, V12, P1652; Rahman O, 2008, WORLD J MICROB BIOT, V24, P2377, DOI 10.1007/s11274-008-9795-2; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; RENAUDIN J, 1995, J BACTERIOL, V177, P2870, DOI 10.1128/jb.177.10.2870-2877.1995; Rikihisa Y, 1997, J CLIN MICROBIOL, V35, P823, DOI 10.1128/JCM.35.4.823-829.1997; Ritzmann M, 2009, VET MICROBIOL, V133, P84, DOI 10.1016/j.vetmic.2008.06.015; ROTTEM S, 1980, BIOCHIM BIOPHYS ACTA, V604, P65, DOI 10.1016/0005-2736(80)90585-4; Sasaki Y, 2002, NUCLEIC ACIDS RES, V30, P5293, DOI 10.1093/nar/gkf667; Saurin W, 1996, MOL MICROBIOL, V22, P389; SCHILLING V, 1928, KLIN WOCHENSCHR, P1854; SPLITTER EJ, 1950, SCIENCE, V111, P513, DOI 10.1126/science.111.2889.513; Viratyosin W, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-38; WANKER EE, 1995, J CELL BIOL, V130, P29, DOI 10.1083/jcb.130.1.29; Yuan CL, 2009, AM J VET RES, V70, P890, DOI 10.2460/ajvr.70.7.890; Yuan CL, 2010, VET MICROBIOL, V142, P303, DOI 10.1016/j.vetmic.2009.10.022; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263; ZACHARY JF, 1985, VET PATHOL, V22, P164, DOI 10.1177/030098588502200211; Zheng X, 2008, SCI CHINA SER C, V51, P182, DOI 10.1007/s11427-008-0017-9; ZINN GM, 1983, J AM VET MED ASSOC, V182, P369	82	36	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19574	10.1371/journal.pone.0019574	http://dx.doi.org/10.1371/journal.pone.0019574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573007	gold, Green Submitted, Green Published			2022-12-25	WOS:000290440200012
J	Yu, YQ; Zhao, F; Guan, SM; Chen, J				Yu, Yao-Qing; Zhao, Feng; Guan, Su-Min; Chen, Jun			Antisense-Mediated Knockdown of Na(V)1.8, but Not Na(V)1.9, Generates Inhibitory Effects on Complete Freund's Adjuvant-Induced Inflammatory Pain in Rat	PLOS ONE			English	Article							GATED SODIUM-CHANNELS; TETRODOTOXIN-RESISTANT; SENSORY NEURONS; NA+ CHANNELS; THERAPEUTIC TARGETS; UP-REGULATION; ION CHANNELS; EXPRESSION; CURRENTS; TRANSMISSION	Tetrodotoxin-resistant (TTX-R) sodium channels Na(V)1.8 and Na(V)1.9 in sensory neurons were known as key pain modulators. Comparing with the widely reported Na(V)1.8, roles of Na(V)1.9 on inflammatory pain are poorly studied by antisense-induced specific gene knockdown. Here, we used molecular, electrophysiological and behavioral methods to examine the effects of antisense oligodeoxynucleotide (AS ODN) targeting Na(V)1.8 and Na(V)1.9 on inflammatory pain. Following complete Freund's adjuvant (CFA) inflammation treatment, Na(V)1.8 and Na(V)1.9 in rat dorsal root ganglion (DRG) up-regulated mRNA and protein expressions and increased sodium current densities. Immunohistochemical data demonstrated that Na(V)1.8 mainly localized in medium and small-sized DRG neurons, whereas Na(V)1.9 only expressed in small-sized DRG neurons. Intrathecal (i.t.) delivery of AS ODN was used to down-regulate Na(V)1.8 or Na(V)1.9 expressions confirmed by immunohistochemistry and western blot. Unexpectedly, behavioral tests showed that only Na(V)1.8 AS ODN, but not Na(V)1.9 AS ODN could reverse CFA-induced heat and mechanical hypersensitivity. Our data indicated that TTX-R sodium channels Na(V)1.8 and Na(V)1.9 in primary sensory neurons played distinct roles in CFA-induced inflammatory pain and suggested that antisense oligodeoxynucleotide-mediated blocking of key pain modulator might point toward a potential treatment strategy against certain types of inflammatory pain.	[Yu, Yao-Qing; Zhao, Feng; Chen, Jun] Fourth Mil Med Univ, Inst Biomed Sci Pain, Xian 710032, Peoples R China; [Yu, Yao-Qing; Zhao, Feng; Chen, Jun] Fourth Mil Med Univ, Tangdu Hosp, Inst Funct Brain Disorders, Xian 710032, Peoples R China; [Guan, Su-Min] Fourth Mil Med Univ, Sch Stomatol, Xian 710032, Peoples R China; [Chen, Jun] Capital Med Univ, Inst Biomed Sci Pain, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Capital Medical University	Yu, YQ (corresponding author), Fourth Mil Med Univ, Inst Biomed Sci Pain, Xian 710032, Peoples R China.	jchsmg@fmmu.edu.cn; junchen@fmmu.edu.cn	Chen, Jun/R-8412-2017; Yu, Yao-Qing/D-6163-2017	Chen, Jun/0000-0003-2637-8442; Yu, Yao-Qing/0000-0002-8047-9714	National Natural Science Foundation of China [30670692, 30770668, 81070899]; Natural Science Foundation of Beijing [KZ200510025016]; Military Health Foundation of PLA [06G095]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Military Health Foundation of PLA	This work was supported in part by the National Natural Science Foundation of China grants (30670692 and 30770668, 81070899), the Natural Science Foundation of Beijing (KZ200510025016) and Military Health Foundation of PLA (06G095) to J.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Amaya F, 2000, MOL CELL NEUROSCI, V15, P331, DOI 10.1006/mcne.1999.0828; Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; Baker MD, 2001, TRENDS PHARMACOL SCI, V22, P27, DOI 10.1016/S0165-6147(00)01585-6; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Benn SC, 2001, J NEUROSCI, V21, P6077, DOI 10.1523/JNEUROSCI.21-16-06077.2001; Berta T, 2008, MOL CELL NEUROSCI, V37, P196, DOI 10.1016/j.mcn.2007.09.007; Brussaard AB, 1997, J NEUROSCI METH, V71, P55, DOI 10.1016/S0165-0270(96)00126-4; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Chen J, 1999, PAIN, V83, P67, DOI 10.1016/S0304-3959(99)00075-5; Chen J, 2010, PROG NEUROBIOL, V92, P151, DOI 10.1016/j.pneurobio.2010.06.006; Coste B, 2004, MOL CELL NEUROSCI, V26, P123, DOI 10.1016/j.mcn.2004.01.015; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Cummins TR, 1997, J NEUROSCI, V17, P3503; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; Dib-Hajj SD, 2009, PAIN MED, V10, P1260, DOI 10.1111/j.1526-4637.2009.00719.x; Duan B, 2007, J NEUROSCI, V27, P11139, DOI 10.1523/JNEUROSCI.3364-07.2007; Ekberg J, 2006, INT J BIOCHEM CELL B, V38, P2005, DOI 10.1016/j.biocel.2006.06.008; Fukuoka T, 2008, J COMP NEUROL, V510, P188, DOI 10.1002/cne.21786; Glorioso JC, 2009, MOL THER, V17, P13, DOI 10.1038/mt.2008.213; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Gould HJ, 1998, BRAIN RES, V802, P69, DOI 10.1016/S0006-8993(98)00568-X; Henry MA, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-56; Hillsley K, 2006, J PHYSIOL-LONDON, V576, P257, DOI 10.1113/jphysiol.2006.113597; Huang ZJ, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-20; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Joshi SK, 2006, PAIN, V123, P75, DOI 10.1016/j.pain.2006.02.011; Kurreck J, 2003, EUR J BIOCHEM, V270, P1628, DOI 10.1046/j.1432-1033.2003.03555.x; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Larsen HJ, 1999, BBA-GENE STRUCT EXPR, V1489, P159, DOI 10.1016/S0167-4781(99)00145-1; Leo S, 2010, BEHAV BRAIN RES, V208, P149, DOI 10.1016/j.bbr.2009.11.023; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Parada CA, 2003, P NATL ACAD SCI USA, V100, P2923, DOI 10.1073/pnas.252777799; Patel VB, 2009, PAIN PHYSICIAN, V12, P345; Porreca F, 1999, P NATL ACAD SCI USA, V96, P7640, DOI 10.1073/pnas.96.14.7640; Priest BT, 2005, P NATL ACAD SCI USA, V102, P9382, DOI 10.1073/pnas.0501549102; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Ritter AM, 2009, NEUROSCI LETT, V452, P28, DOI 10.1016/j.neulet.2008.12.051; Rogers M, 2006, SEMIN CELL DEV BIOL, V17, P571, DOI 10.1016/j.semcdb.2006.10.009; Rush AM, 2005, EUR J NEUROSCI, V22, P39, DOI 10.1111/j.1460-9568.2005.04186.x; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; STEIN C, 1988, PHARMACOL BIOCHEM BE, V31, P445, DOI 10.1016/0091-3057(88)90372-3; Tarnawa Istvan, 2007, Recent Pat CNS Drug Discov, V2, P57, DOI 10.2174/157488907779561754; Tate S, 1998, NAT NEUROSCI, V1, P653, DOI 10.1038/3652; Villarreal CF, 2005, NEUROSCI LETT, V386, P72, DOI 10.1016/j.neulet.2005.04.060; Yu YQ, 2005, NEUROSCI LETT, V381, P194, DOI 10.1016/j.neulet.2005.02.033	51	58	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19865	10.1371/journal.pone.0019865	http://dx.doi.org/10.1371/journal.pone.0019865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572961	Green Published, Green Submitted, gold			2022-12-25	WOS:000290440200030
J	Fang, Y; Benjamin, W; Sun, MT; Ramani, K				Fang, Yi; Benjamin, William; Sun, Mengtian; Ramani, Karthik			Global Geometric Affinity for Revealing High Fidelity Protein Interaction Network	PLOS ONE			English	Article							STRUCTURE DEFINITION; HARMONIC-ANALYSIS; DATA INTEGRATION; INTERACTION MAP; YEAST; DIFFUSIONS; GRAPH; TOOL	Protein-protein Interaction (PPI) network analysis presents an e essential role in understanding the functional relationship among proteins in a living biological system. Despite the success of current approaches for understanding the PPI network, he large fraction of missing and spurious PPIs and a low coverage of complete PP1 network are the sources of major concern. In this paper based on the diffusion process, we propose a new concept of global geometric affinity and an accompanying computational scheme to filter he uncertain PP1s, namely, reduce the spurious PPIS and recover the missing PPIs in the network. The main concept defines a diffusion process in which all proteins simultaneously participate to define similarity metric (global geometric affinity)) to robustly reflect the internal connectivity among proteins. The robustness of he GGA is attributed to propagating the local connectivity to a global representation of similarity among proteins in a diffusion process. The propagation process is extremely fast as only simple matrix products are required in this computation process and thus our method is geared toward applications in high-throughput PPI networks. Furthermore, we proposed two new approaches that determine he optimal geometric scale of the PPI network and the optimal threshold for assigning he PPI from the GGA matrix. Our approach is tested with three protein-protein interaction networks and performs well with significant random noises of deletions and insertions in true PPIs. Our approach has the potential to benefit biological experiments, to better characterize network data sets, and to drive new discoveries.	[Fang, Yi; Benjamin, William; Sun, Mengtian; Ramani, Karthik] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Ramani, Karthik] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Fang, Y (corresponding author), Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA.	fang4@purdue.edu; ramani@purdue.edu	Fang, Yi/G-6190-2012		National Institutes of health [GM-075004]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075004] Funding Source: NIH RePORTER; Directorate For Engineering [0917959] Funding Source: National Science Foundation	National Institutes of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Institutes of health, GM-075004, http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Coifman RR, 2006, APPL COMPUT HARMON A, V21, P5, DOI 10.1016/j.acha.2006.04.006; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7432, DOI 10.1073/pnas.0500896102; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Edwards AM, 2002, TRENDS GENET, V18, P529, DOI 10.1016/S0168-9525(02)02763-4; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fang Yi, 2010, BMC Med Imaging, V10, P12, DOI 10.1186/1471-2342-10-12; Fang Y, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-29; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; Higham DJ, 2008, BIOINFORMATICS, V24, P1093, DOI 10.1093/bioinformatics/btn079; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuchaiev O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000454; Lafon S, 2006, IEEE T PATTERN ANAL, V28, P1784, DOI 10.1109/TPAMI.2006.223; Lafon S, 2006, IEEE T PATTERN ANAL, V28, P1393, DOI 10.1109/TPAMI.2006.184; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lerman G, 2007, P NATL ACAD SCI USA, V104, P11334, DOI 10.1073/pnas.0702965104; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Liu YS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-157; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Saito R, 2002, NUCLEIC ACIDS RES, V30, P1163, DOI 10.1093/nar/30.5.1163; Singer A, 2008, P NATL ACAD SCI USA, V105, P9507, DOI 10.1073/pnas.0709842104; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; UCAR D, 2005, BIBE, V129, P371; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wang J, 2009, P NATL ACAD SCI USA, V106, P3752, DOI 10.1073/pnas.0806427106; Yi Fang, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2145, DOI 10.1109/CVPR.2011.5995695; Yu HY, 2006, BIOINFORMATICS, V22, P823, DOI 10.1093/bioinformatics/btl014	43	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19349	10.1371/journal.pone.0019349	http://dx.doi.org/10.1371/journal.pone.0019349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559288	gold, Green Published			2022-12-25	WOS:000290223500019
J	Liu, SS; Chan, KYK; Leung, RCY; Chan, KKL; Tam, KF; Luk, MHM; Lo, SST; Fong, DYT; Cheung, ANY; Lin, ZQ; Ngan, HYS				Liu, Stephanie Si; Chan, Kelvin Yuen Kwong; Leung, Rebecca Ching Yu; Chan, Karen Kar Loen; Tam, Kar Fai; Luk, May Hiu Mei; Lo, Sue Seen Tsing; Fong, Daniel Yee Tak; Cheung, Annie Nga Yin; Lin, Zhong Qiu; Ngan, Hextan Yuen Sheung			Prevalence and Risk Factors of Human Papillomavirus (HPV) Infection in Southern Chinese Women - A Population-Based Study	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; CERVICAL-CANCER; INTERNATIONAL AGENCY; SEXUAL-BEHAVIOR; POOLED ANALYSIS; TRENDS; DETERMINANTS; MORTALITY; PROVINCE; SMOKING	Background: Persistent high-risk type Human papillomavirus (HPV) infection is recognized as a necessary cause of cervical cancer. This study aimed to compare the HPV prevalence and risk factors between women residing in Hong Kong (HK) and Guangzhou (GZ) region of China. Methodology/Principal Findings: A total of 1,570 and 1,369 women were recruited from HK and GZ, respectively. The cytology samples were collected and tested for HPV infection. The overall and type-specific HPV prevalence and the potential risk factors for acquisition of HPV infection were studied. Women with normal cytology in the GZ cohort had significantly higher HPV prevalence (10%) than those in the HK cohort (6.2%, p < 0.001). The patterns of the age-specific HPV prevalence were also different between the two cohorts. In the HK cohort, women at the age of 20-29 years old had the highest prevalence and a second peak was observed in the age of >= 60 years old. In the GZ cohort, the highest HPV prevalence was also observed in 20-29 years old but declined as the age increased and a second peak was not seen. HPV16 and HPV52 were the most common high-risk types found in the HK and GZ cohorts, respectively. Age was the most consistently observed independent risk factor for HPV infection in the HK, while the number of sexual partners had association in the GZ cohort. Conclusions/Significance:Our study provides the current status and the epidemiological characteristics of HPV prevalence in Southern Chinese women. The results strongly suggested that population education and the effective cervical cancer screening would be vital in the prevention of cervical cancer.	[Liu, Stephanie Si; Chan, Kelvin Yuen Kwong; Leung, Rebecca Ching Yu; Chan, Karen Kar Loen; Tam, Kar Fai; Ngan, Hextan Yuen Sheung] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Cheung, Annie Nga Yin] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Fong, Daniel Yee Tak] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Lo, Sue Seen Tsing] Family Planning Assoc Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Luk, May Hiu Mei; Lin, Zhong Qiu] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Obstet & Gynaecol, Guangzhou 510275, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Sun Yat Sen University	Liu, SS (corresponding author), Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.	lin-zhongqiu@163.com; hysngan@hkusua.hku.hk	Chan, Kelvin/HGA-3097-2022; Fong, Daniel YT/C-4269-2009; Luk, Hiu Mei May/A-7651-2013; Chan, Karen/E-4041-2015; Cheung, Annie Nga Yin/C-4231-2009	Fong, Daniel YT/0000-0001-7365-9146; Lo, Sue Seen-Tsing/0000-0003-1259-1680; Chan, Karen/0000-0001-9947-4713; Cheung, Annie Nga Yin/0000-0002-1584-7568; Ngan, Hextan Y S/0000-0003-3945-159X	Hong Kong Special Administrative Region Government [RFCID: 05050052]	Hong Kong Special Administrative Region Government	This study was supported by a grant from Research Fund for the Control of Infectious Disease Grant, Hong Kong Special Administrative Region Government (RFCID: 05050052). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YP, 2008, INT J STD AIDS, V19, P106, DOI 10.1258/ijsa.2007.007113; Bao YP, 2008, INT J GYNECOL CANCER, V18, P71, DOI 10.1111/j.1525-1438.2007.00959.x; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Chan PKS, 2009, J MED VIROL, V81, P1635, DOI 10.1002/jmv.21575; Chan PKS, 2002, J INFECT DIS, V185, P28, DOI 10.1086/338010; Chan PKS, 2002, J MED VIROL, V68, P273, DOI 10.1002/jmv.10189; Chen JG, 2006, INT J CANCER, V119, P1447, DOI 10.1002/ijc.21952; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Dai M, 2006, BRIT J CANCER, V95, P96, DOI 10.1038/sj.bjc.6603208; De Sanjose S, 2003, SEX TRANSM DIS, V30, P788, DOI 10.1097/01.OLQ.0000080177.82204.E0; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Deacon JM, 2000, BRIT J CANCER, V83, P1565, DOI 10.1054/bjoc.2000.1523; Ferreccio C, 2004, CANCER EPIDEM BIOMAR, V13, P2271; HOLM S, 1979, SCAND J STAT, V6, P65; Inoue M, 2006, INT J GYNECOL CANCER, V16, P1007, DOI 10.1111/j.1525-1438.2006.00460.x; Jin F, 1999, INT J CANCER, V83, P435, DOI 10.1002/(SICI)1097-0215(19991112)83:4&lt;435::AID-IJC1&gt;3.0.CO;2-J; Lazcano-Ponce E, 2001, INT J CANCER, V91, P412, DOI 10.1002/1097-0215(20010201)91:3&lt;412::AID-IJC1071&gt;3.0.CO;2-M; Li HQ, 2000, INT J EPIDEMIOL, V29, P398, DOI 10.1093/ije/29.3.398; Li LK, 2006, BRIT J CANCER, V95, P1593, DOI 10.1038/sj.bjc.6603450; Lin H, 2006, GYNECOL ONCOL, V101, P40, DOI 10.1016/j.ygyno.2005.09.028; Liu SS, 2010, J CLIN MICROBIOL, V48, P758, DOI 10.1128/JCM.00989-09; Molano M, 2002, BRIT J CANCER, V87, P324, DOI 10.1038/sj.bjc.6600442; Moscicki AB, 2008, J ADOLESCENT HEALTH, V43, pS1, DOI 10.1016/j.jadohealth.2008.07.008; Nielsen A, 2009, SEX TRANSM DIS, V36, P609, DOI 10.1097/OLQ.0b013e3181a96d0e; RICHARD L, 1979, ELEMENTARY SURVEY SA; Sankaranarayanan R, 2006, BEST PRACT RES CL OB, V20, P207, DOI 10.1016/j.bpobgyn.2005.10.007; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958; Stephen AL, 2000, INT J CANCER, V86, P695, DOI 10.1002/(SICI)1097-0215(20000601)86:5&lt;695::AID-IJC15&gt;3.0.CO;2-C; Vaccarella S, 2006, CANCER EPIDEM BIOMAR, V15, P326, DOI 10.1158/1055-9965.EPI-05-0577; Vaccarella S, 2008, INT J EPIDEMIOL, V37, P536, DOI 10.1093/ije/dyn033; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wu EQ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-202; Wu RF, 2007, INT J CANCER, V121, P1306, DOI 10.1002/ijc.22726; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300	36	49	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19244	10.1371/journal.pone.0019244	http://dx.doi.org/10.1371/journal.pone.0019244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559276	Green Published, gold, Green Submitted			2022-12-25	WOS:000290223500013
J	Villalta, JI; Galli, S; Iacaruso, MF; Arciuch, VGA; Poderoso, JJ; Jares-Erijman, EA; Pietrasanta, LI				Ignacio Villalta, Jorge; Galli, Soledad; Florencia Iacaruso, Maria; Antico Arciuch, Valeria Gabriela; Jose Poderoso, Juan; Andrea Jares-Erijman, Elizabeth; Isabel Pietrasanta, Lia			New Algorithm to Determine True Colocalization in Combination with Image Restoration and Time-Lapse Confocal Microscopy to Map Kinases in Mitochondria	PLOS ONE			English	Article								The subcellular localization and physiological functions of biomolecules are closely related and thus it is crucial to precisely determine the distribution of different molecules inside the intracellular structures. This is frequently accomplished by fluorescence microscopy with well-characterized markers and posterior evaluation of the signal colocalization. Rigorous study of colocalization requires statistical analysis of the data, albeit yet no single technique has been established as a standard method. Indeed, the few methods currently available are only accurate in images with particular characteristics. Here, we introduce a new algorithm to automatically obtain the true colocalization between images that is suitable for a wide variety of biological situations. To proceed, the algorithm contemplates the individual contribution of each pixel's fluorescence intensity in a pair of images to the overall Pearsons correlation and Manders' overlap coefficients. The accuracy and reliability of the algorithm was validated on both simulated and real images that reflected the characteristics of a range of biological samples. We used this algorithm in combination with image restoration by deconvolution and time-lapse confocal microscopy to address the localization of MEK1 in the mitochondria of different cell lines. Appraising the previously described behavior of Akt1 corroborated the reliability of the combined use of these techniques. Together, the present work provides a novel statistical approach to accurately and reliably determine the colocalization in a variety of biological images.	[Ignacio Villalta, Jorge; Florencia Iacaruso, Maria; Isabel Pietrasanta, Lia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Ctr Microscopias Avanzadas, Buenos Aires, DF, Argentina; [Galli, Soledad; Andrea Jares-Erijman, Elizabeth] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, CIHIDECAR,CONICET, RA-1428 Buenos Aires, DF, Argentina; [Antico Arciuch, Valeria Gabriela; Jose Poderoso, Juan] Univ Buenos Aires, Fac Med, Lab Oxygen Metab, Univ Hosp Jose de San Martin, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Villalta, JI (corresponding author), Univ Buenos Aires, Fac Med, Dept Fisiol, RA-1425 Buenos Aires, DF, Argentina.	eli@qo.fcen.uba.ar; lia@df.uba.ar		PIETRASANTA, LIA/0000-0002-2714-3162	Universidad de Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Max Planck Society	Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Max Planck Society(Max Planck Society)	This work was supported by the Universidad de Buenos Aires, the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Arciuch VGA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007523; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Comeau JWD, 2006, BIOPHYS J, V91, P4611, DOI 10.1529/biophysj.106.089441; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Craig EA, 2008, DEV DYNAM, V237, P3102, DOI 10.1002/dvdy.21750; Fletcher PA, 2010, BIOPHYS J, V99, P1996, DOI 10.1016/j.bpj.2010.07.006; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Galli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007541; Galli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002379; Galmiche A, 2008, J BIOL CHEM, V283, P14857, DOI 10.1074/jbc.M709098200; Horgan AM, 2003, EXP CELL RES, V285, P208, DOI 10.1016/S0014-4827(03)00037-5; Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Ramay HR, 2009, BIOPHYS J, V97, P443, DOI 10.1016/j.bpj.2009.04.062; Ramirez O, 2010, J MICROSC-OXFORD, V239, P173, DOI 10.1111/j.1365-2818.2010.03369.x; Sedarat F, 2004, J APPL PHYSIOL, V97, P1098, DOI 10.1152/japplphysiol.00089.2004; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SEGER R, 1992, J BIOL CHEM, V267, P14373; Yao Z, 2001, ONCOGENE, V20, P7588, DOI 10.1038/sj.onc.1204963; ZHENG CF, 1993, J BIOL CHEM, V268, P23933; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	30	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19031	10.1371/journal.pone.0019031	http://dx.doi.org/10.1371/journal.pone.0019031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559502	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700054
J	Koeva, M; Forsberg, EC; Stuart, JM				Koeva, Martina; Forsberg, E. Camilla; Stuart, Joshua M.			Computational Integration of Homolog and Pathway Gene Module Expression Reveals General Stemness Signatures	PLOS ONE			English	Article							SELF-RENEWAL; PROTEINS; CELLS; DIFFERENTIATION; ACETYLATION; NETWORKS; BINDING; KEGG; DNA	The stemness hypothesis states that all stem cells use common mechanisms to regulate self-renewal and multi-lineage potential. However, gene expression meta-analyses at the single gene level have failed to identify a significant number of genes selectively expressed by a broad range of stem cell types. We hypothesized that stemness may be regulated by modules of homologs. While the expression of any single gene within a module may vary from one stem cell type to the next, it is possible that the expression of the module as a whole is required so that the expression of different, yet functionally-synonymous, homologs is needed in different stem cells. Thus, we developed a computational method to test for stem cell-specific gene expression patterns from a comprehensive collection of 49 murine datasets covering 12 different stem cell types. We identified 40 individual genes and 224 stemness modules with reproducible and specific up-regulation across multiple stem cell types. The stemness modules included families regulating chromatin remodeling, DNA repair, and Wnt signaling. Strikingly, the majority of modules represent evolutionarily related homologs. Moreover, a score based on the discovered modules could accurately distinguish stem cell-like populations from other cell types in both normal and cancer tissues. This scoring system revealed that both mouse and human metastatic populations exhibit higher stemness indices than non-metastatic populations, providing further evidence for a stem cell-driven component underlying the transformation to metastatic disease.	[Koeva, Martina; Forsberg, E. Camilla; Stuart, Joshua M.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Koeva, M (corresponding author), Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA.	jstuart@soe.ucsc.edu; cforsber@soe.ucsc.edu		Stuart, Joshua/0000-0002-2171-565X	California Institute for Regenerative Medicine; NSF; Sloan; Davis CRC Cancer Grant; Alfred P. Sloan Foundation	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NSF(National Science Foundation (NSF)); Sloan(Alfred P. Sloan Foundation); Davis CRC Cancer Grant; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	MK was supported by a California Institute for Regenerative Medicine Training grant. ECF is supported by a New Faculty Award from the California Institute for Regenerative Medicine. JMS was supported by grants from NSF, Sloan, Davis CRC Cancer Grant, and a fellowship from the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angelelli C, 2008, NUCLEIC ACIDS RES, V36, P915, DOI 10.1093/nar/gkm1114; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chavez L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-314; Chen R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-548; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Fortunel NO, 2003, SCIENCE, V302, P393; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Hirst CE, 2006, DEV BIOL, V293, P90, DOI 10.1016/j.ydbio.2006.01.023; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Laurent A, 2008, INT J DEV BIOL, V52, P9, DOI 10.1387/ijdb.072304al; Ma KW, 2005, MOL CELL BIOL, V25, P3575, DOI 10.1128/MCB.25.9.3575-3582.2005; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Ravindranath A, 2008, CURR MOL MED, V8, P38; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sun Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003406; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yokota Y, 2002, J CELL PHYSIOL, V190, P21, DOI 10.1002/jcp.10042	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18968	10.1371/journal.pone.0018968	http://dx.doi.org/10.1371/journal.pone.0018968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559491	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700045
J	Liu, JL; Zhang, N; Li, Q; Zhang, WW; Ke, F; Leng, QB; Wang, H; Chen, JF; Wang, HL				Liu, Jinlin; Zhang, Ning; Li, Qun; Zhang, Weiwei; Ke, Fang; Leng, Qibin; Wang, Hong; Chen, Jinfei; Wang, Honglin			Tumor-Associated Macrophages Recruit CCR6(+) Regulatory T Cells and Promote the Development of Colorectal Cancer via Enhancing CCL20 Production in Mice	PLOS ONE			English	Article							COLON CARCINOGENESIS; IN-VIVO; RECEPTOR; INFILTRATION; EXPRESSION; CHEMOKINE; IMMUNITY; SURVIVAL; FOXP3; CARCINOMA	Background: Tumor-associated macrophages (TAMs) remodel the colorectal cancer (CRC) microenvironment. Yet, findings on the role of TAMs in CRC seem to be contradictory compared with other cancers. FoxP3(+) regulatory T (Treg)-cells dominantly infiltrate CRC. However, the underlying molecular mechanism in which TAMs may contribute to the trafficking of Treg-cells to the tumor mass remains unknown. Methodology/Principal Findings: CRC was either induced by N-methyl-N-nitrosourea (MNU) and H. pylori or established by subcutaneous injection of mouse colorectal tumor cell line (CMT93) in mice. CMT93 cells were co-cultured with primary macrophages in a transwell apparatus. Recruitment of FoxP3 green fluorescence protein positive (FoxP3(GFP+)) Treg-cells was assessed using the IVIS Imaging System or immunofluorescence staining. A role for macrophages in trafficking of Treg-cells and in the development of CRC was investigated in CD11b diphtheria toxin receptor (CD11b-DTR) transgenic C57BL/6J mice in which macrophages can be selectively depleted. Treg-cells remarkably infiltrated solid tumor, and predominantly expressed the homing chemokine receptor (CCR) 6 in the induced CRC model. Both CMT93 cancer cells and macrophages produced a large amount of CCL20, the sole ligand of CCR6 in vitro and in vivo. Injection of recombinant mouse CCL20 into tumor sites promoted its development with a marked recruitment of Treg-cells in the graft CRC model. Conditional macrophage ablation decreased CCL20 levels, blocked Treg-cell recruitment and inhibited tumor growth in CD11b-DTR mice grafted with CMT93. Conclusions/Significance: TAMs recruit CCR6(+) Treg-cells to tumor mass and promote its development via enhancing the production of CCL20 in a CRC mouse model.	[Liu, Jinlin; Zhang, Weiwei; Ke, Fang; Wang, Hong; Wang, Honglin] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Zhang, Ning] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Pathol, Shanghai 200030, Peoples R China; [Li, Qun] Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Shanghai Key Lab Vasc Biol, State Key Lab Med Genom,Ruijin Hosp,Sch Med, Shanghai 200030, Peoples R China; [Leng, Qibin] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Chen, Jinfei] Nanjing Med Univ, Affiliated Nanjing Hosp 1, Dept Oncol, Nanjing, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Nanjing Medical University	Liu, JL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China.	honglin_wang@shsmu.edu.cn	WANG, Honglin/AAJ-2708-2020	WANG, Honglin/0000-0001-6302-6927	National Natural Science Foundation of China [30972787]; Shanghai Institutions of Higher Learning; Science and Technology Commission of Shanghai Municipality [09140902600]; Shanghai Municipal Education Commission [J50208, J50207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Institutions of Higher Learning; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This research is supported by a grant from the National Natural Science Foundation of China (No: 30972787), by the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, by the Science and Technology Commission of Shanghai Municipality (No.:09140902600), and by the Leading Academic Discipline Project of the Shanghai Municipal Education Commission (No: J50208 and No: J50207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony PA, 2002, J IMMUNOTHER, V25, P202, DOI 10.1097/00002371-200205000-00002; Campbell DJ, 2007, NAT REV IMMUNOL, V7, P305, DOI 10.1038/nri2061; Chen JJW, 2003, CLIN CANCER RES, V9, P729; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Clarke SL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000129; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; Funada Y, 2003, ONCOL REP, V10, P309; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Ghadjar P, 2006, J CLIN ONCOL, V24, P1910, DOI 10.1200/JCO.2005.04.1822; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Heinze E, 2009, INT J ONCOL, V35, P167, DOI 10.3892/ijo_00000325; Hromas R, 1997, BLOOD, V89, P3315; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Huehn J, 2005, TRENDS IMMUNOL, V26, P632, DOI 10.1016/j.it.2005.10.001; Jones E, 2003, IMMUNOL LETT, V85, P141, DOI 10.1016/S0165-2478(02)00240-7; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Khorana AA, 2003, CANCER, V97, P960, DOI 10.1002/cncr.11152; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Kunkel EJ, 2003, MICROCIRCULATION, V10, P313, DOI 10.1038/sj.mn.7800196; Leek RD, 1996, CANCER RES, V56, P4625; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; Li YK, 2006, J BIOL CHEM, V281, P6707, DOI 10.1074/jbc.M510579200; Liao F, 1999, J IMMUNOL, V162, P186; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Ling Khoon Lin, 2007, Cancer Immun, V7, P7; Loddenkemper C, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-52; Mantovani A, 2009, HUM IMMUNOL, V70, P325, DOI 10.1016/j.humimm.2009.02.008; Nakayama Y, 2002, ANTICANCER RES, V22, P4291; NARISAWA T, 1974, JNCI-J NATL CANCER I, V53, P1093, DOI 10.1093/jnci/53.4.1093; Onizuka S, 1999, CANCER RES, V59, P3128; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qin FXF, 2009, CELL MOL IMMUNOL, V6, P3, DOI 10.1038/cmi.2009.2; Roncador G, 2005, LEUKEMIA, V19, P2247, DOI 10.1038/sj.leu.2403965; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Shimizu J, 1999, J IMMUNOL, V163, P5211; Smith PD, 2005, IMMUNOL REV, V206, P149, DOI 10.1111/j.0105-2896.2005.00288.x; Stoneman V, 2007, CIRC RES, V100, P884, DOI 10.1161/01.RES.0000260802.75766.00; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Valzasina B, 2006, CANCER RES, V66, P4488, DOI 10.1158/0008-5472.CAN-05-4217; van der Burg SH, 2007, P NATL ACAD SCI USA, V104, P12087, DOI 10.1073/pnas.0704672104; Vence L, 2007, P NATL ACAD SCI USA, V104, P20884, DOI 10.1073/pnas.0710557105; Wang HL, 2009, J INVEST DERMATOL, V129, P1100, DOI 10.1038/jid.2009.43; Yaqub S, 2008, CANCER IMMUNOL IMMUN, V57, P813, DOI 10.1007/s00262-007-0417-x; Yoshida R, 1997, J BIOL CHEM, V272, P13803, DOI 10.1074/jbc.272.21.13803; Zhou G, 2007, J IMMUNOL, V178, P2155, DOI 10.4049/jimmunol.178.4.2155; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	54	154	168	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19495	10.1371/journal.pone.0019495	http://dx.doi.org/10.1371/journal.pone.0019495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559338	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700194
J	Masliah, E; Rockenstein, E; Mante, M; Crews, L; Spencer, B; Adame, A; Patrick, C; Trejo, M; Ubhi, K; Rohn, TT; Mueller-Steiner, S; Seubert, P; Barbour, R; McConlogue, L; Buttini, M; Games, D; Schenk, D				Masliah, Eliezer; Rockenstein, Edward; Mante, Michael; Crews, Leslie; Spencer, Brian; Adame, Anthony; Patrick, Christina; Trejo, Margarita; Ubhi, Kiren; Rohn, Troy T.; Mueller-Steiner, Sarah; Seubert, Peter; Barbour, Robin; McConlogue, Lisa; Buttini, Manuel; Games, Dora; Schenk, Dale			Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease	PLOS ONE			English	Article							A-BETA COMPONENT; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MOUSE MODEL; CEREBROSPINAL-FLUID; BILAYER CHARGE; IN-VITRO; AGGREGATION; PROTEIN; IMMUNOTHERAPY	Dementia with Lewy bodies (DLB) and Parkinson's Disease (PD) are common causes of motor and cognitive deficits and are associated with the abnormal accumulation of alpha-synuclein (alpha-syn). This study investigated whether passive immunization with a novel monoclonal alpha-syn antibody (9E4) against the C-terminus (CT) of alpha-syn was able to cross into the CNS and ameliorate the deficits associated with alpha-syn accumulation. In this study we demonstrate that 9E4 was effective at reducing behavioral deficits in the water maze, moreover, immunization with 9E4 reduced the accumulation of calpain-cleaved alpha-syn in axons and synapses and the associated neurodegenerative deficits. In vivo studies demonstrated that 9E4 traffics into the CNS, binds to cells that display alpha-syn accumulation and promotes alpha-syn clearance via the lysosomal pathway. These results suggest that passive immunization with monoclonal antibodies against the CT of alpha-syn may be of therapeutic relevance in patients with PD and DLB.	[Masliah, Eliezer; Rockenstein, Edward; Mante, Michael; Spencer, Brian; Adame, Anthony; Patrick, Christina; Trejo, Margarita; Ubhi, Kiren] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer; Crews, Leslie] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Rohn, Troy T.] Boise State Univ, Dept Biol, Boise, ID 83725 USA; [Mueller-Steiner, Sarah; Seubert, Peter; Barbour, Robin; McConlogue, Lisa; Buttini, Manuel; Games, Dora; Schenk, Dale] ELAN Pharmaceut, San Francisco, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Idaho; Boise State University	Masliah, E (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	emasliah@ucsd.edu	Crews, Leslie/B-7584-2014	Crews, Leslie/0000-0003-0704-0067; Buttini, Manuel/0000-0003-1805-0279	National Institutes of Health (NIH) [AG 11385, AG 18840, AG 022074, NS 044233]; ELAN Pharmaceuticals; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074, R01AG011385, R37AG011385] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ELAN Pharmaceuticals; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by National Institutes of Health (NIH) grants AG 11385, AG 18840, AG 022074 and NS 044233 and by ELAN Pharmaceuticals. NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sarah Mueller-Steiner, Peter Seubert, Robin Barbour, Lisa McConlogue, Manuel Buttini, Dora Games and Dale Schenk are employed by ELAN Pharmaceuticals, who, in collaboration with the group at UCSD, were intellectually involved in the conception and execution of the in vitro and in vivo passive immunization experiments.	Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Bussiere T, 2004, AM J PATHOL, V165, P987, DOI 10.1016/S0002-9440(10)63360-3; Buttini M, 2005, J NEUROSCI, V25, P9096, DOI 10.1523/JNEUROSCI.1697-05.2005; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; CREWS L, 2010, PLOS ONE IN PRESS; Crews L, 2009, NEUROTOX RES, V16, P306, DOI 10.1007/s12640-009-9073-6; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dickson DW, 2001, CURR OPIN NEUROL, V14, P423, DOI 10.1097/00019052-200108000-00001; Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Emadi S, 2004, BIOCHEMISTRY-US, V43, P2871, DOI 10.1021/bi036281f; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Hashimoto M, 2003, J NEUROCHEM, V85, P1468, DOI 10.1046/j.1471-4159.2003.01791.x; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Iwatsubo T, 1996, AM J PATHOL, V148, P1517; Kim HY, 2009, J AM CHEM SOC, V131, P17482, DOI 10.1021/ja9077599; Koob AO, 2010, EXP NEUROL, V221, P267, DOI 10.1016/j.expneurol.2009.11.015; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Langston JW, 2006, ANN NEUROL, V59, P591, DOI 10.1002/ana.20834; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; Lemere CA, 2006, REJUV RES, V9, P77, DOI 10.1089/rej.2006.9.77; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McKeith IG, 2000, NEUROL CLIN, V18, P865, DOI 10.1016/S0733-8619(05)70230-9; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Noguchi-Shinohara M, 2009, BRAIN RES, V1251, P1, DOI 10.1016/j.brainres.2008.11.055; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; de Laureto PP, 2006, BIOCHEMISTRY-US, V45, P11523, DOI 10.1021/bi052614s; Rhodes SL, 2011, ANN HUM GENET, V75, P195, DOI 10.1111/j.1469-1809.2010.00616.x; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Rockenstein E, 2007, ADV DRUG DELIVER REV, V59, P1093, DOI 10.1016/j.addr.2007.08.013; ROEDER LM, 1982, J NEUROSCI RES, V8, P671, DOI 10.1002/jnr.490080412; Salem SA, 2007, BRAIN RES, V1170, P103, DOI 10.1016/j.brainres.2007.07.027; Schenk DB, 2005, NEURODEGENER DIS, V2, P255, DOI 10.1159/000090365; Sigurdsson EM, 2008, J ALZHEIMERS DIS, V15, P157; Sigurdsson EM, 2009, CURR ALZHEIMER RES, V6, P446, DOI 10.2174/156720509789207930; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Takeda A, 1998, LAB INVEST, V78, P1169; Takenouchi T, 2001, MOL CELL NEUROSCI, V17, P141, DOI 10.1006/mcne.2000.0923; Trojanowski JQ, 1998, ARCH NEUROL-CHICAGO, V55, P151, DOI 10.1001/archneur.55.2.151; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; Tsigelny IF, 2008, NANOMED-NANOTECHNOL, V4, P350, DOI 10.1016/j.nano.2008.05.005; van Rooijen BD, 2009, BBA-BIOMEMBRANES, V1788, P1271, DOI 10.1016/j.bbamem.2009.03.010; van Rooijen BD, 2008, FEBS LETT, V582, P3788, DOI 10.1016/j.febslet.2008.10.009; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wolfgang WJ, 2005, P NATL ACAD SCI USA, V102, P11563, DOI 10.1073/pnas.0505321102; Xilouri M, 2008, AUTOPHAGY, V4, P917, DOI 10.4161/auto.6685; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Zhou C, 2004, MOL THER, V10, P1023, DOI 10.1016/j.ymthe.2004.08.019	63	307	341	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19338	10.1371/journal.pone.0019338	http://dx.doi.org/10.1371/journal.pone.0019338			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559417	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700140
J	Nakamura, M; Fukami, M; Sugawa, F; Miyado, M; Nonomura, K; Ogata, T				Nakamura, Michiko; Fukami, Maki; Sugawa, Fumihiro; Miyado, Mami; Nonomura, Katsuya; Ogata, Tsutomu			Mamld1 Knockdown Reduces Testosterone Production and Cyp17a1 Expression in Mouse Leydig Tumor Cells	PLOS ONE			English	Article							CXORF6; HYPOSPADIAS; TESTIS; GENE; CANCER; FAMILY	Background: MAMLD1 is known to be a causative gene for hypospadias. Although previous studies have indicated that MAMLD1 mutations result in hypospadias primarily because of compromised testosterone production around the critical period for fetal sex development, the underlying mechanism(s) remains to be clarified. Furthermore, although functional studies have indicated a transactivation function of MAMLD1 for the non-canonical Notch target Hes3, its relevance to testosterone production remains unknown. To examine these matters, we performed Mamld1 knockdown experiments. Methodology/Principal Findings: Mamld1 knockdown was performed with two siRNAs, using mouse Leydig tumor cells (MLTCs). Mamld1 knockdown did not influence the concentrations of pregnenolone and progesterone but significantly reduced those of 17-OH pregnenolone, 17-OH progesterone, dehydroepiandrosterone, androstenedione, and testosterone in the culture media. Furthermore, Mamld1 knockdown significantly decreased Cyp17a1 expression, but did not affect expressions of other genes involved in testosterone biosynthesis as well as in insulin-like 3 production. Hes3 expression was not significantly altered. In addition, while 47 genes were significantly up-regulated (fold change >2.0x) and 38 genes were significantly down-regulated (fold change <0.5x), none of them was known to be involved in testosterone production. Cell proliferation analysis revealed no evidence for compromised proliferation of siRNA-transfected MLTCs. Conclusions/Significance: The results, in conjunction with the previous data, imply that Mamld1 enhances Cyp17a1 expression primarily in Leydig cells and permit to produce a sufficient amount of testosterone for male sex development, independently of the Hes3-related non-canonical Notch signaling.	[Nakamura, Michiko; Fukami, Maki; Sugawa, Fumihiro; Miyado, Mami; Ogata, Tsutomu] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan; [Nakamura, Michiko; Nonomura, Katsuya] Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan	National Center for Child Health & Development - Japan; Hokkaido University	Nakamura, M (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan.	tomogata@nch.go.jp	Fukami, Maki/ABE-4694-2020	Fukami, Maki/0000-0001-9971-4035; Ogata, Tsutomu/0000-0001-7178-9991	Ministry of Health, Labor and Welfare [H22-98]; Japan Society for the Promotion of Science (JSPS) [20390265, B-22791715]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22132004 A01]; Grants-in-Aid for Scientific Research [22227002] Funding Source: KAKEN	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant for Research on Intractable Diseases (H22-98) from the Ministry of Health, Labor and Welfare (http://www.mhlw.go.jp/english/), and Grants-in-Aid for Scientific Research (B) (20390265) and for Young Scientists (B-22791715) from the Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/), and by Grant-in-Aid for Scientific Research on Innovative Areas (22132004 A01) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 2008, WILLIAMS TXB ENDOCRI, V22, P783; ASCOLI M, 1978, P NATL ACAD SCI USA, V75, P99, DOI 10.1073/pnas.75.1.99; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Chen YG, 2010, EUR J MED GENET, V53, P122, DOI 10.1016/j.ejmg.2010.03.005; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Fukami M, 2008, J BIOL CHEM, V283, P5525, DOI 10.1074/jbc.M703289200; Fukami M, 2006, NAT GENET, V38, P1369, DOI 10.1038/ng1900; Hughes IA, 2008, EUR J ENDOCRINOL, V159, pS75, DOI 10.1530/EJE-08-0458; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kalfa N, 2008, EUR J ENDOCRINOL, V159, P453, DOI 10.1530/EJE-08-0085; Katoh M, 2007, INT J ONCOL, V31, P461; Lin L, 2008, SEX DEV, V2, P200, DOI 10.1159/000152036; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Ogata T, 2009, HORM RES, V71, P245, DOI 10.1159/000208797; Panesar NS, 2003, STEROIDS, V68, P245, DOI 10.1016/S0039-128X(02)00183-6; REBOIS RV, 1982, J CELL BIOL, V94, P70, DOI 10.1083/jcb.94.1.70; Tang H, 2008, DEVELOPMENT, V135, P3745, DOI 10.1242/dev.024786	18	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19123	10.1371/journal.pone.0019123	http://dx.doi.org/10.1371/journal.pone.0019123			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559465	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700069
J	Kean, MJ; Ceccarelli, DF; Goudreault, M; Sanches, M; Tate, S; Larsen, B; Gibson, LCD; Derry, WB; Scott, IC; Pelletier, L; Baillie, GS; Sicheri, F; Gingras, AC				Kean, Michelle J.; Ceccarelli, Derek F.; Goudreault, Marilyn; Sanches, Mario; Tate, Stephen; Larsen, Brett; Gibson, Lucien C. D.; Derry, W. Brent; Scott, Ian C.; Pelletier, Laurence; Baillie, George S.; Sicheri, Frank; Gingras, Anne-Claude			Structure-Function Analysis of Core STRIPAK Proteins A SIGNALING COMPLEX IMPLICATED IN GOLGI POLARIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; VASCULAR INTEGRITY; CELL-GROWTH; SACCHAROMYCES-CEREVISIAE; STRIATIN FAMILY; PHOSPHATASE 2A; GENOME-SCALE; RHO GTPASES; KINASE; PATHWAY	Cerebral cavernous malformations (CCMs) are alterations in brain capillary architecture that can result in neurological deficits, seizures, or stroke. We recently demonstrated that CCM3, a protein mutated in familial CCMs, resides predominantly within the STRIPAK complex (striatin interacting phosphatase and kinase). Along with CCM3, STRIPAK contains the Ser/Thr phosphatase PP2A. The PP2A holoenzyme consists of a core catalytic subunit along with variable scaffolding and regulatory subunits. Within STRIPAK, striatin family members act as PP2A regulatory subunits. STRIPAK also contains all three members of a subfamily of Sterile 20 kinases called the GCKIII proteins (MST4, STK24, and STK25). Here, we report that striatins and CCM3 bridge the phosphatase and kinase components of STRIPAK and map the interacting regions on each protein. We show that striatins and CCM3 regulate the Golgi localization of MST4 in an opposite manner. Consistent with a previously described function for MST4 and CCM3 in Golgi positioning, depletion of CCM3 or striatins affects Golgi polarization, also in an opposite manner. We propose that STRIPAK regulates the balance between MST4 localization at the Golgi and in the cytosol to control Golgi positioning.	[Kean, Michelle J.; Ceccarelli, Derek F.; Goudreault, Marilyn; Sanches, Mario; Larsen, Brett; Pelletier, Laurence; Sicheri, Frank; Gingras, Anne-Claude] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Kean, Michelle J.; Derry, W. Brent; Scott, Ian C.; Pelletier, Laurence; Sicheri, Frank; Gingras, Anne-Claude] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Tate, Stephen] AB SCIEX, Concord, ON L4K 4V8, Canada; [Gibson, Lucien C. D.] Univ Glasgow, Inst Psychol & Neurosci, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Derry, W. Brent; Scott, Ian C.; Baillie, George S.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Glasgow; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Gingras, AC (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave,Rm 992, Toronto, ON M5G 1X5, Canada.	gingras@lunenfeld.ca	Derry, Brent/CAF-4503-2022; Pelletier, Laurence/F-8858-2013; Sicheri, Frank/F-8856-2013; Gingras, Anne-Claude/E-9982-2010; Gingras, Anne-Claude/ABA-8341-2020	Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Ceccarelli, Derek/0000-0002-2674-9234; Scott, Ian/0000-0001-6665-1410; tate, stephen/0000-0001-5508-0819; Derry, Brent/0000-0002-1977-8475	Canadian Institutes of Health Research [MOP-36399, MOP-84314]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grants MOP-36399 (to F. S.) and MOP-84314 (to A.-C. G.).	Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; Ceccarelli DF, 2011, J BIOL CHEM, V286, P25056, DOI 10.1074/jbc.M110.213777; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Dan I, 2002, J BIOL CHEM, V277, P5929, DOI 10.1074/jbc.M110882200; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Farhan H, 2011, J CELL SCI, V124, P171, DOI 10.1242/jcs.076455; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Gaillard S, 2006, TRAFFIC, V7, P74, DOI 10.1111/j.1600-0854.2005.00363.x; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Gonon EM, 2005, FEBS LETT, V579, P6169, DOI 10.1016/j.febslet.2005.09.090; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; Guzzo RM, 2004, BIOCHEM J, V381, P599, DOI 10.1042/BJ20031723; Helliwell SB, 1998, GENETICS, V148, P99; Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kemp HA, 2003, MOL CELL BIOL, V23, P1750, DOI 10.1128/MCB.23.5.1750-1763.2003; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Li X, 2009, J BIOL CHEM, V284, P16170, DOI 10.1074/jbc.M109.008078; Li XF, 2010, J BIOL CHEM, V285, P24099, DOI 10.1074/jbc.M110.128470; Liu GM, 2010, NAT BIOTECHNOL, V28, P1015, DOI 10.1038/nbt1010-1015; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Moreno CS, 2001, J BIOL CHEM, V276, P24253, DOI 10.1074/jbc.M102398200; Pelletier L, 2000, NAT CELL BIOL, V2, P840, DOI 10.1038/35041089; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Riant F, 2010, FEBS J, V277, P1070, DOI 10.1111/j.1742-4658.2009.07535.x; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Simonin AR, 2010, FUNGAL GENET BIOL, V47, P855, DOI 10.1016/j.fgb.2010.06.010; Skarra DV, 2011, PROTEOMICS, V11, P1508, DOI 10.1002/pmic.201000770; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Xiang QJ, 2002, GENETICS, V160, P169; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679	49	97	99	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25065	25075		10.1074/jbc.M110.214486	http://dx.doi.org/10.1074/jbc.M110.214486			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21561862	Green Published, hybrid			2022-12-25	WOS:000292547900055
J	Rybchyn, MS; Slater, M; Conigrave, AD; Mason, RS				Rybchyn, Mark S.; Slater, Michael; Conigrave, Arthur D.; Mason, Rebecca S.			An Akt-dependent Increase in Canonical Wnt Signaling and a Decrease in Sclerostin Protein Levels Are Involved in Strontium Ranelate-induced Osteogenic Effects in Human Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; BONE-FORMATION; BETA-CATENIN; KINASE-B; VERTEBRAL FRACTURE; IN-VITRO; RECEPTOR; CALCIUM; EXPRESSION; PROMOTES	Sclerostin is an important regulator of bone homeostasis and canonical Wnt signaling is a key regulator of osteogenesis. Strontium ranelate is a treatment for osteoporosis that has been shown to reduce fracture risk, in part, by increasing bone formation. Here we show that exposure of human osteoblasts in primary culture to strontium increased mineralization and decreased the expression of sclerostin, an osteocyte-specific secreted protein that acts as a negative regulator of bone formation by inhibiting canonical Wnt signaling. Strontium also activated, in an apparently separate process, an Akt-dependent signaling cascade via the calcium-sensing receptor that promoted the nuclear translocation of beta-catenin. We propose that two discrete pathways linked to canonical Wnt signaling contribute to strontium-induced osteogenic effects in osteoblasts.	[Rybchyn, Mark S.; Slater, Michael; Mason, Rebecca S.] Univ Sydney, Dept Physiol, Sydney, NSW 2006, Australia; [Rybchyn, Mark S.; Slater, Michael; Conigrave, Arthur D.; Mason, Rebecca S.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Conigrave, Arthur D.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Mason, RS (corresponding author), Univ Sydney, Dept Physiol, Anderson Stuart Bldg,F13, Sydney, NSW 2006, Australia.	rebeccam@physiol.usyd.edu.au	Mason, Rebecca/AHB-5478-2022	Mason, Rebecca/0000-0003-1534-9697; Rybchyn, Mark/0000-0002-4336-6227; Conigrave, Arthur/0000-0002-7232-3891	National Health and Medical Research Council of Australia [21124]; Servier, France	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Servier, France(Servier)	This work was supported by the National Health and Medical Research Council of Australia (Grant 21124 to A. D. C. and R. S. M.) and by Servier, France. The research project was funded by Servier, France, which markets strontium ranelate as an agent for the treatment of osteoporosis. The research proposal originated from the authors group. Servier had no input into the conduct of the research, analysis of data, or preparation of this manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Arlot ME, 2008, J BONE MINER RES, V23, P215, DOI 10.1359/JBMR.071012; Atkins GJ, 2009, OSTEOPOROSIS INT, V20, P653, DOI 10.1007/s00198-008-0728-6; Barve V, 2006, J MED CHEM, V49, P3800, DOI 10.1021/jm051068y; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Blake GM, 2005, J BONE MINER RES, V20, P1901, DOI 10.1359/JBMR.050810; Boivin G, 2010, OSTEOPOROSIS INT, V21, P667, DOI 10.1007/s00198-009-1005-z; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; BOWERS GN, 1986, CLIN CHEM, V32, P1437; Brennan TC, 2009, BRIT J PHARMACOL, V157, P1291, DOI 10.1111/j.1476-5381.2009.00305.x; Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Chattopadhyay N, 2007, BIOCHEM PHARMACOL, V74, P438, DOI 10.1016/j.bcp.2007.04.020; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Coulombe J, 2004, BIOCHEM BIOPH RES CO, V323, P1184, DOI 10.1016/j.bbrc.2004.08.209; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fromigue O, 2010, J BIOL CHEM, V285, P25251, DOI 10.1074/jbc.M110.110502; Grebenova D, 2003, J PHOTOCH PHOTOBIO B, V69, P71, DOI 10.1016/S1011-1344(02)00410-4; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kiel DP, 2007, BONE, V40, P587, DOI 10.1016/j.bone.2006.09.029; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kubota T, 2009, J BONE MINER METAB, V27, P265, DOI 10.1007/s00774-009-0064-8; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Lichtinghagen R, 2002, EUR UROL, V42, P398, DOI 10.1016/S0302-2838(02)00324-X; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Malluche H.H., 1986, ATLAS MINERALIZED BO, P10; Meunier PJ, 2009, OSTEOPOROSIS INT, V20, P1663, DOI 10.1007/s00198-008-0825-6; Meunier PJ, 2002, J CLIN ENDOCR METAB, V87, P2060, DOI 10.1210/jc.87.5.2060; Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436; Mukherjee A, 2010, MOL CELL BIOL, V30, P1018, DOI 10.1128/MCB.01401-09; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nemeth EF, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290015; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Reginster JY, 2009, BONE, V45, P1059, DOI 10.1016/j.bone.2009.08.004; Reginster JY, 2002, OSTEOPOROSIS INT, V13, P925, DOI 10.1007/s001980200129; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Shin SY, 2004, CANCER LETT, V212, P225, DOI 10.1016/j.canlet.2004.03.003; SLATER M, 1995, J ORTHOP RES, V13, P655, DOI 10.1002/jor.1100130504; SLATER M, 1994, AM J PHYSIOL-ENDOC M, V267, pE990, DOI 10.1152/ajpendo.1994.267.6.E990; SLATER M, 1994, J BONE MINER RES, V9, P161; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599	58	82	89	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23771	23779		10.1074/jbc.M111.251116	http://dx.doi.org/10.1074/jbc.M111.251116			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566129	Green Published, hybrid			2022-12-25	WOS:000292294900019
J	Watson, AA; Lebedev, AA; Hall, BA; Fenton-May, AE; Vagin, AA; Dejnirattisai, W; Felce, J; Mongkolsapaya, J; Palma, AS; Liu, Y; Feizi, T; Screaton, GR; Murshudov, GN; O'Callaghan, CA				Watson, Aleksandra A.; Lebedev, Andrey A.; Hall, Benjamin A.; Fenton-May, Angharad E.; Vagin, Alexei A.; Dejnirattisai, Wanwisa; Felce, James; Mongkolsapaya, Juthathip; Palma, Angelina S.; Liu, Yan; Feizi, Ten; Screaton, Gavin R.; Murshudov, Garib N.; O'Callaghan, Christopher A.			Structural Flexibility of the Macrophage Dengue Virus Receptor CLEC5A IMPLICATIONS FOR LIGAND BINDING AND SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOSACCHARIDE MICROARRAYS; CRYSTAL-STRUCTURE; LECTIN-LIKE; RECOGNITION; DOMAIN; CELLS; MDL-1; EXPRESSION; PROTEINS; TRANSDUCTION	The human C-type lectin-like molecule CLEC5A is a critical macrophage receptor for dengue virus. The binding of dengue virus to CLEC5A triggers signaling through the associated adapter molecule DAP12, stimulating proinflammatory cytokine release. We have crystallized an informative ensemble of CLEC5A structural conformers at 1.9-angstrom resolution and demonstrate how an on-off extension to a beta-sheet acts as a binary switch regulating the flexibility of the molecule. This structural information together with molecular dynamics simulations suggests a mechanism whereby extracellular events may be transmitted through the membrane and influence DAP12 signaling. We demonstrate that CLEC5A is homodimeric at the cell surface and binds to dengue virus serotypes 1-4. We used blotting experiments, surface analyses, glycan microarray, and docking studies to investigate the ligand binding potential of CLEC5A with particular respect to dengue virus. This study provides a rational foundation for understanding the dengue virus-macrophage interaction and the role of CLEC5A in dengue virus-induced lethal disease.	[O'Callaghan, Christopher A.] Univ Oxford, Oxford OX3 7BN, England; [Lebedev, Andrey A.; Vagin, Alexei A.; Murshudov, Garib N.] Univ York, Struct Biol Lab, Dept Chem, York YO10 5YW, N Yorkshire, England; [Hall, Benjamin A.] Univ Oxford, Struct Bioinformat & Computat Biochem Unit, Dept Biochem, Oxford OX1 3QU, England; [Dejnirattisai, Wanwisa; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Med, London W12 0NN, England; [Mongkolsapaya, Juthathip] Mahidol Univ, Fac Med, Bangkok 10700, Thailand; [Palma, Angelina S.; Liu, Yan; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Glycosci Lab, Dept Med, London HA1 3UJ, England; [Palma, Angelina S.] Univ Nova Lisboa, Rede Quim & Tecnol REQUIMTE, Dept Chem, Fac Sci & Technol, P-2829516 Caparica, Portugal; [Felce, James] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DU, England	University of Oxford; University of York - UK; University of Oxford; Imperial College London; Mahidol University; Imperial College London; Universidade Nova de Lisboa; University of Oxford	O'Callaghan, CA (corresponding author), Univ Oxford, Henry Wellcome Bldg Mol Physiol,Roosevelt Dr, Oxford OX3 7BN, England.	chris.ocallaghan@ndm.ox.ac.uk	Hall, Ben/AAA-4981-2020; Palma, Angelina S/D-2052-2013; Liu, Yan/D-9117-2013	Hall, Ben/0000-0003-0355-2946; Palma, Angelina S/0000-0001-5797-6555; Fenton-May, Angharad/0000-0002-6267-1315; Liu, Yan/0000-0002-2566-6867; Feizi, Ten/0000-0001-6495-0329; Screaton, Gavin/0000-0002-3549-4309; Felce, James/0000-0001-5531-9244	UK Medical Research Council, National Institute for Health; UK Research Council [GR/S79268]; Engineering and Physical Research Council [EP/G037604/1]; Portuguese Foundation for Science and Technology; National Institutes of Health [GM62116]; NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F001134/1] Funding Source: researchfish; British Heart Foundation [PG/11/4/28645] Funding Source: researchfish; Engineering and Physical Sciences Research Council [GR/S79268/02, EP/G037604/1] Funding Source: researchfish; Medical Research Council [G116/165, G0400720, G0801508] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10303] Funding Source: researchfish; BBSRC [BB/F001134/1] Funding Source: UKRI; EPSRC [EP/G037604/1] Funding Source: UKRI; MRC [G0801508, G116/165, G0400720] Funding Source: UKRI	UK Medical Research Council, National Institute for Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Research Council; Engineering and Physical Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council, National Institute for Health Research Oxford Comprehensive Biomedical Research Centre Program, UK Research Councils Basic Technology Grant GR/S79268 ("Glycoarrays"), Engineering and Physical Research Councils Translational Grant EP/G037604/1, and the Portuguese Foundation for Science and Technology.; We thank Mark Ellis at the Synchrotron Radiation Source, Daresbury, UK and Keith Morris, Paul Young, Aleksandra Flanagan, Jon Grimes, Geoff Sutton, and Mark Sansom for useful conversations. We acknowledge colleagues in the Glycosciences Laboratory: Wengang Chai, Yibing Zhang, Maria Campanero-Rhodes, and Robert Childs for help with microarrays. We acknowledge The Protein-Glycan Interaction Core (H) of The Consortium for Functional Glycomics (funded by National Institutes of Health Grant GM62116 from the NIGMS) for the glycan array analysis.	Aoki N, 2009, J LEUKOCYTE BIOL, V85, P508, DOI 10.1189/jlb.0508329; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Barrett CP, 2004, ACTA CRYSTALLOGR D, V60, P2280, DOI 10.1107/S0907444904019171; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BLOK J, 1985, J GEN VIROL, V66, P1323, DOI 10.1099/0022-1317-66-6-1323; Brown J, 2007, PROTEIN SCI, V16, P1042, DOI 10.1110/ps.072791207; Call ME, 2010, NAT IMMUNOL, V11, P1023, DOI 10.1038/ni.1943; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Dimasi N, 2004, IMMUNOL RES, V30, P95, DOI 10.1385/IR:30:1:095; DRICKAMER K, 1989, BIOCHEM SOC T, V17, P13, DOI 10.1042/bst0170013; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falke JJ, 2009, STRUCTURE, V17, P1149, DOI 10.1016/j.str.2009.08.005; Feizi T, 2004, NAT REV MOL CELL BIO, V5, P582, DOI 10.1038/nrm1428; Feng JW, 2006, PLOS BIOL, V4, P768, DOI 10.1371/journal.pbio.0040142; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Gingras MC, 2002, MOL IMMUNOL, V38, P817, DOI 10.1016/S0161-5890(02)00004-4; Hacker K, 2009, J GEN VIROL, V90, P2097, DOI 10.1099/vir.0.012120-0; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inui M, 2009, P NATL ACAD SCI USA, V106, P4816, DOI 10.1073/pnas.0900463106; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07; Moore JO, 2009, STRUCTURE, V17, P1195, DOI 10.1016/j.str.2009.07.015; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; O'Callaghan CA, 2001, IMMUNITY, V15, P201, DOI 10.1016/S1074-7613(01)00187-X; Ohki I, 2005, STRUCTURE, V13, P905, DOI 10.1016/j.str.2005.03.016; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; PERUTZ M, 1994, PROTEIN SCI, V3, P1629, DOI 10.1002/pro.5560031002; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Psachoulia E, 2008, BIOCHEMISTRY-US, V47, P10503, DOI 10.1021/bi800678t; Radaev S, 2001, IMMUNITY, V15, P1039, DOI 10.1016/S1074-7613(01)00241-2; Sullivan LC, 2007, IMMUNITY, V27, P900, DOI 10.1016/j.immuni.2007.10.013; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Tomiya N, 2004, GLYCOCONJUGATE J, V21, P343, DOI 10.1023/B:GLYC.0000046275.28315.87; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Watson AA, 2005, ACTA CRYSTALLOGR F, V61, P1094, DOI 10.1107/S1744309105037991; Watson AA, 2007, J BIOL CHEM, V282, P3165, DOI 10.1074/jbc.M610383200; Watson AA, 2010, ACTA CRYSTALLOGR F, V66, P29, DOI 10.1107/S1744309109047915; Watson AA, 2009, BIOCHEMISTRY-US, V48, P10988, DOI 10.1021/bi901427d; *WHO, 2009, 117 WHO; Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927; Yim D, 2001, CELL IMMUNOL, V209, P42, DOI 10.1006/cimm.2001.1782; Zelensky AN, 2003, PROTEINS, V52, P466, DOI 10.1002/prot.10626	53	36	39	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24208	24218		10.1074/jbc.M111.226142	http://dx.doi.org/10.1074/jbc.M111.226142			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566123	Green Published, hybrid			2022-12-25	WOS:000292294900063
J	Bishop, DVM; Anderson, M; Reid, C; Fox, AM				Bishop, Dorothy V. M.; Anderson, Mike; Reid, Corinne; Fox, Allison M.			Auditory Development between 7 and 11 Years: An Event-Related Potential (ERP) Study	PLOS ONE			English	Article							SYSTEM ACTIVITY; EVOKED POTENTIALS; THETA RESPONSE; MATURATION; COMPONENT; CHILDHOOD; ARTIFACTS; DYNAMICS; SPEECH; AGE	Background: There is considerable uncertainty about the time-course of central auditory maturation. On some indices, children appear to have adult-like competence by school age, whereas for other measures development follows a protracted course. Methodology: We studied auditory development using auditory event-related potentials (ERPs) elicited by tones in 105 children on two occasions two years apart. Just over half of the children were 7 years initially and 9 years at follow-up, whereas the remainder were 9 years initially and 11 years at follow-up. We used conventional analysis of peaks in the auditory ERP, independent component analysis, and time-frequency analysis. Principal Findings: We demonstrated maturational changes in the auditory ERP between 7 and 11 years, both using conventional peak measurements, and time-frequency analysis. The developmental trajectory was different for temporal vs. fronto-central electrode sites. Temporal electrode sites showed strong lateralisation of responses and no increase of low-frequency phase-resetting with age, whereas responses recorded from fronto-central electrode sites were not lateralised and showed progressive change with age. Fronto-central vs. temporal electrode sites also mapped onto independent components with differently oriented dipole sources in auditory cortex. A global measure of waveform shape proved to be the most effective method for distinguishing age bands. Conclusions/Significance: The results supported the idea that different cortical regions mature at different rates. The ICC measure is proposed as the best measure of 'auditory ERP age'.	[Bishop, Dorothy V. M.; Anderson, Mike; Fox, Allison M.] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia; [Reid, Corinne] Murdoch Univ, Sch Psychol, Perth, WA, Australia; [Bishop, Dorothy V. M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Anderson, Mike; Reid, Corinne; Fox, Allison M.] Univ Western Australia, Neurocognit Dev Unit, Perth, WA 6009, Australia	University of Western Australia; Murdoch University; University of Oxford; University of Western Australia	Bishop, DVM (corresponding author), Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia.	dorothy.bishop@psy.ox.ac.uk	Fox, Allison M/H-9218-2014	Fox, Allison M/0000-0001-5189-6271; reid, corinne/0000-0001-5252-041X; Bishop, Dorothy/0000-0002-2448-4033	Australian Research Council [DP0665616]; School of Psychology, University of Western Australia; Wellcome Trust [053335]	Australian Research Council(Australian Research Council); School of Psychology, University of Western Australia; Wellcome Trust(Wellcome TrustEuropean Commission)	Funding support was provided by the Australian Research Council DP0665616 (http://www.arc.gov.au/) and the School of Psychology, University of Western Australia. DB is supported by a Principal Research Fellowship affiliated with Wellcome Trust Programme Grant 053335 (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht R, 2000, CLIN NEUROPHYSIOL, V111, P2268, DOI 10.1016/S1388-2457(00)00464-8; Bishop DVM, 2007, DEVELOPMENTAL SCI, V10, P565, DOI 10.1111/j.1467-7687.2007.00619.x; BISHOP DV, 2010, DEVELOPMENTAL SCI, DOI DOI 10.1111/J.1467-7687.2010.00990.X; Bruneau N, 1997, PSYCHOPHYSIOLOGY, V34, P32, DOI 10.1111/j.1469-8986.1997.tb02413.x; Bruneau N., 1998, NEUROIMAGING CHILD N, P113, DOI 10.1007/978-3-642-95848-9_10; Burkard RF., 2007, AUDITORY EVOKED POTE; Ceponiene R, 1998, EVOKED POTENTIAL, V108, P345, DOI 10.1016/S0168-5597(97)00081-6; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Devous MD, 2006, J SPEECH LANG HEAR R, V49, P856, DOI 10.1044/1092-4388(2006/061); Fox AM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-49; Gomes H, 2001, DEV BRAIN RES, V129, P147, DOI 10.1016/S0165-3806(01)00196-1; Holmes AE, 2004, EAR HEARING, V25, P397, DOI 10.1097/01.AUD.0000134553.60120.3A; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Kotecha R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004811; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Moore DR, 2010, PEDIATRICS, V126, pE382, DOI 10.1542/peds.2009-2826; MOORE DR, 2011, EAR HEARING, V32, P1; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Muller V, 2009, DEVELOPMENTAL SCI, V12, P839, DOI 10.1111/j.1467-7687.2009.00834.x; Ponton C, 2002, CLIN NEUROPHYSIOL, V113, P407, DOI 10.1016/S1388-2457(01)00733-7; Ponton CW, 2000, CLIN NEUROPHYSIOL, V111, P220, DOI 10.1016/S1388-2457(99)00236-9; Poulsen C, 2009, DEVELOPMENTAL SCI, V12, P220, DOI 10.1111/j.1467-7687.2008.00760.x; Scherg M, 1989, J Cogn Neurosci, V1, P336, DOI 10.1162/jocn.1989.1.4.336; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shahin AJ, 2010, J NEUROPHYSIOL, V103, P218, DOI 10.1152/jn.00402.2009; Sharma A, 1997, EVOKED POTENTIAL, V104, P540, DOI 10.1016/S0168-5597(97)00050-6; Talarico M, 2007, AUDIOL NEURO-OTOL, V12, P13, DOI 10.1159/000096153; Tonnquist-Uhlen I, 2003, CLIN NEUROPHYSIOL, V114, P685, DOI 10.1016/S1388-2457(03)00005-1; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; WOLPAW JR, 1977, ELECTROEN CLIN NEURO, V43, P99, DOI 10.1016/0013-4694(77)90200-0; WOLPAW JR, 1975, ELECTROEN CLIN NEURO, V39, P609, DOI 10.1016/0013-4694(75)90073-5; Yordanova J, 1998, J PSYCHOPHYSIOL, V12, P113; Yordanova J, 1997, EVOKED POTENTIAL, V104, P418, DOI 10.1016/S0168-5597(97)00054-3	34	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e18993	10.1371/journal.pone.0018993	http://dx.doi.org/10.1371/journal.pone.0018993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	761GX	21573058	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000290386800005
J	Flowers, MT; Paton, CM; O'Byrne, SM; Schiesser, K; Dawson, JA; Blaner, WS; Kendziorski, C; Ntambi, JM				Flowers, Matthew T.; Paton, Chad M.; O'Byrne, Sheila M.; Schiesser, Kevin; Dawson, John A.; Blaner, William S.; Kendziorski, Christina; Ntambi, James M.			Metabolic Changes in Skin Caused by Scd1 Deficiency: A Focus on Retinol Metabolism	PLOS ONE			English	Article							STEAROYL-COA DESATURASE; STRATUM-CORNEUM HYDRATION; TRANSEPIDERMAL WATER-LOSS; GENE-EXPRESSION; BARRIER FUNCTION; PROTECTS MICE; KERATINOCYTE PROLIFERATION; SEBACEOUS GLANDS; LIPID-METABOLISM; BINDING-PROTEIN	We previously reported that mice with skin-specific deletion of stearoyl-CoA desaturase-1 (Scd1) recapitulated the skin phenotype and hypermetabolism observed in mice with a whole-body deletion of Scd1. In this study, we first performed a diet-induced obesity experiment at thermoneutral temperature (33 degrees C) and found that skin-specific Scd1 knockout (SKO) mice still remain resistant to obesity. To elucidate the metabolic changes in the skin that contribute to the obesity resistance and skin phenotype, we performed microarray analysis of skin gene expression in male SKO and control mice fed a standard rodent diet. We identified an extraordinary number of differentially expressed genes that support the previously documented histological observations of sebaceous gland hypoplasia, inflammation and epidermal hyperplasia in SKO mice. Additionally, transcript levels were reduced in skin of SKO mice for genes involved in fatty acid synthesis, elongation and desaturation, which may be attributed to decreased abundance of key transcription factors including SREBP1c, ChREBP and LXR alpha. Conversely, genes involved in cholesterol synthesis were increased, suggesting an imbalance between skin fatty acid and cholesterol synthesis. Unexpectedly, we observed a robust elevation in skin retinol, retinoic acid and retinoic acid-induced genes in SKO mice. Furthermore, SEB-1 sebocytes treated with retinol and SCD inhibitor also display an elevation in retinoic acid-induced genes. These results highlight the importance of monounsaturated fatty acid synthesis for maintaining retinol homeostasis and point to disturbed retinol metabolism as a novel contributor to the Scd1 deficiency-induced skin phenotype.	[Flowers, Matthew T.; Paton, Chad M.; Schiesser, Kevin; Ntambi, James M.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Flowers, Matthew T.; Paton, Chad M.; Ntambi, James M.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Paton, Chad M.] W Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA; [O'Byrne, Sheila M.; Blaner, William S.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [O'Byrne, Sheila M.; Blaner, William S.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Dawson, John A.; Kendziorski, Christina] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; West Virginia University; Columbia University; Columbia University; University of Wisconsin System; University of Wisconsin Madison	Flowers, MT (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	mflowers@biochem.wisc.edu	Dawson, John/HDM-6702-2022		National Institutes of Health [R01DK062388, 667, R01DK079221]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062388, R01DK079221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01DK062388 (to J.M.N.), 667 and R01DK079221 to (W.S.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNER T, 1990, J INVEST DERMATOL, V95, P543, DOI 10.1111/1523-1747.ep12504896; Barua AB, 1998, MOL BIOTECHNOL, V10, P167, DOI 10.1007/BF02760863; Beaudoin GMJ, 2005, P NATL ACAD SCI USA, V102, P14653, DOI 10.1073/pnas.0507609102; Berry DC, 2007, PPAR RES, V2007, DOI 10.1155/2007/73256; Binczek E, 2007, BIOL CHEM, V388, P405, DOI 10.1515/BC.2007.046; BLANER WS, 1987, J BIOL CHEM, V262, P53; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; CHOUDHRY R, 1992, J ENDOCRINOL, V133, P467, DOI 10.1677/joe.0.1330467; Djalilian AR, 2006, J CLIN INVEST, V116, P1243, DOI 10.1172/JCI27186; Drake DR, 2008, J LIPID RES, V49, P4, DOI 10.1194/jlr.R700016-JLR200; ELIAS P M, 1987, Dermatologica (Basel), V175, P28; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; ELIAS PM, 1981, LAB INVEST, V44, P531; Everts HB, 2007, J INVEST DERMATOL, V127, P1593, DOI 10.1038/sj.jid.5700753; Feingold KR, 2009, J LIPID RES, V50, pS417, DOI 10.1194/jlr.R800039-JLR200; FEINGOLD KR, 1991, J INVEST DERMATOL, V96, P201, DOI 10.1111/1523-1747.ep12461153; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Flowers JB, 2007, DIABETES, V56, P1228, DOI 10.2337/db06-1142; Flowers MI, 2009, BBA-MOL CELL BIOL L, V1791, P85, DOI 10.1016/j.bbalip.2008.12.011; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Fluhr JW, 2003, J INVEST DERMATOL, V120, P728, DOI 10.1046/j.1523-1747.2003.12134.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goren I, 2006, J INVEST DERMATOL, V126, P477, DOI 10.1038/sj.jid.5700063; GRUBAUER G, 1987, J LIPID RES, V28, P746; Hellemans K, 2003, J LIPID RES, V44, P280, DOI 10.1194/jlr.M200376-JLR200; House JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009837; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jennemann R, 2007, J BIOL CHEM, V282, P3083, DOI 10.1074/jbc.M610304200; Johnson EN, 1999, J INVEST DERMATOL, V112, P861, DOI 10.1046/j.1523-1747.1999.00595.x; JUGERT FK, 1994, J INVEST DERMATOL, V102, P970, DOI 10.1111/1523-1747.ep12384210; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Kurlandsky SB, 1996, J BIOL CHEM, V271, P15346, DOI 10.1074/jbc.271.26.15346; Lee SH, 2004, J LIPID RES, V45, P1674, DOI 10.1194/jlr.M400039-JLR200; Ma TH, 2002, J BIOL CHEM, V277, P17147, DOI 10.1074/jbc.M200925200; Man M, 2009, EXP DERMATOL, V18, P962, DOI 10.1111/j.1600-0625.2009.00882.x; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Miyazaki M, 2009, BIOCHEM BIOPH RES CO, V380, P818, DOI 10.1016/j.bbrc.2009.01.183; Mizutani Y, 2009, BIOCHIMIE, V91, P784, DOI 10.1016/j.biochi.2009.04.001; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nelson AM, 2008, J CLIN INVEST, V118, P1468, DOI 10.1172/JCI33869; Nelson AM, 2006, J INVEST DERMATOL, V126, P2178, DOI 10.1038/sj.jid.5700289; Nelson AM, 2009, DERM-ENDOCRINOL, V1, P177, DOI 10.4161/derm.1.3.8258; Newton MA, 2004, BIOSTATISTICS, V5, P155, DOI 10.1093/biostatistics/5.2.155; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Ogawa K, 2005, J DERMATOL SCI, V40, P35, DOI 10.1016/j.jdermsci.2005.06.001; Oran A, 1997, BRIT J DERMATOL, V136, P519, DOI 10.1046/j.1365-2133.1997.6081584.x; Pares X, 2008, CELL MOL LIFE SCI, V65, P3936, DOI 10.1007/s00018-008-8591-3; R Development Core Team, 2005, R LANG ENV STAT COMP; Reichrath J, 2007, HORM METAB RES, V39, P71, DOI 10.1055/s-2007-958715; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943; Romanowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009701; Roos TC, 1998, PHARMACOL REV, V50, P315; Rowe JM, 2008, J INVEST DERMATOL, V128, P1866, DOI 10.1038/sj.jid.5701236; Sampath H, 2009, J BIOL CHEM, V284, P19961, DOI 10.1074/jbc.M109.014225; Schmuth M, 2008, J LIPID RES, V49, P499, DOI 10.1194/jlr.R800001-JLR200; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Schroder JM, 2006, CELL MOL LIFE SCI, V63, P469, DOI 10.1007/s00018-005-5364-0; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; SEIER AM, AM J PATHOL, V176, P246; SHAHIDULLAH M, 1969, BRIT J DERMATOL, V81, P722, DOI 10.1111/j.1365-2133.1969.tb15931.x; Shih MYS, 2009, J BIOL CHEM, V284, P4292, DOI 10.1074/jbc.M807503200; Skorija K, 2005, MOL ENDOCRINOL, V19, P855, DOI 10.1210/me.2004-0415; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sundberg JP, 2000, AM J PATHOL, V156, P2067, DOI 10.1016/S0002-9440(10)65078-X; Tamura K, 2009, CANCER RES, V69, P8133, DOI 10.1158/0008-5472.CAN-09-0775; Thompson Catherine C, 2009, Nucl Recept Signal, V7, pe010, DOI 10.1621/nrs.07010; Thorey IS, 2001, J BIOL CHEM, V276, P35818, DOI 10.1074/jbc.M104871200; Tsukada M, 2000, J INVEST DERMATOL, V115, P321, DOI 10.1046/j.1523-1747.2000.00066.x; Uchida Y, 2007, J BIOL CHEM, V282, P13211, DOI 10.1074/jbc.M611562200; Velasco P, 2009, J INVEST DERMATOL, V129, P2022, DOI 10.1038/jid.2008.447; WEI SH, 1995, J BIOL CHEM, V270, P866, DOI 10.1074/jbc.270.2.866; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Wu MH, 2009, AM J PATHOL, V175, P1041, DOI 10.2353/ajpath.2009.090241; Zheng Y, 1999, NAT GENET, V23, P268, DOI 10.1038/15446; Zheng Y, 2001, GENOMICS, V71, P182, DOI 10.1006/geno.2000.6429	87	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19734	10.1371/journal.pone.0019734	http://dx.doi.org/10.1371/journal.pone.0019734			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573029	Green Published, gold, Green Submitted			2022-12-25	WOS:000290386800035
J	Goerlich, KS; Witteman, J; Aleman, A; Martens, S				Goerlich, Katharina Sophia; Witteman, Jurriaan; Aleman, Andre; Martens, Sander			Hearing Feelings: Affective Categorization of Music and Speech in Alexithymia, an ERP Study	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; AUTOMATIC ACTIVATION; EMOTIONAL PROSODY; RECOGNITION; POTENTIALS; EXPRESSION; REACTIVITY; LANGUAGE; CONTEXT; CORTEX	Background: Alexithymia, a condition characterized by deficits in interpreting and regulating feelings, is a risk factor for a variety of psychiatric conditions. Little is known about how alexithymia influences the processing of emotions in music and speech. Appreciation of such emotional qualities in auditory material is fundamental to human experience and has profound consequences for functioning in daily life. We investigated the neural signature of such emotional processing in alexithymia by means of event-related potentials. Methodology: Affective music and speech prosody were presented as targets following affectively congruent or incongruent visual word primes in two conditions. In two further conditions, affective music and speech prosody served as primes and visually presented words with affective connotations were presented as targets. Thirty-two participants (16 male) judged the affective valence of the targets. We tested the influence of alexithymia on cross-modal affective priming and on N400 amplitudes, indicative of individual sensitivity to an affective mismatch between words, prosody, and music. Our results indicate that the affective priming effect for prosody targets tended to be reduced with increasing scores on alexithymia, while no behavioral differences were observed for music and word targets. At the electrophysiological level, alexithymia was associated with significantly smaller N400 amplitudes in response to affectively incongruent music and speech targets, but not to incongruent word targets. Conclusions: Our results suggest a reduced sensitivity for the emotional qualities of speech and music in alexithymia during affective categorization. This deficit becomes evident primarily in situations in which a verbalization of emotional information is required.	[Goerlich, Katharina Sophia; Aleman, Andre; Martens, Sander] Univ Groningen, Neuroimaging Ctr, Univ Med Ctr Groningen, Groningen, Netherlands; [Witteman, Jurriaan] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Witteman, Jurriaan] Leiden Univ, Ctr Linguist, Leiden, Netherlands	University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Goerlich, KS (corresponding author), Univ Groningen, Neuroimaging Ctr, Univ Med Ctr Groningen, Groningen, Netherlands.	K.Goerlich@med.umcg.nl	Aleman, Andre/E-1341-2012; Goerlich, Katharina S./J-6040-2016	Witteman, Jurriaan/0000-0003-3990-7569; Martens, Sander/0000-0001-8237-7984	European Science Foundation [044035001]	European Science Foundation(European Science Foundation (ESF)European Commission)	KG and AA were supported by a European Science Foundation EURYI grant (N.W.O. no. 044035001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftanas L, 2004, INT J NEUROSCI, V114, P1443, DOI 10.1080/00207450490509230; Altenmuller E, 2002, NEUROPSYCHOLOGIA, V40, P2242, DOI 10.1016/S0028-3932(02)00107-0; Bagby RM, 2009, PERS INDIV DIFFER, V47, P413, DOI 10.1016/j.paid.2009.04.012; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Berthoz S, 2002, AM J PSYCHIAT, V159, P961, DOI 10.1176/appi.ajp.159.6.961; BERTHOZ S, 2005, EUROPEAN J PSYCHIAT, V20, P281; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; Boersma Paul, 1996, 132 I PHON SCI U AMS; Bostanov V, 2004, PSYCHOPHYSIOLOGY, V41, P259, DOI 10.1111/j.1469-8986.2003.00142.x; Chen J, 2008, NEUROSCI LETT, V445, P135, DOI 10.1016/j.neulet.2008.08.061; Daltrozzo J, 2009, J COGNITIVE NEUROSCI, V21, P1882, DOI 10.1162/jocn.2009.21113; Duan XJ, 2010, NEUROIMAGE, V52, P401, DOI 10.1016/j.neuroimage.2010.04.021; Fazio RH, 2001, COGNITION EMOTION, V15, P115, DOI 10.1080/02699930125908; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Flores-Gutierrez EO, 2009, INT J PSYCHOPHYSIOL, V71, P43, DOI 10.1016/j.ijpsycho.2008.07.007; Franz M, 2004, AM J PSYCHIAT, V161, P728, DOI 10.1176/appi.ajp.161.4.728; Gundel H, 2004, J PSYCHOSOM RES, V56, P699, DOI 10.1016/S0022-3999(03)00124-7; Heaton P, 2009, ANN NY ACAD SCI, V1169, P318, DOI 10.1111/j.1749-6632.2009.04583.x; Hermans D, 2001, COGNITION EMOTION, V15, P143, DOI 10.1080/0269993004200033; Hill E, 2004, J AUTISM DEV DISORD, V34, P229, DOI 10.1023/B:JADD.0000022613.41399.14; Ilie G, 2006, MUSIC PERCEPT, V23, P319, DOI 10.1525/mp.2006.23.4.319; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Klauer KC, 1997, J EXP PSYCHOL LEARN, V23, P246, DOI 10.1037/0278-7393.23.1.246; Klauer KC, 2003, PSYCHOLOGY OF EVALUATION, P7; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Kooiman CG, 2002, J PSYCHOSOM RES, V53, P1083, DOI 10.1016/S0022-3999(02)00348-3; Kotz SA, 2007, BRAIN RES, V1151, P107, DOI 10.1016/j.brainres.2007.03.015; Kugel H, 2008, NEUROSCI LETT, V435, P40, DOI 10.1016/j.neulet.2008.02.005; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Larsen JK, 2003, J PSYCHOSOM RES, V54, P533, DOI 10.1016/S0022-3999(02)00466-X; Logeswaran N, 2009, NEUROSCI LETT, V455, P129, DOI 10.1016/j.neulet.2009.03.044; Luminet O, 2006, J RES PERS, V40, P713, DOI 10.1016/j.jrp.2005.09.001; Lumley MA, 2007, J PERS ASSESS, V89, P230, DOI 10.1080/00223890701629698; Mantani T, 2005, BIOL PSYCHIAT, V57, P982, DOI 10.1016/j.biopsych.2005.01.047; MARIN MM, 2010, MUSIC ED, V1, P38; Meriau K, 2006, NEUROIMAGE, V33, P1016, DOI 10.1016/j.neuroimage.2006.07.031; Nater UM, 2006, INT J PSYCHOPHYSIOL, V62, P300, DOI 10.1016/j.ijpsycho.2006.05.011; Nemiah J.C., 1976, MODERN TRENDS PSYCHO, P430, DOI DOI 10.1016/J.IJNURSTU.2009.03.014; Pollatos O, 2008, PSYCHOPHYSIOLOGY, V45, P839, DOI 10.1111/j.1469-8986.2008.00674.x; Pouga L, 2010, HUM BRAIN MAPP, V31, P1469, DOI 10.1002/hbm.20953; PRKACHIN GC, 2008, PERSONALITY INDIVIDU, V46, P412; Reker M, 2010, CORTEX, V46, P658, DOI 10.1016/j.cortex.2009.05.008; Schirmer A, 2005, COGNITIVE BRAIN RES, V24, P442, DOI 10.1016/j.cogbrainres.2005.02.022; Schirmer A, 2002, COGNITIVE BRAIN RES, V14, P228, DOI 10.1016/S0926-6410(02)00108-8; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Schneider W., 2002, E PRIME VERSION 20 C; Sollberger B, 2003, MUSIC PERCEPT, V20, P263, DOI 10.1525/mp.2003.20.3.263; Steinbeis N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002226; Steinbeis N, 2011, J COGNITIVE NEUROSCI, V23, P604, DOI 10.1162/jocn.2009.21383; Suslow T, 1998, EUR J PERSONALITY, V12, P433, DOI 10.1002/(SICI)1099-0984(199811/12)12:6<433::AID-PER320>3.0.CO;2-O; Suslow T, 2002, PERS INDIV DIFFER, V32, P541, DOI 10.1016/S0191-8869(01)00056-3; Suslow T, 2001, CAH PSYCHOL COGN, V20, P297; Swart M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005751; Taylor G.J., 1997, DISORDERS AFFECT REG; Taylor GJ, 2000, CAN J PSYCHIAT, V45, P134, DOI 10.1177/070674370004500203; Vermeulen N, 2006, COGNITION EMOTION, V20, P64, DOI 10.1080/02699930500304654; Vermeulen N, 2010, EUR J PERSONALITY, V24, P551, DOI 10.1002/per.758; Vorst HCM, 2001, PERS INDIV DIFFER, V30, P413, DOI 10.1016/S0191-8869(00)00033-7; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	61	38	42	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19501	10.1371/journal.pone.0019501	http://dx.doi.org/10.1371/journal.pone.0019501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	761GX	21573026	Green Published, Green Submitted, gold			2022-12-25	WOS:000290386800017
J	Fernandez-Brando, RJ; Bentancor, LV; Mejias, MP; Ramos, MV; Exeni, A; Exeni, C; Laso, MD; Exeni, R; Isturiz, MA; Palermo, MS				Fernandez-Brando, Romina J.; Bentancor, Leticia V.; Pilar Mejias, Maria; Victoria Ramos, Maria; Exeni, Andrea; Exeni, Claudia; del Carmen Laso, Maria; Exeni, Ramon; Isturiz, Martin A.; Palermo, Marina S.			Antibody Response to Shiga Toxins in Argentinean Children with Enteropathic Hemolytic Uremic Syndrome at Acute and Long-Term Follow-Up Periods	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; LINKED IMMUNOSORBENT ASSAYS; PROTECT MICE; RISK FACTOR; INFECTION; VEROCYTOTOXIN; DIARRHEA; STX2; LIPOPOLYSACCHARIDE; TRANSMISSION	Shiga toxin (Stx)-producing Escherichia coli (STEC) infection is associated with a broad spectrum of clinical manifestations that include diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome (HUS). Systemic Stx toxemia is considered to be central to the genesis of HUS. Distinct methods have been used to evaluate anti-Stx response for immunodiagnostic or epidemiological analysis of HUS cases. The development of enzyme-linked immunosorbent assay (ELISA) and western blot (WB) assay to detect the presence of specific antibodies to Stx has introduced important advantages for serodiagnosis of HUS. However, application of these methods for seroepidemiological studies in Argentina has been limited. The aim of this work was to develop an ELISA to detect antibodies against the B subunit of Stx2, and a WB to evaluate antibodies against both subunits of Stx2 and Stx1, in order to analyze the pertinence and effectiveness of these techniques in the Argentinean population. We studied 72 normal healthy children (NHC) and 105 HUS patients of the urban pediatric population from the surrounding area of Buenos Aires city. Using the WB method we detected 67% of plasma from NHC reactive for Stx2, but only 8% for Stx1. These results are in agreement with the broad circulation of Stx2-expressing STEC in Argentina and the endemic behavior of HUS in this country. Moreover, the simultaneous evaluation by the two methods allowed us to differentiate acute HUS patients from NHC with a great specificity and accuracy, in order to confirm the HUS etiology when pathogenic bacteria were not isolated from stools.	[Fernandez-Brando, Romina J.; Bentancor, Leticia V.; Pilar Mejias, Maria; Victoria Ramos, Maria; Isturiz, Martin A.; Palermo, Marina S.] Acad Nacl Med Buenos Aires, Inst Invest Hematol, Div Inmunol, Buenos Aires, DF, Argentina; [Fernandez-Brando, Romina J.; Pilar Mejias, Maria; Isturiz, Martin A.; Palermo, Marina S.] Consejo Nacl Invest Cient & Tecn, Inst Leucemia Expt, RA-1033 Buenos Aires, DF, Argentina; [Exeni, Andrea] Hosp Austral, Serv Nefrol, Pilar, Buenos Aires, Argentina; [Exeni, Claudia; del Carmen Laso, Maria; Exeni, Ramon] Hosp Municipal Nino, Dept Nefrol, La Matanza, Buenos Aires, Argentina	Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Austral University; Hospital Universitario Austral	Fernandez-Brando, RJ (corresponding author), Acad Nacl Med Buenos Aires, Inst Invest Hematol, Div Inmunol, Buenos Aires, DF, Argentina.	mspalermo@hematologia.anm.edu.ar			Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PICT 06/591]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT)	This work was supported by PICT 06/591 from the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (to M. S. P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT TJ, 1991, CURR MICROBIOL, V23, P189, DOI 10.1007/BF02092278; BITZAN M, 1993, EPIDEMIOL INFECT, V110, P183, DOI 10.1017/S0950268800068102; BITZAN M, 1991, J PEDIATR-US, V119, P380, DOI 10.1016/S0022-3476(05)82049-9; Bitzan M, 2009, KIDNEY INT, V75, pS62, DOI 10.1038/ki.2008.624; CAPRIOLI A, 1992, J INFECT DIS, V166, P154, DOI 10.1093/infdis/166.1.154; Cornick NA, 2002, J INFECT DIS, V186, P57, DOI 10.1086/341295; Creydt VP, 2004, BRAZ J MED BIOL RES, V37, P799, DOI 10.1590/S0100-879X2004000600004; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; HEAD SC, 1988, LANCET, V2, P751; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Karmali MA, 2003, J INFECT DIS, V188, P1724, DOI 10.1086/379726; KARMALI MA, 1994, J CLIN MICROBIOL, V32, P1457, DOI 10.1128/JCM.32.6.1457-1463.1994; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Karmali MA, 2009, KIDNEY INT, V75, pS4, DOI 10.1038/ki.2008.608; Krautz-Peterson G, 2008, INFECT IMMUN, V76, P1931, DOI 10.1128/IAI.01282-07; Kulkarni H, 2002, COMP IMMUNOL MICROB, V25, P249, DOI 10.1016/S0147-9571(02)00011-5; Li YL, 2000, INFECT IMMUN, V68, P5090, DOI 10.1128/IAI.68.9.5090-5095.2000; LINDGREN SW, 1994, INFECT IMMUN, V62, P623, DOI 10.1128/IAI.62.2.623-631.1994; LOPEZ EL, 1989, J INFECT DIS, V160, P469, DOI 10.1093/infdis/160.3.469; Ludwig K, 2002, J CLIN MICROBIOL, V40, P1773, DOI 10.1128/JCM.40.5.1773-1782.2002; Ludwig K, 2002, J INFECT DIS, V186, P566, DOI 10.1086/341781; Ludwig K, 2001, J CLIN MICROBIOL, V39, P2272, DOI 10.1128/JCM.39.6.2272-2279.2001; Masana MO, 2010, J FOOD PROTECT, V73, P649, DOI 10.4315/0362-028X-73.4.649; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; Palermo MS, 2009, EXPERT REV ANTI-INFE, V7, P697, DOI [10.1586/eri.09.49, 10.1586/ERI.09.49]; Reymond D, 1997, J CLIN MICROBIOL, V35, P609, DOI 10.1128/JCM.35.3.609-613.1997; Rivas M, 2006, FOODBORNE PATHOG DIS, V3, P88, DOI 10.1089/fpd.2006.3.88; Rivas M, 2006, MEDICINA-BUENOS AIRE, V66, P27; ROWE PC, 1993, EPIDEMIOL INFECT, V110, P9, DOI 10.1017/S0950268800050627; ROWE PC, 1994, J PEDIATR-US, V124, P21, DOI 10.1016/S0022-3476(94)70249-7; Serna A, 2008, CURR OPIN GASTROEN, V24, P38, DOI 10.1097/MOG.0b013e3282f2dfb8; Sheoran AS, 2003, INFECT IMMUN, V71, P3125, DOI 10.1128/IAI.71.6.3125-3130.2003; Smith MJ, 2006, VACCINE, V24, P4122, DOI 10.1016/j.vaccine.2006.02.035; Tzipori S, 2004, CLIN MICROBIOL REV, V17, P926, DOI 10.1128/CMR.17.4.926-941.2004; Wen SX, 2006, VACCINE, V24, P1142, DOI 10.1016/j.vaccine.2005.08.094; Werber D, 2008, CLIN INFECT DIS, V46, P1189, DOI 10.1086/587670; YAMADA S, 1993, MICROBIOL IMMUNOL, V37, P111, DOI 10.1111/j.1348-0421.1993.tb03187.x; YAMADA S, 1994, J CLIN MICROBIOL, V32, P955, DOI 10.1128/JCM.32.4.955-959.1994	40	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19136	10.1371/journal.pone.0019136	http://dx.doi.org/10.1371/journal.pone.0019136			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559455	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700074
J	Kapadia, D; Sadikovic, A; Vanloubbeeck, Y; Brockstedt, D; Fong, L				Kapadia, Dilnawaz; Sadikovic, Aida; Vanloubbeeck, Yannick; Brockstedt, Dirk; Fong, Lawrence			Interplay between CD8 alpha(+) Dendritic Cells and Monocytes in Response to Listeria monocytogenes Infection Attenuates T Cell Responses	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; IN-VIVO; IMMUNE-RESPONSES; INTERFERON-PRODUCTION; MONOCLONAL-ANTIBODY; MICE DEFICIENT; NITRIC-OXIDE; IFN-GAMMA; ACTIVATION; RESISTANCE	During the course of a microbial infection, different antigen presenting cells (APCs) are exposed and contribute to the ensuing immune response. CD8 alpha(+) dendritic cells (DCs) are an important coordinator of early immune responses to the intracellular bacteria Listeria monocytogenes (Lm) and are crucial for CD8(+) T cell immunity. In this study, we examine the contribution of different primary APCs to inducing immune responses against Lm. We find that CD8 alpha(+) DCs are the most susceptible to infection while plasmacytoid DCs are not infected. Moreover, CD8 alpha(+) DCs are the only DC subset capable of priming an immune response to Lm in vitro and are also the only APC studied that do so when transferred into beta 2 microglobulin deficient mice which lack endogenous cross-presentation. Upon infection, CD11b(+) DCs primarily secrete low levels of TNF alpha while CD8 alpha(+) DCs secrete IL-12 p70. Infected monocytes secrete high levels of TNFa and IL-12p70, cytokines associated with activated inflammatory macrophages. Furthermore, co-culture of infected CD8 alpha(+) DCs and CD11b(+) DCs with monocytes enhances production of IL-12 p70 and TNF alpha. However, the presence of monocytes in DC/T cell co-cultures attenuates T cell priming against Lm-derived antigens in vitro and in vivo. This suppressive activity of spleen-derived monocytes is mediated in part by both TNF alpha and inducible nitric oxide synthase (iNOS). Thus these monocytes enhance IL-12 production to Lm infection, but concurrently abrogate DC-mediated T cell priming.	[Kapadia, Dilnawaz; Sadikovic, Aida; Vanloubbeeck, Yannick; Fong, Lawrence] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA; [Brockstedt, Dirk] Aduro Biotech, Berkeley, CA USA	University of California System; University of California San Francisco	Kapadia, D (corresponding author), Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA.	lfong@medicine.ucsf.edu			National Institutes of Health [CA R01 102303]; NATIONAL CANCER INSTITUTE [R01CA102303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health CA R01 102303. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dirk Brockstedt is an employee of Aduro Biotech and played a role in the design of the experiments and analysis.	Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Brockstedt DG, 2005, NAT MED, V11, P853, DOI 10.1038/nm1276; Brockstedt DG, 2004, P NATL ACAD SCI USA, V101, P13832, DOI 10.1073/pnas.0406035101; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Conlan JW, 1996, J MED MICROBIOL, V44, P295, DOI 10.1099/00222615-44-4-295; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; CZUPRYNSKI CJ, 1994, INFECT IMMUN, V62, P5161, DOI 10.1128/IAI.62.11.5161-5163.1994; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Humann J, 2010, J IMMUNOL, V184, P5172, DOI 10.4049/jimmunol.0903759; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jiang J, 2003, J IMMUNOL, V171, P4352, DOI 10.4049/jimmunol.171.8.4352; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Lu LN, 1996, J IMMUNOL, V157, P3577; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Merrick JC, 1997, AM J PATHOL, V151, P785; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Neuenhahn M, 2007, IMMUNOL LETT, V114, P66, DOI 10.1016/j.imlet.2007.09.007; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pron B, 2001, CELL MICROBIOL, V3, P331, DOI 10.1046/j.1462-5822.2001.00120.x; Ren GW, 2008, J IMMUNOL, V181, P3277, DOI 10.4049/jimmunol.181.5.3277; ROGERS HW, 1993, INFECT IMMUN, V61, P5090, DOI 10.1128/IAI.61.12.5090-5096.1993; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Steinman RM, 2007, EUR J IMMUNOL, V37, pS53, DOI 10.1002/eji.200737400; Tada Y, 2006, BRIT J DERMATOL, V154, P1180, DOI 10.1111/j.1365-2133.2006.07180.x; Tam MA, 2006, CELL MICROBIOL, V8, P1172, DOI 10.1111/j.1462-5822.2006.00700.x; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	49	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19376	10.1371/journal.pone.0019376	http://dx.doi.org/10.1371/journal.pone.0019376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559416	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700152
J	Petrini, K; Crabbe, F; Sheridan, C; Pollick, FE				Petrini, Karin; Crabbe, Frances; Sheridan, Carol; Pollick, Frank E.			The Music of Your Emotions: Neural Substrates Involved in Detection of Emotional Correspondence between Auditory and Visual Music Actions	PLOS ONE			English	Article							EVENT-RELATED FMRI; AUDIOVISUAL INTEGRATION; BRAIN-REGIONS; PICTURES; CHILDREN; SIGNALS; SPEECH; INSULA; CONNECTIVITY; ACTIVATION	In humans, emotions from music serve important communicative roles. Despite a growing interest in the neural basis of music perception, action and emotion, the majority of previous studies in this area have focused on the auditory aspects of music performances. Here we investigate how the brain processes the emotions elicited by audiovisual music performances. We used event-related functional magnetic resonance imaging, and in Experiment 1 we defined the areas responding to audiovisual (musician's movements with music), visual (musician's movements only), and auditory emotional (music only) displays. Subsequently a region of interest analysis was performed to examine if any of the areas detected in Experiment 1 showed greater activation for emotionally mismatching performances (combining the musician's movements with mismatching emotional sound) than for emotionally matching music performances (combining the musician's movements with matching emotional sound) as presented in Experiment 2 to the same participants. The insula and the left thalamus were found to respond consistently to visual, auditory and audiovisual emotional information and to have increased activation for emotionally mismatching displays in comparison with emotionally matching displays. In contrast, the right thalamus was found to respond to audiovisual emotional displays and to have similar activation for emotionally matching and mismatching displays. These results suggest that the insula and left thalamus have an active role in detecting emotional correspondence between auditory and visual information during music performances, whereas the right thalamus has a different role.	[Petrini, Karin; Crabbe, Frances; Sheridan, Carol; Pollick, Frank E.] Univ Glasgow, Dept Psychol, Glasgow, Lanark, Scotland	University of Glasgow	Petrini, K (corresponding author), Univ Glasgow, Dept Psychol, Glasgow, Lanark, Scotland.	karin@psy.gla.ac.uk	Pollick, Frank/F-3186-2011	Pollick, Frank/0000-0002-7212-4622; Petrini, Karin/0000-0001-5354-5600	Economic and Social Research Council (ESRC) [RES-060-25-0010]; ESRC [ES/E020933/1] Funding Source: UKRI; Economic and Social Research Council [ES/E020933/1] Funding Source: researchfish	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	K.P. and F.E.P. are supported by a grant from the Economic and Social Research Council (ESRC) (RES-060-25-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Baumgartner T, 2006, BRAIN RES, V1075, P151, DOI 10.1016/j.brainres.2005.12.065; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; CALVERT GA, 2004, HDB MULTISENSORY PRO, P483; Chapin H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013812; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Ethofer T, 2006, PROG BRAIN RES, V156, P345, DOI 10.1016/S0079-6123(06)56019-4; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Griffiths TD, 2004, J NEUROL NEUROSUR PS, V75, P344; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2005, NEUROIMAGE, V25, P1068, DOI 10.1016/j.neuroimage.2004.12.050; Koelsch S, 2010, TRENDS COGN SCI, V14, P131, DOI 10.1016/j.tics.2010.01.002; Komura Y, 2005, NAT NEUROSCI, V8, P1203, DOI 10.1038/nn1528; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Miller LM, 2005, J NEUROSCI, V25, P5884, DOI 10.1523/JNEUROSCI.0896-05.2005; MUFSON EJ, 1984, J COMP NEUROL, V227, P109, DOI 10.1002/cne.902270112; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Naghavi HR, 2007, NEUROSCI LETT, V422, P77, DOI 10.1016/j.neulet.2007.06.009; Petrini K, 2010, BRAIN RES, V1323, P139, DOI 10.1016/j.brainres.2010.02.012; Saito DN, 2005, CEREB CORTEX, V15, P1750, DOI 10.1093/cercor/bhi052; Stewart L, 2006, BRAIN, V129, P2533, DOI 10.1093/brain/awl171; Vines BW, 2006, COGNITION, V101, P80, DOI 10.1016/j.cognition.2005.09.003; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2	34	24	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19165	10.1371/journal.pone.0019165	http://dx.doi.org/10.1371/journal.pone.0019165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756OZ	21559468	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000290024700087
J	Zhang, LM; Yan, JQ; Xu, YQ; Long, L; Zhu, CS; Chen, XH; Jiang, Y; Yang, LJ; Bian, LF; Wang, Q				Zhang, Limin; Yan, Junqiang; Xu, Yunqi; Long, Ling; Zhu, Cansheng; Chen, Xiaohong; Jiang, Ying; Yang, Lijuan; Bian, Lianfang; Wang, Qing			The Combination of Homocysteine and C-Reactive Protein Predicts the Outcomes of Chinese Patients with Parkinson's Disease and Vascular Parkinsonism	PLOS ONE			English	Article							LEVODOPA-TREATED PATIENTS; PLASMA HOMOCYSTEINE; NONMOTOR SYMPTOMS; ASSOCIATION; RISK; DEMENTIA; LEVEL; MOTOR	Background: The elevation of plasma homocysteine (Hcy) and C-reactive protein (CRP) has been correlated to an increased risk of Parkinson's disease (PD) or vascular diseases. The association and clinical relevance of a combined assessment of Hcy and CRP levels in patients with PD and vascular parkinsonism (VP) are unknown. Methodology/Principal Findings: We performed a cross-sectional study of 88 Chinese patients with PD and VP using a clinical interview and the measurement of plasma Hcy and CRP to determine if Hcy and CRP levels in patients may predict the outcomes of the motor status, non-motor symptoms (NMS), disease severity, and cognitive declines. Each patient's NMS, cognitive deficit, disease severity, and motor status were assessed by the Nonmotor Symptoms Scale (NMSS), Mini-Mental State Examination (MMSE), the modified Hoehn and Yahr staging scale (H&Y), and the unified Parkinson's disease rating scale part III (UPDRS III), respectively. We found that 100% of patients with PD and VP presented with NMS. The UPDRS III significantly correlated with CRP (P = 0.011) and NMSS (P = 0.042) in PD patients. The H&Y was also correlated with Hcy (P = 0.002), CRP (P = 0.000), and NMSS (P = 0.023) in PD patients. In VP patients, the UPDRS III and H&Y were not significantly associated with NMSS, Hcy, CRP, or MMSE. Strong correlations were observed between Hcy and NMSS as well as between CRP and NMSS in PD and VP. Conclusions/Significance: Our findings support the hypothesis that Hcy and CRP play important roles in the pathogenesis of PD. The combination of Hcy and CRP may be used to assess the progression of PD and VP. Whether or not anti-inflammatory medication could be used in the management of PD and VP will produce an interesting topic for further research.	[Zhang, Limin; Yan, Junqiang; Xu, Yunqi; Long, Ling; Zhu, Cansheng; Chen, Xiaohong; Jiang, Ying; Yang, Lijuan; Bian, Lianfang; Wang, Qing] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, LM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	denniswq@yahoo.com		Wang, Qing/0000-0002-3882-6540	Third Affiliated Hospital of Sun Yat-Sen University; Fundamental Research Funds for the Central Universities [A77, 10ykzd08]; Program for New Century Excellent Talents in University, P.R. China [NCET2010]	Third Affiliated Hospital of Sun Yat-Sen University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University, P.R. China(Program for New Century Excellent Talents in University (NCET))	This work was supported by a Grant-In-Aid from the Third Affiliated Hospital of Sun Yat-Sen University and the Fundamental Research Funds for the Central Universities (Grant No. A77 and 10ykzd08), and the Program for New Century Excellent Talents in University (NCET2010, P.R. China) to Q. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone P, 2008, MOVEMENT DISORD, V23, P1532, DOI 10.1002/mds.21997; Benamer HTS, 2009, EUR NEUROL, V61, P11, DOI 10.1159/000165343; Camicioli RM, 2009, MOVEMENT DISORD, V24, P176, DOI 10.1002/mds.22227; Chaudhuri KR, 2007, MOVEMENT DISORD, V22, P1901, DOI 10.1002/mds.21596; Chen H, 2008, AM J EPIDEMIOL, V167, P90, DOI 10.1093/aje/kwm260; Critchley M, 1929, BRAIN, V52, P23, DOI 10.1093/brain/52.1.23; Dufek M, 2009, PARKINSONISM RELAT D, V15, P318, DOI 10.1016/j.parkreldis.2008.05.014; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ichihara Y, 2002, CIRC J, V66, P677, DOI 10.1253/circj.66.677; Kalra S, 2010, MOVEMENT DISORD, V25, P149, DOI 10.1002/mds.22937; Kjaergaard AD, 2010, ANN NEUROL, V68, P672, DOI 10.1002/ana.22220; Klepac N, 2010, PARKINSONISM RELAT D, V16, P21, DOI 10.1016/j.parkreldis.2009.07.003; Lamberti P, 2005, EUR J NEUROL, V12, P365, DOI 10.1111/j.1468-1331.2004.00973.x; Lamberti P, 2005, MOVEMENT DISORD, V20, P69, DOI 10.1002/mds.20261; Li H, 2010, MOV DISORD IN PRESS; Louis ED, 2007, ARCH NEUROL-CHICAGO, V64, P1646, DOI 10.1001/archneur.64.11.1646; Muller T, 2009, MOVEMENT DISORD, V24, P1339, DOI 10.1002/mds.22607; Muller T, 2009, MOVEMENT DISORD, V24, P929, DOI 10.1002/mds.22482; O'Suilleabhain PE, 2004, ARCH NEUROL-CHICAGO, V61, P865, DOI 10.1001/archneur.61.6.865; Pfeiffer RF, 2009, NAT REV NEUROL, V5, P531, DOI 10.1038/nrneurol.2009.156; Prins ND, 2002, NEUROLOGY, V59, P1375, DOI 10.1212/01.WNL.0000032494.05619.93; Przedborski S, 2010, MOVEMENT DISORD, V25, pS55, DOI 10.1002/mds.22638; Rodriguez-Oroz MC, 2009, MOVEMENT DISORD, V24, P1437, DOI 10.1002/mds.22522; Rogers JD, 2003, ARCH NEUROL-CHICAGO, V60, P59, DOI 10.1001/archneur.60.1.59; Saiki M, 2010, J NEUROL NEUROSUR PS, V81, P890, DOI 10.1136/jnnp.2008.162883; Seet RCS, 2010, FREE RADICAL BIO MED, V48, P560, DOI 10.1016/j.freeradbiomed.2009.11.026; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Song IU, 2009, EUR NEUROL, V62, P99, DOI 10.1159/000222780; Song IU, 2010, NUEUOL SCI IN PRESS; Swinscow D, 1997, CORRELATION REGRESSI; Winikates J, 1999, ARCH NEUROL-CHICAGO, V56, P98, DOI 10.1001/archneur.56.1.98; Zijlmans J, 2007, MOVEMENT DISORD, V22, P1278, DOI 10.1002/mds.21479; Zijlmans JCM, 2004, J NEUROL NEUROSUR PS, V75, P545, DOI 10.1136/jnnp.2003.018309; Zijlmans JCM, 2004, MOVEMENT DISORD, V19, P630, DOI 10.1002/mds.20083; Zijlmans JCM, 1995, NEUROLOGY, V45, P2183, DOI 10.1212/WNL.45.12.2183; Zoccolella S, 2010, CURR MED CHEM, V17, P213, DOI 10.2174/092986710790149774; Zoccolella S, 2009, MOVEMENT DISORD, V24, P1028, DOI 10.1002/mds.22511	40	14	16	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19333	10.1371/journal.pone.0019333	http://dx.doi.org/10.1371/journal.pone.0019333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556377	Green Submitted, Green Published, gold			2022-12-25	WOS:000290019400050
J	Ceccarelli, DF; Laister, RC; Mulligan, VK; Kean, MJ; Goudreault, M; Scott, IC; Derry, WB; Chakrabartty, A; Gingras, AC; Sicheri, F				Ceccarelli, Derek F.; Laister, Rob C.; Mulligan, Vikram Khipple; Kean, Michelle J.; Goudreault, Marilyn; Scott, Ian C.; Derry, W. Brent; Chakrabartty, Avijit; Gingras, Anne-Claude; Sicheri, Frank			CCM3/PDCD10 Heterodimerizes with Germinal Center Kinase III (GCKIII) Proteins Using a Mechanism Analogous to CCM3 Homodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CAVERNOUS MALFORMATION; IN-FRAME DELETION; MUTATIONS; INSIGHTS; ACTIVATION; INTERACTS; PATHWAY; COMPLEX; PDCD10; PAK1	CCM3 mutations give rise to cerebral cavernous malformations (CCMs) of the vasculature through a mechanism that remains unclear. Interaction of CCM3 with the germinal center kinase III (GCKIII) subfamily of Sterile 20 protein kinases, MST4, STK24, and STK25, has been implicated in cardiovascular development in the zebrafish, raising the possibility that dysregulated GCKIII function may contribute to the etiology of CCM disease. Here, we show that the amino-terminal region of CCM3 is necessary and sufficient to bind directly to the C-terminal tail region of GCKIII proteins. This same region of CCM3 was shown previously to mediate homodimerization through the formation of an interdigitated alpha-helical domain. Sequence conservation and binding studies suggest that CCM3 may preferentially heterodimerize with GCKIII proteins through a manner structurally analogous to that employed for CCM3 homodimerization.	[Ceccarelli, Derek F.; Kean, Michelle J.; Goudreault, Marilyn; Gingras, Anne-Claude; Sicheri, Frank] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Laister, Rob C.] Ontario Canc Inst, Div Stem Cell & Dev Biol, Toronto, ON M5G 1L7, Canada; [Mulligan, Vikram Khipple; Chakrabartty, Avijit] Univ Toronto, Campbell Family Inst Canc Res, Ontario Canc Inst, Univ Hlth Network,Dept Biochem, Toronto, ON M5G 1L7, Canada; [Kean, Michelle J.; Scott, Ian C.; Derry, W. Brent; Gingras, Anne-Claude; Sicheri, Frank] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Scott, Ian C.; Derry, W. Brent] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Chakrabartty, Avijit] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Gingras, AC (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	gingras@lunenfeld.ca; sicheri@lunenfeld.ca	Derry, Brent/CAF-4503-2022; Sicheri, Frank/F-8856-2013; Gingras, Anne-Claude/E-9982-2010; Gingras, Anne-Claude/ABA-8341-2020	Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Derry, Brent/0000-0002-1977-8475; Mulligan, Vikram/0000-0001-6038-8922; Ceccarelli, Derek/0000-0002-2674-9234; Scott, Ian/0000-0001-6665-1410; Chakrabartty, Avi/0000-0001-7002-8381	Canadian Institutes of Health Research [MOP-36399, MOP-84314]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grants MOP-36399 (to F. S.) and MOP-84314 (to A.-C. G.).	Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Dibble CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011740; Ding JJ, 2010, BIOCHEM BIOPH RES CO, V399, P587, DOI 10.1016/j.bbrc.2010.07.119; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li XF, 2010, J BIOL CHEM, V285, P24099, DOI 10.1074/jbc.M110.128470; Louvi A, 2011, P NATL ACAD SCI USA, V108, P3737, DOI 10.1073/pnas.1012617108; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Revencu N, 2006, J MED GENET, V43, P716, DOI 10.1136/jmg.2006.041079; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Skarra DV, 2011, PROTEOMICS, V11, P1508, DOI 10.1002/pmic.201000770; Stahl S, 2008, HUM MUTAT, V29, P709, DOI 10.1002/humu.20712; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Voss K, 2009, HUM MUTAT, V30, P1003, DOI 10.1002/humu.20996; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679	25	50	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25056	25064		10.1074/jbc.M110.213777	http://dx.doi.org/10.1074/jbc.M110.213777			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21561863	hybrid, Green Published			2022-12-25	WOS:000292547900054
J	Fortini, BK; Pokharel, S; Polaczek, P; Balakrishnan, L; Bambara, RA; Campbell, JL				Fortini, Barbara K.; Pokharel, Subhash; Polaczek, Piotr; Balakrishnan, Lata; Bambara, Robert A.; Campbell, Judith L.			Characterization of the Endonuclease and ATP-dependent Flap Endo/Exonuclease of Dna2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OKAZAKI FRAGMENT MATURATION; REPLICATION-PROTEIN-A; END RESECTION MACHINERIES; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; ENZYMATIC-PROPERTIES; ESCHERICHIA-COLI; POLYMERASE ALPHA; XENOPUS DNA2; IN-VIVO	Two processes, DNA replication and DNA damage repair, are key to maintaining genomic fidelity. The Dna2 enzyme lies at the heart of both of these processes, acting in conjunction with flap endonuclease 1 and replication protein A in DNA lagging strand replication and with BLM/Sgs1 and MRN/X in double strand break repair. In vitro, Dna2 helicase and flap endo/exonuclease activities require an unblocked 5' single-stranded DNA end to unwind or cleave DNA. In this study we characterize a Dna2 nuclease activity that does not require, and in fact can create, 5' single-stranded DNA ends. Both endonuclease and flap endo/exonuclease are abolished by the Dna2-K677R mutation, implicating the same active site in catalysis. In addition, we define a novel ATP-dependent flap endo/exonuclease activity, which is observed only in the presence of Mn2+. The endonuclease is blocked by ATP and is thus experimentally distinguishable from the flap endo/exonuclease function. Thus, Dna2 activities resemble those of RecB and AddAB nucleases even more closely than previously appreciated. This work has important implications for understanding the mechanism of action of Dna2 in multiprotein complexes, where dissection of enzymatic activities and cofactor requirements of individual components contributing to orderly and precise execution of multistep replication/repair processes depends on detailed characterization of each individual activity.	[Balakrishnan, Lata; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Fortini, Barbara K.; Pokharel, Subhash; Polaczek, Piotr; Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; California Institute of Technology	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu; jcampbel@caltech.edu		Fortini, Barbara/0000-0003-3230-2604	National Institutes of Health [GM024441, GM078666]; Army Research Office [ARO 09-1-0041]; Ellison Foundation [AG-55-2143]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078666, R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; Ellison Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM024441 (to R. A. B.) and GM078666 (to J. L. C.). This work was also supported by Army Research Office Grant ARO 09-1-0041 and Ellison Foundation Grant AG-55-2143 (to J. L. C.).	ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Balakrishnan L, 2010, J BIOL CHEM, V285, P38861, DOI 10.1074/jbc.M110.165191; Budd ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004267; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007; Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08; Formosa T, 1999, GENETICS, V151, P1459; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Herdendorf TJ, 2011, J BIOL CHEM, V286, P2382, DOI 10.1074/jbc.M110.178871; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; KOOISTRA J, 1993, MOL MICROBIOL, V7, P915, DOI 10.1111/j.1365-2958.1993.tb01182.x; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200; Masuda-Sasa T, 2006, J BIOL CHEM, V281, P38555, DOI 10.1074/jbc.M604925200; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Niu HY, 2009, GENE DEV, V23, P1481, DOI 10.1101/gad.1824209; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pike JE, 2009, J BIOL CHEM, V284, P25170, DOI 10.1074/jbc.M109.023325; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Stewart JA, 2010, NUCLEIC ACIDS RES, V38, P920, DOI 10.1093/nar/gkp1055; Stewart JA, 2009, J BIOL CHEM, V284, P8283, DOI 10.1074/jbc.M809189200; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; Sun JZ, 2006, BIOCHEMISTRY-US, V45, P131, DOI 10.1021/bi051150v; Supek F, 1996, P NATL ACAD SCI USA, V93, P5105, DOI 10.1073/pnas.93.10.5105; Tsutsui Y, 2005, CURR GENET, V48, P34, DOI 10.1007/s00294-005-0584-2; Wawrousek KE, 2010, CELL CYCLE, V9, P1156, DOI 10.4161/cc.9.6.11049; Weitao T, 2003, J BIOL CHEM, V278, P22513, DOI 10.1074/jbc.M301610200; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	48	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23763	23770		10.1074/jbc.M111.243071	http://dx.doi.org/10.1074/jbc.M111.243071			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572043	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000292294900018
J	Li, PF; Ham, BK; Lucas, WJ				Li, Pingfang; Ham, Byung-Kook; Lucas, William J.			CmRBP50 Protein Phosphorylation Is Essential for Assembly of a Stable Phloem-mobile High-affinity Ribonucleoprotein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; LONG-DISTANCE TRANSPORT; TRACT BINDING-PROTEIN; YELLOW-MOSAIC-VIRUS; SIGNALING PATHWAY; 7SK SNRNA; IN-VIVO; PLANTS; MOVEMENT; LOCALIZATION	RNA-binding proteins (RBPs) form ribonucleoprotein (RNP) complexes that play crucial roles in RNA processing for gene regulation. The angiosperm sieve tube system contains a unique population of transcripts, some of which function as long-distance signaling agents involved in regulating organ development. These phloem-mobile mRNAs are translocated as RNP complexes. One such complex is based on a phloem RBP named Cucurbita maxima RNA-binding protein 50 (CmRBP50), a member of the polypyrimidine track binding protein family. The core of this RNP complex contains six additional phloem proteins. Here, requirements for assembly of this CmRBP50 RNP complex are reported. Phosphorylation sites on CmRBP50 were mapped, and then coimmunoprecipitation and protein overlay studies established that the phosphoserine residues, located at the C terminus of CmRBP50, are critical for RNP complex assembly. In vitro pull-down experiments revealed that three phloem proteins, C. maxima phloem protein 16, C. maxima GTP-binding protein, and C. maxima phosphoinositide-specific phospholipase-like protein, bind directly with CmRBP50. This interaction required CmRBP50 phosphorylation. Gel mobility-shift assays demonstrated that assembly of the CmRBP50-based protein complex results in a system having enhanced binding affinity for phloem-mobile mRNAs carrying polypyrimidine track binding motifs. This property would be essential for effective long-distance translocation of bound mRNA to the target tissues.	[Li, Pingfang; Ham, Byung-Kook; Lucas, William J.] Univ Calif Davis, Coll Biol Sci, Dept Plant Biol, Davis, CA 95616 USA; [Li, Pingfang] Zhejiang Univ, Dept Hort, Hangzhou 310029, Zhejiang, Peoples R China	University of California System; University of California Davis; Zhejiang University	Lucas, WJ (corresponding author), Univ Calif Davis, Coll Biol Sci, Dept Plant Biol, Davis, CA 95616 USA.	wjlucas@ucdavis.edu	Ham, Byung-Kook/AAU-7771-2020		National Science Foundation [IOS-0752997, IOS-0918433]; Chinese Scholarship Council	National Science Foundation(National Science Foundation (NSF)); Chinese Scholarship Council(China Scholarship Council)	This work was supported by National Science Foundation grants IOS-0752997 and IOS-0918433 (to W. J. L.). P. L. was supported in part by a graduate fellowship from the Chinese Scholarship Council.	Allemand E, 2007, NAT STRUCT MOL BIOL, V14, P630, DOI 10.1038/nsmb1257; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Aoki K, 2005, PLANT CELL, V17, P1801, DOI 10.1105/tpc.105.031419; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Auweter SD, 2008, CELL MOL LIFE SCI, V65, P516, DOI 10.1007/s00018-007-7378-2; Banerjee AK, 2006, PLANT CELL, V18, P3443, DOI 10.1105/tpc.106.042473; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Buhtz A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-64; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; Czudnochowski N, 2010, J MOL BIOL, V395, P28, DOI 10.1016/j.jmb.2009.10.055; D'Orso I, 2001, J BIOL CHEM, V276, P15783, DOI 10.1074/jbc.M010959200; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Gomez G, 2005, PLANT J, V41, P107, DOI 10.1111/j.1365-313X.2004.02278.x; Gomez G, 2004, J VIROL, V78, P10104, DOI 10.1128/JVI.78.18.10104-10110.2004; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Ham BK, 2009, PLANT CELL, V21, P197, DOI 10.1105/tpc.108.061317; Haywood V, 2005, PLANT J, V42, P49, DOI 10.1111/j.1365-313X.2005.02351.x; Hsu CH, 2004, J ALLERGY CLIN IMMUN, V113, P1079, DOI 10.1016/j.jaci.2004.02.047; Ishmael FT, 2011, J IMMUNOL, V186, P1189, DOI 10.4049/jimmunol.1001794; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kehr J, 2008, J EXP BOT, V59, P85, DOI 10.1093/jxb/erm176; Kim M, 2001, SCIENCE, V293, P287, DOI 10.1126/science.1059805; Kloc M, 2002, CELL, V108, P533, DOI 10.1016/S0092-8674(02)00651-7; Lee JY, 2003, SCIENCE, V299, P392, DOI 10.1126/science.1077813; Lin MK, 2009, MOL CELL PROTEOMICS, V8, P343, DOI 10.1074/mcp.M800420-MCP200; Lin SS, 2002, BOT BULL ACAD SINICA, V43, P261; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Lucas WJ, 2001, NAT REV MOL CELL BIO, V2, P849, DOI 10.1038/35099096; Ma Y, 2010, PLANT J, V64, P536, DOI 10.1111/j.1365-313X.2010.04347.x; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Patel M, 2010, CURR BIOL, V20, P2021, DOI 10.1016/j.cub.2010.10.028; Ruiz-Medrano R, 1999, DEVELOPMENT, V126, P4405; Shav-Tal Y, 2005, J CELL SCI, V118, P4077, DOI 10.1242/jcs.02543; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Taoka K, 2007, PLANT CELL, V19, P1866, DOI 10.1105/tpc.107.052522; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Van Bel AJE, 2003, PLANT CELL ENVIRON, V26, P125, DOI 10.1046/j.1365-3040.2003.00963.x; van Bel AJE, 2002, TRENDS PLANT SCI, V7, P126, DOI 10.1016/S1360-1385(01)02225-7; Wang C, 2004, EMBO J, V23, P1857, DOI 10.1038/sj.emboj.7600181; Xoconostle-Cazares B, 1999, SCIENCE, V283, P94, DOI 10.1126/science.283.5398.94; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Zhang SD, 2009, PLANT PHYSIOL, V150, P378, DOI 10.1104/pp.108.134767	47	30	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23142	23149		10.1074/jbc.M111.244129	http://dx.doi.org/10.1074/jbc.M111.244129			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21572046	Green Published, hybrid			2022-12-25	WOS:000292025000048
J	Park, J; Arakawa-Takeuchi, S; Jinno, S; Okayama, H				Park, Jung-ha; Arakawa-Takeuchi, Shiho; Jinno, Shigeki; Okayama, Hiroto			Rho-associated Kinase Connects a Cell Cycle-controlling Anchorage Signal to the Mammalian Target of Rapamycin Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; DOMINANTLY INHERITED CANCER; SCLEROSIS TSC2 GENE; EKER RAT MODEL; TUBEROUS SCLEROSIS; PROTEIN-KINASE; S-PHASE; ACTIVATION; GROWTH; PHOSPHORYLATION	When deprived of anchorage to the extracellular matrix, fibroblasts arrest in G(1) phase at least in part due to inactivation of G(1) cyclin-dependent kinases. Despite great effort, how anchorage signals control the G(1)-S transition of fibroblasts remains highly elusive. We recently found that the mammalian target of rapamycin ( mTOR) cascade might convey an anchorage signal that regulates S phase entry. Here, we show that Rho-associated kinase connects this signal to the TSC1/TSC2-RHEB-mTOR pathway. Expression of a constitutively active form of ROCK1 suppressed all of the anchorage deprivation effects suppressible by tsc2 mutation in rat embryonic fibroblasts. TSC2 contains one evolutionarily conserved ROCK target-like sequence, and an alanine substitution for Thr(1203) in this sequence severely impaired the ability of ROCK1 to counteract the anchorage loss-imposed down-regulation of both G(1) cell cycle factors and mTORC1 activity. Moreover, TSC2 Thr(1203) underwent ROCK-dependent phosphorylation in vivo and could be phosphorylated by bacterially expressed active ROCK1 in vitro, providing biochemical evidence for a direct physical interaction between ROCK and TSC2.	[Okayama, Hiroto] Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Okayama, H (corresponding author), Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	okayama@m.u-tokyo.ac.jp			Ministry of Education, Science, and Culture of Japan	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research (S) and the Global Center of Excellence from the Ministry of Education, Science, and Culture of Japan.	Arakawa-Takeuchi S, 2010, FEBS LETT, V584, P2779, DOI 10.1016/j.febslet.2010.05.005; Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; Blais A, 2004, CURR OPIN GENET DEV, V14, P527, DOI 10.1016/j.gde.2004.07.003; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Fang F, 1996, SCIENCE, V271, P499, DOI 10.1126/science.271.5248.499; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gan BY, 2006, J BIOL CHEM, V281, P37321, DOI 10.1074/jbc.M605241200; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Huveneers S, 2007, INT J RADIAT BIOL, V83, P743, DOI 10.1080/09553000701481808; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Jinno S, 2002, ONCOGENE, V21, P1777, DOI 10.1038/sj.onc.1205249; Kan QM, 2008, J BIOL CHEM, V283, P17864, DOI 10.1074/jbc.M802055200; Kan QM, 2008, P NATL ACAD SCI USA, V105, P4757, DOI 10.1073/pnas.0706392105; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; KOBAYASHI T, 1995, NUCLEIC ACIDS RES, V23, P2608, DOI 10.1093/nar/23.14.2608; KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70; KUME K, 1992, NEW BIOL, V4, P504; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Momose S, 2002, HUM MOL GENET, V11, P2997, DOI 10.1093/hmg/11.24.2997; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Olsson PG, 1996, MAMM GENOME, V7, P212, DOI 10.1007/s003359900057; OTSUKA H, 1976, J CELL PHYSIOL, V87, P213, DOI 10.1002/jcp.1040870209; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Philips A, 1999, ONCOGENE, V18, P1819, DOI 10.1038/sj.onc.1202530; Ren XD, 2004, J CELL SCI, V117, P3511, DOI 10.1242/jcs.01205; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; ROGNE S, 1985, J CELL PHYSIOL, V125, P528, DOI 10.1002/jcp.1041250324; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schulze A, 1996, MOL CELL BIOL, V16, P4632; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Soucek T, 1998, P NATL ACAD SCI USA, V95, P15653, DOI 10.1073/pnas.95.26.15653; Vojtechova M, 2008, NEOPLASIA, V10, P99, DOI 10.1593/neo.07905; Woodsome TP, 2006, J CELL SCI, V119, P1769, DOI 10.1242/jcs.02805; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; XIAO GH, 1995, ONCOGENE, V11, P81; XIAO GH, 1995, CELL GROWTH DIFFER, V6, P1185; XU L, 1995, GENOMICS, V27, P475, DOI 10.1006/geno.1995.1079; YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5; Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391	57	21	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23132	23141		10.1074/jbc.M110.209114	http://dx.doi.org/10.1074/jbc.M110.209114			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561859	Green Published, hybrid			2022-12-25	WOS:000292025000047
J	Sun, XX; DeVine, T; Challagundla, KB; Dai, MS				Sun, Xiao-Xin; DeVine, Tiffany; Challagundla, Kishore B.; Dai, Mu-Shui			Interplay between Ribosomal Protein S27a and MDM2 Protein in p53 Activation in Response to Ribosomal Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOREGULATORY FEEDBACK LOOP; CELL-CYCLE ARREST; NUCLEOLAR DISRUPTION; DEGRADATION; INHIBITION; L11; BIOGENESIS; UBIQUITIN; PATHWAY; HDM2	Ribosomal proteins play a critical role in tightly coordinating p53 signaling with ribosomal biogenesis. Several ribosomal proteins have been shown to induce and activate p53 via inhibition of MDM2. Here, we report that S27a, a small subunit ribosomal protein synthesized as an 80-amino acid ubiquitin C-terminal extension protein (CEP80), functions as a novel regulator of the MDM2-p53 loop. S27a interacts with MDM2 at the central acidic domain of MDM2 and suppresses MDM2-mediated p53 ubiquitination, leading to p53 activation and cell cycle arrest. Knockdown of S27a significantly attenuates the p53 activation in cells in response to treatment with ribosomal stress-inducing agent actinomycin D or 5-fluorouracil. Interestingly, MDM2 in turn ubiquitinates S27a and promotes proteasomal degradation of S27a in response to actinomycin D treatment, thus forming a mutual-regulatory loop. Altogether, our results reveal that S27a plays a non-redundant role in mediating p53 activation in response to ribosomal stress via interplaying with MDM2.	[Dai, Mu-Shui] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Sch Med, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Dai, MS (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	daim@ohsu.edu	Challagundla, Kishore B./H-8189-2019	Challagundla, Kishore B./0000-0001-8654-7717	National Institutes of Health [R00CA127134]; Department of Defense [W81XWH-10-1-1029]; Medical Research Foundation of Oregon; Oregon Health and Science University; OHSU Knight Cancer Institute; NATIONAL CANCER INSTITUTE [R00CA127134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Medical Research Foundation of Oregon; Oregon Health and Science University; OHSU Knight Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R00CA127134. This work was also supported by a grant from Department of Defense under Award W81XWH-10-1-1029, a grant from Medical Research Foundation of Oregon, and by a startup fund from the Oregon Health and Science University (to M.-S.D.).; Recipient of a Cancer Research Development Award from the OHSU Knight Cancer Institute. To whom correspondence should be addressed: Dept. of Molecular and Medical Genetics, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd., Portland, OR 97239. Tel.: 503-494-9917; Fax: 503-494-4411; E-mail: daim@ohsu.edu.	BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; PICKSLEY SM, 1993, BIOESSAYS, V15, P689, DOI 10.1002/bies.950151008; REDMAN KL, 1989, NATURE, V338, P438, DOI 10.1038/338438a0; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Shabek N, 2010, CELL CYCLE, V9, P523, DOI 10.4161/cc.9.3.11152; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P6544, DOI 10.1093/nar/gkq536; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	44	66	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22730	22741		10.1074/jbc.M111.223651	http://dx.doi.org/10.1074/jbc.M111.223651			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561866	Green Published, hybrid			2022-12-25	WOS:000292025000007
J	Mackenzie, S; Schmermer, C; Charnley, A; Sim, D; Tah, V; Dumskyj, M; Nussey, S; Egan, C				Mackenzie, Sarah; Schmermer, Christian; Charnley, Amanda; Sim, Dawn; Tah, Vikas; Dumskyj, Martin; Nussey, Stephen; Egan, Catherine			SDOCT Imaging to Identify Macular Pathology in Patients Diagnosed with Diabetic Maculopathy by a Digital Photographic Retinal Screening Programme	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; TIME-DOMAIN; FLUORESCEIN ANGIOGRAPHY; THICKNESS MEASUREMENTS; FUNDUS PHOTOGRAPHY; LAYER THICKNESS; EYE DISEASE; EDEMA; RETINOPATHY; OPHTHALMOSCOPY	Introduction: Diabetic macular edema (DME) is an important cause of vision loss. England has a national systematic photographic retinal screening programme to identify patients with diabetic eye disease. Grading retinal photographs according to this national protocol identifies surrogate markers for DME. We audited a care pathway using a spectral-domain optical coherence tomography (SDOCT) clinic to identify macular pathology in this subset of patients. Methods: A prospective audit was performed of patients referred from screening with mild to moderate non-proliferative diabetic retinopathy (R1) and surrogate markers for diabetic macular edema (M1) attending an SDOCT clinic. The SDOCT images were graded by an ophthalmologist as SDOCT positive, borderline or negative. SDOCT positive patients were referred to the medical retina clinic. SDOCT negative and borderline patients were further reviewed in the SDOCT clinic in 6 months. Results: From a registered screening population of 17 551 patients with diabetes mellitus, 311 patients met the inclusion criteria between (March 2008 and September 2009). We analyzed images from 311 patients' SDOCT clinic episodes. There were 131 SDOCT negative and 12 borderline patients booked for revisit in the OCT clinic. Twenty-four were referred back to photographic screening for a variety of reasons. A total of 144 were referred to ophthalmology with OCT evidence of definite macular pathology requiring review by an ophthalmologist. Discussion: This analysis shows that patients with diabetes, mild to moderate non-proliferative diabetic retinopathy (R1) and evidence of diabetic maculopathy on non-stereoscopic retinal photographs (M1) have a 42.1% chance of having no macular edema on SDOCT imaging as defined by standard OCT definitions of DME when graded by a retinal specialist. SDOCT imaging is a useful adjunct to colour fundus photography in screening for referable diabetic maculopathy in our screening population.	[Mackenzie, Sarah; Sim, Dawn; Tah, Vikas; Egan, Catherine] Moorfields St Georges Hosp, London, England; [Schmermer, Christian; Charnley, Amanda; Dumskyj, Martin; Nussey, Stephen] St George Hosp, Dept Endocrinol, London, England	St Georges University London	Mackenzie, S (corresponding author), Moorfields St Georges Hosp, London, England.	sarah.mackenzie@moorfields.nhs.uk		Egan, Catherine/0000-0001-5593-1169				Aiello LP, 2010, OPHTHALMOLOGY, V117, P946, DOI 10.1016/j.ophtha.2009.10.002; Baskin DE, 2010, CURR OPIN OPHTHALMOL, V21, P172, DOI 10.1097/ICU.0b013e32833866ae; Beck RW, 2009, ARCH OPHTHALMOL-CHIC, V127, P245, DOI 10.1001/archophthalmol.2008.610; Broadbent DM, 1999, EYE, V13, P160, DOI 10.1038/eye.1999.43; Brown JC, 2004, ARCH OPHTHALMOL-CHIC, V122, P330, DOI 10.1001/archopht.122.3.330; Browning DJ, 2008, OPHTHALMOLOGY, V115, P1366, DOI 10.1016/j.ophtha.2007.12.004; Browning DJ, 2008, AM J OPHTHALMOL, V145, P889, DOI 10.1016/j.ajo.2008.01.007; Browning DJ, 2004, OPHTHALMOLOGY, V111, P712, DOI 10.1016/j.ophtha.2003.06.028; Bruce A, 2009, OPEN OPHTHALMOL J, V3, P10, DOI 10.2174/1874364100903010010; DANIS RP, 2006, DIABETIC RETINOPATHY, V124, P1701; Davis MD, 2008, INVEST OPHTH VIS SCI, V49, P1745, DOI 10.1167/iovs.07-1257; Emanuele N, 2009, J DIABETES COMPLICAT, V23, P323, DOI 10.1016/j.jdiacomp.2008.02.010; Fong DS, 1999, AM J OPHTHALMOL, V127, P137, DOI 10.1016/S0002-9394(98)00309-2; Forooghian F, 2008, INVEST OPHTH VIS SCI, V49, P4290, DOI 10.1167/iovs.08-2113; Glassman AR, 2009, INVEST OPHTH VIS SCI, V50, P560, DOI 10.1167/iovs.08-1881; HARDING SP, 1995, BMJ-BRIT MED J, V311, P1131, DOI 10.1136/bmj.311.7013.1131; Ho J, 2009, OPHTHALMOLOGY, V116, P1960, DOI 10.1016/j.ophtha.2009.03.034; International Council of Ophthalmology, INT CLIN DIAB RET DI; JAVITT JC, 1989, OPHTHALMOLOGY, V96, P255; Jittpoonkuson T, 2010, BRIT J OPHTHALMOL, V94, P1197, DOI 10.1136/bjo.2009.170589; Jyothi S, 2009, PRIM CARE DIABETES, V3, P67, DOI 10.1016/j.pcd.2009.05.005; Kim BY, 2006, AM J OPHTHALMOL, V142, P405, DOI 10.1016/j.ajo.2006.04.023; KINYOUN J, 1989, OPHTHALMOLOGY, V96, P746; KINYOUN JL, 1992, INVEST OPHTH VIS SCI, V33, P1888; LAMMER J, 2010, COMP 4 OPT COH TOM S, V10, P1; LEE VS, 1993, OPHTHALMOLOGY, V100, P1504; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4893, DOI 10.1167/iovs.07-1326; Massin P, 2006, ACTA OPHTHALMOL SCAN, V84, P466, DOI 10.1111/j.1600-0420.2006.00694.x; Moreira Rodrigo O., 2001, International Ophthalmology, V24, P331, DOI 10.1023/B:INTE.0000006784.52885.e9; *NAT HLTH SERV RET, NAT SCREEN PROGR DIA; *NAT I HLTH RES, 2007, 1703 SCAND, V85, P613; NATHAN DM, 1991, DIABETES CARE, V14, P26, DOI 10.2337/diacare.14.1.26; PATEL PJ, 2009, ACTA OPHTHALMOL 1021; PATEL PJ, 2009, ACTA OPHTHALMOL 1107; Patel PJ, 2009, INVEST OPHTH VIS SCI, V50, P5405, DOI 10.1167/iovs.09-3505; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; *ROYAL COLL OPHTH, 2005, GUID MAN DIAB RET LO; SADDA SR, 2006, OPHTHALMOL, V113; Sadda SR, 2006, OPHTHALMOLOGY, V113, P1187, DOI 10.1016/j.ophtha.2005.12.020; SCOTLAND GS, 2009, BR J OPHTHALMOL 1203; Scott IU, 2007, OPHTHALMOLOGY, V114, P1860, DOI 10.1016/j.ophtha.2007.05.062; Tangelder GJM, 2008, INVEST OPHTH VIS SCI, V49, P2627, DOI 10.1167/iovs.07-0820; van Dijk HW, 2010, INVEST OPHTH VIS SCI, V51, P3660, DOI 10.1167/iovs.09-5041; van Dijk HW, 2009, INVEST OPHTH VIS SCI, V50, P3404, DOI 10.1167/iovs.08-3143; VANDIJK HW, 2010, VISION RES      0827; Virgili G, 2007, INVEST OPHTH VIS SCI, V48, P4963, DOI 10.1167/iovs.06-1472; World Health Organization, DIAB PROGR; Yeung L, 2009, OPHTHALMOLOGY, V116, P1158, DOI 10.1016/j.ophtha.2008.12.063	48	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e14811	10.1371/journal.pone.0014811	http://dx.doi.org/10.1371/journal.pone.0014811			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573106	Green Published, Green Submitted, gold			2022-12-25	WOS:000290305600002
J	Raghu, SV; Borst, A				Raghu, Shamprasad Varija; Borst, Alexander			Candidate Glutamatergic Neurons in the Visual System of Drosophila	PLOS ONE			English	Article							PLATE TANGENTIAL CELLS; INTRINSIC ELECTROPHYSIOLOGICAL CHARACTERISTICS; MOTION SENSITIVE INTERNEURONS; GAMMA-AMINOBUTYRIC-ACID; LOBULA PLATE; OPTIC LOBE; DESCENDING NEURONS; DETECTION CIRCUITS; OPTOMOTOR SYSTEM; HORIZONTAL CELLS	The visual system of Drosophila contains approximately 60,000 neurons that are organized in parallel, retinotopically arranged columns. A large number of these neurons have been characterized in great anatomical detail. However, studies providing direct evidence for synaptic signaling and the neurotransmitter used by individual neurons are relatively sparse. Here we present a first layout of neurons in the Drosophila visual system that likely release glutamate as their major neurotransmitter. We identified 33 different types of neurons of the lamina, medulla, lobula and lobula plate. Based on the previous Golgi-staining analysis, the identified neurons are further classified into 16 major subgroups representing lamina monopolar (L), transmedullary (Tm), transmedullary Y (TmY), Y, medulla intrinsic (Mi, Mt, Pm, Dm, Mi Am), bushy T (T), translobula plate (Tlp), lobula intrinsic (Lcn, Lt, Li), lobula plate tangential (LPTCs) and lobula plate intrinsic (LPi) cell types. In addition, we found 11 cell types that were not described by the previous Golgi analysis. This classification of candidate glutamatergic neurons fosters the future neurogenetic dissection of information processing in circuits of the fly visual system.	[Raghu, Shamprasad Varija; Borst, Alexander] Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, Martinsried, Germany	Max Planck Society	Raghu, SV (corresponding author), Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, Martinsried, Germany.	sham@neuro.mpg.de	Raghu, Shamprasad Varija/AAV-3044-2020		Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BICKER G, 1988, J NEUROSCI, V8, P2108; Borst A, 1996, J COMPUT NEUROSCI, V3, P313, DOI 10.1007/BF00161091; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brotz TM, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-1; BUCHNER E, 1986, CELL TISSUE RES, V246, P57; BUCHNER E, 1984, J COMP PHYSIOL, V155, P471, DOI 10.1007/BF00611912; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Buschbeck EK, 1996, J NEUROSCI, V16, P4563; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Cully DF, 1996, J BIOL CHEM, V271, P20187, DOI 10.1074/jbc.271.33.20187; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; DOUGLASS JK, 1995, J NEUROSCI, V15, P5596; Duarte CB, 1999, J NEUROSCI RES, V58, P475, DOI 10.1002/(SICI)1097-4547(19991115)58:4<475::AID-JNR1>3.0.CO;2-O; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; GILBERT C, 1995, J COMP NEUROL, V361, P285, DOI 10.1002/cne.903610207; GRONENBERG W, 1990, J COMP NEUROL, V302, P973, DOI 10.1002/cne.903020420; Haag J, 1997, J COMPUT NEUROSCI, V4, P349, DOI 10.1023/A:1008804117334; Haag J, 1999, J COMPUT NEUROSCI, V7, P213, DOI 10.1023/A:1008950515719; Haag J, 2002, J NEUROSCI, V22, P3227, DOI 10.1523/JNEUROSCI.22-08-03227.2002; Haag J, 2007, J NEUROSCI, V27, P1992, DOI 10.1523/JNEUROSCI.4393-06.2007; Hardie R.C., 1989, P235; HARDIE RC, 1987, J COMP PHYSIOL A, V161, P201, DOI 10.1007/BF00615241; Hasegawa E, 2011, DEVELOPMENT, V138, P983, DOI 10.1242/dev.058370; HAUSEN K, 1982, BIOL CYBERN, V46, P67, DOI 10.1007/BF00335352; HAUSEN K, 1982, BIOL CYBERN, V45, P143, DOI 10.1007/BF00335241; Hausen K., 1984, PHOTORECEPTION VISIO, P523, DOI [10.1007/978-1-4613-2743-1_15, DOI 10.1007/978-1-4613-2743-1_15]; HENGSTENBERG R, 1982, J COMP PHYSIOL, V149, P163, DOI 10.1007/BF00619211; HERTZ L, 1983, GLUTAMINE GLUTAMATE; HOMBERG U, 1989, CELL TISSUE RES, V258, P1, DOI 10.1007/BF00223139; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Kitamoto T, 1998, J BIOL CHEM, V273, P2706, DOI 10.1074/jbc.273.5.2706; Kolodziejczyk A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002110; LEA TJ, 1973, GEN PHARMACOL, V4, P351; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Meinertzhagen I. A., 1996, Society for Neuroscience Abstracts, V22, P655; MEYER EP, 1986, HISTOCHEMISTRY, V84, P207, DOI 10.1007/BF00495784; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Nassel D.R., 1988, Journal of Chemical Neuroanatomy, V1, P311; NASSEL DR, 1983, COMP BIOCHEM PHYS C, V75, P259, DOI 10.1016/0742-8413(83)90190-1; NEAL MJ, 1992, NEUROCHEM INT, V20, P43, DOI 10.1016/0197-0186(92)90124-A; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; POLLACK I, 1991, CELL TISSUE RES, V266, P391, DOI 10.1007/BF00318195; Raghu SV, 2007, J COMP NEUROL, V502, P598, DOI 10.1002/cne.21319; Raghu SV, 2011, J COMP NEUROL, V519, P162, DOI 10.1002/cne.22512; Raghu SV, 2009, J NEUROGENET, V23, P200, DOI 10.1080/01677060802471684; Ramaekers A, 2001, J COMP NEUROL, V438, P213, DOI 10.1002/cne.1310; Reiff DF, 2010, NAT NEUROSCI, V13, P973, DOI 10.1038/nn.2595; SCHAFER S, 1988, J COMP NEUROL, V268, P60, DOI 10.1002/cne.902680107; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; SCHURMANN FW, 1989, CELL TISSUE RES, V256, P399, DOI 10.1007/BF00218898; Schuster CM, 2006, CELL TISSUE RES, V326, P287, DOI 10.1007/s00441-006-0290-5; Scott EK, 2002, J COMP NEUROL, V454, P470, DOI 10.1002/cne.10467; Sinakevitch I, 2004, J COMP NEUROL, V468, P6, DOI 10.1002/cne.10929; Strausfeld N.J., 1976, P245; STRAUSFELD NJ, 1984, PHOTORECEPTION VISIO, P483; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Stuart AE, 2007, PROG NEUROBIOL, V82, P202, DOI 10.1016/j.pneurobio.2007.03.006; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; USHERWOOD PN, 1968, J EXP BIOL, V49, P341; Volkner M, 2000, J NEUROCHEM, V75, P1791, DOI 10.1046/j.1471-4159.2000.0751791.x; Wertz A, 2008, J NEUROSCI, V28, P3131, DOI 10.1523/JNEUROSCI.5460-07.2008; Wertz A, 2009, J NEUROSCI, V29, P14993, DOI 10.1523/JNEUROSCI.3786-09.2009; Wertz A, 2009, J COMP PHYSIOL A, V195, P1107, DOI 10.1007/s00359-009-0481-0; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	71	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19472	10.1371/journal.pone.0019472	http://dx.doi.org/10.1371/journal.pone.0019472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573163	Green Submitted, Green Published, gold			2022-12-25	WOS:000290256400013
J	Li, Y; Li, CQ; Xia, J; Jin, YX				Li, Yang; Li, Chaoqun; Xia, Jie; Jin, Youxin			Domestication of Transposable Elements into MicroRNA Genes in Plants	PLOS ONE			English	Article							SMALL RNAS; ARABIDOPSIS-THALIANA; ORYZA-SATIVA; CATALYTIC SUBUNIT; RICE; TARGETS; EVOLUTION; GENOME; BIOGENESIS; SIRNAS	Transposable elements (TE) usually take up a substantial portion genome. Activities TEs can cause genome harmful or even disastrous to the host. TEs also contribute to gene and genom RNA genes in mammals have been found to derive from transposons while convincing found that a considerable number of previously annotated plant miRNAs are identical or include a small number of bona fide miRNA genes that conform to generally which and hairpin derived Transposable elements TE) usually instability or gene mutations that evolution at many aspects. Part evidences are absent for plant transposons (TE-MIR) RNA annotation rule. medium to hi h wed siRNAs likely to be pre-evolved miRNAs. Analysis of these TEn indicate that transitions from the copy TEs into rniRNA genes may undergo steps such as inverted ormation, sequence speciation and adaptation to miRNA biogenesis. We also identified initial target genes of the TE-which contain homologous sequences in their CDS as consequence of cognate TE insertions. About one-third of the mRNAs are supported by publicly available degradome sequencing data for TE-MIR sRNA induced cleavages. he TE-MIRs are biased to non-TE related genes indicating their penchant to acquire cellular functions during evolution. Interestingly, most of these TE insertions span boundaries between coding and non-coding sequences indicating incorporation into CDS through alteration of splicing or translation start or p signals. Taken together, findings suggest that TEs in gene rich regions can form foldlaacks in non-coding part of anscrips that may eventually evolve into rniRNA genes or be integrated into protein coding sequences to form potential targets in a "temperate" manner. Thus, tranposons may supply as resources for the evolution of miRNA-target interactions in plants.	[Li, Yang; Jin, Youxin] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China; [Li, Yang; Xia, Jie; Jin, Youxin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China; [Li, Chaoqun] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Gastroenterol, Shanghai 200433, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Li, Y (corresponding author), Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China.	yxjin@sibs.ac.cn	Li, Chao/GSM-8117-2022; Li, Yang/A-7139-2017	Li, Chao/0000-0001-6110-6210; Li, Yang/0000-0001-5861-5313	National Key Basic Research and Development Program [2011CB811304]; National Basic Research Program of China [2011CBA01105]; Chinese Academy of Sciences [KSCX2-YW-R-096]	National Key Basic Research and Development Program(National Basic Research Program of China); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Key Basic Research and Development Program (No. 2011CB811304), National Basic Research Program of China (No. 2011CBA01105) and the Chinese Academy of Sciences (KSCX2-YW-R-096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Berninger P, 2008, METHODS, V44, P13, DOI 10.1016/j.ymeth.2007.10.002; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; De Felippes FF, 2008, RNA, V14, P2455, DOI 10.1261/rna.1149408; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Dooner HK, 2007, CURR OPIN GENET DEV, V17, P486, DOI 10.1016/j.gde.2007.08.010; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Heisel SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002871; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kuang HH, 2009, GENOME RES, V19, P42, DOI [10.1101/gr.07816.108, 10.1101/gr.078196.108]; Lehnert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004456; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Liu J, 2004, GENE DEV, V18, P2873, DOI 10.1101/gad.1217304; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mao L, 2000, GENOME RES, V10, P982, DOI 10.1101/gr.10.7.982; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; Nakazaki T, 2003, NATURE, V421, P170, DOI 10.1038/nature01219; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; Oki N, 2008, GENES GENET SYST, V83, P321, DOI 10.1266/ggs.83.321; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Piriyapongsa J, 2007, GENETICS, V176, P1323, DOI 10.1534/genetics.107.072553; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smalheiser NR, 2006, TRENDS GENET, V22, P532, DOI 10.1016/j.tig.2006.08.007; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Talmor-Neiman M, 2006, PLANT J, V47, P25, DOI 10.1111/j.1365-313X.2006.02768.x; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Yao CG, 2007, ACTA BIOCH BIOPH SIN, V39, P829, DOI 10.1111/j.1745-7270.2007.00346.x; Zhang Q, 2000, P NATL ACAD SCI USA, V97, P1160, DOI 10.1073/pnas.97.3.1160; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157; Zhou M., 2010, FRONT BIOL, V5, P67, DOI [DOI 10.1007/S11515-010-0007-8, 10.1007/s11515-010-0007-8]; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	65	65	71	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19212	10.1371/journal.pone.0019212	http://dx.doi.org/10.1371/journal.pone.0019212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559273	Green Published, gold, Green Submitted			2022-12-25	WOS:000290223500011
J	Ahmed, SB; Ronksley, PE; Hemmelgarn, BR; Tsai, WH; Manns, BJ; Tonelli, M; Klarenbach, SW; Chin, R; Clement, FM; Hanly, PJ				Ahmed, Sofia B.; Ronksley, Paul E.; Hemmelgarn, Brenda R.; Tsai, Willis H.; Manns, Braden J.; Tonelli, Marcello; Klarenbach, Scott W.; Chin, Rick; Clement, Fiona M.; Hanly, Patrick J.			Nocturnal Hypoxia and Loss of Kidney Function	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; ALCOHOL-CONSUMPTION; ADMINISTRATIVE DATA; FUNCTION DECLINE; RENAL-FUNCTION; PROTEINURIA; DISEASE; MANAGEMENT; ASSOCIATION; DYSFUNCTION	Background: Although obstructive sleep apnea (OSA) is more common in patients with kidney disease, whether nocturnal hypoxia affects kidney function is unknown. Methods: We studied all adult subjects referred for diagnostic testing of sleep apnea between July 2005 and December 31 2007 who had serial measurement of their kidney function. Nocturnal hypoxia was defined as oxygen saturation (SaO2) below 90% for >= 12% of the nocturnal monitoring time. The primary outcome, accelerated loss of kidney function, was defined as a decline in estimated glomerular filtration rate (eGFR) >= 4 ml/min/1.73 m(2) per year. Results: 858 participants were included and followed for a mean study period of 2.1 years. Overall 374 (44%) had nocturnal hypoxia, and 49 (5.7%) had accelerated loss of kidney function. Compared to controls without hypoxia, patients with nocturnal hypoxia had a significant increase in the adjusted risk of accelerated kidney function loss (odds ratio (OR) 2.89, 95% confidence interval [CI] 1.25, 6.67). Conclusion: Nocturnal hypoxia was independently associated with an increased risk of accelerated kidney function loss. Further studies are required to determine whether treatment and correction of nocturnal hypoxia reduces loss of kidney function.	[Ahmed, Sofia B.; Hemmelgarn, Brenda R.; Tsai, Willis H.; Manns, Braden J.; Chin, Rick; Clement, Fiona M.; Hanly, Patrick J.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Ronksley, Paul E.; Hemmelgarn, Brenda R.; Tsai, Willis H.; Manns, Braden J.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Tonelli, Marcello; Klarenbach, Scott W.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Ahmed, Sofia B.; Ronksley, Paul E.; Hemmelgarn, Brenda R.; Manns, Braden J.; Tonelli, Marcello; Klarenbach, Scott W.; Chin, Rick; Clement, Fiona M.] Alberta Kidney Dis Network, Calgary, AB, Canada; [Ronksley, Paul E.; Tsai, Willis H.; Hanly, Patrick J.] Univ Calgary, Foothills Med Ctr, Sleep Ctr, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Alberta; University of Calgary	Ahmed, SB (corresponding author), Univ Calgary, Dept Med, Calgary, AB, Canada.	sofia.ahmed@albertahealthservices.ca	Tonelli, Marcello/B-3028-2009; Ahmed, Sofia/J-7876-2015; Klarenbach, Scott/E-7731-2013; Hemmelgarn, Brenda R./I-6894-2012; Manns, Braden J/I-8942-2012	Tonelli, Marcello/0000-0002-0846-3187; Klarenbach, Scott/0000-0002-8611-1056; Ronksley, Paul/0000-0002-3958-7561	Alberta Kidney Disease Network; Alberta Heritage Foundation for Medical Research; Calgary Health Region; Queen Elizabeth II Graduate Scholarship; Canadian Health Services Research Foundation; Alberta Health and Wellness; Universities of Alberta and Calgary	Alberta Kidney Disease Network; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Calgary Health Region; Queen Elizabeth II Graduate Scholarship; Canadian Health Services Research Foundation; Alberta Health and Wellness; Universities of Alberta and Calgary	This study was funded by the Alberta Kidney Disease Network and operating grants from the Alberta Heritage Foundation for Medical Research and the Calgary Health Region. SBA, BRH, MT and SWK are supported by the Alberta Heritage Foundation for Medical Research. PER is supported by a Queen Elizabeth II Graduate Scholarship. FC is supported by a Canadian Health Services Research Foundation and an Alberta Heritage Foundation for Medical Research post-doctoral fellowship. SBA, BRH, BJM and MT are supported by the Canadian Institute of Health Research. SBA, BRH, BJM, MT, SWK and PJH are supported by a joint initiative between Alberta Health and Wellness and the Universities of Alberta and Calgary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SB, 2005, HYPERTENSION, V46, P1316, DOI 10.1161/01.HYP.0000190819.07663.da; Ahmed SB, 2008, KIDNEY INT, V74, P370, DOI 10.1038/ki.2008.205; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; BAILEY RR, 1989, AUST NZ J MED, V19, P473, DOI 10.1111/j.1445-5994.1989.tb00310.x; Baumel MJ, 1997, AM J RESP CRIT CARE, V155, P9, DOI 10.1164/ajrccm.155.1.9001281; Bostrom KB, 2007, J HYPERTENS, V25, P779, DOI 10.1097/HJH.0b013e328017f6d5; Bratel T, 2003, RESP MED, V97, P308, DOI 10.1053/rmed.2002.1401; Casserly LF, 2001, KIDNEY INT, V60, P1484, DOI 10.1046/j.1523-1755.2001.00952.x; CHAUDHARY BA, 1988, SLEEP, V11, P69, DOI 10.1093/sleep/11.1.69; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Faulx MD, 2007, SLEEP, V30, P923, DOI 10.1093/sleep/30.7.923; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Fine LG, 1998, KIDNEY INT, pS74; Fletcher EC, 1999, HYPERTENSION, V34, P309, DOI 10.1161/01.HYP.34.2.309; FLETCHER EC, 1993, J AM SOC NEPHROL, V4, P1111; Ghahramani N, 2011, NEPHROLOGY, V16, P219, DOI 10.1111/j.1440-1797.2010.01332.x; Gusbeth-Tatomir P, 2007, INT UROL NEPHROL, V39, P1217, DOI 10.1007/s11255-007-9262-2; Hanly PJ, 2001, NEW ENGL J MED, V344, P102, DOI 10.1056/NEJM200101113440204; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Huzel Lisa, 2002, Can Respir J, V9, P407; Iseki K, 2008, HYPERTENS RES, V31, P249, DOI 10.1291/hypres.31.249; ISSA FG, 1993, AM REV RESPIR DIS, V148, P1023, DOI 10.1164/ajrccm/148.4_Pt_1.1023; KIMMEL PL, 1989, AM J MED, V86, P308, DOI 10.1016/0002-9343(89)90301-X; Kinebuchi SI, 2004, CLIN SCI, V107, P317, DOI 10.1042/CS20040074; Knight EL, 2003, NEPHROL DIAL TRANSPL, V18, P1549, DOI 10.1093/ndt/gfg228; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Lin J, 2003, J AM SOC NEPHROL, V14, P2573, DOI 10.1097/01.ASN.0000088721.98173.4B; Manns BJ, 2001, CLIN INVEST MED, V24, P164; Mello P, 2004, AM J KIDNEY DIS, V44, P636, DOI 10.1053/j.ajkd.2004.06.014; Menon V, 2010, NEPHROL DIAL TRANSPL, V25, P3301, DOI 10.1093/ndt/gfq188; Mulgrew AT, 2007, ANN INTERN MED, V146, P157, DOI 10.7326/0003-4819-146-3-200702060-00004; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Ronksley PE, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-50; Schaeffner ES, 2005, ARCH INTERN MED, V165, P1048, DOI 10.1001/archinte.165.9.1048; SKLAR AH, 1988, ARCH INTERN MED, V148, P87, DOI 10.1001/archinte.148.1.87; SKLAR AH, 1989, NEPHRON, V51, P35, DOI 10.1159/000185239; Statistics Canada, 2006, COMM PROF VIS MIN PO; TU K, 2007, OPEN MED, V1, pE3; Vazquez JC, 2000, THORAX, V55, P302, DOI 10.1136/thorax.55.4.302; Wuerzner G, 2010, AM J KIDNEY DIS, V56, P303, DOI 10.1053/j.ajkd.2010.03.017; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	46	91	99	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19029	10.1371/journal.pone.0019029	http://dx.doi.org/10.1371/journal.pone.0019029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559506	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700053
J	Amarnath, S; Chen, H; Foley, JE; Costanzo, CM; Sennesh, JD; Solomon, MA; Fowler, DH				Amarnath, Shoba; Chen, Hao; Foley, Jason E.; Costanzo, Carliann M.; Sennesh, Joel D.; Solomon, Michael A.; Fowler, Daniel H.			Host-Based Th2 Cell Therapy for Prolongation of Cardiac Allograft Viability	PLOS ONE			English	Article							REGULATORY T-CELLS; IN-VIVO; TRANSPLANTATION TOLERANCE; INFECTIOUS TOLERANCE; BLOOD-TRANSFUSIONS; GRAFT-REJECTION; RAPAMYCIN; CYCLOSPORINE; RECIPIENTS; SURVIVAL	Donor T cell transfusion, which is a long-standing approach to prevent allograft rejection, operates indirectly by alteration of host T cell immunity. We therefore hypothesized that adoptive transfer of immune regulatory host Th2 cells would represent a novel intervention to enhance cardiac allograft survival. Using a well-described rat cardiac transplant model, we first developed a method for ex vivo manufacture of rat host-type Th2 cells in rapamycin, with subsequent injection of such Th2. R cells prior to class I and class II disparate cardiac allografting. Second, we determined whether Th2. R cell transfer polarized host immunity towards a Th2 phenotype. And third, we evaluated whether Th2. R cell therapy prolonged allograft viability when used alone or in combination with a short-course of cyclosporine (CSA) therapy. We found that host-type Th2. R cell therapy prior to cardiac allografting: (1) reduced the frequency of activated T cells in secondary lymphoid organs; (2) shifted post-transplant cytokines towards a Th2 phenotype; and (3) prolonged allograft viability when used in combination with short-course CSA therapy. These results provide further support for the rationale to use "direct" host T cell therapy for prolongation of allograft viability as an alternative to "indirect" therapy mediated by donor T cell infusion.	[Amarnath, Shoba; Foley, Jason E.; Costanzo, Carliann M.; Fowler, Daniel H.] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA; [Chen, Hao; Solomon, Michael A.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Chen, Hao] Fudan Univ, Huadong Hosp, Dept Cardiac Surg, Shanghai 200433, Peoples R China; [Sennesh, Joel D.] Inova Fairfax Hosp, Dept Pathol, Fairfax, VA USA; [Solomon, Michael A.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Fudan University; Inova Fairfax Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Amarnath, S (corresponding author), NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA.	samarnath@mail.nih.gov	amarnath, shoba/AAP-4391-2020	Solomon, Michael/0000-0001-7400-6614	Center for Cancer Research; National Cancer Institute; Critical Care Medicine Department; NATIONAL CANCER INSTITUTE [ZIASC010288, ZIABC011220] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL008094] Funding Source: NIH RePORTER	Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Critical Care Medicine Department; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER	This work was supported by the Center for Cancer Research, National Cancer Institute, and Critical Care Medicine Department, Clinical Center Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007840; AMARNATH S, AUTOPHAGY, V6; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Cobbold SP, 2006, IMMUNOL REV, V213, P239, DOI 10.1111/j.1600-065X.2006.00428.x; COCHRUM K, 1981, TRANSPLANT P, V13, P1657; COOLEY DFO, 1983, TRANSPLANT P, V15; Deans KJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-280; Delfs MW, 2001, TRANSPLANTATION, V71, P606, DOI 10.1097/00007890-200103150-00005; Egidi MF, 2003, TRANSPLANTATION, V75, P572, DOI 10.1097/01.TP.0000046940.27269.43; Foley JE, 2005, J IMMUNOL, V175, P5732, DOI 10.4049/jimmunol.175.9.5732; FOWLER DH, 1994, J IMMUNOL, V152, P1004; Gao W, 2007, AM J TRANSPLANT, V7, P1722, DOI 10.1111/j.1600-6143.2007.01842.x; Golshayan D, 2007, BLOOD, V109, P827, DOI 10.1182/blood-2006-05-025460; Hackstein H, 2003, BLOOD, V101, P4457, DOI 10.1182/blood-2002-11-3370; Hall BM, 2007, TRANSPLANTATION, V83, P1075, DOI 10.1097/01.tp.0000259553.66185.2f; Illigens BM, 2009, EUR J IMMUNOL, V39, P3000, DOI 10.1002/eji.200838980; Isobe M, 1997, CIRCULATION, V96, P2247; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Jung U, 2003, BLOOD, V102, P3439, DOI 10.1182/blood-2002-12-3936; Jung US, 2006, BIOL BLOOD MARROW TR, V12, P905, DOI 10.1016/j.bbmt.2006.05.014; Kang SM, 2007, AM J TRANSPLANT, V7, P1457, DOI 10.1111/j.1600-6143.2007.01829.x; Kataoka M, 2003, SURGERY, V134, P227, DOI 10.1067/msy.2003.226; Kataoka M, 2002, SURGERY, V132, P167, DOI 10.1067/msy.2002.125303; Ke BB, 2000, J IMMUNOL, V164, P5739, DOI 10.4049/jimmunol.164.11.5739; Khush KK, 2009, EXPERT OPIN EMERG DR, V14, P1, DOI [10.1517/14728210902791605, 10.1517/14728210902791605 ]; Kitade H, 2004, TRANSPLANTATION, V78, P1747, DOI 10.1097/01.TP.0000147788.23922.5B; Levine BL, 1997, J IMMUNOL, V159, P5921; Levy AE, 1997, TRANSPL IMMUNOL, V5, P83, DOI 10.1016/S0966-3274(97)80047-0; Li YS, 1998, TRANSPLANTATION, V66, P1387, DOI 10.1097/00007890-199811270-00021; Lucas JG, 2011, EXPERT OPIN PHARMACO, V12, P579, DOI 10.1517/14656566.2011.525219; Maes BD, 2004, TRANSPL P, V36, p40S, DOI 10.1016/j.transproceed.2004.01.038; Mariotti J, 2008, J IMMUNOL, V180, P89, DOI 10.4049/jimmunol.180.1.89; Mariotti J, 2008, BLOOD, V112, P4765, DOI 10.1182/blood-2008-05-154278; Onodera K, 1997, J IMMUNOL, V158, P1572; OPELZ G, 1979, TRANSPLANT P, V11, P145; Patel JK, 2004, TRANSPL P, V36, p323S, DOI 10.1016/j.transproceed.2004.01.039; Paulos CM, 2008, IMMUNOL RES, V42, P182, DOI 10.1007/s12026-008-8070-9; RAIMONDI G, J IMMUNOL, V184, P624; Schenk AD, 2008, AM J TRANSPLANT, V8, P1652, DOI 10.1111/j.1600-6143.2008.02302.x; SHAPIRA OM, 1993, J CLIN INVEST, V91, P388, DOI 10.1172/JCI116211; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; WOODRUFF MFA, 1983, LANCET, V1, P1201; Yamada A, 2003, AM J TRANSPLANT, V3, P23, DOI 10.1034/j.1600-6143.2003.30105.x; YOKOYAMA H, 1995, J HEART LUNG TRANSPL, V14, P706; Young KJ, 2002, BLOOD, V100, P3408, DOI 10.1182/blood-2002-01-0235; Zhai Y, 1999, CRIT REV IMMUNOL, V19, P155	46	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18885	10.1371/journal.pone.0018885	http://dx.doi.org/10.1371/journal.pone.0018885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559526	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700031
J	Pinho, S; Simonsson, PR; Trevers, KE; Stower, MJ; Sherlock, WT; Khan, M; Streit, A; Sheng, GJ; Stern, CD				Pinho, Sonia; Simonsson, Pamela R.; Trevers, Katherine E.; Stower, Matthew J.; Sherlock, William T.; Khan, Mohsin; Streit, Andrea; Sheng, Guojun; Stern, Claudio D.			Distinct Steps of Neural Induction Revealed by Asterix, Obelix and TrkC, Genes Induced by Different Signals from the Organizer	PLOS ONE			English	Article							TRANSLATION INITIATION-FACTORS; PRIMITIVE STREAK FORMATION; MESSENGER-RNA EXPRESSION; IN-SITU HYBRIDIZATION; CHICK-EMBRYO; BMP INHIBITION; AVIAN EMBRYOS; XENOPUS-LAEVIS; SPEMANN ORGANIZER; RETINOIC ACID	The amniote organizer (Hensen's node) can induce a complete nervous system when grafted into a peripheral region of a host embryo. Although BMP inhibition has been implicated in neural induction, non-neural cells cannot respond to BMP antagonists unless previously exposed to a node graft for at least 5 hours before BMP inhibitors. To define signals and responses during the first 5 hours of node signals, a differential screen was conducted. Here we describe three early response genes: two of them, Asterix and Obelix, encode previously undescribed proteins of unknown function but Obelix appears to be a nuclear RNA-binding protein. The third is TrkC, a neurotrophin receptor. All three genes are induced by a node graft within 4-5 hours but they differ in the extent to which they are inducible by FGF: FGF is both necessary and sufficient to induce Asterix, sufficient but not necessary to induce Obelix and neither sufficient nor necessary for induction of TrkC. These genes are also not induced by retinoic acid, Noggin, Chordin, Dkk1, Cerberus, HGF/SF, Somatostatin or ionomycin-mediated Calcium entry. Comparison of the expression and regulation of these genes with other early neural markers reveals three distinct "epochs'', or temporal waves, of gene expression accompanying neural induction by a grafted organizer, which are mirrored by specific stages of normal neural plate development. The results are consistent with neural induction being a cascade of responses elicited by different signals, culminating in the formation of a patterned nervous system.	[Pinho, Sonia; Simonsson, Pamela R.; Trevers, Katherine E.; Stower, Matthew J.; Sherlock, William T.; Khan, Mohsin; Sheng, Guojun; Stern, Claudio D.] UCL, Dept Cell & Dev Biol, London, England; [Streit, Andrea] Kings Coll London, Dept Craniofacial Dev, London WC2R 2LS, England	University of London; University College London; University of London; King's College London	Pinho, S (corresponding author), Fac Med Porto, Serv Fisiol, Oporto, Portugal.	c.stern@ucl.ac.uk	Sheng, Guojun/G-8746-2013; Streit, Andrea/F-2683-2010; Stern, Claudio D/C-6265-2008; Sheng, Guojun/I-4900-2015; Sheng, Guojun/G-4116-2014; Stern, Claudio/AAZ-7381-2021	Stern, Claudio D/0000-0002-9907-889X; Stern, Claudio/0000-0002-9907-889X; Streit, Andrea/0000-0001-7664-7917; Khan, Mohsin/0000-0001-8028-2500	Medical Research Council; National Institutes of Health (USA) [R01MH60156]; Portuguese Foundation for Science and Technology (FCT); BBSRC; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060156] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [953782] Funding Source: researchfish; Medical Research Council [G0400559] Funding Source: researchfish; MRC [G0400559] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants from the Medical Research Council and the National Institutes of Health (USA) (R01MH60156). SP was part of the GABBA Programme, University of Porto and was supported by the Portuguese Foundation for Science and Technology (FCT). PRS was supported by a BBSRC quota studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albazerchi A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-25; Albazerchi A, 2007, DEV BIOL, V301, P489, DOI 10.1016/j.ydbio.2006.08.057; Baig MA, 1996, INT J DEV NEUROSCI, V14, P55, DOI 10.1016/0736-5748(95)00076-3; Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; BENNE R, 1978, J BIOL CHEM, V253, P3070; Bernd P, 1999, DEV BRAIN RES, V116, P205, DOI 10.1016/S0165-3806(99)00082-6; Bertocchini F, 2002, DEV CELL, V3, P735, DOI 10.1016/S1534-5807(02)00318-0; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10056, DOI 10.1073/pnas.89.21.10056; CHEN YP, 1992, DEV DYNAM, V195, P142, DOI 10.1002/aja.1001950209; Dale L, 1999, SEMIN CELL DEV BIOL, V10, P319, DOI 10.1006/scdb.1999.0308; DALE L, 1987, DEVELOPMENT, V100, P279; DALE L, 1992, DEVELOPMENT, V115, P573; de Almeida I, 2008, MECH DEVELOP, V125, P421, DOI 10.1016/j.mod.2008.02.002; Delaune E, 2005, DEVELOPMENT, V132, P299, DOI 10.1242/dev.01582; DEVER TE, 1994, J BIOL CHEM, V269, P3212; DIAS MS, 1990, ANAT RECORD, V228, P437, DOI 10.1002/ar.1092280410; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Foley AC, 2000, DEVELOPMENT, V127, P3839; GALLERA J, 1969, J EMBRYOL EXP MORPH, V21, P105; GALLERA J, 1964, J EMBRYOL EXP MORPH, V12, P693; Gallera J., 1971, EXPERIENTIA, V26, P1953; GIBSON A, 2010, REGULATION PRO UNPUB; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; GURDON JB, 1987, DEVELOPMENT, V99, P285; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; KEELING PJ, 1995, MOL MICROBIOL, V17, P399; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Launay C, 1996, DEVELOPMENT, V122, P869; Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445; Linker C, 2009, DEV BIOL, V327, P478, DOI 10.1016/j.ydbio.2008.12.034; LUTHER WOLFGANG, 1935, BIOL ZENTRALBL, V55, P114; Marchal L, 2009, P NATL ACAD SCI USA, V106, P17437, DOI 10.1073/pnas.0906352106; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P326; Oppenheimer JM, 1936, J EXP ZOOL, V72, P409, DOI 10.1002/jez.1400720304; Oppenheimer JM, 1936, P SOC EXP BIOL MED, V34, P461; Papanayotou C, 2008, PLOS BIOL, V6, P109, DOI 10.1371/journal.pbio.0060002; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Sambrook J, 1989, MOL CLONING LABORATO; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Sette M, 1997, EMBO J, V16, P1436, DOI 10.1093/emboj/16.6.1436; Sheng GJ, 2003, CELL, V115, P603, DOI 10.1016/S0092-8674(03)00927-9; Skromne I, 2001, DEVELOPMENT, V128, P2915; SMITH JC, 1989, DEVELOPMENT, V107, P149; SMITH JC, 1983, J EMBRYOL EXP MORPH, V78, P299; SMITH WC, 1993, NATURE, V361, P547, DOI 10.1038/361547a0; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Sorensen HP, 2001, IUBMB LIFE, V51, P321; Spemann Hans., 1924, ROUXS ARCH ENTW MECH, V100, P599, DOI 10.1007/BF02108133; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; STERN CD, 1981, ANAT EMBRYOL, V163, P245, DOI 10.1007/BF00315703; Stern Claudio D., 2008, V461, P265, DOI 10.1007/978-1-60327-483-8_18; STOREY KG, 1992, DEVELOPMENT, V114, P729; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; STREIT A, 1995, DEVELOPMENT, V121, P813; Streit A, 1999, MECH DEVELOP, V85, P85, DOI 10.1016/S0925-4773(99)00085-4; Streit A, 1997, DEVELOPMENT, V124, P1191; Streit A, 1998, DEVELOPMENT, V125, P507; Streit A, 1999, MECH DEVELOP, V82, P51, DOI 10.1016/S0925-4773(99)00013-1; Streit A, 2001, METHODS, V23, P339, DOI 10.1006/meth.2000.1146; Streit A, 2008, METHOD CELL BIOL, V87, P3, DOI 10.1016/S0091-679X(08)00201-X; Tonegawa A, 1997, DEVELOPMENT, V124, P1975; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Waddington C. H., 1937, Archives de Biologie Liege, V48, P273; Waddington CH, 1934, J EXP BIOL, V11, P211; Waddington CH, 1932, PHILOS T R SOC LON B, V221, P179, DOI 10.1098/rstb.1932.0003; Waddington CH, 1933, ROUX ARCH DEV BIOL, V128, P522, DOI 10.1007/BF00649863; Waddington CH, 1930, NATURE, V125, P924, DOI 10.1038/125924b0; Waddington CH, 1933, J EXP BIOL, V10, P38; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Wilson SI, 2001, NATURE, V411, P325, DOI 10.1038/35077115; YAO LH, 1994, DEV BIOL, V165, P727, DOI 10.1006/dbio.1994.1288; Zhang C, 2000, PROTEINS, V40, P409, DOI 10.1002/1097-0134(20000815)40:3<409::AID-PROT60>3.0.CO;2-6; Zhang DM, 1996, DEV DYNAM, V205, P150, DOI 10.1002/(SICI)1097-0177(199602)205:2<150::AID-AJA6>3.0.CO;2-H; ZHANG DM, 1994, J NEUROBIOL, V25, P1517, DOI 10.1002/neu.480251205; Zhu L, 1999, CURR BIOL, V9, P931, DOI 10.1016/S0960-9822(99)80419-9	84	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19157	10.1371/journal.pone.0019157	http://dx.doi.org/10.1371/journal.pone.0019157			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559472	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700082
J	Winsel, S; Sommer, A; Eschenbrenner, J; Mittelstaedt, K; Klar, U; Hammer, S; Hoffmann, J				Winsel, Sebastian; Sommer, Anette; Eschenbrenner, Julia; Mittelstaedt, Kevin; Klar, Ulrich; Hammer, Stefanie; Hoffmann, Jens			Molecular Mode of Action and Role of TP53 in the Sensitivity to the Novel Epothilone Sagopilone (ZK-EPO) in A549 Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							FULLY SYNTHETIC EPOTHILONE; PIFITHRIN-ALPHA; PROLONGED MITOSIS; INDUCED APOPTOSIS; GENE-EXPRESSION; P53 FUNCTION; TUMOR-CELLS; PACLITAXEL; INACTIVATION; ARREST	Sagopilone, an optimized fully synthetic epothilone, is a microtubule-stabilizing compound that has shown high in vitro and in vivo activity against a broad range of human tumor models. We analyzed the differential mechanism of action of sagopilone in non-small cell lung cancer cell lines in vitro. Sagopilone inhibited proliferation of non-small cell lung cancer cell lines at lower nanomolar concentration. The treatment with sagopilone caused strong disturbances of cellular cytoskeletal organization. Two concentration-dependent phenotypes were observed. At 2.5 nM sagopilone or 4 nM paclitaxel an aneuploid phenotype occur whereas a mitotic arrest phenotype was induced by 40 nM sagopilone or paclitaxel. Interestingly, treatment with 2.5 nM of sagopilone effectively inhibited cell proliferation, but - compared to high concentrations (40 nM) - only marginally induced apoptosis. Treatment with a high versus a low concentration of sagopilone or paclitaxel regulates a non-overlapping set of genes, indicating that both phenotypes substantially differ from each other. Genes involved in G2/M phase transition and the spindle assembly checkpoint, like Cyclin B1 and BUBR1 were upregulated by treatment with 40 nM sagopilone. Unexpectedly, also genes involved in DNA damage response were upregulated under that treatment. In contrast, treatment of A549 cells with a low concentration of sagopilone revealed an upregulation of direct transcriptional target genes of TP53, like CDKN1A, MDM2, GADD45A, FAS. Knockdown of TP53, which inhibited the transcriptional induction of TP53 target genes, led to a significant increase in apoptosis induction in A549 cells when treated with a low concentration of sagopilone. The results indicate that activation of TP53 and its downstream effectors like CDKN1A by low concentrations of sagopilone is responsible for the relative apoptosis resistance of A549 cells and might represent a mechanism of resistance to sagopilone.	[Winsel, Sebastian; Sommer, Anette; Eschenbrenner, Julia; Mittelstaedt, Kevin; Klar, Ulrich; Hammer, Stefanie; Hoffmann, Jens] Bayer Healthcare, Global Drug Discovery, Berlin, Germany; [Winsel, Sebastian] Free Univ Berlin, Inst Chem Biochem, D-1000 Berlin, Germany; [Winsel, Sebastian] VTT Tech Res Ctr Finland, Turku, Finland; [Eschenbrenner, Julia] Tech Univ Berlin, Inst Biotechnol, Berlin, Germany; [Mittelstaedt, Kevin] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Hoffmann, Jens] Max Delbruck Ctr Mol Med, Berlin, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Free University of Berlin; VTT Technical Research Center Finland; Technical University of Berlin; University of Melbourne; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Winsel, S (corresponding author), Bayer Healthcare, Global Drug Discovery, Berlin, Germany.	stefanie.hammer@bayer.com; jens.hoffmann@mdc-berlin.de	Sommer, Anette/T-7674-2019	Sommer, Anette/0000-0002-1576-3110; Hoffmann, Jens/0000-0003-3880-1658	Bayer Healthcare	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals)	The work was funded by the Bayer Healthcare (www.bayerhealthcare.com). The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. All the authors are employees or former employees of the Bayer Healthcare. Grant support in detail: S. Winsel, J. Eschenbrenner, K. Mittelstaedt recieved commercial research grants from Bayer Healthcare; A. Sommer, U. Klar, S. Hammer, J. Hoffmann are current or former employes of Bayer Healthcare and hold patents on Bayer Healthcare as well as shares on Bayer.	Altaha R, 2004, INT J MOL MED, V14, P959; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Bergstralh DT, 2004, J CHEMOTHERAPY, V16, P563, DOI 10.1179/joc.2004.16.6.563; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Blagosklonny MV, 2006, CELL CYCLE, V5, P971, DOI 10.4161/cc.5.9.2711; Blagosklonny MV, 1999, INT J CANCER, V83, P151, DOI 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5; Cassinelli G, 2001, INT J CANCER, V92, P738, DOI 10.1002/1097-0215(20010601)92:5<738::AID-IJC1249>3.0.CO;2-2; Castedo M, 2002, J IMMUNOL METHODS, V265, P39, DOI 10.1016/S0022-1759(02)00069-8; Chen JG, 2003, CANCER RES, V63, P7891; Coate LE, 2009, LANCET ONCOL, V10, P1001, DOI 10.1016/S1470-2045(09)70155-X; Das S, 2008, CELL CYCLE, V7, P154, DOI 10.4161/cc.7.2.5236; Demidenko ZN, 2008, ONCOGENE, V27, P4402, DOI 10.1038/onc.2008.82; Fan SJ, 1998, CLIN CANCER RES, V4, P1047; FISCHER J, 2008, ESMO, V33; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Gazdar AF, 2009, NEW ENGL J MED, V361, P1018, DOI 10.1056/NEJMe0905763; Gudkov AV, 2005, BIOCHEM BIOPH RES CO, V331, P726, DOI 10.1016/j.bbrc.2005.03.153; Hammer S, 2010, CLIN CANCER RES, V16, P1452, DOI 10.1158/1078-0432.CCR-09-2455; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hawkins DS, 1996, CANCER RES, V56, P892; Heliez C, 2003, ONCOGENE, V22, P3260, DOI 10.1038/sj.onc.1206409; Hoagland MS, 2005, J PHARMACOL EXP THER, V314, P603, DOI 10.1124/jpet.105.084186; Hoffmann J, 2008, CANCER RES, V68, P5301, DOI 10.1158/0008-5472.CAN-08-0237; HORNER MJ, 2009, SEER CANC STAT REV; Horwitz Susan Band, 1993, Journal of the National Cancer Institute Monographs, V0, P55; Ioffe ML, 2004, PROSTATE, V61, P243, DOI 10.1002/pros.20108; Janicke RU, 2007, CELL CYCLE, V6, P407; Jin SF, 1997, EMBO J, V16, P6874, DOI 10.1093/emboj/16.22.6874; Kaji A, 2003, MOL CARCINOGEN, V37, P138, DOI 10.1002/mc.10130; Klar U, 2006, ANGEW CHEM INT EDIT, V45, P7942, DOI 10.1002/anie.200602785; Lichtner RB, 2001, P NATL ACAD SCI USA, V98, P11743, DOI 10.1073/pnas.171023398; Ling YH, 2000, ANTICANCER RES, V20, P693; Mozzetti S, 2008, CANCER RES, V68, P10197, DOI 10.1158/0008-5472.CAN-08-2091; Murphy PJM, 2004, J BIOL CHEM, V279, P30195, DOI 10.1074/jbc.M403539200; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; National Cancer Institute, GEN INF NONSM CELL L; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; OConnor PM, 1997, CANCER RES, V57, P4285; POPANDA O, 1992, BIOCHIM BIOPHYS ACTA, V1129, P155, DOI 10.1016/0167-4781(92)90480-N; Rigas JR, 2004, ONCOLOGIST, V9, P16, DOI 10.1634/theoncologist.9-suppl_2-16; Riley KJL, 2007, RNA, V13, P1825, DOI 10.1261/rna.673407; Schmid P, 2010, ANN ONCOL, V21, P633, DOI 10.1093/annonc/mdp491; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Seve Pascal, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P73, DOI 10.2174/1568011053352604; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sohn D, 2009, CELL DEATH DIFFER, V16, P869, DOI 10.1038/cdd.2009.17; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Suzuki A, 1999, ONCOGENE, V18, P1239, DOI 10.1038/sj.onc.1202409; Tomizawa Y, 1999, ONCOGENE, V18, P1007, DOI 10.1038/sj.onc.1202384; Torres K, 1998, CANCER RES, V58, P3620; Vikhanskaya F, 1998, EXP CELL RES, V241, P96, DOI 10.1006/excr.1998.4018; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Xu SQ, 2000, BIOCHEM BIOPH RES CO, V269, P179, DOI 10.1006/bbrc.2000.2247; Zuco V, 2008, NEOPLASIA, V10, P587, DOI 10.1593/neo.08262	54	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19273	10.1371/journal.pone.0019273	http://dx.doi.org/10.1371/journal.pone.0019273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559393	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000290024700122
J	Yang, XH; Boateng, KA; Yuan, L; Wu, S; Baskin, TI; Makaroff, CA				Yang, Xiaohui; Boateng, Kingsley A.; Yuan, Li; Wu, Shuang; Baskin, Tobias I.; Makaroff, Christopher A.			The Radially Swollen 4 Separase Mutation of Arabidopsis thaliana Blocks Chromosome Disjunction and Disrupts the Radial Microtubule System in Meiocytes	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; MEIOSIS-I; CAENORHABDITIS-ELEGANS; ANAPHASE ONSET; ARM COHESION; CLEAVAGE; PROTEIN; PROPHASE; MITOSIS; CELLS	The caspase-family protease, separase, is required at the onset of anaphase to cleave the cohesin complex that joins replicated sister chromatids. However, in various eukaryotes, separase has acquired additional and distinct functions. A single amino-acid substitution in separase is responsible for phenotypes of the Arabidopsis thaliana mutant, radially swollen 4 (rsw4). This is a conditional mutant, resembling the wild type at the permissive temperature (similar to 20 degrees C) and expressing mutant phenotypes at the restrictive temperature (similar to 30 degrees C). Root cells in rsw4 at the restrictive temperature undergo nondisjunction and other indications of the loss of separase function. To determine to what extent separase activity remains at 30 degrees C, we examined the effect of the mutation on meiosis, where the effects of loss of separase activity through RNA interference are known; and in addition, we examined female gametophyte development. Here, we report that, at the restrictive temperature, replicated chromosomes in rsw4 meiocytes typically fail to disjoin and the cohesin complex remains at centromeres after metaphase. Meiotic spindles appear normal in rsw4 male meiocytes; however the mutation disrupts the radial microtubule system, which is replaced by asymmetric arrays. Surprisingly, female gametophyte development was relatively insensitive to loss of separase activity, through either rsw4 or RNAi. These effects confirm that phenotypes in rsw4 result from loss of separase activity and establish a role for separase in regulating cell polarization following male meiosis.	[Yang, Xiaohui; Boateng, Kingsley A.; Yuan, Li; Makaroff, Christopher A.] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA; [Wu, Shuang; Baskin, Tobias I.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University System of Ohio; Miami University; University of Massachusetts System; University of Massachusetts Amherst	Yang, XH (corresponding author), Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA.	makaroca@muohio.edu	Wu, Shuang/M-1839-2013; Yuan, Li/D-6069-2015; Baskin, Tobias/W-5011-2019	Yuan, Li/0000-0003-1803-6661; Makaroff, Christopher/0000-0001-6237-1868	United States National Science Foundation [MCB-0718191]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG-03ER15421]	United States National Science Foundation(National Science Foundation (NSF)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by a grant (MCB-0718191)from the United States National Science Foundation to CAM and by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy through Grant DE-FG-03ER15421 (to TIB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bembenek JN, 2007, DEVELOPMENT, V134, P3837, DOI 10.1242/dev.011361; Brown RC, 2001, PROTOPLASMA, V215, P35, DOI 10.1007/BF01280302; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Cai X, 2003, J CELL SCI, V116, P2999, DOI 10.1242/jcs.00601; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; Fransz PF, 1996, PLANT J, V9, P421, DOI 10.1046/j.1365-313X.1996.09030421.x; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Lam WS, 2005, J CELL SCI, V118, P3037, DOI 10.1242/jcs.02443; Lee J, 2003, J CELL SCI, V116, P2781, DOI 10.1242/jcs.00495; Liu Z, 2006, PLANT CELL, V18, P1213, DOI 10.1105/tpc.105.036913; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Otegui MS, 2004, PLANT CELL PHYSIOL, V45, pS10; Pandey R, 2005, J CELL SCI, V118, P733, DOI 10.1242/jcs.01663; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Queralt E, 2005, NAT CELL BIOL, V7, P930, DOI 10.1038/ncb1005-930; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rappleye CA, 2002, DEV CELL, V2, P195, DOI 10.1016/S1534-5807(02)00114-4; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; Shepard JL, 2007, GENE DEV, V21, P55, DOI 10.1101/gad.1470407; Siomos MF, 2001, CURR BIOL, V11, P1825, DOI 10.1016/S0960-9822(01)00588-7; STAIGER CJ, 1990, DEV BIOL, V138, P231, DOI 10.1016/0012-1606(90)90193-M; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wiedemeier AMD, 2002, DEVELOPMENT, V129, P4821; Wu S, 2010, DEVELOPMENT, V137, P953, DOI 10.1242/dev.041939; Xiong B, 2010, ANNU REV BIOCHEM, V79, P131, DOI 10.1146/annurev-biochem-061708-092640; YANG X, 2006, J CELL SCI, V19, P4025; Yang XH, 2009, PLANT PHYSIOL, V151, P323, DOI 10.1104/pp.109.140699; Yu HG, 2005, CELL, V123, P397, DOI 10.1016/j.cell.2005.09.014	44	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19459	10.1371/journal.pone.0019459	http://dx.doi.org/10.1371/journal.pone.0019459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559383	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700183
J	Wen, JM; Grenz, A; Zhang, YJ; Dai, YB; Kellems, RE; Blackburn, MR; Eltzschig, HK; Xia, Y				Wen, Jiaming; Grenz, Almut; Zhang, Yujin; Dai, Yingbo; Kellems, Rodney E.; Blackburn, Michael R.; Eltzschig, Holger K.; Xia, Yang			A(2B) adenosine receptor contributes to penile erection via PI3K/AKT signaling cascade-mediated eNOS activation	FASEB JOURNAL			English	Article						shear stress; vascular tone; CD73; erectile function	DEAMINASE-DEFICIENT MICE; NITRIC-OXIDE SYNTHASE; AKT-DEPENDENT PHOSPHORYLATION; ENDOTHELIAL-CELLS; PULMONARY-FIBROSIS; ADENINE-NUCLEOTIDES; CORPUS CAVERNOSUM; PRIAPISM; TISSUE; ESTABLISHMENT	Normal penile erection is under the control of multiple factors and signaling pathways. Although adenosine signaling is implicated in normal and abnormal penile erection, the exact role and the underlying mechanism for adenosine signaling in penile physiology remain elusive. Here we report that shear stress leads to increased adenosine release from endothelial cells. Subsequently, we determined that ecto-5'-nucleotidase (CD73) is a key enzyme required for the production of elevated adenosine from ATP released by shear-stressed endothelial cells. Mechanistically, we demonstrate that shear stress-mediated elevated adenosine functions through the adenosine A(2B) receptor (A(2B)R) to activate the PI3K/AKT signaling cascade and subsequent increased endothelial nitric oxide synthase (eNOS) phosphorylation. These in vitro studies led us to discover further that adenosine was induced during sustained penile erection and contributes to PI3K/AKT activation and subsequent eNOS phosphorylation via A(2B)R signaling in intact animal. Finally, we demonstrate that lowering adenosine in wild-type mice or genetic deletion of A(2B)R in mutant mice significantly attenuated PI3K/AKT activation, eNOS phosphorylation, and subsequent impaired penile erection featured with the reduction of ratio of maximal intracavernosal pressure to systemic arterial pressure from 0.49 +/- 0.03 to 0.41 +/- 0.05 and 0.38 +/- 0.04, respectively (both P < 0.05). Overall, using biochemical, cellular, genetic, and physiological approaches, our findings reveal that adenosine is a novel molecule signaling via A(2B)R activation, contributing to penile erection via PI3K/AKT-dependent eNOS activation. These studies suggest that this signaling pathway may be a novel therapeutic target for erectile disorders.-Wen, J., Grenz, A., Zhang, Y., Dai, Y., Kellems, R. E., Blackburn, M. R., Eltzschig, H. K., Xia, Y. A(2B) adenosine receptor contributes to penile erection via PI3K/AKT signaling cascade-mediated eNOS activation. FASEB J. 25, 2823-2830 (2011). www.fasebj.org	[Wen, Jiaming; Zhang, Yujin; Dai, Yingbo; Kellems, Rodney E.; Blackburn, Michael R.; Xia, Yang] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX USA; [Wen, Jiaming; Dai, Yingbo] Cent S Univ, Xiangya Hosp 3, Dept Urol, Changsha, Hunan, Peoples R China; [Grenz, Almut; Eltzschig, Holger K.] Univ Colorado, Dept Anesthesiol, Denver, CO 80202 USA	University of Texas System; University of Texas Health Science Center Houston; Central South University; University of Colorado System; University of Colorado Denver	Xia, Y (corresponding author), Univ Texas Houston, Med Sch Houston, Dept Biochem & Mol Biol, 6431 Fannin St,MSB 6-200, Houston, TX 77030 USA.	yang.xia@uth.tmc.edu		Blackburn, Michael/0000-0002-1394-9966	U.S. National Institute of Health [DK077748, DK083559, HL070952, HL092188]; China Scholarship Council [2008637068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092188, R01HL070952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083559, R21DK077748] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institute of Health grants DK077748 and DK083559 (to Y.X.), HL070952 (to M.R.B.), and HL092188 (to H.E.) and China Scholarship Council grant 2008637068 (to J.W.). The authors declare no conflicts of interest.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Bivalacqua TJ, 2009, J SEX MED, V6, P2494, DOI 10.1111/j.1743-6109.2009.01359.x; Blackburn MR, 2000, J BIOL CHEM, V275, P32114, DOI 10.1074/jbc.M005153200; Blackburn MR, 1996, J BIOL CHEM, V271, P15203, DOI 10.1074/jbc.271.25.15203; Blackburn MR, 1998, J BIOL CHEM, V273, P5093, DOI 10.1074/jbc.273.9.5093; Burnett AL, 2003, J ANDROL, V24, pS2; BURNETT AL, 1992, SCIENCE, V257, P401, DOI 10.1126/science.1378650; Champion HC, 2005, P NATL ACAD SCI USA, V102, P1661, DOI 10.1073/pnas.0407183102; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chunn JL, 2006, AM J PHYSIOL-LUNG C, V290, pL579, DOI 10.1152/ajplung.00258.2005; Chunn JL, 2005, J IMMUNOL, V175, P1937, DOI 10.4049/jimmunol.175.3.1937; da Silva CG, 2009, CIRCULATION, V119, P871, DOI 10.1161/CIRCULATIONAHA.108.764571; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Faria M, 2006, J PHARMACOL EXP THER, V319, P405, DOI 10.1124/jpet.106.107821; Feoktistov I, 2002, CIRC RES, V90, P531, DOI 10.1161/01.RES.0000012203.21416.14; Filippi S, 2000, INT J ANDROL, V23, P210, DOI 10.1046/j.1365-2605.2000.00232.x; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 2001, PHARMACOL REV, V53, P527; GORDON EL, 1986, J BIOL CHEM, V261, P5496; Gorman MW, 2003, LUMINESCENCE, V18, P173, DOI 10.1002/bio.721; Hurt KJ, 2002, P NATL ACAD SCI USA, V99, P4061, DOI 10.1073/pnas.052712499; Kilic S, 1994, Int J Impot Res, V6, P191; Lin CS, 2005, J SEX MED, V2, P478, DOI 10.1111/j.1743-6109.2005.00080.x; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; LONDOS C, 1980, P NATL ACAD SCI-BIOL, V77, P2551, DOI 10.1073/pnas.77.5.2551; Lue TF, 2000, NEW ENGL J MED, V342, P1802, DOI 10.1056/NEJM200006153422407; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; Noto T, 2001, EUR J PHARMACOL, V425, P51, DOI 10.1016/S0014-2999(01)01167-0; Phatarpekar PV, 2010, J SEX MED, V7, P3553, DOI 10.1111/j.1743-6109.2009.01555.x; Schilder RJ, 2008, J CLIN ONCOL, V26, P3418, DOI 10.1200/JCO.2007.14.3420; Shalev M, 1999, J UROLOGY, V161, P955, DOI 10.1016/S0022-5347(01)61828-7; Sharifzadeh M, 1995, GEN PHARMACOL-VASC S, V26, P1785, DOI 10.1016/0306-3623(95)00114-X; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Stiles Gary L., 1997, P29; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55; Xie DH, 2005, J SEX MED, V2, P634, DOI 10.1111/j.1743-6109.2005.00111.x; Yegutkin G, 2000, BRIT J PHARMACOL, V129, P921, DOI 10.1038/sj.bjp.0703136; Yonezawa Akihiko, 2002, Nihon Rinsho, V60 Suppl 6, P52; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224	41	33	35	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2011	25	8					2823	2830		10.1096/fj.11-181057	http://dx.doi.org/10.1096/fj.11-181057			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21566208	Green Published			2022-12-25	WOS:000293337800030
J	Michalski, JP; Anderson, C; Beauvais, A; De Repentigny, Y; Kothary, R				Michalski, John-Paul; Anderson, Carrie; Beauvais, Ariane; De Repentigny, Yves; Kothary, Rashmi			The Proteolipid Protein Promoter Drives Expression outside of the Oligodendrocyte Lineage during Embryonic and Early Postnatal Development	PLOS ONE			English	Article							SOMA-RESTRICTED PRODUCTS; NERVOUS-SYSTEM MYELIN; DM-20 MESSENGER-RNA; TRANSGENIC MICE; PLP GENE; IN-VIVO; CELLS; MOUSE; NEURONS; PROGENITORS	The proteolipid protein (Plp) gene promoter is responsible for driving expression of one of the major components of myelin - PLP and its splice variant DM-20. Both products are classically thought to express predominantly in oligodendrocytes. However, accumulating evidence suggests Plp expression is more widespread than previously thought. In an attempt to create a mouse model for inducing oligodendrocyte-specific gene deletions, we have generated transgenic mice expressing a Cre recombinase cDNA under control of the mouse Plp promoter. We demonstrate Plp promoter driven Cre expression is restricted predominantly to mature oligodendrocytes of the central nervous system (CNS) at postnatal day 28. However, crosses into the Rosa26(LacZ) and mT/mG reporter mouse lines reveal robust and widespread Cre activity in neuronal tissues at E15.5 and E10.5 that is not strictly oligodendrocyte lineage specific. By P28, all CNS tissues examined displayed high levels of reporter gene expression well outside of defined white matter zones. Importantly, our study reinforces the emerging idea that Plp promoter activity is not restricted to the myelinating cell lineage, but rather, has widespread activity both during embryonic and early postnatal development in the CNS. Specificity of the promoter to the oligodendrocyte cell lineage, as shown through the use of a tamoxifen inducible Plp-CreER(t) line, occurs only at later postnatal stages. Understanding the temporal shift in Plp driven expression is of consequence when designing experimental models to study oligodendrocyte biology.	[Michalski, John-Paul; Anderson, Carrie; Beauvais, Ariane; De Repentigny, Yves; Kothary, Rashmi] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Michalski, John-Paul] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Kothary, Rashmi] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Michalski, JP (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.	rkothary@ohri.ca		Kothary, Rashmi/0000-0002-9239-7310	Multiple Sclerosis Society of Canada	Multiple Sclerosis Society of Canada	This work was supported by a grant from the Multiple Sclerosis Society of Canada to R.K. J-P.M. is supported by a Studentship from the Multiple Sclerosis Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bongarzone ER, 1999, J NEUROSCI, V19, P8349; CAMPAGNONI CW, 1992, J NEUROSCI RES, V33, P148, DOI 10.1002/jnr.490330119; Delaunay D, 2008, J NEUROSCI, V28, P2551, DOI 10.1523/JNEUROSCI.5497-07.2008; Dickinson PJ, 1997, J NEUROCYTOL, V26, P181, DOI 10.1023/A:1018584013739; Dickinson PJ, 1996, NEUROPATH APPL NEURO, V22, P188; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Fuss B, 2001, MOL CELL NEUROSCI, V18, P221, DOI 10.1006/mcne.2001.1011; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Greenfield EA, 2006, J NEUROSCI RES, V83, P415, DOI 10.1002/jnr.20748; Guo FZ, 2009, J NEUROSCI, V29, P7256, DOI 10.1523/JNEUROSCI.5653-08.2009; IKENAKA K, 1992, J NEUROCHEM, V58, P2248, DOI 10.1111/j.1471-4159.1992.tb10970.x; Jacobs EC, 2004, NEUROCHEM RES, V29, P997, DOI 10.1023/B:NERE.0000021244.38279.c4; Jacobs EC, 2003, DEV NEUROSCI-BASEL, V25, P96, DOI 10.1159/000072259; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; Le Bras B, 2005, INT J DEV BIOL, V49, P209, DOI 10.1387/ijdb.041963bl; MACKLIN WB, 1987, J NEUROSCI RES, V18, P383, DOI 10.1002/jnr.490180302; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Miller MJ, 2009, J NEUROSCI RES, V87, P2842, DOI 10.1002/jnr.22121; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nadon NL, 1997, INT J DEV NEUROSCI, V15, P285, DOI 10.1016/S0736-5748(97)00009-9; Nadon NL, 1998, DEV NEUROSCI-BASEL, V20, P533, DOI 10.1159/000017354; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; Pribyl TM, 1996, J NEUROIMMUNOL, V67, P125; Pribyl TM, 1996, J NEUROSCI RES, V45, P812; PUCKETT C, 1987, J NEUROSCI RES, V18, P511, DOI 10.1002/jnr.490180402; Sarret C, 2010, NEUROSCIENCE, V166, P522, DOI 10.1016/j.neuroscience.2009.12.047; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spassky N, 1998, J NEUROSCI, V18, P8331; TIMSIT S, 1995, J NEUROSCI, V15, P1012; TIMSIT SG, 1992, J NEUROCHEM, V58, P1172, DOI 10.1111/j.1471-4159.1992.tb09378.x; Tuason MC, 2008, J NEUROSCI, V28, P6895, DOI 10.1523/JNEUROSCI.4579-07.2008; WIGHT PA, 1993, J CELL BIOL, V123, P443, DOI 10.1083/jcb.123.2.443; Ye P, 2003, J NEUROSCI, V23, P4401	34	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19772	10.1371/journal.pone.0019772	http://dx.doi.org/10.1371/journal.pone.0019772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572962	Green Submitted, gold, Green Published			2022-12-25	WOS:000290440200029
J	Bajwa, EK; Cremer, PC; Gong, MN; Zhai, RH; Su, L; Thompson, BT; Christiani, DC				Bajwa, Ednan K.; Cremer, Paul C.; Gong, Michelle N.; Zhai, Rihong; Su, Li; Thompson, B. Taylor; Christiani, David C.			An NFKB1 Promoter Insertion/Deletion Polymorphism Influences Risk and Outcome in Acute Respiratory Distress Syndrome among Caucasians	PLOS ONE			English	Article							NF-KAPPA-B; FACTOR GENE POLYMORPHISMS; LUNG INFLAMMATION; ARDS; SUSCEPTIBILITY; ASSOCIATION; MECHANISMS; MORTALITY; DISEASES; PATHWAY	Background: Nuclear factor-kappa B (NF-kappa B) is required for transcription of many pro-inflammatory genes and has been implicated in the pathogenesis of acute respiratory distress syndrome (ARDS). We hypothesized that a known functional polymorphism in the promoter of the NFKB1 gene may affect susceptibility to and outcome from ARDS. Methods: A case control study was conducted among a cohort of patients admitted to the intensive care unit (ICU) with risk factors for the development of ARDS. 379 patients with ARDS and 793 at-risk controls were studied. Patients were followed for 60 days with development of ARDS as a primary outcome; ARDS-related mortality and organ dysfunction were secondary outcomes. Results: Patients homozygous for the 4 base pair deletion in the promoter of NFKB1 (del/del) did not have an increased odds ratio (OR) of developing ARDS in unadjusted analysis but were more likely to develop ARDS in the presence of a significant interaction between the del/del genotype and age (OR 5.21, 95% CI 1.35-20.0). In multivariate analysis, patients with ARDS and the del/del genotype also had increased 60 day mortality (HR 1.54, 95% CI 1.01-2.36) and more severe daily organ dysfunction (P <.001) when compared to ARDS patients with other genotypes. Conclusion: The del/del genotype is associated with an age-dependent increase in odds of developing ARDS. Patients with the del/del genotype and ARDS also have increased hazard of 60 day mortality and more organ failure.	[Bajwa, Ednan K.; Cremer, Paul C.; Thompson, B. Taylor; Christiani, David C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Pulm & Crit Care Unit,Dept Med, Boston, MA 02115 USA; [Gong, Michelle N.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Crit Care Med,Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Zhai, Rihong; Su, Li; Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Bajwa, EK (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Pulm & Crit Care Unit,Dept Med, Boston, MA 02115 USA.	dchris@hsph.harvard.edu		Bajwa, Ednan/0000-0001-9026-1009	National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) [HL60710, HL67197, HL07874, ES0002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060710, K23HL067197, T32HL007874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) grants HL60710, HL67197, HL07874, and ES0002 (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamzik M, 2007, INTENS CARE MED, V33, P1199, DOI 10.1007/s00134-007-0649-4; Albani D, 2009, AGE, V31, P155, DOI 10.1007/s11357-009-9092-5; Bajwa EK, 2007, CRIT CARE MED, V35, P1290, DOI 10.1097/01.CCM.0000260243.22758.4F; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Cheng DS, 2007, J IMMUNOL, V178, P6504, DOI 10.4049/jimmunol.178.10.6504; Christman JW, 2000, CHEST, V117, P1482, DOI 10.1378/chest.117.5.1482; Di Bona D, 2009, AGEING RES REV, V8, P36, DOI 10.1016/j.arr.2008.09.001; Gadjeva M, 2004, J IMMUNOL, V173, P5786, DOI 10.4049/jimmunol.173.9.5786; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gong MN, 2006, EUR RESPIR J, V27, P674, DOI 10.1183/09031936.06.00046405; Gong MN, 2005, EUR RESPIR J, V26, P382, DOI 10.1183/09031936.05.00000505; Han W, 2009, AM J PHYSIOL-LUNG C, V296, pL320, DOI 10.1152/ajplung.90485.2008; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hildebrand F, 2007, CYTOKINE, V37, P192, DOI 10.1016/j.cyto.2007.03.008; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Invidia L, 2010, BIOGERONTOLOGY, V11, P67, DOI 10.1007/s10522-009-9229-z; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Lasky-Su J, 2008, AM J HUM GENET, V82, P849, DOI 10.1016/j.ajhg.2008.01.018; Marik PE, 2001, J AM GERIATR SOC, V49, P5, DOI 10.1046/j.1532-5415.2001.49003.x; Marshall RP, 2002, CHEST, V121, p68S, DOI 10.1378/chest.121.3_suppl.68S; Mizgerd JP, 2003, AM J RESP CRIT CARE, V168, P810, DOI 10.1164/rccm.200303-412OC; Piantadosi CA, 2004, ANN INTERN MED, V141, P460, DOI 10.7326/0003-4819-141-6-200409210-00012; Schwartz MD, 1996, CRIT CARE MED, V24, P1285, DOI 10.1097/00003246-199608000-00004; Sheu CC, 2009, EUR RESPIR J, V33, P543, DOI 10.1183/09031936.00091308; Su L, 2009, INTENS CARE MED, V35, P1024, DOI 10.1007/s00134-009-1413-8; Zhai RH, 2007, CRIT CARE MED, V35, P893, DOI 10.1097/01.CCM.0000256845.92640.38	29	15	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19469	10.1371/journal.pone.0019469	http://dx.doi.org/10.1371/journal.pone.0019469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573030	Green Published, gold, Green Submitted			2022-12-25	WOS:000290386800013
J	Kelley, AL; Karita, E; Sullivan, PS; Katangulia, F; Chomba, E; Carael, M; Telfair, J; Dunham, SM; Vwalika, CM; Kautzman, MG; Wall, KM; Allen, SA				Kelley, April L.; Karita, Etienne; Sullivan, Patrick S.; Katangulia, Francois; Chomba, Elwyn; Carael, Michel; Telfair, Joseph; Dunham, Steve M.; Vwalika, Cheswa M.; Kautzman, Michele G.; Wall, Kristin M.; Allen, Susan A.			Knowledge and Perceptions of Couples' Voluntary Counseling and Testing in Urban Rwanda and Zambia: A Cross-Sectional Household Survey	PLOS ONE			English	Article							HIV-SEROSTATUS DISCLOSURE; IMMUNODEFICIENCY-VIRUS TYPE-1; DAR-ES-SALAAM; DISCORDANT COUPLES; ANTENATAL CLINICS; SEXUAL PARTNERS; PREGNANT-WOMEN; CONDOM USE; TRANSMISSION; PREVENTION	Background: Most incident HIV infections in sub-Saharan Africa occur between cohabiting, discordant, heterosexual couples. Though couples' voluntary HIV counseling and testing (CVCT) is an effective, well-studied intervention in Africa < 1% of couples have been jointly tested. Methods: We conducted cross-sectional household surveys in Kigali, Rwanda (n = 600) and Lusaka, Zambia (n = 603) to ascertain knowledge, perceptions, and barriers to use of CVCT. Results: Compared to Lusaka, Kigali respondents were significantly more aware of HIV testing sites (79% vs. 56%); had greater knowledge of HIV serodiscordance between couples (83% vs. 43%); believed CVCT is good (96% vs. 72%); and were willing to test jointly (91% vs. 47%). Stigma, fear of partner reaction, and distance/cost/logistics were CVCT barriers. Conclusions: Though most respondents had positive attitudes toward CVCT, the majority were unaware that serodiscordance between cohabiting couples is possible. Future messages should target gaps in knowledge about serodiscordance, provide logistical information about CVCT services, and aim to reduce stigma and fear.	[Kelley, April L.; Karita, Etienne] Rwanda Zambia HIV Res Grp, Project San Francisco, Kigali, Rwanda; [Sullivan, Patrick S.; Wall, Kristin M.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Katangulia, Francois] Social Sci Syst Inc, Monitoring & Evaluation Management Serv SSS MEMS, Kigali, Rwanda; [Chomba, Elwyn; Dunham, Steve M.; Vwalika, Cheswa M.; Kautzman, Michele G.] Rwanda Zambia HIV Res Grp, Zambia Emory HIV Res Project, Lusaka, Zambia; [Carael, Michel] UNAIDS, Geneva, Switzerland; [Telfair, Joseph] Univ N Carolina, Dept Publ Hlth Res & Practice, Ctr Social Community & Hlth Res & Evaluat, Greensboro, NC 27412 USA; [Allen, Susan A.] Emory Univ, Dept Pathol & Lab Sci, Sch Med, Dept Epidemiol, Atlanta, GA 30322 USA; [Allen, Susan A.] Emory Univ, Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; UNAIDS; University of North Carolina; University of North Carolina Greensboro; Emory University; Emory University; Rollins School Public Health	Kelley, AL (corresponding author), Rwanda Zambia HIV Res Grp, Project San Francisco, Kigali, Rwanda.	kmwall@emory.edu		Sullivan, Patrick Sean/0000-0002-7728-0587	National Institute of Mental Health (NIMH) [R01 MH66767]; Fogarty AIDS International Training and Research Program (AITRP) [FIC 2D43 TW001042]; Emory Center for AIDS Research (CFAR) [P30 AI050409]; International AIDS Vaccine Initiative; FOGARTY INTERNATIONAL CENTER [D43TW001042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066767] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fogarty AIDS International Training and Research Program (AITRP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Emory Center for AIDS Research (CFAR); International AIDS Vaccine Initiative; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funding from the National Institute of Mental Health (NIMH) Grant No. R01 MH66767, Fogarty AIDS International Training and Research Program (AITRP) FIC 2D43 TW001042, the Emory Center for AIDS Research (CFAR) P30 AI050409, and the International AIDS Vaccine Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; ALLEN S, 1992, JAMA-J AM MED ASSOC, V268, P3338, DOI 10.1001/jama.268.23.3338; Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; Angotti N, 2009, SOC SCI MED, V68, P2263, DOI 10.1016/j.socscimed.2009.02.041; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Baiden F, 2007, J BIOSOC SCI, V39, P721, DOI 10.1017/S0021932006001829; Bakari JP, 2000, ANN NY ACAD SCI, V918, P64; Bentley ME, 1998, AIDS, V12, P1869, DOI 10.1097/00002030-199814000-00019; Bunnell RE, 2005, AIDS CARE, V17, P999, DOI 10.1080/09540120500100718; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Castle S, 2003, HEALTH POLICY PLANN, V18, P146, DOI 10.1093/heapol/czg019; Centers for Disease Control (CDC), 2007, COUPL HIV COUNS TEST; CHOMBA E, 2007, J ACQUIR IMMUNE DEFI; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Conkling M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-10; de Zoysa I, 1996, AIDS, V10 Suppl A, pS197, DOI 10.1097/00002030-199601001-00028; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Fylkesnes K, 2004, TROP MED INT HEALTH, V9, P566, DOI 10.1111/j.1365-3156.2004.01231.x; Gaillard P, 2002, AIDS, V16, P937, DOI 10.1097/00002030-200204120-00019; Gaillard P, 2000, AIDS, V14, P2341, DOI 10.1097/00002030-200010200-00015; Ginwalla SK, 2002, AIDS CARE, V14, P707, DOI 10.1080/0954012021000005533; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Grinstead OA, 2001, AIDS, V15, P1045, DOI 10.1097/00002030-200105250-00013; Hudson CP, 1996, INT J STD AIDS, V7, P302, DOI 10.1258/0956462961917906; *INSR, RWAND DEM HLTH SURV; KAMENGA M, 1991, AIDS, V5, P61, DOI 10.1097/00002030-199101000-00009; KEOGH P, 1994, SOC SCI MED, V38, P1047, DOI 10.1016/0277-9536(94)90221-6; King R, 2008, AIDS BEHAV, V12, P232, DOI 10.1007/s10461-007-9307-7; Lie GT, 1996, AIDS CARE, V8, P285, DOI 10.1080/09540129650125713; Maman S, 2003, AIDS BEHAV, V7, P373, DOI 10.1023/B:AIBE.0000004729.89102.d4; Maman S, 2001, AIDS CARE, V13, P595, DOI 10.1080/09540120120063223; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; McKenna SL, 1997, AIDS, V11, pS103; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Mlay R, 2008, AIDS CARE, V20, P356, DOI 10.1080/09540120701561304; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Mutale W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-347; Painter TM, 2001, SOC SCI MED, V53, P1397, DOI 10.1016/S0277-9536(00)00427-5; Pool R, 2001, AIDS CARE, V13, P605, DOI 10.1080/09540120120063232; Skurnick JH, 1998, CLIN INFECT DIS, V26, P855, DOI 10.1086/513929; Skurnick JH, 1998, AIDS EDUC PREV, V10, P493; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; SWEAT M, 1998, INT C AIDS, V12, P467; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; *UNAIDS, 2008, 2008 REP GLOB AIDS E; van Dyk AC, 2003, S AFR J PSYCHOL, V33, P118, DOI 10.1177/008124630303300207; VANDERSTRATEN A, 1995, AIDS, V9, P935, DOI 10.1097/00002030-199508000-00016; VANDERSTRATEN A, 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; Were WA, 2006, JAIDS-J ACQ IMM DEF, V43, P91, DOI 10.1097/01.qai.0000225021.81384.28	50	33	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19573	10.1371/journal.pone.0019573	http://dx.doi.org/10.1371/journal.pone.0019573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	761GX	21573068	Green Published, gold			2022-12-25	WOS:000290386800019
J	Rautiainen, A; Wernick, I; Waggoner, PE; Ausubel, JH; Kauppi, PE				Rautiainen, Aapo; Wernick, Iddo; Waggoner, Paul E.; Ausubel, Jesse H.; Kauppi, Pekka E.			A National and International Analysis of Changing Forest Density	PLOS ONE			English	Article								Like cities, forests grow by spreading out or by growing denser. Both inventories taken steadily by a single nation and other inventories gathered recently from many nations by the United Nations confirm the asynchronous effects of changing area and of density or volume per hectare. United States forests spread little after 1953, while growing density per hectare increased national volume and thus sequestered carbon. The 2010 United Nations appraisal of global forests during the briefer span of two decades after 1990 reveals a similar pattern: A slowing decline of area with growing volume means growing density in 68 nations encompassing 72% of reported global forest land and 68% of reported global carbon mass. To summarize, the nations were placed in 5 regions named for continents. During 1990-2010 national density grew unevenly, but nevertheless grew in all regions. Growing density was responsible for substantially increasing sequestered carbon in the European and North American regions, despite smaller changes in area. Density nudged upward in the African and South American regions as area loss outstripped the loss of carbon. For the Asian region, density grew in the first decade and fell slightly in the second as forest area expanded. The different courses of area and density disqualify area as a proxy for volume and carbon. Applying forestry methods traditionally used to measure timber volumes still offers a necessary route to measuring carbon stocks. With little expansion of forest area, managing for timber growth and density offered a way to increase carbon stocks.	[Rautiainen, Aapo; Kauppi, Pekka E.] Univ Helsinki, Fac Biosci, Helsinki, Finland; [Wernick, Iddo; Ausubel, Jesse H.] Rockefeller Univ, Program Human Environm, New York, NY 10021 USA; [Waggoner, Paul E.] Connecticut Agr Expt Stn, Dept Hort & Forestry, New Haven, CT 06504 USA	University of Helsinki; Rockefeller University; Connecticut Agricultural Experiment Station	Rautiainen, A (corresponding author), Univ Helsinki, Fac Biosci, Helsinki, Finland.	iwernick@rockefeller.edu		Rautiainen, Aapo/0000-0002-6885-215X	Rockefeller University; Academy of Finland [IFEE 1117822]; University of Helsinki [HENVI 470149031]	Rockefeller University; Academy of Finland(Academy of Finland); University of Helsinki	Funding for this work was provided by Rockefeller University, the Academy of Finland (IFEE 1117822), and the University of Helsinki (HENVI 470149031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel JH, 2008, P NATL ACAD SCI USA, V105, P12774, DOI 10.1073/pnas.0806099105; DeFries, 2009, MEASUREMENT MONITORI; Grainger A, 2008, P NATL ACAD SCI USA, V105, P818, DOI 10.1073/pnas.0703015105; KALACSKAA M, 2007, J ENVIRON MANAGE, V88, P348; Kauppi PE, 2006, P NATL ACAD SCI USA, V103, P17574, DOI 10.1073/pnas.0608343103; Kirilenko AP, 2007, P NATL ACAD SCI USA, V104, P19697, DOI 10.1073/pnas.0701424104; *MIN ENV FOR, 2008, STAT REP 2003, pCH7; Naesset E, 2008, REMOTE SENS ENVIRON, V112, P3079, DOI 10.1016/j.rse.2008.03.004; Sanchez-Azofeifa GA, 2009, ECOL APPL, V19, P480, DOI 10.1890/08-1149.1; SEDJO RA, 1984, FOREST ECOL MANAG, V9, P245, DOI 10.1016/0378-1127(84)90011-2; SEDJO RA, 1987, GLOBAL FOREST SECTOR, P7; SEDJO RA, 1986, SYSTEMS ANAL FORESTR, P55; Smith WB, 2009, WO78 USDA; *UN NAT FOOD AGR O, 2010, GLOB FOR RES ASS 201; *UNECE UNFAO, 2003, 27 UNECEUNFAO RUSS F; Victor DG, 2000, FOREIGN AFF, V79, P127, DOI 10.2307/20049972; Waggoner PE, 2001, POPUL DEV REV, V27, P239, DOI 10.1111/j.1728-4457.2001.00239.x; WAGGONER PE, 2009, 0929 RFF DF; Wernick IK, 2000, J FOREST, V98, P8; WERNICK IK, 2010, P NATL ACAD SCI USA, DOI DOI 10.1073/PNAS1008669107	20	40	40	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19577	10.1371/journal.pone.0019577	http://dx.doi.org/10.1371/journal.pone.0019577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573125	Green Published, Green Submitted, gold			2022-12-25	WOS:000290305600030
J	Zurla, C; Lifland, AW; Santangelo, PJ				Zurla, Chiara; Lifland, Aaron W.; Santangelo, Philip J.			Characterizing mRNA Interactions with RNA Granules during Translation Initiation Inhibition	PLOS ONE			English	Article							MAMMALIAN STRESS GRANULES; NATURAL-PRODUCT PATEAMINE; P-BODIES; SACCHAROMYCES-CEREVISIAE; BINDING PROTEIN; CELL-MIGRATION; LOCALIZATION; DECAY; PHOSPHORYLATION; RECRUITMENT	When cells experience environmental stresses, global translational arrest is often accompanied by the formation of stress granules (SG) and an increase in the number of p-bodies (PBs), which are thought to play a crucial role in the regulation of eukaryotic gene expression through the control of mRNA translation and degradation. SGs and PBs have been extensively studied from the perspective of their protein content and dynamics but, to date, there have not been systematic studies on how they interact with native mRNA granules. Here, we demonstrate the use of live-cell hybridization assays with multiply-labeled tetravalent RNA imaging probes (MTRIPs) combined with immunofluorescence, as a tool to characterize the polyA+ and beta-actin mRNA distributions within the cytoplasm of epithelial cell lines, and the changes in their colocalization with native RNA granules including SGs, PBs and the RNA exosome during the inhibition of translational initiation. Translation initiation inhibition was achieved via the induction of oxidative stress using sodium arsenite, as well as through the use of Pateamine A, puromycin and cycloheximide. This methodology represents a valuable tool for future studies of mRNA trafficking and regulation within living cells.	[Zurla, Chiara] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; Emory Univ, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Zurla, C (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	philip.santangelo@bme.gatech.edu			National Institutes of Health, through NIBIB [EB009455]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094198] Funding Source: NIH RePORTER	National Institutes of Health, through NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health R21 grant EB009455, through NIBIB (www.nibib.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2010, METHOD ENZYMOL, V470, P619, DOI 10.1016/S0076-6879(10)70025-2; Condeelis J, 2005, BIOL CELL, V97, P97; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Dang YJ, 2009, J BIOL CHEM, V284, P23613, DOI 10.1074/jbc.M109.009985; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Giles RV, 1998, NUCLEIC ACIDS RES, V26, P1567, DOI 10.1093/nar/26.7.1567; Grunwald D, 2008, METHOD ENZYMOL, V448, P553, DOI 10.1016/S0076-6879(08)02627-X; Ivanov PA, 2003, EXP CELL RES, V290, P227, DOI 10.1016/S0014-4827(03)00290-8; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Latham VM, 2001, CURR BIOL, V11, P1010, DOI 10.1016/S0960-9822(01)00291-3; Lin WJ, 2007, J BIOL CHEM, V282, P19958, DOI 10.1074/jbc.M702281200; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lloyd BH, 2001, NUCLEIC ACIDS RES, V29, P3664, DOI 10.1093/nar/29.17.3664; Loschi M, 2009, J CELL SCI, V122, P3973, DOI 10.1242/jcs.051383; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Nadezhdina ES, 2010, BBA-MOL CELL RES, V1803, P361, DOI 10.1016/j.bbamcr.2009.12.004; Nielsen FC, 2002, J CELL SCI, V115, P2087; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Santangelo PJ, 2009, NAT METHODS, V6, P347, DOI [10.1038/nmeth.1316, 10.1038/NMETH.1316]; Stohr N, 2006, J CELL BIOL, V175, P527, DOI 10.1083/jcb.200608071; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; Tyagi S, 2004, BIOPHYS J, V87, P4153, DOI 10.1529/biophysj.104.045153; UNSWORTH H, 2010, FASEB J; Yamagishi M, 2009, BIOCHEM BIOPH RES CO, V390, P750, DOI 10.1016/j.bbrc.2009.10.043; Yamagishi M, 2009, EXP CELL RES, V315, P1142, DOI 10.1016/j.yexcr.2009.02.009; Yamasaki S, 2007, J BIOL CHEM, V282, P30070, DOI 10.1074/jbc.M706273200; Yancy SL, 2005, TOXICOL SCI, V84, P278, DOI 10.1093/toxsci/kfi032	41	37	37	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19727	10.1371/journal.pone.0019727	http://dx.doi.org/10.1371/journal.pone.0019727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573130	Green Submitted, gold, Green Published			2022-12-25	WOS:000290256400041
J	Poletti, P; Messeri, G; Ajellii, M; Vallorani, R; Rizzo, C; Merler, S				Poletti, Piero; Messeri, Gianni; Ajellii, Marco; Vallorani, Roberto; Rizzo, Caterina; Merler, Stefano			Transmission Potential of Chikungunya Virus and Control Measures: The Case of Italy	PLOS ONE			English	Article							AEDES-ALBOPICTUS DIPTERA; CLIMATE-CHANGE; INDIAN-OCEAN; REUNION ISLAND; DENGUE-FEVER; EPIDEMIC; POPULATION; INFECTION; VECTOR; OUTBREAK	During summer 2007 Italy has experienced an epidemic caused by Chikungunya virus a temperate climate country - with approximately 161 laboratory confirmed cases concentraited in North-Eastern Italy comprising 3,968 inhabitants. The seroprevalence was recently estimated to be 10.2% provide estimates of the transmission potential of the virus and we assess the efficacy of he measures undhealth authorities to control the epidemic spread. To such aim, we developed a model describing the temporal dynamics of competent vector, known as Aedes albapictus, explicitly depending on climatic factors, coupled to an epidemicission model describing the spread of the epidemic in both humans and mosquitoes. The cumulative number notifified cases predicted by the model was 185 on average (95% Cl 117-278), in good agreement with observed data. The probability of observing a major outbreak after the introduction of an infective human case was estimated to be in the range of 32%-76%. We found that the basic reproduction number was in the range of 1.8-6 but it could have been even depending on the density of mosquitoes, which in turn depends on seasonal meteorological effects, besides other local a abiotic factors. These results confirm the increasing risk of tropical vector-borne diseases in temperate climate countries, as a consequence of globalization. However, our results show that an epidemic can be controlled by performing a timely intervention, even if the transmission potential of Chikungunya virus is sensibly high.	[Poletti, Piero; Ajellii, Marco; Merler, Stefano] Bruno Kessler Fdn, Trento, Italy; [Messeri, Gianni] CNR, Inst Biometeorol, Florence, Italy; [Messeri, Gianni; Vallorani, Roberto] Consorzio LaMMa Lab Monitoring & Environm Modelli, Sesto Fiorentino, Italy; [Messeri, Gianni; Vallorani, Roberto] CNR, Sesto Fiorentino, Italy; [Rizzo, Caterina] Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, I-00161 Rome, Italy	Fondazione Bruno Kessler; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Superiore di Sanita (ISS)	Poletti, P (corresponding author), Bruno Kessler Fdn, Trento, Italy.	merler@fbk.eu	merler, stefano/I-3557-2017; Rizzo, Caterina/H-4092-2012	merler, stefano/0000-0002-5117-0611; Rizzo, Caterina/0000-0002-5583-7508; Poletti, Piero/0000-0001-5453-5199	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This work was funded by the Italian Ministry of Health "Chikungunya virus infection: epidemiological and clinical features" project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajelli M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-190; Albieri A, 2010, B INSECTOL, V63, P209; Allen LJS, 2000, MATH BIOSCI, V163, P1, DOI 10.1016/S0025-5564(99)00047-4; ANDERSON R M, 1991; Angelini R, 2007, Euro Surveill, V12; Angelini R, 2007, Euro Surveill, V12; Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161; Boelle PY, 2008, VECTOR-BORNE ZOONOT, V8, P207, DOI 10.1089/vbz.2006.0620; Chhabra M, 2008, INDIAN J MED MICROBI, V26, P5, DOI 10.4103/0255-0857.38850; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011; Comiskey NM, 1999, J MED ENTOMOL, V36, P313, DOI 10.1093/jmedent/36.3.313; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Dumont Y, 2008, MATH BIOSCI, V213, P80, DOI 10.1016/j.mbs.2008.02.008; Erickson RA, 2010, ECOL MODEL, V221, P1273, DOI 10.1016/j.ecolmodel.2010.01.018; *EUR CTR DIS PREV, 2007, MISS REP CHIK IT JOI; FONTENILLE D, EMERGING PESTS VECTO, P169; Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005; Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177; Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013; Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08; Lloyd AL, 2007, J R SOC INTERFACE, V4, P851, DOI 10.1098/rsif.2007.1064; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Massad E, 2010, TROP MED INT HEALTH, V15, P120, DOI 10.1111/j.1365-3156.2009.02413.x; Mavalankar D, 2007, LANCET INFECT DIS, V7, P306, DOI 10.1016/S1473-3099(07)70091-9; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322; Moulay D, 2011, MATH BIOSCI, V229, P50, DOI 10.1016/j.mbs.2010.10.008; NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P339; Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; POZZA GD, 1992, J AM MOSQUITO CONTR, V8, P318; Reiter P, 2008, REV SCI TECH OIE, V27, P383, DOI 10.20506/rst.27.2.1804; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; REITER P, 1987, J AM MOSQUITO CONTR, V3, P494; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Renault P, 2007, AM J TROP MED HYG, V77, P727; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Roberts MG, 2003, P ROY SOC B-BIOL SCI, V270, P1359, DOI 10.1098/rspb.2003.2339; Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098; Romi R., 1995, Parassitologia (Rome), V37, P99; Romi R, 1999, J AM MOSQUITO CONTR, V15, P425; SABATANI A, 1990, Parassitologia (Rome), V32, P301; Seyler T, 2008, EURO SURVEILL, V13; Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066; Tilston N, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-61; Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174; WOODRUFF AW, 1978, BRIT MED J, V1, P956, DOI 10.1136/bmj.1.6118.956; CHIKUNGUNYA FEVER; 2001 CENSUS DATA COM	63	99	102	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e18860	10.1371/journal.pone.0018860	http://dx.doi.org/10.1371/journal.pone.0018860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559329	Green Published, gold, Green Submitted			2022-12-25	WOS:000290223500004
J	Curran, MA; Kim, M; Montalvo, W; Al-Shamkhani, A; Allison, JP				Curran, Michael A.; Kim, Myoungjoo; Montalvo, Welby; Al-Shamkhani, Aymen; Allison, James P.			Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production	PLOS ONE			English	Article							REGULATORY T; IMMUNE-RESPONSE; ANTIBODIES; IMMUNOTHERAPY; COSTIMULATION; EXPRESSION; EFFECTOR; SUBSETS; IL-2; VIVO	Background: The co-inhibitory receptor Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) attenuates immune responses and prevent autoimmunity, however, tumors exploit this pathway to evade the host T-cell response. The T-cell co-stimulatory receptor 4-1BB is transiently upregulated on T-cells following activation and increases their proliferation and inflammatory cytokine production when engaged. Antibodies which block CTLA-4 or which activate 4-1BB can promote the rejection of some murine tumors, but fail to cure poorly immunogenic tumors like B16 melanoma as single agents. Methodology/Principal Findings: We find that combining alpha CTLA-4 and alpha 4-1BB antibodies in the context of a Flt3-ligand, but not a GM-CSF, based B16 melanoma vaccine promoted synergistic levels of tumor rejection. 4-1BB activation elicited strong infiltration of CD8+ T-cells into the tumor and drove the proliferation of these cells, while CTLA-4 blockade did the same for CD4+ effector T-cells. Anti-4-1BB also depressed regulatory T-cell infiltration of tumors. 4-1BB activation strongly stimulated inflammatory cytokine production in the vaccine and tumor draining lymph nodes and in the tumor itself. The addition of CTLA-4 blockade further increased IFN-gamma production from CD4+ effector T-cells in the vaccine draining node and the tumor. Anti 4-1BB treatment, with or without CTLA-4 blockade, induced approximately 75% of CD8+ and 45% of CD4+ effector T-cells in the tumor to express the killer cell lectin-like receptor G1 (KLRG1). Tumors treated with combination antibody therapy showed 1.7-fold greater infiltration by these KLRG1+CD4+ effector T-cells than did those treated with alpha 4-1BB alone. Conclusions/Significance: This study shows that combining T-cell co-inhibitory blockade with aCTLA-4 and active co-stimulation with alpha 4-1BB promotes rejection of B16 melanoma in the context of a suitable vaccine. In addition, we identify KLRG1 as a useful marker for monitoring the anti-tumor immune response elicited by this therapy. These findings should aid in the design of future trials for the immunotherapy of melanoma.	[Curran, Michael A.; Kim, Myoungjoo; Montalvo, Welby; Allison, James P.] Mem Sloan Kettering Canc Ctr, Dept Immunol, Howard Hughes Med Inst, New York, NY 10021 USA; [Al-Shamkhani, Aymen] Univ Southampton, Southampton Gen Hosp, Sch Med, Canc Sci Div, Southampton, Hants, England	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; University of Southampton	Curran, MA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Immunol, Howard Hughes Med Inst, New York, NY 10021 USA.	allisonj@mskcc.org		Curran, Michael/0000-0003-4996-7207; Allison, James/0000-0001-8980-5697; Al-Shamkhani, Aymen/0000-0003-0727-4189	Howard Hughes Medical Institute; Ludwig Center for Cancer Immunotherapy	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ludwig Center for Cancer Immunotherapy	This work was supported by the Howard Hughes Medical Institute and the Ludwig Center for Cancer Immunotherapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyersdorf N, 2007, EUR J IMMUNOL, V37, P3445, DOI 10.1002/eji.200737126; Choi BK, 2004, J LEUKOCYTE BIOL, V75, P785, DOI 10.1189/jlb.1003491; Curran M.A., 2009, CANC RES; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Elpek KG, 2007, J IMMUNOL, V179, P7295, DOI 10.4049/jimmunol.179.11.7295; Gray JC, 2008, EUR J IMMUNOL, V38, P2499, DOI 10.1002/eji.200838208; Kim J, 2005, BLOOD, V105, P2206, DOI 10.1182/blood-2004-06-2080; Kocak E, 2006, CANCER RES, V66, P7276, DOI 10.1158/0008-5472.CAN-05-2128; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Li B, 2007, CLIN IMMUNOL, V125, P76, DOI 10.1016/j.clim.2007.07.005; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Rubinstein MP, 2008, BLOOD, V112, P3704, DOI 10.1182/blood-2008-06-160945; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Taraban VY, 2002, EUR J IMMUNOL, V32, P3617, DOI 10.1002/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Wang C, 2009, IMMUNOL REV, V229, P192, DOI 10.1111/j.1600-065X.2009.00765.x; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wolchok JD, 2008, ONCOLOGIST, V13, P2, DOI 10.1634/theoncologist.13-S4-2; Zhang BY, 2007, J CLIN INVEST, V117, P3029, DOI 10.1172/JCI32426; Zheng GX, 2004, J IMMUNOL, V173, P2428, DOI 10.4049/jimmunol.173.4.2428	24	155	178	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19499	10.1371/journal.pone.0019499	http://dx.doi.org/10.1371/journal.pone.0019499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559358	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000290024700196
J	Dibra, D; Cutrera, J; Xia, XQ; Li, SL				Dibra, Denada; Cutrera, Jeffry; Xia, Xueqing; Li, Shulin			WSX1 Expression in Tumors Induces Immune Tolerance via Suppression of Effector Immune Cells	PLOS ONE			English	Article							I CYTOKINE RECEPTOR; CD8(+) T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; AUTOIMMUNE-DISEASES; COMPLETE REGRESSION; IL-27; INTERLEUKIN-27; ACTIVATION; ANTITUMOR; RESPONSES	Crosstalk between tumor cells and the cognate microenvironment plays a crucial role in tumor initiation and progression. However, only a few genes are known to affect such a crosstalk. This study reveals that WSX1 plays such a role when highly expressed in tumor cells. The expression of WSX1 in Lewis Lung Carcinoma (LLC) and the melanoma cell line AGS induces the death of T cells and inhibits the production of the effector cytokine IFN gamma from NK and T cells, resulting in the promotion of tumor growth. These pro-tumorigenic properties of WSX1 are independent of IL27. This key observation reveals a new pathway of tumor-host interaction, which will ultimately lead to better strategies in immune therapy to reverse tumor tolerance.	[Dibra, Denada; Cutrera, Jeffry; Xia, Xueqing; Li, Shulin] Univ Texas MD Anderson Canc Ctr, Pediat Res Dept, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Dibra, D (corresponding author), Univ Texas MD Anderson Canc Ctr, Pediat Res Dept, Houston, TX 77030 USA.	sli4@mdanderson.org	Li, Shulin/D-6478-2011		National Institutes of Health/National Cancer Institute (NIH/NCI) [RO1 CA098928]; NATIONAL CANCER INSTITUTE [R01CA142855, R01CA098928] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by National Institutes of Health/National Cancer Institute (NIH/NCI) RO1 CA098928. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao YX, 2008, J IMMUNOL, V180, P922, DOI 10.4049/jimmunol.180.2.922; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Chiyo M, 2005, INT J CANCER, V115, P437, DOI 10.1002/ijc.20848; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dibra D, 2009, CANCER RES, V69, P5505, DOI 10.1158/0008-5472.CAN-08-4311; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Ho MY, 2009, J IMMUNOL, V183, P6217, DOI 10.4049/jimmunol.0901272; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Kamiya S, 2004, J IMMUNOL, V173, P3871, DOI 10.4049/jimmunol.173.6.3871; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Mapara MY, 2004, J CLIN ONCOL, V22, P1136, DOI 10.1200/JCO.2004.10.041; Mellor AL, 2002, J IMMUNOL, V168, P3771, DOI 10.4049/jimmunol.168.8.3771; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Niedbala W, 2008, ANN RHEUM DIS, V67, P1474, DOI 10.1136/ard.2007.083360; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Oniki S, 2006, CANCER RES, V66, P6395, DOI 10.1158/0008-5472.CAN-05-4087; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Pradhan A, 2007, P NATL ACAD SCI USA, V104, P18502, DOI 10.1073/pnas.0702388104; Salcedo R, 2004, J IMMUNOL, V173, P7170, DOI 10.4049/jimmunol.173.12.7170; Salcedo R, 2009, J IMMUNOL, V182, P4328, DOI 10.4049/jimmunol.0800471; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sauer KA, 2008, J IMMUNOL, V181, P6148, DOI 10.4049/jimmunol.181.9.6148; Schoenherr C, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-19; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Siebler J, 2008, J IMMUNOL, V180, P30, DOI 10.4049/jimmunol.180.1.30; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Sugiyama N, 2008, ANN RHEUM DIS, V67, P1461, DOI 10.1136/ard.2007.077537; TANNER JW, 1995, J BIOL CHEM, V270, P6523, DOI 10.1074/jbc.270.12.6523; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Yamanaka A, 2004, J IMMUNOL, V172, P3590, DOI 10.4049/jimmunol.172.6.3590; Yoshimoto T, 2008, J IMMUNOL, V180, P6527, DOI 10.4049/jimmunol.180.10.6527	43	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19072	10.1371/journal.pone.0019072	http://dx.doi.org/10.1371/journal.pone.0019072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559505	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700059
J	Geffen, E; Rowe, KC; Yom-Tov, Y				Geffen, Eli; Rowe, Kevin C.; Yom-Tov, Yoram			Reproductive Rates in Australian Rodents Are Related to Phylogeny	PLOS ONE			English	Article							LONG-TERM DYNAMICS; INTERSPECIFIC COMPETITION; ASYMMETRIC COMPETITION; HABITAT; RATTUS; HEATHLAND; COEXISTENCE; MECHANISM; RAINFALL; ECOLOGY	Background: The native rodents of Australia are commonly divided into two groups based on the time of their colonization of the Sahulian continent, which encompasses Australia, New Guinea, and the adjacent islands. The first group, the "old endemics,'' is a diverse assemblage of 34 genera that are descended from a single colonization of the continent during the Pliocene. A second group, the "new endemics,'' is composed of several native Rattus species that are descended from a single colonization during the Pleistocene. Finally, a third group is composed of three non-native species of Rattus and Mus introduced into Australia by humans over the last 200 years. Previous studies have claimed that the three groups differ in their reproductive rates and that this variation in rates is associated with the unique environmental conditions across Australia. We examined these hypotheses using phylogenetically controlled methods. Methodology and Results: We examined the relationship between the reproductive rates of the Australian rodents and the environmental variations across the continent, as well as the epoch of their colonization of the continent. Our results revealed no significant correlation with environmental variables but a significant association between colonization age and all the reproductive parameters examined. Discussion: Based on a larger phylogeny of the subfamily Murinae, we showed that significant differences in reproductive rates among colonization groups are shared with their closest relatives outside Sahul. Therefore, the lower reproductive rates in the old endemics are more likely to be the result of phylogenetic history and conservation of traits than an adaptation to the Australian environment. In the new endemics, we found a trend of increasing reproductive rates with diversification. We suggest that the differences in reproductive rates of the old endemic rodents and the native Rattus represent alternative adaptive strategies that have allowed them to utilize similar ecological niches across Australia.	[Geffen, Eli; Yom-Tov, Yoram] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Rowe, Kevin C.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	Tel Aviv University; University of California System; University of California Berkeley	Geffen, E (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	geffene@post.tau.ac.il		Rowe, Kevin Christopher/0000-0002-1215-9153	Israel Cohen Chair for Environmental Zoology	Israel Cohen Chair for Environmental Zoology	The Israel Cohen Chair for Environmental Zoology (to YYT) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aplin K.P., 2006, P707; Archer M, 1984, VERTEBRATE ZOOGEOGRA; Armstrong K.N., 2008, MAMMALS AUSTR, P470; BAVERSTOCK PR, 1986, GENETICA, V71, P11, DOI 10.1007/BF00123228; Breed B, 2007, AUSTRAL NAT HIST SER, P1; Cox MPG, 2000, AUSTRAL ECOL, V25, P375, DOI 10.1111/j.1442-9993.2000.tb00043.x; Dickman CR, 1999, WILDLIFE RES, V26, P389, DOI 10.1071/WR97057; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Flannery T. F., 1995, MAMMALS SW PACIFIC M; FLANNERY TF, 1995, MAMMALS NEW GUINEA R; FORD HA, 1988, BEHAV ECOL SOCIOBIOL, V22, P239, DOI 10.1007/BF00299838; FOX BJ, 1989, AUST J ECOL, V14, P357, DOI 10.1111/j.1442-9993.1989.tb01444.x; Geffen E, 2000, BEHAV ECOL SOCIOBIOL, V47, P250, DOI 10.1007/s002650050662; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Hall Robert, 1998, P99; Heinsohn G, 1999, WILDLIFE RES, V26, P187, DOI 10.1071/WR98020; HIGGS P, 1993, AUST J ECOL, V18, P193, DOI 10.1111/j.1442-9993.1993.tb00443.x; Jackson S., 2003, AUSTR MAMMALS BIOL C; KEAST A, 1968, J ZOOL, V155, P185; Keast A., 1981, ECOLOGICAL BIOGEOGRA, P1891; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Leeper GW, 1971, AUSTR ENV, P12; Lindenmayer DB, 2000, J MAMMAL, V81, P787, DOI 10.1644/1545-1542(2000)081<0787:HFLCAM>2.3.CO;2; Luo J, 1996, AUST J ECOL, V21, P121, DOI 10.1111/j.1442-9993.1996.tb00593.x; Lydekker R, 1896, GEOGRAPHICAL HIST MA; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Maddison WP, 2010, MESQUITE MODULAR SYS; Madsen T, 1999, AUST J ECOL, V24, P80, DOI 10.1046/j.1442-9993.1999.00948.x; Maitz WE, 2001, OECOLOGIA, V128, P526, DOI 10.1007/s004420100689; Monamy V, 1999, J MAMMAL, V80, P232, DOI 10.2307/1383223; Morris DW, 2000, OIKOS, V91, P294, DOI 10.1034/j.1600-0706.2000.910210.x; Nix H, 1982, EVOLUTION FLORA FAUN, P47; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orians GH, 2007, BIOL REV, V82, P393, DOI 10.1111/j.1469-185X.2007.00017.x; Pigram C. J., 1987, BMR Journal of Australian Geology & Geophysics, V10, P193; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; Rowe KC, 2008, MOL PHYLOGENET EVOL, V47, P84, DOI 10.1016/j.ympev.2008.01.001; Rowe KC, 2011, SYST BIOL, V60, P188, DOI 10.1093/sysbio/syq092; Rowley I., 1991, Oxford Ornithology Series, P22; Russell EM, 2004, BEHAV ECOL, V15, P831, DOI 10.1093/beheco/arh088; Steppan SJ, 2005, MOL PHYLOGENET EVOL, V37, P370, DOI 10.1016/j.ympev.2005.04.016; THOMPSON P, 1993, OIKOS, V67, P264, DOI 10.2307/3545471; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wallace A. R., 1863, J ROYAL GEOGRAPHICAL, V33, P217, DOI DOI 10.2307/1798448; WATTS C, 1981, RODENTS AUSTR; Weber M, 1904, SAUGETIERE EINFUHRUN; Wellesley-Whitehouse H, 1983, AUSTR MUSEUM COMPLET, P371; Woinarski J.C.Z., 1985, Proceedings of the Ecological Society of Australia, V14, P159; YOMTOV Y, 1985, OECOLOGIA, V66, P250, DOI 10.1007/BF00379862; YOMTOV Y, 1987, AUST WILDLIFE RES, V14, P319, DOI 10.1071/WR9870319	52	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19199	10.1371/journal.pone.0019199	http://dx.doi.org/10.1371/journal.pone.0019199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559433	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700099
J	Lee, SW; Song, YS; Lee, SY; Yoon, YG; Lee, SH; Park, BS; Yun, I; Choi, H; Kim, K; Chung, WT; Yoo, YH				Lee, Sung Won; Song, Yeon Suk; Lee, Sang Yeob; Yoon, Young Geol; Lee, Sang Hwa; Park, Bong Soo; Yun, Il; Choi, Hyantae; Kim, Kunhong; Chung, Won Tae; Yoo, Young Hyun			Downregulation of Protein Kinase CK2 Activity Facilitates Tumor Necrosis Factor-alpha-Mediated Chondrocyte Death through Apoptosis and Autophagy	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; CANCER-CELLS; HUMAN OSTEOARTHRITIS; GROWTH-PLATE; INDUCTION; CARTILAGE; DEGRADATION; MECHANISM; PHOSPHORYLATION; CLASSIFICATION	Despite the numerous studies of protein kinase CK2, little progress has been made in understanding its function in chondrocyte death. Our previous study first demonstrated that CK2 is involved in apoptosis of rat articular chondrocytes. Recent studies have suggested that CK2 downregulation is associated with aging. Thus examining the involvement of CK2 downregulation in chondrocyte death is an urgently required task. We undertook this study to examine whether CK2 downregulation modulates chondrocyte death. We first measured CK2 activity in articular chondrocytes of 6-, 21- and 30-month-old rats. Noticeably, CK2 activity was downregulated in chondrocytes with advancing age. To build an in vitro experimental system for simulating tumor necrosis factor (TNF)-alpha-induced cell death in aged chondrocytes with decreased CK2 activity, chondrocytes were co-treated with CK2 inhibitors and TNF-alpha. Viability assay demonstrated that CK2 inhibitors facilitated TNF-alpha-mediated chondrocyte death. Pulsed-field gel electrophoresis, nuclear staining, flow cytometry, TUNEL staining, confocal microscopy, western blot and transmission electron microscopy were conducted to assess cell death modes. The results of multiple assays showed that this cell death was mediated by apoptosis. Importantly, autophagy was also involved in this process, as supported by the appearance of a punctuate LC3 pattern and autophagic vacuoles. The inhibition of autophagy by silencing of autophage-related genes 5 and 7 as well as by 3-methyladenine treatment protected chondrocytes against cell death and caspase activation, indicating that autophagy led to the induction of apoptosis. Autophagic cells were observed in cartilage obtained from osteoarthritis (OA) model rats and human OA patients. Our findings indicate that CK2 down regulation facilitates TNF-alpha-mediated chondrocyte death through apoptosis and autophagy. It should be clarified in the future if autophagy observed is a consequence versus a cause of the degeneration in vivo.	[Lee, Sung Won; Chung, Won Tae] Dong A Univ, Dept Rheumatol, Coll Med, Pusan, South Korea; [Song, Yeon Suk; Lee, Sang Yeob; Yoon, Young Geol; Yoo, Young Hyun] Dong A Univ, Dept Anat & Cell Biol, Coll Med, Pusan, South Korea; [Song, Yeon Suk; Lee, Sang Yeob; Yoon, Young Geol; Yoo, Young Hyun] Dong A Univ, Mitochondria Hub Regulat Ctr, Coll Med, Pusan, South Korea; [Lee, Sang Hwa] Dong A Univ, Dept Microbiol, Coll Med, Pusan, South Korea; [Park, Bong Soo; Yun, Il] Pusan Natl Univ, Dept Oral Anat & Cell Biol, Coll Dent, Yangsan, South Korea; [Choi, Hyantae; Kim, Kunhong] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Choi, Hyantae; Kim, Kunhong] Yonsei Univ, Coll Med, Ctr Chron Metab Dis Res, Seoul, South Korea	Dong A University; Dong A University; Dong A University; Dong A University; Pusan National University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, SW (corresponding author), Dong A Univ, Dept Rheumatol, Coll Med, Pusan, South Korea.	yhyoo@dau.ac.kr		Lee, Sang Hwa/0000-0003-4792-1248; Yoon, Young Geol/0000-0003-4524-9531	Korean government (MEST) [2009-0093193, 2010-0001942, 2011-0001262, R01-2007-000-20100-0]	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by National Research Foundation of Korea grant funded by the Korean government (MEST) (No. 2009-0093193, 2010-0001942, 2011-0001262 and R01-2007-000-20100-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Aizawa T, 2001, J ORTHOP RES, V19, P785, DOI 10.1016/S0736-0266(00)00078-4; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Almonte-Becerril M, 2010, APOPTOSIS, V15, P631, DOI 10.1007/s10495-010-0458-z; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Baehrecke EH, 2003, CELL DEATH DIFFER, V10, P940, DOI 10.1038/sj.cdd.4401280; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Bohensky J, 2007, J CELL PHYSIOL, V213, P246, DOI 10.1002/jcp.21117; Bohensky J, 2007, AUTOPHAGY, V3, P207, DOI 10.4161/auto.3708; Bohensky J, 2009, ARTHRITIS RHEUM-US, V60, P1406, DOI 10.1002/art.24444; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Carames B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305; Cho TJ, 2003, ARTHRITIS RHEUM-US, V48, P2845, DOI 10.1002/art.11390; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Del Carlo Marcello Jr, 2008, Curr Rheumatol Rep, V10, P37; Farah M, 2003, AM J PHYSIOL-GASTR L, V285, pG919, DOI 10.1152/ajpgi.00205.2003; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Goldring M. B., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P517; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1266, DOI 10.1002/1529-0131(199807)41:7<1266::AID-ART18>3.0.CO;2-Y; Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1632, DOI 10.1002/1529-0131(199809)41:9<1632::AID-ART14>3.0.CO;2-A; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kim EK, 2009, GENE, V431, P55, DOI 10.1016/j.gene.2008.10.020; Kim HA, 2000, J RHEUMATOL, V27, P455; Kim KY, 2004, J PHARMACOL EXP THER, V308, P97, DOI 10.1124/jpet.103.058768; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kuhn K, 2001, ARTHRITIS RHEUM-US, V44, P1644, DOI 10.1002/1529-0131(200107)44:7<1644::AID-ART287>3.0.CO;2-S; Lee SW, 2008, ARTHRITIS RHEUM-US, V58, P790, DOI 10.1002/art.23220; Lee SW, 2004, ARTHRITIS RHEUM-US, V50, P534, DOI 10.1002/art.20052; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; McElhinny JA, 1996, MOL CELL BIOL, V16, P899; Miwa M, 2000, OSTEOARTHR CARTILAGE, V8, P17, DOI 10.1053/joca.1999.0266; Pulsatelli L, 1999, J RHEUMATOL, V26, P1992; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Ryu SW, 2006, FEBS LETT, V580, P988, DOI 10.1016/j.febslet.2006.01.028; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shin S, 2005, EMBO J, V24, P3532, DOI 10.1038/sj.emboj.7600827; Srinivas V, 2006, AUTOPHAGY, V2, P215, DOI 10.4161/auto.2649; Srinivas V, 2009, CELL CYCLE, V8, P391, DOI 10.4161/cc.8.3.7545; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Wang DJ, 2009, CANCER RES, V69, P8200, DOI 10.1158/0008-5472.CAN-09-1976; Wang GX, 2005, MOL CELL BIOCHEM, V274, P201, DOI 10.1007/s11010-005-2952-0; Watanabe H, 2008, J CELL PHYSIOL, V216, P419, DOI 10.1002/jcp.21408	52	35	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19163	10.1371/journal.pone.0019163	http://dx.doi.org/10.1371/journal.pone.0019163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559479	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700086
J	Mei, B; Li, F; Gu, YR; Cui, ZZ; Tsien, JZ				Mei, Bing; Li, Fei; Gu, Yiran; Cui, Zhenzhong; Tsien, Joe Z.			NMDA Receptors Are Not Required for Pattern Completion During Associative Memory Recall	PLOS ONE			English	Article							OLFACTORY MEMORY; SPATIAL MEMORY; NR1 KNOCKOUT; RETRIEVAL; CONSOLIDATION; ACQUISITION; ACTIVATION; CORTEX; MICE; ENHANCEMENT	Pattern completion, the ability to retrieve complete memories initiated by subsets of external cues, has been a major focus of many computation models. A previously study reports that such pattern completion requires NMDA receptors in the hippocampus. However, such a claim was derived from a non-inducible gene knockout experiment in which the NMDA receptors were absent throughout all stages of memory processes as well as animal's adult life. This raises the critical question regarding whether the previously described results were truly resulting from the requirement of the NMDA receptors in retrieval. Here, we have examined the role of the NMDA receptors in pattern completion via inducible knockout of NMDA receptors limited to the memory retrieval stage. By using two independent mouse lines, we found that inducible knockout mice, lacking NMDA receptor in either forebrain or hippocampus CA1 region at the time of memory retrieval, exhibited normal recall of associative spatial reference memory regardless of whether retrievals took place under full-cue or partial-cue conditions. Moreover, systemic antagonism of NMDA receptor during retention tests also had no effect on full-cue or partial-cue recall of spatial water maze memories. Thus, both genetic and pharmacological experiments collectively demonstrate that pattern completion during spatial associative memory recall does not require the NMDA receptor in the hippocampus or forebrain.	[Mei, Bing; Gu, Yiran] E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Lab Brain Funct Genom, MOE, Shanghai 200062, Peoples R China; [Mei, Bing; Gu, Yiran] E China Normal Univ, STCSM, Shanghai 200062, Peoples R China; [Li, Fei] Jiao Tong Univ, Key Lab Childrens Environm Hlth, Shanghai Childrens Med Ctr, Dept Dev & Behav Pediat,Sch Med,MOE, Shanghai 200030, Peoples R China; [Li, Fei] Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, STCSM, Shanghai 200030, Peoples R China; [Gu, Yiran] Banna Biomed Res Inst, Xi Shuang Ban Na, Yunnan, Peoples R China; [Mei, Bing; Li, Fei; Cui, Zhenzhong; Tsien, Joe Z.] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA USA; [Mei, Bing; Li, Fei; Cui, Zhenzhong; Tsien, Joe Z.] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA	East China Normal University; East China Normal University; Science & Technology Commission of Shanghai Municipality (STCSM); Shanghai Jiao Tong University; Science & Technology Commission of Shanghai Municipality (STCSM); Shanghai Jiao Tong University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Mei, B (corresponding author), E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Lab Brain Funct Genom, MOE, Shanghai 200062, Peoples R China.	jtsien@georgiahealth.edu	/AAI-4103-2021		National Institutes of Health [MH06023, AG034663, AG025918]; National Natural Science Foundation of China [30870790, 81070876, 81000592]; Shanghai Commission of Science and Technology [10140900500, 09DZ2200900, 10DZ2272200, 10PJ1407500, 10JC1411200, 11ZZ38, 11ZZ103, 2010004]; Shanghai Jiaotong University; 973 Project [2009CB918402]; NATIONAL INSTITUTE ON AGING [R01AG025918, R01AG034663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Shanghai Jiaotong University; 973 Project(National Basic Research Program of China); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from National Institutes of Health (MH06023, AG034663, AG025918) (All to JZT), and was also supported by grants from National Natural Science Foundation of China (30870790, 81070876, 81000592) to BM and FL, from Shanghai Commission of Science and Technology (10140900500, 09DZ2200900, 10DZ2272200, 10PJ1407500, 10JC1411200, 11ZZ38, 11ZZ103, 2010004) to BM and FL and from Morning Star Rewarding Fund (Category B, 2011) of Shanghai Jiaotong University and from the 973 Project (2009CB918402) to FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bast T, 2005, J NEUROSCI, V25, P5845, DOI 10.1523/JNEUROSCI.0698-05.2005; Brown R, 2004, CELL, V117, P3, DOI 10.1016/S0092-8674(04)00295-8; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; Cohen NJ, 1993, MEMORY AMNESIA HIPPO, pxii; Cui ZZ, 2005, EUR J NEUROSCI, V22, P755, DOI 10.1111/j.1460-9568.2005.04257.x; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; DEVAUGES V, 1991, BEHAV BRAIN RES, V43, P93, DOI 10.1016/S0166-4328(05)80056-7; Donchin O, 2002, J NEUROPHYSIOL, V88, P2114, DOI 10.1152/jn.2002.88.4.2114; Hetem LAB, 2000, PSYCHOPHARMACOLOGY, V152, P283, DOI 10.1007/s002130000511; Izquierdo LA, 2000, BEHAV BRAIN RES, V111, P93, DOI 10.1016/S0166-4328(00)00137-6; Jerman T, 2006, LEARN MEMORY, V13, P458, DOI 10.1101/lm.246906; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Lassalle JM, 2000, NEUROBIOL LEARN MEM, V73, P243, DOI 10.1006/nlme.1999.3931; Li F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015401; Liang K C, 1994, Chin J Physiol, V37, P201; Liu X, 2006, CURR OPIN NEUROBIOL, V16, P679, DOI 10.1016/j.conb.2006.09.003; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Matus-Amat P, 2004, J NEUROSCI, V24, P2431, DOI 10.1523/JNEUROSCI.1598-03.2004; Moulds ML, 2005, J TRAUMA STRESS, V18, P233, DOI 10.1002/jts.20022; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; Osan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016507; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rosenblum K, 1997, J NEUROSCI, V17, P5129; SARA SJ, 1985, ANN NY ACAD SCI, V444, P178, DOI 10.1111/j.1749-6632.1985.tb37588.x; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Servatius RJ, 1996, BEHAV NEUROSCI, V110, P1040; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Takehara-Nishiuchi K, 2006, J NEUROSCI, V26, P5049, DOI 10.1523/JNEUROSCI.4381-05.2006; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; Tronel S, 2002, LEARN MEMORY, V9, P105, DOI 10.1101/lm.47802; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; Wittenberg GM, 2002, TRENDS NEUROSCI, V25, P501, DOI 10.1016/S0166-2236(02)02231-2; Yasuda M, 2006, NEURON, V50, P309, DOI 10.1016/j.neuron.2006.03.035	37	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19326	10.1371/journal.pone.0019326	http://dx.doi.org/10.1371/journal.pone.0019326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559402	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700137
J	Saez, ME; Smani, T; Ramirez-Lorca, R; Diaz, I; Serrano-Rios, M; Ruiz, A; Ordonez, A				Saez, Maria E.; Smani, Tarik; Ramirez-Lorca, Reposo; Diaz, Ignacio; Serrano-Rios, Manuel; Ruiz, Agustin; Ordonez, Antonio			Association Analysis of Urotensin II Gene (UTS2) and Flanking Regions with Biochemical Parameters Related to Insulin Resistance	PLOS ONE			English	Article							RECEPTOR ANTAGONIST PALOSURAN; ACUTE MYOCARDIAL-INFARCTION; TYPE-2 DIABETES-MELLITUS; PERFUSED RAT PANCREAS; METABOLIC SYNDROME; ADMISSION HYPERGLYCEMIA; GLUCOSE-TOLERANCE; ORPHAN RECEPTOR; EXPRESSION; RISK	Background: Urotensin II (UII) is a potent vasoconstrictor peptide, which signals through a G-protein coupled receptor (GPCR) known as GPR14 or urotensin receptor (UTR). UII exerts a broad spectrum of actions in several systems such as vascular cell, heart muscle or pancreas, where it inhibits insulin release. Objective: Given the reported role of UII in insulin secretion, we have performed a genetic association analysis of the UTS2 gene and flanking regions with biochemical parameters related to insulin resistance (fasting glucose, glucose 2 hours after a glucose overload, fasting insulin and insulin resistance estimated as HOMA). Results and Conclusions: We have identified several polymorphisms associated with the analysed clinical traits, not only at the UTS2 gene, but also in thePER3 gene, located upstream from UTS2. Our results are compatible with a role for UII in glucose homeostasis and diabetes although we cannot rule out the possibility that PER3 gene may underlie the reported associations.	[Saez, Maria E.; Ramirez-Lorca, Reposo; Ruiz, Agustin] Neocodex, Dept Struct Genom, Seville, Spain; [Smani, Tarik; Diaz, Ignacio; Ordonez, Antonio] Univ Seville, CSIC, Hosp Univ Virgen Rocio, Inst Biomed Sevilla,Grp Fisiopathol Cardiovasc, Seville, Spain; [Serrano-Rios, Manuel] Univ Hosp Clin San Carlos, Biomed Res Fdn, Diabet Res Lab, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Clinico San Carlos	Saez, ME (corresponding author), Neocodex, Dept Struct Genom, Seville, Spain.	mesaez@neocodex.es	Ruiz, Agustin/G-5677-2012; Ruiz, Agustín/L-4469-2019; IBIS, CARDIOVASCULAR/P-3910-2015; Ordoñez, Antonio/G-9195-2018; Reposo, Ramirez-Lorca/D-7907-2014; Saez, Maria E/C-8093-2012; Hajami, Tarik Smani/D-5372-2016; Serrano Ríos, Manuel/E-4625-2019; Ramirez-Lorca, Reposo/A-5807-2012	Ruiz, Agustín/0000-0003-2633-2495; Ordoñez, Antonio/0000-0002-4344-8660; Hajami, Tarik Smani/0000-0002-1877-7438; Serrano Ríos, Manuel/0000-0002-3214-1444; Ramirez Lorca, Reposo/0000-0002-1594-0404; Saez, Maria/0000-0001-9299-2534	Centro para el Desarrollo Tecnologico Industrial (CDTI) [CENIT-2008 1004]; Ministerio de Ciencia e Innovacion; CIBER of Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Spain; Spanish Ministry MICINN [BFU2010-21043-C02-02, PS09-02287]; Red RECAVA [RD06-0014-0020]; Government of Andalucia [P08-CVI-3913; P09-CTS-4715]	Centro para el Desarrollo Tecnologico Industrial (CDTI); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); CIBER of Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Spain(Instituto de Salud Carlos III); Spanish Ministry MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red RECAVA; Government of Andalucia	This work has been supported by grant CENIT-2008 1004 from the Centro para el Desarrollo Tecnologico Industrial (CDTI) and the Ministerio de Ciencia e Innovacion under the Ingenio 2010 program. The work by the Diabetes Research Laboratory, Biomedical Research Foundation, University Hospital Clinico San Carlos, Madrid, Spain (P.I: Manuel Serrano-Rios) is supported by CIBER of Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Spain. The Group of "Fisiopatologia Cardiovascular" is supported by funding from Spanish Ministry MICINN (BFU2010-21043-C02-02; PS09-02287) and Red RECAVA [RD06-0014-0020]; from the Government of Andalucia (CICE: [P08-CVI-3913; P09-CTS-4715]. Tarik Smani is a Researcher from "Fundacion Publica Andaluza Progreso y Salud". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainla T, 2005, DIABETIC MED, V22, P1321, DOI 10.1111/j.1464-5491.2005.01625.x; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Ando H, 2009, DIABETOLOGIA, V52, P329, DOI 10.1007/s00125-008-1194-6; Ando H, 2010, J GERONTOL A-BIOL, V65, P9, DOI 10.1093/gerona/glp160; Angeli F, 2010, CURR DIABETES REV, V6, P102, DOI 10.2174/157339910790909413; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chu LW, 2008, CANCER EPIDEM BIOMAR, V17, P3268, DOI 10.1158/1055-9965.EPI-08-0073; Clozel M, 2006, J PHARMACOL EXP THER, V316, P1115, DOI 10.1124/jpet.105.094821; Davenport AP, 2000, TRENDS PHARMACOL SCI, V21, P80, DOI 10.1016/S0165-6147(00)01449-8; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Gangwisch JE, 2009, OBES REV, V10, P37, DOI 10.1111/j.1467-789X.2009.00663.x; Gayan J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-326; Genuth S, 2003, DIABETES CARE, V26, P3160; Gruson D, 2010, PEPTIDES, V31, P1326, DOI 10.1016/j.peptides.2010.04.009; Gruson D, 2010, J CLIN HYPERTENS, V12, P653, DOI 10.1111/j.1751-7176.2010.00336.x; Guess J, 2009, INTEGR CANCER THER, V8, P329, DOI 10.1177/1534735409352029; Jiang Z, 2008, INT J BIOL SCI, V4, P96; Kolman L, 2009, AM J CARDIOL, V104, P470, DOI 10.1016/j.amjcard.2009.04.006; Kosiborod M, 2005, CIRCULATION, V111, P3078, DOI 10.1161/CIRCULATIONAHA.104.517839; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Liu Fang, 2010, Shengli Xuebao, V62, P129; Lorenzo C, 2001, DIABETES CARE, V24, P2059, DOI 10.2337/diacare.24.12.2059; Marco J, 2008, PEPTIDES, V29, P852, DOI 10.1016/j.peptides.2007.08.025; Martinez-Larrad MT, 2005, MED CLIN-BARCELONA, V125, P481; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Milvidaite I, 2007, MEDICINA-LITHUANIA, V43, P935, DOI 10.3390/medicina43120121; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Nishihama K, 2007, INT J MOL MED, V19, P129; Oguri M, 2009, ATHEROSCLEROSIS, V206, P486, DOI 10.1016/j.atherosclerosis.2009.02.037; Ong KL, 2005, CARDIOVASC DRUG THER, V19, P65, DOI 10.1007/s10557-005-6899-x; Ong KL, 2008, PEPTIDES, V29, P859, DOI 10.1016/j.peptides.2007.06.003; Ong KL, 2006, PEPTIDES, V27, P1659, DOI 10.1016/j.peptides.2006.02.008; Papadopoulos P, 2008, PEPTIDES, V29, P764, DOI 10.1016/j.peptides.2007.09.012; Petursson P, 2007, INT J CARDIOL, V116, P315, DOI 10.1016/j.ijcard.2006.04.043; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ross B, 2010, AM J PHYSIOL-REG I, V298, pR1156, DOI 10.1152/ajpregu.00706.2009; Schiele F, 2006, DIABETIC MED, V23, P1370, DOI 10.1111/j.1464-5491.2006.02000.x; SHERIDAN MA, 1987, GEN COMP ENDOCR, V66, P405, DOI 10.1016/0016-6480(87)90251-6; Sidharta PN, 2006, CLIN PHARMACOL THER, V80, P246, DOI 10.1016/j.clpt.2006.05.013; Sidharta PN, 2009, BRIT J CLIN PHARMACO, V68, P502, DOI 10.1111/j.1365-2125.2009.03480.x; Silvestre R, 2004, EUR J ENDOCRINOL, V151, P803, DOI 10.1530/eje.0.1510803; Silvestre RA, 2001, HORM METAB RES, V33, P379, DOI 10.1055/s-2001-15414; Silvestre RA, 2009, REGUL PEPTIDES, V153, P37, DOI 10.1016/j.regpep.2008.11.008; Stranders I, 2004, ARCH INTERN MED, V164, P982, DOI 10.1001/archinte.164.9.982; Suguro T, 2008, CLIN SCI, V115, P327, DOI 10.1042/CS20080014; Sun Hong-xia, 2002, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V24, P223; Suzuki S, 2004, PEPTIDES, V25, P1803, DOI 10.1016/j.peptides.2004.03.030; Tan Yu-Jie, 2006, Zhonghua Fu Chan Ke Za Zhi, V41, P732; Thalib L, 2010, CLIN MED RES; Tooke JE, 2000, J INTERN MED, V247, P425, DOI 10.1046/j.1365-2796.2000.00671.x; Totsune K, 2003, CLIN SCI, V104, P1, DOI 10.1042/CS20020271; Tzanidis A, 2003, CIRC RES, V93, P246, DOI 10.1161/01.RES.0000084382.64418.BC; Vaudry H, 2010, ANN NY ACAD SCI, V1200, P53, DOI 10.1111/j.1749-6632.2010.05514.x; Vogt L, 2010, HYPERTENSION, V55, P1206, DOI 10.1161/HYPERTENSIONAHA.109.149559; Wenyi Z, 2003, DIABETOLOGIA, V46, P972, DOI 10.1007/s00125-003-1145-1; Yi L, 2006, J INT MED RES, V34, P272, DOI 10.1177/147323000603400306; Zhu Fang, 2002, Zhonghua Yi Xue Za Zhi, V82, P1473	57	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19327	10.1371/journal.pone.0019327	http://dx.doi.org/10.1371/journal.pone.0019327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559414	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700138
J	Wang, YF; Broderick, P; Matakidou, A; Eisen, T; Houlston, RS				Wang, Yufei; Broderick, Peter; Matakidou, Athena; Eisen, Timothy; Houlston, Richard S.			Chromosome 15q25 (CHRNA3-CHRNA5) Variation Impacts Indirectly on Lung Cancer Risk	PLOS ONE			English	Article							SUSCEPTIBILITY LOCUS; NICOTINE DEPENDENCE; SMOKING; ASSOCIATION; VARIANTS; SMOKERS; GENES	Genetic variants at the 15q25 CHRNA5-CHRNA3 locus have been shown to influence lung cancer risk however there is controversy as to whether variants have a direct carcinogenic effect on lung cancer risk or impact indirectly through smoking behavior. We have performed a detailed analysis of the 15q25 risk variants rs12914385 and rs8042374 with smoking behavior and lung cancer risk in 4,343 lung cancer cases and 1,479 controls from the Genetic Lung Cancer Predisposition Study (GELCAPS). A strong association between rs12914385 and rs8042374, and lung cancer risk was shown, odds ratios (OR) were 1.44, (95% confidence interval (CI): 1.29-1.62, P = 3.69x10(-10)) and 1.35 (95% CI: 1.18-1.55, P = 9.99x10(-6)) respectively. Each copy of risk alleles at rs12914385 and rs8042374 was associated with increased cigarette consumption of 1.0 and 0.9 cigarettes per day (CPD) (P = 5.18x10(-5) and P = 5.65x10(-3)). These genetically determined modest differences in smoking behavior can be shown to be sufficient to account for the 15q25 association with lung cancer risk. To further verify the indirect effect of 15q25 on the risk, we restricted our analysis of lung cancer risk to never-smokers and conducted a meta-analysis of previously published studies of lung cancer risk in never-smokers. Never-smoker studies published in English were ascertained from PubMed stipulating - lung cancer, risk, genome-wide association, candidate genes. Our study and five previously published studies provided data on 2,405 never-smoker lung cancer cases and 7,622 controls. In the pooled analysis no association has been found between the 15q25 variation and lung cancer risk (OR = 1.09, 95% CI: 0.94-1.28). This study affirms the 15q25 association with smoking and is consistent with an indirect link between genotype and lung cancer risk.	[Wang, Yufei; Broderick, Peter; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Matakidou, Athena; Eisen, Timothy] Univ Cambridge, Dept Oncol, Cambridge, England	University of London; Institute of Cancer Research - UK; University of Cambridge	Wang, YF (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	richard.houlston@icr.ac.uk		Houlston, Richard/0000-0002-5268-0242; Broderick, Peter/0000-0002-8348-5829	Cancer Research UK [C1298/A8780, C1298/A8362]; Allan J Lerner Fund; NHS; Sanofi-Anventis	Cancer Research UK(Cancer Research UK); Allan J Lerner Fund; NHS; Sanofi-Anventis	This work was supported by Cancer Research UK (C1298/A8780 and C1298/A8362-Bobby Moore Fund for Cancer Research UK) who provided principal funding for this study. Athena Matakidou was the recipient of a clinical research fellowship from the Allan J Lerner Fund. The authors are also grateful to the National Cancer Research Network, Helen Rollason Heal Cancer Charity and Sanofi-Aventis. They acknowledge NHS funding for the Royal Marsden Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was partially supported by commercial funder Sanofi-Anventis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The commercial funder Sanofi-Aventis has declared that no competing interests exist.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; [Anonymous], NAT GENET, V42, P441; Bermejo JL, 2005, CANCER EPIDEM BIOMAR, V14, P1738, DOI 10.1158/1055-9965.EPI-05-0201; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Broms U, 2006, TWIN RES HUM GENET, V9, P64, DOI 10.1375/183242706776403046; DOLL R, 1978, J EPIDEMIOL COMMUN H, V32, P303, DOI 10.1136/jech.32.4.303; Eisen T, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-244; Falvella FS, 2009, CLIN CANCER RES, V15, P1837, DOI 10.1158/1078-0432.CCR-08-2107; Falvella FS, J NATL CANC I, V102, P1366; Flanders WD, 2003, CANCER RES, V63, P6556; Freathy RM, 2009, HUM MOL GENET, V18, P2922, DOI 10.1093/hmg/ddp216; Galvan A, 2010, CARCINOGENESIS, V31, P331, DOI 10.1093/carcin/bgp282; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Le Marchand L, 2008, CANCER RES, V68, P9137, DOI 10.1158/0008-5472.CAN-08-2271; Li XJ, 2005, LUNG CANCER, V47, P301, DOI 10.1016/j.lungcan.2004.07.048; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Pettiti D, 1994, METAANALYSIS DECISIO; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Shiraishi K, 2009, CARCINOGENESIS, V30, P65, DOI 10.1093/carcin/bgn257; Spitz MR, 2008, J NATL CANCER I, V100, DOI 10.1093/jnci/djn363; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Truong T, J NATL CANC I, V102, P959; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125	31	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19085	10.1371/journal.pone.0019085	http://dx.doi.org/10.1371/journal.pone.0019085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559498	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700063
J	Yan, Y; Cui, HC; Jiang, SS; Huang, YH; Huang, XH; Wei, SN; Xu, WY; Qin, QW				Yan, Yang; Cui, Huachun; Jiang, Songshan; Huang, Youhua; Huang, Xiaohong; Wei, Shina; Xu, Weiyi; Qin, Qiwei			Identification of a Novel Marine Fish Virus, Singapore Grouper Iridovirus-Encoded MicroRNAs Expressed in Grouper Cells by Solexa Sequencing	PLOS ONE			English	Article							SPOTTED GROUPER; GENE-EXPRESSION; GENOMICS; CLONING; PCR; RNA	Background: MicroRNAs (miRNAs) are ubiquitous non-coding RNAs that regulate gene expression at the post-transcriptional level. An increasing number of studies has revealed that viruses can also encode miRNAs, which are proposed to be involved in viral replication and persistence, cell-mediated antiviral immune response, angiogenesis, and cell cycle regulation. Singapore grouper iridovirus (SGIV) is a pathogenic iridovirus that has severely affected grouper aquaculture in China and Southeast Asia. Comprehensive knowledge about the related miRNAs during SGIV infection is helpful for understanding the infection and the pathogenic mechanisms. Methodology/Principal Findings: To determine whether SGIV encoded miRNAs during infection, a small RNA library derived from SGIV-infected grouper (GP) cells was constructed and sequenced by Illumina/Solexa deep-sequencing technology. We recovered 6,802,977 usable reads, of which 34,400 represented small RNA sequences encoded by SGIV. Sixteen novel SGIV-encoded miRNAs were identified by a computational pipeline, including a miRNA that shared a similar sequence to herpesvirus miRNA HSV2-miR-H4-5p, which suggests miRNAs are conserved in far related viruses. Generally, these 16 miRNAs are dispersed throughout the SGIV genome, whereas three are located within the ORF057L region. Some SGIV-encoded miRNAs showed marked sequence and length heterogeneity at their 39 and/or 59 end that could modulate their functions. Expression levels and potential biological activities of these viral miRNAs were examined by stem-loop quantitative RT-PCR and luciferase reporter assay, respectively, and 11 of these viral miRNAs were present and functional in SGIV-infected GP cells. Conclusions: Our study provided a genome-wide view of miRNA production for iridoviruses and identified 16 novel viral miRNAs. To the best of our knowledge, this is the first experimental demonstration of miRNAs encoded by aquatic animal viruses. The results provide a useful resource for further in-depth studies on SGIV infection and iridovirus pathogenesis.	[Yan, Yang; Cui, Huachun; Jiang, Songshan; Xu, Weiyi] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Youhua; Huang, Xiaohong; Wei, Shina; Qin, Qiwei] Chinese Acad Sci, S China Sea Inst Oceanol, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Yan, Y (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	qinqw@scsio.ac.cn			Natural Science Foundation of China [30725027, 30930070]; Chinese Academy of Sciences [KZCX2-YW-BR-08, KZCX2-EW-Q213]; National Basic Research Program of China (973) [2006CB101802]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973)(National Basic Research Program of China)	This work was supported by the grants from the Natural Science Foundation of China (30725027, 30930070), the Knowledge Innovation Program of Chinese Academy of Sciences (KZCX2-YW-BR-08, KZCX2-EW-Q213) and the National Basic Research Program of China (973)(2006CB101802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Boss IW, 2010, CURR OPIN MICROBIOL, V13, P540, DOI 10.1016/j.mib.2010.05.017; Burnside J, 2006, J VIROL, V80, P8778, DOI 10.1128/JVI.00831-06; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012745; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Chinchar VG, 2002, ARCH VIROL, V147, P447, DOI 10.1007/s007050200000; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Dolken L, 2007, J VIROL, V81, P13771, DOI 10.1128/JVI.01313-07; Dunn W, 2005, CELL MICROBIOL, V7, P1684, DOI 10.1111/j.1462-5822.2005.00598.x; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Grassmann R, 2008, BBA-GENE REGUL MECH, V1779, P706, DOI 10.1016/j.bbagrm.2008.05.005; GRAVELL M, 1965, ANN NY ACAD SCI, V126, P555, DOI 10.1111/j.1749-6632.1965.tb14302.x; Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Huang XH, 2008, BIOCHEM BIOPH RES CO, V373, P140, DOI 10.1016/j.bbrc.2008.06.003; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Qin QW, 2003, DIS AQUAT ORGAN, V53, P1, DOI 10.3354/dao053001; Qin QW, 2001, J VIROL METHODS, V98, P17, DOI 10.1016/S0166-0934(01)00350-0; Rachamadugu R, 2009, VIRUS GENES, V39, P301, DOI 10.1007/s11262-009-0397-3; Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Schafer A, 2007, VIROLOGY, V364, P21, DOI 10.1016/j.virol.2007.03.029; Song WJ, 2004, J VIROL, V78, P12576, DOI 10.1128/JVI.78.22.12576-12590.2004; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Tang S, 2008, P NATL ACAD SCI USA, V105, P10931, DOI 10.1073/pnas.0801845105; Tang S, 2009, J VIROL, V83, P1433, DOI 10.1128/JVI.01723-08; Teng Y, 2008, VIROLOGY, V377, P39, DOI 10.1016/j.virol.2008.04.011; Umbach JL, 2010, J VIROL, V84, P1189, DOI 10.1128/JVI.01712-09; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wan QJ, 2010, ARCH VIROL, V155, P351, DOI 10.1007/s00705-010-0594-3; Williams T, 2005, ADV VIRUS RES, V65, P173, DOI 10.1016/S0065-3527(05)65006-3; Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744; Xia LQ, 2010, VIRUS RES, V147, P30, DOI 10.1016/j.virusres.2009.09.015; Xia LQ, 2009, ARCH VIROL, V154, P1409, DOI 10.1007/s00705-009-0457-y; Yao YX, 2007, J VIROL, V81, P7164, DOI 10.1128/JVI.00112-07; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	53	38	43	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19148	10.1371/journal.pone.0019148	http://dx.doi.org/10.1371/journal.pone.0019148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559453	Green Submitted, gold, Green Published			2022-12-25	WOS:000290024700077
J	Kumar, S; Hinks, JA; Maman, J; Ravirajan, CT; Pearl, LH; Isenberg, DA				Kumar, Sanjeev; Hinks, John A.; Maman, Joseph; Ravirajan, Chelliah T.; Pearl, Laurence H.; Isenberg, David A.			p185, an Immunodominant Epitope, Is an Autoantigen Mimotope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTI-DNA ANTIBODIES; MONOCLONAL-ANTIBODY; PEPTIDE LIBRARIES; TYROSINE KINASES; CARCINOMA CELLS; MAMMALIAN DNA; NEU ONCOGENE; EXPRESSION; C-ERBB-2	An immunodominant peptide (p185(378-394)) derived from the c-erbB2 gene product, was recognized by an anti-DNA antibody, B3, and importantly by two classical DNA-binding proteins, Tgo polymerase and Pa-UDG. These reactivities were inhibited by DNA, confirming that the peptide mimicked DNA. BALB/c mice immunized with p185(378-394) developed significant titers of IgG anti-dsDNA antibodies. Screening of 39 human lupus sera revealed that 5% of these sera possessed reactivity toward p185(378-394). Representative mouse and human sera with anti-p185(378-394) reactivity bound intact p185, and this binding was inhibited by dsDNA. This is the first demonstration of a naturally occurring autoantigen mimotope. The present study identifies a potential antigenic stimulus that might trigger systemic lupus erythematosus in a subset of patients.	[Kumar, Sanjeev; Ravirajan, Chelliah T.; Isenberg, David A.] Univ Coll London Hosp, UCL Div Med, Ctr Rheumatol, London W1T 4JF, England; [Kumar, Sanjeev; Hinks, John A.; Maman, Joseph; Pearl, Laurence H.] Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Kumar, S (corresponding author), Univ Coll London Hosp, UCL Div Med, Ctr Rheumatol, London W1T 4JF, England.	s.kumar@ucl.ac.uk		Pearl, Laurence/0000-0002-6910-1809; Isenberg, David/0000-0001-9514-2455	Arthritis Research Campaign, UK	Arthritis Research Campaign, UK(Versus Arthritis)	This work was supported by the Arthritis Research Campaign, UK.	AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; BAST RC, 1993, CANCER, V71, P1597, DOI 10.1002/cncr.2820710426; Bollag D.M., 1991, PROTEIN METHODS; CALDERONI A, 1994, DEUT MED WOCHENSCHR, V119, P1194, DOI 10.1055/s-2008-1058821; DEPOTTER CR, 1989, HISTOPATHOLOGY, V15, P351; DESAI DD, 1993, J IMMUNOL, V151, P1614; DIAMOND B, 1992, ANNU REV IMMUNOL, V10, P731, DOI 10.1146/annurev.iy.10.040192.003503; Dimitrova I, 2010, LUPUS, V19, P1261, DOI 10.1177/0961203310371153; DOUGALL WC, 1993, J CELL BIOCHEM, V53, P61, DOI 10.1002/jcb.240530108; Ethier SP, 1996, MOL CARCINOGEN, V15, P134; FELICI F, 1993, GENE, V128, P21, DOI 10.1016/0378-1119(93)90148-V; FUKUSHIGE S, 1986, MOL CELL BIOL, V6, P955, DOI 10.1128/MCB.6.3.955; Gaynor B, 1997, P NATL ACAD SCI USA, V94, P1955, DOI 10.1073/pnas.94.5.1955; GILKESON GS, 1995, J CLIN INVEST, V95, P1398, DOI 10.1172/JCI117793; Goldenberg MM, 1999, CLIN THER, V21, P309, DOI 10.1016/S0149-2918(00)88288-0; GOULD RJ, 1981, BIOCHEMISTRY-US, V20, P6776, DOI 10.1021/bi00527a006; Greagg MA, 1999, P NATL ACAD SCI USA, V96, P9045, DOI 10.1073/pnas.96.16.9045; GULLICK WJ, 1987, INT J CANCER, V40, P246, DOI 10.1002/ijc.2910400221; Ignatovich O, 1997, J MOL BIOL, V268, P69, DOI 10.1006/jmbi.1997.0956; ISENBERG D, 1990, J AUTOIMMUN, V3, P393, DOI 10.1016/S0896-8411(05)80008-3; Isenberg D. A., 1998, OXFORD TXB RHEUMATOL, P1145; Isenberg DA, 1997, BRIT J RHEUMATOL, V36, P229; Kumar S, 2000, J BIOL CHEM, V275, P35129, DOI 10.1074/jbc.M001976200; LEPAGE SH, 1989, CLIN EXP IMMUNOL, V77, P314; LEWIS GD, 1993, CANCER IMMUNOL IMMUN, V37, P255, DOI 10.1007/BF01518520; Lundin K, 1996, IMMUNOLOGY, V89, P579, DOI 10.1046/j.1365-2567.1996.d01-772.x; MADAIO MP, 1984, J IMMUNOL, V132, P872; MARCHINI B, 1995, CLIN EXP RHEUMATOL, V13, P7; Mellemkjaer L, 1997, ARTHRITIS RHEUM-US, V40, P761, DOI 10.1002/art.1780400424; Molina R, 1997, TUMOR BIOL, V18, P188, DOI 10.1159/000218029; Mountain A, 1992, Biotechnol Genet Eng Rev, V10, P1; NATALI PG, 1990, INT J CANCER, V45, P457, DOI 10.1002/ijc.2910450314; OHNISHI Y, 1995, BRIT J CANCER, V71, P969, DOI 10.1038/bjc.1995.187; PADHY LC, 1982, CELL, V28, P865, DOI 10.1016/0092-8674(82)90065-4; Park BW, 2000, NAT BIOTECHNOL, V18, P194, DOI 10.1038/72651; PISETSKY DS, 1990, ARTHRITIS RHEUM, V33, P153, DOI 10.1002/art.1780330202; Putterman C, 1998, J EXP MED, V188, P29, DOI 10.1084/jem.188.1.29; Ramsey-Goldman R, 1998, J INVEST MED, V46, P217; Rekvig OP, 1997, METHODS, V11, P44, DOI 10.1006/meth.1996.0386; Sartori AA, 2001, J BIOL CHEM, V276, P29979, DOI 10.1074/jbc.M102985200; SCOTT JK, 1992, TRENDS BIOCHEM SCI, V17, P241, DOI 10.1016/0968-0004(92)90401-T; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spatz L, 1997, METHODS, V11, P70, DOI 10.1006/meth.1996.0389; SULKES A, 1991, CANCER, V68, P1389, DOI 10.1002/1097-0142(19910915)68:6<1389::AID-CNCR2820680635>3.0.CO;2-Y; Sultan SM, 2000, RHEUMATOLOGY, V39, P1147, DOI 10.1093/rheumatology/39.10.1147; SWAAK AJG, 1979, ARTHRITIS RHEUM, V22, P226, DOI 10.1002/art.1780220304; Tam JP, 1996, J IMMUNOL METHODS, V196, P17, DOI 10.1016/0022-1759(96)00066-X; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; TANAKA K, 1983, AM J EPIDEMIOL, V118, P728, DOI 10.1093/oxfordjournals.aje.a113683; Valadon P, 1996, J MOL BIOL, V261, P11, DOI 10.1006/jmbi.1996.0438; VANDEVIJVER MJ, 1988, EUR J SURG ONCOL, V14, P111; WALLACH HW, 1977, ARCH INTERN MED, V137, P532, DOI 10.1001/archinte.137.4.532; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Williams SC, 1996, J MOL BIOL, V264, P220, DOI 10.1006/jmbi.1996.0636; ZABRECKY JR, 1991, J BIOL CHEM, V266, P1716; Zhou XX, 2010, J GASTROEN HEPATOL, V25, P1266, DOI 10.1111/j.1440-1746.2010.06287.x	56	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26220	26227		10.1074/jbc.M111.224303	http://dx.doi.org/10.1074/jbc.M111.224303			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21566138	hybrid, Green Published			2022-12-25	WOS:000293073000079
J	Meng, X; Zaidi, Q				Meng, Xin; Zaidi, Qasim			Visual Effects of Haptic Feedback Are Large but Local	PLOS ONE			English	Article							3-DIMENSIONAL SHAPE; PERCEPTION; TOUCH; VISION; SURFACES; TEXTURES; OBJECTS; SENSES	Vision generally provides reliable predictions for touch and motor-control, but some classes of stimuli evoke visual illusions. Using haptic feedback on virtual 3-D surfaces, we tested the function of touch in such cases. Our experiments show that in the perception of 3-D shapes from texture cues, haptic information can dominate vision in some cases, changing percepts qualitatively from convex to concave and concave to slant. The effects take time to develop, do not outlive the cessation of the feedback, are attenuated by distance, and drastically reduced by gaps in the surface. These dynamic shifts in qualitative perceived shapes could be invaluable in neural investigations that test whether haptic feedback modifies selective activation of neurons or changes the shape-tuning of neurons responsible for percepts of 3-D shapes.	[Meng, Xin; Zaidi, Qasim] SUNY Coll Optometry, Grad Ctr Vis Res, New York, NY 10010 USA	State University of New York (SUNY) System; SUNY Optometry	Meng, X (corresponding author), SUNY Coll Optometry, Grad Ctr Vis Res, New York, NY 10010 USA.	qz@sunyopt.edu			National Institute of Health [EY07556, EY13312]; NATIONAL EYE INSTITUTE [R01EY013312, R01EY007556, R29EY007556] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institute of Health grants EY07556 and EY13312 to Q. Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2004, NAT NEUROSCI, V7, P1057, DOI 10.1038/nn1312; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; BERKELEY G, 1702, ESSAY NEW THEORY VIS; Blake R, 2004, PSYCHOL SCI, V15, P397, DOI 10.1111/j.0956-7976.2004.00691.x; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Ernst MO, 2000, NAT NEUROSCI, V3, P69, DOI 10.1038/71140; Griffiths AF, 1998, PERCEPTION, V27, P799, DOI 10.1068/p270799; HELLER MA, 1992, PERCEPTION, V21, P655, DOI 10.1068/p210655; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Li A, 2004, J VISION, V4, P860, DOI 10.1167/4.10.3; Li A, 2003, VISION RES, V43, P2741, DOI 10.1016/j.visres.2003.07.001; Li A, 2000, VISION RES, V40, P217, DOI 10.1016/S0042-6989(99)00169-8; Lunghi C, 2010, CURR BIOL, V20, pR143, DOI 10.1016/j.cub.2009.12.015; MAUNSELL JHR, 1991, VISUAL NEUROSCI, V7, P561, DOI 10.1017/S095252380001035X; Newell FN, 2001, PSYCHOL SCI, V12, P37, DOI 10.1111/1467-9280.00307; ROCK I, 1964, SCIENCE, V143, P594, DOI 10.1126/science.143.3606.594; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Violentyev A, 2005, NEUROREPORT, V16, P1107, DOI 10.1097/00001756-200507130-00015; Yamane Y, 2008, NAT NEUROSCI, V11, P1352, DOI 10.1038/nn.2202; ZAIDI Q, 2011, VISUAL INFE IN PRESS	23	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19877	10.1371/journal.pone.0019877	http://dx.doi.org/10.1371/journal.pone.0019877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	761YU	21572964	Green Published, gold			2022-12-25	WOS:000290440200032
J	Clyde, K; Glaunsinger, BA				Clyde, Karen; Glaunsinger, Britt A.			Deep Sequencing Reveals Direct Targets of Gammaherpesvirus-Induced mRNA Decay and Suggests That Multiple Mechanisms Govern Cellular Transcript Escape	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; AU-RICH ELEMENTS; GENE-EXPRESSION; HOST SHUTOFF; GENOTOXIC STRESS; LYTIC INFECTION; C-MYC; PROTEIN; KSHV; PATHOGENESIS	One characteristic of lytic infection with gammaherpesviruses, including Kaposi's sarcoma-associated herpesvirus (KSHV), Epstein-Barr virus (EBV) and murine herpesvirus 68 (MHV68), is the dramatic suppression of cellular gene expression in a process known as host shutoff. The alkaline exonuclease proteins (KSHV SOX, MHV-68 muSOX and EBV BGLF5) have been shown to induce shutoff by destabilizing cellular mRNAs. Here we extend previous analyses of cellular mRNA abundance during lytic infection to characterize the effects of SOX and muSOX, in the absence of other viral genes, utilizing deep sequencing technology (RNA-seq). Consistent with previous observations during lytic infection, the majority of transcripts are downregulated in cells expressing either SOX or muSOX, with muSOX acting as a more potent shutoff factor than SOX. Moreover, most cellular messages fall into the same expression class in both SOX- and muSOX-expressing cells, indicating that both factors target similar pools of mRNAs. More abundant mRNAs are more efficiently downregulated, suggesting a concentration effect in transcript targeting. However, even among highly expressed genes there are mRNAs that escape host shutoff. Further characterization of select escapees reveals multiple mechanisms by which cellular genes can evade downregulation. While some mRNAs are directly refractory to SOX, the steady state levels of others remain unchanged, presumably as a consequence of downstream effects on mRNA biogenesis. Collectively, these studies lay the framework for dissecting the mechanisms underlying the susceptibility of mRNA to destruction during lytic gammaherpesvirus infection.	[Clyde, Karen; Glaunsinger, Britt A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Clyde, K (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	glaunsinger@berkeley.edu			Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award; Ruth L. Kirschstein National Research Service [F32AI080082]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI080082] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided by the Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award (http://www.bwfund.org/page.php?mode=privateview&pageID=105) to B.A.G. and the Ruth L. Kirschstein National Research Service Award (F32AI080082) to K.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAER MR, 1992, BLOOD, V79, P1319; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Buisson M, 2009, J MOL BIOL, V391, P717, DOI 10.1016/j.jmb.2009.06.034; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chandriani S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000811; Clyde K, 2010, ADV VIRUS RES, V78, P1, DOI 10.1016/S0065-3527(10)78001-5; Covarrubias S, 2009, J VIROL, V83, P9554, DOI 10.1128/JVI.01051-09; Cuenin S, 2008, ONCOGENE, V27, P387, DOI 10.1038/sj.onc.1210635; Deng HY, 2002, BLOOD, V100, P1919, DOI 10.1182/blood-2002-01-0015; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Ebrahimi B, 2003, J GEN VIROL, V84, P99, DOI 10.1099/vir.0.18639-0; GANEM D, 2007, FIELDS VIROLOGY; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Glaunsinger B, 2005, J VIROL, V79, P7396, DOI 10.1128/JVI.79.12.7396-7401.2005; Glaunsinger B, 2004, J EXP MED, V200, P391, DOI 10.1084/jem.20031881; Glaunsinger B, 2004, MOL CELL, V13, P713, DOI 10.1016/S1097-2765(04)00091-7; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee YJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000107; Mages J, 2008, J CELL MOL MED, V12, P1974, DOI 10.1111/j.1582-4934.2008.00235.x; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McCormick C, 2005, SCIENCE, V307, P739, DOI 10.1126/science.1105779; MODROW S, 1983, J GEN VIROL, V64, P37, DOI 10.1099/0022-1317-64-1-37; Roan F, 2002, VIROLOGY, V301, P293, DOI 10.1006/viro.2002.1582; Rowe M, 2007, P NATL ACAD SCI USA, V104, P3366, DOI 10.1073/pnas.0611128104; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Voynow JA, 2006, AM J RESP CELL MOL, V34, P661, DOI 10.1165/rcmb.2006-0035SF; Wilkinson DE, 2003, IUBMB LIFE, V55, P451, DOI 10.1080/15216540310001612237; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232; Zuo J, 2008, J VIROL, V82, P2385, DOI 10.1128/JVI.01946-07	38	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19655	10.1371/journal.pone.0019655	http://dx.doi.org/10.1371/journal.pone.0019655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573023	Green Published, gold			2022-12-25	WOS:000290386800029
J	Fong, DH; Xiong, B; Hwang, JY; Berghuis, AM				Fong, Desiree H.; Xiong, Bing; Hwang, Jiyoung; Berghuis, Albert M.			Crystal Structures of Two Aminoglycoside Kinases Bound with a Eukaryotic Protein Kinase Inhibitor	PLOS ONE			English	Article							PRELIMINARY CRYSTALLOGRAPHIC ANALYSIS; ANTIBIOTIC-RESISTANCE; KINETIC MECHANISM; PHOSPHOTRANSFERASE; SELECTIVITY; ENZYME; SUBSTRATE; BINDING; POTENT; IIIA	Antibiotic resistance is recognized as a growing healthcare problem. To address this issue, one strategy is to thwart the causal mechanism using an adjuvant in partner with the antibiotic. Aminoglycosides are a class of clinically important antibiotics used for the treatment of serious infections. Their usefulness has been compromised predominantly due to drug inactivation by aminoglycoside-modifying enzymes, such as aminoglycoside phosphotransferases or kinases. These kinases are structurally homologous to eukaryotic Ser/Thr and Tyr protein kinases and it has been shown that some can be inhibited by select protein kinase inhibitors. The aminoglycoside kinase, APH(3')-IIIa, can be inhibited by CKI-7, an ATP- competitive inhibitor for the casein kinase 1. We have determined that CKI-7 is also a moderate inhibitor for the atypical APH(9)-Ia. Here we present the crystal structures of CKI-7-bound APH(3')-IIIa and APH(9)-Ia, the first structures of a eukaryotic protein kinase inhibitor in complex with bacterial kinases. CKI-7 binds to the nucleotide-binding pocket of the enzymes and its binding alters the conformation of the nucleotide-binding loop, the segment homologous to the glycine-rich loop in eurkaryotic protein kinases. Comparison of these structures with the CKI-7-bound casein kinase 1 reveals features in the binding pockets that are distinct in the bacterial kinases and could be exploited for the design of a bacterial kinase specific inhibitor. Our results provide evidence that an inhibitor for a subset of APHs can be developed in order to curtail resistance to aminoglycosides.	[Fong, Desiree H.; Hwang, Jiyoung; Berghuis, Albert M.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Fong, Desiree H.; Berghuis, Albert M.] McGill Univ, Grp Rech GRASP, Montreal, PQ, Canada; [Xiong, Bing; Berghuis, Albert M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Fong, DH (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	albert.berghuis@mcgill.ca	Xiong, Bing/B-8849-2008; Berghuis, Albert M/A-6495-2008; Xiong, Bin/L-7560-2019	Xiong, Bing/0000-0001-9776-8136; Xiong, Bin/0000-0001-9776-8136; Berghuis, Albert/0000-0002-2663-025X	Canadian Institutes of Health Research [MOP-13107]; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Structural Biology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Structural Biology	This work was supported by an operating grant from the Canadian Institutes of Health Research awarded to AMB (MOP-13107; http://www.cihr-irsc.gc.ca/). Support for the X8C synchrotron beamline was in part received from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/). AMB is the recipient of a Canada Research Chair in Structural Biology (http://www.chairs-chaires.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akritopoulou-Zanze I, 2009, DRUG DISCOV TODAY, V14, P291, DOI 10.1016/j.drudis.2008.12.002; ALLINGER NL, 1977, J AM CHEM SOC, V99, P8127, DOI 10.1021/ja00467a001; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burk DL, 2002, PHARMACOL THERAPEUT, V93, P283, DOI 10.1016/S0163-7258(02)00197-3; Burk DL, 2001, BIOCHEMISTRY-US, V40, P8756, DOI 10.1021/bi010504p; Burkert U., 1982, MOL MECH, DOI 10.1002/jcc.540040420; Cherry M, 2004, CURR MED CHEM, V11, P663, DOI 10.2174/0929867043455792; CHIJIWA T, 1989, J BIOL CHEM, V264, P4924; Daigle DM, 1997, J BIOL CHEM, V272, P24755, DOI 10.1074/jbc.272.40.24755; Daigle DM, 1999, CHEM BIOL, V6, P11, DOI 10.1016/S1074-5521(99)80016-7; De Pascale G, 2010, CHEMBIOCHEM, V11, P1325, DOI 10.1002/cbic.201000067; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fong DH, 2010, J BIOL CHEM, V285, P9545, DOI 10.1074/jbc.M109.038364; Fong DH, 2009, ANTIMICROB AGENTS CH, V53, P3049, DOI 10.1128/AAC.00062-09; Fong DH, 2004, ACTA CRYSTALLOGR D, V60, P1897, DOI 10.1107/S0907444904019390; Fong DH, 2002, EMBO J, V21, P2323, DOI 10.1093/emboj/21.10.2323; Gao F, 2006, J MED CHEM, V49, P5273, DOI 10.1021/jm060732n; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; Huang DZ, 2010, BIOINFORMATICS, V26, P198, DOI 10.1093/bioinformatics/btp650; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lemke CT, 2005, ACTA CRYSTALLOGR F, V61, P606, DOI 10.1107/S1744309105016301; Liao JJL, 2007, J MED CHEM, V50, P409, DOI 10.1021/jm0608107; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P6936, DOI 10.1021/bi00188a024; MCKAY GA, 1995, J BIOL CHEM, V270, P24686, DOI 10.1074/jbc.270.42.24686; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Sowadski JM, 1999, PHARMACOL THERAPEUT, V82, P157, DOI 10.1016/S0163-7258(98)00054-0; Therrien C, 2000, FEMS MICROBIOL REV, V24, P251, DOI 10.1111/j.1574-6976.2000.tb00541.x; Thompson PR, 1999, J BIOL CHEM, V274, P30697, DOI 10.1074/jbc.274.43.30697; Thompson PR, 1996, CHEM BIOL, V3, P747, DOI 10.1016/S1074-5521(96)90251-3; Toth M, 2010, PROTEIN SCI, V19, P1565, DOI 10.1002/pro.437; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Xu RM, 1996, P NATL ACAD SCI USA, V93, P6308, DOI 10.1073/pnas.93.13.6308; Young PG, 2009, J BACTERIOL, V191, P4133, DOI 10.1128/JB.00149-09	42	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19589	10.1371/journal.pone.0019589	http://dx.doi.org/10.1371/journal.pone.0019589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573013	gold, Green Submitted, Green Published			2022-12-25	WOS:000290386800021
J	Grumelli, S; Lu, B; Peterson, L; Maeno, T; Gerard, C				Grumelli, Sandra; Lu, Bao; Peterson, Leif; Maeno, Toshitaka; Gerard, Craig			CD46 Protects against Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							MEMBRANE COFACTOR PROTEIN; T-CELLS; RETINOIC ACID; LUNG-FUNCTION; EXPRESSION; ACTIVATION; EMPHYSEMA; INFLAMMATION; MACROPHAGE; INDUCTION	Background: Chronic obstructive pulmonary disease and emphysema develops in 15% of ex-smokers despite sustained quitting, while 10% are free of emphysema or severe lung obstruction. The cause of the incapacity of the immune system to clear the inflammation in the first group remains unclear. Methods and Findings: We searched genes that were protecting ex-smokers without emphysema, using microarrays on portions of human lungs surgically removed; we found that loss of lung function in patients with chronic obstructive pulmonary disease and emphysema was associated with a lower expression of CD46 and verified this finding by qRT-PCR and flow cytometry. Also, there was a significant association among decreased CD46(+) cells with decreased CD4(+)T cells, apoptosis mediator CD95 and increased CD8(+)T cells that were protecting patients without emphysema or severe chronic obstructive pulmonary disease. CD46 not only regulates the production of T regulatory cells, which suppresses CD8(+)T cell proliferation, but also the complement cascade by degradation of C3b. These results were replicated in the murine smoking model, which showed increased C5a (produced by C3b) that suppressed IL12 mediated bias to T helper 1 cells and elastin co-precipitation with C3b, suggesting that elastin could be presented as an antigen. Thus, using ELISA from elastin peptides, we verified that 43% of the patients with severe early onset of chronic obstructive pulmonary disease tested positive for IgG to elastin in their serum compared to healthy controls. Conclusions: These data suggest that higher expression of CD46 in the lungs of ex-smoker protects them from emphysema and chronic obstructive pulmonary disease by clearing the inflammation impeding the proliferation of CD8(+)T cells and necrosis, achieved by production of T regulatory cells and degradation of C3b; restraining the complement cascade favors apoptosis over necrosis, protecting them from autoimmunity and chronic inflammation.	[Grumelli, Sandra; Maeno, Toshitaka] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Grumelli, Sandra] Univ Catolica Cordoba, Ctr Invest Med Resp, Cordoba, Argentina; [Peterson, Leif] Baylor Coll Med, Dept Med, Chron Dis Prevent & Res Program, Houston, TX 77030 USA; [Lu, Bao; Gerard, Craig] Harvard Univ, Childrens Hosp, Sch Med, Div Pulm, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Catholic University of Cordoba; Baylor College of Medicine; Harvard University; Boston Children's Hospital; Harvard Medical School	Grumelli, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA.	sgrumelli@yahoo.com		Peterson, Leif/0000-0002-1187-0883	National Heart, Lung and Blood Institute	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The funding provided by the National Heart, Lung and Blood Institute made this study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; Cai XZ, 2003, AM J PHYSIOL-LUNG C, V285, pL1263, DOI 10.1152/ajplung.00274.2002; Cai XZ, 2002, J INTERF CYTOK RES, V22, P1175, DOI 10.1089/10799900260475687; Cosio MG, 1999, AM J RESP CRIT CARE, V160, pS21, DOI 10.1164/ajrccm.160.supplement_1.7; Cottin V, 2009, EUR RESPIR J, V33, P219, DOI 10.1183/09031936.00140208; Curtis Jeffrey L, 2007, Proc Am Thorac Soc, V4, P512, DOI 10.1513/pats.200701-002FM; De Sanctis JB, 2009, RECENT PATENTS INFLA, V3, P149, DOI 10.2174/187221309788489814; Devaux P, 1999, EUR J IMMUNOL, V29, P815; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Fernandez-Salas E, 2002, MOL CELL BIOL, V22, P3610, DOI 10.1128/MCB.22.11.3610-3620.2002; Gianni M, 1997, BLOOD, V89, P1001, DOI 10.1182/blood.V89.3.1001; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Greene CM, 2010, AM J RESP CRIT CARE, V181, P31, DOI 10.1164/rccm.200904-0545OC; GROSSO LE, 1993, ARCH BIOCHEM BIOPHYS, V305, P401, DOI 10.1006/abbi.1993.1438; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; He JP, 2000, J EXP MED, V191, P1605, DOI 10.1084/jem.191.9.1605; Huber-Lang M, 2002, AM J PATHOL, V161, P1849, DOI 10.1016/S0002-9440(10)64461-6; Inoue T, 2001, Hinyokika Kiyo, V47, P321; Jani TS, 2009, CELL RES, V19, P358, DOI 10.1038/cr.2008.314; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Lai KC, 2008, MOL CANCER RES, V6, P1431, DOI 10.1158/1541-7786.MCR-08-0141; Lane N, 2010, CLIN SCI, V119, P75, DOI 10.1042/CS20100033; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Madani A, 2001, EUR RESPIR J, V18, P720, DOI 10.1183/09031936.01.00255701; Maeno T, 2007, J IMMUNOL, V178, P8090, DOI 10.4049/jimmunol.178.12.8090; Matikainen S, 1996, BLOOD, V88, P114; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pauwels R, 2001, EUR RESPIR J, V18, P901, DOI 10.1183/09031936.01.0027401; Richards A, 2003, P NATL ACAD SCI USA, V100, P12966, DOI 10.1073/pnas.2135497100; Rochat-Steiner V, 2000, J EXP MED, V192, P1165, DOI 10.1084/jem.192.8.1165; Saetta M, 2002, AM J RESP CRIT CARE, V165, P1404, DOI 10.1164/rccm.2107139; Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Skokowa J, 2005, J IMMUNOL, V174, P3041, DOI 10.4049/jimmunol.174.5.3041; Sprent J, 2002, IMMUNOL REV, V185, P126, DOI 10.1034/j.1600-065X.2002.18512.x; Uppaluri R, 1997, AM J RESP CRIT CARE, V156, P248, DOI 10.1164/ajrccm.156.1.9606093; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; Wood AM, 2010, OCCUP ENVIRON MED, V67, P556, DOI 10.1136/oem.2009.047589; Xu JS, 2006, J BIOL CHEM, V281, P38894, DOI 10.1074/jbc.M609339200; YAMAMOTO K, 1994, MOL CELL BIOL, V14, P4342, DOI 10.1128/MCB.14.7.4342; Zou CB, 2007, NAT MED, V13, P1078, DOI 10.1038/nm1625	48	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e18785	10.1371/journal.pone.0018785	http://dx.doi.org/10.1371/journal.pone.0018785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573156	Green Submitted, Green Published, gold			2022-12-25	WOS:000290305600006
J	Rudolph, AE; Latkin, C; Crawford, ND; Jones, KC; Fuller, CM				Rudolph, Abby E.; Latkin, Carl; Crawford, Natalie D.; Jones, Kandice C.; Fuller, Crystal M.			Does Respondent Driven Sampling Alter the Social Network Composition and Health-Seeking Behaviors of Illicit Drug Users Followed Prospectively?	PLOS ONE			English	Article							HIV RISK BEHAVIORS; INJECTION-DRUG; HIDDEN POPULATIONS; INTERVENTION; AIDS; OUTREACH; PREVENTION; PATTERNS; PROGRAM; COCAINE	Respondent driven sampling (RDS) was originally developed to sample and provide peer education to injection drug users at risk for HIV. Based on the premise that drug users' social networks were maintained through sharing rituals, this peer-driven approach to disseminate educational information and reduce risk behaviors capitalizes and expands upon the norms that sustain these relationships. Compared with traditional outreach interventions, peer-driven interventions produce greater reductions in HIV risk behaviors and adoption of safer behaviors over time, however, control and intervention groups are not similarly recruited. As peer-recruitment may alter risk networks and individual risk behaviors over time, such comparison studies are unable to isolate the effect of a peer-delivered intervention. This analysis examines whether RDS recruitment (without an intervention) is associated with changes in health-seeking behaviors and network composition over 6 months. New York City drug users (N = 618) were recruited using targeted street outreach (TSO) and RDS (2006-2009). 329 non-injectors (RDS = 237; TSO = 92) completed baseline and 6-month surveys ascertaining demographic, drug use, and network characteristics. Chi-square and t-tests compared RDS- and TSO-recruited participants on changes in HIV testing and drug treatment utilization and in the proportion of drug using, sex, incarcerated and social support networks over the follow-up period. The sample was 66% male, 24% Hispanic, 69% black, 62% homeless, and the median age was 35. At baseline, the median network size was 3, 86% used crack, 70% used cocaine, 40% used heroin, and in the past 6 months 72% were tested for HIV and 46% were enrolled in drug treatment. There were no significant differences by recruitment strategy with respect to changes in health-seeking behaviors or network composition over 6 months. These findings suggest no association between RDS recruitment and changes in network composition or HIV risk, which supports prior findings from prospective HIV behavioral surveillance and intervention studies.	[Rudolph, Abby E.; Latkin, Carl] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Crawford, Natalie D.; Jones, Kandice C.; Fuller, Crystal M.] New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY USA; [Crawford, Natalie D.; Fuller, Crystal M.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; New York Academy of Medicine; Columbia University	Rudolph, AE (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	abby.rudolph@gmail.com		Rudolph, Abby/0000-0003-1786-3307	National Institute on Drug Abuse [R01 DA019964-01, T32 DA007282]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007282, R01DA019964] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institute on Drug Abuse (R01 DA019964-01, T32 DA007282). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MD, 1996, J DRUG ISSUES, V26, P619, DOI 10.1177/002204269602600307; Barrington C, 2009, SOC SCI MED, V68, P2037, DOI 10.1016/j.socscimed.2009.03.009; BOOTH R, 1991, AM J DRUG ALCOHOL AB, V17, P337, DOI 10.3109/00952999109027557; Booth RE, 1996, DRUG ALCOHOL DEPEN, V42, P11, DOI 10.1016/0376-8716(96)01257-4; Booth RE, 2011, AM J PUBLIC HEALTH, V101, P336, DOI 10.2105/AJPH.2009.172304; Borders TF, 2008, ADDICTION, V103, P800, DOI 10.1111/j.1360-0443.2008.02159.x; Broadhead RS, 2006, INT J DRUG POLICY, V17, P379, DOI 10.1016/j.drugpo.2006.06.001; Broadhead RS, 1999, PUBLIC HEALTH, V113, P42; Broadhead RS, 2002, SOC SCI MED, V55, P235, DOI 10.1016/S0277-9536(01)00167-8; BROADHEAD RS, 1994, SOC PROBL, V41, P473, DOI 10.1525/sp.1994.41.3.03x0449g; BUX DA, 1993, HOSP COMMUNITY PSYCH, V44, P1066; CAMACHO LM, 1995, AM J ADDICTION, V4, P49; COLEMAN JS, 1959, SOC APPL ANTHR, V17, P28; Colon H M, 1993, P R Health Sci J, V12, P27; COLON HM, 1992, BRIT J ADDICT, V87, P585; Costenbader EC, 2006, ADDICTION, V101, P1003, DOI 10.1111/j.1360-0443.2006.01431.x; Cottler L B, 1998, Public Health Rep, V113 Suppl 1, P31; Coyle S L, 1998, Public Health Rep, V113 Suppl 1, P19; Curry AD, 2003, J URBAN HEALTH, V80, P482, DOI 10.1093/jurban/jtg049; Deering K. N., 2009, AIDS PATIENT CARE ST; DEREN S, 1995, AIDS EDUC PREV, V7, P379; DEREN S, 1995, J DRUG ISSUES, V25, P57, DOI 10.1177/002204269502500105; FRIEDMAN SR, 1992, BRIT J ADDICT, V87, P393; Gile KJ, 2010, SOCIOL METHODOL, V40, P285, DOI 10.1111/j.1467-9531.2010.01223.x; He HO, 1996, J DRUG ISSUES, V26, P649, DOI 10.1177/002204269602600309; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 1999, SOCIOL FOCUS, V32, P159, DOI [DOI 10.1080/00380237.1999.10571133, 10.1080/00380237.1999.10571133]; Hoffmann JP, 1997, DRUG ALCOHOL DEPEN, V46, P41, DOI 10.1016/S0376-8716(97)00038-0; KLOVDAHL AS, 1994, SOC SCI MED, V38, P79, DOI 10.1016/0277-9536(94)90302-6; Kotranski L, 1998, AIDS EDUC PREV, V10, P19; Latkin C, 1996, J ACQ IMMUN DEF SYND, V13, P273, DOI 10.1097/00042560-199611010-00010; LATKIN C, 1995, DRUG ALCOHOL DEPEN, V38, P1, DOI 10.1016/0376-8716(94)01082-V; Latkin CA, 1999, AM J DRUG ALCOHOL AB, V25, P463, DOI 10.1081/ADA-100101873; LAUMANN EO, 1993, J HEALTH SOC BEHAV, V34, P7, DOI 10.2307/2137301; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; McCoy CB, 2001, SUBST USE MISUSE, V36, P49, DOI 10.1081/JA-100000228; Neaigus A, 1990, AIDS Educ Prev, V2, P253; Neaigus A, 1998, Public Health Rep, V113 Suppl 1, P140; Pilowsky DJ, 2007, SUBST USE MISUSE, V42, P1629, DOI 10.1080/10826080701205372; Rhodes F, 1996, CLAR SYMP, P207; Robinson WT, 2006, J URBAN HEALTH, V83, pI29, DOI 10.1007/s11524-006-9100-3; Rudolph AE, 2011, ANN EPIDEMIOL, V21, P280, DOI 10.1016/j.annepidem.2010.11.007; Scott G, 2008, INT J DRUG POLICY, V19, P42, DOI 10.1016/j.drugpo.2007.11.014; Semaan Salaam, 2002, AIDS Reviews, V4, P213; Sergeyev B, 1999, J DRUG ISSUES, V29, P777, DOI 10.1177/002204269902900403; SIEGAL HA, 1995, AIDS EDUC PREV, V7, P308; STEPHENS RC, 1991, AM J PUBLIC HEALTH, V81, P568, DOI 10.2105/AJPH.81.5.568; Stevens SJ, 1998, WOMEN HEALTH, V27, P25, DOI 10.1300/J013v27n01_03; SUFIAN M, 1991, Journal of Addictive Diseases, V10, P89, DOI 10.1300/J069v10n04_07; Tobin KE, 2011, ADDICTION, V106, P366, DOI 10.1111/j.1360-0443.2010.03146.x; WATTERS JK, 1989, SOC PROBL, V36, P416, DOI 10.1525/sp.1989.36.4.03a00070; WECHSBERG WM, 1994, EVAL PROGRAM PLANN, V17, P371, DOI 10.1016/0149-7189(94)90037-X; WEEKS MR, 2002, AIDS BEHAV, V6, P193, DOI DOI 10.1023/A:1015457400897; WEEKS RM, 2002, AIDS BEHAV, V6, P193; Williams CT, 2007, AM J PREV MED, V32, pS203, DOI 10.1016/j.amepre.2007.02.006	56	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19615	10.1371/journal.pone.0019615	http://dx.doi.org/10.1371/journal.pone.0019615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	760DZ	21573122	Green Published, gold, Green Submitted			2022-12-25	WOS:000290305600036
J	Liang, G; Ahlqvist, K; Pannem, R; Posern, G; Massoumi, R				Liang, Gang; Ahlqvist, Kristofer; Pannem, Rajeswararao; Posern, Guido; Massoumi, Ramin			Serum Response Factor Controls CYLD Expression via MAPK Signaling Pathway	PLOS ONE			English	Article							TUMOR-SUPPRESSOR CYLD; NF-KAPPA-B; DEPENDENT GENE-EXPRESSION; NEGATIVE REGULATION; CELL-PROLIFERATION; MULTIPLE-MYELOMA; GROWTH-FACTORS; BINDING SITE; IN-VIVO; KINASE	Tumor suppressor gene CYLD is a deubiquitinating enzyme which negatively regulates various signaling pathways by removing the lysine 63-linked polyubiquitin chains from several specific substrates. Loss of CYLD in different types of tumors leads to either cell survival or proliferation. In this study we demonstrate that lack of CYLD expression in CYLD-/- MEFs increases proliferation rate of these cells compared to CYLD+/+ in a serum concentration dependent manner without affecting cell survival. The reduced proliferation rate in CYLD+/+ in the presence of serum was due to the binding of serum response factor (SRF) to the serum response element identified in the CYLD promoter for the up-regulation of CYLD levels. The serum regulated recruitment of SRF to the CYLD promoter was dependent on p38 mitogen-activated protein kinase (MAPK) activity. Elimination of SRF by siRNA or inhibition of p38 MAPK reduced the expression level of CYLD and increased cell proliferation. These results show that SRF acts as a positive regulator of CYLD expression, which in turn reduces the mitogenic activation of serum for aberrant proliferation of MEF cells.	[Liang, Gang; Ahlqvist, Kristofer; Pannem, Rajeswararao; Massoumi, Ramin] Lund Univ, UMAS, Dept Lab Med, Malmo, Sweden; [Posern, Guido] Max Planck Inst Biochem, Dept Mol Biol, AG Regulat Gene Express, D-82152 Martinsried, Germany	Lund University; Skane University Hospital; Max Planck Society	Liang, G (corresponding author), Lund Univ, UMAS, Dept Lab Med, Malmo, Sweden.	Ramin.Massoumi@med.lu.se	Massoumi, Ramin/AAG-4786-2019	Massoumi, Ramin/0000-0001-8875-6440	Swedish Society for Medical Research; Swedish Cancer Foundation; Swedish Medical Research Council; Crafoordska Foundation; Royal Physiographic Society in Lund; U-MAS Research Foundations; ERC	Swedish Society for Medical Research; Swedish Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Crafoordska Foundation; Royal Physiographic Society in Lund; U-MAS Research Foundations; ERC(European Research Council (ERC)European Commission)	This work was supported by the Swedish Society for Medical Research, Swedish Cancer Foundation, Swedish Medical Research Council, Crafoordska Foundation, Royal Physiographic Society in Lund, U-MAS Research Foundations and ERC starting independent researcher grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2008, CANCER CELL, V14, P394, DOI 10.1016/j.ccr.2008.10.007; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Davis FJ, 2003, J BIOL CHEM, V278, P20047, DOI 10.1074/jbc.M209998200; Descot A, 2008, MOL CELL BIOL, V28, P6171, DOI 10.1128/MCB.00303-08; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; GAUTHIERROUVIERE C, 1991, CELL REGUL, V2, P575, DOI 10.1091/mbc.2.7.575; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Heidenreich O, 1999, J BIOL CHEM, V274, P14434, DOI 10.1074/jbc.274.20.14434; Hellerbrand C, 2007, CARCINOGENESIS, V28, P21, DOI 10.1093/carcin/bgl081; HILL CS, 1995, EMBO J, V14, P5037, DOI 10.1002/j.1460-2075.1995.tb00186.x; Hirai Y, 2004, INT J ONCOL, V24, P977; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; JANKNECHT R, 1992, EMBO J, V11, P1045, DOI 10.1002/j.1460-2075.1992.tb05143.x; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; JOHANSEN FE, 1995, BBA-REV CANCER, V1242, P1, DOI 10.1016/0304-419X(94)00014-S; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Koegel H, 2009, J CLIN INVEST, V119, P899, DOI 10.1172/JCI37771; Koga T, 2008, J BIOL CHEM, V283, P12546, DOI 10.1074/jbc.M710518200; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; MARAIS RM, 1992, EMBO J, V11, P97, DOI 10.1002/j.1460-2075.1992.tb05032.x; Massoumi R, TRENDS BIOCH SCI, V35, P392; Massoumi R, 2007, BIOESSAYS, V29, P1203, DOI 10.1002/bies.20677; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Montagne J, 1996, DEVELOPMENT, V122, P2589; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Regamey A, 2003, J EXP MED, V198, P1959, DOI 10.1084/jem.20031187; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; Ronkina N, NUCL ACIDS RES; Sara A, 2009, EMBO J; Schratt G, 2001, MOL CELL BIOL, V21, P2933, DOI 10.1128/MCB.21.8.2933-2943.2001; Soulez M, 1996, MOL CELL BIOL, V16, P6065; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200	48	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19613	10.1371/journal.pone.0019613	http://dx.doi.org/10.1371/journal.pone.0019613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573132	gold, Green Published			2022-12-25	WOS:000290256400035
J	Chen, HY; Poon, A; Yeung, C; Helms, C; Pons, J; Bowcock, AM; Kwok, PY; Liao, W				Chen, Haoyan; Poon, Annie; Yeung, Celestine; Helms, Cynthia; Pons, Jennifer; Bowcock, Anne M.; Kwok, Pui-Yan; Liao, Wilson			A Genetic Risk Score Combining Ten Psoriasis Risk Loci Improves Disease Prediction	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; REVEALS ASSOCIATION; EXTENDED HAPLOTYPE; HLA-C; VARIANTS; ONSET; IDENTIFICATION; ARTHRITIS; TRAF3IP2	Psoriasis is a chronic, immune-mediated skin disease affecting 2-3% of Caucasians. Recent genetic association studies have identified multiple psoriasis risk loci; however, most of these loci contribute only modestly to disease risk. In this study, we investigated whether a genetic risk score (GRS) combining multiple loci could improve psoriasis prediction. Two approaches were used: a simple risk alleles count (cGRS) and a weighted (wGRS) approach. Ten psoriasis risk SNPs were genotyped in 2815 case-control samples and 858 family samples. We found that the total number of risk alleles in the cases was significantly higher than in controls, mean 13.16 (SD 1.7) versus 12.09 (SD 1.8), p = 4.577 x 10(-40). The wGRS captured considerably more risk than any SNP considered alone, with a psoriasis OR for high-low wGRS quartiles of 10.55 (95% CI 7.63-14.57), p = 2.010 x 10(-65). To compare the discriminatory ability of the GRS models, receiver operating characteristic curves were used to calculate the area under the curve (AUC). The AUC for wGRS was significantly greater than for cGRS (72.0% versus 66.5%, p = 2.13 x 10(-8)). Additionally, the AUC for HLA-C alone (rs10484554) was equivalent to the AUC for all nine other risk loci combined (66.2% versus 63.8%, p = 0.18), highlighting the dominance of HLA-C as a risk locus. Logistic regression revealed that the wGRS was significantly associated with two subphenotypes of psoriasis, age of onset (p = 4.91 x 10(-6)) and family history (p = 0.020). Using a liability threshold model, we estimated that the 10 risk loci account for only 11.6% of the genetic variance in psoriasis. In summary, we found that a GRS combining 10 psoriasis risk loci captured significantly more risk than any individual SNP and was associated with early onset of disease and a positive family history. Notably, only a small fraction of psoriasis heritability is captured by the common risk variants identified to date.	[Poon, Annie; Yeung, Celestine; Pons, Jennifer; Kwok, Pui-Yan] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Poon, Annie; Yeung, Celestine; Pons, Jennifer; Kwok, Pui-Yan] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Chen, Haoyan; Kwok, Pui-Yan; Liao, Wilson] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Helms, Cynthia; Bowcock, Anne M.] Washington Univ, Sch Med, Dept Genet, Div Human Genet, St Louis, MO 63110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington University (WUSTL)	Chen, HY (corresponding author), Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA.	liaowi@derm.ucsf.edu	Kwok, Pui-Yan/F-7725-2014	Kwok, Pui-Yan/0000-0002-5087-3059; Bowcock, Anne/0000-0001-8691-9090	Dermatology Foundation; National Institutes of Health [K08AR057763, R01AR050266]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR057763, R01AR050266] Funding Source: NIH RePORTER	Dermatology Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Financial support for this study was provided, in part, by the Dermatology Foundation to WL and by the National Institutes of Health to WL (K08AR057763) and AB (R01AR050266). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2010, AM HEART J, V160, P250, DOI 10.1016/j.ahj.2010.05.031; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chang M, 2008, GENES IMMUN, V9, P176, DOI 10.1038/sj.gene.6364451; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Duffin KC, 2008, J RHEUMATOL, V35, P1449; ELDER JT, 1994, ARCH DERMATOL, V130, P216, DOI 10.1001/archderm.130.2.216; Elder JT, 2001, ARCH DERMATOL, V137, P1447; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Enerback C, 1997, ACTA DERM-VENEREOL, V77, P273; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gudjonsson JE, 2002, J INVEST DERMATOL, V118, P362, DOI 10.1046/j.0022-202x.2001.01656.x; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; Henseler T, 1998, ARCH DERMATOL RES, V290, P463, DOI 10.1007/s004030050338; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Li YH, 2009, J INVEST DERMATOL, V129, P629, DOI 10.1038/jid.2008.297; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Mallon E, 2000, BRIT J DERMATOL, V143, P1177, DOI 10.1046/j.1365-2133.2000.03885.x; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Nair RP, 2008, J INVEST DERMATOL, V128, P1653, DOI 10.1038/sj.jid.5701255; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Pawitan Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007969; Piccolo Stephen R, 2009, BMC Proc, V3 Suppl 7, pS46; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roberson EDO, 2010, TRENDS GENET, V26, P415, DOI 10.1016/j.tig.2010.06.006; Schafer T, 2006, DERMATOLOGY, V212, P327, DOI 10.1159/000092283; SchmittEgenolf M, 1996, J INVEST DERMATOL, V106, P711, DOI 10.1111/1523-1747.ep12345600; SCHMITTEGENOLF M, 1993, J INVEST DERMATOL, V100, P749, DOI 10.1111/1523-1747.ep12476080; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	41	63	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19454	10.1371/journal.pone.0019454	http://dx.doi.org/10.1371/journal.pone.0019454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559375	Green Published, gold			2022-12-25	WOS:000290024700180
J	Ciabattini, A; Pettini, E; Fiorino, F; Prota, G; Pozzi, G; Medaglini, D				Ciabattini, Annalisa; Pettini, Elena; Fiorino, Fabio; Prota, Gennaro; Pozzi, Gianni; Medaglini, Donata			Distribution of Primed T Cells and Antigen-Loaded Antigen Presenting Cells Following Intranasal Immunization in Mice	PLOS ONE			English	Article							LYMPH-NODES; DENDRITIC CELLS; L-SELECTIN; MIGRATION; TRAFFICKING; CD4(+); EXPRESSION; GENERATION; INDUCTION; INTEGRIN	Priming of T cells is a key event in vaccination, since it bears a decisive influence on the type and magnitude of the immune response. T-cell priming after mucosal immunization via the nasal route was studied by investigating the distribution of antigen-loaded antigen presenting cells (APCs) and primed antigen-specific T cells. Nasal immunization studies were conducted using the model protein antigen ovalbumin (OVA) plus CpG oligodeoxynucleotide adjuvant. Trafficking of antigen-specific primed T cells was analyzed in vivo after adoptive transfer of OVA-specific transgenic T cells in the presence or absence of fingolimod, a drug that causes lymphocytes sequestration within lymph nodes. Antigen-loaded APCs were observed in mediastinal lymph nodes, draining the respiratory tract, but not in distal lymph nodes. Antigen-specific proliferating T cells were first observed within draining lymph nodes, and later in distal iliac and mesenteric lymph nodes and in the spleen. The presence at distal sites was due to migration of locally primed T cells as shown by fingolimod treatment that caused a drastic reduction of proliferated T cells in non-draining lymph nodes and an accumulation of extensively divided T cells within draining lymph nodes. Homing of nasally primed T cells in distal iliac lymph nodes was CD62L-dependent, while entry into mesenteric lymph nodes depended on both CD62L and alpha 4 beta 7, as shown by in vivo antibody-mediated inhibition of T-cell trafficking. These data, elucidating the trafficking of antigen-specific primed T cells to non-draining peripheral and mucosa-associated lymph nodes following nasal immunization, provide relevant insights for the design of vaccination strategies based on mucosal priming.	[Ciabattini, Annalisa; Pettini, Elena; Fiorino, Fabio; Prota, Gennaro; Pozzi, Gianni; Medaglini, Donata] Univ Siena, Dipartimento Biotecnol, Lab Microbiol Mol & Biotecnol LAMMB, I-53100 Siena, Italy	University of Siena	Ciabattini, A (corresponding author), Univ Siena, Dipartimento Biotecnol, Lab Microbiol Mol & Biotecnol LAMMB, Via Laterina 8, I-53100 Siena, Italy.	medaglini@unisi.it	Pozzi, Gianni/Q-2713-2018; Pettini, Elena/R-4188-2018; Medaglini, Donata/R-1149-2018; Ciabattini, Annalisa/Q-2721-2018	Pozzi, Gianni/0000-0002-9557-4714; Pettini, Elena/0000-0002-0308-7127; Medaglini, Donata/0000-0003-1729-7325; Ciabattini, Annalisa/0000-0002-4585-7783; Fiorino, Fabio/0000-0002-1440-8061	Commission of the European Communities [LSHP-CT-2003-503240]; "European Vaccines and Microbicides Enterprise" (EUROPRISE) [037611]; "Azione Concertata Italiana per lo Sviluppo di un Vaccino HIV/AIDS" (ICAV) of the Istituto Superiore di Sanita [45G.27]	Commission of the European Communities(European Commission); "European Vaccines and Microbicides Enterprise" (EUROPRISE); "Azione Concertata Italiana per lo Sviluppo di un Vaccino HIV/AIDS" (ICAV) of the Istituto Superiore di Sanita	This study has been carried out with the financial support from the Commission of the European Communities, Sixth Framework Programme, contract LSHP-CT-2003-503240, "Mucosal Vaccines for Poverty-Related Diseases'' (MUVAPRED), and contract 037611 "European Vaccines and Microbicides Enterprise" (EUROPRISE) and from "Azione Concertata Italiana per lo Sviluppo di un Vaccino HIV/AIDS" (ICAV) of the Istituto Superiore di Sanita contract no. 45G.27. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BRADLEY LM, 1994, J EXP MED, V180, P2401, DOI 10.1084/jem.180.6.2401; Brandtzaeg P, 2008, MUCOSAL IMMUNOL, V1, P31, DOI 10.1038/mi.2007.9; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Brinkman CC, 2008, J IMMUNOL, V181, P1814, DOI 10.4049/jimmunol.181.3.1814; Caccamo N, 2006, EUR J IMMUNOL, V36, P2681, DOI 10.1002/eji.200636220; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; Ciabattini A, 2008, INFECT IMMUN, V76, P5817, DOI 10.1128/IAI.00793-08; Ciabattini A, 2010, VACCINE, V28, P1226, DOI 10.1016/j.vaccine.2009.11.021; Dutt S, 2005, BLOOD, V106, P4009, DOI 10.1182/blood-2005-06-2339; Enioutina EY, 2008, VACCINE, V26, P601, DOI 10.1016/j.vaccine.2007.11.084; Enioutina EY, 2009, J IMMUNOL, V182, P4296, DOI 10.4049/jimmunol.0804344; Estcourt MJ, 2005, EUR J IMMUNOL, V35, P2532, DOI 10.1002/eji.200535184; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; HAMANN A, 1994, J IMMUNOL, V152, P3282; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Jakubzick C, 2008, J IMMUNOL METHODS, V337, P121, DOI 10.1016/j.jim.2008.07.005; Johansson-Lindbom B, 2007, IMMUNOL REV, V215, P226, DOI 10.1111/j.1600-065X.2006.00482.x; Kaufman DR, 2009, CLIN EXP IMMUNOL, V157, P165, DOI 10.1111/j.1365-2249.2009.03927.x; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; KRAAL G, 1995, AM J PATHOL, V147, P763; Lan YY, 2005, AM J TRANSPLANT, V5, P2649, DOI 10.1111/j.1600-6143.2005.01085.x; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; McCluskie MJ, 2002, FEMS IMMUNOL MED MIC, V32, P179, DOI 10.1016/S0928-8244(01)00305-4; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Pettini E, 2009, METHODS, V49, P340, DOI 10.1016/j.ymeth.2009.03.026; Reines I, 2009, J INVEST DERMATOL, V129, P1954, DOI 10.1038/jid.2008.454; Song JH, 2009, J IMMUNOL, V182, P6851, DOI 10.4049/jimmunol.0803568; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; Vendetti S, 2009, METHODS, V49, P334, DOI 10.1016/j.ymeth.2009.04.018; Wagner N, 1998, EUR J IMMUNOL, V28, P3832, DOI 10.1002/(SICI)1521-4141(199811)28:11<3832::AID-IMMU3832>3.0.CO;2-J; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016	46	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19346	10.1371/journal.pone.0019346	http://dx.doi.org/10.1371/journal.pone.0019346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559409	Green Submitted, gold, Green Published			2022-12-25	WOS:000290024700144
J	de Herve, MGD; Durali, D; Dembele, B; Giuliani, M; Tran, TA; Azzarone, B; Eid, P; Tardieu, M; Delfraissy, JF; Taoufik, Y				de Herve, Marie-Ghislaine de Goer; Durali, Deniz; Dembele, Bamory; Giuliani, Massimo; Tu-Anh Tran; Azzarone, Bruno; Eid, Pierre; Tardieu, Marc; Delfraissy, Jean-Francois; Taoufik, Yassine			Interferon-Alpha Triggers B Cell Effector 1 (Be1) Commitment	PLOS ONE			English	Article							IFN-ALPHA; T-CELLS; STAT4 ACTIVATION; GAMMA PRODUCTION; VIRAL-INFECTION; NATURAL-KILLER; TH2 CELLS; EXPRESSION; RESPONSES; IL-12	B-cells can contribute to the pathogenesis of autoimmune diseases not only through auto-antibody secretion but also via cytokine production. Therapeutic depletion of B-cells influences the functions and maintenance of various T-cell subsets. The mechanisms governing the functional heterogeneity of B-cell subsets as cytokine-producing cells are poorly understood. B-cells can differentiate into two functionally polarized effectors, one (B-effector-1-cells) producing a Th-1-like cytokine pattern and the other (Be2) producing a Th-2-like pattern. IL-12 and IFN-gamma play a key role in Be1 polarization, but the initial trigger of Be1 commitment is unclear. Type-I-interferons are produced early in the immune response and prime several processes involved in innate and adaptive responses. Here, we report that IFN-alpha triggers a signaling cascade in resting human naive B-cells, involving STAT4 and T-bet, two key IFN-gamma gene imprinting factors. IFN-alpha primed naive B-cells for IFN-gamma production and increased IFN-gamma gene responsiveness to IL-12. IFN-gamma continues this polarization by re-inducing T-bet and up-regulating IL-12R beta 2 expression. IFN-alpha and IFN-gamma therefore pave the way for the action of IL-12. These results point to a coordinated action of IFN-alpha, IFN-gamma and IL-12 in Be1 polarization of naive B-cells, and may provide new insights into the mechanisms by which type-I-interferons favor autoimmunity.	[de Herve, Marie-Ghislaine de Goer; Durali, Deniz; Dembele, Bamory; Tu-Anh Tran; Tardieu, Marc; Delfraissy, Jean-Francois; Taoufik, Yassine] INSERM, U1012, Le Kremlin Bicetre, France; [de Herve, Marie-Ghislaine de Goer; Durali, Deniz; Dembele, Bamory; Tu-Anh Tran; Tardieu, Marc; Delfraissy, Jean-Francois; Taoufik, Yassine] Univ Paris Sud, Le Kremlin Bicetre, France; [de Herve, Marie-Ghislaine de Goer; Taoufik, Yassine] Hop Bicetre, Unite Immunol Biol, Le Kremlin Bicetre, France; [Durali, Deniz] GEBI, Vaccine Technol Lab, TUBITAK Marmara Res Ctr, Gebze, Turkey; [Giuliani, Massimo; Azzarone, Bruno; Eid, Pierre] INSERM, U542, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Gebze Technical University; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Institut National de la Sante et de la Recherche Medicale (Inserm)	de Herve, MGD (corresponding author), INSERM, U1012, Le Kremlin Bicetre, France.	yassine.taoufik@bct.aphp.fr	Azzarone, Bruno/AAH-9251-2019; DURALI, Deniz/Y-6325-2019	Azzarone, Bruno/0000-0002-5962-3849; DEMBELE, Bamory/0000-0002-6165-9090; TRAN, Tu-Anh/0000-0001-6587-1876				Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; AGRAWAL S, 2011, J CLIN IMMUNOL; Airoldi I, 2000, J IMMUNOL, V165, P6880, DOI 10.4049/jimmunol.165.12.6880; Bekeredjian-Ding I, 2007, J IMMUNOL, V178, P2803, DOI 10.4049/jimmunol.178.5.2803; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Cho SS, 1996, J IMMUNOL, V157, P4781; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; Durali D, 2003, BLOOD, V102, P4084, DOI 10.1182/blood-2003-02-0518; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; Farrar JD, 2000, J BIOL CHEM, V275, P2693, DOI 10.1074/jbc.275.4.2693; Harris DP, 2005, J IMMUNOL, V175, P7103, DOI 10.4049/jimmunol.175.11.7103; Harris DP, 2005, J IMMUNOL, V174, P6781, DOI 10.4049/jimmunol.174.11.6781; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Hermann P, 1998, J IMMUNOL, V161, P2011; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; PARRONCHI P, 1992, J IMMUNOL, V149, P2977; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pistoia V, 1997, IMMUNOL TODAY, V18, P343, DOI 10.1016/S0167-5699(97)01080-3; Rogge L, 1998, J IMMUNOL, V161, P6567; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Sanz I, 2007, FRONT BIOSCI-LANDMRK, V12, P2546, DOI 10.2741/2254; Stasi R, 2010, SEMIN HEMATOL, V47, P170, DOI 10.1053/j.seminhematol.2010.01.010; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Zimmerer JM, 2007, J IMMUNOL, V178, P4832, DOI 10.4049/jimmunol.178.8.4832	33	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19366	10.1371/journal.pone.0019366	http://dx.doi.org/10.1371/journal.pone.0019366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559410	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700150
J	Huang, PP; Khan, I; Suhail, MSA; Malkmus, S; Yaksh, TL				Huang, Polly P.; Khan, Imran; Suhail, Mohammed S. A.; Malkmus, Shelle; Yaksh, Tony L.			Spinal Botulinum Neurotoxin B: Effects on Afferent Transmitter Release and Nociceptive Processing	PLOS ONE			English	Article							SUBSTANCE-P RELEASE; LIGHT-CHAIN PROTEASE; INTRATHECAL MORPHINE; TACTILE ALLODYNIA; NEUROPATHIC PAIN; NERVE LIGATION; FORMALIN TEST; DORSAL-HORN; RAT; RECEPTOR	Botulinum neurotoxin B (BoNT-B) mediates proteolytic cleavage of VAMP I/II (synaptobrevins I/II), which prevents vesicle-membrane fusion and blocks neurotransmitter release. In the present study, we investigated the effects of BoNT-B on neurotransmitter release in vivo from spinal primary afferent sensory fibers and the effects of this blockade on nociception. With intrathecally (IT) delivered BoNT-B in C57B/l6 mice, we characterized the effects of such block on the release of substance P (SP) from spinal afferent nociceptors (as measured by neurokinin-1 receptor, NK1-R, internalization), spinal neuronal activation (as indicated by spinal C-Fos expression) and nociceptive behavior after intraplantar (IPLT) formalin. In addition, we investigated the effect of IT BoNT-B on spinal nerve ligation-induced tactile allodynia. A single percutaneous IT injection of BoNT-B 0.5 U at 2 or 5 days prior to IPLT formalin reduced NK1-R internalization and C-Fos expression. These effects correlated with BoNT-B cleavage of VAMPI/II protein in tissue lysate. IT BoNT-B also produced a corresponding reduction in phase 2 of formalin-evoked flinching behavior for over 30 days after IT injection. In mice with spinal nerve ligation (SNL), tactile allodynia was observed, which was attenuated by IT BoNT-B 0.5 U over the next 15 days, as compared to vehicle animals. These effects were observed without effects upon motor function. The specificity of the IT BoNT-B effect is indicated by: i) IT co-injection of BoNT-B and anti-BoNTB antibody prevented effects on SP release, and ii) IT BoNT-B 50 U in the Sprague Dawley rats showed no effect on formalin-evoked flinching or SNL-induced tactile allodynia, which is consistent with rat resistance to BoNT-B. IT BoNT-B blocks transmitter release from spinal primary afferents, and attenuates inflammatory nociceptive response and spinal nerve injury-induced neuropathic pain, in the absence of motor impairment. These observations provide an initial assessment of the ability of IT BoNT-B to regulate spinal nociceptive processing.	[Huang, Polly P.] Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA; [Khan, Imran] US FDA, Dept Hlth & Human Serv, Bethesda, MD 20014 USA; [Suhail, Mohammed S. A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Malkmus, Shelle; Yaksh, Tony L.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; US Food & Drug Administration (FDA); University of California System; University of California San Diego; University of California System; University of California San Diego	Huang, PP (corresponding author), Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA.	tyaksh@ucsd.edu	Yaksh, Tony/D-4119-2009		National Institutes of Health, Bethesda, MD [NIH-DA02110]; Solstice Neurosciences; National Institutes of Health [DA02110]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002110] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Solstice Neurosciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by funding from the National Institutes of Health: NIH-DA02110, Bethesda, MD (TLY); Solstice Neurosciences, 701 Gateway Boulevard, Suite 250, South San Francisco, CA 94080. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A portion of the funds and drugs used in this work was supplied by Solstice Neuroscience and by the National Institutes of Health (DA02110). The support by Solstice did not involve any compensation for consulting nor any restriction on the publication of the results or on the contents of this manuscript. The authors have no patent position associated with this product or research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abbadie C, 1997, PAIN, V69, P101, DOI 10.1016/S0304-3959(96)03285-X; Antonucci F, 2008, J NEUROSCI, V28, P3689, DOI 10.1523/JNEUROSCI.0375-08.2008; Bleakman D, 2006, SEMIN CELL DEV BIOL, V17, P592, DOI 10.1016/j.semcdb.2006.10.008; Chaplan SR, 1997, J PHARMACOL EXP THER, V280, P829; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Coderre TJ, 2005, J NEUROCHEM, V94, P1131, DOI 10.1111/j.1471-4159.2005.03263.x; de Paiva A, 1999, P NATL ACAD SCI USA, V96, P3200, DOI 10.1073/pnas.96.6.3200; DICKENSON A, 1990, PAIN, V43, P353, DOI 10.1016/0304-3959(90)90032-9; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Durham PL, 2004, HEADACHE, V44, P35, DOI 10.1111/j.1526-4610.2004.04007.x; Eisenach JC, 2010, PAIN, V149, P417, DOI 10.1016/j.pain.2010.02.028; FENSTERMACHER J, 1988, ANN NY ACAD SCI, V531, P29, DOI 10.1111/j.1749-6632.1988.tb51416.x; Garry EM, 2003, MOL CELL NEUROSCI, V24, P10, DOI 10.1016/S1044-7431(03)00134-9; Henry JL, 1999, J NEUROSCI, V19, P6588; Hughes DI, 2007, J NEUROSCI, V27, P2035, DOI 10.1523/JNEUROSCI.5401-06.2007; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Juzans P, 1996, NEUROMUSCULAR DISORD, V6, P177, DOI 10.1016/0960-8966(96)00041-7; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kondo I, 2005, J NEUROSCI, V25, P3651, DOI 10.1523/JNEUROSCI.0252-05.2005; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kozaki S, 1998, MICROB PATHOGENESIS, V25, P91, DOI 10.1006/mpat.1998.0214; Larsson M, 2009, MOL NEUROBIOL, V40, P260, DOI 10.1007/s12035-009-8086-8; Linninger AA, 2008, J BIOMECH, V41, P2176, DOI 10.1016/j.jbiomech.2008.04.025; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luvisetto S, 2006, BRAIN RES, V1082, P124, DOI 10.1016/j.brainres.2006.01.117; MANTYH PW, 1995, P NATL ACAD SCI USA, V92, P2622, DOI 10.1073/pnas.92.7.2622; Marvizon JCG, 2003, NEUROSCIENCE, V118, P535, DOI 10.1016/S0306-4522(02)00977-6; MCMAHON HT, 1992, J BIOL CHEM, V267, P21338; Meunier FA, 2002, J PHYSIOL-PARIS, V96, P105, DOI 10.1016/S0928-4257(01)00086-9; Montal M, 2009, TOXICON, V54, P565, DOI 10.1016/j.toxicon.2008.11.018; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Morris JL, 2001, AM J PHYSIOL-HEART C, V281, pH2124, DOI 10.1152/ajpheart.2001.281.5.H2124; Nicholson C, 1999, STRUCTURE EXTRACELLU; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1994, J BIOL CHEM, V269, P20213; Sorkin LS, 2009, NEUROTHERAPEUTICS, V6, P609, DOI 10.1016/j.nurt.2009.07.007; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Urban LA, 2000, TRENDS PHARMACOL SCI, V21, P462; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Welch MJ, 2000, TOXICON, V38, P245, DOI 10.1016/S0041-0101(99)00153-1; YAKSH TL, 1980, NATURE, V286, P155, DOI 10.1038/286155a0; Yaksh TL, 2001, J APPL PHYSIOL, V90, P2386, DOI 10.1152/jappl.2001.90.6.2386; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yaksh TL, 2004, ANESTH ANALG, V98, P1536, DOI 10.1213/01.ANE.0000122638.41130.BF; YAKSH TL, 1986, PHARMACOL BIOCHEM BE, V25, P483, DOI 10.1016/0091-3057(86)90028-6; Yaksh TL, 1999, P NATL ACAD SCI USA, V96, P7680, DOI 10.1073/pnas.96.14.7680; YAMAMOTO T, 1991, LIFE SCI, V49, P1955, DOI 10.1016/0024-3205(91)90637-Q; Yasaka T, 2010, PAIN, V151, P475, DOI 10.1016/j.pain.2010.08.008	50	32	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19126	10.1371/journal.pone.0019126	http://dx.doi.org/10.1371/journal.pone.0019126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559464	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700070
J	Kajiya, M; Komatsuzawa, H; Papantonakis, A; Seki, M; Makihira, S; Ouhara, K; Kusumoto, Y; Murakami, S; Taubman, MA; Kawai, T				Kajiya, Mikihito; Komatsuzawa, Hitoshi; Papantonakis, Annatoula; Seki, Makoto; Makihira, Seicho; Ouhara, Kazuhisa; Kusumoto, Yutaka; Murakami, Shinya; Taubman, Martin A.; Kawai, Toshihisa			Aggregatibacter actinomycetemcomitans Omp29 Is Associated with Bacterial Entry to Gingival Epithelial Cells by F-Actin Rearrangement	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; PATHOGEN ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; EXPERIMENTAL PERIODONTAL-DISEASE; INFLAMMATORY BONE-RESORPTION; BLOOD-BRAIN-BARRIER; ESCHERICHIA-COLI; PORPHYROMONAS-GINGIVALIS; YERSINIA-ENTEROCOLITICA; BACTEROIDES-GINGIVALIS; JUNCTIONAL EPITHELIUM	The onset and progressive pathogenesis of periodontal disease is thought to be initiated by the entry of Aggregatibacter actinomycetemcomitans (Aa) into periodontal tissue, especially gingival epithelium. Nonetheless, the mechanism underlying such bacterial entry remains to be clarified. Therefore, this study aimed to investigate the possible role of Aa outer membrane protein 29 kD (Omp29), a homologue of E. coli OmpA, in promoting bacterial entry into gingival epithelial cells. To accomplish this, Omp29 expression vector was incorporated in an OmpA-deficient mutant of E. coli. Omp29(+)/OmpA(-) 2 E. coli demonstrated 22-fold higher entry into human gingival epithelial line cells (OBA9) than Omp29(-)/OmpA(-) E. coli. While the entry of Aa and Omp29(+)/OmpA(-) E. coli into OBA9 cells were inhibited by anti-Omp29 antibody, their adherence to OBA9 cells was not inhibited. Stimulation of OBA9 cells with purified Omp29 increased the phosphorylation of focal adhesion kinase (FAK), a pivotal cell-signaling molecule that can up-regulate actin rearrangement. Furthermore, Omp29 increased the formation of F-actin in OBA9 cells. The internalization of Omp29-coated beads and the entry of Aa into OBA9 were partially inhibited by treatment with PI3-kinase inhibitor (Wortmannin) and Rho GTPases inhibitor (EDIN), both known to convey FAK-signaling to actin-rearrangement. These results suggest that Omp29 is associated with the entry of Aa into gingival epithelial cells by up-regulating F-actin rearrangement via the FAK signaling pathway.	[Kajiya, Mikihito; Papantonakis, Annatoula; Seki, Makoto; Makihira, Seicho; Ouhara, Kazuhisa; Taubman, Martin A.; Kawai, Toshihisa] Forsyth Inst, Dept Immunol, Boston, MA USA; [Kajiya, Mikihito; Kawai, Toshihisa] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Komatsuzawa, Hitoshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Microbiol, Kagoshima 890, Japan; [Kusumoto, Yutaka] Osaka Ohtani Univ, Fac Pharm, Immunol Lab, Osaka, Japan; [Murakami, Shinya] Osaka Univ, Grad Sch Dent, Dept Periodontol, Div Oral Biol & Dis Control, Osaka, Japan	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; Kagoshima University; Osaka University	Kajiya, M (corresponding author), Forsyth Inst, Dept Immunol, Boston, MA USA.	tkawai@forsyth.org	Ouhara, Kazuhisa/G-5251-2019; Komatsuzawa, Hitoshi/AAC-7731-2019; Kajiya, Mikihito/A-4288-2018	Kajiya, Mikihito/0000-0001-6652-0007	National Institute of Dental and Craniofacial Research [DE-03420, DE-18499, DE-19917]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE003420, R01DE019917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE003420, R01DE018499] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The study reported herein was supported in part by grants DE-03420, DE-18499 and DE-19917 from the National Institute of Dental and Craniofacial Research (http://www.nidcr.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa R, 2003, MOL MICROBIOL, V50, P1125, DOI 10.1046/j.1365-2958.2003.03748.x; BREMER E, 1986, FEMS MICROBIOL LETT, V33, P173, DOI 10.1016/0378-1097(86)90232-6; Brissette CA, 1999, ORAL MICROBIOL IMMUN, V14, P137, DOI 10.1034/j.1399-302X.1999.140301.x; Cary LA, 1999, HISTOL HISTOPATHOL, V14, P1001, DOI 10.14670/HH-14.1001; CHRISTERSSON LA, 1987, J PERIODONTOL, V58, P540, DOI 10.1902/jop.1987.58.8.540; Fives-Taylor P, 1995, Adv Dent Res, V9, P55; Fives-Taylor PM, 1999, PERIODONTOL 2000, V20, P136, DOI 10.1111/j.1600-0757.1999.tb00161.x; FLUGEL A, 1994, J BIOL CHEM, V269, P29732; Henderson B, 2003, ANNU REV MICROBIOL, V57, P29, DOI 10.1146/annurev.micro.57.030502.090908; Kachlany SC, 2010, J DENT RES, V89, P561, DOI 10.1177/0022034510363682; Kawai T, 1998, CLIN DIAGN LAB IMMUN, V5, P11, DOI 10.1128/CDLI.5.1.11-17.1998; Kawai T, 2000, J IMMUNOL, V164, P2102, DOI 10.4049/jimmunol.164.4.2102; Komatsuzawa H, 2002, GENE, V288, P195, DOI 10.1016/S0378-1119(02)00500-0; Komatsuzawa H, 1999, INFECT IMMUN, V67, P942, DOI 10.1128/IAI.67.2.942-945.1999; Kusumoto Y, 2004, J PERIODONTOL, V75, P370, DOI 10.1902/jop.2004.75.3.370; Li L, 2004, ORAL MICROBIOL IMMUN, V19, P16, DOI 10.1046/j.0902-0055.2003.00102.x; Matsuyama T, 2005, INFECT IMMUN, V73, P1044, DOI 10.1128/IAI.73.2.1044-1051.2005; Meyer DH, 1997, CRIT REV ORAL BIOL M, V8, P389, DOI 10.1177/10454411970080040301; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Prasadarao NV, 1996, INFECT IMMUN, V64, P154, DOI 10.1128/IAI.64.1.154-160.1996; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Rolhion N, 2005, J BACTERIOL, V187, P2286, DOI 10.1128/JB.187.7.2286-2296.2005; ROMANOWSKI AW, 1988, J PERIODONTAL RES, V23, P81, DOI 10.1111/j.1600-0765.1988.tb01338.x; SAGLIE FR, 1988, J PERIODONTOL, V59, P259, DOI 10.1902/jop.1988.59.4.259; Schmid Y, 2004, INFECT IMMUN, V72, P6780, DOI 10.1128/IAI.72.12.6780-6789.2004; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; Shimoji Y, 1999, P NATL ACAD SCI USA, V96, P9857, DOI 10.1073/pnas.96.17.9857; SLOTS J, 1986, J CLIN PERIODONTOL, V13, P570, DOI 10.1111/j.1600-051X.1986.tb00849.x; Soulas C, 2000, J IMMUNOL, V165, P2335, DOI 10.4049/jimmunol.165.5.2335; SUGAI M, 1990, BIOCHEM BIOPH RES CO, V173, P92, DOI 10.1016/S0006-291X(05)81026-5; TAKATA T, 1988, J PERIODONTOL, V59, P823, DOI 10.1902/jop.1988.59.12.823; Valverde P, 2005, J DENT RES, V84, P488, DOI 10.1177/154405910508400603; Valverde P, 2004, J BONE MINER RES, V19, P155, DOI 10.1359/JBMR.0301213; WILSON ME, 1995, INFECT IMMUN, V63, P1062, DOI 10.1128/IAI.63.3.1062-1069.1995; Xie Y, 2004, FEMS IMMUNOL MED MIC, V42, P271, DOI 10.1016/j.femsim.2004.09.001	36	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18287	10.1371/journal.pone.0018287	http://dx.doi.org/10.1371/journal.pone.0018287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559515	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700010
J	Kallas, A; Pook, M; Maimets, M; Zimmermann, K; Maimets, T				Kallas, Ade; Pook, Martin; Maimets, Martti; Zimmermann, Kuelli; Maimets, Toivo			Nocodazole Treatment Decreases Expression of Pluripotency Markers Nanog and Oct4 in Human Embryonic Stem Cells	PLOS ONE			English	Article							ROCK INHIBITOR; SELF-RENEWAL; HISTONE H3; TRANSCRIPTIONAL REGULATION; RNA INTERFERENCE; ES CELLS; DIFFERENTIATION; TAXOL; P53; PACLITAXEL	Nocodazole is a known destabiliser of microtubule dynamics and arrests cell-cycle at the G2/M phase. In the context of the human embryonic stem cell (hESC) it is important to understand how this arrest influences the pluripotency of cells. Here we report for the first time the changes in the expression of transcription markers Nanog and Oct4 as well as SSEA-3 and SSEA-4 in human embryonic cells after their treatment with nocodazole. Multivariate permeabilised-cell flow cytometry was applied for characterising the expression of Nanog and Oct4 during different cell cycle phases. Among untreated hESC we detected Nanog-expressing cells, which also expressed Oct4, SSEA-3 and SSEA-4. We also found another population expressing SSEA-4, but without Nanog, Oct4 and SSEA-3 expression. Nocodazole treatment resulted in a decrease of cell population positive for all four markers Nanog, Oct4, SSEA-3, SSEA-4. Nocodazole-mediated cell-cycle arrest was accompanied by higher rate of apoptosis and upregulation of p53. Twenty-four hours after the release from nocodazole block, the cell cycle of hESC normalised, but no increase in the expression of transcription markers Nanog and Oct4 was detected. In addition, the presence of ROCK-2 inhibitor Y-27632 in the medium had no effect on increasing the expression of pluripotency markers Nanog and Oct4 or decreasing apoptosis or the level of p53. The expression of SSEA-3 and SSEA-4 increased in Nanog-positive cells after wash-out of nocodazole in the presence and in the absence of Y-27632. Our data show that in hESC nocodazole reversible blocks cell cycle, which is accompanied by irreversible loss of expression of pluripotency markers Nanog and Oct4.	[Kallas, Ade; Pook, Martin; Maimets, Martti; Zimmermann, Kuelli; Maimets, Toivo] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	University of Tartu	Kallas, A (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	ade@ebc.ee	Pook, Martin/Q-9707-2019; Kallas, Ade/H-2498-2012; Maimets, Toivo/E-9268-2017; Pook, Martin/G-3467-2017; Kallas-Kivi, Ade/F-2411-2017	Maimets, Toivo/0000-0001-6461-3365; Pook, Martin/0000-0002-8386-0203; Kallas-Kivi, Ade/0000-0002-0536-5020; Maimets, Martti/0000-0001-7343-2769	Estonian Ministry of Education and Science [SF0180100s08]; Estonian Science Foundation [7578]	Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); Estonian Science Foundation	This study was supported by grant no. SF0180100s08 of the Estonian Ministry of Education and Science, and Estonian Science Foundation (no. 7578). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Becker KA, 2010, J CELL PHYSIOL, V222, P103, DOI 10.1002/jcp.21925; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Becker KA, 2007, J CELL PHYSIOL, V210, P517, DOI 10.1002/jcp.20903; Braithwaite AW, 2005, CARCINOGENESIS, V26, P1161, DOI 10.1093/carcin/bgi091; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Claassen DA, 2009, MOL REPROD DEV, V76, P722, DOI 10.1002/mrd.21021; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; DONALDSON KL, 1994, INT J CANCER, V57, P847, DOI 10.1002/ijc.2910570614; Edel MJ, 2010, GENE DEV, V24, P561, DOI 10.1101/gad.1876710; Gauthaman K, 2010, STEM CELL REV REP, V6, P86, DOI [10.1007/s12015-010-9166-x, 10.1007/s12015-009-9107-8]; Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; HAKOMORI S, 1983, JNCI-J NATL CANCER I, V71, P231; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hoffman LM, 2005, STEM CELL REV, V1, P139, DOI 10.1385/SCR:1:2:139; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Jordan MA, 1996, CANCER RES, V56, P816; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Krutzik PO, 2005, J IMMUNOL, V175, P2357, DOI 10.4049/jimmunol.175.4.2357; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Martin-Ibanez R, 2008, HUM REPROD, V23, P2744, DOI 10.1093/humrep/den316; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Michalakis J, 2007, ANN SURG ONCOL, V14, P1220, DOI 10.1245/s10434-006-9305-4; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sena G, 1999, CYTOMETRY, V37, P113, DOI 10.1002/(SICI)1097-0320(19991001)37:2<113::AID-CYTO4>3.0.CO;2-M; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Teperek-Tkacz M, 2010, CELL CYCLE, V9, P4674, DOI 10.4161/cc.9.23.14023; Torres K, 1998, CANCER RES, V58, P3620; Trounson A, 2006, ENDOCR REV, V27, P208, DOI 10.1210/er.2005-0016; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; WOODS CM, 1995, MOL MED, V1, P506, DOI 10.1007/BF03401588; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013	48	19	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19114	10.1371/journal.pone.0019114	http://dx.doi.org/10.1371/journal.pone.0019114			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559451	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700066
J	Salehi-Had, H; Roh, MI; Giani, A; Hisatomi, T; Nakao, S; Kim, IK; Gragoudas, ES; Vavvas, D; Guccione, S; Miller, JW				Salehi-Had, Hani; Roh, Mi In; Giani, Andrea; Hisatomi, Toshio; Nakao, Shintaro; Kim, Ivana K.; Gragoudas, Evangelos S.; Vavvas, Demetrios; Guccione, Samira; Miller, Joan W.			Utilizing Targeted Gene Therapy with Nanoparticles Binding Alpha v Beta 3 for Imaging and Treating Choroidal Neovascularization	PLOS ONE			English	Article							MACULAR DEGENERATION; INTEGRIN ALPHA(V)BETA(3); PHOTODYNAMIC THERAPY; RETINAL NEOVASCULARIZATION; VISUAL IMPAIRMENT; TUMOR-REGRESSION; CELL-SURVIVAL; ANGIOGENESIS; DELIVERY; MODEL	Purpose: The integrin avb3 is differentially expressed on neovascular endothelial cells. We investigated whether a novel intravenously injectable avb3 integrin-ligand coupled nanoparticle (NP) can target choroidal neovascular membranes (CNV) for imaging and targeted gene therapy. Methods: CNV lesions were induced in rats using laser photocoagulation. The utility of NP for in vivo imaging and gene delivery was evaluated by coupling the NP with a green fluorescing protein plasmid (NP-GFPg). Rhodamine labeling (Rd-NP) was used to localize NP in choroidal flatmounts. Rd-NP-GFPg particles were injected intravenously on weeks 1, 2, or 3. In the treatment arm, rats received NP containing a dominant negative Raf mutant gene (NP-ATP mu-Raf) on days 1, 3, and 5. The change in CNV size and leakage, and TUNEL positive cells were quantified. Results: GFP plasmid expression was seen in vivo up to 3 days after injection of Rd-NP-GFPg. Choroidal flatmounts confirmed the localization of the NP and the expression of GFP plasmid in the CNV. Treating the CNV with NP-ATP mu-Raf decreased the CNV size by 42% (P < 0.001). OCT analysis revealed that the reduction of CNV size started on day 5 and reached statistical significance by day 7. Fluorescein angiography grading showed significantly less leakage in the treated CNV (P < 0.001). There were significantly more apoptotic (TUNEL-positive) nuclei in the treated CNV. Conclusion: Systemic administration of avb3 targeted NP can be used to label the abnormal blood vessels of CNV for imaging. Targeted gene delivery with NP-ATP mu-Raf leads to a reduction in size and leakage of the CNV by induction of apoptosis in the CNV.	[Salehi-Had, Hani; Roh, Mi In; Giani, Andrea; Hisatomi, Toshio; Nakao, Shintaro; Kim, Ivana K.; Gragoudas, Evangelos S.; Vavvas, Demetrios; Miller, Joan W.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol,Angiogenesis Lab, Boston, MA 02115 USA; [Guccione, Samira] Stanford Univ, Lucas Ctr, Radiol Sci Lab, Palo Alto, CA 94304 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Stanford University	Salehi-Had, H (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol,Angiogenesis Lab, Boston, MA 02115 USA.	guccione@stanford.edu	; Giani, Andrea/L-5926-2017	Miller, Joan/0000-0003-2046-3996; Vavvas, Demetrios/0000-0002-8622-6478; Roh, Miin/0000-0003-3346-754X; Hisatomi, Toshio/0000-0003-2552-9595; Giani, Andrea/0000-0003-0682-1945; Kim, Ivana/0000-0003-0310-6129	Research to Prevent Blindness (NY); Neovascular Research Fund; AMD Center of Excellence	Research to Prevent Blindness (NY)(Research to Prevent Blindness (RPB)); Neovascular Research Fund; AMD Center of Excellence	This work was supported by: Research to Prevent Blindness (NY) Unrestricted Grant to the Harvard Department of Ophthalmology and Neovascular Research Fund; AMD Center of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERINSTEIN A, 1995, J VIROL, V69, P2664, DOI 10.1128/JVI.69.4.2664-2666.1995; Blinder KJ, 2003, AM J OPHTHALMOL, V136, P407, DOI 10.1016/S0002-9394(03)00223-X; Bressler NM, 2009, OPHTHALMOLOGY, V116, pS15, DOI 10.1016/j.ophtha.2009.06.048; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; DAMATO RJ, 1995, OPHTHALMOLOGY, V102, P1261, DOI 10.1016/S0161-6420(95)30876-7; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Friedlander M, 1996, P NATL ACAD SCI USA, V93, P9764, DOI 10.1073/pnas.93.18.9764; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Gaudreault J, 2005, INVEST OPHTH VIS SCI, V46, P726, DOI 10.1167/iovs.04-0601; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Guccione S, 2004, IEEE ENG MED BIOL, V23, P50, DOI 10.1109/MEMB.2004.1360408; Hammes HP, 1996, NAT MED, V2, P529, DOI 10.1038/nm0596-529; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; Honda S, 2009, GRAEF ARCH CLIN EXP, V247, P515, DOI 10.1007/s00417-008-1010-5; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Kamizuru H, 2001, INVEST OPHTH VIS SCI, V42, P2664; Kobayashi H, 2006, NANOMEDICINE-UK, V1, P17, DOI 10.2217/17435889.1.1.17; Kumar CC, 2000, ADV EXP MED BIOL, V476, P169; Luna J, 1996, LAB INVEST, V75, P563; Marneros AG, 2007, FASEB J, V21, P3809, DOI 10.1096/fj.07-8422com; Nakazawa T, 2006, MOL VIS, V12, P867; Ning A, 2008, CAN J OPHTHALMOL, V43, P683, DOI 10.3129/i08-145; Pascolini D, 2004, OPHTHAL EPIDEMIOL, V11, P67, DOI 10.1076/opep.11.2.67.28158; Renno RZ, 2004, ARCH OPHTHALMOL-CHIC, V122, P1002, DOI 10.1001/archopht.122.7.1002; ROBBINS SG, 1994, INVEST OPHTH VIS SCI, V35, P3475; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P2743, DOI 10.1167/iovs.02-1246; Scatena MT, 2002, TRENDS CARDIOVAS MED, V12, P83, DOI 10.1016/S1050-1738(01)00151-7; Seddon Johanna M., 2004, International Ophthalmology Clinics, V44, P17, DOI 10.1097/00004397-200404440-00004; She HC, 2007, INVEST OPHTH VIS SCI, V48, P2268, DOI 10.1167/iovs.06-0979; Singh SR, 2009, GENE THER, V16, P645, DOI 10.1038/gt.2008.185; Stromblad S, 1996, CHEM BIOL, V3, P881, DOI 10.1016/S1074-5521(96)90176-3; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Tang Renhong, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P762; Thomson H, 2009, NANOMEDICINE-UK, V4, P599, DOI 10.2217/nnm.09.43; Tucker Gordon C, 2003, Curr Opin Investig Drugs, V4, P722; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9; Zacks DN, 2002, INVEST OPHTH VIS SCI, V43, P2384; Zambarakji HJ, 2006, INVEST OPHTH VIS SCI, V47, P2623, DOI 10.1167/iovs.05-0855	45	20	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18864	10.1371/journal.pone.0018864	http://dx.doi.org/10.1371/journal.pone.0018864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559527	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700029
J	Soleimani, R; Heytens, E; Oktay, K				Soleimani, Reza; Heytens, Elke; Oktay, Kutluk			Enhancement of Neoangiogenesis and Follicle Survival by Sphingosine-1-Phosphate in Human Ovarian Tissue Xenotransplants	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; SPHINGOSINE 1-PHOSPHATE; LYSOPHOSPHATIDIC ACID; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; RECEPTOR EDG-1; ACTIVIN-A; TRANSPLANTATION; FTY720; ANGIOGENESIS	Ovarian transplantation is one of the key approaches to restoring fertility in women who became menopausal as a result of cancer treatments. A major limitation of human ovarian transplants is massive follicular loss during revascularization. Here we investigated whether sphingosine-1-phosphate or its receptor agonists could enhance neoangiogenesis and follicle survival in ovarian transplants in a xenograft model. Human ovarian tissue xenografts in severe-combined-immunodeficient mice were treated with sphingosine-1-phosphate, its analogs, or vehicle for 1-10 days. We found that sphingosine-1-phosphate treatment increased vascular density in ovarian transplants significantly whereas FTY720 and SEW2871 had the opposite effect. In addition, sphingosine-1-phosphate accelerated the angiogenic process compared to vehicle-treated controls. Furthermore, sphingosine-1-phosphate treatment was associated with a significant proliferation of ovarian stromal cell as well as reduced necrosis and tissue hypoxia compared to the vehicle-treated controls. This resulted in a significantly lower percentage of apoptotic follicles in sphingosine-1-phosphate-treated transplants. We conclude that while sphingosine-1-phosphate promotes neoangiogenesis in ovarian transplants and reduces ischemic reperfusion injury, sphingosine-1-phosphate receptor agonists appear to functionally antagonize this process. Sphingosine-1-phosphate holds great promise to clinically enhance the survival and longevity of human autologous ovarian transplants.	[Soleimani, Reza] New York Med Coll, Lab Mol Reprod, Inst Fertil Preservat, Dept Obstet & Gynecol, Valhalla, NY 10595 USA; New York Med Coll, Lab Mol Reprod, Inst Fertil Preservat, Dept Cell Biol & Anat, Valhalla, NY 10595 USA	New York Medical College; New York Medical College	Soleimani, R (corresponding author), New York Med Coll, Lab Mol Reprod, Inst Fertil Preservat, Dept Obstet & Gynecol, Valhalla, NY 10595 USA.	koktay@fertilitypreservation.org			National Institute of Health [HD053112, R21HD061259]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053112, R21HD061259] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the National Institute of Health, HD053112 and R21HD061259 to Kutluk Oktay. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CY, 2008, HUM REPROD, V23, P2266, DOI 10.1093/humrep/den244; Anselmo DM, 2002, AM J TRANSPLANT, V2, P843, DOI 10.1034/j.1600-6143.2002.20906.x; Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462; Boguslawski G, 2002, EXP CELL RES, V274, P264, DOI 10.1006/excr.2002.5472; Brinkmann V, 2002, CURR OPIN IMMUNOL, V14, P569, DOI 10.1016/S0952-7915(02)00374-6; Bussink J, 2003, RADIOTHER ONCOL, V67, P3, DOI 10.1016/S0167-8140(03)00011-2; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; DAWSON AB, 1951, J MORPHOL, V88, P543, DOI 10.1002/jmor.1050880305; DeLisser HM, 1997, AM J PATHOL, V151, P671; Demeestere I, 2006, HUM REPROD, V21, P2010, DOI 10.1093/humrep/del092; Donnez J, 2004, LANCET, V364, P1405, DOI 10.1016/S0140-6736(04)17222-X; Dragun D, 2004, KIDNEY INT, V65, P1076, DOI 10.1111/j.1523-1755.2004.00478.x; Dudek SM, 2007, CELL SIGNAL, V19, P1754, DOI 10.1016/j.cellsig.2007.03.011; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Igarashi J, 2003, P NATL ACAD SCI USA, V100, P10664, DOI 10.1073/pnas.1934494100; Jassem W, 2004, KIDNEY INT, V66, P514, DOI 10.1111/j.1523-1755.2004.761_9.x; Kato T, 2003, BRIT J CANCER, V88, P1900, DOI 10.1038/sj.bjc.6600921; Kimura T, 2003, TRANSPLANTATION, V75, P1469, DOI 10.1097/01.TP.0000058816.13525.92; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; Kridel RWH, 1998, ARCH OTOLARYNGOL, V124, P73, DOI 10.1001/archotol.124.1.73; LaMontagne K, 2006, CANCER RES, V66, P221, DOI 10.1158/0008-5472.CAN-05-2001; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Liu J, 2002, HUM REPROD, V17, P605, DOI 10.1093/humrep/17.3.605; Man K, 2005, AM J TRANSPLANT, V5, P40, DOI 10.1111/j.1600-6143.2004.00642.x; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Meirow D, 2005, NEW ENGL J MED, V353, P318, DOI 10.1056/NEJMc055237; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Nguyen Minh-Doan, 2010, Eplasty, V10, pe48; Oktay K, 1998, HUM REPROD, V13, P1133, DOI 10.1093/humrep/13.5.1133; Oktay K, 2000, NEW ENGL J MED, V342, P1919, DOI 10.1056/NEJM200006223422516; Oktay K, 2004, LANCET, V363, P837, DOI 10.1016/S0140-6736(04)15728-0; Oktay K, 2001, JAMA-J AM MED ASSOC, V286, P1490, DOI 10.1001/jama.286.12.1490; OKTAY K, 1995, BIOL REPROD, V53, P295, DOI 10.1095/biolreprod53.2.295; Oktay K, 2000, BIOL REPROD, V63, P457, DOI 10.1095/biolreprod63.2.457; Oktay K, 2010, FERTIL STERIL, V93, P762, DOI 10.1016/j.fertnstert.2008.10.006; Oktem O, 2007, CANCER RES, V67, P10159, DOI 10.1158/0008-5472.CAN-07-2042; Oktem O, 2007, REPROD SCI, V14, P358, DOI 10.1177/1933719107303397; Ortiz AM, 2003, TRANSPL P, V35, P1571, DOI 10.1016/S0041-1345(03)00374-9; Oyama O, 2008, CARDIOVASC RES, V78, P301, DOI 10.1093/cvr/cvn002; Paugh SW, 2006, MOL PHARMACOL, V70, P41, DOI 10.1124/mol.105.020552; Payne SG, 2002, FEBS LETT, V531, P54, DOI 10.1016/S0014-5793(02)03480-4; Payne SG, 2007, BLOOD, V109, P1077, DOI 10.1182/blood-2006-03-011437; PHILLIPS GD, 1991, AM J ANAT, V192, P257, DOI 10.1002/aja.1001920305; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Rosendahl M, 2006, HUM REPROD, V21, pI154; Rosenfeldt HM, 2001, BIOCHEM SOC T, V29, P836, DOI 10.1042/0300-5127:0290836; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Siess W, 2002, BBA-MOL CELL BIOL L, V1582, P204, DOI 10.1016/S1388-1981(02)00173-7; Soleimani R, 2010, HUM REPROD, V25, P1458, DOI 10.1093/humrep/deq055; Spiegel S, 2000, FEBS LETT, V476, P55, DOI 10.1016/S0014-5793(00)01670-7; Van Eyck AS, 2010, FERTIL STERIL, V93, P1676, DOI 10.1016/j.fertnstert.2009.04.048; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Xin C, 2007, BRIT J PHARMACOL, V150, P943, DOI 10.1038/sj.bjp.0707171	56	128	133	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19475	10.1371/journal.pone.0019475	http://dx.doi.org/10.1371/journal.pone.0019475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559342	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700192
J	Zhang, SH; Banerjee, D; Kuhn, JR				Zhang, Sihui; Banerjee, Diya; Kuhn, Jeffrey R.			Isolation and Culture of Larval Cells from C. elegans	PLOS ONE			English	Article							HEAVY-CHAIN ISOFORMS; DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; NEMATODE; MUSCLE; IDENTIFICATION; NEURONS; CUTICLE; INTERFERENCE	Cell culture is an essential tool to study cell function. In C. elegans the ability to isolate and culture cells has been limited to embryonically derived cells. However, cells or blastomeres isolated from mixed stage embryos terminally differentiate within 24 hours of culture, thus precluding post-embryonic stage cell culture. We have developed an efficient and technically simple method for large-scale isolation and primary culture of larval-stage cells. We have optimized the treatment to maximize cell number and minimize cell death for each of the four larval stages. We obtained up to 7.8x10(4) cells per microliter of packed larvae, and up to 97% of adherent cells isolated by this method were viable for at least 16 hours. Cultured larval cells showed stage-specific increases in both cell size and multinuclearity and expressed lineage-and cell type-specific reporters. The majority (81%) of larval cells isolated by our method were muscle cells that exhibited stage-specific phenotypes. L1 muscle cells developed 1 to 2 wide cytoplasmic processes, while L4 muscle cells developed 4 to 14 processes of various thicknesses. L4 muscle cells developed bands of myosin heavy chain A thick filaments at the cell center and spontaneously contracted ex vivo. Neurons constituted less than 10% of the isolated cells and the majority of neurons developed one or more long, microtubule-rich protrusions that terminated in actin-rich growth cones. In addition to cells such as muscle and neuron that are high abundance in vivo, we were also able to isolate M-lineage cells that constitute less than 0.2% of cells in vivo. Our novel method of cell isolation extends C. elegans cell culture to larval developmental stages, and allows use of the wealth of cell culture tools, such as cell sorting, electrophysiology, co-culture, and high-resolution imaging of subcellular dynamics, in investigation of post-embryonic development and physiology.	[Zhang, Sihui; Banerjee, Diya; Kuhn, Jeffrey R.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Zhang, SH (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	jrkuhn@vt.edu			Burroughs Wellcome Fund [1003964]; Virginia Tech Institute for Critical Technology and Applied Science	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Virginia Tech Institute for Critical Technology and Applied Science	Burroughs Wellcome Fund Interfaces in Science Career Award, (Award 1003964) http://www.bwfund.org/. Virginia Tech Institute for Critical Technology and Applied Science Doctoral Scholars Assistantship (To S.Z.) http://www.ictas.vt.edu/scholars.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun Z.F., 2009, WORMATLAS; ARDIZZI JP, 1987, J CELL BIOL, V105, P2763, DOI 10.1083/jcb.105.6.2763; AUSTIN J, 1994, DEVELOPMENT, V120, P313; Bianchi Laura, 2006, WormBook, P1; Bloom L, 1993, THESIS MIT; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Caldwell KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007227; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; COWAN AE, 1985, CELL, V41, P923, DOI 10.1016/S0092-8674(85)80073-8; COX GN, 1981, DEV BIOL, V86, P456, DOI 10.1016/0012-1606(81)90204-9; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Dixon SJ, 2005, DEVELOPMENT, V132, P3079, DOI 10.1242/dev.01883; DURBIN RM, 1987, THESIS U CAMBRIDGE; EDGAR LG, 1988, CELL, V53, P589, DOI 10.1016/0092-8674(88)90575-2; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fox RM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r188; Fox RM, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-42; Francis Michael M., 2006, V351, P175; GOLDSTEIN B, 1992, NATURE, V357, P255, DOI 10.1038/357255a0; Harfe BD, 1998, GENE DEV, V12, P2623, DOI 10.1101/gad.12.16.2623; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; HONDA S, 1990, P NATL ACAD SCI USA, V87, P876, DOI 10.1073/pnas.87.3.876; JOHNSTONE IL, 1994, BIOESSAYS, V16, P171, DOI 10.1002/bies.950160307; Lin S, 2011, METHODS MOL BIOL, V690, P31, DOI 10.1007/978-1-60761-962-8_2; Lints R, 2009, WORMATLAS, DOI 103908/wormatlas25; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; MADURO M, 1995, GENETICS, V141, P977; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; Merritt Christopher, 2010, WormBook, P1, DOI 10.1895/wormbook.1.148.1; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; MILLER DM, 1983, CELL, V34, P477, DOI 10.1016/0092-8674(83)90381-1; Moldaver MV, 2009, MECH AGEING DEV, V130, P337, DOI 10.1016/j.mad.2009.02.002; Nass R, 2007, CURR PROTOCOLS TOXIC, P191; Nickell WT, 2002, J MEMBRANE BIOL, V189, P55, DOI 10.1007/s00232-002-1004-x; OKKEMA PG, 1993, GENETICS, V135, P385; Page AP, 2007, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.138.1; Pan CY, 2010, J GENET GENOMICS, V37, P241, DOI 10.1016/S1673-8527(09)60042-4; PAPADOPOULOS NG, 1994, J IMMUNOL METHODS, V177, P101, DOI 10.1016/0022-1759(94)90147-3; Podbilewicz Benjamin, 2006, WormBook, P1; Portela VM, 2010, FERTIL STERIL, V93, P2050, DOI 10.1016/j.fertnstert.2009.01.151; Prast J., 2006, CELL BIOL, V1, P557, DOI [10.1016/b978-012164730-8/50068-x, DOI 10.1016/B978-012164730-8/50068-X]; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; SCHACHAT F, 1978, CELL, V15, P405, DOI 10.1016/0092-8674(78)90009-0; Shemer G, 2000, DEV DYNAM, V218, P30, DOI 10.1002/(SICI)1097-0177(200005)218:1<30::AID-DVDY4>3.0.CO;2-W; Shih JD, 2009, RNA, V15, P384, DOI 10.1261/rna.1286409; Sobkowiak R, 2009, DRUG CHEM TOXICOL, V32, P252, DOI 10.1080/01480540902882184; Strange K, 2003, PHYSIOL REV, V83, P377, DOI 10.1152/physrev.00025.2002; Strange K, 2007, NAT PROTOC, V2, P1003, DOI 10.1038/nprot.2007.143; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SZILAGYI M, 2006, GLOBAL ALTERATIONS G; Teramoto T, 2006, CELL CALCIUM, V40, P319, DOI 10.1016/j.ceca.2006.04.009; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Wang JJ, 2002, DEVELOPMENT, V129, P4989; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Yang ZY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni149; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891; Zhou KM, 2007, NEURON, V56, P657, DOI 10.1016/j.neuron.2007.09.015	60	46	46	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19505	10.1371/journal.pone.0019505	http://dx.doi.org/10.1371/journal.pone.0019505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559335	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700198
J	Zhao, ZY; Chen, Y; Wang, J; Sternberg, P; Freeman, ML; Grossniklaus, HE; Cai, JY				Zhao, Zhenyang; Chen, Yan; Wang, Jian; Sternberg, Paul; Freeman, Michael L.; Grossniklaus, Hans E.; Cai, Jiyang			Age-Related Retinopathy in NRF2-Deficient Mice	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; FUNDUS AUTOFLUORESCENCE; RETINAL DEGENERATION; GEOGRAPHIC ATROPHY; OXIDATIVE STRESS; BRUCHS MEMBRANE; DRUSEN; AUTOPHAGY	Background: Cumulative oxidative damage is implicated in the pathogenesis of age-related macular degeneration (AMD). Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that plays key roles in retinal antioxidant and detoxification responses. The purposes of this study were to determine whether NRF2-deficient mice would develop AMD-like retinal pathology with aging and to explore the underlying mechanisms. Methods and Findings: Eyes of both wild type and Nrf2(-/-) mice were examined in vivo by fundus photography and electroretinography (ERG). Structural changes of the outer retina in aged animals were examined by light and electron microscopy, and immunofluorescence labeling. Our results showed that Nrf2(-/-) mice developed age-dependent degenerative pathology in the retinal pigment epithelium (RPE). Drusen-like deposits, accumulation of lipofuscin, spontaneous choroidal neovascularization (CNV) and sub-RPE deposition of inflammatory proteins were present in Nrf2(-/-) mice after 12 months. Accumulation of autophagy-related vacuoles and multivesicular bodies was identified by electron microcopy both within the RPE and in Bruch's membrane of aged Nrf2(-/-) mice. Conclusions: Our data suggest that disruption of Nfe2l2 gene increased the vulnerability of outer retina to age-related degeneration. NRF2-deficient mice developed ocular pathology similar to cardinal features of human AMD and deregulated autophagy is likely a mechanistic link between oxidative injury and inflammation. The Nrf2(-/-) mice can provide a novel model for mechanistic and translational research on AMD.	[Zhao, Zhenyang; Chen, Yan; Wang, Jian; Sternberg, Paul; Cai, Jiyang] Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN 37203 USA; [Freeman, Michael L.] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN USA; [Grossniklaus, Hans E.] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA	Vanderbilt University; Vanderbilt University; Emory University	Zhao, ZY (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN 37203 USA.	jiyang.cai@vanderbilt.edu	Zhao, Zhenyang/N-3321-2015	Zhao, Zhenyang/0000-0002-1701-3751; Freeman, Michael/0000-0003-1881-366X	International Retinal Research Foundation; Research to Prevent Blindness, Inc.; NIH [EY019706, EY07892, EY08126, CA115556, EY018715]; NATIONAL CANCER INSTITUTE [R01CA115556] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R29EY007892, P30EY008126, R01EY007892, K99EY019706, R21EY018715] Funding Source: NIH RePORTER	International Retinal Research Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by International Retinal Research Foundation, an unrestricted department grant from Research to Prevent Blindness, Inc. and NIH grants EY019706, EY07892, EY08126, CA115556 and EY018715. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert DM, 2010, ARCH OPHTHALMOL-CHIC, V128, P212, DOI 10.1001/archophthalmol.2009.395; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Burk RF, 2008, FREE RADICAL BIO MED, V44, P1617, DOI 10.1016/j.freeradbiomed.2008.01.016; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Curcio CA, 1999, ARCH OPHTHALMOL-CHIC, V117, P329, DOI 10.1001/archopht.117.3.329; DILORETO D, 1994, CURR EYE RES, V13, P157, DOI 10.3109/02713689409042411; Greco T, 2010, J ALZHEIMERS DIS, V20, pS427, DOI 10.3233/JAD-2010-100519; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; GREEN WR, 1996, OPHTHALMIC PATHOLOGY, P1025; Hageman GS, 1999, FASEB J, V13, P477, DOI 10.1096/fasebj.13.3.477; Handa James T., 2007, International Ophthalmology Clinics, V47, P15, DOI 10.1097/IIO.0b013e31802bd546; HERIOT WJ, 1984, OPHTHALMOLOGY, V91, P1603; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Holz FG, 2001, INVEST OPHTH VIS SCI, V42, P1051; Hwang JC, 2006, INVEST OPHTH VIS SCI, V47, P2655, DOI 10.1167/iovs.05-1027; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Li J, 2001, BRIT J OPHTHALMOL, V85, P287, DOI 10.1136/bjo.85.3.287; Lotery A, 2007, HUM GENET, V122, P219, DOI 10.1007/s00439-007-0406-3; Lukinova N, 2009, INVEST OPHTH VIS SCI, V50, P1440, DOI 10.1167/iovs.08-2545; Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Ni MW, 2010, TOXICOL SCI, V116, P590, DOI 10.1093/toxsci/kfq126; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Pearson KJ, 2008, P NATL ACAD SCI USA, V105, P2325, DOI 10.1073/pnas.0712162105; POLLACK A, 1986, ARCH OPHTHALMOL-CHIC, V104, P1372, DOI 10.1001/archopht.1986.01050210126039; Rojo AI, 2010, GLIA, V58, P588, DOI 10.1002/glia.20947; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sakaguchi H, 2002, EXP EYE RES, V74, P547, DOI 10.1006/exer.2002.1186; Solbach U, 1997, RETINA-J RET VIT DIS, V17, P385; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Spraul CW, 1997, ARCH OPHTHALMOL-CHIC, V115, P267, DOI 10.1001/archopht.1997.01100150269022; Uno K, 2010, EXP EYE RES, V90, P493, DOI 10.1016/j.exer.2009.12.012; von Ruckmann A, 1999, GRAEF ARCH CLIN EXP, V237, P1, DOI 10.1007/s004170050186; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Walter P, 1999, GRAEF ARCH CLIN EXP, V237, P962, DOI 10.1007/s004170050331; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012; Zhu H, 2008, CARDIOVASC TOXICOL, V8, P115, DOI 10.1007/s12012-008-9020-4	62	213	224	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19456	10.1371/journal.pone.0019456	http://dx.doi.org/10.1371/journal.pone.0019456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559389	gold, Green Submitted, Green Published			2022-12-25	WOS:000290024700182
J	Nicholls, SB; Chu, J; Abbruzzese, G; Tremblay, KD; Hardy, JA				Nicholls, Samantha B.; Chu, Jun; Abbruzzese, Genevieve; Tremblay, Kimberly D.; Hardy, Jeanne A.			Mechanism of a Genetically Encoded Dark-to-Bright Reporter for Caspase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; APOPTOSIS; ACTIVATION; STAUROSPORINE; CELLS; TIME; IDENTIFICATION; DENATURATION; INHIBITORS; INDUCTION	Fluorescent proteins have revolutionized modern biology with their ability to report the presence of tagged proteins in living systems. Although several fluorescent proteins have been described in which the excitation and emission properties can be modulated by external triggers, no fluorescent proteins have been described that can be activated from a silent dark state to a bright fluorescent state directly by the activity of an enzyme. We have developed a version of GFP in which fluorescence is completely quenched by appendage of a hydrophobic quenching peptide that tetramerizes GFP and prevents maturation of the chromophore. The fluorescence can be fully restored by catalytic removal of the quenching peptide, making it a robust reporter of proteolysis. We have demonstrated the utility of this uniquely dark state of GFP as a genetically encoded apoptosis reporter that monitors the function of caspases, which catalyze the fate-determining step in programmed cell death. Caspase Activatable-GFP (CA-GFP) can be activated both in vitro and in vivo, resulting in up to a 45-fold increase in fluorescent signal in bacteria and a 3-fold increase in mammalian cells. We used CA-GFP successfully to monitor real-time apoptosis in mammalian cells. This dark state of GFP may ultimately serve as a useful platform for probes of other enzymatic processes.	[Nicholls, Samantha B.; Chu, Jun; Abbruzzese, Genevieve; Tremblay, Kimberly D.; Hardy, Jeanne A.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Chu, Jun] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Hardy, JA (corresponding author), Univ Massachusetts, Dept Chem, 104 Lederle Grad Res Tower,710 N Pleasant St, Amherst, MA 01003 USA.	hardy@chem.umass.edu		Tremblay, Kimberly/0000-0002-3059-9910; Hardy, Jeanne/0000-0002-3406-7997; Abbruzzese, Genevieve/0000-0002-3194-9353	National Institutes of Health [R01 GM080532]; Center of Excellence in Apoptosis Research; NSF [IGERT DGE-0654128]; MRC [G0701075] Funding Source: UKRI; Alzheimers Research UK [ART-PPG2011A-14] Funding Source: researchfish; Medical Research Council [G0701075] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Apoptosis Research; NSF(National Science Foundation (NSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM080532 and a grant from the Center of Excellence in Apoptosis Research. The work was also supported by NSF Grant IGERT DGE-0654128 (to S. B. N.).	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Alkaabi KM, 2005, APPL BIOCHEM BIOTECH, V126, P149, DOI 10.1385/ABAB:126:2:149; Bardet PL, 2008, P NATL ACAD SCI USA, V105, P13901, DOI 10.1073/pnas.0806983105; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Berger AB, 2006, MOL CELL, V23, P509, DOI 10.1016/j.molcel.2006.06.021; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Boulware KT, 2006, P NATL ACAD SCI USA, V103, P7583, DOI 10.1073/pnas.0511108103; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Chu J, 2008, P SOC PHOTO-OPT INS, V6857, pR8570, DOI 10.1117/12.767864; Chu J, 2009, BIOSENS BIOELECTRON, V25, P234, DOI 10.1016/j.bios.2009.06.008; Clontech, 2009, APOALERT ANN 5 US MA; Enoki S, 2004, BIOCHEMISTRY-US, V43, P14238, DOI 10.1021/bi048733+; Gao Q, 2006, JPN J APPL PHYS 2, V45, pL929, DOI 10.1143/JJAP.45.L929; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Goode DR, 2005, ORG LETT, V7, P3529, DOI 10.1021/ol051287d; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Kawai H, 2005, J PHARMACOL SCI, V97, P361, DOI 10.1254/jphs.FP0040592; Lee AY, 2004, PROTEOMICS, V4, P3429, DOI 10.1002/pmic.200400979; Lee P, 2002, BIOTECHNIQUES, V33, P1284, DOI 10.2144/02336rr02; LI Y, 1995, STROKE, V26, P1252, DOI 10.1161/01.STR.26.7.1252; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; MacFarlane M, 2000, J CELL BIOL, V148, P1239, DOI 10.1083/jcb.148.6.1239; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Patre M, 2006, J BIOL CHEM, V281, P1296, DOI 10.1074/jbc.M511717200; Ray P, 2008, CLIN CANCER RES, V14, P5801, DOI 10.1158/1078-0432.CCR-07-5244; Reed JC, 2000, CURR OPIN BIOTECH, V11, P586, DOI 10.1016/S0958-1669(00)00148-8; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Stennicke HR, 1999, METHODS, V17, P313, DOI 10.1006/meth.1999.0745; Stepczynska A, 2001, ONCOGENE, V20, P1193, DOI 10.1038/sj.onc.1204221; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Visser NV, 2002, FEBS LETT, V521, P31, DOI 10.1016/S0014-5793(02)02808-9; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wood TI, 2005, BIOCHEMISTRY-US, V44, P16211, DOI 10.1021/bi051388j; Wu XL, 2006, CYTOM PART A, V69A, P477, DOI 10.1002/cyto.a.20300; Zhang LP, 2006, J AM CHEM SOC, V128, P4766, DOI 10.1021/ja0580439	41	44	45	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24977	24986		10.1074/jbc.M111.221648	http://dx.doi.org/10.1074/jbc.M111.221648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21558267	Green Published, hybrid			2022-12-25	WOS:000292547900046
J	Stroud, MJ; Kammerer, RA; Ballestrem, C				Stroud, Matthew J.; Kammerer, Richard A.; Ballestrem, Christoph			Characterization of G2L3 (GAS2-like 3), a New Microtubule- and Actin-binding Protein Related to Spectraplakins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARREST-SPECIFIC PROTEIN; GROWTH ARREST; CH-DOMAIN; F-ACTIN; CELL-MIGRATION; GAS2; IDENTIFICATION; CALPONIN; TUBULIN; CYTOSKELETON	The microtubule (MT) and actin cytoskeletons are fundamental to cell integrity, because they control a host of cellular activities, including cell division, growth, polarization, and migration. Proteins involved in mediating the cross-talk between MT and actin cytoskeletons are key to many cellular processes and play important physiological roles. We identified a new member of the GAS2 family of MT-actin cross-linking proteins, named G2L3 (GAS2-like 3). We show that GAS2-like 3 is widely conserved throughout evolution and is ubiquitously expressed in human tissues. GAS2-like 3 interacts with filamentous actin and MTs via its single calponin homology type 3 domain and C terminus, respectively. Interestingly, the role of the putative MT-binding GAS2-related domain is to modulate the binding of GAS2-like 3 to both filamentous actin and MTs. This is in contrast to GAS2-related domains found in related proteins, where it functions as a MT-binding domain. Furthermore, we show that tubulin acetylation drives GAS2-like 3 localization to MTs and may provide functional insights into the role of GAS2-like 3.	[Stroud, Matthew J.; Kammerer, Richard A.; Ballestrem, Christoph] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Manchester	Kammerer, RA (corresponding author), Paul Scherrer Inst, Lab Biomol Res, OFLC 106, CH-5232 Villigen, Switzerland.	richard.kammerer@psi.ch; christoph.ballestrem@manchester.ac.uk		Ballestrem, Christoph/0000-0002-5375-7985; Stroud, Matthew John/0000-0002-3337-6851; Kammerer, Richard/0000-0003-4570-5197; Stroud, Matthew/0000-0003-0451-3367	Wellcome Trust [080878/Z/06/Z]; Biotechnology and Biological Sciences Research Council [BB/G004552/1]; BBSRC [BB/G004552/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust Ph.D. studentship (to M. J. S.), a Wellcome Trust Senior Research Fellowship ((080878/Z/06/Z), to R. A. K.), and Biotechnology and Biological Sciences Research Council Grant BB/G004552/1 (to C. B.).	Applewhite DA, 2010, MOL BIOL CELL, V21, P1714, DOI 10.1091/mbc.E10-01-0011; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; BLOSE SH, 1984, J CELL BIOL, V98, P847, DOI 10.1083/jcb.98.3.847; BRANCOLINI C, 1992, J CELL BIOL, V117, P1251, DOI 10.1083/jcb.117.6.1251; BRANCOLINI C, 1995, EMBO J, V14, P5179, DOI 10.1002/j.1460-2075.1995.tb00202.x; BRANCOLINI C, 1994, J CELL BIOL, V124, P743, DOI 10.1083/jcb.124.5.743; Carisey A., 2011, METHODS MOL IN PRESS; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Galkin VE, 2006, J MOL BIOL, V359, P478, DOI 10.1016/j.jmb.2006.03.044; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Gimona M, 1998, J CELL SCI, V111, P1813; Goriounov D, 2003, J CELL SCI, V116, P1045, DOI 10.1242/jcs.00272; GUNDERSEN GG, 1994, J CELL SCI, V107, P645; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602; KAMMERER RA, 1995, J MOL BIOL, V250, P64, DOI 10.1006/jmbi.1995.0358; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; LEDIZET M, 1991, METHOD ENZYMOL, V196, P264; Lee KKH, 1999, DEV BIOL, V207, P14; Lee S, 2002, DEVELOPMENT, V129, P1195; Leinweber BD, 1999, BIOCHEM J, V344, P117, DOI 10.1042/0264-6021:3440117; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Pines MK, 2010, DEVELOPMENT, V137, P913, DOI 10.1242/dev.043224; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun DM, 2001, J CELL SCI, V114, P161; WEBSTER DR, 1989, J CELL SCI, V92, P57; Wiechen K, 2001, AM J PATHOL, V158, P833, DOI 10.1016/S0002-9440(10)64031-X; Wohnsland F, 2000, J BIOL CHEM, V275, P20873, DOI 10.1074/jbc.M910298199; Wolff J, 1998, BIOCHEMISTRY-US, V37, P10722, DOI 10.1021/bi980400n; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Zucman-Rossi J, 1996, GENOMICS, V38, P247, DOI 10.1006/geno.1996.0625	43	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24987	24995		10.1074/jbc.M111.242263	http://dx.doi.org/10.1074/jbc.M111.242263			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21561867	Green Published, hybrid			2022-12-25	WOS:000292547900047
J	Mahn, F; Hullemann, P; Gockel, U; Brosz, M; Freynhagen, R; Tolle, TR; Baron, R				Mahn, Friederike; Huellemann, Philipp; Gockel, Ulrich; Brosz, Mathias; Freynhagen, Rainer; Toelle, Thomas R.; Baron, Ralf			Sensory Symptom Profiles and Co-Morbidities in Painful Radiculopathy	PLOS ONE			English	Article							LOW-BACK-PAIN; NEUROPATHIC PAIN; RADICULAR PAIN; QUESTIONNAIRE; DEGENERATION; EXPRESSION; DEPRESSION; DISC	Painful radiculopathies (RAD) and classical neuropathic pain syndromes (painful diabetic polyneuropathy, postherpetic neuralgia) show differences how the patients express their sensory perceptions. Furthermore, several clinical trials with neuropathic pain medications failed in painful radiculopathy. Epidemiological and clinical data of 2094 patients with painful radiculopathy were collected within a cross sectional survey (painDETECT) to describe demographic data and co-morbidities and to detect characteristic sensory abnormalities in patients with RAD and compare them with other neuropathic pain syndromes. Common co-morbidities in neuropathic pain (depression, sleep disturbance, anxiety) do not differ considerably between the three conditions. Compared to other neuropathic pain syndromes touch-evoked allodynia and thermal hyperalgesia are relatively uncommon in RAD. One distinct sensory symptom pattern (sensory profile), i.e., severe painful attacks and pressure induced pain in combination with mild spontaneous pain, mild mechanical allodynia and thermal hyperalgesia, was found to be characteristic for RAD. Despite similarities in sensory symptoms there are two important differences between RAD and other neuropathic pain disorders: (1) The paucity of mechanical allodynia and thermal hyperalgesia might be explained by the fact that the site of the nerve lesion in RAD is often located proximal to the dorsal root ganglion. (2) The distinct sensory profile found in RAD might be explained by compression-induced ectopic discharges from a dorsal root and not necessarily by nerve damage. These differences in pathogenesis might explain why medications effective in DPN and PHN failed to demonstrate efficacy in RAD.	[Mahn, Friederike; Huellemann, Philipp; Baron, Ralf] Univ Klinikum Schleswig Holstein, Sekt Neurol Schmerzforsch & Therapie, Neurol Klin, Kiel, Germany; [Gockel, Ulrich] CASQUAR GmbH, Comp Assoziierte Qualitatssicherung & Rehabil For, Bochum, Germany; [Brosz, Mathias] StatConsult GmbH, Magdeburg, Germany; [Freynhagen, Rainer] Benedictus Krankenhaus Tutzing, Zentrum Anasthesiol Intensivmed Schmerztherapie &, Tutzing, Germany; [Toelle, Thomas R.] Tech Univ Munich, Neurol Klin, Munich, Germany	University of Kiel; Schleswig Holstein University Hospital; Technical University of Munich	Mahn, F (corresponding author), Univ Klinikum Schleswig Holstein, Sekt Neurol Schmerzforsch & Therapie, Neurol Klin, Campus Kiel, Kiel, Germany.	r.baron@neurologie.uni-kiel.de		Freynhagen, Rainer/0000-0002-3759-1508	Pfizer Germany; Pfizer at 450 outpatient centers throughout Germany	Pfizer Germany(Pfizer); Pfizer at 450 outpatient centers throughout Germany	This research was supported by a grant from Pfizer Germany. Data were collected within the PainDetect project, which was funded by Pfizer at 450 outpatient centers throughout Germany. The funder had no role in study design, analysis, decision to publish, or preparation of the manuscript. The lead investigators (RB, RF, TRT) designed the study in collaboration with the DFNS. MB is statistician at StatConsult GmbH, Germany. StatConsult maintains painDETECT, and supports research technically as well as statistically. UG was an employee of Pfizer Germany in the past twelve years. UG developed, programmed and supported the technical devices.	Baron R, 2010, PAIN, V150, P420, DOI 10.1016/j.pain.2010.04.013; Baron R, 2009, PAIN, V146, P34, DOI 10.1016/j.pain.2009.06.001; Bogduk N, 2009, PAIN, V147, P17, DOI 10.1016/j.pain.2009.08.020; Daniel HC, 2008, EUR J PAIN, V12, P731, DOI 10.1016/j.ejpain.2007.11.006; Freynhagen R, 2008, PAIN, V135, P65, DOI 10.1016/j.pain.2007.05.004; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; HOWE JF, 1977, PAIN, V3, P25, DOI 10.1016/0304-3959(77)90033-1; Junker U, 2008, CURR MED RES OPIN, V24, P1797, DOI 10.1185/03007990802121059; Khoromi S, 2005, J PAIN, V6, P829, DOI 10.1016/j.jpain.2005.08.002; Khoromi S, 2007, PAIN, V130, P66, DOI 10.1016/j.pain.2006.10.029; LaCroix-Fralish ML, 2006, ANESTHESIOLOGY, V104, P1283, DOI 10.1097/00000542-200606000-00025; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Manchikanti Laxmaiah, 2002, Pain Physician, V5, P149; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Meyer T, 2007, SPINE, V32, P2380, DOI 10.1097/BRS.0b013e3181557955; Moldovan M, 2009, BRAIN, V132, P511, DOI 10.1093/brain/awn332; Nakata M, 2008, MUSCLE NERVE, V37, P721, DOI 10.1002/mus.21031; Palmgren T, 1996, SPINE, V21, P1301, DOI 10.1097/00007632-199606010-00004; Shamji MF, 2009, SPINE, V34, P648, DOI 10.1097/BRS.0b013e318197f013; SMYTH MJ, 1958, J BONE JOINT SURG AM, V40, P1401, DOI 10.2106/00004623-195840060-00016; SULLIVAN MJL, 1992, PAIN, V50, P5, DOI 10.1016/0304-3959(92)90107-M; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Wu G, 2002, J NEUROSCI, V22, P7746	24	60	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e18018	10.1371/journal.pone.0018018	http://dx.doi.org/10.1371/journal.pone.0018018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573064	Green Published, gold, Green Submitted			2022-12-25	WOS:000290386800002
J	Turk, S; Verlaine, O; Gerards, T; Zivec, M; Humljan, J; Sosic, I; Amoroso, A; Zervosen, A; Luxen, A; Joris, B; Gobec, S				Turk, Samo; Verlaine, Olivier; Gerards, Thomas; Zivec, Matej; Humljan, Jan; Sosic, Izidor; Amoroso, Ana; Zervosen, Astrid; Luxen, Andre; Joris, Bernard; Gobec, Stanislav			New Noncovalent Inhibitors of Penicillin-Binding Proteins from Penicillin-Resistant Bacteria	PLOS ONE			English	Article							BETA-LACTAM RESISTANCE; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE	Background: Penicillin-binding proteins (PBPs) are well known and validated targets for antibacterial therapy. The most important clinically used inhibitors of PBPs beta-lactams inhibit transpeptidase activity of PBPs by forming a covalent penicilloyl-enzyme complex that blocks the normal transpeptidation reaction; this finally results in bacterial death. In some resistant bacteria the resistance is acquired by active-site distortion of PBPs, which lowers their acylation efficiency for beta-lactams. To address this problem we focused our attention to discovery of novel noncovalent inhibitors of PBPs. Methodology/Principal Findings: Our in-house bank of compounds was screened for inhibition of three PBPs from resistant bacteria: PBP2a from Methicillin-resistant Staphylococcus aureus (MRSA), PBP2x from Streptococcus pneumoniae strain 5204, and PBP5fm from Enterococcus faecium strain D63r. Initial hit inhibitor obtained by screening was then used as a starting point for computational similarity searching for structurally related compounds and several new noncovalent inhibitors were discovered. Two compounds had promising inhibitory activities of both PBP2a and PBP2x 5204, and good in-vitro antibacterial activities against a panel of Gram-positive bacterial strains. Conclusions: We found new noncovalent inhibitors of PBPs which represent important starting points for development of more potent inhibitors of PBPs that can target penicillin-resistant bacteria.	[Turk, Samo; Zivec, Matej; Humljan, Jan; Sosic, Izidor; Gobec, Stanislav] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Verlaine, Olivier; Amoroso, Ana; Joris, Bernard] Univ Liege, Ctr Prot Engn, Liege, Belgium; [Gerards, Thomas; Zervosen, Astrid; Luxen, Andre] Univ Liege, Organ Chem Lab, Liege, Belgium; [Humljan, Jan] Lek Pharmaceut DD, Menges, Slovenia	University of Ljubljana; University of Liege; University of Liege; Novartis	Turk, S (corresponding author), Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.	gobecs@ffa.uni-lj.si	Turk, Samo/C-3905-2012; Turk, Samo/ABD-5492-2021	Turk, Samo/0000-0003-2044-7670; Turk, Samo/0000-0003-2044-7670; Sosic, Izidor/0000-0002-3370-4587; Gobec, Stanislav/0000-0002-9678-3083				ADAM M, 1990, BIOCHEM J, V270, P525, DOI 10.1042/bj2700525; Carapito R, 2006, J BIOL CHEM, V281, P1771, DOI 10.1074/jbc.M511506200; Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781, DOI 10.1128/CMR.10.4.781; Clinical and Laboratory Standards Institute (CLSI), 2009, METHODS DILUTION ANT, V8th ed.; Dessen A, 2001, J BIOL CHEM, V276, P45106, DOI 10.1074/jbc.M107608200; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; *ESCMID, 2003, E DIS; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Humljan J, 2008, J MED CHEM, V51, P7486, DOI 10.1021/jm800762u; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; LAKAYE B, 1994, BIOCHEM J, V300, P141, DOI 10.1042/bj3000141; Lemaire S, 2009, ANTIMICROB AGENTS CH, V53, P2289, DOI 10.1128/AAC.01135-08; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Macheboeuf P, 2007, NAT CHEM BIOL, V3, P565, DOI 10.1038/nchembio.2007.21; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Miguet L, 2009, J MED CHEM, V52, P5926, DOI 10.1021/jm900625q; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rarey M, 2001, J COMPUT AID MOL DES, V15, P497, DOI 10.1023/A:1011144622059; Sauvage E, 2002, CELL MOL LIFE SCI, V59, P1223, DOI 10.1007/s00018-002-8500-0; SCHWYZER R, 1954, HELV CHIM ACTA, V37, P155, DOI 10.1002/hlca.19540370119; Shoichet BK, 2006, DRUG DISCOV TODAY, V11, P607, DOI 10.1016/j.drudis.2006.05.014; Toney JH, 1998, ANAL BIOCHEM, V255, P113, DOI 10.1006/abio.1997.2458; Wilke MS, 2005, CURR OPIN MICROBIOL, V8, P525, DOI 10.1016/j.mib.2005.08.016; Wu SW, 2001, J BACTERIOL, V183, P2417, DOI 10.1128/JB.183.8.2417-2424.2001; Zervosen A, 2004, ANTIMICROB AGENTS CH, V48, P961, DOI 10.1128/AAC.48.3.961-969.2004	25	29	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19418	10.1371/journal.pone.0019418	http://dx.doi.org/10.1371/journal.pone.0019418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573060	gold, Green Submitted, Green Published			2022-12-25	WOS:000290386800012
J	Kajla, MK; Shi, L; Li, B; Luckhart, S; Li, JY; Paskewitz, SM				Kajla, Mayur K.; Shi, Lei; Li, Bin; Luckhart, Shirley; Li, Jianyong; Paskewitz, Susan M.			A New Role for an Old Antimicrobial: Lysozyme c-1 Can Function to Protect Malaria Parasites in Anopheles Mosquitoes	PLOS ONE			English	Article							PLASMODIUM-BERGHEI; SEPHADEX BEADS; GAMBIAE; MELANIZATION; LAMININ; DETERMINANT; ACTIVATION; INVASION; SURFACE; BINDS	Background: Plasmodium requires an obligatory life stage in its mosquito host. The parasites encounter a number of insults while journeying through this host and have developed mechanisms to avoid host defenses. Lysozymes are a family of important antimicrobial immune effectors produced by mosquitoes in response to microbial challenge. Methodology/Principal Findings: A mosquito lysozyme was identified as a protective agonist for Plasmodium. Immunohistochemical analyses demonstrated that Anopheles gambiae lysozyme c-1 binds to oocysts of Plasmodium berghei and Plasmodium falciparum at 2 and 5 days after infection. Similar results were observed with Anopheles stephensi and P. falciparum, suggesting wide occurrence of this phenomenon across parasite and vector species. Lysozyme c-1 did not bind to cultured ookinetes nor did recombinant lysozyme c-1 affect ookinete viability. dsRNA-mediated silencing of LYSC-1 in Anopheles gambiae significantly reduced the intensity and the prevalence of Plasmodium berghei infection. We conclude that this host antibacterial protein directly interacts with and facilitates development of Plasmodium oocysts within the mosquito. Conclusions/Significance: This work identifies mosquito lysozyme c-1 as a positive mediator of Plasmodium development as its reduction reduces parasite load in the mosquito host. These findings improve our understanding of parasite development and provide a novel target to interrupt parasite transmission to human hosts.	[Kajla, Mayur K.; Shi, Lei; Li, Bin; Paskewitz, Susan M.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Shi, Lei] Univ Wisconsin, Sch Med & Publ Hlth, Sect Allergy Pulm & Crit Care, Dept Med, Madison, WI 53706 USA; [Li, Bin] Univ Calif Davis, Microbiol Sect, Coll Biol Sci, Davis, CA 95616 USA; [Luckhart, Shirley] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Li, Jianyong] Virginia Tech, Dept Biochem, Blacksburg, VA USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis; University of California System; University of California Davis; Virginia Polytechnic Institute & State University	Kajla, MK (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	paskewit@entomology.wisc.edu			NIH [AI037083]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI037083 to SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini A, 1999, PARASITOLOGY, V119, P331, DOI 10.1017/S0031182099004874; Ahmed AM, 2002, OIKOS, V97, P371, DOI 10.1034/j.1600-0706.2002.970307.x; Arrighi RBG, 2005, J EXP BIOL, V208, P2497, DOI 10.1242/jeb.01664; Bedoya RJU, 2005, INSECT MOL BIOL, V14, P89, DOI 10.1111/j.1365-2583.2004.00534.x; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Castillo JC, 2006, INSECT BIOCHEM MOLEC, V36, P891, DOI 10.1016/j.ibmb.2006.08.010; CHUN JD, 1995, J INVERTEBR PATHOL, V66, P11, DOI 10.1006/jipa.1995.1054; CLARKE AJ, 1992, CAN J MICROBIOL, V38, P85, DOI 10.1139/m92-014; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gandhe AS, 2007, INSECT BIOCHEM MOLEC, V37, P655, DOI 10.1016/j.ibmb.2007.03.013; Gao Y, 2000, INSECT MOL BIOL, V9, P553, DOI 10.1046/j.1365-2583.2000.00216.x; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Hultmark D., 1996, Experientia Supplementum (Basel), V75, P87; Kajla MK, 2010, COMP BIOCHEM PHYS B, V155, P201, DOI 10.1016/j.cbpb.2009.11.012; Kotsyfakis M, 2005, MOL MICROBIOL, V57, P171, DOI 10.1111/j.1365-2958.2005.04664.x; Li B, 2005, GENE, V360, P131, DOI 10.1016/j.gene.2005.07.001; Li B, 2006, J INSECT PHYSIOL, V52, P936, DOI 10.1016/j.jinsphys.2006.06.002; Mahairaki V, 2005, MOL BIOCHEM PARASIT, V140, P119, DOI 10.1016/j.molbiopara.2004.11.012; MEIS JFGM, 1989, PARASITOL RES, V76, P13, DOI 10.1007/BF00931065; Moss JM, 1997, ARCH BIOCHEM BIOPHYS, V348, P49, DOI 10.1006/abbi.1997.0365; Nacer A, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-33; Nakimbugwe D, 2006, INT J FOOD MICROBIOL, V108, P355, DOI 10.1016/j.ijfoodmicro.2005.11.021; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Park PW, 1996, J INVEST DERMATOL, V106, P1075, DOI 10.1111/1523-1747.ep12339292; Paskewitz SM, 1999, INSECT MOL BIOL, V8, P329, DOI 10.1046/j.1365-2583.1999.83124.x; Paskewitz SM, 1998, EXP PARASITOL, V90, P34, DOI 10.1006/expr.1998.4305; REDDY JT, 1990, J INSECT PHYSIOL, V36, P397, DOI 10.1016/0022-1910(90)90057-M; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; SALAZAR CE, 1993, NUCLEIC ACIDS RES, V21, P4147, DOI 10.1093/nar/21.17.4147; Surachetpong W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000366; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Vlachou D, 2001, MOL BIOCHEM PARASIT, V112, P229, DOI 10.1016/S0166-6851(00)00371-6; WINGER LA, 1988, PARASITE IMMUNOL, V10, P193, DOI 10.1111/j.1365-3024.1988.tb00214.x; Yu KH, 2002, DEV COMP IMMUNOL, V26, P707, DOI 10.1016/S0145-305X(02)00027-7	39	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19649	10.1371/journal.pone.0019649	http://dx.doi.org/10.1371/journal.pone.0019649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573077	Green Submitted, gold, Green Published			2022-12-25	WOS:000290305600039
J	Oliveira, FL; Brand, C; Paula, AA; Arcanjo, KD; Hsu, DK; Liu, FT; Takiya, CM; Borojevic, R; Chammas, R; El-Cheikh, MC				Oliveira, Felipe L.; Brand, Camila; Paula, Adelzon A.; Arcanjo, Katia D.; Hsu, Daniel K.; Liu, Fu-Tong; Takiya, Christina M.; Borojevic, Radovan; Chammas, Roger; El-Cheikh, Marcia C.			Lack of Galectin-3 Disturbs Mesenteric Lymph Node Homeostasis and B Cell Niches in the Course of Schistosoma mansoni Infection	PLOS ONE			English	Article							EXPERIMENTAL MURINE SCHISTOSOMIASIS; T-CELL; IMMUNE; LYMPHOCYTES; MACROPHAGES; EXPRESSION; DIFFERENTIATION; RESPONSES; INCREASE; GLYCANS	Galectin-3 is a beta-galactoside-binding protein that has been shown to regulate pathophysiological processes, including cellular activation, differentiation and apoptosis. Recently, we showed that galectin-3 acts as a potent inhibitor of B cell differentiation into plasma cells. Here, we have investigated whether galectin-3 interferes with the lymphoid organization of B cell compartments in mesenteric lymph nodes (MLNs) during chronic schistosomiasis, using WT and galectin-3(-/-) mice. Schistosoma mansoni synthesizes GalNAc beta 1-4(Fuc alpha 1-3) GlcNAc(Lac-DiNAc) structures (N-acetylgalactosamine beta 1-4 N-acetylglucosamine), which are known to interact with galectin-3 and elicit an intense humoral response. Antigens derived from the eggs and adult worms are continuously drained to MLNs and induce a polyclonal B cell activation. In the present work, we observed that chronically-infected galectin-3(-/-) mice exhibited a significant reduced amount of macrophages and B lymphocytes followed by drastic histological changes in B lymphocyte and plasma cell niches in the MLNs. The lack of galectin-3 favored an increase in the lymphoid follicle number, but made follicular cells more susceptible to apoptotic stimuli. There were an excessive quantity of apoptotic bodies, higher number of annexin V+/PI- cells, and reduced clearance of follicular apoptotic cells in the course of schistosomiasis. Here, we observed that galectin-3 was expressed in nonlymphoid follicular cells and its absence was associated with severe damage to tissue architecture. Thus, we convey new information on the role of galectin-3 in regulation of histological events associated with B lymphocyte and plasma cell niches, apoptosis, phagocytosis and cell cycle properties in the MLNs of mice challenged with S. mansoni.	[Oliveira, Felipe L.; Brand, Camila; Paula, Adelzon A.; Arcanjo, Katia D.; Borojevic, Radovan; El-Cheikh, Marcia C.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Proliferacao & Diferenciacao Celular, Rio De Janeiro, Brazil; [Hsu, Daniel K.; Liu, Fu-Tong] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Takiya, Christina M.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Patol Celular, Rio De Janeiro, Brazil; [Chammas, Roger] Univ Sao Paulo, Fac Med, Dept Radiol & Oncol, Expt Oncol Lab, Sao Paulo, Brazil; [Chammas, Roger] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; University of California System; University of California Davis; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Oliveira, FL (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Proliferacao & Diferenciacao Celular, Rio De Janeiro, Brazil.	felipe@histo.ufrj.br; marcia@histo.ufrj.br	Oliveira, Felipe L/H-9902-2012; Liu, FU-TONG/A-5749-2019; Borojevic, Radovan/V-8500-2019; Chammas, Roger/A-8004-2011; Takiya, Christina/AAU-5959-2021; Brand, Camila/D-8873-2014	Liu, FU-TONG/0000-0002-3354-1001; Borojevic, Radovan/0000-0002-2393-7280; Chammas, Roger/0000-0003-0342-8726; Takiya, Christina/0000-0002-8019-628X; Leite de Oliveira, Felipe/0000-0001-6193-1616	Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) [472553/2008-9]; Fundacoes de Amparo a Pesquisa do Estado do Rio de Janeiro e de Sao Paulo (FAPERJ); FAPESP; Associacao Paul Ehrlich de Biologia Celular Aplicada a Medicina (APABCAM)	Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacoes de Amparo a Pesquisa do Estado do Rio de Janeiro e de Sao Paulo (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Associacao Paul Ehrlich de Biologia Celular Aplicada a Medicina (APABCAM)	This work was supported by Conselho Nacional de Pesquisa e Desenvolvimento (CNPq - 472553/2008-9); Fundacoes de Amparo a Pesquisa do Estado do Rio de Janeiro e de Sao Paulo (FAPERJ and FAPESP) and Associacao Paul Ehrlich de Biologia Celular Aplicada a Medicina (APABCAM). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2004, J IMMUNOL, V172, P493, DOI 10.4049/jimmunol.172.1.493; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Benson MJ, 2007, CURR OPIN IMMUNOL, V19, P275, DOI 10.1016/j.coi.2007.04.009; BOROJEVIC R, 1992, MEM I OSWALDO CRUZ, V87, P171, DOI 10.1590/S0074-02761992000800026; Breuilh L, 2007, INFECT IMMUN, V75, P5148, DOI 10.1128/IAI.02006-06; Colnot C, 1998, IMMUNOLOGY, V94, P290, DOI 10.1046/j.1365-2567.1998.00517.x; Dietz AB, 2000, BIOCHEM BIOPH RES CO, V275, P731, DOI 10.1006/bbrc.2000.3372; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; El-Cheikh MC, 1998, IMMUNOBIOLOGY, V199, P51, DOI 10.1016/S0171-2985(98)80063-6; ELCHEIKH MC, 1994, BRAZ J MED BIOL RES, V27, P1605; ELCHEIKH MC, 1990, INFECT IMMUN, V58, P816, DOI 10.1128/IAI.58.3.816-821.1990; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hoyer KK, 2004, AM J PATHOL, V164, P893, DOI 10.1016/S0002-9440(10)63177-X; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; Joo HG, 2001, J LEUKOCYTE BIOL, V69, P555; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; KRAAL G, 1987, SCAND J IMMUNOL, V26, P653, DOI 10.1111/j.1365-3083.1987.tb02301.x; Lenzi HL, 1996, BRAZ J MED BIOL RES, V29, P19; LIU FT, 1995, AM J PATHOL, V147, P1016; Lundy SK, 2001, INFECT IMMUN, V69, P271, DOI 10.1128/IAI.69.1.271-280.2001; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Montalvao F, 2010, EUR J IMMUNOL, V40, P417, DOI 10.1002/eji.200939606; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Nakamura M, 1996, EUR J IMMUNOL, V26, P1211, DOI 10.1002/eji.1830260604; Nyame AK, 2003, EXP PARASITOL, V104, P1, DOI 10.1016/S0014-4894(03)00110-3; Oliveira FL, 2007, J LEUKOCYTE BIOL, V82, P300, DOI 10.1189/jlb.1206747; Oliveira FL, 2009, GLYCOBIOLOGY, V19, P1248, DOI 10.1093/glycob/cwp120; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Smith J P, 1998, Dev Immunol, V6, P285, DOI 10.1155/1998/38923; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; Villa-Verde DMS, 2002, EUR J IMMUNOL, V32, P1434, DOI 10.1002/1521-4141(200205)32:5<1434::AID-IMMU1434>3.0.CO;2-M; VINDELOV LL, 1980, CANCER RES, V40, P4295; Willard-Mack CL, 2006, TOXICOL PATHOL, V34, P409, DOI 10.1080/01926230600867727; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737	41	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19216	10.1371/journal.pone.0019216	http://dx.doi.org/10.1371/journal.pone.0019216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573150	Green Published, Green Submitted, gold			2022-12-25	WOS:000290305600015
J	Gangarossa, G; Di Benedetto, M; O'Sullivan, GJ; Dunleavy, M; Alcacer, C; Bonito-Oliva, A; Henshall, DC; Waddington, JL; Valjent, E; Fisone, G				Gangarossa, Giuseppe; Di Benedetto, Manuela; O'Sullivan, Gerard J.; Dunleavy, Mark; Alcacer, Cristina; Bonito-Oliva, Alessandra; Henshall, David C.; Waddington, John L.; Valjent, Emmanuel; Fisone, Gilberto			Convulsant Doses of a Dopamine D1 Receptor Agonist Result in Erk-Dependent Increases in Zif268 and Arc/Arg3.1 Expression in Mouse Dentate Gyrus	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; ACTIVATED PROTEIN-KINASE; INDUCED NEURONAL INJURY; LONG-TERM POTENTIATION; FACTOR MESSENGER-RNAS; C-FOS PROTEIN(S); RAT-BRAIN; STATUS EPILEPTICUS; INDUCED SEIZURES; DIFFERENTIAL EXPRESSION	Activation of dopamine D1 receptors (D1Rs) has been shown to induce epilepti changes occurring in the hippocampus in response to the administration of the D1 297 at 2.5 and 5.0 kg induced behavioral seizures. Electrophysiological recordings presence of epileptiform discharges peaking at 30-45 min post-injection and declining activity. We studied the molecular type receptor agonist, SKF 81297. SKF recordings in he dentate gyrus revealed the g by 60 min. Seizures were prevented by the D1-type receptor antagonist, SCH 23390, or the cannabinoid CB1 receptor agonist, CP 55,940. The effect of SKF 81297 ccompanied by increased phosphorylation of the extracellular signal-regulated protein kinases 1 and 2 (ERK), in the granule cells of the dentate gyrus. This effect was also observed in response to administration of other D1-type receptor agonists, such as SKF83822 and SKF83959. In addition, SKF 81297 increased the phosphorylation of the ribosomal protein S6 and histone H3, two downstream targets of ERK. These effects were prevented by genetic inactivation of D1 Rs, or by pharmacological inhibition of ERK. SKF 81297 was also able to enhance the levels of Zif268 and ArciArg3.1, two immediate genes involved in transcriptional regulation and synaptic plasticity. These changes may be involved in forms dependent plasticity linked to the manifestation of seizures and to the ability of dopamine to affect learning and memory.	[Gangarossa, Giuseppe; Di Benedetto, Manuela; Bonito-Oliva, Alessandra; Valjent, Emmanuel; Fisone, Gilberto] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [O'Sullivan, Gerard J.; Waddington, John L.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Dunleavy, Mark; Henshall, David C.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Alcacer, Cristina] INSERM, UMR S 839, Paris, France; [Alcacer, Cristina] Univ Paris 06, Paris, France; [Alcacer, Cristina] Inst Fer Moulin, Paris, France	Karolinska Institutet; Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Gangarossa, G (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	gilberto.fisone@ki.se	Alcacer, Cristina/GMW-6161-2022; Dunleavy, Mark/B-4260-2012; Henshall, David/C-3364-2012	Alcacer, Cristina/0000-0003-2502-0983; Dunleavy, Mark/0000-0001-5916-9722; Valjent, Emmanuel/0000-0002-1034-606X; Fisone, Gilberto/0000-0002-0719-8000; Henshall, David/0000-0001-6237-9632; Gangarossa, Giuseppe/0000-0001-9045-2139	Swedish Medical Research Council [20715, 13482]; Wenner-Gren Foundations; Science Foundation Ireland [07/IN1/B960, 08/IN1/B1875]; Health Research Board [RP/2007/37]; Irish Research Council for Science, Engineering Technology; ATIP-Avenir; Sanofi-Aventis	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Wenner-Gren Foundations; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board; Irish Research Council for Science, Engineering Technology(Irish Research Council for Science, Engineering and Technology); ATIP-Avenir; Sanofi-Aventis(Sanofi-Aventis)	These studies were supported by Swedish Medical Research Council grants 20715 and 13482 and the Wenner-Gren Foundations (to GF), Science Foundation Ireland Principal Investigator grant 07/IN1/B960 (to JLW), Science Foundation Ireland Principal Investigator grant 08/IN1/B1875 and Health Research Board grant RP/2007/37 (to DCH), Irish Research Council for Science, Engineering & Technology INSPIRE fellowship (to MD), ATIP-Avenir grant and Sanofi-Aventis (to EV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson F, 2008, J NEUROSCI, V28, P3925, DOI 10.1523/JNEUROSCI.1754-07.2008; BARABAN JM, 1993, J NEUROCHEM, V60, P330, DOI 10.1111/j.1471-4159.1993.tb05855.x; Berkeley JL, 2002, J NEUROCHEM, V82, P192, DOI 10.1046/j.1471-4159.2002.00977.x; BHAT RV, 1992, MOL BRAIN RES, V13, P263, DOI 10.1016/0169-328X(92)90034-9; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Brami-Cherrier K, 2005, J NEUROSCI, V25, P11444, DOI 10.1523/JNEUROSCI.1711-05.2005; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; COLE AJ, 1990, J NEUROCHEM, V55, P1920, DOI 10.1111/j.1471-4159.1990.tb05777.x; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Davie James R, 2003, Sci STKE, V2003, pPE33; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; DOUGLAS RM, 1988, MOL BRAIN RES, V4, P259, DOI 10.1016/0169-328X(88)90033-2; DRAGUNOW M, 1987, NEUROSCI LETT, V82, P157, DOI 10.1016/0304-3940(87)90121-2; DRAGUNOW M, 1987, NATURE, V329, P441, DOI 10.1038/329441a0; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Fujikawa TG, 2000, EPILEPSIA, V41, P981, DOI 10.1111/j.1528-1157.2000.tb00283.x; Garrido YCS, 1998, BRAIN RES BULL, V47, P223, DOI 10.1016/S0361-9230(98)00075-6; Holmes GL, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.9_suppl_5.S3; Houser CR, 2008, NEUROSCIENCE, V156, P222, DOI 10.1016/j.neuroscience.2008.07.010; HUGHES P, 1994, MOL BRAIN RES, V24, P166, DOI 10.1016/0169-328X(94)90129-5; KIM YS, 1994, BIOCHEM BIOPH RES CO, V202, P1163, DOI 10.1006/bbrc.1994.2050; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; O'Sullivan GJ, 2008, NEUROPHARMACOLOGY, V54, P1051, DOI 10.1016/j.neuropharm.2008.02.011; O'Sullivan GJ, 2005, SYNAPSE, V55, P201, DOI 10.1002/syn.20107; Otani N, 2003, ACTA NEUROCHIR SUPPL, V86, P571; Panja D, 2009, J BIOL CHEM, V284, P31498, DOI 10.1074/jbc.M109.056077; RICHARDSON CL, 1992, BRAIN RES, V580, P147, DOI 10.1016/0006-8993(92)90938-6; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; SAFFEN DW, 1988, P NATL ACAD SCI USA, V85, P7795, DOI 10.1073/pnas.85.20.7795; Sankar R, 1998, J NEUROSCI, V18, P8382; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; SIMONATO M, 1991, MOL BRAIN RES, V11, P115, DOI 10.1016/0169-328X(91)90113-C; STARR MS, 1993, J NEURAL TRANSM-PARK, V6, P27, DOI 10.1007/BF02252620; THOMAS G, 1979, P NATL ACAD SCI USA, V76, P3952, DOI 10.1073/pnas.76.8.3952; Tuunanen J, 1999, NEUROSCIENCE, V94, P473, DOI 10.1016/S0306-4522(99)00251-1; Valjent E, 2000, J NEUROSCI, V20, P8701; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; van der Stelt M, 2002, MOL NEUROBIOL, V26, P317, DOI 10.1385/MN:26:2-3:317; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y	42	46	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19415	10.1371/journal.pone.0019415	http://dx.doi.org/10.1371/journal.pone.0019415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559295	Green Submitted, gold, Green Published			2022-12-25	WOS:000290223500023
J	Rengaraj, D; Lee, BR; Lee, SI; Seo, HW; Han, JY				Rengaraj, Deivendran; Lee, Bo Ram; Lee, Sang In; Seo, Hee Won; Han, Jae Yong			Expression Patterns and miRNa Regulation of DNA Methyltransferases in Chicken Primordial Germ Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; DNMT3A; METHYLATION; REPRESSOR; MIR-29B; TARGET; MICRORNAS; CARCINOMA; REPLICATION; CLEAVAGE	DNA methylation is widespread in most species, from bacteria to mammals, and is crucial for genomic imprinting, gene expression, and embryogenesis. DNA methylation occurs via two major classes of enzymatic reactions: maintenance-type methylation catalyzed by DNA (cytosine-5-)-methyltransferase (DNMT) 1, and de novo methylation catalyzed by DNMT 3 alpha (DNMT3A) and -beta (DNMT3B). The expression pattern and regulation of DNMT genes in primordial germ cells (PGCs) and germ line cells has not been sufficiently established in birds. Therefore, we employed bioinformatics, RT-PCR, real-time PCR, and in situ hybridization analyses to examine the structural conservation and conserved expression patterns of chicken DNMT family genes. We further examined the regulation of a candidate de novo DNA methyltransferase gene, cDNMT3B by cotransfection of cDNMT3B 3'UTR- and cDNMT3B 3'UTR-specific miRNAs through a dual fluorescence reporter assay. All cDNMT family members were differentially detected during early embryonic development. Of interest, cDNMT3B expression was highly detected in early embryos and in PGCs. During germ line development and sexual maturation, cDNMT3B expression was reestablished in a female germ cell-specific manner. In the dual fluorescence reporter assay, cDNMT3B expression was significantly downregulated by four miRNAs: gga-miR-15c (25.82%), gga-miR-29b (30.01%), gga-miR-383 (30.0%), and gga-miR-222 (31.28%). Our data highlight he structural conservation and conserved expression patterns of chicken DNMTs. The miRNAs investigated in this study may induce downregulation of gene expression in chicken PGCs and germ cells.	[Rengaraj, Deivendran] Seoul Natl Univ, WCU Biomodulat Major, Dept Agr Biotechnol, Seoul, South Korea; Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Rengaraj, D (corresponding author), Seoul Natl Univ, WCU Biomodulat Major, Dept Agr Biotechnol, Seoul, South Korea.	jaehan@snu.ac.kr	Rengaraj, Deivendran/C-5593-2015	Rengaraj, Deivendran/0000-0001-9274-9921; Lee, Bo Ram/0000-0002-0537-6205	Ministry of Education, Science and Technology [20070401034010, R31-10056]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the BioGreen 21 Program (20070401034010) and by the World Class University (WCU) program (R31-10056) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2009, DEV BIOL, V334, P213, DOI 10.1016/j.ydbio.2009.07.017; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; Callebaut I, 1999, FEBS LETT, V446, P189, DOI 10.1016/S0014-5793(99)00132-5; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Choi JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012968; Cortez MA, 2010, GENE CHROMOSOME CANC, V49, P981, DOI 10.1002/gcc.20808; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; De Arcangelis V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012098; DENTELLI P, 2010, ARTERIOSCLEROSIS THR, V30; Di Leva G, 2010, JNCI-J NATL CANCER I, V102, P706, DOI 10.1093/jnci/djq102; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frenquelli M, 2010, BLOOD, V115, P3949, DOI 10.1182/blood-2009-11-254656; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Han JY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-220; Jiao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010551; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; La Salle S, 2006, DEV BIOL, V296, P71, DOI 10.1016/j.ydbio.2006.04.436; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lian J, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-13; Liu Y, 2010, HYPERTENSION, V55, P974, DOI 10.1161/HYPERTENSIONAHA.109.144428; Mishra MV, 2008, MOL CANCER RES, V6, P243, DOI 10.1158/1541-7786.MCR-07-0373; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Qian K, 2009, ENDOCRINOLOGY, V150, P4734, DOI 10.1210/en.2008-1629; Rengaraj D, 2007, ENDOCRINE, V31, P193, DOI 10.1007/s12020-007-0027-6; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sakai Y, 2001, CELL STRUCT FUNCT, V26, P685, DOI 10.1247/csf.26.685; Shao P, 2008, GENE, V418, P34, DOI 10.1016/j.gene.2008.04.004; TAJIMA S, 1995, J BIOCHEM-TOKYO, V117, P1050, DOI 10.1093/oxfordjournals.jbchem.a124805; Takada S, 2009, RNA, V15, P1507, DOI 10.1261/rna.1418309; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Wurz K, 2010, GENE CHROMOSOME CANC, V49, P577, DOI 10.1002/gcc.20768; YEN RWC, 1992, NUCLEIC ACIDS RES, V20, P2287, DOI 10.1093/nar/20.9.2287; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229	49	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19524	10.1371/journal.pone.0019524	http://dx.doi.org/10.1371/journal.pone.0019524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559294	Green Submitted, Green Published, gold			2022-12-25	WOS:000290223500026
J	Boegsted, M; Holst, JM; Fogd, K; Falgreen, S; Sorensen, S; Schmitz, A; Bukh, A; Johnsen, HE; Nyegaard, M; Dybkaer, K				Boegsted, Martin; Holst, Johanne M.; Fogd, Kirsten; Falgreen, Steffen; Sorensen, Suzette; Schmitz, Alexander; Bukh, Anne; Johnsen, Hans E.; Nyegaard, Mette; Dybkaer, Karen			Generation of a Predictive Melphalan Resistance Index by Drug Screen of B-Cell Cancer Cell Lines	PLOS ONE			English	Article							CHONDROITIN SULFATE; HEPARAN-SULFATE; CHEMOSENSITIVITY; EXPRESSION; TARGET; BIOINFORMATICS; LYMPHOMA; PATHWAY	Background: Recent reports indicate that in vitro drug screens combined with gene expression profiles (GEP) of cancer cell lines may generate informative signatures predicting the clinical outcome of chemotherapy. In multiple myeloma (MM) a range of new drugs have been introduced and now challenge conventional therapy including high dose melphalan. Consequently, the generation of predictive signatures for response to melphalan may have a clinical impact. The hypothesis is that melphalan screens and GEPs of B-cell cancer cell lines combined with multivariate statistics may provide predictive clinical information. Materials and Methods: Microarray based GEPs and a melphalan growth inhibition screen of 59 cancer cell lines were downloaded from the National Cancer Institute database. Equivalent data were generated for 18 B-cell cancer cell lines. Linear discriminant analyses (LDA), sparse partial least squares (SPLS) and pairwise comparisons of cell line data were used to build resistance signatures from both cell line panels. A melphalan resistance index was defined and estimated for each MM patient in a publicly available clinical data set and evaluated retrospectively by Cox proportional hazards and Kaplan-Meier survival analysis. Principal Findings: Both cell line panels performed well with respect to internal validation of the SPLS approach but only the B-cell panel was able to predict a significantly higher risk of relapse and death with increasing resistance index in the clinical data sets. The most sensitive and resistant cell lines, MOLP-2 and RPMI-8226 LR5, respectively, had high leverage, which suggests their differentially expressed genes to possess important predictive value. Conclusion: The present study presents a melphalan resistance index generated by analysis of a B-cell panel of cancer cell lines. However, the resistance index needs to be functionally validated and correlated to known MM biomarkers in independent data sets in order to better understand the mechanism underlying the preparedness to melphalan resistance.	[Boegsted, Martin; Holst, Johanne M.; Fogd, Kirsten; Falgreen, Steffen; Sorensen, Suzette; Schmitz, Alexander; Bukh, Anne; Johnsen, Hans E.; Nyegaard, Mette; Dybkaer, Karen] Aarhus Univ Hosp, Dept Haematol, Aalborg Hosp, Sci & Innovat Ctr, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aarhus University	Boegsted, M (corresponding author), Aarhus Univ Hosp, Dept Haematol, Aalborg Hosp, Sci & Innovat Ctr, Aalborg, Denmark.	martin.boegsted@rn.dk	Nyegaard, Mette/M-3379-2019; Nyegaard, Mette/G-4443-2012	Nyegaard, Mette/0000-0003-4973-8543; Nyegaard, Mette/0000-0003-4973-8543; Johnsen, Hans Erik/0000-0001-8253-2913; Bogsted, Martin/0000-0001-9192-1814; Dybkaer, Karen/0000-0003-2488-435X	MSCNET; EU; CHEPRE; The Danish Agency for Science, Technology and Innovation; Det Obelske Familiefond and Karen Elise Jensen Fonden	MSCNET; EU(European Commission); CHEPRE; The Danish Agency for Science, Technology and Innovation; Det Obelske Familiefond and Karen Elise Jensen Fonden	The research is supported by MSCNET, a translational program studying cancer stem cells in multiple myeloma supported by the EU FP6, and CHEPRE, a program studying chemosensitivity in malignant lymphoma by genomic signatures supported by The Danish Agency for Science, Technology and Innovation, as well as Det Obelske Familiefond and Karen Elise Jensen Fonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahdesmaki M, 2010, ANN APPL STAT, V4, P503, DOI 10.1214/09-AOAS277; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], REGRESSION MODELLING, DOI DOI 10.1200/JCO.2017.76.1155; Baggerly KA, 2009, ANN APPL STAT, V3, P1309, DOI 10.1214/09-AOAS291; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; BELLAMY WT, 1991, CANCER RES, V51, P995; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; BOYD MR, 1995, DRUG DEVELOP RES, V34, P91, DOI 10.1002/ddr.430340203; Bret C, 2009, BRIT J HAEMATOL, V145, P350, DOI 10.1111/j.1365-2141.2009.07633.x; Burr ML, 2011, P NATL ACAD SCI USA, V108, P2034, DOI 10.1073/pnas.1016229108; Chen Q, 2005, BLOOD, V106, P698, DOI 10.1182/blood-2004-11-4286; Child JA, 2003, NEW ENGL J MED, V348, P1875, DOI 10.1056/NEJMoa022340; Chun H, 2010, J R STAT SOC B, V72, P3, DOI 10.1111/j.1467-9868.2009.00723.x; Coombes KR, 2007, NAT MED, V13, P1276, DOI 10.1038/nm1107-1276b; Dutta-Simmons J, 2009, BLOOD, V114, P2699, DOI 10.1182/blood-2008-12-194290; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GOLDMANLEIKIN RE, 1989, J LAB CLIN MED, V113, P335; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Havaleshko DM, 2007, MOL CANCER THER, V6, P578, DOI 10.1158/1535-7163.MCT-06-0497; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kimura T, 2003, CANCER SCI, V94, P431, DOI 10.1111/j.1349-7006.2003.tb01460.x; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Leisch F., 2003, CHANCE, V16, P46; Liedtke C, 2010, BREAST CANCER RES TR, V121, P301, DOI 10.1007/s10549-009-0445-7; Mehra S, 2002, GENE CHROMOSOME CANC, V33, P225, DOI 10.1002/gcc.10025; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; RAPRAEGER A, 1985, J BIOL CHEM, V260, P1046; SAMUELS BL, 1995, J CLIN ONCOL, V13, P1786, DOI 10.1200/JCO.1995.13.7.1786; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shen CL, 2005, J BIOL CHEM, V280, P35967, DOI 10.1074/jbc.M505220200; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Subramanian J, 2010, NAT REV CLIN ONCOL, V7, P327, DOI 10.1038/nrclinonc.2010.60; Tan YM, 2008, CANCER LETT, V271, P1, DOI 10.1016/j.canlet.2008.04.036; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Yarde DN, 2009, CANCER RES, V69, P9367, DOI 10.1158/0008-5472.CAN-09-2616; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	41	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19322	10.1371/journal.pone.0019322	http://dx.doi.org/10.1371/journal.pone.0019322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559449	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700133
J	Farnelid, H; Andersson, AF; Bertilsson, S; Abu Al-Soud, W; Hansen, LH; Sorensen, S; Steward, GF; Hagstrom, A; Riemann, L				Farnelid, Hanna; Andersson, Anders F.; Bertilsson, Stefan; Abu Al-Soud, Waleed; Hansen, Lars H.; Sorensen, Soren; Steward, Grieg F.; Hagstrom, Ake; Riemann, Lasse			Nitrogenase Gene Amplicons from Global Marine Surface Waters Are Dominated by Genes of Non-Cyanobacteria	PLOS ONE			English	Article							CHESAPEAKE BAY; NIFH GENE; DIVERSITY; DISTRIBUTIONS; AMPLIFICATION; SEA; MICROORGANISMS; TRICHODESMIUM; ASSEMBLAGES; TRANSCRIPTS	Cyanobacteria are thought to be the main N-2-fixing organisms (diazotrophs) in marine pelagic waters, but recent molecular analyses indicate that non-cyanobacterial diazotrophs are also present and active. Existing data are, however, restricted geographically and by limited sequencing depths. Our analysis of 79,090 nitrogenase (nifH) PCR amplicons encoding 7,468 unique proteins from surface samples (ten DNA samples and two RNA samples) collected at ten marine locations worldwide provides the first in-depth survey of a functional bacterial gene and yield insights into the composition and diversity of the nifH gene pool in marine waters. Great divergence in nifH composition was observed between sites. Cyanobacteria-like genes were most frequent among amplicons from the warmest waters, but overall the data set was dominated by nifH sequences most closely related to non-cyanobacteria. Clusters related to Alpha-, Beta-, Gamma-, and Delta-Proteobacteria were most common and showed distinct geographic distributions. Sequences related to anaerobic bacteria (nifH Cluster III) were generally rare, but preponderant in cold waters, especially in the Arctic. Although the two transcript samples were dominated by unicellular cyanobacteria, 42% of the identified non-cyanobacterial nifH clusters from the corresponding DNA samples were also detected in cDNA. The study indicates that non-cyanobacteria account for a substantial part of the nifH gene pool in marine surface waters and that these genes are at least occasionally expressed. The contribution of non-cyanobacterial diazotrophs to the global N-2 fixation budget cannot be inferred from sequence data alone, but the prevalence of non-cyanobacterial nifH genes and transcripts suggest that these bacteria are ecologically significant.	[Farnelid, Hanna; Hagstrom, Ake; Riemann, Lasse] Linnaeus Univ, Dept Nat Sci, Kalmar, Sweden; [Andersson, Anders F.] KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, Stockholm, Sweden; [Bertilsson, Stefan] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Abu Al-Soud, Waleed; Hansen, Lars H.; Sorensen, Soren] Univ Copenhagen, Dept Biol, Microbiol Sect, Copenhagen, Denmark; [Steward, Grieg F.] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA; [Riemann, Lasse] Univ Copenhagen, Marine Biol Lab, Dept Biol, DK-3000 Helsingor, Denmark	Linnaeus University; Royal Institute of Technology; Uppsala University; University of Copenhagen; University of Hawaii System; University of Copenhagen	Farnelid, H (corresponding author), Linnaeus Univ, Dept Nat Sci, Kalmar, Sweden.	lriemann@bio.ku.dk	Abu Al-Soud, Waleed/AAH-3477-2021; Andersson, Anders/J-9310-2019; Hagström, Åke/Q-9257-2019; Abu Al-Soud, Waleed/K-4408-2014; Sørensen, Søren J/J-5015-2014; Steward, Grieg F./D-9768-2011; Riemann, Lasse/J-7091-2014; Sørensen, Søren Johannes/N-2120-2019; Abu Al-Soud, Waleed/K-4408-2014	Abu Al-Soud, Waleed/0000-0002-1143-9233; Andersson, Anders/0000-0002-3627-6899; Abu Al-Soud, Waleed/0000-0002-1143-9233; Sørensen, Søren J/0000-0001-6227-9906; Steward, Grieg F./0000-0001-5988-0522; Riemann, Lasse/0000-0001-9207-2543; Sørensen, Søren Johannes/0000-0001-6227-9906; Abu Al-Soud, Waleed/0000-0002-1488-4826; Hestbjerg Hansen, Lars/0000-0003-0027-1524	Swedish (FORMAS) [217-2006-342, 621-205-4710, VR 2009-3784, 2008-1293]; Danish Research Council [FNU09-066396]; American Research Council (US NSF) [OCE 08-26650, EF 04-24599]	Swedish (FORMAS)(Swedish Research Council Formas); Danish Research Council(Det Frie Forskningsrad (DFF)); American Research Council (US NSF)(National Science Foundation (NSF))	This work was supported by the Swedish (FORMAS, http://www.formas.se/, 217-2006-342 to L.R., VR, http://www.vr.se/, 621-205-4710 to A.H., and VR 2009-3784 and 2008-1293 to S.B.), Danish (FNU09-066396 to L.R.), and American (US NSF, http://www.nsf.gov/, OCE 08-26650 and EF 04-24599 to G.F.S.) Research Councils. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Affourtit J, 2001, MICROBIAL ECOL, V41, P114; [Anonymous], 2008, MICROBIAL ECOLOGY OC; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Berg OG, 2002, MOL BIOL EVOL, V19, P2265, DOI 10.1093/oxfordjournals.molbev.a004050; Bird C, 2005, APPL ENVIRON MICROB, V71, P2079, DOI 10.1128/AEM.71.4.2079-2085.2005; Bostrom KH, 2007, J PLANKTON RES, V29, P391, DOI 10.1093/plankt/fbm019; Braun ST, 1999, FEMS MICROBIOL ECOL, V28, P273, DOI 10.1016/S0168-6496(98)00132-9; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Carpenter EJ, 1999, MAR ECOL PROG SER, V185, P273, DOI 10.3354/meps185273; CHAO A, 1984, SCAND J STAT, V11, P265; Chien YT, 1996, J BACTERIOL, V178, P143, DOI 10.1128/jb.178.1.143-148.1996; Church MJ, 2008, LIMNOL OCEANOGR, V53, P63, DOI 10.4319/lo.2008.53.1.0063; Church MJ, 2005, AQUAT MICROB ECOL, V38, P3, DOI 10.3354/ame038003; Church MJ, 2005, APPL ENVIRON MICROB, V71, P5362, DOI 10.1128/AEM.71.9.5362-5370.2005; Diallo MD, 2008, FEMS MICROBIOL ECOL, V65, P220, DOI 10.1111/j.1574-6941.2008.00545.x; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Farnelid H, 2010, AQUAT MICROB ECOL, V61, P105, DOI 10.3354/ame01440; Farnelid H, 2009, ENV MICROBIOL REP, V1, P145, DOI 10.1111/j.1758-2229.2009.00021.x; Foster RA, 2009, LIMNOL OCEANOGR, V54, P219, DOI 10.4319/lo.2009.54.1.0219; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Goto M, 2005, FEMS MICROBIOL LETT, V246, P33, DOI 10.1016/j.femsle.2005.03.042; Hamilton AK, 2008, LIMNOL OCEANOGR, V53, P922, DOI 10.4319/lo.2008.53.3.0922; Hewson I, 2007, ISME J, V1, P78, DOI 10.1038/ismej.2007.5; Hewson I, 2007, AQUAT MICROB ECOL, V46, P15, DOI 10.3354/ame046015; Horner-Devine MC, 2008, SCIENCE, V320, P757, DOI 10.1126/science.1147012; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jenkins BD, 2004, APPL ENVIRON MICROB, V70, P1767, DOI 10.1128/AEM.70.3.1767-1776.2004; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Langlois RJ, 2008, APPL ENVIRON MICROB, V74, P1922, DOI 10.1128/AEM.01720-07; Langlois RJ, 2005, APPL ENVIRON MICROB, V71, P7910, DOI 10.1128/AEM.71.12.7910-7919.2005; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin WC, 2004, APPL ENVIRON MICROB, V70, P2525, DOI 10.1128/AEM.70.4.2525-2528.2004; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Man-Aharonovich D, 2007, ENVIRON MICROBIOL, V9, P2354, DOI 10.1111/j.1462-2920.2007.01353.x; Moisander PH, 2008, ISME J, V2, P954, DOI 10.1038/ismej.2008.51; Moisander PH, 2007, ENVIRON MICROBIOL, V9, P1823, DOI 10.1111/j.1462-2920.2007.01304.x; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; Oelze J, 1996, ARCH MICROBIOL, V165, P219, DOI 10.1007/s002030050319; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Pommier T, 2005, AQUAT MICROB ECOL, V41, P79, DOI 10.3354/ame041079; Riemann L, 2010, AQUAT MICROB ECOL, V61, P225, DOI 10.3354/ame01431; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sicking C, 2005, J BACTERIOL, V187, P92, DOI 10.1128/JB.187.1.92-98.2005; Sorensen T, 1948, K DAN VIDENSK SELSK, V5, P1, DOI DOI 10.1234/12345678; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TURK A, 2011, ISME J, DOI DOI 10.1038/ISMEJ.2010.205; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zehr JP, 2007, P NATL ACAD SCI USA, V104, P17807, DOI 10.1073/pnas.0701017104; Zehr JP, 2003, BIOTECHNIQUES, V35, P996, DOI 10.2144/03355st08; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; ZEHR JP, 1989, APPL ENVIRON MICROB, V55, P2522, DOI 10.1128/AEM.55.10.2522-2526.1989; Zehr JP, 2001, METHOD MICROBIOL, V30, P271, DOI 10.1016/S0580-9517(01)30049-1; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	62	132	136	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19223	10.1371/journal.pone.0019223	http://dx.doi.org/10.1371/journal.pone.0019223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559425	Green Published, gold			2022-12-25	WOS:000290024700104
J	Miggins, M; Hasan, A; Hohmann, S; Southwick, F; Casella, G; Schain, D; Liu, HZ; Bihorac, A; Moldawer, L; Efron, P; Ang, D				Miggins, Makesha; Hasan, Anjum; Hohmann, Samuel; Southwick, Frederick; Casella, George; Schain, Denise; Liu, Huazhi; Bihorac, Azra; Moldawer, Lyle; Efron, Philip; Ang, Darwin			The Potential Influence of Common Viral Infections Diagnosed during Hospitalization among Critically Ill Patients in the United States	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; INTENSIVE-CARE-UNIT; ACTIVE CYTOMEGALOVIRUS-INFECTION; SURGICAL-PATIENTS; VENTILATION; MORTALITY; TYPE-1; REACTIVATION; DISEASE	Viruses are the most common source of infection among immunocompetent individuals, yet they are not considered a clinically meaningful risk factor among the critically ill. This work examines the association of viral infections diagnosed during the hospital stay or not documented as present on admission to the outcomes of ICU patients with no evidence of immunosuppression on admission. This is a population-based retrospective cohort study of University HealthSystem Consortium (UHC) academic centers in the U. S. from the years 2006 to 2009. The UHC is an alliance of over 90% of the non-profit academic medical centers in the U. S. A total of 209,695 critically ill patients were used in this analysis. Eight hospital complications were examined. Patients were grouped into four cohorts: absence of infection, bacterial infection only, viral infection only, and bacterial and viral infection during same hospital admission. Viral infections diagnosed during hospitalization significantly increased the risk of all complications. There was also a seasonal pattern for viral infections. Specific viruses associated with poor outcomes included influenza, RSV, CMV, and HSV. Patients who had both viral and bacterial infections during the same hospitalization had the greatest risk of mortality RR 6.58, 95% CI (5.47, 7.91); multi-organ failure RR 8.25, 95% CI (7.50, 9.07); and septic shock RR 271.2, 95% CI (188.0, 391.3). Viral infections may play a significant yet unrecognized role in the outcomes of ICU patients. They may serve as biological markers or play an active role in the development of certain adverse complications by interacting with coincident bacterial infection.	[Miggins, Makesha; Liu, Huazhi; Moldawer, Lyle; Efron, Philip; Ang, Darwin] Univ Florida, Dept Surg, Gainesville, FL 32611 USA; [Hasan, Anjum; Southwick, Frederick; Schain, Denise] Univ Florida, Dept Infect Dis, Gainesville, FL USA; [Hohmann, Samuel] Univ HealthSyst Consortium, Gainesville, FL USA; [Casella, George] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [Bihorac, Azra] Univ Florida, Dept Anesthesiol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Miggins, M (corresponding author), Univ Florida, Dept Surg, Gainesville, FL 32611 USA.	darwin.ang@surgery.ufl.edu	Ang, Darwin/AIA-3852-2022; Bihorac, Azra/Q-6500-2016	Bihorac, Azra/0000-0002-5745-2863; Moldawer, Lyle/0000-0002-9041-9838	NCI NIH HHS [T32 CA106493] Funding Source: Medline; NIGMS NIH HHS [K23 GM087709] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA106493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM087709] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Beadling C, 2004, CURR OPIN INFECT DIS, V17, P185, DOI 10.1097/00001432-200406000-00003; Bruynseels P, 2003, LANCET, V362, P1536, DOI 10.1016/S0140-6736(03)14740-X; Cameron RJ, 2006, INTENS CARE MED, V32, P1022, DOI 10.1007/s00134-006-0202-x; Centers for Disease Control and Prevention, 2010, OV BRFSS 2010; Chiche L, 2009, CRIT CARE MED, V37, P1850, DOI 10.1097/CCM.0b013e31819ffea6; Cook CH, 1998, AM J SURG, V176, P357, DOI 10.1016/S0002-9610(98)00205-0; Cook CH, 2003, CRIT CARE MED, V31, P1923, DOI 10.1097/01.CCM.0000070222.11325.C4; Couch Robert B., 1997, American Journal of Medicine, V102, P2, DOI 10.1016/S0002-9343(97)00003-X; da Silva AR, 2007, BRAZ J INFECT DIS, V11, P163, DOI 10.1590/S1413-86702007000100034; Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1111/j.1574-695X.1999.tb01389.x; Heininger A, 2001, CRIT CARE MED, V29, P541, DOI 10.1097/00003246-200103000-00012; Jaber S, 2005, CHEST, V127, P233, DOI 10.1378/chest.127.1.233; Kalil AC, 2009, CRIT CARE MED, V37, P2350, DOI 10.1097/CCM.0b013e3181a3aa43; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Luyt CE, 2008, CURR OPIN CRIT CARE, V14, P605, DOI 10.1097/MCC.0b013e32830f1e12; Luyt CE, 2007, AM J RESP CRIT CARE, V175, P935, DOI 10.1164/rccm.200609-1322OC; Ong GM, 2004, J MED VIROL, V72, P121, DOI 10.1002/jmv.10524; Papazian L, 1996, ANESTHESIOLOGY, V84, P280, DOI 10.1097/00000542-199602000-00005; PORTEOUS C, 1984, CRIT CARE MED, V12, P626, DOI 10.1097/00003246-198408000-00003; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V104, P587, DOI 10.1093/oxfordjournals.aje.a112335; Stollenwerk N, 2008, CRIT CARE, V12, DOI 10.1186/cc6917; van den Brink JW, 2004, J CLIN VIROL, V30, P68, DOI 10.1016/j.jcv.2003.09.003; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Ziemann M, 2008, CRIT CARE MED, V36, P3145, DOI 10.1097/CCM.0b013e31818f3fc4	26	21	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18890	10.1371/journal.pone.0018890	http://dx.doi.org/10.1371/journal.pone.0018890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21573031	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700034
J	Whim, MD				Whim, Matthew D.			Pancreatic Beta Cells Synthesize Neuropeptide Y and Can Rapidly Release Peptide Co-Transmitters	PLOS ONE			English	Article							VASOACTIVE INTESTINAL POLYPEPTIDE; CA2+-INDUCED CA2+ RELEASE; IN-SITU HYBRIDIZATION; INSULIN-SECRETION; DEXAMETHASONE TREATMENT; ENDOCRINE PANCREAS; CHROMAFFIN CELLS; ISLET HORMONES; DEFICIENT MICE; RAT PANCREAS	Background: In addition to polypeptide hormones, pancreatic endocrine cells synthesize a variety of bioactive molecules including classical transmitters and neuropeptides. While these co-transmitters are thought to play a role in regulating hormone release little is known about how their secretion is regulated. Here I investigate the synthesis and release of neuropeptide Y from pancreatic beta cells. Methodology/Principal Findings: NPY appears to be an authentic co-transmitter in neonatal, but not adult, beta cells because (1) early in mouse post-natal development, many beta cells are NPY-immunoreactive whereas no staining is observed in beta cells from NPY knockout mice; (2) GFP-expressing islet cells from an NPY(GFP) transgenic mouse are insulin-ir; (3) single cell RT-PCR experiments confirm that the NPY(GFP) cells contain insulin mRNA, a marker of beta cells. The NPY-immunoreactivity previously reported in alpha and delta cells is therefore likely to be due to the presence of NPY-related peptides. INS-1 cells, a beta cell line, are also NPY-ir and contain NPY mRNA. Using the FMRFamide tagging technique, NPY secretion was monitored from INS-1 beta cells with high temporal resolution. Peptide release was evoked by brief depolarizations and was potentiated by activators of adenylate cyclase and protein kinase A. Following a transient depolarization, NPY-containing dense core granules fused with the cell membrane and discharged their contents within a few milliseconds. Conclusions: These results indicate that after birth, NPY expression in pancreatic islets is restricted to neonatal beta cells. The presence of NPY suggests that peptide co-transmitters could mediate rapid paracrine or autocrine signaling within the endocrine pancreas. The FMRFamide tagging technique may be useful in studying the release of other putative islet co-transmitters in real time.	LSU, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University; Louisiana State University Health Sciences Center New Orleans	Whim, MD (corresponding author), LSU, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA 70112 USA.	mwhim@lsuhsc.edu			National Institutes of Health [DK080441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK080441, R01DK080441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institutes of Health to MDW (DK080441). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E, 2001, PEPTIDES, V22, P99, DOI 10.1016/S0196-9781(00)00361-2; AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; Arumugam R, 2007, ENDOCRINOLOGY, V148, P258, DOI 10.1210/en.2006-0888; Bennet WM, 1996, J CLIN ENDOCR METAB, V81, P2117, DOI 10.1210/jc.81.6.2117; Braun M, 2004, J PHYSIOL-LONDON, V559, P397, DOI 10.1113/jphysiol.2004.066563; Cabrera O, 2008, CELL METAB, V7, P545, DOI 10.1016/j.cmet.2008.03.004; CETIN Y, 1993, P NATL ACAD SCI USA, V90, P2360, DOI 10.1073/pnas.90.6.2360; Cho YR, 2004, BIOCHEM BIOPH RES CO, V314, P773, DOI 10.1016/j.bbrc.2003.12.170; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Cottrell GA, 1997, J EXP BIOL, V200, P2377; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; German I, 2001, ELECTROPHORESIS, V22, P3659, DOI 10.1002/1522-2683(200109)22:17<3659::AID-ELPS3659>3.0.CO;2-I; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Gu C, CELL METAB, V11, P298; HOLE RL, 1988, AM J PHYSIOL, V254, pE167, DOI 10.1152/ajpendo.1988.254.2.E167; HUTTON JC, 1983, BIOCHEM J, V210, P297, DOI 10.1042/bj2100297; Imai Y, 2007, ENDOCRINOLOGY, V148, P5716, DOI 10.1210/en.2007-0404; Jackerott M, 1996, J HISTOCHEM CYTOCHEM, V44, P809, DOI 10.1177/44.8.8756753; Jacques-Silva MC, P NATL ACAD SCI US, V107, P6465; JAMAL H, 1991, ENDOCRINOLOGY, V129, P3372, DOI 10.1210/endo-129-6-3372; Kang GX, 2006, J PHYSIOL-LONDON, V573, P595, DOI 10.1113/jphysiol.2006.107391; Kang GX, 2005, J PHYSIOL-LONDON, V566, P173, DOI 10.1113/jphysiol.2005.087510; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kushi A, 1998, P NATL ACAD SCI USA, V95, P15659, DOI 10.1073/pnas.95.26.15659; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; MacDonald PE, 2006, CELL METAB, V4, P283, DOI 10.1016/j.cmet.2006.08.011; Marx R, 1999, J NEUROSCI, V19, P8300; Meneghel-Rozzo T, 2004, CELL TISSUE RES, V316, P295, DOI 10.1007/s00441-004-0886-6; Michael DJ, 2006, TRENDS ENDOCRIN MET, V17, P408, DOI 10.1016/j.tem.2006.10.011; Mitchell GC, 2008, J NEUROSCI, V28, P14428, DOI 10.1523/JNEUROSCI.0343-08.2008; MOLTZ JH, 1985, PEPTIDES, V6, P1155, DOI 10.1016/0196-9781(85)90443-7; Morgan DG, 1998, DIABETOLOGIA, V41, P1482, DOI 10.1007/s001250051095; MYRSEN U, 1995, REGUL PEPTIDES, V57, P65, DOI 10.1016/0167-0115(95)00020-C; MYRSEN U, 1995, REGUL PEPTIDES, V60, P19, DOI 10.1016/0167-0115(95)00114-5; MyrsenAxcrona U, 1997, REGUL PEPTIDES, V68, P165, DOI 10.1016/S0167-0115(96)02113-1; MyrsenAxcrona U, 1997, J BIOL CHEM, V272, P10790; Ponery AS, 2000, PEPTIDES, V21, P1503, DOI 10.1016/S0196-9781(00)00304-1; Ramamoorthy P, 2008, J NEUROSCI, V28, P13815, DOI 10.1523/JNEUROSCI.5361-07.2008; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; Seino S, 2009, DIABETES OBES METAB, V11, P180, DOI 10.1111/j.1463-1326.2009.01108.x; Smith PA, 1999, J PHYSIOL-LONDON, V521, P651, DOI 10.1111/j.1469-7793.1999.00651.x; TEITELMAN G, 1993, DEVELOPMENT, V118, P1031; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; WAEBER G, 1993, ENDOCRINOLOGY, V133, P1061, DOI 10.1210/en.133.3.1061; Whim MD, 2006, J NEUROSCI, V26, P6637, DOI 10.1523/JNEUROSCI.5100-05.2006; Whim MD, 2001, NEURON, V30, P37, DOI 10.1016/S0896-6273(01)00261-6	46	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19478	10.1371/journal.pone.0019478	http://dx.doi.org/10.1371/journal.pone.0019478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559341	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700193
J	Kern, J; Wilton, R; Zhang, RG; Binkowski, TA; Joachimiak, A; Schneewind, O				Kern, Justin; Wilton, Rosemarie; Zhang, Rongguang; Binkowski, T. Andrew; Joachimiak, Andrzej; Schneewind, Olaf			Structure of Surface Layer Homology (SLH) Domains from Bacillus anthracis Surface Array Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL POLYSACCHARIDE; S-LAYER; CHOLERA-TOXIN; MACROMOLECULAR STRUCTURES; CLOSTRIDIUM-THERMOCELLUM; CRYSTAL-STRUCTURE; BINDING; CRYSTALLIZATION; ATTACHMENT; MECHANISM	Surface (S)-layers, para-crystalline arrays of protein, are deposited in the envelope of most bacterial species. These surface organelles are retained in the bacterial envelope through the non-covalent association of proteins with cell wall carbohydrates. Bacillus anthracis, a Gram-positive pathogen, produces S-layers of the protein Sap, which uses three consecutive repeats of the surface-layer homology (SLH) domain to engage secondary cell wall polysaccharides (SCWP). Using x-ray crystallography, we reveal here the structure of these SLH domains, which assume the shape of a three-prong spindle. Each SLH domain contributes to a three-helical bundle at the spindle base, whereas another alpha-helix and its connecting loops generate the three prongs. The inter-prong grooves contain conserved cationic and anionic residues, which are necessary for SLH domains to bind the B. anthracis SCWP. Modeling experiments suggest that the SLH domains of other S-layer proteins also fold into three-prong spindles and capture bacterial envelope carbohydrates by a similar mechanism.	[Kern, Justin; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Wilton, Rosemarie; Zhang, Rongguang; Binkowski, T. Andrew; Joachimiak, Andrzej] Argonne Natl Lab, Biosci Div, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Wilton, Rosemarie; Zhang, Rongguang; Binkowski, T. Andrew; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA; [Joachimiak, Andrzej] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Schneewind, O (corresponding author), 920 E 58th St, Chicago, IL USA.	oschnee@bsd.uchicago.edu		Wilton, Rosemarie/0000-0001-5221-6354	National Institutes of Health [GM074942, AI69227, GM007183]; Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institute of Allergy and Infectious Diseases) [1-U54-AI-057153]; U.S. Dept. of Energy Office of Science laboratory [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI069227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, U54GM074942, T32GM007183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Dept. of Energy Office of Science laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grants GM074942 (to A. J.) and AI69227 (to O. S.) from the National Institutes of Health.; Supported by National Institutes of Health Training Grant GM007183.; Membership within and support from the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institute of Allergy and Infectious Diseases Award 1-U54-AI-057153). To whom correspondence should be addressed: 920 E. 58<SUP>th</SUP> St., Chicago, IL 6063. Fax: 773-834-8150; E-mail: oschnee@bsd.uchicago.edu.; The submitted manuscript has been created by University of Chicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne"). Argonne, a U.S. Dept. of Energy Office of Science laboratory, is operated under Contract No. DE-AC02-06CH11357. The U. S. Government retains for itself, and others acting on its behalf, a paid-up nonexclusive, irrevocable worldwide license in said article to reproduce, prepare derivative works, distribute copies to the public, and perform publicly and display publicly, by or on behalf of the Government.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUCKNER V, 1953, NATURE, V172, P508, DOI 10.1038/172508a0; Candela T, 2005, MICROBIOL-SGM, V151, P1485, DOI 10.1099/mic.0.27832-0; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cava F, 2004, MOL MICROBIOL, V52, P677, DOI 10.1111/j.1365-2958.2004.04011.x; Chauvaux S, 1999, J BACTERIOL, V181, P2455, DOI 10.1128/JB.181.8.2455-2458.1999; CHICH JF, 1995, PROTEINS, V23, P278, DOI 10.1002/prot.340230216; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; Couture-Tosi E, 2002, J BACTERIOL, V184, P6448, DOI 10.1128/JB.184.23.6448-6456.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelhardt H, 1998, J STRUCT BIOL, V124, P276, DOI 10.1006/jsbi.1998.4070; Engelhardt H, 2007, J STRUCT BIOL, V160, P115, DOI 10.1016/j.jsb.2007.08.003; ETIENNETOUMELIN I, 1995, J BACTERIOL, V177, P614, DOI 10.1128/jb.177.3.614-620.1995; Fouet A, 2009, MOL ASPECTS MED, V30, P374, DOI 10.1016/j.mam.2009.07.001; FUJINO T, 1993, J BACTERIOL, V175, P1891, DOI 10.1128/JB.175.7.1891-1899.1993; Houwink A.L., 1952, PHYS VERHANDLUNG, V3, P98; HOUWINK AL, 1953, BIOCHIM BIOPHYS ACTA, V10, P360, DOI 10.1016/0006-3002(53)90266-2; HOUWINK AL, 1956, J GEN MICROBIOL, V15, P146, DOI 10.1099/00221287-15-1-146; Kern J, 2010, J MOL BIOL, V401, P757, DOI 10.1016/j.jmb.2010.06.059; Kern J, 2010, MOL MICROBIOL, V75, P324, DOI 10.1111/j.1365-2958.2009.06958.x; Kern JW, 2008, MOL MICROBIOL, V68, P504, DOI 10.1111/j.1365-2958.2008.06169.x; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leoff C, 2009, GLYCOBIOLOGY, V19, P665, DOI 10.1093/glycob/cwp036; LUPAS A, 1994, J BACTERIOL, V176, P1224, DOI 10.1128/jb.176.5.1224-1233.1994; Lupas A, 1996, MOL MICROBIOL, V20, P897, DOI 10.1111/j.1365-2958.1996.tb02528.x; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; May A, 2006, ARCH MICROBIOL, V185, P263, DOI 10.1007/s00203-006-0092-x; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Mesnage S, 1997, MOL MICROBIOL, V23, P1147, DOI 10.1046/j.1365-2958.1997.2941659.x; Mesnage S, 2002, J BACTERIOL, V184, P331, DOI 10.1128/JB.184.1.331-334.2002; Mesnage S, 1999, MOL MICROBIOL, V31, P927, DOI 10.1046/j.1365-2958.1999.01232.x; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Mesnage S, 1998, J BACTERIOL, V180, P52, DOI 10.1128/JB.180.1.52-58.1998; Mignot T, 2002, MOL MICROBIOL, V43, P1615, DOI 10.1046/j.1365-2958.2002.02852.x; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pavkov T, 2008, STRUCTURE, V16, P1226, DOI 10.1016/j.str.2008.05.012; Richter S, 2009, MOL MICROBIOL, V71, P404, DOI 10.1111/j.1365-2958.2008.06533.x; Schaffer C, 2005, MICROBIOL-SGM, V151, P643, DOI 10.1099/mic.0.27749-0; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sleytr UB, 1997, FEMS MICROBIOL REV, V20, P5, DOI 10.1016/S0168-6445(97)00039-9; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VANHEYNINGEN WE, 1971, J INFECT DIS, V124, P415, DOI 10.1093/infdis/124.4.415; ZHANG RG, 1995, J MOL BIOL, V251, P550, DOI 10.1006/jmbi.1995.0455	47	63	63	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26042	26049		10.1074/jbc.M111.248070	http://dx.doi.org/10.1074/jbc.M111.248070			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21572039	Green Published, hybrid			2022-12-25	WOS:000293073000062
J	Pham, P; Calabrese, P; Park, SJ; Goodman, MF				Pham, Phuong; Calabrese, Peter; Park, Soo Jung; Goodman, Myron F.			Analysis of a Single-stranded DNA-scanning Process in Which Activation-induced Deoxycytidine Deaminase (AID) Deaminates C to U Haphazardly and Inefficiently to Ensure Mutational Diversity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CYTIDINE DEAMINASE; T7 RNA-POLYMERASE; SOMATIC HYPERMUTATION; FACILITATED DIFFUSION; RESTRICTION ENZYMES; TARGETED DNA; DEMETHYLATION; SEQUENCE; PROTEIN; REPAIR	Enzymes that scan single-stranded (ss) DNA have been studied far less extensively than those that scan double-stranded (ds) DNA. Activation-induced deoxycytidine deaminase (AID) deaminates C to U on single-stranded DNA to initiate immunological diversity. Except for processive deaminations favoring WRC hot motifs(W = (A/T) and R = (G/C)), the rules governing AID scanning remain vague. Here, we examine the patterns of deaminations on naked single-stranded DNA and during transcription of dsDNA by embedding cassettes containing combinations of motifs within a lacZ mutational reporter gene. Deaminations arise randomly, spatially distributed as isolated events and in clusters. The deamination frequency depends on the motif and its surrounding sequence. We propose a random walk model that fits the data well, having a deamination probability of 1-7% per motif encounter. We suggest that inefficient, haphazard deamination produces antibody diversity associated with AID.	[Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA; Univ So Calif, Dept Chem, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA.	mgoodman@usc.edu			National Institutes of Health [GM21422, ES013192]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES013192, R01ES013192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021422, R01GM021422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM21422 and ES013192.	Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; BENNETT SE, 1995, BIOCHEMISTRY-US, V34, P6109, DOI 10.1021/bi00018a014; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bonnet I, 2008, NUCLEIC ACIDS RES, V36, P4118, DOI 10.1093/nar/gkn376; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Canugovi C, 2009, FASEB J, V23, P34, DOI 10.1096/fj.08-115352; Carey DC, 1999, BIOCHEMISTRY-US, V38, P16553, DOI 10.1021/bi9907429; Chahwan R, 2010, TRENDS GENET, V26, P443, DOI 10.1016/j.tig.2010.07.005; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chelico L, 2009, J BIOL CHEM, V284, P27761, DOI 10.1074/jbc.R109.052449; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; DOWD DR, 1990, J BIOL CHEM, V265, P3424; Fritz EL, 2010, GENE DEV, V24, P2107, DOI 10.1101/gad.1963010; Gorman J, 2008, NAT STRUCT MOL BIOL, V15, P768, DOI 10.1038/nsmb.1441; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Halford SE, 2001, BIOCHEM SOC T, V29, P363, DOI 10.1042/BST0290363; Jiricny J, 2008, CELL, V135, P1167, DOI 10.1016/j.cell.2008.12.008; Kochaniak AB, 2009, J BIOL CHEM, V284, P17700, DOI 10.1074/jbc.M109.008706; Komazin-Meredith G, 2008, P NATL ACAD SCI USA, V105, P10721, DOI 10.1073/pnas.0802676105; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Larijani M, 2007, MOL CELL BIOL, V27, P8038, DOI 10.1128/MCB.01046-07; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; MacCarthy T, 2009, P NATL ACAD SCI USA, V106, P8629, DOI 10.1073/pnas.0903803106; MacDuff DA, 2009, NUCLEIC ACIDS RES, V37, P1854, DOI 10.1093/nar/gkp030; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Porecha RH, 2008, P NATL ACAD SCI USA, V105, P10791, DOI 10.1073/pnas.0801612105; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ross S. M., 1994, 1 COURSE PROBABILITY, P167; Shen HM, 2005, MOL CELL BIOL, V25, P10815, DOI 10.1128/MCB.25.24.10815-10821.2005; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Sohn YH, 2005, P NATL ACAD SCI USA, V102, P75, DOI 10.1073/pnas.0406581101; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; TERRY BJ, 1985, J BIOL CHEM, V260, P3130; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Wang M, 2010, J EXP MED, V207, P141, DOI 10.1084/jem.20092238; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200	48	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24931	24942		10.1074/jbc.M111.241208	http://dx.doi.org/10.1074/jbc.M111.241208			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21572036	Green Published, hybrid			2022-12-25	WOS:000292547900042
J	Farshi, P; Ohlig, S; Pickhinke, U; Hoing, S; Jochmann, K; Lawrence, R; Dreier, R; Dierker, T; Grobe, K				Farshi, Pershang; Ohlig, Stefanie; Pickhinke, Ute; Hoeing, Susanne; Jochmann, Katja; Lawrence, Roger; Dreier, Rita; Dierker, Tabea; Grobe, Kay			Dual Roles of the Cardin-Weintraub Motif in Multimeric Sonic Hedgehog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NDST1 GENE-FUNCTION; GLYPICAN DALLY-LIKE; HEPARAN-SULFATE; CHOLESTEROL MODIFICATION; CELLS; DROSOPHILA; PROTEINS; PATHWAY; DOMAIN; PROTEOGLYCANS	The fly morphogen Hedgehog (Hh) and its mammalian orthologs, Sonic, Indian, and Desert hedgehog, are secreted signaling molecules that mediate tissue patterning during embryogenesis and function in tissue homeostasis and regeneration in the adult. The function of all Hh family members is regulated at the levels of morphogen multimerization on the surface of producing cells, multimer release, multimer diffusion to target cells, and signal reception. These mechanisms are all known to depend on interactions of positively charged Hh amino acids (the Cardin-Weintraub (CW) motif) with negatively charged heparan sulfate (HS) glycosaminoglycan chains. However, a precise mechanistic understanding of these interactions is still lacking. In this work, we characterized ionic HS interactions of multimeric Sonic hedgehog (called ShhNp) as well as mutant forms lacking one or more CW residues. We found that deletion of all five CW residues as well as site-directed mutagenesis of CW residues Lys(33), Arg(35), and Lys(39) (mouse nomenclature) abolished HS binding. In contrast, CW residues Arg(34) and Lys(38) did not contribute to HS binding. Analysis and validation of Shh crystal lattice contacts provided an explanation for this finding. We demonstrate that CW residues Arg(34) and Lys(38) make contact with an acidic groove on the adjacent molecule in the multimer, suggesting a new function of these residues in ShhNp multimerization rather than HS binding. Therefore, the recombinant monomeric morphogen (called ShhN) differs in CW-dependent HS binding and biological activity from physiologically relevant ShhNp multimers, providing new explanations for functional differences observed between ShhN and ShhNp.	[Farshi, Pershang; Ohlig, Stefanie; Pickhinke, Ute; Dreier, Rita] Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Hoeing, Susanne] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Jochmann, Katja; Dierker, Tabea] Univ Duisburg Essen, Ctr Med Biotechnol, D-45117 Essen, Germany; [Lawrence, Roger] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Max Planck Society; University of Duisburg Essen; University of California System; University of California San Diego		kgrobe@uni-muenster.de	Grobe, Kay/F-2399-2011	Dierker, Tabea/0000-0003-1991-2723	Deutsche Forschungsgemeinschaft (German Research Council) [SFB 492-B15, GRK1549/1]	Deutsche Forschungsgemeinschaft (German Research Council)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (German Research Council) Grants SFB 492-B15 and GRK1549/1.	Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Callejo A, 2006, DEVELOPMENT, V133, P471, DOI 10.1242/dev.02217; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Chan JA, 2009, NAT NEUROSCI, V12, P409, DOI 10.1038/nn.2287; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Desbordes SC, 2003, DEVELOPMENT, V130, P6245, DOI 10.1242/dev.00874; Dierker T, 2009, J BIOL CHEM, V284, P32562, DOI 10.1074/jbc.M109.044867; Dierker T, 2009, J BIOL CHEM, V284, P8013, DOI 10.1074/jbc.M806838200; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Feng J, 2004, DEVELOPMENT, V131, P4357, DOI 10.1242/dev.01301; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Goetz JA, 2002, BIOESSAYS, V24, P157, DOI 10.1002/bies.10056; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Huang X, 2007, DEVELOPMENT, V134, P2095, DOI 10.1242/dev.000729; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; Li YN, 2006, P NATL ACAD SCI USA, V103, P6548, DOI 10.1073/pnas.0600124103; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; McLellan JS, 2006, P NATL ACAD SCI USA, V103, P17208, DOI 10.1073/pnas.0606738103; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Ohlig S, 2011, DEV CELL, V20, P764, DOI 10.1016/j.devcel.2011.05.010; Pallerla SR, 2007, DEV DYNAM, V236, P556, DOI 10.1002/dvdy.21038; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pepinsky RB, 2000, J BIOL CHEM, V275, P10995, DOI 10.1074/jbc.275.15.10995; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Rubin JB, 2002, DEVELOPMENT, V129, P2223; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tian H, 2005, DEVELOPMENT, V132, P133, DOI 10.1242/dev.01563; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Williams KP, 1999, J CELL SCI, V112, P4405; Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhang FM, 2007, BIOCHEMISTRY-US, V46, P3933, DOI 10.1021/bi6025424	43	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23608	23619		10.1074/jbc.M110.206474	http://dx.doi.org/10.1074/jbc.M110.206474			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21572042	hybrid, Green Published			2022-12-25	WOS:000292025000091
J	Barbour, AB; Allen, MS; Frazer, TK; Sherman, KD				Barbour, Andrew B.; Allen, Michael S.; Frazer, Thomas K.; Sherman, Krista D.			Evaluating the Potential Efficacy of Invasive Lionfish (Pterois volitans) Removals	PLOS ONE			English	Article							INDO-PACIFIC LIONFISH; CORAL-REEF FISH; MARINE NURSERIES; EAST-COAST; RECRUITMENT; MANAGEMENT; MANGROVES; DISPERSAL	The lionfish, Pterois volitans (Linnaeus) and Pterois miles (Bennett), invasion of the Western Atlantic Ocean, Caribbean Sea and Gulf of Mexico has the potential to alter aquatic communities and represents a legitimate ecological concern. Several local removal programs have been initiated to control this invasion, but it is not known whether removal efforts can substantially reduce lionfish numbers to ameliorate these concerns. We used an age-structured population model to evaluate the potential efficacy of lionfish removal programs and identified critical data gaps for future studies. We used high and low estimates for uncertain parameters including: length at 50% vulnerability to harvest (L-vul), instantaneous natural mortality (M), and the Goodyear compensation ratio (CR). The model predicted an annual exploitation rate between 35 and 65% would be required to cause recruitment overfishing on lionfish populations for our baseline parameter estimates for M and CR (0.5 and 15). Lionfish quickly recovered from high removal rates, reaching 90% of unfished biomass six years after a 50-year simulated removal program. Quantifying lionfish natural mortality and the size-selective vulnerability to harvest are the most important knowledge gaps for future research. We suggest complete eradication of lionfish through fishing is unlikely, and substantial reduction of adult abundance will require a long-term commitment and may be feasible only in small, localized areas where annual exploitation can be intense over multiple consecutive years.	[Barbour, Andrew B.; Allen, Michael S.; Frazer, Thomas K.] Univ Florida, Sch Forest Resources & Conservat, Fisheries & Aquat Sci Program, Gainesville, FL 32611 USA; [Sherman, Krista D.] Bahamas Natl Trust, Nassau, Bahamas	State University System of Florida; University of Florida	Barbour, AB (corresponding author), Univ Florida, Sch Forest Resources & Conservat, Fisheries & Aquat Sci Program, Gainesville, FL 32611 USA.	snook@ufl.edu		Barbour, Andrew/0000-0003-1405-4897	NOAA National Sea Grant College; National Science Foundation [DGE-0802270]; NOAA; NOAA National Centers for Coastal Ocean Science; National Marine Fisheries Service's Southeast Fisheries Science Center; University of Florida	NOAA National Sea Grant College; National Science Foundation(National Science Foundation (NSF)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA National Centers for Coastal Ocean Science; National Marine Fisheries Service's Southeast Fisheries Science Center; University of Florida(University of Florida)	This publication was supported by a grant from the NOAA National Sea Grant College Program, and the National Science Foundation Graduate Research Fellowship under grant No. DGE-0802270 to ABB, the NOAA Aquatic Invasive Species Program, the NOAA National Centers for Coastal Ocean Science, and the National Marine Fisheries Service's Southeast Fisheries Science Center. Publication of this article was funded, in part, by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2006, MAR ECOL PROG SER, V318, P287, DOI 10.3354/meps318287; Adams AJ, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P185, DOI 10.1007/978-90-481-2406-0_6; Ahrenholz DW, 2010, ENVIRON BIOL FISH, V88, P305, DOI 10.1007/s10641-010-9647-4; Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Allen MS, 2009, FISH RES, V95, P260, DOI 10.1016/j.fishres.2008.09.028; [Anonymous], 2009, NOAA TECHNICAL MEMOR; AQUILARPERERA A, 2010, AQ INV S1, V5, P9; Barbour AB, 2010, MAR ECOL PROG SER, V401, P291, DOI 10.3354/meps08373; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Beck MW., 2003, ISSUES ECOL, V11, P1; BOTSFORD LW, 1981, AM NAT, V117, P38, DOI 10.1086/283685; BOTSFORD LW, 1981, J MATH BIOL, V12, P265, DOI 10.1007/BF00276917; BOTSFORD LW, 1979, P 13 EUR MAR BIOL S, V13, P73; CONNELL SD, 1991, J EXP MAR BIOL ECOL, V151, P271, DOI 10.1016/0022-0981(91)90129-K; Dahlgren CP, 2006, MAR ECOL PROG SER, V312, P291, DOI 10.3354/meps312291; DAVIS JE, 2003, NONNATIVE SPECIES MO; Freshwater DW, 2009, MAR BIOL, V156, P1213, DOI 10.1007/s00227-009-1163-8; Goodwin NB, 2006, CAN J FISH AQUAT SCI, V63, P494, DOI 10.1139/f05-234; Goodyear C.P., 1980, P253; Goodyear C. Philip, 1993, Canadian Special Publication of Fisheries and Aquatic Sciences, V120, P67; Green SJ, 2009, CORAL REEFS, V28, P107, DOI 10.1007/s00338-008-0446-8; Hamner RM, 2007, J FISH BIOL, V71, P214, DOI 10.1111/j.1095-8649.2007.01575.x; Harding EK, 2001, CONSERV BIOL, V15, P1114, DOI 10.1046/j.1523-1739.2001.0150041114.x; Hare JA, 2003, NOAA TECH MEMO NOS N; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Johnson LE, 1996, ECOLOGY, V77, P1686, DOI 10.2307/2265774; Kimball ME, 2004, MAR ECOL PROG SER, V283, P269, DOI 10.3354/meps283269; MACE PM, 1994, CAN J FISH AQUAT SCI, V51, P110, DOI 10.1139/f94-013; Maljkovic A, 2008, CORAL REEFS, V27, P501, DOI 10.1007/s00338-008-0372-9; Morris, 2009, THESIS N CAROLINA ST; Morris JA, 2011, SCI MAR, V75, P147, DOI 10.3989/scimar.2011.75n1147; Morris JA, 2011, BIOL INVASIONS, V13, P7, DOI 10.1007/s10530-010-9786-8; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Mueller GA, 2005, FISHERIES, V30, P10, DOI 10.1577/1548-8446(2005)30[10:PFRANF]2.0.CO;2; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Myers RA, 1999, CAN J FISH AQUAT SCI, V56, P2404, DOI 10.1139/cjfas-56-12-2404; Nagelkerken I, 2002, MAR ECOL PROG SER, V244, P299, DOI 10.3354/meps244299; POTTS JC, P 63 GULF C IN PRESS; Schofield Pamela J., 2009, Aquatic Invasions, V4, P473; SCHOFIELD PJ, 2010, PTEROIS VOLITANS MIL; Serbesoff-King K, 2003, J AQUAT PLANT MANAGE, V41, P98; SHULMAN MJ, 1987, MAR ECOL PROG SER, V39, P233, DOI 10.3354/meps039233; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; Whitfield, 2009, P GULF CARIB FISH I, V29, P409; Whitfield PE, 2002, MAR ECOL PROG SER, V235, P289, DOI 10.3354/meps235289	45	137	148	2	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19666	10.1371/journal.pone.0019666	http://dx.doi.org/10.1371/journal.pone.0019666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572951	Green Submitted, Green Published, gold			2022-12-25	WOS:000290440200019
J	So, AY; Jung, JW; Lee, S; Kim, HS; Kang, KS				So, Ah-Young; Jung, Ji-Won; Lee, Seunghee; Kim, Hyung-Sik; Kang, Kyung-Sun			DNA Methyltransferase Controls Stem Cell Aging by Regulating BMI1 and EZH2 through MicroRNAs	PLOS ONE			English	Article							HUMAN CANCER-CELLS; HISTONE DEACETYLASE; HUMAN FIBROBLASTS; PROSTATE-CANCER; BREAST-CANCER; LUNG-CANCER; IN-VITRO; GENE; DIFFERENTIATION; METHYLATION	Epigenetic regulation of gene expression is well known mechanism that regulates cellular senescence of cancer cells. Here we show that inhibition of DNA methyltransferases (DNMTs) with 5-azacytidine (5-AzaC) or with specific small interfering RNA (siRNA) against DNMT1 and 3b induced the cellular senescence of human umbilical cord blood-derived multipotent stem cells (hUCB-MSCs) and increased p16(INK4A) and p21(CIP1/WAF1) expression. DNMT inhibition changed histone marks into the active forms and decreased the methylation of CpG islands in the p16(INK4A) and p21(CIP1/WAF1) promoter regions. Enrichment of EZH2, the key factor that methylates histone H3 lysine 9 and 27 residues, was decreased on the p16(INK4A) and p21(CIP1/WAF1) promoter regions. We found that DNMT inhibition decreased expression levels of Polycomb-group (PcG) proteins and increased expression of microRNAs (miRNAs), which target PcG proteins. Decreased CpG island methylation and increased levels of active histone marks at genomic regions encoding miRNAs were observed after 5-AzaC treatment. Taken together, DNMTs have a critical role in regulating the cellular senescence of hUCB-MSCs through controlling not only the DNA methylation status but also active/inactive histone marks at genomic regions of PcG-targeting miRNAs and p16(INK4A) and p21(CIP1/WAF1) promoter regions.	[So, Ah-Young; Lee, Seunghee; Kim, Hyung-Sik; Kang, Kyung-Sun] Seoul Natl Univ, Adult Stem Cell Res Ctr, Coll Vet Med, Seoul, South Korea; [So, Ah-Young; Lee, Seunghee; Kim, Hyung-Sik; Kang, Kyung-Sun] Seoul Natl Univ, Dept Vet Publ Hlth, Coll Vet Med, Seoul, South Korea; [So, Ah-Young; Lee, Seunghee; Kim, Hyung-Sik; Kang, Kyung-Sun] Seoul Natl Univ, Res Inst Vet Sci, Coll Vet Med, Seoul, South Korea; [Jung, Ji-Won] Korea Natl Inst Hlth, Div Intractable Dis, Ctr Biomed Sci, Chungbuk, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science	So, AY (corresponding author), Seoul Natl Univ, Adult Stem Cell Res Ctr, Coll Vet Med, Seoul, South Korea.	kangpub@snu.ac.kr	Kang, Kyung-Sun/G-6205-2013		National Research Foundation of Korea (NRF) [2010-0020265]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) (MEST, 2010-0020265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2001, GYNECOL ONCOL, V82, P299, DOI 10.1006/gyno.2001.6284; Allan LA, 2000, MOL CELL BIOL, V20, P1291, DOI 10.1128/MCB.20.4.1291-1298.2000; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Banerjee S, 2010, EXP CELL RES, V316, P172, DOI 10.1016/j.yexcr.2009.08.011; Barh D, 2010, CURR ONCOL, V17, P70; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Casillas MA, 2003, MOL CELL BIOCHEM, V252, P33, DOI 10.1023/A:1025548623524; Chen Chun-ling, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P770; Cheng H., 2010, MOL BIOL REP; Datta J, 2003, J CELL BIOCHEM, V88, P855, DOI 10.1002/jcb.10457; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fabbri M, 2010, ADV GENET, V70, P87, DOI [10.1016/S0065-2660(10)70004-3, 10.1016/B978-0-12-380866-0.60004-6]; Fandy TE, 2009, CURR MED CHEM, V16, P2075, DOI 10.2174/092986709788612738; Fang JY, 2004, CHINESE MED J-PEKING, V117, P99; Fang JY, 2002, WORLD J GASTROENTERO, V8, P400, DOI 10.3748/wjg.v8.i3.400; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; HUPKES M, 2011, BIOCH BIOPHYS ACTA; IMAM JS, ONCOGENE; Jin BL, 2009, CANCER RES, V69, P7412, DOI 10.1158/0008-5472.CAN-09-0116; Jori FP, 2005, J CELL BIOCHEM, V94, P645, DOI 10.1002/jcb.20315; Jorl FP, 2005, CELL DEATH DIFFER, V12, P65, DOI 10.1038/sj.cdd.4401499; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Jung JW, 2010, CELL MOL LIFE SCI, V67, P1165, DOI 10.1007/s00018-009-0242-9; Jung JW, 2005, CANCER LETT, V225, P199, DOI 10.1016/j.canlet.2004.11.029; KOMASHKO VM, EPIGENETICS, V5; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; LEE S, CELL MOL LIFE SCI; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Li Y, 2010, CURR MED CHEM, V17, P2141, DOI 10.2174/092986710791299966; Lin TS, 2005, CANCER LETT, V226, P77, DOI 10.1016/j.canlet.2004.12.031; Lopatina N, 2002, J CELL BIOCHEM, V84, P324, DOI 10.1002/jcb.10015; MAHPATRA S, ETHN DIS, V20; Majumder S, 2002, J BIOL CHEM, V277, P16048, DOI 10.1074/jbc.M111662200; Milutinovic S, 2000, J BIOL CHEM, V275, P6353, DOI 10.1074/jbc.275.9.6353; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Orciani M, 2011, J BIOL REG HOMEOS AG, V25, P115; Park JR, 2008, CELL PROLIFERAT, V41, P859, DOI 10.1111/j.1365-2184.2008.00565.x; Patra SK, 2002, MOL CARCINOGEN, V33, P163, DOI 10.1002/mc.10033; Pignolo RJ, 2008, AGING CELL, V7, P23, DOI 10.1111/j.1474-9726.2007.00350.x; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Rong QF, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-36; ROSCA AM, 2011, STEM CELLS DEV; Saito Y, 2006, CELL CYCLE, V5, P2220, DOI 10.4161/cc.5.19.3340; Schneider-Stock R, 2007, IDRUGS, V10, P557; Seo KW, 2009, BIOCHEM BIOPH RES CO, V384, P120, DOI 10.1016/j.bbrc.2009.04.094; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shin JY, 2000, CANCER RES, V60, P262; Soleimani M, 2010, INT J DEV BIOL, V54, P1295, DOI 10.1387/ijdb.092999ms; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Su Yu, 2009, Yichuan, V31, P1087, DOI 10.3724/SP.J.1005.2009.01087; Takeuchi S, 2010, CANCER RES, V70, P9381, DOI 10.1158/0008-5472.CAN-10-0801; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Valeri N, 2009, MAMM GENOME, V20, P573, DOI 10.1007/s00335-009-9206-5; VINKEN M, TOXICOL IN VITRO, V24, P445; VRBA L, PLOS ONE, V5, pE8697; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; Wang HJ, EUR J CANC, V46, P2295; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; XU C, EUR J CANC; Xu WR, 2004, EXP BIOL MED, V229, P623, DOI 10.1177/153537020422900706; Young JI, 2001, J BIOL CHEM, V276, P19610, DOI 10.1074/jbc.M009470200; Yuan Yan, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P170; Zardo G, 2005, CELL RES, V15, P679, DOI 10.1038/sj.cr.7290337; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x	69	121	128	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19503	10.1371/journal.pone.0019503	http://dx.doi.org/10.1371/journal.pone.0019503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572997	Green Submitted, gold, Green Published			2022-12-25	WOS:000290440200009
J	Spear, GT; Kendrick, SR; Chen, HY; Thomas, TT; Bahk, M; Balderas, R; Ghosh, S; Weinberg, A; Landay, AL				Spear, Gregory T.; Kendrick, Sabrina R.; Chen, Hua Y.; Thomas, Tin T.; Bahk, Mieoak; Balderas, Robert; Ghosh, Santosh; Weinberg, Aaron; Landay, Alan L.			Multiplex Immunoassay of Lower Genital Tract Mucosal Fluid from Women Attending an Urban STD Clinic Shows Broadly Increased IL1 beta and Lactoferrin	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; BACTERIAL-VAGINOSIS; INNATE IMMUNITY; INFLAMMATORY CYTOKINES; PREGNANT-WOMEN; CERVICAL-MUCUS; ACTIVATION; MARKERS; PROTEIN; CELLS	Background: More than one million new cases of sexually transmitted diseases (STDs) occur each day. The immune responses and inflammation induced by STDs and other frequent non-STD microbial colonizations (i.e. Candida and bacterial vaginosis) can have serious pathologic consequences in women including adverse pregnancy outcomes, infertility and increased susceptibility to infection by other pathogens. Understanding the types of immune mediators that are elicited in the lower genital tract by these infections/colonizations can give important insights into the innate and adaptive immune pathways that are activated and lead to strategies for preventing pathologic effects. Methodology/Principal Findings: 32 immune mediators were measured by multiplexed immunoassays to assess the immune environment of the lower genital tract mucosa in 84 women attending an urban STD clinic. IL-3, IL-1 beta, VEGF, angiogenin, IL-8, beta 2Defensin and beta 3Defensin were detected in all subjects, Interferon-a was detected in none, while the remaining mediators were detected in 40% to 93% of subjects. Angiogenin, VEGF, FGF, IL-9, IL-7, lymphotoxin-alpha and IL-3 had not been previously reported in genital mucosal fluid from women. Strong correlations were observed between levels of TNF-alpha, IL-1 beta and IL-6, between chemokines IP-10 and MIG and between myeloperoxidase, IL-8 and G-CSF. Samples from women with any STD/colonization had significantly higher levels of IL-8, IL-3, IL-7, IL-1 beta, lactoferrin and myeloperoxidase. IL-1 beta and lactoferrin were significantly increased in gonorrhea, Chlamydia, cervicitis, bacterial vaginosis and trichomoniasis. Conclusions/Significance: These studies show that mucosal fluid in general appears to be an environment that is rich in immune mediators. Importantly, IL-1 beta and lactoferrin are biomarkers for STDs/colonizations providing insights into immune responses and pathogenesis at this mucosal site.	[Spear, Gregory T.; Landay, Alan L.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Kendrick, Sabrina R.; Thomas, Tin T.; Bahk, Mieoak] John H Stroger Jr Hosp Cook Cty, Dept Med, Chicago, IL USA; [Kendrick, Sabrina R.] Ruth M Rothstein CORE Ctr, Chicago, IL USA; [Chen, Hua Y.] Univ Illinois, Div Epidemiol & Biostat, Chicago, IL USA; [Balderas, Robert] BD Biosci, San Diego, CA USA; [Ghosh, Santosh; Weinberg, Aaron] Case Sch Dent Med, Dept Biol Sci, Cleveland, OH USA	Rush University; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Case Western Reserve University	Spear, GT (corresponding author), Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA.	gspear@rush.edu	Ghosh, Santosh K/I-5461-2019	Ghosh, Santosh K/0000-0001-5669-7853; Weinberg, Aaron/0000-0002-9960-7181	Rush University Translational Science Consortium; NIH [P01HD40539]; BD Biosciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD040539] Funding Source: NIH RePORTER	Rush University Translational Science Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BD Biosciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Financial support for this work was provided by a Rush University Translational Science Consortium Pilot award and by NIH Grant P01HD40539. BD Biosciences is also a funder since it provided the salary of author RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except that author RB had a role in the conceiving and designing of the experiments, and in the interpretation of the results.	Agrawal T, 2009, CLIN MICROBIOL INFEC, V15, P50, DOI 10.1111/j.1469-0691.2008.02113.x; Capitini CM, 2009, J INTERN MED, V266, P141, DOI 10.1111/j.1365-2796.2009.02085.x; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Culhane JF., 2007, AM J OBSTET GYNECOL, V196; Cummins JE, 2006, AIDS RES HUM RETROV, V22, P788, DOI 10.1089/aid.2006.22.788; Farnaud S, 2003, MOL IMMUNOL, V40, P395, DOI 10.1016/S0161-5890(03)00152-4; Frantz S, 2005, CIRC RES, V96, P15, DOI 10.1161/01.RES.0000153188.68898.ac; Ghosh SK, 2007, CLIN CHEM, V53, P757, DOI 10.1373/clinchem.2006.081430; Goldenherg RL, 2000, AM J OBSTET GYNECOL, V182, P631, DOI 10.1067/mob.2000.104211; Hedges SR, 1998, J INFECT DIS, V178, P742, DOI 10.1086/515372; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Imseis HM, 1997, J SOC GYNECOL INVEST, V4, P90, DOI 10.1016/S1071-5576(97)00003-8; Keller MJ, 2006, AM J REPROD IMMUNOL, V56, P356, DOI 10.1111/j.1600-0897.2006.00436.x; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Lieberman JA, 2008, CLIN VACCINE IMMUNOL, V15, P49, DOI 10.1128/CVI.00216-07; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mattsby-Baltzer I, 1998, ACTA OBSTET GYN SCAN, V77, P701, DOI 10.1034/j.1600-0412.1998.770701.x; Mayaud P, 2004, SEX TRANSM INFECT, V80, P174, DOI 10.1136/sti.2002.004101; Novak RM, 2007, CLIN VACCINE IMMUNOL, V14, P1102, DOI 10.1128/CVI.00386-06; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Rein MF, 1996, SEX TRANSM DIS, V23, P517, DOI 10.1097/00007435-199611000-00014; Sawada M, 2006, INT J GYNECOL OBSTET, V92, P117, DOI 10.1016/j.ijgo.2005.10.004; Simhan HN, 2007, AM J OBSTET GYNECOL, V196, P59, DOI 10.1016/j.ajog.2006.08.035; Sobel JD, 1998, AM J OBSTET GYNECOL, V178, P203, DOI 10.1016/S0002-9378(98)80001-X; SOUKKA T, 1992, FEMS MICROBIOL LETT, V90, P223, DOI 10.1111/j.1574-6968.1992.tb05156.x; St John Elizabeth, 2007, Curr HIV/AIDS Rep, V4, P22, DOI 10.1007/s11904-007-0004-y; Sulak PJ, 2003, SEMIN REPROD MED, V21, P399; Trifonova RT, 2007, BIOMARKERS, V12, P608, DOI 10.1080/13547500701600670; van der Strate BWA, 2001, ANTIVIR RES, V52, P225, DOI 10.1016/S0166-3542(01)00195-4; Wald A, 2003, J INFECT DIS, V188, P1345, DOI 10.1086/379043; Ward PP, 2005, CELL MOL LIFE SCI, V62, P2540, DOI 10.1007/s00018-005-5369-8; WIRA CR, 2010, AM J REPROD IMMUNOL	34	36	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19560	10.1371/journal.pone.0019560	http://dx.doi.org/10.1371/journal.pone.0019560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572958	Green Published, gold, Green Submitted			2022-12-25	WOS:000290440200011
J	Brun, ME; Lana, E; Rivals, I; Lefranc, G; Sarda, P; Claustres, M; Megarbane, A; De Sario, A				Brun, Marie-Elisabeth; Lana, Erica; Rivals, Isabelle; Lefranc, Gerard; Sarda, Pierre; Claustres, Mireille; Megarbane, Andre; De Sario, Albertina			Heterochromatic Genes Undergo Epigenetic Changes and Escape Silencing in Immunodeficiency, Centromeric Instability, Facial Anomalies (ICF) Syndrome	PLOS ONE			English	Article							DNA METHYLTRANSFERASE GENE; MAMMALIAN DEVELOPMENT; DNMT3B MUTATIONS; POTE PARALOGS; METHYLATION; HUMAN-CHROMOSOME-21; EXPRESSION; HYPOMETHYLATION; REGIONS; DYSREGULATION	Immunodeficiency, Centromeric Instability, Facial Anomalies (ICF) syndrome is a rare autosomal recessive disorder that is characterized by a marked immunodeficiency, severe hypomethylation of the classical satellites 2 and 3 associated with disruption of constitutive heterochromatin, and facial anomalies. Sixty percent of ICF patients have mutations in the DNMT3B (DNA methyltransferase 3B) gene, encoding a de novo DNA methyltransferase. In the present study, we have shown that, in ICF lymphoblasts and peripheral blood, juxtacentromeric heterochromatic genes undergo dramatic changes in DNA methylation, indicating that they are bona fide targets of the DNMT3B protein. DNA methylation in heterochromatic genes dropped from about 80% in normal cells to approximately 30% in ICF cells. Hypomethylation was observed in five ICF patients and was associated with activation of these silent genes. Although DNA hypomethylation occurred in all the analyzed heterochromatic genes and in all the ICF patients, gene expression was restricted to some genes, every patient having his own group of activated genes. Histone modifications were preserved in ICF patients. Heterochromatic genes were associated with histone modifications that are typical of inactive chromatin: they had low acetylation on H3 and H4 histones and were slightly enriched in H3K9Me(3), both in ICF and controls. This was also the case for those heterochromatic genes that escaped silencing. This finding suggests that gene activation was not generalized to all the cells, but rather was restricted to a clonal cell population that may contribute to the phenotypic variability observed in ICF syndrome. A slight increase in H3K27 monomethylation was observed both in heterochromatin and active euchromatin in ICF patients; however, no correlation between this modification and activation of heterochromatic genes was found.	[Brun, Marie-Elisabeth; Lefranc, Gerard] CNRS, UPR 1142, Montpellier, France; [Lana, Erica; Claustres, Mireille; De Sario, Albertina] INSERM, U827, Montpellier, France; [Lana, Erica; Claustres, Mireille; De Sario, Albertina] Univ Montpellier 1, Montpellier, France; [Rivals, Isabelle] ESPCI ParisTech, Paris, France; [Lefranc, Gerard] Univ Montpellier 2, Montpellier, France; [Sarda, Pierre; Claustres, Mireille] CHRU, Montpellier, France; [Megarbane, Andre] St Joseph Univ, Fac Med, Unite Genet Med, Beirut, Lebanon; [Megarbane, Andre] St Joseph Univ, Fac Med, Lab Assoc, INSERM,UMR S910, Beirut, Lebanon; [Megarbane, Andre] Inst Jerome Lejeune, Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm)	Brun, ME (corresponding author), CNRS, UPR 1142, Montpellier, France.	albertina.de-sario@inserm.fr	Megarbane, Andre/ABD-5574-2021; Rivals, Isabelle/AAE-7971-2022	Rivals, Isabelle/0000-0002-8736-7010; DE SARIO, Albertina/0000-0002-9997-1645	Fondation Jerome Lejeune; Association pour la Recherche sur le Cancer; Saint Joseph University; Fondation pour la Recherche Medicale	Fondation Jerome Lejeune; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Saint Joseph University; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Fondation Jerome Lejeune (http://subvention.fondationlejeune.org/subvention/index.aspx), by the Association pour la Recherche sur le Cancer (http://www.arc-cancer.net/) and by grants from the Saint Joseph University. E. L. was supported by the Fondation Jerome Lejeune and the Fondation pour la Recherche Medicale (http://www.frm.org/chercheurs.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bera TK, 2008, STEM CELLS DEV, V17, P325, DOI 10.1089/scd.2007.0079; Bera TK, 2006, CANCER RES, V66, P52, DOI 10.1158/0008-5472.CAN-05-3014; Blanco-Betancourt CE, 2004, BLOOD, V103, P2683, DOI 10.1182/blood-2003-08-2632; Brun ME, 2003, GENE, V312, P41, DOI 10.1016/S0378-1119(03)00530-4; DEAR S, 1991, NUCLEIC ACIDS RES, V19, P3907, DOI 10.1093/nar/19.14.3907; Ehrlich M, 2001, HUM MOL GENET, V10, P2917, DOI 10.1093/hmg/10.25.2917; Ehrlich M, 2008, AUTOIMMUNITY, V41, P253, DOI 10.1080/08916930802024202; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gartler SM, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-21; Gopalakrishnan S, 2009, HUM MOL GENET, V18, P3178, DOI 10.1093/hmg/ddp256; Grunau C, 2005, GENE CHROMOSOME CANC, V43, P11, DOI 10.1002/gcc.20155; Grunau C, 2000, NUCLEIC ACIDS RES, V28, P1053, DOI 10.1093/nar/28.5.1053; Grunau C, 2006, GENOME RES, V16, P1198, DOI 10.1101/gr.5440306; Hahn Y, 2006, GENE, V366, P238, DOI 10.1016/j.gene.2005.07.045; Hansen RS, 2000, HUM MOL GENET, V9, P2575, DOI 10.1093/hmg/9.18.2575; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Ise T, 2008, BIOCHEM BIOPH RES CO, V365, P603, DOI 10.1016/j.bbrc.2007.10.195; Jiang YL, 2005, HUM MUTAT, V25, P56, DOI 10.1002/humu.20113; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; Kondo T, 2000, HUM MOL GENET, V9, P597, DOI 10.1093/hmg/9.4.597; Miniou P, 1997, CYTOGENET CELL GENET, V77, P308, DOI 10.1159/000134605; Miniou P, 1997, HUM GENET, V99, P738, DOI 10.1007/s004390050441; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Ruault M, 2003, GENOMICS, V81, P391, DOI 10.1016/S0888-7543(03)00025-9; Ruault M, 2002, EUR J HUM GENET, V10, P833, DOI 10.1038/sj.ejhg.5200891; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tapparel C, 2003, GENE, V323, P189, DOI 10.1016/j.gene.2003.09.038; Ueda Y, 2006, DEVELOPMENT, V133, P1183, DOI 10.1242/dev.02293; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yehezkel S, 2008, HUM MOL GENET, V17, P2776, DOI 10.1093/hmg/ddn177	37	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19464	10.1371/journal.pone.0019464	http://dx.doi.org/10.1371/journal.pone.0019464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559330	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700186
J	Jham, BC; Ma, T; Hu, JD; Chaisuparat, R; Friedman, ER; Pandolfi, PP; Schneider, A; Sodhi, A; Montaner, S				Jham, Bruno C.; Ma, Tao; Hu, Jiadi; Chaisuparat, Risa; Friedman, Eitan R.; Pandolfi, Pier Paolo; Schneider, Abraham; Sodhi, Akrit; Montaner, Silvia			Amplification of the Angiogenic Signal through the Activation of the TSC/mTOR/HIF Axis by the KSHV vGPCR in Kaposi's Sarcoma	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; PARACRINE NEOPLASIA; TUBEROUS SCLEROSIS; CHEMOKINE RECEPTOR; TUMOR ANGIOGENESIS; FACTOR EXPRESSION; VIRAL ONCOGENE; HERPESVIRUS	Background: Kaposi's sarcoma (KS) is a vascular neoplasm characterized by the dysregulated expression of angiogenic and inflammatory cytokines. The driving force of the KS lesion, the KSHV-infected spindle cell, secretes elevated levels of vascular endothelial growth factor (VEGF), essential for KS development. However, the origin of VEGF in this tumor remains unclear. Methodology/Principal Findings: Here we report that the KSHV G protein-coupled receptor (vGPCR) upregulates VEGF in KS through an intricate paracrine mechanism. The cytokines secreted by the few vGPCR-expressing tumor cells activate in neighboring cells multiple pathways (including AKT, ERK, p38 and IKK beta) that, in turn, converge on TSC1/2, promoting mTOR activation, HIF upregulation, and VEGF secretion. Conditioned media from vGPCR-expressing cells lead to an mTOR-dependent increase in HIF-1 alpha and HIF-2 alpha protein levels and VEGF upregulation. In a mouse allograft model for KS, specific inhibition of the paracrine activation of mTOR in non-vGPCR-expressing cells was sufficient to inhibit HIF upregulation in these cells, and abolished the ability of the vGPCR-expressing cells to promote tumor formation in vivo. Similarly, pharmacologic inhibition of HIF in this model blocked VEGF secretion and also lead to tumor regression. Conclusions/Significance: Our findings provide a compelling explanation for how the few tumor cells expressing vGPCR can contribute to the dramatic amplification of VEGF secretion in KS, and further provide a molecular mechanism for how cytokine dysregulation in KS fuels angiogenesis and tumor development. These data further suggest that activation of HIF by vGPCR may be a vulnerable target for the treatment of patients with KS.	[Jham, Bruno C.; Ma, Tao; Hu, Jiadi; Chaisuparat, Risa; Friedman, Eitan R.; Schneider, Abraham; Montaner, Silvia] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Montaner, Silvia] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Schneider, Abraham; Montaner, Silvia] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Canc Genet Program, Dept Med,Med Sch, Boston, MA 02215 USA; [Sodhi, Akrit] Johns Hopkins Univ, Wilmer Eye Inst, Johns Hopkins Sch Med, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine	Jham, BC (corresponding author), Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA.	smontaner@umaryland.edu	Jham, Bruno/F-1596-2013; Schneider, Abraham/AAR-5941-2021	Pandolfi, Pier Paolo/0000-0002-5352-5295	National Cancer Institute, National Institutes of Health [R01CA119911]; CNPq-Brazil; NATIONAL CANCER INSTITUTE [R01CA119911] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R01CA119911 (National Cancer Institute, National Institutes of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Gary S. Hayward for kindly providing the specific antibody recognizing KSHV vGPCR. BCJ is a recipient of a predoctoral fellowship from the CNPq-Brazil. We thank Xin Wang for her help with the immunohistochemistry experiments.	Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Bais C, 2003, CANCER CELL, V3, P131, DOI 10.1016/S1535-6108(03)00024-2; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Brinkmann MM, 2003, J VIROL, V77, P9346, DOI 10.1128/JVI.77.17.9346-9358.2003; Brown LF, 1996, AM J PATHOL, V148, P1065; Cai QL, 2006, PLOS PATHOG, V2, P1002, DOI 10.1371/journal.ppat.0020116; Cai Q, 2007, J VIROL, V81, P10413, DOI 10.1128/JVI.00611-07; Campistol JM, 2004, TRANSPLANTATION, V77, P760, DOI 10.1097/01.TP.0000115344.18025.0B; Carroll PA, 2006, J VIROL, V80, P10802, DOI 10.1128/JVI.00673-06; Catrina SB, 2006, CLIN CANCER RES, V12, P4506, DOI 10.1158/1078-0432.CCR-05-2473; Cesarman E, 2000, J EXP MED, V191, P417, DOI 10.1084/jem.191.3.417; Cesarman E, 1996, J VIROL, V70, P8218, DOI 10.1128/JVI.70.11.8218-8223.1996; Cornali E, 1996, AM J PATHOL, V149, P1851; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guo HG, 2003, J VIROL, V77, P2631, DOI 10.1128/JVI.77.4.2631-2639.2003; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jensen KK, 2005, J IMMUNOL, V174, P3686, DOI 10.4049/jimmunol.174.6.3686; Jham BC, 2010, J CELL BIOCHEM, V110, P1, DOI 10.1002/jcb.22524; Lee DF, 2007, CELL CYCLE, V6, P3011, DOI 10.4161/cc.6.24.5085; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Martin D, 2008, ONCOGENE, V27, P1844, DOI [10.1038/sj.onc.1210817, 10.1038/onc.2009.351]; Masood R, 1997, P NATL ACAD SCI USA, V94, P979, DOI 10.1073/pnas.94.3.979; McCormick C, 2005, SCIENCE, V307, P739, DOI 10.1126/science.1105779; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Montaner S, 2006, CANCER RES, V66, P168, DOI 10.1158/0008-5472.CAN-05-1026; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535-6108(02)00237-4; Montaner S, 2004, BLOOD, V104, P2903, DOI 10.1182/blood-2003-12-4436; Nakamura S, 1997, J IMMUNOL, V158, P4992; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; ROSENBERG ZF, 1988, ANN NY ACAD SCI, V546, P164, DOI 10.1111/j.1749-6632.1988.tb21631.x; Sakakibara S, 2009, J VIROL, V83, P2140, DOI 10.1128/JVI.01871-08; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shin YC, 2008, CANCER RES, V68, P1751, DOI 10.1158/0008-5472.CAN-07-2766; Sodhi A, 2000, CANCER RES, V60, P4873; Sodhi A, 2006, CANCER CELL, V10, P133, DOI 10.1016/j.ccr.2006.05.026; Stallone G, 2005, NEW ENGL J MED, V352, P1317, DOI 10.1056/NEJMoa042831; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Tomlinson CC, 2004, J VIROL, V78, P1918, DOI 10.1128/JVI.78.4.1918-1927.2004; WEINDEL K, 1992, BIOCHEM BIOPH RES CO, V183, P1167, DOI 10.1016/S0006-291X(05)80313-4; Yang TY, 2000, J EXP MED, V191, P445, DOI 10.1084/jem.191.3.445; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105	47	47	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19103	10.1371/journal.pone.0019103	http://dx.doi.org/10.1371/journal.pone.0019103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559457	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700065
J	Joshi, DC; Bakowska, JC				Joshi, Dinesh C.; Bakowska, Joanna C.			SPG20 Protein Spartin Associates with Cardiolipin via Its Plant-Related Senescence Domain and Regulates Mitochondrial Ca2+ Homeostasis	PLOS ONE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ALPHA-SYNUCLEIN; TROYER-SYNDROME; OXIDATIVE STRESS; CELL-DEATH; CALCIUM; MEMBRANE; IDENTIFICATION; TRANSLOCATION; LOCALIZATION	Hereditary spastic paraplegias (HSPs) are a group of neurological disorders characterized clinically by spasticity of lower limbs and pathologically by degeneration of the corticospinal tract. Troyer syndrome is an autosomal recessive HSP caused by a frameshift mutation in the spartin (SPG20) gene. Previously, we established that this mutation results in a lack of expression of the truncated mutant spartin protein. Spartin is involved in many cellular processes and associates with several intracellular organelles, including mitochondria. Spartin contains a conserved plant-related senescence domain at its C-terminus. However, neither the function of this domain nor the roles of spartin in mitochondrial physiology are currently known. In this study, we determined that the plant-related senescence domain of spartin interacts with cardiolipin but not with two other major mitochondrial phospholipids, phosphatidylcholine and phosphatidylethanolamine. We also found that knockdown of spartin by small interfering RNA in a human neuroblastoma cell line resulted in depolarization of the mitochondrial membrane. In addition, depletion of spartin resulted in a significant decrease in both mitochondrial calcium uptake and mitochondrial membrane potential in cells treated with thapsigargin. Our results suggest that impairment of mitochondrial calcium uptake might contribute to the neurodegeneration of long corticospinal axons and the pathophysiology of Troyer syndrome.	[Joshi, Dinesh C.; Bakowska, Joanna C.] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL USA	Loyola University Chicago	Joshi, DC (corresponding author), Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL USA.	jbakowska@lumc.edu		Joshi, Dinesh/0000-0003-1158-7890	National Institutes of Health [K22NS050137]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K22NS050137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (grant number K22NS050137 to J.C.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aromolaran AS, 2007, AM J PHYSIOL-CELL PH, V293, pC106, DOI 10.1152/ajpcell.00543.2006; Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112; Bakowska JC, 2005, BIOCHEM BIOPH RES CO, V334, P1042, DOI 10.1016/j.bbrc.2005.06.201; Bakowska JC, 2008, ARCH NEUROL-CHICAGO, V65, P520, DOI 10.1001/archneur.65.4.520; Bakowska JC, 2007, MOL BIOL CELL, V18, P1683, DOI 10.1091/mbc.E06-09-0833; Cabiscol E, 2002, J BIOL CHEM, V277, P44531, DOI 10.1074/jbc.M206525200; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Casari G, 2001, CURR OPIN GENET DEV, V11, P336, DOI 10.1016/S0959-437X(00)00199-4; Chen JS, 2002, J CELL BIOCHEM, V86, P784, DOI 10.1002/jcb.10266; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Cole NB, 2008, EXP CELL RES, V314, P2076, DOI 10.1016/j.yexcr.2008.03.012; Crosby AH, 2002, AM J HUM GENET, V71, P1009, DOI 10.1086/344206; CROSS HE, 1967, ARCH NEUROL-CHICAGO, V16, P473, DOI 10.1001/archneur.1967.00470230025003; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; deKroon AIPM, 1997, BBA-BIOMEMBRANES, V1325, P108, DOI 10.1016/S0005-2736(96)00240-4; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Eastman SW, 2009, J CELL BIOL, V184, P881, DOI 10.1083/jcb.200808041; Edwards TL, 2009, BIOCHEM J, V423, P31, DOI 10.1042/BJ20082398; FARKAS DL, 1989, BIOPHYS J, V56, P1053, DOI 10.1016/S0006-3495(89)82754-7; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gizatullina ZZ, 2006, ANN NEUROL, V59, P407, DOI 10.1002/ana.20754; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hooper C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-72; JOSHI DC, 2011, J VIS EXP IN PRESS; Kerbiriou M, 2007, BBA-MOL BASIS DIS, V1772, P1236, DOI 10.1016/j.bbadis.2007.10.004; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; Lu J, 2006, J NEUROCHEM, V98, P1908, DOI 10.1111/j.1471-4159.2006.04008.x; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Manfredi G, 2005, MITOCHONDRION, V5, P77, DOI 10.1016/j.mito.2005.01.002; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Marks JD, 2005, J NEUROSCI, V25, P6561, DOI 10.1523/JNEUROSCI.1450-05.2005; Mehta B, 2008, J GEN PHYSIOL, V132, P339, DOI 10.1085/jgp.200810043; Milakovic T, 2006, J BIOL CHEM, V281, P34785, DOI 10.1074/jbc.M603845200; Milewska M, 2009, J NEUROCHEM, V111, P1022, DOI 10.1111/j.1471-4159.2009.06382.x; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937; Ramakrishnan M, 2003, BIOCHEMISTRY-US, V42, P12919, DOI 10.1021/bi035048e; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; Robay D, 2006, EXP CELL RES, V312, P2764, DOI 10.1016/j.yexcr.2006.05.003; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200	54	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19290	10.1371/journal.pone.0019290	http://dx.doi.org/10.1371/journal.pone.0019290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559443	Green Submitted, gold, Green Published			2022-12-25	WOS:000290024700125
J	Liu, CH; Li, L; Chen, Z; Wang, Q; Hu, YL; Zhu, BL; Woo, PCY				Liu, Cui Hua; Li, Ling; Chen, Zhi; Wang, Qi; Hu, Yong Liang; Zhu, Baoli; Woo, Patrick C. Y.			Characteristics and Treatment Outcomes of Patients with MDR and XDR Tuberculosis in a TB Referral Hospital in Beijing: A 13-Year Experience	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; RISK-FACTORS	Background: Information on treatment outcomes among hospitalized patients with multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) are scarce in China. Methodology/Principal Findings: We conducted this retrospective study to analyze the characteristics and treatment outcomes in MDR- and XDR-TB patients in the 309 Hospital in Beijing, China during 1996-2009. Socio-demographic and clinical data were retrieved from medical records and analyzed. Logistic regression analysis was performed to identify risk factors associated with poor treatment outcomes and Cox proportional hazards regression model was further used to determine risk factors associated with death in TB patients. Among the 3,551 non-repetitive hospitalized TB patients who had drug susceptibility testing (DST) results, 716 (20.2%) had MDR-TB and 51 (1.4%) had XDR-TB. A total of 3,270 patients who had medical records available were used for further analyses. Treatment success rates (cured and treatment completed) were 90.9%, 53.4% and 29.2% for patients with non-MDR-TB, patients with MDR-TB excluding XDR-TB and patients with XDR-TB, respectively. Independent risk factors associated with poor treatment outcomes in MDR-TB patients included being a migrant (adjusted OR = 1.77), smear-positivity at treatment onset (adjusted OR = 1.94) and not receiving 3 or more potentially effective drugs (adjusted OR = 3.87). Independent risk factors associated with poor treatment outcomes in XDR-TB patients were smear-positivity at treatment onset (adjusted OR = 10.42) and not receiving 3 or more potentially effective drugs (adjusted OR = 14.90). The independent risk factors associated with death in TB patients were having chronic obstructive pulmonary disease (adjusted HR = 5.25) and having hypertension (adjusted HR = 4.31). Conclusions/Significance: While overall satisfactory treatment success for non-MDR-TB patients was achieved, more intensive efforts should be made to better manage MDR-and XDR-TB cases in order to improve their treatment outcomes and to minimize further emergence of so-called totally drug-resistant TB cases.	[Liu, Cui Hua; Wang, Qi; Zhu, Baoli] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Liu, Cui Hua; Chen, Zhi; Hu, Yong Liang] 309 Hosp, Inst TB Res, Beijing, Peoples R China; [Li, Ling] So Med Univ, Inst Genet Engn, Guangzhou, Guangdong, Peoples R China; [Woo, Patrick C. Y.] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Southern Medical University - China; University of Hong Kong	Liu, CH (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	cuihualiu@gmail.com; zhubaoli@im.ac.cn; pcywoo@hkucc.hku.hk	Woo, Patrick Chiu Yat/C-4449-2009	Woo, Patrick Chiu Yat/0000-0001-9401-1832	309 Hospital, Beijing, China [09QD01]; State Key Development Program for Basic Research of China, China [2009CB522605]; Chinese Academy of Sciences [KSCX2-EW-J-6, KSCX2-YW-R-164]	309 Hospital, Beijing, China; State Key Development Program for Basic Research of China, China(State Key Development Program for Basic Research of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research project received funding from the Start-up Grant of the 309 Hospital, Beijing, China (09QD01) and the State Key Development Program for Basic Research of China, China (2009CB522605). This work was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-6 and KSCX2-YW-R-164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beijing Municipal Bureau of Statistics, 2007, BEIJ STAT YB 2007; Bonilla Cesar A, 2008, PLoS One, V3, pe2957, DOI 10.1371/journal.pone.0002957; Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55, P1176; Chan ED, 2008, CURR OPIN INFECT DIS, V21, P587, DOI 10.1097/QCO.0b013e328319bce6; Chen XY, 2004, LANCET, V364, P417; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Eker B, 2008, EMERG INFECT DIS, V14, P1700, DOI 10.3201/eid1411.080729; Fan H, 2010, PLOS ONE, V5; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; Jeon CY, 2008, CLIN INFECT DIS, V46, P42, DOI 10.1086/524017; Jia ZW, 2008, EMERG INFECT DIS, V14, P1413, DOI [10.3201/1409.071543, 10.3201/eid1409.071543]; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kim DH, 2008, AM J RESP CRIT CARE, V178, P1075, DOI 10.1164/rccm.200801-132OC; Kliiman K, 2009, EUR RESPIR J, V33, P1085, DOI 10.1183/09031936.00155708; Lai CC, 2008, CLIN INFECT DIS, V47, pE57, DOI 10.1086/591702; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; LoBue P, 2009, CURR OPIN INFECT DIS, V22, P167, DOI 10.1097/QCO.0b013e3283229fab; Migliori GB, 2008, EUR RESPIR J, V31, P904, DOI 10.1183/09031936.00159807; Shah NS, 2008, JAMA-J AM MED ASSOC, V300, P2153, DOI 10.1001/jama.300.18.2153; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; Vashakidze L, 2009, INT J TUBERC LUNG D, V13, P1148; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Wei XL, 2009, TROP MED INT HEALTH, V14, P754, DOI 10.1111/j.1365-3156.2009.02286.x; WHO, 2010, MULT EXT DRUG RES TU; [WHO IUATLD], 2009, 4 WHO IUATLD; World Health Organization, 2008, WHOHTMTB2008402; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370	35	42	48	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19399	10.1371/journal.pone.0019399	http://dx.doi.org/10.1371/journal.pone.0019399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559362	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700158
J	Losada, L; Varga, JJ; Hostetler, J; Radune, D; Kim, M; Durkin, S; Schneewind, O; Nierman, WC				Losada, Liliana; Varga, John J.; Hostetler, Jessica; Radune, Diana; Kim, Maria; Durkin, Scott; Schneewind, Olaf; Nierman, William C.			Genome Sequencing and Analysis of Yersina pestis KIM D27, an Avirulent Strain Exempt from Select Agent Regulation	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; PASTEURELLA PESTIS; IDENTIFICATION; REPEATS; PLAGUE	Yersinia pestis is the causative agent of the plague. Y. pestis KIM 10+ strain was passaged and selected for loss of the 102 kb pgm locus, resulting in an attenuated strain, KIM D27. In this study, whole genome sequencing was performed on KIM D27 in order to identify any additional differences. Initial assemblies of 454 data were highly fragmented, and various bioinformatic tools detected between 15 and 465 SNPs and INDELs when comparing both strains, the vast majority associated with A or T homopolymer sequences. Consequently, Illumina sequencing was performed to improve the quality of the assembly. Hybrid sequence assemblies were performed and a total of 56 validated SNP/INDELs and 5 repeat differences were identified in the D27 strain relative to published KIM 10+ sequence. However, further analysis showed that 55 of these SNP/INDELs and 3 repeats were errors in the KIM 10+ reference sequence. We conclude that both 454 and Illumina sequencing were required to obtain the most accurate and rapid sequence results for Y. pestis KIMD27. SNP and INDELS calls were most accurate when both Newbler and CLC Genomics Workbench were employed. For purposes of obtaining high quality genome sequence differences between strains, any identified differences should be verified in both the new and reference genomes.	[Losada, Liliana; Varga, John J.; Hostetler, Jessica; Radune, Diana; Kim, Maria; Durkin, Scott; Nierman, William C.] J Craig Venter Inst, Rockville, MD USA; [Schneewind, Olaf] Univ Chicago, Chicago, IL 60637 USA; [Nierman, William C.] George Washington Univ, Washington, DC USA	J. Craig Venter Institute; University of Chicago; George Washington University	Losada, L (corresponding author), J Craig Venter Inst, Rockville, MD USA.	llosada@jcvi.org	Varga, John J/I-8130-2012	Varga, John J/0000-0002-4868-1971	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900007C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract number HHSN272200900007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BRUBAKER RR, 1969, J BACTERIOL, V98, P1404, DOI 10.1128/JB.98.3.1404-1406.1969; Buchrieser C, 1999, INFECT IMMUN, V67, P4851, DOI 10.1128/IAI.67.9.4851-4861.1999; Carniel E, 2001, MICROBES INFECT, V3, P561, DOI 10.1016/S1286-4579(01)01412-5; Chen PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012397; Conrad TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r118; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Easton J, 2009, RARE INFECT MAY HAVE; FINEGOLD MJ, 1968, AM J PATHOL, V53, P99; Forman S, 2006, MICROBIOL-SGM, V152, P3399, DOI 10.1099/mic.0.29224-0; ITEMAN I, 1993, INFECT IMMUN, V61, P2717, DOI 10.1128/IAI.61.6.2717-2722.1993; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Kuroda M, 2010, J CLIN MICROBIOL, V48, P2821, DOI 10.1128/JCM.00137-10; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Kurtz S, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P228; Lahteenmaki K, 1998, INFECT IMMUN, V66, P5755; Lillard JW, 1997, GENE, V193, P13, DOI 10.1016/S0378-1119(97)00071-1; Losada L, 2010, GENOME BIOL EVOL, V2, P102, DOI 10.1093/gbe/evq003; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Paauw A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008240; Perry RD, 2008, CURR PROTOC MICROBIO; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837; Schutzer SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002058; Sjodin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011556	29	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19054	10.1371/journal.pone.0019054	http://dx.doi.org/10.1371/journal.pone.0019054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559501	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700057
J	Wansleeben, C; van Gurp, L; Feitsma, H; Kroon, C; Rieter, E; Verberne, M; Guryev, V; Cuppen, E; Meijlink, F				Wansleeben, Carolien; van Gurp, Leon; Feitsma, Harma; Kroon, Carla; Rieter, Ester; Verberne, Marlies; Guryev, Victor; Cuppen, Edwin; Meijlink, Frits			An ENU-Mutagenesis Screen in the Mouse: Identification of Novel Developmental Gene Functions	PLOS ONE			English	Article							BLOOD-VESSEL DEVELOPMENT; ETHYL-N-NITROSOUREA; LUNG DEVELOPMENT; BRANCHING MORPHOGENESIS; MUTATIONS; DROSOPHILA; DEFECTS; DELTA; MICE; TRAFFICKING	Background: Mutagenesis screens in the mouse have been proven useful for the identification of novel gene functions and generation of interesting mutant alleles. Here we describe a phenotype-based screen for recessive mutations affecting embryonic development. Methodology/Principal Findings: Mice were mutagenized with N-ethyl-N-nitrosurea (ENU) and following incrossing the offspring, embryos were analyzed at embryonic day 10.5. Mutant phenotypes that arose in our screen include cardiac and nuchal edema, neural tube defects, situs inversus of the heart, posterior truncation and the absence of limbs and lungs. We isolated amongst others novel mutant alleles for Dll1, Ptprb, Plexin-B2, Fgf10, Wnt3a, Ncx1, Scrib(Scrib, Scribbled homolog [Drosophila]) and Sec24b. We found both nonsense alleles leading to severe protein truncations and mutants with single-amino acid substitutions that are informative at a molecular level. Novel findings include an ectopic neural tube in our Dll1 mutant and lung defects in the planar cell polarity mutants for Sec24b and Scrib. Conclusions/Significance: Using a forward genetics approach, we have generated a number of novel mutant alleles that are linked to disturbed morphogenesis during development.	Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Rieter, Ester] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands; [Rieter, Ester] Univ Med Ctr Utrecht, Inst Biomembranes, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Wansleeben, C (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	f.meijlink@hubrecht.eu	Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011; van Gurp, Leon/M-1218-2016	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; van Gurp, Leon/0000-0002-6281-5964; Guryev, Victor/0000-0002-5810-6022; Feitsma, Harma/0000-0002-8173-7164	Dutch government [03038]	Dutch government	This work was supported by a grant from the Dutch government (BSIK program 03038, Stem Cells in Development and Disease) to FM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; Beier DR, 2004, GENETICA, V122, P65, DOI 10.1007/s10709-004-1437-5; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Beverdam A, 2001, DEVELOPMENT, V128, P3975; Brown SDM, 2001, CURR OPIN GENET DEV, V11, P268, DOI 10.1016/S0959-437X(00)00189-1; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Ching YH, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-106; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Deng SH, 2007, J NEUROSCI, V27, P6333, DOI 10.1523/JNEUROSCI.5381-06.2007; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; Friedel RH, 2007, J NEUROSCI, V27, P3921, DOI 10.1523/JNEUROSCI.4710-06.2007; Garcia-Garcia MJ, 2005, P NATL ACAD SCI USA, V102, P5913, DOI 10.1073/pnas.0501071102; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hirschberg A, 2010, MOL CELL BIOL, V30, P764, DOI 10.1128/MCB.01458-09; HITOTSUMACHI S, 1985, P NATL ACAD SCI USA, V82, P6619, DOI 10.1073/pnas.82.19.6619; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Loscertales M, 2008, DEVELOPMENT, V135, P1365, DOI 10.1242/dev.010504; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Moore KA, 2005, DEV DYNAM, V232, P268, DOI 10.1002/dvdy.20237; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Parks AL, 2006, GENETICS, V174, P1947, DOI 10.1534/genetics.106.061630; Przemeck GKH, 2003, DEVELOPMENT, V130, P3, DOI 10.1242/dev.00176; Rida PCG, 2009, SEMIN CELL DEV BIOL, V20, P978, DOI 10.1016/j.semcdb.2009.02.007; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Teppner I, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-68; Wansleeben C, 2010, INT J DEV BIOL, V54, P1465, DOI 10.1387/ijdb.093051cw; Wansleeben C, 2010, DEVELOPMENT, V137, P1067, DOI 10.1242/dev.041434; Weber JS, 2000, GENESIS, V26, P230, DOI 10.1002/(SICI)1526-968X(200004)26:4<230::AID-GENE20>3.0.CO;2-S; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yates L, 2009, BIOCHEM SOC T, V37, P838, DOI 10.1042/BST0370838; Yates LL, 2010, HUM MOL GENET, V19, P2251, DOI 10.1093/hmg/ddq104; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219	43	26	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19357	10.1371/journal.pone.0019357	http://dx.doi.org/10.1371/journal.pone.0019357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559415	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700147
J	Nyman, E; Brannmark, C; Palmer, R; Brugard, J; Nystrom, FH; Stralfors, P; Cedersund, G				Nyman, Elin; Brannmark, Cecilia; Palmer, Robert; Brugard, Jan; Nystrom, Fredrik H.; Stralfors, Peter; Cedersund, Gunnar			A Hierarchical Whole-body Modeling Approach Elucidates the Link between in Vitro Insulin Signaling and in Vivo Glucose Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; SYSTEMS BIOLOGY; PHOSPHORYLATION; ADIPOCYTES; TRANSPORT; RESISTANCE; BINDING; LEVEL; MASS; OBESITY	Type 2 diabetes is a metabolic disease that profoundly affects energy homeostasis. The disease involves failure at several levels and subsystems and is characterized by insulin resistance in target cells and tissues (i.e. by impaired intracellular insulin signaling). We have previously used an iterative experimental-theoretical approach to unravel the early insulin signaling events in primary human adipocytes. That study, like most insulin signaling studies, is based on in vitro experimental examination of cells, and the in vivo relevance of such studies for human beings has not been systematically examined. Herein, we develop a hierarchical model of the adipose tissue, which links intracellular insulin control of glucose transport in human primary adipocytes with whole-body glucose homeostasis. An iterative approach between experiments and minimal modeling allowed us to conclude that it is not possible to scale up the experimentally determined glucose uptake by the isolated adipocytes to match the glucose uptake profile of the adipose tissue in vivo. However, a model that additionally includes insulin effects on blood flow in the adipose tissue and GLUT4 translocation due to cell handling can explain all data, but neither of these additions is sufficient independently. We also extend the minimal model to include hierarchical dynamic links to more detailed models (both to our own models and to those by others), which act as submodules that can be turned on or off. The resulting multilevel hierarchical model can merge detailed results on different subsystems into a coherent understanding of whole-body glucose homeostasis. This hierarchical modeling can potentially create bridges between other experimental model systems and the in vivo human situation and offers a framework for systematic evaluation of the physiological relevance of in vitro obtained molecular/cellular experimental data.	[Nyman, Elin; Brannmark, Cecilia; Palmer, Robert; Stralfors, Peter; Cedersund, Gunnar] Linkoping Univ, Dept Clin & Expt Med Diabet & Integrat Syst Biol, SE-58185 Linkoping, Sweden; [Nystrom, Fredrik H.] Linkoping Univ, Dept Med & Hlth Sci, SE-58185 Linkoping, Sweden; [Brugard, Jan] MathCore Engn AB, SE-58330 Linkoping, Sweden; [Cedersund, Gunnar] Freiburg Inst Adv Sci, Sch Life Sci, D-79104 Freiburg, Germany	Linkoping University; Linkoping University	Stralfors, P (corresponding author), Linkoping Univ, Dept Clin & Expt Med Diabet & Integrat Syst Biol, SE-58185 Linkoping, Sweden.	peter.stralfors@liu.se; gunnar.cedersund@liu.se	Nyman, Elin/I-3363-2019; Brännmark, Cecilia/K-2132-2012	Nyman, Elin/0000-0002-4261-0291; Stralfors, Peter/0000-0002-1196-1806; Nystrom, Fredrik/0000-0002-1680-1000	European Commission Commission Networks of Excellence Biosim and BioBridge; Ostergotland County Council; Novo Nordisk Foundation; Lions, Swedish Diabetes Association; Swedish Research Council	European Commission Commission Networks of Excellence Biosim and BioBridge; Ostergotland County Council; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lions, Swedish Diabetes Association; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the European Commission Networks of Excellence Biosim and BioBridge, Ostergotland County Council, Novo Nordisk Foundation, Lions, Swedish Diabetes Association, and Swedish Research Council. J. B. is employed by MatchCore Engineering AB, the company developing MathModelica.	Basu R, 2003, AM J PHYSIOL-ENDOC M, V284, pE55, DOI 10.1152/ajpendo.00190.2001; Basu R, 2006, DIABETES, V55, P2001, DOI 10.2337/db05-1692; Bergman RN, 2003, J CLIN ENDOCR METAB, V88, P4556, DOI 10.1210/jc.2003-031431; Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Brannmark C, 2010, J BIOL CHEM, V285, P20171, DOI 10.1074/jbc.M110.106849; Cedersund G, 2009, FEBS J, V276, P903, DOI 10.1111/j.1742-4658.2008.06845.x; Cedersund G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000096; Chew YH, 2009, MOL CELL ENDOCRINOL, V303, P13, DOI 10.1016/j.mce.2009.01.018; COBELLI C, 1983, MED BIOL ENG COMPUT, V21, P390, DOI 10.1007/BF02442625; Danielsson A, 2005, J BIOL CHEM, V280, P34389, DOI 10.1074/jbc.C500230200; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Erlingsson S, 2009, METABOLISM, V58, P995, DOI 10.1016/j.metabol.2009.02.028; FROST SC, 1987, J BIOL CHEM, V262, P9872; Gerich JE, 2000, DIABETES OBES METAB, V2, P345, DOI 10.1046/j.1463-1326.2000.00085.x; Ghosh S., 2007, C P IEEE ENG MED BIO, P3292; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; JANSSON PA, 1988, AM J PHYSIOL, V255, pE218, DOI 10.1152/ajpendo.1988.255.2.E218; Johnston AM, 2003, FEBS LETT, V546, P32, DOI 10.1016/S0014-5793(03)00438-1; Jones D, 2008, NAT REV DRUG DISCOV, V7, P278, DOI 10.1038/nrd2565; Kahn BB, 1996, DIABETES, V45, P1644, DOI 10.2337/diabetes.45.11.1644; Kim J, 2007, ANN BIOMED ENG, V35, P69, DOI [10.1007/s10439-006-9201-x, 10.1007/s10439-006-9210-x]; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Kitano H, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00003; Li Q, 2009, J MED INVESTIG, V56, P142, DOI 10.2152/jmi.56.142; Lindpointner S, 2010, DIABETES CARE, V33, P833, DOI 10.2337/dc09-1531; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; MARTIN TJ, 1986, J RECEPTOR RES, V6, P323, DOI 10.3109/10799898609074818; Mitrou P, 2009, J CLIN ENDOCR METAB, V94, P2958, DOI 10.1210/jc.2008-2297; Ost A, 2007, FASEB J, V21, P3696, DOI 10.1096/fj.07-8173com; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Pettersson T., 2008, THESIS LINKOPING U; Schaupp L, 1999, AM J PHYSIOL-ENDOC M, V276, pE401, DOI 10.1152/ajpendo.1999.276.2.E401; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; VEGA FV, 1979, ARCH BIOCHEM BIOPHYS, V192, P120, DOI 10.1016/0003-9861(79)90077-8; Virtanen KA, 2005, DIABETES, V54, P2720, DOI 10.2337/diabetes.54.9.2720; Wanant S, 2000, J THEOR BIOL, V205, P355, DOI 10.1006/jtbi.2000.2069; Wu M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008040; Zielinski R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-88	41	56	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26028	26041		10.1074/jbc.M110.188987	http://dx.doi.org/10.1074/jbc.M110.188987			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21572040	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000293073000061
J	Barkefors, I; Fuchs, PF; Heldin, J; Bergstrom, T; Forsberg-Nilsson, K; Kreuger, J				Barkefors, Irmeli; Fuchs, Peder Fredlund; Heldin, Johan; Bergstrom, Tobias; Forsberg-Nilsson, Karin; Kreuger, Johan			Exocyst Complex Component 3-like 2 (EXOC3L2) Associates with the Exocyst Complex and Mediates Directional Migration of Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIP CELLS; ANGIOGENESIS; CHEMOTAXIS; RECEPTOR; TRAFFICKING; MECHANISMS; EXOCYTOSIS; FILOPODIA; DISEASE; GROWTH	The exocyst is a protein complex that ensures spatial targeting of exocytotic vesicles to the plasma membrane. We present microarray data obtained from differentiating mouse embryonic stem cell cultures that identify an up-regulation of exocyst complex component 3-like 2 (exoc3l2) mRNA in sprouting blood vessels. Vascular expression of exoc3l2 is confirmed by qPCR analysis of different mouse tissues and immunofluorescence analyses of mouse brain sections. We detect an up-regulation of exoc3l2 mRNA synthesis in primary human endothelial cells in response to VEGFA, and this response is enhanced when the cells are grown on a three-dimensional collagen I matrix. Myc-tagged EXOC3L2 co-precipitates with the exocyst protein EXOC4, and immunofluorescence detection of EXOC3L2 shows partial subcellular colocalization with EXOC4 and EXOC7. Finally, we show that exoc3l2 silencing inhibits VEGF receptor 2 phosphorylation and VEGFA-directed migration of cultured endothelial cells.	[Barkefors, Irmeli; Fuchs, Peder Fredlund; Heldin, Johan; Kreuger, Johan] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, SE-75123 Uppsala, Sweden; [Bergstrom, Tobias; Forsberg-Nilsson, Karin] Uppsala Univ, Dept Genet & Pathol, Sci Life Lab, SE-75185 Uppsala, Sweden	Uppsala University; Uppsala University	Kreuger, J (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Husargatan 3,POB 582, SE-75123 Uppsala, Sweden.	Johan.Kreuger@imbim.uu.se	Forsberg-Nilsson, Karin/D-9604-2019; Kreuger, Johan/HDM-1503-2022; Heldin, Johan/AAF-1095-2021	Forsberg-Nilsson, Karin/0000-0003-0692-6245; Heldin, Johan/0000-0002-0915-5303; Bergstrom, Tobias/0000-0002-4557-2390	Swedish Research Council; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish Foundation for Strategic Research; Uppsala University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Uppsala University	This work was supported by grants from the Swedish Research Council, Swedish Cancer Society, Swedish Childhood Cancer Foundation, Swedish Foundation for Strategic Research, and Uppsala University (to J. K.).	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Barkefors I, 2008, J BIOL CHEM, V283, P13905, DOI 10.1074/jbc.M704917200; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Califano JP, 2010, J BIOMECH, V43, P79, DOI 10.1016/j.jbiomech.2009.09.012; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jakobsson L, 2007, J CELL BIOL, V177, P751, DOI 10.1083/jcb.200701146; Larrivee B, 2007, GENE DEV, V21, P2433, DOI 10.1101/gad.437807; Lundkvist Andrea, 2007, Novartis Found Symp, V283, P194; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Murthy M, 2010, DEVELOPMENT, V137, P2773, DOI 10.1242/dev.048330; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Navankasattusas S, 2008, DEVELOPMENT, V135, P659, DOI 10.1242/dev.013623; NICHOLS WW, 1977, SCIENCE, V196, P60, DOI 10.1126/science.841339; Oztan A, 2007, MOL BIOL CELL, V18, P3978, DOI 10.1091/mbc.E07-02-0097; Prigent M, 2003, J CELL BIOL, V163, P1111, DOI 10.1083/jcb.200305029; Saito T, 2008, BIOMED RES-TOKYO, V29, P85, DOI 10.2220/biomedres.29.85; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sivaram MVS, 2006, NAT STRUCT MOL BIOL, V13, P555, DOI 10.1038/nsmb1096; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Sugita S, 2008, ACTA PHYSIOL, V192, P185, DOI 10.1111/j.1748-1716.2007.01803.x; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; Yamamura N, 2007, TISSUE ENG, V13, P1443, DOI 10.1089/ten.2006.0333; Zajac A, 2005, MOL BIOL CELL, V16, P1500, DOI 10.1091/mbc.E04-10-0896	32	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24189	24199		10.1074/jbc.M110.212209	http://dx.doi.org/10.1074/jbc.M110.212209			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566143	Green Published, hybrid			2022-12-25	WOS:000292294900061
J	Hu, QA; Hollunder, J; Niehl, A; Korner, CJ; Gereige, D; Windels, D; Arnold, A; Kuiper, M; Vazquez, F; Pooggin, M; Heinlein, M				Hu, Quanan; Hollunder, Jens; Niehl, Annette; Korner, Camilla Julie; Gereige, Dalya; Windels, David; Arnold, Andreas; Kuiper, Martin; Vazquez, Franck; Pooggin, Mikhail; Heinlein, Manfred			Specific Impact of Tobamovirus Infection on the Arabidopsis Small RNA Profile	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; TRANS-ACTING SIRNAS; SMALL SILENCING RNAS; DNA METHYLATION; VIRAL SUPPRESSORS; PLANT DEVELOPMENT; REPLICATION PROTEIN; ANTIVIRAL IMMUNITY; ARGONAUTE PROTEINS; BIOGENESIS	Tobamoviruses encode a silencing suppressor that binds small RNA (sRNA) duplexes in vitro and supposedly in vivo to counteract antiviral silencing. Here, we used sRNA deep-sequencing combined with transcriptome profiling to determine the global impact of tobamovirus infection on Arabidopsis sRNAs and their mRNA targets. We found that infection of Arabidopsis plants with Oilseed rape mosaic tobamovirus causes a global size-specific enrichment of miRNAs, ta-siRNAs, and other phased siRNAs. The observed patterns of sRNA enrichment suggest that in addition to a role of the viral silencing suppressor, the stabilization of sRNAs might also occur through association with unknown host effector complexes induced upon infection. Indeed, sRNA enrichment concerns primarily 21-nucleotide RNAs with a 5 '-terminal guanine. Interestingly, ORMV infection also leads to accumulation of novel miRNA-like sRNAs from miRNA precursors. Thus, in addition to canonical miRNAs and miRNA*s, miRNA precursors can encode additional sRNAs that may be functional under specific conditions like pathogen infection. Virus-induced sRNA enrichment does not correlate with defects in miRNA-dependent ta-siRNA biogenesis nor with global changes in the levels of mRNA and ta-siRNA targets suggesting that the enriched sRNAs may not be able to significantly contribute to the normal activity of pre-loaded RISC complexes. We conclude that tobamovirus infection induces the stabilization of a specific sRNA pool by yet unknown effector complexes. These complexes may sequester viral and host sRNAs to engage them in yet unknown mechanisms involved in plant: virus interactions.	[Hu, Quanan; Korner, Camilla Julie; Windels, David; Arnold, Andreas; Vazquez, Franck; Pooggin, Mikhail; Heinlein, Manfred] Univ Basel, Inst Bot, Dept Plant Physiol, Zurich Basel Plant Sci Ctr, CH-4056 Basel, Switzerland; [Hollunder, Jens] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Hollunder, Jens] Univ Ghent, Dept Plant Biotechnol & Genet, B-9000 Ghent, Belgium; [Niehl, Annette; Gereige, Dalya; Heinlein, Manfred] Univ Strasbourg, Inst Biol Mol Plantes, CNRS, UPR 2357, Strasbourg, France; [Kuiper, Martin] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway	University of Basel; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Norwegian University of Science & Technology (NTNU)	Hu, QA (corresponding author), Univ Basel, Inst Bot, Dept Plant Physiol, Zurich Basel Plant Sci Ctr, Hebelstr 1, CH-4056 Basel, Switzerland.	manfred.heinlein@ibmp-cnrs.unistra.fr	Kuiper, Martin/AAM-7279-2020; Hollunder, Jens/G-6588-2016; Vazquez, Franck/B-9849-2013; david, windels/C-1112-2013	Kuiper, Martin/0000-0002-1171-9876; Hollunder, Jens/0000-0003-3234-6762; Vazquez, Franck/0000-0002-7967-3798; Pooggin, Mikhail/0000-0003-2308-393X; Hu, Quan'An/0000-0002-0295-3820	Human Frontier Science Program Organization [RGP0022/2006]; Swiss National Science Foundation [3100A0-111916, 31003A-124940, 31003A-122469, 31003A-127514, PZ00P3-126329]	Human Frontier Science Program Organization(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank the Functional Genomics Center Zurich for providing the resources for RNA profiling using Affimetrix oligonucleotide arrays. This work was supported with financial support by the Human Frontier Science Program Organization (RGP0022/2006) and the Swiss National Science Foundation grants 3100A0-111916 and 31003A-124940 to M.H., 31003A-122469 and 31003A-127514 to M.M.P., and PZ00P3-126329) to F.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist.	Addo-Quaye C, 2009, RNA, V15, P2112, DOI 10.1261/rna.1774909; Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Bologna NG, 2009, EMBO J, V28, P3646, DOI 10.1038/emboj.2009.292; Boutet S, 2003, CURR BIOL, V13, P843, DOI 10.1016/S0960-9822(03)00293-8; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Buck KW, 1999, PHILOS T R SOC B, V354, P613, DOI 10.1098/rstb.1999.0413; Charon C, 2010, MOL PLANT, V3, P729, DOI 10.1093/mp/ssq037; Chellappan P, 2010, NUCLEIC ACIDS RES, V38, P6883, DOI 10.1093/nar/gkq590; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; Csorba T, 2007, J VIROL, V81, P11768, DOI 10.1128/JVI.01230-07; Diaz-Pendon JA, 2008, ANNU REV PHYTOPATHOL, V46, P303, DOI 10.1146/annurev.phyto.46.081407.104746; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Ding XS, 2004, MOL PLANT MICROBE IN, V17, P583, DOI 10.1094/MPMI.2004.17.6.583; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Endres MW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000729; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; KIELLANDBRANDT MC, 1974, J MOL BIOL, V87, P489, DOI 10.1016/0022-2836(74)90099-0; Kubota K, 2003, J VIROL, V77, P11016, DOI 10.1128/JVI.77.20.11016-11026.2003; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Kurihara Y, 2007, J GEN VIROL, V88, P2347, DOI 10.1099/vir.0.82994-0; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEWANDOWSKI DJ, 1993, MOL PLANT MICROBE IN, V6, P157, DOI 10.1094/MPMI-6-157; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lindow M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-119; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Martinez G, 2010, MOL PLANT PATHOL, V11, P347, DOI [10.1111/J.1364-3703.2009.00608.X, 10.1111/j.1364-3703.2009.00608.x]; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Pantaleo V, 2010, VIROLOGY, V408, P49, DOI 10.1016/j.virol.2010.09.001; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Schwab R, 2009, EMBO J, V28, P3633, DOI 10.1038/emboj.2009.334; Soosaar JLM, 2005, NAT REV MICROBIOL, V3, P789, DOI 10.1038/nrmicro1239; Szittya G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000838; Tagami Y, 2007, DNA RES, V14, P227, DOI 10.1093/dnares/dsm022; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Varallyay E, 2010, EMBO J, V29, P3507, DOI 10.1038/emboj.2010.215; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Vazquez F, 2010, TRENDS PLANT SCI, V15, P337, DOI 10.1016/j.tplants.2010.04.001; Vogler H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000038; Vogler H, 2007, J VIROL, V81, P10379, DOI 10.1128/JVI.00727-07; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Wu QF, 2010, CELL HOST MICROBE, V8, P12, DOI 10.1016/j.chom.2010.06.009; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; YANG JH, 2010, NUCL ACIDS RES; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zhang WX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r81; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	83	45	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19549	10.1371/journal.pone.0019549	http://dx.doi.org/10.1371/journal.pone.0019549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572953	Green Published, Green Submitted, gold			2022-12-25	WOS:000290440200010
J	Qiu, LH; Rivera-Perez, JA; Xu, ZS				Qiu, Linghua; Rivera-Perez, Jaime A.; Xu, Zuoshang			A Non-Specific Effect Associated with Conditional Transgene Expression Based on Cre-loxP Strategy in Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MEDIATED RECOMBINATION; DISEASE PROGRESSION; DNA RECOMBINATION; DOUBLE REPORTER; NERVOUS-SYSTEM; MOTOR-NEURONS; CELL ABLATION; MOUSE; PROGRANULIN	Transgenes flanked by loxP sites have been widely used to generate transgenic mice where the transgene expression can be controlled spatially and temporally by Cre recombinase. Data from this approach has led to important conclusions in cancer, neurodevelopment and neurodegeneration. Using this approach to conditionally express micro RNAs (miRNAs) in mice, we found that Cre-mediated recombination in neural progenitor cells caused microcephaly in five of our ten independent transgenic lines. This effect was not associated with the types or the quantity of miRNAs being expressed, nor was it associated with specific target knockdown. Rather, it was correlated with the presence of multiple tandem transgene copies and inverted (head-to-head or tail-to-tail) transgene repeats. The presence of these inverted repeats caused a high level of cell death in the ventricular zone of the embryonic brain, where Cre was expressed. Therefore, results from this Cre-loxP approach to generate inducible transgenic alleles must be interpreted with caution and conclusions drawn in previous reports may need reexamination.	[Qiu, Linghua; Xu, Zuoshang] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Rivera-Perez, Jaime A.; Xu, Zuoshang] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Xu, Zuoshang] Univ Massachusetts, Sch Med, Neurosci Program, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Qiu, LH (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	Zuoshang.xu@umassmed.edu		Rivera-Perez, Jaime/0000-0001-5776-6291	National Institute of Neurological Disorders and Stroke and National Center for Research Resources [RO1NS048145, R21NS062230, R21RR024395, RC1NS068391]; Diabetes Endocrinology Research Center [DK32520]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062230, R01NS048145, RC1NS068391] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke and National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); Diabetes Endocrinology Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants (RO1NS048145, R21NS062230, R21RR024395, RC1NS068391) from the National Institute of Neurological Disorders and Stroke and National Center for Research Resources. Core resources were supported by the Diabetes Endocrinology Research Center grant DK32520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Coumoul X, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni100; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Fritsch L, 2004, EMBO REP, V5, P178, DOI 10.1038/sj.embor.7400064; GIBSON GE, 1988, ARCH NEUROL-CHICAGO, V45, P836, DOI 10.1001/archneur.1988.00520320022009; GORDON JW, 1985, GENE, V33, P121, DOI 10.1016/0378-1119(85)90087-3; Gregoire D, 2008, P NATL ACAD SCI USA, V105, P14492, DOI 10.1073/pnas.0807484105; Grieshammer U, 1998, DEV BIOL, V197, P234, DOI 10.1006/dbio.1997.8859; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Huang ZJ, 2002, GENESIS, V32, P209, DOI 10.1002/gene.10054; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; Kamei K, 2006, GENESIS, V44, P177, DOI 10.1002/dvg.20199; Kayasuga Y, 2007, BEHAV BRAIN RES, V185, P110, DOI 10.1016/j.bbr.2007.07.020; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Leppanen P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000013; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Liu J, 2007, GENESIS, V45, P259, DOI 10.1002/dvg.20282; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lo ACY, 2004, TRANSGENIC RES, V13, P119, DOI 10.1023/B:TRAG.0000026072.01351.10; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lobsiger CS, 2009, P NATL ACAD SCI USA, V106, P4465, DOI 10.1073/pnas.0813339106; Matsumura H, 2004, BIOCHEM BIOPH RES CO, V321, P275, DOI 10.1016/j.bbrc.2004.06.139; Matsumura H, 2007, NAT METHODS, V4, P23, DOI 10.1038/NMETH973; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Mills AA, 2001, TRENDS GENET, V17, P331, DOI 10.1016/S0168-9525(01)02321-6; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Otsuji T, 2008, J MOL BIOL, V378, P328, DOI 10.1016/j.jmb.2008.01.065; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; Qiu LH, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-77; Streicher JM, 2010, J MOL CELL CARDIOL, V49, P88, DOI 10.1016/j.yjmcc.2010.01.021; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang LJ, 2009, NEUROBIOL DIS, V35, P234, DOI 10.1016/j.nbd.2009.05.002; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; Zhu Y, 2010, J BIOL CHEM, V285, P26005, DOI 10.1074/jbc.M110.139196	41	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e18778	10.1371/journal.pone.0018778	http://dx.doi.org/10.1371/journal.pone.0018778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572998	gold, Green Published, Green Submitted			2022-12-25	WOS:000290440200003
J	Cabral, A; Stassen, JHM; Seidl, MF; Bautor, J; Parker, JE; Van den Ackerveken, G				Cabral, Adriana; Stassen, Joost H. M.; Seidl, Michael F.; Bautor, Jaqueline; Parker, Jane E.; Van den Ackerveken, Guido			Identification of Hyaloperonospora arabidopsidis Transcript Sequences Expressed during Infection Reveals Isolate-Specific Effectors	PLOS ONE			English	Article							DOWNY MILDEW RESISTANCE; PATHOGEN CLADOSPORIUM-FULVUM; PERONOSPORA-PARASITICA; DISEASE SUSCEPTIBILITY; CELL-DEATH; PLANT; AVIRULENCE; GENES; PROTEINS; LOCUS	Biotrophic plant pathogens secrete effector proteins that are important for infection of the host. The aim of this study was to identify effectors of the downy mildew pathogen Hyaloperonospora arabidopsidis (Hpa) that are expressed during infection of its natural host Arabidopsis thaliana. Infection-related transcripts were identified from Expressed Sequence Tags (ESTs) derived from leaves of the susceptible Arabidopsis Ws eds1-1 mutant inoculated with the highly virulent Hpa isolate Waco9. Assembly of 6364 ESTs yielded 3729 unigenes, of which 2164 were Hpa-derived. From the translated Hpa unigenes, 198 predicted secreted proteins were identified. Of these, 75 were found to be Hpa-specific and six isolate Waco9-specific. Among 42 putative effectors identified there were three Elicitin-like proteins, 16 Cysteine-rich proteins and 18 host-translocated RXLR effectors. Sequencing of alleles in different Hpa isolates revealed that five RXLR genes show signatures of diversifying selection. Thus, EST analysis of Hpa-infected Arabidopsis is proving to be a powerful method for identifying pathogen effector candidates expressed during infection. Delivery of the Waco9-specific protein RXLR29 in planta revealed that this effector can suppress PAMP-triggered immunity and enhance disease susceptibility. We propose that differences in host colonization can be conditioned by isolate-specific effectors.	[Cabral, Adriana; Stassen, Joost H. M.; Van den Ackerveken, Guido] Univ Utrecht, Dept Plant Microbe Interact, Dept Biol, Utrecht, Netherlands; [Seidl, Michael F.; Van den Ackerveken, Guido] Ctr BioSyst Genom CBSG, Wageningen, Netherlands; [Bautor, Jaqueline; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany	Utrecht University; Centre for BioSystems Genomics; Max Planck Society	Cabral, A (corresponding author), Univ Utrecht, Dept Plant Microbe Interact, Dept Biol, Utrecht, Netherlands.	parker@mpipz.mpg.de; g.vandenackerveken@uu.nl	Seidl, Michael F./ABD-6042-2021; Cabral, Adriana/AAX-3284-2021; Van den Ackerveken, Guido/B-8568-2011	Van den Ackerveken, Guido/0000-0002-0183-8978; Seidl, Michael F/0000-0002-5218-2083; Stassen, Joost/0000-0001-5483-325X	Alexander von Humboldt Foundation; The Netherlands Organization for Scientific Research (NWO); ERA-NET Plant Genomics 'Effectoromics' consortium	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ERA-NET Plant Genomics 'Effectoromics' consortium	This work was funded by the Alexander von Humboldt Foundation to Jane Parker, by a VIDI innovational research grant from The Netherlands Organization for Scientific Research (NWO) to Guido Van den Ackerveken, and grants within the ERA-NET Plant Genomics 'Effectoromics' consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Aguileta G, 2009, INFECT GENET EVOL, V9, P656, DOI 10.1016/j.meegid.2009.03.010; Alfano JR, 2009, MOL PLANT PATHOL, V10, P805, DOI 10.1111/j.1364-3703.2009.00588.x; Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Allen RL, 2008, MOL PLANT PATHOL, V9, P511, DOI 10.1111/J.1364-3703.2008.00481.X; Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BAXTER L, SCIENCE IN PRESS; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bittner-Eddy P, 1999, MOL PLANT MICROBE IN, V12, P792, DOI 10.1094/MPMI.1999.12.9.792; Bittner-Eddy PD, 2003, MOL PLANT PATHOL, V4, P501, DOI 10.1046/J.1364-3703.2003.00194.X; Boissy G, 1999, PROTEIN SCI, V8, P1191, DOI 10.1110/ps.8.6.1191; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Botella MA, 1998, PLANT CELL, V10, P1847, DOI 10.1105/tpc.10.11.1847; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Dong SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005556; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Eisenhaber B, 2003, PLANT PHYSIOL, V133, P1691, DOI 10.1104/pp.103.023580; Fan J, 2008, PLANT J, V53, P393, DOI 10.1111/j.1365-313X.2007.03303.x; Gan PHP, 2009, MOL GENET GENOMICS, V281, P565, DOI 10.1007/s00438-009-0431-0; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Guo M, 2009, MOL PLANT MICROBE IN, V22, P1069, DOI 10.1094/MPMI-22-9-1069; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; HOLUB EB, 1994, MOL PLANT MICROBE IN, V7, P223, DOI 10.1094/MPMI-7-0223; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jiang RHY, 2006, MOL BIOL EVOL, V23, P338, DOI 10.1093/molbev/msj039; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Luderer R, 2002, MOL MICROBIOL, V45, P875, DOI 10.1046/j.1365-2958.2002.03060.x; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; Mikes V, 1998, BIOCHEM BIOPH RES CO, V245, P133, DOI 10.1006/bbrc.1998.8341; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NEI M, 1986, MOL BIOL EVOL, V3, P418; NESPOULOUS C, 1992, PLANTA, V186, P551, DOI 10.1007/BF00198035; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; O'Connell RJ, 2006, NEW PHYTOL, V171, P699, DOI 10.1111/j.1469-8137.2006.01829.x; Panabieres F, 1997, MYCOL RES, V101, P1459, DOI 10.1017/S0953756297004413; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Parker JE, 1997, PLANT CELL, V9, P879, DOI 10.1105/tpc.9.6.879; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qutob D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005066; Randall TA, 2005, MOL PLANT MICROBE IN, V18, P229, DOI 10.1094/MPMI-18-0229; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P224, DOI 10.1093/nar/gkg076; Rodrigues ML, 2006, BBA-PROTEINS PROTEOM, V1764, P110, DOI 10.1016/j.bbapap.2005.09.008; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Sierra R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009847; Slusarenko AJ, 2003, MOL PLANT PATHOL, V4, P159, DOI 10.1046/j.1364-3703.2003.00166.x; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Staden R, 2000, Methods Mol Biol, V132, P115; Stergiopoulos I, 2007, MOL PLANT MICROBE IN, V20, P1271, DOI 10.1094/MPMI-20-10-1271; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Torto-Alalibo TA, 2007, MOL PLANT MICROBE IN, V20, P781, DOI 10.1094/MPMI-20-7-0781; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Van Damme M, 2005, MOL PLANT MICROBE IN, V18, P583, DOI 10.1094/MPMI-18-0583; van der Biezen EA, 2000, MOL PLANT MICROBE IN, V13, P895, DOI 10.1094/MPMI.2000.13.8.895; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; van Esse HP, 2007, MOL PLANT MICROBE IN, V20, P1092, DOI 10.1094/MPMI-20-9-1092; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; VANKAN JAL, 1991, MOL PLANT MICROBE IN, V4, P52, DOI 10.1094/MPMI-4-052; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	82	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19328	10.1371/journal.pone.0019328	http://dx.doi.org/10.1371/journal.pone.0019328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573066	gold, Green Published, Green Accepted			2022-12-25	WOS:000290386800010
J	Liu, XJ; Lin, H; Tang, Q; Li, C; Yang, ST; Wang, ZC; Wang, CJ; He, Q; Cao, B; Feng, ZQ; Guan, XH; Zhu, J				Liu, Xinjian; Lin, Hong; Tang, Qi; Li, Chen; Yang, Songtao; Wang, Zhongcan; Wang, Changjun; He, Qing; Cao, Brian; Feng, Zhenqing; Guan, Xiaohong; Zhu, Jin			Characterization of a Human Antibody Fragment Fab and Its Calcium Phosphate Nanoparticles that Inhibit Rabies Virus Infection with Vaccine	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODY; DRUG-DELIVERY; GLYCOPROTEIN; COMBINATION; PROTEINS; COCKTAIL; LIBRARY	Recombinant antibody phage display technology has been used to mimic many aspects of the processes that govern the generation and selection of high-affinity natural human antibodies in the human immune system, especially for infectious disease prophylaxis. An anti-rabies virus immunized phage-display Fab library was constructed from peripheral blood lymphocytes from vaccinated volunteers. The immunized antibody library, with a diversity of 6.7x10(8), was used to select and produce antibodies that bound to rabies virus glycoprotein. After five rounds of immobilized fixed rabies virion panning, four unique DNA sequences were found in the higher binding clones, and only one, Fab094, showed neutralization activity. Fab094 components were analyzed by ELISA, immunoprecipitation and immunofluorescent staining. ELISA and immunofluorescence showed that Fab094 bound specifically to rabies virions. Immunoprecipitation and mass spectrometry showed that Fab094 reacted with rabies virus glycoprotein. To improve the penetration power of Fab094 antibodies, we developed Fab094 calcium phosphate nanoparticles (Fab094-CPNPs) and tested their efficacy. The rapid fluorescent focus inhibition test indicated that the neutralizing antibody titers of Fab094 and Fab094-CPNPs were reached at 200.17 IU/Kg and 246.12 IU/Kg, respectively. These findings were confirmed in vivo in a Kunming mouse challenge model. Our results demonstrate that human Fab094 and Fab094-CPNPs are efficacious candidate drugs to replace rabies immunoglobulin in post-exposure prophylaxis (PEP).	[Liu, Xinjian; Lin, Hong; Tang, Qi; Li, Chen; He, Qing; Feng, Zhenqing; Guan, Xiaohong; Zhu, Jin] Nanjing Med Univ, Minist Hlth, Key Lab Antibody Tech, Nanjing, Peoples R China; [Wang, Zhongcan; Wang, Changjun; Zhu, Jin] Huadong Med Inst Biotech, Nanjing, Peoples R China; [Lin, Hong; Cao, Brian] Van Andel Inst, Antibody Technol Lab, Grand Rapids, MI USA; [Yang, Songtao] Acad Mil Med Sci, Vet Inst, Changchun, Peoples R China; [Liu, Xinjian] Nanjing Med Univ, Dept Pathol, Nanjing, Peoples R China	Nanjing Medical University; Van Andel Institute; Academy of Military Medical Sciences - China; Nanjing Medical University	Liu, XJ (corresponding author), Nanjing Med Univ, Minist Hlth, Key Lab Antibody Tech, Nanjing, Peoples R China.	xiaohongguan1@163.com; zjsimmons@yahoo.com.cn			National High Technology Research and Development Program of China (863 Program) [2007AA02Z418]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (863 Program) (grant no. 2007AA02Z418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Ando T, 2005, MICROBIOL IMMUNOL, V49, P311, DOI 10.1111/j.1348-0421.2005.tb03735.x; Bakker ABH, 2005, J VIROL, V79, P9062, DOI 10.1128/JVI.79.14.9062-9068.2005; Barbas C.F., 2004, PHAGE DISPLAY LAB MA; Bourhy H., 1990, LAB METHODS RABIES D, P191; Cai K, 2008, MICROBES INFECT, V10, P548, DOI 10.1016/j.micinf.2008.02.008; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; de Kruif J, 2007, ANNU REV MED, V58, P359, DOI 10.1146/annurev.med.58.061705.145053; DIETZSCHOLD B, 1990, J VIROL, V64, P3804, DOI 10.1128/JVI.64.8.3804-3809.1990; Feyssaguet M, 2007, VACCINE, V25, P2244, DOI 10.1016/j.vaccine.2006.12.012; Goudsmit J, 2006, J INFECT DIS, V193, P796, DOI 10.1086/500470; Harper A, 1996, WHO, V12, P1; Houimel M, 2009, VACCINE, V27, P4648, DOI 10.1016/j.vaccine.2009.05.055; MEBATSION T, 1995, J VIROL, V69, P1444, DOI 10.1128/JVI.69.3.1444-1451.1995; MESLIN FX, 2001, PROSPECTS IMMUNIZATI, P15; [明平刚 MING Pinggang], 2006, [中国生物制品学杂志, Chinese Journal of Biologicals], V19, P217; Prosniak M, 2003, J INFECT DIS, V188, P53, DOI 10.1086/375247; Ray K, 2001, CLIN EXP IMMUNOL, V125, P94, DOI 10.1046/j.1365-2249.2001.01515.x; Redwan ERM, 2009, COMP IMMUNOL MICROB, V32, P9, DOI 10.1016/j.cimid.2007.11.004; Sloan SE, 2007, VACCINE, V25, P2800, DOI 10.1016/j.vaccine.2006.12.031; Stayton PS, 2000, J CONTROL RELEASE, V65, P203, DOI 10.1016/S0168-3659(99)00236-9; Wagner S, 2010, BIOMATERIALS, V31, P2388, DOI 10.1016/j.biomaterials.2009.11.093; WHO, 2005, WHO TECH REP SER, V931, P1; WHO, 2004, WHO TECHN REP SER; Wilde H, 2003, CLIN INFECT DIS, V37, P96, DOI 10.1086/375605	25	10	13	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19848	10.1371/journal.pone.0019848	http://dx.doi.org/10.1371/journal.pone.0019848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573024	Green Published, gold, Green Submitted			2022-12-25	WOS:000290386800038
J	Hoadley, KD; Szmant, AM; Pyott, SJ				Hoadley, Kenneth D.; Szmant, Alina M.; Pyott, Sonja J.			Circadian Clock Gene Expression in the Coral Favia fragum over Diel and Lunar Reproductive Cycles	PLOS ONE			English	Article							RHYTHMS; PATTERNS; SYNCHRONIZATION; CRYPTOCHROMES; COMPONENTS; ROLES	Natural light cycles synchronize behavioral and physiological cycles over varying time periods in both plants and animals. Many scleractinian corals exhibit diel cycles of polyp expansion and contraction entrained by diel sunlight patterns, and monthly cycles of spawning or planulation that correspond to lunar moonlight cycles. The molecular mechanisms for regulating such cycles are poorly understood. In this study, we identified four molecular clock genes (cry1, cry2, clock and cycle) in the scleractinian coral, Favia fragum, and investigated patterns of gene expression hypothesized to be involved in the corals' diel polyp behavior and lunar reproductive cycles. Using quantitative PCR, we measured fluctuations in expression of these clock genes over both diel and monthly spawning timeframes. Additionally, we assayed gene expression and polyp expansion-contraction behavior in experimental corals in normal light: dark (control) or constant dark treatments. Well-defined and reproducible diel patterns in cry1, cry2, and clock expression were observed in both field-collected and the experimental colonies maintained under control light: dark conditions, but no pattern was observed for cycle. Colonies in the control light: dark treatment also displayed diel rhythms of tentacle expansion and contraction. Experimental colonies in the constant dark treatment lost diel patterns in cry1, cry2, and clock expression and displayed a diminished and less synchronous pattern of tentacle expansion and contraction. We observed no pattern in cry1, cry2, clock, or cycle expression correlated with monthly spawning events suggesting these genes are not involved in the entrainment of reproductive cycles to lunar light cycles in F. fragum. Our results suggest a molecular clock mechanism, potentially similar to that in described in fruit flies, exists within F. fragum.	[Hoadley, Kenneth D.; Szmant, Alina M.; Pyott, Sonja J.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA; [Szmant, Alina M.] Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28401 USA	University of North Carolina; University of North Carolina Wilmington; University of North Carolina; University of North Carolina Wilmington	Hoadley, KD (corresponding author), Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA.	pyotts@uncw.edu	Pyott, Sonja/AAW-8789-2020	Hoadley, Kenneth/0000-0002-9287-181X; Pyott, Sonja/0000-0001-7750-2437	UNC Wilmington Center for Marine Science; UNC Wilmington Academic Affairs; UNC Wilmington; AWARE Foundation	UNC Wilmington Center for Marine Science; UNC Wilmington Academic Affairs; UNC Wilmington; AWARE Foundation	The authors acknowledge the following funding sources: UNC Wilmington Center for Marine Science Pilot Project to SJP and AMS; UNC Wilmington Academic Affairs funding to AMS for support of coral reef research; Friends of UNC Wilmington to SJP; Project AWARE Foundation grant to KDH; and funding from UNC Wilmington to SJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N., 1939, PALAO TROP BIOL STN, V1, P651; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Boden MJ, 2006, REPRODUCTION, V132, P379, DOI 10.1530/rep.1.00614; Brady AK, 2009, CORAL REEFS, V28, P677, DOI 10.1007/s00338-009-0498-4; Caldelas I, 2003, NEUROSCIENCE, V116, P583, DOI 10.1016/S0306-4522(02)00654-1; Challet E, 2003, BIOL CHEM, V384, P711, DOI 10.1515/BC.2003.079; Challet E, 2010, J COMP PHYSIOL B, V180, P631, DOI 10.1007/s00360-010-0451-4; Chong NW, 2003, J NEUROCHEM, V85, P851, DOI 10.1046/j.1471-4159.2003.01723.x; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; Dolatshad H, 2009, REPROD FERT DEVELOP, V21, P1, DOI 10.1071/RD08223; Hardin PE, 2009, SLEEP BIOL RHYTHMS, V7, P235, DOI 10.1111/j.1479-8425.2009.00412.x; HARDIN PE, 1992, EMBO J, V11, P1; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; JOKIEL PL, 1985, MAR BIOL, V88, P167, DOI 10.1007/BF00397164; Kawaguti S., 1948, Bulletin of the Oceanographical Institute of Taiwan, VNo. 4, P65; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LASKER HR, 1979, BIOL BULL, V156, P196, DOI 10.2307/1541043; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Lin CT, 2005, CRYPTOCHROMES, V6; Looby P, 2005, TRENDS GENET, V21, P46, DOI 10.1016/j.tig.2004.11.012; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Reitzel AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012805; Sandrelli F, 2008, INSECT MOL BIOL, V17, P447, DOI 10.1111/j.1365-2583.2008.00832.x; SEBENS KP, 1977, MAR BIOL, V43, P247, DOI 10.1007/BF00402317; SWEENEY BM, 1976, BIOL BULL, V151, P236, DOI 10.2307/1540717; SZMANTFROELICH A, 1985, B MAR SCI, V37, P880; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Vize PD, 2009, BIOL BULL-US, V216, P131; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Yonge C. M., 1940, Scientific Reports Great Barrier Reef Expedition 1928-29 London, V1, P353; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zhu HS, 2001, MOL VIS, V7, P210	39	43	44	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19755	10.1371/journal.pone.0019755	http://dx.doi.org/10.1371/journal.pone.0019755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573070	Green Submitted, gold, Green Published			2022-12-25	WOS:000290305600044
J	Iacobaeus, E; Amoudruz, P; Strom, M; Khademi, M; Brundin, L; Hillert, J; Kockum, I; Malmstrom, V; Olsson, T; Tham, E; Piehl, F				Iacobaeus, Ellen; Amoudruz, Petra; Strom, Mikael; Khademi, Mohsen; Brundin, Lou; Hillert, Jan; Kockum, Ingrid; Malmstrom, Vivianne; Olsson, Tomas; Tham, Emma; Piehl, Fredrik			The Expression of VEGF-A Is Down Regulated in Peripheral Blood Mononuclear Cells of Patients with Secondary Progressive Multiple Sclerosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELLS; DIAGNOSTIC-CRITERIA; ALZHEIMERS-DISEASE; ANGIOGENIC FACTORS; NERVOUS-SYSTEM; BRAIN; BETA; NEUROINFLAMMATION	Background: Most patients with relapsing-remitting multiple sclerosis (RRMS) eventually enter a secondary progressive (SPMS) phase, characterized by increasing neurological disability. The mechanisms underlying transition to SPMS are unknown and effective treatments and biomarkers are lacking. Vascular endothelial growth factor-A (VEGF-A) is an angiogenic factor with neuroprotective effects that has been associated with neurodegenerative diseases. SPMS has a prominent neurodegenerative facet and we investigated a possible role for VEGF-A during transition from RRMS to SPMS. Methodology/Principal Findings: VEGF-A mRNA expression in peripheral blood mononuclear (PBMC) and cerebrospinal fluid (CSF) cells from RRMS (n = 128), SPMS (n = 55) and controls (n = 116) were analyzed using real time PCR. We demonstrate reduced expression of VEGF-A mRNA in MS CSF cells compared to controls (p<0.001) irrespective of disease course and expression levels are restored by natalizumab treatment(p<0.001). VEGF-A was primarily expressed in monocytes and our CSF findings in part may be explained by effects on relative monocyte proportions. However, VEGF-A mRNA expression was also down regulated in the peripheral compartment of SPMS (p<0.001), despite unchanged monocyte counts, demonstrating a particular phenotype differentiating SPMS from RRMS and controls. A possible association of allelic variability in the VEGF-A gene to risk of MS was also studied by genotyping for six single nucleotide polymorphisms (SNPs) in MS (n = 1114) and controls (n = 1234), which, however, did not demonstrate any significant association between VEGF-A alleles and risk of MS. Conclusions/Significance: Expression of VEGF-A in CSF cells is reduced in MS patients compared to controls irrespective of disease course. In addition, SPMS patients display reduced VEGF-A mRNA expression in PBMC, which distinguish them from RRMS and controls. This indicates a possible role for VEGF-A in the mechanisms regulating transition to SPMS. Decreased levels of PBMC VEGF-A mRNA expression should be further evaluated as a biomarker for SPMS.	[Iacobaeus, Ellen; Strom, Mikael; Khademi, Mohsen; Brundin, Lou; Kockum, Ingrid; Olsson, Tomas; Piehl, Fredrik] Karolinska Inst Solna, Ctr Mol Med, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden; [Amoudruz, Petra; Malmstrom, Vivianne] Karolinska Inst Solna, Ctr Mol Med, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Hillert, Jan] Karolinska Inst Solna, Ctr Mol Med, Dept Clin Neurosci, Multiple Sclerosis Res Grp, Stockholm, Sweden; [Tham, Emma] Karolinska Univ Hosp, Dept Clin Genet, Solna, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Iacobaeus, E (corresponding author), Karolinska Inst Solna, Ctr Mol Med, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden.	Ellen.Iacobaeus@karolinska.se	Kockum, Ingrid/O-8781-2018; Piehl, Fredrik/E-3451-2013	Kockum, Ingrid/0000-0002-0867-4726; Brundin, Lou/0000-0003-4408-7817; Tham, Emma/0000-0001-6079-164X; Khademi, Mohsen/0000-0003-0801-1444; Olsson, Tomas/0000-0002-2938-1877	European Union [LSHM-CT-2005-018637, LSHG-CT-2005019015]; Swedish Research Council; Swedish Society for Medical Research; Swedish Brain Foundation; Nils and Bibbi Jenssens Foundation; Montel Williams' MS Foundation; GV80 Foundation; Soderberg Foundation; Swedish Association of Persons with Neurological Disabilities; BiogenIdec Sweden AB	European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research; Swedish Brain Foundation; Nils and Bibbi Jenssens Foundation; Montel Williams' MS Foundation; GV80 Foundation; Soderberg Foundation; Swedish Association of Persons with Neurological Disabilities; BiogenIdec Sweden AB	This study was supported by the 6th Framework Program of the European Union, NeuroproMiSe, LSHM-CT-2005-018637 and EURATools, LSHG-CT-2005019015, the Swedish Research Council, the Swedish Society for Medical Research, the Swedish Brain Foundation, the Nils and Bibbi Jenssens Foundation, the Montel Williams' MS Foundation, the GV80 Foundation, the Soderberg Foundation, the Swedish Association of Persons with Neurological Disabilities, and an unrestricted research grant from BiogenIdec Sweden AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Balashov KE, 1997, P NATL ACAD SCI USA, V94, P599, DOI 10.1073/pnas.94.2.599; Bergh FT, 2004, J NEUROIMMUNOL, V146, P176, DOI 10.1016/j.jneuroim.2003.10.037; Boneschi FM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002127.pub2; Cepok S, 2001, BRAIN, V124, P2169, DOI 10.1093/brain/124.11.2169; Coles AJ, 2006, J NEUROL, V253, P98, DOI 10.1007/s00415-005-0934-5; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Croll SD, 2004, EXP NEUROL, V187, P388, DOI 10.1016/j.expneurol.2004.02.010; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Del Bo R, 2009, J NEUROL SCI, V283, P66, DOI 10.1016/j.jns.2009.02.318; Eriksson M, 2003, MULT SCLER J, V9, P260, DOI 10.1191/1352458503ms914oa; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Graumann U, 2003, BRAIN PATHOL, V13, P554, DOI 10.1111/j.1750-3639.2003.tb00485.x; Hamzaoui K, 2009, J NEUROIMMUNOL, V213, P148, DOI 10.1016/j.jneuroim.2009.05.005; Ingram G, 2010, BRAIN, V133, P1602, DOI 10.1093/brain/awq085; Kirk SL, 2003, J AUTOIMMUN, V21, P353, DOI 10.1016/S0896-8411(03)00139-2; Kivisakk P, 2009, NEUROLOGY, V72, P1922, DOI 10.1212/WNL.0b013e3181a8266f; Kozak T, 2002, J NEUROL, V249, P1088, DOI 10.1007/s00415-002-0800-7; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; LAMBRECHTS D, 2008, J MED GENET; Lopez-Diego RS, 2008, NAT REV DRUG DISCOV, V7, P909, DOI 10.1038/nrd2358; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Manoonkitiwongsa PS, 2004, J CEREBR BLOOD F MET, V24, P693, DOI 10.1097/01.WCB.0000126236.54306.21; Mor F, 2004, J IMMUNOL, V172, P4618, DOI 10.4049/jimmunol.172.7.4618; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Proescholdt MA, 2002, J NEUROPATH EXP NEUR, V61, P914, DOI 10.1093/jnen/61.10.914; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Rovaris M, 2006, LANCET NEUROL, V5, P343, DOI 10.1016/S1474-4422(06)70410-0; Salzer J, 2010, MULT SCLER J, V16, P287, DOI 10.1177/1352458509359725; Seabrook TJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-95; SEABROOK TJ, J NEUROINFLAMMATION, V7, P95; Sellebjerg F, 2009, NEUROLOGY, V73, P2003, DOI 10.1212/WNL.0b013e3181c5b457; Shahbazi M, 2002, J AM SOC NEPHROL, V13, P260, DOI 10.1681/ASN.V131260; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Su JJ, 2006, J NEUROL SCI, V243, P21, DOI 10.1016/j.jns.2005.11.006; Tarkowski E, 2002, NEUROBIOL AGING, V23, P237, DOI 10.1016/S0197-4580(01)00285-8; Teunissen CE, 2009, NEUROLOGY, V72, P1322, DOI 10.1212/WNL.0b013e3181a0fe3f; Tham E, 2006, SCAND J IMMUNOL, V64, P609, DOI 10.1111/j.1365-3083.2006.01851.x; Vogt J, 2009, ANN NEUROL, V66, P310, DOI 10.1002/ana.21719; Yang SP, 2004, NEUROBIOL AGING, V25, P283, DOI 10.1016/S0197-4580(03)00111-8; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336	46	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19138	10.1371/journal.pone.0019138	http://dx.doi.org/10.1371/journal.pone.0019138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573104	Green Submitted, Green Published, gold			2022-12-25	WOS:000290305600012
J	Stoimenov, I; Schultz, N; Gottipati, P; Helleday, T				Stoimenov, Ivaylo; Schultz, Niklas; Gottipati, Ponnari; Helleday, Thomas			Transcription Inhibition by DRB Potentiates Recombinational Repair of UV Lesions in Mammalian Cells	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; REPLICATION FORK PROGRESSION; NUCLEOTIDE EXCISION-REPAIR; HOMOLOGOUS RECOMBINATION; P-TEFB; XERODERMA-PIGMENTOSUM; H2AX PHOSPHORYLATION; DNA-REPAIR; CHO-CELLS; CYCLE	Homologous recombination (HR) is intricately associated with replication, transcription and DNA repair in all organisms studied. However, the interplay between all these processes occurring simultaneously on the same DNA molecule is still poorly understood. Here, we study the interplay between transcription and HR during ultraviolet light (UV)-induced DNA damage in mammalian cells. Our results show that inhibition of transcription with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) increases the number of UV-induced DNA lesions (gamma H2AX, 53BP1 foci formation), which correlates with a decrease in the survival of wild type or nucleotide excision repair defective cells. Furthermore, we observe an increase in RAD51 foci formation, suggesting HR is triggered in response to an increase in UV-induced DSBs, while inhibiting transcription. Unexpectedly, we observe that DRB fails to sensitise HR defective cells to UV treatment. Thus, increased RAD51 foci formation correlates with increased cell death, suggesting the existence of a futile HR repair of UV-induced DSBs which is linked to transcription inhibition.	[Stoimenov, Ivaylo; Schultz, Niklas; Helleday, Thomas] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; [Gottipati, Ponnari; Helleday, Thomas] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England	Stockholm University; University of Oxford	Stoimenov, I (corresponding author), Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden.	helleday@gmt.su.se	Helleday, Thomas/D-5224-2013; Schultz, Niklas/AFQ-8244-2022	Gottipati, Ponnari/0000-0002-3596-5633; Helleday, Thomas/0000-0002-7384-092X; Stoimenov, Ivaylo/0000-0002-2133-7396	Swedish Cancer Society; Swedish Children's Cancer Foundation; Swedish Research Council; Swedish Pain Relief Foundation; Medical Research Council; MRC [G0700730] Funding Source: UKRI; Medical Research Council [G0700730] Funding Source: researchfish	Swedish Cancer Society(Swedish Cancer Society); Swedish Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Pain Relief Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Swedish Cancer Society, Swedish Children's Cancer Foundation, Swedish Research Council, and Swedish Pain Relief Foundation and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; AUBRECHT J, 1995, CARCINOGENESIS, V16, P2841, DOI 10.1093/carcin/16.11.2841; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; CALDECOTT K, 1991, MUTAT RES, V255, P111, DOI 10.1016/0921-8777(91)90046-R; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Chavez S, 1997, GENE DEV, V11, P3459, DOI 10.1101/gad.11.24.3459; CHRISTIANS FC, 1992, MUTAT RES, V274, P93, DOI 10.1016/0921-8777(92)90056-9; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; FULLER LF, 1988, MUTAT RES, V193, P109, DOI 10.1016/0167-8817(88)90041-7; Gottipati P, 2008, MOL CELL BIOL, V28, P154, DOI 10.1128/MCB.00816-07; Gottipati P, 2009, MUTAGENESIS, V24, P203, DOI 10.1093/mutage/gen072; Helleday T, 1998, CARCINOGENESIS, V19, P973, DOI 10.1093/carcin/19.6.973; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hendriks G, 2008, DNA REPAIR, V7, P1330, DOI 10.1016/j.dnarep.2008.04.015; Hendriks G, 2010, CURR BIOL, V20, P170, DOI 10.1016/j.cub.2009.11.061; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Saleh-Gohari N, 2004, NUCLEIC ACIDS RES, V32, P3683, DOI 10.1093/nar/gkh703; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Savolainen L, 2009, NUCLEIC ACIDS RES, V37, P405, DOI 10.1093/nar/gkn971; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; SMITH KC, 1987, MUTAT RES, V183, P1, DOI 10.1016/0167-8817(87)90039-3; Stoimenov I, 2011, MUTAT RES-FUND MOL M, V706, P1, DOI 10.1016/j.mrfmmm.2010.10.012; Theron T, 2005, MOL CELL BIOL, V25, P8368, DOI 10.1128/MCB.25.18.8368-8378.2005; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; WANG YY, 1988, MOL CELL BIOL, V8, P196, DOI 10.1128/MCB.8.1.196; WEBER CA, 1988, MOL CELL BIOL, V8, P1137, DOI 10.1128/MCB.8.3.1137; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Wilson PF, 2010, DNA REPAIR, V9, P737, DOI 10.1016/j.dnarep.2010.03.009; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8	42	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19492	10.1371/journal.pone.0019492	http://dx.doi.org/10.1371/journal.pone.0019492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573160	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000290256400015
J	Savvidou, MD; Kaihura, C; Anderson, JM; Nicolaides, KH				Savvidou, Makrina D.; Kaihura, Christina; Anderson, James M.; Nicolaides, Kypros H.			Maternal Arterial Stiffness in Women Who Subsequently Develop Pre-Eclampsia	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; HYPERTENSIVE DISORDERS; ANTIHYPERTENSIVE THERAPY; CENTRAL HEMODYNAMICS; GESTATIONAL-AGE; PREGNANCY; PRESSURE; PREDICTION; DOPPLER; REFLECTIONS	Background/Objectives: Pre-eclampsia (PE) is associated with profound changes in the maternal cardiovascular system. The aim of the present study was to assess whether alterations in the maternal arterial stiffness precede the onset of PE in at risk women. Methodology/Principal Findings: This was a cross sectional study involving 70 pregnant women with normal and 70 women with abnormal uterine artery Doppler examination at 22-24 weeks of gestation. All women had their arterial stiffness (augmentation index and pulse wave velocity of the carotid-femoral and carotid-radial parts of the arterial tree) assessed by applanation tonometry in the second trimester of pregnancy, at the time of the uterine artery Doppler imaging. Among the 140 women participating in the study 29 developed PE (PE group) and 111 did not (non-PE group). Compared to the non-PE group, women that developed PE had higher central systolic (94.9 +/- 8.6 mmHg vs 104.3 +/- 11.1 mmHg; p = < 0.01) and diastolic (64.0 +/- 6.0 vs 72.4 +/- 9.1; p < 0.01) blood pressures. All the arterial stiffness indices were adjusted for possible confounders and expressed as multiples of the median (MoM) of the non-PE group. The adjusted median augmentation index was similar between the two groups (p = 0.84). The adjusted median pulse wave velocities were higher in the PE group compared to the non-PE group (carotid-femoral: 1.10 +/- 0.14 MoMs vs 0.99 +/- 0.11 MoMs; p < 0.01 and carotid-radial: 1.08 +/- 0.12 MoMs vs 1.0 +/- 0.11 MoMs; p < 0.01). Conclusions/Significance: Increased maternal arterial stiffness, as assessed by pulse wave velocity, predates the development of PE in at risk women.	[Savvidou, Makrina D.] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Sch Med, Dept Maternal Fetal Med, London, England; [Savvidou, Makrina D.; Kaihura, Christina; Anderson, James M.; Nicolaides, Kypros H.] Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London, England	Imperial College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Savvidou, MD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Sch Med, Dept Maternal Fetal Med, London, England.	msavvidou@dsla.ndo.co.uk		Nicolaides, Kypros/0000-0003-1266-0711; SAVVIDOU, MAKRINA/0000-0002-0125-2299	Fetal Medicine Foundation (United Kingdom) [1037116]	Fetal Medicine Foundation (United Kingdom)	This study was supported by a grant from the Fetal Medicine Foundation (United Kingdom charity No. 1037116), which is an independent charity organisation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti-Rosei E, 2007, HYPERTENSION, V50, P154, DOI 10.1161/HYPERTENSIONAHA.107.090068; AVOLIO AP, 1983, CIRCULATION, V68, P50, DOI 10.1161/01.CIR.68.1.50; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; CAMPBELL S, 1983, LANCET, V1, P675; DAVEY DA, 1988, AM J OBSTET GYNECOL, V158, P892, DOI 10.1016/0002-9378(88)90090-7; Dodds L, 2008, CLIN CHEM, V54, P326, DOI 10.1373/clinchem.2007.097469; Elvan-Taspinar A, 2005, J HYPERTENS, V23, P147, DOI 10.1097/00004872-200501000-00025; Elvan-Taspinar A, 2004, AM J HYPERTENS, V17, P941, DOI 10.1016/j.amjhyper.2004.05.018; Gedikli O, 2008, AM J HYPERTENS, V21, P989, DOI 10.1038/ajh.2008.235; Giltay EJ, 1999, DIABETOLOGIA, V42, P214, DOI 10.1007/s001250051141; Kaihura C, 2009, AM J PHYSIOL-HEART C, V297, pH759, DOI 10.1152/ajpheart.01106.2008; Kelly RP, 2001, HYPERTENSION, V37, P1429, DOI 10.1161/01.HYP.37.6.1429; Khalil AA, 2009, BJOG-INT J OBSTET GY, V116, P268, DOI 10.1111/j.1471-0528.2008.01906.x; Khalil A, 2009, OBSTET GYNECOL, V113, P646, DOI 10.1097/AOG.0b013e318197c392; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Macedo ML, 2008, HYPERTENSION, V51, P1047, DOI 10.1161/HYPERTENSIONAHA.107.106062; Mayer O, 2006, J HUM HYPERTENS, V20, P267, DOI 10.1038/sj.jhh.1001983; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; ORourke MF, 1996, J HYPERTENS, V14, pS147; Papageorghiou AT, 2004, BEST PRACT RES CL OB, V18, P383, DOI 10.1016/j.bpobgyn.2004.02.003; Pauca AL, 2001, HYPERTENSION, V38, P932, DOI 10.1161/hy1001.096106; Poon LCY, 2008, HYPERTENSION, V51, P1027, DOI 10.1161/HYPERTENSIONAHA.107.104646; Reinders A, 2005, BJOG-INT J OBSTET GY, V112, P915, DOI 10.1111/j.1471-0528.2005.00617.x; Robb AO, 2009, HYPERTENSION, V53, P952, DOI 10.1161/HYPERTENSIONAHA.109.130898; Ronnback M, 2005, HYPERTENS PREGNANCY, V24, P171, DOI 10.1081/PRG-200059871; Safar ME, 2002, HYPERTENSION, V39, P735, DOI 10.1161/hy0202.098325; Savvidou MD, 2003, LANCET, V361, P1511, DOI 10.1016/S0140-6736(03)13177-7; SPASOJEVIC M, 2009, BJOG, V112, P1475; Vyssoulis GP, 2010, INT J CARDIOL, V138, P119, DOI 10.1016/j.ijcard.2008.08.005; *WHO COLL, 2005, WORLD HLTH REP WHO C; Wilkinson IB, 1998, J HYPERTENS, V16, P2079, DOI 10.1097/00004872-199816121-00033; Wilkinson IB, 2002, J AM COLL CARDIOL, V39, P1005, DOI 10.1016/S0735-1097(02)01723-0; Wolf M, 2002, J CLIN ENDOCR METAB, V87, P1563, DOI 10.1210/jc.87.4.1563; Yu CKH, 2008, ULTRASOUND OBST GYN, V31, P310, DOI 10.1002/uog.5252; Yu CKH, 2005, AM J OBSTET GYNECOL, V193, P429, DOI 10.1016/j.ajog.2004.12.014	35	51	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e18703	10.1371/journal.pone.0018703	http://dx.doi.org/10.1371/journal.pone.0018703			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559278	Green Submitted, gold, Green Published			2022-12-25	WOS:000290223500001
J	Hacker, S; Karl, S; Mader, I; Cristofanon, S; Schweitzer, T; Krauss, J; Rutkowski, S; Debatin, KM; Fulda, S				Haecker, S.; Karl, S.; Mader, I.; Cristofanon, S.; Schweitzer, T.; Krauss, J.; Rutkowski, S.; Debatin, K-M; Fulda, S.			Histone deacetylase inhibitors prime medulloblastoma cells for chemotherapy-induced apoptosis by enhancing p53-dependent Bax activation	ONCOGENE			English	Article						HDACI; apoptosis; medulloblastoma; mitochondria; chemotherapy	IN-VIVO; KU70 ACETYLATION; PROSTATE-CANCER; EXPRESSION; RESISTANCE; CASPASE-8; THERAPY; TRAIL; SENSITIZATION; SYSTEM	Despite aggressive therapies, the prognosis of children with high-risk medulloblastoma is still poor, thus underscoring the need to develop novel treatment strategies. Here, we report that histone deacetylase inhibitors (HDACI), that is, MS-275, valproic acid or SAHA, provide a novel strategy for sensitization of medulloblastoma to DNA-damaging drugs such as Doxorubicin, VP16 and Cisplatin by promoting p53-dependent, mitochondrial apoptosis. Mechanistic studies reveal that single-agent treatment with MS-275 causes acetylation of the non-histone protein Ku70, an event reported to release Bax from Ku70, whereas DNA-damaging drugs trigger p53 acetylation and accumulation. Combined treatment with MS-275 and Doxorubicin or VP16 cooperates to promote binding of p53 to Bax and p53-dependent Bax activation, resulting in enhanced loss of mitochondrial membrane potential, cytochrome c release and caspase-dependent apoptosis. Overexpression of Bcl-2 almost completely abolishes the MS-275-mediated chemosensitization, underlining the importance of the mitochondrial pathway for inducing apoptosis. Also, MS-275 cooperates with chemotherapeutics to inhibit long-term clonogenic survival. Most importantly, MS-275 increases chemotherapeutic drug-induced apoptosis in primary medulloblastoma samples, and cooperates with Doxorubicin to suppress medulloblastoma growth in an in vivo model, which underscores the clinical relevance of the findings. Thus, HDACI such as MS-275 present a promising approach for chemosensitization of medulloblastoma by enhancing mitochondrial apoptosis in a p53-dependent manner. These findings have important clinical implications for the design of experimental treatment protocols for medulloblastoma. Oncogene (2011) 30, 2275-2281; doi:10.1038/onc.2010.599; published online 17 January 2011	[Cristofanon, S.; Fulda, S.] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60528 Frankfurt, Germany; [Haecker, S.; Karl, S.; Mader, I.; Debatin, K-M] Univ Childrens Hosp, Ulm, Germany; [Schweitzer, T.; Krauss, J.] Univ Wurzburg, Dept Neurosurg, Wurzburg, Germany; [Rutkowski, S.] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany	Goethe University Frankfurt; Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Komturstr 3A, D-60528 Frankfurt, Germany.	simone.fulda@kgu.de	Schweitzer, Tilmann/K-6471-2014; Debatin, Klaus-Michael/J-9704-2014	Fulda, Simone/0000-0002-0459-6417; Debatin, Klaus-Michael/0000-0002-8397-1886	Deutsche Forschungsgemeinschaft [IAP6/18]; European Community	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community(European Commission)	We thank R Agami (The Netherlands Cancer Institute, Amsterdam, The Netherlands) for kindly providing pRETRO-SUPER vector, CA Schmitt (Berlin, Germany) for providing mouse Bcl-2 vector and A Dittrich for expert technical assistance. This work has been partially supported by grants from the Deutsche Forschungsgemeinschaft, Else Kroner-Fresenius-Stiftung, IAP6/18 and the European Community (ApopTrain, APO-SYS) (to SF).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen CS, 2007, CANCER RES, V67, P5318, DOI 10.1158/0008-5472.CAN-06-3996; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; Giagkousiklidis S, 2005, CANCER RES, V65, P10502, DOI 10.1158/0008-5472.CAN-05-0866; Grotzer MA, 2000, ONCOGENE, V19, P4604, DOI 10.1038/sj.onc.1203816; Hacker S, 2009, ONCOGENE, V28, P3097, DOI 10.1038/onc.2009.161; Hess-Stumpp H, 2007, INT J BIOCHEM CELL B, V39, P1388, DOI 10.1016/j.biocel.2007.02.009; Jaboin J, 2002, CANCER RES, V62, P6108; Karl S, 2009, J CELL MOL MED, V13, P4239, DOI 10.1111/j.1582-4934.2009.00888.x; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Kuefer R, 2004, BRIT J CANCER, V90, P535, DOI 10.1038/sj.bjc.6601510; Lee MJ, 2008, CURR OPIN ONCOL, V20, P639, DOI 10.1097/CCO.0b013e3283127095; Rossi A, 2008, CLIN CANCER RES, V14, P971, DOI 10.1158/1078-0432.CCR-07-2072; Rutkowski S, 2007, CLIN CANCER RES, V13, P2651, DOI 10.1158/1078-0432.CCR-06-1779; Subramanian C, 2005, P NATL ACAD SCI USA, V102, P4842, DOI 10.1073/pnas.0408351102; Sykes SM, 2009, J BIOL CHEM, V284, P20197, DOI 10.1074/jbc.M109.026096; Tabori U, 2010, J CLIN ONCOL, V28, P1345, DOI 10.1200/JCO.2009.23.5952; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200	24	38	38	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2011	30	19					2275	2281		10.1038/onc.2010.599	http://dx.doi.org/10.1038/onc.2010.599			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	762XD	21562496				2022-12-25	WOS:000290514600010
J	Chatterjee, C; Kumar, S; Chakraborty, S; Tan, YW; Leung, KY; Sivaraman, J; Mok, YK				Chatterjee, Chiradip; Kumar, Sundramurthy; Chakraborty, Smarajit; Tan, Yih Wan; Leung, Ka Yin; Sivaraman, J.; Mok, Yu-Keung			Crystal Structure of the Heteromolecular Chaperone, AscE-AscG, from the Type III Secretion System in Aeromonas hydrophila	PLOS ONE			English	Article							PROTEIN; COMPLEX; BINDING; REGIONS; CRYSTALLOGRAPHY; ALIGNMENT; DISORDER; MODELS; FOLD	Background: The putative needle complex subunit AscF forms a ternary complex with the chaperones AscE and AscG in the type III secretion system of Aeromonas hydrophila so as to avoid premature assembly. Previously, we demonstrated that the C-terminal region of AscG (residues 62-116) in the hetero-molecular chaperone, AscE-AscG, is disordered and susceptible to limited protease digestion. Methodology/Principal Findings: Here, we report the crystal structure of the ordered AscG(1-61) region in complex with AscE at 2.4 angstrom resolution. Helices alpha(2) and alpha(3) of AscE in the AscE-AscG(1-61) complex assumes a helix-turn-helix conformation in an anti-parallel fashion similar to that in apo AscE. However, in the presence of AscG, an additional N-terminal helix alpha 1 in AscE (residues 4-12) is observed. PscG or YscG in the crystal structures of PscE-PscF-PscG or YscE-YscF-YscG, respectively, assumes a typical tetratricopeptide repeat (TPR) fold with three TPR repeats and one C-terminal capping helix. By comparison, AscG in AscE-AscG(1-61) comprises three anti-parallel helices that resembles the N-terminal TPR repeats in the corresponding region of PscG or YscG in PscE-PscF-PscG or YscE-YscF-YscG. Thermal denaturation of AscE-AscG and AscE-AscG(1-61) complexes demonstrates that the C-terminal disordered region does not contribute to the thermal stability of the overall complex. Conclusion/Significance: The N-terminal region of the AscG in the AscE-AscG complex is ordered and assumes a structure similar to those in the corresponding regions of PscE-PscG-PscF or YscE-YscF-YscG complexes. While the C-terminal region of AscG in the AscE-AscG complex is disordered and will assume its structure only in the presence of the substrate AscF. We hypothesize that AscE act as a chaperone of the chaperone to keep AscG in a stable but partially disordered state for interaction with AscF.	[Chatterjee, Chiradip; Kumar, Sundramurthy; Chakraborty, Smarajit; Tan, Yih Wan; Leung, Ka Yin; Sivaraman, J.; Mok, Yu-Keung] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Chatterjee, C (corresponding author), Republ Polytech, Sch Appl Sci, Singapore, Singapore.	dbsmokh@nus.edu.sg	Sivaraman, J/H-8028-2012; Mok, Yu Keung/H-8019-2012	Mok, Yu Keung/0000-0002-2829-4878; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council (BMRC) of the Agency for Science Technology and Research (A*STAR) of Singapore [07/1/21/19/495]; Natural Science and Engineering Research Council (NSERC) [372373-2010]; Trinity [0488]	Biomedical Research Council (BMRC) of the Agency for Science Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Trinity	This work was supported by a grant from the Biomedical Research Council (BMRC) of the Agency for Science Technology and Research (A*STAR) of Singapore to YKM (07/1/21/19/495), a Natural Science and Engineering Research Council (NSERC) Discovery Grant (372373-2010) and a Trinity Western Startup Grant (0488) to KYL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin B, 1996, GENUS AEROMONAS, P197; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Birtalan S, 2001, NAT STRUCT BIOL, V8, P974, DOI 10.1038/nsb1101-974; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buttner CR, 2008, J MOL BIOL, V375, P997, DOI 10.1016/j.jmb.2007.11.009; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Edqvist PJ, 2006, MOL MICROBIOL, V59, P31, DOI 10.1111/j.1365-2958.2005.04923.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Gugolya Z, 2003, FEBS LETT, V535, P66, DOI 10.1016/S0014-5793(02)03859-0; Janda JM, 2001, MOL MED MICROBIOLOGY, P1237; Job V, 2010, J BIOL CHEM, V285, P23222, DOI 10.1074/jbc.M110.111278; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P1; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phan J, 2005, PROTEIN SCI, V14, P2759, DOI 10.1110/ps.051706105; Quinaud M, 2005, J BIOL CHEM, V280, P36293, DOI 10.1074/jbc.M508089200; Quinaud M, 2007, P NATL ACAD SCI USA, V104, P7803, DOI 10.1073/pnas.0610098104; Rodgers L, 2008, J BIOL CHEM, V283, P20857, DOI 10.1074/jbc.M802339200; RUIZSANZ J, 1995, BIOCHEMISTRY-US, V34, P1695, DOI 10.1021/bi00005a026; Sha J, 2007, MICROB PATHOGENESIS, V43, P127, DOI 10.1016/j.micpath.2007.05.002; Sierra JC, 2007, MICROB PATH IN PRESS; Sippl MJ, 2008, BIOINFORMATICS, V24, P872, DOI 10.1093/bioinformatics/btn040; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Sun P, 2008, J MOL BIOL, V377, P819, DOI 10.1016/j.jmb.2007.12.067; Tan YW, 2008, PROTEIN SCI, V17, P1748, DOI 10.1110/ps.036798.108; Tan YW, 2009, PROTEIN SCI, V18, P1724, DOI 10.1002/pro.187; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thune Ronald L., 1993, Annual Review of Fish Diseases, V3, P37, DOI 10.1016/0959-8030(93)90028-A; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Vilches S, 2007, MICROB PATH IN PRESS; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659; Yip CK, 2006, TRENDS BIOCHEM SCI, V31, P223, DOI 10.1016/j.tibs.2006.02.005; Yu HB, 2004, INFECT IMMUN, V72, P1248, DOI 10.1128/IAI.72.3.1248-1256.2004; Yu HB, 2007, PROTEOMICS, V7, P436, DOI 10.1002/pmic.200600396	45	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19208	10.1371/journal.pone.0019208	http://dx.doi.org/10.1371/journal.pone.0019208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559439	gold, Green Submitted, Green Published			2022-12-25	WOS:000290024700103
J	Cherezova, L; Burnside, KL; Rose, TM				Cherezova, Lidia; Burnside, Kellie L.; Rose, Timothy M.			Conservation of Complex Nuclear Localization Signals Utilizing Classical and Non-Classical Nuclear Import Pathways in LANA Homologs of KSHV and RFHV	PLOS ONE			English	Article							SARCOMA-ASSOCIATED-HERPESVIRUS; IMMUNODEFICIENCY-VIRUS TYPE-1; KAPOSIS-SARCOMA; STRUCTURAL BASIS; BINDING PROTEIN; TUMOR-CELLS; REV PROTEIN; HNRNP A1; LATENCY; ANTIGEN	ORF73 latency-associated nuclear antigen (LANA) of the Kaposi's sarcoma-associated herpesvirus (KSHV) is targeted to the nucleus of infected cells where it binds to chromatin and mediates viral episome persistence, interacts with cellular proteins and plays a role in latency and tumorigenesis. A structurally related LANA homolog has been identified in the retroperitoneal fibromatosis herpesvirus (RFHV), the macaque homolog of KSHV. Here, we report the evolutionary and functional conservation of a novel bi-functional nuclear localization signal (NLS) in KSHV and RFHV LANA. N-terminal peptides from both proteins were fused to EGFP or double EGFP fusions to examine their ability to induce nuclear transport of a heterologous protein. In addition, GST-pull down experiments were used to analyze the ability of LANA peptides to interact with members of the karyopherin family of nuclear transport receptors. Our studies revealed that both LANA proteins contain an N-terminal arginine/glycine (RG)-rich domain spanning a conserved chromatin-binding motif, which binds directly to importin beta 1 in a RanGTP-sensitive manner and serves as an NLS in the importin beta 1-mediated non-classical nuclear import pathway. Embedded within this domain is a conserved lysine/arginine-(KR)-rich bipartite motif that binds directly to multiple members of the importin a family of nuclear import adaptors in a RanGTP-insensitive manner and serves as an NLS in the classical importin alpha/beta-mediated nuclear import pathway. The positioning of a classical bipartite kr-NLS embedded within a non-classical rg-NLS is a unique arrangement in these viral proteins, whose nuclear localization is critical to their functionality and to the virus life cycle. The ability to interact with multiple import receptors provides alternate pathways for nuclear localization of LANA. Since different import receptors can import cargo to distinct subnuclear compartments, a multifunctional NLS may provide LANA with an increased ability to interact with different nuclear components in its multifunctional role to maintain viral latency.	[Cherezova, Lidia] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Cherezova, Lidia; Burnside, Kellie L.; Rose, Timothy M.] Seattle Childrens Res Inst, Ctr Childhood Infect & Prematur Res, Seattle, WA USA; [Rose, Timothy M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Cherezova, L (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	timothy.rose@seattlechildrens.org			National Center for Research Resource (NCRR) [RR13154]; National Institute for Dental and Craniofacial Research (NIDCR) [DE016826]; National Institutes of Health (NIH); National Institute of Dental and Craniofacial Research [DE07023]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR013154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007023, R21DE016826] Funding Source: NIH RePORTER	National Center for Research Resource (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute for Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Public Health Service grants to T.M.R. from the National Center for Research Resource (NCRR) (RR13154) and the National Institute for Dental and Craniofacial Research (NIDCR) (DE016826), National Institutes of Health (NIH), and to K.L.B. who received support from the Cross-Disciplinary Dental Science Research Training Grant DE07023 from the National Institute of Dental and Craniofacial Research. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of NCRR, NIDCR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBINDER RF, 1991, J VIROL, V65, P1466, DOI 10.1128/JVI.65.3.1466-1478.1991; Antman K, 2000, NEW ENGL J MED, V342, P1027, DOI 10.1056/NEJM200004063421407; Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Barbera AJ, 2004, J VIROL, V78, P294, DOI 10.1128/JVI.78.1.294-301.2004; Bian XL, 2007, J VIROL, V81, P2899, DOI 10.1128/JVI.01850-06; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; Bruce AG, 2006, J GEN VIROL, V87, P3529, DOI 10.1099/vir.0.82339-0; Burnside KL, 2006, VIROLOGY, V354, P103, DOI 10.1016/j.virol.2006.06.022; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Corredor AG, 2009, J VIROL, V83, P12842, DOI 10.1128/JVI.01613-09; Cotter MA, 1999, VIROLOGY, V264, P254, DOI 10.1006/viro.1999.9999; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Forwood JK, 2001, BIOCHEMISTRY-US, V40, P5208, DOI 10.1021/bi002732+; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fujimuro M, 2005, J VIROL, V79, P10429, DOI 10.1128/JVI.79.16.10429-10441.2005; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Garber AC, 2001, J VIROL, V75, P7882, DOI 10.1128/JVI.75.17.7882-7892.2001; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Harel A, 2003, MOL BIOL CELL, V14, P4387, DOI 10.1091/mbc.E03-05-0275; Henderson BR, 1997, J MOL BIOL, V274, P693, DOI 10.1006/jmbi.1997.1420; Hogarth CA, 2006, DEV DYNAM, V235, P253, DOI 10.1002/dvdy.20569; Hosokawa K, 2008, NEUROSCIENCE, V157, P864, DOI 10.1016/j.neuroscience.2008.09.045; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Ito S, 2000, VIROLOGY, V266, P110, DOI 10.1006/viro.1999.0054; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Johnson-Saliba M, 2000, FEBS LETT, V467, P169, DOI 10.1016/S0014-5793(00)01142-X; Kedes DH, 1997, J CLIN INVEST, V100, P2606, DOI 10.1172/JCI119804; Kellam P, 1997, J Hum Virol, V1, P19; Kitamura R, 2006, J VIROL, V80, P1979, DOI 10.1128/JVI.80.4.1979-1991.2006; Knapp AA, 2009, VIROLOGY, V383, P60, DOI 10.1016/j.virol.2008.09.037; Kurnari G, 2007, J MOL BIOL, V367, P1294, DOI 10.1016/j.jmb.2007.01.026; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Lam MHC, 2001, BIOCHEM BIOPH RES CO, V282, P629, DOI 10.1006/bbrc.2001.4607; Lan K, 2004, J VIROL, V78, P6585, DOI 10.1128/JVI.78.12.6585-6594.2004; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Le Roux LG, 2003, J VIROL, V77, P2330, DOI 10.1128/JVI.77.4.2330-2337.2003; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Leslie DM, 2004, MOL CELL BIOL, V24, P8487, DOI 10.1128/MCB.24.19.8487-8503.2004; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; Lin CY, 2000, J BIOL CHEM, V275, P37815, DOI 10.1074/jbc.M002470200; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Moore JD, 1999, J CELL BIOL, V144, P213, DOI 10.1083/jcb.144.2.213; Moroianu J, 1998, J CELL BIOCHEM, V70, P231; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; Nakahara S, 2006, CANCER RES, V66, P9995, DOI 10.1158/0008-5472.CAN-06-1772; Narayanan U, 2002, HUM MOL GENET, V11, P1785, DOI 10.1093/hmg/11.15.1785; Palmeri D, 1999, MOL CELL BIOL, V19, P1218; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Piolot T, 2001, J VIROL, V75, P3948, DOI 10.1128/JVI.75.8.3948-3959.2001; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Radkov SA, 2000, NAT MED, V6, P1121, DOI 10.1038/80459; Rainbow L, 1997, J VIROL, V71, P5915, DOI 10.1128/JVI.71.8.5915-5921.1997; Rao MRKS, 2006, J MOL BIOL, V364, P637, DOI 10.1016/j.jmb.2006.09.007; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Sakakida Y, 2005, J BIOL CHEM, V280, P13272, DOI 10.1074/jbc.M413236200; Schickling O, 2001, CELL DEATH DIFFER, V8, P1157, DOI 10.1038/sj.cdd.4400928; Schwam DR, 2000, J VIROL, V74, P8532, DOI 10.1128/JVI.74.18.8532-8540.2000; Shinohara H, 2002, J VIROL, V76, P12917, DOI 10.1128/JVI.76.24.12917-12924.2002; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tiganis T, 1997, J BIOL CHEM, V272, P21548, DOI 10.1074/jbc.272.34.21548; Truant R, 1998, MOL CELL BIOL, V18, P1449, DOI 10.1128/MCB.18.3.1449; Truant R, 1999, MOL CELL BIOL, V19, P1210; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; WEIGHARDT F, 1995, J CELL SCI, V108, P545; Wodrich H, 2006, J VIROL, V80, P9608, DOI 10.1128/JVI.00850-06; Wong LY, 2004, J VIROL, V78, P10074, DOI 10.1128/JVI.78.18.10074-10085.2004; Xiao Z, 2000, J BIOL CHEM, V275, P23425, DOI 10.1074/jbc.C000345200; Yeung PL, 2006, BIOCHEM BIOPH RES CO, V348, P13, DOI 10.1016/j.bbrc.2006.06.163; ZACKSENHAUS E, 1993, MOL CELL BIOL, V13, P4588, DOI 10.1128/MCB.13.8.4588	81	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18920	10.1371/journal.pone.0018920	http://dx.doi.org/10.1371/journal.pone.0018920			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559489	Green Submitted, gold, Green Published			2022-12-25	WOS:000290024700036
J	Jin, QE; Chen, HY; Luo, AP; Ding, F; Liu, ZH				Jin, Qing'e; Chen, Hongyan; Luo, Aiping; Ding, Fang; Liu, Zhihua			S100A14 Stimulates Cell Proliferation and Induces Cell Apoptosis at Different Concentrations via Receptor for Advanced Glycation End Products (RAGE)	PLOS ONE			English	Article							NEURITE OUTGROWTH; CANCER; PROTEINS; SURVIVAL; GROWTH; ACTIVATION; EXPRESSION; AMPHOTERIN; S100A8/A9; MIGRATION	S100A14 is an EF-hand containing calcium-binding protein of the S100 protein family that exerts its biological effects on different types of cells. However, exact extracellular roles of S100A14 have not been clarified yet. Here we investigated the effects of S100A14 on esophageal squamous cell carcinoma (ESCC) cell lines. Results demonstrated that low doses of extracellular S100A14 stimulate cell proliferation and promote survival in KYSE180 cells through activating ERK1/2 MAPK and NF-kappa B signaling pathways. Immunoprecipitation assay showed that S100A14 binds to receptor for advanced glycation end products (RAGE) in KYSE180 cells. Inhibition of RAGE signaling by different approaches including siRNA for RAGE, overexpression of a dominant-negative RAGE construct or a RAGE antagonist peptide (AmphP) significantly blocked S100A14-induced effects, suggesting that S100A14 acts via RAGE ligation. Furthermore, mutation of the N-EF hand of S100A14 (E39A, E45A) virtually reduced 10 mg/ml S100A14-induced cell proliferation and ERK1/2 activation. However, high dose (80 mg/ml) of S100A14 causes apoptosis via the mitochondrial pathway with activation of caspase-3, caspase-9, and poly(ADP-ribose) polymerase. High dose S100A14 induces cell apoptosis is partially in a RAGE-dependent manner. This is the first study to demonstrate that S100A14 binds to RAGE and stimulates RAGE-dependent signaling cascades, promoting cell proliferation or triggering cell apoptosis at different doses.	[Jin, Qing'e] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Jin, QE (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	liuzh@cicams.ac.cn			National Natural Science Foundation of China [30721001, 81000954]; National Basic Research Program of China [2011CB504205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (30721001, 81000954) and National Basic Research Program of China (2011CB504205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PJ, 2003, J BIOL CHEM, V278, P6482, DOI 10.1074/jbc.M210184200; Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Businaro R, 2006, J NEUROSCI RES, V83, P897, DOI 10.1002/jnr.20785; Cecil DL, 2005, J IMMUNOL, V175, P8296, DOI 10.4049/jimmunol.175.12.8296; Chen HY, 2009, CANCER RES, V69, P3451, DOI 10.1158/0008-5472.CAN-08-4231; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Emberley ED, 2004, BIOCHEM CELL BIOL, V82, P508, DOI 10.1139/O04-052; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Fuentes MK, 2007, DIS COLON RECTUM, V50, P1230, DOI 10.1007/s10350-006-0850-5; Ghavami S, 2004, J LEUKOCYTE BIOL, V76, P169, DOI 10.1189/jlb.0903435; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; Ghavami S, 2008, BBA-MOL CELL RES, V1783, P297, DOI 10.1016/j.bbamcr.2007.10.015; Han Yaling, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P455; Heizmann C. W., 2007, V45, P93; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hsieh HL, 2004, BIOCHEM BIOPH RES CO, V316, P949, DOI 10.1016/j.bbrc.2004.02.135; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Huttunen HJ, 2002, CANCER RES, V62, P4805; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Ismail TM, 2010, J BIOL CHEM, V285, P914, DOI 10.1074/jbc.M109.010892; Lavoie C, 2002, MOL ENDOCRINOL, V16, P2462, DOI 10.1210/me.2002-0079; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Logsdon CD, 2007, CURR MOL MED, V7, P777, DOI 10.2174/156652407783220697; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Pietas A, 2002, GENOMICS, V79, P513, DOI 10.1006/geno.2002.6744; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Schmidt-Hansen B, 2004, J BIOL CHEM, V279, P24498, DOI 10.1074/jbc.M400441200; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Sorci G, 2004, J CELL PHYSIOL, V199, P274, DOI 10.1002/jcp.10462; Sorci G, 2003, MOL CELL BIOL, V23, P4870, DOI 10.1128/MCB.23.14.4870-4881.2003; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Vincent AM, 2007, ENDOCRINOLOGY, V148, P548, DOI 10.1210/en.2006-0073; Wang HY, 2010, ONCOL REP, V23, P45, DOI 10.3892/or_00000604; Yammani RR, 2006, ARTHRITIS RHEUM-US, V54, P2901, DOI 10.1002/art.22042; Yao R, 2007, ANTICANCER RES, V27, P3051; Zhang LY, 2006, CLIN CANCER RES, V12, P1639, DOI 10.1158/1078-0432.CCR-05-1858; Zhang S, 2005, ONCOGENE, V24, P4401, DOI 10.1038/sj.onc.1208663	46	66	73	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19375	10.1371/journal.pone.0019375	http://dx.doi.org/10.1371/journal.pone.0019375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559403	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700151
J	Tuttelmann, F; Simoni, M; Kliesch, S; Ledig, S; Dworniczak, B; Wieacker, P; Ropke, A				Tuettelmann, Frank; Simoni, Manuela; Kliesch, Sabine; Ledig, Susanne; Dworniczak, Bernd; Wieacker, Peter; Roepke, Albrecht			Copy Number Variants in Patients with Severe Oligozoospermia and Sertoli-Cell-Only Syndrome	PLOS ONE			English	Article							MALE-INFERTILITY; GENE; POLYMORPHISMS; FAMILY; MEN; AZOOSPERMIA; CHROMOSOME; EXCRETION; CLONING; H2B	A genetic origin is estimated in 30% of infertile men with the common phenotypes of oligo-or azoospermia, but the pathogenesis of spermatogenic failure remains frequently obscure. To determine the involvement of Copy Number Variants (CNVs) in the origin of male infertility, patients with idiopathic severe oligozoospermia (N = 89), Sertoli-cell-only syndrome (SCOS, N = 37)) and controls with normozoospermia (N = 100) were analysed by array-CGH using the 244A/400K array sets (Agilent Technologies). The mean number of CNVs and the amount of DNA gain/loss were comparable between all groups. Ten recurring CNVs were only found in patients with severe oligozoospermia, three only in SCOS and one CNV in both groups with spermatogenic failure but not in normozoospermic men. Sex-chromosomal, mostly private CNVs were significantly overrepresented in patients with SCOS. CNVs found several times in all groups were analysed in a case-control design and four additional candidate genes and two regions without known genes were associated with SCOS (P<1 x 10(-3)). In conclusion, by applying array-CGH to study male infertility for the first time, we provide a number of candidate genes possibly causing or being risk factors for the men's spermatogenic failure. The recurring, patient-specific and private, sex-chromosomal CNVs as well as those associated with SCOS are candidates for further, larger case-control and re-sequencing studies.	[Tuettelmann, Frank; Ledig, Susanne; Dworniczak, Bernd; Wieacker, Peter; Roepke, Albrecht] Univ Munster, Inst Human Genet, D-4400 Munster, Germany; [Simoni, Manuela] Univ Modena & Reggio Emilia, Dept Med Endocrinol Metab & Geriatr, Modena, Italy; [Kliesch, Sabine] Univ Munster, Dept Clin Androl, Ctr Reprod Med & Androl, Munster, Germany	University of Munster; Universita di Modena e Reggio Emilia; University of Munster	Tuttelmann, F (corresponding author), Univ Munster, Inst Human Genet, D-4400 Munster, Germany.	frank.tuettelmann@ukmuenster.de	Tüttelmann, Frank/ABH-8185-2020; Simoni, Manuela/A-9600-2013	Tüttelmann, Frank/0000-0003-2745-9965; Simoni, Manuela/0000-0002-2133-4304	Deutsche Forschungsgemeinschaft Research Unit [FOR 1041, TU 298/1-1]	Deutsche Forschungsgemeinschaft Research Unit(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft Research Unit 'Germ Cell Potential' (FOR 1041, grant TU 298/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aston KI, 2010, HUM REPROD, V25, P1383, DOI 10.1093/humrep/deq081; Aston KI, 2009, J ANDROL, V30, P711, DOI 10.2164/jandrol.109.007971; Boulard M, 2006, MOL CELL BIOL, V26, P1518, DOI 10.1128/MCB.26.4.1518-1526.2006; Burgoyne P S, 1984, Symp Soc Exp Biol, V38, P349; Chen YT, 2003, GENOMICS, V82, P628, DOI 10.1016/S0888-7543(03)00183-6; Churikov D, 2004, GENOMICS, V84, P745, DOI 10.1016/j.ygeno.2004.06.001; Fanciulli M, 2010, CLIN GENET, V77, P201, DOI 10.1111/j.1399-0004.2009.01342.x; Ferlin A, 2007, REPROD BIOMED ONLINE, V14, P734, DOI 10.1016/S1472-6483(10)60677-3; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Foresta C, 2005, J CLIN ENDOCR METAB, V90, P152, DOI 10.1210/jc.2004-1469; Gure AO, 2002, INT J CANCER, V101, P448, DOI 10.1002/ijc.10634; Guttman JA, 1999, ANAT RECORD, V254, P418, DOI 10.1002/(SICI)1097-0185(19990301)254:3<418::AID-AR13>3.0.CO;2-C; Huang WJ, 2008, SEX DEV, V2, P251, DOI 10.1159/000152041; Jakobsson J, 2006, J CLIN ENDOCR METAB, V91, P687, DOI 10.1210/jc.2005-1643; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Juul A, 2009, J CLIN ENDOCR METAB, V94, P1005, DOI 10.1210/jc.2008-1984; Kim J, 2010, MOL CELL BIOL, V30, P1582, DOI 10.1128/MCB.01605-09; Kohn M, 2004, EUR J HUM GENET, V12, P29, DOI 10.1038/sj.ejhg.5201085; Kouprina N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000359; Ledig S, 2010, HUM REPROD, V25, P2637, DOI 10.1093/humrep/deq167; Ledig S, 2010, SEX DEV, V4, P225, DOI 10.1159/000314958; LEDIG S, 2010, FERTIL STERIL, V4, P213; Lee J, 2009, J CELL MOL MED, V13, P1942, DOI 10.1111/j.1582-4934.2009.00830.x; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; McLachlan RI, 2010, J CLIN ENDOCR METAB, V95, P1013, DOI 10.1210/jc.2009-1925; Nishimune Y, 2006, J ANDROL, V27, P326, DOI 10.2164/jandrol.05162; Nuti F, 2008, REPROD BIOMED ONLINE, V16, P504, DOI 10.1016/S1472-6483(10)60457-9; Pan JY, 2009, DEV BIOL, V330, P167, DOI 10.1016/j.ydbio.2009.03.022; Radhakrishnan Y, 2009, BIOL REPROD, V81, P647, DOI 10.1095/biolreprod.109.077545; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sasaki M, 2005, GENOMICS, V85, P641, DOI 10.1016/j.ygeno.2005.01.003; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Sutton KA, 2004, DEV BIOL, V274, P426, DOI 10.1016/j.ydbio.2004.07.031; Tuttelmann F, 2007, REPROD BIOMED ONLINE, V15, P643, DOI 10.1016/s1472-6483(10)60531-7; Tuttelmann F, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P87, DOI 10.1007/978-3-540-78355-8_4; Tuttelmann F, 2006, ASIAN J ANDROL, V8, P235, DOI 10.1111/j.1745-7262.2006.00131.x; TUTTELMANN F, 2010, INT J ANDROL    0628; VanAssche E, 1996, HUM REPROD, V11, P1, DOI 10.1093/humrep/11.suppl_4.1; Vincent MC, 2002, J ANDROL, V23, P45; Vincent MC, 2002, J ANDROL, V23, P18, DOI 10.1002/j.1939-4640.2002.tb02597.x; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yang QS, 2002, BIOCHEM GENET, V40, P1, DOI 10.1023/A:1014565320998	43	93	98	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19426	10.1371/journal.pone.0019426	http://dx.doi.org/10.1371/journal.pone.0019426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559371	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700166
J	Vikan, JR; Fossoy, F; Huhta, E; Moksnes, A; Roskaft, E; Stokke, BG				Vikan, Johan Reinert; Fossoy, Frode; Huhta, Esa; Moksnes, Arne; Roskaft, Eivin; Stokke, Bard Gunnar			Outcomes of Brood Parasite-Host Interactions Mediated by Egg Matching: Common Cuckoos Cuculus canorus versus Fringilla Finches	PLOS ONE			English	Article							COEVOLUTIONARY ARMS-RACE; LOCAL ADAPTATION; BEHAVIORAL-RESPONSES; COLOR PATTERNS; SITE-TENACITY; GENE FLOW; EVOLUTION; POPULATIONS; MONTIFRINGILLA; REJECTION	Background: Antagonistic species often interact via matching of phenotypes, and interactions between brood parasitic common cuckoos (Cuculus canorus) and their hosts constitute classic examples. The outcome of a parasitic event is often determined by the match between host and cuckoo eggs, giving rise to potentially strong associations between fitness and egg phenotype. Yet, empirical efforts aiming to document and understand the resulting evolutionary outcomes are in short supply. Methods/Principal Findings: We used avian color space models to analyze patterns of egg color variation within and between the cuckoo and two closely related hosts, the nomadic brambling (Fringilla montifringilla) and the site fidelic chaffinch (F. coelebs). We found that there is pronounced opportunity for disruptive selection on brambling egg coloration. The corresponding cuckoo host race has evolved egg colors that maximize fitness in both sympatric and allopatric brambling populations. By contrast, the chaffinch has a more bimodal egg color distribution consistent with the evolutionary direction predicted for the brambling. Whereas the brambling and its cuckoo host race show little geographical variation in their egg color distributions, the chaffinch's distribution becomes increasingly dissimilar to the brambling's distribution towards the core area of the brambling cuckoo host race. Conclusion: High rates of brambling gene flow is likely to cool down coevolutionary hot spots by cancelling out the selection imposed by a patchily distributed cuckoo host race, thereby promoting a matching equilibrium. By contrast, the site fidelic chaffinch is more likely to respond to selection from adapting cuckoos, resulting in a markedly more bimodal egg color distribution. The geographic variation in the chaffinch's egg color distribution could reflect a historical gradient in parasitism pressure. Finally, marked cuckoo egg polymorphisms are unlikely to evolve in these systems unless the hosts evolve even more exquisite egg recognition capabilities than currently possessed.	[Vikan, Johan Reinert; Fossoy, Frode; Moksnes, Arne; Roskaft, Eivin; Stokke, Bard Gunnar] Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway; [Huhta, Esa] Finnish Forest Res Inst, Rovaniemi Res Stn, Rovaniemi, Finland	Norwegian University of Science & Technology (NTNU); Natural Resources Institute Finland (Luke)	Vikan, JR (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway.	johanrei@bio.ntnu.no	Røskaft, Eivin/N-7476-2019; Fossoy, Frode/O-3073-2017	Røskaft, Eivin/0000-0003-0262-8443; Fossoy, Frode/0000-0002-7535-9574	European Community [RITA-CT-2006-025969]	European Community(European Commission)	This work was supported by the European Community - LAPBIAT project RITA-CT-2006-025969. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1980, J ANIM ECOL, V49, P175, DOI 10.2307/4282; Aviles JM, 2006, J EVOLUTION BIOL, V19, P1901, DOI 10.1111/j.1420-9101.2006.01166.x; Aviles JM, 2011, J EVOLUTION BIOL, V24, P314, DOI 10.1111/j.1420-9101.2010.02168.x; Aviles JM, 2010, J EVOLUTION BIOL, V23, P293, DOI 10.1111/j.1420-9101.2009.01898.x; Aviles JM, 2008, P ROY SOC B-BIOL SCI, V275, P2345, DOI 10.1098/rspb.2008.0720; Baker ECS, 1942, CUCKOO PROBLEMS; Benkman CW, 2003, AM NAT, V162, P182, DOI 10.1086/376580; BLOW WL, 1950, POULTRY SCI, V29, P381, DOI 10.3382/ps.0290381; BROOKE MD, 1988, NATURE, V335, P630; Chance EP., 1940, TRUTH CUCKOO; Clayton DH, 1999, AM NAT, V154, P261, DOI 10.1086/303237; COLLIAS EC, 1993, AUK, V110, P683, DOI 10.2307/4088624; Cramp S., 1994, BIRDS W PALEARCTIC; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; DAVIES NB, 1989, J ANIM ECOL, V58, P225, DOI 10.2307/4996; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; DIECKMANN U, 1995, J THEOR BIOL, V176, P91, DOI 10.1006/jtbi.1995.0179; DYBDAHL MF, 1995, P ROY SOC B-BIOL SCI, V260, P99, DOI 10.1098/rspb.1995.0065; Dybdahl MF, 2003, TRENDS ECOL EVOL, V18, P523, DOI 10.1016/S0169-5347(03)00223-4; Endler JA, 2005, EVOLUTION, V59, P1795, DOI 10.1111/j.0014-3820.2005.tb01827.x; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Enemar Anders, 2004, Ornis Svecica, V14, P63; Fransson T., 2008, SWEDISH BIRD RINGING; FRY CH, 1988, BIRDS AFRICA; Furrer R., 2009, FIELDS TOOLS SPATIAL; Gandon S, 2002, ECOL LETT, V5, P246, DOI 10.1046/j.1461-0248.2002.00305.x; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; Gavrilets S, 1997, J THEOR BIOL, V186, P527, DOI 10.1006/jtbi.1997.0426; Gavrilets S, 1998, J THEOR BIOL, V191, P415, DOI 10.1006/jtbi.1997.0615; Gibbs HL, 2000, NATURE, V407, P183, DOI 10.1038/35025058; Glue D, 1984, BRIT TRUST ORNITHOLO, V5, P134; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Hanifin CT, 2008, PLOS BIOL, V6, P471, DOI 10.1371/journal.pbio.0060060; HILDEN O, 1982, Ornis Fennica, V59, P20; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Hogstad O, 2000, ORNIS FENNICA, V77, P97; Hogstad O, 2005, IBIS, V147, P77, DOI [10.1111/j.1474-919X.2004.00338.x, 10.1111/j.1474-919x.2004.00338]; HOYT DF, 1979, AUK, V96, P73; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; Kruger O, 2007, PHILOS T R SOC B, V362, P1873, DOI 10.1098/rstb.2006.1849; Lahti DC, 2008, AUK, V125, P796, DOI 10.1525/auk.2008.07033; Lahti DC, 2005, P NATL ACAD SCI USA, V102, P18057, DOI 10.1073/pnas.0508930102; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; LINDSTROM A, 1987, ORNIS FENNICA, V64, P50; Lindstrom A, 2005, OIKOS, V110, P155, DOI 10.1111/j.0030-1299.2005.13828.x; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; Malchevsky A. S., 1987, CUCKOO ITS HOSTS; Matsuura K, 2009, CURR BIOL, V19, P30, DOI 10.1016/j.cub.2008.11.030; Mielke PW, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-69813-7; MIKKONEN AV, 1983, ORNIS SCAND, V14, P36, DOI 10.2307/3676248; Minka TP, 2009, MAPS DRAW GEOGRAPHIC; MOKSNES A, 1995, J ZOOL, V236, P625, DOI 10.1111/j.1469-7998.1995.tb02736.x; MOKSNES A, 1991, BEHAVIOUR, V116, P64, DOI 10.1163/156853990X00365; MONTELL J, 1917, ACTA SOC FAUNA FLORA, V44, P135; Nash DR, 2008, SCIENCE, V319, P88, DOI 10.1126/science.1149180; Nuismer SL, 2005, EVOLUTION, V59, P2073; Numerov A.D., 2003, INTERSPECIFIC INTRAS; OIEN IJ, 1995, BEHAV ECOL, V6, P166, DOI 10.1093/beheco/6.2.166; Oksanen J., 2009, VEGAN COMMUNITY ECOL; Osorio D, 2005, P ROY SOC B-BIOL SCI, V272, P1745, DOI 10.1098/rspb.2005.3156; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; PICMAN J, 1989, AUK, V106, P577; Reiss PT, 2010, BIOMETRICS, V66, P636, DOI 10.1111/j.1541-0420.2009.01300.x; Roskaft E, 2002, BEHAVIOUR, V139, P613, DOI 10.1163/15685390260136735; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; Rothstein SI, 1998, OX ORN SER, V9, P419; Servedio MR, 2003, EVOLUTION, V57, P1164; Soler JJ, 2001, ECOL LETT, V4, P470, DOI 10.1046/j.1461-0248.2001.00247.x; Soler JJ, 1999, EVOLUTION, V53, P947, DOI 10.1111/j.1558-5646.1999.tb05388.x; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Stokke BG, 2007, EVOLUTION, V61, P2212, DOI 10.1111/j.1558-5646.2007.00176.x; Stokke BG, 2004, ETHOLOGY, V110, P459, DOI 10.1111/j.1439-0310.2004.00978.x; Stokke BG, 2002, EVOLUTION, V56, P199; Swynnerton C.F.M., 1918, IBIS, V6, P127, DOI DOI 10.1111/J.1474-919X.1918.TB00774.X; Takasu F, 2003, EVOL ECOL RES, V5, P345; Takasu Fugo, 2005, Ornithological Science, V4, P65, DOI 10.2326/osj.4.65; Thompson JN, 2002, INTEGR COMP BIOL, V42, P381, DOI 10.1093/icb/42.2.381; Vikan JR, 2009, ETHOLOGY, V115, P840, DOI 10.1111/j.1439-0310.2009.01679.x; Vikan JR, 2010, EVOL ECOL, V24, P1141, DOI 10.1007/s10682-010-9360-y; VIRKKALA R, 1989, ANN ZOOL FENN, V26, P277; Wasenius E., 1936, Ornis Fennica, V13, P147; WEI R, 1992, POULTRY SCI, V71, P406, DOI 10.3382/ps.0710406; Yang CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010816; Zangerl AR, 2003, EVOLUTION, V57, P806, DOI 10.1111/j.0014-3820.2003.tb00292.x	87	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19288	10.1371/journal.pone.0019288	http://dx.doi.org/10.1371/journal.pone.0019288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559400	Green Published, gold			2022-12-25	WOS:000290024700124
J	von Levetzow, C; Jiang, XH; Gwye, Y; von Levetzow, G; Hung, L; Cooper, A; Hsu, JHR; Lawlor, ER				von Levetzow, Cornelia; Jiang, Xiaohua; Gwye, Ynnez; von Levetzow, Gregor; Hung, Long; Cooper, Aaron; Hsu, Jessie Hao-Ru; Lawlor, Elizabeth R.			Modeling Initiation of Ewing Sarcoma in Human Neural Crest Cells	PLOS ONE			English	Article							STEM-CELLS; EWS/FLI1 EXPRESSION; GENE-EXPRESSION; IN-VIVO; DIFFERENTIATION; PROLIFERATION; TUMORS; FAMILY; TRANSFORMATION; FIBROBLASTS	Ewing sarcoma family tumors (ESFT) are aggressive bone and soft tissue tumors that express EWS-ETS fusion genes as driver mutations. Although the histogenesis of ESFT is controversial, mesenchymal (MSC) and/or neural crest (NCSC) stem cells have been implicated as cells of origin. For the current study we evaluated the consequences of EWS-FLI1 expression in human embryonic stem cell-derived NCSC (hNCSC). Ectopic expression of EWS-FLI1 in undifferentiated hNCSC and their neuro-mesenchymal stem cell (hNC-MSC) progeny was readily tolerated and led to altered expression of both well established as well as novel EWS-FLI1 target genes. Importantly, whole genome expression profiling studies revealed that the molecular signature of established ESFT is more similar to hNCSC than any other normal tissue, including MSC, indicating that maintenance or reactivation of the NCSC program is a feature of ESFT pathogenesis. Consistent with this hypothesis, EWS-FLI1 induced hNCSC genes as well as the polycomb proteins BMI-1 and EZH2 in hNC-MSC. In addition, up-regulation of BMI-1 was associated with avoidance of cellular senescence and reversible silencing of p16. Together these studies confirm that, unlike terminally differentiated cells but consistent with bone marrow-derived MSC, NCSC tolerate expression of EWS-FLI1 and ectopic expression of the oncogene initiates transition to an ESFT-like state. In addition, to our knowledge this is the first demonstration that EWS-FLI1-mediated induction of BMI-1 and epigenetic silencing of p16 might be critical early initiating events in ESFT tumorigenesis.	[von Levetzow, Cornelia; von Levetzow, Gregor; Hsu, Jessie Hao-Ru; Lawlor, Elizabeth R.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [von Levetzow, Cornelia; von Levetzow, Gregor; Hsu, Jessie Hao-Ru; Lawlor, Elizabeth R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Jiang, Xiaohua; Gwye, Ynnez; Hung, Long; Cooper, Aaron] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Children's Hospital Los Angeles	von Levetzow, C (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	elawlor@med.umich.edu	jiang, cynthia xiaohua/F-7580-2017	jiang, cynthia xiaohua/0000-0002-7372-4961; Cooper, Aaron/0000-0003-4588-2513	CIRM [RS1-00249, R01 CA134604, U01 CA114757, SU2C-AACR-IRG1309, T2-00005, T1-00004]; NATIONAL CANCER INSTITUTE [R01CA134604, U01CA114757] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support for this work was provided by CIRM SEED Grant RS1-00249, R01 CA134604, U01 CA114757, SU2C-AACR-IRG1309, and by CIRM Training Grants T2-00005 (to CvL and XJ) and T1-00004 (to JH-RH). Philanthropic support from the My Brother Joey, T. J. Martell and Bogart Foundations is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Braunreiter CL, 2006, CELL CYCLE, V5, P2753, DOI 10.4161/cc.5.23.3505; CAVAZZANA AO, 1987, AM J PATHOL, V127, P507; Chinnasamy D, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-14; Coles EG, 2008, STEM CELLS, V26, P2237, DOI 10.1634/stemcells.2008-0133; Crawford YG, 2004, CANCER CELL, V5, P263, DOI 10.1016/S1535-6108(04)00023-6; Deneen B, 2001, ONCOGENE, V20, P6731, DOI 10.1038/sj.onc.1204875; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Douglas D, 2008, CANCER RES, V68, P6507, DOI 10.1158/0008-5472.CAN-07-6152; Feldhahn N, 2007, J EXP MED, V204, P1157, DOI 10.1084/jem.20062662; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Hu-Lieskovan S, 2005, CANCER RES, V65, P4633, DOI 10.1158/0008-5472.CAN-04-2857; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HY, 2005, J CLIN ONCOL, V23, P548, DOI 10.1200/JCO.2005.02.081; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jiang XH, 2009, STEM CELLS DEV, V18, P1059, DOI 10.1089/scd.2008.0362; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; Knezevich SR, 1998, HUM PATHOL, V29, P289, DOI 10.1016/S0046-8177(98)90049-1; Kovar H, 2010, GENOME MED, V2, DOI 10.1186/gm129; Lawlor ER, 2006, CANCER RES, V66, P4591, DOI 10.1158/0008-5472.CAN-05-3826; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; Lessnick SL, 2002, CANCER CELL, V1, P393, DOI 10.1016/S1535-6108(02)00056-9; Miyagawa Y, 2008, MOL CELL BIOL, V28, P2125, DOI 10.1128/MCB.00740-07; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; OREGAN S, 1995, J NEUROCHEM, V64, P69; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rajasekhar Vinagolu K., 2009, P285, DOI 10.1007/978-1-60327-227-8_24; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Riggi N, 2009, EXPERT REV ANTICANC, V9, P1025, DOI 10.1586/ERA.09.81; Smith KS, 2003, MOL CELL, V12, P393, DOI 10.1016/S1097-2765(03)00277-6; Staege MS, 2004, CANCER RES, V64, P8213, DOI 10.1158/0008-5472.CAN-03-4059; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Torchia EC, 2007, MOL CELL BIOL, V27, P7918, DOI 10.1128/MCB.00099-07; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Zou JH, 2005, MOL CELL BIOL, V25, P6235, DOI 10.1128/MCB.25.14.6235-6246.2005; Zwerner JP, 2003, EXP CELL RES, V290, P414, DOI 10.1016/S0014-4827(03)00371-9	44	109	112	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19305	10.1371/journal.pone.0019305	http://dx.doi.org/10.1371/journal.pone.0019305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559395	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700129
J	Zhang, L; Bhasin, M; Schor-Bardach, R; Wang, XE; Collins, MP; Panka, D; Putheti, P; Signoretti, S; Alsop, DC; Libermann, T; Atkins, MB; Mier, JW; Goldberg, SN; Bhatt, RS				Zhang, Liang; Bhasin, Manoj; Schor-Bardach, Rachel; Wang, Xiaoen; Collins, Michael P.; Panka, David; Putheti, Prabhakar; Signoretti, Sabina; Alsop, David C.; Libermann, Towia; Atkins, Michael B.; Mier, James W.; Goldberg, S. Nahum; Bhatt, Rupal S.			Resistance of Renal Cell Carcinoma to Sorafenib Is Mediated by Potentially Reversible Gene Expression	PLOS ONE			English	Article							ANTIANGIOGENIC THERAPY; CANCER; MICROARRAYS; SUMMARIES; BIOLOGY; GROWTH; TUMORS	Purpose: Resistance to antiangiogenic therapy is an important clinical problem. We examined whether resistance occurs at least in part via reversible, physiologic changes in the tumor, or results solely from stable genetic changes in resistant tumor cells. Experimental Design: Mice bearing two human RCC xenografts were treated with sorafenib until they acquired resistance. Resistant 786-O cells were harvested and reimplanted into naive mice. Mice bearing resistant A498 cells were subjected to a 1 week treatment break. Sorafenib was then again administered to both sets of mice. Tumor growth patterns, gene expression, viability, blood vessel density, and perfusion were serially assessed in treated vs control mice. Results: Despite prior resistance, reimplanted 786-O tumors maintained their ability to stabilize on sorafenib in sequential reimplantation steps. A transcriptome profile of the tumors revealed that the gene expression profile of tumors upon reimplantation reapproximated that of the untreated tumors and was distinct from tumors exhibiting resistance to sorafenib. In A498 tumors, revascularization was noted with resistance and cessation of sorafenib therapy and tumor perfusion was reduced and tumor cell necrosis enhanced with re-exposure to sorafenib. Conclusions: In two RCC cell lines, resistance to sorafenib appears to be reversible. These results support the hypothesis that resistance to VEGF pathway therapy is not solely the result of a permanent genetic change in the tumor or selection of resistant clones, but rather is due to a great extent to reversible changes that likely occur in the tumor and/or its microenvironment.	[Zhang, Liang; Panka, David; Atkins, Michael B.; Mier, James W.; Bhatt, Rupal S.] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA; [Bhasin, Manoj; Libermann, Towia] Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Bhasin, Manoj] Beth Israel Deaconess Med Ctr, Genom & Prote Ctr, Boston, MA 02215 USA; [Schor-Bardach, Rachel; Wang, Xiaoen; Alsop, David C.; Goldberg, S. Nahum] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; [Schor-Bardach, Rachel; Goldberg, S. Nahum] Hadassah Hebrew Univ, Med Ctr, Dept Radiol, Jerusalem, Israel; [Collins, Michael P.; Signoretti, Sabina] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Putheti, Prabhakar] Beth Israel Deaconess Med Ctr, Dept Surg, Transplant Inst, Boston, MA 02215 USA; [Putheti, Prabhakar] Beth Israel Deaconess Med Ctr, Dept Med, Transplant Inst, Boston, MA 02215 USA; [Signoretti, Sabina] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bhatt, Rupal S.] Dana Farber Harvard Canc Ctr, Kidney Canc Program, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Zhang, L (corresponding author), Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA.	rbhatt@bidmc.harvard.edu	Alsop, David C/J-5764-2013; Goldberg, S. Nahum/AAV-4526-2020	Alsop, David C/0000-0002-8206-1995; Bhasin, Manoj/0000-0001-5172-420X; Collins, Michael/0000-0002-1806-6775; Libermann, Towia/0000-0002-4006-8179	DF/HCC Kidney Cancer SPORE [2 P50 CA101942]; National Comprehensive Cancer Network, Jenkintown, PA; NATIONAL CANCER INSTITUTE [K08CA138900, P50CA101942] Funding Source: NIH RePORTER	DF/HCC Kidney Cancer SPORE; National Comprehensive Cancer Network, Jenkintown, PA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by DF/HCC Kidney Cancer SPORE: 2 P50 CA101942, a Career Development Award (RB), and the National Comprehensive Cancer Network, Jenkintown, PA (JM). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 1996, J CEREBR BLOOD F MET, V16, P1236, DOI 10.1097/00004647-199611000-00019; Bhatt R.S., 2010, P 101 ANN M AM ASS C; Bhatt RS, 2010, MOL CANCER THER, V9, P2793, DOI 10.1158/1535-7163.MCT-10-0477; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Hammers HJ, 2010, MOL CANCER THER, V9, P1525, DOI 10.1158/1535-7163.MCT-09-1106; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Janne PA, 2005, J CLIN ONCOL, V23, P3227, DOI 10.1200/JCO.2005.09.985; Jones J, 2007, CLIN CANCER RES, V13, p685S, DOI 10.1158/1078-0432.CCR-06-1867; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; MOTZER RJ, 2011, J CLIN ONCOL S7, V29; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Rini BI, 2009, J CLIN ONCOL, V27, P4462, DOI 10.1200/JCO.2008.21.7034; Sabir A, 2008, AM J ROENTGENOL, V191, P133, DOI 10.2214/AJR.07.2848; Sablin MP, 2009, J UROLOGY, V182, P29, DOI 10.1016/j.juro.2009.02.119; Schor-Bardach R, 2009, RADIOLOGY, V251, P731, DOI 10.1148/radiol.2521081059; Simon R, 2007, CANCER INFORM, V3, P11; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Tamaskar I, 2008, J UROLOGY, V179, P8186; Tang TC, 2010, NEOPLASIA, V12, P928, DOI 10.1593/neo.10804; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zama IN, 2010, CANCER-AM CANCER SOC, V116, P5400, DOI 10.1002/cncr.25583	34	46	47	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19144	10.1371/journal.pone.0019144	http://dx.doi.org/10.1371/journal.pone.0019144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559452	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700075
J	Zemskov, EA; Mikhailenko, I; Hsia, RC; Zaritskaya, L; Belkin, AM				Zemskov, Evgeny A.; Mikhailenko, Irina; Hsia, Ru-Ching; Zaritskaya, Liubov; Belkin, Alexey M.			Unconventional Secretion of Tissue Transglutaminase Involves Phospholipid-Dependent Delivery into Recycling Endosomes	PLOS ONE			English	Article							CELL-ADHESION; SURFACE TRANSGLUTAMINASE; PROTEIN SECRETION; IL-1-BETA SECRETION; PLASMA-MEMBRANE; INTEGRIN; FIBRONECTIN; GOLGI; MIGRATION; RELEASE	Although endosomal compartments have been suggested to play a role in unconventional protein secretion, there is scarce experimental evidence for such involvement. Here we report that recycling endosomes are essential for externalization of cytoplasmic secretory protein tissue transglutaminase (tTG). The de novo synthesized cytoplasmic tTG does not follow the classical ER/Golgi-dependent secretion pathway, but is targeted to perinuclear recycling endosomes, and is delivered inside these vesicles prior to externalization. On its route to the cell surface tTG interacts with internalized beta 1 integrins inside the recycling endosomes and is secreted as a complex with recycled beta 1 integrins. Inactivation of recycling endosomes, blocking endosome fusion with the plasma membrane, or downregulation of Rab11 GTPase that controls outbound trafficking of perinuclear recycling endosomes, all abrogate tTG secretion. The initial recruitment of cytoplasmic tTG to recycling endosomes and subsequent externalization depend on its binding to phosphoinositides on endosomal membranes. These findings begin to unravel the unconventional mechanism of tTG secretion which utilizes the long loop of endosomal recycling pathway and indicate involvement of endosomal trafficking in non-classical protein secretion.	[Zemskov, Evgeny A.; Belkin, Alexey M.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Zemskov, Evgeny A.; Mikhailenko, Irina; Belkin, Alexey M.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Mikhailenko, Irina] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Belkin, Alexey M.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Belkin, Alexey M.] Univ Maryland, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA; [Hsia, Ru-Ching] Univ Maryland, Sch Dent, Core Imaging Facil, Baltimore, MD 21201 USA; [Zaritskaya, Liubov] Sci Applicat Int Corp, Appl & Dev Res Support Program, Frederick, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Science Applications International Corporation (SAIC)	Zemskov, EA (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	abelkin@som.umaryland.edu			National Institutes of Health [RO1GM62895]; Maryland Stem Cell Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was partly supported by National Institutes of Health RO1GM62895 and Maryland Stem Cell Research Fund grants to AMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen H, 2010, CURR BIOL, V20, pR415, DOI 10.1016/j.cub.2010.03.011; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2003, J BIOL CHEM, V278, P35609, DOI 10.1074/jbc.M303488200; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Balklava Z, 2002, J BIOL CHEM, V277, P16567, DOI 10.1074/jbc.M109836200; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; FESUS L, 1983, FEBS LETT, V155, P1, DOI 10.1016/0014-5793(83)80196-3; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; GENTILE V, 1991, J BIOL CHEM, V266, P478; Hang J, 2005, J BIOL CHEM, V280, P23675, DOI 10.1074/jbc.M503323200; HARSFALVI J, 1987, BIOCHIM BIOPHYS ACTA, V923, P42, DOI 10.1016/0304-4165(87)90123-1; Hobman TC, 1998, MOL BIOL CELL, V9, P1265, DOI 10.1091/mbc.9.6.1265; Janiak A, 2006, MOL BIOL CELL, V17, P1606, DOI 10.1091/mbc.E05-06-0549; Jena BP, 2009, PROTEIN PEPTIDE LETT, V16, P712, DOI 10.2174/092986609788681869; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Landriscina M, 2001, J BIOL CHEM, V276, P25549, DOI 10.1074/jbc.M102925200; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lee YC, 2008, PROTEIN EXPRES PURIF, V62, P223, DOI 10.1016/j.pep.2008.08.003; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pfeffer SR, 2010, J CELL BIOL, V188, P451, DOI 10.1083/jcb.201001121; Proux-Gillardeaux V, 2005, P NATL ACAD SCI USA, V102, P6362, DOI 10.1073/pnas.0409613102; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Scarpellini A, 2009, J BIOL CHEM, V284, P18411, DOI 10.1074/jbc.M109.012948; Skalski M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-62; Skwarek LC, 2009, DEV CELL, V16, P12, DOI 10.1016/j.devcel.2008.12.006; Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x; Sugawara K, 2009, GENES CELLS, V14, P445, DOI 10.1111/j.1365-2443.2009.01285.x; Tayeb MA, 2005, EXP CELL RES, V305, P63, DOI 10.1016/j.yexcr.2004.12.004; Telci D, 2008, J BIOL CHEM, V283, P20937, DOI 10.1074/jbc.M801763200; Temmerman K, 2008, TRAFFIC, V9, P1204, DOI 10.1111/j.1600-0854.2008.00749.x; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Verges M, 1999, P NATL ACAD SCI USA, V96, P10146, DOI 10.1073/pnas.96.18.10146; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863; Zemskov EA, 2007, J CELL SCI, V120, P3188, DOI 10.1242/jcs.010397; Zemskov EA, 2009, J BIOL CHEM, V284, P16693, DOI 10.1074/jbc.M109.010769; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032	59	83	83	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19414	10.1371/journal.pone.0019414	http://dx.doi.org/10.1371/journal.pone.0019414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556374	Green Published, gold, Green Submitted			2022-12-25	WOS:000290019400058
J	Castillo, DD; Zarco-Zavala, M; Olvera-Sanchez, S; Pardo, JP; Juarez, O; Martinez, F; Mendoza-Hernandez, G; Garcia-Trejo, JJ; Flores-Herrera, O				De Los Rios Castillo, Daniela; Zarco-Zavala, Mariel; Olvera-Sanchez, Sofia; Pablo Pardo, Juan; Juarez, Oscar; Martinez, Federico; Mendoza-Hernandez, Guillermo; Garcia-Trejo, Jose J.; Flores-Herrera, Oscar			Atypical Cristae Morphology of Human Syncytiotrophoblast Mitochondria ROLE FOR COMPLEX V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN SUPERCOMPLEXES; MEMBRANE-PROTEIN COMPLEXES; YEAST F1FO-ATP SYNTHASE; ATP SYNTHASE; INHIBITOR PROTEIN; F1F0-ATP SYNTHASE; INNER MEMBRANE; SUBUNIT-E; OXIDATIVE-PHOSPHORYLATION; PARACOCCUS-DENITRIFICANS	Mitochondrial complexes I, III2, and IV from human cytotrophoblast and syncytiotrophoblast associate to form supercomplexes or respirasomes, with the following stoichiometries: I-1:(III2)(1) and I-1:(III2)(1-2):IV1-4. The content of respirasomes was similar in both cell types after isolating mitochondria. However, syncytiotrophoblast mitochondria possess low levels of dimeric complex V and do not have orthodox cristae morphology. In contrast, cytotrophoblast mitochondria show normal cristae morphology and a higher content of ATP synthase dimer. Consistent with the dimerizing role of the ATPase inhibitory protein (IF1) (Garcia, J.J., Morales-Rios, E., Cortes-Hernandez, P., and Rodriguez-Zavala, J. S. (2006) Biochemistry 45, 12695-12703), higher relative amounts of IF1 were observed in cytotrophoblast when compared with syncytiotrophoblast mitochondria. Therefore, there is a correlation between dimerization of complex V, IF1 expression, and the morphology of mitochondrial cristae in human placental mitochondria. The possible relationship between cristae architecture and the physiological function of the syncytiotrophoblast mitochondria is discussed.	[De Los Rios Castillo, Daniela; Olvera-Sanchez, Sofia; Pablo Pardo, Juan; Martinez, Federico; Mendoza-Hernandez, Guillermo; Flores-Herrera, Oscar] Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem & Mol Biol, Mexico City 04510, DF, Mexico; [Zarco-Zavala, Mariel; Garcia-Trejo, Jose J.] Univ Nacl Autonoma Mexico, Fac Chem, Dept Biol, Mexico City 04510, DF, Mexico; [Juarez, Oscar] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol, Troy, NY 12180 USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Rensselaer Polytechnic Institute	Flores-Herrera, O (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Apdo Postal 70-159, Mexico City 04510, DF, Mexico.	oflores@bq.unam.mx	Martinez, Federico/Y-2411-2018	Juarez, Oscar/0000-0002-2915-8413; ZARCO-ZAVALA, MARIEL/0000-0002-9892-0758	Direccion General de Asuntos del Personal Academico (DGAPA) from Universidad Nacional Autonoma de Mexico [IN238402, IN213809, IN217609]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [52211, 59855]	Direccion General de Asuntos del Personal Academico (DGAPA) from Universidad Nacional Autonoma de Mexico; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Research Grants IN238402 (to O. F.-H.), The latter contains two functionally different layers, the IN217609 (to F. M.), and IN213809 (to J. J. G.-T.) from Direccion General de Asuntos del Personal Academico (DGAPA) from Universidad Nacional Autonoma de Mexico and Grants 52211 (to O. F.-H.) and 59855 (to J. P. P.) from Consejo Nacional de Ciencia y Tecnologia (CONACyT).	Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204; ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 2004, J BIOL CHEM, V279, P40392, DOI 10.1074/jbc.M404316200; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Boekema EJ, 2007, J BIOL CHEM, V282, P1, DOI 10.1074/jbc.R600031200; Brand C, 1998, J BIOL CHEM, V273, P6410, DOI 10.1074/jbc.273.11.6410; Bravo C, 2004, J BIOENERG BIOMEMBR, V36, P257, DOI 10.1023/B:JOBB.0000031977.99479.ea; Brunner S, 2002, J BIOL CHEM, V277, P48484, DOI 10.1074/jbc.M209382200; Cabezon E, 2000, J BIOL CHEM, V275, P28353, DOI 10.1074/jbc.C000427200; Cabezon E, 2002, J BIOL CHEM, V277, P41334, DOI 10.1074/jbc.M207169200; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Cano-Estrada A, 2010, BBA-BIOENERGETICS, V1797, P1439, DOI 10.1016/j.bbabio.2010.02.024; CHERRADI N, 1994, ENDOCRINOLOGY, V134, P1358, DOI 10.1210/en.134.3.1358; Couoh-Cardel SJ, 2010, J BIOL CHEM, V285, P36447, DOI 10.1074/jbc.M110.144907; Dienhart M, 2002, J BIOL CHEM, V277, P39289, DOI 10.1074/jbc.M205720200; Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065; Eubel H, 2004, PLANT PHYSIOL BIOCH, V42, P937, DOI 10.1016/j.plaphy.2004.09.010; Everard-Gigot V, 2005, EUKARYOT CELL, V4, P346, DOI 10.1128/EC.4.2.346-355.2005; Flores-Herrera O, 2002, BBA-MOL CELL BIOL L, V1585, P11, DOI 10.1016/S1388-1981(02)00302-5; Garcia JJ, 2006, BIOCHEMISTRY-US, V45, P12695, DOI 10.1021/bi060339j; Gavin PD, 2004, J CELL SCI, V117, P2333, DOI 10.1242/jcs.01074; Gonzalez-Zamnorano M, 2009, J PROTEOME RES, V8, P721, DOI 10.1021/pr800756a; Gordon-Smith DJ, 2001, J MOL BIOL, V308, P325, DOI 10.1006/jmbi.2001.4570; Maldonado-Mercado MG, 2008, INT J BIOCHEM CELL B, V40, P901, DOI 10.1016/j.biocel.2007.10.026; KAO LC, 1988, DEV BIOL, V130, P693, DOI 10.1016/0012-1606(88)90361-2; Lenaz G, 2001, FEBS LETT, V509, P151, DOI 10.1016/S0014-5793(01)03172-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mannella CA, 1998, BIOFACTORS, V8, P225, DOI 10.1002/biof.5520080309; Mannella CA, 2001, IUBMB LIFE, V52, P93, DOI 10.1080/15216540152845885; Martinez F, 1997, ENDOCRINOLOGY, V138, P2172, DOI 10.1210/en.138.5.2172; Miller WL, 1998, CLIN PERINATOL, V25, P799, DOI 10.1016/S0095-5108(18)30084-8; Minauro-Sanmiguel F, 2005, P NATL ACAD SCI USA, V102, P12356, DOI 10.1073/pnas.0503893102; Morales-Rios E, 2010, FASEB J, V24, P599, DOI 10.1096/fj.09-137356; OLIVERA AA, 1975, BIOCHIM BIOPHYS ACTA, V376, P426, DOI 10.1016/0005-2728(75)90164-4; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Prince FP, 2002, MITOCHONDRION, V1, P381, DOI 10.1016/S1567-7249(01)00038-1; Reichert AS, 2002, BBA-MOL CELL RES, V1592, P41, DOI 10.1016/S0167-4889(02)00263-X; Rexroth S, 2004, BBA-BIOENERGETICS, V1658, P202, DOI 10.1016/j.bbabio.2004.05.014; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Thomas D, 2008, BIOL CELL, V100, P591, DOI 10.1042/BC20080022; TUCKEY RC, 1992, J STEROID BIOCHEM, V42, P883, DOI 10.1016/0960-0760(92)90097-3; Vazquez-Acevedo M, 2006, J BIOENERG BIOMEMBR, V38, P271, DOI 10.1007/s10863-006-9046-x; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2007, METHOD CELL BIOL, V80, P723, DOI 10.1016/S0091-679X(06)80033-6	54	48	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23911	23919		10.1074/jbc.M111.252056	http://dx.doi.org/10.1074/jbc.M111.252056			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572045	Green Published, hybrid			2022-12-25	WOS:000292294900033
J	Wang, J; Zhou, JY; Wu, GS				Wang, Juan; Zhou, Jun-Ying; Wu, Gen Sheng			Bim Protein Degradation Contributes to Cisplatin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN-CANCER CELLS; KINASE PHOSPHATASE-1; BH3-ONLY PROTEIN; BCL-2 FAMILY; PHOSPHORYLATION; APOPTOSIS; CHEMOTHERAPY; PROMOTES; BIM(EL); DEATH	Cisplatin is the first-line chemotherapy for the treatment of several cancers. However, the development of cisplatin resistance represents a major clinical problem, and the mechanisms of acquired resistance are not fully understood. Here we show that degradation of the Bcl-2 homology 3-only proapoptotic protein Bim plays an important role in cisplatin resistance in ovarian cancer. Specifically, we show that treatment of ovarian cancer cells with cisplatin caused Bim phosphorylation and subsequent degradation and that its degradation is associated with cisplatin resistance. We also show that cisplatin treatment caused the activation of ERK, which correlated with Bim phosphorylation and degradation. By inhibiting ERK phosphorylation with the MEK inhibitor and knocking down ERK expression with siRNA, we show that Bim phosphorylation and degradation were blocked, which suggests that Bim is phosphorylated by ERK and that such phosphorylation is responsible for cisplatin-induced Bim degradation. We show that ERK was activated in cisplatin-resistant OV433 cells as compared with their counterpart parental OV433 cells. We also show that Bim was phosphorylated and degraded in cisplatin-resistant OV433 cells but not in the parental OV433 cells. Importantly, we show that inhibition of Bim degradation by the proteasome inhibitor MG132 sensitized resistant OV433 cells to cisplatin-induced death. Taken together, our data indicate that degradation of Bim via ERK-mediated phosphorylation can lead to cisplatin resistance. Therefore, these findings suggest that cisplatin resistance can be overcome by the combination of cisplatin and the proteasome inhibitors in ovarian cancer cells.	[Wu, Gen Sheng] Wayne State Univ, Sch Med, Program Mol Biol & Genet, Karmanos Canc Inst,Dept Oncol, Detroit, MI 48201 USA; [Wu, Gen Sheng] Wayne State Univ, Sch Med, Program Mol Biol & Genet, Karmanos Canc Inst,Dept Pathol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Wu, GS (corresponding author), Wayne State Univ, Sch Med, Program Mol Biol & Genet, Karmanos Canc Inst,Dept Oncol, Detroit, MI 48201 USA.	wug@karmanos.org			Gail Purtan Ovarian Cancer Research Fund	Gail Purtan Ovarian Cancer Research Fund	This work was supported by the Gail Purtan Ovarian Cancer Research Fund.	Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Beale PJ, 2000, BRIT J CANCER, V82, P436; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cullen KJ, 2003, CANCER RES, V63, P8097; DABHOLKAR M, 1994, J CLIN INVEST, V94, P703, DOI 10.1172/JCI117388; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1432, DOI 10.1210/me.12.9.1432; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Johnson SW, 1996, EXP CELL RES, V226, P133, DOI 10.1006/excr.1996.0211; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kuo MT, 2007, CANCER METAST REV, V26, P71, DOI 10.1007/s10555-007-9045-3; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Pei XY, 2007, BLOOD, V110, P2092, DOI 10.1182/blood-2007-04-083204; Peng DJ, 2010, BIOCHEM BIOPH RES CO, V394, P600, DOI 10.1016/j.bbrc.2010.03.029; Perego P, 1996, CANCER RES, V56, P556; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Tan TT, 2005, CANCER CELL, V7, P227, DOI 10.1016/j.ccr.2005.02.008; Turchi JJ, 2006, P NATL ACAD SCI USA, V103, P4337, DOI 10.1073/pnas.0601001103; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Wang J, 2009, CELL CYCLE, V8, P3191, DOI 10.4161/cc.8.19.9751; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280; Weinberg LE, 2010, J SURG ONCOL, V101, P334, DOI 10.1002/jso.21482; Weston CR, 2003, ONCOGENE, V22, P1281, DOI 10.1038/sj.onc.1206261; Wu GS, 2007, CANCER METAST REV, V26, P579, DOI 10.1007/s10555-007-9079-6; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Xu J, 2007, CANCER RES, V67, P1203, DOI 10.1158/0008-5472.CAN-06-2310; Zhou JY, 2006, CANCER RES, V66, P4888, DOI 10.1158/0008-5472.CAN-05-4229	35	49	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22384	22392		10.1074/jbc.M111.239566	http://dx.doi.org/10.1074/jbc.M111.239566			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21561860	Green Published, hybrid			2022-12-25	WOS:000291719900048
J	Wu, K; Taki, Y; Sato, K; Sassa, Y; Inoue, K; Goto, R; Okada, K; Kawashima, R; He, Y; Evans, AC; Fukuda, H				Wu, Kai; Taki, Yasuyuki; Sato, Kazunori; Sassa, Yuko; Inoue, Kentaro; Goto, Ryoi; Okada, Ken; Kawashima, Ryuta; He, Yong; Evans, Alan C.; Fukuda, Hiroshi			The Overlapping Community Structure of Structural Brain Network in Young Healthy Individuals	PLOS ONE			English	Article							CORTICAL THICKNESS; NEURONAL OSCILLATIONS; ANATOMICAL NETWORKS; COMPLEX NETWORKS; CORTEX; ATLAS; ORGANIZATION; MECHANISM; FREQUENCY; PATHWAYS	Community structure is a universal and significant feature of many complex networks in biology, society, and economics. Community structure has also been revealed in human brain structural and functional networks in previous studies. However, communities overlap and share many edges and nodes. Uncovering the overlapping community structure of complex networks remains largely unknown in human brain networks. Here, using regional gray matter volume, we investigated the structural brain network among 90 brain regions (according to a predefined anatomical atlas) in 462 young, healthy individuals. Overlapped nodes between communities were defined by assuming that nodes (brain regions) can belong to more than one community. We demonstrated that 90 brain regions were organized into 5 overlapping communities associated with several well-known brain systems, such as the auditory/language, visuospatial, emotion, decision-making, social, control of action, memory/learning, and visual systems. The overlapped nodes were mostly involved in an inferior-posterior pattern and were primarily related to auditory and visual perception. The overlapped nodes were mainly attributed to brain regions with higher node degrees and nodal efficiency and played a pivotal role in the flow of informa- tion through the structural brain network. Our results revealed fuzzy boundaries between communities by identifying overlapped nodes and provided new insights into the understanding of the relationship between the structure and function of the human brain. This study provides the first report of the overlapping community structure of the structural network of the human brain.	[Wu, Kai; Taki, Yasuyuki; Sato, Kazunori; Inoue, Kentaro; Goto, Ryoi; Okada, Ken; Fukuda, Hiroshi] Tohoku Univ, Dept Nucl Med & Radiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki; Sassa, Yuko; Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Evans, Alan C.] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada	Tohoku University; Tohoku University; Tohoku University; Beijing Normal University; McGill University	Wu, K (corresponding author), Tohoku Univ, Dept Nucl Med & Radiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	kai.wu.22@gmail.com	Evans, Alan C/B-2373-2013; Wu, Kai/C-5362-2011; He, Yong/C-2161-2009; He, Yong/Q-5756-2018; wu, kai/G-1229-2014	Evans, Alan C/0000-0003-3841-6098; Wu, Kai/0000-0003-4467-1597; wu, kai/0000-0003-4467-1597	Ministry of Education, Culture, Sports, Science and Technology [22103501, 23240056]; Tohoku University	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tohoku University	This study was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (22103501 and 23240056) and the 2007 Tohoku University Global COE Program "Global Nano-Biomedical Engineering Education and Research Network Centre''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Baumes J, 2005, LECT NOTES COMPUT SC, V3495, P27; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Farkas IJ, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/180; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fransson P, CEREB CORTE IN PRESS; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gazzaniga M. S., 2009, COGNITIVE NEUROSCIEN; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goel V, 1998, J COGNITIVE NEUROSCI, V10, P293, DOI 10.1162/089892998562744; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Graziano MSA, 2001, NEURON, V29, P4, DOI 10.1016/S0896-6273(01)00174-X; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; HIKOSAKA K, 1988, J NEUROPHYSIOL, V60, P1615, DOI 10.1152/jn.1988.60.5.1615; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jeannerod M., 1997, COGNITIVE NEUROSCIEN; Kaiser M, 2004, BIOL CYBERN, V90, P311, DOI 10.1007/s00422-004-0479-1; Kayser C, 2009, HEARING RES, V258, P80, DOI 10.1016/j.heares.2009.02.011; Knauff M, 2003, J COGNITIVE NEUROSCI, V15, P559, DOI 10.1162/089892903321662949; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Marchand WR, 2008, NEUROREPORT, V19, P957, DOI 10.1097/WNR.0b013e328302c873; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Morgan VL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006660; Nepusz T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016107; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nicosia V, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/03/P03024; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Recanzone GH, 2009, HEARING RES, V258, P89, DOI 10.1016/j.heares.2009.04.009; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Sato K, 2003, NEURAL NETWORKS, V16, P1301, DOI 10.1016/j.neunet.2003.06.004; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Shen HW, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07042; Shen HW, 2009, PHYSICA A, V388, P1706, DOI 10.1016/j.physa.2008.12.021; Stam CJ, 2010, INT J PSYCHOPHYSIOL, V77, P186, DOI 10.1016/j.ijpsycho.2010.06.024; Talairach J., 1988, COPLANAR STEREOTAXIC; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wu K, HUM BRAIN M IN PRESS; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang SH, 2007, PHYSICA A, V374, P483, DOI 10.1016/j.physa.2006.07.023; Zhu W, NEUROBIOLOG IN PRESS	86	44	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19608	10.1371/journal.pone.0019608	http://dx.doi.org/10.1371/journal.pone.0019608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573111	gold, Green Published, Green Submitted			2022-12-25	WOS:000290305600035
J	Querings, S; Altmuller, J; Ansen, S; Zander, T; Seidel, D; Gabler, F; Peifer, M; Markert, E; Stemshorn, K; Timmermann, B; Saal, B; Klose, S; Ernestus, K; Scheffler, M; Engel-Riedel, W; Stoelben, E; Brambilla, E; Wolf, J; Nurnberg, P; Thomas, RK				Querings, Silvia; Altmueller, Janine; Ansen, Sascha; Zander, Thomas; Seidel, Danila; Gabler, Franziska; Peifer, Martin; Markert, Eva; Stemshorn, Kathryn; Timmermann, Bernd; Saal, Beate; Klose, Stefan; Ernestus, Karen; Scheffler, Matthias; Engel-Riedel, Walburga; Stoelben, Erich; Brambilla, Elisabeth; Wolf, Juergen; Nuernberg, Peter; Thomas, Roman K.			Benchmarking of Mutation Diagnostics in Clinical Lung Cancer Specimens	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EGFR MUTATIONS; GENE-MUTATIONS; KRAS MUTATION; GEFITINIB; POLYMERASE; SYSTEM; SAMPLES; TUMORS	Treatment of EGFR-mutant non-small cell lung cancer patients with the tyrosine kinase inhibitors erlotinib or gefitinib results in high response rates and prolonged progression-free survival. Despite the development of sensitive mutation detection approaches, a thorough validation of these in a clinical setting has so far been lacking. We performed, in a clinical setting, a systematic validation of dideoxy 'Sanger' sequencing and pyrosequencing against massively parallel sequencing as one of the most sensitive mutation detection technologies available. Mutational annotation of clinical lung tumor samples revealed that of all patients with a confirmed response to EGFR inhibition, only massively parallel sequencing detected all relevant mutations. By contrast, dideoxy sequencing missed four responders and pyrosequencing missed two responders, indicating a dramatic lack of sensitivity of dideoxy sequencing, which is widely applied for this purpose. Furthermore, precise quantification of mutant alleles revealed a low correlation (r(2) = 0.27) of histopathological estimates of tumor content and frequency of mutant alleles, thereby questioning the use of histopathology for stratification of specimens for individual analytical procedures. Our results suggest that enhanced analytical sensitivity is critically required to correctly identify patients responding to EGFR inhibition. More broadly, our results emphasize the need for thorough evaluation of all mutation detection approaches against massively parallel sequencing as a prerequisite for any clinical implementation.	[Querings, Silvia; Seidel, Danila; Gabler, Franziska; Peifer, Martin; Saal, Beate; Thomas, Roman K.] Max Planck Gesell, Klaus Joachim Zulch Labs, Max Planck Inst Neurol Res, Cologne, Germany; [Querings, Silvia; Seidel, Danila; Gabler, Franziska; Peifer, Martin; Saal, Beate; Thomas, Roman K.] Univ Cologne, Fac Med, Cologne, Germany; [Querings, Silvia; Seidel, Danila; Gabler, Franziska; Wolf, Juergen; Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol Koln Bonn, Lab Translat Canc Genom, Cologne, Germany; [Altmueller, Janine; Stemshorn, Kathryn; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Ansen, Sascha; Zander, Thomas; Scheffler, Matthias; Wolf, Juergen; Thomas, Roman K.] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Ansen, Sascha; Zander, Thomas; Scheffler, Matthias; Wolf, Juergen; Thomas, Roman K.] Univ Hosp Cologne, Ctr Integrated Oncol Koln Bonn, Cologne, Germany; [Markert, Eva; Ernestus, Karen] Hosp Merheim, Inst Pathol, Cologne, Germany; [Timmermann, Bernd] Max Planck Inst Mol Genet, Berlin, Germany; [Engel-Riedel, Walburga] Lung Clin Merheim, Dept Med Oncol, Cologne, Germany; [Klose, Stefan] Pneumol Gemeinschaftpraxis Dr HP Wagner Dr St Kos, Chemnitz, Germany; [Stoelben, Erich] Lung Clin Merheim, Dept Thorac Surg, Cologne, Germany; [Brambilla, Elisabeth] Univ Grenoble 1, CHU Grenoble Hop Michallon, INSERM, Dept Pathol,Inst Albert Bonniot,U823, Grenoble, France	Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Max Planck Society; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Querings, S (corresponding author), Max Planck Gesell, Klaus Joachim Zulch Labs, Max Planck Inst Neurol Res, Cologne, Germany.	nini@nf.mpg.de	Scheffler, Matthias/AAC-1656-2019; Seidel, Danila/Y-6795-2018; Brambilla, Elisabeth MP/L-8796-2013	Seidel, Danila/0000-0003-4388-3117; Peifer, Martin/0000-0002-5243-5503; Scheffler, Matthias/0000-0002-9031-1368; Altmuller, Janine/0000-0003-4372-1521	German Cancer Aid as part of the Centers of Excellence in Oncology program; Federal German Ministry of Science and Education (BMBF) [01GS08100, 01GS08101]; AstraZeneca; Roche; Boehringer Ingelheim; JohnsonJohnson; Lilly; Merck; Atlas Biolabs; Sanofi-Aventis	German Cancer Aid as part of the Centers of Excellence in Oncology program; Federal German Ministry of Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); AstraZeneca(AstraZeneca); Roche(Roche Holding); Boehringer Ingelheim(Boehringer Ingelheim); JohnsonJohnson(Johnson & JohnsonJohnson & Johnson USA); Lilly(Eli Lilly); Merck(Merck & Company); Atlas Biolabs; Sanofi-Aventis(Sanofi-Aventis)	This work was supported by the German Cancer Aid as part of the Centers of Excellence in Oncology program to the Center of Integrated Oncology Koln - Bonn and by the Federal German Ministry of Science and Education (BMBF) as part of the National Genome Research Network program (NGFNplus, grants 01GS08100 and 01GS08101) to Jurgen Wolf, Peter Nurnberg and Roman Thomas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Roman K. Thomas received research support from AstraZeneca and received lecture or consultancy fees from Roche, Boehringer Ingelheim, Johnson&Johnson, AstraZeneca, Lilly, Merck, Atlas Biolabs and Sanofi-Aventis. Jurgen Wolf received research support and served as a consultant to Roche and AstraZeneca. Research support mentioned in this section was not used for conducting this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Asano H, 2006, CLIN CANCER RES, V12, P43, DOI 10.1158/1078-0432.CCR-05-0934; Brevet M, 2010, J MOL DIAGN, V12, P169, DOI 10.2353/jmoldx.2010.090140; Cappuzzo F, 2007, J CLIN ONCOL, V25, P2248, DOI 10.1200/JCO.2006.09.4300; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Dufort S, 2009, ANAL BIOCHEM, V391, P166, DOI 10.1016/j.ab.2009.05.027; FELLEYBOSCO E, 1991, NUCLEIC ACIDS RES, V19, P2913, DOI 10.1093/nar/19.11.2913; Flaherty KT, N ENGL J MED, V363, P809; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fukui T, 2008, CLIN CANCER RES, V14, P4751, DOI 10.1158/1078-0432.CCR-07-5207; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Miyazawa H, 2008, CANCER SCI, V99, P595, DOI 10.1111/j.1349-7006.2007.00706.x; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Molina-Vila MA, 2008, J THORAC ONCOL, V3, P1224, DOI 10.1097/JTO.0b013e318189f579; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Nomoto K, 2006, AM J CLIN PATHOL, V126, P608, DOI 10.1309/N5PQNGW2QKMX09X7; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Oh YH, 2010, J MOL DIAGN, V12, P644, DOI 10.2353/jmoldx.2010.090208; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pan QL, 2005, J MOL DIAGN, V7, P396, DOI 10.1016/S1525-1578(10)60569-7; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Poehlmann A, 2007, PATHOL RES PRACT, V203, P489, DOI 10.1016/j.prp.2007.06.001; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Rosell R, 2011, CLIN CANCER RES, V17, P1160, DOI 10.1158/1078-0432.CCR-10-2158; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Smith GD, 2008, J CLIN PATHOL, V61, P487, DOI 10.1136/jcp.2007.051425; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Uramoto H, 2007, BRIT J CANCER, V96, P857, DOI 10.1038/sj.bjc.6603665	33	96	96	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19601	10.1371/journal.pone.0019601	http://dx.doi.org/10.1371/journal.pone.0019601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573178	Green Published, Green Submitted, gold			2022-12-25	WOS:000290256400033
J	Son, MY; Kim, HJ; Kim, MJ; Cho, S				Son, Mi-Young; Kim, Hyun-Jin; Kim, Min-Jeong; Cho, Sook			Physical Passaging of Embryoid Bodies Generated from Human Pluripotent Stem Cells	PLOS ONE			English	Article							STRESS DEFENSE-MECHANISMS; DIFFERENTIATION; PROPAGATION; CULTIVATION; SUSPENSION; EFFICIENCY; LINES	Spherical three-dimensional cell aggregates called embryoid bodies E have been widely used in in v cols for human pluripotent stem cells including human embryonic stem cells (hESCs) and human induced pluripotent cells (hiPSCs). Recent studies highlight the new devices and techniques for hEB formation and expansion but are not involved in the passaging or subculture process. Here, we provide evidence that a simple periodic passaging markedly improved hEB culture condition and thus allowed the size-controlled, mass production of human embryoid bodies (hEBs) derived from both hESCs and hiPSCs. hEBs maintained in prolonged suspension culture without passaging (> 2 weeks) showed a progressive decrease in the cell growth and proliferation and increase in the apoptosis compared to 7-day-old hEBs. However, when serially passaged in suspension, hEB cell populations were significantly increased in number whil maintaining the normal rates of cell proliferation and apoptosis and the differentiation potential. Uniform-sized hEBs produced by manual passaging using a 1:4 split ratio have been successfully maintained for over 20 continuous passages. The passaging culture method of hEBs, which is simple, readily expandable, and reproducible, could be a powerful tool for improving a robust and scalable in vitro differentiation system of human pluripotent stem cells.	[Son, Mi-Young; Kim, Hyun-Jin; Kim, Min-Jeong; Cho, Sook] Korea Res Inst Biosci & Biotechnol, Dev & Differentiat Res Ctr, Taejon, South Korea; [Kim, Min-Jeong; Cho, Sook] Univ Sci & Technol, Dept Funct Genom, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Son, MY (corresponding author), Korea Res Inst Biosci & Biotechnol, Dev & Differentiat Res Ctr, Taejon, South Korea.	june@kribb.re.kr			Ministry of Education, Science and Technology (MEST) [2010-0020272]; Korea Research Council of Fundamental Sciences and Technology (KRCF)/Korea Research Institute of Bioscience and Biotechnology (KRIBB)	Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Research Council of Fundamental Sciences and Technology (KRCF)/Korea Research Institute of Bioscience and Biotechnology (KRIBB)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (MEST)(2010-0020272). This work was also supported by the Korea Research Council of Fundamental Sciences and Technology (KRCF)/Korea Research Institute of Bioscience and Biotechnology (KRIBB) stem cell research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; Cameron CM, 2006, BIOTECHNOL BIOENG, V94, P938, DOI 10.1002/bit.20919; Dang SM, 2002, BIOTECHNOL BIOENG, V78, P442, DOI 10.1002/bit.10220; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Fernandes AM, 2009, BRAZ J MED BIOL RES, V42, P515, DOI 10.1590/S0100-879X2009000600007; Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V86, P493, DOI 10.1002/bit.20045; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Joannides A, 2006, STEM CELLS, V24, P230, DOI 10.1634/stemcells.2005-0243; Khoo MLM, 2005, BIOL REPROD, V73, P1147, DOI 10.1095/biolreprod.104.036673; Kim MS, 2007, LAB CHIP, V7, P513, DOI 10.1039/b617760n; Mohr JC, 2010, BIOMATERIALS, V31, P1885, DOI 10.1016/j.biomaterials.2009.11.033; Nagy A., 2003, MANIPULATING MOUSE E; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Park SW, 2010, BLOOD, V116, P5762, DOI 10.1182/blood-2010-04-280719; Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628; Shukla-Dave A, 2009, RADIOLOGY, V250, P803, DOI 10.1148/radiol.2503080473; Son MY, 2011, J CELL MOL MED, V15, P152, DOI 10.1111/j.1582-4934.2009.00956.x; Steiner D, 2010, NAT BIOTECHNOL, V28, P361, DOI 10.1038/nbt.1616; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; Yirme G, 2008, STEM CELLS DEV, V17, P1227, DOI 10.1089/scd.2007.0272	20	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19134	10.1371/journal.pone.0019134	http://dx.doi.org/10.1371/journal.pone.0019134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559272	Green Submitted, gold, Green Published			2022-12-25	WOS:000290223500008
J	Altermatt, F; Bieger, A; Carrara, F; Rinaldo, A; Holyoak, M				Altermatt, Florian; Bieger, Annette; Carrara, Francesco; Rinaldo, Andrea; Holyoak, Marcel			Effects of Connectivity and Recurrent Local Disturbances on Community Structure and Population Density in Experimental Metacommunities	PLOS ONE			English	Article							SOURCE-SINK DYNAMICS; COLONIZATION TRADE-OFF; DEPENDENT DISPERSAL; HABITAT PATCHES; SPATIAL SCALES; COEXISTENCE; COMPETITION; MIGRATION; MECHANISMS; FRAMEWORK	Metacommunity theory poses that the occurrence and abundance of species is a product of local factors, including disturbance, and regional factors, like dispersal among patches. While metacommunity ideas have been broadly tested there is relatively little work on metacommunities subject to disturbance. We focused on how localized disturbance and dispersal interact to determine species composition in metacommunities. Experiments conducted in simple two-patch habitats containing eight protozoa and rotifer species tested how dispersal altered community composition in both communities that were disturbed and communities that connected to refuge communities not subject to disturbance. While disturbance lowered population densities, in disturbed patches connected to undisturbed patches this was ameliorated by immigration. Furthermore, species with high dispersal abilities or growth rates showed the fastest post-disturbance recovery in presence of immigration. Connectivity helped to counteract the negative effect of disturbances on local populations, allowing mass-effect-driven dispersal of individuals from undisturbed to disturbed patches. In undisturbed patches, however, local population sizes were not significantly reduced by emigration. The absence of a cost of dispersal for undisturbed source populations is consistent with a lack of complex demography in our system, such as age-or sex-specific emigration. Our approach provides an improved way to separate components of population growth from organisms' movement in post-disturbance recovery of (meta) communities. Further studies are required in a variety of ecosystems to investigate the transient dynamics resulting from disturbance and dispersal.	[Altermatt, Florian] Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland; [Altermatt, Florian; Bieger, Annette; Holyoak, Marcel] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Carrara, Francesco; Rinaldo, Andrea] Ecole Polytech Fed Lausanne, Lab Ecohydrol, ENAC Sch Architecture Civil & Environm Engn, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of California System; University of California Davis; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Altermatt, F (corresponding author), Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland.	florian.altermatt@eawag.ch	Holyoak, Marcel/C-3475-2009	Holyoak, Marcel/0000-0001-9727-3627; Altermatt, Florian/0000-0002-4831-6958	Swiss National Science Foundation [PBBSP3-124435, 200021-124930/1]; European Research Council (ERC) [RINEC 227612]; NSF [DEB 0414465]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); NSF(National Science Foundation (NSF))	FA was supported by the Swiss National Science Foundation (grant Nr. PBBSP3-124435). FC and AR acknowledge funding from the European Research Council (ERC Advanced Grant RINEC 227612) and by the Swiss National Science Foundation (grant N. 200021-124930/1). MH was supported by NSF-DEB 0414465. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTERMATT F, 2011, ECOLOGY IN PRESS, V92; Altermatt F, 2008, OECOLOGIA, V157, P441, DOI 10.1007/s00442-008-1080-4; Altermatt F, 2007, EVOL ECOL, V21, P561, DOI 10.1007/s10682-006-9136-6; Amarasekare P, 2001, AM NAT, V158, P572, DOI 10.1086/323586; Amarasekare P, 2004, AM NAT, V164, P310, DOI 10.1086/422858; Amarasekare P, 2004, J THEOR BIOL, V226, P159, DOI 10.1016/j.jtbi.2003.08.007; Bates AJ, 2006, OECOLOGIA, V150, P50, DOI 10.1007/s00442-006-0508-y; Bendix J, 1997, GEOGR REV, V87, P468, DOI 10.2307/215226; Bertuzzo E, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005533; Bloch CP, 2007, OIKOS, V116, P395, DOI 10.1111/j.0030-1299.2007.15391.x; Brown BL, 2011, J N AM BENTHOL SOC, V30, P310, DOI 10.1899/10-129.1; Brudvig LA, 2009, P NATL ACAD SCI USA, V106, P9328, DOI 10.1073/pnas.0809658106; Cadotte MW, 2007, ECOLOGY, V88, P823, DOI 10.1890/06-1117; Cadotte MW, 2006, AM NAT, V168, P704, DOI 10.1086/508296; Cadotte MW, 2006, ECOLOGY, V87, P1008, DOI 10.1890/0012-9658(2006)87[1008:MIOCRA]2.0.CO;2; Calcagno V, 2006, ECOL LETT, V9, P897, DOI 10.1111/j.1461-0248.2006.00930.x; Campos D, 2006, THEOR POPUL BIOL, V69, P88, DOI 10.1016/j.tpb.2005.09.001; Chesson P, 2000, THEOR POPUL BIOL, V58, P211, DOI 10.1006/tpbi.2000.1486; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Clobert J, 2001, DISPERSAL; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Davies KF, 2009, J ANIM ECOL, V78, P937, DOI 10.1111/j.1365-2656.2009.01559.x; Donahue MJ, 2003, AM NAT, V162, P302, DOI 10.1086/377185; Elkin CM, 2008, AM NAT, V172, P563, DOI 10.1086/590962; Fox JW, 2007, AM NAT, V170, P396, DOI 10.1086/519855; Fukami T, 2004, ECOLOGY, V85, P3234, DOI 10.1890/04-0340; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Gundersen G, 2002, ECOL LETT, V5, P294, DOI 10.1046/j.1461-0248.2002.00320.x; Gundersen G, 2001, ECOL LETT, V4, P14, DOI 10.1046/j.1461-0248.2001.00182.x; Haddad N.M., 2006, CONNECTIVITY CONSERV, P390; Haddad NM, 2008, ECOL LETT, V11, P348, DOI 10.1111/j.1461-0248.2007.01149.x; Hastings A, 2001, ECOL LETT, V4, P215, DOI 10.1046/j.1461-0248.2001.00220.x; Hauzy C, 2007, J ANIM ECOL, V76, P552, DOI 10.1111/j.1365-2656.2007.01227.x; HOLT RD, 1985, THEOR POPUL BIOL, V28, P181, DOI 10.1016/0040-5809(85)90027-9; Holt Robert D., 1993, P77; Holyoak M, 2005, ADV ECOL RES, V37, P245, DOI 10.1016/S0065-2504(04)37008-X; Holyoak M, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P1; Jiang L, 2008, ECOLOGY, V89, P1931, DOI 10.1890/07-1263.1; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Kolmogorov A. N., 1937, B MOSCOW STATE U, V1, DOI DOI 10.1016/B978-0-08-092523-3.50014-9; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LOVELY PS, 1975, J THEOR BIOL, V50, P477, DOI 10.1016/0022-5193(75)90094-6; MacIsaac HJ, 1996, OECOLOGIA, V105, P484, DOI 10.1007/BF00330011; Matthiessen B, 2010, ECOLOGY, V91, P2022, DOI 10.1890/09-1395.1; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Mouquet N, 2002, AM NAT, V159, P420, DOI 10.1086/338996; Nakamaru M, 2007, J THEOR BIOL, V248, P288, DOI 10.1016/j.jtbi.2007.05.012; Niemela J, 1999, FOREST ECOL MANAG, V115, P127, DOI 10.1016/S0378-1127(98)00393-4; Niitepold K, 2009, ECOLOGY, V90, P2223, DOI 10.1890/08-1498.1; R Development Core Team, 2009, R FDN STAT COMP; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Salomon Y, 2010, ECOL LETT, V13, P432, DOI 10.1111/j.1461-0248.2009.01436.x; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; SOUTHWOOD TRE, 1962, BIOL REV, V37, P171, DOI 10.1111/j.1469-185X.1962.tb01609.x; Srivastava DS, 2004, TRENDS ECOL EVOL, V19, P379, DOI 10.1016/j.tree.2004.04.010; Steiner CF, 2006, ECOLOGY, V87, P996, DOI 10.1890/0012-9658(2006)87[996:PACRIM]2.0.CO;2; TRAVIS JMJ, 1999, P ROYAL SOC B, V226; Vasseur DA, 2009, NATURE, V460, P1007, DOI 10.1038/nature08208; Violle C, 2010, P NATL ACAD SCI USA, V107, P12925, DOI 10.1073/pnas.1000699107; Warren PH, 1996, OIKOS, V77, P317, DOI 10.2307/3546071; Worsfold NT, 2009, OIKOS, V118, P1319, DOI 10.1111/j.1600-0706.2009.17500.x	63	58	58	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19525	10.1371/journal.pone.0019525	http://dx.doi.org/10.1371/journal.pone.0019525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559336	Green Published, gold			2022-12-25	WOS:000290024700201
J	Eshima, N; Tokumaru, O; Hara, S; Bacal, K; Korematsu, S; Tabata, M; Karukaya, S; Yasui, Y; Okabe, N; Matsuishi, T				Eshima, Nobuoki; Tokumaru, Osamu; Hara, Shohei; Bacal, Kira; Korematsu, Seigo; Tabata, Minoru; Karukaya, Shigeru; Yasui, Yoshinori; Okabe, Nobuhiko; Matsuishi, Toyojiro			Sex- and Age-Related Differences in Morbidity Rates of 2009 Pandemic Influenza A H1N1 Virus of Swine Origin in Japan	PLOS ONE			English	Article							IMMUNE-RESPONSES; UNITED-STATES; INFECTION; HUMANS; TRANSMISSION; EMERGENCE; GENDER	Background: The objective of the present study was to determine whether the morbidity rates of the 2009 pandemic influenza A H1N1 virus (pdmH1N1) varied by age and/or sex. Methods and Findings: Retrospective analysis of 2,024,367 cases of pdmH1N1 was performed using the national surveillance data from influenza sentinel points in Japan. The male-to-female morbidity ratios (M/F ratios) in nineteen age groups were estimated as the primary outcome. The M/F ratios for pdmH1N1 influenza were: >1 in age groups <20 years and >= 80 years (p<0.001); <1 in age groups 20-79 years (p<0.001). This data suggests that males <20 years of age may be more likely to suffer from pdmH1N1 influenza than females in the same age categories. When the infection pattern for pdmH1N1 was compared with that of seasonal influenza outbreaks between 2000 and 2008, the M/F ratio for pdmH1N1 influenza was higher in ages 3-29 years and lower in ages 40-79 years. Because the present study was based on the national surveillance, it was impossible to estimate the morbidity rate for the Japanese population. It is also likely that the data did not capture asymptomatic or mild infections. Conclusions: Although exposure to the pdmH1N1 virus is assumed to be similar in both boys and girls, M/F ratios were >1 in those younger than 20 years. The subsequent reversal of the M/F ratio in the adult generation could be due to several possibilities, including: greater immunity among adult males, more asymptomatic infections among males, less reporting of illness by males, or differences in exposure to the virus and probability of visiting a clinic. These results suggest that the infection and virulence patterns of pdmH1N1 are more complex than previously considered.	[Eshima, Nobuoki] Oita Univ, Fac Med, Dept Biostat, Yufu City, Oita, Japan; [Tokumaru, Osamu] Oita Univ, Fac Med, Dept Neurophysiol, Yufu City, Oita, Japan; [Hara, Shohei] Yomiuri Shimbun Osaka Newspaper, Osaka, Japan; [Bacal, Kira] Univ Auckland, Med Programme Directorate, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Korematsu, Seigo] Oita Univ, Fac Med, Dept Pediat, Yufu City, Oita, Japan; [Tabata, Minoru] Osaka Prefecture Univ, Dept Math Sci, Grad Sch Engn, Sakai, Osaka 591, Japan; [Karukaya, Shigeru; Matsuishi, Toyojiro] Kurume Univ, Sch Med, Dept Pediat, Kurume, Fukuoka 830, Japan; [Yasui, Yoshinori; Okabe, Nobuhiko] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan	Oita University; Oita University; University of Auckland; Oita University; Osaka Metropolitan University; Kurume University; National Institute of Infectious Diseases (NIID)	Eshima, N (corresponding author), Oita Univ, Fac Med, Dept Biostat, Yufu City, Oita, Japan.	ostokuma@oita-u.ac.jp	Tokumaru, Osamu/AAN-3055-2020; Tabata, Minoru/X-5682-2018	Tabata, Minoru/0000-0003-3876-7437	Japan Ministry of Education, Culture, Sports, Science and Technology [22500260]; Grants-in-Aid for Scientific Research [22500260] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded in part by a Grant-in-Aid for Scientific Research (C) #22500260 to NE from the Japan Ministry of Education, Culture, Sports, Science and Technology (www.jsps.go.jp/english/e-grants/grants.html). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carr MJ, 2009, J CLIN VIROL, V45, P196, DOI 10.1016/j.jcv.2009.06.001; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ding N, 2009, VIRUS GENES, V39, P293, DOI 10.1007/s11262-009-0393-7; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Engler RJM, 2008, ARCH INTERN MED, V168, P2405, DOI 10.1001/archinternmed.2008.513; Eshima N, 2009, J CLIN VIROL, V45, P135, DOI 10.1016/j.jcv.2009.03.012; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Glezen WP, 2006, J CLIN VIROL, V37, P237, DOI 10.1016/j.jcv.2006.08.020; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; May RC, 2007, BIOESSAYS, V29, P795, DOI 10.1002/bies.20614; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0; Noymer A, 2000, POPUL DEV REV, V26, P565, DOI 10.1111/j.1728-4457.2000.00565.x; Odaira F, 2009, EURO SURVEILL, V14; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Picone O, 2005, PRENATAL DIAG, V25, P34, DOI 10.1002/pd.944; Sikora C, 2010, J CLIN VIROL, V49, P90, DOI 10.1016/j.jcv.2010.06.015; Stensballe L, 2004, SCAND J INFECT DIS, V36, P291, DOI 10.1080/00365540410019589; Wang TE, 2010, EPIDEMIOLOGY, V21, P726, DOI 10.1097/EDE.0b013e3181e94274; *WHO DEP GEND WOM, 2007, ADDR SEX GEND EP PRO; World Health Organaization, 2009, WKLY EPIDEMIOLOGICAL, V84, P249; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	26	49	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19409	10.1371/journal.pone.0019409	http://dx.doi.org/10.1371/journal.pone.0019409			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559366	gold, Green Submitted, Green Published			2022-12-25	WOS:000290024700160
J	Gilbert, AE; Karagiannis, P; Dodev, T; Koers, A; Lacy, K; Josephs, DH; Takhar, P; Geh, JLC; Healy, C; Harries, M; Acland, KM; Rudman, SM; Beavil, RL; Blower, PJ; Beavil, AJ; Gould, HJ; Spicer, J; Nestle, FO; Karagiannis, SN				Gilbert, Amy E.; Karagiannis, Panagiotis; Dodev, Tihomir; Koers, Alexander; Lacy, Katie; Josephs, Debra H.; Takhar, Pooja; Geh, Jenny L. C.; Healy, Ciaran; Harries, Mark; Acland, Katharine M.; Rudman, Sarah M.; Beavil, Rebecca L.; Blower, Philip J.; Beavil, Andrew J.; Gould, Hannah J.; Spicer, James; Nestle, Frank O.; Karagiannis, Sophia N.			Monitoring the Systemic Human Memory B Cell Compartment of Melanoma Patients for Anti-Tumor IgG Antibodies	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; METASTATIC MELANOMA; BREAST-CANCER; T-CELLS; RESPONSES; ANTIGENS; IMMUNOTHERAPY; MECHANISMS; MULTIPLE; SURVIVAL	Melanoma, a potentially lethal skin cancer, is widely thought to be immunogenic in nature. While there has been much focus on T cell-mediated immune responses, limited knowledge exists on the role of mature B cells. We describe an approach, including a cell-based ELISA, to evaluate mature IgG antibody responses to melanoma from human peripheral blood B cells. We observed a significant increase in antibody responses from melanoma patients (n = 10) to primary and metastatic melanoma cells compared to healthy volunteers (n = 10) (P < 0.0001). Interestingly, we detected a significant reduction in antibody responses to melanoma with advancing disease stage in our patient cohort (n = 21) (P < 0.0001). Overall, 28% of melanoma patient-derived B cell cultures (n = 1,800) compared to 2% of cultures from healthy controls (n = 600) produced antibodies that recognized melanoma cells. Lastly, a patient-derived melanoma-specific monoclonal antibody was selected for further study. This antibody effectively killed melanoma cells in vitro via antibody-mediated cellular cytotoxicity. These data demonstrate the presence of a mature systemic B cell response in melanoma patients, which is reduced with disease progression, adding to previous reports of tumor-reactive antibodies in patient sera, and suggesting the merit of future work to elucidate the clinical relevance of activating humoral immune responses to cancer.	[Gilbert, Amy E.; Karagiannis, Panagiotis; Lacy, Katie; Josephs, Debra H.; Nestle, Frank O.; Karagiannis, Sophia N.] Kings Coll London, Cutaneous Med & Immunotherapy Unit, Div Genet & Mol Med, NIHR Biomed Res Ctr Guys & St Thomass Hosp, London WC2R 2LS, England; [Gilbert, Amy E.; Karagiannis, Panagiotis; Lacy, Katie; Josephs, Debra H.; Nestle, Frank O.; Karagiannis, Sophia N.] Kings Coll London, Sch Med, St Johns Inst Dermatol, Guys Hosp, London WC2R 2LS, England; [Dodev, Tihomir; Takhar, Pooja; Beavil, Rebecca L.; Beavil, Andrew J.; Gould, Hannah J.] Kings Coll London, Randall Div Cell & Mol Biophys, MRC & Asthma UK Ctr Allerg Mech Asthma, London WC2R 2LS, England; [Dodev, Tihomir; Takhar, Pooja; Beavil, Rebecca L.; Beavil, Andrew J.; Gould, Hannah J.] Kings Coll London, Div Asthma Allergy & Lung Biol, MRC & Asthma UK Ctr Allerg Mech Asthma, London WC2R 2LS, England; [Koers, Alexander; Blower, Philip J.] Kings Coll London, Div Imaging Sci, Sch Med, Rayne Inst,St Thomass Hosp, London WC2R 2LS, England; [Geh, Jenny L. C.; Healy, Ciaran; Acland, Katharine M.] Guys Hosp, Skin Tumour Unit, Guys & St Thomass NHS Trust, St Johns Inst Dermatol, London SE1 9RT, England; [Harries, Mark] Guys & St Thomass NHS Fdn Trust, London, England; [Rudman, Sarah M.; Spicer, James] Kings Coll London, Guys Hosp, Div Canc Studies, Dept Acad Oncol, London WC2R 2LS, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Gilbert, AE (corresponding author), Kings Coll London, Cutaneous Med & Immunotherapy Unit, Div Genet & Mol Med, NIHR Biomed Res Ctr Guys & St Thomass Hosp, London WC2R 2LS, England.	frank.nestle@kcl.ac.uk; sophia.karagiannis@kcl.ac.uk	Karagiannis, Sophia/H-1097-2011; Geh, Jenny/F-1031-2018; Blower, Phil/GSD-5552-2022	Karagiannis, Sophia/0000-0002-4100-7810; Geh, Jenny/0000-0001-7031-3844; Beavil, Andrew/0000-0002-0768-122X; Blower, Philip/0000-0001-6290-1590; Spicer, James/0000-0003-3732-8491; Gould, Hannah/0000-0003-0411-688X; Karagiannis, Panagiotis/0000-0001-6459-7561	Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; St. Thomas's NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust, UK; CR UK/EPSRC/MRC/NIHR KCL/UCL Comprehensive Cancer Imaging Centre [C1519/A10331]; Cancer Research UK [C30122/A11527]; Mary Dunhill Trust; CR UK/NIHR in England/DoH for Scotland; Wales and Northern Ireland Experimental Cancer Medicine Centre (FON); Overseas Research Students Award Scheme (AEG); MRC [G0501494] Funding Source: UKRI; Medical Research Council [G1000758B, G0501494, G1000758, G0600698B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); St. Thomas's NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust, UK; CR UK/EPSRC/MRC/NIHR KCL/UCL Comprehensive Cancer Imaging Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Cancer Research UKEngineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); Mary Dunhill Trust(Dunhill Medical Trust); CR UK/NIHR in England/DoH for Scotland(Cancer Research UK); Wales and Northern Ireland Experimental Cancer Medicine Centre (FON); Overseas Research Students Award Scheme (AEG); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's, and St. Thomas's NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust, UK (AEG, PK, TD, AK, KL, PT, FON, SNK) (http://www.guysandstthomas.nhs.uk/healthprof/researchanddevelopment/biomedicalresearch/biomedhome.aspx); CR UK/EPSRC/MRC/NIHR KCL/UCL Comprehensive Cancer Imaging Centre (C1519/A10331) (DHJ, PJB, JS, SNK) (http://www.cancerimagingcentre.org.uk/); Cancer Research UK (C30122/A11527) (DHJ) (http://www.cancerresearchuk.org/); Mary Dunhill Trust (FON) (http://www.dunhillmedical.org.uk/page_viewer.asp?page=welcome & pid=8); CR UK/NIHR in England/DoH for Scotland, Wales and Northern Ireland Experimental Cancer Medicine Centre (FON) (http://www.ecmcnetwork.org.uk/network-centres/london-kcl/); and the Overseas Research Students Award Scheme (AEG) (http://www.orsas.ac.uk/). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Bouaziz J-D, EUROPEAN J IMMUNOLOG, V40, P2686; CAI XH, 1995, P NATL ACAD SCI USA, V92, P6537, DOI 10.1073/pnas.92.14.6537; Campoli MR, 2004, CRITICAL REV IMMUNOL, V24, P30; Carpenter EL, 2009, CLIN CANCER RES, V15, P4277, DOI 10.1158/1078-0432.CCR-09-0537; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cummins DL, 2006, MAYO CLIN PROC, V81, P500, DOI 10.4065/81.4.500; DiLillo DJ, 2010, J IMMUNOL, V184, P4006, DOI 10.4049/jimmunol.0903009; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; Gril B, 2008, JNCI-J NATL CANCER I, V100, P1092, DOI 10.1093/jnci/djn216; Hodi FS, 2006, CLIN CANCER RES, V12, P673, DOI 10.1158/1078-0432.CCR-05-2616; Hodi FS, N ENGL J MED, V363, P711; Houghton AN, 2001, CURR OPIN IMMUNOL, V13, P134, DOI 10.1016/S0952-7915(00)00195-3; Huang SKS, 1998, J INVEST DERMATOL, V111, P662, DOI 10.1046/j.1523-1747.1998.00354.x; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Kalialis LV, 2009, MELANOMA RES, V19, P275, DOI 10.1097/CMR.0b013e32832eabd5; Karagiannis P, 2009, CANCER IMMUNOL IMMUN, V58, P915, DOI 10.1007/s00262-008-0607-1; Karagiannis SN, 2003, EUR J IMMUNOL, V33, P1030, DOI 10.1002/eji.200323185; Karagiannis SN, 2007, J IMMUNOL, V179, P2832, DOI 10.4049/jimmunol.179.5.2832; KIRKWOOD JM, 1990, CANCER IMMUNOL IMMUN, V32, P228, DOI 10.1007/BF01741705; Kirkwood JM, 2006, CLIN CANCER RES, V16, P1042; Kirkwood JM, 2008, J CLIN ONCOL, V26, P3445, DOI 10.1200/JCO.2007.14.6423; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Lanzavecchia A, 2007, CURR OPIN BIOTECH, V18, P523, DOI 10.1016/j.copbio.2007.10.011; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; LEWIS MG, 1969, BMJ-BRIT MED J, V3, P547, DOI 10.1136/bmj.3.5670.547; Marincola FM, 2003, TRENDS IMMUNOL, V24, P335, DOI 10.1016/S1471-4906(03)00116-9; MITTELMAN A, 1992, P NATL ACAD SCI USA, V89, P466, DOI 10.1073/pnas.89.2.466; Nestle FO, 2007, DERMATOLOGY; Perez DG, 2009, CANCER-AM CANCER SOC, V115, P119, DOI 10.1002/cncr.23987; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; PUNT CJA, 1994, CANCER IMMUNOL IMMUN, V38, P225, DOI 10.1007/s002620050058; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Schadendorf D, 2006, ANN ONCOL, V17, P563, DOI 10.1093/annonc/mdj138; Schadendorf D, 2009, ANN ONCOL, V20, P41, DOI 10.1093/annonc/mdp253; Shimbo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010566; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; Stove C, 2003, J INVEST DERMATOL, V121, P802, DOI 10.1046/j.1523-1747.2003.12522.x; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Takahashi T, 1999, J INVEST DERMATOL, V112, P205, DOI 10.1046/j.1523-1747.1999.00493.x; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Vajdic CM, 2009, CANCER EPIDEM BIOMAR, V18, P2297, DOI 10.1158/1055-9965.EPI-09-0278; Vence L, 2007, P NATL ACAD SCI USA, V104, P20884, DOI 10.1073/pnas.0710557105; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wewetzer K, 1996, J IMMUNOL METHODS, V191, P171, DOI 10.1016/0022-1759(96)00018-X; Wistuba II, 1999, CLIN CANCER RES, V5, P991; YAMAGUCHI H, 1987, P NATL ACAD SCI USA, V84, P2416, DOI 10.1073/pnas.84.8.2416; YEILDING NM, 1992, INT J CANCER, V52, P967, DOI 10.1002/ijc.2910520623; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105; ZHANG H, 1995, CANCER RES, V55, P3584	60	48	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19330	10.1371/journal.pone.0019330	http://dx.doi.org/10.1371/journal.pone.0019330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559411	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700139
J	Inbar, S; Neeman, E; Avraham, R; Benish, M; Rosenne, E; Ben-Eliyahu, S				Inbar, Shelly; Neeman, Elad; Avraham, Roi; Benish, Marganit; Rosenne, Ella; Ben-Eliyahu, Shamgar			Do Stress Responses Promote Leukemia Progression? An Animal Study Suggesting a Role for Epinephrine and Prostaglandin-E-2 through Reduced NK Activity	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ENDOTHELIAL GROWTH-FACTOR; ACUTE MYELOID-LEUKEMIA; PROSTATE-CANCER CELLS; CHRONIC LYMPHOCYTIC-LEUKEMIA; BETA-ADRENERGIC ANTAGONIST; CLASS-I MOLECULES; QUALITY-OF-LIFE; TUMOR-METASTASIS; SIGNAL-TRANSDUCTION	In leukemia patients, stress and anxiety were suggested to predict poorer prognosis. Oncological patients experience ample physiological and psychological stress, potentially leading to increased secretion of stress factors, including epinephrine, corticosteroids, and prostaglandins. Here we tested whether environmental stress and these stress factors impact survival of leukemia-challenged rats, and studied mediating mechanisms. F344 rats were administered with a miniscule dose of 60 CRNK-16 leukemia cells, and were subjected to intermittent forced swim stress or to administration of physiologically relevant doses of epinephrine, prostaglandin-E-2 or corticosterone. Stress and each stress factor, and/or their combinations, doubled mortality rates when acutely applied simultaneously with, or two or six days after tumor challenge. Acute administration of the beta-adrenergic blocker nadolol diminished the effects of environmental stress, without affecting baseline survival rates. Prolonged beta-adrenergic blockade or COX inhibition (using etodolac) also increased baseline survival rates, possibly by blocking tumor-related or normal levels of catecholamines and prostaglandins. Searching for mediating mechanisms, we found that each of the stress factors transiently suppressed NK activity against CRNK-16 and YAC-1 lines on a per NK basis. In contrast, the direct effects of stress factors on CRNK-16 proliferation, vitality, and VEGF secretion could not explain or even contradicted the in vivo survival findings. Overall, it seems that environmental stress, epinephrine, and prostaglandins promote leukemia progression in rats, potentially through suppressing cell mediated immunity. Thus, patients with hematological malignancies, which often exhibit diminished NK activity, may benefit from extended beta-blockade and COX inhibition.	[Inbar, Shelly; Neeman, Elad; Avraham, Roi; Benish, Marganit; Rosenne, Ella; Ben-Eliyahu, Shamgar] Tel Aviv Univ, Dept Psychol, Neuroimmunol Res Unit, IL-69978 Tel Aviv, Israel	Tel Aviv University	Inbar, S (corresponding author), Tel Aviv Univ, Dept Psychol, Neuroimmunol Res Unit, IL-69978 Tel Aviv, Israel.	shamgar@post.tau.ac.il	Ben-Eliyahu, Shamgar/AAE-5444-2020	Ben-Eliyahu, Shamgar/0000-0003-3832-0678; Avraham, Roi/0000-0002-9098-3885	National Institutes of Health/National Cancer Institute (NIH/NCI) [CA125456]; Israel-USA bi-national Science Foundation [2005331]; NATIONAL CANCER INSTITUTE [R01CA125456] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Israel-USA bi-national Science Foundation(US-Israel Binational Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health/National Cancer Institute (NIH/NCI) grant # CA125456 (SBE), and a grant from the Israel-USA bi-national Science Foundation # 2005331 (SBE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algarra I, 1997, INT J CLIN LAB RES, V27, P95, DOI 10.1007/BF02912442; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Avraham R, 2006, CANCER IMMUNOL IMMUN, V55, P1348, DOI 10.1007/s00262-006-0139-5; Avraham R, 2010, BRAIN BEHAV IMMUN, V24, P952, DOI 10.1016/j.bbi.2010.03.010; BARLOZZARI T, 1985, J IMMUNOL, V134, P2783; BAXEVANIS CN, 1993, CANCER-AM CANCER SOC, V72, P491, DOI 10.1002/1097-0142(19930715)72:2<491::AID-CNCR2820720227>3.0.CO;2-1; Beglinger LJ, 2007, J INT NEUROPSYCH SOC, V13, P172, DOI 10.1017/S1355617707070208; Ben-Eliyahu S, 1999, INT J CANCER, V80, P880; BenEliyahu S, 1996, NAT MED, V2, P457, DOI 10.1038/nm0496-457; BENELIYAHU S, 1991, BRAIN BEHAV IMMUN, V5, P193, DOI 10.1016/0889-1591(91)90016-4; BENELIYAHU S, 2007, BRAIN BEHAV IMMUN; Benish M, 2008, ANN SURG ONCOL, V15, P2042, DOI 10.1245/s10434-008-9890-5; BERKELHAMMER J, 1982, CANCER RES, V42, P3157; Binstadt BA, 1997, IMMUNOL REV, V155, P197, DOI 10.1111/j.1600-065X.1997.tb00952.x; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Calcagni E, 2006, ANN NY ACAD SCI, V1069, P62, DOI 10.1196/annals.1351.006; CALLEWAERT DM, 1991, FEBS LETT, V285, P108, DOI 10.1016/0014-5793(91)80736-M; Chakraborti AK, 2010, CURR MED CHEM, V17, P1563, DOI 10.2174/092986710790979980; CHAMBERS WH, 1992, J IMMUNOL, V148, P3658; COLON EA, 1991, PSYCHOSOMATICS, V32, P420, DOI 10.1016/S0033-3182(91)72045-8; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; CRARY B, 1983, J IMMUNOL, V131, P1178; DHABHAR F, 1996, J IMMUNOL, V15, P1638; Dhabhar FS, 2010, BRAIN BEHAV IMMUN, V24, P127, DOI 10.1016/j.bbi.2009.09.004; Dhabhar FS, 2003, ANN NY ACAD SCI, V992, P205, DOI 10.1111/j.1749-6632.2003.tb03151.x; Dunn AJ, 2000, ANN NY ACAD SCI, V917, P608, DOI 10.1111/j.1749-6632.2000.tb05426.x; Elenkov IJ, 2006, NEUROIMMUNOMODULAT, V13, P257, DOI 10.1159/000104853; Fehder W P, 1999, CRNA, V10, P124; GIGUERE V, 1983, BIOCHEM BIOPH RES CO, V110, P456, DOI 10.1016/0006-291X(83)91171-3; Glasner A, 2010, J IMMUNOL, V184, P2449, DOI 10.4049/jimmunol.0903301; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Grulke N, 2005, BONE MARROW TRANSPL, V35, P1107, DOI 10.1038/sj.bmt.1704971; Haim S, 2003, J ENDOCRINOL INVEST, V26, P1013, DOI 10.1007/BF03348201; HUCKER HB, 1996, PHARM EXPT THERAPEUT, V153, P237; Jetschmann JU, 1997, J NEUROIMMUNOL, V74, P159, DOI 10.1016/S0165-5728(96)00221-4; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; Karre K, 2002, SCIENCE, V295, P2029, DOI 10.1126/science.1070538; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; Kishikawa H, 1997, TOXICOL APPL PHARM, V147, P180, DOI 10.1006/taap.1997.8308; KUMAR V, 1979, J IMMUNOL, V123, P1832; LANDMANN R, 1992, EUR J CLIN INVEST, V22, P30; Leibson PJ, 1997, IMMUNITY, V6, P655, DOI 10.1016/S1074-7613(00)80441-0; Letilovic T, 2006, CANCER-AM CANCER SOC, V107, P925, DOI 10.1002/cncr.22086; LEUNG KH, 1984, J IMMUNOL, V132, P1445; Levin TT, 2007, GEN HOSP PSYCHIAT, V29, P251, DOI 10.1016/j.genhosppsych.2007.01.014; LIPPMAN M, 1976, CANCER RES, V36, P4602; Lowdell MW, 2002, BRIT J HAEMATOL, V117, P821, DOI 10.1046/j.1365-2141.2002.03495.x; Lutgendorf SK, 2000, CANCER, V89, P1402, DOI 10.1002/1097-0142(20000915)89:6<1402::AID-CNCR26>3.3.CO;2-8; Lutgendorf SK, 2003, CLIN CANCER RES, V9, P4514; Ma WY, 2008, NEUROSCI LETT, V437, P165, DOI 10.1016/j.neulet.2008.02.072; Melamed R, 2005, BRAIN BEHAV IMMUN, V19, P114, DOI 10.1016/j.bbi.2004.07.004; Menetrier-Caux C, 1999, BRIT J CANCER, V79, P119, DOI 10.1038/sj.bjc.6690021; Montgomery C, 2003, J PSYCHOSOM RES, V54, P289, DOI 10.1016/S0022-3999(02)00396-3; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Nieborowska-Skorska M, 2006, CANCER RES, V66, P4108, DOI 10.1158/0008-5472.CAN-05-1584; Nielsen NR, 2008, J INTERN MED, V263, P192, DOI 10.1111/j.1365-2796.2007.01826.x; Page GG, 2008, J NEUROIMMUNOL, V193, P113, DOI 10.1016/j.jneuroim.2007.10.023; PAGE GG, 1994, BRAIN BEHAV IMMUN, V8, P241, DOI 10.1006/brbi.1994.1022; PARK PG, 1995, CANCER RES, V55, P3504; PAWELEC G, 1995, LEUKEMIA LYMPHOMA, V18, P471, DOI 10.3109/10428199509059647; Pierson BA, 1996, BLOOD, V88, P2279, DOI 10.1182/blood.V88.6.2279.bloodjournal8862279; Prieto JM, 2005, J CLIN ONCOL, V23, P6063, DOI 10.1200/JCO.2005.05.751; Rasmussen HN, 2009, ANN BEHAV MED, V37, P239, DOI 10.1007/s12160-009-9111-x; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Rettori V, 2009, ANN NY ACAD SCI, V1153, P35, DOI 10.1111/j.1749-6632.2008.03968.x; REYNOLDS CW, 1984, J IMMUNOL, V132, P534; Rolstad B, 2001, IMMUNOL REV, V181, P149, DOI 10.1034/j.1600-065X.2001.1810112.x; Ryan JC, 2000, METH MOL B, V121, P283; Sanders VM, 1995, ADV NEUROIMMUNOL, V5, P283, DOI 10.1016/0960-5428(95)00019-X; Saul AN, 2005, JNCI-J NATL CANCER I, V97, P1760, DOI 10.1093/jnci/dji401; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Schuch G, 2002, BLOOD, V100, P4622, DOI 10.1182/blood.V100.13.4622; Shakhar G, 1998, J IMMUNOL, V160, P3251; Shakhar G, 2003, J NEUROIMMUNOL, V138, P83, DOI 10.1016/S0165-5728(03)00118-8; Shakhar G, 2007, ANN SURG ONCOL, V14, P841, DOI 10.1245/s10434-006-9078-9; Shang ZJ, 2009, J ORAL PATHOL MED, V38, P371, DOI 10.1111/j.1600-0714.2008.00691.x; SIMON WE, 1984, JNCI-J NATL CANCER I, V73, P313, DOI 10.1093/jnci/73.2.313; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Sood AK, 2010, J CLIN INVEST, V120, P1515, DOI 10.1172/JCI40802; Specht C, 2001, INT J CANCER, V91, P705, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1066>3.0.CO;2-J; Steiner K, 2006, LEUKEMIA, V20, P2076, DOI 10.1038/sj.leu.2404391; Tajima F, 1996, LEUKEMIA, V10, P478; TALMADGE JE, 1982, J NATL CANCER I, V69, P975; TOFT P, 1992, APMIS, V100, P593, DOI 10.1111/j.1699-0463.1992.tb03971.x; Uotila P, 1996, CANCER IMMUNOL IMMUN, V43, P1; Vazquez S, 2006, CANCER CHEMOTH PHARM, V58, P50, DOI 10.1007/s00280-005-0130-4; WojtowiczPraga S, 1997, J IMMUNOTHER, V20, P165, DOI 10.1097/00002371-199705000-00001; Wong HPS, 2009, DIGESTION, V80, P209, DOI 10.1159/000231898; Xie YF, 2002, IMMUNOBIOLOGY, V206, P345, DOI 10.1078/0171-2985-00185; Yakar I, 2003, ANN SURG ONCOL, V10, P469, DOI 10.1245/ASO.2003.08.017; Yang EV, 2006, CANCER RES, V66, P10357, DOI 10.1158/0008-5472.CAN-06-2496; Yang EV, 2009, BRAIN BEHAV IMMUN, V23, P267, DOI 10.1016/j.bbi.2008.10.005; Yano A, 2006, CLIN CANCER RES, V12, P6012, DOI 10.1158/1078-0432.CCR-06-0749; Yano A, 2006, CLIN CANCER RES, V12, P3003, DOI 10.1158/1078-0432.CCR-05-2085; Zhao XY, 2000, NAT MED, V6, P703, DOI 10.1038/76287	95	80	81	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19246	10.1371/journal.pone.0019246	http://dx.doi.org/10.1371/journal.pone.0019246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559428	gold, Green Submitted, Green Published			2022-12-25	WOS:000290024700110
J	Wikman, A; Wardle, J; Steptoe, A				Wikman, Anna; Wardle, Jane; Steptoe, Andrew			Quality of Life and Affective Well-Being in Middle-Aged and Older People with Chronic Medical Illnesses: A Cross-Sectional Population Based Study	PLOS ONE			English	Article							FUNCTIONAL IMPAIRMENT; CANCER-PATIENTS; RESPONSE SHIFT; HEART-FAILURE; MENTAL-HEALTH; DEPRESSION; DISEASE; MORTALITY; QUESTIONNAIRE; METAANALYSIS	Background: There has been considerable research into the impact of chronic illness on health-related quality of life. However, few studies have assessed the impact of different chronic conditions on general quality of life (QOL). The objective of this paper was to compare general (rather than health-related) QOL and affective well-being in middle aged and older people across eight chronic illnesses. Methods and Findings: This population-based, cross-sectional study involved 11,523 individuals aged 50 years and older, taking part in wave 1 of the English Longitudinal Study of Ageing. General QOL was assessed using the CASP-19, happiness was evaluated using two items drawn from the GHQ-12, and depression was measured with the CES-D. Analysis of covariance and logistic regression, adjusting for age, gender and wealth, were performed. General QOL was most impaired in people with stroke (mean 37.56, CI 36.73-38.39), and least in those reporting cancer (mean 41.78, CI 41.12-42.44, respectively), compared with no illness (mean 44.15, CI 43.92-44.39). Stroke (mean 3.65, CI 3.58-3.73) was also associated with the greatest reduction in positive well-being whereas diabetes (mean 3.81, CI 3.76-3.86) and cancer were least affected (3.85, CI 3.79-3.91), compared with no illness (mean 3.97, CI 3.95-4.00). Depression was significantly elevated in all conditions, but was most common in chronic lung disease (OR 3.04, CI 2.56-3.61), with more modest elevations in those with osteoarthritis (OR 2.08, CI 1.84-2.34) or cancer (OR 2.07, CI 1.69-2.54). Multiple co-morbidities were associated with greater decrements in QOL and affective well-being. Conclusion: The presence of chronic illness is associated with impairments in broader aspects of QOL and affective wellbeing, but different conditions vary in their impact. Further longitudinal work is needed to establish the temporal links between chronic illness and impairments in QOL and affective well-being.	[Wikman, Anna; Steptoe, Andrew] UCL, Dept Epidemiol & Publ Hlth, Psychobiol Grp, London, England; [Wikman, Anna] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Wardle, Jane] UCL, Dept Epidemiol & Publ Hlth, Hlth Behav Res Ctr, London, England	University of London; University College London; Karolinska Institutet; University of London; University College London	Wikman, A (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Psychobiol Grp, London, England.	anna.wikman@ki.se	Steptoe, Andrew/Y-2440-2019	Steptoe, Andrew/0000-0001-7808-4943	National Institute on Aging in the United States [2RO1AG7644-01A1, 2RO1AG017644]; consortium of UK government departments; NATIONAL INSTITUTE ON AGING [R01AG017644] Funding Source: NIH RePORTER; British Heart Foundation [RG/10/005/28296] Funding Source: researchfish	National Institute on Aging in the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); consortium of UK government departments; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation)	The data for this study were made available through the UK Data Archive. The English Longitudinal Study of Ageing (ELSA) was developed by a team of researchers based at University College London, the Institute of Fiscal Studies and the National Centre for Social Research. The funding is provided by the National Institute on Aging in the United States (grants 2RO1AG7644-01A1 and 2RO1AG017644) and a consortium of UK government departments coordinated by the Office for National Statistics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The developers and funders of ELSA and the Archive do not bear any responsibility for the analyses or interpretations presented here.	Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; Banks J, 2003, HLTH WEALTH LIFESTYL, P71; Beckett M, 2000, AM J EPIDEMIOL, V151, P315, DOI 10.1093/oxfordjournals.aje.a010208; Carver CS, 2004, HEALTH PSYCHOL, V23, P595, DOI 10.1037/0278-6133.23.6.595; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P75, DOI 10.1093/geronb/gbq088; Dolan P, 2005, HEALTH ECON, V14, P197, DOI 10.1002/hec.924; Erens B, 1999, HLTH SURVEY ENGLAND, V2; Falachetti E, 2007, HLTH SURVEY ENGLAND, V2, P41; Fogel RW, 1997, PHILOS T R SOC B, V352, P1905, DOI 10.1098/rstb.1997.0177; Freedman VA, 2004, DEMOGRAPHY, V41, P417, DOI 10.1353/dem.2004.0022; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Hobbs FDR, 2002, EUR HEART J, V23, P1867, DOI 10.1053/euhj.2002.3255; Hopman WM, 2009, CHRONIC DIS CAN, V29, P108; Huang CQ, 2010, AGE AGEING, V39, P23, DOI 10.1093/ageing/afp187; Hunt SM, 1986, MEASURING HLTH STATU; Hyde M, 2003, AGING MENT HEALTH, V7, P186, DOI 10.1080/1360786031000101157; Juenger J, 2002, HEART, V87, P235, DOI 10.1136/heart.87.3.235; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005; LYONS RA, 1994, J EPIDEMIOL COMMUN H, V48, P388, DOI 10.1136/jech.48.4.388; Marmot M, 2003, HLTH WEALTH LIFESTYL; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Nussbaum MC., 1993, QUALITY LIFE; PAGANINIHILL A, 1993, AM J EPIDEMIOL, V138, P101, DOI 10.1093/oxfordjournals.aje.a116832; Piazza JR, 2007, J GERONTOL B-PSYCHOL, V62, pP313, DOI 10.1093/geronb/62.6.P313; Pinquart M, 2010, PSYCHOL MED, V40, P1797, DOI 10.1017/S0033291709992285; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Satin JR, 2009, CANCER-AM CANCER SOC, V115, P5349, DOI 10.1002/cncr.24561; Schwartz CE, 1999, SOC SCI MED, V48, P1531, DOI 10.1016/S0277-9536(99)00047-7; Singer MA, 1999, QUAL LIFE RES, V8, P687, DOI 10.1023/A:1008917016998; Singh JA, 2005, J AM GERIATR SOC, V53, P108, DOI 10.1111/j.1532-5415.2005.53020.x; Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Steffick DE., 2000, DOCUMENTATION AFFECT; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Taylor R, 2003, HLTH WEALTH LIFESTYL, P357; Vodermaier A, 2009, JNCI-J NATL CANCER I, V101, P1464, DOI 10.1093/jnci/djp336; Walker AE, 2007, CHRONIC ILLN, V3, P202, DOI 10.1177/1742395307081504; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wee HL, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-93; Werneke U, 2000, PSYCHOL MED, V30, P823, DOI 10.1017/S0033291799002287; Wiggins RD, 2008, SOC INDIC RES, V89, P61, DOI 10.1007/s11205-007-9220-5; Zeiss AM, 1996, PSYCHOL AGING, V11, P572, DOI 10.1037/0882-7974.11.4.572	46	110	111	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18952	10.1371/journal.pone.0018952	http://dx.doi.org/10.1371/journal.pone.0018952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756OZ	21559485	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700041
J	Momcilovic, M; Carlson, M				Momcilovic, Milica; Carlson, Marian			Alterations at Dispersed Sites Cause Phosphorylation and Activation of SNF1 Protein Kinase during Growth on High Glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPK HOMOLOG SNF1; UBIQUITIN-ASSOCIATED DOMAINS; GLYCOGEN-BINDING DOMAIN; SACCHAROMYCES-CEREVISIAE; YEAST SNF1; SUBCELLULAR-LOCALIZATION; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; UPSTREAM KINASES; STRUCTURAL BASIS	The SNF1/AMP-activated protein kinases are central energy regulators in eukaryotes. SNF1 of Saccharomyces cerevisiae is inhibited during growth on high levels of glucose and is activated in response to glucose depletion and other stresses. Activation entails phosphorylation of Thr(210) on the activation loop of the catalytic subunit Snf1 by Snf1-activating kinases. We have used mutational analysis to identify Snf1 residues that are important for regulation. Alteration of Tyr(106) in the alpha C helix or Leu(198) adjacent to the Asp-Phe-Gly motif on the activation loop relieved glucose inhibition of phosphorylation, resulting in phosphorylation of Thr(210) during growth on high levels of glucose. Substitution of Arg for Gly(53), at the N terminus of the kinase domain, increased activation on both high and low glucose. Alteration of the ubiquitin-associated domain revealed a modest autoinhibitory effect. Previous studies identified alterations of the Gal83 (beta) and Snf4 (gamma) subunits that relieve glucose inhibition, and we have here identified a distinct set of Gal83 residues that are required. Together, these results indicate that alterations at dispersed sites within each subunit of SNF1 cause phosphorylation of the kinase during growth on high levels of glucose. These findings suggest that the conformation of the SNF1 complex is crucial to maintenance of the inactive state during growth on high glucose and that the default state for SNF1 is one in which Thr(210) is phosphorylated and the kinase is active.	[Momcilovic, Milica] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Carlson, Marian] Columbia Univ, Dept Genet & Dev & Microbiol & Immunol, New York, NY 10032 USA	Columbia University; Columbia University	Carlson, M (corresponding author), 701 W 168th St,HSC1216, New York, NY 10032 USA.	mbc1@columbia.edu			National Institutes of Health [GM34095]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034095, R37GM034095] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34095 (to M. C.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Amodeo GA, 2010, BIOCHEM BIOPH RES CO, V397, P197, DOI 10.1016/j.bbrc.2010.05.083; CELENZA JL, 1989, MOL CELL BIOL, V9, P5034, DOI 10.1128/MCB.9.11.5034; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; ESTRUCH F, 1992, GENETICS, V132, P639; Hedbacker K, 2004, MOL CELL BIOL, V24, P8255, DOI 10.1128/MCB.24.18.8255-8263.2004; Hedbacker K, 2004, MOL CELL BIOL, V24, P1836, DOI 10.1128/MCB.24.5.1836-1843.2004; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Hedbacker K, 2006, EUKARYOT CELL, V5, P1950, DOI 10.1128/EC.00256-06; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hong SP, 2005, J BIOL CHEM, V280, P21804, DOI 10.1074/jbc.M501887200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Jiang R, 1997, MOL CELL BIOL, V17, P2099, DOI 10.1128/MCB.17.4.2099; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kuchin S, 2000, P NATL ACAD SCI USA, V97, P7916, DOI 10.1073/pnas.140109897; Leech A, 2003, EUKARYOT CELL, V2, P265, DOI 10.1128/EC.2.2.265-273.2003; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; Marx A, 2006, J BIOL CHEM, V281, P27586, DOI 10.1074/jbc.M604865200; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; Momcilovic M, 2008, J BIOL CHEM, V283, P19521, DOI 10.1074/jbc.M803624200; Murphy JM, 2007, P NATL ACAD SCI USA, V104, P14336, DOI 10.1073/pnas.0703012104; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; NEIGEBORN L, 1987, GENETICS, V115, P247; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Rubenstein EM, 2008, J BIOL CHEM, V283, P222, DOI 10.1074/jbc.M707957200; Rudolph MJ, 2010, ACTA CRYSTALLOGR F, V66, P999, DOI 10.1107/S1744309110028265; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Ruiz A, 2011, P NATL ACAD SCI USA, V108, P6349, DOI 10.1073/pnas.1102758108; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Schmidt MC, 2000, EMBO J, V19, P4936, DOI 10.1093/emboj/19.18.4936; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Vincent O, 1999, EMBO J, V18, P6672, DOI 10.1093/emboj/18.23.6672; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Wiatrowski HA, 2004, MOL CELL BIOL, V24, P352, DOI 10.1128/MCB.24.1.352-361.2004; WOODS A, 1994, J BIOL CHEM, V269, P19509; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161	55	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23544	23551		10.1074/jbc.M111.244111	http://dx.doi.org/10.1074/jbc.M111.244111			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561858	Green Published, hybrid			2022-12-25	WOS:000292025000084
J	Nagyeri, G; Radacs, M; Ghassemi-Nejad, S; Tryniszewska, B; Olasz, K; Hutas, G; Gyorfy, Z; Hascall, VC; Glant, TT; Mikecz, K				Nagyeri, Gyorgy; Radacs, Marianna; Ghassemi-Nejad, Sheida; Tryniszewska, Beata; Olasz, Katalin; Hutas, Gabor; Gyorfy, Zsuzsa; Hascall, Vincent C.; Glant, Tibor T.; Mikecz, Katalin			TSG-6 Protein, a Negative Regulator of Inflammatory Arthritis, Forms a Ternary Complex with Murine Mast Cell Tryptases and Heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOGLYCAN-INDUCED ARTHRITIS; COLLAGEN-INDUCED ARTHRITIS; ALPHA-TRYPSIN INHIBITOR; LINK MODULE; EXTRACELLULAR-MATRIX; STIMULATED GENE-6; INNATE IMMUNITY; MONOCLONAL-ANTIBODIES; RHEUMATOID-ARTHRITIS; BINDING DOMAIN	TSG-6 (TNF-alpha-stimulated gene/protein 6), a hyaluronan (HA)-binding protein, has been implicated in the negative regulation of inflammatory tissue destruction. However, little is known about the tissue/cell-specific expression of TSG-6 in inflammatory processes, due to the lack of appropriate reagents for the detection of this protein in vivo. Here, we report on the development of a highly sensitive detection system and its use in cartilage proteoglycan (aggrecan)-induced arthritis, an autoimmune murine model of rheumatoid arthritis. We found significant correlation between serum concentrations of TSG-6 and arthritis severity throughout the disease process, making TSG-6 a better biomarker of inflammation than any of the other arthritis-related cytokines measured in this study. TSG-6 was present in arthritic joint tissue extracts together with the heavy chains of inter-alpha-inhibitor (I alpha I). Whereas TSG-6 was broadly detectable in arthritic synovial tissue, the highest level of TSG-6 was co-localized with tryptases in the heparin-containing secretory granules of mast cells. In vitro, TSG-6 formed complexes with the tryptases murine mast cell protease-6 and -7 via either heparin or HA. In vivo TSG-6-tryptase association could also be detected in arthritic joint extracts by co-immunoprecipitation. TSG-6 has been reported to suppress inflammatory tissue destruction by enhancing the serine protease-inhibitory activity of I alpha I against plasmin. TSG-6 achieves this by transferring heavy chains from I alpha I to HA, thus liberating the active bikunin subunit of I alpha I. Because bikunin is also present in mast cell granules, we propose that TSG-6 can promote inhibition of tryptase activity via a mechanism similar to inhibition of plasmin.	[Nagyeri, Gyorgy; Radacs, Marianna; Ghassemi-Nejad, Sheida; Tryniszewska, Beata; Olasz, Katalin; Hutas, Gabor; Gyorfy, Zsuzsa; Glant, Tibor T.; Mikecz, Katalin] Rush Univ, Med Ctr, Sect Mol Med, Dept Orthoped Surg,Sect Rheumatol, Chicago, IL 60612 USA; [Nagyeri, Gyorgy; Radacs, Marianna; Ghassemi-Nejad, Sheida; Tryniszewska, Beata; Olasz, Katalin; Hutas, Gabor; Gyorfy, Zsuzsa; Glant, Tibor T.; Mikecz, Katalin] Rush Univ, Med Ctr, Sect Mol Med, Dept Biochem,Sect Rheumatol, Chicago, IL 60612 USA; [Nagyeri, Gyorgy; Radacs, Marianna; Ghassemi-Nejad, Sheida; Tryniszewska, Beata; Olasz, Katalin; Hutas, Gabor; Gyorfy, Zsuzsa; Glant, Tibor T.; Mikecz, Katalin] Rush Univ, Med Ctr, Sect Mol Med, Dept Med,Sect Rheumatol, Chicago, IL 60612 USA; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA	Rush University; Rush University; Rush University; Cleveland Clinic Foundation	Glant, TT (corresponding author), Rush Univ, Med Ctr, Sect Mol Med, Dept Orthoped Surg,Sect Rheumatol, Cohn Res Bldg,1735 W Harrison St, Chicago, IL 60612 USA.	Tibor_Glant@rush.edu; Katalin_Mikecz@rush.edu		Mikecz, Katalin/0000-0003-1506-4296	National Institutes of Health [P01 AR45652, R01 AR051163, R01 AR40310, R01 HL081064]; Grainger Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR045652, R01AR040310, R01AR051163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grainger Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AR45652, R01 AR051163, R01 AR40310, and R01 HL081064. This work was also supported by a grant from the Grainger Foundation.	Adarichev VA, 2005, ARTHRITIS RES THER, V7, pR196, DOI 10.1186/ar1472; Adarichev VA, 2003, J IMMUNOL, V170, P2283, DOI 10.4049/jimmunol.170.5.2283; Angyal A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2954; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; BJELLE A, 1982, SCAND J RHEUMATOL, V11, P124, DOI 10.3109/03009748209098176; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; CRISP AJ, 1984, ARTHRITIS RHEUM, V27, P845, DOI 10.1002/art.1780270802; EGGLI PS, 1993, J INVEST DERMATOL, V100, P121, DOI 10.1111/1523-1747.ep12462777; Fulop C, 1997, GENE, V202, P95, DOI 10.1016/S0378-1119(97)00459-9; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Giant TT, 2004, METH MOLEC MED, V102, P313; Glant TT, 2003, CRIT REV IMMUNOL, V23, P199, DOI 10.1615/CritRevImmunol.v23.i3.20; GLANT TT, 1987, ARTHRITIS RHEUM-US, V30, P201, DOI 10.1002/art.1780300211; Glant TT, 1998, ARTHRITIS RHEUM, V41, P1007, DOI 10.1002/1529-0131(199806)41:6<1007::AID-ART7>3.0.CO;2-6; GLANT TT, 1986, BIOCHEM J, V234, P31, DOI 10.1042/bj2340031; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; GRUBER BL, 1989, J CLIN INVEST, V84, P1657, DOI 10.1172/JCI114344; Hanyecz A, 2004, ARTHRITIS RHEUM-US, V50, P1665, DOI 10.1002/art.20180; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Hutas G, 2008, BLOOD, V112, P4999, DOI 10.1182/blood-2008-04-150383; Ide H, 1999, CELL TISSUE RES, V297, P149, DOI 10.1007/s004410051342; ITOH H, 1994, J BIOL CHEM, V269, P3818; Jaen O, 2009, IMMUNOLOGY, V126, P35, DOI 10.1111/j.1365-2567.2008.02875.x; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; Major B, 2010, J BIOL CHEM, V285, P11863, DOI 10.1074/jbc.M109.098541; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; McNeil HP, 2007, J BIOL CHEM, V282, P20785, DOI 10.1074/jbc.R700017200; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; Mindrescu C, 2000, ARTHRITIS RHEUM, V43, P2668, DOI 10.1002/1529-0131(200012)43:12<2668::AID-ANR6>3.0.CO;2-E; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanggaard KW, 2010, BBA-PROTEINS PROTEOM, V1804, P1011, DOI 10.1016/j.bbapap.2010.01.013; Shi M, 2001, J IMMUNOL, V167, P123, DOI 10.4049/jimmunol.167.1.123; Shin K, 2006, ARTHRITIS RHEUM-US, V54, P2863, DOI 10.1002/art.22058; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; STANKER LH, 1985, J IMMUNOL METHODS, V76, P157, DOI 10.1016/0022-1759(85)90488-0; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; WISNIEWSKI HG, 1994, BIOCHEMISTRY-US, V33, P7423, DOI 10.1021/bi00189a049; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Zhang P, 2007, BLOOD, V110, P1887, DOI 10.1182/blood-2007-04-083329; Zielen S, 1996, J IMMUNOL METHODS, V193, P1, DOI 10.1016/0022-1759(96)00033-6	58	31	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23559	23569		10.1074/jbc.M111.222026	http://dx.doi.org/10.1074/jbc.M111.222026			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21566135	hybrid, Green Published			2022-12-25	WOS:000292025000086
J	Hu, TS; Gimferrer, I; Simmons, A; Wiest, D; Alberola-Ila, J				Hu, Taishan; Gimferrer, Idoia; Simmons, Amie; Wiest, David; Alberola-Ila, Jose			The Ras/MAPK Pathway Is Required for Generation of iNKT Cells	PLOS ONE			English	Article							NEGATIVE SELECTION; CUTTING EDGE; INNATE; SAP; DIFFERENTIATION; ACTIVATION; MATURATION; THYMOCYTES; INDUCTION	iNKT cells derive from CD4(+)CD8(+)DP thymocytes, and are selected by thymocyte-thymocyte interactions through signals from their invariant V alpha 14-J alpha 18 TCR and from the costimulatory molecules SLAMF1 and SLAMF6. Genetic studies have demonstrated the contribution of different signaling pathways to this process. Surprisingly, current models imply that the Ras/MAPK pathway, one of the critical mediators of conventional alpha beta T cell positive selection, is not necessary for iNKT cell development. Using mice defective at different levels of this pathway our results refute this paradigm, and demonstrate that Ras, and its downstream effectors Egr-1 and Egr-2 are required for positive selection of iNKT cells. Interestingly our results also show that there are differences in the contributions of several of these molecules to the development of iNKT and conventional alpha beta T cells.	[Hu, Taishan; Gimferrer, Idoia; Simmons, Amie; Alberola-Ila, Jose] Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, Oklahoma City, OK 73104 USA; [Wiest, David] Fox Chase Canc Ctr, Immune Cell Dev & Host Def Program, Philadelphia, PA USA; [Alberola-Ila, Jose] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; Fox Chase Cancer Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Hu, TS (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	alberolaj@omrf.org	Lin, Zongli/L-6084-2019	alberola-ila, Jose/0000-0003-2439-553X; Wiest, David/0000-0002-0792-3188	NIH/NIAID [AI059302]; AHA [0855002F]; Spanish Education and Science Department; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081314, R01AI059302, R21AI088546] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AHA(American Heart Association); Spanish Education and Science Department; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI059302 (NIH/NIAID) and 0855002F (AHA) to JAI. IG was supported in part by a grant from the Spanish Education and Science Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Alonzo ES, 2010, J IMMUNOL, V184, P1268, DOI 10.4049/jimmunol.0903218; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bettini M, 2002, J IMMUNOL, V169, P1713, DOI 10.4049/jimmunol.169.4.1713; Borowski C, 2005, J EXP MED, V201, P833, DOI 10.1084/jem.20050339; Carter JH, 2007, J IMMUNOL, V178, P6796, DOI 10.4049/jimmunol.178.11.6796; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Eberl G, 1999, J IMMUNOL, V163, P4091; Felices M, 2008, J IMMUNOL, V180, P3007, DOI 10.4049/jimmunol.180.5.3007; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Hernandez-Hoyos G, 2005, METHOD ENZYMOL, V392, P199, DOI 10.1016/S0076-6879(04)92012-5; Hu TS, 2010, NAT IMMUNOL, V11, P435, DOI 10.1038/ni.1865; Kronenberg M, 2007, CURR OPIN IMMUNOL, V19, P186, DOI 10.1016/j.coi.2007.02.009; Lauritsen JPH, 2008, J IMMUNOL, V181, P7778, DOI 10.4049/jimmunol.181.11.7778; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; Stanic AK, 2004, J IMMUNOL, V172, P2265, DOI 10.4049/jimmunol.172.4.2265; Stankovic S, 2011, IMMUNOL CELL BIOL, V89, P294, DOI 10.1038/icb.2010.93; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Taillebourg E, 2002, GENESIS, V32, P112, DOI 10.1002/gene.10062; Taniguchi M, 2010, INT IMMUNOL, V22, P1, DOI 10.1093/intimm/dxp104; Verykokakis M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009303; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xi HK, 2004, J IMMUNOL, V172, P964, DOI 10.4049/jimmunol.172.2.964	34	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19890	10.1371/journal.pone.0019890	http://dx.doi.org/10.1371/journal.pone.0019890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572967	Green Submitted, Green Published, gold			2022-12-25	WOS:000290440200033
J	MacKenzie, BR; Eero, M; Ojaveer, H				MacKenzie, Brian R.; Eero, Margit; Ojaveer, Henn			Could Seals Prevent Cod Recovery in the Baltic Sea?	PLOS ONE			English	Article							GADUS-MORHUA; HALICHOERUS-GRYPUS; CLIMATE-CHANGE; SOUTHERN GULF; ECOSYSTEM; FISH; RECRUITMENT; ATLANTIC; VARIABILITY; COLLAPSE	Fish populations are increasingly affected by multiple human and natural impacts including exploitation, eutrophication, habitat alteration and climate change. As a result many collapsed populations may have to recover in ecosystems whose structure and functioning differ from those in which they were formerly productive and supported sustainable fisheries. Here we investigate how a cod (Gadus morhua) population in the Baltic Sea whose biomass was reduced due to a combination of high exploitation and deteriorating environmental conditions might recover and develop in the 21st century in an ecosystem that likely will change due to both the already started recovery of a cod predator, the grey seal Halichoerus grypus, and projected climate impacts. Simulation modelling, assuming increased seal predation, fishing levels consistent with management plan targets and stable salinity, shows that the cod population could reach high levels well above the long-term average. Scenarios with similar seal and fishing levels but with 15% lower salinity suggest that the Baltic will still be able to support a cod population which can sustain a fishery, but biomass and yields will be lower. At present knowledge of cod and seal interactions, seal predation was found to have much lower impact on cod recovery, compared to the effects of exploitation and salinity. These results suggest that dual management objectives (recovery of both seal and cod populations) are realistic but success in achieving these goals will also depend on how climate change affects cod recruitment.	[MacKenzie, Brian R.; Eero, Margit] Tech Univ Denmark DTU Aqua, Natl Inst Aquat Resources, Charlottenlund, Denmark; [MacKenzie, Brian R.] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Ojaveer, Henn] Univ Tartu, Estonian Marine Inst, Parnu, Estonia	Technical University of Denmark; University of Copenhagen; University of Tartu; Estonian Marine Institute	MacKenzie, BR (corresponding author), Tech Univ Denmark DTU Aqua, Natl Inst Aquat Resources, Charlottenlund, Denmark.	brm@aqua.dtu.dk	Eero, Margit/AAK-2845-2021; MacKenzie, Brian R./T-9379-2019; Ojaveer, Henn/K-2160-2016	Eero, Margit/0000-0002-1848-0597; MacKenzie, Brian R./0000-0002-4798-0363; Ojaveer, Henn/0000-0003-2742-6063	Census of Marine Life-History of Marine Animal Populations (CoML-HMAP; Sloan Foundation); EU [266445]; Estonian Ministry of Education and Research [SF0180005s10]; European Community [217246]; Danish National Science Foundation; Danish National Research Foundation (Dansk Grundforskningsfond)	Census of Marine Life-History of Marine Animal Populations (CoML-HMAP; Sloan Foundation)(Alfred P. Sloan Foundation); EU(European Commission); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Community(European Commission); Danish National Science Foundation(Danmarks Grundforskningsfond); Danish National Research Foundation (Dansk Grundforskningsfond)(Danmarks Grundforskningsfond)	We thank the Census of Marine Life-History of Marine Animal Populations (CoML-HMAP; Sloan Foundation), EU UNCOVER project (BRM), and Estonian Ministry of Education and Research (grant no. SF0180005s10 to HO) for support. DTU Aqua (BRM, ME) has received funding from the European Community's Seventh Framework Programme (FP/2007-2013) under grant agreement no 217246 made with the joint Baltic Sea research and development programme BONUS, and from the Danish National Science Foundation (ECOSUPPORT project). We thank the Danish National Research Foundation (Dansk Grundforskningsfond) for support to the Center for Macroecology, Evolution and Climate, University of Copenhagen. The study contributes to the EU FP7 project VECTORS (266445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; BACC, 2007, INT C GOTH SWED MAY; Bakun A, 2006, PROG OCEANOGR, V68, P271, DOI 10.1016/j.pocean.2006.02.004; Bastardie F, 2010, FISH RES, V101, P188, DOI 10.1016/j.fishres.2009.10.009; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Bundy A, 2009, PROG OCEANOGR, V81, P188, DOI 10.1016/j.pocean.2009.04.010; Caddy JF, 2004, REV FISH BIOL FISHER, V14, P43, DOI 10.1007/s11160-004-3770-2; Cardoso A. C., 2010, JRC SCI TECHNICAL RE; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Chassot E, 2009, MAR ECOL PROG SER, V379, P279, DOI 10.3354/meps07897; Chouinard GA, 2005, CAN J FISH AQUAT SCI, V62, P1991, DOI 10.1139/f05-107; Commission of the european communities (EC), 2009, GREEN PAP REF COMM F; EERO M, 2010, ECOL APPL IN PRESS; Eero M, 2008, CAN J FISH AQUAT SCI, V65, P2728, DOI 10.1139/F08-176; EILOLA K, 2010, 1012010 SMHI; ELMGREN R, 1989, AMBIO, V18, P326; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; HAMMOND PS, 2006, GREY SEAL DIET COMP; Hansson S, 2007, AMBIO, V36, P265, DOI 10.1579/0044-7447(2007)36[265:MBSFUC]2.0.CO;2; Harding KC, 1999, AMBIO, V28, P619; Heikinheimo O, 2008, BOREAL ENVIRON RES, V13, P457; HELCOM, 2007, HELCOM BALT SEA ACT; HILBORN R, 1992; Hinrichsen HH, 2009, ICES J MAR SCI, V66, P101, DOI 10.1093/icesjms/fsn207; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; *ICES, 2006, 2006OCC12 ICES CM; *ICES, 2008, 2008ACOM ICES CM, V6, P220; *ICES, 2010, ICES ADV BALT SEA EC, P25; *ICES, 2009, 2009ACOM ICES CM, V53, P1; *ICES, 2010, 2010ACOM ICES CM, V54, P1; *ICES, 2008, 2008ACOM ICES CM, P44; *ICES, 2007, 2007ACFM ICES CM, V25, P1; *ICES, 2009, REP ICES BALT FISH A; *ICES, 2007, 2007RMC ICES CM, P8; *ICES, 2010, 2010SSGRSP ICES CM, V2, P1; *ICES, 2005, 2005ACFM ICES CM, P19; *ICES, 2010, 2010ACOM ICES CM, V10, P1; *ICES, 2007, 2007ACFM ICES CM, V5, P1; Kempf A, 2008, MAR ECOL PROG SER, V367, P295, DOI 10.3354/meps07555; Koster F.W, 2009, J NW ATLANTIC FISHER, V41, P205, DOI DOI 10.2960/J.V41.M636; Koster FW, 2000, ICES J MAR SCI, V57, P310, DOI 10.1006/jmsc.1999.0528; Koster FW, 2005, ICES J MAR SCI, V62, P1408, DOI 10.1016/j.icesjms.2005.05.004; Kramer AM, 2010, J ANIM ECOL, V79, P633, DOI 10.1111/j.1365-2656.2009.01657.x; Lindegren M, 2010, P ROY SOC B-BIOL SCI, V277, P2121, DOI 10.1098/rspb.2010.0353; Lindstrom U, 2009, DEEP-SEA RES PT II, V56, P2068, DOI 10.1016/j.dsr2.2008.11.017; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Lundstrom K., 2007, NAMMCO Scientific Publications, V6, P177; LUNDSTROM K, 2010, ICES J MAR IN PRESS, P67; MacKenzie BR, 2002, CAN J FISH AQUAT SCI, V59, P173, DOI 10.1139/F01-201; MacKenzie BR, 2004, ECOLOGY, V85, P784, DOI 10.1890/02-0780; MacKenzie BR, 2007, FISH RES, V87, P106, DOI 10.1016/j.fishres.2007.07.003; Mackenzie BR, 2007, GLOBAL CHANGE BIOL, V13, P1348, DOI 10.1111/j.1365-2486.2007.01369.x; MacKenzie BR, 2009, CONSERV LETT, V2, P25, DOI 10.1111/j.1755-263X.2008.00039.x; Murawski SA, 2010, ICES J MAR SCI, V67, P1830, DOI 10.1093/icesjms/fsq125; Neumann T, 2010, J MARINE SYST, V81, P213, DOI 10.1016/j.jmarsys.2009.12.001; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Osterblom H, 2010, MAR POLICY, V34, P1290, DOI 10.1016/j.marpol.2010.05.007; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Pohl C., 2008, STATE EVOLUTION BALT, P367; Rick TC, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P1; Rindorf A, 2005, J EXP MAR BIOL ECOL, V324, P1, DOI 10.1016/j.jembe.2005.04.013; Smout S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010761; SODERBERG S, 1975, P S SEAL BALT JUN 4; Sparholt H, 1996, ICES J MAR SCI, V53, P771, DOI 10.1006/jmsc.1996.0098; Sparholt Henrik, 1994, Dana, V10, P131; Swain DP, 2008, CAN J FISH AQUAT SCI, V65, P2315, DOI 10.1139/F08-175; Thrush SF, 2010, ANNU REV MAR SCI, V2, P419, DOI 10.1146/annurev-marine-120308-081129; Uzars D, 2000, ICES J MAR SCI, V57, P324, DOI 10.1006/jmsc.1999.0527; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	69	30	30	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e18998	10.1371/journal.pone.0018998	http://dx.doi.org/10.1371/journal.pone.0018998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573062	Green Published, Green Submitted, gold			2022-12-25	WOS:000290386800006
J	Wohlfart, S; Khalansky, AS; Gelperina, S; Maksimenko, O; Bernreuther, C; Glatzel, M; Kreuter, J				Wohlfart, Stefanie; Khalansky, Alexander S.; Gelperina, Svetlana; Maksimenko, Olga; Bernreuther, Christian; Glatzel, Markus; Kreuter, Joerg			Efficient Chemotherapy of Rat Glioblastoma Using Doxorubicin-Loaded PLGA Nanoparticles with Different Stabilizers	PLOS ONE			English	Article							POLY(BUTYL CYANOACRYLATE) NANOPARTICLES; ANGIOGENESIS; INHIBITION; TUMORS; ACID)	Background: Chemotherapy of glioblastoma is largely ineffective as the blood-brain barrier (BBB) prevents entry of most anticancer agents into the brain. For an efficient treatment of glioblastomas it is necessary to deliver anti-cancer drugs across the intact BBB. Poly(lactic-co-glycolic acid) (PLGA) nanoparticles coated with poloxamer 188 hold great promise as drug carriers for brain delivery after their intravenous injection. In the present study the anti-tumour efficacy of the surfactant-coated doxorubicin-loaded PLGA nanoparticles against rat glioblastoma 101/8 was investigated using histological and immunohistochemical methods. Methodology: The particles were prepared by a high-pressure solvent evaporation technique using 1% polyvinylalcohol (PLGA/PVA) or human serum albumin (PLGA/HSA) as stabilizers. Additionally, lecithin-containing PLGA/HSA particles (Dox-Lecithin-PLGA/HSA) were prepared. For evaluation of the antitumour efficacy the glioblastoma-bearing rats were treated intravenously with the doxorubicin-loaded nanoparticles coated with poloxamer 188 using the following treatment regimen: 362.5 mg/kg on day 2, 5 and 8 after tumour implantation; doxorubicin and poloxamer 188 solutions were used as controls. On day 18, the rats were sacrificed and the antitumour effect was determined by measurement of tumour size, necrotic areas, proliferation index, and expression of GFAP and VEGF as well as Isolectin B4, a marker for the vessel density. Conclusion: The results reveal a considerable anti-tumour effect of the doxorubicin-loaded nanoparticles. The overall best results were observed for Dox-Lecithin-PLGA/HSA. These data demonstrate that the poloxamer 188-coated PLGA nanoparticles enable delivery of doxorubicin across the blood-brain barrier in the therapeutically effective concentrations.	[Wohlfart, Stefanie; Kreuter, Joerg] Goethe Univ Frankfurt, Inst Pharmaceut Technol, Frankfurt, Germany; [Khalansky, Alexander S.] Inst Human Morphol, Moscow, Russia; [Gelperina, Svetlana; Maksimenko, Olga] Nanosyst Ltd, Moscow, Russia; [Bernreuther, Christian; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany	Goethe University Frankfurt; Russian Academy of Medical Sciences; Research Institute of Human Morphology; University of Hamburg; University Medical Center Hamburg-Eppendorf	Wohlfart, S (corresponding author), Goethe Univ Frankfurt, Inst Pharmaceut Technol, Frankfurt, Germany.	Kreuter@em.uni-frankfurt.de	Gelperina, Svetlana/T-9112-2019; Glatzel, Markus/V-8844-2019; Maksimenko, Olga Olegovna/T-1267-2018; Glatzel, Markus/G-3356-2011	Gelperina, Svetlana/0000-0003-1113-6715; Glatzel, Markus/0000-0002-7720-8817; Maksimenko, Olga Olegovna/0000-0002-1230-4680; Glatzel, Markus/0000-0002-7720-8817; Khalansky, Aleksandr S/0000-0002-2575-7523	INTAS (International Association) [00-838]; DFG (Deutsche Forschungsgemeinschaft); Goethe/University Frankfurt of the University Clinics Hamburg	INTAS (International Association)(INTAS); DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Goethe/University Frankfurt of the University Clinics Hamburg	This study was supported in part (S.G and O.M.) by residual funds from INTAS (International Association for the promotion of cooperation with scientists from the new independent states of the former Soviet Union, Brussels, Belgium, Grant 00-838) and by travel grants for A.S.K. and S.G. by the DFG (Deutsche Forschungsgemeinschaft). All studies in Frankfurt and Hamburg including the work of A.S.K. were supported by the regular department funds of Goethe/University Frankfurt of the University Clinics Hamburg. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambruosi A, 2006, J DRUG TARGET, V14, P97, DOI 10.1080/10611860600636135; Barker FG, 1996, CANCER, V77, P1161, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1161::AID-CNCR24>3.0.CO;2-Z; Brat DJ, 2002, ADV ANAT PATHOL, V9, P24, DOI 10.1097/00125480-200201000-00004; BREM S, 1972, J NATL CANCER I, V48, P347; Ding H, 2010, P NATL ACAD SCI USA, V107, P18143, DOI 10.1073/pnas.1003919107; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Frank PG, 2000, J LIPID RES, V41, P853; Fujita Manabu, 2006, Angiogenesis, V9, P183, DOI 10.1007/s10456-006-9046-9; Gelperina SE, 2002, TOXICOL LETT, V126, P131, DOI 10.1016/S0378-4274(01)00456-8; Gelperina S, 2010, EUR J PHARM BIOPHARM, V74, P157, DOI 10.1016/j.ejpb.2009.09.003; GERDES J, 1984, J IMMUNOL, V133, P1710; HAMAYA K, 1985, ACTA MED OKAYAMA, V39, P453; Hekmatara T, 2009, CLIN NEUROPATHOL, V28, P153; Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8; Kreuter J, 2008, TUMORI J, V94, P271; Lee BS, 2006, BIOCONJUGATE CHEM, V17, P317, DOI 10.1021/bc0502457; Petri B, 2007, J CONTROL RELEASE, V117, P51, DOI 10.1016/j.jconrel.2006.10.015; Roullin VG, 2002, EUR J PHARM BIOPHARM, V53, P293, DOI 10.1016/S0939-6411(02)00011-5; Schoch G, 2006, PLOS MED, V3, P236, DOI 10.1371/journal.pmed.0030014; Steiniger SCJ, 2004, INT J CANCER, V109, P759, DOI 10.1002/ijc.20048; Ulbrich K, 2011, J DRUG TARGET, V19, P125, DOI 10.3109/10611861003734001; Veronese SM, 1995, ANTICANCER RES, V15, P2717; VERRECCHIA T, 1993, J BIOMED MATER RES, V27, P1019, DOI 10.1002/jbm.820270807; Weidner N, 2000, HUM PATHOL, V31, P403, DOI 10.1053/hp.2000.6724; Wohlfart S, 2009, J NANONEUROSCI, V1, P144; Zensi A, 2009, J CONTROL RELEASE; Zhirnov AE, 2005, BBA-BIOMEMBRANES, V1720, P73, DOI 10.1016/j.bbamem.2005.11.010	27	119	131	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19121	10.1371/journal.pone.0019121	http://dx.doi.org/10.1371/journal.pone.0019121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573151	Green Published, Green Submitted, gold			2022-12-25	WOS:000290305600011
J	Luquero, FJ; Banga, CN; Remartinez, D; Palma, PP; Baron, E; Grais, RF				Luquero, Francisco J.; Banga, Cunhate Na; Remartinez, Daniel; Palma, Pedro Pablo; Baron, Emanuel; Grais, Rebeca F.			Cholera Epidemic in Guinea-Bissau (2008): The Importance of "Place"	PLOS ONE			English	Article							RISK; VACCINATION; AREA	Background: As resources are limited when responding to cholera outbreaks, knowledge about where to orient interventions is crucial. We describe the cholera epidemic affecting Guinea-Bissau in 2008 focusing on the geographical spread in order to guide prevention and control activities. Methodology/Principal Findings: We conducted two studies: 1) a descriptive analysis of the cholera epidemic in Guinea-Bissau focusing on its geographical spread (country level and within the capital); and 2) a cross-sectional study to measure the prevalence of houses with at least one cholera case in the most affected neighbourhood of the capital (Bairro Bandim) to detect clustering of households with cases (cluster analysis). All cholera cases attending the cholera treatment centres in Guinea-Bissau who fulfilled a modified World Health Organization clinical case definition during the epidemic were included in the descriptive study. For the cluster analysis, a sample of houses was selected from a satellite photo (Google Earth (TM)); 140 houses (and the four closest houses) were assessed from the 2,202 identified structures. We applied K-functions and Kernel smoothing to detect clustering. We confirmed the clustering using Kulldorff's spatial scan statistic. A total of 14,222 cases and 225 deaths were reported in the country (AR = 0.94%, CFR = 1.64%). The more affected regions were Biombo, Bijagos and Bissau (the capital). Bairro Bandim was the most affected neighborhood of the capital (AR = 4.0). We found at least one case in 22.7% of the houses (95% CI: 19.5-26.2) in this neighborhood. The cluster analysis identified two areas within Bairro Bandim at highest risk: a market and an intersection where runoff accumulates waste (p < 0.001). Conclusions/Significance: Our analysis allowed for the identification of the most affected regions in Guinea-Bissau during the 2008 cholera outbreak, and the most affected areas within the capital. This information was essential for making decisions on where to reinforce treatment and to guide control and prevention activities.	[Luquero, Francisco J.; Baron, Emanuel; Grais, Rebeca F.] Epicentre, Paris, France; [Luquero, Francisco J.] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden; [Banga, Cunhate Na] Minist Hlth, Dept Epidemiol, Bissau, Guinea Bissau; [Remartinez, Daniel; Palma, Pedro Pablo] Med Sin Fronteras, Barcelona, Spain	European Centre for Disease Prevention & Control	Luquero, FJ (corresponding author), Epicentre, Paris, France.	fluquero@epicentre.msf.org		Freeman Grais, Rebecca/0000-0002-5037-8218	Medecins Sans Frontieres	Medecins Sans Frontieres	This research was funded by Medecins Sans Frontieres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABY P, 1997, PROSPECTIVE COMMUNIT, P276; Ali M, 2002, SOC SCI MED, V55, P1015, DOI 10.1016/S0277-9536(01)00230-1; Ali M, 2002, HEALTH PLACE, V8, P201, DOI 10.1016/S1353-8292(01)00043-0; Ali Mohammad, 2006, Int J Health Geogr, V5, P45, DOI 10.1186/1476-072X-5-45; Bompangue D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000436; Cavailler P, 2006, VACCINE, V24, P4890, DOI 10.1016/j.vaccine.2005.10.006; Chevallier E, 2004, EUR J PUBLIC HEALTH, V14, P274, DOI 10.1093/eurpub/14.3.274; Coulombier D, 2002, Med Trop (Mars), V62, P391; Deen JL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000173; DIGGLE P., 1985, APPL STAT-J ROY ST C, V34, P138, DOI DOI 10.2307/2347366; DIGGLE PJ, 1991, BIOMETRICS, V47, P1155, DOI 10.2307/2532668; Griffith DC, 2006, AM J TROP MED HYG, V75, P973, DOI 10.4269/ajtmh.2006.75.973; KULLDORFF M., 2010, SOFTWARE SPATIAL SPA; Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323; *MED SAN FRONT, 2004, CHOL GUID; Myaux J, 1997, HEALTH PLACE, V3, P181, DOI 10.1016/S1353-8292(97)00013-0; Osei FB, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-44; R Core Team, 2022, R LANG ENV STAT COMP; Sasaki S, 2008, AM J TROP MED HYG, V79, P414, DOI 10.4269/ajtmh.2008.79.414; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; Waldman EA, 2002, J HEALTH POPUL NUTR, V20, P85; *WHO, 2008, CHOL GUIN BISS; *WHO, 2008, COUNTR HLTH SYST FAC; WHO, 2004, CHOL OUTBR ASS OUTBR; WHO, 2006, WKLY EPIDEMIOL REC, V81, P297; *WORK GROUP MORT E, 2007, EMERG THEMES EPIDEMI, V1, P4; Zuckerman JN, 2007, LANCET INFECT DIS, V7, P521, DOI 10.1016/S1473-3099(07)70138-X; 2004, MMWR MORB MORTAL WKL, V53, P783	28	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2011	6	5							e19005	10.1371/journal.pone.0019005	http://dx.doi.org/10.1371/journal.pone.0019005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EZ	21572530	Green Published, gold, Green Submitted			2022-12-25	WOS:000290224800013
J	duVerle, DA; Ono, Y; Sorimachi, H; Mamitsuka, H				duVerle, David A.; Ono, Yasuko; Sorimachi, Hiroyuki; Mamitsuka, Hiroshi			Calpain Cleavage Prediction Using Multiple Kernel Learning	PLOS ONE			English	Article							MUSCLE-SPECIFIC CALPAIN; MU-CALPAIN; CASPASE; PROTEIN; SPECIFICITY; PROTEOLYSIS; CALCIUM; SITES; CALPASTATIN; ACTIVATION	Calpain, an intracellular C alpha(2+)-dependent cysteine protease, is known to play a role in a wide range of e metabolic path through limited proteolysis of its substrate However, only a limited number of he e substrates are currently known, e exact mechanism of substrate recognition and cleavage by calpain still largely unknown While previous research has successfully applied standard machine-learning algorithms to accurately predict substrate cleavage by other similar types of proteases, their approach does not extend well to calpain, possibly due to its particular mode of proteolytic action and limited amount of experimental data. Through the use of Multiple Kernel Learning, a recent extension to the classic Support Vector Machine framework, we were able to train complex models based on rich, heterogeneous feature sets, leading to significantly improved prediction quality (6% over highest AUC score produced by state-of-the-art methods). In addition producing a stronger machine-learning model for the prediction of calpain cleavage, we were able to highlight importance and role of each feature of substrate sequences in defining specificity: primary sequence, secondary structure and solvent accessibility. Most notably, we showed there existed significant specificity differences across calpain sub-types despite previous assumption to the contrary. Prediction accuracy further successfully validated using, as an unbiased mutated sequences of calpastatin endogenous inhibitor of calpain) modified to no longer block calpain's proteolytic action. An online implementation of our prediction tool is available at http.//calpain.org.	[duVerle, David A.; Mamitsuka, Hiroshi] Kyoto Univ, Bioinformat Ctr, Kyoto, Japan; [Ono, Yasuko; Sorimachi, Hiroyuki] Calpain Project, Tokyo, Japan	Kyoto University	duVerle, DA (corresponding author), Kyoto Univ, Bioinformat Ctr, Kyoto, Japan.	dave@kuicr.kyoto-u.ac.jp	Sorimachi, Hiroyuki/Q-6956-2017; Sorimachi, Hiroyuki/C-6448-2009; Mamitsuka, Hiroshi/R-1110-2016	Sorimachi, Hiroyuki/0000-0001-9509-6727; Sorimachi, Hiroyuki/0000-0001-9509-6727; Mamitsuka, Hiroshi/0000-0002-6607-5617	MEXT.KAKENHI [18076007, 22770139]; JSPS.KAKENHI [19658057, 20370055]; Ministry of Health, Labor and Welfare [20B-13]; Takeda Science Foundation	MEXT.KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS.KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by MEXT.KAKENHI 18076007 (to HS) and 22770139 (to YO); JSPS.KAKENHI 19658057 and 20370055 (to HS); a research grant (20B-13) for Nervous and Mental Disorders from the Ministry of Health, Labor and Welfare (to HS); and a Takeda Science Foundation research grant (to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes C, 2005, NUCLEIC ACIDS RES, V33, pW208, DOI 10.1093/nar/gki433; BANIK NL, 1994, J NEUROSCI RES, V37, P489, DOI 10.1002/jnr.490370408; Barkan DT, 2010, BIOINFORMATICS, V26, P1714, DOI 10.1093/bioinformatics/btq267; Barrett A. J., 1998, HDB PROTEOLYTIC ENZY; Bartoli M, 2005, INT J BIOCHEM CELL B, V37, P2115, DOI 10.1016/j.biocel.2004.12.012; Bertipaglia I., 2007, V45, P29; Carillo S, 1996, BIOCHEM J, V313, P245, DOI 10.1042/bj3130245; Chapelle O, 2002, MACH LEARN, V46, P131, DOI 10.1023/A:1012450327387; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; CRAIK CS, 1985, SCIENCE, V228, P291, DOI 10.1126/science.3838593; Croall DE, 1996, BBA-PROTEIN STRUCT M, V1298, P276, DOI 10.1016/S0167-4838(96)00138-0; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Demon D, 2009, TRENDS BIOTECHNOL, V27, P680, DOI 10.1016/j.tibtech.2009.09.007; duVerle David, 2010, V22, P202; Friedrich P, 2005, BIOL CHEM, V386, P609, DOI 10.1515/BC.2005.071; GOLL DE, 1992, BIOESSAYS, V14, P549, DOI 10.1002/bies.950140810; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Harris F, 2006, ANN NY ACAD SCI, V1084, P452, DOI 10.1196/annals.1372.011; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KAWASAKI H, 1993, ARCH BIOCHEM BIOPHYS, V305, P467, DOI 10.1006/abbi.1993.1448; Kelly JC, 2009, BBA-PROTEINS PROTEOM, V1794, P1505, DOI 10.1016/j.bbapap.2009.06.013; KIKUCHI H, 1993, BIOCHIM BIOPHYS ACTA, V1162, P171, DOI 10.1016/0167-4838(93)90144-G; Kimura Y, 2000, NEUROPATHOLOGY, V20, P153, DOI 10.1046/j.1440-1789.2000.00326.x; Kloft M., 2009, ADV NEURAL INFORM PR, P997; Lanckriet GRG, 2004, BIOINFORMATICS, V20, P2626, DOI 10.1093/bioinformatics/bth294; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Moldoveanu T, 2003, NAT STRUCT BIOL, V10, P371, DOI 10.1038/nsb917; Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353; MOLINARI M, 1995, J BIOL CHEM, V270, P2032, DOI 10.1074/jbc.270.5.2032; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; ROLIUS R, 2010, CELLULAR MOL BIOL LE, P1; SAIDO TC, 1993, J BIOL CHEM, V268, P7422; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; SAKAI K, 1987, J BIOCHEM-TOKYO, V101, P911, DOI 10.1093/oxfordjournals.jbchem.a121959; SASAKI T, 1984, J BIOL CHEM, V259, P2489; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Sonnenburg S, 2006, J MACH LEARN RES, V7, P1531; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334; Wells A, 2005, INT REV CYTOL, V245, P1, DOI 10.1016/S0074-7696(05)45001-9; Yang ZR, 2005, BIOINFORMATICS, V21, P1831, DOI 10.1093/bioinformatics/bti281; Zhang ZL, 2006, BIOCHEMISTRY-US, V45, P11681, DOI 10.1021/bi060273s	53	76	77	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19035	10.1371/journal.pone.0019035	http://dx.doi.org/10.1371/journal.pone.0019035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559271	gold, Green Submitted, Green Published			2022-12-25	WOS:000290223500006
J	Zhao, ZG; Ma, WJ; Zeng, GH; Qi, DF; Ou, LL; Liang, YP				Zhao, Zhigang; Ma, Wenjing; Zeng, Guohua; Qi, Defeng; Ou, Lili; Liang, Yeping			Serum Early Prostate Cancer Antigen (EPCA) Level and Its Association with Disease Progression in Prostate Cancer in a Chinese Population	PLOS ONE			English	Article							NUCLEAR-MATRIX PROTEINS; ANDROGEN-DEPRIVATION THERAPY; RADICAL PROSTATECTOMY; EXPRESSION; RISK; MEN; MANAGEMENT; RECURRENCE; PREDICTOR; PROGNOSIS	Background: Early prostate cancer antigen (EPCA) has been shown a prostate cancer (PCa)-associated nuclear matrix protein, however, its serum status and prognostic power in PCa are unknown. The goals of this study are to measure serum EPCA levels in a cohort of patients with PCa prior to the treatment, and to evaluate the clinical value of serum EPCA. Methods: Pretreatment serum EPCA levels were determined with an ELISA in 77 patients with clinically localized PCa who underwent radical prostatectomy and 51 patients with locally advanced or metastatic disease who received primary androgen deprivation therapy, and were correlated with clinicopathological variables and disease progression. Serum EPCA levels were also examined in 40 healthy controls. Results: Pretreatment mean serum EPCA levels were significantly higher in PCa patients than in controls (16.84 +/- 7.60 ng/ml vs. 4.12 +/- 2.05 ng/ml, P < 0.001). Patients with locally advanced and metastatic PCa had significantly higher serum EPCA level than those with clinically localized PCa (22.93 +/- 5.28 ng/ml and 29.41 +/- 8.47 ng/ml vs. 15.17 +/- 6.03 ng/ml, P=0.014 and P < 0.001, respectively). Significantly elevated EPCA level was also found in metastatic PCa compared with locally advanced disease (P < 0.001). Increased serum EPCA levels were significantly and positively correlated with Gleason score and clinical stage, but not with PSA levels and age. On multivariate analysis, pretreatment serum EPCA level held the most significantly predictive value for the biochemical recurrence and androgen-independent progression among pretreatment variables (HR = 4.860, P < 0.001 and HR = 5.418, P < 0.001, respectively). Conclusions: Serum EPCA level is markedly elevated in PCa. Pretreatment serum EPCA level correlates significantly with the poor prognosis, showing prediction potential for PCa progression.	[Zhao, Zhigang; Ma, Wenjing; Zeng, Guohua; Qi, Defeng; Ou, Lili; Liang, Yeping] Guangzhou Med Univ, Guangdong Prov Key Lab Urol, Affiliated Hosp 1, Dept Urol,Minimally Invas Surg Ctr, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Zhao, ZG (corresponding author), Guangzhou Med Univ, Guangdong Prov Key Lab Urol, Affiliated Hosp 1, Dept Urol,Minimally Invas Surg Ctr, Guangzhou, Guangdong, Peoples R China.	zgzhaodr@yahoo.com.cn						Alberti I, 2000, J CELL BIOCHEM, V79, P471, DOI 10.1002/1097-4644(20001201)79:3<471::AID-JCB120>3.3.CO;2-F; Barboro P, 2005, ANTICANCER RES, V25, P3999; Benaim EA, 2002, UROLOGY, V59, P73, DOI 10.1016/S0090-4295(01)01440-6; Bickers B, 2009, ANTICANCER RES, V29, P3289; Boccardo F, 2003, PROSTATE, V55, P259, DOI 10.1002/pros.10248; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cooperberg MR, 2005, J CLIN ONCOL, V23, P8146, DOI 10.1200/JCO.2005.02.9751; Dai B, 2008, ASIAN J ANDROL, V10, P325, DOI 10.1111/j.1745-7262.2008.00345.x; Davido T, 2000, J CELL BIOCHEM, P136; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Dhir R, 2004, J UROLOGY, V171, P1419, DOI 10.1097/01.ju.0000116545.94813.27; Freedland SJ, 2006, J UROLOGY, V176, P1404, DOI 10.1016/j.juro.2006.06.017; GLEASON DF, 1998, UROLOGIC PATHOLOGY P, P171; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Hughes JH, 1999, AM J CLIN PATHOL, V111, P267; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Leman ES, 2007, UROLOGY, V69, P714, DOI 10.1016/j.urology.2007.01.097; Loeb S, 2010, J UROLOGY, V184, P157, DOI 10.1016/j.juro.2010.03.033; Miyake H, 2010, EJSO-EUR J SURG ONC, V36, P281, DOI 10.1016/j.ejso.2009.10.013; Morote J, 2004, INT J CANCER, V108, P877, DOI 10.1002/ijc.11639; Paul B, 2005, CANCER RES, V65, P4097, DOI 10.1158/0008-5472.CAN-04-4523; Peyromaure M, 2005, J UROLOGY, V174, P1794, DOI 10.1097/01.ju.0000176817.46279.93; Ross RW, 2008, J CLIN ONCOL, V26, P842, DOI 10.1200/JCO.2007.13.6804; Ross RW, 2008, CANCER-AM CANCER SOC, V112, P1247, DOI 10.1002/cncr.23304; Sandler HM, 2007, J UROLOGY, V178, pS20, DOI 10.1016/j.juro.2007.04.034; Shariat Shahrokh F, 2007, Future Oncol, V3, P449, DOI 10.2217/14796694.3.4.449; Simmons MN, 2007, EUR UROL, V51, P1175, DOI 10.1016/j.eururo.2007.01.015; Smith DS, 1996, JAMA-J AM MED ASSOC, V276, P1309, DOI 10.1001/jama.276.16.1309; Smith RC, 1996, J UROLOGY, V156, P454, DOI 10.1016/S0022-5347(01)65877-4; Uetsuki H, 2005, J UROLOGY, V174, P514, DOI 10.1097/01.ju.0000165154.41159.b1; Zhao ZG, 2010, PROSTATE, V70, P1788, DOI 10.1002/pros.21215; Zhao ZG, 2010, ENDOCR-RELAT CANCER, V17, P505, DOI 10.1677/ERC-10-0017	32	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19284	10.1371/journal.pone.0019284	http://dx.doi.org/10.1371/journal.pone.0019284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559289	Green Submitted, Green Published, gold			2022-12-25	WOS:000290223500016
J	Colson, P; Gimenez, G; Boyer, M; Fournous, G; Raoult, D				Colson, Philippe; Gimenez, Gregory; Boyer, Mickael; Fournous, Ghislain; Raoult, Didier			The Giant Cafeteria roenbergensis Virus That Infects a Widespread Marine Phagocytic Protist Is a New Member of the Fourth Domain of Life	PLOS ONE			English	Article							DNA VIRUSES; SEQUENCE; EVOLUTION; GENES; CLASSIFICATION; SOFTWARE; FAMILIES; DATABASE; LESSONS; ORIGIN	Background: A recent work has provided strong arguments in favor of a fourth domain of Life composed of nucleocytoplasmic large DNA viruses (NCLDVs). This hypothesis was supported by phylogenetic and phyletic analyses based on a common set of proteins conserved in Eukarya, Archaea, Bacteria, and viruses, and implicated in the functions of information storage and processing. Recently, the genome of a new NCLDV, Cafeteria roenbergensis virus (CroV), was released. The present work aimed to determine if CroV supports the fourth domain of Life hypothesis. Methods: A consensus phylogenetic tree of NCLDVs including CroV was generated from a concatenated alignment of four universal proteins of NCLDVs. Some features of the gene complement of CroV and its distribution along the genome were further analyzed. Phylogenetic and phyletic analyses were performed using the previously identified common set of informational genes present in Eukarya, Archaea, Bacteria, and NCLDVs, including CroV. Findings: Phylogenetic reconstructions indicated that CroV is clearly related to the Mimiviridae family. The comparison between the gene repertoires of CroV and Mimivirus showed similarities regarding the gene contents and genome organization. In addition, the phyletic clustering based on the comparison of informational gene repertoire between Eukarya, Archaea, Bacteria, and NCLDVs unambiguously classified CroV with other NCLDVs and clearly included it in a fourth domain of Life. Taken together, these data suggest that Mimiviridae, including CroV, may have inherited a common gene content probably acquired from a common Mimiviridae ancestor. Conclusions: This further analysis of the gene repertoire of CroV consolidated the fourth domain of Life hypothesis and contributed to outline a functional pan-genome for giant viruses infecting phagocytic protistan grazers.	[Colson, Philippe; Gimenez, Gregory; Boyer, Mickael; Fournous, Ghislain; Raoult, Didier] Univ Mediterranee, Fac Med & Pharm, CNRS, IRD 3R198,URMITE,UMR 6236, Marseille, France; [Colson, Philippe; Raoult, Didier] CHU Timone, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Colson, P (corresponding author), Univ Mediterranee, Fac Med & Pharm, CNRS, IRD 3R198,URMITE,UMR 6236, Marseille, France.	didier.raoult@gmail.com	Boyer, Mickaël/F-6608-2013; RAOULT, Didier/A-8434-2008; Colson, Philippe/P-6355-2014	Boyer, Mickaël/0000-0001-5384-1151; RAOULT, Didier/0000-0002-0633-5974; Colson, Philippe/0000-0001-6285-0308				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Boyer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015530; Boyer M, 2010, INTERVIROLOGY, V53, P310, DOI 10.1159/000312916; Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106; Claverie JM, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2108-c3; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; Delaroque N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-110; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EVANS DH, 1988, J VIROL, V62, P367, DOI 10.1128/JVI.62.2.367-375.1988; Filee J, 2007, TRENDS GENET, V23, P10, DOI 10.1016/j.tig.2006.11.002; Fischer D, 1999, BIOINFORMATICS, V15, P759, DOI 10.1093/bioinformatics/15.9.759; Fischer Matthias G, 2010, Proc Natl Acad Sci U S A, V107, P19508, DOI 10.1073/pnas.1007615107; Forterre P, 2010, INTERVIROLOGY, V53, P362, DOI 10.1159/000312921; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Koonin EV, 2010, INTERVIROLOGY, V53, P284, DOI 10.1159/000312913; Koonin EV, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2108-c5; La Scola B, 2003, SCIENCE, V299, P2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; La Scola B, 2010, INTERVIROLOGY, V53, P344, DOI 10.1159/000312919; Massana R, 2007, ENVIRON MICROBIOL, V9, P2660, DOI 10.1111/j.1462-2920.2007.01378.x; McLysaght A, 2003, P NATL ACAD SCI USA, V100, P15655, DOI 10.1073/pnas.2136653100; Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12; Moreira D, 2009, NAT REV MICROBIOL, V7, P306, DOI 10.1038/nrmicro2108; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Raoult D, 2008, NAT REV MICROBIOL, V6, P315, DOI 10.1038/nrmicro1858; Raoult D, 2007, CLIN INFECT DIS, V45, P95, DOI 10.1086/518608; Raoult D, 2010, INTERVIROLOGY, V53, P321, DOI 10.1159/000312917; Raoult D, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2108-c6; Shackelton LA, 2004, TRENDS MICROBIOL, V12, P458, DOI 10.1016/j.tim.2004.08.005; Suhre K, 2005, J VIROL, V79, P14095, DOI 10.1128/JVI.79.22.14095-14101.2005; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Thomas V, 2010, INTERVIROLOGY, V53, P254, DOI 10.1159/000312910; Van Etten JL, 2010, ANNU REV MICROBIOL, V64, P83, DOI 10.1146/annurev.micro.112408.134338; Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223	42	49	51	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18935	10.1371/journal.pone.0018935	http://dx.doi.org/10.1371/journal.pone.0018935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559486	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700039
J	Kanazawa, H; Fujimoto, Y; Teratani, T; Iwasaki, J; Kasahara, N; Negishi, K; Tsuruyama, T; Uemoto, S; Kobayashi, E				Kanazawa, Hiroyuki; Fujimoto, Yasuhiro; Teratani, Takumi; Iwasaki, Junji; Kasahara, Naoya; Negishi, Kouji; Tsuruyama, Tatsuaki; Uemoto, Shinji; Kobayashi, Eiji			Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Hepatic Ischemia Reperfusion Injury in a Rat Model	PLOS ONE			English	Article							IN-VIVO; LIVER-TRANSPLANTATION; DIFFERENTIATION; THERAPY	Background: Ischemia-reperfusion (I/R) injury associated with living donor liver transplantation impairs liver graft regeneration. Mesenchymal stem cells (MSCs) are potential cell therapeutic targets for liver disease. In this study, we demonstrate the impact of MSCs against hepatic I/R injury and hepatectomy. Methodology/Principal Findings: We used a new rat model in which major hepatectomy with I/R injury was performed. Male Lewis rats were separated into two groups: an MSC group given MSCs after reperfusion as treatment, and a Control group given phosphate-buffered saline after reperfusion as placebo. The results of liver function tests, pathologic changes in the liver, and the remnant liver regeneration rate were assessed. The fate of transplanted MSCs in the luciferase-expressing rats was examined by in vivo luminescent imaging. The MSC group showed peak luciferase activity of transplanted MSCs in the remnant liver 24 h after reperfusion, after which luciferase activity gradually declined. The elevation of serum alanine transaminase levels was significantly reduced by MSC injection. Histopathological findings showed that vacuolar change was lower in the MSC group compared to the Control group. In addition, a significantly lower percentage of TUNEL-positive cells was observed in the MSC group compared with the controls. Remnant liver regeneration rate was accelerated in the MSC group. Conclusions/Significance: These data suggest that MSC transplantation provides trophic support to the I/R-injured liver by inhibiting hepatocellular apoptosis and by stimulating regeneration.	[Kanazawa, Hiroyuki; Fujimoto, Yasuhiro; Teratani, Takumi; Iwasaki, Junji; Kasahara, Naoya; Negishi, Kouji; Kobayashi, Eiji] Jichi Med Univ, Ctr Dev Adv Med Technol, Div Dev Adv Treatment, Yakushiji City, Tochigi, Japan; [Kanazawa, Hiroyuki; Iwasaki, Junji; Tsuruyama, Tatsuaki] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto 606, Japan; [Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Hepatopancreatobiliary Surg & Transplantat, Kyoto, Japan	Jichi Medical University; Kyoto University; Kyoto University	Kanazawa, H (corresponding author), Jichi Med Univ, Ctr Dev Adv Med Technol, Div Dev Adv Treatment, Yakushiji City, Tochigi, Japan.	kagoshimakurobuta@hotmail.com						Azoulay D, 1996, ANN SURG, V224, P737, DOI 10.1097/00000658-199612000-00009; Baertschiger RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006657; Banas A, 2008, STEM CELLS, V26, P2705, DOI 10.1634/stemcells.2008-0034; Banas A, 2007, DEV DYNAM, V236, P3228, DOI 10.1002/dvdy.21330; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Ben-Haim M, 2001, LIVER TRANSPLANT, V7, P948, DOI 10.1053/jlts.2001.29033; Dahlke MH, 2009, TRANSPLANTATION, V88, P614, DOI 10.1097/TP.0b013e3181b4425a; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Forte A, 2008, J CELL PHYSIOL, V217, P789, DOI 10.1002/jcp.21559; Fujishiro J, 2005, NEPHROL DIAL TRANSPL, V20, P1385, DOI 10.1093/ndt/gfh783; Goss JA, 1997, TRANSPLANTATION, V64, P871, DOI 10.1097/00007890-199709270-00014; Hakamata Y, 2006, TRANSPLANTATION, V81, P1179, DOI 10.1097/01.tp.0000203137.06587.4a; Inoue H, 2005, BIOCHEM BIOPH RES CO, V329, P288, DOI 10.1016/j.bbrc.2005.01.132; Inoue S, 2004, TRANSPLANTATION, V77, P997, DOI 10.1097/01.TP.0000118404.66106.E8; Lam SP, 2010, LIVER TRANSPLANT, V16, P1195, DOI 10.1002/lt.22136; Meer C, 1976, CIRC SHOCK, V3, P191; Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026; Parekkadan B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000941; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; SUZUKI S, 1991, TRANSPLANTATION, V52, P978, DOI 10.1097/00007890-199112000-00008; Tsai PC, 2009, LIVER TRANSPLANT, V15, P484, DOI 10.1002/lt.21715; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Wang YJ, 2009, BIOCHEM BIOPH RES CO, V390, P1309, DOI 10.1016/j.bbrc.2009.10.143; Yadav SS, 1998, TRANSPLANTATION, V65, P1433, DOI 10.1097/00007890-199806150-00004; Zhang D, 2011, PLOS ONE, V2	26	142	163	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19195	10.1371/journal.pone.0019195	http://dx.doi.org/10.1371/journal.pone.0019195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559442	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700096
J	Nakajima, K; Yokoyama, K; Koizumi, T; Koizumi, A; Asakura, T; Terada, T; Masuda, K; Ito, K; Shimizu-Ibuka, A; Misaka, T; Abe, K				Nakajima, Ken-ichiro; Yokoyama, Kanako; Koizumi, Taichi; Koizumi, Ayako; Asakura, Tomiko; Terada, Tohru; Masuda, Katsuyoshi; Ito, Keisuke; Shimizu-Ibuka, Akiko; Misaka, Takumi; Abe, Keiko			Identification and Modulation of the Key Amino Acid Residue Responsible for the pH Sensitivity of Neoculin, a Taste-Modifying Protein	PLOS ONE			English	Article							SWEET PROTEIN; PURIFICATION; CURCULIN; STABILITY; PRINCIPLE; RECEPTOR; FRUIT	Neoculin occurring in the tropical fruit of Curculigo latifolia is currently the only protein that possesses both a sweet taste and a taste-modifying activity of converting sourness into sweetness. Structurally, this protein is a heterodimer consisting of a neoculin acidic subunit (NAS) and a neoculin basic subunit (NBS). Recently, we found that a neoculin variant in which all five histidine residues are replaced with alanine elicits intense sweetness at both neutral and acidic pH but has no taste-modifying activity. To identify the critical histidine residue(s) responsible for this activity, we produced a series of His-to-Ala neoculin variants and evaluated their sweetness levels using cell-based calcium imaging and a human sensory test. Our results suggest that NBS His11 functions as a primary pH sensor for neoculin to elicit taste modification. Neoculin variants with substitutions other than His-to-Ala were further analyzed to clarify the role of the NBS position 11 in the taste-modifying activity. We found that the aromatic character of the amino acid side chain is necessary to elicit the pH-dependent sweetness. Interestingly, since the His-to-Tyr variant is a novel taste-modifying protein with alternative pH sensitivity, the position 11 in NBS can be critical to modulate the pH-dependent activity of neoculin. These findings are important for understanding the pH-sensitive functional changes in proteinaceous ligands in general and the interaction of taste receptor-taste substance in particular.	[Nakajima, Ken-ichiro; Koizumi, Taichi; Koizumi, Ayako; Asakura, Tomiko; Ito, Keisuke; Shimizu-Ibuka, Akiko; Misaka, Takumi; Abe, Keiko] Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan; [Yokoyama, Kanako] Tokyo Univ Agr, Dept Nutr Sci, Tokyo, Japan; [Terada, Tohru; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Tokyo, Japan; [Masuda, Katsuyoshi] Suntory Inst Bioorgan Res, Osaka 618, Japan; [Abe, Keiko] Kanagawa Acad Sci & Technol, Food Safety & Reliabil Project, Kawasaki, Kanagawa, Japan	University of Tokyo; Tokyo University of Agriculture; University of Tokyo; Suntory Holdings Ltd; Kanagawa Academy Science & Technology	Nakajima, K (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan.	aka7308@mail.ecc.u-tokyo.ac.jp	Terada, Tohru/W-2956-2019; Ito, Keisuke/J-5926-2013	Terada, Tohru/0000-0002-7091-0646; SHIMIZU-IBUKA, Akiko/0000-0002-5310-9216; Nakajima, Ken-ichiro/0000-0003-1932-418X; Ito, Keisuke/0000-0002-8719-9635; Misaka, Takumi/0000-0002-9547-5767	Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [21880015, 19300248, 20688015, 21658046, 20380183]; Nisshin Seifun Foundation	Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nisshin Seifun Foundation	This study was performed with a grant from the Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution. This work was also supported by the Nisshin Seifun Foundation (to K. N.), by the Japan Society for the Promotion of Science Research Fellowship for Young Scientists (to A. K.), by Grant-in-aid for Research Activity Start-up 21880015 (to K. N.), and by Grants-in-aid for Scientific Research 19300248 (to T. A.), 20688015 and 21658046 (to T. M.) and 20380183 (to K. A.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cui M, 2006, CURR PHARM DESIGN, V12, P4591, DOI 10.2174/138161206779010350; Koizumi A, 2007, BIOCHEM BIOPH RES CO, V358, P585, DOI 10.1016/j.bbrc.2007.04.171; KURIHARA Y, 1992, CRIT REV FOOD SCI, V32, P231, DOI 10.1080/10408399209527598; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Maehashi K, 1998, BIOSCI BIOTECH BIOCH, V62, P605, DOI 10.1271/bbb.62.605; Masuda T, 2001, J AGR FOOD CHEM, V49, P4937, DOI 10.1021/jf010404q; MING D, 1994, FEBS LETT, V355, P106, DOI 10.1016/0014-5793(94)01184-2; MORRIS JA, 1972, BIOCHIM BIOPHYS ACTA, V261, P114, DOI 10.1016/0304-4165(72)90320-0; Nakajima KI, 2008, FASEB J, V22, P2323, DOI 10.1096/fj.07-100289; Nakajima K, 2006, APPL ENVIRON MICROB, V72, P3716, DOI 10.1128/AEM.72.5.3716-3723.2006; NIRASAWA S, 1994, EUR J BIOCHEM, V223, P989, DOI 10.1111/j.1432-1033.1994.tb19077.x; Shirasuka Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1403, DOI 10.1271/bbb.68.1403; Suzuki M, 2004, FEBS LETT, V573, P135, DOI 10.1016/j.febslet.2004.07.073; THEERASILP S, 1988, J BIOL CHEM, V263, P11536; VANDERWEL H, 1989, CHEM SENSES, V14, P75; VANDERWEL H, 1972, EUR J BIOCHEM, V31, P221; YAMASHITA H, 1990, J BIOL CHEM, V265, P15770; YAMASHITA H, 1995, CHEM SENSES, V20, P239, DOI 10.1093/chemse/20.2.239; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001	19	12	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19448	10.1371/journal.pone.0019448	http://dx.doi.org/10.1371/journal.pone.0019448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559382	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700177
J	Hu, VW; Addington, A; Hyman, A				Hu, Valerie W.; Addington, Anjene; Hyman, Alexander			Novel Autism Subtype-Dependent Genetic Variants Are Revealed by Quantitative Trait and Subphenotype Association Analyses of Published GWAS Data	PLOS ONE			English	Article							SPECTRUM DISORDERS; TUBEROUS-SCLEROSIS; GTP CYCLOHYDROLASE; LOCUS ANALYSIS; LINKAGE; COMMON; SCAN; HAPLOTYPE; FAMILIES; 5P14.1	The heterogeneity of symptoms associated with autism spectrum disorders (ASDs) has presented a significant challenge to genetic analyses. Even when associations with genetic variants have been identified, it has been difficult to associate them with a specific trait or characteristic of autism. Here, we report that quantitative trait analyses of ASD symptoms combined with case-control association analyses using distinct ASD subphenotypes identified on the basis of symptomatic profiles result in the identification of highly significant associations with 18 novel single nucleotide polymorphisms (SNPs). The symptom categories included deficits in language usage, non-verbal communication, social development, and play skills, as well as insistence on sameness or ritualistic behaviors. Ten of the trait-associated SNPs, or quantitative trait loci (QTL), were associated with more than one subtype, providing partial replication of the identified QTL. Notably, none of the novel SNPs is located within an exonic region, suggesting that these hereditary components of ASDs are more likely related to gene regulatory processes (or gene expression) than to structural or functional changes in gene products. Seven of the QTL reside within intergenic chromosomal regions associated with rare copy number variants that have been previously reported in autistic samples. Pathway analyses of the genes associated with the QTL identified in this study implicate neurological functions and disorders associated with autism pathophysiology. This study underscores the advantage of incorporating both quantitative traits as well as subphenotypes into large-scale genome-wide analyses of complex disorders.	[Hu, Valerie W.; Hyman, Alexander] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Addington, Anjene] NIMH, Child Psychiat Branch, NIH, Bethesda, MD 20892 USA	George Washington University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Hu, VW (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmvwh@gwumc.edu		Addington, Anjene/0000-0001-7770-299X; Hu, Valerie/0000-0002-3357-0777				Alarcon M, 2005, MOL PSYCHIATR, V10, P747, DOI 10.1038/sj.mp.4001666; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Campbell CM, 2009, PAIN, V141, P114, DOI 10.1016/j.pain.2008.10.023; Cannon DS, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-3; Cao L, 2010, MOVEMENT DISORD, V25, P755, DOI 10.1002/mds.22646; Chen GK, 2006, MOL PSYCHIATR, V11, P214, DOI 10.1038/sj.mp.4001753; Coon H, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-8; Duvall JA, 2007, AM J PSYCHIAT, V164, P656, DOI 10.1176/appi.ajp.164.4.656; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Hu VW, 2009, AUTISM RES, V2, P67, DOI 10.1002/aur.72; Kato T, 2005, DRUG TODAY, V41, P335, DOI 10.1358/dot.2005.41.5.893616; Kim S, 2000, J BONE MINER RES, V15, pS362; Li J, 2007, AM J MED GENET B, V144B, P14, DOI 10.1002/ajmg.b.30373; Ma DQ, 2009, ANN HUM GENET, V73, P263, DOI 10.1111/j.1469-1809.2009.00523.x; Nijmeijer JS, 2010, J AM ACAD CHILD PSY, V49, P675, DOI 10.1016/j.jaac.2010.03.015; Nurmi EL, 2003, J AM ACAD CHILD PSY, V42, P856, DOI 10.1097/01.CHI.0000046868.56865.0F; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pourcain BS, 2010, AM J PSYCHIAT, V167, P1364, DOI 10.1176/appi.ajp.2010.09121789; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ronald A, 2010, BEHAV GENET, V40, P31, DOI 10.1007/s10519-009-9308-6; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sbacchi S, 2010, CURR GENOMICS, V11, P136, DOI 10.2174/138920210790886880; Serova LI, 1999, BIOL PSYCHIAT, V45, P853, DOI 10.1016/S0006-3223(98)90360-2; SMALLEY SL, 1994, J MED GENET, V31, P761, DOI 10.1136/jmg.31.10.761; Suzuki T, 2003, AM J MED GENET B, V121B, P7, DOI 10.1002/ajmg.b.20060; Tegeder I, 2008, EUR J PAIN, V12, P1069, DOI 10.1016/j.ejpain.2008.02.004; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Vincent JB, 2009, AM J MED GENET B, V150B, P817, DOI 10.1002/ajmg.b.30903; VOLKMAR FR, 1991, HOSP COMMUNITY PSYCH, V42, P33; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; ZHOU CY, 1995, GENOMICS, V25, P304, DOI 10.1016/0888-7543(95)80143-A	36	55	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19067	10.1371/journal.pone.0019067	http://dx.doi.org/10.1371/journal.pone.0019067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556359	gold, Green Submitted, Green Published			2022-12-25	WOS:000290019400027
J	Shang, X; Cancelas, JA; Li, LN; Guo, FK; Liu, W; Johnson, JF; Ficker, A; Daria, D; Geiger, H; Ratner, N; Zheng, Y				Shang, Xun; Cancelas, Jose A.; Li, Lina; Guo, Fukun; Liu, Wei; Johnson, James F.; Ficker, Ashley; Daria, Deidre; Geiger, Hartmut; Ratner, Nancy; Zheng, Yi			R-Ras and Rac GTPase Cross-talk Regulates Hematopoietic Progenitor Cell Migration, Homing, and Mobilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST EPITHELIAL-CELLS; STEM-CELL; INTEGRIN ACTIVATION; BONE-MARROW; RHO-GTPASES; NICHE; ADHESION; CDC42; IDENTIFICATION; ORGANIZATION	Adult hematopoietic progenitor cells (HPCs) are maintained by highly coordinated signals in the bone marrow. The molecular mechanisms linking intracellular signaling network of HPCs with their microenvironment remain poorly defined. The Rho family GTPase Rac1/Rac2 has previously been implicated in cell functions involved in HPC maintenance, including adhesion, migration, homing, and mobilization. In the present studies we have identified R-Ras, a member of the Ras family, as a key signal mediator required for Rac1/Rac2 activation. We found that whereas Rac1 activity is up-regulated upon stem cell factor, integrin, or CXCL12 stimulation, R-Ras activity is inversely up-regulated. Expression of a constitutively active R-Ras mutant resulted in down-regulation of Rac1-activity whereas deletion of R-Ras led to an increase in Rac1/Rac2 activity and signaling. R-Ras(-/-) HPCs displayed a constitutively assembled cortical actin structure and showed increased directional migration. Rac1/Rac2 inhibition reversed the migration phenotype of R-Ras(-/-) HPCs, similar to that by expressing an R-Ras active mutant. Furthermore, R-Ras(-/-) mice showed enhanced responsiveness to G-CSF for HPC mobilization and exhibited decreased bone marrow homing. Transplantation experiments indicate that the R-Ras deficiency-induced HPC mobilization is a HPC intrinsic property. These results indicate that R-Ras is a critical regulator of Rac signaling required for HPC migration, homing, and mobilization.	[Shang, Xun; Cancelas, Jose A.; Li, Lina; Guo, Fukun; Liu, Wei; Johnson, James F.; Ficker, Ashley; Daria, Deidre; Geiger, Hartmut; Ratner, Nancy; Zheng, Yi] Univ Cincinnati, Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Zheng, Y (corresponding author), Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	yi.zheng@cchmc.org	Zheng, Yi/J-7235-2015; Cancelas, Jose/AAR-9324-2020	Zheng, Yi/0000-0001-7089-6074; RATNER, NANCY/0000-0001-5030-9354	National Institutes of Health [R01 CA125658, R01 CA141341, P30 DK090971, R01 HL087159]; NATIONAL CANCER INSTITUTE [R01CA125658, R01CA141341] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA125658, R01 CA141341, and P30 DK090971 (to Y. Z.) and R01 HL087159 (to J. A. C.).	Ada-Nguema AS, 2006, J CELL SCI, V119, P1307, DOI 10.1242/jcs.02835; Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; BOGGS DR, 1984, AM J HEMATOL, V16, P277, DOI 10.1002/ajh.2830160309; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Cancelas JA, 2006, EXP HEMATOL, V34, P976, DOI 10.1016/j.exphem.2006.03.016; Cancelas JA, 2009, CURR OPIN HEMATOL, V16, P249, DOI 10.1097/MOH.0b013e32832c4b80; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X; GINSBERG MH, 1992, COLD SPRING HARB SYM, V57, P221, DOI 10.1101/SQB.1992.057.01.027; Goldfinger LE, 2006, J CELL BIOL, V174, P877, DOI 10.1083/jcb.200603111; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Holly SP, 2005, MOL BIOL CELL, V16, P2458, DOI 10.1091/mbc.E03-12-0917; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Jeong HW, 2005, CANCER RES, V65, P507; Keely PJ, 1999, J CELL BIOL, V145, P1077, DOI 10.1083/jcb.145.5.1077; Kiel MJ, 2006, IMMUNITY, V25, P862, DOI 10.1016/j.immuni.2006.11.005; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Komatsu M, 2005, NAT MED, V11, P1346, DOI 10.1038/nm1324; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; LOWE DG, 1987, MOL CELL BIOL, V7, P2845, DOI 10.1128/MCB.7.8.2845; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Nakada M, 2005, AM J PATHOL, V167, P565, DOI 10.1016/S0002-9440(10)62998-7; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Ryan MA, 2010, NAT MED, V16, P1141, DOI 10.1038/nm.2217; SAEZ R, 1994, ONCOGENE, V9, P2977; SELF AJ, 1993, ONCOGENE, V8, P655; Sethi T, 1999, MOL BIOL CELL, V10, P1799, DOI 10.1091/mbc.10.6.1799; Straub AC, 2009, AM J PATHOL, V174, P1949, DOI 10.2353/ajpath.2009.081016; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; Wang L, 2006, BLOOD, V107, P98, DOI 10.1182/blood-2005-05-2171; Wang L, 2007, P NATL ACAD SCI USA, V104, P1248, DOI 10.1073/pnas.0609149104; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wozniak MA, 2005, MOL BIOL CELL, V16, P84, DOI 10.1091/mbc.E04-04-0277; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	42	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24068	24078		10.1074/jbc.M111.226951	http://dx.doi.org/10.1074/jbc.M111.226951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572048	hybrid, Green Published			2022-12-25	WOS:000292294900049
J	Smith, AM; Qualls, JE; O'Brien, K; Balouzian, L; Johnson, PF; Schultz-Cherry, S; Smale, ST; Murray, PJ				Smith, Amber M.; Qualls, Joseph E.; O'Brien, Kevin; Balouzian, Liza; Johnson, Peter F.; Schultz-Cherry, Stacey; Smale, Stephen T.; Murray, Peter J.			A Distal Enhancer in Il12b Is the Target of Transcriptional Repression by the STAT3 Pathway and Requires the Basic Leucine Zipper (B-ZIP) Protein NFIL3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE SUSCEPTIBILITY LOCI; INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; T-HELPER-CELLS; ANTIINFLAMMATORY RESPONSE; INTESTINAL INFLAMMATION; CHRONIC ENTEROCOLITIS; PRIMARY MACROPHAGES; SIGNALING PATHWAY; CROHNS-DISEASE	Deregulated IL-12 and IL-23 production from activated myeloid lineage cells is a key driver of numerous T cell-dependent autoimmune and inflammatory diseases. IL-12 and IL-23 share a common p40 subunit encoded by Il12b, which is negatively regulated at the transcriptional level by the STAT3(signal transducer and activator of transcription 3)-activating anti-inflammatory cytokine IL-10. We found that IL-10 targets an enhancer 10 kb upstream of the Il12b transcriptional start site. Within the enhancer, a single 10-bp site is required for the inhibitory effects of IL-10 and is bound by NFIL3 (nuclear factor, interleukin 3-regulated), a B-ZIP transcription factor. Myeloid cells lacking NFIL3 produce excessive IL-12p40 and increased IL-12p70. Thus, the STAT3-dependent expression of NFIL3 is a key component of a negative feedback pathway in myeloid cells that suppresses proinflammatory responses.	[Smith, Amber M.; Qualls, Joseph E.; O'Brien, Kevin; Balouzian, Liza; Schultz-Cherry, Stacey; Murray, Peter J.] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Smith, Amber M.; Qualls, Joseph E.; Balouzian, Liza; Murray, Peter J.] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; [Johnson, Peter F.] NCI, Lab Canc Prevent, Ctr Canc Res, Ft Detrick, MD 21702 USA; [Smale, Stephen T.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Los Angeles	Murray, PJ (corresponding author), St Jude Childrens Hosp, Dept Infect Dis, Mail Stop 320,262 Danny Thomas Pl, Memphis, TN 38105 USA.	peter.murray@stjude.org	Schultz-Cherry, Stacey/N-2506-2018; Murray, Peter J/K-4725-2018; Johnson, Peter/A-1940-2012	Murray, Peter J/0000-0001-6329-9802; Qualls, Joseph/0000-0002-0113-2166; Johnson, Peter/0000-0002-4145-4725	National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Institutes of Health [F32 CA138064]; Hartwell Foundation; CORE grant [P30 CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765, F32CA138064] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; CORE grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, National Cancer Institute, Center for Cancer Research (to P. F. J.). This work was also supported by National Institutes of Health Grant F32 CA138064 (to J. E. Q.), The Hartwell Foundation (to P. J. M.), CORE grant P30 CA21765, and the American Lebanese Syrian Associated Charities.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Craver MPJ, 2010, MOL BIOCHEM PARASIT, V169, P120, DOI 10.1016/j.molbiopara.2009.10.006; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Elliott M, 2009, ANN NY ACAD SCI, V1182, P97, DOI 10.1111/j.1749-6632.2009.05070.x; Engel DR, 2010, NAT MED, V16, P1407, DOI 10.1038/nm.2255; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Gingras S, 2004, J BIOL CHEM, V279, P54702, DOI 10.1074/jbc.M411043200; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hou B., 2010, NATL ACAD SCI US, V108, P278; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Kamada N, 2005, J IMMUNOL, V175, P6900, DOI 10.4049/jimmunol.175.10.6900; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kashiwada M, 2011, BLOOD, V117, P6193, DOI 10.1182/blood-2010-07-295873; Kashiwada M, 2011, EMBO J, V30, P2071, DOI 10.1038/emboj.2011.111; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; Kobayashi M, 2003, J CLIN INVEST, V111, P1297, DOI 10.1172/JCI200317085; Kobayashi T, 2011, J IMMUNOL, V186, P4649, DOI 10.4049/jimmunol.1003888; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Mizoguchi A, 2007, J CLIN INVEST, V117, P605, DOI 10.1172/JCI30150; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Motomura Y, 2011, NAT IMMUNOL, V12, P450, DOI 10.1038/ni.2020; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Olleros ML, 2007, IMMUNOLOGY, V122, P350, DOI 10.1111/j.1365-2567.2007.02646.x; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Qualls JE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000955; Smallie T, 2010, J EXP MED, V207, P2081, DOI 10.1084/jem.20100414; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Teng MWL, 2011, CANCER RES, V71, P2077, DOI 10.1158/0008-5472.CAN-10-3994; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567; Williams LM, 2004, IMMUNOLOGY, V113, P281, DOI 10.1111/j.1365-2567.2004.01988.x; ZHANG W, 1995, MOL CELL BIOL, V15, P6055; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489; Zhou L, 2004, MOL CELL BIOL, V24, P2385, DOI 10.1128/MCB.24.6.2385-2396.2004; Zhou L, 2007, MOL CELL BIOL, V27, P2698, DOI 10.1128/MCB.00788-06; Zwiers A, 2011, J IMMUNOL, V186, P3572, DOI 10.4049/jimmunol.1001330	58	49	50	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23582	23590		10.1074/jbc.M111.249235	http://dx.doi.org/10.1074/jbc.M111.249235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21566115	Green Published, hybrid			2022-12-25	WOS:000292025000088
J	Yue, M; Singh, A; Wang, Z; Xu, YJ				Yue, Ming; Singh, Amanpreet; Wang, Zhuo; Xu, Yong-jie			The Phosphorylation Network for Efficient Activation of the DNA Replication Checkpoint in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CHECKPOINT; DAMAGE CHECKPOINT; S-PHASE; KINASE CDS1; IN-VITRO; SACCHAROMYCES-CEREVISIAE; PROTEIN; COMPLEX; CLAMP; RAD9	Protein phosphorylation is the hallmark of checkpoint activation. Hundreds of targets of checkpoint kinases have been identified recently by genome-wide investigations. However, the complete picture of a phosphorylation network required for activation of a checkpoint pathway has not been available. The DNA replication checkpoint in Schizosaccharomyces pombe contains two major protein kinases, the sensor kinase Rad3 and the effector kinase Cds1, with the latter mediating most of the checkpoint functions. We show here that when DNA replication is arrested, efficient activation of Cds1 requires five phosphorylations that cooperate in a parallel or a sequential manner. Phosphorylation of a threonine residue (Thr(11)) in Cds1 by Rad3 occurs at a basal level in the absence of three other parallel Rad3-dependent phosphorylations on the mediator Mrc1 and Rad9 in the checkpoint clamp complex. However, the three parallel Rad3-dependent phosphorylations are all required for efficient phosphorylation of Thr11 in Cds1 by Rad3. Phosphorylation of Thr11 has been shown previously to promote autophosphorylation of Thr(328) in the kinase domain of Cds1, which directly activates the enzyme, leading to full activation of the checkpoint pathway. Interestingly, phosphorylation of Mrc1 by Rad3 does not require the phosphorylation of Rad9, suggesting that activation of the sensor kinase Rad3 in the replication checkpoint of fission yeast may involve a different mechanism.	[Yue, Ming; Singh, Amanpreet; Wang, Zhuo; Xu, Yong-jie] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Xu, YJ (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, 148 Diggs,3640 Col Glenn Hwy, Dayton, OH 45435 USA.	yong-jie.xu@wright.edu	Wang, Zhuo/F-1759-2017	Wang, Zhuo/0000-0002-8218-6819	Ohio Cancer Research Associates, Inc.	Ohio Cancer Research Associates, Inc.	This work was supported in part by a grant from Ohio Cancer Research Associates, Inc.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Callegari AJ, 2007, CELL CYCLE, V6, P660, DOI 10.4161/cc.6.6.3984; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; Furuya K, 2003, J CELL SCI, V116, P3847, DOI 10.1242/jcs.00790; Furuya K, 2010, MOL CELL, V40, P606, DOI 10.1016/j.molcel.2010.10.026; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Kai M, 2007, NAT CELL BIOL, V9, P691, DOI 10.1038/ncb1600; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Lupardus PJ, 2006, MOL BIOL CELL, V17, P1559, DOI 10.1091/mbc.E05-09-0865; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; Mochida S, 2004, EMBO J, V23, P418, DOI 10.1038/sj.emboj.7600018; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Nakamura TM, 2002, GENETICS, V161, P1437; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Paciotti V, 1998, EMBO J, V17, P4199, DOI 10.1093/emboj/17.14.4199; Roos-Mattjus P, 2003, J BIOL CHEM, V278, P24428, DOI 10.1074/jbc.M301544200; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; SAKA Y, 1993, CELL, V74, P383, DOI 10.1016/0092-8674(93)90428-S; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Sohn SY, 2009, J MOL BIOL, V390, P490, DOI 10.1016/j.jmb.2009.05.028; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Tanaka K, 2004, J BIOL CHEM, V279, P32079, DOI 10.1074/jbc.M404834200; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka K, 2001, MOL CELL BIOL, V21, P3398, DOI 10.1128/MCB.21.10.3398-3404.2001; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsang E, 2008, DNA REPAIR, V7, P1613, DOI 10.1016/j.dnarep.2008.06.010; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Xu YJ, 2006, GENE DEV, V20, P990, DOI 10.1101/gad.1406706; Xu YJ, 2010, P NATL ACAD SCI USA, V107, P13561, DOI 10.1073/pnas.1008909107; Xu YJ, 2009, J BIOL CHEM, V284, P16016, DOI 10.1074/jbc.M900785200; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373; Zhao H, 2003, MOL CELL BIOL, V23, P8395, DOI 10.1128/MCB.23.22.8395-8403.2003	60	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22864	22874		10.1074/jbc.M111.236687	http://dx.doi.org/10.1074/jbc.M111.236687			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561865	hybrid, Green Published			2022-12-25	WOS:000292025000021
J	Chappell, JM; Lohe, MA; von Smekal, L; Iqbal, A; Abbott, D				Chappell, James M.; Lohe, Max A.; von Smekal, Lorenz; Iqbal, Azhar; Abbott, Derek			A Precise Error Bound for Quantum Phase Estimation	PLOS ONE			English	Article							ALGORITHMS	Quantum phase estimation is one of the key algorithms in the field of quantum computing, but up until now, only approximate expressions have been derived for the probability of error. We revisit these derivations, and find that by ensuring symmetry in the error definitions, an exact formula can be found. This new approach may also have value in solving other related problems in quantum computing, where an expected error is calculated. Expressions for two special cases of the formula are also developed, in the limit as the number of qubits in the quantum computer approaches infinity and in the limit as the extra added qubits to improve reliability goes to infinity. It is found that this formula is useful in validating computer simulations of the phase estimation procedure and in avoiding the overestimation of the number of qubits required in order to achieve a given reliability. This formula thus brings improved precision in the design of quantum computers.	[Chappell, James M.; Lohe, Max A.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA, Australia; [von Smekal, Lorenz] Tech Univ Darmstadt, Inst Kernphys, Darmstadt, Germany; [Iqbal, Azhar; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	University of Adelaide; Technical University of Darmstadt; University of Adelaide	Chappell, JM (corresponding author), Univ Adelaide, Sch Chem & Phys, Adelaide, SA, Australia.	james.m.chappell@adelaide.edu.au	Lohe, Max/C-3193-2012; Iqbal, Azhar/E-8749-2011; Abbott, Derek/E-8352-2011	Lohe, Max/0000-0002-5214-2225; Iqbal, Azhar/0000-0002-5221-9384; Abbott, Derek/0000-0002-0945-2674				Abramowitz M., 1964, HDB MATH FUNCTIONS F; Cleve R, 1998, P ROY SOC A-MATH PHY, V454, P339, DOI 10.1002/(SICI)1099-0526(199809/10)4:1<33::AID-CPLX10>3.0.CO;2-U; Imre S, 2002, ISIT: 2002 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY, PROCEEDINGS, P43, DOI 10.1109/ISIT.2002.1023315; Mosca M., 1999, THESIS U OXFORD; Nielsen MA., 2002, QUANTUM COMPUTATION; Shor PW, 1997, SIAM J COMPUT, V26, P1484, DOI [10.1137/S0097539795293172, 10.1137/S0036144598347011]	6	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19663	10.1371/journal.pone.0019663	http://dx.doi.org/10.1371/journal.pone.0019663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573006	Green Submitted, Green Published, gold			2022-12-25	WOS:000290440200018
J	Krupovic, M; Forterre, P				Krupovic, Mart; Forterre, Patrick			Microviridae Goes Temperate: Microvirus-Related Proviruses Reside in the Genomes of Bacteroidetes	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MOLECULAR CHARACTERIZATION; PHAGE INTEGRATION; TAILED VIRUSES; DNA; PROTEIN; DIVERSITY; EVOLUTION; BACTERIOPHAGE; BIOGEOGRAPHY	The Microviridae comprises icosahedral lytic viruses with circular single-stranded DNA genomes. The family is divided into two distinct groups based on genome characteristics and virion structure. Viruses infecting enterobacteria belong to the genus Microvirus, whereas those infecting obligate parasitic bacteria, such as Chlamydia, Spiroplasma and Bdellovibrio, are classified into a subfamily, the Gokushovirinae. Recent metagenomic studies suggest that members of the Microviridae might also play an important role in marine environments. In this study we present the identification and characterization of Microviridae-related prophages integrated in the genomes of species of the Bacteroidetes, a phylum not previously known to be associated with microviruses. Searches against metagenomic databases revealed the presence of highly similar sequences in the human gut. This is the first report indicating that viruses of the Microviridae lysogenize their hosts. Absence of associated integrase-coding genes and apparent recombination with dif-like sequences suggests that Bacteroidetes-associated microviruses are likely to rely on the cellular chromosome dimer resolution machinery. Phylogenetic analysis of the putative major capsid proteins places the identified proviruses into a group separate from the previously characterized microviruses and gokushoviruses, suggesting that the genetic diversity and host range of bacteriophages in the family Microviridae is wider than currently appreciated.	[Krupovic, Mart; Forterre, Patrick] Inst Pasteur, Dept Microbiol, Unite Biol Mol Gene Chez Extremophiles, Paris, France; [Forterre, Patrick] Univ Paris 11, CNRS, Inst Genet & Microbiol, UMR 8621, Orsay, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Krupovic, M (corresponding author), Inst Pasteur, Dept Microbiol, Unite Biol Mol Gene Chez Extremophiles, Paris, France.	krupovic@pasteur.fr	Krupovic, Mart/ABD-6255-2021; Krupovic, Mart/I-4209-2012	Krupovic, Mart/0000-0001-5486-0098; Krupovic, Mart/0000-0001-5486-0098	European Molecular Biology Organization [ALTF 347-2010]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by the European Molecular Biology Organization (Long-Term Fellowship ALTF 347-2010 to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; AZUMA J, 1980, J BIOCHEM, V88, P525, DOI 10.1093/oxfordjournals.jbchem.a132999; Brentlinger KL, 2002, J BACTERIOL, V184, P1089, DOI 10.1128/jb.184.4.1089-1094.2002; Carnoy C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006531; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Cherwa JE, 2011, VIROLOGY, V411, P9, DOI 10.1016/j.virol.2010.12.026; Chipman PR, 1998, STRUCTURE, V6, P135, DOI 10.1016/S0969-2126(98)00016-1; Clarke IN, 2004, J BACTERIOL, V186, P7571, DOI 10.1128/JB.186.22.7571-7574.2004; Cortez D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001166; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Das B, 2011, P NATL ACAD SCI USA, V108, P2516, DOI 10.1073/pnas.1017061108; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Downes J, 2006, INT J SYST EVOL MICR, V56, P609, DOI 10.1099/ijs.0.63888-0; Duncan MJ, 2003, CRIT REV ORAL BIOL M, V14, P175, DOI 10.1177/154411130301400303; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fane B., 2006, BACTERIOPHAGES, P129; Fane BA, 2003, ADV PROTEIN CHEM, V64, P259; Garner SA, 2004, VIRUS GENES, V28, P207, DOI 10.1023/B:VIRU.0000016860.53035.f3; Held NL, 2009, ENVIRON MICROBIOL, V11, P457, DOI 10.1111/j.1462-2920.2008.01784.x; Hendrickson H, 2007, MOL MICROBIOL, V64, P42, DOI 10.1111/j.1365-2958.2007.05596.x; Huber KE, 2002, NATURE, V417, P656, DOI 10.1038/nature00782; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; Ip SCY, 2003, EMBO J, V22, P6399, DOI 10.1093/emboj/cdg589; Jalasvuori M, 2010, J BACTERIOL, V192, P3231, DOI 10.1128/JB.00124-10; Kim KH, 2008, APPL ENVIRON MICROB, V74, P5975, DOI 10.1128/AEM.01275-08; Krupovic M, 2008, VIROLOGY, V375, P292, DOI 10.1016/j.virol.2008.01.043; Krupovic M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-236; Krupovic M, 2011, BIOCHEM SOC T, V39, P82, DOI 10.1042/BST0390082; Krupovic M, 2010, J VIROL, V84, P12476, DOI 10.1128/JVI.01489-10; Krupovic M, 2010, J MOL BIOL, V397, P144, DOI 10.1016/j.jmb.2010.01.037; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Liu BL, 2000, J VIROL, V74, P3464, DOI 10.1128/JVI.74.8.3464-3469.2000; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McDaniel LD, 2006, J MAR BIOL ASSOC UK, V86, P517, DOI 10.1017/S0025315406013427; MCKENNA R, 1992, NATURE, V355, P137, DOI 10.1038/355137a0; McLeod SM, 2004, MOL MICROBIOL, V54, P935, DOI 10.1111/j.1365-2958.2004.04309.x; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; O'Sullivan LA, 2002, APPL ENVIRON MICROB, V68, P201, DOI 10.1128/AEM.68.1.201-210.2002; Ohkuma M, 2002, BIOSCI BIOTECH BIOCH, V66, P78, DOI 10.1271/bbb.66.78; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Read TD, 2003, NUCLEIC ACIDS RES, V31, P2134, DOI 10.1093/nar/gkg321; REITER WD, 1989, NUCLEIC ACIDS RES, V17, P1907, DOI 10.1093/nar/17.5.1907; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Rokyta DR, 2006, J BACTERIOL, V188, P1134, DOI 10.1128/JB.188.3.1134-1142.2006; Ruboyianes MV, 2009, J VIROL, V83, P9952, DOI 10.1128/JVI.01077-09; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SHAH HN, 1998, MICROBIOLOGY MICROBI, P1305; Srinivasiah S, 2008, RES MICROBIOL, V159, P349, DOI 10.1016/j.resmic.2008.04.010; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TUCKER KP, 2010, ISME J IN PRESS; Val ME, 2005, MOL CELL, V19, P559, DOI 10.1016/j.molcel.2005.07.002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yates J, 2006, MOL MICROBIOL, V59, P1754, DOI 10.1111/j.1365-2958.2005.05033.x	58	81	83	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19893	10.1371/journal.pone.0019893	http://dx.doi.org/10.1371/journal.pone.0019893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21572966	Green Published, Green Submitted, gold			2022-12-25	WOS:000290440200034
J	Deng, KY; Chu, TG				Deng, Kuiying; Chu, Tianguang			Action Being Character: A Promising Perspective on the Solution Concept of Game Theory	PLOS ONE			English	Article							ECONOMIC MAN; COOPERATION; DYNAMICS; BEHAVIOR	The inconsistency of predictions from solution concepts of conventional game theory with experimental observations is an enduring question. These solution concepts are based on the canonical rationality assumption that people are exclusively self-regarding utility maximizers. In this article, we think this assumption is problematic and, instead, assume that rational economic agents act as if they were maximizing their implicit utilities, which turns out to be a natural extension of the canonical rationality assumption. Implicit utility is defined by a player's character to reflect his personal weighting between cooperative, individualistic, and competitive social value orientations. The player who actually faces an implicit game chooses his strategy based on the common belief about the character distribution for a general player and the self-estimation of his own character, and he is not concerned about which strategies other players will choose and will never feel regret about his decision. It is shown by solving five paradigmatic games, the Dictator game, the Ultimatum game, the Prisoner's Dilemma game, the Public Goods game, and the Battle of the Sexes game, that the framework of implicit game and its corresponding solution concept, implicit equilibrium, based on this alternative assumption have potential for better explaining people's actual behaviors in social decision making situations.	[Deng, Kuiying; Chu, Tianguang] Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China; [Chu, Tianguang] Peking Univ, Key Lab Machine Percept, Minist Educ, Beijing 100871, Peoples R China	Peking University; Peking University	Deng, KY (corresponding author), Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China.	chutg@pku.edu.cn	Chu, Tianguang/C-3521-2012		National Natural Science Foundation of China (NSFC) [60974064, 60736022]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC) under grant Nos. 60974064 and 60736022 (http://www.nsfc.gov.cn/Portal0/default124.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER CG, 1978, AM J PHYS, V46, P199, DOI 10.1119/1.11165; Ahn TK, 2001, PUBLIC CHOICE, V106, P137, DOI 10.1023/A:1005219123532; [Anonymous], 1995, EVOLUTIONARY GAME TH; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; Colman AM, 2003, BEHAV BRAIN SCI, V26, P139, DOI 10.1017/S0140525X03000050; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Eckel CC, 1998, ECON J, V108, P726, DOI 10.1111/1468-0297.00311; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Fehr E, 2007, ANNU REV SOCIOL, V33, P43, DOI 10.1146/annurev.soc.33.040406.131812; FRANK RH, 1993, J ECON PERSPECT, V7, P159, DOI 10.1257/jep.7.2.159; Gintis H, 2007, BEHAV BRAIN SCI, V30, P1, DOI 10.1017/S0140525X07000581; Hauert C, 2006, P R SOC B, V273, P2565, DOI 10.1098/rspb.2006.3600; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hoffman E, 1996, AM ECON REV, V86, P653; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; Murnighan JK, 2001, GAME ECON BEHAV, V37, P388, DOI 10.1006/game.2001.0847; Nowak MA, 2004, SCIENCE, V303, P793, DOI 10.1126/science.1093411; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; RABIN M, 1993, AM ECON REV, V83, P1281; Rose J, 2007, PSYCHOL REP, V101, P803, DOI 10.2466/PR0.101.3.803-815; ROTH AE, 1991, AM ECON REV, V81, P1068; SALLY D, 1995, RATION SOC, V7, P58, DOI 10.1177/1043463195007001004; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sugden R, 2000, ECON PHILOS, V16, P175, DOI 10.1017/S0266267100000213; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337	29	0	0	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19014	10.1371/journal.pone.0019014	http://dx.doi.org/10.1371/journal.pone.0019014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	761GX	21573055	gold, Green Published, Green Submitted			2022-12-25	WOS:000290386800007
J	Pachathundikandi, SK; Brandt, S; Madassery, J; Backert, S				Pachathundikandi, Suneesh Kumar; Brandt, Sabine; Madassery, Joseph; Backert, Steffen			Induction of TLR-2 and TLR-5 Expression by Helicobacter pylori Switches cagPAI-Dependent Signalling Leading to the Secretion of IL-8 and TNF-alpha	PLOS ONE			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; EPITHELIAL-CELLS; GENE-EXPRESSION; IV SECRETION; CAGA; ACTIVATION; IMMUNITY; RECOGNITION; INFECTION	Helicobacter pylori is the causative agent for developing gastritis, gastric ulcer, and even gastric cancer. Virulent strains carry the cag pathogenicity island (cagPAI) encoding a type-IV secretion system (T4SS) for injecting the CagA protein. However, mechanisms of sensing this pathogen through Toll-like receptors (TLRs) and downstream signalling pathways in the development of different pathologies are widely unclear. Here, we explored the involvement of TLR-2 and TLR-5 in THP-1 cells and HEK293 cell lines ( stably transfected with TLR-2 or TLR-5) during infection with wild-type H. pylori and isogenic cagPAI mutants. H. pylori triggered enhanced TLR-2 and TLR-5 expression in THP-1, HEK293-TLR2 and HEK293-TLR5 cells, but not in the HEK293 control. In addition, IL-8 and TNF-alpha cytokine secretion in THP-1 cells was induced in a cagPAI-dependent manner. Furthermore, we show that HEK293 cells are not competent for the uptake of T4SS-delivered CagA, and are therefore ideally suited for studying TLR signalling in the absence of T4SS functions. HEK293 control cells, which do not induce TLR-2 and TLR-5 expression during infection, only secreted cytokines in small amounts, in agreement with T4SS functions being absent. In contrast, HEK293-TLR2 and HEK293-TLR5 cells were highly competent for inducing the secretion of IL-8 and TNF-alpha cytokines in a cagPAI-independent manner, suggesting that the expression of TLR-2 or TLR-5 has profoundly changed the capability to trigger pro-inflammatory signalling upon infection. Using phospho-specific antibodies and luciferase reporter assays, we further demonstrate that H. pylori induces IRAK-1 and I kappa B phosphorylation in a TLR-dependent manner, and this was required for activation of transcription factor NF-kappa B. Finally, NF-kappa B activation in HEK293-TLR2 and HEK293-TLR5 cells was confirmed by expressing p65-GFP which was translocated from the cytoplasm into the nucleus. These data indicate that H. pylori-induced expression of TLR-2 and TLR-5 can qualitatively shift cagPAI-dependent to cagPAI-independent pro-inflammatory signalling pathways with possible impact on the outcome of H. pylori-associated diseases.	[Pachathundikandi, Suneesh Kumar; Brandt, Sabine; Backert, Steffen] Otto Von Guericke Univ, Inst Med Microbiol, Magdeburg, Germany; [Pachathundikandi, Suneesh Kumar; Madassery, Joseph] Univ Calicut, Dept Biotechnol, Calicut, Kerala, India	Otto von Guericke University; University of Calicut	Pachathundikandi, SK (corresponding author), Otto Von Guericke Univ, Inst Med Microbiol, Magdeburg, Germany.	Steffen.Backert@ucd.ie	Brandt, Sabine/ABE-9674-2020		DAAD; Deutsche Forschungsgemeinschaft DFG [Ba1671/8-1]; National Institute of Diabetes and Digestive and Kidney Diseases [R56DK064371]; University College Dublin [R11408]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064371] Funding Source: NIH RePORTER	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University College Dublin; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work of SKP was supported by a DAAD Fellowship. The work of SBA is supported through grants from the Deutsche Forschungsgemeinschaft DFG grant (Ba1671/8-1), from the National Institute of Diabetes and Digestive and Kidney Diseases (R56DK064371) and from University College Dublin (R11408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Backert S, 2004, INFECT IMMUN, V72, P1043, DOI 10.1128/IAI.72.2.1043-1056.2004; Backert S, 2010, TRENDS MICROBIOL, V18, P479, DOI 10.1016/j.tim.2010.08.003; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Backhed F, 2003, J INFECT DIS, V187, P829; Bauer B, 2005, INFECT IMMUN, V73, P4643, DOI 10.1128/IAI.73.8.4643-4652.2005; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Contestabile A, 2005, J BIOL CHEM, V280, P33541, DOI 10.1074/jbc.M413323200; D'Elios MM, 2004, MICROBES INFECT, V6, P1395, DOI 10.1016/j.micinf.2004.10.001; Ding SZ, 2005, HELICOBACTER, V10, P193, DOI 10.1111/j.1523-5378.2005.00311.x; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; Fukata M, 2008, ONCOGENE, V27, P234, DOI 10.1038/sj.onc.1210908; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Gieseler S, 2005, MICROBES INFECT, V7, P437, DOI 10.1016/j.micinf.2004.11.018; Graham DY, 2004, GUT, V53, P1235, DOI 10.1136/gut.2003.037499; Hatakeyama M, 2008, CURR OPIN MICROBIOL, V11, P30, DOI 10.1016/j.mib.2007.12.003; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jimenez-Soto LF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000684; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kawahara Tsukasa, 2001, Journal of Medical Investigation, V48, P190; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Kurtoglu E, 2004, WORLD J GASTROENTERO, V10, P2113, DOI 10.3748/wjg.v10.i14.2113; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda S, 2001, J BIOL CHEM, V276, P44856, DOI 10.1074/jbc.M105381200; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Moese S, 2004, INFECT IMMUN, V72, P3646, DOI 10.1128/IAI.72.6.3646-3649.2004; Moese S, 2002, INFECT IMMUN, V70, P4687, DOI 10.1128/IAI.70.8.4687-4691.2002; Ogawa T, 2003, FEMS IMMUNOL MED MIC, V36, P1, DOI 10.1016/S0928-8244(03)00093-2; Pedron T, 2008, CELL HOST MICROBE, V3, P344, DOI 10.1016/j.chom.2008.05.010; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Rad R, 2007, GASTROENTEROLOGY, V133, P150, DOI 10.1053/j.gastro.2007.04.071; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Rothenbacher D, 2003, MICROBES INFECT, V5, P693, DOI 10.1016/S1286-4579(03)00111-4; Sayi A, 2011, J IMMUNOL, V186, P878, DOI 10.4049/jimmunol.1002269; Schmausser B, 2004, CLIN EXP IMMUNOL, V136, P521, DOI 10.1111/j.1365-2249.2004.02464.x; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; Selbach M, 2003, EMBO J, V22, P515, DOI 10.1093/emboj/cdg050; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Shaykhiev R, 2007, J LEUKOCYTE BIOL, V82, P1, DOI 10.1189/jlb.0207096; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tato CM, 2002, INFECT IMMUN, V70, P3311, DOI 10.1128/IAI.70.7.3311-3317.2002; Torok AM, 2005, INFECT IMMUN, V73, P1523, DOI 10.1128/IAI.73.3.1523-1531.2005; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Watanabe T, 2010, J CLIN INVEST, V120, P1645, DOI 10.1172/JCI39481; Wessler S, 2008, TRENDS MICROBIOL, V16, P397, DOI 10.1016/j.tim.2008.05.005; Yokota SI, 2007, FEMS IMMUNOL MED MIC, V51, P140, DOI 10.1111/j.1574-695X.2007.00288.x; Yokota S, 2010, INFECT IMMUN, V78, P468, DOI 10.1128/IAI.00903-09; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	60	71	72	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19614	10.1371/journal.pone.0019614	http://dx.doi.org/10.1371/journal.pone.0019614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573018	Green Published, gold, Green Submitted			2022-12-25	WOS:000290386800024
J	Myllymaki, SM; Teravainen, TP; Manninen, A				Myllymaki, Satu Marja; Teravainen, Terhi Piritta; Manninen, Aki			Two Distinct Integrin-Mediated Mechanisms Contribute to Apical Lumen Formation in Epithelial Cells	PLOS ONE			English	Article							BASOLATERAL PLASMA-MEMBRANE; SPINDLE ORIENTATION; RHO-FAMILY; MATRIX ADHESION; LIGAND-BINDING; CYST FORMATION; SMALL GTPASES; MDCK CELLS; CDC42 GEF; IN-VITRO	Background: Formation of apical compartments underlies the morphogenesis of most epithelial organs during development. The extracellular matrix (ECM), particularly the basement membrane (BM), plays an important role in orienting the apico-basal polarity and thereby the positioning of apical lumens. Integrins have been recognized as essential mediators of matrix-derived polarity signals. The importance of beta 1-integrins in epithelial polarization is well established but the significance of the accompanying alpha-subunits have not been analyzed in detail. Principal Findings: Here we demonstrate that two distinct integrin-dependent pathways regulate formation of apical lumens to ensure robust apical membrane biogenesis under different microenvironmental conditions; 1) alpha 2 beta 1- and alpha 6 beta 4-integrins were required to establish a basal cue that depends on Rac1-activity and guides apico-basal cell polarization. 2) alpha 3 beta 1-integrins were implicated in positioning of mitotic spindles in cysts, a process that is essential for Cdc42-driven epithelial hollowing. Significance: Identification of the separate processes driven by particular integrin receptors clarifies the functional hierarchies between the different integrins co-expressed in epithelial cells and provides valuable insight into the complexity of cell-ECM interactions thereby guiding future studies addressing the molecular basis of epithelial morphogenesis during development and disease.	[Myllymaki, Satu Marja; Teravainen, Terhi Piritta; Manninen, Aki] Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, Dept Med Biochem & Mol Biol, Oulu, Finland	University of Oulu	Myllymaki, SM (corresponding author), Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, Dept Med Biochem & Mol Biol, Oulu, Finland.	aki.manninen@oulu.fi	Manninen, Aki/AAC-8067-2019	Manninen, Aki/0000-0002-6263-8101; Myllymaki, Satu-Marja/0000-0003-0521-5062	Academy of Finland [114330]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by an Academy of Finland Grant to A.M. (114330) and by the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2006, J CELL BIOL, V173, P781, DOI 10.1083/jcb.200601059; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; CHEN FA, 1991, J EXP MED, V173, P1111, DOI 10.1084/jem.173.5.1111; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Cohen D, 2001, TRAFFIC, V2, P556, DOI 10.1034/j.1600-0854.2001.20805.x; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Ferletta M, 1999, J CELL SCI, V112, P1; Friedrichs J, 2007, J BIOL CHEM, V282, P29375, DOI 10.1074/jbc.M701867200; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; HALL DE, 1990, J CELL BIOL, V110, P2175, DOI 10.1083/jcb.110.6.2175; Hodivala-Dilke KM, 1998, J CELL BIOL, V142, P1357, DOI 10.1083/jcb.142.5.1357; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Jou TS, 1998, J CELL BIOL, V142, P85, DOI 10.1083/jcb.142.1.85; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Manninen A, 2005, MOL CELL BIOL, V25, P10087, DOI 10.1128/MCB.25.22.10087-10096.2005; Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Matlin KS, 2003, METHODS, V30, P235, DOI 10.1016/S1046-2023(03)00030-6; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Merdek KD, 2007, J BIOL CHEM, V282, P30322, DOI 10.1074/jbc.M703156200; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Nguyen BP, 2001, J BIOL CHEM, V276, P43860, DOI 10.1074/jbc.M103404200; Nievers MG, 1998, J CELL SCI, V111, P1659; Nievers MG, 2000, J CELL SCI, V113, P963; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Rasband W., 2006, IMAGEJ; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Rogers KK, 2003, KIDNEY INT, V63, P1632, DOI 10.1046/j.1523-1755.2003.00902.x; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Schuck S, 2004, P NATL ACAD SCI USA, V101, P4912, DOI 10.1073/pnas.0401285101; SCHWIMMER R, 1995, J CELL SCI, V108, P2487; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Torkko JM, 2008, J CELL SCI, V121, P1193, DOI 10.1242/jcs.015495; Wang ZM, 1999, J CELL SCI, V112, P2925; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Yu W, 2003, MOL BIOL CELL, V14, P748, DOI 10.1091/mbc.E02-06-0350; Yu W, 2008, EMBO REP, V9, P923, DOI 10.1038/embor.2008.135; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9; Zhang F, 2003, J CELL BIOL, V163, P177, DOI 10.1083/jcb.200304065; Zhou H, 2005, J BIOL CHEM, V280, P10624, DOI 10.1074/jbc.M411900200	54	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19453	10.1371/journal.pone.0019453	http://dx.doi.org/10.1371/journal.pone.0019453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573123	gold, Green Published, Green Submitted			2022-12-25	WOS:000290305600026
J	Ren, XF; Meng, FD; Yin, JC; Li, GX; Li, XL; Wang, C; Herrler, G				Ren, Xiaofeng; Meng, Fandan; Yin, Jiechao; Li, Guangxing; Li, Xunliang; Wang, Chao; Herrler, Georg			Action Mechanisms of Lithium Chloride on Cell Infection by Transmissible Gastroenteritis Coronavirus	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CASPASE-DEPENDENT APOPTOSIS; BRONCHITIS VIRUS; CULTURED-CELLS; REPLICATION; DIAMMONIUM; EXPRESSION; INDUCTION; PCR	Transmissible gastroenteritis virus (TGEV) is a porcine coronavirus. Lithium chloride (LiCl) has been found to be effective against several DNA viruses, such as Herpes simplex virus and vaccinia virus. Recently, we and others have reported the inhibitory effect of LiCl on avian infectious bronchitis coronavirus (IBV) infection, an RNA virus. In the current study, the action mechanism of LiCl on cell infection by TGEV was investigated. Plaque assays and 3-(4,5)-dimethylthiahiazo(-z-y1)-3,5di-phenyl tetrazoliumbromide (MTT) assays showed that the cell infection by TGEV was inhibited in a dose-dependent manner, when LiCl was added to virus-infected cells; the cell infection was not affected when either cells or viruses were pretreated with the drug. The inhibition of TGEV infection in vitro by LiCl was observed at different virus doses and with different cell lines. The inhibitory effect of LiCl against TGEV infection and transcription was confirmed by RT-PCR and real-time PCR targeting viral S and 3CL-protease genes. The time-of-addition effect of the drug on TGEV infection indicated that LiCl acted on the initial and late stage of TGEV infection. The production of virus was not detected at 36 h post-infection due to the drug treatment. Moreover, immunofluorescence (IF) and flow cytometry analyses based on staining of Annexin V and propidium iodide staining of nuclei indicated that early and late cell apoptosis induced by TGEV was inhibited efficiently. The ability of LiCl to inhibit apoptosis was investigated by IF analysis of caspase-3 expression. Our data indicate that LiCl inhibits TGEV infection by exerting an anti-apoptotic effect. The inhibitory effect of LiCl was also observed with porcine epidemic diarrhea coronavirus. Together with other reports concerning the inhibitory effect of lithium salts on IBV in cell culture, our results indicate that LiCl may be a potent agent against porcine and avian coronaviruses.	[Ren, Xiaofeng; Meng, Fandan; Li, Guangxing; Li, Xunliang; Wang, Chao] NE Agr Univ, Coll Vet Med, Harbin, Peoples R China; [Yin, Jiechao] NE Agr Univ, Coll Life Sci, Harbin, Peoples R China; [Herrler, Georg] Tierarztlichen Hsch Hannover, Inst Virol, D-3000 Hannover, Germany	Northeast Agricultural University - China; Northeast Agricultural University - China; University of Veterinary Medicine Hannover, Foundation	Ren, XF (corresponding author), NE Agr Univ, Coll Vet Med, Harbin, Peoples R China.	rxfemail@yahoo.com.cn			National Natural Science Foundation of China [30972195, 30700590]; Heilongjiang Provincial University [1155-NCET-005]; Ministry of Education of the People's Republic of China; Deutsche Forschungsgemeinschaft [SFB 621, TPB7]; Ministry of Education of China [NO706019]; Northeast Agricultural University, China [CXZ008-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial University; Ministry of Education of the People's Republic of China(Ministry of Education, China); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Education of China(Ministry of Education, China); Northeast Agricultural University, China	The work of X.R. is funded by the National Natural Science Foundation of China (30972195; 30700590), the Program for New Century Excellent Talents at the Heilongjiang Provincial University (1155-NCET-005), and the New Century Excellent Talents program from the Ministry of Education of the People's Republic of China. The work of G.H. was supported by Deutsche Forschungsgemeinschaft (SFB 621, TPB7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support of the Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education of China (NO706019) and Northeast Agricultural University, China (CXZ008-1).	AO Z, 2006, LIVEST POULT IND, V191, P50; Baba Chiaki, 2005, Antiviral Chemistry & Chemotherapy, V16, P33; BAI W, 2005, FUJIAN J ANIM HUSBAN, V27, P34; BURLESON FG, 1992, VIROLOGY LAB MANUAL, P74; Choi HJ, 2009, ANTIVIR RES, V81, P77, DOI 10.1016/j.antiviral.2008.10.002; Eleouet JF, 1998, J VIROL, V72, P4918, DOI 10.1128/JVI.72.6.4918-4924.1998; ENJUANES L, 1992, VET MICROBIOL, V33, P249, DOI 10.1016/0378-1135(92)90053-V; GEBAUER F, 1991, VIROLOGY, V183, P225, DOI 10.1016/0042-6822(91)90135-X; Harrison SM, 2007, AVIAN PATHOL, V36, P109, DOI 10.1080/03079450601156083; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; LAUDE H, 1993, VET RES, V24, P125; Li J, 2009, AVIAN PATHOL, V38, P215, DOI 10.1080/03079450902912184; Liu C, 2001, J VIROL, V75, P6402, DOI 10.1128/JVI.75.14.6402-6409.2001; Liu Y, 2003, J VIROL, V77, P11952, DOI 10.1128/JVI.77.22.11952-11963.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizutani T, 2004, BIOCHEM BIOPH RES CO, V319, P1228, DOI 10.1016/j.bbrc.2004.05.107; Moreno JL, 2008, J VIROL, V82, P3882, DOI 10.1128/JVI.02622-07; Muller V, 2007, PHYTOTHER RES, V21, P970, DOI 10.1002/ptr.2198; Musial BL, 2004, AM J HEALTH-SYST PH, V61, P1365, DOI 10.1093/ajhp/61.13.1365; Ni ZJ, 2004, CURR OPIN DRUG DISC, V7, P446; Penzes Z, 2001, VIRUS GENES, V23, P105, DOI 10.1023/A:1011147832586; Ren XF, 2008, VIRUS RES, V137, P220, DOI 10.1016/j.virusres.2008.07.023; Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082; Saif L.J., 1999, DIS SWINE, P295; Schwegmann-Wessels C, 2006, DEUT TIERARZTL WOCH, V113, P157; Schwegmann-Wessels C, 2003, J VIROL, V77, P11846, DOI 10.1128/JVI.77.21.11846-11848.2003; SKINNER GRB, 1980, MED MICROBIOL IMMUN, V168, P139, DOI 10.1007/BF02121762; SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939; Sui XW, 2010, ANTIVIR RES, V85, P346, DOI 10.1016/j.antiviral.2009.10.014; Suzuki K, 2008, VET MICROBIOL, V129, P390, DOI 10.1016/j.vetmic.2007.11.034; Wang S, 2003, HEBEI ANIM HUSB VET, V19, P38; Wei Y, 2001, SHANGHAI J ANIM HUSB, V4, P37; Wu CY, 2004, P NATL ACAD SCI USA, V101, P10012, DOI 10.1073/pnas.0403596101; Yang CW, 2007, ANTIMICROB AGENTS CH, V51, P3924, DOI 10.1128/AAC.00408-07; ZIAIE Z, 1989, BIOCHEM BIOPH RES CO, V160, P1073, DOI 10.1016/S0006-291X(89)80112-3	35	42	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e18669	10.1371/journal.pone.0018669	http://dx.doi.org/10.1371/journal.pone.0018669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573100	Green Submitted, Green Published, gold			2022-12-25	WOS:000290305600004
J	Saddic, LA; Wirt, S; Vogel, H; Felsher, DW; Sage, J				Saddic, Louis A.; Wirt, Stacey; Vogel, Hannes; Felsher, Dean W.; Sage, Julien			Functional Interactions between Retinoblastoma and c-MYC in a Mouse Model of Hepatocellular Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR-ALPHA; CELL-CYCLE CONTROL; TUMOR-SUPPRESSOR; HEPATITIS-B; GENOMIC INSTABILITY; TRANSGENIC MICE; PRB/E2F PATHWAY; ABERRANT PLOIDY; LIVER-CANCER; STEM-CELLS	Inactivation of the RB tumor suppressor and activation of the MYC family of oncogenes are frequent events in a large spectrum of human cancers. Loss of RB function and MYC activation are thought to control both overlapping and distinct cellular processes during cell cycle progression. However, how these two major cancer genes functionally interact during tumorigenesis is still unclear. Here, we sought to test whether loss of RB function would affect cancer development in a mouse model of c-MYC-induced hepatocellular carcinoma (HCC), a deadly cancer type in which RB is frequently inactivated and c-MYC often activated. We found that RB inactivation has minimal effects on the cell cycle, cell death, and differentiation features of liver tumors driven by increased levels of c-MYC. However, combined loss of RB and activation of c-MYC led to an increase in polyploidy in mature hepatocytes before the development of tumors. There was a trend for decreased survival in double mutant animals compared to mice developing c-MYC-induced tumors. Thus, loss of RB function does not provide a proliferative advantage to c-MYC-expressing HCC cells but the RB and c-MYC pathways may cooperate to control the polyploidy of mature hepatocytes.	[Saddic, Louis A.; Wirt, Stacey; Sage, Julien] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Saddic, Louis A.; Wirt, Stacey; Sage, Julien] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Vogel, Hannes; Felsher, Dean W.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Felsher, Dean W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Saddic, LA (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	julsage@stanford.edu		Vogel, Otto Hannes/0000-0002-0960-3508	Lucile Packard Foundation for Children's Health; NIH-NCI [RO1 CA114102]; NATIONAL CANCER INSTITUTE [R01CA114102, T32CA009302] Funding Source: NIH RePORTER	Lucile Packard Foundation for Children's Health; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Lucile Packard Foundation for Children's Health and NIH-NCI RO1 CA114102 (J.S.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouElella A, 1996, MODERN PATHOL, V9, P95; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Burkhart DL, 2010, MOL CELL BIOL, V30, P1729, DOI 10.1128/MCB.00952-09; Caldwell S, 2009, J GASTROENTEROL, V44, P96, DOI 10.1007/s00535-008-2258-6; Calvisi DF, 2004, GASTROENTEROLOGY, V126, P1374, DOI 10.1053/j.gastro.2004.02.014; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Conner EA, 2003, BIOCHEM BIOPH RES CO, V302, P114, DOI 10.1016/S0006-291X(03)00125-6; Dang CV, 1999, MOL CELL BIOL, V19, P1; Deshpande A, 2006, CURR MOL MED, V6, P809; Edamoto Y, 2003, INT J CANCER, V106, P334, DOI 10.1002/ijc.11254; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Giuriato S, 2006, P NATL ACAD SCI USA, V103, P16266, DOI 10.1073/pnas.0608017103; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; HO VM, 2009, ONCOGENE; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hsieh YH, 2007, MOL CANCER RES, V5, P1063, DOI 10.1158/1541-7786.MCR-07-0098; Iavarone A, 2004, NATURE, V432, P1040, DOI 10.1038/nature03068; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kaposi-Novak P, 2009, CANCER RES, V69, P2775, DOI 10.1158/0008-5472.CAN-08-3357; Kawate S, 1999, ONCOLOGY-BASEL, V57, P157, DOI 10.1159/000012024; Khidr L, 2006, ONCOGENE, V25, P5210, DOI 10.1038/sj.onc.1209612; Kim JW, 2010, CANCER RES, V70, P4820, DOI 10.1158/0008-5472.CAN-10-0659; KIM YJ, 2009, CANC LETT; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Knudsen ES, 2006, CURR MOL MED, V6, P749; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; MACHIDA K, 2009, J VIROL; MacPherson D, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-9; MANNING AL, 2010, GENES DEV; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Mayer RJ, 2006, BIOCHEM SOC T, V34, P746, DOI 10.1042/BST0340746; Mayhew CN, 2007, GASTROENTEROLOGY, V133, P976, DOI 10.1053/j.gastro.2007.06.025; Mayhew CN, 2005, CANCER RES, V65, P4568, DOI 10.1158/0008-5472.CAN-04-4221; McGivern DR, 2009, ANNU REV PATHOL-MECH, V4, P399, DOI 10.1146/annurev.pathol.4.110807.092202; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; MURAKAMI H, 1993, CANCER RES, V53, P1719; Nguyen DX, 2005, J CELL BIOCHEM, V94, P870, DOI 10.1002/jcb.20375; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Park SG, 2006, J BIOL CHEM, V281, P31770, DOI 10.1074/jbc.M603194200; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sage J, 2010, GENE DEV, V24, P1329, DOI 10.1101/gad.1948010; SANDGREN EP, 1989, ONCOGENE, V4, P715; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Santoni-Rugiu E, 1998, CANCER RES, V58, P123; Sargent LM, 1999, AM J PATHOL, V154, P1047, DOI 10.1016/S0002-9440(10)65357-6; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sherman M, 2010, SEMIN LIVER DIS, V30, P3, DOI 10.1055/s-0030-1247128; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Skapek SX, 2006, ONCOGENE, V25, P5268, DOI 10.1038/sj.onc.1209710; Srinivasan SV, 2007, J BIOL CHEM, V282, P23867, DOI 10.1074/jbc.M700542200; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Thomas DM, 2003, CANCER BIOL THER, V2, P124, DOI 10.4161/cbt.2.2.235; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; VANHARN T, 2010, GENES DEV; Wang WH, 2008, J BIOL CHEM, V283, P25455, DOI 10.1074/jbc.M801934200; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Zheng L, 2002, ADV CANCER RES, V85, P13, DOI 10.1016/S0065-230X(02)85002-3; Zheng L, 2002, CANCER RES, V62, P2498	78	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19758	10.1371/journal.pone.0019758	http://dx.doi.org/10.1371/journal.pone.0019758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573126	Green Published, Green Submitted, gold			2022-12-25	WOS:000290305600045
J	Mullaly, SC; Burrows, K; Antignano, F; Zaph, C				Mullaly, Sarah C.; Burrows, Kyle; Antignano, Frann; Zaph, Colby			Assessing the Role of CD103 in Immunity to an Intestinal Helminth Parasite	PLOS ONE			English	Article							REGULATORY T-CELLS; RETINOIC-ACID; DENDRITIC CELLS; TRICHURIS-MURIS; E-CADHERIN; INFECTION; DIFFERENTIATION; EXPRESSION; INTEGRIN; MICE	Background: In the intestine, the integrin CD103 is expressed on a subset of T regulatory (T(reg)) cells and a population of dendritic cells (DCs) that produce retinoic acid and promote immune homeostasis. However, the role of CD103 during intestinal helminth infection has not been tested. Methodology/Principal Findings: We demonstrate that CD103 is dispensable for the development of protective immunity to the helminth parasite Trichuris muris. While we observed an increase in the frequency of CD103(+) DCs in the lamina propria (LP) following acute high-dose infection with Trichuris, lack of CD103 had no effect on the frequency of CD11c(+) DCs in the LP or mesenteric lymph nodes (mLN). CD103-deficient (CD103(-/-)) mice develop a slightly increased and earlier T cell response but resolve infection with similar kinetics to control mice. Similarly, low-dose chronic infection of CD103(-/-) mice with Trichuris resulted in no significant difference in immunity or parasite burden. Absence of CD103 also had no effect on the frequency of CD4(+) CD25(+) Foxp3(+) Treg cells in the mLN or LP. Conclusions/Significance: These results suggest that CD103 is dispensable for intestinal immunity during helminth infection. Furthermore, lack of CD103 had no effect on DC or Treg recruitment or retention within the large intestine.	[Mullaly, Sarah C.; Burrows, Kyle; Antignano, Frann; Zaph, Colby] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Zaph, Colby] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Mullaly, SC (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	colby@brc.ubc.ca		Burrows, Kyle/0000-0001-5371-3512; Zaph, Colby/0000-0002-9889-9848; Antignano, Frann/0000-0003-0502-5330	Canadian Institutes of Health Research [MSH-95368, MOP-89773, MOP-106623]; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by the Canadian Institutes of Health Research (www.cihr.ca) (MSH-95368, MOP-89773, and MOP-106623) and the Canada Foundation for Innovation (www.innovation.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; ELSE KJ, 1991, IMMUNOLOGY, V72, P508; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Johansson-Lindbom B, 2007, IMMUNOL REV, V215, P226, DOI 10.1111/j.1600-065X.2006.00482.x; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; LOCKSLEY RM, 1993, SCIENCE, V261, P1448, DOI 10.1126/science.8367726; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nair MG, 2008, J IMMUNOL, V181, P4709, DOI 10.4049/jimmunol.181.7.4709; Schon MP, 1999, J IMMUNOL, V162, P6641; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Svensson M, 2008, MUCOSAL IMMUNOL, V1, P38, DOI 10.1038/mi.2007.4; Van den Bossche J, 2009, BLOOD, V114, P4664, DOI 10.1182/blood-2009-05-221598; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wurbel MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016442	31	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19580	10.1371/journal.pone.0019580	http://dx.doi.org/10.1371/journal.pone.0019580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573179	Green Published, Green Submitted, gold			2022-12-25	WOS:000290256400028
J	Veen, T; Faulks, J; Rodriguez-Munoz, R; Tregenza, T				Veen, Thor; Faulks, Joseph; Rodriguez-Munoz, Rolando; Tregenza, Tom			Premating Reproductive Barriers between Hybridising Cricket Species Differing in Their Degree of Polyandry	PLOS ONE			English	Article							CONSPECIFIC SPERM PRECEDENCE; GRYLLUS-FULTONI ORTHOPTERA; IN-FIELD CRICKETS; SEXUAL SELECTION; MATE CHOICE; MATING-BEHAVIOR; GENE EXCHANGE; ALLOPATRIC POPULATIONS; RAPID EVOLUTION; FEMALE CHOICE	Understanding speciation hinges on understanding how reproductive barriers arise between incompletely isolated populations. Despite their crucial role in speciation, prezygotic barriers are relatively poorly understood and hard to predict. We use two closely related cricket species, Gryllus bimaculatus and G. campestris, to experimentally investigate premating barriers during three sequential mate choice steps. Furthermore, we experimentally show a significant difference in polyandry levels between the two species and subsequently test the hypothesis that females of the more polyandrous species, G. bimaculatus, will be less discriminating against heterospecific males and hence hybridise more readily. During close-range mating behaviour experiments, males showed relatively weak species discrimination but females discriminated very strongly. In line with our predictions, this discrimination is asymmetric, with the more polyandrous G. bimaculatus mating heterospecifically and G. campestris females never mating heterospecifically. Our study shows clear differences in the strength of reproductive isolation during the mate choice process depending on sex and species, which may have important consequences for the evolution of reproductive barriers.	[Veen, Thor; Faulks, Joseph; Rodriguez-Munoz, Rolando; Tregenza, Tom] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Veen, Thor] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of Exeter; University of British Columbia	Veen, T (corresponding author), Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, Cornwall, England.	veen@biodiversity.ubc.ca	Tregenza, Tom/B-1078-2014	Tregenza, Tom/0000-0003-4182-2222	Netherlands Organisation for Scientific Research; NSERC-CREATE; Natural Environment Research Council; Natural Environment Research Council [NE/H02249X/1, NE/E005403/1] Funding Source: researchfish; NERC [NE/H02249X/1] Funding Source: UKRI	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NSERC-CREATE; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	TV was supported by a Rubicon grant from the Netherlands Organisation for Scientific Research and the NSERC-CREATE Training Program in Biodiversity Research. RR-M and TT were supported by grants from the Natural Environment Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMO SA, 1994, ANIM BEHAV, V47, P857, DOI 10.1006/anbe.1994.1117; ARNOLD ML, 1992, ANNU REV ECOL SYST, V23, P237, DOI 10.1146/annurev.es.23.110192.001321; Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; Arnqvist Goran, 2005, pUnpaginated; Birge LM, 2010, J INSECT BEHAV, V23, P268, DOI 10.1007/s10905-010-9213-0; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Bretman A, 2005, MOL ECOL, V14, P2169, DOI 10.1111/j.1365-294X.2005.02556.x; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; Coyne JA, 2004, SPECIATION, V37; Crawley MJ., 2007, R BOOK; Gangwere S. K., 1992, EOS-Revista Espanola de Entomologia, V68, P51; Gavrilets S, 2005, EVOL ECOL, V19, P167, DOI 10.1007/s10682-004-7916-4; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Gray DA, 2005, BEHAV ECOL, V16, P201, DOI 10.1093/beheco/arh144; Gray DA, 2000, P NATL ACAD SCI USA, V97, P14449, DOI 10.1073/pnas.97.26.14449; HARRISON RG, 1985, EVOLUTION, V39, P244, DOI 10.1111/j.1558-5646.1985.tb05664.x; HARRISON RG, 1983, EVOLUTION, V37, P245, DOI 10.1111/j.1558-5646.1983.tb05534.x; Hedwig B, 2005, J EXP BIOL, V208, P915, DOI 10.1242/jeb.01452; Howard DJ, 1998, EVOLUTION, V52, P511, DOI 10.1111/j.1558-5646.1998.tb01650.x; Izzo AS, 2011, ANIM BEHAV, V81, P259, DOI 10.1016/j.anbehav.2010.10.015; Jang Y, 2006, J EVOLUTION BIOL, V19, P459, DOI 10.1111/j.1420-9101.2005.01014.x; Jang Y, 2007, ETHOLOGY, V113, P87, DOI 10.1111/j.1439-0310.2006.01304.x; Jang Y, 2006, BEHAV ECOL SOCIOBIOL, V60, P150, DOI 10.1007/s00265-005-0151-3; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; Lemmon EM, 2010, EVOLUTION, V64, P1748, DOI 10.1111/j.1558-5646.2010.00955.x; Leonard AS, 2009, ANIM BEHAV, V77, P151, DOI 10.1016/j.anbehav.2008.09.029; Linder HP, 1996, OECOLOGIA, V108, P85, DOI 10.1007/BF00333218; Maroja LS, 2009, BIOL J LINN SOC, V97, P390, DOI 10.1111/j.1095-8312.2009.01201.x; Mendelson TC, 2007, EVOLUTION, V61, P2596, DOI 10.1111/j.1558-5646.2007.00220.x; Mendelson TC, 2002, GENETICA, V116, P301, DOI 10.1023/A:1021244812270; Mullen SP, 2007, EVOLUTION, V61, P223, DOI 10.1111/j.1558-5646.2007.00019.x; Munoz AG, 2010, J EVOLUTION BIOL, V23, P1312, DOI 10.1111/j.1420-9101.2010.02001.x; ORR HA, 1995, GENETICS, V139, P1805; Orr MR, 1996, EVOLUTION, V50, P704, DOI 10.1111/j.1558-5646.1996.tb03880.x; Pardo J.E., 1993, Zoologica Baetica, V4, P113; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Pfennig KS, 1998, P ROY SOC B-BIOL SCI, V265, P1743, DOI 10.1098/rspb.1998.0497; Pfennig KS, 2000, BEHAV ECOL, V11, P220, DOI 10.1093/beheco/11.2.220; Price CSC, 1997, NATURE, V388, P663, DOI 10.1038/41753; Price T, 2007, SPECIATION BIRDS; Price TD, 2002, EVOLUTION, V56, P2083; R Core Team, 2022, R LANG ENV STAT COMP; Ramsey J, 2003, EVOLUTION, V57, P1520, DOI 10.1111/j.0014-3820.2003.tb00360.x; Rodriguez-Munoz R, 2010, SCIENCE, V328, P1269, DOI 10.1126/science.1188102; Ross CL, 2002, EVOLUTION, V56, P2296, DOI 10.1111/j.0014-3820.2002.tb00153.x; ROST R, 1987, BEHAV ECOL SOCIOBIOL, V21, P279, DOI 10.1007/BF00299965; Ryan MJ, 2003, AM NAT, V161, P380, DOI 10.1086/367588; RYAN MJ, 1993, PHILOS T ROY SOC B, V340, P187, DOI 10.1098/rstb.1993.0057; Seehausen O, 1998, BEHAV ECOL SOCIOBIOL, V42, P1, DOI 10.1007/s002650050405; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Simmons LW, 2001, EVOLUTION, V55, P1386, DOI 10.1111/j.0014-3820.2001.tb00660.x; Simmons LW, 1996, P ROY SOC B-BIOL SCI, V263, P1305, DOI 10.1098/rspb.1996.0191; Svedin N, 2008, P ROY SOC B-BIOL SCI, V275, P735, DOI 10.1098/rspb.2007.0967; THORSON J, 1982, J COMP PHYSIOL, V146, P361, DOI 10.1007/BF00612706; Tregenza T, 1998, EVOLUTION, V52, P1726, DOI [10.1111/j.1558-5646.1998.tb02252.x, 10.2307/2411345]; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; Veen T, 2009, BEHAV ECOL SOCIOBIOL, V63, P329, DOI 10.1007/s00265-008-0665-6; VONHORMANNHECK S, 1995, Z TIERPSYCHOL, V14, P137; Ward PI, 2007, ADV STUD BEHAV, V37, P343, DOI 10.1016/S0065-3454(07)37007-1; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144; Zuk Marlene, 1997, P89, DOI 10.1017/CBO9780511721946.006	62	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19531	10.1371/journal.pone.0019531	http://dx.doi.org/10.1371/journal.pone.0019531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573165	Green Submitted, Green Published, gold			2022-12-25	WOS:000290256400018
J	Batard, E; Jamme, F; Villette, S; Jacqueline, C; de la Cochetiere, MF; Caillon, J; Refregiers, M				Batard, Eric; Jamme, Frederic; Villette, Sandrine; Jacqueline, Cedric; de la Cochetiere, Marie-France; Caillon, Jocelyne; Refregiers, Matthieu			Diffusion of Ofloxacin in the Endocarditis Vegetation Assessed with Synchrotron Radiation UV Fluorescence Microspectrocopy	PLOS ONE			English	Article							CARDIAC VEGETATIONS; PENETRATION; CIPROFLOXACIN; PEFLOXACIN; EFFICACY; BIOFILMS	The diffusion of antibiotics in endocarditis vegetation bacterial masses has not been described, although it may influence the efficacy of antibiotic therapy in endocarditis. The objective of this work was to assess the diffusion of ofloxacin in experimental endocarditis vegetation bacterial masses using synchrotron-radiation UV fluorescence microspectroscopy. Streptococcal endocarditis was induced in 5 rabbits. Three animals received an unique IV injection of 150 mg/kg ofloxacin, and 2 control rabbits were left untreated. Two fluorescence microscopes were coupled to a synchrotron beam for excitation at 275 nm. A spectral microscope collected fluorescence spectra between 285 and 550 nm. A second, full field microscope was used with bandpass filters at 510-560 nm. Spectra of ofloxacin-treated vegetations presented higher fluorescence between 390 and 540 nm than control. Full field imaging showed that ofloxacin increased fluorescence between 510 and 560 nm. Ofloxacin diffused into vegetation bacterial masses, although it accumulated in their immediate neighborhood. Fluorescence images additionally suggested an ofloxacin concentration gradient between the vegetation peripheral and central areas. In conclusion, ofloxacin diffuses into vegetation bacterial masses, but it accumulates in their immediate neighborhood. Synchrotron radiation UV fluorescence microscopy is a new tool for assessment of antibiotic diffusion in the endocarditis vegetation bacterial masses.	[Batard, Eric; Jacqueline, Cedric; de la Cochetiere, Marie-France; Caillon, Jocelyne] Univ Nantes, Therapeut Clin & Expt Infect EA3826, Nantes, France; [Jamme, Frederic; Refregiers, Matthieu] Synchrotron Soleil, Disco Beamline, St Aubin, France; [Jamme, Frederic] INRA, CEPIA, F-44026 Nantes, France; [Villette, Sandrine] CNRS, Ctr Biophys Mol UPR 4301, Orleans, France	Nantes Universite; SOLEIL Synchrotron; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Batard, E (corresponding author), Univ Nantes, Therapeut Clin & Expt Infect EA3826, Nantes, France.	eric.batard@chu-nantes.fr	CAILLON, Jocelyne/AAF-8179-2020; Réfrégiers, Matthieu/AAE-2075-2022; Jacqueline, Cédric/G-5650-2010; JAMME, Frederic/E-2170-2011; Réfrégiers, Matthieu/A-4249-2011	Jacqueline, Cédric/0000-0001-9606-5930; JAMME, Frederic/0000-0002-7398-7868; Réfrégiers, Matthieu/0000-0002-3281-2308; Batard, Eric/0000-0002-1927-228X	Synchrotron SOLEIL [20090085, 20090754]	Synchrotron SOLEIL	This work was partly funded by Synchrotron SOLEIL (grants #20090085 and #20090754). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Batard E, 2010, APPL SPECTROSC, V64, P901, DOI 10.1366/000370210792081172; CREMIEUX AC, 1989, J INFECT DIS, V159, P938, DOI 10.1093/infdis/159.5.938; Drakopoulos AI, 1997, ANAL CHIM ACTA, V354, P197, DOI 10.1016/S0003-2670(97)00465-0; FANTIN B, 1994, ANTIMICROB AGENTS CH, V38, P432, DOI 10.1128/AAC.38.3.432; FOWLER VG, 2009, PRINCIPLES PRACTICE, P1067; Giuliani A, 2009, J SYNCHROTRON RADIAT, V16, P835, DOI 10.1107/S0909049509034049; JAMME F, 2010, MICROSC MICROANAL, V25, P1; Jefferson KK, 2005, ANTIMICROB AGENTS CH, V49, P2467, DOI 10.1128/AAC.49.6.2467-2473.2005; KAATZ GW, 1990, ANTIMICROB AGENTS CH, V34, P257, DOI 10.1128/AAC.34.2.257; Lefort AS, 2003, ANTIMICROB AGENTS CH, V47, P216, DOI 10.1128/AAC.47.1.216-222.2003; MERTES PM, 1992, ANTIMICROB AGENTS CH, V36, P2493, DOI 10.1128/AAC.36.11.2493; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Papadakis JA, 2000, CHEMOTHERAPY, V46, P116, DOI 10.1159/000007265; Pautke C, 2010, J ANAT, V217, P76, DOI 10.1111/j.1469-7580.2010.01237.x; Saleh-Mghir A, 1999, ANTIMICROB AGENTS CH, V43, P115, DOI 10.1128/AAC.43.1.115; Stewart PS, 2009, ANTIMICROB AGENTS CH, V53, P3505, DOI 10.1128/AAC.01728-08; Stone G, 2002, ANTIMICROB AGENTS CH, V46, P2458, DOI 10.1128/AAC.46.8.2458-2461.2002; Wagnieres GA, 1998, PHOTOCHEM PHOTOBIOL, V68, P603	18	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19440	10.1371/journal.pone.0019440	http://dx.doi.org/10.1371/journal.pone.0019440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559378	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700171
J	Srivastava, P; Mehrotra, S; Tiwary, P; Chakravarty, J; Sundar, S				Srivastava, Pankaj; Mehrotra, Sanjana; Tiwary, Puja; Chakravarty, Jaya; Sundar, Shyam			Diagnosis of Indian Visceral Leishmaniasis by Nucleic Acid Detection Using PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; KALA-AZAR PATIENTS; CLINICAL-SAMPLES; NASBA-OLIGOCHROMATOGRAPHY; OLIGOC-TEST; STRIP TEST; IDENTIFICATION; BLOOD; DONOVANI; SUDAN	Background: PCR based diagnosis for Visceral Leishmaniasis (VL), despite numerous published primers, remains far from being applied in the field. The present study was planned to design a Leishmania specific diagnostic assay and to evaluate its sensitivity and specificity on a sample size, which to the best of our knowledge is the largest ever screened in one study. Methods: Leishmania specific primers were developed using 18S rRNA gene and their sensitivity was evaluated on 500 parasitologically confirmed patients with VL and 25 Post Kala-azar Dermal Leishmaniasis (PKDL) patients. Specificity was calculated on 250 healthy endemic controls, 250 healthy non endemic controls and 250 non leishmanial diseases like malaria. Results: Our PCR assay had a sensitivity of 87.8% (95% CI: 84.1-89.8) using 200 mu L of patient's peripheral-blood. Specificity was absolute in non-endemic healthy controls and in subjects with different diseases while in endemic controls it was 84% (95% CI: 78.9-88.0). Its overall specificity was 94.6% (95% CI-92.8-96.1). Conclusions: The PCR assay developed is sensitive enough to detect the 18S rRNA gene in an amount equivalent to a single parasite or less in a one million human cell environment. The high sensitivity of this PCR diagnostic test with relatively non-invasive peripheral blood sampling method opens up the possibility of its deployment in field for the routine diagnosis of VL.	[Srivastava, Pankaj; Mehrotra, Sanjana; Tiwary, Puja; Chakravarty, Jaya; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Infect Dis Res Lab, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Srivastava, P (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Med, Infect Dis Res Lab, Varanasi 221005, Uttar Pradesh, India.	drshyamsundar@hotmail.com	TIWARY, PUJA/F-3395-2012	TIWARY, PUJA/0000-0002-8180-2739	Indian Council for Medical Research and NIAID, NIH TMRC [1P50AI074321]; Council of Scientific and Industrial Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI074321] Funding Source: NIH RePORTER	Indian Council for Medical Research and NIAID, NIH TMRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Indian Council for Medical Research and NIAID, NIH TMRC Grant No. 1P50AI074321 for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank KAMRC, Sitaram Memorial Trust, Muzaffarpur, Bihar, India, for their constant support in conducting this study. Author SM is thankful to Council of Scientific and Industrial Research for financial support.	Adhya S, 1995, T ROY SOC TROP MED H, V89, P622, DOI 10.1016/0035-9203(95)90416-6; Basiye FL, 2010, TROP MED INT HEALTH, V15, P806, DOI 10.1111/j.1365-3156.2010.02548.x; Chiurillo MA, 2001, AM J TROP MED HYG, V65, P573; CHULAY JD, 1983, AM J TROP MED HYG, V32, P475, DOI 10.4269/ajtmh.1983.32.475; Deborggraeve S, 2008, J INFECT DIS, V198, P1565, DOI 10.1086/592509; Dujardin J C, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS81, DOI 10.1016/S0035-9203(02)90056-8; le Fichoux Y, 1999, J CLIN MICROBIOL, V37, P1953, DOI 10.1128/JCM.37.6.1953-1957.1999; Maurya R, 2005, J CLIN MICROBIOL, V43, P3038, DOI 10.1128/JCM.43.7.3038-3041.2005; Minodier P, 1997, J CLIN MICROBIOL, V35, P2551, DOI 10.1128/JCM.35.10.2551-2555.1997; Mugasa CM, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-13; Noyes HA, 1998, J CLIN MICROBIOL, V36, P2877, DOI 10.1128/JCM.36.10.2877-2881.1998; Ramos A, 1996, EXP PARASITOL, V82, P242, DOI 10.1006/expr.1996.0031; Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06; Saad AA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000776; Salotra P, 2001, J CLIN MICROBIOL, V39, P849, DOI 10.1128/JCM.39.3.849-854.2001; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; SMYTH AJ, 1992, PARASITOLOGY, V105, P183, DOI 10.1017/S0031182000074096; Sundar S, 1998, LANCET, V351, P563, DOI 10.1016/S0140-6736(97)04350-X; Sundar S, 2006, T ROY SOC TROP MED H, V100, P533, DOI 10.1016/j.trstmh.2005.08.018; Sundar S, 2002, CLIN DIAGN LAB IMMUN, V9, P951, DOI 10.1128/CDLI.9.5.951-958.2002; Topno RK, 2010, AM J TROP MED HYG, V83, P502, DOI 10.4269/ajtmh.2010.09-0345; VANEYS GJJM, 1992, MOL BIOCHEM PARASIT, V51, P133, DOI 10.1016/0166-6851(92)90208-2; Zijlstra EE, 2001, TROP MED INT HEALTH, V6, P108, DOI 10.1046/j.1365-3156.2001.00680.x	23	44	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19304	10.1371/journal.pone.0019304	http://dx.doi.org/10.1371/journal.pone.0019304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559398	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700128
J	Wong, RCB; Ibrahim, A; Fong, H; Thompson, N; Lock, LF; Donovan, PJ				Wong, Raymond Ching-Bong; Ibrahim, Abel; Fong, Helen; Thompson, Noelle; Lock, Leslie F.; Donovan, Peter J.			L1TD1 Is a Marker for Undifferentiated Human Embryonic Stem Cells	PLOS ONE			English	Article							ORF1 PROTEIN; RNA INTERFERENCE; LINE-1 RETROTRANSPOSITION; TRANSPOSABLE ELEMENT; CHAPERONE ACTIVITY; HUMAN BLASTOCYSTS; SELF-RENEWAL; IN-VITRO; DIFFERENTIATION; BINDING	Background: Human embryonic stem cells (hESC) are stem cells capable of differentiating into cells representative of the three primary embryonic germ layers. There has been considerable interest in understanding the mechanisms regulating stem cell pluripotency, which will ultimately lead to development of more efficient methods to derive and culture hESC. In particular, Oct4, Sox2 and Nanog are transcription factors known to be important in maintenance of hESC. However, many of the downstream targets of these transcription factors are not well characterized. Furthermore, it remains unknown whether additional novel stem cell factors are involved in the establishment and maintenance of the stem cell state. Methodology/Principal Findings: Here we show that a novel gene, L1TD1 (also known as FLJ10884 or ECAT11), is abundantly expressed in undifferentiated hESC. Differentiation of hESC via embryoid body (EB) formation or BMP4 treatment results in the rapid down-regulation of L1TD1 expression. Furthermore, populations of undifferentiated and differentiated hESC were sorted using the stem cell markers SSEA4 and TRA160. Our results show that L1TD1 is enriched in the SSEA4-positive or TRA160-positive population of hESC. Using chromatin immunoprecipitation we found enriched association of Nanog to the predicted promoter region of L1TD1. Furthermore, siRNA-mediated knockdown of Nanog in hESC also resulted in downregulation of L1TD1 expression. Finally, using luciferase reporter assay we demonstrated that Nanog can activate the L1TD1 upstream promoter region. Altogether, these results provide evidence that L1TD1 is a downstream target of Nanog. Conclusion/Significance: Taken together, our results suggest that L1TD1 is a downstream target of Nanog and represents a useful marker for identifying undifferentiated hESC.	[Wong, Raymond Ching-Bong; Ibrahim, Abel; Fong, Helen; Thompson, Noelle; Lock, Leslie F.; Donovan, Peter J.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Lock, Leslie F.; Donovan, Peter J.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Wong, Raymond Ching-Bong; Ibrahim, Abel; Fong, Helen; Thompson, Noelle; Lock, Leslie F.; Donovan, Peter J.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Wong, RCB (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA.	pdonovan@uci.edu		Wong, Raymond Ching-Bong/0000-0002-8092-9455; Maheswara Reddy, Emani/0000-0002-3455-1818	California Institute of Regenerative Medicine [T1-00008, TG2-01152, RCI-00110]; University of California; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); University of California(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the California Institute of Regenerative Medicine (http://www.cirm.ca.gov/; T1-00008 for RC-BW and HF, TG2-01152 for NT, RCI-00110 to PJD) and the University of California Irvine startup funds to LFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; Hohenstein KA, 2008, STEM CELLS, V26, P1436, DOI 10.1634/stemcells.2007-0857; Hohjoh H, 1997, EMBO J, V16, P6034, DOI 10.1093/emboj/16.19.6034; HOLMES SE, 1992, J BIOL CHEM, V267, P19765; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Kolosha VO, 2003, J BIOL CHEM, V278, P8112, DOI 10.1074/jbc.M210487200; Laslett AL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-12; Levine AJ, 2006, DEVELOPMENT, V133, P209, DOI 10.1242/dev.02192; Martin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/45621; Martin SL, 2005, J MOL BIOL, V348, P549, DOI 10.1016/j.jmb.2005.03.003; Martin SL, 2001, MOL CELL BIOL, V21, P467, DOI 10.1128/MCB.21.2.467-475.2001; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wong RCB, 2007, STEM CELLS DEV, V16, P989, DOI 10.1089/scd.2007.0057; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	32	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19355	10.1371/journal.pone.0019355	http://dx.doi.org/10.1371/journal.pone.0019355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559406	Green Published, gold			2022-12-25	WOS:000290024700146
J	Fratini, E; Licursi, V; Artibani, M; Kobos, K; Colautti, P; Negri, R; Amendola, R				Fratini, Emiliano; Licursi, Valerio; Artibani, Mara; Kobos, Katarzyna; Colautti, Paolo; Negri, Rodolfo; Amendola, Roberto			Dose-Dependent Onset of Regenerative Program in Neutron Irradiated Mouse Skin	PLOS ONE			English	Article							GENE-EXPRESSION CHANGES; LINEAR NO-THRESHOLD; IONIZING-RADIATION; IN-VIVO; EPIDERMAL DIFFERENTIATION; HUMAN KERATINOCYTES; MICROARRAY ANALYSIS; OXIDATIVE-METABOLISM; HUMAN FIBROBLASTS; CANCER-RISKS	Background: Tissue response to irradiation is not easily recapitulated by cell culture studies. The objective of this investigation was to characterize, the transcriptional response and the onset of regenerative processes in mouse skin irradiated with different doses of fast neutrons. Methodology/Principal Findings: To monitor general response to irradiation and individual animal to animal variation, we performed gene and protein expression analysis with both pooled and individual mouse samples. A high-throughput gene expression analysis, by DNA oligonucleotide microarray was done with three months old C57Bl/6 mice irradiated with 0.2 and 1 Gy of mono-energetic 14 MeV neutron compared to sham irradiated controls. The results on 440 irradiation modulated genes, partially validated by quantitative real time RT-PCR, showed a dose-dependent up-regulation of a subclass of keratin and keratin associated proteins, and members of the S100 family of Ca2+-binding proteins. Immunohistochemistry confirmed mRNA expression data enabled mapping of protein expression. Interestingly, proteins up-regulated in thickening epidermis: keratin 6 and S100A8 showed the most significant up-regulation and the least mouse-to-mouse variation following 0.2 Gy irradiation, in a concerted effort toward skin tissue regeneration. Conversely, mice irradiated at 1 Gy showed most evidence of apoptosis (Caspase-3 and TUNEL staining) and most 8-oxo-G accumulation at 24 h post-irradiation. Moreover, no cell proliferation accompanied 1 Gy exposure as shown by Ki67 immunohistochemistry. Conclusions/Significance: The dose-dependent differential gene expression at the tissue level following in vivo exposure to neutron radiation is reminiscent of the onset of re-epithelialization and wound healing and depends on the proportion of cells carrying multiple chromosomal lesions in the entire tissue. Thus, this study presents in vivo evidence of a skin regenerative program exerted independently from DNA repair-associated pathways.	[Fratini, Emiliano; Artibani, Mara; Kobos, Katarzyna; Amendola, Roberto] ENEA, Agenzia Nazl Nuove tecnol, Rome, Italy; [Licursi, Valerio; Negri, Rodolfo] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, Rome, Italy; [Colautti, Paolo] Ist Nazl Fis Nucl, Lab Nazl Legnaro, I-35020 Legnaro, Italy; [Negri, Rodolfo] Ist Pasteur Fdn Cenci Bolognetti, Rome, Italy	Italian National Agency New Technical Energy & Sustainable Economics Development; Sapienza University Rome; Istituto Nazionale di Fisica Nucleare (INFN); Fondazione Cenci Bolognetti	Fratini, E (corresponding author), ENEA, Agenzia Nazl Nuove tecnol, Rome, Italy.	roberto.amendola@enea.it	Fratini, Emiliano/C-3604-2014; Amendola, Roberto/AAM-2034-2020	Fratini, Emiliano/0000-0003-2522-1718; Artibani, Mara/0000-0002-4780-3199; Licursi, Valerio/0000-0002-8172-1437	Italian Space Agency (ASI)	Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI))	This study was partially funded by Italian Space Agency (ASI, www.asi.it). ASI had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amundson SA, 2004, CANCER RES, V64, P6368, DOI 10.1158/0008-5472.CAN-04-1883; Amundson SA, 2001, RADIAT RES, V156, P657, DOI 10.1667/0033-7587(2001)156[0657:IOGEAA]2.0.CO;2; Archambeau JO, 2004, INT J RADIAT ONCOL, V60, P351, DOI 10.1016/j.ijrobp.2004.04.050; Azzam EI, 2002, CANCER RES, V62, P5436; BENTZEN SM, 1993, EUR J CANCER, V29A, P1373, DOI 10.1016/0959-8049(93)90004-Y; Berglund SR, 2008, INT J RADIAT ONCOL, V70, P229, DOI 10.1016/j.ijrobp.2007.09.026; Bhogal N, 2010, RADIAT RES, V173, P1, DOI 10.1667/RR1851.1; Bittner N, 2008, INT J RADIAT ONCOL, V72, P410, DOI 10.1016/j.ijrobp.2008.01.016; Blakely WF, 2001, RADIAT PROT DOSIM, V97, P17, DOI 10.1093/oxfordjournals.rpd.a006633; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brenner DJ, 2006, RADIAT ENVIRON BIOPH, V44, P253, DOI 10.1007/s00411-006-0029-4; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Broome AM, 2003, J HISTOCHEM CYTOCHEM, V51, P675, DOI 10.1177/002215540305100513; Caswell RS, 1974, P 4 S MICR LUX COMM, V5452, P967; CECIL FE, 1984, PHYS REV LETT, V53, P767, DOI 10.1103/PhysRevLett.53.767; Chen XF, 2002, CANCER RES, V62, P1213; COHEN L, 1982, ANNU REV BIOPHYS BIO, V11, P359, DOI 10.1146/annurev.bb.11.060182.002043; Dainiak N, 2002, EXP HEMATOL, V30, P513, DOI 10.1016/S0301-472X(02)00802-0; de Toledo SM, 2006, RADIAT RES, V166, P849, DOI 10.1667/RR0640.1; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Ding LH, 2005, RADIAT RES, V164, P523, DOI 10.1667/RR3350.1; Douglas JG, 2003, ARCH OTOLARYNGOL, V129, P944, DOI 10.1001/archotol.129.9.944; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Goldberg Z, 2006, CLIN CANCER RES, V12, P3723, DOI 10.1158/1078-0432.CCR-05-2625; Gollapalle E, 2007, RADIAT RES, V167, P207, DOI 10.1667/RR0659.1; Grimbaldeston MA, 2003, J INVEST DERMATOL, V121, P1168, DOI 10.1046/j.1523-1747.2003.12561.x; Hammer GP, 2009, RADIAT PROT DOSIM, V136, P232, DOI 10.1093/rpd/ncp125; Hanselmann C, 2001, BIOCHEM J, V353, P459, DOI 10.1042/0264-6021:3530459; HENDRY JH, 1982, INT J RADIAT BIOL, V42, P611, DOI 10.1080/09553008214551591; Horstmann M, 2005, RADIAT ENVIRON BIOPH, V44, P219, DOI 10.1007/s00411-005-0017-0; Kis E, 2006, INT J RADIAT ONCOL, V66, P1506, DOI 10.1016/j.ijrobp.2006.08.004; Koike M, 2005, J RADIAT RES, V46, P173, DOI 10.1269/jrr.46.173; Lee YM, 2009, ARCH DERMATOL RES, V301, P523, DOI 10.1007/s00403-009-0960-8; Lee YS, 2008, J DERMATOL SCI, V51, P11, DOI 10.1016/j.jdermsci.2008.01.003; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; MARTONE M, 1994, J NUCL MATER, V212, P1661, DOI 10.1016/0022-3115(94)91109-6; McGowan K, 1998, Subcell Biochem, V31, P173; Meineke V, 2003, MIL MED, V168, P219, DOI 10.1093/milmed/168.3.219; Meineke V, 2005, BJR S, V27, P85; MENZEL HG, 1994, RADIAT PROT DOSIM, V52, P1; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Mothersill C, 2006, MUTAT RES-FUND MOL M, V597, P5, DOI 10.1016/j.mrfmmm.2005.10.011; Muller K, 2006, BRIT J DERMATOL, V155, P670, DOI 10.1111/j.1365-2133.2006.07407.x; Muller K, 2007, EXP HEMATOL, V35, P96, DOI 10.1016/j.exphem.2007.01.017; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; PAPAIOANNOU VE, 1993, LAB ANIM SCI, V43, P189; Peter RU, 1994, ADV TREATMENT RAD IN, P237; Ponten F, 2001, JNCI-J NATL CANCER I, V93, P128, DOI 10.1093/jnci/93.2.128; Prise KM, 2006, OCCUP MED-OXFORD, V56, P156, DOI 10.1093/occmed/kql010; Prise KM, 2005, LANCET ONCOL, V6, P520, DOI 10.1016/S1470-2045(05)70246-1; Romano S, 2009, CELL DEATH DIFFER, V17, P1; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sandberg R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r65; Santanam L, 2007, INT J RADIAT ONCOL, V68, P1546, DOI 10.1016/j.ijrobp.2007.04.040; Schalla S, 1998, STRAHLENTHER ONKOL, V174, P204, DOI 10.1007/BF03038528; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Smiley AK, 2005, J INVEST DERMATOL, V125, P1286, DOI 10.1111/j.0022-202X.2005.23971.x; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Srdoc D, 1996, RADIAT RES, V146, P466, DOI 10.2307/3579309; Stelzer KJ, 2008, NEURO-ONCOLOGY, V10, P88, DOI 10.1215/15228517-2007-044; Su YR, 2010, EXP DERMATOL, V19, pE16, DOI 10.1111/j.1600-0625.2009.00945.x; Sugiura H, 2005, BRIT J DERMATOL, V152, P146, DOI 10.1111/J.1365-2133.2005.06352.X; Sun T, 2006, J BIOTECHNOL, V122, P372, DOI 10.1016/j.jbiotec.2005.12.021; Thorey IS, 2001, J BIOL CHEM, V276, P35818, DOI 10.1074/jbc.M104871200; Tubiana M, 2006, J RADIOL PROT, V26, P317, DOI 10.1088/0952-4746/26/3/N01; Tubiana M, 2004, LANCET, V363, P1908, DOI 10.1016/S0140-6736(04)16370-8; TUCKER SL, 1992, EUR J CANCER, V28A, P1783, DOI 10.1016/0959-8049(92)90004-L; Warters RL, 2009, RADIAT RES, V172, P82, DOI 10.1667/RR1677.1; Xue L, 2009, MUTAT RES-FUND MOL M, V670, P15, DOI 10.1016/j.mrfmmm.2009.06.016; Zhang YR, 1997, RADIAT RES, V148, P81, DOI 10.2307/3579541	72	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19242	10.1371/journal.pone.0019242	http://dx.doi.org/10.1371/journal.pone.0019242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556364	Green Published, Green Submitted, gold			2022-12-25	WOS:000290019400040
J	Zheng, YX; Yin, HY; Boeglin, WE; Elias, PM; Crumrine, D; Beier, DR; Brash, AR				Zheng, Yuxiang; Yin, Huiyong; Boeglin, William E.; Elias, Peter M.; Crumrine, Debra; Beier, David R.; Brash, Alan R.			Lipoxygenases Mediate the Effect of Essential Fatty Acid in Skin Barrier Formation A PROPOSED ROLE IN RELEASING OMEGA-HYDROXYCERAMIDE FOR CONSTRUCTION OF THE CORNEOCYTE LIPID ENVELOPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL PERMEABILITY BARRIER; STRATUM-CORNEUM; LINOLEIC-ACID; MAMMALIAN EPIDERMIS; LIPID ENVELOPE; PIG EPIDERMIS; 12R-LIPOXYGENASE; DEFICIENCY; METABOLISM; CERAMIDES	A barrier to water loss is vital to maintaining life on dry land. Formation of the mammalian skin barrier requires both the essential fatty acid linoleate and the two lipoxygenases 12R-lipoxygenase (12R-LOX) and epidermal lipoxygenase-3 (eLOX3), although their roles are poorly understood. Linoleate occurs in O-linoleoyl-omega-hydroxyceramide, which, after hydrolysis of the linoleate moiety, is covalently attached to protein via the free omega-hydroxyl of the ceramide, forming the corneocyte lipid envelope, a scaffold between lipid and protein that helps seal the barrier. Here we show using HPLC-UV, LC-MS, GC-MS, and H-1 NMR that O-linoleoyl-omega-hydroxyceramide is oxygenated in a regio- and stereospecific fashion by the consecutive actions of 12R-LOX and eLOX3 and that these products occur naturally in pig and mouse epidermis. 12R-LOX forms 9R-hydroperoxy-linoleoyl-omega-hydroxyceramide, further converted by eLOX3 to specific epoxyalcohol (9R, 10R-trans-epoxy-11E-13R-hydroxy) and 9-keto-10E, 12Z esters of the ceramide; an epoxy-ketone derivative (9R, 10R-trans-epoxy-11E-13-keto) is the most prominent oxidized ceramide in mouse skin. These products are absent in 12R-LOX-deficient mice, which crucially display a near total absence of protein-bound omega-hydroxyceramides and of the corneocyte lipid envelope and die shortly after birth from transepidermal water loss. We conclude that oxygenation of O-linoleoyl-omega-hydroxyceramide is required to facilitate the ester hydrolysis and allow bonding of the omega-hydroxyceramide to protein, providing a coherent explanation for the roles of multiple components in epidermal barrier function. Our study uncovers a hitherto unknown biochemical pathway in which the enzymic oxygenation of ceramides is involved in building a crucial structure of the epidermal barrier.	[Zheng, Yuxiang; Yin, Huiyong; Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; [Zheng, Yuxiang; Yin, Huiyong; Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Sch Med, Nashville, TN 37232 USA; [Elias, Peter M.; Crumrine, Debra] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94122 USA; [Beier, David R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA	Vanderbilt University; Vanderbilt University; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Brash, AR (corresponding author), Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA.	alan.brash@vanderbilt.edu		yin, hui yong/0000-0001-7049-1560	National Institutes of Health [AR051968, AR019098, HD36404]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051968, R01AR019098, R01AR061106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR051968 (to A. R. B.), AR019098 (to P. M. E.), and HD36404 (to D. R. B.).	Akiyama M, 2008, EXP DERMATOL, V17, P373, DOI 10.1111/j.1600-0625.2007.00691.x; Behne M, 2000, J INVEST DERMATOL, V114, P185, DOI 10.1046/j.1523-1747.2000.00846.x; Belkner J, 2000, BIOCHEM J, V352, P125, DOI 10.1042/0264-6021:3520125; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boeglin WE, 1998, P NATL ACAD SCI USA, V95, P6744, DOI 10.1073/pnas.95.12.6744; Bouwstra JA, 2002, J INVEST DERMATOL, V118, P606, DOI 10.1046/j.1523-1747.2002.01706.x; Brash AR, 2007, FEBS J, V274, P3494, DOI 10.1111/j.1742-4658.2007.05909.x; Burr GO, 1929, J BIOL CHEM, V82, P345; Butovich IA, 2001, BBA-PROTEIN STRUCT M, V1546, P379, DOI 10.1016/S0167-4838(01)00162-5; Chang MS, 1996, BIOCHEMISTRY-US, V35, P464, DOI 10.1021/bi952081v; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Doering T, 2002, J LIPID RES, V43, P1727, DOI 10.1194/jlr.M200208-JLR200; DOWNING DT, 1992, J LIPID RES, V33, P301; Elias PM, 2005, J INVEST DERMATOL, V125, P183, DOI 10.1111/j.0022-202X.2005.23668.x; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; Farwanah H, 2005, ANAL BIOANAL CHEM, V383, P632, DOI 10.1007/s00216-005-0044-3; FEUSSNER I, 1995, P NATL ACAD SCI USA, V92, P11849, DOI 10.1073/pnas.92.25.11849; Fischer J, 2009, J INVEST DERMATOL, V129, P1319, DOI 10.1038/jid.2009.57; GALLIARD T, 1971, BIOCHEM J, V124, P431, DOI 10.1042/bj1240431; Groen D, 2010, LANGMUIR, V26, P4168, DOI 10.1021/la9047038; HAMANAKA S, 1989, J BIOCHEM-TOKYO, V105, P684, DOI 10.1093/oxfordjournals.jbchem.a122727; HEDBERG CL, 1988, J INVEST DERMATOL, V91, P169, DOI 10.1111/1523-1747.ep12464438; HOUTSMULLER U M T, 1981, Progress in Lipid Research, V20, P219, DOI 10.1016/0163-7827(81)90041-2; Jobard F, 2002, HUM MOL GENET, V11, P107, DOI 10.1093/hmg/11.1.107; Kinzig A, 1999, GENOMICS, V58, P158, DOI 10.1006/geno.1999.5816; Krieg P, 2010, EXP DERMATOL, V19, P941; Lin D, 2007, J ORG CHEM, V72, P9471, DOI 10.1021/jo701373f; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; Meguro S, 2000, ARCH DERMATOL RES, V292, P463, DOI 10.1007/s004030000160; Meruvu S, 2005, J BIOL CHEM, V280, P36633, DOI 10.1074/jbc.M508260200; Moran JL, 2007, J INVEST DERMATOL, V127, P1893, DOI 10.1038/sj.jid.5700825; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; NUGTEREN DH, 1985, BIOCHIM BIOPHYS ACTA, V834, P429, DOI 10.1016/0005-2760(85)90017-7; PEERS KE, 1983, CHEM PHYS LIPIDS, V32, P49, DOI 10.1016/0009-3084(83)90069-5; Schneider C, 1997, CHIRALITY, V9, P563, DOI 10.1002/(SICI)1520-636X(1997)9:5/6<563::AID-CHIR25>3.0.CO;2-L; SEVANIAN A, 1985, Journal of Free Radicals in Biology and Medicine, V1, P263, DOI 10.1016/0748-5514(85)90130-8; Siebert M, 2001, BIOCHEM J, V355, P97, DOI 10.1042/0264-6021:3550097; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; SWARTZENDRUBER DC, 1987, J INVEST DERMATOL, V88, P709, DOI 10.1111/1523-1747.ep12470383; Uchida Y, 2008, J DERMATOL SCI, V51, P77, DOI 10.1016/j.jdermsci.2008.01.002; WERTZ PW, 1983, J LIPID RES, V24, P753; WERTZ PW, 1982, SCIENCE, V217, P1261, DOI 10.1126/science.7112128; WERTZ PW, 1987, BIOCHIM BIOPHYS ACTA, V917, P108, DOI 10.1016/0005-2760(87)90290-6; WERTZ PW, 1983, BIOCHIM BIOPHYS ACTA, V753, P350, DOI 10.1016/0005-2760(83)90058-9; WERTZ PW, 1990, J LIPID RES, V31, P1839; WOOLLARD PM, 1986, BIOCHEM BIOPH RES CO, V136, P169, DOI 10.1016/0006-291X(86)90891-0; Yu ZY, 2003, P NATL ACAD SCI USA, V100, P9162, DOI 10.1073/pnas.1633612100; Zheng YX, 2008, J BIOL CHEM, V283, P5138, DOI 10.1074/jbc.M705780200; Zheng YX, 2010, J BIOL CHEM, V285, P39876, DOI 10.1074/jbc.M110.180794; Zheng YX, 2010, J BIOL CHEM, V285, P13427, DOI 10.1074/jbc.M109.084632	50	105	108	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24046	24056		10.1074/jbc.M111.251496	http://dx.doi.org/10.1074/jbc.M111.251496			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21558561	hybrid, Green Published			2022-12-25	WOS:000292294900047
J	Stys, A; Galy, B; Starzynski, RR; Smuda, E; Drapier, JC; Lipinski, P; Bouton, C				Stys, Agnieszka; Galy, Bruno; Starzynski, Rafal R.; Smuda, Ewa; Drapier, Jean-Claude; Lipinski, Pawel; Bouton, Cecile			Iron Regulatory Protein 1 Outcompetes Iron Regulatory Protein 2 in Regulating Cellular Iron Homeostasis in Response to Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR MESSENGER-RNA; NEURODEGENERATIVE DISEASE; FERRITIN SYNTHESIS; NITROGEN MONOXIDE; J774 MACROPHAGES; S-NITROSYLATION; DOWN-REGULATION; METABOLISM; IRP2; MICE	In mammals, iron regulatory proteins (IRPs) 1 and 2 posttranscriptionally regulate expression of genes involved in iron metabolism, including transferrin receptor 1, the ferritin (Ft) H and L subunits, and ferroportin by binding mRNA motifs called iron responsive elements (IREs). IRP1 is a bifunctional protein that mostly exists in a non-IRE-binding, [4Fe-4S] cluster aconitase form, whereas IRP2, which does not assemble an Fe-S cluster, spontaneously binds IREs. Although both IRPs fulfill a trans-regulatory function, only mice lacking IRP2 misregulate iron metabolism. NO stimulates the IRE-binding activity of IRP1 by targeting its Fe-S cluster. IRP2 has also been reported to sense NO, but the intrinsic function of IRP1 and IRP2 in NO-mediated regulation of cellular iron metabolism is controversial. In this study, we exposed bone marrow macrophages from Irp1(-/-) and Irp2(-/-) mice to NO and showed that the generated apo-IRP1 was entirely responsible for the posttranscriptional regulation of transferrin receptor 1, H-Ft, L-Ft, and ferroportin. The powerful action of NO on IRP1 also remedies the defects of iron storage found in IRP2-null bone marrow macrophages by efficiently reducing Ft overexpression. We also found that NO-dependent IRP1 activation, resulting in increased iron uptake and reduced iron sequestration and export, maintains enough intracellular iron to fuel the Fe-S cluster biosynthetic pathway for efficient restoration of the citric acid cycle aconitase in mitochondria. Thus, IRP1 is the dominant sensor and transducer of NO for posttranscriptional regulation of iron metabolism and participates in Fe-S cluster repair after exposure to NO.	[Lipinski, Pawel] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Mol Biol, PL-05552 Jastrzebiec, Wolka Kosowska, Poland; [Stys, Agnieszka; Drapier, Jean-Claude; Bouton, Cecile] CNRS, Ctr Rech Gif, Inst Chim Subst Nat, UPR2301, F-91190 Gif Sur Yvette, France; [Galy, Bruno] European Mol Biol Lab, D-69117 Heidelberg, Germany	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; European Molecular Biology Laboratory (EMBL)	Lipinski, P (corresponding author), Polish Acad Sci, Inst Genet & Anim Breeding, Dept Mol Biol, Ul Postepu 1, PL-05552 Jastrzebiec, Wolka Kosowska, Poland.	p.lipinski@ighz.pl	Bouton, Cecile/J-8663-2013	Galy, Bruno/0000-0002-0501-6357; , Rafal/0000-0002-7470-0507	Embassy of France in Poland, Regional Council of Ile-de-France [09SETCI019]; Polish State Committee for Scientific Research [N N303 373636, 1365/1]	Embassy of France in Poland, Regional Council of Ile-de-France; Polish State Committee for Scientific Research(Polish State Committee for Scientific Research)	This work was supported by a French government scholarship (These en Cotutelle) granted by the Embassy of France in Poland, Regional Council of Ile-de-France Grant 09SETCI019, Polish State Committee for Scientific Research Grant N N303 373636 (cofinanced within the framework of Integrated Regional Development Operational Programme (PhD student scholarship no. 1365/1).	Andersen JK, 2004, J ALZHEIMERS DIS, V6, pS47; Bouton C, 1996, J BIOL CHEM, V271, P2300, DOI 10.1074/jbc.271.4.2300; Bouton C, 1998, J BIOL CHEM, V273, P9403, DOI 10.1074/jbc.273.16.9403; Bouton C, 2002, J BIOL CHEM, V277, P31220, DOI 10.1074/jbc.M203276200; BOUTON C, 2003, SCI STKE, pPE17; Corna G, 2006, J MOL MED, V84, P551, DOI 10.1007/s00109-006-0068-y; Cross RK, 2003, INFLAMM BOWEL DIS, V9, P179, DOI 10.1097/00054725-200305000-00006; DRAPIER JC, 1993, EMBO J, V12, P3643, DOI 10.1002/j.1460-2075.1993.tb06038.x; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Garcia-Caldero H, 2011, J HEPATOL, V54, P660, DOI 10.1016/j.jhep.2010.07.034; Ghosh MC, 2008, P NATL ACAD SCI USA, V105, P12028, DOI 10.1073/pnas.0805361105; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hill BG, 2010, J BIOL CHEM, V285, P19699, DOI 10.1074/jbc.R110.101618; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Inami K, 2006, NITRIC OXIDE-BIOL CH, V14, P309, DOI 10.1016/j.niox.2006.01.003; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; Kim S, 1999, J BIOL CHEM, V274, P33035, DOI 10.1074/jbc.274.46.33035; Kim S, 2004, MOL CELL BIOL, V24, P330, DOI 10.1128/MCB.24.1.330-337.2004; Kim S, 2000, J BIOL CHEM, V275, P6220, DOI 10.1074/jbc.275.9.6220; Kim SW, 2002, P NATL ACAD SCI USA, V99, P12214, DOI 10.1073/pnas.192316099; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Liu XM, 2007, CARDIOVASC RES, V75, P381, DOI 10.1016/j.cardiores.2007.03.004; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Mulero V, 1999, BLOOD, V94, P2383, DOI 10.1182/blood.V94.7.2383.419k20_2383_2389; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Oliveira L, 2000, P NATL ACAD SCI USA, V97, P6550, DOI 10.1073/pnas.120571797; PANTOPOULOS K, 1995, P NATL ACAD SCI USA, V92, P1267, DOI 10.1073/pnas.92.5.1267; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Phillips JD, 1996, BLOOD, V87, P2983, DOI 10.1182/blood.V87.7.2983.bloodjournal8772983; Recalcati S, 1998, BLOOD, V91, P1059, DOI 10.1182/blood.V91.3.1059.1059_1059_1066; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Soule BP, 2007, FREE RADICAL BIO MED, V42, P1632, DOI 10.1016/j.freeradbiomed.2007.02.030; Soum E, 2003, BIOCHEMISTRY-US, V42, P7648, DOI 10.1021/bi030041i; Soum E, 2003, J BIOL INORG CHEM, V8, P226, DOI 10.1007/s00775-002-0412-9; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Viatte L, 2009, J MOL MED, V87, P913, DOI 10.1007/s00109-009-0494-8; Wang J, 2005, MOL CELL BIOL, V25, P1347, DOI 10.1128/MCB.25.4.1347-1353.2005; Wang J, 2006, MOL CELL BIOL, V26, P1948, DOI 10.1128/MCB.26.5.1948-1954.2006; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200; Watts RN, 2003, BIOCHEM J, V369, P429, DOI 10.1042/BJ20021302; WEISS G, 1993, EMBO J, V12, P3651, DOI 10.1002/j.1460-2075.1993.tb06039.x	51	48	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22846	22854		10.1074/jbc.M111.231902	http://dx.doi.org/10.1074/jbc.M111.231902			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21566147	Green Published, hybrid			2022-12-25	WOS:000292025000019
J	Sy, SMH; Jiang, J; Dong, SS; Lok, GTM; Wu, J; Cai, H; Yeung, ESL; Huang, J; Chen, JJ; Deng, YQ; Huen, MSY				Sy, Shirley M. -H.; Jiang, Jun; Dong, Sui-sui; Lok, Gabriel Tsz Mei; Wu, Jun; Cai, Hua; Yeung, Enoch S. L.; Huang, Jun; Chen, Junjie; Deng, Yiqun; Huen, Michael S. Y.			Critical Roles of Ring Finger Protein RNF8 in Replication Stress Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA; REPAIR; CHROMATIN; PHOSPHORYLATION; UBIQUITINATION; HISTONES; CASCADE; RNF168; DOMAIN; H2A	Histone ubiquitylation is emerging as an important protective component in cellular responses to DNA damage. The ubiquitin ligases RNF8 and RNF168 assemble ubiquitin chains onto histone molecules surrounding DNA breaks and facilitate retention of DNA repair proteins. Although RNF8 and RNF168 play important roles in repair of DNA double strand breaks, their requirement for cell protection from replication stress is largely unknown. In this study, we uncovered RNF168-independent roles of RNF8 in repair of replication inhibition-induced DNA damage. We showed that RNF8 depletion, but not RNF168 depletion, hyper-sensitized cells to hydroxyurea and aphidicolin treatment. Consistently, hydroxyurea induced persistent single strand DNA lesions and sustained CHK1 activation in RNF8-depleted cells. In line with strict requirement for RAD51-dependent repair of hydroxyurea-stalled replication forks, RNF8depletion compromised RAD51 accumulation onto single strand DNA lesions, suggesting that impaired replication fork repair may underlie the enhanced cellular sensitivity to replication arrest observed in RNF8-depleted cells. In total, our study highlights the differential requirement for the ubiquitin ligase RNF8 in facilitating repair of replication stress-associated DNA damage.	[Jiang, Jun; Wu, Jun; Cai, Hua; Deng, Yiqun] S China Agr Univ, Coll Life Sci, Guangzhou 510642, Guangdong, Peoples R China; [Sy, Shirley M. -H.; Dong, Sui-sui; Lok, Gabriel Tsz Mei; Yeung, Enoch S. L.; Huen, Michael S. Y.] Univ Hong Kong, Genome Stabil Res Lab, Hong Kong, Hong Kong, Peoples R China; [Sy, Shirley M. -H.; Dong, Sui-sui; Lok, Gabriel Tsz Mei; Yeung, Enoch S. L.; Huen, Michael S. Y.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Sy, Shirley M. -H.; Dong, Sui-sui; Lok, Gabriel Tsz Mei; Huen, Michael S. Y.] Univ Hong Kong, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Huang, Jun] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	South China Agricultural University; University of Hong Kong; University of Hong Kong; University of Hong Kong; Zhejiang University; University of Texas System; UTMD Anderson Cancer Center	Deng, YQ (corresponding author), S China Agr Univ, Coll Life Sci, 483 Wushan Rd, Guangzhou 510642, Guangdong, Peoples R China.	yqdeng@scau.edu.cn; huen.michael@hku.hk	Deng, Yiqun/K-7709-2013	Deng, Yiqun/0000-0002-6838-3779; Sy, Ming Hui/0000-0002-2731-6692; Huen, Michael Shing-Yan/0000-0003-1774-2425	Faculty Development Fund and Seed Funding Programme for Applied Research [201007160001]; National Basic Research Program of China (973 Program) [2009CB118802]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; NATIONAL CANCER INSTITUTE [R01CA092312] Funding Source: NIH RePORTER	Faculty Development Fund and Seed Funding Programme for Applied Research; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Faculty Development Fund and Seed Funding Programme for Applied Research (Project Code 201007160001, to M. S. Y. H.), by grants from the National Basic Research Program of China (973 Program, Grant 2009CB118802, to M. S. Y. H. and Y. D.), and by Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2009, to Y. D.).	Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huen MSY, 2008, MOL CELL BIOL, V28, P6104, DOI 10.1128/MCB.00987-08; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MSY, 2010, MOL CELL, V37, P854, DOI 10.1016/j.molcel.2009.12.040; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Lundin C, 2003, J MOL BIOL, V328, P521, DOI 10.1016/S0022-2836(03)00313-9; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Pinato S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-55; Ramachandran S, 2010, P NATL ACAD SCI USA, V107, P809, DOI 10.1073/pnas.0913790107; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Sy SMH, 2009, J BIOL CHEM, V284, P18302, DOI 10.1074/jbc.M109.016717; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yuan JS, 2009, J BIOL CHEM, V284, P31746, DOI 10.1074/jbc.M109.023424	26	29	30	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22355	22361		10.1074/jbc.M111.232041	http://dx.doi.org/10.1074/jbc.M111.232041			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21558560	Green Published, hybrid			2022-12-25	WOS:000291719900045
J	Tang, YT; Li, SJ; Kao, HY; Tsai, SJ; Wang, HC				Tang, Yi-Tsung; Li, Shuo-Jang; Kao, Hung-Yu; Tsai, Shaw-Jenq; Wang, Hei-Chia			Using Unsupervised Patterns to Extract Gene Regulation Relationships for Network Construction	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; INFORMATION; SYSTEM	Background: The gene expression is usually described in the literature as a transcription factor X that regulates the target gene Y. Previously, some studies discovered gene regulations by using information from the biomedical literature and most of them require effort of human annotators to build the training dataset. Moreover, the large amount of textual knowledge recorded in the biomedical literature grows very rapidly, and the creation of manual patterns from literatures becomes more difficult. There is an increasing need to automate the process of establishing patterns. Methodology/Principal Findings: In this article, we describe an unsupervised pattern generation method called AutoPat. It is a gene expression mining system that can generate unsupervised patterns automatically from a given set of seed patterns. The high scalability and low maintenance cost of the unsupervised patterns could help our system to extract gene expression from PubMed abstracts more precisely and effectively. Conclusions/Significance: Experiments on several regulators show reasonable precision and recall rates which validate AutoPat's practical applicability. The conducted regulation networks could also be built precisely and effectively. The system in this study is available at http://ikmbio.csie.ncku.edu.tw/AutoPat/.	[Tang, Yi-Tsung; Li, Shuo-Jang; Kao, Hung-Yu] Natl Cheng Kung Tainan, Dept Comp Sci & Informat Engn, Tainan, Taiwan; [Tsai, Shaw-Jenq] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan; [Wang, Hei-Chia] Natl Cheng Kung Univ, Inst Informat Management, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University	Tang, YT (corresponding author), Natl Cheng Kung Tainan, Dept Comp Sci & Informat Engn, Tainan, Taiwan.	p7895125@mail.ncku.edu.tw	Tsai, Shaw-Jenq/AAG-6569-2019	TSAI, SHAW-JENQ/0000-0002-3569-5813	National Science Council of Taiwan [NSC97-2627-B-006-003]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This paper was supported in part by National Science Council of Taiwan under Contract NSC97-2627-B-006-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaschke C, 2001, Genome Inform, V12, P123; BUYKO E, 2008, TESTING DIFFERENT AC, P21; Chiang JH, 2004, BIOINFORMATICS, V20, P120, DOI 10.1093/bioinformatics/btg369; Chowdhary R, 2009, BIOINFORMATICS, V25, P1536, DOI 10.1093/bioinformatics/btp245; Fundel K, 2007, BIOINFORMATICS, V23, P365, DOI 10.1093/bioinformatics/btl616; HAHN U, 2009, FEASIBLE ROBUST AUTO, P37; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Huang ML, 2004, BIOINFORMATICS, V20, P3604, DOI 10.1093/bioinformatics/bth451; Jelier R, 2005, BIOINFORMATICS, V21, P2049, DOI 10.1093/bioinformatics/bti268; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Kim S, 2008, NUCLEIC ACIDS RES, V36, pW411, DOI 10.1093/nar/gkn281; Klein D, 2003, 41ST ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P423, DOI 10.3115/1075096.1075150; Klein D, 2002, ADV NEUR IN, V14, P35; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; NEDELLEC C, 2005, P ICML05 WORKSH LEAR; Ozgur A, 2008, BIOINFORMATICS, V24, pI277, DOI 10.1093/bioinformatics/btn182; Ono T, 2001, BIOINFORMATICS, V17, P155, DOI 10.1093/bioinformatics/17.2.155; Pyysalo S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S6; Rodriguez-Penagos C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-293; Saric J, 2006, BIOINFORMATICS, V22, P645, DOI 10.1093/bioinformatics/bti597; SARIC J, 2004, EXTRACTING REGULATOR, P191; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Stapley B J, 2000, Pac Symp Biocomput, P529; Tanabe L, 2002, BIOINFORMATICS, V18, P1124, DOI 10.1093/bioinformatics/18.8.1124; van der Eijk CC, 2004, J AM SOC INF SCI TEC, V55, P436, DOI 10.1002/asi.10392	25	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19633	10.1371/journal.pone.0019633	http://dx.doi.org/10.1371/journal.pone.0019633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573008	Green Published, Green Submitted, gold			2022-12-25	WOS:000290440200016
J	LaBarre, P; Hawkins, KR; Gerlach, J; Wilmoth, J; Beddoe, A; Singleton, J; Boyle, D; Weigl, B				LaBarre, Paul; Hawkins, Kenneth R.; Gerlach, Jay; Wilmoth, Jared; Beddoe, Andrew; Singleton, Jered; Boyle, David; Weigl, Bernhard			A Simple, Inexpensive Device for Nucleic Acid Amplification without Electricity-Toward Instrument-Free Molecular Diagnostics in Low-Resource Settings	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; RAPID DETECTION; REVERSE-TRANSCRIPTION; DNA AMPLIFICATION; LAMP; ASSAY; TECHNOLOGIES; VIRUS; HIV-1	Background: Molecular assays targeted to nucleic acid (NA) markers are becoming increasingly important to medical diagnostics. However, these are typically confined to wealthy, developed countries; or, to the national reference laboratories of developing-world countries. There are many infectious diseases that are endemic in low-resource settings (LRS) where the lack of simple, instrument-free, NA diagnostic tests is a critical barrier to timely treatment. One of the primary barriers to the practicality and availability of NA assays in LRS has been the complexity and power requirements of polymerase chain reaction (PCR) instrumentation (another is sample preparation). Methodology/Principal Findings: In this article, we investigate the hypothesis that an electricity-free heater based on exothermic chemical reactions and engineered phase change materials can successfully incubate isothermal NA amplification assays. We assess the heater's equivalence to commercially available PCR instruments through the characterization of the temperature profiles produced, and a minimal method comparison. Versions of the prototype for several different isothermal techniques are presented. Conclusions/Significance: We demonstrate that an electricity-free heater based on exothermic chemical reactions and engineered phase change materials can successfully incubate isothermal NA amplification assays, and that the results of those assays are not significantly different from ones incubated in parallel in commercially available PCR instruments. These results clearly suggest the potential of the non-instrumented nucleic acid amplification (NINA) heater for molecular diagnostics in LRS. When combined with other innovations in development that eliminate power requirements for sample preparation, cold reagent storage, and readout, the NINA heater will comprise part of a kit that should enable electricity-free NA testing for many important analytes.	[LaBarre, Paul; Hawkins, Kenneth R.; Gerlach, Jay; Wilmoth, Jared; Beddoe, Andrew; Singleton, Jered; Boyle, David; Weigl, Bernhard] PATH, Seattle, WA 98121 USA		LaBarre, P (corresponding author), PATH, Seattle, WA 98121 USA.	plabarr@path.org	Gerlach, Jay/GOJ-7886-2022		United States Agency for International Development; National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering [1U54EB007949-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB007949] Funding Source: NIH RePORTER	United States Agency for International Development(United States Agency for International Development (USAID)); National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	PATH is a nonprofit international health agency that designs and develops appropriate and affordable technologies to solve health problems, especially in developing countries. This work, such as the technology described in this paper, is supported by grants from the United States Agency for International Development, the National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering Grant 1U54EB007949-01, other governments, and private foundations. Since the authors do not manufacture or distribute products themselves, they work with private-sector collaborators willing to work on products for these types of markets. Support for this project is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of the HealthTech Cooperative Agreement # GPH-A-00-01-00005-00. The contents are the responsibility of PATH and do not necessarily reflect the views of USAID or the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade TPD, 2009, J FISH DIS, V32, P911, DOI 10.1111/j.1365-2761.2009.01072.x; Andresen D, 2009, EXPERT REV MOL DIAGN, V9, P645, DOI 10.1586/ERM.09.46; BOYLE DS, 2009, CLIN CHEM, V55, P1891; BURGESS DH, 2006, NATURE LONDON S, V1; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; Curtis KA, 2009, J MED VIROL, V81, P966, DOI 10.1002/jmv.21490; Dominguez M, 2010, INT J TUBERC LUNG D, V14, P1468; Fang RD, 2009, J CLIN MICROBIOL, V47, P845, DOI 10.1128/JCM.01528-08; Fujino M, 2005, J MED VIROL, V76, P406, DOI 10.1002/jmv.20371; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Hatano B, 2010, JPN J INFECT DIS, V63, P36; Hill J, 2008, J CLIN MICROBIOL, V46, P2800, DOI 10.1128/JCM.00152-08; Ihira M, 2007, J CLIN VIROL, V39, P22, DOI 10.1016/j.jcv.2007.02.001; Lai JJ, 2007, LANGMUIR, V23, P7385, DOI 10.1021/la062527g; Lee SY, 2008, SENSOR ACTUAT B-CHEM, V133, P493, DOI 10.1016/j.snb.2008.03.008; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Morisset D, 2008, EUR FOOD RES TECHNOL, V227, P1287, DOI 10.1007/s00217-008-0850-x; Morshed MG, 2007, FEMS IMMUNOL MED MIC, V49, P184, DOI 10.1111/j.1574-695X.2006.00191.x; Neumaier M, 1998, CLIN CHEM, V44, P12; Ngom B, 2010, ANAL BIOANAL CHEM, V397, P1113, DOI 10.1007/s00216-010-3661-4; NIEMZ A, 2010, TRENDS BIOT IN PRESS; Nimitphak T, 2010, MOL CELL PROBE, V24, P1, DOI 10.1016/j.mcp.2009.09.004; Njiru ZK, 2008, INT J PARASITOL, V38, P589, DOI 10.1016/j.ijpara.2007.09.006; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Paris DH, 2008, T ROY SOC TROP MED H, V102, P1239, DOI 10.1016/j.trstmh.2008.04.040; Peeling RW, 2006, NAT REV MICROBIOL, V4, P909, DOI 10.1038/nrmicro1555; Poon LLM, 2006, CLIN CHEM, V52, P303; Rafael Maria E, 2006, Nature, V444 Suppl 1, P39, DOI 10.1038/nature05445; Rigano LA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-176; Thai HTC, 2004, J CLIN MICROBIOL, V42, P1956, DOI 10.1128/JCM.42.5.1956-1961.2004; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Tucker JD, 2010, LANCET INFECT DIS, V10, P381, DOI 10.1016/S1473-3099(10)70092-X; Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448; Weigl BH, 2009, EXPERT REV MED DEVIC, V6, P461, DOI [10.1586/erd.09.31, 10.1586/ERD.09.31]; Weigl B, 2008, LAB CHIP, V8, P1999, DOI 10.1039/b811314a; Wu WJ, 2009, CLIN LAB MED, V29, P673, DOI 10.1016/j.cll.2009.07.005; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; 2010, FACTORS AFFECTING QU	40	107	114	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19738	10.1371/journal.pone.0019738	http://dx.doi.org/10.1371/journal.pone.0019738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573065	Green Published, gold			2022-12-25	WOS:000290386800036
J	Dheekollu, J; Wiedmer, A; Hayden, J; Speicher, D; Gotter, AL; Yen, T; Lieberman, PM				Dheekollu, Jayaraju; Wiedmer, Andreas; Hayden, James; Speicher, David; Gotter, Anthony L.; Yen, Tim; Lieberman, Paul M.			Timeless Links Replication Termination to Mitotic Kinase Activation	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DNA-REPLICATION; AURORA-A; S-PHASE; SCHIZOSACCHAROMYCES-POMBE; CHECKPOINT RESPONSE; INTERACTING PROTEIN; HISTONE H3; CELL-CYCLE; COMPLEX	The mechanisms that coordinate the termination of DNA replication with progression through mitosis are not completely understood. The human Timeless protein (Tim) associates with S phase replication checkpoint proteins Claspin and Tipin, and plays an important role in maintaining replication fork stability at physical barriers, like centromeres, telomeres and ribosomal DNA repeats, as well as at termination sites. We show here that human Tim can be isolated in a complex with mitotic entry kinases CDK1, Auroras A and B, and Polo-like kinase (Plk1). Plk1 bound Tim directly and colocalized with Tim at a subset of mitotic structures in M phase. Tim depletion caused multiple mitotic defects, including the loss of sister-chromatid cohesion, loss of mitotic spindle architecture, and a failure to exit mitosis. Tim depletion caused a delay in mitotic kinase activity in vivo and in vitro, as well as a reduction in global histone H3 S10 phosphorylation during G2/M phase. Tim was also required for the recruitment of Plk1 to centromeric DNA and formation of catenated DNA structures at human centromere alpha satellite repeats. Taken together, these findings suggest that Tim coordinates mitotic kinase activation with termination of DNA replication.	[Dheekollu, Jayaraju; Wiedmer, Andreas; Hayden, James; Speicher, David; Lieberman, Paul M.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Gotter, Anthony L.] Merk Res Labs, West Point, PA USA; [Yen, Tim] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	The Wistar Institute; Fox Chase Cancer Center	Dheekollu, J (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA.	Lieberman@wistar.org		Yen, Tim/0000-0003-2159-0997	National Institutes of Health (NIH) [RO1 CA093606]; Wistar Institute Cancer Center [5 P30 CA 010815-41]; NATIONAL CANCER INSTITUTE [P30CA010815, R01CA093606] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wistar Institute Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this study was provided by National Institutes of Health (NIH) RO1 CA093606 to PML and the Wistar Institute Cancer Center Core Grant 5 P30 CA 010815-41. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers T, 2000, Nucleic Acids Res, V28, pe6, DOI 10.1093/nar/28.2.e6; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Biswas S, 2008, MOL CELL BIOL, V28, P6844, DOI 10.1128/MCB.01235-08; Burkhalter MD, 2004, MOL CELL, V15, P409, DOI 10.1016/j.molcel.2004.06.024; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; Chini CCS, 2004, DNA REPAIR, V3, P1033, DOI 10.1016/j.dnarep.2004.03.001; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Conti C, 2007, CELL CYCLE, V6, P2760, DOI 10.4161/cc.6.22.4932; Dalgaard JZ, 2000, CELL, V102, P745, DOI 10.1016/S0092-8674(00)00063-5; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Dheekollu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001257; Egel R, 2004, CURR BIOL, V14, pR915, DOI 10.1016/j.cub.2004.10.012; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Errico A, 2007, P NATL ACAD SCI USA, V104, P14929, DOI 10.1073/pnas.0706347104; Gotter AL, 2003, J MOL BIOL, V331, P167, DOI 10.1016/S0022-2836(03)00633-8; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Hwang JY, 2008, DNA REPAIR, V7, P1426, DOI 10.1016/j.dnarep.2008.05.006; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Karisson-Rosenthal C, 2006, TRENDS CELL BIOL, V16, P285, DOI 10.1016/j.tcb.2006.04.002; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kemp MG, 2010, J BIOL CHEM, V285, P16562, DOI 10.1074/jbc.M110.110304; King MC, 2008, CELL, V134, P427, DOI 10.1016/j.cell.2008.06.022; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Kondratov RV, 2007, TRENDS CELL BIOL, V17, P311, DOI 10.1016/j.tcb.2007.07.001; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Labib K, 2007, EMBO REP, V8, P346, DOI 10.1038/sj.embor.7400940; Lee MG, 2006, METHODS, V40, P327, DOI 10.1016/j.ymeth.2006.07.030; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Macurek L, 2009, CANCER RES, V69, P4555, DOI 10.1158/0008-5472.CAN-09-0142; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; McFarlane RJ, 2010, CELL CYCLE, V9, P700, DOI 10.4161/cc.9.4.10676; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Pebernard S, 2008, EMBO J, V27, P3011, DOI 10.1038/emboj.2008.220; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Rush BL, 2006, J BIOL RHYTHM, V21, P272, DOI 10.1177/0748730406290416; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; Taylor SS, 2001, J CELL SCI, V114, P4385; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Tsvetkov L, 2005, J BIOL CHEM, V280, P11943, DOI 10.1074/jbc.M413514200; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Urtishak KA, 2008, J BIOL CHEM; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200	65	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19596	10.1371/journal.pone.0019596	http://dx.doi.org/10.1371/journal.pone.0019596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573113	Green Published, gold, Green Submitted			2022-12-25	WOS:000290305600033
J	Frost, D; Meechoovet, B; Wang, T; Gately, S; Giorgetti, M; Shcherbakova, I; Dunckley, T				Frost, Danielle; Meechoovet, Bessie; Wang, Tong; Gately, Stephen; Giorgetti, Marco; Shcherbakova, Irina; Dunckley, Travis			beta-Carboline Compounds, Including Harmine, Inhibit DYRK1A and Tau Phosphorylation at Multiple Alzheimer's Disease-Related Sites	PLOS ONE			English	Article							DOWN-SYNDROME; FUNCTIONAL-LINK; PROTEIN; BINDING; MICE; HYPERPHOSPHORYLATION; CELLS	Harmine, a beta-carboline alkaloid, is a high affinity inhibitor of the dual specificity tyrosine phosphorylation regulated kinase 1A (DYRK1A) protein. The DYRK1A gene is located within the Down Syndrome Critical Region (DSCR) on chromosome 21. We and others have implicated DYRK1A in the phosphorylation of tau protein on multiple sites associated with tau pathology in Down Syndrome and in Alzheimer's disease (AD). Pharmacological inhibition of this kinase may provide an opportunity to intervene therapeutically to alter the onset or progression of tau pathology in AD. Here we test the ability of harmine, and numerous additional beta-carboline compounds, to inhibit the DYRK1A dependent phosphorylation of tau protein on serine 396, serine 262/serine 356 (12E8 epitope), and threonine 231 in cell culture assays and in vitro phosphorylation assays. Results demonstrate that the beta-carboline compounds (1) potently reduce the expression of all three phosphorylated forms of tau protein, and (2) inhibit the DYRK1A catalyzed direct phosphorylation of tau protein on serine 396. By assaying several beta-carboline compounds, we define certain chemical groups that modulate the affinity of this class of compounds for inhibition of tau phosphorylation.	[Frost, Danielle; Meechoovet, Bessie; Dunckley, Travis] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ USA; [Wang, Tong; Gately, Stephen] Translat Genom Res Inst, Scottsdale, AZ USA; [Giorgetti, Marco; Shcherbakova, Irina] MediProPharma Inc, Salt Lake City, UT USA; [Frost, Danielle; Meechoovet, Bessie; Dunckley, Travis] Arizona Alzheimers Res Consortium, Phoenix, AZ USA	Translational Genomics Research Institute; Translational Genomics Research Institute	Frost, D (corresponding author), Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ USA.	tdunckley@tgen.org			Arizona Alzheimer's Research Consortium; MediProPharma, Inc.;  [R21AG029576];  [K01AG024079];  [P30AG19610]; NATIONAL INSTITUTE ON AGING [K01AG024079, P30AG019610, R21AG029576] Funding Source: NIH RePORTER	Arizona Alzheimer's Research Consortium; MediProPharma, Inc.; ; ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by R21AG029576, K01AG024079, P30AG19610 to TD, the Arizona Alzheimer's Research Consortium, and a charitable contribution to TGen from the Louis Charitable Trust. Studies of MPP-021 and MPP-313 were supported by MediProPharma, Inc. MediProPharma provided information about compound solubility and IC50 data to assist in compound dosing. Aside from this, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Alonso AD, 2010, J BIOL CHEM, V285, P30851, DOI 10.1074/jbc.M110.110957; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Arib O, 2010, EUR J PHARMACOL, V629, P47, DOI 10.1016/j.ejphar.2009.12.012; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Azorsa DO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-25; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Du W, 1997, BRAIN RES, V770, P26, DOI 10.1016/S0006-8993(97)00606-9; Glennon RA, 2000, DRUG ALCOHOL DEPEN, V60, P121, DOI 10.1016/S0376-8716(99)00148-9; Gockler N, 2009, FEBS J, V276, P6324, DOI 10.1111/j.1742-4658.2009.07346.x; GUSTKE N, 1992, FEBS LETT, V307, P199, DOI 10.1016/0014-5793(92)80767-B; Herraiz T, 2010, FOOD CHEM TOXICOL, V48, P839, DOI 10.1016/j.fct.2009.12.019; Jayaprakash V, 2008, BIOORG MED CHEM LETT, V18, P6362, DOI 10.1016/j.bmcl.2008.10.084; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; Vazquez-Higuera JL, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-129; Mandelkow EM, 1996, ANN NY ACAD SCI, V777, P96, DOI 10.1111/j.1749-6632.1996.tb34407.x; Park J, 2007, MOL CELL NEUROSCI, V36, P270, DOI 10.1016/j.mcn.2007.07.007; PIMPINELLA G, 1995, NEUROSCI LETT, V189, P121, DOI 10.1016/0304-3940(95)11469-D; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Wegiel J, 2008, ACTA NEUROPATHOL, V116, P391, DOI 10.1007/s00401-008-0419-6; Yang YJ, 2008, EUR J PHARMACOL, V587, P57, DOI 10.1016/j.ejphar.2008.03.050	22	125	129	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19264	10.1371/journal.pone.0019264	http://dx.doi.org/10.1371/journal.pone.0019264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573099	gold, Green Published, Green Submitted			2022-12-25	WOS:000290305600017
J	Torres-Diaz, C; Gomez-Gonzalez, S; Stotz, GC; Torres-Morales, P; Paredes, B; Perez-Millaqueo, M; Gianoli, E				Torres-Diaz, Cristian; Gomez-Gonzalez, Susana; Stotz, Gisela C.; Torres-Morales, Patricio; Paredes, Brayam; Perez-Millaqueo, Matias; Gianoli, Ernesto			Extremely Long-Lived Stigmas Allow Extended Cross-Pollination Opportunities in a High Andean Plant	PLOS ONE			English	Article							HIGH TEMPERATE ANDES; POLLEN LIMITATION; CENTRAL CHILE; SELF-FERTILIZATION; INSECT POLLINATION; MT-OLYMPOS; ALPINE; COMMUNITY; ECOLOGY; CONSEQUENCES	High-elevation ecosystems are traditionally viewed as environments in which predominantly autogamous breeding systems should be selected because of the limited pollinator availability. Chaetanthera renifolia (Asteraceae) is an endemic monocarpic triennial herb restricted to a narrow altitudinal range within the high Andes of central Chile (3300-3500 m a.s.l.), just below the vegetation limit. This species displays one of the larger capitulum within the genus. Under the reproductive assurance hypothesis, and considering its short longevity (monocarpic triennial), an autogamous breeding system and low levels of pollen limitation would be predicted for C. renifolia. In contrast, considering its large floral size, a xenogamous breeding system, and significant levels of pollen limitation could be expected. In addition, the increased pollination probability hypothesis predicts prolonged stigma longevity for high alpine plants. We tested these alternative predictions by performing experimental crossings in the field to establish the breeding system and to measure the magnitude of pollen limitation in two populations of C. renifolia. In addition, we measured the stigma longevity in unpollinated and open pollinated capitula, and pollinator visitation rates in the field. We found low levels of self-compatibility and significant levels of pollen limitation in C. renifolia. Pollinator visitation rates were moderate (0.047-0.079 visits per capitulum per 30 min). Although pollinator visitation rate significantly differed between populations, they were not translated into differences in achene output. Finally, C. renifolia stigma longevity of unpollinated plants was extremely long and significantly higher than that of open pollinated plants (26.3 +/- 2.8 days vs. 10.1 +/- 2.2, respectively), which gives support to the increased pollination probability hypothesis for high-elevation flowering plants. Our results add to a growing number of studies that show that xenogamous breeding systems and mechanisms to increase pollination opportunities can be selected in high-elevation ecosystems.	[Torres-Diaz, Cristian; Gomez-Gonzalez, Susana] Univ Bio Bio, Dept Ciencias Basicas, LGB, Chillan, Chile; [Torres-Diaz, Cristian; Stotz, Gisela C.; Torres-Morales, Patricio; Paredes, Brayam; Perez-Millaqueo, Matias; Gianoli, Ernesto] Univ Concepcion, Dept Bot, Concepcion, Chile; [Gianoli, Ernesto] Pontificia Univ Catolica Chile, CASEB, Santiago, Chile; [Gianoli, Ernesto] Univ La Serena, Dept Biol, La Serena, Chile	Universidad del Bio-Bio; Universidad de Concepcion; Pontificia Universidad Catolica de Chile; Universidad de La Serena	Torres-Diaz, C (corresponding author), Univ Bio Bio, Dept Ciencias Basicas, LGB, Chillan, Chile.	crtorres@ubiobio.cl	Gómez-González, Susana/AAL-2631-2021; GOMEZ-GONZALEZ, SUSANA/J-7637-2018; Torres, Patricio/D-2405-2010; Stotz, Gisela/E-2197-2017; Gianoli, Ernesto/A-7984-2015	Gómez-González, Susana/0000-0002-3779-8701; GOMEZ-GONZALEZ, SUSANA/0000-0002-3779-8701; Stotz, Gisela/0000-0001-8687-7361; Gianoli, Ernesto/0000-0003-4246-8640	FONDECYT [3090020]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The study was supported FONDECYT-3090020 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo MTK, 2006, ACTA OECOL, V30, P248, DOI 10.1016/j.actao.2006.05.006; ARROYO MTK, 1982, AM J BOT, V69, P82, DOI 10.2307/2442833; ARROYO MTK, 1985, PLANT SYST EVOL, V149, P187, DOI 10.1007/BF00983305; ARROYO MTK, 1981, J ECOL, V69, P205, DOI 10.2307/2259826; ARROYO MTK, 1990, BIOL APPROACHES EVOL, P205; Ashman T. L., 1996, FLORAL BIOL STUDIES, P112, DOI DOI 10.1007/978-1-4613-1165-2_5; Barrett S.C.H., 1990, BIOL APPROACHES EVOL, P229, DOI DOI 10.1016/B978-0-12-402960-6.50019-6; BILLINGS WD, 1968, BIOL REV, V43, P481, DOI 10.1111/j.1469-185X.1968.tb00968.x; Bingham RA, 1998, NATURE, V391, P238, DOI 10.1038/34564; Blionis GJ, 2002, PLANT SYST EVOL, V232, P89, DOI 10.1007/s006060200029; Blionis GJ, 2001, ECOGRAPHY, V24, P696, DOI 10.1034/j.1600-0587.2001.240608.x; BLISS L. C., 1962, ARCTIC, V15, P117; Bliss L. C., 1971, ANNU REV ECOL SYST, V2, P405, DOI [10.1146/annurev.es.02.110171.002201, DOI 10.1146/ANNUREV.ES.02.110171.002201]; Bu HY, 2008, PLANT ECOL, V195, P87, DOI 10.1007/s11258-007-9301-1; CABRERA AL, 1937, REV MUSEO PLATA B, V1, P87; Cavieres LA, 2000, REV CHIL HIST NAT, V73, P331; DAVIS A, 2009, THESIS LUDWIG MAXIMI; Di Castri F, 1976, BIOCLIMATOLOGIA CHIL; Fabbro T, 2004, FLORA, V199, P70, DOI 10.1078/0367-2530-00128; FAEGRI K, 1979, P244; Fitting H., 1909, Z BOT, V1, P1; Garcia-Camacho R, 2009, ARCT ANTARCT ALP RES, V41, P103, DOI [10.1657/1938-4246(08-028)[GARCIA-CAMACHO]2.0.CO;2, 10.1657/1523-0430-41.1.103]; HERRERA CM, 1987, OIKOS, V50, P79, DOI 10.2307/3565403; HOCKING B, 1968, OIKOS, V19, P359, DOI 10.2307/3565022; KEARNS CA, 1994, AM J BOT, V81, P1091, DOI 10.2307/2445470; KEVAN PG, 1972, J ECOL, V60, P831, DOI 10.2307/2258569; Kudo Gaku, 1999, Plant Species Biology, V14, P181, DOI 10.1046/j.1442-1984.1999.00012.x; Larson BMH, 2000, BIOL J LINN SOC, V69, P503, DOI 10.1111/j.1095-8312.2000.tb01221.x; LLOYD DG, 1992, INT J PLANT SCI, V153, P370, DOI 10.1086/297041; LLOYD DG, 1992, INT J PLANT SCI, V153, P358, DOI 10.1086/297040; Mamayev, 1972, PINACEAE URALE TYPES; Mani M.S., 1962, INTRO HIGH ALTITUDE; Medan D, 2002, ARCT ANTARCT ALP RES, V34, P233, DOI 10.2307/1552480; MOLDENKE A R, 1979, Phytologia, V42, P349; Muller H, 1881, ALPENBLUMEN IHRE BEF; Norden N, 2009, FUNCT ECOL, V23, P203, DOI 10.1111/j.1365-2435.2008.01477.x; Primack R.B., 1978, New Zealand Journal of Ecology, V1, P66; PRIMACK RB, 1985, ANNU REV ECOL SYST, V16, P15, DOI 10.1146/annurev.es.16.110185.000311; PRIMACK RB, 1983, NEW ZEAL J BOT, V21, P317, DOI 10.1080/0028825X.1983.10428561; Richards A.J, 1997, PLANT BREEDING SYSTE; Santibanez F, 1990, ATLAS AGROCLIMATICO; SCHEMSKE DW, 1985, EVOLUTION, V39, P41, DOI [10.2307/2408515, 10.1111/j.1558-5646.1985.tb04078.x]; STEAD AD, 1992, PLANT GROWTH REGUL, V11, P13, DOI 10.1007/BF00024427; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Torices R, 2010, OECOLOGIA, V164, P949, DOI 10.1007/s00442-010-1715-0; Torres-Diaz C, 2007, REV CHIL HIST NAT, V80, P455, DOI 10.4067/S0716-078X2007000400007; TOTLAND O, 1993, CAN J BOT, V71, P1072, DOI 10.1139/b93-124; Totland O, 2001, ECOLOGY, V82, P2233, DOI 10.1890/0012-9658(2001)082[2233:EDPLAS]2.0.CO;2; Totland O, 2001, AM J BOT, V88, P1011, DOI 10.2307/2657082; Utelli AB, 2000, OIKOS, V89, P461, DOI 10.1034/j.1600-0706.2000.890305.x; Wirth LR, 2010, AM J BOT, V97, P899, DOI 10.3732/ajb.0900297	51	34	40	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19497	10.1371/journal.pone.0019497	http://dx.doi.org/10.1371/journal.pone.0019497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573159	gold, Green Published, Green Submitted			2022-12-25	WOS:000290256400016
J	DeAngelis, KM; Allgaier, M; Chavarria, Y; Fortney, JL; Hugenholtz, P; Simmons, B; Sublette, K; Silver, WL; Hazen, TC				DeAngelis, Kristen M.; Allgaier, Martin; Chavarria, Yaucin; Fortney, Julian L.; Hugenholtz, Phillip; Simmons, Blake; Sublette, Kerry; Silver, Whendee L.; Hazen, Terry C.			Characterization of Trapped Lignin-Degrading Microbes in Tropical Forest Soil	PLOS ONE			English	Article							PHOSPHORUS AVAILABILITY; IRON REDUCTION; DIVERSITY; PRETREATMENT; DEGRADATION; PEROXIDASE; BACTERIA; SOLUBILIZATION; POPULATIONS; NITROGEN	Lignin is often the most difficult portion of plant biomass to degrade, with fungi generally thought to dominate during late stage decomposition. Lignin in feedstock plant material represents a barrier to more efficient plant biomass conversion and can also hinder enzymatic access to cellulose, which is critical for biofuels production. Tropical rain forest soils in Puerto Rico are characterized by frequent anoxic conditions and fluctuating redox, suggesting the presence of lignin-degrading organisms and mechanisms that are different from known fungal decomposers and oxygen-dependent enzyme activities. We explored microbial lignin-degraders by burying bio-traps containing lignin-amended and unamended biosep beads in the soil for 1, 4, 13 and 30 weeks. At each time point, phenol oxidase and peroxidase enzyme activity was found to be elevated in the lignin-amended versus the unamended beads, while cellulolytic enzyme activities were significantly depressed in lignin-amended beads. Quantitative PCR of bacterial communities showed more bacterial colonization in the lignin-amended compared to the unamended beads after one and four weeks, suggesting that the lignin supported increased bacterial abundance. The microbial community was analyzed by small subunit 16S ribosomal RNA genes using microarray (PhyloChip) and by high-throughput amplicon pyrosequencing based on universal primers targeting bacterial, archaeal, and eukaryotic communities. Community trends were significantly affected by time and the presence of lignin on the beads. Lignin-amended beads have higher relative abundances of representatives from the phyla Actinobacteria, Firmicutes, Acidobacteria and Proteobacteria compared to unamended beads. This study suggests that in low and fluctuating redox soils, bacteria could play a role in anaerobic lignin decomposition.	[DeAngelis, Kristen M.; Chavarria, Yaucin; Fortney, Julian L.; Silver, Whendee L.; Hazen, Terry C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Dept Ecol, Berkeley, CA 94720 USA; [DeAngelis, Kristen M.; Allgaier, Martin; Hugenholtz, Phillip; Simmons, Blake; Hazen, Terry C.] Joint BioEnergy Inst, Microbial Communities Grp, Deconstruct Div, Emeryville, CA USA; [Allgaier, Martin; Hugenholtz, Phillip] DOE Joint Genome Inst, Microbial Ecol Program, Walnut Creek, CA USA; [Simmons, Blake] Sandia Natl Labs, Livermore, CA USA; [Sublette, Kerry] Univ Tulsa, Ctr Appl Biogeosci, Tulsa, OK 74104 USA; [Silver, Whendee L.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); United States Department of Energy (DOE); Sandia National Laboratories; University of Tulsa; University of California System; University of California Berkeley	DeAngelis, KM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Dept Ecol, Berkeley, CA 94720 USA.	Kristen@post.harvard.edu	Hugenholtz, Philip/AAD-9138-2019; Simmons, Blake/N-6022-2016; Silver, Whendee L./H-1118-2012; Hazen, Terry C/C-1076-2012	Hugenholtz, Philip/0000-0001-5386-7925; Simmons, Blake/0000-0002-1332-1810; Silver, Whendee L./0000-0003-0372-8745; Hazen, Terry C/0000-0002-2536-9993; DeAngelis, Kristen/0000-0002-5585-4551	United States Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; National Science Foundation [DEB 0543558]; Seaborg Fellowship; U.S. Department of Agriculture Forest Service International Institute of Tropical Forestry;  [DEB-008538];  [DEB-0218039]	United States Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Seaborg Fellowship; U.S. Department of Agriculture Forest Service International Institute of Tropical Forestry; ; 	This work was conducted as part of the Joint BioEnergy Institute (http://www.jbei.org) supported by the United States Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. DOE. Additional funding was provided in part by National Science Foundation grant DEB 0543558 to WS, by a Seaborg Fellowship to KMD, by DEB-008538 and DEB-0218039 to Institute for Tropical Ecosystem Studies at the University of Puerto Rico, and by U.S. Department of Agriculture Forest Service International Institute of Tropical Forestry as part of the NSF Long Term Ecological Research (LTER) program in the Luquillo Experimental Forest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2010, MOL BIOSYST, V6, P815, DOI 10.1039/b908966g; Allison SD, 2005, SOIL BIOL BIOCHEM, V37, P937, DOI 10.1016/j.soilbio.2004.09.014; Allison SD, 2004, BIOTROPICA, V36, P285, DOI 10.1646/03180; Aneja MK, 2006, MICROBIAL ECOLOGY; Baldrian P, 2008, FUNGAL ECOL, V1, P4, DOI 10.1016/j.funeco.2008.02.001; Berg B, 1997, ENVIRON REV, V5, P1, DOI DOI 10.1139/ER-5-1-1; Birks SJ, 1997, MICROBIOL-UK, V143, P755, DOI 10.1099/00221287-143-3-755; Blanch HW, 2008, ACS CHEM BIOL, V3, P17, DOI 10.1021/cb700267s; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Chacon N, 2006, BIOGEOCHEMISTRY, V78, P67, DOI 10.1007/s10533-005-2343-3; Charles D, 2009, SCIENCE, V324, P587, DOI 10.1126/science.324_587; Cusack DF, 2009, GLOBAL CHANGE BIOL, V15, P1339, DOI 10.1111/j.1365-2486.2008.01781.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; DEANGELIS KM, 2010, ENV MICROBI IN PRESS; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; Degelmann DM, 2009, FEMS MICROBIOL ECOL, V68, P312, DOI 10.1111/j.1574-6941.2009.00681.x; DeRito CM, 2005, APPL ENVIRON MICROB, V71, P7858, DOI 10.1128/AEM.71.12.7858-7865.2005; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; DeSantis TZ, 2007, MICROBIAL ECOLOGY; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; DUBINSKY EA, 2008, ENV CONTROLS MICROBI; Dubinsky EA, 2010, ECOLOGY, V91, P2604, DOI 10.1890/09-1365.1; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Glissmann K, 2005, FEMS MICROBIOL ECOL, V52, P43, DOI 10.1016/j.femsec.2004.10.004; Heising S, 1998, MICROBIOL-SGM, V144, P2263, DOI 10.1099/00221287-144-8-2263; Hershberger KL, 1996, NATURE, V384, P420, DOI 10.1038/384420a0; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Koga S, 1999, BBA-PROTEIN STRUCT M, V1435, P117, DOI 10.1016/S0167-4838(99)00190-9; Kunin V, 2010, OPEN J; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Liptzin D, 2011, ECOSYSTEMS, V14, P171, DOI 10.1007/s10021-010-9402-x; Liptzin D, 2009, SOIL BIOL BIOCHEM, V41, P1696, DOI 10.1016/j.soilbio.2009.05.013; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Ostertag R, 2001, ECOLOGY, V82, P485, DOI 10.1890/0012-9658(2001)082[0485:EONAPA]2.0.CO;2; PARKIN TB, 1984, SOIL BIOL BIOCHEM, V16, P331, DOI 10.1016/0038-0717(84)90027-0; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Pett-Ridge J, 2006, BIOGEOCHEMISTRY, V81, P95, DOI 10.1007/s10533-006-9032-8; Pruesse E, 2007, NUCL ACIDS RES, V35; RAMACHANDRA M, 1988, APPL ENVIRON MICROB, V54, P3057, DOI 10.1128/AEM.54.12.3057-3063.1988; Schloss PD, 2006, ENVIRON ENTOMOL, V35, P625, DOI 10.1603/0046-225X-35.3.625; Silver WL, 1999, BIOGEOCHEMISTRY, V44, P301, DOI 10.1007/BF00996995; Singh S, 2009, BIOTECHNOL BIOENG, V104, P68, DOI 10.1002/bit.22386; Steinman HM, 1997, J BACTERIOL, V179, P6831, DOI 10.1128/jb.179.21.6831-6836.1997; Sublette K, 2006, GROUND WATER MONIT R, V26, P70, DOI 10.1111/j.1745-6592.2006.00072.x; Valaskova V, 2009, ISME J, V3, P1218, DOI 10.1038/ismej.2009.64; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Webb CO, 2007, PHYLOCOM SOFTWARE AN; Wei H, 2009, CURR OPIN BIOTECH, V20, P330, DOI 10.1016/j.copbio.2009.05.008; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990	54	125	131	2	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19306	10.1371/journal.pone.0019306	http://dx.doi.org/10.1371/journal.pone.0019306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559391	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700130
J	Drake, AC; Khoury, M; Leskov, I; Iliopoulou, BP; Fragoso, M; Lodish, H; Chen, JZ				Drake, Adam C.; Khoury, Maroun; Leskov, Ilya; Iliopoulou, Bettina P.; Fragoso, Maria; Lodish, Harvey; Chen, Jianzhu			Human CD34(+) CD133(+) Hematopoietic Stem Cells Cultured with Growth Factors Including Angptl5 Efficiently Engraft Adult NOD-SCID Il2r gamma(-/-) (NSG) Mice	PLOS ONE			English	Article							EX-VIVO EXPANSION; UMBILICAL-CORD BLOOD; PROGENITOR CELLS; TRANSPLANTATION; PROGRESS	Increasing demand for human hematopoietic stem cells (HSCs) in clinical and research applications necessitates expansion of HSCs in vitro. Before these cells can be used they must be carefully evaluated to assess their stem cell activity. Here, we expanded cord blood CD34(+) CD133(+) cells in a defined medium containing angiopoietin like 5 and insulin-like growth factor binding protein 2 and evaluated the cells for stem cell activity in NOD-SCID Il2rg(-/-) (NSG) mice by multi-lineage engraftment, long term reconstitution, limiting dilution and serial reconstitution. The phenotype of expanded cells was characterized by flow cytometry during the course of expansion and following engraftment in mice. We show that the SCID repopulating activity resides in the CD34(+) CD133(+) fraction of expanded cells and that CD34(+) CD133(+) cell number correlates with SCID repopulating activity before and after culture. The expanded cells mediate long-term hematopoiesis and serial reconstitution in NSG mice. Furthermore, they efficiently reconstitute not only neonate but also adult NSG recipients, generating human blood cell populations similar to those reported in mice reconstituted with uncultured human HSCs. These findings suggest an expansion of long term HSCs in our culture and show that expression of CD34 and CD133 serves as a marker for HSC activity in human cord blood cell cultures. The ability to expand human HSCs in vitro should facilitate clinical use of HSCs and large-scale construction of humanized mice from the same donor for research applications.	[Drake, Adam C.; Khoury, Maroun; Leskov, Ilya; Iliopoulou, Bettina P.; Fragoso, Maria; Lodish, Harvey; Chen, Jianzhu] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Khoury, Maroun; Chen, Jianzhu] Singapore MIT Alliance Res & Technol SMART, Interdisciplinary Res Grp Infect Dis, Singapore, Singapore; [Lodish, Harvey] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART); Massachusetts Institute of Technology (MIT); Whitehead Institute	Drake, AC (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jchen@mit.edu		Khoury, Maroun/0000-0002-9965-6266	Singapore MIT Alliance for Research and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Singapore MIT Alliance for Research and Technology(Singapore-MIT Alliance for Research & Technology Centre (SMART)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by the Singapore MIT Alliance for Research and Technology Infectious disease research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; CHEN Q, 2009, P NATL ACAD SCI US; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Dieterlen-Lievre F, 2007, CR BIOL, V330, P504, DOI 10.1016/j.crvi.2007.05.003; Giassi LJ, 2008, EXP BIOL MED, V233, P997, DOI 10.3181/0802-RM-70; Gluckman E, 2009, HAEMATOL-HEMATOL J, V94, P451, DOI 10.3324/haematol.2009.005694; Hayakawa J, 2009, STEM CELLS, V27, P175, DOI 10.1634/stemcells.2008-0583; Huynh HD, 2008, STEM CELLS, V26, P1628, DOI 10.1634/stemcells.2008-0064; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Manz Markus G, 2009, Nat Immunol, V10, P1039, DOI 10.1038/ni1009-1039; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pecora AL, 2001, CURR OPIN HEMATOL, V8, P142, DOI 10.1097/00062752-200105000-00003; Robinson S, 2005, CYTOTHERAPY, V7, P243, DOI 10.1080/14653240510027172; Sauvageau G, 2010, SCIENCE, V329, P1291, DOI 10.1126/science.1195173; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Wodnar-Filipowicz A, 2003, NEWS PHYSIOL SCI, V18, P247, DOI 10.1152/nips.01452.2003; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang CC, 2008, CURR OPIN HEMATOL, V15, P307, DOI 10.1097/MOH.0b013e3283007db5; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	27	44	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18382	10.1371/journal.pone.0018382	http://dx.doi.org/10.1371/journal.pone.0018382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559522	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700012
J	Eliasson, B; Svensson, AM; Miftaraj, M; Jonasson, JM; Eeg-Olofsson, K; Sundell, KA; Gudbjornsdottir, S				Eliasson, Bjorn; Svensson, Ann-Marie; Miftaraj, Mervete; Jonasson, Junmei Miao; Eeg-Olofsson, Katarina; Sundell, Karolina Andersson; Gudbjornsdottir, Soffia			Clinical Use and Effectiveness of Lipid Lowering Therapies in Diabetes Mellitus-An Observational Study from the Swedish National Diabetes Register	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ATORVASTATIN; CHOLESTEROL; EFFICACY; METAANALYSIS; SIMVASTATIN; PRAVASTATIN; STATINS	Objectives: To describe the use and evaluate the effectiveness of different lipid lowering therapies in unselected patients with type 1 and type 2 diabetes in clinical practice. Design: Observational population-based study using the personal identification number to link information from the National Diabetes Register, the Prescribed Drug Register and the Patient register in Sweden. All patients in the NDR aged 18-75 years with diabetes more than one year were eligible, but only patients starting any lipid lowering treatment with at least three prescriptions 1 July 2006-30 June 2007 were included (n = 37182). The mean blood lipid levels in 2008 and reductions in LDL cholesterol were examined. Results: Blood lipid levels were similar in patients treated with simvastatin, atorvastatin and rosuvastatin, showing similar lipid lowering effect as currently used. Users of pravastatin, fluvastatin, ezetimib and fibrate more seldom reach treatment goals. Moderate daily doses of the statins were used, with 76% of simvastatin users taking 20 mg or less, 48% of atorvastatin users taking 10 mg, 55% of pravastatin users taking 20 mg, and 76% of rosuvastatin users taking 5 or 10 mg. Conclusions: This observational study shows that the LDL-C levels in patients taking simvastatin, atorvastatin or rosuvastatin are very similar as currently used, as well as their LDL-C lowering abilities. There is potential to intensify lipid lowering treatment to reduce the remaining high residual risk and achieve better fulfilment of treatment goals, since the commonly used doses are only low to moderate.	[Eliasson, Bjorn; Eeg-Olofsson, Katarina; Gudbjornsdottir, Soffia] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Med, Gothenburg, Sweden; [Jonasson, Junmei Miao] Univ Gothenburg, Inst Clin Sci, Dept Oncol, Gothenburg, Sweden; [Svensson, Ann-Marie; Miftaraj, Mervete; Jonasson, Junmei Miao; Gudbjornsdottir, Soffia] Natl Diabet Register NDR, Gothenburg, Sweden; [Sundell, Karolina Andersson] Nord Sch Publ Hlth, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg	Eliasson, B (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Med, Gothenburg, Sweden.	bjorn.eliasson@gu.se	Sundell, Karolina A Andersson/E-6046-2010; Miao Jonasson, Junmei/B-3242-2014; Eliasson, Bjorn/H-5783-2016	Miao Jonasson, Junmei/0000-0003-0206-8538; Eliasson, Bjorn/0000-0003-2569-4160	Region Vastra Gotaland; Swedish Association of Local Authorities and Regions; Pfizer AB, Sweden	Region Vastra Gotaland; Swedish Association of Local Authorities and Regions; Pfizer AB, Sweden	The Region Vastra Gotaland and the Swedish Association of Local Authorities and Regions fund the NDR. This study was also supported by an unrestricted research grant from Pfizer AB, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, DIABETES CARE S1, V33, pS4, DOI DOI 10.2337/DC10-S004; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Eeg-Olofsson K, 2009, DIABETOLOGIA, V52, P65, DOI 10.1007/s00125-008-1190-x; Eeg-Olofsson K, 2010, DIABETES CARE, V33, P1640, DOI 10.2337/dc10-0398; Eriksson M, 2011, EUR J CARDIOV PREV R, V18, P97, DOI 10.1097/HJR.0b013e32833ba61e; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gudbjornsdottir S, 2009, DIABETIC MED, V26, P53, DOI 10.1111/j.1464-5491.2008.02633.x; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Merlo J, 2000, EUR J EPIDEMIOL, V16, P235, DOI 10.1023/A:1007634722658; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Weng TC, 2010, J CLIN PHARM THER, V35, P139, DOI 10.1111/j.1365-2710.2009.01085.x; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	17	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18744	10.1371/journal.pone.0018744	http://dx.doi.org/10.1371/journal.pone.0018744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559521	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700023
J	Lindgren, J; Uvdal, P; Engdahl, A; Lee, AH; Alwmark, C; Bergquist, KE; Nilsson, E; Ekstrom, P; Rasmussen, M; Douglas, DA; Polcyn, MJ; Jacobs, LL				Lindgren, Johan; Uvdal, Per; Engdahl, Anders; Lee, Andrew H.; Alwmark, Carl; Bergquist, Karl-Erik; Nilsson, Einar; Ekstrom, Peter; Rasmussen, Magnus; Douglas, Desiree A.; Polcyn, Michael J.; Jacobs, Louis L.			Microspectroscopic Evidence of Cretaceous Bone Proteins	PLOS ONE			English	Article							COLLAGEN; PRESERVATION; PURIFICATION; SEQUENCES; HADROSAUR; BACTERIAL	Low concentrations of the structural protein collagen have recently been reported in dinosaur fossils based primarily on mass spectrometric analyses of whole bone extracts. However, direct spectroscopic characterization of isolated fibrous bone tissues, a crucial test of hypotheses of biomolecular preservation over deep time, has not been performed. Here, we demonstrate that endogenous proteinaceous molecules are retained in a humerus from a Late Cretaceous mosasaur (an extinct giant marine lizard). In situ immunofluorescence of demineralized bone extracts shows reactivity to antibodies raised against type I collagen, and amino acid analyses of soluble proteins extracted from the bone exhibit a composition indicative of structural proteins or their breakdown products. These data are corroborated by synchrotron radiation-based infrared microspectroscopic studies demonstrating that amino acid containing matter is located in bone matrix fibrils that express imprints of the characteristic 67 nm D-periodicity typical of collagen. Moreover, the fibrils differ significantly in spectral signature from those of potential modern bacterial contaminants, such as biofilms and collagen-like proteins. Thus, the preservation of primary soft tissues and biomolecules is not limited to large-sized bones buried in fluvial sandstone environments, but also occurs in relatively small-sized skeletal elements deposited in marine sediments.	[Lindgren, Johan; Alwmark, Carl] Lund Univ, Div Geol, Dept Earth & Ecosyst Sci, Lund, Sweden; [Uvdal, Per; Engdahl, Anders] Lund Univ, Max Lab, Lund, Sweden; [Engdahl, Anders] Midwestern Univ, Dept Anat, Glendale, AZ USA; [Bergquist, Karl-Erik; Nilsson, Einar] Lund Univ, Dept Chem, Div Organ Chem, Lund, Sweden; [Ekstrom, Peter; Douglas, Desiree A.] Lund Univ, Dept Biol, Lund, Sweden; [Rasmussen, Magnus] Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Polcyn, Michael J.; Jacobs, Louis L.] So Methodist Univ, Roy M Huffington Dept Earth Sci, Dallas, TX 75275 USA	Lund University; Lund University; Midwestern University; Lund University; Lund University; Lund University; Southern Methodist University	Lindgren, J (corresponding author), Lund Univ, Div Geol, Dept Earth & Ecosyst Sci, Lund, Sweden.	johan.lindgren@geol.lu.se; per.uvdal@chemphys.lu.se	Engdahl, Anders/A-5081-2019	Lee, Andrew/0000-0001-7829-334X; Rasmussen, Magnus/0000-0003-1588-5473; Engdahl, Anders/0000-0001-6562-0639; Jacobs, Louis/0000-0002-7735-3678	Swedish Research Council; Crafoord Foundation; Royal Swedish Academy of Sciences	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Royal Swedish Academy of Sciences	This research was supported by the Swedish Research Council, the Crafoord Foundation and the Royal Swedish Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Buckley M, 2008, SCIENCE, V319, DOI 10.1126/science.1147046; Cai SW, 2004, BIOCHEMISTRY-US, V43, P2541, DOI 10.1021/bi030149y; Cai YL, 2006, SCRIPTA MATER, V54, P89, DOI 10.1016/j.scriptamat.2005.09.001; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; Derrick M., 1991, BOOK PAPER ANN, V10, P49; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Geigl EM, 2004, ENVIRON CHEM LETT, V2, P45, DOI 10.1007/s10311-004-0059-6; Goffredi SK, 2005, ENVIRON MICROBIOL, V7, P1369, DOI 10.1111/j.1462-2920.2005.00824.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Holmberg A, 2009, CLIN MICROBIOL INFEC, V15, P787, DOI 10.1111/j.1469-0691.2009.02747.x; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; JAKOBSEN RJ, 1983, SCIENCE, V220, P1288, DOI 10.1126/science.6857249; Jamin N, 1998, P NATL ACAD SCI USA, V95, P4837, DOI 10.1073/pnas.95.9.4837; Kaminska A, 1996, POLYM DEGRAD STABIL, V51, P19, DOI 10.1016/0141-3910(95)00159-X; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; Kennedy CJ, 2003, RESTAURATOR, V24, P61, DOI 10.1515/REST.2003.61; Kolovou P, 2007, NATO SEC SCI B PHYS, P267, DOI 10.1007/978-1-4020-5724-3_24; Lindgren J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011998; Manning PL, 2009, P ROY SOC B-BIOL SCI, V276, P3429, DOI 10.1098/rspb.2009.0812; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Peterson JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013334; Petibois C, 2001, CLIN CHEM, V47, P730; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Russell D. A., 1967, Bulletin of the Peabody Museum of Natural History, V23, P1; Schweitzer MH, 2009, SCIENCE, V324, P626, DOI 10.1126/science.1165069; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Sionkowska A, 2006, INT J PHOTOENERGY, V2006, DOI 10.1155/IJP/2006/29196; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Tuross N, 2002, ARCHAEOMETRY, V44, P427, DOI 10.1111/1475-4754.00075; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740	35	38	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19445	10.1371/journal.pone.0019445	http://dx.doi.org/10.1371/journal.pone.0019445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559386	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700174
J	Milenkovic, VM; Krejcova, S; Reichhart, N; Wagner, A; Strauss, O				Milenkovic, Vladimir M.; Krejcova, Sarka; Reichhart, Nadine; Wagner, Andrea; Strauss, Olaf			Interaction of Bestrophin-1 and Ca2+ Channel beta-Subunits: Identification of New Binding Domains on the Bestrophin-1 C-Terminus	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; CALCIUM-CHANNELS; BEST-DISEASE; LIGHT PEAK; GENE; ACTIVATION; MUTATIONS; COMPLEX; CELLS; ONSET	Bestrophin-1 modulates currents through voltage-dependent L-type Ca2+ channels by physically interacting with the beta-subunits of Ca2+ channels. The main function of beta-subunits is to regulate the number of pore-forming Ca-V-subunits in the cell membrane and modulate Ca2+ channel currents. To understand the influence of full-length bestrophin-1 on beta-subunit function, we studied binding and localization of bestrophin-1 and Ca2+ channel subunits, together with modulation of Ca(V)1.3 Ca2+ channels currents. In heterologeous expression, bestrophin-1 showed co-immunoprecipitation with either, beta 3-, or beta 4-subunits. We identified a new highly conserved cluster of proline-rich motifs on the bestrophin-1 C-terminus between amino acid position 468 and 486, which enables possible binding to SH3-domains of beta-subunits. A bestrophin-1 that lacks these proline-rich motifs (Delta CT-PxxP bestrophin-1) showed reduced efficiency to co-immunoprecipitate with beta 3 and beta 4-subunits. In the presence of Delta CT-PxxP bestrophin-1, beta 4-subunits and Ca(V)1.3 subunits partly lost membrane localization. Currents from Ca(V)1.3 subunits were modified in the presence of beta 4-subunit and wild-type bestrophin-1: accelerated time-dependent activation and reduced current density. With Delta CTPxxP bestrophin-1, currents showed the same time-dependent activation as with wild-type bestrophin-1, but the current density was further reduced due to decreased number of Ca2+ channels proteins in the cell membrane. In summary, we described new proline-rich motifs on bestrophin-1 C-terminus, which help to maintain the ability of beta-subunits to regulate surface expression of pore-forming Ca-V Ca2+-channel subunits.	[Milenkovic, Vladimir M.; Reichhart, Nadine; Wagner, Andrea; Strauss, Olaf] Univ Med Ctr Regensburg, Hosp Eye, Regensburg, Germany; [Krejcova, Sarka] Univ Klinikum Hamburg Eppendorf, Klin & Poliklin Augenheilkunde, Hamburg, Germany	University of Regensburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Milenkovic, VM (corresponding author), Univ Med Ctr Regensburg, Hosp Eye, Regensburg, Germany.	strauss@eye-regensburg.de	Strauss, Olaf/AAA-6485-2019	Strauss, Olaf/0000-0002-6272-8596	Deutsche Forschungsgemeinschaft (German Research Council) DFG [STR480/9-2, STRA480/10-1]; Gertrud Kusen Stiftung	Deutsche Forschungsgemeinschaft (German Research Council) DFG(German Research Foundation (DFG)); Gertrud Kusen Stiftung	Deutsche Forschungsgemeinschaft (German Research Council) DFG grants STR480/9-2 and STRA480/10-1 and Gertrud Kusen Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arden GB, 2006, PROG RETIN EYE RES, V25, P207, DOI 10.1016/j.preteyeres.2005.11.001; Bakall B, 2007, EXP EYE RES, V85, P34, DOI 10.1016/j.exer.2007.02.018; Buraei Z, PHYSL REV, V90, P1461; Burgess R, 2008, AM J HUM GENET, V82, P19, DOI 10.1016/j.ajhg.2007.08.004; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; CROSS HE, 1974, AM J OPHTHALMOL, V77, P46, DOI 10.1016/0002-9394(74)90603-5; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Fan JS, 2001, AM J PHYSIOL-CELL PH, V280, pC565, DOI 10.1152/ajpcell.2001.280.3.C565; FRANGIEH GT, 1982, ARCH OPHTHALMOL-CHIC, V100, P1115; GALLEMORE RP, 1989, J NEUROSCI, V9, P1977; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Karl MO, 2008, CELL SIGNAL, V20, P1159, DOI 10.1016/j.cellsig.2008.02.005; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Marmorstein AD, 2007, EXP EYE RES, V85, P423, DOI 10.1016/j.exer.2006.03.021; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; Marquardt A, 1998, HUM MOL GENET, V7, P1517, DOI 10.1093/hmg/7.9.1517; Michna M, 2003, J PHYSIOL-LONDON, V553, P747, DOI 10.1113/jphysiol.2003.053256; Milenkovic VM, 2009, PFLUG ARCH EUR J PHY, V458, P431, DOI 10.1007/s00424-008-0626-y; Mullins RF, 2005, ARCH OPHTHALMOL-CHIC, V123, P1588, DOI 10.1001/archopht.123.11.1588; Mullins RF, 2007, INVEST OPHTH VIS SCI, V48, P3372, DOI 10.1167/iovs.06-0868; OGORMAN S, 1988, ARCH OPHTHALMOL-CHIC, V106, P1261; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Reichhart N, 2010, EXP EYE RES, V91, P630, DOI 10.1016/j.exer.2010.08.001; Renner AB, 2005, OPHTHALMOLOGY, V112, P586, DOI 10.1016/j.ophtha.2004.10.041; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Rosenthal R, 2005, FASEB J, V19, P178, DOI 10.1096/fj.05-4495fje; Rosenthal R, 2007, MOL VIS, V13, P443; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Striessnig J, 2004, BIOCHEM BIOPH RES CO, V322, P1341, DOI 10.1016/j.bbrc.2004.08.039; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Wabbels B, 2006, GRAEF ARCH CLIN EXP, V244, P1453, DOI 10.1007/s00417-006-0286-6; WEINGEIST TA, 1982, ARCH OPHTHALMOL-CHIC, V100, P1108; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002; Yu K, 2008, J NEUROSCI, V28, P5660, DOI 10.1523/JNEUROSCI.0065-08.2008	39	33	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19364	10.1371/journal.pone.0019364	http://dx.doi.org/10.1371/journal.pone.0019364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559412	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700149
J	Moncalero, VL; Costanzo, RV; Perandones, C; Radrizzani, M				Moncalero, Vera L.; Costanzo, Roxana V.; Perandones, Claudia; Radrizzani, Martin			Different Conformations of Phosphatase and Tensin Homolog, Deleted on Chromosome 10 (PTEN) Protein within the Nucleus and Cytoplasm of Neurons	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; SUBCELLULAR-LOCALIZATION; PRION PROTEIN; EXPRESSION; TISSUE; OLIGOBODIES; MUTATIONS; MOLECULES; GERMLINE; SURVIVAL	PTEN is a critical gene involved in the regulation of many cellular processes. The product of this gene has dual phosphatase activity and is able to dephosphorylate the 59 end of the phosphatidylinositol (3,4,5)-trisphosphate. Within the cellular nucleus, this protein has been associated with regulation of the expression of many genes, although the mechanism of this regulation remains unclear. In this paper, two specific oligonucleotide aptamers were developed and selected, using the SELEX procedure, according to their ability to detect the PTEN protein in different subcellular compartments of neurons. While one aptamer was able to detect PTEN in the nucleus, the other recognized PTEN in the cytoplasm. The recognition pattern of PTEN by both aptamers was confirmed using antibodies in western blots of the proteins purified from mouse cerebellar homogenates and subcellular fractions. Additionally, we demonstrated that the two aptamers recognized different epitopes of the target peptide. The results presented here could not be fully explained by the canonical phosphatase structure of PTEN, suggesting the existence of different conformations of phosphatase in the nucleus and the cytoplasm.	[Moncalero, Vera L.; Radrizzani, Martin] Univ Nacl San Martin, CONICET, Ctr Estudios Salud & Medio Ambiente, Lab Neuro & Citogenet Mol, Buenos Aires, DF, Argentina; [Costanzo, Roxana V.; Perandones, Claudia] Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Perandones, Claudia] Natl Agcy Labs, ANLIS, Buenos Aires, DF, Argentina; [Perandones, Claudia] Hlth Inst Argentina, Buenos Aires, DF, Argentina; [Perandones, Claudia] Univ Buenos Aires, Hosp Clin Jose de San Martin, Parkinsons Dis & Movement Disorders Program, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires	Moncalero, VL (corresponding author), Univ Nacl San Martin, CONICET, Ctr Estudios Salud & Medio Ambiente, Lab Neuro & Citogenet Mol, Buenos Aires, DF, Argentina.	martin.radrizzani@gmail.com			"Consejo Nacional de Investigaciones cientificas y tecnologicas" CONICET [236]	"Consejo Nacional de Investigaciones cientificas y tecnologicas" CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the "Consejo Nacional de Investigaciones cientificas y tecnologicas" CONICET, PICT 2006 No 236 to M. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Blanco-Aparicio C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009305; Chung JH, 2005, CANCER RES, V65, P4108, DOI 10.1158/0008-5472.CAN-05-0124; CONTI CJ, 1988, J HISTOCHEM CYTOCHEM, V36, P547, DOI 10.1177/36.5.3282007; Deleris P, 2003, J BIOL CHEM, V278, P38884, DOI 10.1074/jbc.M300816200; Deleris P, 2006, J CELL BIOCHEM, V98, P469, DOI 10.1002/jcb.20695; Denning G, 2007, ONCOGENE, V26, P3930, DOI 10.1038/sj.onc.1210175; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Fridberg M, 2007, LEUKEMIA LYMPHOMA, V48, P2221, DOI 10.1080/10428190701636443; Gil A, 2007, CELL DEATH DIFFER, V14, P395, DOI 10.1038/sj.cdd.4402073; Gillespie JW, 2002, AM J PATHOL, V160, P449, DOI 10.1016/S0002-9440(10)64864-X; Gimm O, 2000, AM J PATHOL, V156, P1693, DOI 10.1016/S0002-9440(10)65040-7; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Lian ZL, 2005, ONCOGENE, V24, P7394, DOI 10.1038/sj.onc.1209089; Lindsay Y, 2006, J CELL SCI, V119, P5160, DOI 10.1242/jcs.000133; Liu FH, 2005, J CELL BIOCHEM, V96, P221, DOI 10.1002/jcb.20525; Liu JL, 2007, CANCER RES, V67, P11054, DOI 10.1158/0008-5472.CAN-07-1263; Lobo GP, 2008, HUM MOL GENET, V17, P2877, DOI 10.1093/hmg/ddn185; Lobo GP, 2009, HUM MOL GENET, V18, P2851, DOI 10.1093/hmg/ddp220; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Moroncini G, 2006, NEUROBIOL DIS, V23, P717, DOI 10.1016/j.nbd.2006.06.008; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Perandones C, 2004, MOL BRAIN RES, V128, P8, DOI 10.1016/j.molbrainres.2004.05.021; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Radrizzani M, 1999, MEDICINA-BUENOS AIRE, V59, P753; Radrizzani M, 2000, MEDICINA-BUENOS AIRE, V60, P55; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stokoe D, 2001, CURR BIOL, V11, pR502, DOI 10.1016/S0960-9822(01)00303-7; Tachibana M, 2002, CANCER-AM CANCER SOC, V94, P1955, DOI 10.1002/cncr.0678; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang JH, 2002, MOL IMMUNOL, V38, P1039, DOI 10.1016/S0161-5890(02)00033-0; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; White R, 2001, MOL THER, V4, P567, DOI 10.1006/mthe.2001.0495; Whiteman DC, 2002, INT J CANCER, V99, P63, DOI 10.1002/ijc.10294; Zhou XP, 2000, HUM MOL GENET, V9, P765, DOI 10.1093/hmg/9.5.765; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9	47	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18857	10.1371/journal.pone.0018857	http://dx.doi.org/10.1371/journal.pone.0018857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559530	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700028
J	Naoki, H; Nakamuta, S; Kaibuchi, K; Ishii, S				Naoki, Honda; Nakamuta, Shinichi; Kaibuchi, Kozo; Ishii, Shin			Flexible Search for Single-Axon Morphology during Neuronal Spontaneous Polarization	PLOS ONE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; SYMMETRY-BREAKING; POLARITY; TRANSPORT; CRMP-2; MECHANISMS; KINESIN-1; COMPLEX; ESTABLISHMENT; PROTEINS	Polarization, a disruption of symmetry in cellular morphology, occurs spontaneously, even in symmetrical extracellular conditions. This process is regulated by intracellular chemical reactions and the active transport of proteins and it is accompanied by cellular morphological changes. To elucidate the general principles underlying polarization, we focused on developing neurons. Neuronal polarity is stably established; a neuron initially has several neurites of similar length, but only one elongates and is selected to develop into an axon. Polarization is flexibly controlled; when multiple neurites are selected, the selection is eventually reduced to yield a single axon. What is the system by which morphological information is decoded differently based on the presence of a single or multiple axons? How are stability and flexibility achieved? To answer these questions, we constructed a biophysical model with the active transport of proteins that regulate neurite growth. Our mathematical analysis and computer simulation revealed that, as neurites elongate, transported factors accumulate in the growth cone but are degraded during retrograde diffusion to the soma. Such a system effectively works as local activation-global inhibition mechanism, resulting in both stability and flexibility. Our model shows good accordance with a number of experimental observations.	[Naoki, Honda; Ishii, Shin] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Nakamuta, Shinichi; Kaibuchi, Kozo] Nagoya Univ, Dept Cell Pharmacol, Aichi, Japan; [Ishii, Shin] RIKEN Computat Sci Res Program, Wako, Saitama, Japan	Kyoto University; Nagoya University; RIKEN	Naoki, H (corresponding author), Kyoto Univ, Grad Sch Informat, Kyoto, Japan.	n-honda@sys.i.kyoto-u.ac.jp	Naoki, Honda/N-5674-2017; Kaibuchi, Kozo/M-4887-2014; Naoki, Honda/AAW-6284-2020	Naoki, Honda/0000-0001-6816-9126; Kaibuchi, Kozo/0000-0003-0714-1992; Naoki, Honda/0000-0001-6816-9126; Ishii, Shin/0000-0001-9385-8230	Japan Society for the Promotion of Science from the MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan [19-11235]; MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan [100081400012]	Japan Society for the Promotion of Science from the MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Honda Naoki was supported by a research fellowship from the Japan Society for the Promotion of Science from the MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan. Grant number: 19-11235, http://www.jsps.go.jp/j-pd/index.html. Shin Ishii and Honda Naoki were supported by the Next Generation Supercomputing Project (Shin Ishii and Honda Naoki) from the MEXT (Ministry of Education, Culture, Sports, Science, and Technology) of Japan. Grant number: 100081400012, http://www.nsc.riken.jp/index-eng.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DROZ B, 1963, J COMP NEUROL, V121, P325, DOI 10.1002/cne.901210304; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Fivaz M, 2008, CURR BIOL, V18, P44, DOI 10.1016/j.cub.2007.11.051; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Hirokawa N, 1997, CURR OPIN NEUROBIOL, V7, P605, DOI 10.1016/S0959-4388(97)80079-7; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.0.CO;2-Z; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; POPOV S, 1992, J NEUROSCI, V12, P77; Ruthel G, 1998, CELL MOTIL CYTOSKEL, V40, P160, DOI 10.1002/(SICI)1097-0169(1998)40:2<160::AID-CM5>3.0.CO;2-J; Samuels DC, 1996, PHILOS T ROY SOC B, V351, P1147, DOI 10.1098/rstb.1996.0099; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shinoda T, 2007, J NEUROSCI, V27, P4, DOI 10.1523/JNEUROSCI.3825-06.2007; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Toriyama M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.51; Tsuboi D, 2005, J NEUROCHEM, V95, P1629, DOI 10.1111/j.1471-4159.2005.03490.x; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19034	10.1371/journal.pone.0019034	http://dx.doi.org/10.1371/journal.pone.0019034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559492	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700055
J	Quaglio, E; Restelli, E; Garofoli, A; Dossena, S; De Luigi, A; Tagliavacca, L; Imperiale, D; Migheli, A; Salmona, M; Sitia, R; Forloni, G; Chiesa, R				Quaglio, Elena; Restelli, Elena; Garofoli, Anna; Dossena, Sara; De Luigi, Ada; Tagliavacca, Luigina; Imperiale, Daniele; Migheli, Antonio; Salmona, Mario; Sitia, Roberto; Forloni, Gianluigi; Chiesa, Roberto			Expression of Mutant or Cytosolic PrP in Transgenic Mice and Cells Is Not Associated with Endoplasmic Reticulum Stress or Proteasome Dysfunction	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; PATHOLOGICAL PRION PROTEIN; DISEASE-MODEL OCCURS; NERVE GROWTH-FACTOR; TRANSCRIPTION FACTOR; QUALITY-CONTROL; MOUSE MODEL; ER STRESS; UBIQUITIN/PROTEASOME SYSTEM; BIOCHEMICAL-PROPERTIES	The cellular pathways activated by mutant prion protein (PrP) in genetic prion diseases, ultimately leading to neuronal dysfunction and degeneration, are not known. Several mutant PrPs misfold in the early secretory pathway and reside longer in the endoplasmic reticulum (ER) possibly stimulating ER stress-related pathogenic mechanisms. To investigate whether mutant PrP induced maladaptive responses, we checked key elements of the unfolded protein response (UPR) in transgenic mice, primary neurons and transfected cells expressing two different mutant PrPs. Because ER stress favors the formation of untranslocated PrP that might aggregate in the cytosol and impair proteasome function, we also measured the activity of the ubiquitin proteasome system (UPS). Molecular, biochemical and immunohistochemical analyses found no increase in the expression of UPR-regulated genes, such as Grp78/Bip, CHOP/GADD153, or ER stress-dependent splicing of the mRNA encoding the X-box-binding protein 1. No alterations in UPS activity were detected in mutant mouse brains and primary neurons using the Ub(G76V)-GFP reporter and a new fluorogenic peptide for monitoring proteasomal proteolytic activity in vivo. Finally, there was no loss of proteasome function in neurons in which endogenous PrP was forced to accumulate in the cytosol by inhibiting cotranslational translocation. These results indicate that neither ER stress, nor perturbation of proteasome activity plays a major pathogenic role in prion diseases.	[Quaglio, Elena; Restelli, Elena; Garofoli, Anna; Dossena, Sara; Chiesa, Roberto] Dulbecco Telethon Inst, Milan, Italy; [Quaglio, Elena; Restelli, Elena; Garofoli, Anna; Dossena, Sara; Forloni, Gianluigi; Chiesa, Roberto] Mario Negri Inst Pharmacol Res, Dept Neurosci, I-20157 Milan, Italy; [De Luigi, Ada; Salmona, Mario] Mario Negri Inst Pharmacol Res, Dept Biochem & Mol Pharmacol, I-20157 Milan, Italy; [Tagliavacca, Luigina; Sitia, Roberto] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Tagliavacca, Luigina; Sitia, Roberto] Univ Vita Salute San Raffaele, Milan, Italy; [Imperiale, Daniele; Migheli, Antonio] Maria Vittoria Hosp, Neurol Unit, Human Prion Dis Ctr DOMP, Turin, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Maria Vittoria Hospital	Quaglio, E (corresponding author), Dulbecco Telethon Inst, Milan, Italy.	roberto.chiesa@marionegri.it	Forloni, Gianluigi/AAB-2115-2020; De Luigi, Ada/ABF-7913-2020; Restelli, Elena/J-7449-2018; Chiesa, Roberto/G-1561-2017; salmona, mario/AAA-7116-2020; salmona, mario/ABI-4066-2020; Sitia, Roberto/AAB-5005-2019	Forloni, Gianluigi/0000-0001-5374-3914; De Luigi, Ada/0000-0001-7907-7139; Restelli, Elena/0000-0002-6081-5178; Chiesa, Roberto/0000-0002-3842-3733; salmona, mario/0000-0002-9098-9873; Sitia, Roberto/0000-0001-7086-4152	Fondazione Telethon Italy [TCR05006]; European Community [QLG-CT-2001-2353]; Associazione Italiana Ricerca sul Cancro; Regione Lombardia; Fondazione Cariplo; Fondazione Monzino; Carrefour Foundation	Fondazione Telethon Italy(Fondazione Telethon); European Community(European Commission); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Regione Lombardia(Regione Lombardia); Fondazione Cariplo(Fondazione Cariplo); Fondazione Monzino; Carrefour Foundation	This work was supported by grants from Fondazione Telethon Italy (TCR05006), the European Community (QLG-CT-2001-2353), Associazione Italiana Ricerca sul Cancro, Regione Lombardia and Fondazione Cariplo. E.Q. was the recipient of fellowships from the Fondazione Monzino and Carrefour Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici M, 2010, J NEUROSCI RES, V88, P191, DOI 10.1002/jnr.22186; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Campana V, 2005, TRENDS CELL BIOL, V15, P102, DOI 10.1016/j.tcb.2004.12.002; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Cenci S, 2006, EMBO J, V25, P1104, DOI 10.1038/sj.emboj.7601009; Cheroni C, 2009, HUM MOL GENET, V18, P82, DOI 10.1093/hmg/ddn319; Chiesa R, 2000, J NEUROCHEM, V75, P72, DOI 10.1046/j.1471-4159.2000.0750072.x; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Chiesa R, 2000, P NATL ACAD SCI USA, V97, P5574, DOI 10.1073/pnas.97.10.5574; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Chiesa R, 2005, P NATL ACAD SCI USA, V102, P238, DOI 10.1073/pnas.0406173102; Chiesa R, 2004, TECHNIQUES PRION RES, P176; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Daude N, 1997, J BIOL CHEM, V272, P11604, DOI 10.1074/jbc.272.17.11604; Dossena S, 2008, NEURON, V60, P598, DOI 10.1016/j.neuron.2008.09.008; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Ferreiro E, 2006, NEUROBIOL DIS, V23, P669, DOI 10.1016/j.nbd.2006.05.011; Fioriti L, 2005, J BIOL CHEM, V280, P11320, DOI 10.1074/jbc.M412441200; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Harant H, 2006, J BIOL CHEM, V281, P30492, DOI 10.1074/jbc.M607243200; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz C, 2008, P NATL ACAD SCI USA, V105, P757, DOI 10.1073/pnas.0711094105; Hetz C, 2007, J BIOL CHEM, V282, P12725, DOI 10.1074/jbc.M611909200; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Jornvall H, 2001, J BIOL CHEM, V276, P5140, DOI 10.1074/jbc.M005200200; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kang SC, 2004, J PATHOL, V203, P603, DOI 10.1002/path.1555; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Massignan T, 2010, MOL CELL PROTEOMICS, V9, P611, DOI 10.1074/mcp.M900271-MCP200; Maynard CJ, 2009, P NATL ACAD SCI USA, V106, P13986, DOI 10.1073/pnas.0906463106; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rask K, 2000, INT J CANCER, V86, P337, DOI 10.1002/(SICI)1097-0215(20000501)86:3<337::AID-IJC6>3.3.CO;2-V; Restelli E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013725; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Ronzoni R, 2010, TRAFFIC, V11, P947, DOI 10.1111/j.1600-0854.2010.01071.x; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Solomon IH, 2010, CURR ISSUES MOL BIOL, V12, P51; Soto C, 2008, DEV CELL, V15, P339, DOI 10.1016/j.devcel.2008.09.001; Steele AD, 2007, PRION, V1, P243, DOI 10.4161/pri.1.4.5551; Tagliavacca L, 2003, BIOL CHEM, V384, P1273, DOI 10.1515/BC.2003.141; Tang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014207; Torres M, 2011, PLOS ONE, V5; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Urru SAM, 2010, J MED CHEM, V53, P7452, DOI 10.1021/jm100362x; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Xing XM, 2006, CLIN CHIM ACTA, V364, P308, DOI 10.1016/j.cca.2005.07.016; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Young Katherine, 1999, P139; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	72	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19339	10.1371/journal.pone.0019339	http://dx.doi.org/10.1371/journal.pone.0019339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559407	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700141
J	Rehman, AM; Coleman, M; Schwabe, C; Baltazar, G; Matias, A; Gomes, IR; Yellott, L; Aragon, C; Nchama, GN; Mzilahowa, T; Rowland, M; Kleinschmidt, I				Rehman, Andrea M.; Coleman, Mike; Schwabe, Christopher; Baltazar, Giovanna; Matias, Abrahan; Roncon Gomes, Irina; Yellott, Lee; Aragon, Cynthia; Nseng Nchama, Gloria; Mzilahowa, Themba; Rowland, Mark; Kleinschmidt, Immo			How Much Does Malaria Vector Control Quality Matter: The Epidemiological Impact of Holed Nets and Inadequate Indoor Residual Spraying	PLOS ONE			English	Article							EQUATORIAL-GUINEA; BIOKO ISLAND; UNTREATED BEDNETS; INTERVENTIONS; INFECTION; AREA	Background: Insecticide treated nets (ITN) and indoor residual spraying (IRS) are the two pillars of malaria vector control in Africa, but both interventions are beset by quality and coverage concerns. Data from three control programs were used to investigate the impact of: 1) the physical deterioration of ITNs, and 2) inadequate IRS spray coverage, on their respective protective effectiveness. Methods: Malaria indicator surveys were carried out in 2009 and 2010 in Bioko Island, mainland Equatorial Guinea and Malawi to monitor infection with P. falciparum in children, mosquito net use, net condition and spray status of houses. Nets were classified by their condition. The association between infection and quality and coverage of interventions was investigated. Results: There was reduced odds of infection with P. falciparum in children sleeping under ITNs that were intact (Odds ratio (OR): 0.65, 95% CI: 0.55-0.77 and OR: 0.81, 95% CI: 0.56-1.18 in Equatorial Guinea and in Malawi respectively), but the protective effect became less with increasingly worse condition of the net. There was evidence for a linear trend in infection per category increase in deterioration of nets. In Equatorial Guinea IRS offered protection to those in sprayed and unsprayed houses alike when neighbourhood spray coverage was high (>= 80%) compared to those living in areas of low IRS coverage (< 20%), regardless of whether the house they lived in was sprayed or not (adjusted OR=0.54, 95% CI 0.33-0.89). ITNs provided only personal protection, offering no protection to non users. Although similar effects were seen in Malawi, the evidence was much weaker than in Equatorial Guinea. Conclusions: Universal coverage strategies should consider policies for repair and replacement of holed nets and promote the care of nets by their owners. IRS programs should ensure high spray coverage since inadequate coverage gives little or no protection at all.	[Rehman, Andrea M.; Kleinschmidt, Immo] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1, England; [Coleman, Mike] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Schwabe, Christopher] Med Care Dev Int, Silver Spring, MD USA; [Baltazar, Giovanna; Matias, Abrahan; Aragon, Cynthia] Med Care Dev Int, Malabo, Equat Guinea; [Roncon Gomes, Irina; Yellott, Lee] Med Care Dev Int, Bata, Equat Guinea; [Nseng Nchama, Gloria] Minist Hlth & Social Welf, Malabo, Equat Guinea; [Mzilahowa, Themba] Malawi Coll Med, Malaria Alert Ctr, Blantyre, Malawi; [Rowland, Mark] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of London; London School of Hygiene & Tropical Medicine	Rehman, AM (corresponding author), London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1, England.	immo.kleinschmidt@lshtm.ac.uk	Rehman, Andrea/AAP-3172-2020; Rehman, Andrea M/H-1351-2015	Rehman, Andrea/0000-0001-9967-5822; Rehman, Andrea M/0000-0001-9967-5822; Coleman, Michael/0000-0003-4186-3526	government of Equatorial Guinea; Global Fund to Fight Aids, Tuberculosis and Malaria (GFATM); Marathon Foundation; Innovative Vector Control Consortium (Liverpool, United Kingdom); MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish	government of Equatorial Guinea; Global Fund to Fight Aids, Tuberculosis and Malaria (GFATM); Marathon Foundation; Innovative Vector Control Consortium (Liverpool, United Kingdom); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Bioko Island Malaria Control Project is funded by a consortium led by Marathon Oil Corporation (Houston, TX) under its corporate social responsibility programme and the government of Equatorial Guinea. Other members of the consortium are Noble Energy, Atlantic Methanol Company, SK of Korea, the Sociedad Nacional de Gas of Equatorial Guinea (SONAGAS), and GE Petrol. The EG Malaria Control Initiative on mainland Equatorial Guinea is funded by the Global Fund to Fight Aids, Tuberculosis and Malaria (GFATM) with additional financial support provided by the Marathon Foundation and the government of Equatorial Guinea. The Malaria Decision Support System project in Malawi is funded by the Innovative Vector Control Consortium (Liverpool, United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and have no commercial interest in the findings made in this article.	[Anonymous], 2009, STATA SURVEY DATA RE; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2009, STAT REL 11 STAT SOF; [Anonymous], 2006, IND RES SPRAYING US; Binka FN, 1998, AM J TROP MED HYG, V59, P80, DOI 10.4269/ajtmh.1998.59.80; Cano J, 2004, J MED ENTOMOL, V41, P158, DOI 10.1603/0022-2585-41.2.158; Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Hii JLK, 2001, T ROY SOC TROP MED H, V95, P7, DOI 10.1016/S0035-9203(01)90315-3; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Kleinschmidt I, 2006, AM J TROP MED HYG, V74, P972, DOI 10.4269/ajtmh.2006.74.972; Kleinschmidt I, 2007, AM J TROP MED HYG, V76, P1027, DOI 10.4269/ajtmh.2007.76.1027; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Malima RC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-38; Maxwell CA, 1999, T ROY SOC TROP MED H, V93, P4, DOI 10.1016/S0035-9203(99)90158-X; Mwangi TW, 2003, T ROY SOC TROP MED H, V97, P369, DOI 10.1016/S0035-9203(03)90056-3; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Ridl FC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-194; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137	24	59	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19205	10.1371/journal.pone.0019205	http://dx.doi.org/10.1371/journal.pone.0019205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559436	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700101
J	Saura, CA; Servian-Morilla, E; Scholl, FG				Saura, Carlos A.; Servian-Morilla, Emilia; Scholl, Francisco G.			Presenilin/gamma-Secretase Regulates Neurexin Processing at Synapses	PLOS ONE			English	Article							SYNAPTIC VESICLE EXOCYTOSIS; AMYLOID PRECURSOR PROTEIN; AUTISM SPECTRUM DISORDER; ALZHEIMERS-DISEASE; ALPHA-NEUREXINS; CELL-ADHESION; LENTIVIRAL VECTORS; ENDOPROTEOLYSIS; MUTATIONS; RELEASE	Neurexins are a large family of neuronal plasma membrane proteins, which function as trans-synaptic receptors during synaptic differentiation. The binding of presynaptic neurexins to postsynaptic partners, such as neuroligins, has been proposed to participate in a signaling pathway that regulates synapse formation/stabilization. The identification of mutations in neurexin genes associated with autism and mental retardation suggests that dysfunction of neurexins may underlie synaptic defects associated with brain disorders. However, the mechanisms that regulate neurexin function at synapses are still unclear. Here, we show that neurexins are proteolytically processed by presenilins (PS), the catalytic components of the gamma-secretase complex that mediates the intramembraneous cleavage of several type I membrane proteins. Inhibition of PS/gamma-secretase by using pharmacological and genetic approaches induces a drastic accumulation of neurexin C-terminal fragments (CTFs) in cultured rat hippocampal neurons and mouse brain. Neurexin-CTFs accumulate mainly at the presynaptic terminals of PS conditional double knockout (PS cDKO) mice lacking both PS genes in glutamatergic neurons of the forebrain. The fact that loss of PS function enhances neurexin accumulation at glutamatergic terminals mediated by neuroligin-1 suggests that PS regulate the processing of neurexins at glutamatergic synapses. Interestingly, presenilin 1 (PS1) is recruited to glutamatergic terminals mediated by neuroligin-1, thus concentrating PS1 at terminals containing beta-neurexins. Furthermore, familial Alzheimer's disease (FAD)-linked PS1 mutations differentially affect beta-neurexin-1 processing. Expression of PS1 M146L and PS1 H163R mutants in PS-/- cells rescues the processing of beta-neurexin-1, whereas PS1 C410Y and PS1 Delta E9 fail to rescue the processing defect. These results suggest that PS regulate the synaptic function and processing of neurexins at glutamatergic synapses, and that impaired neurexin processing by PS may play a role in FAD.	[Saura, Carlos A.] Univ Autonoma Barcelona, Inst Neurociencies, Dept Bioquim & Biol Mol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-08193 Barcelona, Spain; [Servian-Morilla, Emilia; Scholl, Francisco G.] Univ Seville, Dept Fisiol Med & Biofis, Inst Biomed Sevilla, Seville, Spain	Autonomous University of Barcelona; CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS)	Saura, CA (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Dept Bioquim & Biol Mol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-08193 Barcelona, Spain.	fgs@us.es	Saura, Carlos A/AFM-9239-2022; IBIS, NEUROGENETICA/P-2947-2015; Saura, Carlos A/D-2727-2011; Gomez Scholl, Francisco/K-7780-2018; SERVIAN MORILLA, EMILIA/S-8354-2017	Saura, Carlos A/0000-0003-3692-5657; Gomez Scholl, Francisco/0000-0003-1762-0700; SERVIAN MORILLA, EMILIA/0000-0002-6467-9740	Junta de Andalucia; Consejeria de Innovacion; Ciencia y Empresa [P07-CVI-02943]; Ministerio de Ciencia e Innovacion of Spain [SAF2010-20925, CIBERNED CB06/05/0042]	Junta de Andalucia(Junta de Andalucia); Consejeria de Innovacion; Ciencia y Empresa; Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the Junta de Andalucia, Consejeria de Innovacion, Ciencia y Empresa to FGS (Proyecto de Excelencia P07-CVI-02943) and Ministerio de Ciencia e Innovacion of Spain to CAS (SAF2010-20925 and CIBERNED CB06/05/0042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; Bot N, 2011, J BIOL CHEM, V286, P2762, DOI 10.1074/jbc.M110.142521; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Lee H, 2010, J NEUROSCI, V30, P11435, DOI 10.1523/JNEUROSCI.2946-10.2010; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Murayama O, 1999, PROG NEURO-PSYCHOPH, V23, P905, DOI 10.1016/S0278-5846(99)00034-2; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Saura CA, 2000, J BIOL CHEM, V275, P17136, DOI 10.1074/jbc.M909624199; Saura CA, 2005, J NEUROSCI, V25, P6755, DOI 10.1523/JNEUROSCI.1247-05.2005; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Steiner H, 1999, J BIOL CHEM, V274, P7615, DOI 10.1074/jbc.274.12.7615; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Wines-Samuelson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010195; Winkler E, 2009, BIOCHEMISTRY-US, V48, P1183, DOI 10.1021/bi801204g; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177	57	51	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19430	10.1371/journal.pone.0019430	http://dx.doi.org/10.1371/journal.pone.0019430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559374	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700168
J	Vazquez, A; Oltvai, ZN				Vazquez, Alexei; Oltvai, Zoltan N.			Molecular Crowding Defines a Common Origin for the Warburg Effect in Proliferating Cells and the Lactate Threshold in Muscle Physiology	PLOS ONE			English	Article							MITOCHONDRIAL ATP PRODUCTION; HUMAN SKELETAL-MUSCLE; AEROBIC GLYCOLYSIS; GLUTAMINE-METABOLISM; LACTIC-ACID; FATTY-ACID; IN-VIVO; OXYGEN; PERFORMANCE; EXERCISE	Aerobic glycolysis is a seemingly wasteful mode of ATP production that is seen both in rapidly proliferating mammalian cells and highly active contracting muscles, but whether there is a common origin for its presence in these widely different systems is unknown. To study this issue, here we develop a model of human central metabolism that incorporates a solvent capacity constraint of metabolic enzymes and mitochondria, accounting for their occupied volume densities, while assuming glucose and/or fatty acid utilization. The model demonstrates that activation of aerobic glycolysis is favored above a threshold metabolic rate in both rapidly proliferating cells and heavily contracting muscles, because it provides higher ATP yield per volume density than mitochondrial oxidative phosphorylation. In the case of muscle physiology, the model also predicts that before the lactate switch, fatty acid oxidation increases, reaches a maximum, and then decreases to zero with concomitant increase in glucose utilization, in agreement with the empirical evidence. These results are further corroborated by a larger scale model, including biosynthesis of major cell biomass components. The larger scale model also predicts that in proliferating cells the lactate switch is accompanied by activation of glutaminolysis, another distinctive feature of the Warburg effect. In conclusion, intracellular molecular crowding is a fundamental constraint for cell metabolism in both rapidly proliferating-and non-proliferating cells with high metabolic demand. Addition of this constraint to metabolic flux balance models can explain several observations of mammalian cell metabolism under steady state conditions.	[Vazquez, Alexei] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USA; [Vazquez, Alexei] Univ Med & Dent New Jersey, Canc Inst New Jersey, New Brunswick, NJ USA; [Oltvai, Zoltan N.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vazquez, A (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USA.	vazqueal@umdnj.edu			Robert Wood Johnson (RWJ) Foundation; National Institutes of Health (NIH) [NIAID U01 AI070499]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070499] Funding Source: NIH RePORTER	Robert Wood Johnson (RWJ) Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AV was sponsored by the Robert Wood Johnson (RWJ) Foundation. This work has been supported in part by National Institutes of Health (NIH) grant NIAID U01 AI070499 to ZNO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten J, 2004, INT J SPORTS MED, V25, P32, DOI 10.1055/s-2003-45231; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; Blomstrand E, 1997, J PHYSIOL-LONDON, V501, P455, DOI 10.1111/j.1469-7793.1997.455bn.x; Conley KE, 1998, J PHYSIOL-LONDON, V511, P935, DOI 10.1111/j.1469-7793.1998.935bg.x; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; FARRELL PA, 1979, MED SCI SPORT EXER, V11, P338; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; GLAS U, 1966, J CELL BIOL, V29, P507, DOI 10.1083/jcb.29.3.507; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hill AV, 1924, P R SOC LOND B-CONTA, V97, P155, DOI 10.1098/rspb.1924.0048; Hogan MC, 2001, J APPL PHYSIOL, V90, P1871, DOI 10.1152/jappl.2001.90.5.1871; HOPPELER H, 1987, J PHYSIOL-LONDON, V385, P661, DOI 10.1113/jphysiol.1987.sp016513; Hou XY, 2002, CLIN PHYSIOL FUNCT I, V22, P226, DOI 10.1046/j.1475-097X.2002.00423.x; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; HUME DA, 1978, BIOCHEM J, V174, P703, DOI 10.1042/bj1740703; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Kemper WF, 2001, P NATL ACAD SCI USA, V98, P723, DOI 10.1073/pnas.011387598; LEE B, 1983, P NATL ACAD SCI USA, V80, P622, DOI 10.1073/pnas.80.2.622; Liu Y, 2006, PROSTATE CANCER P D, V9, P230, DOI 10.1038/sj.pcan.4500879; Liu YY, 2010, ANTICANCER RES, V30, P369; Locasale JW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-88; Marcinek DJ, 2004, AM J PHYSIOL-CELL PH, V286, pC457, DOI 10.1152/ajpcell.00237.2003; MUNYON WH, 1959, EXP CELL RES, V17, P490, DOI 10.1016/0014-4827(59)90069-2; Parra-Bonilla G, 2010, AM J PHYSIOL-LUNG C, V299, pL513, DOI 10.1152/ajplung.00274.2009; Rich PR, 2003, BIOCHEM SOC T, V31, P1095; SAVINELL JM, 1992, J THEOR BIOL, V154, P421, DOI 10.1016/S0022-5193(05)80161-4; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; SCHWERZMANN K, 1989, P NATL ACAD SCI USA, V86, P1583, DOI 10.1073/pnas.86.5.1583; SCOPES RK, 1973, BIOCHEM J, V134, P197, DOI 10.1042/bj1340197; Sheikh K, 2005, BIOTECHNOL PROGR, V21, P112, DOI 10.1021/bp0498138; Shlomi T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002018; Short KR, 2001, AM J PHYSIOL-ENDOC M, V280, pE761, DOI 10.1152/ajpendo.2001.280.5.E761; Sidorenko Y, 2008, BIOTECHNOL PROGR, V24, P311, DOI 10.1021/bp0702673; Trabold O, 2003, WOUND REPAIR REGEN, V11, P504, DOI 10.1046/j.1524-475X.2003.11621.x; Vazquez A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-7; Vazquez A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-58; Vazquez A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000195; VOET D, 2006, FUNDAMENTALS BIOCH L; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WIBOM R, 1992, J APPL PHYSIOL, V73, P2004, DOI 10.1152/jappl.1992.73.5.2004; WILLIAMS R, 1993, J INVEST DERMATOL, V100, P834, DOI 10.1111/1523-1747.ep12476744; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105	44	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19538	10.1371/journal.pone.0019538	http://dx.doi.org/10.1371/journal.pone.0019538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559344	Green Published, gold, Green Accepted			2022-12-25	WOS:000290024700204
J	Yumoto, N; Lu, XF; Henry, TR; Miyachi, S; Nambu, A; Fukai, T; Takada, M				Yumoto, Naosugi; Lu, Xiaofeng; Henry, Thomas R.; Miyachi, Shigehiro; Nambu, Atsushi; Fukai, Tomoki; Takada, Masahiko			A Neural Correlate of the Processing of Multi-Second Time Intervals in Primate Prefrontal Cortex	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SUPPLEMENTARY EYE FIELD; NEURONAL-ACTIVITY; ELAPSED TIME; PREMOTOR CORTEX; WORKING-MEMORY; INTERNAL CLOCK; BASAL GANGLIA; REPRESENTATION; MACAQUE	Several areas of the brain are known to participate in temporal processing. Neurons in the prefrontal cortex (PFC) are thought to contribute to perception of time intervals. However, it remains unclear whether the PFC itself can generate time intervals independently of external stimuli. Here we describe a group of PFC neurons in area 9 that became active when monkeys recognized a particular elapsed time within the range of 1-7 seconds. Another group of area 9 neurons became active only when subjects reproduced a specific interval without external cues. Both types of neurons were individually tuned to recognize or reproduce particular intervals. Moreover, the injection of muscimol, a GABA agonist, into this area bilaterally resulted in an increase in the error rate during time interval reproduction. These results suggest that area 9 may process multi-second intervals not only in perceptual recognition, but also in internal generation of time intervals.	[Yumoto, Naosugi; Lu, Xiaofeng; Miyachi, Shigehiro; Takada, Masahiko] Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Neurosci, Dept Syst Neurosci, Tokyo, Japan; [Lu, Xiaofeng; Henry, Thomas R.] Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA; [Lu, Xiaofeng; Henry, Thomas R.] Univ Minnesota, Med Ctr, Clin Neurosci Ctr, Minneapolis, MN 55455 USA; [Lu, Xiaofeng] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan; [Miyachi, Shigehiro] Kyoto Univ, Primate Res Inst, Cognit Neurosci Sect, Aichi, Japan; [Nambu, Atsushi] Natl Inst Physiol Sci, Div Syst Neurophysiol, Aichi, Japan; [Fukai, Tomoki] RIKEN, Brain Sci Inst, Lab Neural Circuit Theory, Wako, Saitama, Japan; [Takada, Masahiko] Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Aichi, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Juntendo University; Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); RIKEN; Kyoto University	Yumoto, N (corresponding author), Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Neurosci, Dept Syst Neurosci, Tokyo, Japan.	luxxx049@umn.edu	Henry, Thomas/X-1756-2019; Fukai, Tomoki/A-3936-2015	Henry, Thomas/0000-0002-5708-903X; Fukai, Tomoki/0000-0001-6977-5638; Nambu, Atsushi/0000-0003-2153-5445	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17021050, 18500247, 20500293]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas "Integrative Brain Research" (17021050) to M. T., and Scientific Research (18500247 and 20500293) to X. L. from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe J, 2006, CURR OPIN NEUROBIOL, V16, P213, DOI 10.1016/j.conb.2006.03.008; Braitenberg V, 1967, Prog Brain Res, V25, P334; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; CHURCH RM, 1994, J EXP PSYCHOL ANIM B, V20, P135, DOI 10.1037/0097-7403.20.2.135; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Fortin C, 2009, ATTEN PERCEPT PSYCHO, V71, P789, DOI 10.3758/APP.71.4.789; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Genovesio A, 2006, J NEUROPHYSIOL, V95, P3281, DOI 10.1152/jn.01011.2005; Harrington DL, 2004, COGNITIVE BRAIN RES, V21, P193, DOI 10.1016/j.cogbrainres.2004.01.010; Hinton SC, 1997, ENDEAVOUR, V21, P82, DOI 10.1016/S0160-9327(97)01043-0; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; IVRY RB, 1988, EXP BRAIN RES, V73, P167, DOI 10.1007/BF00279670; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Jin DZZ, 2009, P NATL ACAD SCI USA, V106, P19156, DOI 10.1073/pnas.0909881106; Joel D, 2002, NEURAL NETWORKS, V15, P535, DOI 10.1016/S0893-6080(02)00047-3; Jones CRG, 2004, EXP BRAIN RES, V158, P366, DOI 10.1007/s00221-004-1912-3; Koch G, 2003, NEUROLOGY, V60, P1844, DOI 10.1212/WNL.60.11.1844; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lu XF, 2002, NEURON, V34, P317, DOI 10.1016/S0896-6273(02)00657-8; Lu XF, 1998, J NEUROPHYSIOL, V79, P2245, DOI 10.1152/jn.1998.79.5.2245; Lu XF, 2005, NEURON, V45, P967, DOI 10.1016/j.neuron.2005.01.036; Lucchetti C, 2005, EUR J APPL PHYSIOL, V95, P121, DOI 10.1007/s00421-005-1360-1; Lucchetti C, 2001, EXP BRAIN RES, V141, P254, DOI 10.1007/s002210100818; Lustig C, 2005, MEMORY, V13, P441, DOI 10.1080/09658210344000404; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; MACHENS CK, J NEUROSCI, V30, P350; Matell MS, 2003, BEHAV NEUROSCI, V117, P760, DOI 10.1037/0735-7044.117.4.760; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Meck WH, 2006, BRAIN RES, V1109, P93, DOI 10.1016/j.brainres.2006.06.031; Meck WH, 2006, BRAIN RES, V1108, P157, DOI 10.1016/j.brainres.2006.06.046; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; Ohmae S, 2008, EXP BRAIN RES, V184, P593, DOI 10.1007/s00221-007-1234-3; PASTOR MA, 1992, BRAIN, V115, P211, DOI 10.1093/brain/115.1.211; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Roesch MR, 2005, J NEUROPHYSIOL, V94, P1469, DOI 10.1152/jn.00064.2005; SELEMON LD, 1985, J NEUROSCI, V5, P776; Tsujimoto S, 2010, NAT NEUROSCI, V13, P120, DOI 10.1038/nn.2453; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Xu D, 2006, J NEUROSCI, V26, P5990, DOI 10.1523/JNEUROSCI.0038-06.2006	41	24	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19168	10.1371/journal.pone.0019168	http://dx.doi.org/10.1371/journal.pone.0019168			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556372	gold, Green Published, Green Submitted			2022-12-25	WOS:000290019400035
J	Satapathy, AK; Richardson, CC				Satapathy, Ajit K.; Richardson, Charles C.			The Glutamate Switch of Bacteriophage T7 DNA Helicase ROLE IN COUPLING NUCLEOTIDE TRIPHOSPHATE (NTP) AND DNA BINDING TO NTP HYDROLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; HEXAMERIC HELICASES; CRYSTAL-STRUCTURE; GENE-4 HELICASE; PROTEINS; PRIMASE; PRIMASE/HELICASE; MECHANISM; DOMAIN; DTTP	The DNA helicase encoded by gene 4 of bacteriophage T7 forms a hexameric ring in the presence of dTTP, allowing it to bind DNA in its central core. The oligomerization also creates nucleotide-binding sites located at the interfaces of the subunits. DNA binding stimulates the hydrolysis of dTTP but the mechanism for this two-step control is not clear. We have identified a glutamate switch, analogous to the glutamate switch found in AAA + enzymes that couples dTTP hydrolysis to DNA binding. A crystal structure of T7 helicase shows that a glutamate residue (Glu-343), located at the subunit interface, is positioned to catalyze a nucleophilic attack on the gamma-phosphate of a bound nucleoside 5'-triphosphate. However, in the absence of a nucleotide, Glu-343 changes orientation, interacting with Arg-493 on the adjacent subunit. This interaction interrupts the interaction of Arg-493 with Asn-468 of the central beta-hairpin, which in turn disrupts DNA binding. When Glu-343 is replaced with glutamine the altered helicase, unlike the wild-type helicase, binds DNA in the presence of dTDP. When both Arg-493 and Asn-468 are replaced with alanine, dTTP hydrolysis is no longer stimulated in the presence of DNA. Taken together, these results suggest that the orientation of Glu-343 plays a key role in coupling nucleotide hydrolysis to the binding of DNA.	[Satapathy, Ajit K.; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu			National Institutes of Health [GM54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397 (to C. C. R.).	Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; Lee SJ, 2008, P NATL ACAD SCI USA, V105, P8908, DOI 10.1073/pnas.0802732105; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MENDELMAN LV, 1992, P NATL ACAD SCI USA, V89, P10638, DOI 10.1073/pnas.89.22.10638; Mogni ME, 2009, BIOCHEMISTRY-US, V48, P8774, DOI 10.1021/bi9012512; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Picha KM, 1998, J BIOL CHEM, V273, P27315, DOI 10.1074/jbc.273.42.27315; Satapathy AK, 2010, P NATL ACAD SCI USA, V107, P6782, DOI 10.1073/pnas.1002734107; Satapathy AK, 2009, J BIOL CHEM, V284, P14286, DOI 10.1074/jbc.M900557200; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; TABOR S, 1981, P NATL ACAD SCI-BIOL, V78, P205, DOI 10.1073/pnas.78.1.205; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825; Zhang XD, 2008, NAT STRUCT MOL BIOL, V15, P1223, DOI 10.1038/nsmb.1501	24	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23113	23120		10.1074/jbc.M111.218651	http://dx.doi.org/10.1074/jbc.M111.218651			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21566126	Green Published, hybrid			2022-12-25	WOS:000292025000045
J	Naik, US; Gangadharan, C; Abbagani, K; Nagalla, B; Dasari, N; Manna, SK				Naik, Usha S.; Gangadharan, Charitha; Abbagani, Kanakalatha; Nagalla, Balakrishna; Dasari, Niranjan; Manna, Sunil K.			A Study of Nuclear Transcription Factor-Kappa B in Childhood Autism	PLOS ONE			English	Article							FACTOR-INDUCED APOPTOSIS; CEREBROSPINAL-FLUID; ACTIVATION; OVEREXPRESSION; CHILDREN; STRESS	Background: Several children with autism show regression in language and social development while maintaining normal motor milestones. A clear period of normal development followed by regression and subsequent improvement with treatment, suggests a multifactorial etiology. The role of inflammation in autism is now a major area of study. Viral and bacterial infections, hypoxia, or medication could affect both foetus and infant. These stressors could upregulate transcription factors like nuclear factor kappa B (NF-kappa B), a master switch for many genes including some implicated in autism like tumor necrosis factor (TNF). On this hypothesis, it was proposed to determine NF-kappa B in children with autism. Methods: Peripheral blood samples of 67 children with autism and 29 control children were evaluated for NF-kappa B using electrophoretic mobility shift assay (EMSA). A phosphor imaging technique was used to quantify values. The fold increase over the control sample was calculated and statistical analysis was carried out using SPSS 15. Results: We have noted significant increase in NF-kappa B DNA binding activity in peripheral blood samples of children with autism. When the fold increase of NF-kappa B in cases (n = 67) was compared with that of controls (n = 29), there was a significant difference (3.14 vs. 1.40, respectively; p < 0.02). Conclusion: This finding has immense value in understanding many of the known biochemical changes reported in autism. As NF-kappa B is a response to stressors of several kinds and a master switch for many genes, autism may then arise at least in part from an NF-kappa B pathway gone awry.	[Naik, Usha S.; Abbagani, Kanakalatha; Dasari, Niranjan] Osmania Med Coll & Hosp, Dept Psychiat, Hyderabad, Andhra Pradesh, India; [Gangadharan, Charitha; Manna, Sunil K.] Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad, Andhra Pradesh, India; [Nagalla, Balakrishna] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Naik, US (corresponding author), Osmania Med Coll & Hosp, Dept Psychiat, Hyderabad, Andhra Pradesh, India.	manna@cdfd.org.in	Nagalla, Balakrishna/GRR-4393-2022	Nagalla, Balakrishna/0000-0002-5613-0942	Department of Biotechnology, Ministry of Science and Technology, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	The study was funded by a Central Government Grant from the Department of Biotechnology, Ministry of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P40, DOI 10.1016/j.bbi.2010.08.003; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; BALTIMORE D, 2006, HDB TRANSCRIPTION FA; Chez MG, 2007, PEDIATR NEUROL, V36, P361, DOI 10.1016/j.pediatrneurol.2007.01.012; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Ghosh Sankar, 2007, P1; GILLBERG C, 1983, J AUTISM DEV DISORD, V13, P153, DOI 10.1007/BF01531816; Goines P, 2010, CURR OPIN NEUROL, V23, P111, DOI 10.1097/WCO.0b013e3283373514; Granpeesheh D, 2009, ANN CLIN PSYCHIATRY, V21, P195; Grosjean-Raillard J, 2008, APOPTOSIS, V13, P1148, DOI 10.1007/s10495-008-0243-4; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0; Kanner L, 1943, NERV CHILD, V2, P217; Kelley E, 2010, RES AUTISM SPECT DIS, V4, P526, DOI 10.1016/j.rasd.2009.12.001; Licinio J, 2002, MOL PSYCHIATR, V7, P329, DOI 10.1038/sj.mp.4001137; Lord C, 2004, J CHILD PSYCHOL PSYC, V45, P936, DOI 10.1111/j.1469-7610.2004.t01-1-00287.x; Malik M, 2011, IMMUNOBIOLOGY, V216, P80, DOI 10.1016/j.imbio.2010.03.001; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; Manna SK, 1999, ONCOGENE, V18, P4371, DOI 10.1038/sj.onc.1202811; Manna SK, 2010, J BIOL CHEM, V285, P11617, DOI 10.1074/jbc.M109.094961; Pardo A.C., 2005, INT REV PSYCHIATR, V17, P485; PHAL LH, 1999, ONCOGENE, V18, P6853; Sajdel-Sulkowska E.M., 2008, AM J BIOCH BIOTECHNO, V4, P73; Schopler E., 1988, CHILDHOOD AUTISM RAT; Shen C, 2011, J MOL NEUROSCI, V43, P443, DOI 10.1007/s12031-010-9463-5; Shimokawa I., 2004, GERIATRIC GERONTOL I, V4, pS149, DOI [10.1111/j.1447-0594.2004.00183.x, DOI 10.1111/J.1447-0594.2004.00183.X]; Thoh M, 2010, J BIOL CHEM, V285, P5888, DOI 10.1074/jbc.M109.065847; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; VOLKMAR FR, 2009, COMPREHENSIVE TXB PS, V2, P3540; Zimmerman AW, 2005, PEDIATR NEUROL, V33, P195, DOI 10.1016/j.pediatrneurol.2005.03.014	34	53	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19488	10.1371/journal.pone.0019488	http://dx.doi.org/10.1371/journal.pone.0019488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573053	gold, Green Published, Green Submitted			2022-12-25	WOS:000290386800015
J	Ivers, LC; Jerome, JG; Cullen, KA; Lambert, W; Celletti, F; Samb, B				Ivers, Louise C.; Jerome, Jean-Gregory; Cullen, Kimberly A.; Lambert, Wesler; Celletti, Francesca; Samb, Badara			Task-Shifting in HIV Care: A Case Study of Nurse-Centered Community-Based Care in Rural Haiti	PLOS ONE			English	Article							HEALTH-WORKERS; ANTIRETROVIRAL THERAPY; HUMAN-RESOURCES; PROGRAM	Introduction: At least 36 countries are suffering from severe shortages of healthcare workers and this crisis of human resources in developing countries is a major obstacle to scale-up of HIV care. We performed a case study to evaluate a health service delivery model where a task-shifting approach to HIV care had been undertaken with tasks shifted from doctors to nurses and community health workers in rural Haiti. Methods: Data were collected using mixed quantitative and qualitative methods at three clinics in rural Haiti. Distribution of tasks for HIV services delivery; types of tasks performed by different cadres of healthcare workers; HIV program outcomes; access to HIV care and acceptability of the model to staff were measured. Results: A shift of tasks occurred from doctors to nurses and to community health workers compared to a traditional doctor-based model of care. Nurses performed most HIV-related tasks except initiation of TB therapy for smear-negative suspects with HIV. Community health workers were involved in over half of HIV-related tasks. HIV services were rapidly scaled-up in the areas served; loss to follow-up of patients living with HIV was less than 5% at 24 months and staff were satisfied with the model of care. Conclusion: Task-shifting using a community-based, nurse-centered model of HIV care in rural Haiti is an effective model for scale-up of HIV services with good clinical and program outcomes. Community health workers can provide essential health services that are otherwise unavailable particularly in rural, poor areas.	[Ivers, Louise C.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Ivers, Louise C.] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Ivers, Louise C.; Cullen, Kimberly A.] Partners Hlth, Boston, MA USA; [Jerome, Jean-Gregory; Lambert, Wesler] Zanmi Lasante, Cange, Haiti; [Celletti, Francesca; Samb, Badara] WHO, CH-1211 Geneva, Switzerland	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Partners Healthcare System; World Health Organization	Ivers, LC (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	livers@pih.org	Ivers, Louise C/Q-4164-2018	Ivers, Louise C/0000-0003-2314-9230	U.S. Office of Global AIDS; World Health Organization; Joint United Nations Programme on AIDS; Presidents Emergency Fund for AIDS Relief; Direzione Generale Cooperazione allo Sviluppo; Ministry of Foreign Affairs of the Republic of Italy; National Institute of Allergy and Infectious Disease [K23 AI063998]; Harvard Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI063998] Funding Source: NIH RePORTER	U.S. Office of Global AIDS; World Health Organization(World Health Organization); Joint United Nations Programme on AIDS; Presidents Emergency Fund for AIDS Relief; Direzione Generale Cooperazione allo Sviluppo; Ministry of Foreign Affairs of the Republic of Italy; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The WHO commissioned study on Task Shifting was funded by the U.S. Office of Global AIDS Coordinator, The World Health Organization, Joint United Nations Programme on AIDS, the Presidents Emergency Fund for AIDS Relief, Direzione Generale Cooperazione allo Sviluppo, Ministry of Foreign Affairs of the Republic of Italy. This work was also supported in part by the National Institute of Allergy and Infectious Disease (K23 AI063998 to LCI) and by the Harvard Center for AIDS Research. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JEL, 1994, J NUTR, V124, pS1828, DOI 10.1093/jn/124.suppl_9.1828S; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS92, DOI 10.1038/sj.jp.7211277; Barry MJ, 2001, NEW ENGL J MED, V344, P1373, DOI 10.1056/NEJM200105033441806; Behforouz HL, 2004, CLIN INFECT DIS, V38, pS429, DOI 10.1086/421408; BERMAN PA, 1987, SOC SCI MED, V25, P443, DOI 10.1016/0277-9536(87)90168-7; Bhattacharyya K, 2001, COMMUNITY HLTH WORKE; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Brownstein JN, 2005, AM J PREV MED, V29, P128, DOI 10.1016/j.amepre.2005.07.024; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Conille G, 2007, ADDRESSING URGENT HU; Daly J, 2007, J CLIN EPIDEMIOL, V60, P43, DOI 10.1016/j.jclinepi.2006.03.014; Delacollette C, 1996, B WORLD HEALTH ORGAN, V74, P423; Doherty TM, 2005, PUBLIC HEALTH NURS, V22, P360, DOI 10.1111/j.0737-1209.2005.220413.x; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Fedder DO, 2003, ETHNIC DIS, V13, P22; GILSON L, 1989, Journal of Public Health Policy, V10, P518, DOI 10.2307/3342522; GREENWOOD AM, 1990, J TROP MED HYG, V93, P58; Hongoro C, 2004, LANCET, V364, P1451, DOI 10.1016/S0140-6736(04)17229-2; Ivers LC, 2010, AIDS, V24, pS73, DOI 10.1097/01.aids.0000366085.14064.6f; Jerome G, 2010, AIDS, V24, pS67, DOI 10.1097/01.aids.0000366084.75945.c9; Kironde S, 2002, INT J TUBERC LUNG D, V6, P104; Mavalankar DV, 2005, AM J PUBLIC HEALTH, V95, P200, DOI 10.2105/AJPH.2003.036715; MINISTERE DE LA SANTE PUBLIQUE ET DE LA POPULATION, 2005, PLAN STRAT NAT REF S; Mukherjee J, 2004, LANCET, V363, P1071, DOI 10.1016/S0140-6736(04)15846-7; Mukherjee JS, 2007, AIDS CARE, V19, pS73, DOI 10.1080/09540120601114485; Mukherjee JS, 2008, 17 INT AIDS 3 8 AUG; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Pereira C, 1996, BRIT J OBSTET GYNAEC, V103, P508, DOI 10.1111/j.1471-0528.1996.tb09797.x; Richardson G, 1998, HEALTH POLICY, V45, P119, DOI 10.1016/S0168-8510(98)00038-4; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Schneider H, 2006, REPROD HEALTH MATTER, V14, P12, DOI 10.1016/S0968-8080(06)27232-X; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Strauss AL, 1998, BASICS QUALITATIVE R, V2nd; Tashakkori A, 2003, HDB MIXED METHODS SO; Tuturu, 2020, COMM CONS HLTH ED; Victora CG, 2004, LANCET, V364, P1541, DOI 10.1016/S0140-6736(04)17279-6; World Health Organization, 2004, SCAL HIV AIDS CAR SE, P1	38	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19276	10.1371/journal.pone.0019276	http://dx.doi.org/10.1371/journal.pone.0019276			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	760DZ	21573152	Green Published, Green Submitted, gold			2022-12-25	WOS:000290305600018
J	Qian, HF; Lu, T; Peng, XF; Han, X; Fu, ZW; Liu, WP				Qian, HaiFeng; Lu, Tao; Peng, XiaoFeng; Han, Xiao; Fu, ZhengWei; Liu, WeiPing			Enantioselective Phytotoxicity of the Herbicide Imazethapyr on the Response of the Antioxidant System and Starch Metabolism in Arabidopsis thaliana	PLOS ONE			English	Article							OXIDATIVE STRESS; HYPERSENSITIVE RESPONSE; PROLINE ACCUMULATION; GENE-EXPRESSION; IMIDAZOLINONE; SULFONYLUREA; PHOSPHATASE; ACCLIMATION; MECHANISMS; SEPARATION	Background: The enantiomers of a chiral compound possess different biological activities, and one of the enantiomers usually shows a higher level of toxicity. Therefore, the exploration of the causative mechanism of enantioselective toxicity is regarded as one of primary goals of biological chemistry. Imazethapyr (IM) is an acetolactate synthase (ALS)-inhibiting chiral herbicide that has been widely used in recent years with racemate. We investigated the enantioselectivity between R- and S-IM to form reactive oxygen species (ROS) and to regulate antioxidant gene transcription and enzyme activity. Results: Dramatic differences between the enantiomers were observed: the enantiomer of R-IM powerfully induced ROS formation, yet drastically reduced antioxidant gene transcription and enzyme activity, which led to an oxidative stress. The mechanism by which IM affects carbohydrate metabolism in chloroplasts has long remained a mystery. Here we report evidence that enantioselectivity also exists in starch metabolism. The enantiomer of R-IM resulted in the accumulation of glucose, maltose and sucrose in the cytoplasm or the chloroplast and disturbed carbohydrates utilization. Conclusion: The study suggests that R-IM more strongly retarded plant growth than S-IM not only by acting on ALS, but also by causing an imbalance in the antioxidant system and the disturbance of carbohydrate metabolism with enantioselective manner.	[Qian, HaiFeng; Lu, Tao; Peng, XiaoFeng; Han, Xiao; Fu, ZhengWei; Liu, WeiPing] Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Technology	Qian, HF (corresponding author), Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China.	azwfu2003@yahoo.com.cn; wliu@zjut.edu.cn	Qian, Haifeng/A-7791-2012; Lu, Tao/Y-3535-2018; Fu, Zhengwei/G-3162-2011; Liu, Weiping/E-9208-2010; qian, haifeng/H-4828-2012	Qian, Haifeng/0000-0003-0807-9991; Lu, Tao/0000-0002-2030-3813; Fu, Zhengwei/0000-0003-3351-3075; Liu, Weiping/0000-0002-1173-892X; 	National Basic Research Program of China [2010CB126100]; Natural Science Foundation of China [21077093]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Basic Research Program of China (No. 2010CB126100) and the Natural Science Foundation of China (21077093). These funders provided financial support to the experiments and research related to this report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, FREE RADICALS BIOL M; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Battaglin WA, 2000, SCI TOTAL ENVIRON, V248, P123, DOI 10.1016/S0048-9697(99)00536-7; Chia T, 2004, PLANT J, V37, P853, DOI 10.1111/j.1365-313X.2003.02012.x; Comparot-Moss S, 2010, PLANT PHYSIOL, V152, P685, DOI 10.1104/pp.109.148981; Dat JF, 1998, PLANT PHYSIOL, V116, P1351, DOI 10.1104/pp.116.4.1351; Doncheva S, 2005, J EXP BOT, V56, P1213, DOI 10.1093/jxb/eri115; Duggleby RG, 2000, J BIOCHEM MOL BIOL, V33, P1; Falconer RL, 1997, J AGR FOOD CHEM, V45, P1946, DOI 10.1021/jf960881m; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Foyer CH, 1997, PHYSIOL PLANTARUM, V100, P241, DOI 10.1034/j.1399-3054.1997.1000205.x; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gaston S, 2002, PHYSIOL PLANTARUM, V114, P524, DOI 10.1034/j.1399-3054.2002.1140404.x; Geoffroy L, 2004, ENVIRON POLLUT, V131, P233, DOI 10.1016/j.envpol.2004.02.021; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Hoekstra PF, 2006, CHEMOSPHERE, V64, P174, DOI 10.1016/j.chemosphere.2005.10.043; Inze D, 2000, OXIDATIVE STRESS PLA, P105; Jin YX, 2009, CHEMOSPHERE, V74, P1238, DOI 10.1016/j.chemosphere.2008.11.015; Kang JM, 2003, P NATL ACAD SCI USA, V100, P6872, DOI 10.1073/pnas.1030961100; Karpinski S, 1999, SCIENCE, V284, P654, DOI 10.1126/science.284.5414.654; Kurt-Karakus PB, 2005, ENVIRON SCI TECHNOL, V39, P8671, DOI 10.1021/es051004c; Laplante J, 2009, THEOR APPL GENET, V119, P577, DOI 10.1007/s00122-009-1067-5; Li YZ, 2010, ENVIRON EXP BOT, V69, P158, DOI 10.1016/j.envexpbot.2010.03.009; Lin KD, 2007, CHIRALITY, V19, P171, DOI 10.1002/chir.20359; Liu YD, 2007, PLANT J, V51, P941, DOI 10.1111/j.1365-313X.2007.03191.x; Lu Y, 2005, PLANT PHYSIOL, V138, P2280, DOI 10.1104/pp.105.061903; Mackerness SAH, 1999, PLANT CELL ENVIRON, V22, P1413, DOI 10.1046/j.1365-3040.1999.00499.x; McCourt JA, 2006, P NATL ACAD SCI USA, V103, P569, DOI 10.1073/pnas.0508701103; Milla MAR, 2003, PLANT J, V36, P602, DOI 10.1046/j.1365-313X.2003.01901.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Miura E, 2010, J EXP BOT, V61, P2433, DOI 10.1093/jxb/erq075; Miyashita M, 2004, CHEMOSPHERE, V54, P1273, DOI 10.1016/j.chemosphere.2003.10.035; Myouga F, 2008, PLANT CELL, V20, P3148, DOI 10.1105/tpc.108.061341; Nozue K, 2006, PLANT CELL ENVIRON, V29, P396, DOI 10.1111/j.1365-3040.2005.01489.x; Pang SS, 2003, J BIOL CHEM, V278, P7639, DOI 10.1074/jbc.M211648200; Parre E, 2007, PLANT PHYSIOL, V144, P503, DOI 10.1104/pp.106.095281; PRASAD TK, 1994, PLANT CELL, V6, P65, DOI 10.1105/tpc.6.1.65; Qian HF, 2008, AQUAT TOXICOL, V88, P301, DOI 10.1016/j.aquatox.2008.05.009; Qian HF, 2008, ENVIRON TOXICOL CHEM, V27, P182, DOI 10.1897/07-163.1; Qian HF, 2009, CHEMOSPHERE, V76, P885, DOI 10.1016/j.chemosphere.2009.05.009; Qian HF, 2009, ECOTOXICOLOGY, V18, P537, DOI 10.1007/s10646-009-0311-8; Ramel F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-28; Rao MV, 1999, PLANT J, V17, P603, DOI 10.1046/j.1365-313X.1999.00400.x; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Royuela M, 2000, J PLANT PHYSIOL, V157, P345, DOI 10.1016/S0176-1617(00)80057-7; Rubio MC, 2009, NEW PHYTOL, V181, P851, DOI 10.1111/j.1469-8137.2008.02718.x; Scarponi L, 1996, J AGR FOOD CHEM, V44, P1572, DOI 10.1021/jf950512a; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Sokolov LN, 2006, P NATL ACAD SCI USA, V103, P9732, DOI 10.1073/pnas.0603329103; Stettler M, 2009, MOL PLANT, V2, P1233, DOI 10.1093/mp/ssp093; [孙云 Sun Yun], 2008, [热带作物学报, Chinese Journal of Tropical Crops], V29, P562; TAKAHASHI M, 1988, ARCH BIOCHEM BIOPHYS, V267, P714, DOI 10.1016/0003-9861(88)90080-X; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; To JPC, 2003, PHYSIOL PLANTARUM, V118, P456, DOI 10.1034/j.1399-3054.2003.00127.x; Wang LM, 2009, J ENVIRON SCI HEAL B, V44, P38, DOI 10.1080/03601230802519611; Xu C., 2008, CHEM RES TOXICOL, V47, P4236; Zeeman SC, 2007, FUNCT PLANT BIOL, V34, P465, DOI 10.1071/FP06313; Zeeman SC, 1999, PLANT CELL ENVIRON, V22, P1445, DOI 10.1046/j.1365-3040.1999.00503.x; Zhou QY, 2010, J AGR FOOD CHEM, V58, P4202, DOI 10.1021/jf9038953; Zhou QY, 2009, J AGR FOOD CHEM, V57, P1624, DOI 10.1021/jf803673e; Zhou Y, 2009, CHIRALITY, V21, P421, DOI 10.1002/chir.20607	64	51	55	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19451	10.1371/journal.pone.0019451	http://dx.doi.org/10.1371/journal.pone.0019451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573119	Green Published, gold, Green Submitted			2022-12-25	WOS:000290305600025
J	Dhar, M; Wiersema, JR; Pourtois, G				Dhar, Monica; Wiersema, Jan Roelf; Pourtois, Gilles			Cascade of Neural Events Leading from Error Commission to Subsequent Awareness Revealed Using EEG Source Imaging	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; HUMAN ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; FUNCTIONAL-SIGNIFICANCE; BRAIN POTENTIALS; ANTISACCADE TASK; SOCIAL-BEHAVIOR; RESPONSE ERRORS; CORRECT TRIALS	The goal of the present study was to shed light on the respective contributions of three important action monitoring brain regions (i.e. cingulate cortex, insula, and orbitofrontal cortex) during the conscious detection of response errors. To this end, fourteen healthy adults performed a speeded Go/Nogo task comprising Nogo trials of varying levels of difficulty, designed to elicit aware and unaware errors. Error awareness was indicated by participants with a second key press after the target key press. Meanwhile, electromyogram (EMG) from the response hand was recorded in addition to high-density scalp electroencephalogram (EEG). In the EMG-locked grand averages, aware errors clearly elicited an error-related negativity (ERN) reflecting error detection, and a later error positivity (Pe) reflecting conscious error awareness. However, no Pe was recorded after unaware errors or hits. These results are in line with previous studies suggesting that error awareness is associated with generation of the Pe. Source localisation results confirmed that the posterior cingulate motor area was the main generator of the ERN. However, inverse solution results also point to the involvement of the left posterior insula during the time interval of the Pe, and hence error awareness. Moreover, consecutive to this insular activity, the right orbitofrontal cortex (OFC) was activated in response to aware and unaware errors but not in response to hits, consistent with the implication of this area in the evaluation of the value of an error. These results reveal a precise sequence of activations in these three non-overlapping brain regions following error commission, enabling a progressive differentiation between aware and unaware errors as a function of time elapsed, thanks to the involvement first of interoceptive or proprioceptive processes (left insula), later leading to the detection of a breach in the prepotent response mode (right OFC).	[Dhar, Monica; Wiersema, Jan Roelf; Pourtois, Gilles] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Ghent University	Dhar, M (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium.	monica.dhar@ugent.be		Dhar, Monica/0000-0003-2998-2872; Pourtois, Gilles/0000-0002-5109-2801	European Research Council [200758]; Ghent University [05Z01708]	European Research Council(European Research Council (ERC)European Commission); Ghent University(Ghent University)	This work is supported by grants from the European Research Council (Starting Grant #200758) and Ghent University (BOF Grant #05Z01708). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts K, 2010, COGN AFFECT BEHAV NE, V10, P479, DOI 10.3758/CABN.10.4.479; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chassagnon S, 2008, J NEUROSURG, V109, P593, DOI 10.3171/JNS/2008/109/10/0593; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Danielmeier C, 2011, J NEUROSCI, V31, P1780, DOI 10.1523/JNEUROSCI.4299-10.2011; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dhar M, 2011, NEUROPSYCHOLOGIA, V49, P1236, DOI 10.1016/j.neuropsychologia.2011.01.006; DUM RP, 1991, J NEUROSCI, V11, P667; Ekman P., 1976, PICTURES FACIAL AFFE; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hajcak G, 2004, BRAIN COGNITION, V56, P189, DOI 10.1016/j.bandc.2003.11.001; Herrmann MJ, 2004, COGNITIVE BRAIN RES, V20, P294, DOI 10.1016/j.cogbrainres.2004.02.013; Hester R, 2009, NEUROPSYCHOPHARMACOL, V34, P2450, DOI 10.1038/npp.2009.67; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jung J, 2010, HUM BRAIN MAPP, V31, P1217, DOI 10.1002/hbm.20930; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; Koban L, 2010, SOC NEUROSCI-UK, V5, P360, DOI 10.1080/17470911003651547; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Luu P, 2000, J NEUROSCI, V20, P464, DOI 10.1523/JNEUROSCI.20-01-00464.2000; Maier M, 2008, J COGNITIVE NEUROSCI, V20, P2263, DOI 10.1162/jocn.2008.20159; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; Miltner WHR, 2003, BIOL PSYCHOL, V64, P157, DOI 10.1016/S0301-0511(03)00107-8; Modirrousta M, 2008, J NEUROSCI, V28, P14000, DOI 10.1523/JNEUROSCI.4450-08.2008; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nobre AC, 1999, NAT NEUROSCI, V2, P11, DOI 10.1038/4513; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; Pailing PE, 2004, BRAIN COGNITION, V56, P215, DOI 10.1016/j.bandc.2004.06.005; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pourtois G, 2010, NEUROPSYCHOLOGIA, V48, P1144, DOI 10.1016/j.neuropsychologia.2009.12.020; Redgrave P, 2008, BRAIN RES REV, V58, P322, DOI 10.1016/j.brainresrev.2007.10.007; Ridderinkhof KR, 2009, PSYCHOPHYSIOLOGY, V46, P531, DOI 10.1111/j.1469-8986.2009.00790.x; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Scheffers MK, 2000, J EXP PSYCHOL HUMAN, V26, P141, DOI 10.1037/0096-1523.26.1.141; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; Shalgi S, 2009, EUR J NEUROSCI, V29, P1522, DOI 10.1111/j.1460-9568.2009.06690.x; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Steinhauser M, 2010, J NEUROSCI, V30, P15643, DOI 10.1523/JNEUROSCI.1899-10.2010; Talairach J., 1988, COPLANAR STEREOTAXIC; Ullsperger M, 2010, BRAIN STRUCT FUNCT, V214, P629, DOI 10.1007/s00429-010-0261-1; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Vidal F, 2003, BIOL PSYCHOL, V64, P265, DOI 10.1016/S0301-0511(03)00097-8; Vocat R, 2008, NEUROPSYCHOLOGIA, V46, P2545, DOI 10.1016/j.neuropsychologia.2008.04.006; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]	68	48	49	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19578	10.1371/journal.pone.0019578	http://dx.doi.org/10.1371/journal.pone.0019578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573173	Green Published, gold, Green Submitted			2022-12-25	WOS:000290256400027
J	Lindner, HB; Zhang, AG; Eldridge, J; Demcheva, M; Tsichilis, P; Seth, A; Vournakis, J; Muise-Helmericks, RC				Lindner, Haley Buff; Zhang, Aiguo; Eldridge, Juanita; Demcheva, Marina; Tsichilis, Philip; Seth, Arun; Vournakis, John; Muise-Helmericks, Robin C.			Anti-Bacterial Effects of Poly-N-Acetyl-Glucosamine Nanofibers in Cutaneous Wound Healing: Requirement for Akt1	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; HUMAN BETA-DEFENSIN-3; MEDIATED HEMOSTASIS; DEFENSIN-1 PROMOTER; BETA-DEFENSINS; HOST-DEFENSE; IN-VITRO; CELLS; ACTIVATION; MECHANISMS	Background: Treatment of cutaneous wounds with poly-N-acetyl-glucosamine nanofibers (sNAG) results in increased kinetics of wound closure in diabetic animal models, which is due in part to increased expression of several cytokines, growth factors, and innate immune activation. Defensins are also important for wound healing and anti-microbial activities. Therefore, we tested whether sNAG nanofibers induce defensin expression resulting in bacterial clearance. Methodology: The role of sNAG in defensin expression was examined using immunofluoresence microscopy, pharmacological inhibition, and shRNA knockdown in vitro. The ability of sNAG treatment to induce defensin expression and bacterial clearance in WT and AKT1(-/-) mice was carried out using immunofluoresent microscopy and tissue gram staining. Neutralization, using an antibody directed against beta-defensin 3, was utilized to determine if the antimicrobial properties of sNAG are dependent on the induction of defensin expression. Conclusions/Findings: sNAG treatment causes increased expression of both alpha- and beta-type defensins in endothelial cells and beta-type defensins in keratinocytes. Pharmacological inhibition and shRNA knockdown implicates Akt1 in sNAG-dependent defensin expression in vitro, an activity also shown in an in vivo wound healing model. Importantly, sNAG treatment results in increased kinetics of wound closure in wild type animals. sNAG treatment decreases bacterial infection of cutaneous wounds infected with Staphylococcus aureus in wild type control animals but not in similarly treated Akt1 null animals. Furthermore, sNAG treatment of S. aureus infected wounds show an increased expression of beta-defensin 3 which is required for sNAG-dependent bacterial clearance. Our findings suggest that Akt1 is involved in the regulation of defensin expression and the innate immune response important for bacterial clearance. Moreover, these findings support the use of sNAG nanofibers as a novel method for enhancing wound closure while simultaneously decreasing wound infection.	[Lindner, Haley Buff; Eldridge, Juanita; Muise-Helmericks, Robin C.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Demcheva, Marina; Vournakis, John] Marine Polymer Technol, Danvers, MA USA; [Zhang, Aiguo; Seth, Arun] Univ Toronto, Sunnybrook Res Inst, Toronto, ON, Canada; [Tsichilis, Philip] Tufts Univ, Mol Oncol Res Inst, Medford, MA 02155 USA	Medical University of South Carolina; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Tufts University	Lindner, HB (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA.	musehelm@musc.edu			Marine Polymer Technologies [R01HL084565-02, 5T32DE017551]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F30DE021612, T32DE017551] Funding Source: NIH RePORTER	Marine Polymer Technologies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by grants from Marine Polymer Technologies and R01HL084565-02 to RM-H and 5T32DE017551 to HBL (http://syvek.com/). The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aarbiou J, 2004, AM J RESP CELL MOL, V30, P193, DOI 10.1165/rcmb.2002-0267OC; Carratelli CR, 2009, FEMS IMMUNOL MED MIC, V57, P116, DOI 10.1111/j.1574-695X.2009.00586.x; Fischer TH, 2005, BIOMATERIALS, V26, P5433, DOI 10.1016/j.biomaterials.2005.01.023; Fischer TH, 2007, J BIOMED MATER RES A, V80A, P167, DOI 10.1002/jbm.a.30877; GANZ T, 1987, INFECT IMMUN, V55, P568, DOI 10.1128/IAI.55.3.568-571.1987; GANZ T, 1989, J IMMUNOL, V143, P1358; GANZ T, 1994, CURR OPIN IMMUNOL, V6, P584, DOI 10.1016/0952-7915(94)90145-7; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ganz T, 2004, CR BIOL, V327, P539, DOI 10.1016/j.crvi.2003.12.007; Garcia JRC, 2001, CELL TISSUE RES, V306, P257, DOI 10.1007/s004410100433; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hertz CJ, 2003, J IMMUNOL, V171, P6820, DOI 10.4049/jimmunol.171.12.6820; Hirsch Joshua A, 2003, Tech Vasc Interv Radiol, V6, P92, DOI 10.1053/tvir.2003.36446; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; Hubert P, 2007, FASEB J, V21, P2765, DOI 10.1096/fj.06-7646com; Imler JL, 2000, CURR OPIN MICROBIOL, V3, P16, DOI 10.1016/S1369-5274(99)00045-4; Lavenburg KR, 2003, FASEB J, V17, P2278, DOI 10.1096/fj.03-0040fje; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Ma YS, 1998, J BIOL CHEM, V273, P8727, DOI 10.1074/jbc.273.15.8727; Mao CC, 2007, J IMMUNOL, V178, P5443, DOI 10.4049/jimmunol.178.9.5443; Mathews M, 1999, INFECT IMMUN, V67, P2740, DOI 10.1128/IAI.67.6.2740-2745.1999; Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; Oren A, 2003, EXP MOL PATHOL, V74, P180, DOI 10.1016/S0014-4800(02)00023-0; Palmer BL, 2004, AM J CARDIOL, V93, P96, DOI 10.1016/j.amjcard.2003.08.077; Pietramaggiori G, 2008, J TRAUMA, V64, P803, DOI 10.1097/01.ta.0000244382.13937.a8; Rieske P, 2001, J BIOL CHEM, V276, P8460, DOI 10.1074/jbc.M007482200; ROHRL J, 2010, J IMMUNOL; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Scherer SS, 2009, ANN SURG, V250, P322, DOI 10.1097/SLA.0b013e3181ae9d45; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Somanath PR, 2008, ANGIOGENESIS, V11, P277, DOI 10.1007/s10456-008-9111-7; Thatte HS, 2004, J TRAUMA, V57, pS13, DOI 10.1097/01.TA.0000136743.12440.89; Threadgill DW, 1997, MAMM GENOME, V8, P390, DOI 10.1007/s003359900453; Vournakis JN, 2008, J VASC RES, V45, P222, DOI 10.1159/000112544; WATT FM, 1983, J INVEST DERMATOL, V81, pS100, DOI 10.1111/1523-1747.ep12540786; Weichhart T, 2008, ANN RHEUM DIS, V67, P70, DOI 10.1136/ard.2008.098459; Williams MJ, 1997, EMBO J, V16, P6120, DOI 10.1093/emboj/16.20.6120; Yaneva M, 2006, J IMMUNOL, V176, P6906, DOI 10.4049/jimmunol.176.11.6906; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525	43	21	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18996	10.1371/journal.pone.0018996	http://dx.doi.org/10.1371/journal.pone.0018996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559496	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700049
J	Rittenour, WR; Chen, M; Cahoon, EB; Harris, SD				Rittenour, William R.; Chen, Ming; Cahoon, Edgar B.; Harris, Steven D.			Control of Glucosylceramide Production and Morphogenesis by the Bar1 Ceramide Synthase in Fusarium graminearum	PLOS ONE			English	Article							DETERGENT-RESISTANT MEMBRANES; LIPID RAFTS; PROTEIN-KINASE; CELL-SURFACE; GROWTH; GENE; PATHOGENICITY; BIOSYNTHESIS; INHIBITION; DEFENSINS	The contribution of plasma membrane proteins to the virulence of plant pathogenic fungi is poorly understood. Accordingly, the objective of this study was to characterize the acyl-CoA dependent ceramide synthase Bar1 (previously implicated in plasma membrane organization) in the wheat pathogen Fusarium graminearum. The role of Bar1 in mediating cell membrane organization was confirmed as DBAR1 mutants failed to display a distinct sterol-rich domain at the hyphal tip. The DBAR1 mutants were non-pathogenic when inoculated onto wheat heads, and their in vitro growth also was severely perturbed. DBAR1 mutants were incapable of producing perithecia (sexual fruiting structures) and only produced macroconidia (asexual spores) in the presence of NaCl. Sphingolipid analyses indicated that Bar1 is specifically necessary for the production of glucosylceramides in both F. graminearum and Aspergillus nidulans. Interestingly, glucosylceramides appear to mediate sensitivity to heat stable antifungal factor (HSAF), as, in addition to DBAR1 mutants, a glucosylceramide synthase deficient mutant of Yarrowia lipolytica is also resistant to HSAF.	[Rittenour, William R.; Harris, Steven D.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Chen, Ming; Cahoon, Edgar B.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Rittenour, William R.; Chen, Ming; Cahoon, Edgar B.; Harris, Steven D.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Rittenour, WR (corresponding author), NIOSH, Morgantown, WV USA.	sharri1@unlnotes.unl.edu			Nebraska Research Foundation; United States National Science Foundation [MCB-0843312]	Nebraska Research Foundation; United States National Science Foundation(National Science Foundation (NSF))	This work was supported by the Nebraska Research Foundation (SH) and the United States National Science Foundation (MCB-0843312) (EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NJ, 1998, APPL ENVIRON MICROB, V64, P221; Alvarez FJ, 2007, EUKARYOT CELL, V6, P755, DOI 10.1128/EC.00008-07; Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043; Bowden RL, 1999, PHYTOPATHOLOGY, V89, P182, DOI 10.1094/PHYTO.1999.89.2.182; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Cerantola V, 2007, BIOCHEM J, V401, P205, DOI 10.1042/BJ20061128; Cheng JJ, 2003, MOL CELL BIOL, V23, P163, DOI 10.1128/MCB.23.1.163-177.2003; Cheng JJ, 2001, MOL CELL BIOL, V21, P6198, DOI 10.1128/MCB.21.18.6198-6209.2001; Cuomo CA, 2007, SCIENCE, V5, P515; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Harris SD, 2005, MYCOLOGIA, V97, P880, DOI 10.3852/mycologia.97.4.880; Horio T, 2005, MOL BIOL CELL, V16, P918, DOI 10.1091/mbc.E04-09-0798; Insenser M, 2006, PROTEOMICS, V6, pS74, DOI 10.1002/pmic.200500465; Kapteyn JC, 1996, GLYCOBIOLOGY, V6, P337, DOI 10.1093/glycob/6.3.337; Lauwers E, 2006, TRAFFIC, V7, P1045, DOI 10.1111/j.1600-0854.2006.00445.x; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; Li S, 2008, PHYTOPATHOLOGY, V98, P695, DOI 10.1094/PHYTO-98-6-0695; Li SJ, 2007, GENETICS, V176, P243, DOI 10.1534/genetics.106.068239; Li SJ, 2006, MOL BIOL CELL, V17, P1218, DOI 10.1091/mbc.E05-06-0533; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Ramamoorthy V, 2007, MOL MICROBIOL, V66, P771, DOI 10.1111/j.1365-2958.2007.05955.x; Ramamoorthy V, 2007, CELL MICROBIOL, V9, P1491, DOI 10.1111/j.1462-5822.2006.00887.x; Ramamoorthy V, 2009, EUKARYOT CELL, V8, P217, DOI 10.1128/EC.00255-08; Rittenour WR, 2010, MOL PLANT PATHOL, V11, P361, DOI [10.1111/J.1364-3703.2010.00609.X, 10.1111/j.1364-3703.2010.00609.x]; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Semighini CP, 2008, FEMS MICROBIOL LETT, V279, P259, DOI 10.1111/j.1574-6968.2007.01042.x; Siafakas AR, 2006, EUKARYOT CELL, V5, P488, DOI 10.1128/EC.5.3.488-498.2006; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Takakuwa N, 2008, FEMS YEAST RES, V8, P839, DOI 10.1111/j.1567-1364.2008.00407.x; Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200; Yu FG, 2007, ANTIMICROB AGENTS CH, V51, P64, DOI 10.1128/AAC.00931-06; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07	41	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19385	10.1371/journal.pone.0019385	http://dx.doi.org/10.1371/journal.pone.0019385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559419	Green Published, gold			2022-12-25	WOS:000290024700154
J	Verkaar, F; van der Stelt, M; Blankesteijn, WM; van der Doelen, AA; Zaman, GJR				Verkaar, Folkert; van der Stelt, Mario; Blankesteijn, W. Matthijs; van der Doelen, Antoon A.; Zaman, Guido J. R.			Discovery of Novel Small Molecule Activators of beta-Catenin Signaling	PLOS ONE			English	Article							WNT; RECEPTOR; PATHWAY; PROTEINS; TRANSCRIPTION; DISEASE; FAMILY; TARGET	Wnt/beta-catenin signaling plays a major role in embryonic development and adult stem cell maintenance. Reduced activation of the Wnt/beta-catenin pathway underlies neurodegenerative disorders and aberrations in bone formation. Screening of a small molecule compound library with a beta-galactosidase fragment complementation assay measuring beta-catenin nuclear entry revealed bona fide activators of beta-catenin signaling. The compounds stabilized cytoplasmic beta-catenin and activated beta-catenin-dependent reporter gene activity. Although the mechanism through which the compounds activate beta-catenin signaling has yet to be determined, several key regulators of Wnt/beta-catenin signaling, including glycogen synthase kinase 3 and Frizzled receptors, were excluded as the molecular target. The compounds displayed remarkable selectivity, as they only induced beta-catenin signaling in a human osteosarcoma U2OS cell line and not in a variety of other cell lines examined. Our data indicate that differences in cellular Wnt/beta-catenin signaling machinery can be exploited to identify cell type-specific activators of Wnt/beta-catenin signaling.	[Verkaar, Folkert; van der Doelen, Antoon A.; Zaman, Guido J. R.] Merck Res Labs, Dept Mol Pharmacol, Oss, Netherlands; [Blankesteijn, W. Matthijs] Maastricht Univ, Dept Pharmacol & Toxicol, Maastricht, Netherlands; [van der Stelt, Mario] Merck Res Labs, Dept Med Chem, Oss, Netherlands	Merck & Company; Maastricht University; Merck & Company	Verkaar, F (corresponding author), Merck Res Labs, Dept Mol Pharmacol, Oss, Netherlands.	guido.zaman@spcorp.com			Dutch government BSIK [03033]	Dutch government BSIK(Ministry of Economic Affairs, Netherlands)	The work was supported by the Dutch government BSIK grant 03033 (to FV and WMB) (http://www.senternovem.nl/bsik) and carried out at Merck Research Laboratories in Oss, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Terstappen GC, 2006, IDRUGS, V9, P35; VANDERSTELT M, 2010, Patent No. 2010063666; Verkaar F, 2010, FASEB J, V24, P1205, DOI 10.1096/fj.09-141671; Verkaar F, 2009, CELL SIGNAL, V21, P22, DOI 10.1016/j.cellsig.2008.09.008; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	22	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19185	10.1371/journal.pone.0019185	http://dx.doi.org/10.1371/journal.pone.0019185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559429	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700095
J	Auweter, SD; Bhavsar, AP; de Hoog, CL; Li, YL; Chan, YA; van der Heijden, J; Lowden, MJ; Coombes, BK; Rogers, LD; Stoynov, N; Foster, LJ; Finlay, BB				Auweter, Sigrid D.; Bhavsar, Amit P.; de Hoog, Carmen L.; Li, Yuling; Chan, Y. Alina; van der Heijden, Joris; Lowden, Michael J.; Coombes, Brian K.; Rogers, Lindsay D.; Stoynov, Nikolay; Foster, Leonard J.; Finlay, B. Brett			Quantitative Mass Spectrometry Catalogues Salmonella Pathogenicity Island-2 Effectors and Identifies Their Cognate Host Binding Partners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION SYSTEM; ENTERICA SEROVAR TYPHIMURIUM; UBIQUITIN LIGASE COMPLEX; NF-KAPPA-B; ESCHERICHIA-COLI; PROTEIN FAMILY; 6-PYRUVOYLTETRAHYDROPTERIN SYNTHASE; PROTEOMIC ANALYSIS; VIRULENCE FACTORS; IMMUNE-RESPONSES	Gram-negative bacterial pathogens have developed specialized secretion systems to transfer bacterial proteins directly into host cells. These bacterial effectors are central to virulence and reprogram host cell processes to favor bacterial survival, colonization, and proliferation. Knowing the complete set of effectors encoded by a particular pathogen is the key to understanding bacterial disease. In addition, the identification of the molecular assemblies that these effectors engage once inside the host cell is critical to determining the mechanism of action of each effector. In this work we used stable isotope labeling of amino acids in cell culture (SILAC), a powerful quantitative proteomics technique, to identify the proteins secreted by the Salmonella pathogenicity island-2 type three secretion system (SPI-2 T3SS) and to characterize the host interaction partners of SPI-2 effectors. We confirmed many of the known SPI-2 effectors and were able to identify several novel substrate candidates of this secretion system. We verified previously published host protein-effector binding pairs and obtained 11 novel interactions, three of which were investigated further and confirmed by reciprocal co-immunoprecipitation. The host cell interaction partners identified here suggest that Salmonella SPI-2 effectors target, in a concerted fashion, cellular processes such as cell attachment and cell cycle control that are underappreciated in the context of infection. The technology outlined in this study is specific and sensitive and serves as a robust tool for the identification of effectors and their host targets that is readily amenable to the study of other bacterial pathogens.	[Rogers, Lindsay D.; Stoynov, Nikolay; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Auweter, Sigrid D.; Bhavsar, Amit P.; de Hoog, Carmen L.; Li, Yuling; Chan, Y. Alina; van der Heijden, Joris; Lowden, Michael J.; Coombes, Brian K.; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada; [Rogers, Lindsay D.; Foster, Leonard J.; Finlay, B. Brett] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Foster, LJ (corresponding author), Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada.	ljfoster@interchange.ubc.ca; bfinlay@interchange.ubc.ca	Rogers, Lindsay/AAO-1985-2021; Coombes, Brian K/A-1727-2009	Chan, Yujia Alina/0000-0002-0731-637X; Bhavsar, Amit/0000-0003-3336-9288; Coombes, Brian/0000-0001-9883-1010	Canadian Institutes of Health Research; Genome Canada/Genome British Columbia; VGH & UBC Hospital Foundation; Michael Smith Foundation for Health Research; British Columbia Knowledge Development Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada/Genome British Columbia(Genome Canada); VGH & UBC Hospital Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); British Columbia Knowledge Development Fund	This work was supported by grants from the Canadian Institutes of Health Research (to L. J. F. and B. B. F.) and from Genome Canada/Genome British Columbia through the PRoteomics for Emerging PAthogen REsponse (PREPARE) project and the VGH & UBC Hospital Foundation.; Supported by fellowships from the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research.; We thank the members of our group for discussions and valuable advice. Mass spectrometry infrastructure used in this work was supported by the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, and the BC Proteomics Network.	Abrahams GL, 2006, CELL MICROBIOL, V8, P728, DOI 10.1111/j.1462-5822.2006.00706.x; Bernal-Bayard J, 2010, J BIOL CHEM, V285, P16360, DOI 10.1074/jbc.M110.100669; Bernal-Bayard J, 2009, J BIOL CHEM, V284, P27587, DOI 10.1074/jbc.M109.010363; Bhavsar AP, 2010, FUTURE MICROBIOL, V5, P253, DOI 10.2217/FMB.09.114; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; Carver LA, 1997, J BIOL CHEM, V272, P11452; Coombes BK, 2005, J MOL BIOL, V348, P817, DOI 10.1016/j.jmb.2005.03.024; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Coombes BK, 2007, INFECT IMMUN, V75, P574, DOI 10.1128/IAI.00985-06; DASILVACORREIA J, 2007, P NATL ACAD SCI USA, V104, P6764; Deiwick J, 2006, INFECT IMMUN, V74, P6965, DOI 10.1128/IAI.00648-06; Deng WY, 2010, J BIOL CHEM, V285, P6790, DOI 10.1074/jbc.M109.086603; Detweiler CS, 2003, MOL MICROBIOL, V48, P385, DOI 10.1046/j.1365-2958.2003.03455.x; Dittrich S, 2008, MOL MICROBIOL, V67, P609, DOI 10.1111/j.1365-2958.2007.06073.x; Fairn GD, 2008, CELL MOL LIFE SCI, V65, P228, DOI 10.1007/s00018-007-7325-2; FINLAY BB, 1991, J CELL SCI, V99, P283; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Grill B, 2004, J IMMUNOL, V172, P2389, DOI 10.4049/jimmunol.172.4.2389; Haraga A, 2006, CELL MICROBIOL, V8, P837, DOI 10.1111/j.1462-5822.2005.00670.x; Harrison RE, 2004, MOL BIOL CELL, V15, P3146, DOI 10.1091/mbc.E04-02-0092; HEILAND I, 1979, BIOCHEMISTRY-US, V18, P4605, DOI 10.1021/bi00588a022; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Huang H, 2007, PLOS COMPUT BIOL, V3, P2155, DOI 10.1371/journal.pcbi.0030214; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Kuhle V, 2002, CELL MICROBIOL, V4, P813, DOI 10.1046/j.1462-5822.2002.00234.x; Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741; Le Negrate G, 2008, J IMMUNOL, V180, P5045, DOI 10.4049/jimmunol.180.7.5045; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Lehto M, 2003, BBA-MOL CELL BIOL L, V1631, P1, DOI 10.1016/S1388-1981(02)00364-5; Lehto M, 2001, J LIPID RES, V42, P1203; Levin I, 2010, P NATL ACAD SCI USA, V107, P2848, DOI 10.1073/pnas.0914821107; Logarinho E, 2008, CELL CYCLE, V7, P1763, DOI 10.4161/cc.7.12.6180; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; Menendez A, 2009, J INFECT DIS, V200, P1703, DOI 10.1086/646608; Miao EA, 2003, MOL MICROBIOL, V48, P401, DOI 10.1046/j.1365-2958.2003.t01-1-03456.x; Mittler G, 2009, GENOME RES, V19, P284, DOI 10.1101/gr.081711.108; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Rodiguez-Escudero I, 2006, MICROBIOL-SGM, V152, P3437, DOI 10.1099/mic.0.29186-0; Rogers LD, 2008, J PROTEOMICS, V71, P97, DOI 10.1016/j.jprot.2008.01.011; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shea JE, 1999, INFECT IMMUN, V67, P213, DOI 10.1128/IAI.67.1.213-219.1999; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Stokes DL, 2007, CURR OPIN CELL BIOL, V19, P565, DOI 10.1016/j.ceb.2007.09.003; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Valdez Y, 2009, CURR TOP MICROBIOL, V337, P93, DOI 10.1007/978-3-642-01846-6_4; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Wang B, 2005, J IMMUNOL, V175, P4274, DOI 10.4049/jimmunol.175.7.4274; Woo HJ, 2002, FEBS LETT, V523, P234, DOI 10.1016/S0014-5793(02)02997-6; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7	67	45	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24023	24035		10.1074/jbc.M111.224600	http://dx.doi.org/10.1074/jbc.M111.224600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21566117	Green Published, hybrid			2022-12-25	WOS:000292294900045
J	Cuisinier, R; Olivier, I; Vaugoyeau, M; Nougier, V; Assaiante, C				Cuisinier, Remy; Olivier, Isabelle; Vaugoyeau, Marianne; Nougier, Vincent; Assaiante, Christine			Reweighting of Sensory Inputs to Control Quiet Standing in Children from 7 to 11 and in Adults	PLOS ONE			English	Article							POSTURAL CONTROL; BALANCE CONTROL; TENDON VIBRATION; MATURATION; SYSTEMS; TASK; AGE	How sensory organization for postural control matures in children is not clear at this time. The present study examined, in children aged 7 to 11 and in adults, the postural control modifications in quiet standing when somatosensory inputs from the ankle were disturbed. Since the reweighting of sensory inputs is not mature before 10, we hypothesized that postural stability was more affected in children than in adults when somatosensory inputs were altered and that this postural instability decreased as age increased during childhood. 37 children aged 7 to 11 years and 9 adults participated in the experiments. The postural task was a semi-tandem position with the right foot in front of the left one. Postural performance was measured by means of a force platform. Two experimental conditions were presented to the participants to maintain quiet standing: With or without altered somatosensory inputs (i.e., with or without ankles vibration). Results showed that postural stability -and thus how the reweighting process of the visual/somatosensory inputs matured-increased non-monotonically between 7 years of age and adult age: There was a linear improvement of postural stability from 7 to 10, followed by a more steady behaviour between 10 and 11 and then postural stability increased to reach the adults' level of performance.	[Cuisinier, Remy; Olivier, Isabelle; Nougier, Vincent] UJF Grenoble 1 CNRS TIMC IMAG, UMR 5525, Grenoble, France; [Vaugoyeau, Marianne; Assaiante, Christine] Univ Aix Marseille 1, CNRS, UMR Grp Dev & Pathol Act 61 49, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cuisinier, R (corresponding author), UJF Grenoble 1 CNRS TIMC IMAG, UMR 5525, Grenoble, France.	isabelle.olivier@ujf-grenoble.fr	Nougier, Vincent M/B-4993-2013; Nougier, Vincent/AAG-5794-2021; Olivier, Isabelle/M-6054-2014	Nougier, Vincent M/0000-0002-9917-0004; 				ASSAIANTE C, 1995, HUM MOVEMENT SCI, V14, P13, DOI 10.1016/0167-9457(94)00048-J; Assaiante Christine, 2005, Neural Plasticity, V12, P109, DOI 10.1155/NP.2005.109; Bair WN, 2007, EXP BRAIN RES, V183, P435, DOI 10.1007/s00221-007-1057-2; Barela JA, 2003, EXP BRAIN RES, V150, P434, DOI 10.1007/s00221-003-1441-5; Duarte M, 2002, EXP BRAIN RES, V146, P60, DOI 10.1007/s00221-002-1154-1; Ferber-Viart C, 2007, INT J PEDIATR OTORHI, V71, P1041, DOI 10.1016/j.ijporl.2007.03.012; FIGURA F, 1991, J SPORT MED PHYS FIT, V31, P235; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; FORSSBERG H, 1982, J NEUROSCI, V2, P545; Hatzitaki V, 2002, J MOTOR BEHAV, V34, P161, DOI 10.1080/00222890209601938; JOUEN F, 1985, BEHAV BRAIN RES, V15, P241, DOI 10.1016/0166-4328(85)90178-0; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; Olivier I, 2007, NEUROREPORT, V18, P817, DOI 10.1097/WNR.0b013e3280e129e1; Palluel E, 2008, CLIN NEUROPHYSIOL, V119, P2546, DOI 10.1016/j.clinph.2008.08.001; Peterka R J, 1990, J Vestib Res, V1, P73; Peterson ML, 2006, GAIT POSTURE, V23, P455, DOI 10.1016/j.gaitpost.2005.05.003; Riach C.L., 1994, GAIT POSTURE, V2, P167, DOI [10.1016/0966-6362(94)90004-3, DOI 10.1016/0966-6362(94)90004-3]; Rival C, 2005, NEUROSCI LETT, V376, P133, DOI 10.1016/j.neulet.2004.11.042; ROLL JP, 1982, EXP BRAIN RES, V47, P177; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Roncesvalles MN, 2005, J MOTOR BEHAV, V37, P404, DOI 10.3200/JMBR.37.5.404-416; Schmitz C, 2002, NEUROSCI LETT, V330, P215, DOI 10.1016/S0304-3940(02)00590-6; SHUMWAYCOOK A, 1985, J MOTOR BEHAV, V17, P131; Sparto PJ, 2006, EXP BRAIN RES, V168, P505, DOI 10.1007/s00221-005-0109-8; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Sundermier L, 2001, EXP BRAIN RES, V136, P340, DOI 10.1007/s002210000579; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd	27	42	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19697	10.1371/journal.pone.0019697	http://dx.doi.org/10.1371/journal.pone.0019697			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	761GX	21573028	Green Submitted, gold, Green Published			2022-12-25	WOS:000290386800032
J	Kondo, N; Takahashi, A; Mori, E; Noda, T; Zdzienicka, MZ; Thompson, LH; Helleday, T; Suzuki, M; Kinashi, Y; Masunaga, S; Ono, K; Hasegawa, M; Ohnishi, T				Kondo, Natsuko; Takahashi, Akihisa; Mori, Eiichiro; Noda, Taichi; Zdzienicka, Malgorzata Z.; Thompson, Larry H.; Helleday, Thomas; Suzuki, Minoru; Kinashi, Yuko; Masunaga, Shinichiro; Ono, Koji; Hasegawa, Masatoshi; Ohnishi, Takeo			FANCD1/BRCA2 Plays Predominant Role in the Repair of DNA Damage Induced by ACNU or TMZ	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; FANCONI-ANEMIA; HOMOLOGOUS RECOMBINATION; MALIGNANT GLIOMA; MOLECULAR TARGET; MAMMALIAN-CELLS; LIGASE IV; PROTEIN; BRCA2; TEMOZOLOMIDE	Nimustine (ACNU) and temozolomide (TMZ) are DNA alkylating agents which are commonly used in chemotherapy for glioblastomas. ACNU is a DNA cross-linking agent and TMZ is a methylating agent. The therapeutic efficacy of these agents is limited by the development of resistance. In this work, the role of the Fanconi anemia (FA) repair pathway for DNA damage induced by ACNU or TMZ was examined. Cultured mouse embryonic fibroblasts were used: FANCA(-/-), FANCC(-/-), FANCA(-/-)C(-/-), FANCD2(-/-) cells and their parental cells, and Chinese hamster ovary and lung fibroblast cells were used: FANCD1/BRCA2mt, FANCG(-/-) and their parental cells. Cell survival was examined after a 3 h ACNU or TMZ treatment by using colony formation assays. All FA repair pathways were involved in ACNU-induced DNA damage. However, FANCG and FANCD1/BRCA2 played notably important roles in the repair of TMZ-induced DNA damage. The most effective molecular target correlating with cellular sensitivity to both ACNU and TMZ was FANCD1/BRCA2. In addition, it was found that FANCD1/BRCA2 small interference RNA efficiently enhanced cellular sensitivity toward ACNU and TMZ in human glioblastoma A172 cells. These findings suggest that the down-regulation of FANCD1/BRCA2 might be an effective strategy to increase cellular chemo-sensitization towards ACNU and TMZ.	[Kondo, Natsuko; Suzuki, Minoru; Kinashi, Yuko; Masunaga, Shinichiro; Ono, Koji] Kyoto Univ, Inst Res Reactor, Particle Radiat Oncol Res Ctr, Osaka 59004, Japan; [Takahashi, Akihisa] Gunma Univ, Adv Sci Res Leaders Dev Unit, Gunma, Japan; [Mori, Eiichiro; Hasegawa, Masatoshi; Ohnishi, Takeo] Nara Med Univ, Dept Radiat Oncol, Sch Med, Nara, Japan; [Noda, Taichi] Nara Med Univ, Dept Dermatol, Sch Med, Nara, Japan; [Zdzienicka, Malgorzata Z.] UMK Coll Med, Dept Mol Cell Genet, Bydgoszcz, Poland; [Thompson, Larry H.] Lawrence Livermore Natl Lab, BBR Program, Livermore, CA USA; [Helleday, Thomas] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	Kyoto University; Gunma University; Nara Medical University; Nara Medical University; Nicolaus Copernicus University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Stockholm University	Kondo, N (corresponding author), Kyoto Univ, Inst Res Reactor, Particle Radiat Oncol Res Ctr, Osaka 59004, Japan.	tohnishi@naramed-u.ac.jp	Mori, Eiichiro/AAY-6830-2020; Helleday, Thomas/D-5224-2013	Mori, Eiichiro/0000-0003-0945-196X; Helleday, Thomas/0000-0002-7384-092X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Central Research Institute of the Electric Power Industry in Japan; Japan Space Forum; MRC [G0700730] Funding Source: UKRI; Medical Research Council [G0700730] Funding Source: researchfish	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Central Research Institute of the Electric Power Industry in Japan; Japan Space Forum; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also funded in part by a grant from the Central Research Institute of the Electric Power Industry in Japan, and by a grant for Exploratory Research for Space Utilization from the Japan Space Forum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Bruun D, 2003, DNA REPAIR, V2, P1007, DOI 10.1016/S1568-7864(03)00112-5; Chen CC, 2007, J MOL MED, V85, P497, DOI 10.1007/s00109-006-0153-2; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Giese A, 2004, J NEURO-ONCOL, V66, P351, DOI 10.1023/B:NEON.0000014539.90077.db; Groth P, 2010, J MOL BIOL, V402, P70, DOI 10.1016/j.jmb.2010.07.010; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Helleday T, 1998, CARCINOGENESIS, V19, P973, DOI 10.1093/carcin/19.6.973; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Kondo N, 2010, CANCER SCI, V101, P1881, DOI 10.1111/j.1349-7006.2010.01591.x; Kondo N, 2009, BIOCHEM BIOPH RES CO, V387, P656, DOI 10.1016/j.bbrc.2009.07.045; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Roos WP, 2009, DNA REPAIR, V8, P72, DOI 10.1016/j.dnarep.2008.09.003; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stachelek GC, 2010, CANCER RES, V70, P409, DOI 10.1158/0008-5472.CAN-09-1353; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Takahashi A, 2004, CANCER RES, V64, P8839, DOI 10.1158/0008-5472.CAN-04-1876; TAKAKURA K, 1986, J NEUROSURG, V64, P53, DOI 10.3171/jns.1986.64.1.0053; Tebbs RS, 2005, DNA REPAIR, V4, P11, DOI 10.1016/j.dnarep.2004.06.013; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; WALKER MD, 1980, NEW ENGL J MED, V303, P1323, DOI 10.1056/NEJM198012043032303; Wiegant WW, 2006, MUTAT RES-FUND MOL M, V600, P79, DOI 10.1016/j.mrfmmm.2006.03.001; Wilson JB, 2008, ONCOGENE, V27, P3641, DOI 10.1038/sj.onc.1211034; Wolff JEA, 2008, J NEURO-ONCOL, V88, P57, DOI 10.1007/s11060-008-9533-5; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003; Yang YG, 2005, CARCINOGENESIS, V26, P1731, DOI 10.1093/carcin/bgi134	37	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19659	10.1371/journal.pone.0019659	http://dx.doi.org/10.1371/journal.pone.0019659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573016	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000290386800030
J	Kenah, E; Chao, DL; Matrajt, L; Halloran, ME; Longini, IM				Kenah, Eben; Chao, Dennis L.; Matrajt, Laura; Halloran, M. Elizabeth; Longini, Ira M., Jr.			The Global Transmission and Control of Influenza	PLOS ONE			English	Article							A H1N1 VIRUS; SEASONAL INFLUENZA; EPIDEMIC MODELS; UNITED-STATES; SPREAD; VACCINATION; NETWORKS; MOBILITY; A(H1N1)	New strains of influenza spread around the globe via the movement of infected individuals. The global dynamics of influenza are complicated by different patterns of influenza seasonality in different regions of the world. We have released an open-source stochastic mathematical model of the spread of influenza across 321 major, strategically located cities of the world. Influenza is transmitted between cities via infected airline passengers. Seasonality is simulated by increasing the transmissibility in each city at the times of the year when influenza has been observed to be most prevalent. The spatiotemporal spread of pandemic influenza can be understood through clusters of global transmission and links between them, which we identify using the epidemic percolation network (EPN) of the model. We use the model to explain the observed global pattern of spread for pandemic influenza A(H1N1) 2009-2010 (pandemic H1N1 2009) and to examine possible global patterns of spread for future pandemics depending on the origin of pandemic spread, time of year of emergence, and basic reproductive number (R-0). We also use the model to investigate the effectiveness of a plausible global distribution of vaccine for various pandemic scenarios. For pandemic H1N1 2009, we show that the biggest impact of vaccination was in the temperate northern hemisphere. For pandemics starting in the temperate northern hemisphere in May or April, vaccination would have little effect in the temperate southern hemisphere and a small effect in the tropics. With the increasing interconnectedness of the world's population, we must take a global view of infectious disease transmission. Our open-source, computationally simple model can help public health officials plan for the next pandemic as well as deal with interpandemic influenza.	[Kenah, Eben; Chao, Dennis L.; Halloran, M. Elizabeth; Longini, Ira M., Jr.] Fred Hutchinson Canc Res Ctr, Ctr Stat & Quantitat Infect Dis, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Kenah, Eben; Halloran, M. Elizabeth; Longini, Ira M., Jr.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Matrajt, Laura] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kenah, E (corresponding author), Fred Hutchinson Canc Res Ctr, Ctr Stat & Quantitat Infect Dis, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	dchao@fhcrc.org	Matrajt, Laura/AAV-5216-2020	Chao, Dennis/0000-0002-8253-6321	National Institute of General Medical Sciences MIDAS [U01-GM070749]; National Institute of Allergy and Infectious Diseases [R01-AI32042]; GlaxoSmithKline; National Institute of General Medical Sciences [F32-GM085945]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749, F32GM085945] Funding Source: NIH RePORTER	National Institute of General Medical Sciences MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); GlaxoSmithKline(GlaxoSmithKline); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by the National Institute of General Medical Sciences MIDAS grant U01-GM070749, the National Institute of Allergy and Infectious Diseases grant R01-AI32042, and by a grant from GlaxoSmithKline. EK was also supported by National Institute of General Medical Sciences grant F32-GM085945. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Basta NE, 2008, AM J EPIDEMIOL, V168, P1343, DOI 10.1093/aje/kwn259; Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918; Bonabeau E, 1998, P ROY SOC B-BIOL SCI, V265, P2421, DOI 10.1098/rspb.1998.0593; Central Intelligence Agency, 2009, WORLD FACTB 2009; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; Edler D., 2010, MAP GENERATOR SOFTWA, DOI http://www.mapequation.org; Flahault A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-129; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hill AN, 2003, MATH BIOSCI, V181, P85, DOI 10.1016/S0025-5564(02)00129-3; HOPESIMPSON RE, 1981, J HYG-CAMBRIDGE, V86, P35, DOI 10.1017/S0022172400068728; Institute for Health Metrics and Evaluation, GROSS DOM PROD GDP D; Jones E., 2001, SCIPY OPEN SOURCE SC; Kenah E, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036113; Kenah E, 2007, J THEOR BIOL, V249, P706, DOI 10.1016/j.jtbi.2007.09.011; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; McBryde ES, 2009, EUROSURVEILLANCE, V14, P45; MURPHY BR, 1980, INFECT IMMUN, V29, P348; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Patel R, 2005, J THEOR BIOL, V234, P201, DOI 10.1016/j.jtbi.2004.11.032; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Schanzer DL, 2010, INFLUENZA OTHER RESP, V4, P295, DOI 10.1111/j.1750-2659.2010.00154.x; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	36	52	52	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19515	10.1371/journal.pone.0019515	http://dx.doi.org/10.1371/journal.pone.0019515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573121	Green Published, gold, Green Submitted			2022-12-25	WOS:000290305600028
J	Latzka, J; Gaier, S; Hofstetter, G; Balazs, N; Smole, U; Ferrone, S; Scheiner, O; Breiteneder, H; Pehamberger, H; Wagner, S				Latzka, Julia; Gaier, Sonja; Hofstetter, Gerlinde; Balazs, Nina; Smole, Ursula; Ferrone, Soldano; Scheiner, Otto; Breiteneder, Heimo; Pehamberger, Hubert; Wagner, Stefan			Specificity of Mimotope-Induced Anti-High Molecular Weight-Melanoma Associated Antigen (HMW-MAA) Antibodies Does Not Ensure Biological Activity	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; TUMOR-GROWTH; IN-VITRO; CANCER-IMMUNOTHERAPY; PEPTIDE MIMOTOPES; IMMUNE-RESPONSE; CELL-SURFACE; VACCINATION; EPITOPE; MICE	Vaccines based on peptide mimics (mimotopes) of conformational tumor antigen epitopes have been investigated for a variety of human tumors including breast cancer, tumors expressing the carcinoembryonic antigen, B cell lymphoma, neuroblastoma, and melanoma. In our previous work, we designed a vaccine based on a mimotope of the high molecular weight-melanoma associated antigen (HMW-MAA) that elicited HMW-MAA-specific antibodies (Abs) with anti-tumor activity in vitro and in vivo. In this study, we aimed to identify mimotopes of additional distinct HMW-MAA epitopes, since they could be used to construct a polymimotope melanoma vaccine. For this purpose, random peptide phage libraries were screened with the anti-HMW-MAA monoclonal antibodies (mAbs) VT80.12 and VF1-TP43 yielding one peptide ligand for each mAb. Both peptides inhibited the binding of the corresponding mAb to the HMW-MAA. Furthermore, when coupled to the carrier protein keyhole limpet hemocyanin (KLH), both HMW-MAA mimotopes elicited peptide-specific Abs in rabbits or BALB/c mice, but only the mimotope isolated with the mAb VT80.12 elicited HMW-MAA-specific Abs and only in mice. However, the latter Abs had no detectable effect on HMW-MAA expressing human melanoma cells in vitro. These results describe limitations related to the phage display technique and emphasize the need to characterize the functional properties of the mAb utilized to isolate mimotopes of the corresponding epitopes.	[Latzka, Julia; Gaier, Sonja; Hofstetter, Gerlinde; Balazs, Nina; Smole, Ursula; Scheiner, Otto; Breiteneder, Heimo; Wagner, Stefan] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Ferrone, Soldano] Univ Pittsburgh, Inst Canc, Dept Surg Immunol & Pathol, Pittsburgh, PA USA; [Pehamberger, Hubert] Med Univ Vienna, Dept Dermatol, Div Gen Dermatol, Vienna, Austria	Medical University of Vienna; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of Vienna	Latzka, J (corresponding author), Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	stefan.wagner@meduniwien.ac.at		Smole, Ursula/0000-0001-5124-2024	Austrian Academy of Sciences at the Department of Pathophysiology and Allergy Research (Medical University of Vienna, Vienna, Austria)	Austrian Academy of Sciences at the Department of Pathophysiology and Allergy Research (Medical University of Vienna, Vienna, Austria)	SG was a recipient of a DOC-fFORTE-fellowship of the Austrian Academy of Sciences at the Department of Pathophysiology and Allergy Research (Medical University of Vienna, Vienna, Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bramswig KH, 2007, CLIN CANCER RES, V13, P6501, DOI 10.1158/1078-0432.CCR-07-0692; Brunner R, 2010, IMMUNOL LETT, V128, P29, DOI 10.1016/j.imlet.2009.10.005; Campoli M, 2010, ADV CANCER RES, V109, P73, DOI 10.1016/B978-0-12-380890-5.00003-X; Campoli MR, 2004, CRIT REV IMMUNOL, V24, P267, DOI 10.1615/CritRevImmunol.v24.i4.40; Chang CC, 2004, ANN NY ACAD SCI, V1028, P340, DOI 10.1196/annals.1322.040; CHEE DO, 1976, CANCER RES, V36, P1503; Engelhard VH, 2002, IMMUNOL REV, V188, P136, DOI 10.1034/j.1600-065X.2002.18812.x; FELICI F, 1991, J MOL BIOL, V222, P301, DOI 10.1016/0022-2836(91)90213-P; GIACOMINI P, 1984, CANCER RES, V44, P1281; Hafner C, 2005, MELANOMA RES, V15, P111, DOI 10.1097/00008390-200504000-00005; Hafner C, 2005, INT J CANCER, V114, P426, DOI 10.1002/ijc.20769; Hartmann C, 2010, ONCOGENE, V29, P4517, DOI 10.1038/onc.2010.195; Holmes K, 2001, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0503s44; Jasinska J, 2003, INT J CANCER, V107, P976, DOI 10.1002/ijc.11485; Jiang BH, 2005, J BIOL CHEM, V280, P4656, DOI 10.1074/jbc.M411047200; Li M, 2006, CELL IMMUNOL, V239, P136, DOI 10.1016/j.cellimm.2006.05.005; Maciag PC, 2008, CANCER RES, V68, P8066, DOI 10.1158/0008-5472.CAN-08-0287; MATSUI M, 1987, J IMMUNOL, V139, P2088; MITTELMAN A, 1992, P NATL ACAD SCI USA, V89, P466, DOI 10.1073/pnas.89.2.466; MITTELMAN A, 1994, CANCER RES, V54, P415; Perosa F, 2005, ANN NY ACAD SCI, V1051, P672, DOI 10.1196/annals.1361.112; Perosa F, 2007, J IMMUNOL, V179, P7967, DOI 10.4049/jimmunol.179.11.7967; Perosa F, 2009, J IMMUNOL, V182, P416, DOI 10.4049/jimmunol.182.1.416; Ray S, 2009, CLIN DERMATOL, V27, P603, DOI 10.1016/j.clindermatol.2008.09.019; Riemer AB, 2005, JNCI-J NATL CANCER I, V97, P1663, DOI 10.1093/jnci/dji373; Riemer AB, 2005, CANCER IMMUNOL IMMUN, V54, P677, DOI 10.1007/s00262-004-0632-7; Riemer AB, 2004, J IMMUNOL, V173, P394, DOI 10.4049/jimmunol.173.1.394; Spiridon CI, 2002, CLIN CANCER RES, V8, P1720; vanElsas A, 1997, J IMMUNOTHER, V20, P343, DOI 10.1097/00002371-199709000-00003; Wagner S, 2005, J IMMUNOL, V174, P976, DOI 10.4049/jimmunol.174.2.976; Wagner S, 2007, BREAST CANCER RES TR, V106, P29, DOI 10.1007/s10549-006-9469-4; Wagner S, 2008, CLIN CANCER RES, V14, P8178, DOI 10.1158/1078-0432.CCR-08-0371; Wang X, 2010, CURR MOL MED, V10, P419, DOI 10.2174/156652410791316977; WILSON BS, 1981, INT J CANCER, V28, P293, DOI 10.1002/ijc.2910280307; Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602; Zhao L, 2008, EXPERT REV VACCINES, V7, P1547, DOI 10.1586/14760584.7.10.1547	36	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19383	10.1371/journal.pone.0019383	http://dx.doi.org/10.1371/journal.pone.0019383			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573118	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000290305600024
J	Tan, NX; Messina, JP; Yang, LG; Yang, B; Emch, M; Chen, XS; Cohen, MS; Tucker, JD				Tan, Nicholas X.; Messina, Jane P.; Yang, Li-Gang; Yang, Bin; Emch, Michael; Chen, Xiang-Sheng; Cohen, Myron S.; Tucker, Joseph D.			A Spatial Analysis of County-level Variation in Syphilis and Gonorrhea in Guangdong Province, China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; FEMALE SEX WORKERS; TO-URBAN MIGRANTS; MALE RURAL MIGRANTS; HIV-INFECTION; RISK-FACTORS; EASTERN CHINA; HEPATITIS-B; DRUG-USERS; MEN	Background: Sexually transmitted infections (STI) have made a resurgence in many rapidly developing regions of southern China, but there is little understanding of the social changes that contribute to this spatial distribution of STI. This study examines county-level socio-demographic characteristics associated with syphilis and gonorrhea in Guangdong Province. Methods/Principal Findings: This study uses linear regression and spatial lag regression to determine county-level (n = 97) socio-demographic characteristics associated with a greater burden of syphilis, gonorrhea, and a combined syphilis/gonorrhea index. Data were obtained from the 2005 China Population Census and published public health data. A range of socio-demographic variables including gross domestic product, the Gender Empowerment Measure, standard of living, education level, migrant population and employment are examined. Reported syphilis and gonorrhea cases are disproportionately clustered in the Pearl River Delta, the central region of Guangdong Province. A higher fraction of employed men among the adult population, higher fraction of divorced men among the adult population, and higher standard of living (based on water availability and people per room) are significantly associated with higher STI cases across all three models. Gross domestic product and gender inequality measures are not significant predictors of reported STI in these models. Conclusions/Significance: Although many ecological studies of STIs have found poverty to be associated with higher reported STI, this analysis found a greater number of reported syphilis cases in counties with a higher standard of living. Spatially targeted syphilis screening measures in regions with a higher standard of living may facilitate successful control efforts. This analysis also reinforces the importance of changing male sexual behaviors as part of a comprehensive response to syphilis control in China.	[Tan, Nicholas X.; Tucker, Joseph D.] Harvard Univ, Cambridge, MA 02138 USA; [Messina, Jane P.; Emch, Michael] Univ N Carolina, Dept Geog, Chapel Hill, NC USA; [Yang, Li-Gang; Yang, Bin; Tucker, Joseph D.] Guangdong Prov STI Control Ctr, Guangzhou, Guangdong, Peoples R China; [Chen, Xiang-Sheng] Natl Ctr STD Control, Nanjing, Peoples R China; [Cohen, Myron S.; Tucker, Joseph D.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA	Harvard University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Tan, NX (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	yanglg3@yahoo.com; jtucker4@partners.org		Tucker, Joseph/0000-0003-2804-1181	National Institutes of Health (NIH) [US NIH 1K01TW008200-01A1]; University of North Carolina (UNC) [NIH FIC D43 TW01039]; UNC Social Science Research on HIV/AIDS in China [NIH NICHD R24 HD056670-01]; Harvard Institute for Global Health; American Society of Tropical Medicine and Hygiene; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R24HD056670] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [K01TW008200, D43TW001039] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina (UNC); UNC Social Science Research on HIV/AIDS in China; Harvard Institute for Global Health; American Society of Tropical Medicine and Hygiene; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors acknowledge a National Institutes of Health (NIH) Fogarty K01 Award (US NIH 1K01TW008200-01A1; JT), the University of North Carolina (UNC) Fogarty AIDS International Research and Training Program (NIH FIC D43 TW01039), the UNC Social Science Research on HIV/AIDS in China (NIH NICHD R24 HD056670-01), the Harvard Institute for Global Health, and Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene Wellcome Postdoctoral Fellowship in Tropical Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZDARDET C, 1985, SEX TRANSM DIS, V12, P166, DOI 10.1097/00007435-198507000-00016; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; Choi KH, 2004, AIDS EDUC PREV, V16, P19, DOI 10.1521/aeap.16.1.19.27721; DUBOISARBER F, 1993, SOC SCI MED, V37, P1539, DOI 10.1016/0277-9536(93)90188-A; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Fan CC, 1999, INT MIGR REV, V33, P954, DOI 10.2307/2547359; Gillespie S, 2007, AIDS, V21, pS1, DOI 10.1097/01.aids.0000300530.67107.45; He N, 2006, AIDS EDUC PREV, V18, P176, DOI 10.1521/aeap.2006.18.2.176; He N, 2005, SEX TRANSM DIS, V32, P286, DOI 10.1097/01.olq.0000152219.58592.9b; He N, 2007, BIOSCI TRENDS, V1, P72; Hesketh T, 2006, SEX TRANSM INFECT, V82, P11, DOI 10.1136/sti.2004.014043; Holtgrave DR, 2003, SEX TRANSM INFECT, V79, P62, DOI 10.1136/sti.79.1.62; Hong FC, 2010, SEX TRANSM DIS, V37, P26, DOI 10.1097/OLQ.0b013e3181b3915b; Hong Y, 2006, AIDS BEHAV, V10, P421, DOI 10.1007/s10461-005-9039-5; Jewkes R, 2010, SCIENCE, V329, P145, DOI 10.1126/science.1193794; Jia YJ, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-29; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; Johnson K, 2006, JAIDS-J ACQ IMM DEF, V42, P627, DOI 10.1097/01.qai.0000225870.87456.ae; Kalichman SC, 2006, SOC SCI MED, V62, P1641, DOI 10.1016/j.socscimed.2005.08.021; Kilmarx PH, 1997, AM J PUBLIC HEALTH, V87, P1937, DOI 10.2105/AJPH.87.12.1937; Law DCG, 2004, SEX TRANSM INFECT, V80, P294, DOI 10.1136/sti.2003.006700; Li DL, 2010, AIDS PATIENT CARE ST, V24, P595, DOI 10.1089/apc.2010.0083; Li SH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-195; LIDDON N, 2010, J WOMENS HLTH LARCHM; LIU DLLL, 2005, HOMOSEXUALITY RES CH, V47, P274; Liu HJ, 2006, SEX TRANSM DIS, V33, P111, DOI 10.1097/01.olq.0000199762.28231.ee; Liu HJ, 2005, AIDS PATIENT CARE ST, V19, P49, DOI 10.1089/apc.2005.19.49; Lu F, 2009, SE ASIAN J TROP MED, V40, P263; Mbonu NC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-334; *NAT BUR STAT CHIN, 1 NAT POP SAMPL SURV; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Piot P, 2007, PLOS MED, V4, P1571, DOI 10.1371/journal.pmed.0040314; Reynolds SJ, 2006, SEX TRANSM INFECT, V82, P121, DOI 10.1136/sti.2005.015040; Ruan YH, 2004, SEX TRANSM DIS, V31, P623; Ruan YH, 2006, SEX TRANSM DIS, V33, P719, DOI 10.1097/01.olq.0000218881.01437.99; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; Schleihauf E, 2009, SEX TRANSM INFECT, V85, P45, DOI 10.1136/sti.2008.030197; Shahmanesh M, 2000, SEX TRANSM INFECT, V76, P268, DOI 10.1136/sti.76.4.268; THOMAS JC, 1995, AM J PUBLIC HEALTH, V85, P1119, DOI 10.2105/AJPH.85.8_Pt_1.1119; Tladi L S, 2006, SAHARA J, V3, P369; Tucker JD, 2005, AIDS, V19, P539, DOI 10.1097/01.aids.0000163929.84154.87; TUCKER JD, 2010, GENDER POLICY HIV CH; Tucker JD, 2010, B WORLD HEALTH ORGAN, V88, P452, DOI 10.2471/BLT.09.070326; Tucker JD, 2010, NEW ENGL J MED, V362, P1658, DOI 10.1056/NEJMp0911149; Turmen T, 2003, INT J GYNECOL OBSTET, V82, P411, DOI 10.1016/S0020-7292(03)00202-9; *UNDP, HUM DEV REP HDR UN D; Uretsky E, 2008, CULT HEALTH SEX, V10, P801, DOI 10.1080/13691050802380966; Wang B, 2007, SEX TRANSM DIS, V34, P1, DOI 10.1097/01.olq.0000222668.95038.03; Wang Man, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P1004; Xia GM, 2005, AIDS EDUC PREV, V17, P143, DOI 10.1521/aeap.17.3.143.62904; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; YANG H, 2010, SEX TRANSM DIS; YANG LG, 2010, ANN STD SURVEILLANCE; YANG LG, BMC PUBLIC IN PRESS; Yang LG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-793; Yang X, 2007, AIDS CARE, V19, P282, DOI 10.1080/09540120600909414; Yang XS, 2006, STUD FAMILY PLANN, V37, P241, DOI 10.1111/j.1728-4465.2006.00103.x; Yi HS, 2010, PSYCHOL HEALTH MED, V15, P172, DOI 10.1080/13548501003623914; Yin Lu, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P293; Yu XJ, 2007, LANDSCAPE URBAN PLAN, V79, P96, DOI 10.1016/j.landurbplan.2006.03.008; [张北川 Zhang Beichuan], 2002, [中华皮肤科杂志, Chinese Journa of Dermatology], V35, P214	62	16	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19648	10.1371/journal.pone.0019648	http://dx.doi.org/10.1371/journal.pone.0019648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	760DZ	21573127	Green Published, gold, Green Submitted			2022-12-25	WOS:000290305600038
J	Teixido, L; Carrasco, B; Alonso, JC; Barbe, J; Campoy, S				Teixido, Laura; Carrasco, Begona; Alonso, Juan C.; Barbe, Jordi; Campoy, Susana			Fur Activates the Expression of Salmonella enterica Pathogenicity Island 1 by Directly Interacting with the hilD Operator In Vivo and In Vitro	PLOS ONE			English	Article							III SECRETION SYSTEM; TYPHIMURIUM INVASION GENES; ESCHERICHIA-COLI; SEROVAR TYPHIMURIUM; NEISSERIA-MENINGITIDIS; TRANSCRIPTIONAL REPRESSION; COORDINATE REGULATION; OXIDATIVE STRESS; IRON-METABOLISM; VIRULENCE GENES	Previous studies have established that the expression of Salmonella enterica pathogenicity island 1 (SPI1), which is essential for epithelial invasion, is mainly regulated by the HilD protein. The ferric uptake regulator, Fur, in turn modulates the expression of the S. enterica hilD gene, albeit through an unknown mechanism. Here we report that S. enterica Fur, in its metal-bound form, specifically binds to an AT-rich region (BoxA), located upstream of the hilD promoter (P-hilD), at position -191 to -163 relative to the hilD transcription start site. Furthermore, in a P-hilD variant with mutations in BoxA, P-hilD*, Fur-Mn2+ binding is impaired. In vivo experiments using S. enterica strains carrying wild-type P-hilD or the mutant variant P-hilD* showed that Fur activates hilD expression, while in vitro experiments revealed that the Fur-Mn2+ protein is sufficient to increase hilD transcription. Together, these results present the first evidence that Fur-Mn2+, by binding to the upstream BoxA sequence, directly stimulates the expression of hilD in S. enterica.	[Teixido, Laura; Barbe, Jordi; Campoy, Susana] Univ Autonoma Barcelona, Dept Genet & Microbiol, Fac Biociencies, Bellaterra, Spain; [Carrasco, Begona] Univ Oviedo, Area Microbiol, Fac Med, Oviedo, Spain; [Alonso, Juan C.] CSIC, Ctr Nacl Biotecnol, Madrid, Spain	Autonomous University of Barcelona; University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Teixido, L (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Fac Biociencies, Bellaterra, Spain.	Susana.Campoy@uab.cat	Alonso, Juan Carlos/D-2595-2009; Campoy, Susana/C-7335-2008; campoy, susana/E-4346-2010; Barbe, Jordi/G-5212-2015	Alonso, Juan Carlos/0000-0002-5178-7179; Campoy, Susana/0000-0003-1369-0197; campoy, susana/0000-0003-1369-0197; Barbe, Jordi/0000-0003-4408-013X; Carrasco, Begona/0000-0002-5671-1296	Ministerio de Ciencia e Innovacion (MICIIN) [BFU2008-01078, BFU2009-07167]; Generalitat de Catalunya [2009SGR1106]	Ministerio de Ciencia e Innovacion (MICIIN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by the Ministerio de Ciencia e Innovacion (MICIIN) [grants BFU2008-01078 to J.B. and BFU2009-07167 to J.C.A.]; and the Generalitat de Catalunya [2009SGR1106 to J.B.]. B. C. was the recipient of a Juan de la Cierva fellowship from the MICIIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 1993, GENE, V132, P1, DOI 10.1016/0378-1119(93)90507-Y; Alamuri P, 2006, J BACTERIOL, V188, P5325, DOI 10.1128/JB.00104-06; Altier C, 2005, J MICROBIOL, V43, P85; Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; Baxter MA, 2003, INFECT IMMUN, V71, P1295, DOI 10.1128/IAI.71.3.1295-1305.2003; Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; Bsat N, 1999, J BACTERIOL, V181, P4299, DOI 10.1128/JB.181.14.4299-4307.1999; Campoy S, 2003, MOL MICROBIOL, V49, P769, DOI 10.1046/j.1365-2958.2003.03592.x; Campoy S, 2002, MICROBIOL-SGM, V148, P1039, DOI 10.1099/00221287-148-4-1039; Carpenter BM, 2009, INFECT IMMUN, V77, P2590, DOI 10.1128/IAI.00116-09; Carrasco B, 2008, DNA REPAIR, V7, P990, DOI 10.1016/j.dnarep.2008.03.019; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; COLLIS CM, 1989, NUCLEIC ACIDS RES, V17, P9447, DOI 10.1093/nar/17.22.9447; Conrad ME, 2002, BLOOD CELL MOL DIS, V29, P336, DOI 10.1006/bcmd.2002.0564; Darwin KH, 1999, J BACTERIOL, V181, P4949; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; Delany I, 2004, MOL MICROBIOL, V52, P1081, DOI 10.1111/j.1365-2958.2004.04030.x; DELORENZO V, 1987, J BACTERIOL, V169, P2624, DOI 10.1128/jb.169.6.2624-2630.1987; DELORENZO V, 1988, J MOL BIOL, V203, P875, DOI 10.1016/0022-2836(88)90113-1; Eichelberg K, 1999, INFECT IMMUN, V67, P4099, DOI 10.1128/IAI.67.8.4099-4105.1999; Ekhnovich IN, 2007, J BACTERIOL, V189, P6882, DOI 10.1128/JB.00905-07; Ellermeier CD, 2005, MOL MICROBIOL, V57, P691, DOI 10.1111/j.1365-2958.2005.04737.x; Ellermeier CD, 2003, J BACTERIOL, V185, P5096, DOI 10.1128/JB.185.17.5096-5108.2003; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Escolar L, 2000, J BIOL CHEM, V275, P24709, DOI 10.1074/jbc.M002839200; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Gao H, 2008, J BACTERIOL, V190, P3063, DOI 10.1128/JB.01910-07; GARCIADELPORTILLO F, 1993, INFECT IMMUN, V61, P4489, DOI 10.1128/IAI.61.10.4489-4492.1993; Garrido ME, 2003, MICROBIOL-SGM, V149, P2273, DOI 10.1099/mic.0.26370-0; Grifantini R, 2004, MOL MICROBIOL, V54, P962, DOI 10.1111/j.1365-2958.2004.04315.x; GRIGGS DW, 1989, J BACTERIOL, V171, P1048, DOI 10.1128/jb.171.2.1048-1054.1989; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Janakiraman A, 2000, MOL MICROBIOL, V35, P1146, DOI 10.1046/j.1365-2958.2000.01783.x; Jones BD, 2005, J MICROBIOL, V43, P110; Lavrrar JL, 2003, J BACTERIOL, V185, P2194, DOI 10.1128/JB.185.7.2194-2202.2003; Lee HJ, 2007, J BACTERIOL, V189, P2629, DOI 10.1128/JB.01791-06; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; LITWIN CM, 1992, J BACTERIOL, V174, P1897, DOI 10.1128/jb.174.6.1897-1903.1992; Lostroh CP, 2001, MICROBES INFECT, V3, P1281; Lostroh CP, 2000, MOL MICROBIOL, V37, P300, DOI 10.1046/j.1365-2958.2000.01991.x; Lucas RL, 2001, J BACTERIOL, V183, P2733, DOI 10.1128/JB.183.9.2733-2745.2001; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mastroeni P, 2009, NAT REV MICROBIOL, V7, P73, DOI 10.1038/nrmicro2034; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Mazon G, 2004, MOL GENET GENOMICS, V271, P40, DOI 10.1007/s00438-003-0952-x; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Nandal A, 2010, MOL MICROBIOL, V75, P637, DOI 10.1111/j.1365-2958.2009.06977.x; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Olekhnovich IN, 2002, J BACTERIOL, V184, P4148, DOI 10.1128/JB.184.15.4148-4160.2002; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; PANG T, 1995, TRENDS MICROBIOL, V3, P253, DOI 10.1016/S0966-842X(00)88937-4; PARK SJ, 1995, J BACTERIOL, V177, P6255, DOI 10.1128/jb.177.21.6255-6262.1995; PEGUES DA, 1995, MOL MICROBIOL, V17, P169, DOI 10.1111/j.1365-2958.1995.mmi_17010169.x; PRINCE RW, 1993, J BACTERIOL, V175, P2589, DOI 10.1128/JB.175.9.2589-2598.1993; Prouty AM, 2000, INFECT IMMUN, V68, P6763, DOI 10.1128/IAI.68.12.6763-6769.2000; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rojo F, 2001, CURR OPIN MICROBIOL, V4, P145, DOI 10.1016/S1369-5274(00)00180-6; Saini S, 2010, PLOS PATHOG, V6, DOI [10.1371/annotation/df7e26bc-4c62-43b4-865f-a39274d98ab3, 10.1371/journal.ppat.1001025]; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schechter LM, 2003, INFECT IMMUN, V71, P5432, DOI 10.1128/IAI.71.9.5432-5435.2003; Schechter LM, 2001, MOL MICROBIOL, V40, P1289, DOI 10.1046/j.1365-2958.2001.02462.x; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; STOJILJKOVIC I, 1994, J MOL BIOL, V236, P531, DOI 10.1006/jmbi.1994.1163; TARDAT B, 1993, MOL MICROBIOL, V9, P53, DOI 10.1111/j.1365-2958.1993.tb01668.x; Teixido L, 2010, INT MICROBIOL, V13, P33, DOI 10.2436/20.1501.01.109; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; THOMAS CE, 1994, MOL MICROBIOL, V11, P725, DOI 10.1111/j.1365-2958.1994.tb00350.x; TOUATI D, 1988, J BACTERIOL, V170, P2511, DOI 10.1128/jb.170.6.2511-2520.1988; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; Troxell B, 2011, J BACTERIOL, V193, P497, DOI 10.1128/JB.00942-10; TSOLIS RM, 1995, J BACTERIOL, V177, P4628, DOI 10.1128/jb.177.16.4628-4637.1995; Vassinova N, 2000, MICROBIOL-SGM, V146, P3171, DOI 10.1099/00221287-146-12-3171; Vivero A, 2008, J BACTERIOL, V190, P1152, DOI 10.1128/JB.01206-07; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; WEINBERG ED, 1978, MICROBIOL REV, V42, P45, DOI 10.1128/MMBR.42.1.45-66.1978; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0	84	56	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19711	10.1371/journal.pone.0019711	http://dx.doi.org/10.1371/journal.pone.0019711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573071	Green Published, Green Submitted, gold			2022-12-25	WOS:000290305600042
J	Li, H; Hughes, AL; Bano, N; McArdle, S; Livingston, S; Deubner, H; McMahon, BJ; Townshend-Bulson, L; McMahan, R; Rosen, HR; Gretch, DR				Li, Hui; Hughes, Austin L.; Bano, Nazneen; McArdle, Susan; Livingston, Stephen; Deubner, Heike; McMahon, Brian J.; Townshend-Bulson, Lisa; McMahan, Rachel; Rosen, Hugo R.; Gretch, David R.			Genetic Diversity of Near Genome-Wide Hepatitis C Virus Sequences during Chronic Infection: Evidence for Protein Structural Conservation Over Time	PLOS ONE			English	Article							ORDERED RNA STRUCTURE; ALASKA NATIVES; NONSYNONYMOUS SUBSTITUTION; MOLECULAR EVOLUTION; IN-VIVO; INTERFERON; MUTATIONS; RIBAVIRIN; DYNAMICS; IMMUNITY	Infection with hepatitis C virus (HCV) is one of the leading causes of chronic hepatitis, liver cirrhosis and end-stage liver disease worldwide. The genetics of HCV infection in humans and the disease course of chronic hepatitis C are both remarkably variable. Although the response to interferon treatment is largely dependent on HCV genotypes, whether or not a relationship exists between HCV genome variability and clinical course of hepatitis C disease still remains unknown. To more thoroughly understand HCV genome evolution over time in association with disease course, near genome-wide HCV genomes present in 9 chronically infected participants over 83 total study years were sequenced. Overall, within HCV genomes, the number of synonymous substitutions per synonymous site (d(S)) significantly exceeded the number of non-synonymous substitutions per site (d(N)). Although both d(S) and d(N) significantly increased with duration of chronic infection, there was a highly significant decrease in d(N)/d(S) ratio in HCV genomes over time. These results indicate that purifying selection acted to conserve viral protein structure despite persistence of high level of nucleotide mutagenesis inherent to HCV replication. Based on liver biopsy fibrosis scores, HCV genomes from participants with advanced fibrosis had significantly greater d(S) values and lower d(N)/d(S) ratios compared to participants with mild liver disease. Over time, viral genomes from participants with mild disease had significantly greater annual changes in d(N), along with higher d(N)/d(S) ratios, compared to participants with advanced fibrosis. Yearly amino acid variations in the HCV p7, NS2, NS3 and NS5B genes were all significantly lower in participants with severe versus mild disease, suggesting possible pathogenic importance of protein structural conservation for these viral gene products.	[Li, Hui; Bano, Nazneen; McArdle, Susan; Gretch, David R.] Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA; [Hughes, Austin L.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Livingston, Stephen; McMahon, Brian J.; Townshend-Bulson, Lisa] Alaska Native Tribal Hlth Consortium, Liver Dis & Hepatitis Program, Anchorage, AK USA; [Deubner, Heike] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98195 USA; [McMahan, Rachel; Rosen, Hugo R.] Univ Colorado, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Aurora, CO USA; [Gretch, David R.] Univ Washington, Med Ctr, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Alaska Native Tribal Health Consortium; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Washington; University of Washington Seattle	Li, H (corresponding author), Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA.	gretch@u.washington.edu			NIH [AI 48214, AI 7044-28]; Alaska Science and Technology Foundation [99-4-113]; Alaska Native Tribal Health Consortium; National Centers for Infectious Diseases, Centers for Disease Control and Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007044, U19AI048214] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alaska Science and Technology Foundation; Alaska Native Tribal Health Consortium; National Centers for Infectious Diseases, Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by NIH grants AI 48214, AI 7044-28, and Alaska Science and Technology Foundation Grant Agreement Number 99-4-113 to the University of Washington, the Liver Disease and Hepatitis Program of the Alaska Native Tribal Health Consortium, and the Arctic Investigations Program of the National Centers for Infectious Diseases, Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowen DG, 2005, J EXP MED, V201, P1709, DOI 10.1084/jem.20050808; Bruce MG, 2008, J VIRAL HEPATITIS, V15, P179, DOI 10.1111/j.1365-2893.2007.00928.x; Bruce MG, 2006, LIVER INT, V26, P643, DOI 10.1111/j.1478-3231.2006.01281.x; DAVIDSON F, 1995, J GEN VIROL, V76, P1197, DOI 10.1099/0022-1317-76-5-1197; Davis M, 2008, J VIROL, V82, P11824, DOI 10.1128/JVI.01078-08; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; El-Shamy A, 2008, HEPATOLOGY, V48, P38, DOI 10.1002/hep.22339; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; FAZOLLAH MR, 1994, INTRO INFORM THEORY; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Golden-Mason L, 2008, J IMMUNOL, V180, P3637, DOI 10.4049/jimmunol.180.6.3637; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Horner SM, 2009, J INTERF CYTOK RES, V29, P489, DOI 10.1089/jir.2009.0063; Hughes AL, 2008, ANN NY ACAD SCI, V1133, P162, DOI 10.1196/annals.1438.001; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Joyce MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000291; Kimura MA, 1985, NEUTRAL THEORY MOL E; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Kuiken Carla, 2009, V510, P33, DOI 10.1007/978-1-59745-394-3_4; Li H, 2008, J VIROL, V82, P7524, DOI 10.1128/JVI.02220-07; Li H, 2008, VIROLOGY, V375, P580, DOI 10.1016/j.virol.2008.02.012; Li H, 2010, VIROLOGY, V402, P248, DOI 10.1016/j.virol.2010.03.040; LI WH, 1978, GENETICS, V90, P349; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; MCMAHAN RH, 2010, J CLIN INVEST; McMahon BJ, 2004, HEPATOLOGY, V39, P325, DOI 10.1002/hep.20046; McMahon BJ, 2010, GASTROENTEROLOGY, V138, P922, DOI 10.1053/j.gastro.2009.10.056; McMullan LK, 2007, P NATL ACAD SCI USA, V104, P2879, DOI 10.1073/pnas.0611267104; Mishima K, 2010, VIROLOGY, V405, P361, DOI 10.1016/j.virol.2010.06.020; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 2000, MOL EVOLUTION PHYLOG; OHTA T, 1976, THEOR POPUL BIOL, V10, P254, DOI 10.1016/0040-5809(76)90019-8; Pavio N, 2005, ONCOGENE, V24, P6119, DOI 10.1038/sj.onc.1208749; Rehermann B, 1996, BAILLIERE CLIN GASTR, V10, P483, DOI 10.1016/S0950-3528(96)90054-8; Scheuer Peter J, 2002, Clin Liver Dis, V6, P335, DOI 10.1016/S1089-3261(02)00009-0; SEEFF LB, 1997, HEPATOLOGY S1, V26, P21; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Simmonds P, 2004, RNA, V10, P1337, DOI 10.1261/rna.7640104; Sullivan DG, 2007, J INFECT DIS, V196, P239, DOI 10.1086/518895; Suzuki T, 2007, J GASTROENTEROL, V42, P411, DOI 10.1007/s00535-007-2030-3; Thimme R, 2006, ANTIVIR RES, V69, P129, DOI 10.1016/j.antiviral.2005.12.001; WHO, 1999, WKLY EPIDEMIOL REC, V74, P425; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Wohnsland A, 2007, CLIN MICROBIOL REV, V20, P23, DOI 10.1128/CMR.00010-06; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Young KC, 2003, HEPATOLOGY, V38, P869, DOI 10.1053/jhep.2003.50445	49	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19562	10.1371/journal.pone.0019562	http://dx.doi.org/10.1371/journal.pone.0019562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573177	Green Submitted, gold, Green Published			2022-12-25	WOS:000290256400024
J	D'Avanzo, N; Hyrc, K; Enkvetchakul, D; Covey, DF; Nichols, CG				D'Avanzo, Nazzareno; Hyrc, Krzysztof; Enkvetchakul, Decha; Covey, Douglas F.; Nichols, Colin G.			Enantioselective Protein-Sterol Interactions Mediate Regulation of Both Prokaryotic and Eukaryotic Inward Rectifier K+ Channels by Cholesterol	PLOS ONE			English	Article							BILAYER-MEMBRANES; ANION CURRENT; IN-VITRO; SENSITIVITY; MODULATION; HYPERCHOLESTEROLEMIA; ELASTICITY; EXPRESSION; KIR2.1; ASSAY	Cholesterol is the major sterol component of all mammalian cell plasma membranes and plays a critical role in cell function and growth. Previous studies have shown that cholesterol inhibits inward rectifier K+ (Kir) channels, but have not distinguished whether this is due directly to protein-sterol interactions or indirectly to changes in the physical properties of the lipid bilayer. Using purified bacterial and eukaryotic Kir channels reconstituted into liposomes of controlled lipid composition, we demonstrate by Rb-86(+) influx assays that bacterial Kir channels (KirBac1.1 and KirBac3.1) and human Kir2.1 are all inhibited by cholesterol, most likely by locking the channels into prolonged closed states, whereas the enantiomer, ent-cholesterol, does not inhibit these channels. These data indicate that cholesterol regulates Kir channels through direct protein-sterol interactions likely taking advantage of an evolutionarily conserved binding pocket.	[D'Avanzo, Nazzareno; Hyrc, Krzysztof; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [D'Avanzo, Nazzareno; Hyrc, Krzysztof; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO USA; [Enkvetchakul, Decha] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Covey, Douglas F.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Saint Louis University; Washington University (WUSTL)	D'Avanzo, N (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	cnichols@wustl.edu	Nichols, Colin/D-6336-2012	Hyrc, Krzysztof/0000-0002-8830-6324	National Institutes of Health [HL54171, DK069424, GM47969]; Neuroscience Blueprint [P30NS057105]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neuroscience Blueprint; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant HL54171 (CGN), DK069424 (DE), GM47969 (DFC) and Neuroscience Blueprint Core Grant P30NS057105 to Washington University in St. Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakoskela JM, 2008, LANGMUIR, V24, P830, DOI 10.1021/la702909q; Ambudkar Indu S, 2004, Sci STKE, V2004, ppe32, DOI 10.1126/stke.2432004pe32; BOLOTINA V, 1989, PFLUG ARCH EUR J PHY, V415, P262, DOI 10.1007/BF00370875; Bowles DK, 2004, J APPL PHYSIOL, V96, P2240, DOI 10.1152/japplphysiol.01229.2003; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; CADENHEAD DA, 1979, CHEM PHYS LIPIDS, V25, P329, DOI 10.1016/0009-3084(79)90115-4; Cheng WWL, 2011, BIOPHYS J, V100, P620, DOI 10.1016/j.bpj.2010.12.3724; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Covey DF, 2009, STEROIDS, V74, P577, DOI 10.1016/j.steroids.2008.11.019; D'Avanzo N, 2010, J BIOL CHEM, V285, P37129, DOI 10.1074/jbc.C110.186692; D'Avanzo N, 2010, CHANNELS, V4, P139, DOI 10.4161/chan.4.3.12129; D'Avanzo N, 2010, PROTEIN EXPRES PURIF, V71, P115, DOI 10.1016/j.pep.2010.01.010; DEMEL RA, 1976, BIOCHIM BIOPHYS ACTA, V457, P109, DOI 10.1016/0304-4157(76)90008-3; Enkvetchakul D, 2005, J BIOL CHEM, V280, P35785, DOI 10.1074/jbc.C500355200; Enkvetchakul D, 2004, J BIOL CHEM, V279, P47076, DOI 10.1074/jbc.C400417200; Epand RM, 2005, BIOCHEM J, V390, P541, DOI 10.1042/BJ20050649; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; EVANS E, 1987, J PHYS CHEM-US, V91, P4219, DOI 10.1021/j100300a003; Gidwani A, 2001, BIOCHEMISTRY-US, V40, P12422, DOI 10.1021/bi010496c; Heaps CL, 2005, AM J PHYSIOL-HEART C, V288, pH568, DOI 10.1152/ajpheart.00157.2004; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jiang X, 2002, J ORG CHEM, V67, P4893, DOI 10.1021/jo025535k; Kahya N, 2006, MOL MEMBR BIOL, V23, P29, DOI 10.1080/09687860500489099; Kellner-Weibel G, 1999, ATHEROSCLEROSIS, V146, P309, DOI 10.1016/S0021-9150(99)00155-0; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Liu J, 2005, BIOCHEM J, V391, P389, DOI 10.1042/BJ20050428; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Lundbaek JA, 1996, BIOCHEMISTRY-US, V35, P3825, DOI 10.1021/bi952250b; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Mannock DA, 2003, BIOPHYS J, V84, P1038, DOI 10.1016/S0006-3495(03)74920-0; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; MURARI R, 1986, BIOCHEMISTRY-US, V25, P1062, DOI 10.1021/bi00353a017; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Nimigean CM, 2006, NAT PROTOC, V1, P1207, DOI 10.1038/nprot.2006.166; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Romanenko VG, 2004, J GEN PHYSIOL, V123, P77, DOI 10.1085/jgp.200308882; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Rosenhouse-Dantsker A, 2010, CHANNELS, V4, P63, DOI 10.4161/chan.4.1.10366; Salton MR, 1997, BIOMEMBRANE, V1, P1; Singh DK, 2009, J BIOL CHEM, V284, P30727, DOI 10.1074/jbc.M109.011221; Tikku S, 2007, AM J PHYSIOL-CELL PH, V293, pC440, DOI 10.1152/ajpcell.00492.2006; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Wang J, 2006, J BIOL CHEM, V281, P27894, DOI 10.1074/jbc.M605603200; Westover EJ, 2003, STEROIDS, V68, P159, DOI 10.1016/S0039-128X(02)00174-5; WU CC, 1995, J MOL CELL CARDIOL, V27, P1263, DOI 10.1016/S0022-2828(05)82388-0; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Yeagle PL, 1985, CHOLESTEROL MEMBRANE, P1	49	48	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19393	10.1371/journal.pone.0019393	http://dx.doi.org/10.1371/journal.pone.0019393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559361	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700156
J	Gosline, SJC; Nascimento, M; McCall, LI; Zilberstein, D; Thomas, DY; Matlashewski, G; Hallett, M				Gosline, Sara J. C.; Nascimento, Mirna; McCall, Laura-Isobel; Zilberstein, Dan; Thomas, David Y.; Matlashewski, Greg; Hallett, Michael			Intracellular Eukaryotic Parasites Have a Distinct Unfolded Protein Response	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; LEISHMANIA-DONOVANI; TRANSCRIPTION FACTOR; TRANSLATIONAL CONTROL; KINASE GCN2; GENE; IDENTIFICATION; EXPRESSION; A2; DIFFERENTIATION	Insult to the endoplasmic reticulum (ER) activates the Unfolded Protein Response (UPR), a set of signaling pathways that protect the cell from the potential damage caused by improperly folded proteins. Accumulation of misfolded proteins in the ER lumen initiates a series of signal transduction events via activation of three transmembrane ER proteins: Ire1, Atf6 and PERK. Activation of these proteins results in the transcriptional up-regulation of the components of the folding, trafficking and degradation machinery in the ER. PERK further reduces the load on the ER via the phosphorylation of eIF2 alpha, attenuating general protein translation. It is believed that the UPR evolved as a transcriptional response that up-regulates protein folding machinery in the ER and later gained the ability to decrease ER load by attenuating general protein translation in metazoa. However, our in silico analyses of protozoan parasites revealed an absence of proteins involved in the transcriptionally mediated UPR and the presence of both PERK and its target eIF2 alpha. Consistent with these observations, stimulation of the UPR in Leishmania donovani identified an absence of up-regulation of the ER chaperone BiP, the canonical ER chaperone modulated by the UPR in higher eukaryotes, while exhibiting increased phosphorylation of eIF2 alpha which has been shown to attenuate protein translation. We further observed that L. donovani is more sensitive to UPR inducing agents than host macrophages, suggesting that the less evolved stress response could provide a new avenue for therapeutic treatment of parasitic infections.	[Gosline, Sara J. C.; Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Gosline, Sara J. C.; Hallett, Michael] McGill Univ, McGill Sch Comp Sci, Montreal, PQ, Canada; [Gosline, Sara J. C.; Hallett, Michael] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada; [Nascimento, Mirna; McCall, Laura-Isobel; Matlashewski, Greg] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Zilberstein, Dan] Technion Israel Inst Technol, Fac Biol, Haifa, Israel; [Thomas, David Y.; Hallett, Michael] McGill Univ, Dept Biochem, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; Technion Israel Institute of Technology; McGill University	Gosline, SJC (corresponding author), McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada.	greg.matlashewski@mcgill.ca; hallett@mcb.mcgill.ca	; Thomas, David/M-7661-2017	Gosline, Sara/0000-0002-6534-4774; Thomas, David/0000-0002-8854-762X; Hallett, Michael/0000-0001-6738-6786	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Israel Ministry of Health Chief Scientist Foundation [33928]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Israel Ministry of Health Chief Scientist Foundation	This research was supported by the Canadian Institutes of Health Research (DYT, GM, MN), the Natural Sciences and Engineering Research Council of Canada (Discovery Grant, MH; PGS D, SJCG), and by grant number 33928 from the Israel Ministry of Health Chief Scientist Foundation (DZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barak E, 2005, MOL BIOCHEM PARASIT, V141, P99, DOI 10.1016/j.molbiopara.2005.02.004; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Boelens J, 2007, IN VIVO, V21, P215; CHAREST H, 1994, MOL CELL BIOL, V14, P2975, DOI 10.1128/MCB.14.5.2975; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Elofsson A, 2007, ANNU REV BIOCHEM, V76, P125, DOI 10.1146/annurev.biochem.76.052705.163539; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; FUNK VA, 1994, MOL BIOCHEM PARASIT, V63, P23, DOI 10.1016/0166-6851(94)90005-1; Goldshmidt H, PLOS PATHOG, V6; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Koong AC, 2006, CANCER BIOL THER, V5, P756, DOI 10.4161/cbt.5.7.2973; Koumandou VL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-298; Lahav T, 2010, FASEB J; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; McCall LI, 2010, MOL MICROBIOL, V77, P518, DOI 10.1111/j.1365-2958.2010.07229.x; Moraes MCS, 2007, EUKARYOT CELL, V6, P1979, DOI 10.1128/EC.00249-07; Mori K, 2009, J BIOCH; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Nascimento M, 2003, MOL MICROBIOL, V50, P1517, DOI 10.1046/j.1365-2958.2003.03811.x; Padyana AK, 2005, J BIOL CHEM, V280, P29289, DOI 10.1074/jbc.M504096200; Reiner DS, 2001, CELL MICROBIOL, V3, P459, DOI 10.1046/j.1462-5822.2001.00129.x; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Roy G, 2000, MOL BIOCHEM PARASIT, V110, P195, DOI 10.1016/S0166-6851(00)00270-X; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Trusina A, 2008, P NATL ACAD SCI USA, V105, P20280, DOI 10.1073/pnas.0803476105; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang WW, 1996, MOL BIOCHEM PARASIT, V78, P79, DOI 10.1016/S0166-6851(96)02612-6; Zhang WW, 2003, J BIOL CHEM, V278, P35508, DOI 10.1074/jbc.M305030200	42	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19118	10.1371/journal.pone.0019118	http://dx.doi.org/10.1371/journal.pone.0019118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559456	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700068
J	Klarenbeek, JB; Goedhart, J; Hink, MA; Gadella, TWJ; Jalink, K				Klarenbeek, Jeffrey B.; Goedhart, Joachim; Hink, Mark A.; Gadella, Theodorus W. J.; Jalink, Kees			A mTurquoise-Based cAMP Sensor for Both FLIM and Ratiometric Read-Out Has Improved Dynamic Range	PLOS ONE			English	Article							FLUORESCENT INDICATORS; EPAC ACTIVATION; CYAN; PROTEINS	FRET-based sensors for cyclic Adenosine Mono Phosphate (cAMP) have revolutionized the way in which this important intracellular messenger is studied. The currently prevailing sensors consist of the cAMP-binding protein Epac1, sandwiched between suitable donor-and acceptor fluorescent proteins (FPs). Through a conformational change in Epac1, alterations in cellular cAMP levels lead to a change in FRET that is most commonly detected by either Fluorescence Lifetime Imaging (FLIM) or by Sensitized Emission (SE), e.g., by simple ratio-imaging. We recently reported a range of different Epac-based cAMP sensors with high dynamic range and signal-to-noise ratio. We showed that constructs with cyan FP as donor are optimal for readout by SE, whereas other constructs with green FP donors appeared much more suited for FLIM detection. In this study, we present a new cAMP sensor, termed (T)Epac(VV), which employs mTurquoise as donor. Spectrally very similar to CFP, mTurquoise has about doubled quantum efficiency and unlike CFP, its fluorescence decay is strictly single-exponential. We show that (T)Epac(VV) appears optimal for detection both by FLIM and SE, that it has outstanding FRET span and signal-to-noise ratio, and improved photostability. Hence, (T)Epac(VV) should become the cAMP sensor of choice for new experiments, both for FLIM and ratiometric detection.	[Klarenbeek, Jeffrey B.; Jalink, Kees] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Goedhart, Joachim; Hink, Mark A.; Gadella, Theodorus W. J.] Univ Amsterdam, Sect Mol Cytol, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Klarenbeek, Jeffrey B.; Goedhart, Joachim; Hink, Mark A.; Gadella, Theodorus W. J.; Jalink, Kees] van Leeuwenhoek Ctr Adv Microscopy, Amsterdam, Netherlands	Netherlands Cancer Institute; University of Amsterdam	Klarenbeek, JB (corresponding author), Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.	k.jalink@nki.nl		Gadella, Theodorus/0000-0002-7639-219X; Jalink, Kees/0000-0001-7019-3440; Goedhart, Joachim/0000-0002-0630-3825	Nederlandse organisatie voor Wetenschappelijk Onderzoek; Nefkens Foundation	Nederlandse organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); Nefkens Foundation	This study was supported by equipment grants from the Nederlandse organisatie voor Wetenschappelijk Onderzoek and the Nefkens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Shcherbo D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-24; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; van Munster EB, 2005, ADV BIOCHEM ENG BIOT, V95, P143; Villoing A, 2008, BIOCHEMISTRY-US, V47, P12483, DOI 10.1021/bi801400d	13	135	138	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19170	10.1371/journal.pone.0019170	http://dx.doi.org/10.1371/journal.pone.0019170			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559477	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700088
J	Lin, K; Taylor, JR; Wu, TD; Gutierrez, J; Elliott, JM; Vernes, JM; Koeppen, H; Phillips, HS; de Sauvage, FJ; Meng, YG				Lin, Kui; Taylor, James R., Jr.; Wu, Thomas D.; Gutierrez, Johnny; Elliott, J. Michael; Vernes, Jean-Michel; Koeppen, Hartmut; Phillips, Heidi S.; de Sauvage, Frederic J.; Meng, Y. Gloria			TMEFF2 Is a PDGF-AA Binding Protein with Methylation-Associated Gene Silencing in Multiple Cancer Types Including Glioma	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROSTATE-CANCER; TRANSMEMBRANE PROTEIN; ABERRANT METHYLATION; RECEPTOR EXPRESSION; DISEASE PROGRESSION; CDNA CLONING; FACTOR-ALPHA; B CHAINS; CELLS	Background: TMEFF2 is a protein containing a single EGF-like domain and two follistatin-like modules. The biological function of TMEFF2 remains unclear with conflicting reports suggesting both a positive and a negative association between TMEFF2 expression and human cancers. Methodology/Principal Findings: Here we report that the extracellular domain of TMEFF2 interacts with PDGF-AA. This interaction requires the amino terminal region of the extracellular domain containing the follistatin modules and cannot be mediated by the EGF-like domain alone. Furthermore, the extracellular domain of TMEFF2 interferes with PDGF-AA-stimulated fibroblast proliferation in a dose-dependent manner. TMEFF2 expression is downregulated in human brain cancers and is negatively correlated with PDGF-AA expression. Suppressed expression of TMEFF2 is associated with its hypermethylation in several human tumor types, including glioblastoma and cancers of ovarian, rectal, colon and lung origins. Analysis of glioma subtypes indicates that TMEFF2 hypermethylation and decreased expression are associated with a subset of non-Proneural gliomas that do not display CpG island methylator phentoype. Conclusions/Significance: These data provide the first evidence that TMEFF2 can function to regulate PDGF signaling and that it is hypermethylated and downregulated in glioma and several other cancers, thereby suggesting an important role for this protein in the etiology of human cancers.	[Lin, Kui; Taylor, James R., Jr.; Wu, Thomas D.; Gutierrez, Johnny; Elliott, J. Michael; Vernes, Jean-Michel; Koeppen, Hartmut; Phillips, Heidi S.; de Sauvage, Frederic J.; Meng, Y. Gloria] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Lin, K (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	klin@gene.com	de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584	Genentech	Genentech(Roche HoldingGenentech)	This study was funded by Genentech. The funder had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Afar DEH, 2004, MOL CANCER THER, V3, P921; Belshaw NJ, 2004, CANCER EPIDEM BIOMAR, V13, P1495; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; CALZOLARI F, BRAIN PATHOL, V20, P527; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Chang CB, 2003, DEV BIOL, V255, P1, DOI 10.1016/S0012-1606(02)00075-1; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; Fudge K, 1996, PROSTATE, V29, P282; FUDGE K, 1994, MODERN PATHOL, V7, P549; Geddert H, 2004, INT J CANCER, V110, P208, DOI 10.1002/ijc.20058; Gery S, 2002, ONCOGENE, V21, P4739, DOI 10.1038/sj.onc.1205142; Glynne-Jones E, 2001, INT J CANCER, V94, P178, DOI 10.1002/ijc.1450; Harms PW, 2003, GENE DEV, V17, P2624, DOI 10.1101/gad.1127703; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; HERMANSON M, 1992, CANCER RES, V52, P3213; Hermanson M, 1996, CANCER RES, V56, P164; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Horie M, 2000, GENOMICS, V67, P146, DOI 10.1006/geno.2000.6228; HUSE JT, 2011, GLIA IN PRESS; Katano M, 1998, ANN SURG, V227, P365, DOI 10.1097/00000658-199803000-00008; Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liang GN, 2000, CANCER RES, V60, P4907; Lin H, 2003, LIFE SCI, V73, P1617, DOI 10.1016/S0024-3205(03)00514-9; Mohler JL, 2002, PROSTATE, V51, P247, DOI 10.1002/pros.10086; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Patel K, 1998, INT J BIOCHEM CELL B, V30, P1087, DOI 10.1016/S1357-2725(98)00064-8; PATTHY L, 1993, TRENDS NEUROSCI, V16, P76, DOI 10.1016/0166-2236(93)90021-D; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Polakis P, 2005, CURR OPIN PHARMACOL, V5, P382, DOI 10.1016/j.coph.2005.04.008; Quayle SN, 2006, GENOMICS, V87, P633, DOI 10.1016/j.ygeno.2005.12.004; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; ROSS R, 1990, PHILOS T ROY SOC B, V327, P155, DOI 10.1098/rstb.1990.0051; ROSS R, 1974, P NATL ACAD SCI USA, V71, P1207, DOI 10.1073/pnas.71.4.1207; Sato F, 2002, CANCER RES, V62, P6820; SEIFERT RA, 1993, J BIOL CHEM, V268, P4473; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; Shibata DM, 2002, CANCER RES, V62, P5637; Soroceanu L, 2007, P NATL ACAD SCI USA, V104, P3466, DOI 10.1073/pnas.0611271104; Suzuki M, 2005, BRIT J CANCER, V93, P1029, DOI 10.1038/sj.bjc.6602837; Suzuki M, 2005, ONCOGENE, V24, P1302, DOI 10.1038/sj.onc.1208263; Takahashi T, 2004, CLIN CANCER RES, V10, P6126, DOI 10.1158/1078-0432.CCR-04-0579; Uchida T, 1999, BIOCHEM BIOPH RES CO, V266, P593, DOI 10.1006/bbrc.1999.1873; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Westermark B, 1989, Prog Growth Factor Res, V1, P253, DOI 10.1016/0955-2235(89)90014-8; Wynter CVA, 2004, GUT, V53, P573, DOI 10.1136/gut.2003.030841; Young J, 2001, P NATL ACAD SCI USA, V98, P265, DOI 10.1073/pnas.011415298	52	58	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18608	10.1371/journal.pone.0018608	http://dx.doi.org/10.1371/journal.pone.0018608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559523	Green Published, gold, Green Submitted			2022-12-25	WOS:000290024700016
J	Ryabinin, VA; Kostina, EV; Maksakova, GA; Neverov, AA; Chumakov, KM; Sinyakov, AN				Ryabinin, Vladimir A.; Kostina, Elena V.; Maksakova, Galiya A.; Neverov, Alexander A.; Chumakov, Konstantin M.; Sinyakov, Alexander N.			Universal Oligonucleotide Microarray for Sub-Typing of Influenza A Virus	PLOS ONE			English	Article							FLUCHIP DIAGNOSTIC MICROARRAY; SUBTYPE IDENTIFICATION; DNA MICROARRAYS; RT-PCR; HYBRIDIZATION; SELECTION; SET	A universal microchip was developed for genotyping Influenza A viruses. It contains two sets of oligonucleotide probes allowing viruses to be classified by the subtypes of hemagglutinin (H1-H13, H15, H16) and neuraminidase (N1-N9). Additional sets of probes are used to detect H1N1 swine influenza viruses. Selection of probes was done in two steps. Initially, amino acid sequences specific to each subtype were identified, and then the most specific and representative oligonucleotide probes were selected. Overall, between 19 and 24 probes were used to identify each subtype of hemagglutinin (HA) and neuraminidase (NA). Genotyping included preparation of fluorescently labeled PCR amplicons of influenza virus cDNA and their hybridization to microarrays of specific oligonucleotide probes. Out of 40 samples tested, 36 unambiguously identified HA and NA subtypes of Influenza A virus.	[Ryabinin, Vladimir A.; Kostina, Elena V.; Maksakova, Galiya A.; Sinyakov, Alexander N.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia; [Neverov, Alexander A.; Chumakov, Konstantin M.] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; US Food & Drug Administration (FDA)	Ryabinin, VA (corresponding author), Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia.	konstantin.chumakov@fda.hhs.gov	Ryabinin, Vladimir/AAF-6454-2021; Sinyakov, Aleksandr/H-1129-2013; Kostina, Elena V/H-4152-2017	Tripp, Ralph/0000-0002-2924-9956	Department of Health and Human Services [140/3803]; International Science and Technology Center	Department of Health and Human Services; International Science and Technology Center	The work was supported by grant 140/3803 from the Department of Health and Human Services Biotechnology Engagement Program and the International Science and Technology Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; Dawson ED, 2006, ANAL CHEM, V78, P7610, DOI 10.1021/ac061739f; Fauquet C.M., 1999, 8 INT COMM TAX VIR, P1730, DOI 10.1006/rwvi.1999.0277; Fesenko EE, 2007, INFLUENZA OTHER RESP, V1, P121, DOI 10.1111/j.1750-2659.2007.00018.x; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gall A, 2009, J VIROL METHODS, V160, P200, DOI 10.1016/j.jviromet.2009.05.004; Gall A, 2009, J CLIN MICROBIOL, V47, P327, DOI 10.1128/JCM.01330-08; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; GUO Z, 1994, NUCLEIC ACIDS RES, V22, P5456, DOI 10.1093/nar/22.24.5456; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Han XQ, 2008, J VIROL METHODS, V152, P117, DOI 10.1016/j.jviromet.2008.05.027; Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Jabado OJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1106; Kessler N, 2004, J CLIN MICROBIOL, V42, P2173, DOI 10.1128/JCM.42.5.2173-2185.2004; Li H, 2007, J CLIN MICROBIOL, V45, P2105, DOI 10.1128/JCM.00210-07; Li JP, 2001, J CLIN MICROBIOL, V39, P696, DOI 10.1128/JCM.39.2.696-704.2001; Lin BC, 2007, J CLIN MICROBIOL, V45, P443, DOI 10.1128/JCM.01870-06; Liu RH, 2006, ANAL CHEM, V78, P4184, DOI 10.1021/ac060450v; Lodes MJ, 2006, J CLIN MICROBIOL, V44, P1209, DOI 10.1128/JCM.44.4.1209-1218.2006; Mehlmann M, 2006, J CLIN MICROBIOL, V44, P2857, DOI 10.1128/JCM.00135-06; Moore CL, 2007, J CLIN MICROBIOL, V45, P3807, DOI 10.1128/JCM.01089-07; Neverov AA, 2006, J CLIN MICROBIOL, V44, P3752, DOI 10.1128/JCM.00998-06; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; *OC BOIS, OLIGOS4ARRAY; Phipps LP, 2004, J VIROL METHODS, V122, P119, DOI 10.1016/j.jviromet.2004.08.008; *PREM BIOS INT, ARR DES; Ryabinin VA, 2006, J MED VIROL, V78, P1325, DOI 10.1002/jmv.20698; Sengupta S, 2003, J CLIN MICROBIOL, V41, P4542, DOI 10.1128/JCM.41.10.4542-4550.2003; Townsend MB, 2006, J CLIN MICROBIOL, V44, P2863, DOI 10.1128/JCM.00134-06; Wang LC, 2008, VET MICROBIOL, V127, P217, DOI 10.1016/j.vetmic.2007.08.019; Wernersson R, 2007, NAT PROTOC, V2, P2677, DOI 10.1038/nprot.2007.370; World Health Organization, 2009, PAND INFL PREP RESP; WRIGHT KE, 1995, J CLIN MICROBIOL, V33, P1180, DOI 10.1128/JCM.33.5.1180-1184.1995	34	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e17529	10.1371/journal.pone.0017529	http://dx.doi.org/10.1371/journal.pone.0017529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559081	gold, Green Submitted, Green Published			2022-12-25	WOS:000290024700005
J	Spassov, DS; Ahuja, D; Wong, CH; Moasser, MM				Spassov, Danislav S.; Ahuja, Deepika; Wong, Ching Hang; Moasser, Mark M.			The Structural Features of Trask That Mediate Its Anti-Adhesive Functions	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEIN-1; TYROSINE PHOSPHORYLATION; SUBSTRATE TRASK; CANCER-CELLS; SRC; ADHESION; EXPRESSION; ADENOCARCINOMA; EPITHELIA; INTEGRINS	Trask/CDCP1 is a transmembrane protein with a large extracellular and small intracellular domains. The intracellular domain (ICD) undergoes tyrosine phosphorylation by Src kinases during anchorage loss and, when phosphorylated, Trask functions to inhibit cell adhesion. The extracellular domain (ECD) undergoes proteolytic cleavage by serine proteases, although the functional significance of this remains unknown. There is conflicting evidence regarding whether it functions to signal the phosphorylation of the ICD. To better define the structural determinants that mediate the anti-adhesive functions of Trask, we generated a series of deletion mutants of Trask and expressed them in tet-inducible cell models to define the structural elements involved in cell adhesion signaling. We find that the ECD is dispensable for the phosphorylation of the ICD or for the inhibition of cell adhesion. The anti-adhesive functions of Trask are entirely embodied within its ICD and are specifically due to tyrosine phosphorylation of the ICD as this function is completely lost in a phosphorylation-defective tyrosine-phenylalanine mutant. Both full length and cleaved ECDs are fully capable of phosphorylation and undergo phosphorylation during anchorage loss and cleavage is not an upstream signal for ICD phosphorylation. These data establish that the anti-adhesive functions of Trask are mediated entirely through its tyrosine phosphorylation. It remains to be defined what role, if any, the Trask ECD plays in its adhesion functions.	[Spassov, Danislav S.; Ahuja, Deepika; Wong, Ching Hang; Moasser, Mark M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Spassov, Danislav S.; Ahuja, Deepika; Wong, Ching Hang; Moasser, Mark M.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Spassov, DS (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	mark.moasser@ucsf.edu	Spassov, Danislav S/GQA-4368-2022	Spassov, Danislav S/0000-0002-6680-877X	National Institutes of Health [CA113952]; Susan G. Komen; California Breast Cancer Research Program; NATIONAL CANCER INSTITUTE [R01CA113952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen(Susan G. Komen Breast Cancer Foundation); California Breast Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Institutes of Health CA113952 (MMM). DS was funded by a Susan G. Komen for the Cure Postdoctoral Fellowship. CHW was funded by a California Breast Cancer Research Program Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; HE Y, 2010, J BIOL CHEM; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Ikeda JI, 2006, J PATHOL, V210, P75, DOI 10.1002/path.2026; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; Mamat S, 2010, ONCOL REP, V23, P1221, DOI 10.3892/or_00000753; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Siva AC, 2008, CANCER RES, V68, P3759, DOI 10.1158/0008-5472.CAN-07-1657; Spassov DS, 2009, AM J PATHOL, V174, P1756, DOI 10.2353/ajpath.2009.080890; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Vuori K, 1998, J MEMBRANE BIOL, V165, P191, DOI 10.1007/s002329900433; Wong CH, 2009, CLIN CANCER RES, V15, P2311, DOI 10.1158/1078-0432.CCR-08-2533	18	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19154	10.1371/journal.pone.0019154	http://dx.doi.org/10.1371/journal.pone.0019154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559459	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700081
J	Muneer, PMA; Alikunju, S; Szlachetka, AM; Haorah, J				Muneer, P. M. Abdul; Alikunju, Saleena; Szlachetka, Adam M.; Haorah, James			Methamphetamine Inhibits the Glucose Uptake by Human Neurons and Astrocytes: Stabilization by Acetyl-L-Carnitine	PLOS ONE			English	Article							MICROGLIAL ACTIVATION; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; BRAIN; NEUROTOXICITY; RATS; METABOLISM; MECHANISM	Methamphetamine (METH), an addictive psycho-stimulant drug exerts euphoric effects on users and abusers. It is also known to cause cognitive impairment and neurotoxicity. Here, we hypothesized that METH exposure impairs the glucose uptake and metabolism in human neurons and astrocytes. Deprivation of glucose is expected to cause neurotoxicity and neuronal degeneration due to depletion of energy. We found that METH exposure inhibited the glucose uptake by neurons and astrocytes, in which neurons were more sensitive to METH than astrocytes in primary culture. Adaptability of these cells to fatty acid oxidation as an alternative source of energy during glucose limitation appeared to regulate this differential sensitivity. Decrease in neuronal glucose uptake by METH was associated with reduction of glucose transporter protein-3 (GLUT3). Surprisingly, METH exposure showed biphasic effects on astrocytic glucose uptake, in which 20 mM increased the uptake while 200 mM inhibited glucose uptake. Dual effects of METH on glucose uptake were paralleled to changes in the expression of astrocytic glucose transporter protein-1 (GLUT1). The adaptive nature of astrocyte to mitochondrial beta-oxidation of fatty acid appeared to contribute the survival of astrocytes during METH-induced glucose deprivation. This differential adaptive nature of neurons and astrocytes also governed the differential sensitivity to the toxicity of METH in these brain cells. The effect of acetyl-L-carnitine for enhanced production of ATP from fatty oxidation in glucose-free culture condition validated the adaptive nature of neurons and astrocytes. These findings suggest that deprivation of glucose-derived energy may contribute to neurotoxicity of METH abusers.	[Muneer, P. M. Abdul; Alikunju, Saleena; Szlachetka, Adam M.; Haorah, James] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Lab Neurovasc Oxidat Injury, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Muneer, PMA (corresponding author), Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Lab Neurovasc Oxidat Injury, Omaha, NE 68198 USA.	jhaorah@unmc.edu			UNMC	UNMC	This work was supported by UNMC Faculty Retention Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr AM, 2006, J PSYCHIATR NEUROSCI, V31, P301; Bellucci A, 2008, J NEUROCHEM, V106, P560, DOI 10.1111/j.1471-4159.2008.05406.x; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; CUBELLS JF, 1994, J NEUROSCI, V14, P2260, DOI 10.1523/jneurosci.14-04-02260.1994; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; Drew B, 2003, AM J PHYSIOL-REG I, V285, pR1259, DOI 10.1152/ajpregu.00264.2003; Escubedo E, 1998, BRAIN RES, V814, P120, DOI 10.1016/S0006-8993(98)01065-8; Floreani NA, 2010, J NEUROIMMUNE PHARM, V5, P533, DOI 10.1007/s11481-010-9213-z; Fujioka M, 1997, STROKE, V28, P584, DOI 10.1161/01.STR.28.3.584; Fukami G, 2004, BRAIN RES, V1016, P90, DOI 10.1016/j.brainres.2004.04.072; Granado N, 2010, NEUROTOX RES, V18, P48, DOI 10.1007/s12640-009-9106-1; Guillot TS, 2008, J NEUROCHEM, V106, P2205, DOI 10.1111/j.1471-4159.2008.05568.x; Hagen TM, 1998, P NATL ACAD SCI USA, V95, P9562, DOI 10.1073/pnas.95.16.9562; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; Kim SJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1383, DOI 10.1038/sj.npp.1300699; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Kuczenski R, 2009, NEUROPSYCHOPHARMACOL, V34, P2430, DOI 10.1038/npp.2009.73; London ED, 2004, ARCH GEN PSYCHIAT, V61, P73, DOI 10.1001/archpsyc.61.1.73; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; Melega WP, 2007, SYNAPSE, V61, P216, DOI 10.1002/syn.20365; Myles BJ, 2008, PSYCHOPHARMACOLOGY, V198, P313, DOI 10.1007/s00213-007-1060-0; Ramirez SH, 2009, J CEREBR BLOOD F MET, V29, P1933, DOI 10.1038/jcbfm.2009.112; Rockville M, 2007, RES 2005 NAT SURV DR; Scott JC, 2007, NEUROPSYCHOL REV, V17, P275, DOI 10.1007/s11065-007-9031-0; Sekine Y, 2008, J NEUROSCI, V28, P5756, DOI 10.1523/JNEUROSCI.1179-08.2008; Sharma HS, 2010, ACTA NEUROCHIR SUPPL, V106, P343, DOI 10.1007/978-3-211-98811-4_63; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Substance Abuse and Mental Health Services Administration (SAMHSA), 2006, RES 2005 NAT SURV DR; TAKAKURA Y, 1991, BIOCHIM BIOPHYS ACTA, V1070, P11, DOI 10.1016/0005-2736(91)90140-4; THEODOROPOULOS PA, 1994, BIOCHEM PHARMACOL, V47, P1875, DOI 10.1016/0006-2952(94)90318-2; Thomas DM, 2008, J NEUROCHEM, V106, P696, DOI 10.1111/j.1471-4159.2008.05421.x; Thomas DM, 2008, J NEUROCHEM, V105, P605, DOI 10.1111/j.1471-4159.2007.05155.x; Thomas DM, 2009, J NEUROCHEM, V109, P1745, DOI 10.1111/j.1471-4159.2009.06094.x; Volkow ND, 2001, AM J PSYCHIAT, V158, P383, DOI 10.1176/appi.ajp.158.3.383; Yeh WL, 2008, MOL PHARMACOL, V73, P170, DOI 10.1124/mol.107.038851	36	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19258	10.1371/journal.pone.0019258	http://dx.doi.org/10.1371/journal.pone.0019258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556365	Green Published, Green Submitted, gold			2022-12-25	WOS:000290019400043
J	Kamishikiryo, J; Fukuhara, H; Okabe, Y; Kuroki, K; Maenaka, K				Kamishikiryo, Jun; Fukuhara, Hideo; Okabe, Yuki; Kuroki, Kimiko; Maenaka, Katsumi			Molecular Basis for LLT1 Protein Recognition by Human CD161 Protein (NKRP1A/KLRB1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KILLER-CELL RECEPTORS; MISSING SELF-RECOGNITION; CLASS-I; HUMAN NKR-P1A; CUTTING EDGE; PEPTIDE-MHC; THERMODYNAMICS; BINDING; LIGAND; ENGAGEMENT	Human Th17 cells express high levels of CD161, a member of the killer cell lectin-like receptor (KLR) family (also referred to as NK receptor-P1A (NKRP1A) or KLRB1), as a representative marker. CD161 is also expressed on natural killer (NK) cells and NKT cells. Lectin-like transcript 1 (LLT1), another KLR family member, was recently identified as a ligand for CD161. This interaction may play pivotal roles in the immunomodulatory functions of Th17 cells as well as those of NK and NKT cells. However, the molecular basis for the interaction is poorly understood. Here we show that the extracellular domain of CD161 bound directly to LLT1 with a K-d of 48 mu M and with the fast kinetics typical of cell-cell recognition receptors. Mutagenesis revealed that the similar membrane-distal beta-sheet and loop regions of both CD161 and LLT1 were utilized for the binding, and notably, these regions correspond to the ligand-binding sites for major histocompatibility complex (MHC)-recognizing KLRs. Furthermore, we found a pair of detrimental mutations for both molecules that restored the binding. These results reveal a new template model for the recognition mode between the KLR family members and provide insights into the molecular mechanism underlying Th17/NK/NKT-mediated immune responses.	[Kamishikiryo, Jun; Fukuhara, Hideo; Okabe, Yuki; Kuroki, Kimiko; Maenaka, Katsumi] Hokkaido Univ, Lab Biomol Sci, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Kamishikiryo, Jun] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Hiroshima 7290292, Japan; [Kamishikiryo, Jun] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8128582, Japan; [Maenaka, Katsumi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Hokkaido University; Fukuyama University; Kyushu University; Japan Science & Technology Agency (JST)	Maenaka, K (corresponding author), Hokkaido Univ, Lab Biomol Sci, Fac Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	maenaka@pharm.hokudai.ac.jp	Kuroki, Kimiko/F-6906-2012	Kamishikiryo, Jun/0000-0002-7505-7429	Japan Society for the Promotion of Science; New Energy and Industrial Technology Development Organization (NEDO) of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22121007] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by a Japan Society for the Promotion of Science postdoctoral fellowship for young researchers.; Supported in part by the New Energy and Industrial Technology Development Organization (NEDO) of Japan and the Ministry of Education, Culture, Sports, Science, and Technology of Japan. To whom correspondence should be addressed: Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan. Tel.: 81-11-706-3970; Fax: 81-11-706-4986; E-mail: maenaka@pharm.hokudai.ac.jp.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Anikeeva N, 2003, BIOCHEMISTRY-US, V42, P4709, DOI 10.1021/bi026864+; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1114, DOI 10.1107/S0907444906029805; Bennett IM, 1996, J EXP MED, V184, P1845, DOI 10.1084/jem.184.5.1845; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; COSMI L, 2011, ARTHRITIS R IN PRESS; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Davis-Harrison RL, 2005, J MOL BIOL, V346, P533, DOI 10.1016/j.jmb.2004.11.063; Garcia KC, 2001, P NATL ACAD SCI USA, V98, P6818, DOI 10.1073/pnas.111161198; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Germain C, 2010, J BIOL CHEM, V285, P36207, DOI 10.1074/jbc.M110.179622; Huarte E, 2008, BLOOD, V112, P1259, DOI 10.1182/blood-2007-12-130773; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; LANIER LL, 1994, J IMMUNOL, V153, P2417; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Li YL, 2009, IMMUNITY, V31, P35, DOI 10.1016/j.immuni.2009.04.019; Maenaka K, 1999, J BIOL CHEM, V274, P28329, DOI 10.1074/jbc.274.40.28329; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; McFarland BJ, 2003, IMMUNITY, V19, P803, DOI 10.1016/S1074-7613(03)00320-0; Mesci A, 2006, IMMUNOL RES, V35, P13, DOI 10.1385/IR:35:1:13; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Shiroishi M, 2006, J MOL BIOL, V355, P237, DOI 10.1016/j.jmb.2005.10.057; Spreu J, 2010, P NATL ACAD SCI USA, V107, P5100, DOI 10.1073/pnas.0913108107; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Takeda M, 2005, J VIROL, V79, P14346, DOI 10.1128/JVI.79.22.14346-14354.2005; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7	33	36	39	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23823	23830		10.1074/jbc.M110.214254	http://dx.doi.org/10.1074/jbc.M110.214254			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21572041	Green Published, hybrid			2022-12-25	WOS:000292294900025
J	Tavoosi, N; Davis-Harrison, RL; Pogorelov, TV; Ohkubo, YZ; Arcario, MJ; Clay, MC; Rienstra, CM; Tajkhorshid, E; Morrissey, JH				Tavoosi, Narjes; Davis-Harrison, Rebecca L.; Pogorelov, Taras V.; Ohkubo, Y. Zenmei; Arcario, Mark J.; Clay, Mary C.; Rienstra, Chad M.; Tajkhorshid, Emad; Morrissey, James H.			Molecular Determinants of Phospholipid Synergy in Blood Clotting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE FACTOR; MEMBRANE-BINDING; FACTOR VIIA; DYNAMICS; PHOSPHATIDYLSERINE; PROTEIN; COAGULATION; VESICLES; EXPOSURE; SYSTEMS	Many regulatory processes in biology involve reversible association of proteins with membranes. Clotting proteins bind to phosphatidylserine (PS) on cell surfaces, but a clear picture of this interaction has yet to emerge. We present a novel explanation for membrane binding by GLA domains of clotting proteins, supported by biochemical studies, solid-state NMR analyses, and molecular dynamics simulations. The model invokes a single "phospho-L-serine-specific" interaction and multiple "phosphate-specific" interactions. In the latter, the phosphates in phospholipids interact with tightly bound Ca2+ in GLA domains. We show that phospholipids with any headgroup other than choline strongly synergize with PS to enhance factor X activation. We propose that phosphatidylcholine and sphingomyelin (the major external phospholipids of healthy cells) are anticoagulant primarily because their bulky choline headgroups sterically hinder access to their phosphates. Following cell damage or activation, exposed PS and phosphatidylethanolamine collaborate to bind GLA domains by providing phospho-L-serine-specific and phosphate-specific interactions, respectively.	[Morrissey, James H.] Univ Illinois, Dept Biochem, Coll Med, Urbana, IL 61801 USA; [Clay, Mary C.; Rienstra, Chad M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Pogorelov, Taras V.; Ohkubo, Y. Zenmei; Arcario, Mark J.; Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Arcario, Mark J.; Rienstra, Chad M.; Tajkhorshid, Emad] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Morrissey, JH (corresponding author), Univ Illinois, Dept Biochem, Coll Med, 417 Med Sci Bldg,MC 714,506 S Mathews Ave, Urbana, IL 61801 USA.	jhmorris@illinois.edu	Morrissey, James H/H-4933-2011; Pogorelov, Taras/AAH-8587-2020; Tajkhorshid, Emad/AAN-8323-2021; Morrissey, James H./GLR-5645-2022	Morrissey, James H/0000-0002-1570-1569; Pogorelov, Taras/0000-0001-5851-7721; Arcario, Mark/0000-0001-5017-1519; Tajkhorshid, Emad/0000-0001-8434-1010	National Institutes of Health [R01 HL47014, R01 HL103999, R01 GM086749, R01 GM067887, R01 GM075937, P41 RR05969]; American Heart Association [0920045G];  [MCA06N060]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103999, R01HL047014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075937, R01GM067887, R01GM086749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL47014, R01 HL103999, R01 GM086749, R01 GM067887, R01 GM075937, and P41 RR05969. This work was also supported by American Heart Association Postdoctoral Fellowship 0920045G to R. L. D.-H. All simulations were performed using computer time on TeraGrid resources (Grant MCA06N060).	Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Boettcher JM, 2011, BIOCHEMISTRY-US, V50, P2264, DOI 10.1021/bi1013694; BURGESS SW, 1992, BIOCHEMISTRY-US, V31, P2653, DOI 10.1021/bi00125a004; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; GILBERT GE, 1995, J BIOL CHEM, V270, P18500, DOI 10.1074/jbc.270.31.18500; HEDIGER S, 1994, CHEM PHYS LETT, V223, P283, DOI 10.1016/0009-2614(94)00470-6; Huang MD, 2003, NAT STRUCT BIOL, V10, P751, DOI 10.1038/nsb971; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mann K G, 1976, Methods Enzymol, V45, P123; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Morrissey JH, 2004, INT J HEMATOL, V79, P103, DOI 10.1532/IJH97.03167; Murzyn K, 2006, BIOINTERPHASES, V1, P98, DOI 10.1116/1.2354573; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004; Ohkubo YZ, 2010, J THROMB HAEMOST, V8, P1044, DOI 10.1111/j.1538-7836.2010.03826.x; Ohkubo YZ, 2008, STRUCTURE, V16, P72, DOI 10.1016/j.str.2007.10.021; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SCHROIT AJ, 1991, BIOCHIM BIOPHYS ACTA, V1071, P313, DOI 10.1016/0304-4157(91)90019-S; Shaw AW, 2007, J BIOL CHEM, V282, P6556, DOI 10.1074/jbc.M607973200; Smeets EF, 1996, THROMB RES, V81, P419, DOI 10.1016/0049-3848(96)00014-X; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; Smith SA, 2004, J THROMB HAEMOST, V2, P1155, DOI 10.1111/j.1538-7836.2004.00772.x; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; VANGEET AL, 1968, ANAL CHEM, V40, P2227, DOI 10.1021/ac50158a064; Waters EK, 2006, BIOCHEMISTRY-US, V45, P3769, DOI 10.1021/bi052600m; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3; Zwaal RFA, 1998, BBA-REV BIOMEMBRANES, V1376, P433, DOI 10.1016/S0304-4157(98)00018-5	32	78	82	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23247	23253		10.1074/jbc.M111.251769	http://dx.doi.org/10.1074/jbc.M111.251769			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21561861	Green Published, hybrid			2022-12-25	WOS:000292025000058
J	Gay, C; Dibben, O; Anderson, JA; Stacey, A; Mayo, AJ; Norris, PJ; Kuruc, JD; Salazar-Gonzalez, JF; Li, H; Keele, BF; Hicks, C; Margolis, D; Ferrari, G; Haynes, B; Swanstrom, R; Shaw, GM; Hahn, BH; Eron, JJ; Borrow, P; Cohen, MS				Gay, Cynthia; Dibben, Oliver; Anderson, Jeffrey A.; Stacey, Andrea; Mayo, Ashley J.; Norris, Philip J.; Kuruc, JoAnn D.; Salazar-Gonzalez, Jesus F.; Li, Hui; Keele, Brandon F.; Hicks, Charles; Margolis, David; Ferrari, Guido; Haynes, Barton; Swanstrom, Ronald; Shaw, George M.; Hahn, Beatrice H.; Eron, Joseph J.; Borrow, Persephone; Cohen, Myron S.			Cross-Sectional Detection of Acute HIV Infection: Timing of Transmission, Inflammation and Antiretroviral Therapy	PLOS ONE			English	Article							PLASMA CYTOKINE LEVELS; CD4(+) T-CELLS; SEXUAL TRANSMISSION; VIRUS; VIREMIA; AMPLIFICATION; RESPONSES; MULTIPLE; REPLICATION; EFFICIENT	Background: Acute HIV infection (AHI) is a critical phase of infection when irreparable damage to the immune system occurs and subjects are very infectious. We studied subjects with AHI prospectively to develop better treatment and public health interventions. Methods: Cross-sectional screening was employed to detect HIV RNA positive, antibody negative subjects. Date of HIV acquisition was estimated from clinical history and correlated with sequence diversity assessed by single genome amplification (SGA). Twenty-two cytokines/chemokines were measured from enrollment through week 24. Results: Thirty-seven AHI subjects were studied. In 7 participants with limited exposure windows, the median exposure to HIV occurred 14 days before symptom onset. Lack of viral sequence diversification confirmed the short duration of infection. Transmission dates estimated by SGA/sequencing using molecular clock models correlated with transmission dates estimated by symptom onset in individuals infected with single HIV variants (mean of 28 versus 33 days). Only 10 of 22 cytokines/chemokines were significantly elevated among AHI participants at enrollment compared to uninfected controls, and only 4 participants remained seronegative at enrollment. Discussion: The results emphasize the difficulty in recruiting subjects early in AHI. Viral sequence diversity proved accurate in estimating time of infection. Regardless of aggressive screening, peak viremia and inflammation occurred before enrollment and potential intervention. Given the personal and public health importance, improved AHI detection is urgently needed.	[Gay, Cynthia; Anderson, Jeffrey A.; Mayo, Ashley J.; Kuruc, JoAnn D.; Margolis, David; Swanstrom, Ronald; Eron, Joseph J.; Cohen, Myron S.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27515 USA; [Dibben, Oliver; Stacey, Andrea; Borrow, Persephone] Univ Oxford, Nuffield Dept Clin Med, Weatherall Inst Mol Med, Oxford, England; [Norris, Philip J.] Blood Syst Res Inst, San Francisco, CA USA; [Norris, Philip J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Salazar-Gonzalez, Jesus F.; Li, Hui; Keele, Brandon F.; Shaw, George M.; Hahn, Beatrice H.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Hicks, Charles; Ferrari, Guido; Haynes, Barton] Duke Univ, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Oxford; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; Duke University	Gay, C (corresponding author), Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27515 USA.	cynthia_gay@med.unc.edu	Margolis, David M./Y-2468-2019; Ferrari, Guido/A-6088-2015; Ferrari, Guido/Z-2137-2019; Gay, Cynthia/AAG-2927-2019	Margolis, David M./0000-0001-5714-0002; Ferrari, Guido/0000-0001-7747-3349; Salazar-Gonzalez, Jesus F./0000-0003-4626-6448; Gay, Cynthia/0000-0002-3620-3059; Borrow, Persephone/0000-0002-3877-9780; Hahn, Beatrice/0000-0002-9400-9887	Division of AIDS, U.S. National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health [AI67854]; Division of Research Resources [RR025747]; UNC Center for AIDS Research (CFAR) National Institutes of Health [AI50410]; Bristol Myers Squibb; Gilead Sciences; GSK; Merck; Tibotec; Gilead; Myriad Pharmaceuticals; Pfizer; Abbott; Roche; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, U01AI067854, P30AI050410] Funding Source: NIH RePORTER	Division of AIDS, U.S. National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UNC Center for AIDS Research (CFAR) National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); GSK(GlaxoSmithKline); Merck(Merck & Company); Tibotec; Gilead(Gilead Sciences); Myriad Pharmaceuticals; Pfizer(Pfizer); Abbott(Abbott Laboratories); Roche(Roche Holding); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Division of AIDS, U.S. National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health (grant AI67854), from a UNC Clinical and Translational Science Award (CTSA) of the Division of Research Resources (grant RR025747), and AI50410 UNC Center for AIDS Research (CFAR) National Institutes of Health. P.B. is a Jenner Institute Investigator. Bristol Myers Squibb and Gilead Sciences, Inc, provided antiretroviral medications for a treatment study in which participants of this study could co-enroll. These companies and all other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C.G. has received research support from Bristol Myers Squibb and Gilead Sciences for studies which participants in this study could co-enroll on, but not for the CHAVI 001 study. C.H. has received grant support and/or consulting/honoraria from BMS, GSK, Merck, Tibotec, Gilead, Myriad Pharmaceuticals, Pfizer, none of which is related to this study. D.M. has received research support from Bristol Myers Squibb, Gilead Sciences, Merck, Abbott, and Roche, but none for this study, and is a honoraria for professional services to Bristol Myers Squibb, Merck, Chimerix, and Tibotec Therapeutics. J.E. receives research support from Merck and GlaxoSmithKline which is not related to this study and is a consultant to Bristol Myers Squibb, Merck, and Tibotec Therapeutics. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The remaining authors have no competing interests to declare.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Abel K, 2005, J VIROL, V79, P12164, DOI 10.1128/JVI.79.19.12164-12172.2005; Anderson JA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001053; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bowman MC, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000970; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EDMONSON PF, 1992, NUCLEIC ACIDS RES, V20, P4933, DOI 10.1093/nar/20.18.4933; FIDLER S, 2010, COMPARISON HIV VIRAL; Fidler S, 2008, CURR OPIN INFECT DIS, V21, P4, DOI 10.1097/QCO.0b013e3282f428bf; GAY C, 2008, EFFICACY NNRTI BASED; GIANELLA S, 2010, IMPACT EARLY ART PRO; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Haissman JM, 2009, JAIDS-J ACQ IMM DEF, V52, P493, DOI 10.1097/QAI.0b013e3181b627dc; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; Lee HY, 2009, J THEOR BIOL, V261, P341, DOI 10.1016/j.jtbi.2009.07.038; Lee HH, 2010, J INFECT DIS, V201, pS65, DOI 10.1086/650385; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lindback S, 2000, AIDS, V14, P2333, DOI 10.1097/00002030-200010200-00014; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mehandru S, 2006, PLOS MED, V3, P2335, DOI 10.1371/journal.pmed.0030484; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Miller WC, 2010, CURR OPIN HIV AIDS, V5, P277, DOI 10.1097/COH.0b013e32833a0d3a; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Regidor DL, 2011, AIDS, V25, P303, DOI 10.1097/QAD.0b013e32834273ad; RIEDER P, 2010, STRONG EFFECT EARLY; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Sachdeva RK, 2010, J INTERF CYTOK RES, V30, P299, DOI 10.1089/jir.2009.0056; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; SIMMONDS P, 1990, J VIROL, V64, P5840, DOI 10.1128/JVI.64.12.5840-5850.1990; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	44	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2011	6	5							e19617	10.1371/journal.pone.0019617	http://dx.doi.org/10.1371/journal.pone.0019617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761YU	21573003	Green Published, gold			2022-12-25	WOS:000290440200014
J	Wang, H; Siddharthan, V; Hall, JO; Morrey, JD				Wang, Hong; Siddharthan, Venkatraman; Hall, Jeffery O.; Morrey, John D.			Autonomic Nervous Dysfunction in Hamsters Infected with West Nile Virus	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; POSTPRANDIAL INTESTINAL MOTILITY; ACUTE FLACCID PARALYSIS; MONOCLONAL-ANTIBODY; ATRIOVENTRICULAR NODE; GOLDEN-HAMSTER; UNITED-STATES; ENCEPHALITIS; CONDUCTION; MYOCARDITIS	Clinical studies and case reports clearly document that West Nile virus (WNV) can cause respiratory and gastrointestinal (GI) complications. Other functions controlled by the autonomic nervous system may also be directly affected by WNV, such as bladder and cardiac functions. To investigate how WNV can cause autonomic dysfunctions, we focused on the cardiac and GI dysfunctions of rodents infected with WNV. Infected hamsters had distension of the stomach and intestines at day 9 after viral challenge. GI motility was detected by a dye retention assay; phenol red dye was retained more in the stomachs of infected hamsters as compared to sham-infected hamsters. The amplitudes of electromygraphs (EMGs) of intestinal muscles were significantly reduced. Myenteric neurons that innervate the intestines, in addition to neurons in the brain stem, were identified to be infected with WNV. These data suggest that infected neurons controlling autonomic function were the cause of GI dysfunction in WNV-infected hamsters. Using radiotelemetry to record electrocardiograms and to measure heart rate variability (HRV), a well-accepted readout for autonomic function, we determined that HRV and autonomic function were suppressed in WNV-infected hamsters. Cardiac histopathology was observed at day 9 only in the right atrium, which was coincident with WNV staining. A subset of WNV infected cells was identified among cells with hyperplarization-activated cyclic nucleotide-gated potassium channel 4 (HCN4) as a marker for cells in the sinoatrial (SA) and atrioventricular (AV) nodes. The unique contribution of this study is the discovery that WNV infection of hamsters can lead to autonomic dysfunction as determined by reduced HRV and reduced EMG amplitudes of the GI tract. These data may model autonomic dysfunction of the human West Nile neurological disease.	[Wang, Hong; Siddharthan, Venkatraman; Hall, Jeffery O.; Morrey, John D.] Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Wang, H (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA.	john.morrey@usu.edu			Rocky Mountain Regional Centers of Excellence, NIAID, NIH [U54 AI-065357-04]; Virology Branch, NIAID, NIH [N01-AI-30063]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030063, U54AI065357] Funding Source: NIH RePORTER	Rocky Mountain Regional Centers of Excellence, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Virology Branch, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U54 AI-065357-04 Rocky Mountain Regional Centers of Excellence, NIAID, NIH, and N01-AI-30063 Virology Branch, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abroug F, 2006, INTENS CARE MED, V32, P1636, DOI 10.1007/s00134-006-0298-z; Betensley AD, 2004, THORAX, V59, P268, DOI 10.1136/thorax.2003.009092; Bilchick KC, 2006, J CARDIOVASC ELECTR, V17, P691, DOI 10.1111/j.1540-8167.2006.00501.x; Bode AV, 2006, CLIN INFECT DIS, V42, P1234, DOI 10.1086/503038; Buttow NC, 2004, BIOCELL, V28, P135; Camm AJ, 1996, EUR HEART J, V17, P354; DEBRITO T, 1992, PATHOL RES PRACT, V188, P177, DOI 10.1016/S0344-0338(11)81176-3; Doron SI, 2003, CLIN INFECT DIS, V37, pE74, DOI 10.1086/377177; FIORAMONTI J, 1994, AM J PHYSIOL-GASTR L, V267, pG960, DOI 10.1152/ajpgi.1994.267.6.G960; Franssen H, 2006, ACTA NEUROL BELG, V106, P73; Gibbs SEJ, 2005, J WILDLIFE DIS, V41, P354, DOI 10.7589/0090-3558-41.2.354; HARRISON AK, 1982, EXP MOL PATHOL, V37, P292, DOI 10.1016/0014-4800(82)90043-0; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; HUIKURI HV, 1993, CIRCULATION, V87, P1220, DOI 10.1161/01.CIR.87.4.1220; Hunsperger EA, 2006, J NEUROVIROL, V12, P129, DOI 10.1080/13550280600758341; Jeha LE, 2003, NEUROLOGY, V61, P55, DOI 10.1212/01.WNL.0000073617.08185.0A; Kabatas S, 2008, NEUROSCIENCE, V154, P1627, DOI 10.1016/j.neuroscience.2008.04.071; Khouzam RN, 2009, SOUTH MED J, V102, P527, DOI 10.1097/SMJ.0b013e31819e9bf7; Kushawaha Anurag, 2009, Cases J, V2, P7147, DOI 10.1186/1757-1626-2-7147; Lanciotti RS, 2001, J CLIN MICROBIOL, V39, P4506, DOI 10.1128/JCM.39.12.4506-4513.2001; Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449; Leis A Arturo, 2005, Curr Treat Options Neurol, V7, P15, DOI 10.1007/s11940-005-0002-6; Lichtensteiger CA, 2003, EMERG INFECT DIS, V9, P1303; Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1; MAYER RF, 1966, PSYCHOSOM MED, V28, P475, DOI 10.1097/00006842-196607000-00026; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Mongue-Din H, 2009, AM J PHYSIOL-REG I, V296, pR610, DOI 10.1152/ajpregu.90376.2008; Morrey JD, 2004, ANTIVIR RES, V63, P41, DOI 10.1016/j.antiviral.2004.02.005; Morrey JD, 2008, J NEUROVIROL, V14, P152, DOI 10.1080/13550280801958930; Morrey JD, 2007, ANTIMICROB AGENTS CH, V51, P2396, DOI 10.1128/AAC.00147-07; Morrey JD, 2006, J INFECT DIS, V194, P1300, DOI 10.1086/508293; Morrey JD, 2010, J NEUROVIROL, V16, P318, DOI 10.3109/13550284.2010.501847; Niskanen JP, 2004, COMPUT METH PROG BIO, V76, P73, DOI 10.1016/j.cmpb.2004.03.004; OBEYESEKERE I, 1973, AM HEART J, V85, P186, DOI 10.1016/0002-8703(73)90459-6; Omalu BI, 2003, BRAIN PATHOL, V13, P465, DOI 10.1111/j.1750-3639.2003.tb00477.x; Ori Z, 1992, Cardiol Clin, V10, P499; Park SK, 2010, ENVIRON HEALTH PERSP, V118, P1406, DOI 10.1289/ehp.0901778; Pergam SA, 2006, AM J TROP MED HYG, V75, P1232, DOI 10.4269/ajtmh.2006.75.1232; Petrecca K, 1997, J PHYSIOL-LONDON, V501, P263, DOI 10.1111/j.1469-7793.1997.263bn.x; RODRIGUEZMEMBRILLA A, 1995, J PHARMACOL EXP THER, V275, P486; Saad M, 2005, J INFECTION, V51, P120, DOI 10.1016/j.jinf.2004.10.005; Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104; Sarnelli G, 2009, DIGEST LIVER DIS, V41, P185, DOI 10.1016/j.dld.2008.06.004; SCHMELZER JD, 1989, P NATL ACAD SCI USA, V86, P1639, DOI 10.1073/pnas.86.5.1639; Sejvar JJ, 2006, EMERG INFECT DIS, V12, P514, DOI 10.3201/eid1203.050643; Sejvar JJ, 2005, EMERG INFECT DIS, V11, P1021, DOI 10.3201/eid1107.040991; Sgoifo A, 1996, PHYSIOL BEHAV, V60, P1397, DOI 10.1016/S0031-9384(96)00228-4; Shpall AI, 2003, UROLOGY, V61, DOI 10.1016/S0090-4295(03)00119-5; Siddharthan V, 2009, J VIROL, V83, P4251, DOI 10.1128/JVI.00017-09; Stein PK, 2005, J CARDIOVASC ELECTR, V16, P13, DOI 10.1046/j.1540-8167.2005.04358.x; Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153; THOMAS PK, 1981, J NEUROL NEUROSUR PS, V44, P233, DOI 10.1136/jnnp.44.3.233; Tonry JH, 2005, AM J TROP MED HYG, V72, P320, DOI 10.4269/ajtmh.2005.72.320; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Vernino S, 2003, J NEUROPHYSIOL, V90, P2053, DOI 10.1152/jn.00408.2003; Viswanathan S, 2007, J MOL CELL CARDIOL, V42, P946, DOI 10.1016/j.yjmcc.2007.02.008; Wang H, 2009, J NEUROVIROL, V15, P293, DOI 10.1080/13550280902973978; Weiss D, 2001, EMERG INFECT DIS, V7, P654, DOI 10.3201/eid0704.010409; Xiao SY, 2001, EMERG INFECT DIS, V7, P714; Yoo S, 2006, CIRCULATION, V114, P1360, DOI 10.1161/CIRCULATIONAHA.106.613182; ZAPANTA L, 2005, THESIS MIT	61	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19575	10.1371/journal.pone.0019575	http://dx.doi.org/10.1371/journal.pone.0019575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21573009	Green Published, gold			2022-12-25	WOS:000290386800020
J	Mutapi, F; Imai, N; Nausch, N; Bourke, CD; Rujeni, N; Mitchell, KM; Midzi, N; Woolhouse, MEJ; Maizels, RM; Mduluza, T				Mutapi, Francisca; Imai, Natsuko; Nausch, Norman; Bourke, Claire D.; Rujeni, Nadine; Mitchell, Kate M.; Midzi, Nicholas; Woolhouse, Mark E. J.; Maizels, Rick M.; Mduluza, Takafira			Schistosome Infection Intensity Is Inversely Related to Auto-Reactive Antibody Levels	PLOS ONE			English	Article							AUTOIMMUNE-DISEASES; HAEMATOBIUM; MANSONI; MALARIA; INTERLEUKIN-10; HELMINTHS; RESPONSES; ZIMBABWE; HYGIENE; ATOPY	In animal experimental models, parasitic helminth infections can protect the host from auto-immune diseases. We conducted a population-scale human study investigating the relationship between helminth parasitism and auto-reactive antibodies and the subsequent effect of anti-helminthic treatment on this relationship. Levels of antinuclear antibodies (ANA) and plasma IL-10 were measured by enzyme linked immunosorbent assay in 613 Zimbabweans (aged 2-86 years) naturally exposed to the blood fluke Schistosoma haematobium. ANA levels were related to schistosome infection intensity and systemic IL-10 levels. All participants were offered treatment with the anti-helminthic drug praziquantel and 102 treated schoolchildren (5-16 years) were followed up 6 months post-antihelminthic treatment. ANA levels were inversely associated with current infection intensity but were independent of host age, sex and HIV status. Furthermore, after allowing for the confounding effects of schistosome infection intensity, ANA levels were inversely associated with systemic levels of IL-10. ANA levels increased significantly 6 months after anti-helminthic treatment. Our study shows that ANA levels are attenuated in helminth-infected humans and that anti-helminthic treatment of helminth-infected people can significantly increase ANA levels. The implications of these findings are relevant for understanding both the aetiology of immune disorders mediated by auto-reactive antibodies and in predicting the long-term consequences of large-scale schistosomiasis control programs.	[Mutapi, Francisca; Imai, Natsuko; Nausch, Norman; Bourke, Claire D.; Rujeni, Nadine; Mitchell, Kate M.; Woolhouse, Mark E. J.; Maizels, Rick M.] Univ Edinburgh, Ashworth Labs, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Midzi, Nicholas] Natl Inst Hlth Res, Harare, Zimbabwe; [Mduluza, Takafira] Univ Zimbabwe, Dept Biochem, Harare, Zimbabwe	University of Edinburgh; University of Zimbabwe	Mutapi, F (corresponding author), Univ Edinburgh, Ashworth Labs, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.	f.mutapi@ed.ac.uk	Imai, Natsuko/J-5817-2017; Nausch, Norman/M-4526-2019; Mitchell, Kate/ABE-5796-2020; Nausch, Norman/L-9276-2013	Imai, Natsuko/0000-0002-4218-9716; Nausch, Norman/0000-0002-9704-2148; Nausch, Norman/0000-0002-9704-2148; Mutapi, Francisca/0000-0002-2537-3466; Bourke, Claire/0000-0002-7244-0895	Cunningham Trust; Carnegie Trust for the Universities of Scotland, Tenovus Scotland; Wellcome Trust [WT082028MA]	Cunningham Trust; Carnegie Trust for the Universities of Scotland, Tenovus Scotland; Wellcome Trust(Wellcome TrustEuropean Commission)	The investigation received financial support from the Cunningham Trust, the Carnegie Trust for the Universities of Scotland, Tenovus Scotland and the Wellcome Trust (Grant no WT082028MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADU D, 1982, CLIN EXP IMMUNOL, V49, P310; Araujo MI, 2006, CHEM IMMUNOL ALLERGY, V90, P29, DOI 10.1159/000088879; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Bach JF, 2005, J AUTOIMMUN, V25, P74, DOI 10.1016/j.jaut.2005.09.024; Blank M, 2007, CLIN REV ALLERG IMMU, V32, P111; Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028; Cooke A, 1999, PARASITE IMMUNOL, V21, P169, DOI 10.1046/j.1365-3024.1999.00213.x; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Cooper PJ, 2003, J ALLERGY CLIN IMMUN, V111, P995, DOI 10.1067/mai.2003.1348; Daniel-Ribeiro CT, 2000, ACTA TROP, V76, P205, DOI 10.1016/S0001-706X(00)00099-1; Endara P, 2010, CLIN EXP ALLERGY, V40, P1669, DOI 10.1111/j.1365-2222.2010.03559.x; Fesel C, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-5; Fleming JO, 2006, NEUROLOGY, V67, P2085, DOI 10.1212/01.wnl.0000247663.40297.2d; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Joseph S, 2004, J INFECT DIS, V190, P835, DOI 10.1086/422604; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; La Flamme AC, 2003, INFECT IMMUN, V71, P4996, DOI 10.1128/IAI.71.9.4996-5004.2003; Liu ZG, 2010, J MOL MED, V88, P27, DOI 10.1007/s00109-009-0546-0; Lleo A, AUTOIMMUN REV, V9, pA259; Lynch NR, 1999, THORAX, V54, P659, DOI 10.1136/thx.54.8.659; Mabaso MLH, 2005, TROP MED INT HEALTH, V10, P909, DOI 10.1111/j.1365-3156.2005.01462.x; Mabaso Musawenkoi L H, 2006, Int J Health Geogr, V5, P20; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Maizels RM, 2005, CURR OPIN IMMUNOL, V17, P656, DOI 10.1016/j.coi.2005.09.001; Midzi N, 2010, ACTA TROP, V115, P103, DOI 10.1016/j.actatropica.2010.02.010; Milner TM, 2010, PARASITE IMMUNOL; Mingomataj EC, 2006, ALLERGY, V61, P400, DOI 10.1111/j.1398-9995.2006.00983.x; MOTT KE, 1983, B SOC PATHOL EXOT, V76, P101; Mutapi F, 2005, J INFECT DIS, V192, P1108, DOI 10.1086/432553; Mutapi F, 1997, PARASITE IMMUNOL, V19, P255, DOI 10.1046/j.1365-3024.1997.d01-206.x; Mutapi F, 2002, LANCET INFECT DIS, V2, P219, DOI 10.1016/S1473-3099(02)00240-2; Nagayama Y, 2004, J IMMUNOL, V173, P2167, DOI 10.4049/jimmunol.173.3.2167; Ndhlovu P, 1996, PARASITE IMMUNOL, V18, P181, DOI 10.1046/j.1365-3024.1996.d01-78.x; Ndhlovu P, 1996, 1992 NATL SCHISTOSOM; Osada Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/743758; Pichler WJ, 2003, CURR OPIN ALLERGY CL, V3, P249, DOI 10.1097/01.all.0000083955.99396.25; Scofield RH, 2004, LANCET, V363, P1544, DOI 10.1016/S0140-6736(04)16154-0; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Smits HH, 2007, J ALLERGY CLIN IMMUN, V120, P932, DOI 10.1016/j.jaci.2007.06.009; Stanley Midzi VT, 2004, ZIMBABWE ROLL BACK M; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; TAYLOR P, 1986, T ROY SOC TROP MED H, V80, P12, DOI 10.1016/0035-9203(86)90185-9; van den Biggelaar AHJ, 2004, J INFECT DIS, V189, P892, DOI 10.1086/381767; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; Woolhouse MEJ, 1998, PARASITOL TODAY, V14, P428, DOI 10.1016/S0169-4758(98)01318-0; World Health Organization, 2002, PREV CONTR SCHIST SO; Youinou P, 2010, J AUTOIMMUN, V34, pJ163, DOI 10.1016/j.jaut.2009.12.005	48	32	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2011	6	5							e19149	10.1371/journal.pone.0019149	http://dx.doi.org/10.1371/journal.pone.0019149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760DZ	21573157	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000290305600013
J	Loukin, S; Su, ZW; Kung, C				Loukin, Stephen; Su, Zhenwei; Kung, Ching			Increased Basal Activity Is a Key Determinant in the Severity of Human Skeletal Dysplasia Caused by TRPV4 Mutations	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNEL; CALMODULIN-BINDING SITE; OF-FUNCTION MUTATIONS; METATROPIC DYSPLASIA; RECEPTOR; ACTIVATION; GENE; BRACHYOLMIA; MECHANISMS; DISEASE	TRPV4 is a mechanically activated Ca2+-passing channel implicated in the sensing of forces, including those acting on bones. To date, 33 mutations are known to affect human bone development to different extents. The spectrum of these skeletal dysplasias (SD) ranges from dominantly inherited mild brachylomia (BO) to neonatal lethal forms of metatropic dysplasia (MD). Complexities of the results from fluorescence and electrophysiological studies have led to questions on whether channel activity is a good predictor of disease severity. Here we report on a systematic examination of 14 TRPV4 mutant alleles covering the entire SD spectrum. Expressed in Xenopus oocyte and without any stimulation, the wild-type channel had a similar to 1% open probability (Po) while those of most of the lethal MD channels approached 100%. All mutant channels had higher basal open probabilities, which limited their further increase by agonist or hypotonicity. The magnitude of this limitation revealed a clear correlation between the degree of over-activity (the molecular phenotype) and the severity of the disease over the entire spectrum (the biological phenotype). Thus, while other factors are at play, our results are consistent with the increased TRPV4 basal activity being a critical determinant of the severity of skeletal dysplasia. We discuss how the channel over-activity may lead to the "gain-of-function'' phenotype and speculate that the function of wild-type TRPV4 may be secondary in normal bone development but crucial in an acute process such as fracture repair in the adult.	[Loukin, Stephen; Su, Zhenwei; Kung, Ching] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Kung, Ching] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Loukin, S (corresponding author), Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA.	shloukin@wisc.edu	Su, Zhenwei/C-3185-2018	Su, Zhenwei/0000-0002-5591-418X	National Institutes of Health (NIH) [GM054867, NS067360, GM047856]; Vilas Trust of the University of Wisconsin, Madison; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS067360] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vilas Trust of the University of Wisconsin, Madison; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant GM054867 (to S.L. and Y.S.), NS067360 and GM047856 (to C.K.) and by the Vilas Trust of the University of Wisconsin, Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; Becker D, 2009, EUR J CELL BIOL, V88, P141, DOI 10.1016/j.ejcb.2008.10.002; Camacho N, 2010, AM J MED GENET A, V152A, P1169, DOI 10.1002/ajmg.a.33392; Cameron TL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-20; Cao DS, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-5; Clark AL, 2010, ARTHRITIS RHEUM-US, V62, P2973, DOI 10.1002/art.27624; Dai J, 2010, J MED GENET, V47, P704, DOI 10.1136/jmg.2009.075358; Dai J, 2010, J HUM GENET, V55, P400, DOI 10.1038/jhg.2010.37; Deng HX, 2010, NAT GENET, V42, P165, DOI 10.1038/ng.509; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Garcia-Elias A, 2008, J BIOL CHEM, V283, P31284, DOI 10.1074/jbc.C800184200; Genevieve D, 2008, AM J MED GENET A, V146A, P992, DOI 10.1002/ajmg.a.32191; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; HRUSKA KA, 1995, NEW ENGL J MED, V333, P166, DOI 10.1056/NEJM199507203330307; Kannu P, 2007, AM J MED GENET A, V143A, P2512, DOI 10.1002/ajmg.a.31941; Klausen TK, 2009, J MED CHEM, V52, P2933, DOI 10.1021/jm9001007; KOZLOWSKI K, 1988, Australasian Radiology, V32, P325, DOI 10.1111/j.1440-1673.1988.tb02748.x; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2008, ANN NY ACAD SCI, V1144, P42, DOI 10.1196/annals.1418.012; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Loukin S, 2010, J BIOL CHEM, V285, P27176, DOI 10.1074/jbc.M110.143370; Loukin S, 2010, J BIOL CHEM, V285, P19884, DOI 10.1074/jbc.M110.113936; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Mizoguchi F, 2008, J CELL PHYSIOL, V216, P47, DOI 10.1002/jcp.21374; Muramatsu S, 2007, J BIOL CHEM, V282, P32158, DOI 10.1074/jbc.M706158200; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Nishimura G, 2010, AM J MED GENET A, V152A, P1443, DOI 10.1002/ajmg.a.33414; Nural Mehmet Selim, 2006, Diagn Interv Radiol, V12, P70; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; SHOHAT M, 1989, AM J MED GENET, V33, P209, DOI 10.1002/ajmg.1320330214; Smith PL, 2006, J BIOL CHEM, V281, P29897, DOI 10.1074/jbc.M605394200; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Strotmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010580; Su ZW, 2007, P NATL ACAD SCI USA, V104, P19607, DOI 10.1073/pnas.0708584104; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Tian W, 2009, P NATL ACAD SCI USA, V106, P14034, DOI 10.1073/pnas.0904084106; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wegierski T, 2009, J BIOL CHEM, V284, P2923, DOI 10.1074/jbc.M805357200; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Yoon J, 2000, J NEUROSCI, V20, P649, DOI 10.1523/JNEUROSCI.20-02-00649.2000; Zhu GH, 2009, HUM MOL GENET, V18, P2053, DOI 10.1093/hmg/ddp111	52	42	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2011	6	5							e19533	10.1371/journal.pone.0019533	http://dx.doi.org/10.1371/journal.pone.0019533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759OB	21573172	Green Submitted, gold, Green Published			2022-12-25	WOS:000290256400020
J	Patton, TG; Dietrich, G; Dolan, MC; Piesman, J; Carroll, JA; Gilmore, RD				Patton, Toni G.; Dietrich, Gabrielle; Dolan, Marc C.; Piesman, Joseph; Carroll, James A.; Gilmore, Robert D., Jr.			Functional Analysis of the Borrelia burgdorferi bba64 Gene Product in Murine Infection via Tick Infestation	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; OUTER SURFACE-PROTEINS; TOLL-LIKE RECEPTORS; BORRELIA-BURGDORFERI; MAMMALIAN HOST; LINEAR PLASMID; IXODES TICKS; LIFE-CYCLE; EXPRESSION; TRANSMISSION	Borrelia burgdorferi, the causative agent of Lyme borreliosis, transmitted to humans to from the bite of Ixodes spp. ticks. During the borrelial tick-to-mammal life cycle, B. burgdorferi must adapt to many environmental changes by regulating several genes, including bba64. Our laboratory recently demonstrated that the bba64 gene product is necessary for mouse infectivity when B. burgdorferi is transmitted by an infected tick bite, but not via needle inoculation. In this study we investigated the phenotypic properties of a bba64 mutant strain, including 1) replication during tick engorgement, 2) migration into the nymphal salivary glands, 3) host transmission, and 4) susceptibility to the MyD88-dependent innate immune response. Results revealed that the bba64 mutant's attenuated infectivity by tick bite was not due to a growth defect inside an actively feeding nymphal tick, or failure to invade the salivary glands. These findings suggested there was either a lack of spirochete transmission to the host dermis or increased susceptibility to the host's innate immune response. Further experiments showed the bba64 mutant was not culturable from mouse skin taken at the nymphal bite site and was unable to establish infection in MyD88-deficient mice via tick infestation. Collectively, the results of this study indicate that BBA64 functions at the salivary gland-to-host delivery interface of vector transmission and is not involved in resistance to MyD88-mediated innate immunity.	[Patton, Toni G.; Dietrich, Gabrielle; Dolan, Marc C.; Piesman, Joseph; Gilmore, Robert D., Jr.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO 80521 USA; [Carroll, James A.] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Patton, TG (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO 80521 USA.	rbg9@cdc.gov		Carroll, James/0000-0003-4329-1488	Centers for Disease Control and Prevention, a branch of the Department of Health and Human Services within the federal government	Centers for Disease Control and Prevention, a branch of the Department of Health and Human Services within the federal government(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Centers for Disease Control and Prevention, a branch of the Department of Health and Human Services within the federal government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JF, 1989, REV INFECT DIS, V11, pS1451; Anguita J, 2003, FEMS MICROBIOL REV, V27, P493, DOI 10.1016/S0168-6445(03)00036-6; BENACH JL, 1987, J INFECT DIS, V155, P1300, DOI 10.1093/infdis/155.6.1300; Bockenstedt LK, 2006, INFECT IMMUN, V74, P2154, DOI 10.1128/IAI.74.4.2154-2160.2006; Brooks CS, 2006, INFECT IMMUN, V74, P296, DOI 10.1128/IAI.74.1.296-304.2006; Brooks CS, 2003, INFECT IMMUN, V71, P3371, DOI 10.1128/IAI.71.6.3371-3383.2003; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Carroll JA, 2000, INFECT IMMUN, V68, P6677, DOI 10.1128/IAI.68.12.6677-6684.2000; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Casjens S, 1999, CURR OPIN MICROBIOL, V2, P529, DOI 10.1016/S1369-5274(99)00012-0; DESILVA AM, 1995, AM J TROP MED HYG, V53, P397, DOI 10.4269/ajtmh.1995.53.397; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Gautam A, 2008, MICROBIOL-SGM, V154, P275, DOI 10.1099/mic.0.2007/011676-0; Gilmore RD, 1997, J CLIN MICROBIOL, V35, P86, DOI 10.1128/JCM.35.1.86-91.1997; Gilmore RD, 2001, MICROBES INFECT, V3, P799, DOI 10.1016/S1286-4579(01)01435-6; Gilmore RD, 2007, INFECT IMMUN, V75, P2753, DOI 10.1128/IAI.00037-07; Gilmore RD, 2010, P NATL ACAD SCI USA, V107, P7515, DOI 10.1073/pnas.1000268107; Guerau-De-Arellano M, 2005, TRENDS MOL MED, V11, P114, DOI 10.1016/j.molmed.2005.01.003; Guo BP, 1998, MOL MICROBIOL, V30, P711, DOI 10.1046/j.1365-2958.1998.01103.x; Hovius JWR, 2007, TRENDS PARASITOL, V23, P434, DOI 10.1016/j.pt.2007.07.001; Hyde JA, 2007, J BACTERIOL, V189, P437, DOI 10.1128/JB.01109-06; Indest KJ, 1997, INFECT IMMUN, V65, P1165, DOI 10.1128/IAI.65.4.1165-1171.1997; Jewett MW, 2009, J BACTERIOL, V191, P6231, DOI 10.1128/JB.00450-09; Karna SLR, 2011, INFECT IMMUN, V79, P732, DOI 10.1128/IAI.00882-10; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kraiczy P, 2004, J BIOL CHEM, V279, P2421, DOI 10.1074/jbc.M308343200; Kumar M, 2010, J INFECT DIS, V201, P1084, DOI 10.1086/651172; Li X, 2007, MOL MICROBIOL, V63, P694, DOI 10.1111/j.1365-2958.2006.05550.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruskova M, 2008, INFECT IMMUN, V76, P391, DOI 10.1128/IAI.01118-07; MBOW ML, 1994, J PARASITOL, V80, P81, DOI 10.2307/3283349; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Neelakanta G, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030033; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; Ouyang ZM, 2009, MOL MICROBIOL, V74, P1331, DOI 10.1111/j.1365-2958.2009.06945.x; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pal U, 2008, J INFECT DIS, V197, P148, DOI 10.1086/523764; Patton TG, 2011, VECTOR-BORNE ZOONOT, V11, P197, DOI 10.1089/vbz.2010.0149; PIESMAN J, 1993, J MED ENTOMOL, V30, P199, DOI 10.1093/jmedent/30.1.199; Promnares K, 2009, MOL MICROBIOL, V74, P112, DOI 10.1111/j.1365-2958.2009.06853.x; Ramamoorthy R, 2001, INFECT IMMUN, V69, P2739, DOI 10.1128/IAI.69.4.2739-2742.2001; Revel AT, 2005, P NATL ACAD SCI USA, V102, P6972, DOI 10.1073/pnas.0502565102; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; RIBEIRO JMC, 1987, J MED ENTOMOL, V24, P201, DOI 10.1093/jmedent/24.2.201; SAMUELS DS, 1993, J GEN MICROBIOL, V139, P2445, DOI 10.1099/00221287-139-10-2445; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Seshu J, 2004, INFECT IMMUN, V72, P1580, DOI 10.1128/IAI.72.3.1580-1586.2004; SINSKY RJ, 1989, J CLIN MICROBIOL, V27, P1723, DOI 10.1128/JCM.27.8.1723-1727.1989; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Tokarz R, 2004, INFECT IMMUN, V72, P5419, DOI 10.1128/IAI.72.9.5419-5432.2004; Xu HJ, 2010, INFECT IMMUN, V78, P2910, DOI 10.1128/IAI.00372-10; Yang XF, 2000, MOL MICROBIOL, V37, P1470, DOI 10.1046/j.1365-2958.2000.02104.x; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960; Zhang XY, 2009, J INFECT DIS, V200, P1318, DOI 10.1086/605846	57	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2011	6	5							e19536	10.1371/journal.pone.0019536	http://dx.doi.org/10.1371/journal.pone.0019536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759EM	21559293	Green Published, gold, Green Submitted			2022-12-25	WOS:000290223500028
J	Cohen-Kupiec, R; Pasmanik-Chor, M; Oron-Karni, V; Weil, M				Cohen-Kupiec, Rachel; Pasmanik-Chor, Metsada; Oron-Karni, Varda; Weil, Miguel			Effects of IKAP/hELP1 Deficiency on Gene Expression in Differentiating Neuroblastoma Cells: Implications for Familial Dysautonomia	PLOS ONE			English	Article							AXON GUIDANCE; NEURAL CREST; MOUSE IKBKAP; ELONGATOR; CLONING; GROWTH; IDENTIFICATION; CYTOSKELETAL; ORGANIZATION; MUTATIONS	Familial dysautonomia (FD) is a developmental neuropathy of the sensory and autonomous nervous systems. The IKBKAP gene, encoding the IKAP/hELP1 subunit of the RNA polymerase II Elongator complex is mutated in FD patients, leading to a tissue-specific mis-splicing of the gene and to the absence of the protein in neuronal tissues. To elucidate the function of IKAP/hELP1 in the development of neuronal cells, we have downregulated IKBKAP expression in SHSY5Y cells, a neuroblastoma cell line of a neural crest origin. We have previously shown that these cells exhibit abnormal cell adhesion when allowed to differentiate under defined culture conditions on laminin substratum. Here, we report results of a microarray expression analysis of IKAP/hELP1 downregulated cells that were grown on laminin under differentiation or non-differentiation growth conditions. It is shown that under non-differentiation growth conditions, IKAP/hELP1 downregulation affects genes important for early developmental stages of the nervous system, including cell signaling, cell adhesion and neural crest migration. IKAP/hELP1 downregulation during differentiation affects the expression of genes that play a role in late neuronal development, in axonal projection and synapse formation and function. We also show that IKAP/hELP1 deficiency affects the expression of genes involved in calcium metabolism before and after differentiation of the neuroblastoma cells. Hence, our data support IKAP/hELP1 importance in the development and function of neuronal cells and contribute to the understanding of the FD phenotype.	[Cohen-Kupiec, Rachel; Weil, Miguel] Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel; [Pasmanik-Chor, Metsada; Oron-Karni, Varda] Tel Aviv Univ, Bioinformat Unit, Ramat Aviv, Israel	Tel Aviv University; Tel Aviv University	Cohen-Kupiec, R (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel.	miguelw@tauex.tau.ac.il			FD Foundation Inc.; FD Israel Foundation; Israel Science Foundation [1491/09]	FD Foundation Inc.; FD Israel Foundation; Israel Science Foundation(Israel Science Foundation)	This study was supported by a grant from the FD research consortium (FD Hope http://www.fdhope.org/, FD Foundation Inc. http://www.familialdysautonomia.org/, FD Israel Foundation http://www.fd-israel.org.il/) and a grant from the Israel Science Foundation www.isf.org.il/english/(grant No. 1491/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-12; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cheishvili D, 2011, HUM MOL GENET; Cheishvili D, 2007, HUM MOL GENET, V16, P2097, DOI 10.1093/hmg/ddm157; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Cisternas FA, 2003, GENOMICS, V81, P279, DOI 10.1016/S0888-7543(02)00040-X; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Cohen-Kupiec R, CELL ADH MIGR, V4; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Cuajungco MP, 2001, DNA CELL BIOL, V20, P579, DOI 10.1089/104454901317094990; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; Dent EW, 2003, NEUROSCIENTIST, V9, P343, DOI 10.1177/1073858403252683; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; FISCHERCOLBRIE R, 1995, PROG NEUROBIOL, V46, P49, DOI 10.1016/0301-0082(94)00060-U; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Gow AJ, 2001, J CELL PHYSIOL, V187, P277, DOI 10.1002/jcp.1085; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Keren H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015884; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lipardi C, FLY AUSTIN, V4, P30; Lorenzon NM, 2008, CHANNELS, V2, P163, DOI 10.4161/chan.2.3.5950; Lykissas MG, 2007, CURR NEUROVASC RES, V4, P143, DOI 10.2174/156720207780637216; Maayan C, 2002, OSTEOPOROSIS INT, V13, P429, DOI 10.1007/s001980200050; Manie S, 2001, TRENDS GENET, V17, P580, DOI 10.1016/S0168-9525(01)02420-9; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Naumanen T, 2008, CELL ADHES MIGR, V2, P236, DOI 10.4161/cam.2.4.6630; Nguyen L, 2010, TRENDS MOL MED, V16, P1, DOI 10.1016/j.molmed.2009.11.002; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pachnis V, 1998, AM J PHYSIOL-GASTR L, V275, pG183, DOI 10.1152/ajpgi.1998.275.2.G183; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; SCHULTZ D, 1993, P NATL ACAD SCI USA, V90, P6228, DOI 10.1073/pnas.90.13.6228; Sefton M, 1998, DEVELOPMENT, V125, P3111; Shibata T, 1997, J BIOL CHEM, V272, P5236, DOI 10.1074/jbc.272.8.5236; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Solinger JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000820; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; Taneyhill LA, 2008, CELL ADHES MIGR, V2, P223, DOI 10.4161/cam.2.4.6835; Woo J, 2009, MOL CELL NEUROSCI, V42, P1, DOI 10.1016/j.mcn.2009.05.008; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yarden Y, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.013; Young HM, 2004, AUTON NEUROSCI-BASIC, V112, P1, DOI 10.1016/j.autneu.2004.02.008; Zaczek A, 2005, HISTOL HISTOPATHOL, V20, P1005, DOI 10.14670/HH-20.1005; Zhang Y, 2003, J BIOL CHEM, V278, P573, DOI 10.1074/jbc.M203094200; Zimmermann DR, 2008, HISTOCHEM CELL BIOL, V130, P635, DOI 10.1007/s00418-008-0485-9	61	22	23	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19147	10.1371/journal.pone.0019147	http://dx.doi.org/10.1371/journal.pone.0019147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559466	gold, Green Published, Green Submitted			2022-12-25	WOS:000290024700076
J	Narzisi, G; Mishra, B				Narzisi, Giuseppe; Mishra, Bud			Comparing De Novo Genome Assembly: The Long and Short of It	PLOS ONE			English	Article							SHORT DNA-SEQUENCES; ALGORITHM; VIRULENCE; MILLIONS; READS	Recent advances in DNA sequencing technology and their focal role in Genome Wide Association Studies (GWAS) have rekindled a growing interest in the whole-genome sequence assembly (WGSA) problem, thereby, inundating the field with a plethora of new formalizations, algorithms, heuristics and implementations. And yet, scant attention has been paid to comparative assessments of these assemblers' quality and accuracy. No commonly accepted and standardized method for comparison exists yet. Even worse, widely used metrics to compare the assembled sequences emphasize only size, poorly capturing the contig quality and accuracy. This paper addresses these concerns: it highlights common anomalies in assembly accuracy through a rigorous study of several assemblers, compared under both standard metrics (N50, coverage, contig sizes, etc.) as well as a more comprehensive metric (Feature-Response Curves, FRC) that is introduced here; FRC transparently captures the trade-offs between contigs' quality against their sizes. For this purpose, most of the publicly available major sequence assemblers - both for low-coverage long (Sanger) and high-coverage short (Illumina) reads technologies - are compared. These assemblers are applied to microbial (Escherichia coli, Brucella, Wolbachia, Staphylococcus, Helicobacter) and partial human genome sequences (Chr. Y), using sequence reads of various read-lengths, coverages, accuracies, and with and without mate-pairs. It is hoped that, based on these evaluations, computational biologists will identify innovative sequence assembly paradigms, bioinformaticists will determine promising approaches for developing "next-generation'' assemblers, and biotechnologists will formulate more meaningful design desiderata for sequencing technology platforms. A new software tool for computing the FRC metric has been developed and is available through the AMOS open-source consortium.	[Narzisi, Giuseppe; Mishra, Bud] NYU, Courant Inst Math Sci, New York, NY 10003 USA; [Mishra, Bud] NYU, Sch Med, New York, NY USA	New York University; New York University	Narzisi, G (corresponding author), NYU, Courant Inst Math Sci, New York, NY 10003 USA.	narzisi@nyu.edu			Abraxis BioScience; NSF CDI	Abraxis BioScience; NSF CDI(National Science Foundation (NSF))	The research reported here was supported by grants from Abraxis BioScience and NSF CDI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Anantharaman TS, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P385; Anantharaman TS, 1997, J COMPUT BIOL, V4, P91, DOI 10.1089/cmb.1997.4.91; Anantharaman TS., 1997, GENOMICS VIA OPTICAL, P18; Antoniotti M, 2001, GENOMICS VIA OPTICAL; Ariyaratne PN, 2011, BIOINFORMATICS, V27, P167, DOI 10.1093/bioinformatics/btq626; Aston C, 1999, TRENDS BIOTECHNOL, V17, P297, DOI 10.1016/S0167-7799(99)01326-8; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Bryant DW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-69; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Green P, 1996, PHRAP DOCUMENTATION; Hall SS, 2010, REVOLUTION POSTPONED, P60; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Hossain MS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S16; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Hung RW, 2006, DISCRETE APPL MATH, V154, P76, DOI 10.1016/j.dam.2005.07.002; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Kidd JM, 2010, NAT METHODS, V7, P365, DOI 10.1038/NMETH.1451; Kim S., 2007, GENOME SEQUENCING TE; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Medvedev P, 2007, LECT N BIOINFORMAT, V4645, P289, DOI 10.1007/978-3-540-74126-8_27; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Mishra B, 2005, OPTICAL MAPPING ENCY; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Narzisi G, 2011, BIOINFORMATICS, V27, P153, DOI 10.1093/bioinformatics/btq646; Paulsen IT, 2002, P NATL ACAD SCI USA, V99, P13148, DOI 10.1073/pnas.192319099; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Salzberg SL, 2005, BIOINFORMATICS, V21, P4320, DOI 10.1093/bioinformatics/bti769; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmidt B, 2009, BIOINFORMATICS, V25, P2279, DOI 10.1093/bioinformatics/btp374; Schwartz DC, 2010, J COMPUT SCI TECH-CH, V25, P3, DOI 10.1007/s11390-010-9300-x; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; TARHIO J, 1988, THEOR COMPUT SCI, V57, P131, DOI 10.1016/0304-3975(88)90167-3; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407	52	70	70	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19175	10.1371/journal.pone.0019175	http://dx.doi.org/10.1371/journal.pone.0019175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21559467	gold, Green Submitted, Green Published			2022-12-25	WOS:000290024700091
J	Cavallari, M; Falco, T; Frontali, M; Romano, S; Bagnato, F; Orzi, F				Cavallari, Michele; Falco, Teresa; Frontali, Marina; Romano, Silvia; Bagnato, Francesca; Orzi, Francesco			Fractal Analysis Reveals Reduced Complexity of Retinal Vessels in CADASIL	PLOS ONE			English	Article							MICROVASCULAR ABNORMALITIES; LACUNAR STROKE; ATHEROSCLEROSIS RISK; MULTIPLE-SCLEROSIS; COMMUNITIES; EVOLUTION; DISEASE	The Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) affects mainly small cerebral arteries and leads to disability and dementia. The relationship between clinical expression of the disease and progression of the microvessel pathology is, however, uncertain as we lack tools for imaging brain vessels in vivo. Ophthalmoscopy is regarded as a window into the cerebral microcirculation. In this study we carried out an ophthalmoscopic examination in subjects with CADASIL. Specifically, we performed fractal analysis of digital retinal photographs. Data are expressed as mean fractal dimension (mean-D), a parameter that reflects complexity of the retinal vessel branching. Ten subjects with genetically confirmed diagnosis of CADASIL and 10 sex and age-matched control subjects were enrolled. Fractal analysis of retinal digital images was performed by means of a computer-based program, and the data expressed as mean-D. Brain MRI lesion volume in FLAIR and T1-weighted images was assessed using MIPAV software. Paired t-test was used to disclose differences in mean-D between CADASIL and control groups. Spearman rank analysis was performed to evaluate potential associations between mean-D values and both disease duration and disease severity, the latter expressed as brain MRI lesion volumes, in the subjects with CADASIL. The results showed that mean-D value of patients (1.42 +/- 0.05; mean +/- SD) was lower than control (1.50 +/- 0.04; p = 0.002). Mean-D did not correlate with disease duration nor with MRI lesion volumes of the subjects with CADASIL. The findings suggest that fractal analysis is a sensitive tool to assess changes of retinal vessel branching, likely reflecting early brain microvessel alterations, in CADASIL patients.	[Cavallari, Michele; Falco, Teresa; Orzi, Francesco] Univ Roma La Sapienza, St Andreas Hosp, Dept Neurosci Mental Hlth & Sensory Organs, Rome, Italy; [Frontali, Marina] CNR, Inst Neurobiol & Mol Med, Rome, Italy; [Romano, Silvia] Univ Roma La Sapienza, St Andreas Hosp, Ctr Expt Neurol Therapies, Rome, Italy; [Bagnato, Francesca] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Inst Imaging Sci, Nashville, TN 37232 USA	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; Vanderbilt University	Cavallari, M (corresponding author), Univ Roma La Sapienza, St Andreas Hosp, Dept Neurosci Mental Hlth & Sensory Organs, Rome, Italy.	francesco.orzi@uniroma1.it	Romano, Silvia/P-7984-2015	Romano, Silvia/0000-0003-0499-8843; Orzi, Francesco/0000-0003-1048-4662	Agenzia Italiana del Farmaco (AIFA) [FARM659PTX EudraCT 2007-004370-55]	Agenzia Italiana del Farmaco (AIFA)	This study is partially supported by a research grant from the Agenzia Italiana del Farmaco (AIFA, FARM659PTX EudraCT 2007-004370-55). Dr. Francesca Bagnato's contribution was sustained by the Intramural program of the National Institute of Neurological Disorders and Stroke-National Institutes of Health (NINDS-NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Other authors report no disclosures. No additional external funding was received for this study.	Bagnato F, 2003, BRAIN, V126, P1782, DOI 10.1093/brain/awg182; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Cheung N, 2010, ANN NEUROL, V68, P107, DOI 10.1002/ana.22011; Doubal FN, 2010, NEUROLOGY, V74, P1102, DOI 10.1212/WNL.0b013e3181d7d8b4; Filippi M, 1995, BRAIN, V118, P1601, DOI 10.1093/brain/118.6.1601; Joutel A, 2010, J CLIN INVEST, V120, P433, DOI 10.1172/JCI39733; Lesage SR, 2009, NEUROLOGY, V73, P862, DOI 10.1212/WNL.0b013e3181b78436; Masters BR, 2004, ANNU REV BIOMED ENG, V6, P427, DOI 10.1146/annurev.bioeng.6.040803.140100; Patton N, 2005, J ANAT, V206, P319, DOI 10.1111/j.1469-7580.2005.00395.x; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Roine S, 2006, OPHTHALMOLOGY, V113, P1411, DOI 10.1016/j.ophtha.2006.03.030; Rouhl RPW, 2008, J NEUROL, V255, P692, DOI 10.1007/s00415-008-0777-y; Wong TY, 2002, JAMA-J AM MED ASSOC, V288, P67, DOI 10.1001/jama.288.1.67; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; Yatsuya H, 2010, STROKE, V41, P1349, DOI 10.1161/STROKEAHA.110.580837	15	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19150	10.1371/journal.pone.0019150	http://dx.doi.org/10.1371/journal.pone.0019150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556373	gold, Green Published, Green Submitted			2022-12-25	WOS:000290019400033
J	Puechmaille, SJ; Wibbelt, G; Korn, V; Fuller, H; Forget, F; Muhldorfer, K; Kurth, A; Bogdanowicz, W; Borel, C; Bosch, T; Cherezy, T; Drebet, M; Gorfol, T; Haarsma, AJ; Herhaus, F; Hallart, G; Hammer, M; Jungmann, C; Le Bris, Y; Lutsar, L; Masing, M; Mulkens, B; Passior, K; Starrach, M; Wojtaszewski, A; Zophel, U; Teeling, EC				Puechmaille, Sebastien J.; Wibbelt, Gudrun; Korn, Vanessa; Fuller, Hubert; Forget, Frederic; Muehldorfer, Kristin; Kurth, Andreas; Bogdanowicz, Wieslaw; Borel, Christophe; Bosch, Thijs; Cherezy, Thomas; Drebet, Mikhail; Goerfoel, Tamas; Haarsma, Anne-Jifke; Herhaus, Frank; Hallart, Guenael; Hammer, Matthias; Jungmann, Christian; Le Bris, Yann; Lutsar, Lauri; Masing, Matti; Mulkens, Bart; Passior, Karsten; Starrach, Martin; Wojtaszewski, Andrzej; Zoephel, Ulrich; Teeling, Emma C.			Pan-European Distribution of White-Nose Syndrome Fungus (Geomyces destructans) Not Associated with Mass Mortality	PLOS ONE			English	Article							GREATER HORSESHOE BAT; MYOTIS-MYOTIS; RHINOLOPHUS-FERRUMEQUINUM; VESPERTILIONID BATS; NATTERERS BATS; CONSERVATION; HIBERNATION; CAVE; DIVERSITY; DURATION	Background: The dramatic mass mortalities amongst hibernating bats in Northeastern America caused by "white nose-syndrome" (WNS) continue to threaten populations of different bat species. The cold-loving fungus, Geomyces destructans, is the most likely causative agent leading to extensive destruction of the skin, particularly the wing membranes. Recent investigations in Europe confirmed the presence of the fungus G. destructans without associated mass mortality in hibernating bats in six countries but its distribution remains poorly known. Methodology/Principal Findings: We collected data on the presence of bats with white fungal growth in 12 countries in Europe between 2003 and 2010 and conducted morphological and genetic analysis to confirm the identity of the fungus as Geomyces destructans. Our results demonstrate the presence of the fungus in eight countries spanning over 2000 km from West to East and provide compelling photographic evidence for its presence in another four countries including Romania, and Turkey. Furthermore, matching prevalence data of a hibernaculum monitored over two consecutive years with data from across Europe show that the temporal occurrence of the fungus, which first becomes visible around February, peaks in March but can still be seen in some torpid bats in May or June, is strikingly similar throughout Europe. Finally, we isolated and cultured G. destructans from a cave wall adjacent to a bat with fungal growth. Conclusions/Significance: G. destructans is widely found over large areas of the European continent without associated mass mortalities in bats, suggesting that the fungus is native to Europe. The characterisation of the temporal variation in G. destructans growth on bats provides reference data for studying the spatio-temporal dynamic of the fungus. Finally, the presence of G. destructans spores on cave walls suggests that hibernacula could act as passive vectors and/or reservoirs for G. destructans and therefore, might play an important role in the transmission process.	[Puechmaille, Sebastien J.; Fuller, Hubert; Teeling, Emma C.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Puechmaille, Sebastien J.; Fuller, Hubert; Teeling, Emma C.] Conway Inst Biomol & Biomed Res, Dublin, Ireland; [Wibbelt, Gudrun; Muehldorfer, Kristin] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Korn, Vanessa] Off Faunist & Landscape Ecol, Schoneberg, Germany; [Forget, Frederic] Assoc Natagora, Plecotus Working Grp, Brussels, Belgium; [Kurth, Andreas] Robert Koch Inst, D-1000 Berlin, Germany; [Bogdanowicz, Wieslaw] Polish Acad Sci, Museum & Inst Zool, Warsaw, Poland; [Borel, Christophe] Sous Sol & Chiroptres Lorraine, Commissi Protect Eaux, Velaine En Haye, France; [Bosch, Thijs] Dutch Bat Workers Grp, Nijmegen, Netherlands; [Cherezy, Thomas] Coordinat Mammal Nord France, Bethune, France; [Drebet, Mikhail] Podilski Tovtry Natl Nat Pk, Kamenets Podilsky, Ukraine; [Goerfoel, Tamas] Nat Conservat Fdn Tolna Cty, Szekszard, Hungary; [Haarsma, Anne-Jifke] Alterra & Wageningen Univ, Ctr Ecosyst Studies, Wageningen, Netherlands; [Herhaus, Frank] Biol Stn Oberberg, Numbrecht, Germany; [Hallart, Guenael] Soc Etude & Protect Nat Thierache, Origny En Thierache, France; [Hammer, Matthias] Erlangen Univ, Ctr Bat Conservat No Bavaria, Dept Biol, Erlangen, Germany; [Jungmann, Christian] Nat & Biodivers Conservat Union Rhineland Palatin, Birkenfeld, Germany; [Le Bris, Yann] Bretagne Vivante SEPNB, Roussimel, Glenac, France; [Lutsar, Lauri] Estonian Fund Nat, Tartu, Estonia; [Masing, Matti] Sicista Dev Ctr, Tartu, Estonia; [Mulkens, Bart] Bat Working Grp, Natuurpunt Vzw, Belgium; [Passior, Karsten] Nat & Biodivers Conservat Union So Lower Saxony, Nordstemmen, Germany; [Starrach, Martin] Biotope Mapping Cooperat, Herford, Germany; [Wojtaszewski, Andrzej] Inst Nat Fibres & Med Plants, Poznan, Poland; [Zoephel, Ulrich] Saxonian State Off Environm Agr & Geol, Dresden, Germany	University College Dublin; University College Dublin; Leibniz Institut fur Zoo und Wildtierforschung; Robert Koch Institute; Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; Wageningen University & Research; University of Erlangen Nuremberg; Institute of Natural Fibres & Medicinal Plants	Puechmaille, SJ (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland.	s.puechmaille@gmail.com	Görföl, Tamás/F-7688-2010; Puechmaille, Sebastien/D-1612-2010	Görföl, Tamás/0000-0002-1910-4024; Puechmaille, Sebastien/0000-0001-9517-5775; Drebet, Mykhailo/0000-0002-7639-8815; Bosch, Thijs/0000-0001-7905-7402; Teeling, Emma/0000-0002-3309-1346; Bogdanowicz, Wieslaw/0000-0003-1196-2494	Science Foundation Ireland; IRCSET-Marie Curie International Mobility Fellowships in Science, Engineering and Technology; Clara-Samariter-Foundation, Germany	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); IRCSET-Marie Curie International Mobility Fellowships in Science, Engineering and Technology; Clara-Samariter-Foundation, Germany	This project was supported by a grant from the President of Ireland Young Researcher Award, Science Foundation Ireland to E. C. T., an IRCSET-Marie Curie International Mobility Fellowships in Science, Engineering and Technology to S.J.P and a grant from the Clara-Samariter-Foundation, Germany, to G. W. and K. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WHIT NOS SYNDR SCI S, VII; [Anonymous], 2010, NATL PLAN A IN PRESS; Arlettaz R, 2000, ECOLOGY, V81, P1004, DOI 10.1890/0012-9658(2000)081[1004:PTATDA]2.0.CO;2; Arthur L, 2009, CHAUVES SOURIS FRANC; Barlow A, 2009, VET REC, V165, P481, DOI 10.1136/vr.165.16.481-a; Bastian F, 2009, J APPL MICROBIOL, V106, P1456, DOI 10.1111/j.1365-2672.2008.04121.x; Battersby J., 2010, GUIDELINES SURVEILLA; Benda Petr, 2003, Acta Societatis Zoologicae Bohemicae, V67, P245; Berthier P, 2006, P ROY SOC B-BIOL SCI, V273, P3101, DOI 10.1098/rspb.2006.3680; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; BRACK V, 1985, CAN J ZOOL, V63, P2952, DOI 10.1139/z85-442; Cabrera A, 1904, MEMORIAS SOC ESPANOL, V2, P249; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; Courtin F, 2010, VET PATHOL, V47, P214, DOI 10.1177/0300985809358614; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Dietz C, 2009, BATS BRITAIN; Feldmann R., 1984, SAUGETIERE WESTFALEN, P107; Flanders J, 2009, MOL ECOL, V18, P306, DOI 10.1111/j.1365-294X.2008.04021.x; Garcia-Mudarra JL, 2009, BIOL J LINN SOC, V96, P434, DOI 10.1111/j.1095-8312.2008.01128.x; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Groth I, 1999, J MICROBIOL METH, V36, P115, DOI 10.1016/S0167-7012(99)00016-0; Hallam TG, 2011, CONSERV BIOL, V25, P189, DOI 10.1111/j.1523-1739.2010.01603.x; Ibanez C, 2006, ACTA CHIROPTEROL, V8, P277, DOI 10.3161/1733-5329(2006)8[277:TICTCD]2.0.CO;2; Kannan K, 2010, CHEMOSPHERE, V80, P613, DOI 10.1016/j.chemosphere.2010.04.060; Kokurewicz T, 2009, INT C MIL HER UTR NE; Kubatova Alena, 2005, Czech Mycology, V57, P221; Larcher G, 2003, J MYCOL MED, V13, P29; Lindner DL, 2010, MYCOLOGIA IN PRESS; Martinkova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013853; Mayer F, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-4; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Mosca AML, 1962, ANALISI MICOLOGICHE, P27; Nagy ZL, 2011, ANIM CONSERV, V14, P74, DOI 10.1111/j.1469-1795.2010.00392.x; Novakova A, 2010, MYCOL PROG, V9, P253, DOI 10.1007/s11557-009-0634-0; Novakova A, 2009, INT J SPELEOL, V38, P71, DOI 10.5038/1827-806X.38.1.8; Park KJ, 2000, FUNCT ECOL, V14, P580, DOI 10.1046/j.1365-2435.2000.00460.x; Parsons KN, 2003, ANIM CONSERV, V6, P283, DOI 10.1017/S1367943003003342; Parsons KN, 2003, J ZOOL, V261, P257, DOI 10.1017/S0952836903004199; Parsons KN, 2003, BIOL CONSERV, V111, P63, DOI 10.1016/S0006-3207(02)00250-1; Puechmaille SJ, 2011, ACTA CHIROPTEROL, V13, P217, DOI 10.3161/150811011X578778; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; RANSOME RD, 1971, J ZOOL, V164, P353, DOI 10.1111/j.1469-7998.1971.tb01323.x; Reichard JD, 2009, ACTA CHIROPTEROL, V11, P457, DOI 10.3161/150811009X485684; Rice AV, 2006, MYCOLOGIA, V98, P307, DOI 10.3852/mycologia.98.2.307; Rivers NM, 2006, BIOL CONSERV, V127, P215, DOI 10.1016/j.biocon.2005.08.010; Rivers NM, 2005, MOL ECOL, V14, P4299, DOI 10.1111/j.1365-294X.2005.02748.x; Rodrigues L, 2003, MAMMALIA, V67, P321, DOI 10.1515/mamm.2003.67.3.321; Sachanowicz Konrad, 2006, Vespertilio, V9-10, P151; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; Serra-Cobo J, 1998, ACTA THERIOL, V43, P271, DOI 10.4098/AT.arch.98-22; TWENTE JW, 1985, CAN J ZOOL, V63, P2955, DOI 10.1139/z85-443; Voyron S, 2011, HYSTRIX, V22, P189, DOI 10.4404/Hystrix-22.1-4481; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002	55	142	147	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19167	10.1371/journal.pone.0019167	http://dx.doi.org/10.1371/journal.pone.0019167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556356	Green Submitted, Green Published, gold			2022-12-25	WOS:000290019400034
J	Walker, RS; Hill, KR; Flinn, MV; Ellsworth, RM				Walker, Robert S.; Hill, Kim R.; Flinn, Mark V.; Ellsworth, Ryan M.			Evolutionary History of Hunter-Gatherer Marriage Practices	PLOS ONE			English	Article							PARENT-OFFSPRING CONFLICT; SEQUENCE	Background: The universality of marriage in human societies around the world suggests a deep evolutionary history of institutionalized pair-bonding that stems back at least to early modern humans. However, marriage practices vary considerably from culture to culture, ranging from strict prescriptions and arranged marriages in some societies to mostly unregulated courtship in others, presence to absence of brideservice and brideprice, and polyandrous to polygynous unions. The ancestral state of early human marriage is not well known given the lack of conclusive archaeological evidence. Methodology: Comparative phylogenetic analyses using data from contemporary hunter-gatherers around the world may allow for the reconstruction of ancestral human cultural traits. We attempt to reconstruct ancestral marriage practices using hunter-gatherer phylogenies based on mitochondrial DNA sequences. Results: Arranged marriages are inferred to go back at least to first modern human migrations out of Africa. Reconstructions are equivocal on whether or not earlier human marriages were arranged because several African hunter-gatherers have courtship marriages. Phylogenetic reconstructions suggest that marriages in early ancestral human societies probably had low levels of polygyny (low reproductive skew) and reciprocal exchanges between the families of marital partners (i.e., brideservice or brideprice). Discussion: Phylogenetic results suggest a deep history of regulated exchange of mates and resources among lineages that enhanced the complexity of human meta-group social structure with coalitions and alliances spanning across multiple residential communities.	[Walker, Robert S.; Flinn, Mark V.; Ellsworth, Ryan M.] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA; [Hill, Kim R.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA	University of Missouri System; University of Missouri Columbia; Arizona State University; Arizona State University-Tempe	Walker, RS (corresponding author), Univ Missouri, Dept Anthropol, 200 Swallow Hall, Columbia, MO 65211 USA.	walkerro@missouri.edu	Flinn, Mark/Q-8311-2017	Flinn, Mark/0000-0002-8732-3085				Alexander R. D., 1979, DARWINISM HUMAN AFFA; Anderson KG, 2006, CURR ANTHROPOL, V47, P513, DOI 10.1086/504167; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Apostolou M, 2007, EVOL HUM BEHAV, V28, P403, DOI 10.1016/j.evolhumbehav.2007.05.007; Apostolou M, 2010, EVOL PSYCHOL-US, V8, P365, DOI 10.1177/147470491000800305; Apostolou M, 2010, EVOL HUM BEHAV, V31, P39, DOI 10.1016/j.evolhumbehav.2009.06.010; Apostolou M, 2008, EVOL PSYCHOL, V6, P456; Apostolou M, 2008, EVOL PSYCHOL, V6, P303; Baker R.R., 1995, HUMAN SPERM COMPETIT; Binford L.R., 2001, CONSTRUCTING FRAMES; Birkhead T, 2000, PROMISCUITY EVOLUTIO; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Buunk AP, 2010, CROSS-CULT RES, V44, P23, DOI 10.1177/1069397109337711; Chagnon N.A., 1979, EVOLUTIONARY BIOL HU, P86; Chapais B, 2010, MIND THE GAP: TRACING THE ORIGINS OF HUMAN UNIVERSALS, P19, DOI 10.1007/978-3-642-02725-3_2; Chapais Bernard, 2008, PRIMEVAL KINSHIP PAI, DOI DOI 10.1111/btp.12564; CRONK L, 1991, ANNU REV ANTHROPOL, V20, P25, DOI 10.1146/annurev.an.20.100191.000325; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dubbs SL, 2010, EVOL PSYCHOL-US, V8, P586, DOI 10.1177/147470491000800405; Flinn M. V., 1986, ECOLOGICAL ASPECTS S, P217; Geary DC, 2000, PSYCHOL BULL, V126, P55, DOI 10.1037/0033-2909.126.1.55; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Harvey P.H., 1984, SPERM COMPETITION EV, P589; Hawkes K, 2001, CURR ANTHROPOL, V42, P681, DOI 10.1086/322559; Hill K, 2009, EVOL ANTHROPOL, V18, P187, DOI 10.1002/evan.20224; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Lee RB, MAN HUNTER; Levi-Strauss Claude, 1949, STRUCTURES ELEMENTAI; Mace R, EVOLUTION CULTURAL D; Maddison WP, 2017, MESQUITE MODULAR SYS; Marlowe FW, 2003, CROSS-CULT RES, V37, P282, DOI 10.1177/1069397103254008; Miller G., 2000, MATING MIND; MURDOCK GP, 1967, ETHNOLOGY, V6, P109, DOI 10.2307/3772751; Murdock GPM, 1949, SOCIAL STRUCTURE; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Plavcan JM, 1997, J HUM EVOL, V32, P345, DOI 10.1006/jhev.1996.0096; RODSETH L, 1991, CURR ANTHROPOL, V32, P221, DOI 10.1086/203952; Service E.R., 1962, PRIMITIVE SOCIAL ORG; Tylor EB, 1889, J ROYAL ANTHR I, V18, P245, DOI [DOI 10.2307/2842423, 10.2307/2842423]; Xing JC, 2010, GENOMICS, V96, P199, DOI 10.1016/j.ygeno.2010.07.004	42	106	106	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19066	10.1371/journal.pone.0019066	http://dx.doi.org/10.1371/journal.pone.0019066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756NO	21556360	Green Published, gold			2022-12-25	WOS:000290019400026
J	Kim, HY; Tsai, S; Lo, SC; Wear, DJ; Izadjoo, MJ				Kim, Hyung-Yong; Tsai, Shien; Lo, Shyh-Ching; Wear, Douglas J.; Izadjoo, Mina J.			Production and Characterization of Chimeric Monoclonal Antibodies against Burkholderia pseudomallei and B. mallei Using the DHFR Expression System	PLOS ONE			English	Article							IMMUNOGLOBULIN VARIABLE DOMAINS; CAPSULAR POLYSACCHARIDE; CHO-CELLS; MELIOIDOSIS; PROTEIN; LIPOPOLYSACCHARIDE; PATHOGENICITY; LIPOPROTEIN; VACCINES; VECTORS	Burkholderia pseudomallei (BP) and B. mallei (BM) are closely related gram-negative, facultative anaerobic bacteria which cause life-threatening melioidosis in human and glanders in horse, respectively. Our laboratory has previously generated and characterized more than 100 mouse monoclonal antibodies (MAbs) against BP and BM, according to in vitro and in vivo assay. In this study, 3 MAbs (BP7 10B11, BP7 2C6, and BP1 7F7) were selected to develop into chimeric mouse-human monoclonal antibodies (cMAbs) against BP and/or BM. For the stable production of cMAbs, we constructed 4 major different vector systems with a dihydrofolate reductase (DHFR) amplification marker, and optimized transfection/selection conditions in mammalian host cells with the single-gene and/or double-gene expression system. These 3 cMAbs were stably produced by the DHFR double mutant Chinese hamster ovarian (CHO)-DG44 cells. By ELISA and Western blot analysis using whole bacterial antigens treated by heat (65 degrees C/90 min), sodium periodate, and proteinase K, the cMAb BP7 10B11 (cMAb CK1) reacted with glycoproteins (34, 38, 48 kDa in BP; 28, 38, 48 kDa in BM). The cMAb BP7 2C6 (cMAb CK2) recognized surface-capsule antigens with molecular sizes of 38 to 52 kDa, and 200 kDa in BM. The cMAb CK2 was weakly reactive to 14 similar to 28, 200 kDa antigens in BP. The cMAb BP1 7F7 (cMAb CK3) reacted with lipopolysaccharides (38 similar to 52 kDa in BP; 38 similar to 60 kDa in B. thailandensis). Western blot results with the outer surface antigens of the 3 Burkholderia species were consistent with results with the whole Burkholderia cell antigens, suggesting that these immunodominant antigens reacting with the 3 cMAbs were primarily present on the outer surface of the Burkholderia species. These 3 cMAbs would be useful for analyzing the role of the major outer surface antigens in Burkholderia infection.	[Kim, Hyung-Yong; Tsai, Shien; Wear, Douglas J.; Izadjoo, Mina J.] Armed Forces Inst Pathol, Dept Environm & Infect Dis Sci, Washington, DC 20306 USA; [Kim, Hyung-Yong; Tsai, Shien; Wear, Douglas J.; Izadjoo, Mina J.] Amer Registry Pathol, Washington, DC USA; [Lo, Shyh-Ching] US Food & Drug Adm FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD USA; [Lo, Shyh-Ching] US Food & Drug Adm FDA, Div Human Tissues, Ctr Biol Evaluat & Res, Bethesda, MD USA	United States Department of Defense; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Kim, HY (corresponding author), Armed Forces Inst Pathol, Dept Environm & Infect Dis Sci, Washington, DC 20306 USA.	izadjoo@afip.osd.mil	Kim, Hyojoong/AAT-8734-2021; Lee, Seunghwan/E-4992-2011	Kim, Hyojoong/0000-0002-1706-2991	Defense Threat Reduction Agency-Joint Science and Technology Office [2.1_05_AF_B, 2.1_07_AF_B]	Defense Threat Reduction Agency-Joint Science and Technology Office(United States Department of DefenseDefense Threat Reduction Agency)	This research was supported by grants 2.1_05_AF_B & 2.1_07_AF_B from the Defense Threat Reduction Agency-Joint Science and Technology Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bianchi AA, 2003, BIOTECHNOL BIOENG, V84, P439, DOI 10.1002/bit.10790; Bondi SK, 2008, EXPERT REV VACCINES, V7, P1357, DOI 10.1586/14760584.7.9.1357; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Casadevall A, 2002, EMERG INFECT DIS, V8, P833, DOI 10.3201/eid0808.010516; Chan SW, 2004, J BIOCHEM MOL BIOL, V37, P556; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chinnasamy D, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-14; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; CRAVITZ L, 1950, J INFECT DIS, V86, P46, DOI 10.1093/infdis/86.1.46; Dinnis DM, 2005, BIOTECHNOL BIOENG, V91, P180, DOI 10.1002/bit.20499; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; Feng SH, 2006, HYBRIDOMA, V25, P193, DOI 10.1089/hyb.2006.25.193; Hara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006496; HOWE C, 1971, J INFECT DIS, V124, P598, DOI 10.1093/infdis/124.6.598; HOWE C, 1947, ANN INTERN MED, V26, P93, DOI 10.7326/0003-4819-26-1-93; Jones SM, 2002, J MED MICROBIOL, V51, P1055, DOI 10.1099/0022-1317-51-12-1055; Kim HY, 1998, J CLIN MICROBIOL, V36, P3278, DOI 10.1128/JCM.36.11.3278-3284.1998; Kim HY, 2002, INFECT IMMUN, V70, P4132, DOI 10.1128/IAI.70.8.4132-4141.2002; Kim SJ, 1998, BIOTECHNOL BIOENG, V58, P73, DOI 10.1002/(SICI)1097-0290(19980405)58:1<73::AID-BIT8>3.0.CO;2-R; Leelarasamee A, 2004, CURR OPIN INFECT DIS, V17, P131, DOI 10.1097/00001432-200404000-00011; LEELARASAMEE A, 1989, REV INFECT DIS, V11, P413; Lucas BK, 1996, NUCLEIC ACIDS RES, V24, P1774, DOI 10.1093/nar/24.9.1774; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833; Plesa M, 2004, J MED MICROBIOL, V53, P389, DOI 10.1099/jmm.0.05504-0; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; REFF ME, 1994, BLOOD, V83, P435; Rogul M, 1970, J BACTERIOL, V101, P827, DOI 10.1128/JB.101.3.827-835.1970; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Trevino SR, 2006, INFECT IMMUN, V74, P1958, DOI 10.1128/IAI.74.3.1958-1961.2006; Vaughan TJ, 1998, NAT BIOTECHNOL, V16, P535, DOI 10.1038/nbt0698-535; Vernel-Pauillac F, 2006, INFECT IMMUN, V74, P4172, DOI 10.1128/IAI.00447-06; WALLS MA, 1993, NUCLEIC ACIDS RES, V21, P2921, DOI 10.1093/nar/21.12.2921; Werner RG, 1998, ARZNEIMITTEL-FORSCH, V48, P870; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; WOODWARD MP, 1985, J IMMUNOL METHODS, V78, P143, DOI 10.1016/0022-1759(85)90337-0; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Zhang HW, 1998, INFECT IMMUN, V66, P5196, DOI 10.1128/IAI.66.11.5196-5201.1998; Zhang SM, 2011, CLIN VACCINE IMMUNOL, V18, P825, DOI 10.1128/CVI.00533-10; Zou NX, 2008, HYBRIDOMA, V27, P231, DOI 10.1089/hyb.2008.0012	44	77	82	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19867	10.1371/journal.pone.0019867	http://dx.doi.org/10.1371/journal.pone.0019867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21935453	gold, Green Submitted, Green Published			2022-12-25	WOS:000290386800039
J	Dalmasso, G; Hang, TTN; Yan, YT; Laroui, H; Charania, MA; Ayyadurai, S; Sitaraman, SV; Merlin, D				Dalmasso, Guillaume; Hang Thi Thu Nguyen; Yan, Yutao; Laroui, Hamed; Charania, Moiz A.; Ayyadurai, Saravanan; Sitaraman, Shanthi V.; Merlin, Didier			Microbiota Modulate Host Gene Expression via MicroRNAs	PLOS ONE			English	Article								Microbiota are known to modulate host gene expression, yet the underlying molecular mechanisms remain elusive. MicroRNAs (miRNAs) are importantly implicated in many cellular functions by post-transcriptionally regulating gene expression via binding to the 3'-untranslated regions (3'-UTRs) of the target mRNAs. However, a role for miRNAs in microbiota-host interactions remains unknown. Here we investigated if miRNAs are involved in microbiota-mediated regulation of host gene expression. Germ-free mice were colonized with the microbiota from pathogen-free mice. Comparative profiling of miRNA expression using miRNA arrays revealed one and eight miRNAs that were differently expressed in the ileum and the colon, respectively, of colonized mice relative to germ-free mice. A computational approach was then employed to predict genes that were potentially targeted by the dysregulated miRNAs during colonization. Overlapping the miRNA potential targets with the microbiota-induced dysregulated genes detected by a DNA microarray performed in parallel revealed several host genes that were regulated by miRNAs in response to colonization. Among them, Abcc3 was identified as a highly potential miRNA target during colonization. Using the murine macrophage RAW 264.7 cell line, we demonstrated that mmu-miR-665, which was dysregulated during colonization, down-regulated Abcc3 expression by directly targeting the Abcc3 3'-UTR. In conclusion, our study demonstrates that microbiota modulate host microRNA expression, which could in turn regulate host gene expression.	[Dalmasso, Guillaume; Hang Thi Thu Nguyen; Yan, Yutao; Laroui, Hamed; Charania, Moiz A.; Ayyadurai, Saravanan; Sitaraman, Shanthi V.; Merlin, Didier] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Merlin, Didier] Vet Affairs Med Ctr, Decatur, GA 30033 USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Dalmasso, G (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	gdalmas@emory.edu	Dalmasso, Guillaume/N-2443-2018; Nguyen, Hang/N-2441-2018	Dalmasso, Guillaume/0000-0002-3433-870X; Nguyen, Hang/0000-0001-7431-5126	National Institutes of Health of Diabetes and Digestive and Kidney Diseases [R24-DK-064399, RO1-DK-071594, RO1-DK-55850]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055850, R01DK071594, R24DK064399] Funding Source: NIH RePORTER	National Institutes of Health of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health of Diabetes and Digestive and Kidney Diseases [R24-DK-064399 center grant, RO1-DK-071594 to D.M., RO1-DK-55850 to S.V.S.]; and a research fellowship award from the Crohn's and Colitis Foundation of America [to G.D.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BUSSEY KJ, 2003, GENOME BIOL, V4, pNIL81; Chen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn387; Dalmasso G, 2010, DIFFERENTIATION, V80, P147, DOI 10.1016/j.diff.2010.06.005; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; WHITT DD, 1980, INFECT IMMUN, V29, P144, DOI 10.1128/IAI.29.1.144-151.1980; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	17	168	182	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19293	10.1371/journal.pone.0019293	http://dx.doi.org/10.1371/journal.pone.0019293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21886824	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700127
J	Kim, H; Lee, S; Jang, Y				Kim, Hyojoong; Lee, Seunghwan; Jang, Yikweon			Macroevolutionary Patterns in the Aphidini Aphids (Hemiptera: Aphididae): Diversification, Host Association, and Biogeographic Origins	PLOS ONE			English	Article							MISSING DATA; MITOCHONDRIAL-DNA; INCOMPLETE TAXA; PHYLOGENETIC-RELATIONSHIPS; HISTORICAL BIOGEOGRAPHY; MOLECULAR PHYLOGENIES; NUCLEAR EF1-ALPHA; FLOWERING PLANTS; DIVERGENCE TIME; RAPID RADIATION	Background: Due to its biogeographic origins and rapid diversification, understanding the tribe Aphidini is key to understanding aphid evolution. Major questions about aphid evolution include origins of host alternation as well as age and patterns of diversification in relation to host plants. To address these questions, we reconstructed the phylogeny of the Aphidini which contains Aphis, the most diverse genus in the family. We used a combined dataset of one nuclear and four mitochondrial DNA regions. A molecular dating approach, calibrated with fossil records, was used to estimate divergence times of these taxa. Principal Findings: Most generic divergences in Aphidini occurred in the Middle Tertiary, and species-level divergences occurred between the Middle and Late Tertiary. The ancestral state of host use for Aphidini was equivocal with respect to three states: monoecy on trees, heteroecy, and monoecy on grasses. The ancestral state of Rhopalosiphina likely included both heteroecy and monoecy, whereas that of Aphidina was most likely monoecy. The divergence times of aphid lineages at the generic or subgeneric levels are close to those of their primary hosts. The species-level divergences in aphids are consistent with the diversification of the secondary hosts, as a few examples suggest. The biogeographic origin of Aphidini as a whole was equivocal, but the major lineages within Aphidina likely separated into Nearctic, Western Palearctic, and Eastern Palearctic regions. Conclusions: Most generic divergences in Aphidini occurred in the Middle Tertiary when primary hosts, mainly in the Rosaceae, were diverging, whereas species-level divergences were contemporaneous with diversification of the secondary hosts such as Poaceae in the Middle to Late Tertiary. Our results suggest that evolution of host alternation within Aphidini may have occurred during the Middle Tertiary (Oligocene) when the secondary hosts emerged.	[Kim, Hyojoong; Jang, Yikweon] Ewha Womans Univ, Div EcoSci, Seoul, South Korea; [Kim, Hyojoong; Jang, Yikweon] Ewha Womans Univ, Res Inst EcoSci, Seoul, South Korea; [Lee, Seunghwan] Seoul Natl Univ, Dept Agr Biotechnol, Res Inst Agr & Life Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Seoul National University (SNU)	Kim, H (corresponding author), Ewha Womans Univ, Div EcoSci, Seoul, South Korea.	seung@snu.ac.kr; jangy@ewha.ac.kr	Kim, Hyojoong/AAT-8734-2021; Lee, Seunghwan/E-4992-2011	Kim, Hyojoong/0000-0002-1706-2991	Ewha Womans University	Ewha Womans University	The paper was supported by RP-Grant 2010 of Ewha Womans University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackman R. L., 2000, Aphids on the world's crops: an identification and information guide.; Blackman R.L., 2021, APHIDS WORLDS PLANTS; BLACKMAN RL, 2006, APHIDS WORLDS HERBAC, V2; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Bremer B, 2009, INT J PLANT SCI, V170, P766, DOI 10.1086/599077; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Carletto J, 2009, SYST ENTOMOL, V34, P307, DOI 10.1111/j.1365-3113.2008.00458.x; CASTRESANA J, 2002, GBLOCLKS SELECTION C; Clark MA, 1999, MOL BIOL EVOL, V16, P1586, DOI 10.1093/oxfordjournals.molbev.a026071; Coeur d'Acier A, 2007, MOL PHYLOGENET EVOL, V42, P598, DOI 10.1016/j.ympev.2006.10.006; DIXON AFG, 1987, APHIDS THEIR BIOL NA, V2, P197; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunn KA, 2003, MOL PHYLOGENET EVOL, V27, P259, DOI 10.1016/S1055-7903(02)00442-6; Farrell BD, 1998, BIOL J LINN SOC, V63, P553, DOI 10.1006/bijl.1997.0207; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FAVRET C, 2011, APHID SPECIES FILE V; Felsenstein J, 1984, DNAML PHYLIP 2 6; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Ford VS, 2007, SYST BOT, V32, P348, DOI 10.1600/036364407781179725; Fulton TL, 2006, MOL PHYLOGENET EVOL, V41, P165, DOI 10.1016/j.ympev.2006.05.025; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Gradstein FM, 2004, LETHAIA, V37, P175, DOI 10.1080/00241160410006483; Harry M, 1998, MOL PHYLOGENET EVOL, V9, P542, DOI 10.1006/mpev.1998.0508; Havill NP, 2007, MOL PHYLOGENET EVOL, V44, P357, DOI 10.1016/j.ympev.2006.11.008; Havill NP, 2007, ANNU REV ENTOMOL, V52, P325, DOI 10.1146/annurev.ento.52.110405.091303; Heie O.E., 1987, World Crop Pests, V2A, P367; Heie OE, 1992, APHIDOIDEA HEMIPTE 1; Heie OE, 1994, APHIDOIDEA HEMIPTE 2; HEIE OE, 1986, APHIDOIDEA HEMIPTERA, V3; Heie Ole E., 1994, P409; HOLMAN J, 1987, ACTA ENTOMOL BOHEMOS, V84, P353; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JERMIIN LS, 1994, J MOL EVOL, V38, P282, DOI 10.1007/BF00176090; Jian SG, 2008, SYST BIOL, V57, P38, DOI 10.1080/10635150801888871; Kim H, 2008, SYST ENTOMOL, V33, P711, DOI 10.1111/J.1365-3113.2008.00440.x; Kim H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011608; Kim H, 2010, ANN ENTOMOL SOC AM, V103, P532, DOI 10.1603/AN09166; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KUNDU R, 1995, J ANIM ECOL, V64, P245, DOI 10.2307/5759; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lee S, 2006, EC INSECTS KOREA S35; Lee S, 2002, ILLUSTRATED CATALO 1; Lopez-Vaamonde C, 2006, J EVOLUTION BIOL, V19, P1314, DOI 10.1111/j.1420-9101.2005.01070.x; Lopez-Vaamonde C, 2001, MOL PHYLOGENET EVOL, V21, P55, DOI 10.1006/mpev.2001.0993; Lopez-Vaamonde C, 2009, MOL PHYLOGENET EVOL, V52, P715, DOI 10.1016/j.ympev.2009.05.028; Mackenzie A, 1996, EVOLUTION, V50, P155, DOI [10.2307/2410790, 10.1111/j.1558-5646.1996.tb04482.x]; MACKENZIE A, 1990, AM NAT, V136, P132, DOI 10.1086/285086; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Martinez-Torres D, 2001, MOL PHYLOGENET EVOL, V20, P437, DOI 10.1006/mpev.2001.0983; MITTER C, 1991, TRENDS ECOL EVOL, V6, P290, DOI 10.1016/0169-5347(91)90007-K; MORAN NA, 1988, AM NAT, V132, P681, DOI 10.1086/284882; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; MORAN NA, 1989, SCIENCE, V245, P173, DOI 10.1126/science.245.4914.173; MORAN NA, 1992, ANNU REV ENTOMOL, V37, P321, DOI 10.1146/annurev.en.37.010192.001541; MORAN NA, 1990, AM NAT, V136, P135, DOI 10.1086/285087; Normark BB, 1996, EVOLUTION, V50, P734, DOI 10.1111/j.1558-5646.1996.tb03883.x; Nylander JAA, 2004, MRMODELTEST 2 0; Ortiz-Rivas B, 2010, MOL PHYLOGENET EVOL, V55, P305, DOI 10.1016/j.ympev.2009.12.005; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M, 2007, BAYESTRAITS IN PRESS; Palumbi Stephen R., 1996, P205; Parham JF, 2008, AM NAT, V171, P132, DOI 10.1086/524198; Percy DM, 2004, SYST BIOL, V53, P120, DOI 10.1080/10635150490264996; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; Qiao Gexia, 2008, Zootaxa, V1746, P1; Rambaut A, 2009, FIGTREE V1 3 1; Rambaut A., 2007, TRACER V1 5; Remaudiere G., 1997, CATALOGUE APHIDIDAE; Richardson JE, 2004, PHILOS T R SOC B, V359, P1495, DOI 10.1098/rstb.2004.1537; Rutschmann F., 2005, BAYESIAN MOL DATING; Rutschmann F, 2007, SYST BIOL, V56, P591, DOI 10.1080/10635150701491156; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 1991, MOL TECHNIQUES TAXON; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stefanovic S, 2009, SYST BOT, V34, P115, DOI 10.1600/036364409787602221; STERN DL, 1994, P ROY SOC B-BIOL SCI, V256, P203, DOI 10.1098/rspb.1994.0071; Stroyan H. L. G., 1984, Handbooks for the Identification of British Insects, Royal Entomological Society, UK, V2; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; Teulon DAJ, 1998, CURRENT STATUS NZ IN, P1; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Turcinaviciene J, 2006, EUR J ENTOMOL, V103, P597, DOI 10.14411/eje.2006.080; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035; Von Dohlen CD, 2003, ANN ENTOMOL SOC AM, V96, P107, DOI 10.1603/0013-8746(2003)096[0107:PAHBON]2.0.CO;2; von Dohlen CD, 2002, MOL PHYLOGENET EVOL, V23, P257, DOI 10.1016/S1055-7903(02)00025-8; Von Dohlen CD, 2000, BIOL J LINN SOC, V71, P689, DOI 10.1006/bijl.2000.0470; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Weiblen GD, 2001, SYST BIOL, V50, P243; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wiens JJ, 2005, SYST BIOL, V54, P731, DOI 10.1080/10635150500234583; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wiens JJ, 2003, J VERTEBR PALEONTOL, V23, P297, DOI 10.1671/0272-4634(2003)023[0297:ITICAP]2.0.CO;2; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wojciechowski W., 1992, STUDIES SYSTEMATIC S; Yamamoto S, 2007, MOL PHYLOGENET EVOL, V44, P711, DOI 10.1016/j.ympev.2006.12.027; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZX, 2010, ENTOMOL SCI, V13, P351, DOI 10.1111/j.1479-8298.2010.00391.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	112	77	82	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24749	10.1371/journal.pone.0024749	http://dx.doi.org/10.1371/journal.pone.0024749			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935453	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700055
J	Shieh, JC; Schaar, BT; Srinivasan, K; Brodsky, FM; McConnell, SK				Shieh, Jennifer C.; Schaar, Bruce T.; Srinivasan, Karpagam; Brodsky, Frances M.; McConnell, Susan K.			Endocytosis Regulates Cell Soma Translocation and the Distribution of Adhesion Proteins in Migrating Neurons	PLOS ONE			English	Article							ALPHA-3-BETA-1 INTEGRIN; MEDIATED ENDOCYTOSIS; RADIAL MIGRATION; FOCAL ADHESIONS; MYOSIN-II; DYNAMIN; MEMBRANE; GROWTH; BETA-1-INTEGRINS; CONTRACTION	Newborn neurons migrate from their birthplace to their final location to form a properly functioning nervous system. During these movements, young neurons must attach and subsequently detach from their substrate to facilitate migration, but little is known about the mechanisms cells use to release their attachments. We show that the machinery for clathrin-mediated endocytosis is positioned to regulate the distribution of adhesion proteins in a subcellular region just proximal to the neuronal cell body. Inhibiting clathrin or dynamin function impedes the movement of migrating neurons both in vitro and in vivo. Inhibiting dynamin function in vitro shifts the distribution of adhesion proteins to the rear of the cell. These results suggest that endocytosis may play a critical role in regulating substrate detachment to enable cell body translocation in migrating neurons.	[Shieh, Jennifer C.; Srinivasan, Karpagam; McConnell, Susan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Shieh, Jennifer C.] Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; [Schaar, Bruce T.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Brodsky, Frances M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Brodsky, Frances M.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Brodsky, Frances M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shieh, JC (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	suemcc@stanford.edu		Brodsky, Frances/0000-0002-1334-9258	National Institutes of Health (NIH) [MH51864, GM038093]; National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051864, R37MH051864] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by National Institutes of Health (NIH) MH51864 (SKM) and NIH GM038093 (FMB). JCS was supported by a National Defense Science and Engineering Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Belvindrah R, 2007, J NEUROSCI, V27, P2704, DOI 10.1523/JNEUROSCI.2991-06.2007; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonanomi D, 2008, J CELL SCI, V121, P3757, DOI 10.1242/jcs.033803; Bretscher MS, 2008, J CELL SCI, V121, P2625, DOI 10.1242/jcs.031120; BRETSCHER MS, 1976, NATURE, V260, P21, DOI 10.1038/260021a0; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; BRODSKY FM, 1983, J MOL BIOL, V167, P197, DOI 10.1016/S0022-2836(83)80041-2; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; DAVIES PJA, 1984, DIABETES CARE, V7, P35; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; EDMONDSON JC, 1988, J CELL BIOL, V106, P505, DOI 10.1083/jcb.106.2.505; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Fletcher SJ, 2010, TRENDS CELL BIOL, V20, P71, DOI 10.1016/j.tcb.2009.11.006; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; GASSER UE, 1990, P NATL ACAD SCI USA, V87, P4543, DOI 10.1073/pnas.87.12.4543; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; GREGORY WA, 1988, J NEUROSCI, V8, P1728; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hawthorne AL, 2010, J NEUROSCI, V30, P420, DOI 10.1523/JNEUROSCI.2333-09.2010; He M, 2010, J NEUROSCI, V30, P10885, DOI 10.1523/JNEUROSCI.0240-10.2010; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Kamiguchi H, 2003, MOL NEUROBIOL, V28, P219, DOI 10.1385/MN:28:3:219; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kirfel G, 2004, EUR J CELL BIOL, V83, P717, DOI 10.1078/0171-9335-00421; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Le Roy C, 2005, DEV CELL, V9, P167, DOI 10.1016/j.devcel.2005.07.007; Levecque C, 2009, AM J PHYSIOL-CELL PH, V297, pC160, DOI 10.1152/ajpcell.00630.2008; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; Marin O, 2006, TRENDS NEUROSCI, V29, P655, DOI 10.1016/j.tins.2006.10.001; Martini FJ, 2010, J NEUROSCI, V30, P8660, DOI 10.1523/JNEUROSCI.1962-10.2010; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McManus MF, 2005, J CHILD NEUROL, V20, P280, DOI 10.1177/08830738050200040301; Moskowitz HS, 2003, MOL BIOL CELL, V14, P4437, DOI 10.1091/mbc.e03-04-0230; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; NANDI PK, 1981, BIOCHEMISTRY-US, V20, P6706, DOI 10.1021/bi00526a028; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Palecek SP, 1996, J CELL SCI, V109, P941; Panicker AK, 2006, EXP CELL RES, V312, P299, DOI 10.1016/j.yexcr.2005.10.031; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; PHONPHOK Y, 1991, FEBS LETT, V281, P188, DOI 10.1016/0014-5793(91)80390-O; Pierini LM, 2000, BLOOD, V95, P2471; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Rid R, 2005, CELL MOTIL CYTOSKEL, V61, P161, DOI 10.1002/cm.20076; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schmid RS, 2004, DEVELOPMENT, V131, P6023, DOI 10.1242/dev.01532; Schneider IC, 2009, MOL BIOL CELL, V20, P3155, DOI 10.1091/mbc.E09-03-0219; Shan YL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000116; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shastry BS, 2007, J HUM GENET, V52, P104, DOI 10.1007/s10038-006-0088-z; Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Strachan LR, 2004, J CELL BIOL, V167, P545, DOI 10.1083/jcb.200405024; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Ward Michael E., 2004, V294, P137; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010; Yuasa S, 1996, INT J DEV NEUROSCI, V14, P429, DOI 10.1016/S0736-5748(96)00021-4; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030	105	58	61	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2011	6	3							e17802	10.1371/journal.pone.0017802	http://dx.doi.org/10.1371/journal.pone.0017802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740QI	21573063	Green Published, Green Submitted, gold			2022-12-25	WOS:000288809100009
